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IL-10 gene polymorphism, but not TGF-"1 gene polymorphisms,
is associated with food allergy in a Japanese population
Eduardo Campos1, Naoki Shimojo1, Yoichi Suzuki2, Takayasu Arima1,
Tomoko Matsuura1, Yuzaburo Inoue1, Akiko Yamaide3, Seiko Tokita1,
Minako Tomiita1, Katsunori Fujii1, and Yoichi Kohno1. 1Chiba University,
Pediatrics, Chiba, Japan; 2Chiba University, Public Health, Chiba, Japan;
3Chiba Children’s Hospital, Pediatrics, Chiba, Japan.
Background: The regulatory IL-10 and TGF-$1 cytokine gene polymor-
phisms have been associated with allergic diseases in different populations,
like Caucasian, Chinese and Indians. However, no associations between IL-10
and TGF-$1 gene polymorphisms and food allergy (FA) in Japanese children
have been evaluated so far. To clarify the relationship of polymorphisms
of these 2 regulatory cytokine genes with FA, not atopy itself, polymorphisms
IL-10 AV1082G, CV819T and TGF-$1 T+869C, G+915C, CV509T in FA
patients were compared with those in non-FA atopic controls.
Methods: One hundred-eleven childhood FA patients, with a mean
7.6T4.0 years of age and 115 atopic control children without FA (mean =
8.2T1.5 years of age) were recruited. Most of FA patients and atopic controls
were sensitized with house dust mite (92% and 93%, respectively). DNA
samples from these subjects were genotyped by using Real Time PCR.
Results: The odds ratio (OR) of IL-10V1082 AA genotype was 2.5 (95%CI,
1.0Y6.4) for food allergy risk when compared with atopic control subjects
(p = 0.03). This study had a power of 80% to achieve significance at the
0.05 level for IL-10V1082A allele when OR is greater than 2.3. Our OR value
was 2.4; therefore, we consider this association had enough statistical power
to support our finding. There were no significative differences in the frequency
of IL-10 CV819T and TGF-$1 gene polymorphisms between both groups.
Conclusion: This result indicates that IL-10 AV1082G gene polymorphism
is associated with food allergy susceptibility in atopic Japanese children. Our
findings should encourage further studies to elucidate the functional
relationship of IL-10 AV1082G gene polymorphism in FA pathogenesis.
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Safety assessment of bacterial choline oxidase protein introduced
in transgenic crops
Abinav Kumar Singh1, Bhanu Pratap Singh1, GBKS Prasad2, Shailendra Nath
Gaur3, and Naveen Arora1. 1Institute of Genomics and Integrative Biology,
Allergy and Immunology Department, Delhi, India; 2Jiwaji University, SOS,
Department of Biotechnology, Gwalior, India; 3V.P. Chest Institute, Depart-
ment of Respiratory medicine, Delhi, India.
Background: Previously, transgenic Brassica juncea expressing bacterial
choline oxidase protein did not show enhanced allergenicity as evaluated by
WHO/FAO guidelines. In the present study, choline oxidase protein derived
from Arthrobacter globiformis was assessed for allergenicity and toxicity.
Methods: In-vitro heat stability of the protein was assessed. Choline oxidase
induced allergenicity was assessed in Balb/c mice. IgE reactivity of choline
oxidase protein was assessed with atopic patients` sera. Acute toxicity of
choline oxidase protein was also assessed in mice model.
Results: Choline oxidase protein was stable at 90-C for 1 hour and reacted
with choline oxidase antibodies on immunoblot. Specific IgE levels were low
in choline oxidase treated mice comparable to control, while OVA sensitized
mice showed high IgE levels. Intravenous challenge with choline oxidase did
not induce any adverse reaction but i.v challenge with OVA led to
anaphylaxis in OVA sensitized mice. Choline oxidase sensitized mice
demonstrated IL-4 release similar to control in splenic culture supernatant
however, OVA sensitized mice showed higher IL-4 levels. Histological
analysis of lung tissues from choline oxidase sensitized mice showed intact
epithelium with normal airways, whereas OVA sensitized mice showed
narrowing of airways with increased eosinophilic infiltration. ELISA with
allergic patients` sera (n=45) revealed low specific IgE binding (mean OD
0.281) with choline oxidase protein. Acute toxicity studies of choline
oxidase protein in mice model showed no significant difference (p90.05)
with control in growth, body weight, food consumption and blood
biochemical indices. Histopathology of gut tissues of mice fed with choline
oxidase showed normal gastric mucosa lining with normal villi in jejunum
and ileum sections.
Conclusion: Bacterial choline oxidase protein is heat stable but failed to elicit
allergic response in mice model. These data indicates choline oxidase protein
may be safe for use in transgenic crops.
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Identification of amino acids critical for IgE-binding to
sequential epitopes of bovine 0-casein and the similarity of these
epitopes to the corresponding human 0-casein sequence
Kirsi M. Jarvinen, Nancy Han, Renata R. Cocco, Paula J. Busse, Hugh A.
Sampson, and Kirsten Beyer. Mount Sinai School of Medicine, Division of
Pediatric Allergy and Immunology, New York, United States.
Background: The delineation of allergenic (i.e. IgE-binding) epitopes in
cow`s milk proteins and the amino acids [AAs] critical for IgE binding is
necessary to better understand the structural properties of an allergen and to
develop more efficacious immunotherapeutic reagents. Furthermore, this
information may enable us to better understand cross-sensitivity between
different allergens.
Methods: Eleven peptides, 10 to 14 AAs in length, representing the IgE-
binding epitopes of 0-casein were synthesized on a derivatized cellulose
membrane with single AA substitutions at each position. Membranes were
incubated with pooled sera from 15 milk-allergic patients and individual sera
from ten of the patients included in the pool.
Results: For 10 of the 11 allergenic peptides, one to five different single
AA substitutions resulted in elimination of IgE-binding of pooled patient
sera. Overall at least one mutated peptide could be found for these 10
IgE-binding sites that resulted in a reduction of IgE binding in at least
80% of the patients who recognized the native protein. Furthermore, the
IgE-binding region at AA104-112 on bovine 0-casein showed a high
degree of similarity with the human 0- casein, respectively, including the
AAs critical for IgE binding.
ABSTRACTS
World Allergy Organization Journal & November 2007 S1
Copyright @ 2007 World Allergy Organization. Unauthorized reproduction of this article is prohibited.
Conclusion: This data suggests that critical AAs should be assessed with both
pooled and individual patient sera to account for the B-cell epitope
heterogeneity between patients with cow`s milk allergy. In addition, we
identified two potentially cross-reactive peptides between bovine and human
caseins of unknown clinical relevance.
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Food allergen absorption kinetics and gastric digestion influence
clinical reactivity in allergic patients
Eva Untersmayr1, Helle Vestergaard2, Hans-Jorgen Malling2, Louise Bjerremann
Jensen3, Michael H. Platzer3, George Boltz-Nitulescu1, Otto Scheiner1,
Per Stahl Skov3, Erika Jensen-Jarolim1, and Lars K. Poulsen2. 1Medical
University Vienna, Department of Pathophysiology, Vienna, Austria; 2National
University Hospital Copenhagen, Laboratory for Medical Allergology,
Copenhagen, Denmark; 3National University Hospital Copenhagen, Labora-
tory for Medical Allergology, Reference Lab, Copenhagen, Denmark.
Background: Severe allergic reactions to minute amounts of ingested food
proteins represent major problems for both, the allergic patients and the food
industry. Even though protein absorption pattern and physiological protein
degradation might substantially influence clinical reactivity in allergic patients
only limited knowledge is available to date. Thus, in the present study we used
fish as a model antigen aiming to analyze protein uptake and the role of gastric
digestion in fish allergy.
Methods and Results: Open challenges of healthy subjects with fish
followed by protein determination in blood samples revealed the absorption
of biologically active fish proteins within 10 minutes after ingestion. Even
though maximal serum levels were measured after 1Y2 h, a partial pregastric
absorption was indicated. Additionally, simulated gastric fluid experiments,
RAST inhibition assay, histamine release and skin testing with fish proteins
determined physiological gastric digestion to reduce the allergic potential of
fish up to 10,000-fold, which was evidenced also by significantly smaller
wheal reactions in skin tests. However, protein digestion was abrogated
when digestion experiments were repeated imitating hypoacidic conditions
in gastric fluids. Fish digested at pH of 2.75 and above revealed comparable
reactivity patterns as undigested extracts. Moreover, these test materials
triggered severe clinical reactions at 10- to 30-fold lower cumulated
challenge doses in fish allergic patients in blinded challenges.
Conclusion: Our data clearly underline the paramount clinical relevance of
gastric digestion in fish allergy. Therefore, insufficient gastric digestion
represents a risk factor for fish allergic patients to develop anaphylactic
reactions at significantly lowered allergen threshold levels.
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Structural, chemical and immunogenic effects of roasting peanut
Soheila Maleki1, Sami Bahna2, and Brian Wilson2. 1US Dept of Agriculture,
Food Allergy Research Unitq, New Orleans, United States; 2Louisiana State
University Health Sciences Center, Allergy & Immunology Section, Shreve-
port, United States.
Background: In previous studies, we have shown that processes such as
roasting, can alter the allergenic properties of peanuts. To understand these
observations at a molecular level, the solubility, digestibility, IgE biding and
structural characteristics of Ara h 1 and Ara h 2 purified from raw and roasted
peanuts were assessed. Also, skin prick test analysis was performed with raw
and roasted peanuts to determine altered immunogenicity.
Methods: The solubility and digestibility of Ara h 1 and Ara h 2 within the
context of peanuts roasted to different degrees were assessed using SDS-PAGE
and allergen specific antibodies. Ara h 1 and Ara h purified from raw, light
roast (LR) and dark roast (DR) peanuts were subjected to circular dichroism
spectroscopy before and after reduction of disulfide bonds, digestion with
trypsin and pepsin followed by SDS-PAGE, and IgE binding with sera from
peanut allergic patients using Western blot analysis. Skin prick test (SPT) were
also performed on 5 peanut allergic patients using raw and light roast peanuts.
Results: We found that while the secondary structure of Ara h 2 from raw, LR
and DR peanut is largely affected with addition of di-thoithreatol (DTT), the
roasting process itself only slightly altered the secondary structure and
solubility, while rendering Ara h 2 much more resistant to digestion. Minor
changes were seen in the secondary structure of Ara h 1 from raw, LR and DR
peanut with the addition of DTT, but the protein became less soluble and more
resistant to digestion (with changes in the size and number of digestion
resistant fragments) with the degree of roasting. The SPT reactivity to roasted
peanut was either equal (2/5) or stronger (3/5) than to raw peanut.
Conclusion: The alterations in IgE binding and resistance to digestion of the
peanut proteins is most likely due to chemical modifications and, minutely, if at
all, to small structural changes. As previously suggested, the Maillard reaction
is most likely the predominant contributor to the decreased solubility and
digestibility of the proteins in roasted peanuts. This implies that patients with
higher skin test reactivity to the roasted peanut have specific IgE to epitopes
that are chemically modified by the roasting process rather than to structurally
altered epitopes in addition to other IgE epitopes that are recognized by the
majority of peanut allergic patients.
INFLAMMATORY MECHANISMS
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Transfer of exosomes between human mast cells
Karin Ekstro¨m, Hadi Valadi, Margareta Sjo¨strand, and Jan Lo¨tvall. Institution
of Medicine, Sahlgrenska Academy, Go¨teborg University, Go¨teborg, Sweden.
Background: Exosomes are 30 to 90 nm membrane vesicles of endocytic
origin released by many different cells including dendritic cells, lymphocytes,
epithelial cells and mast cells. The function of exosomes is not fully known,
but they are believed to take part in communication between cells. The aim of
this study was to examine the transfer of exosomes between human mast cells.
Mast cell derived exosomes have previously been shown to contain a selection
of mRNA and miRNA in addition to proteins.
Methods: Exosomes released from the human mast cell line HMC-1 were
isolated by repeated centrifugations and filtrations steps. Exosomes were
detected using electron microscopy and flow cytometry. For flow cytometric
analysis, exosomes were conjugated to anti-CD63 latex beads and immuno-
stained against the tetraspanins CD9, CD63 and CD81 with PE labelled anti-
bodies. Exosomes were labelled with the green fluorescent stain PKH67, washed
and co-cultured with HMC-1 cells. The cells were harvested after 0, 3 and 5 h,
washed, fixed in formaldehyde and examined by flow cytometric analysis and by
fluorescence microscopy. Results are presented as % positive cells and mean
fluorescence intensity (MFI) from two independent experiments (n=4).
Results: HMC-1 exosomes were identified by electron microscopy and by
flow cytometric analysis. These exosomes were positive for the tetraspanins
CD9, CD63 and CD81 and could be transferred to HMC-1 cells. After 3h
incubation, 54% of the HMC-1 cells were positive for PKH67 (MFI 243) and
after 5h 71% of the cells were positive (MFI 332) compared to the negative
control.
Conclusion: The results demonstrate that human mast cells release exosomes
that can be transferred to other human mast cells. This exosome-mediated
communication between mast cells may be important in allergic diseases.
8
Interferon-$ augments eosinophil adhesion-inducing activity of
endothelial cells
Makoto Nagata, Takehito Kobayashi, Yotaro Takaku, Koichi Hagiwara, and
Minoru Kanazawa. Saitama Medical University, Respiratory Medicine,
Moroyama-machi, Iruma-gun, Saitama, Japan.
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Background: Viral infections induce exacerbations of asthma. One of the
earliest host responses to viral infections is the production of innate cytokines
including type I interferons (IFNs), such as IFN-$, which may act to modify
airway inflammation. The objective of this study was to investigate whether
IFN-$ modifies the eosinophil adhesion-inducing activity of endothelial cells.
Methods: Human umbilical vein endothelial cells (HUVECs) were stimulated
with IFN-$ for 24 h in the presence or absence of TNF-". Eosinophils were
isolated from the peripheral blood of healthy volunteers. The ability of the
IFN-$-stimulated HUVEC monolayers to induce eosinophil adhesion was
assessed according to the eosinophil peroxidase assay.
Results: Eosinophil adhesion to HUVECs was significantly augmented
by IFN-$ not in the absence but in the presence of TNF-". The augmented
adhesion was inhibited by anti-"4 integrin monoclonal antibody (mAb)
or anti-$2 integrin mAb. IFN-$ significantly enhanced the expression of
VCAM-1 and ICAM-1 on HUVECs in the presence of TNF-".
Conclusion: IFN-$ can augment the adhesiveness of endothelial cells to
eosinophils, mainly through the expressions of VCAM-1 and ICAM-1. This
action of IFN-$may contribute to the intensification of airway inflammation in
asthma that is associated with exacerbations induced by viral infections.
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CXC and CC chemokines produced by human
respiratory epithelium
Ilja Striz1, Eliska Krasna1, Libor Kolesar1, Antonij Slavcev1, Marcela
Jaresova1, and Jaromir Musil2. 1Institute for Clinical and Experimental
Medicine, Department of Immunology, Prague, Czech Republic; 2University
Hospital Motol, Pulmonary Department, Prague, Czech Republic.
: Chemokines regulate leukocyte trafficking during their physiological
turnover and recruitment to mucosal surfaces in inflammatory reactions.
Respiratory epithelium with the ability to respond to locally generated
cytokines might be an important source of chemokines attracting diverse cell
populations. With this respect, the aim of our study was to compare the
capacity of different proinflammatory cytokines to stimulate the gene
expression, production and release of multiple CC and CXC chemokines by
respiratory epithelial cell line. The chemokine distribution was studied also in
bronchoalveolar lavage fluid (BAL) and exhaled breath condensates (EBC) of
patients undergoing lung transplantation.
A total of 96 chemokines and chemokine receptor genes has been
studied using an oligoarray system (Superarray Inc.) in cultured human
alveolar type-II like cells A549 stimulated by multiple concentrations of TNF
alpha, IFN gamma, IL-1 beta, IL-18, and IL-33. The chemokine levels in
culture supernatants, BAL, and EBC were measured using multiplex
immunoluminometric assay (Luminex) or by ELISA.
In repetitive experiments, epithelial cells constitutively expressed
mRNA for CXCL1 (Gro-alpha), CXCL2 (Gro-beta), CXCL3 (Gro-gamma),
CXCL5 (ENA-78), CXCL6 (GCP-2), and CXCL8 (IL-8), chemokines
attracting preferentially neutrophils. Cells stimulated with IL-1 beta or TNF
alpha upregulated mRNA expression of chemokines specific for mononuclear
cells recruitment such as CCL2 (MCP-1), CCL4 (MIP 1 beta), CCL5
(RANTES), and CCL20 (MIP 3 alpha). For the induction of of CXCL10 (IP-
10) and CXCL11 (I-TAC) which attract activated T lymphocytes, IFN gamma
was the most potent stimulus. The induction of epithelial cells by IL-1
related cytokines, IL-33 and IL-18, resulted only in a moderate upregulation
of few CC or CXC chemokines compared to a potent effect of IL-1 beta
stimulation. Epithelium derived chemokines such as CXCL5, CXCL8,
CCL2, CCL4 or CCL5 are abundant in BAL fluids but can be only rarely
detected in EBC. We conclude from our data that respiratory epithelial cells
are involved in regulating the influx of different populations of inflamma-
tory cells by release of multiple CC and CXC chemokines in a highly
coordinated manner.
11
The influence of maternal allergy on p38-MAPKinase activity in
CD14+ monocytes from 2- and 5-year old children following
microbial challenge
Shanie Saghafian-Hedengren1, Petra Amoudruz1, Ulrika Holmlund1, Caro-
line Nilsson2, and Eva Sverremark-Ekstro¨m1. 1Wenner-Gren institute, Dep. of
Immunology, Stockholm University, Sweden; 2Sachs Children’s Hospital,
Department of Pediatrics, Stockholm, Sweden.
Background: Monocytes are members of the innate branch of the immune
system and express awide range of different pattern-recognition receptors called
toll-like receptors (TLRs) that recognize conserved pathogen derived motifs.
TLR-mediated signalling, which involves p-38 mitogen activated protein kinase
(MAPK) activation, ultimately bridges innate- to adaptive immune responses.
We showed previously that cord blood mononuclear cells from neonates with
maternal allergy had decreased IL-6 levels upon challenge with the bacterial
component and TLR-ligand peptidoglycan (PGN), suggesting that themonocyte
population in children of allergic mothers has an altered microbial response
already at birth. It is possible that such alteration persists during childhood.
Objective: To examine monocytic microbial responses with regards to p-38
MAPK activation in CD14+ cells and to measure IL-6 release from mono-
nuclear cells in 2- and 5-year old children.
Methods: The 2- and 5-year old subjects (n=61 total) were grouped based on
having or not having allergic mothers. Peripheral blood mononuclear cells
(PBMCs) from the children were stimulated either with medium, LPS or PGN
in vitro. CD14+ monocytes were analyzed for p-38 MAPK activity by FACS
and IL-6 release from PBMC cultureswere quantified by either CBA or ELISA.
Results: PBMCs from 2-year old children with allergic mothers release
significantly less (pG0.05) IL-6 upon PGN stimuli compared to age matched
infants with non-allergic mothers. 2-year old infants with allergic mothers also
display markedly reduced CD14+ monocyte p38-MAPK phosphorylation
after LPS (pG0.05) and PGN (pG0.01) challenge. This altered microbial
response was attributed to maternal allergy rather than to being IgE-
sensitized at 2-years of age. At the age of 5 however, these differences could not
be seen between the groups on the basis of maternal allergy. However, children
with a developed IgE-mediated allergy tended to have higher levels of
phosphorylated p38-MAPK upon challenge with LPS and PGN. They also
showed significantly increased basal levels of IL-6 in the culture supernatants.
Conclusion: Maternal allergy renders the monocytic population less
responsive to microbial challenge to (at least) the age of 2 while this influence
is not noted at the age of 5. However, 5-year old infants with IgE-mediated
allergy tended to have higher inflammatory activity both at basal IL-6 levels as
well as upon challenge with bacterial components.
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Prenatal exposure to household pets influences fetal
immunoglobulin E production
Christine C. Johnson1, Niladri Aichbhaumik2, Ronald Strickler3, Ganesa
Wegienka1, Dennis R. Ownby4, Suzanne L. Havstad1, and Edward Zoratti2.
1Henry Ford Hospital, Biostatistics & Research Epidemiology, Detroit, United
States; 2Henry Ford Hospital, Medicine, Detroit, United States; 3Henry Ford
Hospital, Obstetrics & Gynecology, Detroit, United States; 4Medical College
of Georgia, Pediatrics, Augusta, United States.
Background: Early life pet exposure may protect against allergic sensitization
during childhood. Few studies have evaluated the effect of prenatal pet ex-
posure on potential neonatal markers of allergic risk. We investigated whether
maternal exposure to pets affects cord blood IgE levels in a population-based,
general risk, ethnically mixed birth cohort.
Methods: Pet keeping during pregnancywas ascertained fromwomen residing
in a defined area of Wayne County Michigan U.S.A. and recruited from five
staff model obstetric clinics. Maternal venous blood was analyzed for total and
allergen-specific IgE along with cord blood total IgE from 808 infants.
Results: During pregnancy, 515 households had no indoor pets and 293
had dogs or cats in the home. Of these 293 households, 147 had dogs only, 96
had cats only, and 50 homes kept both dogs and cats in the home during
pregnancy. Compared to infants from households with no cats or dogs kept
indoors during pregnancy, infants whose homes had either cats or dogs had
significantly reduced mean cord IgE levels [0.33 IU/ml (95%CI 0.29Y0.37)
versus 0.23 IU/ml (95%CI 0.19Y0.27) p = 0.03]. This association was most
prominent among children of mothers that did not exhibit IgE sensitization
to common allergens [0.24 IU/ml (95%CI 0.20Y0.30) versus 0.14 IU/ml
(95%CI 0.10Y0.16) p = 0.02] and those who did not smoke during pregnancy
[0.33 IU/ml (95%CI 0.28Y0.37) versus 0.22 IU/ml (95%CI 0.18Y0.27)
p = 0.01]. There was no effect on results when excluding mothers who
reported avoiding pets due to allergy-related concerns.
Conclusion: Mothers with either cats or dogs in their home during pregnancy,
especially those mothers who are non-sensitized or are non-smokers, deliver
children with lower cord blood IgE levels compared to mothers who do not live
with these pets, supporting the hypothesis that pet exposure influences
immune development in a manner that is protective for atopy and is operant
even before birth.
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Gene-environment interactions between CD14 C-260T
and endotoxin exposure on Foxp3+ and
Foxp3- CD4+ lymphocyte numbers and total serum
IgE in early childhood
L. Keoki Williams1, Jennifer Oliver2, Edward L. Peterson2, Kevin R. Bobbit2,
Michael J. McCabe Jr.3, Derek Smolarek2, Suzanne L. Havstad2, Ganesa
Wegienka2, GanesaWegienka2, Esteban G. Burchard4, Dennis R. Ownby5, and
Christine C. Johnson2. 1Henry Ford Hospital, Internal Medicine, Detroit,
Michigan, United States; 2Henry Ford Hospital, Biostatistics and Research
Epidemiology, Detroit, Michigan, United States; 3University of Rochester
School of Medicine, Environmental Medicine, Rochester, New York, United
States; 4University of Californial San Francisco, Internal Medicine, San
Francisco, California, United States; 5Medical College of Georgia, Pediatrics,
Augusta, Georgia, United States.
Background: Innate immune system stimuli, such as endotoxin, appear to
influence allergy risk. Previously we described gene-environment interaction
between an endotoxin receptor polymorphism, CD14 C-260T, and endotoxin
exposure on total serum IgE; however, the mechanism of this interaction
is not known. The objective of this study was to examine whether this
gene-environment interaction influences early CD4+Foxp3- and CD4+
Foxp3+ lymphocyte numbers.
Methods: Participating children were part of a birth cohort in the Detroit,
metropolitan area. Participants were genotyped for the CD14 C-260T poly-
morphism. Endotoxin exposure was estimated from dust measured in the home
when children were age 6 months. Intracellular Foxp3 protein expression, a
regulatory T-cell (Treg-cell) marker, was used to characterize CD4+ lym-
phocytes in blood collected at age 12 months; total serum IgE was also mea-
sured at this time. Since race-ethnicity may confound or modify genetic
associations, we stratified all analyses by race-ethnicity.
Results: We observed a significant gene-environment interaction between
CD14 C-260T genotype and endotoxin exposure on CD4+ lymphocyte num-
bers, particularly CD4+Foxp3- lymphocytes. Stratified analyses suggested
effect modification by race-ethnicity on CD4+Foxp3+ lymphocyte numbers
with a significant interaction in African-American children but not in white
children. The interaction between CD14 C-260T genotype and endotoxin
exposure on total IgE levels was opposite that observed for CD4+ lymphocyte
numbers, suggesting reciprocal relationships.
Conclusion: A gene-environment interaction between endotoxin and CD14
C-260T genotype on IgE levels may be the result of an upstream, opposing
effect on CD4+Foxp3+ and CD4+Foxp3- lymphocyte numbers. Race-
ethnicity may influence which of these cell populations is affected by this
gene-environment interaction.
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Exposure to animals, allergies and parental education
Christian Apfelbacher1, Markus Ollert2, Johannes Ring2, Heidrun Behrendt3,
andUrsula Kraemer4. 1Brighton and SussexMedical School, Division of Public
Health and Primary Care, Brighton, United Kingdom; 2Technical University,
Department of Dermatology and Allergy Biederstein, Munich, Germany;
3GSF/Technical University, Division of Environmental Dermatology&Allergy,
Munich, Germany; 4Heinrich-Heine-Universitaet, Institut fuer umweltmedizi-
nische Forschung, Duesseldorf, Germany.
Background: Studies have yielded different results regarding the associations
between animal exposure and atopy. Whether or not these associations are
homogeneous across social strata has not yet been investigated. To estimate the
association between current animal exposure (cat and dog) and allergic sensi-
tization and manifestations of atopic diseases in 5 to 7 year old school be-
ginners, stratified by parental educational level.
Methods: 30794 six year old children participated in cross-sectional studies
between 1991 and 2000 in Germany. Allergic sensitizations to common
areoallergens as measured by skin prick and Radio Allergo Sorbent Test and
symptoms and diagnoses of atopic diseases (asthma, atopic dermatitis, hay
fever) were the dependent variables. Exposure to dog and cat were the
independent variables. Logistic regression was used to adjust for confounding.
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Analyses were stratified for parental educational level (stratum I, II, III
corresponding to G10 years, 10 years and 910 years of schooling).
Results: Prevalences of hay fever, eczema, specific sensitization to pollen and
house dust mite and contact to cat or dog were significantly different between
educational strata. Globally significant associations between cat contact
and sensitization to cat (RAST OR 1.92, 95% CI 1.18Y3.11) and hay fever
(OR 0.61, 95%CI 0.45Y0.82) remained significant after stratification only in the
highest educational stratum (OR 3.68, 95% CI 1.90Y7.12 and OR 0.55, 95% CI
0.36Y0.85). Globally significant associations of contact to dog with sensitization
to pollen (OR 0.71, 95% CI 0.56Y0.89), wheezing (OR 1.31, 95% CI
1.11Y1.55), nose problems (OR 0.72, 95%CI 0.56Y0.93) and eczema (OR 0.84,
95% CI 0.77Y0.92) remained significant in educational stratum II. Globally
significant associations of dog contact with sneezing attacks (OR=0.84, 95% CI
0.71Y1.00) and eczema (OR=0.82, 95% CI 0.75Y0.91) remained significant in
educational stratum III, and in stratum I and II respectively.
Conclusion: In 5 to 7 year old German children, differences across social
strata concerning allergic sensitizations, hay fever and eczema may possibly be
explained by animal exposure differences. Associations between animal
contact and allergic sensitization and manifestations of atopic diseases are not
homogeneous across social strata.
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Maternal childhood exposures, previous pregnancies and breast
milk characteristics: an influence on offspring`s disease risk?
Petra Amoudruz1, Ulrika Holmlund1, Jens Schollin2, Eva Sverremark-
Ekstro¨m1, and Scott M Montgomery2. 1Wenner-Gren Institute, Stockholm
University, Department of Immunology, Stockholm, Sweden; 2Clinical
Research Centre O¨rebro University Hospital, Department of Paediatrics,
O¨rebro, Sweden.
Background: Populations in high infectious exposure countries are at low risk
of some immune-mediated diseases such as Crohn`s disease and allergy. This
low risk is maintained on immigration to an industrialized country, but the
offspring of such immigrants have a higher immune-mediated disease risk than
the indigenous population. We hypothesize that early life exposures in a devel-
oping country shape the maternal immune system, and that this stimulates
development of her offspring in a manner inappropriate for the low infectious
load of a developed county. Other maternal exposures may also influence
disease risk in offspring.
Objective: To investigate if exposures in childhood (indicated by country of
origin) and subsequent exposures influence immunological characteristics
relevant to stimulation of offspring.
Methods: ELISA and Cytometric Bead Array examination of breast milk
components among 64 mothers resident in Sweden, 32 of whom immigrated
from a developing country.
Results: Immigrants from a developing country had statistically significantly
higher levels of breast milk IL-6, IL-8 and TGF-"1. A larger number of
previous pregnancies was associated with down-regulation of several
substances, statistically significant for soluble CD14 and IL-8.
Conclusion: Childhood exposures influence adult immune characteristics
potentially relevant to disease risk in offspring. Such a mechanismmay explain
the higher immune-mediated disease risk among children of migrants from a
developing to developed country. Older siblings may influence disease risk
through the action of previous pregnancies onmaternal immune characteristics.
Clinical Implication: Maternal immune characteristics resulting from child-
hood exposures and previous pregnancies may be relevant to disease risk in
offspring.
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Prevalence of self-reported allergic rhinitis in China
Luo Zhang1, Demin Han1, Zhen Dong2, Geng Xu3, Weijia Kong4, and Claus
Bachert5. 1Beijing Institute of Otolaryngology, Otolaryngology Head and
Neck Surgery, Beijing, China; 2Department of Otorhinolaryngology Head
and Neck Surgery, China-Japan Union Hospital, Jilin University, Chang-
chun, China; 3Hospital of Otolaryngology, First Affiliated Hospital of Sun
Yat-Sen Universit, Guangzhou, China; 4Department of Otolaryngology,
Union Hospital, Tongji medical College, Huazhong U, Wuhan, China; 5Ghent
University, Department of Otolaryngology, Ghent, Belgium.
Background: Allergic rhinitis (AR) is a common disease with an increasing
prevalence. However, little is known about the current national prevalence of AR
in China, especially the Mainland China. The aim of this study is to investigate
the prevalence of self-reported allergic rhinitis; its association with factors of
populations, location, socioeconomic status, meteorology and air pollution; the
proportion of persistent and intermittent allergic rhinitis, aswell as the percentage
of undiagnosed subjects from 11 main cities of the mainland of China.
Methods: Telephone interviews were conducted in 11 main cities of the main-
land of China after sampling target phone numbers by the approach of random
digital dialing (RDD) via computers. And the questionnaires in Chinese for the
telephone interviews were mostly based on the well-validated ones.
Results: A total of 38,203 telephone interviews were conducted from
September 2004 to May 2005. The response rate is 63.7%. The self-reported
prevalence of allergic rhinitis was the lowest in XiAn (8.0%), and the highest is
in Urumqi (21.4%). The gender-adjusted prevalence ranged from 8.5% inXiAn
to 21.3% in Urumqi; while the age-adjusted prevalence of self-reported allergic
rhinitis ranged from 8.7% in Beijing to 24.1% in Urumqi. The adjusted self-
reported prevalence of allergic rhinitis was positively correlated with the
concentration of SO2.Within the subjects self-reporting allergic rhinitis, about
one-fourth (25.6%) were diagnosed as persistent allergic rhinitis, and the other
three-fourth (74.4%) were intermittent allergic rhinitis. In addition, the
proportion of persistent allergic rhinitis was higher in northern cities than
that in southern cities. Less than half of the subjects with self-reported allergic
rhinitis had a history of visiting a health clinic. Among them, only 37.3% were
previously diagnosed as allergic rhinitis by physicians and 33.1% subjects
received surgical and/or medical treatment.
Conclusion: The study demonstrates that the self-reported prevalence of al-
lergic rhinitis in 11 cities throughout themainland of China haswide variations.
Frequently subjects with self-reported allergic rhinitis could not benefit from
proper diagnosis or treatment. Subjects with self-reported allergic rhinitis were
mostly diagnosed as intermittent allergic rhinitis, and the proportion of per-
sistent allergic rhinitis was higher in northern cities than that in southern cities.
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Detection of specific IgE by proteomic microarray system based
on allergenic molecules: a powerful tool for worldwide
epidemiology of allergic sensitization
Enrico Scala, Donato Quaratino, Alessandra Zaffiro, Maria Livia Bernardi,
Rosetta Ferrara, Danila Zennaro, Paola Palazzo, Stefano Ridolfi, Debora
Pomponi, Mauro Giani, and Adriano Mari. IDI-IRCCS, Center for Clinical
and Experimental Allergology, Rome, Italy.
Background: The availability of highly purified natural and recombinant
allergenic molecules and nanotechnology tools applied to IgE detection allows
the collection of huge amount of data in a single test for every single subject.
The purpose of this study was to analyse the prevalence of allergenic molecule
IgE reactivity within an Italian allergic population and to see whether
sensitization to rare allergen are detected as well as most common ones.
Methods: Sera from consecutive patients claiming for allergic symptoms
caused by exposure on contact, inhalation, or ingestion were studied. Demo-
graphic and clinical information were recorded for each of them. A protein
microarray having 90 spotted natural or recombinant allergenic molecules
(ISAC CRD 90, VBC-Genomics, Austria) has been used for IgE detection
under routine testing conditions. Results were collected, stored and analyzed by
customized databases and procedures.
Results: 12,058 consecutive individuals (39.2/60.8% male/female, mean age
32.2T19.1 years, range 1Y93) having history of urticaria, rhinitis, asthma, or
exzema were recruited from March 2006 to June 2007. Patients with at least
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one positive molecule (76% subjects, 42.5/57.5% m/f, and mean age
31T30.3 yrs) represented our study group. The allergens most frequently
recognized were from the cypress pollen, Cup a 1 (37.3%), timothy grass
pollen, Phl p 1 (36%), and house dust mite, Der f 2 (35%) or Der p 2 (29%).
Allergen specific IgE to other molecules were detected less frequently (Bos d
7 26%; Der f 1 23.2%; Par j 2 22.8%; Phl p 2 22.5%; Der p 1 22%; Phl p 5 22%,
Par j 1 20%; Ole e 1 20%; Fel d 1 19.3%; Phl p 6 15.4%). Allergens as Bla g 2
and Bla g 5 were rarely positive defining a low exposure by the studied cohort.
Conclusion: Allergenic molecules IgE reactivity detected by microarray
system represents a powerful, low-invasive and innovative tool for the
molecule-based epidemiology and diagnosis of allergic sensitization. This
application allows generating a wealth of information otherwise not available
with current singleplex diagnostic tests.
AUTOIMMUNITY
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Immunohistochemical staining for differential diagnosis of
cutaneous graft versus host disease and drug reactions
Carolin Weiss1, Walter Burgdorf1, Michael Flaig1, Johanna Tischer2, Julia
Tietze1, Hans-Jochem Kolb2, and Andreas Wollenberg1. 1Ludwig-Maximilian
University, Dept. of Dermatology and Allergy, Munich, Germany; 2Ludwig-
Maximilian University, Dept. of Internal Medicine, Munich, Germany.
Purpose of the Study: Cutanous Graft-versus-Host-Disease (GvHD) may
show maculopapular rash, bullous dematitis and epidermal necrolysis.
Differential diagnosis of GvHD from drug reactions is difficult both clinically
and histologically. The immunobiology of GvHD suggests a key role of
Dendritic cells (DC) in GvHD pathogenesis. The presence of three different
dendritic cell subsets, i.e. plasmacytoid dendritic cells (PDC), inflammatory
dendritic epidermal cells (IDEC) and Langerhans cells (LC) and other cell
types was analyzed by immunohistochemical staining to improve our
understanding of GvHD immunobiology and to evaluate immunohistochem-
istry as a tool for differential diagnosis of GvHD and drug reactions.
Methods: Skin biopsies of patients with clinically diagnosed GvHD (n=27)
and drug reactions (n=14) were processed for immunohistochemistry in
APAAP technique. Skin sections were stained and semi-quantitatively
analyzed for CD1a, CD1b,CD2, CD4, CD8, CD11c, CD20, CD25, CD68,
CD206, CD207, CD208 and CD209, BDCA-2 and CCR-7.
Results and Discussion: A relevant dermal infiltration (920 cells per mm2) of
BDCA-2+ PDC was specific for GvHD. The presence of the PDC correlated
significantly with the presence of DC expressing CD1b, CD11c and CCR-7.
Hence, the presence of many PDC supports the clinical diagnosis of GvHD.
CD1a and CD207 expressing dermal dendritic cells were present in GvHD and
drug reactions, whereas high amounts of CD207 expressing epidermal LC
were more frequently observed in GvHD. T cells expressing CD2, CD4 or
CD8 were equally observed in both patient groups.
Conclusion: The observed differences between a PDC dominated dermal
infiltrate in GvHD and a myeloid DC dominated dermal infiltrate in drug
reactions should be confirmed by an independent study, as these differences may
become clinically useful for differential diagnosis of GvHD from drug reactions.
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Unusual biphasic presentation of intestinal lymphangiectasia: a
case report
Alejandro Dı´az1, Sandra N. Gonza´lez-Dı´az1, Gabriela Galindo1, and David A.
Khan2. 1University Hospital of Monterrey, Allergy and Clinical Immunology,
Monterrey, Mexico; 2Southwestern Medical Center, Internal Medicine-
Allergy and Immunology, Dallas, United States.
Introduction: Chronic diarrhea in adults is a frequent cause of consultation, in
the United States, with prevalence between 3Y5%. Among the rarest causes of
diarrhea are, protein-losing gastroenteropathies. Intestinal lymphangiectasia
(InL). Is a rare entity which can be congenital or acquired it is characterized
by abnormal, dilated lymphatics throughout the intestinal tract. The disorder
leads to leakage of lymph causing hypoproteinemia, lymphopenia and
hypogamaglobulinemia, which can leads to depression of both the humoral
and cellular immune systems.
Case Report: A 35 year old woman from rural Mexico with a history of
asthma for 20 years, presented with a chief complaint of diarrhea for
15 months with up to 10 evacuations a day, she referred colic pain with
abdominal distension and flatulence with recurrent symmetrical systemic
edema. The patient showed fatigue, weaknesses and muscle spasms as well as
myalgias and fasciculations, she lost 22 lbs and developed onychomycosis in all
of her toenails. She recalls showing the same clinical signs and symptoms once
during childhood. Her medical team did not have a clear diagnosis. Laboratory
revealed a lymphopenia, hypoalbuminemia, hypogammaglobulinemia, hypo-
calcemia and negative HIV by ELISA. The stool U¨1-antitrypsin level was
elevated. The CT of chest and abdomen was normal. An esophagogastroduo-
denoscopy and colonoscopy were performed showing gastritis, a duodenal
biopsy demonstrates dilated lymphatics and white villi spots.
Discussion: The lack of elevated levels of protein in the urine along with the
depressed serum levels of IgG drew attention to the gastrointestinal tract as the
likely portal of protein loss. Detecting an elevated level of "1-antitrypsin in a
24-hour stool collection adds support to the diagnosis of InL. A duodenal
biopsy with the characteristic histological findings, demonstrating dilated
lymphatics and white spots, confirmed the diagnosis. Treatment of primary InL
is symptomatic and only marginally effective. We treat our patient with strict
dietary lipid restrictions, pancreatic enzymes, probiotics, diuretics, Medium-
chain triglycerides and multivitamins. The patient showed a marked response
regained her normal weight, but the diarrhea and edema sporadically presents.
To date is the seventh reported case of primary InL in Mexico and to our
knowledge the only described in literature of biphasic presentation.
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Atrial natriuretic peptide receptor (NPRA) signaling in human
dendritic cells controls treg development
Weidong Zhang1, Xueqin Cao1, Gary Hellermann1, Xiaoyuan Kong1,
Dongqing Chen1, Jia-Wang Wang1, Richard F. Lockey2, and Shyam S.
Mohapatra1. 1University of South Florida, Internal Medicine, Tampa, United
States; 2James A. Haley VA Hospital, Internal Medicine, Tampa, United States.
: The natriuretic peptides (NP) are key endogenous factors that control
inflammation and immune tolerance, the latter is essential to maintain immune
homeostasis, control autoreactive T cells, prevent the onset of autoimmune
diseases and achieve tolerance of transplants. The mechanism of regulation of
ANP-NPRA signaling in DCs is crucial for the understanding of how ANP
regulates innate immunity and how failure of this signaling might contribute to
autoimmune disease, chronic inflammation and tissue damage. Herein, the role
of the c-terminal NP, ANP and one tolerance inducing NP, NP73-102, in
modulating DC function was examined. The results demonstrate that in
contrast to ANP, NP73-102 primes DCs to induce regulatory T (Treg) cells. The
ANP receptor, NPRA, binds to TLR-2, SOCS3 and STAT3 and affects
induction of IL-6, IL-10 and TGF-!, not IL-17. SOCS3 expression is controlled
in a MyD88-dependent manner. Also, down-regulation of SOCS3 and TLR2,
but not STAT3, affects NPRA expression. These results demonstrate that
TLR2, and SOCS3 are key players in integrating ANP-NPRA signaling with
innate immunity and provide insight into how inhibition of IRNP affects ANP-
NPRA signaling promoting the tolerogenic phenotype of DCs.
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Immune response to Rotavirus in the pathogenesis of celiac
disease: molecular effects of anti-VP7 viral protein antibodies on
intestinal epithelial cells using a gene array approach
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G. Zanoni1, M. Dolcino2, A. Peretti1, O. Gabrielli1, G. Tridente1, A. Puccetti2,
Giorgio Walter Canonica3, and C. Lunardi4. 1University Hospital, Department
of Pathology, Immunology Unit, Verona, Italy; 2University of Genoa and
Immunology Unit, Institute G. Gaslini, Histology, Dept of Experimental
Medicine, Genoa, Italy; 3Genoa University, Dept of Internal Medicine - DIMI,
Genoa, Italy; 4University of Verona, Internal Medicine, Dept of Clinical and
Experimental Medicine, Verona, Italy.
Background: Celiac disease (CD) is sustained by an inappropriate response
against gluten in genetically susceptible individuals. In addiction to genetic
and dietary factors, also rotavirus infections have been implicated in CD
pathogenesis. Specific recognition of a peptide sharing omology with the VP-7
rotavirus protein by sera of CD patients with active disease has been recently
demonstrated. This study evaluated the functional modifications induced by
anti-viral peptide antibodies in intestinal epithelial cells.
Methods: Specific antibodies directed against the viral-derived VP7 peptide
were affinity-purified from the sera of patients with active CD. The effect of
these antibodies cross-reacting with self antigens on T84 intestinal cells were
analyzed with the gene array technique. Genes up- and down-regulated were
identified by a 2-fold or more change in expression. The analysis was validated
by quantitative PCR. The different gene expression patterns were analyzed by
using the Array Assist i software (Stratagene, La Jolla, California, United
States) and a functional clusterization was performed.
Results: Exposure of T84 cells to anti-VP7 antibodies resulted in the
upregulation of 697 transcripts with a 2-fold or more increase in expression.
Several gene clusters were upregulated including genes encoding for chemo-
kines and molecules involved in inflammation and immune response pro-
cesses, as well as in apoptosis and cell proliferation regulation.
Conclusion: The exposure of intestinal epithelial cells to anti-VP7 rotavirus
antibodies modulates clusters of genes similar to those modulated during CD.
These results confirm the important role played by rotavirus infection in the
pathogenesis of celiac disease.
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A retrospective study of autoimmune bullous diseases
Irma Suryani Idris, Muh Dali Amiruddin, Andi Sastri Zainuddin, and
Khairuddin Djawad. Medical Faculty Hasanuddin University / Dr. Wahidin
Sudirohusodo General Hospital, Dermato-Venereology, Makassar, Indonesia.
Background: Autoimmune Bullous Diseases cause impaired adhesion of
epidermis to epidermal basement membrane or impaired adhesion of epidermal
cells to each other with characterized by substantial morbidity (pruritus, pain,
disfigurement) and in some instance, mortality (secondary to loss of epidermal
barrier function).
Objective: The aim of this study is to evaluate the frequency distribution of
Autoimmune Bullous Diseases (Pemphigus Vulgaris, Pemphigus Foliaceus,
Bullous Pemphigoid, Cicatrical Pemphigoid, Dermatitis Herpetiformis,
Epidermolysis Bullosa, Linear IgA Bullous Dermatosis).
Methods: A retrospective study was conducted on the medical record of
Autoimmune Bullous Diseases patients that visited to Dr. Wahidin
Sudirohusodo General Hospital Makassar, Indonesia for a year (January
2006 to December 2006).
Results: In this retrospective study, there were 6 patients of Pemphigus
Vulgaris 4 males and 2 females with ages between 19Y35 years old. Three
patients of Bullous Pemphigoid 1male and 2 females, with ages between 23Y64
years old. One male patient of Dermatitis Herpetiformis with age 42 years
old. There was not patient of Pemphigus Foliaceus, Cicatrical Pemphigoid,
Linear IgA Bullous Dermatosis, Epidermolysis Bullosa. All patients
recovered from disease.
Conclusion: There has been reported only 10 patients of Autoimmune bullous
diseases for a year (January 2006 to December 2006) in Dr. Wahidin
Sudirohusodo General Hospital Makassar, Indonesia. This is a rare case. All
the patients were treated by systemic corticosteroid and another therapies that
suitable for standard therapies and give good result.
Keywords: Autoimmune Bullous Diseases, retrospective study.
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Autoimmunity in families of IgAD individuals
Gu8mundur H. Jo¨rgensen1, and Bjo¨rn R. Ludviksson2. 1University of
Iceland, Department of Family Medicine, Reykjavı´k, Iceland; 2Landspitali-
University Hospital, Department of Immunlogy, Reykjavı´k, Iceland.
Background: The prevalence of autoimmune diseases is thought to be
increased among IgA deficient individuals (IgAD). The prevalence of
autoimmune diseases among IgAD Icelandic individuals and their first degree
relatives was investigated. This is a part of a larger ongoing study aimed to
evaluate the prevalence, geneaology, complications and the genetic compo-
nents of IgA deficiency (IgAD) in Iceland.
Materials and Methods: A total of 43 IgAD individuals have been found
through the screening of blood donors (5), re-evaluating IgAD individuals
from a previous IgAD study from 1977 (10) and by evaluating individuals that
were found to have low IgA from 1990 until present at the Institute of
Laboratory medicine, Landspitali- University hospital of Iceland (28) Clinical
evaluation was done by standard questionnaires that focused on symptoms
and signs suggestive of infections, allergies, autoimmunity and cancer.
Results: Among the 43 IgAD individuals, 21% were found to have definite
autoimmunity (9/43). Of those, four had two or more autoimmune diseases.
This is much higher than has been reported for the general population.
Amongst organ specific autoimmunity, thyroid dieases were the most common
found (4/9). Whereas, Rheumatoid arthritis was the most common systemic
autoimmunity found (2/9). In first degree relatives with IgAD 20/43 or 46.5%
had history of autoimmune diseases, RA, DM type1 and autoimmune thyroid
diseases being the most common.
Conclusion: Autoimmune diseases are common in patents with selective
IgA deficiency. Since the prevalence of various autoimmunity are found to be
high amongst IgAD first degree relatives, this suggest that a strong common
genetic component could be associated with both conditions. Thus,
demonstrating that autoimmunity is an important complications associated
with IgA deficiency.
MECHANISMS OF ASTHMA I
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A critical role for atrial natriuretic peptide receptor signaling in
allergic disease
Shyam S. Mohapatra1, Xiaoyuan Kong1, Xiaoqin Wang1, Weidong Xu1,
Jia-Wang Wang1, Gary Hellermann1, Raji Singham1, Shawna Shirley1,
Prasanna Jena1, Weidong Zhang1, Subhra Mohapatra2, Richard F. Lockey1,
and William Gower3. 1University of South Florida, Internal Medicine, Tampa,
United States; 2H. LeeMoffitt Cancer Center, Oncology, Tampa, United States;
3James A Haley VA Hospital, Internal Medicine, Tampa, United States.
: Atrial natriuretic peptide (ANP), which has been extensively studied
for cardiovascular effects, has received little attention for its role in immunity
and in inflammation. In humans, ANP modifies airway hyperreactivity,
however, the precise role of ANP in the lungs and on local inflammationand
immunity remains to be established. Herein, we show that mice deficient in
the atrial natriuretic peptide (ANP) receptor, NPRA, are resistant to
developing allergen induced pulmonary inflammation, T helper type (Th2)
response and eosinophilia. Chitosan nanocomplexes of a novel peptide,
NP73-102 or a plasmid encoding the peptide, that inhibits NPRA expression,
or a short interference RNA (siRNA) for the NPRA induces bronchopro-
tective and anti-inflammatory activity including decreased eosinophilia and
Th2 cytokines in the lung and reverses asthma in mice. In addition, mice
deficient in NPRA and mice with decreased expression of NPRA exhibit an
increase in FoxP3+T regulatory cells. Together, these results show that NPRA
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signalling may provide a novel target for developing new treatment for
asthma.
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Up-regulation of epithelial and fibroblast prostaglandin D2
CRTH2-receptors in asthma
Lena Uller1, Anna Ribbene2, David Sammut2, Peter Howarth2, Stephen
Holgate2, and Donna Davies2. 1Southampton General Hospital, Allergy and
Inflammation Research, Southampton, United Kingdom; 2Southampton
General Hospital, Allergy and Inflammation Research, Southampton, United
Kingdom.
Background: Mast cell-derived prostaglandin D2 (PGD2), now known to act
through DP1 and CRTH2 receptors is regarded a central mediator in many
allergic diseases including asthma. Blockade of CRTH2 receptors has been
shown to inhibit airway eosinophilia and mucus production in allergic mice
(Uller et al Respiratory Research 2007:8:16). However, it is not known if
airway structural cells express these receptors or produce PGD2. Thus, this
study explores whether epithelial cells and fibroblasts obtained from asthmatic
and healthy airways express CRTH2 and DP1 receptors in response to factors
involved in causing asthma exacerbation.
Methods: Using well-validated cell culture techniques, primary bronchial
epithelial cells (PBECs) and primary lung fibroblasts from normal or asthmatic
subjects were grown from bronchial brushings and biopsies, respectively.
PBECs were seeded in 12 well plates and stimulated with the bacterial product
LPS (0.1Y10 ?g) or virus analogue PolyIC (0.01Y10 ?g). Primary lung
fibroblasts were stimulated with the mediators IL-13, TGF-beta and infected
with the minor rhinovirus RV1?. Cells were harvested at different time points
after stimulation using Trizol extraction for RNA. Then mRNA levels for
PGD2 synthase and its receptors were quantified by RT-qPCR.
Results: PBECs stimulated with Poly:IC or LPS resulted in a dose-dependent
up-regulation of toll-receptor TLR3 and TLR4 and proinflammatory cytokines
IL-8, IFN-beta, and IFN-lambda. PBECs stimulated with Poly:IC exhibited no
up-regulation of CRTH2 whereas LPS stimulation dose-dependently up-
regulated the CRTH2 receptor. Neither LPS nor Poly:IC stimulation up-
regulated DP1-receptors in PBECs. In bronchial fibroblasts the allergic
remodelling cytokines (IL-13 and TGF-beta), up-regulated the expression of
CRTH2 and, additionally, induced PGD2 synthase production.
Conclusion: We demonstrate that airway structural cells in asthma such as
epithelial cells and fibroblasts harbour CRTH2-receptors which are further up-
regulated at exposure to bacterial products and allergic cytokines, respectively.
Hence, studies on roles of PGD2 and, particularly, CRTH2 receptors in remod-
elling of asthmatic airways and at exacerbations of the disease are warranted.
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Association of acidic mammalian chitinase (AMCase) with
atopic asthma and serum total IgE
Rajshekhar Chatterjee, Jyotsna Batra, and Balaram Ghosh. Institute of
Genomics and Integrative Biology, Molecular immunogenetics, Delhi, India.
Background: AMCase, an enzyme known to degrade chitin, has been shown
to be highly expressed in asthmatic lungs. It has also been shown to contribute
towards asthma pathogenesis by affecting the IL-13 downstream pathway.
Hence, AMCase is a potential candidate for asthma genetic studies.
Methods: To investigate the association of the AMCase polymorphisms and
haplotypes with atopic asthma and total serum IgE levels in Indian
population; Polymorphisms were identified by sequencing 60 unrelated
subjects. On the basis of LD and heterozygosity index, a total of six SNPs
were short-listed and further genotyped for 270 asthmatic subjects and 292
non-asthmatic unrelated controls and were analyzed for genotype and
haplotype association. The results were confirmed using an independent
paediatric cohort (Patients=150; Controls=101). Electrophoretic mobility shift
assay (EMSA) was performed to check the functional significance of the
CY1261T promoter SNP.
Results: The GY1279A promoter polymorphism and the G29968A SNP
showed significant association with atopic asthma (pG0.05). Moreover, the
GY1279A and CY1261T promoter polymorphism was found to be associated
with serum total IgE in the patients (pG0.05). At the haplotype level, ATGG
was found to be a major risk (pG0.05), while GTGA was found to be a
protective haplotype (pG0.05). Using electrophoretic mobility shift assay, we
demonstrated that the C to T substitution at Y1261 position abolished
transcription factor Oct-1 binding site.
Conclusion: The results suggest that genetic variation in the AMCase gene
promoter influences susceptibility to asthma and serum total IgE.
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Direct activation of natural killer T cells induces airway
hyperreactivity in a non-human primate model of asthma
Ponpan Matangkasombut1, Muriel Pichavant2, Takahiro Yasumi2, Carrie
Hendricks3, Rosemarie H. DeKruyff1, and Dale T. Umetsu2. 1Children’s
Hospital Boston, Harvard Medical School, Harvard School of Public Health,
Immunology, Boston, United States; 2Children’s Hospital Boston, Harvard
Medical School, Immunology, Boston, United States; 3Charles River
Laboratories, Preclinical Services, Worcester, United States.
Background: In mouse models of asthma, we and others demonstrated that
the presence of natural killer T (NKT) cells is required for the development of
airway hyperreactivity (AHR), a cardinal feature of asthma. Thus, AHR failed
to occur in the absence of NKT cells. Furthermore, direct activation of NKT
cells with glycolipid antigens alone was sufficient to induce AHR, in the
complete absence of conventional CD4+T cells and adaptive immunity. These
findings indicated that NKT cells are both necessary and sufficient for the
induction of AHR in mice. Moreover, NKT cells are increased in number in
the lungs of patients with asthma compared to that of healthy control subjects
or patients with sarcoidosis, strongly suggesting that NKT cells play an
important role in human asthma.
Purpose: To examine the functional role of pulmonary NKT cells in primates,
we used a Cynomolgus monkey model of asthma, and determined whether the
direct activation of pulmonary NKT cells results in the development of AHR.
Methods: Using a cross-over study design in which each monkey served as its
own control, and which minimized the number of monkeys used, we
intratracheally challenged four monkeys with vehicle control or a low dose of
a´-Galactosyl Ceramide (a´-GalCer), a glycolipid that specifically activates NKT
cells. The monkeys were anesthetized, intubated and intratracheally
challenged either with vehicle (two monkeys) or a´-GalCer (two monkeys).
Twenty-four hours later, AHR was evaluated by measuring airway
resistance and dynamic compliance in response to increasing doses of
methacholine. Six weeks later, the monkeys were again intubated and
challenged with the alternative treatment (a´-GalCer or vehicle), followed by
assessment of AHR.
Results: All four monkeys tolerated challenge with a´-GalCer. Furthermore,
after airway challengewith a´-GalCer, all four monkeys demonstrated increased
AHR, significantly greater than that induced with the vehicle control.
Conclusion: Direct activation of pulmonary NKT cells with a´-GalCer induced
AHR in a non-human primate model. Therefore, NKT cells play an important
functional role in the development of AHR in both mice and in primates.
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Dolichyl phosphate dependent mechanism of steroid resistant
asthma development
Ivans Kuznecovs, Inese Joksta, Sergejs Kuznecovs, and Klara Jegina.
Preventive medicine research laboratory, Allergy Unit, Riga, Latvia.
Background: In most cases of steroid resistant asthma (SRA) there is a
functional hyporesponsiveness of glucocorticoid receptors (GR) on T cells and
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disbalance in activity of IL-2, IL-4, IL-10. Dolichyl phosphate (DolP) plays an
essential role in cytokine synthesis and in constancy of glycoproteins of the
GR and activity of P-glycoprotein. The present study was carried out to
estimate the possible role of DolP in mechanism of steroid resistant
development.
Methods: The samples obtained from 128 patients with asthma: 60 patients
with steroid sensitive asthma (SSA) and 68 patients with SRA and from 44
donors. 1) Dolichyl phosphate was defined in T-cells. 2) Alpha-and beta-GR
isoforms expression were measured in patients with SRA and SSA. 3) T-cells
taken from SRA were cultured in vitro with DolP 4) P-glycoprotein MDR1
expression was assessed by immunohistochemical technique 5) Dolichyl
phosphate N-acetylglucosamine-1-phosphate transferase (GPT) due to
DPAGT1 polymorphism was assessed in T-cells.
Results: 1) Blood Dol in patients with SRA was increased up to six times
making up 689.2 + 47.9ng/mL and urinary Dol concentration was increased
up to 590.9%, making up to 48.8 + 9.7 mg/mmol in comparison with
SSA patients. 2) The synthesis of DolP was 8.8-10.5-fold decreased in
T-lymphocytes in patients with SRA. 3) SRA T-cells membrans contain
5,6Y6,4% of P-glycoprotein-170 (the total protein amount) as a resistance
marker. SRAT-cells differ from sensitive ones in Pgp content by 10-12 times. 4)
DolP in the concentration 10Y6 M aid 7Y9-fold reducing P-glycoprotein-170
content in membranes of SRA T-cells to 0,4Y0,6%. 5) T-cells from SRA
patients cultivated with corticosteroids and DolP ( Polyprenols) restore the
possibility to induce IL-10 synthesis in vitro. 6) The DolP concentration in
SRA T-cells was returned to the normal level. Adding polyprenol to culture
of T-cells from SRA patients enhanced the expression of alpha GP isoforms
and made these cells more responsive to steroids.
Conclusion: The results show the evidence that DolP is rate limiting mech-
anism of steroid resistance in asthma, associatedThe situation can be changed
by resistant T-cells treatment with DolP substitute polyprenol. with
hyperactivity of P-glycoprotein and a marked defect of GR glycosylation in
T-cells. It is, also, a hypothesis, which has suggested that there is a genetic
polymorphism of DPAGT1 that blunts the response to steroids.
RISK FACTORS FOR ALLERGY
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Total IgE levels and in vitro sensitization to Ascaris spp.,
dermatophagoides pteronyssinus, Blomia tropicalis and Blatella
germanica in the tropical Island of Martinique
Enrique Ferna´ndez-Caldas. Dr. Beckmann Pharma GmbH, Research &
Development, Seefeld, Germany.
Background: We have previously demonstrated that the presence detectable
specific IgE to Ascaris spp., increases the prevalence of positive skin tests to
common aeroallergens, especially mites and cockroaches, and to food aller-
gens, such as shrimp in Martinique.
Objective: The objective of this study was to analyse the correlation between
sensitization to Ascaris spp., total IgE levels, and in vitro sensitization to
Dermatophagoides pteronyssinus, Blomia tropicalis and Blatella germanica
in a population of patients residing in the tropical Island of Martinique.
Materials and Methods: 607 consecutive patients (321 females and 286
males) were evaluated at a local allergy clinic for allergic respiratory
complaints from February 2003 to March 2007. Mean age was 20.36 (1Y75
years). Specific IgE was determined by the CAP method (Phadia). The patients
were divided into 2 groups: Group 1: 333 patients with G15 years of age, and
Group 2: 274 patients with 915 years of age.
Results: Mean total IgE levels in the studied population was 752.03 kU/L
(2Y39.888); 238 patients (39.2%) had a positive specific IgE determination to
Ascaris spp; 387 (63.76%) to D. pteronyssinus; 399 (65.73%) to B. tropicalis
and 218 to B. germanica (35.9%). In Group 1: mean total IgE levels:
987.83 kU/L (2.13Y39.888); 147 (44.14%) were positive to Ascaris spp.;
234 (70.27%) to D. pteronyssinus and B. tropicalis and 134 (40.24%) to
B. germanica. In group 2, mean total IgE: 465.46 kU/L (2Y8.453); 91 (33.2%)
were positive to Ascaris spp; 153 (55.84%) to D. pteronyssinus; 165 (60.22%)
to B. tropicalis and 84 (30.66%) to B. germanica. In group 1, 146 of the
147 Ascaris spp. positive patients (99.32%) were positive to at least 1 mite and
142 to both species; 186 patients in this group were negative to Ascaris spp.; in
this group 98 (52.69%) were positive to mites (pG0.05). In group 2: 91
(33.21%) were positive to Ascaris spp. and among them, 81 were positive to at
least 1 mite species (89.01%); in the Ascaris spp. negative group (183), 97
(53%) were positive to at least one mite species (pG0.05).
Conclusion: Sensitization to Ascaris spp. seems to be a risk factor for
sensitization to mite allergens in the tropics.
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Study on the FcERI" gene polymorphism in pollen allergic
population of Calcutta city
Amitava Roy1, Pampa Chakraborty2, Indrani Roy3, and Swati Gupta
Bhattacharya4. 1Scottish Church College, Department of Botany, Calcutta,
India; 2Sree Chaitanya College-Habra, Department of Botany, Habra, India;
3Institute of Child Health, Allergy Department, Calcutta, India; 4Bose
Institute, Department of Botany, Calcutta, India.
Background: IgE dependent activation of mast cells and basophils through
the high affinity IgE receptor (FcERI$) is involved in the pathogenesis of
type 1 respiratory allergy. The FcERI$ gene is located on chromosome
11q13, showing linkage to atopy and asthma.Mutations in this gene could alter
IL-4 production and thus modify IgE levels. An amino acid substitution at
position 237 in this gene has been reported to be associated with atopic asthma
phenotypes in Japanese and white population. The present study aims to
investigate the relationship between the atopic asthma phenotypes and the
FcERI$ gene polymorphism in the population of Calcutta city.
Method: 232 adult pollen allergic patients from Calcutta participated in an
asthma and allergy phenotype- genotype study. Phenotypes obtained by
studying case history, total and specific IgE, IL-4 level, forced expiratory
volume in 1 second (FEV1), forced vital capacity (FVC), etc. Genotyping was
done by restriction endonuclease fragment length polymorphism of a
polymerase chain reaction product spanning the E237G polymorphism site
of FcERI$ gene on the DNA samples isolated from the peripheral blood
samples of study and control group.
Results: Among 232 subjects 44.4% were suffering from allergic rhinitis,
55.6% from bronchial asthma and 19.8% from combination of both. The skin
reaction diameter showed positive correlation (pG0.01) with specific IgE,
FEV1, IL-4 level and no correlation with total IgE. The restriction
endonuclease fragment length polymorphism study of E237G variant of
FcERI$ gene showed no significant difference with control group.
Conclusion: The pollen allergic patients have specific IgE level correlated
with skin reaction. In the tested population of Calcutta city it has been found
that the E237G variant of FcERI$ gene is not at all involved.
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Deworming improves current wheeze and temporarily
deteriorates atopy: longitudinal anthelminthic treatment studies
in Cuban schoolchildren
Meike Wo¨rdemann1, Joris Menten2, Raquel Junco Diaz3, Lenina Menocal
Heredia3, Aniran Ruiz Espinosa4, Bruno Gryseels5, Mariano Bonet Gorbea6,
and Katja Polman1. 1Institute of Tropical Medicine, Parasitology Department,
Antwerp, Belgium; 2Institute of Tropical Medicine, Clincial Sciences
Department, Antwerp, Belgium; 3National Institute of Hygiene, Epidemiology
and Microbiology, Research Department, Havana, Cuba; 4Institute Pedro
Kouri, Parasitology Department, Havana, Cuba; 5Institute of Tropical
Medicine, Director, Antwerp, Belgium; 6National Institute of Hygiene,
Epidemiology and Microbiology, Director, Havana, Cuba.
Background: Although helminth infections have been suggested to protect
from atopy and atopic diseases, there is still no consensus on their
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relationship. We investigated the effect of deworming and intestinal
helminth (re)infections on atopy, asthma, allergic rhinoconjunctivitis and
atopic dermatitis.
Methods: We examined 440 4Y13 year-old Cuban schoolchildren in six-
monthly intervals for 24 months. Intestinal helminth infections were diagnosed
by stool examination. Atopic diseaseswere diagnosed by ISAAC (International
Study of Asthma and Allergies in Childhood) questionnaire, asthma
additionally by spirometry, and atopy by skin prick testing (SPT).
Results: After deworming the frequency of current wheeze (pG0.001) and
allergic rhinoconjunctivitis (p = 0.015) significantly decreased. The percen-
tage of SPT positives temporarily increased from 9.7% (95% CI: 5.5Y16.6%)
to 32.7% (95% CI: 24.7Y42.9%) (pG0.001) and subsequently returned to
baseline values (11.9%, 95% CI: 6.9Y19.6%). (Re)infection with A.
lumbricoides and T. trichuria was positively and hookworm negatively
associated with the development or retention of these atopic diseases, while for
atopy an opposite trend was seen.
Conclusion: Our data indicate that atopic diseases improve after anthelminthic
treatment. Atopy on the other hand increases after deworming. As this increase
appears only temporarily, deworming of schoolchildren does not seem to be a
risk factor for the development of atopy, nor for atopic disease. Effects of
helminth (re)infections on atopy and atopic diseases appear to be species-
specific.
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Association of cord blood cytokine production with wheezy
infants in the first year of life
Akihiro Morikawa1, Hiromi Tadaki1, Hirokazu Arakawa1, Mikio Sugiyama1,
Kiyoshi Ozawa2, Takahisa Mizuno,1 Hiroyuki Mochizuki,1 and Kenichi
Tokuyama3. 1Gunma University Graduate School of Medicine, Pediatrics and
Developmental Medicine, Gunma, Japan; 2Ozawa Obstetric and Gynecology
office, Ozawa Obstetric and Gynecology office, Gunma, Japan; 3Takasaki
University of Health and Welfare, Pharmacy, Gunma, Japan.
Background: Previous studies indicate that antenatal factors are important in
determining susceptibility to asthma. Since cord-blood cytokine productions
may influence the development of atopy-predisposing immune response, cord-
blood cytokine productions may be an important predictor for asthma. We
investigated antenatal cytokines in a prospective birth cohort, intensively
monitored for wheezy infants outcome at 1 year.
Methods: Cord-blood serum samples from 234 children were assayed for
interleukin (IL)-1$,-2,-4,-8,-10,-12,-13, and-17, interferon-,, tumor necrosis
factor-" (TNF-"), granulocyte-macrophage colony-stimulating factor (GM-
CSF), granulocyte colony-stimulating factor (G-CSF), monocyte chemotactic
protein-1 (MCP-1), and macrophage inflammatory protein-1-$ (MIP-1$).
Associations between family history, antenatal and perinatal factors, cord-
blood cytokine concentrations, and wheezy infant outcomes (wheezing more
than two times) were analyzed.
Results: Data were obtained for 213, including 33 wheezing, infants. Risk of
wheezing was related to gestational age, birth weight, cesarean section, and
maternal eczema, but not to bacterial/viral infection during pregnancy,
maternal asthma, maternal smoking or paternal history. High level of IL-8
had a significant association with wheezy infant outcome at 1 year (p =
0.025). IL-5 and-7, MCP1, and MIP-1$ were high with maternal bacterial
infection, and IL-13 was high with maternal viral infection during
pregnancy. Moreover, there were associations between high levels of IL-5
and GM-CSF, and cesarean section. When we included gestational age, birth
weight, cesarean section, maternal eczema and cord-blood IL-8 concentration
in multivariate logistic regression analysis, birth weight (odds ratio = 0.998,
95% CI = 0.997Y1.000) and maternal eczema (odds ratio = 5.356, 95% CI =
1.340Y21.41), but no other factors, were significant predictors of wheezy infants.
Conclusion: Maternal eczema and prematurity were important risk factors for
wheezing in the first year of life. Infection during pregnancy and cesarean
section was related to cord-blood cytokine concentrations. Cord-blood IL-8
may be a predictor for recurrent wheezing at 1year.
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Atopy in young children with asthma
Li Xiang, Zhang Qi, and Kun-ling Shen. Bejing Children’s Hospital affiliated
to Capital University of Medical Science, Center of Asthma, Beijing, China.
Background: A close association between outcome in patients with early-
onset asthma and atopy has been reported in several population studies.
Allergic sensitization in early life seems to be an important risk factor for
subsequently persistent asthma during childhood and adulthood. It might be
valuable for evaluation of atopy in patients with early-onset asthma in order to
predict prognosis and take early intervention.
Methods: Clinical history data of 62 asthmatic children under 4 years of age
were collected. The atopy status of each patient was determined by both
personal allergic history (eczema and/or allergic rhinitis) and specific
diagnosis of allergens (screening tests of fx5E, mx2 and Phadiatop conducted
by fluoroenzyme-immunometric assay using the UniCAP100 system ). The
total serum IgE level was also measured. Logistic regression was used to
analyze the effect of clinical characteristics on allergic sensitization.
Results: In comparison with that 74.2% children reported personal history of
atopy and 33.9% reported parents’ history of atopy based on the clinical
history data, the positive rates of fx5E, mx2, Phadiatop were 40.3%, 14.5%,
14.5% respectively. The total allergic sensitization screening test rate was
46.8% and the sensitization rate to inhalant allergens was 24.2%. The allergic
history of parent(s), the sensitization to food allergen, the age of first wheezing
attack and total serum IgE level were main factors influencing sensitization to
inhalant allergens.
Conclusion: Almost half of asthmatic children under 4 years of age were
shown as positive atopy tests and a quarter of those patients were sensitized to
inhalant allergens. The asthmatic history of parent(s), the sensitization to food
allergens, the age of first wheezing attack greater than 2 years and the
significantly higher total serum IgE level may increase the possibility of
sensitization to inhalant allergens in asthmatic children under 4 years of age.
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Do boys do the Batopic march^ while girls dawdle?
Adrian Lowe1, John Carlin1, Catherine Bennett1, Clifford Hosking2, Michael
Abramson3, David Hill4, and Shyamali Dharmage1. 1University of Melbourne,
MEGA Epidemiology, Melbourne, Australia; 2John Hunter Children`s Hos-
pital, Department of Pediatrics, Newcastle, Australia; 3Monash University,
Epidemiology and Preventive Medicine, Melbourne, Australia; 4Royal
Children`s Hospital, Murdoch Children’s Research Institute, Melbourne,
Australia.
Background: The Batopic march^ hypothesis suggests that infants with
eczema are at increased risk of asthma and allergic rhinitis. Others argue that
eczema is not a risk factor for asthma or allergic rhinitis, unless there is also
sensitisation or early wheezing. The role of infantile eczema as a predictor of
risk of childhood asthma and allergic rhinitis was examined in a prospective
birth cohort, while controlling statistically for the effects of early wheeze,
sensitisation and gender.
Methods: A birth cohort of 620 infants with an atopic family history was
recruited. Presence of eczema and wheeze was prospectively documented
up to 2 years of age. Sensitisation was determined by skin prick tests (SPT)
at 6, 12 and 24 months to 6 common food and inhalant allergens.
Interviews were conducted at 6 and 7 years to ascertain asthma in the
previous 12 months.
Results: Eczema within the first two years of life was associated with an
increased risk of childhood asthma in boys (Odds Ratio [OR] = 3.05, 95%CI
1.74Y5.35) but not in girls (OR = 1.44, 95%CI 0.74Y2.78, p for interaction =
0.031). There was a similar pattern for allergic rhinitis, where eczema in boys
conveyed increased risk (OR = 2.37, 1.32Y4.23) but less so in girls (OR = 1.17,
0.58Y2.39, p for interaction = 0.123). Adjusting for allergic sensitisation in
early life reduced the strength of both these associations in boys by
approximately 20% (adjusted OR 2.45, 1.32Y4.56 for risk of asthma, and
aOR 1.84, 1.02Y3.35 for allergic rhinitis) but adjustment for wheeze in the first
two years did not substantially alter these associations. If it is assumed that
these relationships are causal, the maximum potential reduction in childhood
asthma and allergic rhinitis by an intervention to eliminate eczema in boys is
approximately 28%.
Conclusion: Eczema in the first two years of life is associated with an
increased risk of childhood asthma and allergic rhinitis in boys but not in girls.
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These results suggest that the Batopic march^ may be more important in boys,
and interventions should be targeted at them.
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New onset of asthma, chronic phlegm and lung function decline
in relation to indoor moulds and building dampness: A nine year
follow up study within ECRHS-II
Dan Norba¨ck1, Jan-Paul Zock2, Joachim Heinrich3, Cecilie Svanes4, Jordi
Sunyer2, Nino Kunzli2, Simona Villani5, Mario Olivieri6, Argo Soon7, Estel
Plana2, and Deborah Jarvis8. 1Uppsala University, Dept. of Medical Science,
Uppsala, Sweden; 2Centre for Research in Environmental Epidemiology
(CREAL), Municipal Institute of Medical Research (IMIM), Barcelona, Spain;
3GSF National Research Center for Environment and Health, Institute of
Epidemiology, Neuherberg, Germany; 4University of Bergen, Dept. of
Thoracic Medicine, Bergen, Norway; 5University of Pavia, Dept. of Health
Science, Pavia, Italy; 6University of Verona, Dept. of Medicine and Public
Health, Verona, Italy; 7University of Tartu, Dept. of Public Health, Tartu,
Estonia; 8National Heart and Lung Institute, Imperial College, Respiratory
Epidemiology and Public Health Group, London, United Kingdom.
: The aim was to study new onset of adult asthma, chronic phlegm,
chronic bronchitis and lung function decline in relation to indoor dampness
and moulds in a 9-year follow-up study (ECRHSII) A follow-up took place
from 1998 to 2002, with 4194 men and 4576 women from 27 centres. New
asthma and wheeze at the follow-up was studied, excluding those (N = 1605)
with either wheeze without a cold, nocturnal attack of shortness of breath or
asthma at baseline. New onset of chronic phlegm at follow up was studied,
excluding 1716 subjects with usual cough or phlegm at baseline. Self-reported
dampness and indoor moulds in the dwelling (ever) and last 12 months was
assessed by yes/no questions. A dampness score (DSC) and a mould score
(MSC) ware calculated, by summing up number of signs. Moreover, 3118
homes were inspected for observed dampness (OD) and moulds. Adjusted
relative risk (RR) were calculated for those ever exposed, or getting new
exposure during the follow up, using never exposed as reference group. Totally
43.0% had ever lived in a homewith water damage, 43.3% ever in a homewith
moulds. There was a significant increase of new asthma among those reporting
moulds, water damage, and indoor damp spots at home (RR 1.3Y2.3).
Moreover, there was an association between observed dampness (OD) and
new asthma (RR = 1.5; 95% CI 1.0Y2.2), between OD in the bedroom
and new wheeze (RR = 1.9; 95% CI 1.2Y3.0), and between OD in the
bedroom and new asthma with BHR (RR = 2.8; 95% CI 1.0Y8.1). The
effect of indoor moulds on new asthma was stronger in those sensitised to
moulds. There was an increased risk of now chronic phlegm among those
reporting new exposure to moulds (RR = 1.47; 95% CI 1.01Y2.13) and new
water damage (RR = 1.54). Females with any reports of dampness at home
had an additional decline in FEV1 of j2.25 ml/year (95% CIY4.25 to
j0.25), and there was a significant trend in lung function decline in relation
to DSC in females (p = 0.03). Moreover, OD in the bedroom was related to
a decline in FEV1 of j7.43 mL/year (95% CI-13.11 to j1.74). Meta-
analysis did not reveal any centre-heterogeneity of the findings. In conclusion,
dampness and moulds in the dwelling can be a risk factor for new asthma and
new chronic phlegm in adults, and for lung function decline in females. Mould
allergy seems to be a risk factor for asthma in damp and mouldy dwellings.
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Beta-glucan exposure and allergic disease in infancy
Rob Siebers1, Kristin Wickens1, Adrienne Parkes1, Mike Epton2, Ian Town2,
and Julian Crane3. 1School of Medicine and Health Sciences, Otago
University, Medicine, Wellington, New Zealand; 2School of Medicine and
Health Sciences, Otago University, Canterbury Respiratory Research Group,
Christchurch, New Zealand; 3School of Medicine and Health Sciences, Otago
University, Wellington, Medicine, Wellington, New Zealand.
Background: Early life exposure to microbial agents may protect against the
development of allergic disease in infancy. This study assessed whether
exposure to beta-glucan (a fungal biomass marker) at age 3 months was
associated with allergic disease and asthma symptoms in infancy.
Methods: Living room floor dust was collected at age 3 months and analysed
for beta-glucan by a modified Limulus amoebocyte lysate method. Skin prick
tests to indoor allergens were performed on 546 infants at age 15 months for
whom dust was available for analysis and asthma symptoms were collected by
questionnaire then and at age 2, 3 and 4 years. Adjusted odds ratios (aOR) for
the association of beta-glucan with allergic disease and asthma symptomswere
determined by logistic regression. Adjusted geometric mean ratios were used
to show determinants of beta-glucan.
Results: The concentration of beta-glucan at the 3rd tertile was significantly
associated with skin prick test positivity, aOR: 1.88 (95% CI: 1.17Y3.03;
p = 0.0097), but not with wheeze or other asthma symptoms at age 15
months, 2, 3 or 4 years. Beta-glucan levels were higher in spring compared
to summer, geometric mean ratios were: 1.22 (95% CI: 1.01Y1.48; p = 0.04)
and 1.25 (95% CI: 1.09Y1.44; p = 0.001) respectively for ng/m2 and ng/g.
Beta-glucan levels expressed as ng/g were slightly higher in Christchurch
than in Wellington, geometric mean ratio: 1.11 (95% CI: 0.99Y1.21; p = 0.06).
No significant differences in beta-glucan levels were found between living
room floors with carpets/rugs and those with bare floors.
Conclusion: Early life exposure to beta-glucan may lead to allergic
sensitisation in infancy.
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Prevalence of asthma and allergy in Swedish school employees
1993 and 2003
Greta Smedje and Dan Norba¨ck. Uppsala University Hospital, Occupational
and Environmental Medicine, Uppsala, Sweden.
Background: During the last decades asthma and allergy have become more
prevalent, but it is not known if the increase continues. Especially among
adults, data are scarce.
Methods: In 1993 we conducted a questionnaire study on prevalence of
asthma and allergy among employees of 39 randomly chosen schools in the
county of Uppsala, Sweden. In total 1410 (85%) of the employees answered
the questionnaire. Ten years later we performed a new study in the same
schools. The same questionnaire was sent to those who worked in the schools
in 2003 and 1194 (67%) responded. The questionnaire included questions on
self-reported allergy and the questions on asthmatic symptoms used in the
European Community Respiratory Health Survey. Differences in prevalence
between the two surveys were calculated by the 2-test.
Results: Both years, 62% of the respondents were teachers and 38% had other
occupations. The proportion of women was 77% in 1993 and 81% in 2003.
Mean age was 45.9 years old in 1993 and 47.7 in 2003. Prevalences of allergy
and asthma are presented in Table 1.
.
1993 2003 p
Furry pet allergy 9.8 13.0 0.012
Pollen allergy 16.7 19.1 0.109
Ever doctor’s diagnosed asthma 6.9 8.8 0.073
Current asthma 5.2 6.9 0.073
Any asthma symptom last year 19.3 16.2 0.023
Present asthma medication 4.6 6.4 0.050
Thus, we found a tendency towards the prevalence of ever having got an
asthma diagnosis, and having current asthma being slightly more common in
2003 compared to 10 years earlier. However, using asthma medication had
increased and suffering from asthma symptoms had decreased. Furthermore,
self-reported allergy had increased, especially towards furry pets.
Discussion: The study population was not a representative sample of the
Swedish adult population, and one should be cautious when generalizing
from the results. However, apart from gender, school employees should not
differ substantially from the general working population. Furthermore, the
two study populations were very homogenous to each other, with respect to
gender, age, occupation and geographical habitat, and the study methods
were identical.
Conclusion: The results imply a small increase of asthma and allergy during
the 10-year period 1993Y2003 in Swedish adults.
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Asthma management in real life; preliminary data from
CPD-ARGA project
Laura Guerra1, Fulvio Braido1, Ivana Valle2, Adele Coccini2, Paolo Guerrera3,
Pierclaudio Brasesco4, Pietrino Forfori5, and Giorgio Walter Canonica1.
1University of Genoa, Department of Internal Medicine, Genoa, Italy; 2Azienda
Sanitaria Locale 3Genovese, Azienda Sanitaria Locale 3 Genovese, Genoa, Italy;
3Azienda Ospedaliera Universitaria San Martino, Azienda Ospedaliera
Universitaria San Martino, Genoa, Italy; 4GP SIMG Sezione Genova, GP SIMG
Sezione Genova, Genoa, Italy; 5GPASSIMEFAC, GPASSIMEFAC, Genoa, Italy.
Background: Despite asthma control and treatment adherence have been
largely investigated in current literature, the appropriateness of general
practitioner in prescribing for patients with asthma is less studied. At the
beginning of a continuing professional development (CPD) program on rhinitis
and asthma, part of ARGA (Allergopatie Respiratorie studio di monitoraggio
linee-guida GINA e ARIA), a study supported by Italian Drug Agency (AIFA),
the drugs prescription and the healthcare resource utilization of physicians
adhering to the study were performed.
Materials and Methods: We observed 70.147 patients followed by 60 GP
during 2006. 709 patients had diagnosis of asthma. 68 patients were
hospitalized for asthma exacerbations, mean age 51 yrs. Among these
patients only 16 were treated with association of beta 2 agonist/inhaled
steroid coupled with antileukotrienes (9/16), antihistamines (8/16), theophyl-
line (4/16). Systemic steroids (prednisone, betamethasone) were prescribed
to 10 patients, among them, 3 received no other therapy, other 3 patients
received only oral antihistamines. In 4/16 patients were prescribed
tiotropium although asthma indication is not approved. The total amount
of prescribed asthma drugs for these patients was low, it could last for a
maximum of two months. The most prescribed drugs were beta 2 short
acting bronchodilators (up to 22 drug boxes for a patient). No patient was
evaluated by a specialist (allergist or pneumonologist) before hospitaliza-
tion; only 6 were visited by a specialist after their discharge from the
hospital and 11 underwent a spirometric evaluation. 7 patients were
hospitalized twice in a year.
Conclusion: Regardless of the efforts of national and international societies
for the diffusion of asthma diagnosis and treatment guidelines, asthma is
still undervalued and untreated by general practitioners; this could be the
principal cause of hospitalization for asthma exacerbation in the observed
group of patients. It could be interesting to evaluate in a CPD blended
program (5 residential plus 4 distance learning courses) in which the
contents are tailored on physicians knowledge, which healthcare resource
utilisation and drugs prescription would be able to improve the asthma
management.
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Development and first validation of the Quality of Life in
Children with Keratoconjunctivitis (QUICK) questionnaire
Ilaria Baiardini1, Marta Sacchetti2, Omar Fassio3, Silvia Aronni2, Alessandro
Lambiase2, Sergio Bonini4, and Stefano Bonini2. 1University of Genoa,
Department of Internal Medicine, Genoa, Italy; 2University of Rome Campus
Bio-Medico, Department of Ophthalmology, Rome, Italy; 3Turin University,
Department of Psychology, Turin, Italy; 4Second University of Naples and
Institute of Neurobilogy an Molecular Medicine, Italian National Research
Council, Department of Internal Medicine, Rome, Italy.
Aim: The aim of our study is to develop and validate a questionnaire to
evaluate Health Related Quality of Life (HRQL) in children with severe vernal
keratoconjunctivitis (VKC).
Methods: An initial list of 42 items was developed and administered to 30
children with VKC in the active phase (6F, 24M; mean age 9 T 2 years).
The 30 most significant items were selected and converted into questions on
a Likert scale of 3 steps for the validation phase. Validation involved 41
children with VKC in the active phase (8F, 33M; mean age 9.4 T 2 years).
Twenty-two children (5F, 17M) also completed the generic KINDL\
questionnaire. Clinical signs were evaluated and scored to correlate QUICK
scores to clinical findings. Total sign score (TSS) was calculated. Validation
was performed by factorial analysis and Pearson`s correlation. Internal
consistency was calculated by Chronbach`s alpha on the extracted factors.
Results: Factorial analysis extracted 2 factors with good internal consistency:
Symptoms (a´ = 0.89), and Daily Activities (a´ = 0.77). Correlations of the final
version of QUICK, (a´ = 16 items) to KINDL\ scores were in the expected
direction. Most patients complained of itching (93%), burning (90%), redness
(90%), the need to use eye-drops (90%), tearing (83%) and photophobia
(80%). The children`s biggest concerns were limitations on going to the pool
(71%), playing sports (58%), meeting friends (58%) or playing outdoors
(42%). QUICK Symptom score was significantly correlated to conjunctival
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hyperemia (p G 0.001), secretion (p = 0.042), chemosis (p = 0.012), superficial
punctuate keratopathy (p G 0.001) and TSS (p = 0.010).
Conclusion: QUICK represents a new and simple tool to assess HRQoL in
children with severe allergic conjunctivitis, useful for the global evaluation of
VKC`s impact on children`s daily life.
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Depression, anxiety and quality of life in pediatric asthma in a
Hungarian pediatric university department
Alexandra Szabo´1, Gyo¨rgyi Mezei2, and Endre Cserha´ti2. 1Bethesda Chil-
dren’s Hospital of the Hungarian Reformed Church, pulmonology, Budapest,
Hungary; 2Semmelweis University Budapest, First Dept. of Pediatrics,
Budapest, Hungary.
Aims: The study`s objective was to examine depression, anxiety and quality of
life according to age and asthma status in pediatric asthma in a pediatric
university department.
Methods: 108 patients, age:11.75 T 3.10 (mean T SD) years; (boys 11.6 T
2.8 years and girls 12.1 T 3.7 years) completed the Child Depression Inventory
(CDI), the State Trait Anxiety Inventory for Children (H.STAIC), the Pediatric
Asthma Quality of Life Questionnaire (PAQLQ), and a symptom score. FEV1
was also measured.
Results: Mean FEV1% was 97.4 T 12.8. 23 patients (21%) had intermittent
asthma, 40 patients (37%) had mild persistent, 43 patients (40%) had moderate
persistent, 2 patients (2%) had severe persistent asthma. The pediatric asthma
patients scored 9.36 T 5.57 points in the CDI. The patients showed as many
depressive symptoms as the Hungarian average population, pre-adolescent
boys with asthma showed even less. Children with asthma scored 31.16 T 4.61
points on the H.STAIC questionnaire; (boys 30.64 T 4.29, girls 32.67 T 5.27).
Children with asthma have the same anxiety level as their healthy peers. On the
PAQLQ asthmatic children reached 6.18 T 1.00 (2.87Y7.00); adolescent girls
scored the worst (5.62 T 1.28). Adolescent asthmatic girls have the worst
quality of life. Boys reach better quality of life scores as they grow older
(p = 0.02). Girls with adolescence have a tendency of decreasing quality of
life, although the difference is not significant. In adolescence, asthmatic girls
experience more QoL deprivation than boys (p = 0.013). Depression score,
anxiety, or quality of life showed no differences between the intermittent and
persistent asthmatic groups. Children in the symptomatic subgroup experi-
enced poorer quality of life. Depression and anxiety were not affected by
current asthma symptoms. There was no significant difference in depression,
anxiety or quality of life scores according to age.
Conclusion: The psychological status of the asthmatic patients is fairly good.
One should concentrate more on the quality of life of girls in adolescence. The
good pediatric care of childhood asthmatics helps to avoid the psychological
consequences of the disease.
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Polysomnographic findings in atopic and non-atopic children
with respiratory sleep disturbances
Jolanta Wasilewska and Maciej Kaczmarski. Medical University, III
Department of Pediatrics, BIALYSTOK, Poland.
Background: Sleep problems are often associated with allergic diseases. The
aim of the study was to compare respiratory disturbances (number of apnea
and hypopnea) in atopic and non-atopic children with sleep-related breathing
disorders.
Methods: In the prospective study a standard polysomnography (EEG,
oculogram, chin EMG, nasal and oral airflow, chest and abdominal wall
movement, ECG, SaO2, body position) with parallel recording of 24-pH-
metry was performed in 27 children (age-and nutrition state-matched): group
IYatopic children with chronic bronchial asthma and/or allergic rhinitis
(n = 11; mean age-6.9 T 2.7ys) and group IIYnon-atopic children with history
of sleep apnea and/or snoring (n = 16;mean age-7.3 T 4.0ys). The Respiratory
Disturbances Index (RDI) was defined as a number of sleep apnea (obstructive,
central, mixed) and hypopnea per hour of sleep and children with RDI95/h
were included and sleep apnea/hypopnea syndrome was diagnosed. Plasma
leptin level was measured with ELISA method.
Results: A mean total IgE and eosinophilia was significantly higher in atopic
group than in non-atopic (736.2 T 1461.1 v 34.3 T 25.35 IU/ml and 5.05 T 5.2%v
1.58 T 1.2%) (p G 0.005). Groups were not differ in the nutrition state measured
by BMI (18.7(T 5.1) v 18.5 (T 3.9) kg/m2) and by plasma leptin level (5275 T
8007 v 6729 T 10829) (p 9 0.05). Significant elevated RDI was registered in both
groups: 11.2( T 9.6)/h v 14.3(T 18.6)/h (p 9 0.05). There were no differences in
the number of sleep apnea in both groups.
Conclusion: In atopic children a basic disease- bronchial asthma or allergic
rhinitis- may be associated with sleep apnea / hypopnea syndrome.
47
Arts meets science to promote awareness of allergy in a school
Anna Dumitriu1, and Helen Smith2. 1Phoenix Gallery, Phoenix Gallery,
Brighton, United Kingdom; 2Brighton and Sussex Medical School, Division
of Public Health and Primaty Care, Brighton, United Kingdom.
Background: Many adolescents experience allergic diseases but they
represent a ’hard to reach’ group for the purposes of health education. The
objective of this study was work with pupils in a school on a collaborative arts-
science focussing on allergy in order to heighten their awareness and knowl-
edge of allergic disease.
Methods: The study particiapnts were fifteen 14-15 year-old pupils who were
talented scientists. At the start of the project they participated in three hours of
lectures and small group discussion addressing
&What do we mean by allergy? (pathophysiology)
&Who gets allergy? (epidemiology)
&How does it impact on people’s lives? (clinical)
&What makes it better? (pharmacology/therapeutics)
They were then challenged with the task of developing art installations for
their school that would convey the keymessages they had learned about allergy
to their peers.
Results: The students worked with a team of four artists (Anna dumitriu,
Rachel Cohen, Carol Quinn and Caroline Doyle). They developed five ins-
tallations around the school and its grounds depicting allergenic items, pro-
duction of exhibition catalogue, evening private viewing attended by 50 visitors
for which the pupils acted as guides and prepared food free from common
allergens. The exhibition was then open to the public for the remainder of the
term. Installations used a range of media including drawing, textile art, sculp-
ture, videos and performance art.
Conclusion: This activity generated a themed exhibition within the school
that promoted discussion about allergy amongst pupils, teachers, parents and
the public.
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Asthma and allergy development in mono-zygotic twins
discordant for severe respiratory syncytial virus infection
in infancy
Porntiva Poorisrisak1, Liselotte B. Halkjaer1, Simon F. Thomsen2, Lone G.
Stensballe3, and Peter O. Schioetz4, Hans Bisgaard1. 1Gentofte Hospital,
Danish Pediatric Asthma Centre, Hellerup, Copenhagen, Denmark; 2Bispeb-
jerg Hospital, Department of Respiratory Medicine, Copenhagen, Denmark;
3Statens Serum Institut, Bandim Health Project, Copenhagen, Denmark;
4Skejby Hospital, Paediatric Department, Aarhus, Denmark.
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Background: Children recovering from severe Respiratory Syncytial Virus
(RSV) bronchiolitis are at increased risk of recurrent wheeze, asthma and
possible allergy in later childhood. It is difficult to differentiate causes of
disease from consequences, especially in complex genetic diseases influenced
by environmental exposures.
Aim: To compare the long-term outcome of pulmonary function, sensitization
and clinical diagnosis of asthma in monozygotic (MZ) twin pairs discordant
for hospitalization with verified severe RSV infection in infancy.
Methods: Clinical examination was conducted on 37 MZ twin pairs (mean
age 7.6 years) discordant for hospitalization with severe RSV infection in
infancy. Asthmawas assessed by interview, lung function (baseline spirometry
for schoolchildren and specific airway resistance for preschool children),
airway reactivity (responsiveness to metacholine for schoolchildren and dry air
hyperventilation for preschool children), fractional exhaled nitric oxide
(FeNO), and sensitization (skin testing to common inhalant allergens).
Results: 7 years (mean) after the severe RSV infection there were no
differences within the discordant MZ twin pairs with respect to lung function,
airway reactivity, FeNO, sensitization or clinical asthma (p 9 0.1 for all
comparisons).
Conclusion:We found no difference on the development of asthma and allergy
from having or not having severe RSV infection in infancy within MZ twin
pairs. This suggests that severe RSV infection is not causative in the
development of asthma or allergy in childhood which is probably caused by
other factors in the shared environmental and genetic factors.
AEROBIOLOGY Y DETAILED CLINICAL ANALYSIS
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The novel 18 kD allergen major of Catharanthus roseus
pollen: Identification, cDNA cloning, cross-reactivity and
characterization as a cyclophilin
Debajyoti Ghosh1, and Swati Gupta Bhattacharya2. 1INSERM U885, Lab.
Physiol. Cell. Resp, Lab.Physiol.Cell.Resp, Bordeaux, France; 2Bose Institute,
Kolkata, Botany, Kolkata, India.
Background: Pollen of Catharanthus roseus, a widely distributed plant in
India and other sub/tropical countries, has repeatedly been reported to cause
allergic reactions, especially among the gardeners. Our objective was to
identify and characterize underlying allergens, in order to make them available
for immunotherapy.
Methods: The major allergen was identified by western blotting of C.
roseus pollen extract using sera from allergic individuals. N-terminal
sequencing and screening of a cDNA library of C. roseus were done
followed by expression of the recombinant protein in E. coli. Biochemical
and bioinformatic analyses were also done to characterize the recombinant
allergen at the molecular level.
Results:Western blotting indicated an 18 kD protein (designated Cat r 1) to be
a major allergen of this pollen. Its deduced protein sequence showed
considerable similarity with cyclophilin family members (Asp f 11, Mal f 6
and human cyclophilin A). The recombinant protein bound to patients` IgE
and showed cyclophilin-like enzymatic activity. The structural elements of this
protein were estimated by CD spectroscopy. Comparative molecular modelling
suggested a considerable 3-D structural similarity with cyclophilins. Inhibition
ELISA revealed cross-reactive binding of serum IgE from Cat r 1-allergic
individuals to the fungal allergenic cyclophilins Asp f 11 and Mal f 6. The
degree of solvent-exposure of different residues was calculated from the
modelled structure and B-cell epitopes were predicted. The results support the
notion that the allergenic cross-reactivity between Cat r 1 and the other
cyclophilins is due to the presence of conserved patches [BBRC. 307(2):422-
9] exposed on the surface of these molecules.
Conclusion: Cat r 1 is a major allergen from Catharanthus roseus pollen,
indigenous in sub/tropical countries, that both on sequence and functional
level belongs to the cyclophilin family. Now also available in recombinant
form, Cat r 1 is a candidate molecule for immunotherapy.
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Crystal structure determination of the group 1 allergen from the
dust mite blomia tropicalis
Kaare Meno1, Jette Sandholm Kastrup2, I-Chun Kuo3, Michael Gajhede2, Nge
Cheong4,Michael Dho Spangfort1, and KawYan Chua4. 1ALK-Abello, Vaccine
Research Department, Horsholm, Denmark; 2University of Copenhagen,
Faculty of Pharmaceutical Sciences, Department of Medicinal Chemistry,
Copenhagen, Denmark; 3Singapore Institute for Clinical Sciences, Agency for
Science, Technology and Research, Singapore, Singapore; 4National Uni-
versity of Singapore, Department of Paediatrics, Singapore, Singapore.
Background: The Blomia tropicalis (Blo t) mite species is an important
source of allergens associated with rhinitis and asthma in the tropics,
where Blo t 1 has been shown to be a major allergen. The group 1 mite
allergens are among the clinically most significant indoor allergens
worldwide. These proteins are cysteine proteases containing a pro-peptide
and a mature region, which can be found in the alimentary canal of the
mites. We have previously determined the structure of Der p 1 (from
Dermatophagoides pteronyssinus), which remains the only member of this
allergen group with known structure. Der p 1 serves as a good structural
model for the group 1 allergens from the closely related mite species Der f
and Eur m (82/84% sequence identity, respectively) but not for Blo t 1
(33% identity). This is reflected in the very low IgE cross-reactivity
between Blo t 1 and Der p 1.
Methods: proBlo t 1 was expressed recombinantly in yeast, purified by
conventional methods and crystallized using the sitting drop vapour diffusion
technique. Single crystals measuring 0.1 mm in the longest dimension were
obtained. X-ray diffraction data were collected at Max-Lab and the ESRF. The
data processing and structure determination by molecular replacement were
performed using the CCP4 program package. Model building was performed
in Coot.
Results: Recombinant proBlo t 1 was expressed, purified and crystallized. X-
ray diffraction data were collected to a maximum resolution of 2.1 A˚. Two
molecules were located in the asymmetric unit by molecular replacement using
mature Der p 1 as search model. The mature part of proBlo t 1 has been fitted to
the resulting electron density. The elucidation of the part of the structure
constituting the pro-peptide is ongoing. Only two of the three disulfide bridges
found in Der p 1 are conserved in Blo t 1. Furthermore, Blo t 1 has a unique
cysteine residue of unknown function.
Conclusion: Like Der p 1, the mature region of Blo t 1 forms a globular protein
with two interacting domains that delimit a cleft on the surface where the active
site is located. The low sequence identity between Blo t 1 andDer p 1 combined
with differences in the structures of several loop regions on the surfaces of these
proteins can explain the low IgE cross-reactivity. If the same is true for other
Blo t allergens this could explain the differential sensitization to Blo t and Der p
observed in several tropical regions.
51
Aerobiological and immunological studies on Delonix regia
pollen: an aeroallergen from India
Jyotshna Mandal1, Indrani Roy2, Soma Chatterjee2, and Swati Gupta
Bhattacharya1. 1Bose Institute, Botany Department, Calcutta, India; 2Institute
of Child Health, Allergy Department, Calcutta, India.
: Pollen allergens are reported to be important triggers of IgE mediated
allergic disorders. Delonix regia, DR or The Gulmohar tree is an important
avenue tree in the tropics, planted for their ornamental value. The aim of this
work was to carry out the aerobiological survey of this pollen in Calcutta and
to identify their IgE binding proteins.
Seasonal periodicity of airborne DR pollen was recorded using a
Burkard sampler. The relationship between the meteorological parameters
and monthly pollen concentration was calculated using Spearman correlation
World Allergy Organization Journal & November 2007 Abstracts
* 2007 World Allergy Organization S15
Copyright @ 2007 World Allergy Organization. Unauthorized reproduction of this article is prohibited.
coefficient. The allergenic potential was studied by SPT, IgE ELISA. Protein
profile of DR pollen extract was studied by reducing SDS-PAGE. The whole
extract was fractioned byDEAE-Sephadex ion exchange column.Allergenicity
of the fractions was confirmed by ELISA inhibition and immunoblotting.
Aerobiological survey (2004-2006) revealed the presence of DR pollen
from April to July. In the peak month, May, it contributed to about 5.56 % to
the total airborne pollen load. Microscopic studies showed that the pollen is
59-606m in size, has tricolporate aperture, with reticulate ornamentation,
prolate-spheroidal in shape and amphiphilous pollination. The variation of the
DR pollen load showed significant positive correlation with temperature
(p G 0.05) and wind speed (p G 0.01). A negative correlation was seen with
relative humidity. Out of the 500 respiratory allergic patients (mean age-34.7
years) visiting the Allergy Unit, Institute of Child Health, tested with DR
allergen extract, 22% showed +1 and 4.8% showed +2/+3 level of reaction in
SPT. Among them 33 patients were selected for sera collection on the basis of
higher level of SPT reaction and high titre of DR pollen IgE specific ELISA
results. On SDS-PAGE, its whole extract resolved in to more than 25 distinct
bands between 16 and 109 kD. 3 fractions were obtained by ion exchange
chromatography. Fraction I had strong IgE binding reactivity. Immunoblotting
with individual patient sera revealed 8 IgE binding protein bands. Among them,
6 were most important as they showed maximum binding. Protein bands of 43
and 32 kD were recognized by 54.5 and 69.7% individual patient sera
respectively. Bands identified by lesser number of patients were 96, 28,
25, 23 kD.
The spread of DR tree in Calcutta has lead to a high concentration of its
pollen and it contributed significantly to the aeropollen load. They need to be
considered as a new potential allergenic source.
52
Structure and functional characterization of recombinant house
dust mite allergen Der p 2 produced from yeast Pichia pastoris
Sasipa Thanyaratsrisakul1, Orathai Jirapongsananuruk2, Nat Malainual3,
Wayne R. Thomas4, and Surapon Piboonpocanun1. 1Mahidol U., Inst.
Molecular Biology and Genetics, Nakhon Pathom, Thailand; 2Siriraj
Hospital, Pediatrics, Bangkok, Thailand; 3Siriraj Hospital, Parasitology,
Bangkok, Thailand; 4U. of Western Australia, Center for Child Health
Research, perth, Australia.
Background: Der p 2 of the house dust miteDermatophagoides pteronyssynus
is a major allergen causing allergic reactions in many countries including
Thailand. Currently, a number of recombinant allergens including Der p 2 have
been expressed and increasingly used in various applications due to their
homogeneous, high quantity, and a lower cost. Thus characterization of rec-
ombinant allergens is an important step to ensure they still retain the properties
of the natural allergen.
Objectives: To determine whether determinations of the secondary structure
and staining of the hydrophobic cavity of recombinant Pichia pastoris-
expressed Der p 2.0101 could be used to predict the allergenicity of rDer p 2.
Methods: Circular Dichroism (CD) spectroscopy was performed for de-
termining a composition of secondary structure. Hydrophobic fluorescent
probe 1-anilinonaphthalene 8-sulfonic acid (ANS) was used for examining a
formation of the hydrophobic cavity. Allergenicity was measured by specific
IgE antibody inhibition assay.
Results: Analysis results of CD data showed that secreted rDer p 2 (rDer p 2s),
purified from culture media, contained 5% "-helix, 24% $-structure and 74%
random coil compared to 14% "-helix, 57% $-structure and 29% random coil of
the natural Der p 2 (nDer p 2). After a denaturing step using Tri-Chloroacetic
Acid (TCA) precipitation, refolded rDer p 2 (rDer p 2t) contained 7% "-helix,
54% $-structure and 38% random coil. The results from ANS-bound the
hydrophobic cavity of both rDer p 2s and rDer p2t showed that, with 50 fold-
molar excess of ANS, relative fluorescent intensity (RFI) of both ANS-rDer p
2s and ANS-rDer p2t were 3.1 and 4.9, respectively, compared to RFI 20 of
ANS-nDer p 2. The results of inhibition of pooled serum specific IgE binding
to Der p 2 confirmed that both rDer p 2s (IC50 42 ng/ml) and rDer p 2t (IC50 38
ng/ml) inhibited specific IgE binding with less affinity than that of nDer p 2
(IC50 5 ng/ml).
Conclusion: This is the first study to report that the P. pastoris-expressed rDer
p 2 had the different composition of "-helix and random coil, and the ANS-
stained hydrophobic cavity when compared to the natural Der p 2. Allergenicity
of the rDer p 2 was also decreased possibly as the results of changes in
secondary structure and in the hydrophobic cavity.
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Identification of B and T cell epitopes of Cur l 3; a major
cross-reactive allergen from Curvularia lunata
Vidhu Sharma1, Bhanu Pratap Singh2, Shailendra Nath Gaur3, Santosh Pasha2,
and Naveen Arora2. 1Institute of Genomics and Integrative Biology, Allergy
and Immunology, Delhi, and Ambedkar Center for Biomedical research,,
University of Delhi, Delhi, India; 2Institute of Genomics and Integrative
Biology, Allergy and Immunology, Delhi, India; 3VP Chest Institute, University
of Delhi, Respiratory Allergy and Medicine, Delhi, India.
Background: Structure function relationship of major allergens is required
to understand molecular mechanism of allergy and to develop suitable
modalities for therapy. In the present study, B and T cell epitopes of Cur l 3,
a major cross-reactive allergen from fungus Curvularia lunata were analyzed
using computational and experimental approaches.
Methods: The epitopes were predicted in silico and validated experimentally.
Five each B cell (peptides 1-5, i.e. P 1-P5) and T cell (peptides 6Y10, i.e.
P6YP10) epitopes were derived based on sequence homology model. The
conserved motif of peptide number 6, i.e. P6 in Cur l 3 present in the core of
protein showed cryptic B cell epitope in silico. These peptides were chemically
synthesized and assessed for their biological activity using ELISA, ELISA
inhibition, dot blot, lymphoproliferation and cytokine profiling in hypersensi-
tive patients` samples. Peptides P4, P6 and P 10 were selected for in vivo
evaluation by skin tests.
Results: P4, P6 and P10 peptides showed higher IgG and IgE reactivity
compared to other peptides. ELISA inhibition demonstrated that P1YP6
achieve 50% IgE binding inhibition at 100 ng, whereas P7YP10 could not
achieve the same inhibition even at thousand fold higher concentration. In
lymphoproliferation assay, peripheral blood mononuclear cells from C. lunata
patients stimulated with P6YP10 peptides showed at least two-fold proliferation
than controls. The levels of IL-4 and IL-5 were elevated in culture supernatants
demonstrating Th 2 type of immune response. Among these peptides, P6
showed marked positive skin reactivity in 35/37 Cur l 3 positive patients
followed by P4 (30/37) and P10 (10/37).
Conclusion: The B and T cell epitopes spanning the entire region of Cur l 3
were mapped in silico and validated experimentally. A cryptic presence of an
IgE interacting region was found in predicted T cell epitope i.e. P6. The
knowledge regarding T and B cell epitopes of this major allergen can help in
developing hypoallergenic variants using mutational strategy.
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Molecular cloning and immunochemical characterization
of a new Japanese cedar pollen allergen homologous to
aspartyl protease
Ahmed Ragaa Nour Ibrahim1, Seiji Kawamoto1, Yayoi Shimada2, Satoshi
Rikimaru3, Isao Oiso3, Tsunehiro Aki1, Kunihiko Hashimoto3, and Kazuhisa
Ono1. 1Grad. Sch. ADSM, Higashi-Hiroshima, Japan; 2JST Plaza, Higashi-
Hiroshima, Japan; 3Nishikawa Rubber Co. Ltd., Hiroshima, Japan.
Background: Among allergenic pollens, Japanese cedar (Cryptomeria
japonica) pollen represents the most important aeroallergens in Japan. It
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elicits rhinitis and conjunctivitis especially in younger generations. The two-
dimensional IgE-binding spectrum of C. japonica pollen allergens demon-
strated that many allergens remain to be identified. Here we present the
molecular cloning and immunochemical characterization of a novel C.
japonica pollen allergen belonging to aspartyl protease family.
Methods: TOF-MS analysis of a high IgE-binding protein, termed CPA63,
revealed its internal amino acid sequences. Based on these sequence
information, cDNA-encoding CPA63was cloned by RACE-PCR. The allergen
was produced as a recombinant protein using baculovirus-insect cell culture
system, and purified by double chromatographic technique using HisTrap and
HiTrap Q columns. Putative mature recombinant CPA63 (r-CPA63) was
produced upon autolysis by incubation in acetate buffer (pH 3.3), and used for
ELISA experiment. Its proteolytic activity was tested using FITC-casein as a
substrate at different pHs, and substrate specificity was evaluated by using
series of protease inhibitors.
Results: CPA63 cDNA encoded a 472 amino acid polypeptide with calculated
molecular weight and isoelectric point of 51.1 kDa and 4.69, respectively.
Homology search revealed that CPA63 polypeptide sequence showed about
40% identity with plant aspartyl protease/nucleoid DNA binding protein
family members. ELISA demonstrated that purified r-CPA63 was recognized
by pollinosis patient IgE at a frequency of 58% (18/31). The r-CPA63 also
showed an aspartyl protease-like proteolytic activity, demonstrating its
enzymatic maturation upon autolysis.
Conclusion: CPA63 is the first plant aspartyl protease identified as an allergen.
That might well open new investigations for other plant aspartyl protease
allergens. The availability of CPA63 sequence and recombinant allergen




Coagulation factor XII (Hageman factor): a new
angioedema gene
Georg Dewald and Konrad Bork. Johannes-Gutenberg University, Depart-
ment of Dermatology, Mainz, Germany.
Background: Hereditary angioedema (HAE) is characterized by recurrent
skin swelling, abdominal pain attacks, and potentially life-threatening upper
airway obstruction. The classic HAE types (I and II) are caused by mutations
in the complement C1 inhibitor gene, resulting in a quantitatve or qualitative
deficiency of C1 inhibitor. In contrast, in a novel HAE type, affecting mainly
women, C1 inhibitor concentration and activity in plasma are normal (HAE
type III, HAE with normal C1 inhibitor); we hypothesized that an abnormal
coagulation factor XII molecule may lead to inappropriate activation of the
kinin-forming cascade and, therefore, performed a search for mutations in the
F12 gene.
Methods: Twenty unrelated index patients from families with hereditary
angioedema and normal C1 inhibitor activity were screened for mutations in
the coagulation factor XII gene by sequencing of the 14 exons and splice
junctions of the F12 gene; subsequently, beside 235 control individuals,
another six such index patients as well as 90 patients with idiopathic
angioedema were selectively sequenced for exon 9 of the F12 gene.
Results: Two different non-conservative missense mutations, both located in
exactly the same position within exon 9, namely in the second position of the
codon (ACG) encoding Thr309 of the mature protein, were identified. Five of
the twenty patients screened showed a heterozygous CYA transversion
(1032CYA), predicting a threonine-to-lysine substitution (Thr309Lys); one
additional patient showed a heterozygous CYG transversion (1032CYG),
resulting in a threonine-to-arginine substitution (Thr309Arg). Sequencing of
exon 9 in another six index patients revealed one further patient heterozygous
for the Thr309Lys mutation. Thus, in 7 of 26 unrelated patients the wild-type
threonine is substituted by a basic amino acid residue. The mutations were not
found in healthy control individuals (n = 235) and co-segregated with the
phenotype in seven families with altogether 23 affected women, providing
strong support that they cause disease. Finally, the Thr309Lys mutation was
also identified in 2 out of 90 patients with idiopathic angioedema; thus, this
mutation may also play a role in a subgroup of these singular angioedema
cases with no affected family members.
Conclusion: These findings provide strong support that the coagulation factor
XII gene is a new angioedema gene.
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Subcutaneous DX-88 (ecallantide) in the treatment of acute
attacks of hereditary angioedema: interim results of EDEMA3\,
an open-label, phase 3 trial
H. Henry Li1, Robyn Levy2, Don McNeil3, Thomas Beck4, and Jennifer
Roberts5. 1Institute for Asthma and Allergy,-, Wheaton, Maryland, United
States; 2Family Allergy and Asthma Center, PC, Atlanta, Georgia, United
States; 3Optimed Infusion Services, Optimed Research, LLC, Columbus, Ohio,
United States; 4Dyax Corp., Clinical Affairs, Cambridge, Massachusetts,
United States; 5Dyax Corp., Clinical Operations, Cambridge, Massachusetts,
United States.
Background: Disinhibition of kallikrein results in excess of bradykinin and is
responsible for signs and symptoms of hereditary angioedema (HAE). The
highly potent, specific plasma kallikrein inhibitor, DX-88 (ecallantide) has
been shown to ameliorate symptoms of HAE.
Methods: Patients 10 years of age or older with documented HAE (12 naBve
patients and 48 patients who were treated for a single acute HAE attack in the
double-blind, placebo-controlled stage of EDEMA3) participated in this open-
label extension. Patients were given 30 mg DX-88 to treat acute HAE attacks at
all anatomic site locations- abdominal, peripheral, and laryngeal. Outcome
measures at 4 and 24 hours were the HAE-specific Treatment Outcome Score
(TOS) and change from baseline in Mean Symptom Complex Severity
(MSCS) score. TOS and MSCS are composite scores measuring all attack
sites. Time to onset of response and time to significant improvement in overall
response were recorded. Safety was assessed by treatment-emergent adverse
events (TEAEs) and serious adverse events (SAEs).
Results: Interim data are presented for 59 patients treated for 145 acute HAE
attacks (20 men, 39 women, median age 34.0 years, range 12Y77 years). Mean
TOS was 75.3 T 39.64 at 4 hours and 81.8 T 36.55 at 24 hours (Q 50=
improvement). Mean MSCS change from baseline was j2.3 T 0.6 at both 4
and 24 hours (j1 toj3 = clinically-significant improvement). Median time to
onset of overall improvement was 37.5 minutes, and time to onset of
significant overall improvement was 165.0 minutes. Safety data for 51 patients
included 166 TEAEs (87% mild or moderate in severity and 89% resolved
without sequelae), with 30 related TEAEs in 15 patients. Related events
experienced by more than 1 patient include diarrhea, nausea, injection site
reaction (3 patients each), HAE, myalgia, headache, cough, and pruritus (2
patients each). A total of 7 SAEs occurred in 7 patients; 6 were unrelated to
DX-88, and 1 SAE of anaphylactic reaction reported previously, was assessed
as related, and resolved without sequelae.
Conclusion: Repeat dosing of DX-88 (ecallantide) for acute HAE attacks
resulted in onset of overall improvement in G40 minutes and significant overall
improvement in G3 hours. Ecallantide was generally well tolerated with the
majority of adverse events being mild or moderate in severity and resolved
without sequelae.
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Clinical symptoms and treatment in hereditary angioedema with
normal C1 inhibitor
Konrad Bork, Do¨ndu¨ Gu¨l, Georg Dewald, and Petra Staubach. University of
Mainz, Dermatology, Mainz, Germany.
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Background: A new type of hereditary angioedema was described recently. It
was characterized by recurrent bouts of angioedema in various organs and
normal C1 inhibitor and was observed mainly in women. Our aim was to
conduct a detailed study of the clinical features of this condition.
Methods: A total of 138 patients with hereditary angioedema and normal C1
inhibitor who belonged to 43 unrelated families were examined through the
use of standardized questionnaires.
Results: A majority of patients with hereditary angioedema and normal C1
inhibitor had skin swellings (92.8%), tongue swellings (53.6%), and
abdominal pain attacks (50%). Laryngeal edema (25.4%) and uvular edema
(21.7%) also were frequent, whereas edema episodes of other organs were rare
(3.6%). Facial swellings and tongue involvement occurred considerably more
frequently compared with hereditary angioedema due to C1 inhibitor
deficiency. The number of patients with recurrent edema of only one organ
was higher than in classic hereditary angioedema. The number of patients with
disease onset in adulthood was significantly higher in hereditary angioedema
with normal C1 inhibitor compared with classic hereditary angioedema.
Erythema marginatum was not observed. A subgroup of patients from families
with coagulation factor XII mutations showed the same symptoms as the other
patients. Long-term treatment consisted in tranexamic acid and attenuated
androgens.
Conclusion: Hereditary angioedema with normal C1 inhibitor levels shows a
characteristic pattern of clinical symptoms. The main clinical features include
skin swellings, tongue swellings, and abdominal pain attacks. There are many
differences in the clinical symptoms and course of disease between this type of
hereditary angioedema and classic hereditary angioedema due to a genetic C1
inhibitor deficiency.
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Skin reactivity to autologous serum and safety of COX-2
inhibitors in NSAID-intolerant patients with urticaria and/or
angioedema
Mauro Cancian, Raffaele Bendo, Elena Ossi, and Giuseppe Realdi. Clinica
Medica 1 - University of Padova, Medical and Surgical Sciences Department,
Padova, Italy.
Background: Pseudoallergic reactions (PAR) to non-steroidal antiinflamma-
tory drugs (NSAID) are very common in chronic urticaria (CU), as aspirin and
related drugs impair symptoms in about 20Y30 % of patients. Moreover, a
group of otherwise normal subjects who develop urticaria and/or angioedema
(UA) only after the intake of NSAIDs also exists. Although the inhibition of
cyclo-oxigenase (COX) pathway seems to play a central role in NSAID-
intolerance, a very high prevalence of skin reactivity to autologous serum (AS)
has also been reported in NSAID-induced UA, pointing to a possible
involvement of the immune system in the pathogenesis of these forms.
Methods: 50 patients who had experienced NSAID-induced UA were
recruited and gave their informed consent. 28 had a history of CU exacerbated
by NSAIDs, whereas the remaining 22 reported acute UA after NSAIDs
intake. In 26 cases, UA had been elicited by a single NSAID, whilst 24 patients
signalled adverse skin reactions to two or more COX-inhibitors. None of the
patients presented nasal polyps, nor had evidence of asthma or sinusitis. Oral
tolerance tests were conducted on different days by single-blind, placebo
controlled challenge with increasing amounts of both conventional (nimesu-
lide, 100 mg whole dose; meloxicam, 15 mg), and highly selective (celecoxib,
400 mg; eterocoxib, 90 mg) COX-inhibitors. The test was continued until the
whole dose was reached, or UA appeared. Furthermore, skin reactivity to AS
was assessed in all subjects in basal conditions, as well as whenever challenge-
induced adverse reactions occurred.
Results: No patients developed skin symptoms on the placebo day, and 28
tolerated each of the four COX-inhibitors. 16 experienced UAwith nimesulide,
8 with meloxicam, 4 with celecoxib and 2 with eterocoxib. Only 4 patients
with CU showed a positive cutaneous response to AS, whilst in the other
subjects skin tests with both basal serum and samples collected during
challenge-induced UA always elicited negative results.
Conclusion: Our findings confirm that highly selective COX-inhibitors
represent the safest anti-inflammatory drugs in NSAID-induced UA, although
it is well known that coxib intake is not recommended in subjects with renal
or cardiovascular diseases. Moreover, these results strengthen the concept
that cutaneous reactivity to AS is almost exclusively confined to chronic
urticaria, and that autoimmunity is not involved in the pathogenesis of
NSAID-induced PAR.
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Treatment of skin swellings with pasteurized C1 inhibitor
concentrate in patients with hereditary angioedema
Petra Staubach and Konrad Bork. University of Mainz, Dermatology, Mainz,
Germany.
Background: C1 inhibitor concentrate is highly effective in treating laryngeal
edema and abdominal pain attacks in patients with hereditary angioedema due
to C1 inhibitor deficiency. Aim was to assess the efficacy and safety of a
pasteurized human C1 inhibitor concentrate in skin swellings of hereditary
angioedema.
Methods: Between 1976 and 2007, a total of 2,104 skin swellings in 47
patients were treated with 500 (1704 attacks) or 1,000 units (400 attacks) of the
C1 inhibitor concentrate. The time to relief, the duration of the swelling, and
the severity of symptoms were documented during personal interviews using
standardized questionnaires and compared to 9.144 untreated skin swellings in
the same patients.
Results: The 1,912 treated skin swellings affected face (483 attacks), hands
and arms (831 swellings), feet and legs (638 swellings), genitals (123
swellings), and the trunk (29 swellings). The mean time to relief of symptoms
was 1.3 hours (SD 1.4 hours) in all treated skin swellings versus 59.8 hours
(SD 27.1 hours) in all untreated swellings. The mean duration of the swellings
was shortened from 85.1 hours (SD 41.2 hours) (untreated swellings) to
39.3 hours (SD 30.2 hours) (treated swellings). All patients responded to
treatment. In 24 skin swellings of 4 patients the course of the treated swellings
was not shortened but symptoms were milder compared to untreated skin
swellings. C1 inhibitor concentrate was more effective when injected early in
the attacks compared to late injections. There were no drug-related side effects.
Conclusion: The pasteurized C1 inhibitor concentrate is highly effective and
safe in treating skin swellings in patients with hereditary angioedema.
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Association of TNF-" promoter polymorphisms with
aspirin-induced urticaria
Jeong-Hee Choi1, Seung-Hyun Kim2, Bo-Young Jo2, Hae-Ran Lee3, Jae-Chun
Lee4, and Hae-Sim Park2. 1Kangdong Sacred Heart Hospital, Hallym
University, Dept of Internal Medicine, Seoul, Republic of Korea; 2Ajou
University Hospital, Department of Allergy and Rheumatology, Suwon,
Republic of Korea; 3Kangdong Sacred Heart Hospital, Hallym University,
Department of Pediatrics, Seoul, Republic of Korea; 4Cheju national
university, Dept of Internal Medicine, Cheju, Republic of Korea.
Background: Although the pathogenesis of aspirin-induced urticaria(AIU)
has not been fully understood, mast cell activation was noted in patients with
aspirin hypersentivity. Tumor necrosis factor(TNF)-", a potent pro-inflamma-
tory cytokine is released by human skin mast cells and other inflammatory
cells, which was detected on the skin lesion of chronic urticaria. To investigate
the role of TNF-" promoter polymorphisms in the development of AIU, we
performed association study of the TNF-" promoter polymorphisms with AIU
phenotype.
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Methods: 239 patients with AIU and 524 normal controls were enrolled from
the Ajou University Hospital in Suwon, Korea. 120 patients of the AIU had
underlying chronic urticaria with more than 6 weeks duration (AICU). AIU
was confirmed by oral aspirin challenge test. Five SNPs in the TNF-"
gene (-1031T9C,-863C9A,-857C9T,-308G9A,-238G9A) were genotyped
by a single base extension method. Haplotype analyses were done.
Results: The genotype frequencies of TNF-1031T9C and TNF-863C9Awere
significantly higher in the AIU patients than in the normal controls in co-
dominant (p = 0.014, p = 0.007) and dominant (p = 0.007, p = 0.004) models,
respectively. The frequency of TNF-ht2[CACGG] was significantly higher in
the AIU patients (20.9%) than in the normal controls (14.5%, p = 0.004).
Conclusion: These findings suggest that the TNF-" promoter polymorphisms
(TNF-1031T9C andTNF-863C9A)may contribute to the development of AIU.
NEW INSIGHTS IN OCCUPATIONAL ALLERGY
AND ASTHMA
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Molecular and immunological characterization of a wheat serine
proteinase-inhibitor as a novel allergen in baker`s asthma
Claudia Constantin1, Santiago Quirce2, Alisher Touraev3, Ines Swoboda4,
AdrianoMari5, Josef Thalhamer6, Erwin Heberle-Bors3, and Rudolf Valenta4.
1Medical University of Vienna, Dep. Pathophysiology, Vienna, Austria;
2Universidad Auto´noma de Madrid, Allergy Department Fundacio´n Jime´nez
Dı´az, Madrid, Spain; 3University of Vienna, Max F. Perutz Laboratories,
Vienna, Austria; 4Medical University of Vienna, Dep. of Pathophysiology,
Vienna, Austria; 5IDI-IRCCS, Center for Clinical and Experimental
Allergology, Rome, Italy; 6Universita¨t Salzburg, Fachbereich Molekulare
Biologie, Salzburg, Austria.
Backround: Immunoglobulin E-mediated sensitization to wheat flour belongs
to the most frequent causes of occupational asthma.
Methods: In order to identify allergens involved in baker`s asthma we have
constructed a cDNA library from wheat seeds and screened the library with
serum IgE from patients with baker`s asthma. The recombinant allergen was
expressed in Escherichia coli and purified to homogeneity.
Results: One phage clone specifically recognized by baker`s asthma patients
contained a full length cDNA coding for an allergen with a molecular weight
of 9.9 kDa and a pI of 6 which according to sequence analysis could be
identified as a member of the potato inhibitor I family, a group of serine
proteinase inhibitors conserved throughout the plant and animal kingdom.
According to circular dichroism analysis it represented a soluble and folded
protein containing mainly $-sheets, random coils and an alpha helical element
and high thermal stability. The recombinant allergen showed allergenic activity
and reacted specifically with IgE from bakers` asthma patients but not with IgE
from grass pollen allergic patients or patients suffering from food allergy to
wheat. Using allergen-specific rabbit antibodies it is demonstrated that the
protein is mainly expressed in mature wheat seeds and, despite an overall
degree of approximately 50% sequence identity, showed no relevant cross-
reactivity with plant food sources such as maize, rice, bean or potato.
Conclusion: Recombinant wheat serine proteinase inhibitor may be useful for
the diagnosis and therapy of IgE-mediated baker`s asthma.
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Gum arabic as a cause of occupational allergy and other
allergic symptoms
Arja Viinanen1, Kaija Lammintausta2, and Maija Salokannel3. 1Turku University
Hospital, Department of Pulmonary Diseases, Turku, Finland; 2Turku University
Hospital, Department of Dermatology, Turku, Finland; 3Medical Center
Mehila¨inen, Occupational Health Service Unit, Turku, Finland.
Background: Gum arabic is used as an emulsifier, a thickening agent and as
stabilizer in foods, in pharmaceutical industry, lithography and cosmetics.
Exposure to gum arabic has been reported to cause occasional cases of
occupational asthma, but ingestion of it does not commonly cause immediate
allergic symptoms.
Methods: In 2005 - 2006 11 workers of a candy factory were examined for
suspected occupational allergy. Hard boiled candies were covered with spray
dried gum arabic in rotating drums, where the workers poured the gum arabic
powder. 7/11 had respiratory and skin symptoms and 4 had skin symptoms.
Spirometry, histamine challenge test, exhaled breath NO and PEF measure-
ments, skin prick tests (SPT), gum arabic IgE measurements and cutaneous or
bronchial challenge tests with gum arabic were carried out. Patch tests were
carried out to a patient with eczematous skin disease. In addition, SPT data
from 2997 subjects examined for food allergy symptoms from 1998 to 2006
were evaluated. Subjects with positive SPT to gum arabic received a postal
questionnaire.
Results: Four workers had occupational asthma caused by gum arabic. All of
them had a positive SPTwith gum arabic and specific IgE to gum arabic (0.60-
5.6 kU/l). Three patients had a positive bronchial challenge test with gum arabic
and one of them had a positive skin challenge test. One patient had significant
PEF decrease when exposed to gum arabic at work, a positive skin challenge
and immediate oral symptoms associated with ingested gum arabic. None of
them had other significant allergies. One worker had contact dermatitis caused
by thiuram chemicals and another with positive SPT to house dust mites had
work related allergy to carmine red used in candies. Five workers had no
occupational disease. Of patients tested for food allergies 17/2997 (0,005%)
had positive SPT to gum arabic and most of them also had positive SPT to
pollen and foods. 11/17 (65%) returned the questionnaire. At the time of skin
testing gum arabic associated allergic symptoms were suspected in three, and
two reported gum arabic ingestion associated oral symptoms in the ques-
tionnaire. One gum arabic SPT positive patient without respiratory symptoms
had an occupational history of work in a candy factory for years ago.
Conclusion: Occupational allergy caused by IgE mediated allergy to gum
arabic is a risk in exposure occupations. Ingested gum arabic causes symptoms
in few patients.
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Determinants of elevated exhaled nitric oxide (eNO) among
bakery workers in South Africa
Roslynn Baatjies and Mohamed Jeebhay. University of Cape Town, Occu-
pational and Environmental Health Research Uni, Cape Town, South Africa.
Background: Measurement of the concentration of NO in exhaled air (eNO)
is a useful non-invasive method of assessing inflammatory airway disease.
This has a potential widespread utility as an early marker for occupational
allergy and asthma in the surveillance of workers exposed to respiratory
sensitisers. The aim of this study was to determine the predictors of elevated
exhaled nitric oxide and their correlation with ocular-nasal and asthma
symptoms among bakery workers.
Methods: A cross-sectional study of 417 bakers was conducted in 31
supermarket bakeries. Baseline demographic and occupational data as well as
work-related respiratory symptoms were collected using an interviewer-based
questionnaire. A hand-held portable nitric oxide sampling device (NIOX
MINO\ Airway Inflammation Monitor; Aerocrine AB, Solna, Sweden) was
used to determine eNO concentrations, during the workshift, according to
ATS/ERS recommendations (2005).
Results: The mean age of the bakers was 33 years and 44% were current
smokers. The prevalence of recent chest infections (past 3 weeks) was 35%,
whilst 16% reported wheezing and 29% ocular-nasal symptoms in the past 12
months. The prevalence of work-related symptoms was higher for ocular-nasal
(39%) than chest (15%) symptoms. The mean eNO was 25ppb, with 19%
demonstrating moderately increased (21Y35ppb) and 17% high (935ppb) eNO
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levels. In the univariate analysis, age (OR: 0.97), male gender (OR: 1.80),
current cigarette smokers (OR:0.54), exercise (OR:2.56) and recent chest
infections (OR:2.29) were significantly (pG0.05) associated with high
(935ppm) eNO levels. In the multivariate analysis, after adjusting for potential
confounders (age, gender, smoking, recent chest infections), workers with high
eNO levels (935ppb), were twice as likely to report wheezing (OR: 2.54) or
ocular-nasal symptoms (OR: 1.98) in the past 12 months and three times
(OR:3.45) more likely to report work-related ocular-nasal symptoms.
Conclusion: This is the first study to demonstrate increased eNO levels among
supermarket bakery workers. Markedly elevated eNO (935ppb) could be used
as a marker for work-related ocular-nasal symptoms and recent wheeze. Its
utility in identifying bakery workers with work-related wheeze needs further
investigation.
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An investigation of respiratory hypersensitivity and work related
allergens on pig slaughters in Taiwan
Yin-Mei Chiung1, Pei-Shan Liu2, and Yu-Tien Liu3. 1Institute of Occupational
Safety and Health, Division of Medicine, Taipei, Taiwan; 2Soochow University,
Department of Microbiology, Taipei, Taiwan; 3National Defense medical Center,
Department of Microbiology and Immunology, Taipei, Taiwan.
: The prevalence of respiratory sensitization among 213 pig slaughters in
Taiwan was investigated through questionnaire and health examination.
Following the allergic syndromes, lung function, MAST test and ELISA, a
work related hypersensitivity was suggested.
It showed about forty percent of the investigated workers contact pig
exudates, over four hours long in their workdays. Almost all of the workers
were not used to wear masks. About 26% of the workers exhibited bad
function of lung and most of them exhibited the restriction type. Among the
35.7% workers having allergic problems, most of that were related to their
working places. Possible allergens were postulated to be pig exudates sources
mainly. From the results of MAST of eighty workers, the respiratory
hypersensitivity are statistically significant with the positive reacted IgE
against Candida albicans, cat dander, especially in some special work kinds or
areas, such as: main bone cutting, body translocation, bleeding out.
Among the serum samples of sensitized workers, 56% were positively
against protein components of pig plasma, and hundred percent to components
of pig saliva. Workers who claimed being allergic showed high positive rate to
IgE titers specific to animal exudates, otherwise, those workers also exhibited
holiday recovery effects mostly.
In SDS-gel electrophoresis, Special components may be evaluated as
antibody biomonitoring factor on exposure assessment, such as components
with MW 55K, 37K, and 32K Da, that were significantly different between
exposed workers and control group.
Two-dimension acrylamide gel electrophoresis was performanced,
using immunoblot analysis, specific IgE binding components in pig salivawere
found.We postulated that might be animal specific allergens. After excising the
reactive spots, we use mass spectrometry to identify those allergenic com-
ponents in pig saliva.
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Evaluation of sensitization in a population of professional
catering students
Manfredi Montalti, Mario Angelo Sanchez, Enrico Luchetti, Marika
Filippousi, Vincenzo Cupelli, and Giulio Arcangeli. University of Florence,
Occupational Health, Firenze, Italy.
Background: The intention of our study is to evaluate the incidence of allergic
problems in a population of catering students at the beginning and at the end of
their course, with the aim of defining certain clinical parameters which may be
considered as risk or prognostic factors for the future emergence of an
occupational allergy.
Methods: We enrolled in the study 601 students of a professional catering
school: 412 in the first year (14/15 years old) and 189 in the fifth years (18/
19 years old). We used a questionnaire for respiratory problems and another for
dermatological ones. 424 subjects were also patch tested with 10 aptens.
26 students were retested 2 years later (16/17 years old) their first patch control.
Results: The incidence of reported symptoms of allergy was higher in fifth year
than in first one. We noticed an increase of referred contact urticaria reaction
due to food contact in fifth year students in comparison to the first year ones.We
could observe a rising in positive reaction between first year students and fifth
year students to Balsam Peru`, Nickel, Fragrance mix and Garlic. In particular
we found an higher incidence of positive patch reaction in female population.
On the contrary the rising in positive reaction to Garlic is higher in male. About
two third of the subjects positive to Garlic present a sensitization to Diallyl
Disulphide. The data related to the group of students retested after 2 years
reveal an higher incidence of positive patch tests reactions (p G 0.05), especially
for Garlic (p G 0.05).
Conclusion: The rising of positive patch test reactions to Garlic and Balsam
Peru` should be caused by the contact with cooking spices. We hypothesize that
the increase in positive reactions to garlic in the male group could depend on
manipulation of garlic in the trainee period; females do not show similar
results, perhaps due to a precedent of cooking activity at home. The higher
incidence of allergic pathology between students during fifth year of school
and students at first year was probably due to scholastic practical activity. To
understand if other garlic antigen are involved in sensitization, we want to TLC
patch test who were positive to garlic and negative to Diallyl Disulphide. The
study will continue following the first year students, repeating the tests in the
third and the fifth year of school in order to highlight the variations in positive
skin reactions to allergens handled during cooking activities.
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Genetic polymorphisms of ADRB2 and IL10 can be associated
with the risk of IgE sensitization to digestive drug powders in
exposed medical personnel
Young-Min Ye1, Sang-Hoon Kim2, Sang-Ha Kim3, Gyu-Young Hur4, Hyun-
Young Lee4, Seung-HyunKim4, andHae-Sim Park4. 1Yonsei University Health
System, Pharmacology, Seoul, Republic of Korea; 2Eulji University School of
Medicine, Internal Medicine, Seoul, Republic of Korea; 3Yonsei University
Wonju College of Medicine, Internal Medicine, Wonju, Republic of Korea;
4Ajou University School of Medicine, Allergy and Rheumatology, Suwon,
Republic of Korea.
Objective: It has been reported that digestive drug powders could induce IgE
mediated respiratory allergy in the medical personnel. The aim of this study
was to evaluate genetic susceptibility factors associated with IgE sensitization
to digestive drug powders in medical personnel.
Methods: We performed a case-control study involving 38 subjects with dig-
estive allergy, 115 asymptomatic exposed subjects and 123 non-exposed
controls working University Hospitals. Digestive allergy was determined by
results of serum specific IgE measured by ELISA and skin prick tests with
5 commonly exposed drugs. 10 single nucleotide polymorphism (SNP)s: beta2
adrenergic receptor (ADRB2 46A9G), high-affinity IgE receptor alpha chain
(FCERIA-344C 9 T, FCERIA-95T 9 C, FCER1B-109T 9 C, FCER1B
237A 9 G), transforming growth factor beta1 (TGFb1-509C 9 T), interleukin
10 (IL10-1082A 9 G), cysteinyl leukotriene receptor type 1 (CYSLTR1-
634C 9 T), cysteinyl leukotriene receptor type2 (CYSLTR2-2079C 9 T,
CYSLTR2-2534A 9 G) were genotyped using a single base extension method.
Results: Among the 10 SNPs, we found two distinct significant associations
with digestive allergy in exposed medical personnel; the AA genotype of
ADRB2 46 A 9 G (p = 0.016, OR = 3.045, CI: 1.229Y7.554), and the AG and
GG genotype of IL10 -1082 A 9 G (p = 0.008, OR = 5.081, CI: 1.517Y17.025,
bymultiple logistic regression analysis controlling for age, atopy andworkplace).
Conclusion: These results suggest that genetic polymorphisms in the ADRB2
46A 9 G and IL10 -1082 A 9 G may be genetic factors to increase IgE




Specific immunotherapy for allergic respiratory diseases:
evidence based evaluation
M Penagos1, E Compalati1, F Tarantini1, F Frati2, G Passalacqua1, and GW
Canonica1. 1Allergy & Respiratory Diseases Clinic, Genoa University,
Department of Internal Medicine, Genoa, Italy; 2Stallergenes, Milan, Italy,
Scientific Dept., Milano, Italy.
Background: According to Evidence based medicine (EBM), conclusions
frommeta-analyses of randomized and controlled trials represent themost solid
source to assess the efficacy of a treatment. Meta-analysis is a statistical
procedure that incorporates the results of different independent studies pooled
together, provides a quantitative estimate of treatment effects, and may explain
and quantify the heterogeneity between results of individual studies.
Objective: To evaluate the efficacy of allergen specific immunotherapy (SIT) in
the treatment of allergic asthma and rhinitis by means of available meta-analyses.
Methods: Electronic databases were searched up to January 31st, 2007, for
meta-analysis of randomized, double-blind and placebo-controlled trials
assessing specific immunotherapy in respiratory allergy. We looked for
studies evaluating the effects on symptom scores and use of rescue medication,
using standardized mean differences (SMD) and the random-effect model. The
individual meta-analysis quality was evaluated following the Cochrane group
and the QUORUM statement recommendations.
Results: Six meta analyses met the inclusion criteria. Four studies evaluated
sublingual (SLIT) and two subcutaneous (SCIT) immunotherapy. All of them
reported a reduction in both symptom and medication scores; but one study did
not find a significant size effect because of studies` inclusion criteria. SMD for
symptoms score and rescue medication are shown in table. Heterogeneity was
significant in all five included reviews. Studies about SCIT in both allergic
rhinitis and asthma are in progress, but results are not available at the moment.
Conclusion: The final conclusion from the present review is a general
acceptance of Allergen Specific Immunotherapy efficacy using the criteria of
Evidence Based Medicine. Nonetheless, we should look forward, the GRADE
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evaluation, taking in consideration efficacy but also safety and costs, will
probably support even more SLIT as the best option. Specific studies are
presently ongoing to apply this new evaluating system to SIT. Finally, the
recent SIT and SLIT studies, with a relevant number of patients, further
support the conclusions obtained through the meta- analysis evaluation.
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Efficacy and safety of grass allergen tablets in patients with grass
pollen rhinoconjunctivitis of differing severity profiles
Hans-Jorgen Malling1, Michel Melac2, Armelle Montagut3, and Alain Didier4.
1National University Hospital, Laboratory of Medical Allergy, Copenhagen,
Denmark; 2Stallergenes, Medical Department, Antony, France; 3Consultant,
Delta Consultants, Meylan, France; 4Larrey Hospital, Chest Department,
Toulouse, France.
Background: The efficacy, safety and optimal dose of grass pollen tablets for
sublingual immunotherapy (SLIT) in allergic rhinoconjunctivitis patients were
investigated in a multinational, randomised, double-blind, placebo-controlled
study in 628 adults. We present the results of further analyses in subgroups of
the original study population.
Methods: Patients were randomised to receive once-daily five-grass-pollen
extract sublingual tablets (Stallerge`nes, Antony, France) of 100 IR (n = 157),
300 IR (n = 155) or 500 IR (n = 160), or placebo (n = 156) for 6 months. Four
sensitivity subgroups were identified. Group 1: Patients with a baseline
immunoglobulin E (IgE) 917.5 kU/L, Group 2: patients with a Retrospective
Rhinoconjunctivitis Total Symptom Score (RRTSS) 915 (the third quartile);
Group 3: Patients with a baseline skin prick test (SPT) wheal diameter
910.5 mm (the third quartile); Group 4: patients with at least one of the above
characteristics. An exploratory analysis was performed on the primary efficacy
outcome, the effect of SLIT on the Rhinoconjunctivitis Total Symptom Score
(RTSS), and adverse event (AE) data.
Results: Across the four subgroups average RTSS scores were Group 1: 3.91
[SD: 3.157] to 4.86 [SD: 3.252], Group 2: 3.83 [SD: 3.135] to 5.34 [SD:
3.049], Group 3: 2.55 [SD: 2.127] to 5.56 [SD: 3.066] and Group 4: 3.61 [SD:
2.967] to 4.94 [SD: 3.188]). Group 3 patients receiving 100 IR differed from
all other treatment groups because rhinorrhoea, rather than sneezing, achieved
the highest average score.
The analysis of covariance (ANCOVA) showed that in Group 1 patients
the average RTSS did not differ significantly with different doses of SLIT
(p = 0.2032). In Groups 2, 3 and 4, doses of 300 IR and 500 IR were more
effective than 100 IR and placebo (p G 0.0346).
The relative safety profiles of the four treatments were similar across all
four subgroups. All doses of SLITadministered in this study can be considered
safe in the patients investigated.
Conclusion: Regardless of severity profile or sensitisation status (high specific
IgE, skin sensitisation or severe clinical symptoms), both 300IR and 500IR
demonstrated a significantly improved RTSS, compared with placebo. In
agreement with previously reported data, the risk-benefit ratio validates the use
of 300IR tablets for clinical practice in all these patient sub-groups.
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Sublingual immunotherapy with grass pollen tablets
demonstrated clinical efficacy in patients with
rhinoconjunctivitis from the first pollen season, at peak season
and throughout the season
Friedrich Horak1, Siegfried Jager2, Margitta Worm3, Michel Melac4, and Alain
Didier5. 1Allergy Center Vienna West, -, Vienna, Austria; 2Medical University
of Vienna, Ear, Nose and Throat Clinic, Vienna, Austria; 3Charite´
Universita¨tsmedizin, Dpt. Dermatology and Allergy, Berlin, Germany;
4Stallergenes, Medical Department, Antony, France; 5Larrey Hospital,
Respiratory Diseases Department, Toulouse, France.
Background: The optimal dose (300IR) of a 5 grass-pollen sublingual
immunotherapy tablet was previously demonstrated in terms of efficacy and
quality of life from the first pollen season. Here we aim to confirm whether this
dose remained optimal during the peak of the pollen season by assessing
efficacy and quality of life data.
Methods: 628 patients with grass pollen rhinoconjunctivitis were randomised
in a double-blind, placebo-controlled, multi-centre, pan-European trial.
Patients received once-daily tablets (Stallergenes, Antony, France) of 100IR,
300IR, 500IR or placebo, starting 4 months before and throughout the 2005
grass pollen season. The pollen season was defined as the first day of three
consecutive days with a grass pollen count above 30 grains/m3 of air, recorded
using Burkard-type volumetric pollen traps, to the last day before three
consecutive days with a pollen count below 30 grains/m3.
Results: The grass pollen season lasted an average of 30 days, with the peak of
the season lasting for 12 days. Of the 42 sites, the Czech sites had the longest
pollen season (22 to 44 days) and the Hungarian sites had the shortest season
(8 to 36 days). The mean treatment duration before the grass pollen season was
similar in the four treatment groups (121.4T31.1 to 128.6T15.4 days in the
safety population). Both the 300IR and 500IR groups had highly significant
improvements in Rhinoconjunctivitis Total Symptom Score (RTSS) versus
placebo at the peak pollen season (p = 0.0005 and p = 0.0014 respectively),
which agreed with improvements in RTSS in the primary efficacy evaluations.
The average RTSS scores were slightly elevated during the peak pollen season
in all treatment groups. Comparisons of efficacy, using only the 10 pooled sites
with the highest pollen counts, also showed statistically significant improve-
ments in the 300IR and 500IR groups versus placebo, but no statistically
significant difference between the 100IR group and placebo. The overall
RQLQ score was highly significantly improved in the 300IR and 500IR groups
versus the placebo group at peak (p G 0.0001) and at the end (p 9 0.0031) of
the pollen season. All doses were well tolerated.
Conclusion: At the peak pollen season, efficacy and quality of life data for
both 300 IR and 500 IR groups was significantly improved versus the placebo
group. These results confirm the conclusions of the primary evaluations and
validate the use of 300IR tablets for clinical practice.
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SQ-standardised grass (phleum pratense) allergen tablet
improves disease specific quality of life in adult patients with
grass pollen induced rhinoconjunctivitis over 2 years of
continuous treatment
Moises Calderon1, Lisbet Groes2, and Ronald Dahl3. 1Royal Brompton
Hospital, Section of Allergy and Clinical Immunology, London, United King-
dom; 2ALK-Abello´ A/S, Research and Development, HLrsholm, Denmark;
3Aarhus University Hospital, Department of Respiratory Diseases, Aarhus,
Denmark.
TABLE 1. Characteristics of the Control and Patients With CPMeta-analysis Disease SIT Number of patients Symptoms score SMD (95% CI) Rescue medication score SMD (95% CI)
Abramson MJ 2003 asthma SCIT 1064 j0.72 (j0.99 a j0.44), p G0.001 j0.80 (j1.13 to j0.48), pG0.001
Calamita Z 2006 asthma SLIT 303 j0.38 (j0.79 to 0.03), p = 0.07 j0.82 (j1.25 to j0.39), p=0.0002
Canonica GW 2007 asthma SLIT 412 j1.42 (j2.25 to j 0.59), p = 0.02 j1.63 (j2.83 to 0.44), p=0.007
Calderon M 2007 rhinitis SCIT 1063 j0.73 (j0.97 to j0.50), p G 0.001 j0.57 (j0.82 to j0.33), pG0.001
Penagos M 2006 rhinitis SLIT 484 j0.56 (j1.01 to j0.10), p = 0.02 j0.76 (j1.46 to j0.06), p=0.03
Wilson DR 2005 rhinitis SLIT 979 j0.42 (j0.69 to j0.15), p = 0.002 j0.43 (j0.63 to j0.23), p=0.0003
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Background: Grass pollen allergy is one of the commonest inhalant allergies
leading to impaired quality of life (QoL) and increased health care expenditure,
with as many as 50% of respiratory allergic patients being allergic to grass pollen.
70% of allergic patients feel that allergy limits their QoL. Specific immunotherapy
(SIT) is currently the only treatment modality able to change the underlying
mechanisms of allergic disease and thereby prevent allergic symptoms.
Methods: Disease specific QoL (Juniper’s Rhinoconjunctivitis Quality of Life
Questionnaire (RQLQ)) data from a randomised, double-blind, placebo
controlled, multi-centre trial, including patients with significant rhinoconjunc-
tivitis due to grass pollen, were analysed. Patients were followed for a 2 year
period, where they were randomised to receive the SQ-standardised grass
allergen tablet (SQsGAT), (ALK-Abello´ A/S), or placebo. Both groups had
access to Bas needed[ symptomatic treatments for their rhinoconjunctivitis.
Second year data on average weekly RQLQ score was available for 351
patients, SQsGAT (n = 189) and placebo (n = 162).
Results: Overall mean RQLQ score was significantly better in the SQsGAT
treated patients compared to placebo (33%, pG0.0001). Analysis of the
individual domains within the RQLQ questionnaire showed that the SQsGAT
improved all 7 domains compared to placebo.
*Median value
Conclusion: These results demonstrate that in adult patients with grass pollen
induced rhinoconjunctivitis, the SQ-standardised grass (phleum pratense)
allergen tablet after 2 years of continuous treatment offers improvements in the
overall RQLQ score and in all 7 individual RQLQ domains compared to
placebo. Resulting in clinically relevant improvements in disease specific QoL
compared to placebo.
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The efficacy of coseasonal SLIT over three consecutive seasons is
maintained after cessation of treatment in patients with grass
pollen allergy
Hagen Ott1, Jochen Sieber2, Jens Baron1, and Hans Merk1. 1RWTH Aachen,
Univ.-Dept. of Dermatology & Allergology, Aachen, Germany; 2Stallergenes,
Germany, Kamp-lintfort, Germany.
Background: The data for the carry-over effect of SLIT treatment are still
scarce. We therefore evaluated the efficacy, carry-over effect and safety of
SLIT in a patient- friendly, seasonal treatment concept.
Methods: A baseline season was followed by seasonal treatment in 3
consecutive years and 1 follow-up season without SLIT. At the beginning of
each season, treatment started by a 5-grasses mixture with titration under
medical observation within 90 minutes (0-30-90-150-300 IR) followed by a
daily intake of 300 IR for the whole season. Symptoms, medication intake and
adverse events (AE) were documented daily in a diary for each pollen season
of the 5-year observation period. Specific IgE and IgG4 were determined by
CAP\ and micro-array technique which also allowed possible cross reactivity
to other proteins sich as food allergens.
Results: 213 patients (99m, 114f, mean age 32.2 years) with AR against grass
pollens (mean disease duration 12.8 years) were randomized. Data from 184
patients were analyzed after the follow-up period. Mean treatment duration
varied between seasons (81.8Y92.7 days). The combined score (symptoms and
medication) improved in the treatment seasons continuously up to 43.4%
compared to baseline in the verum group (V) and fluctuated between +8.9 to
j8.5% in the placebo group (P). Similar changes were observed for the
symptoms score with a consecutive decrease of 39.0% (V), and fluctuations
between +7.0 and +17.8% in P. All intergroup differences were significant in
all seasons (p G 0.05). The improvement for verum continued in the follow-
up period in the combined score (j1.76 (V) vs. j1.19 (P), p = 0.0508) and
the symptoms score (j1.94 (V) vs. j0.30 (P), p = 0.0144). Intake of rescue
medication was very low (n.s. for V vs. P in all seasons). There was an increase
of specific IgG4 in the first season which remained at this higher level during
the treatment seasons for V vs. P (p = 0.0001). Titration and daily SLIT intake
were well tolerated. Most frequent reactions were mild to moderate local itch-
ing and burning in the mouth. Serious systemic or anaphylactic reactions were
not reported.
Conclusion: This study shows in a large patient cohort that the seasonal
sublingual immunotherapy with ultra-rush titration is effective with significant
differences versus. placebo from the first treatment season on. It is indicative
for a carry-over effect of seasonal SLIT. The treatment was well tolerated.
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Long-lasting effect according to the duration of sublingual
immunotherapy: a 15-year prospective study
Maurizio Marogna1, Igino Spadolini2, Alessandro Massolo3, G. Walter
Canonica4, and Giovanni Passalacqua4. 1Macchi Hospital Foundation-Varese,
Pneumology Unit - Cuasso al Monte, Varese, Italy; 2Anallergo SpA, Anallergo
SpA, Florence, Italy; 3University of Florence, University of Florence, Florence,
Italy; 4University of Genoa - Dept. of Internal Medicine, Allergy & Respiratory
Diseases, Genoa, Italy.
Background: There are still few data on the longterm effects of sublingual
immunotherapy and it is not known which is the optimal duration of the
treatment.
Methods: In this prospective open controlled studywe followed up for 15 years
patients with respiratory allergy and monosensitized to mites. The subjects
were subdivided in 4 groups: only drug therapy and sublingual immunotherapy
for 3, 4 or 5 years. Clinical scores, pulmonary function and skin sensitizations
were evaluated every year during winter months. The clinical effect was con-
sidered significant when clinical scores decreased by at least 50% from
baseline. When the clinical scores overcome 50% of the baseline, the patients
were vaccinated again.
Results: Seventy-eight patients were enrolled and 59 completed. In the 12
controls no change in clinical scores was seen throughout the study. In the
patients receiving immunotherapy for 3 years a significant clinical benefit
persisted for 3 years, then a progressive worsening was seen and after 7 years
the scores raised significantly. In those receiving immunotherapy for 4 or
5 years, the clinical benefit persisted for 5 years and a significant worsening was
seen 8 years after discontinuation. 58% of the controls displayed a reduction of
FEV1 below 80% of predicted over 15 years, whereas this percentage was
G10% in the immunotherapy groups. The occurrence of new sensitizations over
15 years in the controls and the 3 immunotherapy groups was 100%, 21%, 12%
and 11%, respectively (pG 0.01). The second course of vaccination achieved a
more rapid benefit (1 year).
Conclusion: This observation suggests that a duration of SLIT of at least 4
years can lead to a long-lasting clinical benefit.
Key words: sublingual immunotherapy, long-term effect; house dust mites
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Correlation between FEV1 and asthma control test in newly
diagnosed asthma
Gianenrico Senna1, Patrizia Bonadonna1, Maria Angela Crivellaro2, Annarita
Dama1, Carlo Lombardi2, Michele Schiappoli1, and Giovanni Passalacqua3.
TABLE 2. Characteristics of the Control and Patients With CPDomain Placebo* SQsGAT* Differe ce* % Diff.
Activities 1.44 1.04 0.40 27.8%
Sleep 0.62 0.20 0.42 67.7%
Non-nose / eye symptoms 0.71 0.32 0.39 54.9%
Practical problems 1.43 0.87 0.56 39.2%
Nasal problems 1.42 1.03 0.39 27.5%
Eye symptoms 1.21 0.61 0.60 49.6%
Emotional 0.61 0.19 0.42 68.9%
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1Verona General Hospital, Allergy Service, Verona, Italy; 2Ospedale S.
Orsola FBF - Brescia, Pneumoallergology Unit, Brescia, Italy; 3University of
Genoa - Dept. of Internal Medicine, Allergy & Respiratory Diseases,
GENOA, Italy.
Background: Tools reflecting the multidimensional nature of asthma and that
can be easily and quickly administered are needed for the assessment of
asthma control in daily practice. The Asthma Control Test (ACT) was
developed to meet this need. It consists of five questions enquiring about the
frequency of symptoms in the last four weeks. Each question has five possible
answers scored from 1 (worst) to 5 (best). Aim of this study was to assess
whether there is some correlation between ACT and functional measures in
outpatients with a new diagnosis of asthma.
Methods: Patients firstly referred for respiratory complaints and without a
previous diagnosis of asthma, underwent a detailed clinical history, clinical
visit, spirometry and ACT. Asthma was diagnosed on the basis of : (i) history
of attacks of chest tightness, cough, wheezing, nocturnal awakenings and (ii)
impaired spirometry with a reversibility of at least 12% in the FEV1 after
salbutamol or, in alternative, a normal spirometry with a positive methacholine
challenge test. Results. From April to June 2006, 32 patients (20 males, mean
age 32.3, range 16Y57 yrs) had a new diagnosis of asthma. Their severity
according to GINA guidelines was: 1 intermittent, 9 mild, 18 moderate and 4
severe. Their FEV1 ranged from 62% to 112%. There was no correlation
between ACT and FEV1 (r = 0.26 ; p = 0.2) (Fig 1).
Conclusion: Despite FEV1 directly reflects the bronchial obstruction, in our
naBve patients it was not correlated with severity as self-assessed by ACT. This
probably reflects the well known individual variability in the perception of
symptoms. Our data further confirm that the diagnosis and follow-up of
asthma must be based on an integrated approach including clinical aspects and
clinical parameters.
Key words: FEV1, Asthma control
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Predicting asthma control in children - using exhaled
nitric oxide (FeNO)
Robin J. Green1, Willis Linton1, Andrew Halkas1, Humphrey Lewis2, and Piet
Bekker3. 1University of Pretoria, South Africa, Paediatrics and Child Health,
Pretoria, South Africa; 2Unitas Hospital, Paediatrics, Pretoria, South Africa;
3Department of Biostatistics, University of Pretoria, Pretoria, South Africa.
Background: The world literature suggests a disappointing lack of asthma
control as reflected by ongoing asthma morbidity. One of the problems in
assessing asthma control has been reliable strategies to do so. Measurement of
exhaled nitric oxide is a useful non-invasive and efficient method of assessing
airway inflammation almost directly in children with asthma.
Methods: A random sample of asthmatic children (aged 5Y11 years) attending
the Childrens Asthma Clinic at Pretoria Academic Hospital and the Private
Paediatric Practice of the second author had their asthma control assessed
by 4 methods, namely, Doctor assessment, Symptom Score (Paediatric ACT),
Lung function (FEV1/FEF25-75) and Exhaled nitric oxide (FeNO).
Results: 80 children (with mild persistent asthma) were studied. There was
no significant correlation between assessment variables. Paerson correla-
tion coefficient r = j0.0179 for ACT vs FeNO, r = j0.1365 for FEV1 vs
FeNO. Only FEV1 and FEF25-75% reveal significant correlation.
Using a multi-regression analysis all the variables together explain only
16.45% of the variation in FeNO and none of the coefficients have significant
p-values.
Conclusion: If FeNO is the Fgold-standard` of assessment of asthma control,
as has been suggested, then all the other measures we tested are a weak
substitute for this assessment. It may be possible that our assessment methods
were incomplete and that some other variable may prove more valuable in this
regard. Alternatively It also seems likely that an important conclusion would
be that asthma control requires more than one end-pont in assessment.
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Oxygen saturation measurement in obstructive outpatient: an
useful tool for exacerbations management in GPs setting?
Sara Cauglia1, Fulvio Braido1, F De Benedetto2, Giancarlo Sevieri3, and
Giorgio Walter Canonica1. 1University of Genoa, Department of Internal
Medicine, Genoa, Italy; 2University of Chieti, University of Chieti, Chieti,
Italy; 3I, D, C, Italy.
Background: Severe asthma and COPD are characterized by clinical
exacerbations. GPs are often required to decide between hospitalisation and
home treatment for these patients.
Aim: To evaluate if the ambulatory measurement of Oxygen Saturation (SO2)
could be safe and effective, to verify the correlation between SO2measurement
during scheduled visits an during exacerbations, to define the patient pattern
that requires hospitalisation, to assess the possibility of SO2 database
registration in Gps setting.
Methods: 450 GPs and 50 pneumologists have been enrolled in the study with
the target to evaluate 16000 ptz (10000 by Gps; 6000 by pneumologists). Each
physician has been provided with a pulse oxymeter. The SO2 measurement
and the fill in of a specific questionnaire have been required to the outpatients
attended for disease exacerbation.
Results: A descriptive analysis of results will be provided. The patients will be
divided in two population according to the necessity of hospitalisation and a
comparison of all the parameter registered in GPS and specialists setting will
be performed. The relative importance of SO2 measurement for GPS and
pneumologists will be evaluated.
Discussion: The present ongoing study should provided important informa-
tion about the utility and safety of SO2 measurement in obstructive patient
evaluation during exacerbation. The results should be useful in defining
guidelines for exacerbation management.
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Budesonide/formoterol reduces the production of IL-5, RANTES
and TNF-" from mononuclear cells but not the adhesion of
activated eosinophils
Tomoyuki Soma1, Yotaro Takaku1, Takehito Kobayashi1, Koichi Hagiwara1,
Minoru Kanazawa1, Kazutsugu Uematsu2, and Makoto Nagata1. 1Saitama
Medical University, Department of Respiratory Medicine, Moroyama, Japan;
2Saitama Medical Center, Division of Respiratory Medicine, Saitama, Japan.
Background: Budesonide (BUD) / formoterol (FOR) combination
(Symbicort\) for both maintenance and reliever therapy (SMART) results
in the reduction in asthma exacerbations as compared with traditional fixed
dosing regimens. The mechanism by which SMART provides outstanding
clinical benefit remains to be elucidated, however, the use of combination
therapy during the early stage of asthma exacerbation may intervenes in the
development of subsequent airway inflammation. The objective of the study
was to evaluate whether the use of BUD/ FOR at the early stage of cell
activation can modify the adhesion of eosinophils or production of cytokines
from mononuclear cells.
Methods: Eosinophils isolated from human peripheral blood were pretreated
with either BUD (0.1 6M), FOR (0.1 6M), or BUD/ FOR for 30 min at 37 -C
and stimulated with IL-5, LTD4, or PMA. The adhesion of eosinophils was
evaluated using an EPO assay. Peripheral blood mononuclear cells (PBMC)
were treated with BUD (0.1 6M), FOR (0.1 6M), or BUD/ FOR either 15 min
or 4hr following the stimulation with a combination of ionomycin and PMA.
The concentrations of IL-5, RANTES, and TNF-! in the culture supernatants
of PBMC were examined by ELISA.
Results: Neither BUD, FOR, nor BUD/ FOR combination modified eosinophil
adhesion induced by IL-5, LTD4, or PMA. By contrast, both BUD alone and
BUD/ FOR combination significantly reduced the productions of IL-5,
RANTES, and TNF-" by PBMC (N = 6, p G 0.001), despite these compounds
were added either 15 min or 4hr following the stimulation of the cells.
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Conclusion: Inhalant BUD/ FOR at early stage of exacerbation of asthma may
suppress the progression of allergic inflammatory cascade via its inhibitory
effect on mononuclear cells and hence prevents the development of severe
asthma exacerbations.
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A review of three quality of life measures in asthma
Christian Apfelbacher1, Matthew Hankins1, and Helen Smith2. 1Brighton and
Sussex Medical School, Division of Public Health and Primary Care, Falmer,
United Kingdom; 2Brighton and Sussex Medical School, Division of Public
Health and Primary Care, Falmer, United Kingdom.
Background: The measurement of quality of life has become a standard
feature in clinical trials, surveys and clinical practice, to capture aspects of
asthma that are salient from the patients’ perspective. Several disease-specific
questionnaires have been developed for asthma. Three arewidely used, but have
never been compared: theAsthmaQuality of LifeQuestionnaire (Juniper et al.),
the Asthma Quality of Life Questionnaire (Marks et al.) and the Living With
Asthma Questionnaire (Hyland et al.) We wish to review these instruments.
Methods: We reviewed the questionnaires with respect to number of items,
item content areas, response format, item generation technique, item selection
technique, and methods by which validity claims were made.
Results: We found variation in the number of items included (20,32,68) and
the item content areas in which the items are grouped. The Hyland et al.
questionnaire includes positive and negative items, while the other two
questionnaires include negative items only. Each questionnaire uses a different
response format. There was variation in the item generation methods, and the
degree to which clinical experience was used as a source. Items were either
selected using standard psychometric methodology (factor analysis, principal
components analysis) or impact analysis, i.e. items are being selected which
are most frequently perceived as important by respondents. Validity claims
were made mainly by weak correlations with clincial markers of asthma (such
as FEV1,% predicted or asthma medication) and strong correlations with
generic quality of life measures.
Conclusion: The variation in methodology is important because the ques-
tionnaires measure different things, depending on the item wording and the
domain structure. Guidance is needed to facilitate the choice of instrument for a
given purpose, and the performance of the questionnaires should be evaluated
against each other, using appropriate methods to show agreement (e.g. Bland-
Altman plots).
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Sensitization patterns of allergens among asthmatics
in Sri Lanka
Anura Weerasinghe1, Sisira Weerasinghe1, Manori Amarasena1, Kushan
Medagoda1, and Constance H Katelaris2. 1University of Kelaniya, Physiology,
Ragama, Sri Lanka; 2University of Western Sydney, Allergy and Immunology,
Sydney, Australia.
Introduction: The sensitization pattern among asthmatics in Sri Lanka is
unknown.
Objectives: To determine the sensitization pattern among asthmatics in Sri
Lanka.
Methodology: The study was carried out in forty physician-diagnosed
asthmatic patients. Twenty two non-asthmatics were recruited as controls.
Sensitization to 12 allergens was assessed by skin prick test using standardized
allergen extracts. A skin wheal diameter, 3mm greater than the negative
control was considered a positive reaction.
Results: The mean age of asthmatics was 32.4 years (range 9Y59) and 57.5%
were males. The mean age of controls was 32.2 years (range 14Y58) and 59.1%
were males. The analysis of the data showed that 97.5% asthmatics had
positive skin reaction to at least one allergen compared to 72.7% prevalence in
the control group. The common allergens among asthmatics were Dermato-
phagoides pteronyssinus (77.5%), blomia (65.5%), cockroach (55%), storage
mite (35%), latex (20%)), cat fur (17.5%), aspergillus (12.5%), grass pollen
(12.5%), cow’s milk (12.5%) egg white (10%) cereals (7.5%) and dog hair
(5.%). The pattern of sensitization among non-asthmatics was Dermatopha-
goides pteronyssinus (54.5%), cockroach (50%), blomia (36.4%), aspergillus
(36.4%), grass pollen (27.3%), storage mite (22.7%), cow`s milk (18.2%),
latex (13.6%), egg white (13.6%), cereals (13.6%), dog hair (9.1%) and cat fur
(9.1%). Sixty two percent (n = 25) of the asthmatics had at least one other
allergic manifestation while non-asthmatics with other allergic manifestation
were 36.4% (n = 8). Other allergic manifestations in the asthmatic group were
rhinitis alone 22 (55%), eczema alone 1(2.5%) and both rhinitis & eczema
2(5%) whereas in the non-asthmatic group it was rhinitis alone 7 (31%),
eczema alone 0% and both rhinitis and eczema 1(4.5%).
The pattern of sensitization for mites alone, cockroaches alone and
mites and cockroaches in the asthmatic group with rhinitis (n = 24) was 23
(57%), 11(27%) and 11(27%) and in the non-asthmatic group with rhinitis
(n = 7) was 3 (13%), 4 (18%) and 3 (13%) respectively.
Conclusion: The results show that mites, and cockroaches are the most
common sensitizing allergens in asthmatics and the commonest association of
asthma was rhinitis in Sri Lanka.
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Successful treatment of disseminated BCG infection in a SCID
patient with granulocyte colony stimulating factor
Wipada Pariyaprasert, Nualanong Visitsunthorn, Pakit Vichyanond, and
Orathai Jirapongsananuruk. Siriraj Hospital, Allergy and Immunology of
Pediatrics Department, Bangkok, Thailand.
Background: Severe combined immunodeficiencies (SCID) are disorders
with impairment of humoral and cellular immune functions. Persistent infec-
tions with opportunistic organisms are major causes of death. The prognosis of
disseminated bacillus Calmette-Gue`rin (BCG) infection in immunocompro-
mised host is unfavorable since response to standard therapy is poor.
Methods: We report a successful treatment of disseminated BCG infection
with granulocyte colony stimulating factor (G-CSF) in a 15-month-old girlwith
SCID. The infection resulted from BCG vaccine administered during the
newborn period. The patient presented at 6 months of age with chronic
diarrhea, failure to thrive, and generalized candidiasis. She was subsequently
diagnosed as a SCID with IL-7R" deficiency by gene sequencing. HLA-
haploidentical bone marrow transplant (BMT) from her father was attempted at
the age 8 months. Graft versus host disease soon developed with failure of
engraftment. Seven months post-BMT, she developed abscess at right upper
arm and multiple subcutaneous nodules on skin all over the body. Numerous
acid-fast bacilli (AFB) were demonstrated from smears of the abscess
materials. M. tuberculosis complex was identified by culture and polymerase
chain reaction (PCR). A diagnosis of disseminated BCG infection was made.
After 2 months of intensive antituberculous (anti-TB) therapy comprising five
agents (isoniazid, rifampicin, ethambutol, levofloxacin and amikacin) guided
by in-vitro antimicrobial sensitivities of the culture, failed to control the
infections. She subsequently developed hepatosplenomegaly and BCG-
osteomyelitis of left femur.
Results: G-CSF was added to her treatment regimen to enhance phagocytosis.
She recovered quickly within 2 weeks with G-CSF treatment as evident by
significant clinical improvement. G-CSF was continued for 4.5 months while
she continued to receive triple anti-TB therapy and monthly intravenous
immunoglobulin infusions without relapsing of active tuberculosis infection.
Conclusion: To our knowledge, this is the first case of SCID with dis-
seminated BCG infection which was successfully treated with anti-TB agents
in conjunction with G-CSF. Since serious BCG infections in SCID is not
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uncommon in developing countries where BCG vaccination is mandatory to
all newborns, combination of G-CSF and anti-TB drugs should be considered.
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IL-17F His(161)Arg but not IL-8 A(j251)T is associated with
the development of respiratory syncitial virus bronchiolitis
in the Japanese population
Yuzaburo Inoue1, Naoki Shimojo1, Yoichi Suzuki2, and Yoichi Kohno1.
1Graduate School of Medicine, Chiba University, Department of Pediatrics,
Chiba, Japan; 2Graduate School of Medicine, Chiba University, Department
of Public Health, Chiba, Japan.
Background: The involvement of neutrophil-mediated inflammation may
play an important role in the pathogenesis of acute respiratory syncytial virus
(RSV) bronchiolitis. Interleukin-8 (IL-8) mediates the activation and
migration of neutrophils from peripheral blood to the airway. IL-17F is a
recently discovered cytokine that plays a role in tissue inflammation by
inducing release of proinflammatory and neutrophil-mobilizing cytokines. The
contribution of genetic polymorphisms of IL-8 and IL-17F has not yet been
clarified in the Japanese population.
Methods: Forty-eight children who had been hospitalized because of severe
RSV bronchiolitis were recruited. The exclusion criteria included cardiac
diseases, chronic respiratory diseases, previous wheezing episodes, an age 9
24 months and prematurity. Two hundred and three children (age 6Y12) who
had never had wheezing episode were recruited as control subjects of this
study. These control subjects were considered to have suffered from a mild
RSV infection but not bronchiolitis during infancy because it is known that
almost all children are infected by RSV at some time before reaching three
years of age.
We genotyped IL-8 A(j251)T and IL-17F His(161)Arg by modi-
fied amplification refractory mutation system polymerase chain reaction
(ARMS-PCR) method, and investigated a relation between these SNPs and the
development of RSV bronchiolitis.
Results: The distribution of the genotype and allele of IL-8 A(j251)T in
children with RSV bronchiolitis was similar to that in controls. On the other
hand, the distribution of genotype of IL-17F His(161)Arg in children with
RSV bronchiolitis was significantly different from that in controls (p = 0.034).
In comparison to the controls, the frequency of His/His (p = 0.011, odds ratio
0.42) was significantly lower in children with RSV bronchiolitis.
Conclusion: IL-17F His(161)Arg but not IL-8 A(j251)T is associated with
the development of RSV bronchiolitis in the Japanese population. Our results
suggest that the dysfunction of IL-17F may be involved in the pathogenesis of
RSV bronchiolitis.
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Expression of alpha-, beta- and lambda-interferon upon during
respiratory virus infection
Musa Khaitov1, Michael Edwards2, Ross Walton2, and Sebastian Johnston2.
1Institute of Immunology, Biomedical Technologies, Moscow, Russian
Federation; 2Imperial College London, Respiratory Medicine, London,
United Kingdom.
Background: Rhinoviruses are a major cause of common colds and asthma
exacerbations worldwide. It is known that rhinovirus infects and replicates in
respiratory epithelial cells of lower respiratory tract inducing proinflammatory
cytokines. Type I interferons such as IFN-alpha, IFN-beta and newly
discovered type III interferons - IFN-lambdas play vital role in innate immune
response against viruses. The method used.
In this study we investigated the potential of different cell types such
as, human bronchial epithelial cells (BEC), BEAS-2B cells and PBMC to
express and produce various type I and type III interferons upon respiratory
virus infection by ELISA and RT-PCR.
Results: In BECs we detected induction of IFN-a mRNA expression by 8
hours, induction of IFN-lambda1 mRNA by 24, IFN-lambda2/3 was induced
by 8 and 24 hours. In BEAS-2B cells we detected induction of IFN-alpha
mRNA expression by 8 hours, IFN-lambda1 mRNA from 8-hours with peak at
24 and induction of IFN-beta from 24 hours. By ELISA we also observed
production of IFN-lambda1 and IFN-beta protein by 24 hours.
Conclusion: IFN-lambdas were induced either earlier and/or to a greater
degree than the type 1 IFNs. In PBMC induction of IFN-alpha, IFN-lambda1
and IFN-beta mRNA expression and protein production were all detected from
8 hours. However induction of IFN-alpha was to a much greater degree than
-beta or -lambda. Lambda IFNs appear important in epithelial cell responses
to rhinovirus infection, while alpha IFNs are the major IFNs released by
macrophages.
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Different kinases (PI3K, p38 MAPK, PKA, and classical, novel,
and atypical PKC isoforms) are critical for ICAM-1
upregulation on RSV-infected human endothelial cells
Ralf Arnold, and Wolfgang Ko¨nig. Otto-von-Guericke-University, Institute of
Medical Microbiology, Magdeburg, Germany.
Background: RSV is the most frequent cause of bronchiolitis and pneumonia
in infants requiring hospitalization. Especially children with underlying heart/
lung failure show an enhanced mortality and morbidity rate during RSV
infection. Thereby, the infection of human lung epithelial cells with respiratory
syncytial virus (RSV) induces an intense inflammatory response resulting in a
prominent recruitment of leukocytes into the lung. Recently, we showed by in
vitro experiments that human primary lung endothelial cells (HMVEC-L,
HPAEC) and HUVEC are also target cells for a productive RSV infection.
Furthermore, infected endothelial cells upregulated their ICAM-1 cell surface
expression resulting in an enhanced adhesion and transmigration rate of
cocultered effector cells. However, cellular signaling pathways mediating the
NF-0B-dependent RSV-induced ICAM-1 expression are still not known.
Therefore, by using HUVEC as a reliably in vitro-RSV-endothelial cell
infection model we investigated signal transduction molecules involved in the
RSV-induced ICAM-1 cell surface expression.
Methods: The endothelial cells were preincubated with pharmacological
inhibitors, infected with highly purified RSV particles, washed, and cultured
for 48 h in the presence of freshly added antagonists. The used inhibitors did
not interfere with the infection process of the HUVEC. The ICAM-1 cell
surface expression was determined by FACS analysis.
Results: We observed a PI3K-, p38 MAPK-, PKA-, and PKC-dependent
ICAM-1 expression pattern in RSV-infected endothelial cells. By analyzing
the involved PKC isotypes in more detail we determined that the classical "
and , PKC isotypes, the novel isotypes ( and K, and the atypical Q isotype are
activated and significantly involved in the ICAM-1 upregulation on RSV-
infected endothelial cells.
Conclusion: Our data suggest that the RSV-induced ICAM-1 expression on
infected human endothelial cells, responsible for an enhanced adhesion and
transmigration rate of immune effector cells into the RSV-infected lung, might
be significantly controlled by inhibition of distinct signal transductiaon
molecules.
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Seropositivity of cytomegalovirus in women with unexplained
recurrent spontaneous abortions
Roya Sherkat1, A. Kalantari2, M. Ahmadi2, F. Daneshmand2, M. Arshadi2, Z.
Alameh3, T. Alameh3, and S. Rostami4. 1Alzahra University Hospital,
Infectiouse Disease, Isfahan, Islamic Republic of Iran; 2Fertility and
Infertility Clinic, OBG Department, Isfahan, Islamic Republic of Iran;
3Beheshti University Hospital, OBG Department, Isfahan, Islamic Republic
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of Iran; 4Sedigheh Tahereh University Hospital, Infectiouse Disease
Reasearch Center, Isfahan, Islamic Republic of Iran.
Background: Cytomegalovirus (CMV) is an ubiquitous agent and the rate of
seropositivity in the worldwide adult populations is 60Y100%. Primary CMV
infection in pregnancy is a cause of spontaneous abortion, IUFD, I. and
congenital illness and disability. To find out about the probability of any
relation of recurrent, non-active or active CMV infection with pregnancy loss,
in women suffering from recurrent spontaneous abortions (RSA), humeral
immunity to CMV has been assessed in these patients.
Materials and Methods: To assess the prevalence of CMV viral infections in
women with RSA in a case control study Patients were recruited and age
matched at the Women’s Clinic, during the period of one year. one group of
recurrent aborters (Group 1; n=108) and One group of normally pregnant
women (Group 2; n =108) were evaluated, including demographic, medical,
clinical, and serological data (anti-CMV IgG , IgM ).
Results: The mean age of the two groups was 28.2 and 24.47 years. The
normal pregnant women had a significantly higher prevalence of anti-CMV
(93.5% IgG, 0% IgM) in contrast to (78.7% IgG, 11.1% IgM) in recurrent
aborters respectively.
A significantly lower prevalence of serum anti-CMV antibodies was
observed for RSA women compared with age-matched pregnant female
controls.
Conclusion: These results indicate that women with unexplained RSA have
difficulty in responding to CMV infection and could be important when
considering fetal infection due to reactivation of chronic CMV infection in the
course of pregnancy.
The role of viruses in induction of autoimmune condition and whether
women with unexplained RSA have difficulty in responding to CMV, all needs
more future researches.
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B-cell reconstitution with cord blood but not with bone marrow
transplantation in two siblings with X-linked SCID
Sonal R. Patel1, Robert L. Roberts2, and E. Richard Stiehm2. 1Charles R.
Drew University, Division of Allergy & Immunology (Pediatrics), Los
Angeles, United States; 2University of California at Los Angeles, Division of
Allergy, Immunology, and Rheumatology, Los Angeles, United States.
Introduction: Stem cell transplantation (SCT) is the treatment of choice for
X-linked SCID. Successful SCT from matched family donors generally results
in T-cell engraftment. Despite this positive outcome, up to 50% of patients do
not achieve B-cell engraftment and require monthly IVIG infusion.
Methods: We followed two siblings with IL-2 Receptor (common , chain)
deficiency X-Linked SCID, prior to, during, and post transplantation. The first
had haploidentical BMT. The second had unrelated umbilical cord blood
transplantation (UCBT).
Results: The sibling 1 received a T cell depleted bone marrow infusion
donated from his mother at age 3 months. His pre-transplant conditioning
consisted of busulfan, cytoxan, ATG and cyclosporine. He received IVIG and
solumedrol post transplantation. He is now 10 years old. He currently has only
a small number of non-functional B cells. Thus he continues with
hypogammaglobulinemia, requiring monthly IVIG infusions. His half-brother
received a 7/8 matched cord blood transplantation at age 2.5 months. His pre-
transplant conditioning consisted of busulfan, cytoxan, and cyclosporine. He
received IVIG and solumedrol post transplantation. He is now 2 years old. He
achieved reconstitution of his B-cells by 3 months post transplantation.
Currently his quantitative immunoglobulins are within normal limits, with
appropriate antibody function, thus he does not require IVIG.
Conclusion: We concluded that unrelated UCB is an alternative source of
stem cells for transplantation in children with severe T-cell immune deficiency
disorders when a suitable HLA-matched donor is not available and when a T-
depleted haploidentical preparation is not beneficial. Benefits of UCBT
include rapid and reliable recovery of immune function, low risk of GvHD,
and low viral transmission rate. We present a family with two siblings, both
with X-linked SCID. There was discordance in B cell engraftment. The sibling
treated with UCBTwas able to reconstitute B cell function, with production of
appropriate quantitative and functional B cells. Overall data from the National
Cord Blood Program documents that the hematopoietic reconstitution after
UCBT, is much better in children given transplants of UCB than in both
children and adults who received BMT. This suggests that cord blood provides
a higher likelihood of B cell function compared to HLA haploidentical





What proportion of allergy referrals could be dealt with
in primary care?
Helen Smith1, and Anthony Frew2. 1Brighton & Sussex Medical School,
Division of Public Health and Primaty Care, Brighton, United Kingdom;
2Brighton & Sussex University Hospitals’ Trust, Department of Respiratory
Medicine, Brighton, United Kingdom.
Background: In the UK it has been proposed that a large proportion of allergy
referrals to a specialist in secondary care could be dealt with in the community
by a GP with special interest (GPwSI) in allergy. This study assesses what
proportion of referrals could be dealt with in a GPwSI clinic with a predefined
range of facilities including: expertise in accurate diagnosis and management
of allergy; skin prick testing for aeroallergens; provision of advice on allergen
avoidance; ability to assess suitability for desensitisation.
Methods: Consecutive referrals of patients with suspected allergy to a
Respiratory Medicine Clinic were reviewed by 3 allergy specialists
independently. The referral letter was reviewed and a judgement made on the
appropriateness for consultation with a GPwSI. The case was then re-assessed
with the benefit of subsequent correspondence and a further judgement made
on the appropriateness for consultation with a GPwSI. The proportion judged
suitable was calculated and inter-rater agreement was assessed.
Results: 46% of referrals were judged appropriate for management by a
GPwSI and after review of the outcome of referral this reduced to 42%. Only
4% of referral letters contained insufficient evidence to make a decision about
appropriateness. Two fifths of patients being referred to a respiratory clinic
with allergic problems may be dealt with by a GP with a special interest in
allergy. The majority of referral letters contain sufficient detail to accurately
predict those patients who are suitable for alternative care.
Discussion: The development of a Primary Care Allergy Service could
liberate capacity in the specialist setting and enable the specialist to focus on
the more complex allergy problems.
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Assessing skin prick tests reliability in ECRHS-I
Philippe Jean Bousquet1, Leda Chatzi2, Sue Chinn1, Deborah Jarvis1, and
Peter Burney3. 1Imperial College, Emmanuel Kaye Building, London, United
Kingdom; 2Faculty of Medicine, Department of Social Medicine, Heraklion,
Greece; 3Imperial College, Emmanuel Kaye Building, London, United
Kingdom.
Introduction: Atopy, the clinical definition of an IgE high-responder, can be
documented by the detection of IgE antibodies in serum or by a positive skin
prick test. Selection of a reaction size at which to declare a skin test reaction as
positive was not well assessed in epidemiological studies. The aim of the study
was to identify the best cut-off level for skin prick tests.
Methods: Using the data collected during the ECRHS I (European
Community Respiratory Health Survey) the association of serum allergen-
specific IgE and skin prick tests (Dermatophagoides pteronyssinus, cat,
timothy grass and Cladosporium) were assessed.
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Results: On the 13,391 subjects (50.4% of men), the proportion of positive
skin tests ranged from 9.7% (cut-off 95mm) to 20.4% (cut-off 90mm) for
Dermatophagoides pteronyssinus, 3.4 to 10.1% for cat, 9.6 to 17.1% for
timothy grass and 0.2 and 2.2 for Cladosporium. The most appropriate cut-off
appeared to be over 0mm for Dermatophagoides pteronissinus, cat and timothy
grass (Youden Index over 0.76). However, the relationship between serum IgE
and skin prick test for Cladosporium was weak (Youden index under 0.55).
Conclusion: In epidemiological studies, a single method may be chosen to
assess allergenic sensitivity. A cut-off level of over 0mm for skin prick tests
appeared to be the most discriminative.
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Combined use of allergen skin prick test and specific IgE
antibody on allergen diagnosis in asthmatic children
Li Xiang, Qi Zhang, and Zhen Li. Bejing Children’s Hospital affiliated to
Capital University of Medical Science, Center of Asthma, Beijing, China.
Background: To analyze the advantages of combined analysis of allergen skin
prick test BSPT[ and Phadiatop/specific IgE antibody on the allergen diagnosis
in asthma children.
Methods: Inhalant allergen SPT and Phadiatop test were done in 57 asthma
children. 33 cases of those asthma children were measured serum specific IgE
antibody against Dermatophagoids pteronyssinus.
Results: Dermatophagoids, molds and pets were the main inhalant allengens
in asthma children. The positive rates of SPT and Phadiatop in 57 asthma
children were 86.0% and 79.0% respectively, and the consistence rate between
SPT and Phadiatop was 86.0%. 5 cases with negative Phadiatop were
confirmed to have molds allergy via SPT and molds specific IgE test. The
consistence rate of Dermatophagoids pteronyssinus SPT and specific IgE was
97.0%.
Conclusion: It is helped to improve the sensitivity and specificity of allergen
diagnosis in asthma children when doctors combined analyze the results of
allergen skin prick test and specific IgE test.
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Comparison between skin prick test and a reversed enzyme
allergo-sorbent test
Michael Mahler1, Christine Lorenz2, Margrit Fooke3, and Jo¨rg Kleine-Tebbe2.
1Dr. Fooke Laboratorien, Development, Neuss, Germany; 2Allergy and
Asthma Center Westend, Allergy Unit, Berlin, Germany; 3Dr. Fooke
Laboratorien, General Manager, Neuss, Germany.
Background: Several methods are available for the quantitative determination
of allergen specific immunoglobulin E (sIgE) representing a hallmark in the
diagnosis of type I hypersensitivity reactions and allergic diseases. One of
these methods, the ALLERG-O-LIQ system (Dr. Fooke Laboratorien,
Germany), is based on the reversed enzyme allergo sorbent test protocol
using anti-IgE coated microtiterplates combined with biotinylated allergens
and streptavidine-HRP conjugate. Objective of our study is the comparison of
the ALLERG-O-LIQ and skin prick test (SPT) results.
Methods: Serum samples (n = 96) were collected from undiagnosed
individuals and tested for sIgE to ten common inhalant allergens including
Timothy Grass (g6), Cultivated Rye (g12), Mugwort (w6), Alternaria
alternata (m6), D. pteronyssinus (d1), D. farinae (d2), cat (e1), dog (e2)
and Aspergillus fumigatus (m3). Further, skin prick tests (SPT, Allergopharma,
Germany) to above mentioned allergens were performed. Agreement between
the results of ALLERG-O-LIQ and SPT was statistically evaluated using
different methods including kappa agreement, positive (PPV) and negative
predictive value (NPV) and diagnostic efficiency (DE).
Results: The prevalence (in %) of the individual allergens was found at (SPT /
ALLERG-O-LIQ) 38.5 / 33.3 (g6), 33.3 / 26.0 (g12), 16.7 / 8.3 (w6), 6.3 / 7.3
(m6), 33.3 / 24.0 (t3), 27.1 / 16.7 (d1), 27.1 / 17.7 (d2), 21.9 / 10.4 (e1), 6.3 / 7.3
(e2) and 0.0 / 1.0 (m3). The agreement (% / Kappa) between both methods was
88.2 / 0.80 (g6), 90.4 / 0.83 (g12), 86.7 / 0.53 (w6), 95.8 / 0.75 (m6), 87.7 / 0.77
(t3), 83.8 / 0.64 (d1), 87.8 / 0.73 (d2), 84.9 / 0.59 (e1) and 95.8 / 0.75 (e5).
Statistics for m3 was not calculated. Overall agreement (% / Kappa / 2) for
seasonal, perennial and all allergens tested was 89.7 / 0.78 / 292.3, 90.1 / 0.68 /
231.7 and 89.9 / 0.74 / 544.0, respectively. Sensitivity, specificity, PPV, NPV
and DE (all values in %) were found at 73.2, 98.6, 94.7, 91.4 (seasonal)
59.5, 99.0, 92.2, 92.5, 92.5 (perennial) and 92.1 and 67.8, 98.8, 93.8, 92.0 and
92.3 (combined).
Conclusion: Overall, ALLERG-O-LIQ and SPT results are in good
agreement. However, differences in the sensitivity of ALLERG-O-LIQ were
observed among individual allergens. Based on our data we conclude that
ALLERG-O-LIQ represents a reliable test for the quantitative detection of
sIgE to inhalant allergens.
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Total IgE in urban black south african teenagers: the influence
of atopy and helminth infection
Michael Levin. Red Cross War Memorial Childrens Hospital, Allergy Clinic,
Cape Town, South Africa.
Background: IgE levels are usually elevated in allergic diseases, being
highest in atopic eczema, followed by atopic asthma and allergic rhinitis.
Genetic factors are believed to play a role in total IgE levels, with higher levels
seen in Black African subjects. Total IgE is also raised in parasite infection.
Thus, the higher total IgE levels in Black Africans could be due to envi-
ronmental rather than genetic factors. Few studies investigate the usefulness of
total IgE levels in the assessment of atopy in Black Africans.
Aim: The objective of this study was to determine the total IgE levels in
unselected urban Black African high school children and to correlate this with
atopy and ascaris sensitization.
Methods: Two hundred and twenty Urban Xhosa children (mean age 17 years)
attending a school in Cape Town were studied. Atopic status was assessed
by means of specific allergen sensitization (ALK\ skin prick tests to 8 in-
halant and 4 food allergens), self reported asthma and bronchial hyper-
responsiveness measured by methacholine challenge. Total IgE and Ascaris
specific IgE were measured by CAP-RAST (Pharmacia). Total IgE levels were
subanalysed according to atopic status and ascaris sensitisation in order to
establish ranges of total IgE in atopic subjects, ascaris sensitised subjects, and
non-atopic, non ascaris sensitised subjects.
Results: Total IgE levels were markedly skewed toward the left and were not
distributed in a Gaussian or a log-normal distribution. Mean total IgE was
307.7 kU/L. The median was 106 kU/l and the interquartile range 50.4 kU/l to
288 kU/l. Skin prick tests were positive for aeroallergens in 32.3 % of subjects.
Thirty four percent had elevated ascaris IgE.
Total IgE was higher in atopic versus non-atopic subjects and
correlated with the number of positive skin prick tests (Kruskall Wallis
ANOVAR p G0.0001), self reported asthma (p = 0.025) and bronchial hyper-
responsiveness (p = 0.0002). In addition total IgE correlated with ascaris IgE
(p G0.0001). Subjects with no ascaris sensitisation had median total IgE of
77.1 kU/l, similar to the levels seen in people of other genetic origins.
Conclusion: This study has demonstrated that total IgE is correlated on one
hand with atopy, bronchial hyper responsiveness and self reported asthma and
on the other hand with ascaris sensitisation. The likelihood of helminthic
infection rather than genetic differences, is thus the major factor determining a
population`s specific IgE range.
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Association between serum total IgE, allergic diseases and
geohelminth infections in Sri Lankan children
NDDM Amarasekera1, NK Gunawardena2, NR de Silva2, J Douglass3, RE
O’Hehir3, and AWeerasinghe1. 1Faculty of Medicine, University of Kelaniya,
Department of Physiology, Ragama, Sri Lanka; 2Faculty of Medicine,
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University of Kelaniya, Department of Parasitology, Ragama, Sri Lanka;
3Alfred Hospital, Allergy, Immunology and Respiratory Medicine, Melbourne,
Australia.
Background: Elevated levels of total IgE (tIgE) in serum are characteristic of
allergic diseases. Levels of tIgE are influenced by genetic predisposition, age,
sex and helminth infections. However, the association between tIgE and
allergic diseases in children living in areas endemic for helminth infections is
not clear. The aim of our study was to assess the relationship between tIgE,
allergic diseases and geohelminth infections in children.
Methods: A total of 640 schoolchildren 9Y11 years of age was selected by
stratified random sampling. Data regarding allergic diseases (asthma, rhinitis
and eczema) were collected by a standard questionnaire given to the parent or
guardian. Screening for helminth infections was done by examining their fresh
stool samples by modified Kato-Katz technique. Serum tIgE was measured by
Fluoroenzymeimmunoassay in 67 geohelminth-positive subjects and in a
comparable group of geohelminth-negative subjects.
Results: The mean age in the study population was 10 years (SDT0.3). The
prevalence of geohelminth infection was 15.5%. Trichuris trichiura (14.3%)
was the most common followed by Ascaris lumbricoides (4.2%) and hook-
worm (0.2%). Mixed infection was detected in 20.3% of infected children.
Infection intensity was light in 68.9% of infected children while 28.4% and
2.7% showed moderate and heavy infection respectively. The cumulative
prevalence of allergic diseases was 33.7%. Prevalence of asthma, rhinitis and
eczema was 17%, 21.4% and 5% respectively. Serum tIgE concentrations
showed a positively skewed distribution. Geometric mean (GM) for tIgE for the
geohelminth infected group (1039.9kU/L) was significantly higher than that of
the non-infected group (575.4kU/L) (p = 0.004). It was also higher in the
allergic group (933.3kU/L) than in the non-allergic group (639.7kU/L) but the
difference was not statistically significant (p = 0.068). The GM for tIgE for
non-allergic children in the study population was much higher than that seen in
non-allergic children in developed countries.
Conclusion: Serum tIgE concentration was strongly associated with the
presence of geohelminth infections in children. Serum tIgE may not be a useful
marker for allergic diseases in children living in areas endemic for
geohelminth infections.
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Evidence of eosinophil activation in adenoid and tonsil tissues
from atopic children
Seung-Youp Shin1, Chang-Ki Hong1, Sung-Jin Choi2, Kun-Hee Lee1, Joong-
Saeng Cho1, and Hae-Sim Park2. 1KyungHee University Hospital, Department
of Otorhinolaryngology, Seoul, Republic of Korea; 2Ajou University Hospital,
Department of Allergy and Rheumatology, Suwon, Republic of Korea.
Background: Adenoid and tonsil have been considered as immune organs.
They may present different cellular and cytokine profiles according to the
atopic status. The objective of this study was to find the status of eosinophil
activation and compare between atopic and non-atopic children.
Materials and Methods: Adenoid and tonsil tissues obtained from 40
children (18 atopics and 22 non-atopics) were enrolled. Seven atopic and 9
non-atopic children had chronic inflammatory diseases such as chronic
rhinosinusitis (CRS) and/or otitis media with effusion (OME). Atopic status
was classified as a positive result ( 92+) on MAST test to common inhalant
allergens. Serum total IgE and eosinophil count were measured. ECP level and
cellular activation markers, including sCD23, sIL-2R and IL-6 within the
supernatant of adenoid and tonsil tissue were measured by CAP system
(Pharmacia, Sweden) or ELISA.
Results: The ECP level in adenoid and tonsil tissue from atopic children was
451.06g/L, 514.26g/L, which were significantly higher than those from non-
atopic children (353.2 6g/L, 374.4 6g/L, respectively). The ECP level in
adenoid and tonsil tissues from atopic children with CRS showed the highest
(564.6 6g/L and 718.1 6g/L), followed by those from non-atopic children with
CRS (449.3 6g/L and 430.7 6g/L), those from atopic children without CRS
(371.5 6g/L and 371.6 6g/L), and those from non-atopic children without CRS
(291.5 6g/L and 338.2 6g/L). And the ECP level in adenoid were significantly
correlated with locally produced total IgE and cellular activation markers,
including sCD23, sIL-2R and IL-6.
Conclusion: This findings suggest that activated eosinophil could be involved
in inflammatory response occurring in the adenoid and tonsil from both atopic
and non-atopic children. The more activated eosinophils, the more CRS can be
combined. The activation of T cell, especially Th2 cell could lead to the
activation of eosinophil in adenoid and tonsil tissues.
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Plant homeodomain finger protein gene polymorphisms are
associated with plasma total IgE and exhaled nitric oxide
levels in Chinese children
Hing Yee Sy1, Ting Fan Leung1, Chung Yi Li1, Iris H. S. Chan2, Edmund
Yung1, Nelson L. S. Tang2, Christopher W. K. Lam2, and Gary W. K. Wong1.
1The Chinese University of Hong Kong, Department of Paediatrics, Hong
Kong, Hong Kong; 2The Chinese University of Hong Kong, Department of
Chemical Pathology, Hong Kong, Hong Kong.
Background: Single-nucleotide polymorphisms (SNPs) of the gene encoding
plant homeodomain finger protein (PHF11) were shown by positional cloning
to be associated with severe asthma and elevated circulating total IgE level in
Caucasians. These SNPs were also associated with childhood atopic
dermatitis. Such genetic association has not been studied in Chinese. The
objective of this study is to investigate the association between PHF11 SNPs
and asthma phenotypes in Chinese children.
Methods: 269 asthmatics and 165 non-allergic children were recruited from
our paediatric clinics. Their lung function was assessed by spirometry, and
exhaled nitric oxide (FeNO) levels were measured online by chemilumines-
cence analyser at expiratory flow rate of 50 ml/s. Plasma total and specific IgE
were quantified by immunoassays. Ten SNPs in PHF11 were genotyped by
multiplex SNaPshoti reaction with an ABI-310 Genetic Analyser. The
linkage disequilibrium (LD) pattern of these SNPs was analysed by Haploview,
and the association between asthma traits and PHF11 was analysed by
multivariate regression.
Results: The mean (SD) log-transformed plasma total IgE and FeNO levels in
cases and controls were 2.62 (0.61) and 80.5 (59.2) ppb and 1.81 (0.71) and
40.6 (43.2) ppb, respectively (P G 0.001 for both). All 10 SNPs followed
Hardy-Weinberg equilibrium (P 9 0.05). There were significant interethnic
variations in PHF11minor alleles (up to 19%) in our children when compared
with Caucasians. PHF11 polymorphisms were not associated with asthma
diagnosis (P 9 0.5), asthmatics with FEV1 G 65% of predicted (P 9 0.3), or
atopy (P 9 0.09). Multivariate linear regression showed that PHF11 T167A
and G491A were associated with plasma total IgE (P = 0.048 and 0.051,
respectively); and C507T and C732Twere associated with FeNO (P = 0.019
for both). Two haplotype blocks could be constructed - onewith T79C, G491A,
C507T and T661A (D’ 9 0.9) and the other with T395C and C732T
(D’ = 0.95). Three major haplotypes from these 6 SNPs (CTGA CT [53%],
TTAT TT [29%] and TCGT TC [18%]) were identified, but which were not
associated with asthma diagnosis (P90.3).
Conclusion: Our results suggest that PHF11 polymorphisms are associated
with plasma total IgE and FeNO levels but not asthma diagnosis in Chinese
children.
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Transforming growth factor beta-1 In early childhood wheezers
F. El Heneidy1, M Abdel Fattah1, M Youssif2, R Faysal2, and S Abdel
Mawgood3. 1Faculty of Medicine, Cairo University, Pediatrics Department,
Cairo, Egypt; 2National Research Center, Child Health Department, Cairo,
Egypt; 3National Research Institute, Clinical and Chemical Pathology
Department, Cairo, Egypt.
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Background: Transforming growth factor beta-1 (TGF beta-1) is a multi-
functional cytokine involved in pro and anti inflammatory pathways. TGF beta-
1 is increased in the lungs of individuals with asthma. This prospective case-
control study was carried out to outline the changes in serum TGF beta-1 in
children with recurrent wheezing episodes and to differentiate between
persistent and transient wheezers.
Methods: Sixty infants and young children with ages ranging from four
months to three years presented by history of recurrent wheezing attending the
Allergy Clinic, New Children’s Hospital, Cairo University were enrolled in the
study as well as twenty age and sex matched healthy children that were
included as control group. Patients were subdivided into 2 subgroups: 41
early-onset asthmatics and 19 transient wheezers. All patients and controls
were subjected to history taking, thorough clinical examination and laboratory
investigations including CBC for Hb, total leucocytic count and absolute
eosinophilic count, liver and renal functions, total serum IgE and biologically
active serum TGF beta-1 by ELISA technique.
Results: 1-Mean serum TGF beta-1 was higher in patients (29.18 T 14.3
ng/ml) than controls (13.13T4.22 ng/ml) with a statistically significant
difference (P G 0.001). 2-Mean serum TGF beta-1 was higher in early-onset
asthmatics (34.76 T 13.78 ng/ml) than in transient wheezers (17.68 T 4.63
ng/ml) with statistically significant difference (P G 0.001). 3-There was a
significant positive correlation between serum TGF-beta 1 and absolute
eosinophilic count in early-onset asthmatics (r = 0.63, PG0.001) as well as in
total patients (r = 0.59, PG0.001). 4-There was no significant correlation
between serum TGF beta-1 and total serum IgE in neither both patients
subgroups nor in the patients group as a whole. Also there was no significant
correlation between IgE and absolute eosinophilic count in total patients
group. 5-Mean total serum IgE level was statistically significant higher in
early-onset asthmatics than that in transient wheezers in those aged less than
one year (P=0.003).
Conclusion: These findings support the hypothesis that serum TGF beta-1
may be a valuable diagnostic and prognostic biomarker in early diagnosis of
asthma and in differentiation between early-onset asthma and transient
wheezing among infants and young toddlers.
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Prostanoid DP receptor gene is not a major candidate gene
for asthma and atopy in Chinese children
Chung Yi Li1, Ting Fan Leung1, Alice P. S. Kong2, Iris H. S. Chan3, Gary W.
K. Wong1, Maggie C. Y. Ng2, Edmund Yung1, Michael H. M. Chan3, Chun
Kwok Wong3, Juliana C. N. Chan2, and Christopher W. K. Lam3. 1The
Chinese University of Hong Kong, Department of Paediatrics, Hong Kong,
Hong Kong; 2The Chinese University of Hong Kong, Department of Medicine
and Therapeutics, Hong Kong, Hong Kong; 3The Chinese University of Hong
Kong, Department of Chemical Pathology, Hong Kong, Hong Kong.
Background: Airway sensitisation requires the expression of prostanoid
DP receptor in mice. Functional haplotypes of this gene (PTGDR) are
associated with asthma but not plasma total IgE in Whites and Black
Americans. In contrast, another study in Latinos suggested that these
genetic markers were not important determinants of asthma-related traits in
this population. This study investigated whether six single-nucleotide
polymorphisms (SNPs) of PTGDR are associated with asthma-related traits
in Chinese children.
Methods: Two independent groups of southern Chinese children were
recruited. The primary cohort consisted of 291 asthmatics and 178 non-
allergic children from our paediatric clinics. Our replication cohort consisted
of 556 schoolchildren from a population-based study that investigated
obesity and metabolic syndrome in Chinese children. Plasma total and spe-
cific IgE were measured by immunoassays. Six PTGDR SNPs were deter-
mined by multiplex SNaPshoti genotyping, and their linkage disequilibrium
(LD) pattern was analysed by Haploview. Multivariate regression was
performed to analyse the association between asthma and atopy traits and
PTGDR SNPs.
Results: T-549C and C-441T were in complete LD (D’ = 1.0 and r2 =
0.934), and T alleles of these SNPs were linked together (with TT
frequency being 0.671). PTGDR C367A and G894A were monomorphic.
There was significant interethnic variations in PTGDR minor alleles and
haplotypes (up to 41% and 38%, respectively) when compared with
Whites or Latinos. Asthma diagnosis and aeroallergen sensitisation did not
differ between children with different PTGDR genotypes (P 9 0.1). Linear
regression revealed weakly significant associations between total IgE and
PTGDR T-197C and G1044A. When primary and replication cohorts were
combined, plasma total IgE was marginally associated with T-197C ($ =
0.061, P = 0.049). None of the SNPs was associated with atopy (P 9 0.2)
and aeroallergen sensitisation (P 9 0.25). PTGDR haplotypes were not
associated with any asthma-related trait.
Conclusion: Our results do not support PTGDR to be a major candidate gene
for asthma diagnosis or severity, or atopy in Chinese children.
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Influence of respiratory syncitial virus in the immunological
development of children from 0 to 2 years of age
Ma Anunciacio´n Martin Mateos1, Montserrat Garriga Badı´a2, Ana Plaza
Martin3, Maite Giner3, and Mo´nica Piquer3. 1Hospital Sant Joan de De´u-
Hospital Clinic., Universidad de Barcelona, Barcelona, Spain; 2Fundacio´n
Altahia, Hospital de Manrresa, Barcelona, Spain; 3Hospital Sant Joan de
De´u-., Seccio´n de Inmunologı´a y Alergia, Barcelona, Spain.
: Following a bronchiolitis caused by respiratory syncytial virus (RSV),
later recurrent wheezing are common.
Objective: The aim of this study was to establish the relationship between
repiratory syncytial virus and the modifications in immunity that cause
appearance of childhood asthma.
Patients and Methods: The prospective study Two groups of study:
CHILDREN WITH BRONCHIOLITIS. (Group A). The problem group of
children was originally made up of 65 children (with an average age of 3
months, 1 day to 7 months) who were admitted to this Hospital for their first
episode of VRS positive bronchiolitis, from December 1997 to February 1998.
50 of them completed follow-up for 2 years. In the tests done at the moment of
admittance :hemogram, and Ig G, Ig M, Ig A, Ig E, lymphocyte count,
eosinophil cationic protein,IL-4 IFN-g. were at 6, 12 and 18 months, At 18
months an adhesion molecules count was requested: sVCAM.1, sLselectin.
The second group (group B), was made up of 80 children, sub-divided into 4
groups of 20 according to age: IL- 4, IFN-g and adhesion molecules.
Results: In the acute stage of the bronchiolitis, the immunological response to
the viral infection was anomalous, in that they presented a humoral immunity
response (with an increase of immunoglobulins G, A, M, the later with
p = 0,014) and a decrease in T, T4 and T8 cellular immunity. The immu-
nolological response to the viral infection must be of cellular predominance, in
order to be effective. Among all children suffering from VRS bronchiolitis, we
found a statistically significant increase (p = 0,001) of sL-Selectine at 18
months of age in comparison with healthy children of the same age.
Conclusion: the characteristic patterns that lead us to believe that a child who
suffers from bronchiolitis will develop asthma are: Increase in humoral immu-
nity response at the acute stage of the bronchiolitis Decrease in cellular
immunity response, from the acute VRS infection until 6 months of age
Increased IL-4 values mainly at 6 and 12 months of age. Decrease in INF-g
between 6 and 18 months of age.
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Association of polymorphism of the mast cell chymase gene
promoter region (-1903 G/A) and (TG)n(GA)m repeat
downstream of the gene with bronchial asthma in children
Elham Hossny1, Nermine Amr1, Shereen Elsayed2, Rasha Nasr2, and Eman
Ibraheim1. 1Ain Shams University, Pediatrics, Cairo, Egypt; 2Ain Shams
University, Microbiology and Immunology, Cairo, Egypt.
Background: Mast cell chymase is an important mediator of inflammation
and remodeling in the asthmatic lung. Various studies examined the
association between -1903 G/A single nucleotide polymorphism (SNP) of
the mast cell chymase gene (CMA1) and allergic phenotypes with inconsistent
results. The (TG)n(GA)m repeat polymorphism 254 bp downstream of the
chymase gene was previously found to associate asthma in adults. We sought
to investigate the association of the -1903 CMA1 SNP as well as the
(TG)n(GA)m repeat polymorphism with childhood asthma and its associated
traits in a case-control study aiming to identify local data from our country.
Methods: The study comprised 15 children (6Y10 years old) with bronchial
asthma and a family history of atopy enrolled consecutively during asthma
exacerbation and 15 age and sex matched children with negative personal or
family history of allergy as a control group. They were subjected to clinical
evaluation and serum total IgE estimation as well as search for polymorphism
in the CMA1 gene promoter region 1903 G/A using PCR restriction fragment
length polymorphism based genotyping (RELP) and the (TG)n(GA)m repeat
polymorphism 254 bp downstream of the CMA1 gene.
Results: Investigating the -1903 G/A SNP revealed significant difference in
the distribution of CMA1 A and G alleles between the patients and controls.
Allele G was detected in 70% of patients compared to 16.7% of controls, while
allele Awas overexpressed in the control group (83.3%). Our data showed for
the first time a positive association between -1903 G/A SNP and asthma.
Concerning the (TG)n(GA)m repeat, a significant difference was obtained in
the allele counts among patients and controls in the current study. The largest
difference was observed in allele 39 which was only represented in the
asthmatic children and allele 37 which was overexpressed among the controls.
A positive association for the allele 39 of the (TG)n(GA)m repeat with serum
IgE levels was also detected in our series. The findings are limited by the
sample size.
Conclusion: We report the association of -1903 G/A SNP and (TG)n(GA)m
repeat polymorphism downstream of the CMA1 gene with bronchial asthma in
a group of Egyptian children. The findings suggest that the alleles, genotypes
and haplotypes investigated are possible important determinants of asthma




Efficacy of mometasone furoate nasal spray-MFNS- in the
treatment of allergic rhinitis. Meta-analysis of randomized
controlled trials
Martin Penagos, EnricoCompalati, Francesco Tarantini, Giovanni Passalacqua,
and Giorgio Walter Canonica. Allergy & Respiratory Diseases Clinic, Genoa
University, Department of Internal Medicine, Genoa, Italy.
Objective: To assess the efficacy of MFNS in the treatment of allergic rhinitis.
Study Selection: Randomized, placebo-controlled and double blind trials that
studied the effects of MFNS in patients with allergic rhinitis. Comprehensive
searches of the EMBASE, LILACS, Cochrane Library and MEDLINE
databases from 1966 up to January 2007 and references of identified articles
and reviews.
Outcomes: Different outcomes measured in the active treatment and control
groups were considered. Review Manager 4.2.8 Program (Cochrane Col-
laboration) was used for data synthesis. Outcomes were extracted from original
articles. If information was not available, authors of each trial were contacted.
Some graphics were digitalized. The analysis included the calculation of
standardized mean difference (SMD). There was significant heterogeneity
among the study results, because of differing study methodologies. Random-
effects model was used.
Results: The initial scanning identified 91 articles, 26 of which were
potentially relevant trials on the use of mometasone for the treatment of
allergic rhinitis. 14 studies were randomized controlled trials and met inclusion
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criteria for the meta-analysis. All randomized clinical trials included 23
comparison groups and more than 20 different outcomes (individual and
global). For efficacy assessment, 2163 patients were analyzed; 1113 received
mometasone and 1050 placebo. MFNS was associated with significant
reduction in total symptoms scores (SMD j0.59; 95% CI j0.80 to j0.39;
P G 0.00001; heterogeneity I2 = 78.3%.).
Safety: For adverse events report, 1758 patients were included. 884 received
MFNS and 874 placebo. No significant difference between MFNS and placebo
was revealed (SMD 1.02; 95% CI 0.83 to 1.25; P = 0.86; heterogeneity
I2 = 1.0%)
Conclusions: First among nasal CSs, MFNS efficacy achieved Evidence Ia in
the treatment of allergic rhinitis.The frequency of adverse events is similar in
both groups, when it was compared with placebo.
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Studies on the role of tumor necrosis factor alpha gene
polymorphisms in the therapeutic response to intranasal UV
phototherapy
Ma´rta Boros-Gyevi, Edina Garaczi, Andrea Koreck, Ma´rta Sze´ll, and Lajos
Keme´ny. University of Szeged, Dermatology and Allergology, Szeged,
Hungary.
: Tumor necrosis factor alpha (TNF") is one of the key cytokines in UV-
induced immunosuppression. We have shown that intranasal phototherapy
with mixed UVA-UVB-visible light (mUV/VIS) is a new therapeutic tool for
the management of allergic rhinitis. The aim of this study was to investigate
whether the efficiency of rhinophototherapy is related to specific TNF"
polymorphisms. Fifty-nine patients with a history of at least 2 years of
ragweed-induced allergic rhinitis were treated during ragweed seasons in
Szeged, Hungary. Rhinophototherapy was carried out 3 times a week for
2 weeks and continued by a one-week follow up period, or 3 times a week for
3 weeks with increasing doses of mUV/VIS. The total dose of mUV/VIS
therapy was the same at the end of the study in both therapeutic regimens. The
patients graded the following 4 symptoms of allergic rhinitis on a standard
severity scale: nasal itching, nasal obstruction, rhinorrhea and sneezing
referred to as total nasal score (TNS). The average improvement in TNS of all
patients was evaluated using repeated measures ANOVA. Patients with more
than 50 percent decrease of the average change in the TNS were considered as
responders and with less than 50 percent decrease as non-responders.
According to these parameters, 38 patients were considered to be responders
(64%) and 21 patients were non-responders (36%). Blood sample was taken
from all patients for single nucleotide polymorphism (SNP) analysis of TNF".
Three SNPs of the promoter region of TNF" gene were selected for
polymerase chain reaction restriction fragment length polymorphism (PCR-
RFLP) analysis. The genotypes and allele frequencies of selected SNPs’ were
compared between the responders and non-responders for rhinophototherapy.
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Allergic rhinitis: occurrence of sinusitis in Bsneezers-runners^
and Bblockers^
Sandeep Sahay, Danish Jamal, and Ashok Shah. Vallabhbhai Patel Chest
Institute, Respiratory Medicine, Delhi, India.
Background: Patients with allergic rhinitis can be categorized as Bsneezers-
runners^ and Bblockers^. The presence of sinusitis is often overlooked in these
patients. The occurrence of sinusitis was assessed in these two clinical
presentations of allergic rhinitis.
Methods: Consecutive patients with allergic rhinitis, with skin allergy test
positivity were enrolled and categorized into Bsneezers-runners^ and
Bblockers^ as per their predominant symptoms based on ARIA guidelines.
All were subjected to computed tomography (CT) of the paranasal sinuses and
extent of sinusitiswas staged as per Lund andKennedy criteria. The presence of
sinusitis was then correlated with their clinical symptoms.
Results: Of the 338 patients (220 males, 118 females), 134 (39.6%) were
Bsneezers-runners^ and 204 (60.4%) were Bblockers^. Sinusitis was present in
257 (76%), 78 (58.2%) were Bsneezers-runners^ while 179 (87.7 %) were
Bblockers^. Sinusitis was significantly higher in Bblockers^ (78/134 vs
179/204, P = 0.019). Furthermore, the occurrence of sinusitis was significant
in Bblockers^ (179/204 vs 25/204, P = 0.000) but not so in Bsneezers-runners^
(78/134 vs 56/134, P = 0.12). The mean sinus CT score was significantly
higher in Bblockers^ as compared to Bsneezers-runners^ (8.9 T 7.6 vs
6.1 T 5.6, P = 0.0014). The mean number of sinuses involved too was
significantly more in Bblockers^ (6.54 T 4.53 vs 4.5 T 3.2, P = 0.0001).
TABLE 1.
Study num. of patients
TSS mometasone
mean (SD IC 95%) num. of patients
TSS placebo
mean (SD IC 95%) Weight % SMD
Meltzer JACI 1998 80 4.36 (0.70) 41 5.99 (1.90) 8.11 j1.31 (j1.72Y0.89)
Stuck Allergy 2003 13 8.80 (7.60) 11 20.40 (14.80) 3.82 j0.98 (j1.84Y0.12)
Bende Ann Allergy
Asthma Immunol 2002
103 2.00 (0.95) 104 3.54 (1.10) 9.81 j0.91 (j1.20Y0.62)
Graft JACI 1996 114 1.10 (0.90) 101 2.40 (2.30) 9.93 j0.76 (j1.04Y0.48)
Hebert Allergy 1996 122 3.30 (2.85) 110 5.20 (4.65) 10.14 j0.50 (j0.76Y0.24)
Bronsky Ann Allergy
Asthma Immunol 1997
94 7.00 (5.50) 95 8.90 (6.90) 9.81 j0.30 (j0.59Y0.02)
Drouin Ann Allergy
Asthma Immunol 1996
129 3.90 (2.45) 124 4.60 (2.29) 10.32 j0.29 (j0.54Y0.05)
Mandl Ann Allergy
Asthma Immunol 1997
181 4.41 (3.50) 184 5.53 (4.50) 10.84 j0.28 (j0.48Y0.07)
Gawchik Ann Allergy
Asthma Immunol 2003
122 5.73 (4.55) 123 6.21 (5.25) 10.29 j0.10 (j0.35Y0.15)
Ciprandi Ann Allergy
Asthma Immunol 2001
9 0.64 (0.44) 11 1.42 (0.56) 2.99 j1.46 (j2.48Y0.45)
Frieri Ann Allergy
Asthma Immunol 1998
11 0.50 (0.60) 10 1.16 (0.85) 3.55 j0.87 (j1.77Y0.04)
Meltzer JACI 1999 135 4.30 (2.08) 136 5.49 (1.92) 10.38 j0.59 (j0.84Y0.35)
I2 = 78.3%; Z = 5.76 (p G 0.00001) 1113 1050 100 j0.59 (j0.80Y0.39)
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Maxillary sinuses were the most commonly involved (214, 83.2 %). This too
was significantly higher in Bblockers^ (168/179 vs 46/78, P = 0.029).
Breathlessness (105/204 vs 38/134, P = 0.006) and posterior purulent nasal
discharge (144/204 vs 44/134, P = 0.046) were significantly more in
Bblockers^ while nasal/palatal itching (83/134 vs 71/204, P = 0.003) and
ocular itching (76/134 vs 64/204, P = 0.003) were significantly higher in
Bsneezers-runners^. BBlockers^ with sinusitis had significantly higher
nocturnal awakening (156/179 vs 10/25, P = 0.041), posterior purulent post
nasal drip (138/179 vs 8/25, P = 0.032) and halitosis (112/179 vs 6/25,
P = 0.035).
Conclusion: Patients with allergic rhinitis should be categorized as Bsneezers-
runners^ and Bblockers^ since they have distinct clinical profiles. BBlockers^
had significantly more sinusitis as compared to Bsneezers-runners^. Radio-
logical severity of sinusitis toowas significantly higher in Bblockers^. Presence
of sinusitis can possibly lead to suboptimal control of allergic rhinitis.
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Evidence based treatment of allergic rhinitis
Enrico Compalati, Martin Penagos, Francesco Tarantini, and G. Walter
Canonica. Allergy & Respiratory Diseases Clinic, Genoa University, Depart-
ment of Internal Medicine, Genoa, Italy.
: In clinical practice, caring for patients generates many questions about
diagnosis, prognosis, and treatment that challenge health professionals to keep
up to date with the medical literature. One approach to meeting these
challenges is to learn how to practise evidence based medicine (EBM).
According to EBM, conclusions from meta-analyses of randomized
trial represent the most solid evidence source to assess the efficacy of a
treatment. Meta-analysis is a statistical procedure that integrates the results of
different independent studies pooled together, thus allowing a more objective
appraisal of the evidence than traditional narrative reviews can do. Meta-
analysis provides a quantitative estimate of treatment effects. Pharmacological
treatment of allergic rhinitis represents a bench mark of therapeutic manage-
ment. Practical guidelines need high quality proves of evidence in order to
provide reliable recommendations for therapeutic management. Meta-analysis
may represent the answer to this need, as a source of solid evidence. Cochrane
Collaboration recommendations and Quorom Statements represent the gold
standard of quality assessment.
At present only few systematic reviews of high methodological quality
are available or in progress: evidence Ia of efficacy for antihistaminic treatment
is provided by desloratadine which on 3108 patients showed a significant
reductions in total symptoms scores, total nasal symptoms score and nasal
blockage relief when compared with placebo; a meta-analysis confirms that
also ebastine induces a greater decrease from baseline in mean rhinitis
symptom scores than placebo (749 patients). Mometasone furoate is at present
the only one nasal steroid which may benefit an evidence of effect Ia by
means of an in-progress meta-analysis, whose preliminary results show in 2163
patients a significant reduction in total symptoms scores. According to a
recent systematic review with pooled analysis, leukotriene receptor antago-
nists produce a small but statistically significant improvement in nasal
symptomwhen comparedwith placebo (3924 patients). All drugs showed good
safety profile.
Antihistamines, nasal steroids and antileukotrienes demonstrated
evidence of efficacy in the treatment of allergic rhinitis; these tools should
also demonstrate a good benefit/cost ratio in order to satisfy the future
methodological approaches of guidelines formulation (GRADE).
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Leukotriene receptor expression in allergic rhinitis: the effect of
allergen exposure and treatment
Teet Pullerits1, Carina Malmha¨ll2, and Jan Lo¨tvall2. 1Lung Pharmacology
Group, Department of Allergology and Lung Medicine, Gothenburg, Sweden;
2Lung Pharmacology Group, Department of Allergology and Lung Medicine,
Gothenburg, Sweden.
Background: Cysteinyl leukotrienes are mediators contributing to the
symptoms of allergic rhinitis and exerting their effect through specific
receptors. We aimed to evaluate the effect of a naturally occurring grass pollen
season and the anti-rhinitis treatment on the expression of cysteinyl leukotriene
receptor 1 (CysLT(1)R) in the nasal mucosa of allergic rhinitis patients.
Methods: In a double-blind randomised study, 59 patients with allergic
rhinitis received treatment with either nasal steroid (fluticasone propionate; FP,
200 microg/day), oral antileukotriene montelukast (ML, 10 mg/day) alone or
in combination with antihistamine loratadine (LT, 10 mg/day), or placebo over
the grass pollen season. Nasal biopsies for immunohistochemical CysLT(1)R
analysis were taken before and during the peak of the grass pollen season.
Results: The grass pollen season induced a significant increase in the
CysLT(1)R expression in placebo (from 0.097 T 0.005 to 0.178 T 0.012 cells/
field), ML (from 0.113 T 0.011 to 0.148 T 0.009), and ML + LT (from
0.122 T 0.008 to 0.154 T 0.016), but not in FP (from 0.123 T 0.013 to
0.128 T 0.016) treated patients. FP treated patients had significantly lower
pollen-season induced change in the CysLT(1)R expression compared to other
groups. Also, both ML and ML+LT treatment groups had significantly lower
increase in the CysLT(1)R expression compared to placebo treatment.
Conclusion: We conclude that the inhibitory effect on CysLT(1)R expression
is one of the mechanisms by which nasal steroids and antileukotrienes alone or
together with antihistamines exert their anti-inflammatory effect in allergic
rhinitis with nasal steroids demonstrating the strongest inhibition.
TABLE 2.Efficacy of desloratadine in the treatment of allergic
rhinitis: a meta-analysis of randomized, double-blind,
controlled trials
G. W. Canonica. Allergy 2007;62:359Y366 symptoms scores (SMD j1.63; 95% CI j2.75
to j0.51; P = 0.004)
total nasal symptoms score (SMD j0.66;
95% CI j0.91 to j0.42; P G 0.001)
nasal blockage relief (SMD 0.32; 95% CI 0.10
to 0.55; P = 0.005)
Meta-Analysis of the Efficacy of Ebastine 20 mg
Compared to Loratadine 10 mg and Placebo in the
Symptomatic Treatment of Seasona
Paul Ratner et al. Int Arch Allergy Immunol
2005;138:312Y318
LS mean TSS (j1.30 (0.16) j1.61 to j0.99;
p G 0.0001)
Efficacy of Mometasone Furoate Nasal Spray-MFNS-
in the treatment of allergic rhinitis. Meta-analysis
of randomized controlled t
Penagos M. In progress (SMD j0.59; 95% CI j0.80 to j0.39;
P G 0.00001; heterogeneity I2 = 78.3%)
Leukotriene Receptor Antagonists for Allergic Rhinitis:
A Systematic Review and Meta-analysis
A. M. Wilson. The american journal of
medicine. volume 116; 2004
NS percentage of maximum score (WMD j5%;
95% CI j7% to j3%; P = 0.01 for heterogeneity)
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Sputum eosinophils negatively correlate with lung functions in
non-asthmatic rhinitis patients
Jae Woo Kwon, Min-Suk Yang, So-Hee Lee, Sae-Hoon Kim, Sang-Min Lee,
Hyouk-Soo Kwon, Chang-Han Park, Heung-Woo Park, Yoon-Seok Chang,
Sun-Sin Kim, Sang-Heon Cho, Kyung-Up Min, and You-Young Kim. Seoul
National University College of Medicine, Seoul, Internal Medicine, SEOUL,
Republic of Korea.
Background: Sputum eosinophilia is frequent findings in non-asthmatic
rhinitis patients. In asthma, sputum eosinophilia is known to be related to
airway remodeling and thus reduced pulmonary functions. However, clinical
significance of sputum eosinophilia in non-asthmatic rhinitis patients has not
yet been determined.
Objective: To evaluate the clinical significance of sputum eosinophil counts in
the pulmonary function of non-asthmatic rhinitis patients.
Methods: A retrospective review of medical records of 89 moderate-to-severe
perennial rhinitis patients without respiratory symptoms was performed. All of
them underwent lung function tests, skin prick testing to common inhalant
allergens, methacholine bronchial challenge tests, and sputum induction with
hypertonic saline to examination the eosinophil counts. Patients were divided
into two groups according to the presence of sputum eosinophilia (Q2%).
Patients who were taking systemic steroid, who had past history of destructive
lung disease and who had asthma or airway hyperresponsiveness were
excluded. Stored sputum samples were used to determine mRNA levels of
TGF-$, MMP-9 and TIMP-1.
Results: Therewas no significant differences in characteristics including atopy
index, smoking and use of nasal corticosteroids between two groups. FEV1/
FVCwas significantly decreased in the group with sputum eosinophilia (98.5 T
0.1 for positive and 103.0 T 0.1 for negative sputum eosinophilia, p = 0.015).
Sputum eosinophil counts were negatively correlated with predicted percent of
FEV1 and FEV1/FVC (R square = .063, p = .017 for FEV1 and R square =
.009, p = .004 for FEV1/FVC). The mRNA levels of TGF-$ and TIMP-1
between two groups showed no significant difference (p = .366). However, the
mRNA level of MMP-9 was significantly increased in subjects with sputum
eosinophilia (p = .035). The ratio of MMP-9 and TIMP-1 mRNAs was also
significantly increased in subjects with sputum eosinophilia (p = .013).
Conclusion: Sputum eosinophilia in non-asthmatic moderate-to-severe
rhinitis patients may affect lung function via airway remodeling.
MECHANISMS OF ASTHMA II
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Maternal asthma enhances umbilical cord blood leptin
expression
Ting Fan Leung1, Chun Kwok Wong2, Wing Hung Tam3, Samantha W. M.
Lun2, Chung Yi Li1, Fanny W. S. Ko4, Christopher W. K. Lam2, and Pak
Cheung Ng1. 1The Chinese University of Hong Kong, Department of
Paediatrics, Hong Kong, Hong Kong; 2The Chinese University of Hong Kong,
Department of Chemical Pathology, Hong Kong, Hong Kong; 3The Chinese
University of Hong Kong, Department of Obstetrics and Gynaecology, Hong
Kong, Hong Kong; 4The Chinese University of Hong Kong, Department of
Medicine and Therapeutics, Hong Kong, Hong Kong.
Background:Maternal asthma is a strong risk factor for asthma susceptibility
in their children. Although this familial inheritance is a well-known
phenomenon, the extent and exact mechanisms leading to this immunomo-
dulation in mother/child pairs are poorly understood. The present cross-
sectional study investigated the in utero priming of fetal allergic inflammatory
responses in relation to the presence of maternal asthma.
Methods: Pregnant women with personal history of asthma and those with-
out any atopic disorder were recruited during antenatal visits. EDTA-
anticoagulated venous blood was collected from these mothers intrapartum,
and also from umbilical veins of their babies postpartum but before placental
separation. The protein signatures of 79 inflammatory mediators from these
paired serum samples were analyzed using RayBio\ Human Cytokine
Antibody Array V. Serum levels of leptin, being differentially expressed in
umbilical cord blood (UCB) from those with maternal asthma, and C-reactive
protein (CRP) were measured by ELISA assays. The respective lower
detection limits for these markers were 125 ng/L and 0.1 mg/L.
Results: Six pregnant mothers with asthma and 6 non-allergic controls were
recruited, with respective mean (SD) age being 30.7 (5.9) years and 35.1 (4.9)
years. Five of 6 UCB samples from newborns with maternal asthma had
increased leptin levels when compared with newborns with non-allergic
mothers. Other mediators with altered levels in two or more UCB samples with
maternal asthma included IL-3, IL-8, IL-12, IL-15, PDGF-BB, NAP-2, GRO
and MIG. Serum leptin and CRP levels from asthmatic mothers were
significantly higher than those in UCB from their newborns (P G 0.001), so
were serum CRP levels in non-allergic mothers as compared with their
newborns (P G 0.01). Leptin levels showed significant positive correlation with
CRP levels (r = 0.712, P G 0.001) in sera from asthmatic mothers. On the other
hand, CRP was below the detectable limit in most UCB serum samples. Serum
leptin levels in UCB did not differ in those with and without maternal asthma.
Conclusion: Maternal asthma may upregulate leptin-related pathway in UCB
of their high-risk newborns, which may predispose them to develop early
allergic manifestations.
Funding: Direct Grant for Research, CUHK.
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Promoter polymorphisms of cysteinyl leukotriene type 1 receptor
in patients with different asthma phenotypes
Milena Sokolowska1, KarolinaWodz1,Malgorzata Cieslak2,MarekKowalski2,
and Rafal Pawliczak1. 1Medical University of Lodz, Department of Immuno-
pathology; Chair of Immunology, Lodz, Poland; 2Medical University of Lodz,
Department of Immunology, Rheumatology and Allergy, Lodz, Poland.
Background: Cysteinyl leukotrienes (cysLTs) are potent inflammatory
mediators acting through at least two receptors CysLTR1 and CysLTR2.
CysLTR1 mRNA and protein expression is upregulated in patients with severe
asthma phenotypes: frequent severe exacerbations, chronic airflow limitation
or steroid-resistant asthma. Changes in the CysLTR1 promoter might influence
its transcriptional activity and therefore might modulate airway inflammation.
Aim: Investigate an association of polymorphisms in the CysLTR1 gene
promoter with severe and non-severe asthma phenotype.
Methods: The study groups consist of 100 patients with severe asthma, 70
patients with non-severe asthma, diagnosed according to GINA 2005 criteria
and 100 healthy subjects. Genomic DNA was isolated from the peripheral
blood leukocytes. Fragments of the CysLTR1 promoter region were amplified
by PCR and sequenced directly.
Results: Three single nucleotide polymorphisms (SPSs) -634 T/C (rs321029),
-475C/A (rs2637204), -336G/A (rs2806489) were identified in the promoter
region of CysLTR1 gene. All SNPs were in strong linkage disequilibrium both
in patients and in control group. Two most common haplotypes were
identified: ht1 [C-A-A] and ht2 [T-C-G], among which ht1 was observed in
71.43% of male patients and 90.48% of male controls. Significant differences
were observed in allele frequencies of -336G/A in male subjects. -336G allele
occurred significantly more often in men with severe asthma comparing with
male control group (pcor = 0.04; OR = 3.800 C.I. = [1.112Y12.983]).
Conclusion: Genetic variants of CysLTR1 gene promoter might be associated
with severe asthma phenotype in male asthmatic patients. Further elucidation
of this association might improve understanding of heterogeneous condition in
severe asthma.
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Inflammatory changes in upper respiratory tract in patients with
aspirin sensitive asthma
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Tatjana Caparoska1, Biserka Kjaeva1, Jagoda Stojkovic1, and Olivera
Caparoska2. 1Clinical Center- Skopje, Clinic for Pulmology and Allergology,
Skopje, Macedonia, Fyrom; 2University Health Network, IMG Ontario,
Toronto, Canada.
Background: Patients with aspirin- sensitive asthma often have continious
inflammation of their upper sinuses complicated by chronic rhinitis, chronic
sinusitis and nasal polyposis which frequently leads to asthma attacks. These
patients often are not aware of the problems in their upper respiratory tract.
Our goal with this study was to evaluate the inflammatory changes in upper
respiratory tract in patients with aspirin sensitive asthma (ASA).
Methods: We followed 88 patients with paranasal x-ray, CTscan, skin prick
tests, pulmonary function test, rhynomanometry and chest x-ray. Patients were
divided in 2 groups. 39 pts with NSAIDs intolerance of ~15yrs were included
in the first group (mean age 45, 8 Q 4,7yrs). In the second group were 49
aspirin intolerant asthma pts (mean age 44, 8 Q 4, 1yrs). The diagnosis of
asthma was made based on clinical evaluation, skin prick test and pulmonary
function test including histamine provocation test. Endoscopic methods were
used for assesment of paranasal sinuses and nasal passages.
Results: Endoscopic examination showed in group 1 nasal polyposis in 8,
deviation of nasal septum in 16, hypertrophy of nasal mucosa in 6, and chronic
tonsilitis in 4 pts. In 16 pts we have observed changes in x-ray of paranasal
sinuses and in 12 changes in CTscans of PNS. In 13 pts- rhynomanometric
evaluation showed decrease in of the nose. pathways Bacteriological analysis of
nose and throat showed predominance of bacteria species Moraxella influenze
in 33,3%, Moraxella cataralis in 28,2% and Stahylococcus aureus in 15,3%.
Conclusion: Our study and results confirm the coexistence of chronic
inflamation in upper respiratory tract in pts with bronchial asthma regardless of
it’s type.
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Role of the RNA-binding protein HuR in posttranscriptional
regulation of IL-13 in T cells
Cristiana Stellato1, J. Fang1, B. Tancowny1, J. Fan1, F. Wu1, Y. Asaki1, U. De
Fanis1, S-K Huang1, M. Gorospe2, Ulus Atasoy3, and V. Casolaro4. 1Johns
Hopkins, Allergy, Baltimore, United States; 2National Institute of Aging,
Immunology, Baltimore, United States; 3University of Missouri-Columbia,
Surgery and Molecular Immunology, Columbia, Missouri, United States;
4Johns Hopkins University, Allergy, Baltimore, United States.
Rationale: Posttranscriptional regulation (PTR) is a key yet ill-defined area of
gene expression in T cells. We investigated the PTR of interleukin (IL)-13 and
the role the RNA-binding protein HuR plays in this process. HuR associates
with adenylate-uridylate-rich elements (ARE) in the 3’untranslated regions
(UTR) of mRNAs, promoting mRNA stability and translation.
Methods: IL-13 mRNA decay was monitored in human peripheral blood-
derived Th2 cells using the transcriptional inhibitor Actinomycin D. The IL-13
3’UTR was subcloned into a tetracycline (Tet)-off $-globin reporter construct
and transiently expressed in the absence or presence of overexpressed HuR in
H2 cells. Association of HuR with IL-13 mRNA was detected by immu-
noprecipitation (IP) of messenger ribonucleoprotein complexes (mRNPs) and
by biotin pull-down.
Results: IL-13 mRNA half-life increased in cells treated with PMA and
ionomycin compared to unstimulated cells (6.5 T 2.0h vs 1.6 T 0.1h, p G 0.05,
n = 3). The decay of the $-globin transcript was faster in cells transfected with
pTet-BBB-IL13 compared to those transfected with the ARE-less pTet-BBB
(2.1 h vs 11.4 h, p G 0.05, n = 6). Overexpression of HuR increased $-globin
mRNA half-life in cells transfected with pTet-BBB-IL13 (22.7 h vs 2.3 h,
p G 0.01, n = 4). Enrichment of IL-13 mRNAwas detected by PCR following
IP of Jurkat cell mRNPs with anti-HuR vs a control antibody. HuR binding to
IL-13 3’UTR was confirmed by pull-down assay using biotin-labeled RNA
probes spanning the 3’UTR or the coding region of IL-13.
Conclusion: PTR plays a relevant role in expression of IL-13. HuR-
mediated stabilization of IL-13 mRNA could be a relevant therapeutic target
in asthma.
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Functional study of prostaglandin D2 receptor (chemoattractant
receptor molecule expressed in th2 cells, CRTH2) promoter
polymorphism with aspirin-intolerant asthma
Nami Palikhe1, Seung-Hyun Kim1, Eun-Mi Yang1, Young-Min Ye2, Gyu-
Young Hur1, Eun-Joo Nam1, and Hae-Sim Park1. 1Ajou University, School of
Medicine, Department of Allergy, Suwon, Republic of Korea; 2Yonsei
University, School of Medicine, Department of Pharmacology, Seoul, Republic
of Korea.
Background and Objective: Prostaglandin D2 (PGD2) is an important lipid
mediator in the pathogenesis of eosinophilic airway inflammation via its
receptor CRTH2. The human CRTH2 gene encodes a G protein-coupled
chemoattractant receptor which is expressed on Th2 cell, eosinophil, basophil
and monocyte. The main objective of the study is to investigate the association
of CRTH2 promoter polymorphism in patients with aspirin intolerant asthma
(AIA).
Subjects and Methods: The case control study was performed in three groups
of patients, 106 AIA, 115 aspirin tolerant asthma (ATA) and 133 normal
controls (NC). Two promoter polymorphism of CRTH2 gene were genotyped
by a primer extension method, which was performed with the SNaPshot
ddNTP primer extension kit (Applied Biosystems, CA, USA).
Results: Two novel single- nucleotide polymorphisms (SNPs), CRTH2-
466T9C and -129 C9Awere identified in the promoter region of gene. Among
two SNPs, the polymorphism of CRTH2 at positions of -466T9C showed a
significant difference in genotype frequency between AIA and ATA; AIA
patients showed significantly higher frequency of homozygous TT genotype
than combined homozygous CC and heterozygous CT genotype of CRTH2 -
466T9C (p = 0.037, multiple logistic regression analysis controlling for age
and sex, recessive model). The luciferase reporter assay showed that the
reporter plasmid carrying the -466C allele showed significantly higher
promoter activity than -466T allele in human monocytes cell line (U937) and
human mast cell line (HMC-1) (p G 0.001and p G 0.001 respectively).
Similarly, the promoter activity of CRTH2 -466C allele cotransfected with
GATA-3 was found to be increased dose dependently from the baseline
promoter activity in HMC-1 cells.
Conclusion: These results suggest that GATA-3 may be directly or indirectly
associated with CRTH2 -466C allele by stimulating mast cell activation with
the release of Th2 cytokines and other proinflammatory mediators contribut-
ing the increased susceptibility of AIA in CRTH2 -466T9C promoter
polymorphism.
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The relationship between early infections due to RSV and the
specificities of subsequent development of asthma
Tatjana Zaharov1, Marianne Rasmussen1, Lise Bjerglund1, Anne Lyn
Pedersen2, Maria Lundahl1, Gert Sangren1, and Lene Bohr1. 1NykLbing F
Hospital, Paediatrics, NykLbing F, Denmark; 2NykLbing F Hospital,
Paediatrics, NykLbing F, Denmark.
: Clinical studies of RSV- infected patients indicated increased levels of
Th2 cytokines and IgE, suggesting that an allergy-like condition developed
during infection and skew the Th1/Th2 balance toward Th2 9 Th1.
Comparative retrospective analysis of 76 children, who been admitted between
winter seasons 2001 and 2005 for a first attack of brochiolitis before the age of
12 months, was performed in order to elaborate and correlate possible
specificity of asthma in term of pathogenesis (A, NAA), immune response and
compliance to treatment. In the 3 groups of children, divided on the basis theirs
phenotypes: I group (n = 21) IgE associated persistent wheezier, II group
(n = 47) nonatopic recurrent wheeze, III (n = 8) viral associated wheeze, RSV
infection was responsible for the first attack of wheezing in 98%, 2% has early
adenovirus infections in the II group. Family history of asthma and multiple
asthmas triggers was performed in 95% in I (bilateral genetic risk was funded
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in 18%) comparing with 3% from II group. In opposite, many risk-factors in
prenatal, peripartal and early neonates period of life in the present of serious
another illness, was found in the II group (p G 0,05): oligohydramnion,
placentas abruptions and infarct, small for date with extremly LBW 800 T 57g,
gigant baby with extremely higher birth weight: 5250 T 50g, low Apgar score
and reanimation/adaptation problems after birth. Patients in I group dem-
onstrated higher levels of Neu, Eo, moderate degree of diseases and recurrent
wheezing and/or asthma. Severity of the illness, many immune, endocrine,
metabolic and genetics deregulations, ly-cytosis and Mo-cytosis were typical
for II group. Compliance to ICS was significantly better in the I group. On the
basis these data we may indirectly conclude implicate excess type 2 and/or
deficient type 1 immune responses in the pathogenesis of RSV bronchiolitis
and subsequent asthma development in I group. In contrast, II group had
probably higher Th1 immune responses during RSV infections, on the basis
maternal and intra-uterine factors, and has more severe disease and had shown
higher percentage of immune deregulations. Patients in II group have
attributes specific for NAA and complex immunoregulatory pattern followed
by inappropriate response to treatment. These results indicate that immuno-
logical background via CD8+T cells may play an important role in the
regulation of the differentiation and activation of the Th2CD4+Tcells during
RSV infection.
CLINICAL IMPLICATIONS OF AEROALLERGENS
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Indoor air quality and dyspnea, mucosal, dermal and general
symptoms in relation to room temperature and ventilation in
university computer classrooms -an experimental study
Dan Norba¨ck, and Klas Nordstro¨m. Uppsala University, Dept. of Medical
Science, Uppsala, Sweden.
: The aim was to study effects of increased ventilation and temperature
changes in computer classrooms on measured indoor air quality and medical
symptoms in university students. Technical university students in four
classrooms participated in a blinded study. Two classrooms had higher air
exchange (4.1Y5.2 ac/h); two others had lower air exchange (2.3Y2.6 ac/h).
After one week, ventilation conditions were shifted between the rooms. The
students reported medical symptoms last hour, on a seven step rating scale.
Room temperature, RH, CO2, PM10, and ultra fine particles were measured
simultaneously during 1 hour. In addition, illumination, air velocity, operative
temperature, supply air temperature, formaldehyde, NO2, O3 and airborne
levels of bacteria, moulds and common allergens was measured. Totally 355
students participated at least once in the study during the two weeks , 121
participated twice in the longitudinal analysis. In total, 31% were females,
2.9% were smokers, 3.8% had asthma, 18.1% pollen allergy (hay fever), and
14.0% furry pet allergy. Mean CO2 was 993 ppm (674Y1450 ppm),
temperature 22.7 C (20Y25 C), and RH 24% (19Y35 %). Low and high air
exchange rate corresponded to a personal outdoor air flow of 7 L/s*p and
10Y13 L/s*p, respectively. Mean PM10 was 20 microgram/m3 at low and 15
microgram/m3 at high ventilation flow. In the crude analysis, ocular, nasal and
throat symptoms, dermal symptoms, dyspnea, sinusitis, headache, tiredness
and nausea was significantly more common at higher CO2 levels and higher
room temperature. At higher air exchange rate dyspnea and dermal symptoms
were significantly less common. Similar results were obtained in the
multivariate analysis, controlling for potential confounders such as gender,
smoking and a history of atopy. In the longitudinal analysis of a subset
participating twice, increased temperature was significantly related to increase
of tiredness. In conclusion, computer classrooms may have CO2 levels above
the current ventilation standards (more than 1000 ppm) and temperatures
above 22 C, due to crowdedness and high thermal load. Increased temperature
and CO2-levels may affect both dermal and mucosal membrane symptoms, as
well as headache and tirdness. It is recommended that the personal ventilation
flow is at least 10 L/s.
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Allergenicity of the recombinant and native blomia tropicalis
allergens among atopic subjects
John Donnie Ramos1, Nge Cheong2, and KawYan Chua2. 1University of Santo
Tomas, Research Center for the Natural Sciences, Manila, Philippines;
2National University of Singapore, Department of Paediatrics, Singapore,
Singapore.
Background: Blomia tropicalis (Bt), a predominant house dust mite (HDM)
species in tropical and subtropical regions of the world, is a source of multiple
allergens causing allergic sensitization among atopic individuals. Isolation and
characterization of the allergenicity these Bt allergens are essential to evaluate
the clinical relevance of this HDM species.
Methods: Eight recombinant Bt allergens were expressed as GST-fusion
allergens in E. coli or secreted allergen in P. pastoris while two native Bt
allergens were purified by immuno-affinity chromatography. Specific-IgE
reactivity of the Bt allergenswere determined using 192 Bt-allergic and 85 non-
atopic sera. The panel of Bt allergens were likewise used for skin prick test
(SPT) in 110 Bt-allergic pediatric patients. The ability of the recombinant and
native Blo t 11 allergens to inhibit the IgE-binding activity in Bt extract was
determined by absorption studies.
Results: Blo t 1, Blo t 3, Blo t 5, Blo t 10, Blo t 11-fD, Blo t 12 andBlo t 19were
expressed as soluble GST-recombinant proteins in E. coli while Blo t 4 was
expressed in P. Pastoris. Native Blo t 5 and Blo t 11 were purified from Bt
extracts using monoclonal antibodies. Of the 192 Bt-allergic patients` sera
tested, 68% and 53% reacted positively to recombinant Blo t 5 and Blo t 11-fD,
respectively, while 5-30% IgE reactivity was observed with the other
recombinant Bt allergens. Interestingly, the IgE reactivity recombinant Blo t
5 and Blo t 11-fD compares with the IgE reactivity of their native counterparts
at 70% and 54%, respectively. SPT results showed comparable results with
ELISA. Absorption assays, showed that up to 80% inhibition of IgE reactivity
in Bt extract can be obtained with the different Bt allergens.
Conclusion: Results obtained from this study suggest the clinical importance
of Blomia tropicalis as major source of allergens causing allergic sensitizations
in tropical regions. The incorporation of Bt allergens in the panel of diagnostic
and immunotherapeutic allergens for HDM allergy are highly recommended.
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Phleum pratense alone is representative for pooideae grass
pollen species due to high immunochemical similarity between
homologous grass pollen allergens
Jorgen N. Larsen, Charlotte Hejl, Henrik Ipsen, Peter A. Wurtzen, and Niels
Johansen. ALK-Abello, Research, Horsholm, Denmark.
Background: The Pooideae grasses constitute a large taxonomical subfamily
with thousands of species and worldwide occurrence. Extensive homology
between amino acid sequences of grass pollen allergens occur, and grass pollen
counts are published together due to a large immunochemical similarity
between the grass pollen allergens.
Objective: Study the immunochemical similarity of grass pollen allergens
from different Pooideae species.
Methods: Amino acid sequences representing grass pollen allergens were
obtained from the Uniprot database. Structural similarity of the group 1
allergens was illustrated by mapping identical amino acids on the surface of the
x-ray structure of Phl p 1, PDB: 1N10. A large number (913,000 data points) of
grass pollen allergic patients’ IgE was measured by Magic Lite solid phase
immunoassay to eight Pooideae grass pollen extracts, respectively. IgE to eight
Pooideae grass pollen extracts was measured by ADVIA Centaur solid phase
immunoassay with or without inhibition by 2 mg Phleum pratense pollen
extract. Standard T cell stimulation assays using T cell lines from grass pollen
allergic donors were applied to assess T cell cross-reactivity.
Results: Sequence alignment of Pooideae grass pollen allergens showed high
homology. Mapping of identical amino acids on the surface of the x-ray
structure of Phl p 1 clearly showed the presence of identical surface structures
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large enough to harbor IgE binding epitopes. A high correlation
(0.86Y0.98 Spearman rank correlation coefficient) was observed when
comparing levels of IgE to Phleum pratense with those of pollen extracts
from individual grass species. Phleum pratense pollen extract inhibited IgE to
other grass species more than 95% in most patients. T cell lines specific for Phl
p 1 and Phl p 5 both showed similar stimulation indices when stimulated with
different grass pollen extracts indicating extensive T cell cross-reactivity
between individual grass species.
Conclusion: Phleum pratense alone covers most of the immunochemical
reactivity of all tested Pooideae grass species with respect to allergic patients’
IgE. T cell lines specific for the group 1 and 5 major allergens showed
extensive cross-reactivity between grass species. One specie alone, e.g.
Phleum pratense, therefore seems adequate for specific management of allergy
to Pooideae grass pollens.
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Gradual shift in the aeroallergen index affecting the allergy
patients in recent years in Texas panhandle
Nabarun Ghosh1, Mandy Whiteside1, Kyla Kersh1, Constantine Saadeh2,
Michael Gaylor2, and Don W. Smith3. 1West Texas A&M University, Life,
Earth, Environmental Sciences, Canyon, United States; 2Allergy Aarts,
Pathology, Amarillo, United States; 3University of North Texas, Biology,
Denton, United States.
: Aeroallergens cause serious allergic and asthmatic reactions. We have
been analyzing the Aeroallergen data of the Texas Panhandle region for the last
7 years. We determined the aeroallergen index regularly by analyzing the
coated Melinex tape from the Burkard Volumetric Spore Trap. Samples were
examined, counted and photographed every 24 hours using a BX-40 Olympus
microscope with a DP-70 Olympus Digital Camera. Data were correlated with
daily temperature, precipitation, peak wind speed and clinical studies
established from Allergy A.R.T.S. Clinical Research Laboratory in an effort
to aid in diagnosis of mold and pollen-related allergies. Aeroallergens that we
recorded were Alaternaria conidia, Pezizales ascospores, Curvularia,
Cladosporium, Dreschlera, Stachybotrysand pollen from short ragweed
(Ambrosia artemisiifolia), grass (Poaceae), hairy sunflower (Helianthus
hirsutus), buffalo bur (Solanum rostratum), purple nightshade (Solanum
elaeagnifolium) and lamb`s quarters (Chenopodium album). Due to severe
drought conditions in the previous years (2002Y5), the pollen concentration
was significantly low, that reached the highest peak from April onwards this
year (2007) with plenty of rainfall. We observed this pick from April to July in
last year 2006. We noticed a gradual shift in the aeroallergen index in the Texas
Panhandle in recent years. Global warming with increased CO2 concentration
exerted widespread impacts on the biotic system. Many regions are currently
experiencing warming effect associated with global climate change including
longer growing seasons and early arrival of spring. Short ragweed (Ambrosia
artemisiifolia) released 54.8% more pollen with an ambient CO2 release
(Rogers et al, 2006). In Japan a 21-year study showed a gradual shift in
Cryptomeria japonica pollen season. These results support the steadily
increasing number of reports indicating a global warming trend. The
temperature change affecting the start dates of the C. japonica pollen season
is particularly relevant in the context of human health. From the clinical data
from the AARTS clinic it is clearly evident that there were more patients
suffering from allergic rhinitis during themonths ofMarch to June. 4 years back
the peak pollen and mold season was between May to September (Ghosh et al.,
2006) that has gradually shifted in 2007 to March-June so as the frequency of
the patients visiting the Allergy Clinic.
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Upper body clothing is a source of fungal $-(1,3)-glucan exposure
Rob Siebers, Jennifer Hayes, and Julian Crane. School of Medicine & Health
Sciences, Otago University, Wellington, Medicine, Wellington, New Zealand.
Background: $-(1,3)-glucan is pro-inflammatory and has been associated
with airway inflammation and respiratory symptoms.
Methods: This study assessed $-(1,3)-glucan levels from upper body clothing
(jerseys) of 55 subjects. $-(1,3)-glucan levels were estimated with a modified
Limulus amoebocyte lysate kinetic assay.
Results: $-(1,3)-glucan levels ranged widely from 2,697 to 162,690 ng/g. $-
(1,3)-glucan levels were significantly lower from cotton jerseys, and from
warm water washed jerseys.
Conclusion: Jerseys are potentially a significant exposure source of $-(1,3)-
glucan.
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Development of a natural cat allergen challenge room
(CACR) model
S.McCue1, L. Nimraj1, V.Walsh1, H. Nandkeshore1,M. Chapman2, J. Corren3,
J. Freihaut4, P. Patel1, and A.M. Salapatek1. 1Allied Research International-
Cetero Research, Research and Development, Mississauga, Canada; 2Indoor
Biotechnologies, Research and Development, Charlottesville, United States;
3Allergy Research Foundation, Research and Development, Los Angeles,
United States; 4Pennsylvania State University, Architectural Engineering,
University Park, United States.
Background: We have developed a natural CACR in which subjects will be
exposed to consistent levels of Fel d 1, the major cat allergen, in a natural setting,
such that there is transient exposure to disturbance of reservoir cat allergen.
Objective: To develop the CACR in which Fel d 1 levels range from
approximately 500Y2500 ng/m3. This concentration range of Fel d 1 was sel-
ected as it is representative of higher levels of Fel d 1 in homes with cats, and is
known to induce an allergic and/or asthmatic response.
Methods: The CACR is fully carpeted, contains a couch covered with a cotton
sheet, and a chair. The CACR was preloaded with Fel d 1 using a proprietary
aerosol generator and maintained by allergen from two CACR inliving cats.
Fel d 1 levels were transiently increased by vigorously shaking the sheet to
aerosolize Fel d 1. Fel d 1 airborne concentrations were measured using per-
sonal air samplers. Total airborne particulate was collected using a Button
Sampler for 1h. Samples were analyzed using ELISA and particle sizes were
independently measured with a laser particle counter.
Results: Background measures indicated that Fel d 1 was undetectable in the
CACR before aerosolization. Following one hour of 1g cat allergen aero-
solization and 11 days cat housing, the average maximum total particle count
was maintained over 4 consecutive days to be 9.01 T 3.65X105 ppm3 and the
Fel d 1 concentration 538 T 192 ng/m3. After an additional 2h aerosolization of
3.2g Fel d 1 and a total of 15 cat housing days, the average maximum total
particle count maintained over an additional 4 consecutive days was 9.8 T
3.65X105 ppm3 and the average Fel d 1 concentration was 621 T 135 ng/m3.
Following an additional two days the concentration of Fel d 1 was 1046 T
982 g/m3. Overall, these two periods of aerosolization of Fel d 1 and a total
of 20 cat housing days resulted in the mean concentration of Fel d 1 to be
686 T 455 ng/m3.
Conclusion: These data indicate that aerosolized Fel d 1 is effective to obtain
natural allergen levels rapidly and that live cats can maintain these levels over
time within the targeted range. This work demonstrates that we have developed
a CACR model that can be used towards the study of the etiology and putative




Drug-induced T regulatory cells in asthma: Toll like receptors 2
and 9 represent distinct markers of glucocorticoid versus 1?25-
dihydroxyvitamin D3 action on human CD4+ T cells
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Catherine Hawrylowicz, Zoe Urry, Emmanuel Xystrakis, Patricia Ozegbe,
Chris Corrigan, and Dave Richards. King’s College London, Asthma, Allergy
and Lung Biology, London, United Kingdom.
Background: We previously demonstrated that the active form of Vitamin D,
1?25-dihydroxyvitamin D3 (1?25VitD3) alone, or together with glucocorti-
coids, induces an IL-10 secreting T regulatory phenotype (IL-10-Treg) in
human CD4+ T cells, and these cells inhibit naBve T cell, Th1 and Th2
responses. Glucocorticoid induced IL-10 production is defective in patients
with clinically insensitive asthma and 1?25VitD3, either in vitro or following
oral ingestion by these patients, restores this impaired IL-10 response.
Aim: To identify the distinct phenotypic and functional effects of the two
drugs on human CD4+ T cells.
Methods: In vitro based tissue culture, quantitative RT-PCR, flow cytometry
and antibody capture assays (ELISA, cytometric bead array) were used to study
human CD4+ T cell phenotype and function following polyclonal activation
(anti CD3, IL-2) in the presence or absence of dexamethasone and/or
1?25VitD3. T cell phenotype following 1?25VitD3 ingestion was also analyzed.
Results: We show that 1?25VitD3 alone inhibits Th1 and Th2 cytokine
production, enhances the generation of IL-10-Treg, but also the percentage of
FoxP3 positive cells. However expression of 1?25VitD3-induced IL-10 and
FoxP3 appears mutually exclusive. Furthermore, optimal effects of 1?25VitD3
on IL-10, Foxp3 and effector cytokine production are observed at distinct drug
concentrations. Dexamethasone selectively induced expression of TLR2 in
vitro whilst 1?25VitD3 selectively induced expression of TLR9 on CD4+ T
cells both in vitro and following patient ingestion of 1?25VitD3, in comparison
to other T cell populations (naBve, CD25+ Treg, Th1, Th2). Ligation of these
TLR on the drug-induced IL-10-Treg resulted in loss of Treg function in both
cases, but by distinct mechanisms.
Conclusion: Glucocorticoids and 1?25VitD3 promote IL-10 production
and regulatory function in human CD4+ T cells alone and in combination.
TLR2 and TLR9 can be used to distinguish glucocorticoid and 1?25VitD3
exposure of human CD4+ T cells and ligation of these receptors downregulates
Treg function.
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Sublingual immunotherapy to inhalant allergen sensitisation and
the effect of chitosan
P. T. Cunningham, C. E. Elliot, P. G. Holt, and Wayne R. Thomas. Telethon
Institute for Child Health Research, Molecular Biotechnology, Perth,
Australia.
Background: Immunotherapy is an established form of treatment but it is
necessary to developmore efficaciousmethods.We have developed amodel for
respiratory sensitisation induced by intranasal (i.n.) administration of the
cysteine protease papain, without adjuvant. It produces high, boostable IgE
titres. Upon challenge pulomonary eosinophilia is evident as is the release of
Th2 cytokines into the bronchoalveolar lavage (BAL) fluid. The model has
been used to optimise sublingual desensitisation in mucosally sensitised
animals. We have previously demonstrated its ability to suppress allergen
specific IgE. In these studies lymph nodes were examined and the effect of the
excipient chitosan.
Methods: Allergic sensitisation was achieved by the i.n. administration of low
doses of papain, a homologue of Der p 1. Desensitisation was examined after
the sublingual administration of the antigen with chitosan, antigen alone, or
chitosan alone. Serum antibodies were examined and high dose challenge
followed by BAL was used to study cellular infiltrates and cytokine production
in the lung. Lymph nodes were cultured and proliferation and cytokine
production in response to allergen stimulation measured.
Results: All treatments, even chitosan alone, suppressed IgE and IgG1
antibodies. Chitosan delivery at desensitisation resulted in a significant
reduction of cells infiltrating the lungs that was not seen in the other treatment
groups however both the chitosan alone and chitosan with papain significantly
suppressed the neutrophilia seen. The Th2 cytokines in BAL fluid were not
reduced in the treatment groups although all groups receiving chitosan had
elevated levels of IL-10 and IFN-,. Cultured lymph node cells had lower levels
of proliferation after sublingual therapy with a soluble antigen but when
chitosanwas used cells proliferated to similar levels to controls. Cytokine levels
in lymph node cell supernatants showed significantly increased levels of TGF-$
and significantly decreased IL-5, IL-10 and IFN-, in all treatment groups.
Conclusion: Sublingual immunotherapy decreased IgE and IgG antibodies
but not lung inflammatory responses. It is however shown that lymph node
proliferation and cytokine production was decreased and this could have a
long-term effect. Chitosan caused a non-specific reduction that was not greater
than allergen alone.
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Analysis of epitope-specific immune responses induced by
vaccination with structurally folded and unfolded recombinant
Bet v 1 allergen derivatives in man
Ines Pree1, Ju¨rgenReisinger1,Margit Focke2, SusanneVrtala2, Gabrielle Pauli3,
Marianne van Hage4, Oliver Cromwell5, Elisabeth Gadermaier2, Cornelia
Egger6, Norbert Reider6, Friedrich Horak1, Rudolf Valenta2, and Verena
Niederberger1. 1Vienna General Hospital, ENT Department, Vienna, Austria;
2Vienna General Hospital, Department of Pathophysiology, Vienna, Austria;
3Hoˆpital Universitaires de Strasbourg, Service de Pneumologie, Strasbourg,
France; 4Karolinska Institutet, Department of Medicine, Stockholm, Sweden;
5Allergopharma, JoachimGanzerKG, Reinbek, Germany; 6MedicalUniversity
of Innsbruck, Clinical Department of Dermatology, Innsbruck, Austria.
Background: Previously we have constructed recombinant derivatives of the
major birch pollen allergen, Bet v 1, with a more than hundredfold reduced
ability to induce IgE-mediated allergic reactions. These derivatives differed
from each other because the two recombinant Bet v 1 fragments represented
unfolded molecules whereas the recombinant trimer resembled most of the
structural fold of the Bet v 1 allergen.
Methods: Here we analyzed the antibody (IgE, IgG subclass, IgA, IgM)
response to Bet v 1, recombinant and synthetic Bet v 1-derived peptides in birch
pollen allergic patients who had been vaccinated with the derivatives or
adjuvant alone. Furthermore, we studied the induction of IgE-mediated skin
responses in these patients using Bet v 1 and Bet v 1 fragments.
Results: Both types of vaccines induced a comparable IgG1 and IgG4 response
against new sequential epitopes which overlap with the conformational IgE
epitopes of Bet v 1. This response was much higher than that induced by
immunotherapy with birch pollen extract. Trimer more than fragments induced
also IgE responses against new epitopes and a transient increase in skin
sensitivity to the fragments at the beginning of therapy. However, skin reactions
to Bet v 1 were reduced one year after treatment in both actively treated groups.
Conclusion: We demonstrate that vaccination with folded and unfolded
recombinant allergen derivatives induces IgG antibodies against new epitopes.
These data may be important for the development of therapeutic as well as
prophylactic vaccines based on recombinant allergens.
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CD4+ CD25+ regulatory T cells in peripheral blood during the
specific immunotherapy to grass pollen
Ewa Springer1, Jacek Karczewski2, and Krzysztof Wiktorowicz2. 1SNZOZ
Alergologia Plus in Poznan, Centre of Diagnostics and Treatment of Allergy,
Poznan, Poland; 2Poznan University of Medical Sciences, Department of
Biology and Environmental Sciences, Poznan, Poland.
Background: Specific immunotherapy (SIT) is a well known procedure to
achieve a clinical tolerance in IgE-dependent allergy. Recent data supports the
concept that SIT restores the peripheral tolerance to allergens by reintroducing
T cell tolerance. This study was an attempt to determine the effect of sub-
cutaneous SIT on CD4+ CD25+ regulatory T cells in allergic patients.
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Materials: Group of 34 subjects included: 19 individuals with allergy to grass
pollen confirmed bymedical history, positive skin prick tests (SPT) and specific
IgE (sIgE) min. 2 class, treated with SIT before pollen season in 2007 (gr. A),
11 sex and age matched control subjects with confirmed as above allergy to
grass pollen untreated with SIT (gr. B) and 4 control healthy nonallergic to
grass pollen subjects (gr. C). Methods: i) subcutaneous SIT to grass pollen with
allergen extract absorbed on aluminum hydroxide according to manufacturer’s
quidline in the gr. A; ii) Evaluation with questionnaires of clinical rhino-
conjunctivitis symptom score during 2006 and 2007 pollen season (the end-
point) in groupsA and B; iii) The flow cytometry analysis of blood sampleswas
performed at the beginning of SIT treatment, after reaching a maintenance dose
and at the end-point in gr. A, and at the end-point in gr. B and C.
Results: 17 subjects from gr. A reached the end point phase of SIT without
significant adverse events. Reduction of symptom score 950% in 6 subjects,
26Y50% in 9 subjects and G25% in 3 subjects after SIT treatment was shown. In
gr. B the symptom score in grass pollen season was comparing to Group A
before the SIT treatment. The flow cytometric analysis showed: i) lower per-
centage of CD4+ CD25+ regulatory T cells in all allergic patients (gr. A-2,1%,
gr. B-1,1%) versus the control (gr. C-3,4%) at the end point; ii) statistically non-
significant percentage upward trend in CD4+ CD25+ regulatory T cell
population during the course of SIT in treated with SIT groups.
Conclusion: Lower count of CD4+CD25+ regulatory T cells in both groups of
allergic patients suggests a dysfunction within this population might con-
tributes to the pathology of allergy. The percentage upward trend in Treg pop-
ulation during the SIT treatment, accompanied by the improvement in symptom
score, suggesting the maintenance of balance between Th1, Th2 and Treg
populations is crucial for peripheral tolerance. The project will be continued to
cover broader population and investigate other immunological parameters.
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Early suppression of basophil activation during allergen-specific
immunotherapy by upregulation of histamine receptor 2
Natalija Novak1, Nihal Mete*2, Mu¨beccel Akdis3, Laura Maintz1, Caroline
Bussmann1, Judith Zumkehr3, Marek Jutel4, and Cezmi Akdis3. 1University
of Bonn, Dermatology, Bonn, Germany; 2Ege University Medical Faculty,
Internal Medicine, Allergy and Clinical Immunology, Izmir, Turkey; 3Swiss
Institute of Allergy and Asthma Research, SIAF, Davos, Switzerland;
4Wroclaw University, Medical Faculty, Wroclow, Poland.
Background: Most of the primary effects of allergen specific immunotherapy
(SIT) are exerted on effector cells. However, there is surprisingly few infor-
mation about the mechanisms by which SIT modifies and suppresses immune
responses of basophils and mast cells in particular during the repetitive
administration of increasing allergen doses in the built-up phase. One of the
main mediators released by effector cells upon allergen challenge is histamine.
The diverse immunoregulatory functions of histamine are based on the
differential distribution of histamine receptors on immunocompetent cells.
While histamine receptor (HR)1 decreases humoral immunity and increases
cellular immunity, HR2 displays opposing functions, decreasing cellular im-
munity and mediating tolerogenic immune mechanisms. Therefore, the early
desensitizing effect of SIT due to reprogramming of effector cell responsive-
ness to histamine via the modulation of the histamine receptor repertoire
represents an exciting and plausible strategy.
Methods: Honey bee and wasp venom SIT was applied to 10 patients
according to the rush protocol. The mRNA level of HR1, HR2 and HR4 in
PBMC isolated from the peripheral blood of patients during the built-up phase
of SIT (5 days) was evaluated by real time PCR. Histamine receptor mRNA
levels in basophils enriched from the peripheral blood, which were triggered
via IgE receptor were determined. Additionally, the activation state of
basophils after IgE receptor cross-linking and treatment with ligands selective
for HR2 as well as cAMP inducer forscolin, a second messenger of HR2, was
analysed by flow cytometry and sulfido-leukotriene release assays.
Results: Significant increase of the HR2 mRNA level as well as the HR2/HR1
ratio was observed in PBMC of patients from the 3rd day of SIT. IgE receptor
cross-linking of basophils from the peripheral blood with increasing anti-IgE
doses led to the upregulation of HR2. The selective triggering of HR2 with
specific agonist dimaprit or forscolin strongly suppressed IgE-receptor-
induced activation of basophils in a dose dependent fashion.
Conclusion: HR2 mediates immunosilencing functions on IgE-receptor
activated basophils. The up-regulation of HR2 expression on basophils in
response to repetitive IgE-receptor cross linking as well as allergen challenge
during the built-up phase of SIT might represent a key mechanism and early
desensitization effect of SIT on the level of effector cells. *these authors
contributed equally.
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Distribution of langerhans cells and mast cells within the human
oral mucosa-new potential application sites of allergens in
sublingual immunotherapy
Jean-Pierre Allam1, Gligor Stojanovski1, Nikolaus Friedrichs2, Thomas
Bieber1, Reinhard Bu¨ttner2, and Natalija Novak1. 1University Hospital Bonn,
Dermatology, Bonn, Germany; 2University Hospital Bonn, Pathology, Bonn,
Germany.
Background: Sublingual immunotherapy (SLIT) has been proven to be a safe
and efficient alternative to subcutaneous immunotherapy (SCIT) in the treat-
ment of allergic rhinitis. While antigen-presenting cells such as Langerhans
cells (LC) are thought to play a major role in the effectiveness of SLIT, mast
cells (MC) most likely account for the observed adverse reactions such as oral
itching and sublingual edema. Since only little is known about LC and MC
within the oral cavity, we investigated their distribution in search for alternative
mucosal application areas with the highest density of LC and lowest presence
of MC.
Methods: Different biopsies were taken simutaneously from mucosal tissue of
the vestibular, buccal, palatinal, lingual, sublingual and gingival region
(n = 10). Tissue was further processed for immunohistochemistry and flow
cytometry. MC were detected by chymase, and LC by CD1a expression.
Results: The highest density of MC could be detected within the gingiva while
the lowest density of MCwas found within the palatinum and lingua. However,
in the sublingual region MC were located within the lobe and duct of sub-
lingual glands in a substantial number of individuals, which might explain
swelling of sublingual caruncle in some SLIT patients. Considering LC, we
could detect the highest density within the vestibular region followed by the
region of bucca, palatinum and lingua. Interestingly, the lowest density of LC
was located in the sublingual region. By flow cytometry, we investigated the
expression of the high affinity receptor for IgE (Fc(RI) which might play a
central role in allergen uptake during SLIT. Thereby, we could detect the
highest expression of Fc(RI on LC of the vestibular region.
Conclusion: In viewof our data, different mucosal application sites such as the
vestibulum might represent an alternative region with potent allergen uptake
especially in SLIT patients suffering from sublingual edema. Furthermore our
data might serve as a basis in the development of new application forms for
SLIT such as tablets or stripes.
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Lactic acid bacteria inhibit IgE-induced mast cell activation
Ce´cile Schiffer-Mannioui1, Sandrine I. Samson2, Ariane van de Moer2, and
Marc Dae¨ron1. 1Unite´ d`Allergologie Mole´culaire et Cellulaire, INSERM
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U.760, Institut Pasteur, De´partement d`Immunologie, Paris, France;
2Danone, Centre de Recherche Danone, Palaiseau, France.
: Because probiotics were proposed to decrease the prevalence of allergy
in susceptible individuals, we investigated whether they could affect IgE-
induced mast cell secretory responses. To this end, mouse Bone Marrow-
derived Mast cells (BMMC) were exposed to lactic acid bacteria. BMMC
express high-affinity receptors for IgE (Fc&RI). When sensitized with IgE
antibodies and challenged with specific antigen, they release and secrete a
variety of inflammatory molecules including granular mediators and enzymes
(among which "-hexosaminidase), lipid mediators, cytokines (among which
TNF-!) and chemokines. We checked first that none of the bacteria tested
activate mast cells. Indeed, an incubation of BMMC for 20 min or 3 hr with
bacteria (at a ratio of 1000 bacteria/cell) did not induced "-hexosaminidase
release or TNF-! secretion, respectively. We then investigated whether a pre-
vious exposure of BMMC to bacteria would affect the subsequent IgE-induced
biological responses of mast cells. We found that an overnight incubation of
BMMC with one strain of bacteria (at a ratio of 1000 bacteria/cell), prior to
sensitization with IgE antibodies, inhibited Ag-induced "-hexosaminidase
release and TNF-! secretion. Live and gamma-irradiated bacteria were equally
inhibitory. These bacteria did not decrease the expression of Fc&RI and did not
affect sensitization of BMMC with IgE. Inhibition required a direct contact
between cells and bacteria. Inhibition were similar in BMMC from TLR-2/4-,
MyD88-, and NOD2-deficient mice as in BMMC from WT mice, excluding
TLR1, 2, 4, 5, 6, 7, 8 and 9, as well as NOD2 as being the responsible receptors.
Preliminary works aiming at analyzing how bacteria interfere with Fc&RI
signaling indicated that: 1) several intracellular signaling molecules had a
reduced expression, 2) both early and late Fc&RI-dependent phosphorylation
events were decreased, 3) I.B degradation was prevented, thus interfering with
the nuclear translocation of NF-.B, 4) the IgE-induced increase of the
intracellular concentration of Ca2+ was profoundly inhibited. Altogether, our
results indicate that probiotics, especially lactic acid bacteria, can exert direct
inhibitory effects on mast cell activation. They support the idea that probiotics
can protect from allergies, by preventing IgE-induced mast cell activation.
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Induction of allergic airway inflammation by house dust mite
allergen specific Th2 cells in mice
C. H. Huang1, L. M. Liew1, I. C. Kuo2, H. M. Wen1, D. L. Goh1, D. L. Goh2,
B. W. Lee1, and K. Y. Chua1. 1National University of Singapore, Paediatrics,
Singapore, Singapore; 2A*STAR, Singapore Institute for Clinical Sciences,
Singapore, Singapore.
Background: It is known that allergic inflammatory diseases such as asthma
are Th2 cells-mediated, however, the pivotal roles of allergen-specific Th2
cells in the induction of allergic lung inflammation have not been fully
elucidated. The aim was to elucidate the imunopathological roles of allergen-
specific-Th2 cells in allergic airway inflammation.
Methods: Mice were epicutaneously sensitized with a major dust mite
allergen, Blo t 5 and a well-characterized Blo t 5-specific-Th2 cell line was
subsequently established from the splenocytes of the sensitized mice. The
immunopathological roles of the cell line were assessed in vivo by adoptive cell
transfer approach. NaBve mice received Blo t 5 specific-Th2 cells intravenously
followed by intranasal challenge with Blo t 5. The responses of recipient mice
were analysed by immunological and histochemical methods.
Results: A long term TCRV$3+ Blo t 5 specific Th2 cell line producing high
levels of IL-4, IL-5, IL-13 and IL-10 but not IFN-, was established. These
CD44highCD62L- Th2 cells showed up-regulation of CTLA-4, ICOS, OX40,
4-1BB, CD27 but not CD40L upon stimulating with Blo t 5. After intranasal
challenge with Blo t 5, Th2 cells recipient mice developed Blo t 5-specific
IgG1 and IgE, airways eosinophilia and mucus production of the Goblet cells.
In addition to the donor Th2 cells, the cellular infiltrate consisted of CD4+,
CD8+ T cells and NK cells of the recipient mice. Such cellular inflammation
could be suppressed by dexamethasone intervention. The pathological results
were not observed in the PBS challenged recipient mice.
Conclusion: Blo t 5-specific Th2 cells played a central pathological role in
mediating allergic airway inflammatory responses resembling those seen in
humans. This animal model is particularly useful for screening of novel
therapeutics for asthma and allergy.
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Differences in Foxp3+CD4+ ratio between symptomatic atopic
patients and asymptomatic atopic controls with similar levels
of Th1/Th2 markers
Kanami Orihara1, Masami Narita2, Akira Akasawa3, Yukihiro Ohya2, Kenji
Matsumoto1, and Hirohisa Saito1. 1National Research Institute for Child
Health&Development, Department of Allergy and Immunology, Tokyo, Japan;
2National Center for Child Health and Development, Division of Allergy,
Tokyo, Japan; 3National Center for Child Health and Development,
Department of Interdisciplinary Medicine, Tokyo, Japan.
Rationale: Foxp3, a responsible gene for IPEX syndrome in which both Th1
and Th2 responses are hyperreactive, is known as a master gene of naturally
occurring regulatory T cell and maybe of some other regulatory T cell subsets.
Therefore, the regulatory roles of Foxp3+ cells in allergic disorders are highly
expected; however, the precise role of circulating Foxp3+ cells in common
allergic diseases remains unclear. Then in order to evaluate its diagnostic
potential, we examined intracellular Foxp3 protein expression in circulating
peripheral blood CD4+ T cells from allergic patients and healthy controls at the
single-cell level.
Methods: The ratio of Foxp3+CD4+ cells in the CD4+ cell fraction as well as
various laboratory data were measured for 64 donors, including 37 patients
with atopic dermatitis and/or bronchial asthma. None of the subjects was
treated with oral corticosteroids. All the patients were judged positive for
specific IgE antibodies against at least one of Dermatophagoides pternyssinus,
Dermatophagoides farinae, and Japanese cedar pollen using Pharmacia’s CAP
system fluorescence enzyme-linked immunoassay (CAP-FEIA). Twenty-three
of the 27 age-matched healthy volunteers also showed at least one positive
reaction to those allergens by CAP-FEIA, although they never had subjective
symptoms related to allergic diseases.
Results: Foxp3+CD4+ ratio in the total population was correlated inversely
with the levels of total serum IgE (p = 0.021), % eosinophil count (p = 0.022),
and serum IFN-, (p = 0.048). By performing a case-control study by matched-
pair analysis to eliminate the influence of the Foxp3+CD4+ level correlations
with the total IgE level and eosinophil ratios, Foxp3+CD4+ ratio was
significantly lower in active atopic patients compared to asymptomatic donors
having similar levels of IgE, eosinophils and IFN-,.
Conclusion: Our findings imply that circulating Foxp3+CD4+ regulates both
Th1 and Th2 responses in vivo. Moreover, symptomatic atopic patients had a
lower Foxp3+CD4+ ratio than asymptomatic atopic controls having similar
levels of Th1/Th2 markers. Measurement of Foxp3+CD4+ ratio has the po-
tential to aid in evaluating the presence of active inflammation in patients with
allergic diseases, which can not be evaluated by known Th1 and Th2-related
markers in patients with allergic diseases.
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Molecular biomarkers of eosinophil-lineage commitment:
Multiplex Q-PCR analysis of GATA-1, MBP and IL-5 receptor
mRNA expression kinetics in both peripheral and umbilical
cord blood
Anne Ellis, Lynn Crawford, and Judah Denburg. McMaster University,
Division of Allergy & Clinical Immunology, Hamilton, Canada.
Background: Using colony assays and flow cytometry, we have shown that
eosinophil/basophil (Eo/B) progenitor phenotype and function are associated
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with both atopic risk at birth and early childhood clinical outcomes. These
assays are cumbersome, however, and we thus endeavored to develop
surrogate molecular markers of eosinophil lineage commitment.
Objective: To utilize Q-PCR to determine the kinetic patterns of expression of
Eo/B-lineage specific genes in cord blood (CB) and peripheral blood (PB) in
response to IL-5 stimulation.
Methods: CB and PB non-adherent mononuclear cells (NAMNC) were
isolated from random fresh (and frozen, for CB) samples, and incubated in the
presence of IL-5 (1 ng/mL). At 24, 48, 72h, 96h (CB only) and 1 week post-
stimulation (PB only), RNA was isolated, reverse transcribed, and expression
of IL-5Ra´, GATA-1, and MBP was determined utilizing multiplex Q-PCR.
Relative expression ratios of stimulated to un-stimulated cells were calculated
using the delta-delta Ct method.
Results: Stimulation of CB NANMC with IL-5 resulted in an up-regulation of
GATA-1 expression, peaking at 48h, and decreasing expression by 72 hours.
Preliminary evaluation of a 96h time-point suggests down-regulation. PB
NAMNC’s similarly showed up-regulation peaking at 48h but with a lower
overall fold-increase and a slower return to baseline expression than that
observed in CB. MBP expression in CB was slowly up-regulated in response
to IL-5 stimulation, maximal at 96h; in PB, MBP expression was stable until
after a full week of incubation when up-regulation could finally be detected.
There was completely stable expression IL-5Ra´, in both CB and PB.
Conclusion: Multiplex Q-PCR analysis of mRNA from CB and PB
demonstrates expression of critical Eo/B lineage-specific events. Further
investigation of the validity and utility of Q-PCR analyses of CB and PB for
surrogate, molecular markers of Eo/B differentiation is underway.
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Double-stranded RNA synergistically enhances MUC5AC
induction by TGF-" in human bronchial epithelial cells
Hiromi Tadaki, Hirokazu Arakawa, Takahisa Mizuno, Tomoko Suzuki,
Hiroyuki Mochizuki, Kenichi Tokuyama, and Akihiro Morikawa. Gunma
University Graduate School of Medicine, Pediatrics and Developmental
Medicine, Maebashi, Japan.
Background: Goblet-cell hyperplasia and upregulated epidermal growth
factor receptor (EGFR) expression are important features in hypersecretory
diseases such as asthma. Since viral infection also induces production of
respiratory mucins, we investigated whether co-stimulation of double-stranded
RNA (dsRNA) and TGF-" enhances the mucin hyperproduction in human
bronchial epithelial cells. Furthermore, we investigated the signaling pathway
regulating dsRNA and TGF-"-induced MUC5AC secretion.
Methods: A human pulmonary mucoepidermoid carcinoma cell line, NCI-
H292, was incubated with polyI:C, which is an analogue of dsRNA, and TGF-
" for an appropriate time. MUC5AC protein, mRNA, and promoter activity
was measured by ELISA, RT-PCR, and luciferase assay. In inhibition studies,
the cells were pretreated with selective MAPK inhibitors prior to stimulation
with polyI:C and TGF-". The activation of ERK was examined by using
Western blot analysis. In order to examine MUC5AC mRNA transcript
stability, NCI-H292 cells were cultured with actinomycin D after induction of
MUC5ACmRNA by polyI:C and/or TGF-" for 18h. EGFRmRNA expression
was measured by RT-PCR to examine whether EGFRmRNA is upregulated by
polyI:C. NCI-H292 cells were incubated with anti-IL-8 antibody prior to
stimulation with polyI:C and TGF-" to investigate the involvement of IL-8.
Results: PolyI:C and TGF-" synergistically increased gene expression and
protein production of MUC5AC in NCI-H292 cells. This increase was dep-
endent on MUC5AC gene transcription. MEK1/2 inhibitor (U0126), but not
p38 MAPK inhibitor (SB20358) and JNK inhibitor (SP600125), significantly
blocked synergistic induction of MUC5AC mucin, indicating that the ERK
pathway is the main stream of polyI:C and TGF-"-induced MUC5AC
production. Western blot analysis confirmed this result. Addition of polyI:C
neither changed the rate of MUC5AC mRNA turnover nor upregulated EGFR
expression. Anti-IL8 antibody did not inhibit MUC5AC mRNA expression
indicating that IL-8 had no role.
Conclusion: These results suggest that double-stranded RNA has the potential
to synergistically amplify induction of MUC5AC mucin by TGF-" stimuli.
The mucus hypersecretion in a viral infection model is not regulated by p38




Monitoring and management of childhood asthma in southeast
asian countries: a questionnaire study
Belle Wong, Colin Tan, Hugo Van Bever, and The APAPARI, study group.
National University Singapore, Department of Pediatrics, Singapore,
Singapore.
Background:We examined practices of physicians in India, China, Sri Lanka,
Australia, Singapore, Indonesia, Philippines and Taiwan in monitoring and
treating childhood asthma.
Methods: Our 6-page standardized questionnaire was sent to doctors via post.
The questionnaire is made up by questions on: a) methods of monitoring of
childhood asthma, b) practices in managing acute asthma exacerbations, and c)
choice of therapy in maintenance treatment.
Results: Our study reflects mostly the practices of doctors who practice in
urban regions. Of respondents, 41.4% were general pediatricians, while 26.3%
were general practitioners. A small fraction of doctors used score cards or
diaries to monitor asthma, ranging from 0% (Philippines and Australia) to
15.9% (India). Only 8.1% (Sri Lanka) to 51.7% (Australia) use either a peak
flow meter and/or spirometry to monitor asthma. However, for frequency of
usage, 35% (China) to 94% (Indonesia) never or seldom make use of a peak
flow meter, and 33% (China) to 97.6% (Indonesia) never or seldom use
spirometry for monitoring. Nebulised salbutamol given every 20 minutes was
the treatment of choice in treating acute asthma attacks by the majority of
doctors in each country, ranging from 29% (China) to 85.7% (Sri Lanka). A
minority (4% (China) to 18.8% (Taiwan)) administer systemic corticosteroids
in an outpatient setting (ER or polyclinic) in acute asthma. 53.6% (India) to
93.9% (Sri Lanka) of doctors also indicated that their duration for treatment
with corticosteroids would be for 3Y5 days, and at the same dosage throughout
the duration. A good number (32.7% (Sri Lanka) to 80.2% (Taiwan)) use
antibiotics in the treatment of acute asthma, but only when pneumonia, otitis
media or sinusitis was likely. Few doctors favoured high-dose inhaled
corticosteroids in acute management, ranging from 0% (Indonesia and Sri
Lanka) to 8.4% (Philippines). For maintenance treatment, a significant fraction
of doctors chose a long-acting beta agonist (LABA) monotherapy as a first-
choice treatment for asthma maintenance. For infants the percentage ranged
from 1.3% (Australia) to 76.3% (Indonesia),in preschoolers 0%(Australia) to
61% (China), and in older children, 0% (Philippines) to 61% (China).
Conclusion: There is much room for improvement in increasing doctors’
awareness to guidelines for more effective management of paediatric asthma in
Southeast Asia, especially regarding the use of LABA monotherapy.
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Efficacy of inhaled heparin is effective in the treatment of acute
exacerbation of asthma
Nancy Mahmoud Abd-Elaty1, Mahmoud Elprince1, and Magdy Abd El-salam2.
1Faculty of medicine, Suez Canal University, Chest Department, Ismailia,
Egypt; 2Faculty of medicine, Ain Shams University, Chest Department, Cairo,
Egypt.
Background: Inhaled Heparin was found to be highly protective against
methacholine induced bronchospasm in bronchial asthma possibly via a direct
effect on smooth muscle or may have potential as anti-inflammatory activity.
Objective: The aim of the study was to determine the additional therapeutic
benefit of inhaled heparin in the treatment of hospitalized patients for acute
asthmatic exacerbation and treated with inhaled bronchodilators and glu-
cocorticoid therapy.
Methods: Thirty patients (20 male, 10 female), mean age( 31 +/j 10 years),
admitted for acute exacerbation of asthma, participated in a prospective, ran-
domized, double-blind, placebo-controlled study. All the subjects received hy-
drocortisone, administered intravenousl, and nebulized salbutamol. The
treatment group received inhaled heparin therapy (20,000 U in 4 mL) every
4 hr. and the placebo group received 0.9% saline solution for 24 hours. Baseline
respiratory parameters such as oxygen saturations, respiratory rates, and peak
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flow rates were measured and repeated after 24 hours treatment. The number of
salbutamol nebulizations needed were recorded at the end of 24 hours.
Results:Most of the patientswere inmoderate severity of asthma exacerbation.
All patients in both groups showed improvement in oxygen saturations,
respiratory rates, and peak flow rates. Statistically significant difference was
observed between the 2 groups regarding both the respiratory parameters and
the mean number of salbutamol nebulizations needed (P 9 0.05, P 9 0.01).
Conclusion: Inhaled Heparin demonstrated additional beneficial effect to the
combination of beta adrenergic agonists and glucocorticoid treatment in acute
asthma attack.
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A descriptive non inferiority comparative analysis of single dose
nebulized formoterol powder (Foradil 24 mcg) in isotonic saline
vs three doses of albuterol (2.5 mgs ampules, GSK) every 20 min
for childrens acute asthma: a cost effective approach for
developing countries
Elizabeth Rodriguez1, Vietnam Vera1, Armando Perez Puigbo2, Arnaldo
Capriles Hulett3, Jesus Manrique1, Jorge Abate4, and Susana Ferro4.
1Hospital Elias Toro, Pediatrics, Caracas, Venezuela; 2Hospital de Clinicas
y Urologia Tamanaco, San Roman, Allergy, Caracas, Venezuela; 3Centro
Medico Docente La Trinidad, Allergy, Caracas, Venezuela; 4Instituto de
Clinicas y Urologia Tamanaco, San Roman, Allergy, Caracas, Venezuela.
: Asthma greater cost expenditures comes from acute care and hospi-
talizations. In Venezuela’s Ministry of Health ambulatory facilities (primary care
for majority of 26 millions inhabitants), acute asthma represents a rising and
significant burden of care close to amillion asthma crisis / year; for the last quarter
of a century standard emergency acute asthma care has been delivered in
nebulized formwith a fixed fenoterol (0.5mg/ml) - ipatropiumbromide (0.25mg/
ml) combination in repeated dosing (Berodual, Boehringer-Ingelheim). We and
others (1, 2) demonstrated formoterol powder to be highly effective in relieving
bronchospasm when used in nebulized form. This study blindly compares at
random a nebulized *single 24 mcg dose (Foradil\ 2 capsules in 2.5 cc / saline)
VS three nebulized * doses every 20minutes of albuterol (GSK) 0.15mg/kg/dose
(maximum 2.5 mgs/dose) in fifty acute asthmatic children (6Y12 years, mean
9 y/o) attending an emergency care setting serving an impoverished area of
metropolitan Caracas. Clinical scoring, oxygen saturation and pulmonary
function, were measured before and one hour after treatment.
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Aleuria aurantia lectin coated microspheres for oral
immunotherapy of grass pollen allergy
Eva Untersmayr1, Susanne Diesner1, Gerda Ratzinger2, Franziska Roth-
Walter1, Isabella Pali1, Giovanna Bises1, Regina Knittelfelder1, Julia Wall-
mann1, Krisztina Szalai1, Otto Scheiner1, Michelle Epstein3, Franz Gabor2, and
Erika Jensen-Jarolim1. 1Medical University of Vienna, Department of
Pathophysiology, Vienna, Austria; 2University of Vienna, Dept. of Pharm.
Tech. and Biopharm., Vienna, Austria; 3Medical University of Vienna,
Department of Dermatology, Vienna, Austria.
Background and Aims: Recently, we could demonstrate that mucosal targeting
with Aleuria aurantia lectin (AAL) coated Poly(D,L-lactide-co-glycolic acid,
PLGA) microspheres modulated a specific immune response in birch pollen
allergy. Using grass pollen as a novel allergen encapsulated in AAL-coated
particles we aimed to further evaluate the immune modulating functionality of
microspheres in a murine asthma model.
Methods: BALB/c mice were sensitized intraperitoneally with grass pollen
extract followed by aerosol challenges inducing acute allergic asthma.
Thereafter, animals were treated repeatedly with grass pollen loaded PLGA
microspheres coated with AAL for M-cell targeting. Mice immunized with
microspheres coated with glycine, with further intraperitoneal allergen
injections and naBve animals served as control. The outcome of the treatment
was evaluated by measurements of grass pollen specific antibodies (IgG1,
IgG2a, IgE and IgA) in sera and bronchio-alveolar lavage (BAL) and by
determination of cytokine profiles (IL-5, IL-10, TGF-$) in spleen supernatants.
Results: In the animals treated with AAL-coated mircrospheres allergen-
specific IgG1, IgG2a and IgE levels were unaffected by treatment. However,
allergen-specific IgA levels increased during therapy. Interestingly, in cytokine
evaluations IL-10 levels did not change, whereas reduced amounts of IL-5 and
high levels of TGF-$ were measured in the mice treated with AAL-
functionalized microspheres compared to the other groups.
Conclusion: These data indicated that in the murine model grass pollen allergy
was beneficially influenced by targeting M-cells via AAL-coated, allergen-
loaded microspheres. Thus, the potential of functionalized microparticles for
specific immunotherapy for acute respiratory allergy was confirmed.
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Oral sulforaphane safely and effectively induces antioxidant
phase II enzymes in the human airway
Marc Riedl, Andrew Saxon, and David Diaz-Sanchez. UCLA - David Geffen
School of Medicine, Clin. Immunology & Allergy, Department of Medicine,
Los Angeles, CA, United States.
: Substantial evidence implicates particulate air pollution exposure as an
important factor for asthma exacerbations and the increasing prevalence of
allergic respiratory disease. As the inflammatory effects of particulate air
pollution are mediated by the induction of cellular oxidative stress, strategies to
reduce oxidative stress may potentially reduce the harmful effects of particulate
air pollution. Endogenous Phase II enzymes abrogate oxidative stress through
metabolism of particulate-associated reactive chemicals and the scavenging of
reactive oxygen species. We conducted a placebo-controlled dose escalation
trial to investigate the in vivo effects of sulforaphane, a naturally occuring
potent inducer of Phase II enzymes, on the expression of GSTM1, GSTP1,
NQO1, and HO-1 in the upper airway of human subjects. Sixty human study
subjects consumed oral standardized broccoli sprout homogenate (BSH) doses
containing sulforaphane once daily for 3 consecutive days. An escalating block
design was used with 25, 50, 75, 100, 125, 150, 175, and 200 grams (g) of BSH
to ensure safety and tolerability. Additional subjects were subsequently
enrolled at doses of 125, 150, 175, and 200 g to examine dose-response effect.
Five subjects completed the protocol with non-sulforaphane containing alfalfa
sprout homogenate dosing at 200 g as a control group. RNA expression for
selected Phase II enzymes was measured in nasal lavage cells by RT-PCR
TABLE 1. n Clinical Score pre Clinical Score post FEV1 pre (%) FEV1 post (%) Sat O2 pre Sat O2 post
ALBUTEROL 25 10.12 8.20 (p 0,001) † 55.80 % 56.09 % (p 0,749 † 95.22 % 96.86 % (p G 0,001)†
FORMOTEROL 25 10.56 7.04 (p G0,001) † 58.08 % 67.84 % (p 0,001) † 94.56 % 96.92 % (p G 0,001) †
(† Wilcoxon) Nebulized single dose formoterol powder (24 mcg) is as effective as three doses of albuterol and at one fifth the cost in children’s acute asthma; is well tolerated and
patients of all ages can benefit. Nebulized Formoterol single dose is non - inferior to three doses of albuterol and underscores many possibly substantial care savings, given the heavy load
that acute asthma care represents in our country and many other developing nations (3). * PARI \ nebulizer (Pronet Turbo) 1. Perez Puigbo A et al. Nebulized saline solution of dry
powder formoterol is useful for acute bronchospasm. Arch Venez Pharmacol Therapeutics 2001; 2:128 2. Ting S et al. Nebulized combined formoterol and budesonide (NCFB) for
children younger than 5 years of age with persistent asthma. JACI 2003; vol11,pS148. 3. Watson JP, Lewis RA. Is asthma treatment affordable in developing countries? Thorax
1997;52:605Y7.
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before and after BSH dosing. All subjects tolerated oral BSH dosing without
significant adverse events. Increased Phase II enzyme expression in nasal
lavage cells occurred in a dose dependent manner with maximal enzyme
induction observed at the highest dose of 200 g BSH. At 200 g BSH daily
GSTM1, GSTP1, NQO1, and HO-1 expression was 219, 201, 299, and 221%
of baseline expression respectively (p e 0.001 for all enzymes). Phase II
enzyme induction was not seen with ingestion of non-sulforaphane containing
alfalfa sprouts. Thus, oral sulforaphane safely and effectively induces mucosal
Phase II enzyme expression in the upper airway of human subjects. Based on
this work and previous in vitro/animal studies, sulforaphane may represent a
novel therapeutic strategy for the treatment of allergic respiratory conditions.
Additional studies are underway to determine whether Phase II enzyme
induction is effective in reducing the inflammatory effects of particulate-
induced oxidative stress in the human airway.
IgE SPECIFICITY AND DIAGNOSIS
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Immunoproteomics approach for identification of novel allergens
of aspergillus fumigatus
Poonam Gautam1, Curam S Sundaram2, Taruna Madan3, Wasudev Namdeo
Gade4, Ashok Shah5, Ravi Sirdeshmukh2, and P. Usha Sarma6. 1Institute of
Genomics and Integrative Biology, Molecular Biochemistry and Diagnostics
Division, Mall Road, Near Jubilee Hall, India; 2Centre for Cellular and
Molecular Biology, Proteomics Research Facility, Hyderabad, India; 3Institue
of Genomics and Integrative Biology, Molecular Biochemistry and Diag-
nostics division, Delhi, India; 4University of Pune, Department of
Biotechnology, Pune, India; 5Vallabhbhai Patel Chest Institute, University
of Delhi, Department of Respiratory Medicine, Delhi, India; 6Indian
Agricultural Research Institute, Department of Plant Pathology, Delhi, India.
Background: Increasing incidences of Aspergillus fumigaus-induced allergic
asthmatics all over the world necessitate identification of a catalogue of al-
lergens of clinical importance. In the present study, immunoproteomic
approach was used to establish a set of candidate allergens, which could be
explored further for diagnostic application in allergic aspergillosis and asth-
matics including ABPA.
Methods: Immunoproteomics combinedwith mass spectrometric analysis was
used to identify proteins of three-week culture filtrate (3wcf) responsible for
inducing A. fumigatus-specific IgE immunoreactivity, using pooled sera from
A. fumigatus-sensitised asthmatics. Their diagnostic potential was also
examined against patients with allergic bronchopulmonary aspergillosis
(ABPA), by 2-DE immunoblotting with individual sera from such patients.
Results: Peptide mass fingerprint (PMF) using matrix-assisted laser
desorption/ionization-time of flight-mass spectrometry (MALDI-TOF-MS)
and/or de novo sequencing by MS/MS analysis of the protein spots from 2-D
gels led to identification of a total of sixteen allergens ofA. fumigatus. Eleven of
them are being reported as allergens for the first time and five were reported
earlier. Putative isoforms of the proteins Asp f 13 and chitosanase have been
observed for the first time.When studied for immunoreactivity of these proteins
among patients with ABPA using their individual sera, these patients exhibited
sensitisation although the pattern was varying. Taken together, these proteins
could thus be considered as potential allergens even among patients with
ABPA. Three of these proteins viz. the hypothetical protein, extracellular ara-
binase and chitosanase could be major allergens.
Conclusion: The immunoproteomic approach applied to the analysis of culture
filtrate proteins resulted in identification of several candidate allergens, many of
them novel, contributing to the catalogue of A. fumigatus allergenic proteins.
These allergensmay facilitate improved serodiagnosis for allergic aspergillosis.
In addition, the immunoreactivity of these proteins observed among the
patients with ABPA may have potential for serodiagnosis and opens up scope
for evaluation and development of personalized immunotherapeutics.
135
Laboratory testing and evaluation of olive pollen allergy and
cross reactivity in Jordan
Hani Ababneh1, Hani Ababneh1, and Ghada Maaytah2. 1President of the
Jordanian Society of Allergy Immunology, Immunology Queen Alia Hospital,
Amman, Jordan; 2KingHusseinMedical Center, Immunology, Amman, Jordan.
Background: The extensive and unorganized planting and cultivation of the
holly olive trees in our country is the first cause of allergy. Olive tree (olea
europaea) pollen is a major cause of seasonal allergy-making it the first outdoor
pollen calendar in Jordan. To date, ten allergens, named Ole e 1 to Ole e 10,
have been isolated and characterized from this pollen Ole e 10, a small protein,
has been recently described as a major allergen from this pollen, since it affects
more than 55% of allergic patients. Few studies regarding olive allergy have
been reported in our area. The olive pollination season lasts two months ap-
proximately from the middle of May to the middle of July.
Objective: The main aim of this study was to address the performance of olive
screen testing by total and specific IgE and the cross reactionwith other pollens.
Methods: Total and specific serum IgE to olive pollen was tested and evaluated
in 400 allergic patients before, during and after the peak pollen season using
immunoblot Allergy Screen-Respiratory pannel.
Results: Out of the 400 patients serum specimens 132 (30%) had allergy to IgE
olive pollens. 125(94%) of the allergic patients had elevated total serum IgE
9100 IU/ml). 10 samples from healthy subjects were used as negative controls.
Cross-reactivity with orange, Banana, Grass pollens and Ambrosia has been
noticed in 10 cases (15%).
Conclusion: Olive tree pollen is one of the main causes of allergy in Medi-
terranean region included Jordan.
It is worth to mention the importance of the total and specific IgE
testing for olive pollen allergy detection and cross-reaction with other pollens
and fruits Suggesting the presence of Ole e 10-like proteins in many sources
which may be related to the development and exacerbation of allergic and
asthmatic process, but these results could be interpreted with caution regarding
clinical symptoms, signs, and skin prick testing.
136 Abstract withdrawn
137
In vivo reactivity to grass pollen in correlation to specific IgE
antibody levels in patients with allergic rhinoconjunctivitis
Johannes Huss-Marp1, Ulf Darsow2, Florian Pfab1, Ingrid Weichenmeier1,
Carl Johan Petersson3, Magnus Borres3, Johannes Ring2, and Heidrun
Behrendt1. 1ZAUM - Center for Allergy and Environment GSF/TUM, Division
of Environmental Dermatology and Allergy, Munich, Germany; 2Department
of Dermatology and Allergy Biederstein, Technical University Munich,
Munich, Germany; 3Phadia AB, Phadia AB, Uppsala, Sweden.
Background: Previous investigations established dose-response curves
between the severity of clinical symptoms and specific IgE antibody levels
to both indoor and food allergens in allergic individuals. We questioned
whether this also holds true for outdoor allergens e.g. grass pollen allergens.
Methods: 100 patients with allergic rhinoconjunctivitis (ARC) and allergy to
timothy grass pollen as well as 40 healthy controls were recruited during the
grass pollen season in 2006 and 2007. To investigate the correlation between
IgE antibody levels and threshold in vivo reactivity we determined specific
serum IgE antibodies to timothy grass pollen (ImmunoCAPi, Phadia AB,
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Uppsala) at three time points during one year (June/July; October; December)
and performed conjunctival and nasal provocation tests with grass pollen
extracts at different concentrations (Phleum pratense, HAL Allergy,
Duesseldorf, Germany). In addition, skin prick tests were performed. The
investigations were paralleled by grass pollen counts using a Burkard trap
performed at the University Campus Biederstein, Munich (G50 m distant from
the laboratory, 1.80 m above the ground). Additionally, the patients scored
their symptoms with visual analog scales and exhaled nitric oxide was
analysed as measure for inflammatory lung reaction.
Results: Preliminary results from 41 patients with ARC revealed a significant
relationship between specific IgE concentration in serum and the titrated level
of the skin prick test (p G 0.0096, Jonckheere-Terpstas trend test). However,
no correlation between specific serum IgE to timothy grass and thresholds of
nasal and conjunctival provocation tests were found.
Conclusion: Measurement of specific serum IgE levels seems to accurately
predict the in vivo reactivity with regard to skin prick test in patients with ARC
to grass pollen allergen. The preliminary results indicate a good correlation
between indicators of sensitization, but not between serum IgE levels and
threshold allergen concentrations that induce symptoms Further data analysis
concerning conjunctival and nasal provocation tests and symptom scores in a
greater number of patients is in progress.
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The diagnosis of Pollen-Food Syndrome (PFS) through the use of
a structured questionnaire
Isabel Skypala1, Moises Calderon2, Anthony Leeds3, and Stephen Durham4.
1Royal Brompton & Harefield NHS Trust, Nutrition and Dietetics, London,
United Kingdom; 2Imperial College, Allergy and Clinical Immunology,
London, United Kingdom; 3Kings College, Nutrition and Dietetics, London,
United Kingdom; 4Imperial College, Allergy and Clinical Immunology,
London, United Kingdom.
: PFS, a manifestation of Oral Allergy Syndrome (OAS), is a common
food allergy. The characteristic symptoms, speed of onset and the typical foods
involved suggest PFS could be diagnosed though clinical history alone.
Subjects with reported springtime hay fever completed a PFS diag-
nostic questionnaire (PFSDQ) and were allocated to either Group 1 (has PFS),
Group 2 (No PFS, ? food allergy) or Group 3 (no PFS or food allergy). All
subjects then had a consultation with an allergy specialist who made a pro-
visional PFS diagnosis. This was followed by skin prick testing to fresh foods
using the prick by prick test method (PPT) and oral food challenge (OFC). The
PFSDQwas measured against the gold standard of positive OFC, and a second
standard, the final diagnosis accorded to each subject by the medical allergy
specialist, using PPT and OFC results to modify his original diagnosis.
119 subjects completed the study; 58 (49%) were allocated to Group 1
(PFS+ve), and 61 (51%) to Groups 2 (30) and 3 (31) (PFS-ve). 47 subjects had a
positiveOFC, 41 of whomwere fromGroup 1. Although therewas a significant
difference between the PFSDQ and OFC results (p G 0.05), this was not the
case when the PFSDQ was compared to the final diagnosis standard (p = 0.5).
The sensitivity, specificity, positive and negative predictive values of the
PFSDQ were all Q 90% when tested against the final diagnosis standard. The
reliability of the PFS-DQ was high with a standardised alpha score of 0.819
(Chronbachs Alpha Test). Factor analysis showed the key components of the
PFSDQ to be symptom type, raw or cooked foods, speed of onset of symptoms
and number of reported symptoms (Varimix rotation). Logistic regression
analysis showed the only predictive factors of PFS diagnosis were reactions to
raw plant foods (p G 0.01), onset of symptoms within 5 minutes of eating
(p G 0.01) and number of reported symptoms to foods (p G 0.05).
Diagnosis of PFS using the PFSDQ was not significantly different to
that made by a specialist allergist using clinical history, PPT and OFC. The
most important predictive variables for PFS were reported reactions to raw
plant foods, rapid onset of symptoms and multiple symptoms. The PFSDQ
could be a useful diagnostic aid for those working in primary care to screen
adults with reported food symptoms for the presence or absence of PFS.
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Importance of benzylpenicillin in beta-lactam
hypersensitivity diagnosis
Laure Rouanet-Bousquet1, Philippe Jean Bousquet2, Bernard Arnoux3, Pascal
Demoly1, and AntoninoRomano4. 1University Hospital Arnaud de Villeneuve,
Exploration des Allergies, INSERM, Montpellier, France; 2University Hospital
of Nıˆmes, De´partement de l`Information Me´dicale, Montpellier, France;
3INSERM,U 454,Montpellier, France; 4Complesso Integrato Columbus, Unita
di Allergologia, Roma, Italy.
Introduction: Drug hypersensitivity to beta-lactam was often skin tested
using benzyl-penicillin, major (PPL) and minor (MDM) penicillin determi-
nants, amoxicillin, ampicillin and any other culprit beta-lactam. However, PPL
and MDM were removed from the marked. The aim of the study was to assess
the importance of benzylpenicillin before and after the withdrawal.
Methods: Using our Drug Allergy and Hypersensitivity Database (DAHD)
and data coming from an Italian centre, we conducted an historico-prospective
cohort study. All patients who consulted between 1996 and 2007 for a
suspected beta-lactam hypersensitivity reaction and who had at least positive
skin test to benzylpenicillin were included. Diagnosis and skin tests followed
the European Network on Drug allergy (ENDA) recommendations. Benzyl-
penicillin, PPL, MDM, Ampicillin, Amoxicillin were always skin tested.
Results: 133 patients (48Y36.1%men), 15 (11.3%) asthmatics and 41 (30.8%)
atopics were included. 13 (9.8%) were only positive to benzylpenicillin, 32
(26.5%) were also positive for PPL and 66 (55.5%) for MDM. Without skin
testing for PPL andMDM, the number of positive to benzylpenicillin increased
to 20 (15.0%). No difference was observed for asthma and atopic between
subjects only positive to benzylpencillin and those also positive for another
penicillin (p = 0.84 and p = 0.34 respectively). Anaphylaxis and anaphylactic
shock were more common in subjects positive to several penicillins (76Y67.3%
vs 7Y35%, p = 0.001). Conversely, only 26 (23.0%) vs 8 (40.0%) presented an
urticaria / angiodema.
Conclusion: Since the withdrawal of PPL and MDM, benzylpenicillin skin
test appeared to be mandatory, 15% of the patients being only positive to this
drug. This should significantly reduce oral challenges.
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Drug-induced hypersensitivity syndrome and herpes
virus infection
Zenro Ikezawa, Chieko Watanabe, Kazuko Nakamura, Yumiko Yamane, Yuki
Shigehira, Yuko Ikezawa, and Michiko Aihara. Yokohama City University
Graduate School of Medicine, Enviromental Immuno-Dermatology, Yokoha-
ma, Japan.
Background: (BDrug-induced hypersensitivity syndrome (DIHS) is a unique
severe adverse drug reaction, which is well known to be accompanied with
reactivation of human herpesvirus 6 (HHV-6) in many cases 2Y3 weeks after
development of drug reactions. The clinical features of this syndrome are acute
widespread maculopapular, polymorphous, eczematous and/or erythrodermic
erythema, fever, lymph node swelling, liver dysfunction, eosinophilia and
leukocytosis with atypical lymphocytes. After first reports of DIHS with HHV-
6 reactivation in Japan in 1998, 118 cases have been reported with data of
HHV-6 reactivation up to now.
Methods: We retrospectively analyzed recent reports of suspected adverse
drug reactions submitted to medical journals from Japan, in order to define the
presenting characteristics of these diseases in Japan.
Results: Ages ranged from 0 to 89 years old with a mean of 48.6 years old and
the ratio of M/F was 64/54. 63.7 % of causative drugs were anticonvulsants
(carbamazepine, 63.3% of the anticonvulsant drugs). The other common
causative drugs were sulfonamides, mexilletine (an antiarrhythmic drug) and
allopurinol. The symptoms developed 3 weeks or more after the beginning of
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causative drug administration in 80.5% of the patients. Recurrence of the
symptoms was observed in 40% of the patients. Four of them died and the
mortality rate was 3.6%. Reactivation of HHV-6 was detected in 83.9% of
the patients by the increase of IgG against HHV-6 and/or increase of HHV-6
DNA in the peripheral blood and sera. On the other hand, reactivation of cyto-
megalovirus was observed in 4 patients without HHV-6 reactivation. In treat-
ment of 118 patients with DIHS, steroid without puls was in 71 cases (60.2%),
steroid puls with mPSL in 15 cases (12.7%; 1g/day in 40.0% of 6/15, under 1g/
day in 33.3% of 5/15, unclear in 26.7% of 4/15), intravenous injection of high
dose immunoglobulin (IVIG) with steroid in 5 cases (4.2%), and plasmaapher-
esis (PA) with steroid in 3 cases (2.5%). The mortality in DIHS was unex-
pectedly high as 3.4% (4/118), as compared to that in SJS.
Discussion: A probable role of HHV-6 in DIHS was discussed in comparison
of that of Epstein-Barr (EB) virus in infectious mononucleosis and Mosquito
bite hypersensitivity.
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Drug provocation test in patients` \drug hypersensitivity reaction
Louis Enjome Ewang1, Ngwene H Muke2, Tommy T. Ebenky3, and Grils B.
Peter4. 1University of Buea, Cameroon, Life Science, BUEA, Cameroon;
2University of Buea, Cameroon, Research andDevelopment, Buea, Cameroon;
3Yaounde Centre Hospital, Yaounde, Medicine, Yaounde, Cameroon; 4Ghana’s
New Research Foundation, Research, Accra, Ghana.
Background: It has bndeen confirmed that, drug hypersensitivity are common
and life threatening. This diagnosis can be vigorous and based on clinical
history and a physical examination, possibly under skin tests and drug
provocation test. We intend to describe the out come of drug provocation test in
analyzing patients with histories suggesting drug allergy, using retrospective
analysis of clinic case series.
Methods: Some 416 consecutive patients with suspected immediate drug
allergy referred to the hospital between, January 1999 to February 2005.
Patients with served skin reaction and those with positive result on skin test for
B-lactams were excluded. it should be noted that single- blinded administration
of increasing doses of the suspected drug up to the usual daily dose, under
struck hospital surveillance.
Results: 920 drug provocation tests were performing using various drugs,
including aspirin (11.4%) nonsteroidel anti-inflammatory drugs (7.5%)
macrolides (8.5%) paracetamole (10.1%) and other non-steroidal anti-
inflammatory drugs (12.2%). We had 192 (15.6%) positive provocation test
results which also reproduce the same symptoms, albeit milder and of a shorter
duration - in the following patients.10 (4.2%) with history of anaphylactic
shock, 15(5.5%) the history of anaphylaxis without shock. 70 (46.4%) with a
history of urticaria and 5(2.4%) with a history maculopapular eruption. All
reactions were completely refers by prednisone and epinephrine. However, we
assume or accept that false negative results on drug provocation test may have
occurred because of sanitation, rare cofactors not included in the diagnostic
procedure and tolerance introduction during provocation.
Conclusion: It can be certain that drug provocation tests in individuals with
suspected drug allergy performed in carefully control settings can confirm
drug hypersensitivity.
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Antituberculous drug rechallenge: success rate among patients
with cutaneous hypersensitivity reactions
Lara Theresa Aleta. University Of The Philippines-Philippine General
Hospital, Allergy, Quezon City, Philippines.
Background: This is the first study to systematically document the proportion
of cutaneous hypersensitivity reaction (CHR) in patients with adverse drug
reactions (ADR) to antituberculous medications and their excipients.
Objective: 1.To determine the proportion of CHR due to specific anti-
tuberculous medications; 2. To investigate the success rate of rechallenging by
shifting to a different brand of antituberculous medication.
Methodology: All patients with CHR to antituberculous medications from
January 1 to August 31, 2001 were included. After at least 48 hours off
antihistamines, the patient was rechalleged with white or light yellow colored
drugs to minimize excipients the patient may be sensitized to. Rechallenge was
considered successful if there was no recurrence of symptoms while on the
multiple antituberculous drug regimen.
Results: Sixty-six patients were referred for ADR to antituberculous
medications. Forty-five had CHR. Forty-two patients were rechallenged.
Fourteen were successful. Sixteen had documented cutaneous adverse
reactions to one or more drugs with the highest incidence occurring with
ethambutol and pyrazinamide. The success rate of rechallenge was 14/42.
Conclusion: 1. Skin allergy is common (68%) with first line anti-TB drugs.
The most common drugs associated with CHR were ethambutol and
pyrazinamide; 2. The success rate of drug rechallenge when shifting to a
different brand of anti-TB medication is 14/42 (33%)
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Meta-analysis: Risk of angioedema with angiotensin receptor
blockers (ARBs) in patients with prior angioedema associated
with angiotensin converting enzyme inhibitor (ACE-I)
Bret Haymore1, Jiun Yoon1, Cecilia Mikita1, and Kent DeZee2. 1Walter Reed
Army Medical Center, Allergy-Immunology, Washington DC, United States;
2William Beaumont Army Medical Center, Internal Medicine, El Paso, United
States.
Background: Patients who experience angioedema (AE) after taking ACE-I
have been reported to develop AE when taking an ARB, but few studies
describe the risk. We sought to answer this question by performing a
systematic review of the medical literature.
Methods: A literature search was performed in MEDLINE, EMBASE,
BIOSIS, and Current Contents with no limitations from Jan 1990-May 2007.
SCISEARCH was also used to identify additional citations of key articles.
Reference lists of retrieved studies and review articles were evaluated for
additional citations. Two authors independently evaluated studies for inclusion
and abstracted relevant data according to pre-defined parameters. Any article
that described a cohort of patients who had experienced AE after taking an
ACE-I, were subsequently exposed to an ARB and followed for at least one
month were included. The percentage of patients experiencing AE was abs-
tracted from each article and confidence intervals were calculated using the
exact binomial method. The pooled percentage was calculated using the in-
verse variance method.
Results: From the 238 unique articles initially identified, three articles des-
cribing 71 patients met inclusion criteria. Onewas a randomized controlled trial
and twowere retrospective cohorts. The mean age of patients was 63 years with
56% male and 44% female. Two of the studies were predominantly Caucasian
subjects with the third study being 69% African-American. The mean time of
follow-up was 20.3 months. These articles described both confirmed and
possible cases of AE secondary to ARB. For possible cases the risk of AE was
9.4% (95%CI 1.6Y17); for confirmed cases it was 3.5% (95% CI 0Y9.2). There
were no fatal events. There was no statistical heterogeneity between trials
(p 9 0.3).
Conclusion: Limited evidence suggests that for patients who developed AE
when taking an ACE-I, the risk of developing any AE when taking an ARB is
between 2Y17% and for confirmed AE the risk is 0Y9.2%. This information
will aid clinicians in counseling patients regarding therapy options after
developing AE due to ACEI.
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Drug allergy and quality of life
Ilaria Baiardini1, Rosaria Calia2, Fulvio Braido1, Gian Enrico Senna3,
Antonino Romano4, and Giorgio Walter Canonica1. 1University of Genoa,
Department of Internal Medicine, Genoa, Italy; 2UCSC-Allergy Unit,
Complesso Integrato Columbus and IRCCS Oasi Maria S.S., Troina,
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Department of Internal Medicine and Geriatrics, Rome, Italy; 3Verona Major
Hospital, Allergy Service, Verona, Italy; 4UCSC-Allergy Unit, Complesso
Integrato Columbus and IRCCS Oasi Maria S.S., Department of Internal
Medicine and Geriatrics, Rome, Italy.
Background: Despite clinical experience suggests that drug hypersensitivity
may have a detrimental impact on patients` life, no data are now available
about this allergic reaction from a subjective viewpoint.
Aim: The aim of our study was to develop and evaluate the psychometric
properties of a questionnaire that assesses the drug hypersensitivity burden
from the patient`s perspective.
Methods: 172 consecutive patients (69.2% female, 30.8% male, mean age:
41.16 years +14.69) were asked to fill in a 20-item questionnaire to evaluate the
impact of drug allergy on QoL.
Results: The different reaction patterns were urticaria (77 patients),
anaphylactic shock (24), angio-oedema (20), exanthema (16), others cutaneous
eruptions (11), bronchospasm (11), other manifestations (7) The preliminary
analysis of patients` answers shows a worse QoL in the elderly (p G 05), in
women (p G 01) and in patients with anaphylaxis (p G 005).
Discussion: The use a of a simple tool permits to capture the burden of drug




Expression of IL-31-producing cells in children with atopic
dermatitis complicated by hen-egg allergy
Noma Takeshi1, Yutaka Kawano1, Kinya Nagata2, and Norifumi Ogawa2.
1Kitasato University School of Medicine, Pediatric Department, sagamihara,
Kanagawa, Japan; 2BioMedical Laboratories, Inc., Research and Develop-
ment Center, Kawagoe, Saitama, Japan.
Background: Cytokines are essential for the development and function of the
nervous systems as well as the immune and hematopoietic systems. IL-31 was
secreted in larger amounts preferentially in Th2 than in Th1 cells. IL-31 func-
tiones by the heterodimeric receptor composed of IL-31RA and OSMR that is
expressed constitutively on epithelial cells and keratinocytes. These cells are
likely to be involved in the dermatitis and pruritis of patients upregulating IL-31.
Objective and Methods: Peripheral blood mononuclear cells were obtained
from 22 patients with atopic dermatitis allergic to hen-egg ranging from 1 to 13
years in age, as well as from 9 healthy individuals who had no allergic symp-
toms. The patients had recurrent eczema, pruritis and positive skin reactions to
egg white. Patients also had positive responses to the oral provocation test to
raw hen egg. Diagnostic criteria for atopic dermatitis was based on the criteria
of Hanifin and Rajk. We evaluated expression of IL-31-pruducing cells by the
methods of newly developed FCAS analysis.
Results and Discussion: IL-31 was preferentially expressed in CLA (skin-
horming cutaneous lymphocyte antigen) as well as CD45RO-positive cells in
atopic children complaining of skin lesions and pruritis compared to normal
subjects. Severity of these symptoms were correlated with amount of IL-31 in
the cells.
Conclusion: These result suggests larger amounts of expression of IL-31 is
likely to be involved in the pruritis as well as skin lesions in atopic children.
146
Dysregulation of TLR-2 induced effects in monocytes from
patients with atopic dermatitis: Impact of the TLR-2
R753Q polymorphism
Margarete Niebuhr1, Jens Langnickel1, Christian Draing2, Alexander Kapp1,
and Thomas Werfel1. 1Hannover Medical School, Department of Dermatol-
ogy and Allergology, Hannover, Germany; 2University of Konstanz,
Biochemical Pharmacology, Department of Biology, Konstanz, Germany.
Background: Atopic dermatitis (AD) is often complicated by an enhanced
susceptibility to bacterial skin infections, especially with Staphylococcus aureus
(S. aureus). Toll-like receptors, especially (TLR)-2 recognizes cell wall com-
ponents of S. aureus, e.g. lipoteichoic acid (LTA) and peptidoglycan (PGN). A
heterozygous TLR-2 R753Q polymorphism occurs in a frequency of 11.5% in
adult AD patients and has been shown to be associated with a severe phenotype.
Objective and Methods: The aim of this study was to investigate the impact
of TLR-2 agonists (LTA, PGN and Pam3Cys) on cytokine production and cell
surface marker expression in human monocytes from AD patients with the
TLR-2 R753Q polymorphism compared to AD patients with Bwild type^
TLR-2 and control individuals to elucidate the functional role of the TLR-2
R753Q polymorphism.
Results: We could show that AD patients with the TLR-2 R753Q mutation
produced significantly more IL-6 and IL-12 and significantly less IL-8
compared to ADpatients with non-mutated TLR-2 upon stimulationwith TLR-
2 agonists. Expression of CD86 was significantly higher upon Pam3Cys sti-
mulation in TLR-2 R753Q polymorph patients. Expression of CD80 was
unaffected after stimulation with TLR2 agonists.
Conclusion: We show for the first time functional differences in TLR-2 res-
ponsiveness of monocytes from AD patients with the TLR-2 R753Q mutation
compared to wild type AD patients in a ligand dependant manner. Clinical
implication: Our data stratify the emerging concept that AD patients have a
dysbalance in innate as well as aquired immunity. TLR-2 might be essential in
the pathogenesis of AD and involved both in the enhanced susceptibility to skin
infections with S. aureus and in a higher inflammatory response in patients with
the TLR-2 polymorphism.
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Impact of atopic dermatitis on the quality of life in
Japanese patients
Yukihiro Ohya1, Yasuo Kubota2, Akira Hoshioka3, Ritsuko Hosoya4, Namiko
Kojima1, Masami Narita1, Akiko Miyazaki1, and Nahoko Sakamoto5.
1National Center for Child Health and Development, Division of Allergy,
Tokyo, Japan; 2Kagawa University, Department of Dermatology, Kagawa,
Japan; 3Chiba Children’s Hospital, Division of Allergy, Chiba, Japan;
4Hosoya clinic, Dermatology, Tokyo, Japan; 5Juntendo University, Depart-
ment of Public Health, Tokyo, Japan.
Background: Prevalence of atopic dermatitis (AD) in Japanese population has
been rapidly increased for these decades. Impact of AD on their quality of life
(QOL) is difficult to be assessed by using a translated QOL scale developed in
western nations because of the influence of different culture. The aim of this
study is to develop an original QOL assessment scale for Japanese patient with
atopic dermatitis.
Methods: We have collected our own data from patients who visited Japanese
hospitals and clinics by using an anonymous open questionnaire and some by
interviews. One hundred and eighty items were extracted from whole data and
based on them, secondary questionnaire comprising 68 items was made by
expert’s discussion. It was applied to 200 patients with atopic dermatitis for
psychometric item reduction.
Results: Through the process of factor analysis and item analysis, sixty eight
items were converged to 9 items comprising of four factors such as influence to
daily activities, burden of medication, itchiness generated annoyance, anxiety
about future. Internal consistency of each factor was excellent such that
Cronbach" of each factor was 0.0772, 0.843, 0.865 and 0.789. Item content
and factor loading score of each item is weak enthusiasm o.818, influence of
sleep disturbance 0.617, burden of house keeping 0.589, burden of topical
therapy 0.824, unwillingness of topical application 0.817, annoyance to
itchiness 0.821, annoyance to scratching 0.756, anxiety about remission 0.824,
and anxiety of fluctuating symptoms 0.684.
Conclusion: This study has revealed impact of atopic dermatitis on the QOL
of patient is not only associated with dermatological symptoms but also
adherence burden and anxiety about prognosis. The compact 9 time ques-
tionnaire developed in Japan this time would be useful to detect compre-
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hensive quality of life of patients with atopic dermatitis even in a busy situation
of our outpatient clinics.
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Eosinophil proteins in serum and urine of children with
atopic dermatitis
Magdalena Czarnecka-Operacz, Dorota Jenerowicz, and Wojciech Silny.
Poznan University of Medical Sciences, Dermatology, Poznan, Poland.
: Atopic dermatitis (AD) is an inflammatory skin disease characterized
by chronic and recurrent course, beginning primarily in an early childhood.
The aim of the project was an evaluation of the usefulness of selected
eosinophil proteins in serum (ECP, EPX) and urine (EPX) of children suffering
from AD, as markers of disease severity. The study also aimed to analyze
correlations between the level of examined proteins and such parameters as:
skin prick tests (SPT) results, serum concentration of total IgE and coexistance
of symptoms of other atopic diseases. We examined 40 AD children attending
Allergic Diseases Diagnostic Center and hospitalized in the Department of
Dermatology. As control group we selected 23 healthy children without any
symptoms of allergic diseases. Mean level of eosinophil proteins measured in
serum (ECP, EPX) and urine (EPX) of children suffering from AD was higher
than in controls and statistically significant difference was detected for serum
level of EPX. Patients presenting with very severe/severe AD had higher level
of eosinophil proteins than patients presenting with mild/moderate AD,
although no significant difference was found. AD children with positive SPT
results and detectable serum specific IgE presented with higher mean level of
serum and urine eosinophil proteins than in compared groups of patients with
negative SPT results and undetectable serum specific IgE, although with no
statistically significant difference. Total IgE level in AD children representing
allergic form of the disease was statistically significantly higher than in
children with non-allergic AD. In children with very severe/severe AD, total
IgE level was significantly higher than in children with moderate/mild disease.
Results presented above indicate singnificant role of eosinophils in etio-
pathogenesis of AD. Measurements of serum and urine level of selected
eosinophil proteins may be considered as an important part of diagnostic
approach in children suffering from AD, especially in differentiating of allergic
and non-allergic form of disease. Among eosinophil proteins, EPX has always
been the subject of particularly thorough investigations, because of easy and
non-invasive way of measurement in urine, which is an important feature in
diagnostics of children. EPX is a marker significantly better differentiating AD
patients from healthy individuals in comparison to other factors, such as ECP
and peripheral blood eosinophilia.
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Quantitative analysis of nerve growth factor (NGF) in the horny
layer of atopic dermatitis and effect of treatment on NGF
Zenro Ikezawa1, Junko Yamaguchi1, Michiko Aihara1, Takeshi Kambara1,
and Yusuke Kobayashi2. 1Yokohama City University Graduate School of
Medicine, Environmental Immuno-Dermatology, Yokohama, Japan; 2Shiseido
CO, R&D Planning Division, Yokohama, Japan.
: The expression of nerve growth factor (NGF) is known to increase in
the skin of patients with atopic dermatitis (AD) and to be related to disease
aggravation. In the present study, we measured skin NGF levels in AD patients
and assessed the possibility of a relationship to AD severity, as well as effects
of treatments.
Methods: NGF in the horny layer (hornNGF) of skin lesions on the cubital fossa
was collected via tape stripping andmeasured using ELISA inADpatients before
and after 2 and 4week treatments. Itching and eruptions on thewhole body andon
lesions measured for NGF were evaluated. Peripheral blood eosinophil count,
serum LDH level and serum total IgE level were also examined.
Results: The level of NGF was significantly higher in AD patients than in
healthy controls, and correlated with the severity of itch, erythema, scale/
xerosis, eosinophil count, and LDH level. The NGF level decreased sig-
nificantly after treatments with olopatadine and/or topical steroid for 2 and
4 weeks. The decrease of NGF correlated with the decrease in the severity
of itching, severity of AD on the whole body, erythema, papule, scale/xerosis
and lichenification of the lesion, eosinophil count, and LDH level.
Conclusion: The level of the horn NGF was found to reflect the severity of
itching and eruptions in AD. Therefore, measurement of the NGF via this
harmless method appears to be useful in assessing severity and therapeutic
effects in AD.
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Association between the allelic variant delta 32 of CCR5 receptor
and the prevalence of urticaria, angioedema and atopic
dermatitis symptoms
Jorge Molinas1, Rut Aguero1, Ledit Ardusso2, Cintia Crudelli1, Rodolfo
Navarrete1, Natalia Pujato1, Guillermo Mujica1, and Nora Figueroa1. 1Rosario
National University, Human Physiology, Rosario, Argentina; 2Rosario
National University, Allergy Department, Rosario, Argentina.
Introduction: C-C chemokines, including RANTES, MIP-1, MCP-2, and the
CCR5 specific receptor play an important role in the genesis of allergic
inflammation. The presence of homozygosis for the delta32 (d32) polymor-
phism of CCR5 produces the absence of this receptor from the cell surface and
heterozygosis promotes a very low expression of this receptor, hence reducing
the availability of receptors capable of interacting with chemokines to induce
the inflammatory response. We have previously informed a reduced risk of
developing asthma and rhinitis in adults that present the d32 allelic variant. We
could not find any report about the relationship between d32 and atopic
dermatitis (AD), urticaria (URT) or angioedema (ANG).
Objective: To evaluate association between d32 polymorphism and AD, URT
and ANG in adults from Rosario city.
Materials and Methods: 111 caucasian subjects, 36 males (32.7%) and 74
females (67.3%), aged 19 to 46 years old (x = 23.88 T 4.45), answered
questionnaires for AD (ISAAC), URT and ANG. DNA was extracted from
blood samples and d32 polymorphism was determined by PCR. Oligonucleo-
tide sequences were: sense: 5¶-GTCTTCCATTACACCTGCAGCTCT-3¶,
antisense: 5¶-CACAGCCCTGTGCCTCTT-3¶.
Results: 6.3% of the subjects presented the heterozygotic polymorphism and
0.9% the homozygotic polymorphism. The risk of suffering from AE, URT or
ANG was significantly lower in the subjects that presented the d32
polymorphism. Among the subjects that referred for AD symptoms at least
once in their life (15.3%), no one presented heterozygosis or homozygosis for
d32, while in the subjects that did not refer these symptoms the frequency of
the same genotype was 8.5% (RR = 0.83 IC:0.77Y0.91; p G 0.05). Among the
subjects that referred for URT symptoms at least once in their life (36.9%),
2.4% presented heterozygosis or homozygosis for d32, while in the subjects
that did not refer these symptoms the frequency of the same genotype was
11.1% (RR = 0.70 IC:0.52Y0.95; p G 0.05). Similar results were obtained in
subjects that referred for ANG symptoms at least once in their life (13.6%),
since no one presented heterozygosis or homozygosis for this polymorphism,
while in the individuals that did not refer these symptoms the frequency of the
mentioned allele was 8.4% (RR= 0.85 IC:0.79Y0.92; p G 0.05).
Conclusion: The results obtained in this study allow us to suggest that the
reduced risk to develop AD, URT and ANG could be influenced by the




Prevalence of atopic dermatitis in infants
Yusuke Inoue, Haruna Yamazaki, Takeshi Kambara, Satoko Tatewaki, Kazuko
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City University School of Medicine, Department of Environmental Immuno-
Dermatology, Yokohama, Japan.
Background: It is generally believed that atopic dermatitis (AD) patients
have been gradually increased compared with the past. But, the prevalence
of AD in infants has not been precisely investigated anywhere. The object
of this work was to evaluate the exact prevalence of AD in infants and the
relationship between induction/exacerbation of AD and skin barrier
dysfunction.
Methods: Four-month-old and eighteen-month-old infants were examined
by dermatologists at regular health check-ups in the public health center in
Yokohama city throughout the year. Diagnosis of AD was based on the
Japanese Dermatological Association criteria for the disease by the
dermatologists. Skin barrier dysfunction was evaluated by measuring
transepidermal water loss (TEWL) on face, abdomen and lower leg of
infants without skin lesions.
Results: The prevalence of AD was 15.9% and 12.7% at four-month-old and
eighteen-month-old infants respectively. The prevalence of eighteen-month-old
infants was significantly decreased compared with that of four-month-old
infants. The infants diagnosed asAD showed significantly higher TEWLvalues
comparedwith healthy infants both four-month and eighteen-month-old infants
at all skin portions.
Conclusion: The prevalence of AD in infants was tend to be decreased from
four month old to eighteen month old. It was also suggested that a relationship
between development/exacerbation of AD and skin barrier dysfunction.
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Validity for atopic dermatitis diagnostic criteria in an adult
hospital population
Irena Angelova-Fischer1, Gencho Genchev2, Mary Gantcheva1, and Nikolai
Tsankov1. 1Department of Dermatology, University of Medicine, Sofia,
Bulgaria; 2Department of Public Health and Health Management, University
of Medicine, Sofia, Bulgaria.
Background: In contrast to the advancement of knowledge on the
pathogenesis of atopic dermatitis (AD), establishing international diagnostic
criteria standards remains a challenge. The criteria of Hanifin and Rajka,
though extensively mentioned in research settings, rely on features with
significant variation due to age, ethnicity or other factors and may be un-
suitable for epidemiological studies when clear-cut case/control definitions are
needed. The validity of the UK Working Party criteria has been reported in
population and hospital-based studies, mostly in children. Data concerning
adults are however very limited.
Objective: We aimed to test the validity of the UK Working Party criteria in
adult patients referred to a university hospital in Bulgaria. We also tested the
relevance of six clinical signs commonly associated with AD without being
criteria, namely, fine hair, periorbital and periauricular dermatitis, infraauri-
cular fissures, cheilitis angularis and Hertoghe sign.
Methods: 118 patients aged 18Y60 years were recruited for the study. All
patients were examined independently by a senior dermatologist and a
resident, both blinded to the study aim. The results were evaluated by a third
independent and blinded observer using contingency tables.
Results: We found higher sensitivity (94,03%), specificity (92,16%), positive
(94,03%) and negative (92,16%) predictive value for the UK Working Party
diagnostic criteria than for the ones of Hanifin and Rajka (88,06%;82,35%;
86,76;55,26 respectively). Family history for atopy and erythroderma were
significant factors for false positive results. Of the additionally examined
features, the highest sensitivity and specificity was found for Binfraauricular
fissures[ (59,70% and 84,31%, respectively).
Conclusion: Our results confirm the validity of the UKWorking Party criteria
in an adult hospital population in Bulgaria. Although the cases may represent a
more severe disease end spectrum, there are only few systematic publications
on AD features in adulthood and our study provides valuable data on the
performance of the diagnostic criteria and relevance of the individual clinical
signs in this age group.
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Is atopic dermatitis really atopic?
Mariana Mandazhieva-Pepelanova, and Nevena Berova. Military Medical
Academy, Department of Dermatology and Allergology, Sofia, Bulgaria.
Background: There is little data on the correlation between atopic dermatitis
and other atopic diseases (asthma, rhinitis) and atopy markers (positive skin
prick test and specific IgE to Dermatophagoides pteronissinus /Dpt./). This is
why the comorbidity of atopic dermatitis and allergic rhinitis and bronchial
asthma and the presence of atopy markers should be further investigated as
well as the correlation between the positive atopy markers and a positive
patch test with Dpt.
Methods: The correlation between patch-test and skin prick test with Dpt.
and specific IgE was evaluated in 32 patients (8 men), with atopic dermatitis,
27 had rhinitis as a concomitant disease (17 with allergic rhinitis) and 16 had
bronchial asthma. All of them were tested for specific IgE and skin prick test
and patch test with Dpt. were performed.
Results: 17 patients had a positive patch test with Dpt., 12 had positive specific
IgE antibodies to Dpt. and 14 - positive skin prick test with Dpt.
Conclusion: Cases with a positive patch test prevail when compared to
positive skin prick test and specific IgE. Positive patch test does not always
correlate with atopy, evaluated as positive skin prick tests and specific IgE to
Dpt. The patch test could be used as a routine and reliable method in practice
for evaluating the role of Dpt. in the pathogenesis of atopic dermatitis.
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Atopic dermatitis in children: immunophenotype of
inflammatory cells in skin lesions
Viktoriia Klymenko. Kharkiv State Medical University, Department of
Propedeutic Pediatrics N2, Kharkiv, Ukraine.
Background: Immune cells play a main role in development of atopic
dermatitis (AD); however, so far only limited data are documented on the
distribution on these cells in the skin during cutaneous inflammation.
Objectives: To gain better insight into the number and phenotype of immune
cells in lesional skin of AD patients.
Methods: The lesional skin biopsies of patients with different forms of atopic
dermatitis (an exudative, an erytemato-squamouse, a lichenoid) has been
investigated. It is carried out 38 skin’s biopsies in the children aged 1,5Y15 years.
Biopsies were made by needles (diameter - 1,6MM). Avidin-biotin immunoper-
oxidase staining of paraffin-embedded skin sections, with quantitative counting
of cells labeled by anti-CD4, anti-CD8, anti-CD16, and anti-HLA-DR (Human
Leukocyte Antigen) anti-IgE monoclonal antibodies was used.
Results: The results of immunomorphologycal analysis showed a great
infiltration of T-lymphocytes and a high intraepidermal expression of IgE. The
amount of main immune cells were (per 100 cells): CD4 = 47 T 5,8;
CD8 = 17,3 T 3,2; CD4:CD8 = 2,8 T 0,5; CD16 = 5,7 T 0,7; HLA-DR =
1,1 T 0,1.
Conclusion: Immunophenotyping was found to be a useful diagnostic method
in AD patients. These data help to elucidate the pathogenesis of AD.
155
Undiagnosed alllergic dermatitis - a prospective study
Vipul Shah1, and D Tripathi2. 1Allergy Clinic, Allergy, Surat, India; 2Bombay
Hospital, Allergy, Mumbai, India.
Introduction: Undiagnosed cases of dermatitis were referred to our clinic
after treated by number of dermatologists in our city. These cases were treated
with different types of symptomatic drugs for last 7 to 10 yrs, but did not yield
any significant result and these were labeled as difficult dermatitis.
Materials and Methods: Ten such patients who were referred to our clinic
were subjected to detailed medical history & clinical examinations. We
decided to perform skin prick test (modified SPT) as to determine possible
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role of airborne allergens. These patients showed positive skin prick test
reactions to many allergens such as Asp. flavus, Asp.Tarmare, Alt Alternaria,
D. Farinae, D.Pter., House dust, Hay dust, Parthenium & Paltophorm among
airborne allergens, while reactions were observed significantly positive to
certain food allergens also ( Milk, Almond, Yeast, Hazel nut ).Since there
patients showed strong reactivity to certain allergens (IgE mediated hyper-
sensitivity), an attempt was made to administer allergen immunotherapy
course. Allergens which were strongly positive and showed airborne domi-
nance in the vicinity of the patient were selected for allergen immunotherapy
mixture. The allergen immunotherapy was initiated on this subject as per
guidelines laid down by WHO.
Results and Discussion: The improvement was observed & symptomatic
relief was recordedwithin 3 to 4month of initiation of allergen immunotherapy.
Conclusion: Allergen immunotherapy could play a major role in the treatment
of airborne contact dermatitis.
156
Prognosis of allergic contact dermatitis in patients patch tested
in a university hospital in Beijing
Lin-feng Li. Peking University Third Hospital, Dermatology, Beijing, China.
Background: Although it is believed that the prognosis of allergic contact
dermatitis (ACD) is good, long-term prognosis of ACD has not been reported.
Objectives: To investigate the 1-year outcome of ACD in a university
dermatology setting.
Patients and Methods: In a two-year period, 655 consecutive patients were
patch tested in Peking University Third Hospital for suspected ACD. At one
year after patch testing, all patients were asked a revisit and prognosis of ACD
was evaluated by the rate of clearance (complete free of dermatitis without
recurrence for more than 3 month before the final evaluation).
Results: Of 599 patients finished study, 167 cases were ACD. The rates of
clearance and relapse were 49.7% and 41.9% respectively. Concurrence of
atopic diathesis, ichthyosis, history of drug allergy as well as disease location
had no effect on the clearance rate. Significant lower clearance rate (26.8%)was
found in patientswith longer disease duration (over 6months) before diagnosis.
The clearance rate in patients with non-continuous ACD was also lower than
that of continuous ACD (28.3% vs. 59.6%, chi square test). Ignorant re-
exposure to contact allergens was the mean reason for relapse.
Conclusion: 1-year outcome of ACD is not as good as expected. Longer
disease duration before diagnosis and non-continuous ACD are main risk
factors for poor prognosis. Patients with suspected ACD should be patch tested
as early as possible. Mandatory ingredient labeling and sufficient patient
education are necessary to improve the prognosis of ACD.
157
Fishing for allergens hiding as prohaptens: cinnamic aldehyde
but not cinnamic alcohol identified as potent sensitizer
Hagen Ott1, Moa Andresen Bergstro¨m2, Gabriele Zwadlo-Klarwasser3, Ann-
Therese Karlberg4, Jens Baron1, and HansMerk1. 1RWTH Aachen, Univ.-Dept.
Dermatology & Allergology, Aachen, Germany; 2Go¨teburg University,
Dermatochemistry and Skin Allergy, Go¨teborg, Sweden; 3RWTH Aachen,
Biomat, Aachen, Germany; 4Go¨teborg University, Dermatochemistry and Skin
Allergy, Go¨teborg, Sweden.
: Skin is a major target organ of allergic reactions to small molecular
weight compounds such as allergic contact dermatitis or allergic drug
allergy. It has been generally accepted that most small molecular weight
compounds must be bound to high molecular weight compounds in order to
become immunogenic. For this binding of the hapten to a protein the hapten
must be a highly reactive chemical such as intermediate metabolites of
cytochrome P450 (CYP) dependent metabolism of prohaptens. Recently we
demonstrated the usefulness of an organotypic CYP cocktail to identify
prohaptens by combining such a CYP cocktail with a dendritic cell-based in
vitro model to identify sensitizing small molecular weight compounds
(Bergstro¨m et al., JID 127 (2007) 1145Y1153; Mukhtar et al., JID (2007)
992Y993). Cinnamic alcohol is oxidised to cinnamic aldehyde by a CYP-
dependent metabolism. Therefore we were interested whether cinnamic
aldehyde is the nominative antigen in allergic reactions to cinnamic alcohol.
We generated immature DCs from human peripheral blood monocytes by
depletion of CD2, CD7, CD19, CD56, CD16, CD235a positive leukocytes
and consecutive incubation with GM-CSF and IL-4. At least 6 million cells
were stimulated with the following test compounds for 30 hours
respectively: 2,4,6-trinitrobenzene sulfonic acid - TNBS (200 mg/ml),
sodium dodecyl sulfate - SDS (5 mg/ml), dimethyl sulfoxide - DMSO
(0.1%), CAld (0,1 mM) and CAlc (0.1 mM). After RNA isolation of the
treated cells, reverse transcriptase-PCR analysis was performed using a
primer/probe set specific for the detection of IL-8 mRNA expression. A
sensitizing effect of CAld could be shown for all 6 donors as indicated by a
median IL-8 upregulation of 34.3 fold normalized relative to medium-
treated controls. In contrast, the median enhancement of IL-8 mRNA
expression was not significantly greater after incubation with CAlc (2.13)
than after stimulation with SDS (2.22), DMSO (1.2). In conclusion,
cinnamic aldehyde possesses a stronger allergenic activity than cinnamic
alcohol which is CYP-dependently metabolised to cinnamic aldehyde. These
results further supports the concept that the combination of prohapten
modified organotypic CYP cocktails with a dendritic cell-based in vitro
model of contact allergens may streamline and increase the predictive
efficiency of current safety test methods in allergic contact dermatitis.
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The profile of patch test reactions to common contact allergens is
related to sex
Jochen Brasch1, Axel Schnuch2, and Wolfgang Uter3. 1University Clinics of
Schleswig-Holstein, Campus Kiel, Department of Dermatology, Kiel,
Germany; 2Institute at the University of Go¨ttingen, Information Network of
Departments of Dermatology, Go¨ttingen, Germany; 3University of Erlangen-
Nu¨rnberg, Dept. of Med. Informatics, Biometry and Epidemiol., Erlangen,
Germany.
Background: It is a worldwide observation that patients exposed to diagnostic
patch tests are predominantly women. This is commonly explained by distinct
sex-related patterns of allergen exposure that cause different patterns of
sensitization in men and women and by a higher health awareness of women.
Nevertheless, additional sex-related differences in the responsiveness to
contact allergens should be taken into consideration.
Methods: Sex-related reaction profiles of 16 common patch test allergens that
are used in standard patch test series were retrospectively analysed based on
data of 47.000 patients filed by the Information Network of Departments of
Dermatology in Germany within a period of 10 years. All patch tests had been
done by use of identical methods in patients with suspected contact allergy but
no history of atopic dermatitis. The proportions of weak positive reactions and
of questionable and irritant reactions were evaluated by calculating the
positivity ratio and the reaction index separately for men and women for each
allergen.
Results: Out of the 16 allergens evaluated, 8 had a slightly higher positivity
ratio and a slightly higher reaction index in women than in men. 4 allergens
had a lower positivity ratio and another 4 had a lower reaction index in women
than in men, but no allergen had a lower positivity ratio plus a lower reaction
index in women than in men. In particular for allergens with similar rates of
positive reactions in men and women female sex was significantly related with
a higher positivity ratio and reaction index (pG0.01).
Conclusion: There is a small but statistically significant disparity in the
reactivity of men and women to common patch test allergens. Women in
general have a higher rate of weak positive reactions but less questionable or
irritant reactions to an allergen than men. This marginal difference is probably
not relevant for patch testing but adds a new element to the pathogenetic puzzle
of contact allergy.
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Reduced allergy rates to contact allergens/haptens with both oral
and cutaneous exposure in atopic eczema subjects. Atopy and the
"hapten hypothesis"
John McFadden1, Jonathan White1, and Ian Kimber2. 1St. John’s Institute of
Dermatology, Department of Cutaneous Allergy, London, United Kingdom;
2University of Manchester, Department of Toxicology, Manchester, United
Kingdom.
Background: Whilst allergy to food proteins is almost exclusively seen in
atopics, it has been our impression that this does not hold true for haptens/
contact allergens which are present in our diet. Diallyl disulfide is the major
haptenic allergen in garlic and allergic contact dermatitis to this has been
observed in people who handle garlic whilst preparing food. Parabens and
lanolin are both contact allergens commonly used in many cosmetic and
medicament creams. However, unlike lanolin, the preservative parabens is
used in some processed foods. We retrospectively reviewed data from our
patch test clinic, comparing the frequency of allergy rates (patch test positive,
PT+) to these haptens between atopic eczema/dermatitis AD and non-AD
dermatitis patients.
Results: Between 1980 and 2006 in total population of 36658 patients with
eczema/dermatitis were patch tested, of whom 10326 (28.2%) had AD; in
contrast 13/83 (12.5 %) patients PT+ to diallyl disulfide/garlic had AD
(AD/total population vs AD/diallyl disulfide PT+ p = 0.011). 54/239
parabens PT+ had AD (22.6%), whilst 181/608 lanolin PT+ had AD
(29.8%) (pG 0.05)
Discussion: Frequency of contact allergy to haptens with both oral and
skin exposure is reduced in AD patients compared to non-AD patients in
direct contrast to food protein allergy. This decrease was not observed in
lanolin, which is used only on the skin. Possible reasons for these results
could be 1) confounding factors e.g. AD patients handle garlic less than
non-AD patients, or 2) AD patients are very efficient at tolerising haptens,
and this is in some way secondary to their atopic status, or 3) oral
tolerance of haptens may in some way antagonise tolerance of proteins and
contribute to the development of atopy (the hapten hypothesis). We note
that the increase in atopy over the last 50 years also coincides with a
period where processed food and milk, with chemical/hapten content, is
used in western diets.
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Incidence and prevalence of para-phenylenediamine allergy in
an adult Thai population: a public health problem
John McFadden1, Jonathan White2, Nicola Gilmour3, Donna Jefferies4,
Imelda Duangdeeden5, Preya Kullavanijaya5, and David Basketter6. 1St.
John’s Institute of Dermatology, Department of Cutaneous Allergy, London,
United Kingdom; 2St. John’s Institute of Dermatology, Department of
Cutaneous Allergy, London, United Kingdom; 3Unilever, Safety and
Environmental Assurance Centre, Sharnbrook, United Kingdom; 4Unilever,
Safety and Environmental Assurance Centre, London, United Kingdom;
5Institute of Dermatology, Dermatology, Bangkok, Thailand; 6Unilever,
Safety and Environmental Assurance Centre, Sharnbrook, United Kingdom.
Background: Most studies on the prevalence of allergy to the permanent hair
dye chemical para-phenylenediamine (PPD) are reported from populations of
eczema patients attending patch-test clinics, and are assumed to be much
higher than in the normal population. No data exists on incidence of
sensitisation to PPD resulting from the use of commercial hair dye
preparations over a defined time period.
Methods: 2545 healthy adult volunteers (Bangkok) were screened for PPD
allergy through standard patch testing. Volunteers not allergic to PPD were
then recruited into two groups; one group applying a commercial hair dye
brand as instructed on a monthly basis for 6 months (n = 548); controls
(n = 516) were instructed not to dye their hair for 6 months. Sensitisation to
PPD resulting from the use of hair dye over this period was then detected by
repeat patch testing.
Results: The prevalence of PPD allergy in a normal adult population was
2.7% (m = 2.4%, f = 3.2%). Projected to the adult Thai population, at least
1,000,000 Thai individuals could be allergic to PPD. The incidence of
sensitisation through monthly application of standard commercial hair dye
preparations over a 6 month period was 1.3%, substantially higher than in
controls (0.4%), although numbers were small and not statistically significant.
ABSTRACTS
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Interpretation: There is a higher prevalence of hair dye allergy amongst the
normal population than previously thought. The incidence of new cases of PPD
allergywould indicate that current regulations and practice of hair dye exposure
lead to PPD sensitisation and allergy, which is a public health problem.
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An unusual form of autoimmune progesterone dermatitis (APD):
the role of diagnostic challange test
Ayse Baccioglu1, Mukadder Kocak2, Onder Bozdag3, and Ayse Fusun
Kalpaklioglu1. 1Kirikkale University Hospital, Allergic Diseases, Kirikkale,
Turkey; 2Kirikkale University Hospital, Dermatology, Kirikkale, Turkey;
3Kirikkale University Hospital, Pathology, Kirikkale, Turkey.
Hypersensitivity to sex hormones has long been recognized as cyclic and
recurrent rushes. Progesterone sensitivity is termed as autoimmune progesterone
dermatitis (APD) which is shownwith a positive skin test . Our patient was a 33-
year-old female who presented with cyclic skin eruptions of two years’duration,
right after she delivered her baby. At the beginning a fixed single maculopapular
and itchy skin lesion of 1-2 cm was occuring two days prior to her monthly
cycles and resolving by the beginning ofmens. However, new lesions occured in
other fingers, lately. She had no prior exogenous hormone use. Her menstruel
cycles were irregular since she was 15 years old. Progesterone levels were found
to be high before her pregnancy, but wasn_t treated. The possibility of APD was
suspected because of the cyclic nature of her lesions.
Serum levels of sex hormones were normal, as well as her
gonadotrophins, and prolactin. Skin biopsy showed a non-spesific dermatitis
with a moderate perivasculer infiltration of lenfocytic cells in the upper dermis.
The direct immunofluorescence studywas negative. Challenge test with aqueous
progesterone was performed. Prick and patch tests were negative, whereas
intradermal test with 50 mg/ml of progesterone was positive confirming the
diagnosis of APD. Despite many localizations reported, there wasn_t any case
appearing only in fingers, as it was seen in this case.Exposure to exogeneous
progesterone as oral contraceptives (OC) has been suggested as a stimulus for
the production of autoantibodies reacting with endogeneous progesterone in
APD. However, in some cases OC use isn_t necessary as was observed in our
patient. There is a possibility of autoimmune damage to progesterone containing
ovarian tissue which could be resulted with premature ovarian failure. In our
patient there was no evidence of ovarian disfunction as she had a child.
In this case, APD was diagnosed with patient_s typical history of
recurrent lesions during the luteal phase of her menstrual cycle and this was
confirmed by intradermal test with progesterone. As the endogenous
progesterone is produced during ovulatory cyclus, the goal of therapy is the
suppression of ovulation by a combination OC. If this is ineffective, danazol,
gonadotropin releasing hormone analogs, tamoxifen, and oophorectomy may
be tried. Our patient didn_t accept any treatment as she wanted another baby.
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Analysis of discoidin domain receptor-1 expression by
tissue-infiltrating eosinophils in allergic skin diseases
Yukari Nishimura, Hiroyuki Murota, Norihisa Kotobuki, Shun Kitaba, Mika
Terao, and Ichiro Katayama. Course of Integrated Medicine Graduate School
of Medicine, Osaka University, Dermatology, Oasaka, Japan.
Background: Discoidin domain receptor 1 (DDR1) is a receptor tyrosine
kinase that is activated on binding to its ligand-collagen a component of the
extracellular matrix (ECM) in the organs and is known to be constitutively
expressed in the normal tissues such as the lungs, kidneys, colon, and brain. It
has been reported that the tissue-infiltrating eosinophils expressed DDR1 and
interaction between endogenous DDR1 on eosinophils and collagen in the
ECM might affect eosinophil survival in the tissue microenvironment through
NFK-B activation in Churg-Strauss syndrome (CSS) characterized by
necrotizing granulomatous angitis with massive eosinophil infiltration,
asthma, and hypereosinophilia.
Patients and Methods: DDR1 expression on peripheral blood eosinophils
from asthma patients, and healthy volunteers has been reported to be
significantly lower than that from CSS patient. However little is known about
the DDR1 expression and its significance in tissue infiltrating eosinophils in
allergic diseases. Therefore, we analysed DDR1 expression by tissue-
infiltrating eosinophils in allergic skin diseases such as atopic dermatitis,
drug eruption and Kimura’s disease with eosinophil infiltration.
Results and Conclusion: DDR1 was significantly expressed by eosinophils in
the lesional skin of CSS, but not atopic dermatitis, drug eruption or Kimura’s
disease. Our current results indicate that DDR1 expression by eosinophils in
the local inflammatory sites is specific for CSS and could be the disease
marker in allergic skin diseases with eosinophil infiltration.Mechanisms of
eosinophil survival and activation might be different between CSS and allergic
skin disease such as atopic dermatitis.
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Gene-gene interaction between IL-13 and IL-13 receptor !1
is associated with total IgE in Korean children with
atopic dermatitis
So-Yeon Lee1, Hyo-Bin Kim2, Byoung-Ju Kim3, Mi-Jin Kang4, Won-AChoi4,
JIn-Ho Yu3, Ja-Hyung Kim3, and Bong-Seong Kim3. 1Hangang Sacred
Heart Hospital, Pediatrics, Seoul, Republic of Korea; 2Inje university,
Pediatrics, Seoul, Republic of Korea; 3Asan Medical Center, Pediatrics,
Seoul, Republic of Korea; 4Asan Institute for Life Science, Pediatrics, Seoul,
Republic of Korea.
Background: Interlukin(IL)-13, which is essential for IgE synthesis, mediates
its effects by binding with a receptor composed of IL-4 receptor(R) ! and IL-
13R!1. We investigated the effects of IL-13 and IL-13R!1 polymorphisms in
Korean children with atopic dermatitis, and whether these have been
associated with IgE production.
Methods: We enrolled 567 children with atopic dermatitis and 172 nonatopic
healthy children. IL-13 and IL-13R!1 genotypes were identified using PCR-
RFLP method.
Results: There was an association between the protection of atopic dermatitis
and homozygosity for risk allele of IL-13R!1 A+1398G(adjusted odds ratio of
0.69[95% CI, 0.47Y1.00]), but the genotype of IL-13 G+2044A was not
associated with the development of atopic dermatitis. The hetero-or
homozygous for +2044A in IL-13 and +1398G in IL-13R!1 tended to higher
total serum IgE levels versus those homozygous for +2044G in IL-13 and +
1398A in IL-13R!1, but not to a significant degree. The gene-gene interaction
between risk alleles of IL-13 G+2044A and IL-13R!1 A+1398G polymorph-
ism was associated with higher total IgE in children with atopic
dermatitis(P = 0.038).
Conclusion: These findings indicate that the IL-13R!1 A+1398G may be
associated with the development of atopic dermatitis and IL-13 and IL-13R!1
polymorphisms may interact to enhance IgE production.
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Age-specific high serum IgE levels are associated with worse
symptomatology in children with atopic dermatitis
Kam-lun Ellis Hon, Man-ching Adrian Lam, and Ting-fan Leung. The
Chinese University of Hong Kong, Paediatrics, Hong Kong, Hong Kong.
Background: Atopic dermatitis (AD) is a distressing disease associated with
excoriations, pruritus, sleep disturbance and elevation of serum total IgE
levels.
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Objective: We evaluated if serum IgE levels correlate with the symptomatol-
ogy and plasma chemokine levels in children with AD.
Methods: AD patients younger than 18 years old were recruited from the
paediatric dermatology clinic of a university teaching hospital and AD severity
evaluated with the SCORing Atopic Dermatitis (SCORAD) index. Concen-
trations of serum total IgE, eosinophil count and plasma AD-associated
chemokines (cutaneous T cell attracting cytokine, CTACK; thymus and
activation regulated chemokine, TARC) were measured.
Results: One hundred and seventeen Chinese children with AD (64 boys and
53 girls), with mean (SD) age of 10.7 (4.4) years, were recruited. Their mean
(SD) overall SCORAD was 51.1 (22.8). % (defined as total serum IgE level
divided by age-specific upper limit) correlated well with the extent and
intensity of AD except for oozing/crusting which was significant only in the
males. There was significant correlation for% with pruritus or sleep loss only
in the females. 82 (70%) of patients reported history of allergic rhinitis and 35
(30%) reported history of asthma or hyperactive airway disease. In a subgroup
of patients who had never had allergic rhinitis, asthma or urticaria (n = 26),
log-transformed % correlated well with the objective SCORAD (Spearman’s
rho = 0.554, p = 0.003).Levels of IgE, CTACK, and TARC and eosinophil
count differed significantly among patients with mild, moderate and severe
disease. % correlated well with TARC (r = 0.50, p G 0.001) and eosinophil
count (r = 0.41, p G 0.001) but not CTACK (r = 0.11, p = 0.270). The
prediction of moderate-to-severe eczema by% gave an area under the receiver-
operating characteristic curve of 0.76 (95% CI 0.65Y0.86, p = 0.004). An
optimum positive predictive value of 94.2% was achieved with a cut-off point
of % of 2.95, sensitivity of 75.0% and specificity of 66.7%.
Conclusion: % correlates well with the objective clinical and serum TARC
level, and may serve as an overall marker for disease severity. Furthermore,%
of 2.95 predicts moderate-to-severe disease. Unlike the chemokines, Serum
IgE measurement is inexpensive and readily available in most clinical service.
IgE is not only a laboratory marker for atopy but also a parameter of disease
severity.
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Soy intake and reduced prevalence of skin allergic
deseases symptoms
Jorge Molinas1, Ledit Ardusso2, Cecilia Torrent1, Paula Daneri1, and Sara
Molinas1. 1Latinoamerican Center University, Physiopatology, Rosario,
Argentina; 2Centenary Hospital, Allergy Department, Rosario, Argentina.
Introduction: Soy is one of the few foods that contain important levels of
linoleic acid, an omega-3 polyunsaturated fatty acid (O3FA). It is known that
O3FA reduces the production of arachidonic acid derivates which are able to
reduce chronic inflammatory response.
Objective: To evaluate the association between dietary soy intake and the
presence of skin allergic symptoms in adults.
Materials and Methods: We conducted a cross-sectional study of 765
students from Centro Educativo Latinoamericano University in Rosario,
randomly chosen, 638 females (83.4%) and 127 males (16.6%), aged from 17
to 65 years old (x = 21.42 T 4.18). They answered questionnaires about
urticaria/angioedema, contact dermatitis, atopic dermatitis and about the
frequency of soyfood intake.
Results: Differences were found when the food intake was classified into
two groups: A (never or less than once a month) and B (once or more
than once a month, week or day). For soy-based mayonnaises and
margarines intake, 48.1% of the subjects were found in group B and the
prevalence of skin diseases within this group was significantly lower than
in group A; for example atopic dermatitis: B = 22.1% vs A = 28.7%
(OR = 0.71; IC:0.51Y0.99; pG0.05), contact dermatitis: B=14.3% vs
A = 22.8% (OR = 0.57; IC:0.38Y0.85; pG0.05) and food angioedema:
B = 12.0% vs A = 40.0% (OR = 0.20; IC:0.03Y1.01; pG0.05). For soy
hamburgers and soy breadcrumbs intake, 70.0% of the subjects were found
in group B and the prevalence of the different skin diseases within this
group was significantly lower than in group A; for example eczema symptoms:
B = 10.2% vs A = 15.7% (OR = 0.61; IC:0.38Y0.99; pG0.05), medical
diagnostic eczema: B = 15.0% vs A = 21.3% (OR = 0.65; IC:0.42Y0.99;
pG0.05), contact dermatitis: B = 16.6% vs A = 23.4% (OR = 0.64;
IC:0.43Y0.95; pG0.05) and food angioedema: B = 13.8% vs A = 66.6%
(OR = 0.08; IC:0.01Y0.74; pG0.05). Group B for soy oil ingestion was
only 19.5% and in this group the prevalence of angioedema symptoms
(1.3%) was lower than in the rest of groups (5.9%) (OR = 0.22; IC:0.04Y0.96;
pG0.05). The soyfood ingestion was significantly higher in male and men
presented significantly less prevalence of the symptoms studied. The statistical
significance remained the same after adjustment for sex and ingestion of
histamine-releasing food. No differences were found between soy intake and
urticaria symptoms.
Conclusion: The results obtained allow us to estimate that the intake of a soy
rich food, at least once a month, could protect against some skin disorders.
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Is house dust mite sensitivity a factor in chronic urticaria?
Mojgan Safari. Hamedan University of Medical Sciences, Pediatric Ward,
Hamedan, Islamic Republic of Iran.
Introduction: chronic urticaria is the most common cutaneous disorder seen
in outpatient allergy clinics. There are a few reports associating house dust
mite sensitivity with chronic urticaria. This study investigates the possible
association between house dust mite sensitivity and chronic urticaria.
Methods: In this study four groups of patients were enrolled. Group I: Chronic
urticaria (35 subjects). Group II: allergic rhinitis(135 subjects). Group III:
asthmatic patients (14 subjects).Group 4: allergic rhinitis +asthma(12
subjects). Group II, III and IV considered as positive controls. All of the
patients underwent skin prick testing with antigens of the house dust mite,
Dermatophagoides pteronyssinus (DP) and Dermatophagoides farinae (DF),
with positive and negative controls.
Results: In Group I, 13/35 (37.1%): In group II 64/135(47.4%); In group III 5/
14(35.7%) and in group IV 4/12(33.3%) patients had skin sensitivity to house
dust mites .There were no statistical differences between prevalence of positive
skin test to mite in four groups.
Conclusion: we suggest a possible association of house dust mite sensitivity
with chronic urticaria.
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Sensitisation and colonisation status of Malassezia in patients
with atopic dermatitis
Susanne Haug1, Antonie Roll1, Ju¨rg Meyer1, Martin Mempel2, and Peter
Schmid-Grendelmeier1. 1University Hospital Zurich, Allergy Unit, Depart-
ment of Dermatology, Zurich, Switzerland; 2Department of Dermatology,
University Hospital Munich, Munich, Germany.
Background: Malassezia represent a contributing factor in AE. Recently, the
genus Malassezia was classified into eleven species based on their
morphological, biochemical, and genetic characteristics. It is still unknown
how, where and why patients suffering from AE become sensitized to allergens
of this lopophilic yeast, it becomes evident that sensitization to Malassezia
particularly M. Sympodialis occurs almost exclusively in AE patients. The
success of antimycotic treatment in some patients with AD indicates that
Malassezia is involved in the pathogenesis of AD.
Methods: We collected skin scales from 52 patients with atopic eczema.
Specific IgE was measured against Malassezia using commercial kit (m70 and
m 223). Presence of the various Malassezia species were analysed by culture,
microscopically examination and a real-time PCR based method for testing
qualities and quantities of patient skin scales so as to detect directly and
confirm the identity of Malassezia species.
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Results: In 33 of 52 patients Malassezia PCR was positive. The presence
of Malassezia did not correlate with the level of specific IgE found against
this yeast. Also we did not detect a correlation between severity of AD
and levels of specific IgE. However response to systemic antifungals was
more prone in patients with high levels of specific IgE against Malassezia.
The presence of M. sympodialis, M. globosa and M. restricta was highly
variable.
Conclusion:We identified three different species of Malassezia colonizing the
skin and leading to IgE-mediated sensitization in atopic eczema. Further
analysis of quantitative fungal load will probably help to identify AE patients
that benefit from antifungal therapy.
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Frequency of selection MRSA-strains in composition of a
microbiocenosis of a skin the patient_s atopic dermatitis
Yuriy Turin, Dmitry Dolbin, Sergey Kulikov, and Olga Tupkina. Kazan
scientific research institute of epidemiology and microbiology, Rospotreb-
nadzor, Kazan, Russian Federation.
Background: to Define a share of allocation MRSA-strains and structure of a
microbiocenosis of a skin of patients an atopic dermatitis. To define properties
staphylococcus with skin of patients.
Methods: 63 patients an atopic dermatitis are examined at the age from
3 till 35 years. Degree of a gravity of the patients defined with use of
the international standard - index SCORAD (Scoring of Atopic
Dermatitis). Research of microbiocenosis of skin is carried out
bacteriological method. 155 strains staphylococcus with skin of patients
are investigated. Are checked up on stability to antibiotics by method of
disks on cups Petri. Activity catalases in lysates staphylococcus by a
colorimetric method on Sinha A. K. The statistical analysis of results is
executed by means of statistical programs Microsoft Excel 2000 and
?Statistica 6X StatSoft.
Results: As a part of a skin microbiocenosis in 84, 2% was Staphylococcus
aureus, in 15, 8% was coagulase negative staphylococcus. High frequency of
occurrence MRSA-strains (75%) in structure microbiocenosis skin of patients
is revealed. High frequency has been found out among MRSA, repeatedly
from steady pressure to antibiotics.
Conclusion: As a part of a microbiocenosis with skin of patients sick an atopic
dermatitis dominate MRSA-strains. Level of activity for pressure MRSA
correlates catalases with their ability to survive in an organism. More
poisonous MRSA also are more often allocated from patients with heavy
degree (SCORAD 87,6 T 1,4).
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Phenotypic features of coccal microflora of skin in the norm and
with atopic dermatitis
Sergey Kulikov, Yuriy Turin, Lira Bayazitova, Dmitriy Dolbin, Rustem
Fassakhov, and Elena Sukmanskaya. Kazan Scientific Research Institute
of Epidemiology and Microbiology, Rospotrebnadzor, Kazan, Russian
Federation.
Background: Phenotypic features of coccal microflora of skin and disease
severity are correlated in children with atopic dermatitis (AD).
Methods: Forty eight AD patients (age 0, 1Y16 years) were recruited. The
SCORing Atopic Dermatitis (SCOARD) we used for clinical score for
assessing AD symptomatology. The skin analyzed for Staphylococcus aureus
and coagulase-negative staphylococci detecting. Ig-protease, collagenase,
lysozyme and DNAase activities of staphylococcal isolates were studied.
Methicillin-resistant Staphylococcus aureus isolates were determined by disk
diffusion method.
Results: S.aureus colonization increased in skin with AD with increasing
SCORAD - 5,2 T 1,2 log10 CFU/sm2 (SCORAD = 35,5 T 5,5) and 5,7 T 0,8
log10 CFU/sm2 (SCORAD = 91,9 T 5,8). 41% staphylococcal isolates from
skin with moderate AD (SCORAD = 35,5 T 5,5) and 100% isolates from skin
with severe AD (SCORAD = 91,9 T 5,8) had DNAase activity. Also Ig-
protease, collagenase activities of staphylococcal isolates from skin with
atopic dermatitis were higher then from skin in the norm.
Conclusion: Virulence factors of staphylococcal isolates correlated with
SCOARD index and disease severity. And staphylococcal isolates from
skin with AD were essentially aggressive in comparison with isolates from
healthy skin
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The role of fecal microflora in children with allergic
eczema/dermatitis syndrome
Alla Nakonechna1, and Tatiana Umanetz2. 1National Medical University,
Clinical Immunology and Allergology, Kiev, Ukraine; 2Institute of Pediatry,
Obstetrics and Gynaecology, Pulmonology, Kiev, Ukraine.
Rationale: The role of intestinal microflora in children with allergic eczema
dermatitis syndrome (AEDS) is still disputable, although a beneficial influence
on AEDS course of certain intestinal bacteria, administered as probiotics has
been described in intervention studies. The purpose was to investigate the
relationship between gut microbiota and sensitization and cytokines produc-
tion in children with AEDS.
Materials and Methods: A case-control study with 57 children (4Y7 years)
having AEDS and 55 age-matched healthy control subjects was conducted. For
differential diagnosis we used Skin Prick Test (SPT) with common allergens,
total and specific IgE. IL-5, IL-10, +-IFN levels were assessed by ELISA. All
patients had investigation of gut microflora.
Results: In children with AEDS were found significantly low counts of
Bifidobacterium comparing to healthy control subjects (105Y106 vs 109Y1010
CFU/g) as well as Lactobacillus (105 vs 107Y108 CFU/g) (pG0.05). At the
same time atopic children presented high level of Escherichia coli,
Staphylococcus aureus, Clostridium dificile, Candida albicans in investigated
microflora profile. Furthermore AEDS children demonstrated positive SPT to
common allergen (especially food allergen); increased level of total and food
specific IgE (mostly - egg, milk, peanut, hazelnut). In this group were shown
increased production of IL-5 to 192,3 T 6,1 pkg/ml (N = 74,3 T 3,3 pkg/ml);
IL-10 to 153 T 9 pkg/ml (N = 5,8 T 0,25 pkg/ml) and decreased production of
+-IFN to 241 T 6 pkg/ml (N = 331 T 35 pkg/ml) (p G0,05).
Conclusion: This investigation demonstrated the relationship between
perturbation in intestinal microbiota and IgE sensitization in children with
AEDS. There is an augmentation of Th-2 type lymphocyte function reflected
by increased IL-5 and IL-10 production in AEDS children. Disorder of the
intestinal microflora might play a role in the onset of atopic eczema.
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Linear dermatitis reactions to paederus beetles (coleoptera:
staphylinidae) in Kazeron, Iran
Mohammad Reza Fakoorziba1, Fariba Eghbal2, and Mahmod Reza
Nikbakhtzadeh3. 1Shiraz University of Medical Sciences, Medical Entomol-
ogy, Shiraz, Islamic Republic of Iran; 2Ialamic Azad University of Kazeron,
Pediatric department, Shiraz, Islamic Republic of Iran; 3Tarbit Modarres
University, Medical Parasitology department, Tehran, Islamic Republic of
Iran.
Background: Dermal irritation resulting from contact with arthropods or
infested products is well documented and often occupational in nature with
entomologist, food handlers and others. Between them, linear dermatitis is a
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self-healing blistering disorder of the skin caused by a small insect belonging
to genus Paederus, family Staphylinidae, order Coleoptera. It appears on the
skin by hemolymph of Paederus beetles. This study was undertaken to identify
the dominant species of paederus beetles and to report the expose parts of the
body in the study area.
Methods: Peaderus beetles were collected by hand and UV black rays every
month for entomological studies. For medical studies questionnaires were
completed by physicians in health centers in the studied areas.
Results: By this investigation, it was revealed that Paederus ilsae Bernhauer
and paederus iliensis Coiffait are two species that were identified for the first
time in the studied area. This research has revealed the 27.02%, 23.42%,
18.01%, 17.11% and 14.41% cases of linear dermatitis occurred in face, neck,
eyes, hands and legs respectively in kazeron area. Furthermore, 42.6% of cases
also had secondary infections later.
Conclusion: Public awareness of how to avoid contact with the adult beetles is
considered to be the best way to reduce the cases of linear dermatitis.
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A new cause of facial eczema: the ferret
Barthelemy Splingard, Jean Pol Dumur, Jean-Luc Schmutz, Annick Barbaud,
and Nancy Barbaud. CHU Nancy, Dermatology, Nancy, France.
Observation: a 36 year old patient has had for one year a face eczema, mainly
on eyelids and lips. She had no history of allergy and no medication. She was a
beautician and suspected a professional sensitization but the eczema persisted
during her holidays. She had been exposed to numerous perfumed products in
her institute for six years. For many years, she had had horses and pets: dogs,
cats, and for two years a ferret.
Patch-tests of the standard, cosmetic product, methacrylate and
fragrance series, with the products brought by the patient (creams, perfumes,
household and professional products) were negative at 48 and 96 hours. Prick-
tests with aeroallergens, molds, latex and 28 foodstuffs were negative. Specific
IgE for ferret were undetectable with normal total IgE. The ferret was given to
one of her friend for two months and the eczema dramatically improved. When
she had a short new contact with the ferret the eczema relapsed.
Conclusion: a few cases of asthma or urticaria caused by ferrets have been
reported but there is no former case of eczema. The ferret belongs to the
fissiped family (mink, marten, ermine and polecat). Theorically a cross
reactivity between them could occur but no case has been yet reported. The
culprit allergens are not well known (albumin?).
Ferrets, like felides, lick themselves and the salivary proteins could be
the allergens (protein contact dermatitis?).
We emphasize that sensitization to ferret, that is a new pet, has to be
evoked in case of eczema or asthma, even when specific allergological tests are
negative.
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Allergic contact dermatitis due to Propolis
Alejandro Joral1, Jose Antonio Navarro1, Jose Francisco Garmendia1, Olga
Villarreal2, Ascensio´n Aranzabal3, and Susana Lizarza1. 1Hospital Donostia,
Allergy Section, San Sebastian, Spain; 2Hospital de Mendaro, Allergy Unit,
Mendaro, Spain; 3Hospital de Zuma´rraga, Allergy Unit, Zuma´rraga, Spain.
Propolis is a product made by bees from various vegetal sources,
mainly from the resin of the poplar; it is well known as an inducer of
occupational dermatitis in apicultors. Its use as a natural cosmetic is
widespread. given its antiinflammatory and antiseptic properties.
We present the case of a 24 years old woman without an atopic
background who presented an eczematous, itchy rash in the areas where she
had used a cosmetic that had Propolis among its ingredients.
Patch test were performed with True Test series, the cosmetic series and
Propolis. The tests were positive for Propolis (+++ at 48 and 96h), and were
negative for the other contact allergens, including Balsam of Peru.
The sensitizing capacity of Propolis is mainly attributed to the
methylbutenil cafetate and to phenylethil cafetate mainly. It has cross-
reactivity with the Balsam of Peru with which it shares at least 13 components.
We therefore present an allergic contact dermatitis to Propolis in a "natural"
cosmetic in a patient who is not an apicultor and who has no relationship with
this hobby.
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Adverse reactions to dark chocolate - a case report
Christina Oberhuber1, Sonja Gaier2, Eva Untersmayr-Elsenhuber2, and Karin
Hoffmann-Sommergruber2. 1Biomay, Vienna, Austria; 2Medical University of
Vienna, Department of Pathophysiology, Vienna, Austria.
Background: Atopic dermatitis (AD) is a chronic inflammatory skin disorder
characterized by pruritus, inflammation, lichenifications, and typically
distributed eczematous lesions. Environmental factors as well as allergens
from various sources may trigger skin inflammation. The exact cause of AD is
unknown, but immunological and psychological factors should be taken into
account. We report a case of a 28-year old female suffering from atopic
dermatitis with a history of recurrent episodes of pruritus, urticaria and facial
angioedema starting 6-12 hours after eating dark chocolate pralines. With the
elimination of milk chocolate and dark chocolate from the diet no more
episodes occurred. White chocolate is well tolerated and consumed frequently.
Methods: Skin prick tests to commercial extracts of common aeroallergens
and food allergens were performed. Furthermore prick to prick tests using
white chocolate, milk chocolate, dark chocolate (65% cocoa powder and 85%
cocoa powder), and cocoa powder were carried out. Specific IgE, IgG1 and
IgG4 levels to a large panel of purified food allergens from milk, egg, peanut,
hazelnut, soy, peach, apple, celery, and chocolate extracts were determined by
ELISA experiments.
Results: Skin prick tests with commercial extracts were negative. IgE and
IgG1 levels to various food allergens and chocolate extracts were not increased
compared to non atopic individuals, whereas IgG4 levels to all tested allergens
and chocolate extracts were significantly higher than in control sera. Prick to
prick tests with chocolate brands revealed erythema with increasing intensities
according to higher contents of cocoa powder. White chocolate (without cocoa
powder) did not elicit any skin reactions.
Conclusion: This case report illustrates the complexity of diagnosing adverse
reactions to foods. Ingestion of dark chocolate elicits angioedema and AD,
while white chocolate is tolerated. Even in the absence of allergen-specific
IgE, an allergen-specific Th2 reactivity (high IgG4 levels) can be observed.
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Case report-contact dermatitis to perfume
Nicoleta Cimpean, Cristina Barbinta, Adriana Bujor, and Diana Dumitrascu.
3rd Medcial Clinic Cluj-Napoca, Allergology, Cluj-Napoca, Romania.
Background: Dermatitis is an inflammation of the skin. Contact dermatitis is
a localized rash or irritation of the skin caused by contact with a foreign
substance. Substances that cause contact dermatitis in many people include
"poisonous" plants such as poison ivy, certain foods, some metals, cleaning
solutions, detergents, cosmetics, perfumes, industrial chemicals, and latex
rubber. Allergic contact dermatitis is a type IVa1 T-cell-mediated
hypersensitivity.
Case Report: A 26-year-old female with clinical signs of persistent allergic
rhinitis (sneezing, itching and rhinorrhea). She presented a severe eruption
with intense itching after using her new perfume. Clinical aspect of skin
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lesions were: erythema, papules and vesicles on the neck and chest with
augmentation of symptoms after solar exposure. The manifestations have
begun after 24 hours of exposure to the new perfume.
Results: Skin prick tests revealed an atopic patient with sensitization to
Alternaria. Skin patch tests with european standards to cosmetic fragrances
(fragrance mix, balsam of Peru), cosmetic preservatives (paraben mix,
quaternium) and other cosmetic ingredients (colophony, thiomerosol,
ethylenediamine, formaldehyde) and her own perfume revealed late sensitiza-
tion (72 hours) to her perfume and fragrance mix. We recomanded to avoid
contact with known allergens and treatment with H1 anihistamine and topical
steroids.
Conclusion: The patient with contact dermatitis may be very uncomfortable
and have poor quality of life. The best treatment is to identify and avoid the
substances that may have caused the allergic reaction.
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Influence of Psidium guajava tea for atopic dermatitis
Itsuo Suzuki, and Masaru KIsida. International University of Health and
Welfare, Pediatrics, Tokyo, Japan.
I previously reported the antihistaminic effect and anti-leukotriene
effect of Psidium guajava(PG) which was a native plant of North America.
Thus I made PG tea and perviewed an effect to atopic dermatitis.
Methods: Seventy-five patients with atopic dermatitis who were treating in
Sanno Hospital,were enrolled in this study. Ages of them 7 to 34 years old. PG
tea made 0.5g with hot water of 200ml and drank it three times per day. After
one week observation without any treatment, I used PG tea for fours weeks and
skin condition. And I measured eosinophil cationic protein (ECP) values and
histamine levels of blood.
Results: Forty-two (56%) improved itching of skin and Thirty (40%)
improved skin condition. ECP valued in serum were decreased from
82.4 T 42.4ng/ml to 21.8 T 23.4ng/ml. The Histamine levels in serum
decreased from 211.0 T 50.4ng/ml to 98.6 T 52.4ng/ml.
Conclusion: I investigated the effects of PG tea for atopic dermatitis. This
study showed it was able to improve the clinical features of this disease
significantly. Furthermore,the ECP values and histamine levels in serum
which are indexes of allergic inflammation were decreased. I concluded
from these results that Pg tea is an Effects method for the treatment of
atopic dermatitis.
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The role of contact sensitization in contact dermatitis patients
among the seaweed farmers in Bantaeng, South
Sulawesi, Indonesia
Fanny Iskandar, Muh Dali Amiruddin, Dewi Melati, and Faridha S Ilyas.
Medical Faculty Hasanuddin University Makassar Indonesia, Dermato-
Venereology, Makassar, Indonesia.
Background: Many materials such as cosmetic products in daily use,
cookware and jewellery can cause contact dermatitis. Contact dermatitis which
are suffered by the seewed farmers are probably cause by many materials that
are used in daily activity.
Aim: To evaluate level of CD4 and CD3 that correlated with patch test results
on seaweed farmers.
Methods and Results: Cross sectional study was conducted in 41 contact
dermatitis on seaweed farmers with CD4 and CD3 levels, also was conducted
patch test with TROLAB patch test series. The most patients are between 19 Y
28 years old (39%) consist of 10 males (24.4%) and 31 females (75.6%). The
increasing of CD4 levels are found on 27 patients (65.9%). The high levels
of CD4 and CD3 seem not to be related significantly with the result of patch
test (p 9 0.05).
Conclusion: The occured contact dermatitis might be caused by other material
in seaweed processing or other component from the sea. Larger amount of
sample is needed to get significant results and other further investigations
might be contributing in the seaweed industries.
Keywords: Contact dermatitis, patch test, CD4, CD3, TROLAB
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Using of probiotics in treatment of children with
atopic dermatitis
Maia Kherkheulidze, Nani Kavlashvili, Eka Kandelaki, and Nino Adamia.
State Medical University, Pediatrics, Tbilisi, Georgia.
Atopic dermatitis remains one of the serious problems of pediatrics
as prevalence of disease among children is quite high (10Y20 % according
data of different countries) and have increasing tendency. The aim of the
study was to assess the effects of probiotics on clinical course of atopic
dermatitis in children. We studied 38 patients aged 1Y6 year, who admitted
at M. Guramishvili Pediatric clinic (2006Y2007). All patients fulfilled the
criteria (at least 3 major and 3 minor) for diagnosis of atopic dermatitis
(Hannifin and Rajka). The children were divided into 2 groups. The first
group (20 children) for 8 weeks received probiotic (Lactobacterine
containing Lactobacillus acidophilus and BifidumBacterine containing
Bifidumbacterin,) and emollient ointment the second group (18 children)
only emollient ointment. The SCORAD index was used to evaluate
severity and extent of AD at the end of the study of disease. Objective
signs - spread of lesions, intensity (erythema, edema, oozing, excoriation,
lichenification, and xerosis) and subjective signs (pruritus and sleeping
disorders) were assessed. The mean SCORAD index before treatment was
45, 9.
After the 4 week as well as 8 week treatment was founded
improvement of clinical (SCORAD index decreases) in both groups. At the
same time the reduction in the SCORAD index was significant in the probiotic
group. After the 8 week of study 65% of children had a better SCORAD index
then baseline, comparing to the second group improvement was in 43%. So,
we can conclude that supplementation with probiotics is beneficial in
improvement severity of AD in children.
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Influence of peeling procedure in allergic contact dermatiitis
Jun Young Lee, and Jung Eun Kim. St. Mary’s Hospital, The Catholic
University of Korea, Dermatology, Seoul, Republic of Korea.
Background: The prevalence of allergic contact dermatitis (ACD) in patients
previously undergone peeling has been rarely studied.
Objectives: We compared the frequency of positive patch test (PT) reactions
in a patient group with a history of peeling, to that of a control group with no
history of peeling.
Patients and Methods: The Korean standard series and cosmetic series, was
performed on a total of 262 patients. Sixty-two patients had previously
undergone peeling, and 200 patients did not.
Results: The frequency of positive PT reactions on Korean standard series was
significantly higher in the peeling group compared to that of the control group
(p G0.05, Chi-square test). However, the most commonly identified allergens
were mostly cosmetic-unrelated allergens. The frequency of positive PT
reactions on cosmetic series in the peeling group was higher than that of the
control group, but lacked statistical significance. There was no relationship
between the frequency of peels and the frequency (%) of positive PT reactions
or the total number of positive PT results.
Abstracts World Allergy Organization Journal & November 2007
S56 * 2007 World Allergy Organization
Copyright @ 2007 World Allergy Organization. Unauthorized reproduction of this article is prohibited.
Conclusion: It appears peeling may not generally affect the development of
contact sensitization. Further work is required focusing on the large scale
prospective studies by performing a PT before and after peeling.
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The therapeutic efficacy & safety profile of allergenic
extracts(EA) in in treating patients with labial lichen planus
M. Ishaq, I. Khan Sameera, and Munir Imran Khan. Al-Junaid Hopsital,
Allergy/Pulmonology, Nowshera, Pakistan.
Introduction: Lichen planus an uncommon skin complaint, thought to be due
to an abnormal immune reaction provoked by a viral infection (such as
hepatitis C),or a drug. Inflammatory cells seem to mistake the skin cells as
foreign and attack them. In 80Y85% of cases it clears from skin surfaces within
18 months but when affecting the mouth may persist longer.
Methods: The classical lichen planus is characterized by shiny, flat-topped,
firm papules varying from pin point size e.g.guttate to larger than a
centimeter. The lesion had shinny flat-topped, firm papules varying from
pinpoint to much larger sized lesions. In the study concerned 2 individuals
were included. Both had been medicated with different empirical therapies.
There was a remitting/ relapsing course patients were treated with a
combination regimen of anti histaminic & gradual lowered dilutions of dust
mite therapeutic extracts over a period of 4 months. The remission of the
lesions were evident in the form of a reduction in the intensity of itchiness,
ooze & redness. The final outcome was evident in the form of scar
formation.
Results: In the ongoing trials the therapeutic response was dramatic in female
than in the male patients.
Conclusion: Lichen planus a chronic intractable condition with multiple
causes some times with a diagnostic dilemma. A detailed drugs/dietary
history supplemented by immunological assessment provides diagnostic
clue. *1Pre- treatment *2Skin prick test profile *3Post treatment
presentation.
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Tacrolimus ointment is effective and well tolerated for the
treatment of atopic dermatitis in asian countries
Nopadon Noppakun1, Kanokvalai Kulthanan2, Xue-jun Zhu3, Ling-ling Liu3,
Kwang Hoon Lee4, Cheng-Che Lan5, Suraiya Hani Hussein6, Donna L.
Sarrosa7, Titi Lestari Sugito8, Yong-Kwang Tay9, and Yoshiko Ueda10. 1King
Chulalongkorn Memorial Hospital, Chulalongkorn University, Dermatology,
Bangkok, Thailand; 2Siriraj Hospital, Mahidol University, Dermatology,
Bangkok, Thailand; 3First Hospital, Peking University, Dermatology, Beijing,
China; 4Yonsei University Hospital, Dermatology, Soul, Republic of Korea;
5Kaohsiung Medical University Hospital, Dermatology, Taiwan, Taiwan;
6Hospital Kuala Lumpur, Dermatology, Kuala Lumpur, Malaysia; 7Makati
Medical Center, Dermatology, Manila, Philippines; 8Cipto Mangunkusumo
Hospital, Dermatology, Jakarta, Indonesia; 9Changi General Hospital,
Dermatology, Singapore, Singapore; 10Astellas Pharma Inc., Department of
Asia International, Tokyo, Japan.
Background: Tacrolimus ointment is used for the treatment of atopic
dermatitis (AD) in adult and pediatric patients worldwide. However, no
studies have been reported on the efficacy and safety in a large population
of Asian patients with AD. The aim of this overview is to survey the
assessments of the efficacy and safety conducted in the patients across 8
Asian areas, China, Indonesia, Korea, Malaysia, Philippines, Singapore,
Taiwan and Thailand.
Methods:We analyzed the combined data of patients with AD from studies
conducted in the Asian areas. Adult and pediatric patients with moderate to
severe AD were enrolled. Adult patients applied 0.1% or 0.03% tacrolimus
ointment and pediatric patients applied 0.03% twice daily for 3 to 4 weeks.
The primary efficacy end point was Physician’s Global Evaluation of
Clinical Response (PGE). Other evaluations included Eczema Area Severity
Index (EASI), Percent Body Surface Area affected (%BSA), Patient’s
Assessment of Itch and Patient’s Assessment of Overall Response, and each
category of Dermatology Life Quality Index (DLQI) and children’s DLQI
(CDLQI).
Results: More than 800 patients were included in these Asian studies.
Success based on PGE was observed in 83.6% of all patients. The
improvement in Patient’s Assessment of Overall Response was similar to
PGE. Percent BSA affected, EASI and Patient’s Assessment of Itch
improved at weeks 1, 2, and at the end of treatment. The decrease of
Patient’s Assessment of Itch was greatest compared with decrease of %BSA
affected and EASI. All DLQI subscales (Symptoms and feelings, Daily
activities, Leisure, Work and school, Personal relationships, and Treatment)
improved, and also the subscales of CDLQI (Symptoms and feelings,
Leisure, School or holidays, Personal relationships, Sleep and Treatment)
improved at the end of treatment. In particular, Symptoms and feelings
showed a marked decrease in both age groups. In subscales of CDLQI,
Sleep also had marked improvement. Improvement in the PGE was
associated with the decrease in %BSA, EASI and Patient’s Assessment of
Itch, and also with DLQI/CDLQI. Adverse events frequently reported were
skin burning and pruritus at the application site. The incidence of skin
burning was lower in pediatric patients than that in adults. No serious
adverse events were reported from the studies.
Conclusion: Tacrolimus ointment is effective and well tolerated in the
treatment of patients with AD in Asian countries.
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Downmodulatory effect of epinastine on Th2 chemokine
production by epidermal Langerhans cells
Kazunari Sugita, Miwa Kobayashi, Tomoko Mori, Kenji Kabashima, and
Yoshiki Tokura. University of Occupational and Environmental Health,
Department of Dermatology, Kitakyushu, Japan.
Background: Epinastine belongs to the second generation of antihistamines
and also possesses anti-inflammatory or anti-allergic properties in cutaneous
as well as systemic allergy, including mast cell stabilization, suppression of co-
stimulatory molecule expression, inhibition of eosinophils chemotaxis and
granulocytes accumulation, and suppression of cytokine and chemokine
production. In Japan, systemic preparation of epinastine has been approved for
not only atopic dermatitis but also pruritic psoriasis vulgaris. Skin is a well-
orchestrated immune organ where epidermal Langerhans cells (LCs) function
as antigen-presenting cells and keratinocytes serve as producers of various
cytokines and chemokines. We have previously reported that epinastine
suppresses the production of Th1 chemokines and RANTES/CCL5 by
keratinocytes. Since keratinocytes and LCs are the main epidermal sources of
Th1 and Th2 chemokines, respectively, the effect of epinastine on the Th2
chemokine production by LCs is an issue to be clarified.
Methods: We prepared epidermal cell suspensions from BALB/c mice and
enriched them for LCs. The LC-enriched epidermal cells were cultured with
epinastine for 48 h, and the expression levels of Th2 chemokines, TARC/
CCL17 and MDC/CCL22, were assessed by real-time PCR analysis.
Results: The expression of CCL17 was depressed by epnastine as low as 10-6
M, and CCL22 expression was also inhibited by epinastine 10-7 M or more in
a dose-dependent manner.
Conclusion: Our study suggests that epinastine exerts not only an anti-
histaminic action but also a downmodulatory effect on Th2 cell migration
toward the epidermis by inhibiting LC production of Th2 chemokines. Taken
together with the previous finding that epinastine downregulates Th1
chemokine production by keratinocytes, we conclude that this antihistamic
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drug has an inhibitory potential for migration of both Th1 and Th2 cells in
the skin.
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Study of efficacy of epinastine hydrochloride in patients with
pruritic dermatosis and chronic urticaria and its effects on QOL
of the patients
Akiko Miyata, Mika Yamamoto, Yoshiaki Hayashi, Mariko Nanbu, Noboru
Nakagawa, Tatsuya Tsuda, Shoichiro Minami, and Kiyofumi Yamanishi.
Hyogo College of Medicine, Dermatology, Nishinomiya, Japan.
Epinastine hydrochloride (Alesion\, Nippon Boehringer Ingelheim
Co., Ltd.) 20 mg once daily was administered to patients aged 15 years and
older with pruritic dermatosis or chronic urticaria for 4 weeks, and its efficacy
and effects on the patients’ QOL were assessed. This study enrolled 57 patients
in total, 35 patients with eczema/dermatitis, 6 patients with cutaneous pruritus,
7 patients with urticaria, and 9 patients with other pruritic dermatosis, and their
mean age was 56. The endpoints were the severity of pruritus, the severity of
skin eruption, visual analog scale (VAS) for pruritus, and QOL of the patients
(symptoms, emotional status, daily living, and leisure, work/school, and
treatment). Concerning general improvement, remarkable and moderate
improvement was achieved in 43% and 33% of all patients, respectively.
The severity of pruritus indicated on VAS was significantly decreased, and
QOL of the patients was also improved. As a possible adverse drug reaction,
an increase in AST was observed in 1 patient. These results show that oral
epinastine hydrochloride once daily appears to be safe and beneficial for
symptoms and QOL of patients with pruritic dermatosis or chronic urticaria.
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A randomised, double-blind, placebo-controlled study of the
efficacy and tolerability of a Chinese herbal medicine concoction
for atopic dermatitis
Kam-lun Ellis Hon1, Ting-fan Leung1, Pak-cheung Ng1, Kwing-chin Kenneth
Lee2, and Ping-chung Leung3. 1The Chinese University of Hong Kong,
Paediatrics, NT, Hong Kong; 2The Chinese University of Hong Kong, School
of Pharmacy, NT, Hong Kong; 3The Chinese University of Hong Kong,
Institute of Chinese Medicine, NT, Hong Kong.
Background: There has been considerable interest in traditional Chinese
herbal medicine (TCHM) as a treatment for atopic dermatitis (AD). A twice-
daily concoction of an ancestral formula containing five herbs has been found
to be beneficial in an open study. The five herbs include Flos lonicerae
(Jinyinhua), Herba menthae (Bohe), Cortex moutan (Danpi), Rhizoma
atractylodis (Cangzhu) and Cortex phellodendri (Huangbai). We demonstrated
that there was no corticosteroid (CS) or CS related compound in this
formulation.
Objective: To assess the efficacy and tolerability of the concoction in children
with AD.
Methods: Following a 2-week run-in period, children with longstanding
moderate-to-severe AD were randomised to receive a 12-week treatment with
twice daily dosing of three capsules of either TCHM or placebo. The SCORing
Atopic Dermatitis (SCORAD) score; Children Dermatology Life Quality
Index (CDLQI), allergic rhinitis score, requirement for topical corticosteroid
and oral antihistamine were assessed before, and at week 4, 8, 12 and 16 after
treatment. Adverse events, tolerability, haematological and biochemical
parameters were monitored during the study.
Results: Eighty-five children with AD were recruited. Over 12 weeks, the
mean SCORAD fell from 58.3 to 49.7 in the TCHM group (n = 42; p = 0.003),
and 56.9 to 46.9 in the placebo group (n = 43; p = 0.001). However, there was
no significant difference in the scores at the corresponding time points between
the two groups. The CDLQI in TCHM treated patients were significantly
improved compared with patients receiving placebo at end of the 3-month
treatment and 4 weeks after stopping therapy (p = 0.008 and 0.059,
respectively). The total amount of topical corticosteroid used was also
significantly reduced by one-third in the TCHM group (p=0.024). No serious
adverse effects were observed between the groups. Analysis of biochemical
data also revealed no significant change in the IgE levels, haematological
(complete blood counts, eosinophil counts) and biochemical (electrolytes,
renal and liver functions) parameters monitored. No patient complained that
the capsule was unpalatable.
Conclusion: The TCHM concoction is efficacious in improving quality of life
and reducing topical corticosteroid usage in children with moderate-to-severe
AD. The formulation was palatable, well tolerated and can probably be used as
an adjunct treatment for children with refractory AD.
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Histamine (H1R) blocker inhibits histamine-induced collagen
synthesis in dermal fibroblasts
Shun Kitaba, Hiroyuki Murota, and Ichiro Katayama. Course of Integrated
Medicine Graduate School of Medicine, Osaka University, Dermatology,
Osaka, Japan.
Background: Mast cell-derived histamine is known to act on dermal
fibroblasts and contribute to formation of an intractable chronic allergic
dermatitis. Although this fibrotic event may also occur in other organs such as
nasal mucosa, no direct evidence has been reported as to whether
responsiveness to histamine by fibroblasts derived from different organs is
of the same intensity. Furthermore, while histamine (H1R) blocker has been
proved to be effective for alleviation of the symptoms of allergic diseases, its
ability to affect histamine-induced tissue remodeling has not yet been clarified.
Objective: Our aim was to study the effect of H1R-blockers on histamine-
induced tissue remodeling.
Methods: A macro array assay was used for a comprehensive analysis of
histamine-induced gene expression by normal human fibroblasts. Fibroblasts
derived from skin or nasal mucosa were cultured in the presence of various
concentrations of histamine, and the synthesis of type 1 collagen was
measured by means of semi-quantitative RT-PCR and ELISA assay. To
determine the effect of the H1R blocker, diphenhydramine hydrochloride and
emedastine difumarate were investigated in this assay.
Results: Histamine induced various kinds of fibrogenic molecules from
fibroblasts. Increased type 1 collagen expression was observed in fibroblasts
treated with high-dose (j4 toj6 logM) and low-dose (j12logM) histamine.
This histamine-induced type 1 collagen synthesis was effectively diminished
by emedastine difumarate.
Conclusion: We found that the expression of these fibroblast-derived genes
are regulated differently by different concentrations of histamine, and that the
robustness of the inhibitory action of H1R blockers is different for skin-
derived and nasal mucosa-derived fibroblasts. We believe that our findings
may contribute to a better understanding of the mechanisms of histamine-
induced tissue remodeling, and provide information useful for the manage-
ment of refractory allergic dermatitis.
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Attenuating effect of fexofenadine hydrochloride on the
development of cutaneous inflammatory responses through the
inhibition of substance P production in mice
Kazuhito Asano1, Ken-Ichi Kanai2, Atsuko Furuta2, and Harumi Suzaki2.
1Showa University, School of NRS, Division of Physiology, Yokohama, Japan;
2Showa University, School of Medicine, Department of Otolaryngology, 1-5-8
Hatanodai, Shinagawa-Ku, Tokyo, Japan.
Background and Purpose: Fexofenadine hydrochloride (FEX), a second-
generation antihistamine, is used for the treatment of both allergic diseases and
inflammatory skin reactions and successful results are reported. The primarily
therapeutic mode of action of FEX is generally believed to be owing to its
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suppressive effect on effector cell activation, which responsible for the
development of allergic inflammation. Recently, neuropeptide such substance
P (SP) attracts attention as the essential factors that trigger, exacerbate or
modulate allergic skin reactions. However, the influence of FEX on
neuropeptide-induced inflammatory skin reaction is not fully understood.
Methods: NC/Nga mice (8-weeks of age, female) were received repeated local
application of 2,4,6-Trinitrochlorbenzene (TNCB) to provoke chronic
cutaneous inflammation. FEX at a single dose of 1.0 mg/kg was orally
administered into mice once a day for 2 weeks from either 1 day before or 1
week after the application of TNCB. The number of scratching for 5 min was
counted 30 min after the final FEX administration. After counting the number
of scratching, the SP content in skin tissues and serum IgE levels were
examined by ELISA.
Results: Repeated local application of TNCB induced itching skin lesions,
together with an increase in the levels of SP and IgE. Treatment of mice with
FEX caused significant decrease in the levels of SP, but not IgE. Scratching
behavior was also decreased significantly by the treatment of mice with FEX:
the number of scratching in non-treated mice was 80 T 13 and that in FEX-
treated mice was 48 T 9.
Conclusion: These results may suggest that FEX inhibits the scratching
behavior observed in chronic cutaneous inflammation through suppression of
SP production in the skin lesions.
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The efficacy and safety of levocetirizine 5mg vs. cetirizine
10mg in patients with dermatitis or eczema with pruritus:
A multi-center, double-blind, double-dummy, radomized,
active-controlled study
Kwang-Hoon Lee1, Chun-Wook Park2, Hae-Young Choi3, You-Chan Kim4,
Hui-Joon Yu5, and Jin-Wou Kim6. 1Severance Hospital, Yonsei University
College of Medicine, Dermatology, Seoul, Republic of Korea; 2Kangnam
Sacred Heart Hospital, Hallym University, Dermatology, Seoul, Republic of
Korea; 3Mokdong Hospital, Ehwa Womans University College of Medicine,
Dermatology, Seoul, Republic of Korea; 4Ajou University Hospital, Ajou
University School of Medicine, Dermatology, Suwon, Republic of Korea;
5Goori Hospital, Hanyang University, School of Medicine, Dermatology,
Goori, Republic of Korea; 6Uijeongbu St. Mary’s Hospital, The Catholic
University, Dermatology, Uijeongbu, Republic of Korea.
Background: Levocetirizine is a lately developed selective H1 antagonist.
The purpose of this study is to assess the efficacy and safety of levocetirizine 5
mg comparing to cetirizine 10 mg in patients suffering from dermatitis or
eczema with pruritus (moderate-severe).
Method: This study was conducted in randomized, 6 centers, parallel, double-
blind, and double-dummy. After screening for 3 to 7 days, subjects were
randomly assigned to either levocetirizine or cetirizine treatment group and
each were administered for 2 weeks with 1% topical hydrocortisone. Patients
visited at screening (visit 1), randomization (visit 2), 7 days after
randomization (visit 3) and 14 days (visit 4). The pruritus severity score was
assessed by patients using the 4-point score scale (0; none, 1; mild, 2;
moderate, 3; severe) and responders were defined as patients who reported a
post treatment score rating of "None" or "Mild" at the visit 4 or at the study
completion visit.
Results: 506 patients were screened and 466 patients of these were
randomized. 423 patients completed the study and 340 patients were adequate
for efficacy evaluation. The proportion of responders was 77.98% (131/168) in
the levocetirizine treated group and 77.91% (134/172) in the cetirizine treated
group. Three patients (1.44%) in the levocetirizine treated group and six
patients (2.80%) in the cetirizine treated group had drug related adverse
events. Unexpected adverse drug reaction was not reported in both groups.
Conclusion: Levocetirizine was non-inferior to cetirizine for the improve-
ment of pruritus in patients with dermatitis or eczema with pruritus.
Levocetirizine is safe and efficient treatment in patients with dermatitis or
eczema with pruritus.
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Immunotherapy of atopic dermatitis patients with recurrent
pyoderma
Elena Fedenko and Olga Elisyutina. The Institute of Immunology, Allergic
and Immune Skin Diseases Department, Moscow, Russian Federation.
Background: The aim of study was to investigate the sensitization to house
dust mite (HDM) and S. aureus in atopic dermatitis patients with recurrent
pyoderma (AD RP patients) and investigate the efﬁcacy and safety of speciﬁc
immunotherapy with staphylococcal and HDM allergovaccines in these
patients.
Materials and Methods: The group of patients consisted of 156 AD RP
patients. Intradermal tests with Staphylococcal allergen and prick tests with
Der. pteronissinus and Der. farinae allergens were carried out in all AD RP
patients. Skin testing was carried out in all AD RP patients in remission period.
Speciﬁc IgE levels to Staphylococcal enterotoxin B as well as to Der.
pteronissinus and Der. farinae in sera of AD RP patients were measured with
UniCap 100 system, Phadia. 28 AD RP patients with positive skin tests and
positive speciﬁc IgE to HDM and staphylococcal enterotoxin B received
speciﬁc immunotherapy (SIT) with staphylococcal and HDM allergovaccines.
Subcutaneous injections of allergen and vaccine were made daily, in
increasing doses. The duration of the main course of speciﬁc immunotherapy
was 10Y14 days and then one maintenance dosage every 2 weeks; further
observation period lasted 12 months.
Results: We observed sensitization to HDM in 83,9% AD RP patients, to S.
aureus in 66,6% patients, both to HDM and S. aureus in 63,5% patients. There
was positive effect of SITwith HDM and staphylococcal vaccine. After 1,6,12
months of the further observation period index SCORAD decreased in 26,1%,
58,3%, 44,8% accordingly. There were no exacerbations of RP in 42,8% of
patients. The topical corticosteroids and antibiotics decreased signiﬁcantly.
Index of respiratory symptoms decreased signiﬁcantly too. While treatment
mild local reactions, such as redness, edema, and ﬂare were observed in 47,6%
patients during Exacerbations of AD Y in 9,5% and RP Y in 4,8% patients were
observed. Inspite of adverse events none of the patients were excluded from
the study. The levels of speciﬁc IgG4 in sera against HDM and S.aureus
increased signiﬁcantly. The levels of speciﬁc IgE in sera to HDM and S.aureus
did not change.
Conclusion: According to our data HDM and S. aureus are the most common
offending allergens in AD RP patients. Thus SIT application in these patients
is needed. SIT in AD RP patients with HDM and staphylococcal vaccine was
effective and safe.
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Topical application of epigallocatechin-3-gallate improves
prolonged atopic dermatitis by suppressing macrophage
migration inhibitory factor
Sun Up Noh, Jung Min Bae, Hyung Ok Kim, and Young Min Park. Kangnam
St. Mary’s Hospital, College of Medicine, The Catholic University of Korea,
Department of Dermatology, Seoul, Republic of Korea.
Background: There are some growing evidences that epigallocatechin-3-
gallate (EGCG) exerts anti-inﬂammatory effects on the chronic inﬂammatory
skin conditions such as atopic dermatitis (AD). Macrophage migration
inhibitory factor (MIF) has been recently suggested to be one of the most
crucial immunoregulatory cytokines of Th1/Th2 imbalance in AD. In this
study we assessed the anti-inﬂammatory effect of EGCG by its topical
application to the AD skin lesions in NC/Nga mouse model, and then we
determined whether this effect of EGCG is mediated by immunoregulatory
cytokines including MIF.
Methods: Induction of AD skin lesions was made by painting Dermatopha-
goides pteronissinus extract (DPE) onto the surface of each ear of NC/Ngamice.
One group was then treated with EGCG solution, another group with vehicle,
and the other group sham-treated for 4 weeks. To compare the clinical signs of
the 3 groups, we measured ear thickness every week. At the last day, all the ears
were excised and prepared for the following procedures; 1) hematoxyline and
eosin stain, 2) immunohistochemistry forMIF, TNF-! and IFN-+ 3) quantitative
reverse transcription polymerase chain reaction for MIF, TNF-!, IFN-+ , IL-2,
IL-4 and IL-12. Blood sampling was also performed for enzyme-linked
immunosorbent assay for MIF and total IgE in serum.
Results: As compared to vehicle treatment, topical application of EGCG
signiﬁcantly reduced the ear thickness (pG0.05). Likewise, the histological
grading of chronic inﬂammation including epidermal hyperplasia and
mononuclear cell inﬁltration into the dermis was also signiﬁcantly decreased
on the skin lesions of EGCG group. On the immunohistochemical staining, in
comparison with vehicle treatment, EGCG treatment signiﬁcantly diminished
the expression of TNF-!, IFN-+ as well as MIF on the lesions (p G 0.05).
Similarly, the mRNA expression of MIF, TNF-!, IFN-+ , IL-2 and IL-12, but
not IL-4 of the lesions was signiﬁcantly down-regulated by EGCG treatment
(p G 0.05). SerumMIF and total IgE production was also signiﬁcantly reduced
with the EGCG. treatment (p G 0.05).
Conclusion: These results demonstrated that topical application of EGCG
could reduce the chronic inﬂammation of AD lesions by suppressing a series
of immunoregulatory cytokines including MIF. Taken together, it is suggested
that topical application of EGCG can be a potential therapeutic modality in
AD.
190
Anti-IgE treatment in a patient with hyper-IgE syndrome and
hepatitis c virus Infection
S. Sa´nchez-Ramo´n, A. Paravisini, R. Aviles, M. Aldeguer, and E. Fernandez-
Cruz. Hospital General Universitario Gregorio Maran˜on, Immunology,
Madrid, Spain.
Background: Hyper-IgE syndrome (HIES) is a primary immunodeﬁciency
characterized by recurrent infections, dermatitis and elevated serum IgE. The
underlying cause of HIES is unknown and the management of the patient is
difﬁcult, the general goals are to control pruritus, eczema, and to prevent
infections. We report a patient with typical features of HIES and hepatitis C
virus (HCV) infection, in whom anti-IgE monoclonal therapy for allergic
manifestations could be an effective therapeutic alternative.
Methods: A 29-year-old woman of non-consanguineous parentage presented
with moderate asthma and severe atopic dermatitis since early infancy. She
had a history of recurrent respiratory infections, delay of shedding of primary
teeth and slight facial dysmorphia. She had persistently elevated serum IgE
levels (3000 kU/L). She suffered relapses of multiple discrete and conﬂuent
erythematous scaly papules and plaques with follicular prominence over face,
trunk and limbs, with licheniﬁcation and warm hypersensitive skin, which
limited her activities of daily living. In 1999, she was diagnosed of HCV
infection. Later on, she developed unusual autoimmune associations:
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haemolitic anaemia, alopecia universalis and autoinmune hypothyroidism.
The rash had been treated with antihistamine drugs and topical steroids, with
poor response. Given the high levels of serum IgE, she was given Omalizumab
therapy in high dose (450 mg sc) and every 15 days schedule, monitoring IgE,
IgG4 levels, hemogram and biochemical analyses.
Results: The patient improved her current symptoms of asthma since the
ﬁrst dose of Omalizumab and two months after the eczema severity
decreased to a mild form. The patient cleared almost all her skin lesions
although light licheniﬁcation areas persisted in ﬂexures, improved xerosis,
lowered itching and suffered no relapses. Serum IgE level persisted elevated
and there were no change in the biochemical analyses. She did not present
any side effects.
Conclusion: Therapy with anti-IgE monoclonal antibodies was found to be
well-tolerated and effective. Although, current knowledge and therapeutic
options in HIES are limited and with variable success, anti-IgE monoclonal
therapy for allergic manifestations seems to be an effective and safe
therapeutical alternative, even more as a steroid sparing agent considering
her HCV infection.
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Efficacy of Omalizumab in the treatment of 3 patients with
severe refractory atopic dermatitis
A. Paravisini1, S. Sa´nchez-Ramo´n1, R. Suarez2, J. Gil1, and E. Fernandez-
Cruz1. 1Hospital General Universitario Gregorio Maran˜on, Immunology,
Madrid, Spain; 2Hospital General Universitario Gregorio Maran˜on,
Dermatology, Madrid, Spain.
Background: Atopic dermatitis is a chronic cutaneous inﬂammatory disease
mediated by type 1 hypersensitivity reaction. High IgE serum levels are
commonly found and correlated with the severity of AD. Treatment of
moderate-severe cases included phototherapy, cyclosporine, azathioprine,
mycophenolate mofetil and intravenous immunoglobulin with variable results.
Omalizumab, humanized monoclonal antibodies bind to free serum IgE and
decrease the levels of its high afﬁnity receptor. It has been successfully used in
allergy asthma, rhinitis,allergic reactions to certain foods and drugs,latex and
insect bites. The experience in the treatment of AD is limited and
controversial. We report the preliminary results on 3 AD patients who
received anti-IgE treatment.
Methods: 3 adult patients(aged 29Y44) with severe refractory AD and high
IgE levels9700kU/L(5.720Y12.310kU/L), were treated with omalizumab
(Xolair, 450mg/kg subcutaneously every 2 weeks), 2 patients during 6
months and one patient is now on the third month of treatment. All patients
had allergic rhinitis, one of them has current symptoms of asthma and other
one has history of asthma. They were previously treated with topical and
systemic steroids, topical calcineurin inhibitors and cyclosporine, with partial
control of the symptoms. All patients were informed this was an ofﬂabel use
and the side effects proﬁle.
Results: All the patients experienced any improvement during the treatment.
After two months the eczema severity decreased in all of them, from severe to
moderate-mild forms. Two patients stopped all medications either antihista-
minic drugs and only one of them continues taking cyclosporine. One patient
obtained partial response, with clearing of lesions, lower itching and was able
to restart sport; other patient suffered autolimited relapses and did not require
other therapies, and ﬁnally reach complete clearance at 6-months; the last one
improves her skin lesions and asthma symptoms at 2-months. This later patient
diminished the dose of cyclosporine (200 to 50 mg/day). All the biochemical
analyses remained normal. None of them suffered adverse reactions.
Conclusion: Omalizumab did not systematically diminished serum IgE levels,
but achieve signiﬁcantly clinical improvement even on monotherapy at 6
months. On the other hand, Omalizumab showed a safe proﬁle and might be a
promising treatment in those patients in whom systemic therapy has not been
successful.
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Treatment of infected severe atopic dermatitis and common
variable immunodeficiency with endovenous high dose
immunoglobulines (HdIVIg): a case report
Enrico Compalati, Anthi Rogkakou, Laura Guerra, Pier Angela Massacane,
Antonio Scordamaglia, Giovanni Passalacqua, and Giorgio Walter Canonica.
Allergy & Respiratory Diseases Clinic, Genoa University, Department of
Internal Medicine, Genoa, Italy.
Atopic dermatitis (AD) is a chronic inﬂammatory skin disease whose
pathophysiology is the product of complex interaction between susceptibility
genes, host environments, infectious agents, defects in skin barrier and
immunologic responses. Basic treatment of AD consists in topical emollients,
topical and systemic CS and immunosuppressive drugs, antihistamines,
phototherapy. Adjunctive HdIVIg for resistant AD may offer a useful
approach, as suggested by small number of uncontrolled trials and case reports,
via a number of immunomodulatory effects. Most patients with AD are
colonized with S aureus and experience exacerbation after infection with this
organism. In these cases treatment with antibiotics can result in reduction of
skin disease. We signal the case of a 46-y-old man affected by pollens-mites-
allergic rhinitis from adolescence, suffering from severe AD for 7 years with
typical signs of lesional chronicity with licheniﬁed plaques and ﬁssuration on
face and neck, upper arms and back, palm and dorsa of hands. To our attention,
typical phenomena of microbial colonization were evident.
The subject conﬁrmed high sensitization to mites, grass; total IgE sum
of 979 KU/L. Negative for celiac disease and food allergy, normal common
haemato-biochemical parameters. Cultural microbiology of lesions demon-
strated S aureus, sensible to common antibiotics.
First line treatments resulted not efﬁcacious. Short courses of oral
antibiotics and CS associated to topical antibiotics obtained a decrease of ﬂare
for just few weeks; relapse occurred frequently justifying a not respondent
disease to common treatments. Further analysis demonstrated a total
gammaglobulins reduction related to a selective decrease of IgG class
(325 mg/dl), normal lymphocyte fenotipe and proliferative response to
common antigens, a mild deﬁcit of granulocytes chemotaxis to IL8. Diagnosis
of common variable immunodeﬁciency was formulated and HdIVIg instaured.
After the ﬁrst administration of 200 mg/kg the severe lesions of AD
signiﬁcantly improvedwith evident resolution of infections. First line treatment
alone resulted efﬁcient in controlling the disease in the following 7 months.
Subjects affected by severe not respondent to conventional therapy
AD, especially with evident infections, may reasonably be investigate for
possible immunodeﬁciency. In these cases HdIVIg treatment may be a useful
support for both immunomodulatory effect and neutralization of cutaneous
pathogens.
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The influence of laser therapy on the functional activity
of nuetrophiles
Anton Dvornikov and Larisa Kruglova. Skin and Venereal Diseases Clinic
No.1, Department of Health, Moscow, Russian Federation.
While carrying out NBT-tests, we have found that in 67 patients with
atopic dermatitis in the original state the number of spontaneously activated
neutrophiles was 17.8 + 1.3% which is considerably higher than in healthy
people (6.4 + 0.9% pG0.001). While studying the neutrophiles activation index
which reﬂects their reactivity to extrinsic stimulation, we have found that, in
the studied group, the general drop in the index was over 2.5 times larger than
compared to the norm of 3.4 + 0.7 and 8.2 + 0.6 (pG0.001). Along with this,
in patients with atopic dermatitis we have also registered a considerable
decrease in phagocytic activity of nuetrophiles, which amounted to 59.8 + 3.3,
compared to the norm of 72.0 + 3.4% (pG0.05).
All the examined patients were divided into 2 groups, comparable by
all criteria. Group I Y 34 patients who were treated with laser and traditional
therapy, and a control group of 33 patients, treated with the traditional drug
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therapy. The positive dynamic of the studied parameters were registered
with the application of different treatment methods; however, it was at its
highest under the inﬂuence of laser therapy. Thus, in the main group the content
of neutrophile leucocytes recovered to the normal quantity and dynamic of the
above mentioned parameters was on average 48% higher than in the control
group. Hence, this newly developed combined method of treating atopic
dermatitis has been proven to have a desensitizing and anti-allergic effect,
which is indicated by the recovery of the functional activity of neutrophiles.
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Quality of life and economic burden in Korean patients with
atopic dermatitis and their parents
Eun Jung Kim, Hyung Ok Kim, and Young Min Park. Kangnam St. Mary’s
Hospital, College of Medicine, The Catholic University of Korea, Department
of Dermatology, Seoul, Republic of Korea.
Background: Because of chronic course and highly disﬁgured skin lesions,
atopic dermatitis (AD) has a substantial impact on quality of life (QOL).
Moreover, previous studies assessing the ﬁnancial cost of AD have shown that
it represents a notable economic burden. However, little has been known about
QOL and economic burden in Korean patients with AD.
Methods: A questionnaire speciﬁcally designed by our clinical experience was
used to determine how AD affects the lives of the patients and/or their parents.
66 and 39 parents completed the self-administrated questionnaires, including
the questions onmultidimensional aspects of QOL. They were also surveyed to
ﬁnd how much money they have spent in the treatment of AD during the last 6
months. All of the QOL scores are linearly transformed to 0Y100 scale, with
100 indicating the worst QOL, and 0 the most favorable. In addition, for each
patient the disease severity was evaluated by using SCORAD index.
Results: The QOL data revealed that AD had signiﬁcantly negative effects on
QOL through all aspects of life including daily living activities (37.4),
psychological status (29.7) and social functioning (23.1). The average of the
total QOL score was 30.1. The QOL scores signiﬁcantly increase in proportion
to the increasing severity of AD (pG0.0001). With regard to daily living
activities, a major stress-causing factor was restriction on cosmetics use (44.5)
and choice of foods (40.6) or clothes (36.7) as well as concern about exposure
of their skin (41.2). For psychological status, 89% of patients reported that
they feel deeply nervous about the likelihood of their offspring having AD in
future (54.5). Regarding social functioning, it was told that AD patients had
difﬁculties in making relationship with someone (26.4) and were less
interested in the opposite sex (24.7). AD parents also had high level of stress
associated with modifying lifestyles (33.8) and keeping their children from
scratching (28.2). The estimated cost related to AD has the positive correlation
with the severity of AD, widely ranging from 60,000 won to 1,990,000 won
per patient a month. Of importance, the average direct medical cost was
77,000 won, corresponding to only 29% of the total, while the indirect cost
represents 71% of the total with average cost of 189,000 won.
Conclusion: These results suggest that AD has a signiﬁcant impact on the




Nerve growth factor (NGF) and allergic disease in top athletes
Matteo Bonini1, Alessandra Micera2, Stefano Del Giacco3, Vittorio
Sargentini4, Simona Cerulli5, and Guido Rasi6. 1Catholic University of
Rome, Institute of Sports Medicine, Rome, Italy; 2Campus Bio Medico,
Interdisciplinary Center for Biomedical Research, Rome, Italy; 3Policlinico
Universitario, Cagliari, Department of Internal Medicine, Cagliari, Italy;
4ASL Roma A, Laboratory of Analisys, Rome, Italy; 5IRCCS San Raffaele,
Department of Neurology, Rome, Italy; 6Consiglio Nazionale delle Ricerche
CNR, Institute of Neurobiology and Molecular Medicine, Rome, Italy.
Background: Extensive evidence has been accumulated on the role of Nerve
Growth Factor (NGF) in allergic diseases. Although physical exercise has
been associated, in animal models, with an increased NGF expression, no data
are available about its effects on NGF in humans.
Aim: To study NGF serum levels in top athletes, a population sample in which
allergic diseases and neuroimmune disorders Y such as amyotrophic lateral
sclerosis (ALS)Yare reported with a signiﬁcant increased prevalence.
Methods: 103male soccer players (mean age 26.1) from ﬁve ﬁrst division teams
were studied for allergic diseases trough an original speciﬁc questionnaire
(AQUAc2007), history, physical examination, skin prick tests and/or Phadiatop.
Sera were taken in all athletes, at different time periods, and stored atj70-C for
NGFdetermination trough a double-antibodyELISA.Data froma pilot sample of
36 athletes and 15 non-allergic, sedentary, matched controls are presented.
Results: The prevalence of allergy in soccer players was 47.8%. In spite of a
high intra- and inter-individual variability of values, possibly due to the
different training loads during the soccer season, mean NGF serum levels were
signiﬁcantly higher in soccer players than in controls (384.19 ng/ml +/j
298.41 ng/ml vs 128.0 ng/ml +/j 10.0 ng/ml; p G0.05). The NGF serum levels
in athletes were increased independently from the presence of allergy.
Conclusion: Our study conﬁrms the high prevalence of allergic diseases in
athletes. The increasedNGF serum levels in allergic soccer players are consistent
with the role of this neurotrophin in allergic inﬂammation. This is the ﬁrst report
of increased serum levels of NGF related to intense physical activity in humans.
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Special features of allergy testing in elite sportsmen
Nataliya Shartanova. The Institute of Immunology, Asthma, Moscow, Russian
Federation.
Sport is inevitable part of modern society. However up today the
precise and convincing data on prevalence and features of current allergic
diseases in elite Russian sportsmen are absent. The purpose of the present
research is to study prevalence, features of allergen spectrum and structure of
allergic diseases in elite sportsmen. The skin prick-tests with different groups
of allergens, the estimation of total IgE end IgA, IgM, IgG in blood serum, the
challenge bronchial tests with physical exercise are used in modern clinical,
laboratory and allergic research methods including gathering allergic, the
pharmacological and food anamnesis. Screening of 319 elite sportsmen was
carried out (fencing, sport and art gymnastics, dzudo, softball, water polo,
volleyball, ﬁgure skating, hockey on a grass, rowing on a canoe, freestyle,
biathlon, a youth soccer team, football). The analysis of carried out research
has shown the following. 23,5 % (75) sportsmen have clinical attributes of
allergic disease: allergic dermatitis - 16%, allergic urticaria - 17,3%, allergic
rhinitis - 30,7%, pollen-allergic rhinitis - 17,3%, bronchial asthma - 5,3%, drug
allergy - 0,94%, food allergy - 0,63%. Increase of total IgE level in blood
serum has been revealed in sportsmen with allergic diseases (23%) from 130 to
1000 ME/ml. Immune status analysis demonstrated the decrease of IgG and
IgA level and increase of IgM level in elite sportsmen without any connection
to atopy. In 94,5% of sportsmen allergy was diagnosed for the ﬁrst time.
Obtained data testiﬁes widespread of allergic diseases among elite sportsmen
and allergic diseases hypo-diagnostics. The hypo-diagnostics of allergic
diseases results in late prescription of adequate therapy and restricts sport
achievements. Changes in immune status indexes require further investigation.
MECHANISMS OF ASTHMA
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Antiproliferative and anti remodelling effect of beclomethasone
dipropionate, formoterol and salbutamol alone or in
combination in primary human bronchial fibroblasts
Desideria Descalzi1, Chiara Folli1, Gabriele Nicolini2, Anna Maria Riccio1,
Cinzia Gamalero1, Francesca Scordamaglia1, and Giorgio Walter Canonica1.
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1University of Genoa, Department of Internal Medicine, Genoa, Italy; 2Chiesi
Farmaceutici, Medical Department, Parma, Italy.
Background: Bronchial asthma is characterized by lower airway inﬂammation
and remodelling. Anti-inﬂammatory treatment with inhaled corticosteroids
provides the mainstay of asthma therapy together with bronchodilation induced
by short and long-acting inhaled $2-agonists. Lower airway ﬁbroblasts may play
a critical role in airway inﬂammation and remodelling suggesting they might
represent an important target for the major antiasthmatic drugs.
The aim of our study was to investigate the effects of beclomethasone
dipropionate, salbutamol and formoterol either alone or in combination on in
vitro cultures of human bronchial ﬁbroblasts.
Methods: Fibroblasts were cultured in the presence of proinﬂammatory and
proliferative stimuli, beclomethasone dipropionate, salbutamol and formo-
terol. The effects of drugs on cell proliferation were ascertained by 3H-
thymidine incorporation. CD90 and CD44 expression were detected by ﬂow
cytometry and ﬁbronectin secretion using an ELISA technique.
Results: This study showed that beclomethasone dipropionate alone has
signiﬁcant anti-proliferative effects on lung ﬁbroblasts treated with bFGF
while LABAs or SABAs by themselves did not show any signiﬁcant effect in
the different cultures. The combination of BDP with formoterol or salbutamol
strengthens these effects. CD44 and CD90 expression and ﬁbronectin pro-
duction were modulated by proinﬂammatory and proliferative stimuli; the
addition of the drugs brought them back near to the basal level.
Conclusion: From this in vitro study we can conclude that beclomethasone
dipropionate, when combined with salbutamol or formoterol, exhibits enhanced
anti remodelling activity in bronchial ﬁbroblasts, providing new insights on the
additive effects of inhaled corticosteroids and $2-agonists for asthma therapy.
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Galectin-9 inhibits CD44-hyaluronan interaction and suppresses
a mirine model of allergic asthma
Shigeki Katoh1, Akira Yamauchi1, and Mitsuomi Hirashima2. 1Faculty of
Medicine, Kagawa University, Department of Cell Regulation, Kagawa,
Japan; 2Faculty of Medicine, Kagawa University, Department of Immunol-
ogy and Immunopathology, Kagawa, Japan.
Background: Galectin-9 (Gal-9) belongs to the galectin family that exhibits
afﬁnity for $ galactosides. Gal-9 has a variety of biological activities, however
its role in allergic inﬂammation is unknown.We evaluated the effect of a stable
form of the human protein on allergic airway inﬂammation in a mite allergen-
induced asthma model.
Methods: Human stable gal-9 was given by intravenous injection to mice
during antigen challenge. The effect of gal-9 on airway inﬂammation and
airway hyper-responsiveness (AHR) was then evaluated.
Results: Gal-9 reduced AHR as well as T helper type 2 (Th2)- associated
airway inﬂammation. Furthermore, administration of gal-9 as well as anti-
CD44 monoclonal antibody inhibited the inﬁltration of peripheral blood Th2
cells into the airway. Interestingly, gal-9 directly bound the CD44 adhesion
molecule and inhibited interactions with hyaluronan (HA). Consistent with the
concept that CD44-HA interactions mediate the migration of T cells into the
lung, gal-9 blocked CD44-dependent adhesion of BW5147 mouse T cells to
HA.
Conclusion: We conclude that gal-9 inhibits allergic inﬂammation of the
airway and AHR by modulating CD44 dependent leukocyte recognition of the
extracellular matrix.
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Suppressive effects of a water-soluble fraction from Artemisia
capillaris on the ovalbumin-induced allergic asthma model
Hyun Joo Youn1, Jin-Ah Lee2, Yeon Suk Cha1, Mi Jung Yun1, Jeong Hwa
Hong1, Burm Jong Lee1, and Joo Hung Park2. 1Inje University, Biohealth
Products Research Center, Gimhae, Republic of Korea; 2Changwon National
University, Department of Biology, Changwon, Republic of Korea.
Background: Asthma is a chronic inﬂammatory disease of the airways
characterized by reversible airway obstruction and hyperreactivity and
remodeling of the airways. Even though a number of medications or
treatments for the disease are available, the demand for a rather mild and
preventive medication using the natural products such as Chinese traditional
medicine is increasing, especially, in a number of Asian countries. Artemisia
carpillaris is a perennial herb easily found around the temperate Asian regions
including the entire Korean peninsula. It is called BInjin[ in Korea and BYin
Chin[ or BYin Chen Hao[ in China, which is traditionally used for the
treatment of liver diseases and also applied to some allergic symptoms such as
hives or rash. In order to identify an anti-allergic principle of the plant, we
have isolated a water-soluble glycoside fraction of smaller than 1kDa and
determined its biological activities on an allergic asthma model animal.
Methods: We have investigated suppressive effects of the fraction on an
ovalbumin-induced allergic asthma in BALB/c mice and studied the cellular
and molecular mechanisms of its anti-allergic activity.
Results: A water-soluble fraction of Artemisia carpillaris signiﬁcantly
reduced the pulmonary eosinophilia and the Th2 cytokine expressions such
as IL4 and IL5 in the lungs as well as serum IgE levels. The surface expression
of the CD11c and class II MHC on the lung dendritic cells was also reduced by
the treatment of the fraction, indicating that the fraction also modulates the
dendritic cell development in lung tissues.
Conclusion: Considering that the pulmonary dendritic cells are crucial in the
differentiation of Th2 cells and the production of IL4 and IL5 in lung tissues
and that the cytokines are important in the IgE antibody production and
eosinophil inﬁltration, the fraction appears to include an anti-allergic prin-
ciple modulating the Th2 differentiation and the resulting allergic asthma
development.
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Protective effect of Glu27 allele of $2-adrenergic receptor gene in
thai asthmatic patients
Ticha Limsuwan1, Ammarin Thakkinstian2, Oravan Verasertniyom3,
Monchand Vanichapuntu3, Kanokrat Nantiruj1, and Suchela Janwityanujit1.
1Allergy Immunology and Rheumatology Unit, Ramathibodi Hospital,
Mahidol University, Department of Medicine, Bangkok, Thailand; 2Clinical
Epidemiology Unit, Ramathibodi Hospital, Department of Medicine,
Bangkok, Thailand; 3Research Center, Ramathibodi Hospital, Department
of Medicine, Bangkok, Thailand.
Background: Genetic polymorphisms involving a variation at the 16th
(ArgY Gly) and 27th (GlnY Glu) amino acid positions of the adrenergic
receptor-$2 (ADRB2) possibly associated with various asthma related
phenotypes including the adverse effect on lung function after regular use
of albuterol in asthmatic patients who are homozygous Arg16 and a protective
effect of homozygous Glu27 on asthma severity.
Objective: To determine association between ADRB2 polymorphisms and
asthma phenotypes in Thai patients.
Methods and Materials: One hundred and thirty asthmatic patients were
genotyped for ArgGly16 and GlnGlu27 polymorphisms. Patients’ demo-
graphic, disease severity, pulmonary function test results and medication used
were collected. Haplotype with unknown phase was inferred using EM
algorithm method. ANOVA was applied to compare means among groups.
Results: Prevalence of Arg16 and Gln27 alleles were 56.9% and 91.2%,
respectively. Linkage disequilibrium coefﬁcient between the two SNPs was
0.36. Three haplotypes were inferred, which were Arg-Gln, Gly-Gln, and Gly-
Glu with frequencies of 148 (56.9%), 89 (34.2%), and 23 (8.6%). Mean
percentage of predicted FEV1 for these corresponding haplotypes were 73.5
(SD = 16.3), 72.4 (SD = 17.4), and 80.7 (13.1), respectively. Although the
means were not statistical different (p = 0.258), the predicted FEV1 ofGly-Glu
was 6%Y9% higher than the rest haplotypes. Number of hospitalization and
emergency visit were also lower in GlnGlu27 than GlnGln27 genotypes (i.e.,
0% versus 11.9%, p = 0.089 for hospitalization; 4.5 % versus 18.8 %, p =
0.084 for visiting emergency). Finally, inhaled corticosteroid/long-acting
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$2-agonist (ICS/LABA) usage was signiﬁcantly lower in patients with
GlnGlu27 than patients with GlnGln27 (i.e., 50% versus 76.6%; p = 0.042).
Conclusion: Presence of Glu27 allele in Thai asthmatic patients is associated
with better parameters of asthma severity, including higher percentage of
predicted FEV1, less hospitalization and emergency department visit during
the past year and signiﬁcant lower amount of ICS/LABA usage.
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Clinical implication of vascular endothelial growth factor in
children with asthma and eosinophilic bronchitis
Kyu-Earn Kim, Kyung Won Kim, Hye Mi Jee, and Myung Hyun Sohn.
Yonsei University College of Medicine, Pediatrics, Seoul, Republic of Korea.
Background: Eosinophilic bronchitis (EB) is a condition characterized by a
corticosteroids responsive cough and sputum eosinophilia, without bronchial
hyperresponsiveness. Vascular endothelial growth factor (VEGF) is an
important mediator of airway inﬂammation and remodeling in asthma. We
aimed to explore whether VEGF is expressed at elevated levels in airways with
asthma or EB and associated with pulmonary function and bronchial
hyperresponsiveness in children.
Methods: One hundred seventeen asthmatic children, 77 children with EB
and 84 healthy controls (mean age, 8.9 years) were enrolled in the study.
Sputum supernatants were collected, and VEGF and eosinophil cationic
protein (ECP) levels were measured. We performed pulmonary function tests
and methacholine challenge tests, while measuring total eosinophil count,
serum total IgE and ECP in all subjects.
Results: Asthmatic children had signiﬁcantly higher levels of VEGF in
induced sputum (1.82 T 0.55 log pg/mL) compared to children with EB (1.50 T
0.53 log pg/mL; p = .00165) or healthy controls (1.48 T 0.48 log pg/mL; p =
.00034). A positive signiﬁcant correlation was found between FEV1/FVC and
sputum VEGF (r = 0.257; p = .006), whereas no signiﬁcant correlations were
found between sputum VEGF and bronchial hyperresponsiveness, sputum
eosinophil count or sputum ECP. Sputum eosinophil count showed higher
levels in children with asthma or EB than in controls (p G 0.001). Sputum ECP
also demonstrated higher levels in children with asthma or EB than in controls
(p = .044, p = .001, respectively).
Conclusion: Our ﬁndings suggest that sputum VEGF might be a valuable
marker to distinguish asthma from EB in children with chronic cough. It is also
suggested that VEGF would affect the airway inﬂammation contributing to
airway remodeling which may reﬂect in FEV1/FVC.
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Proportion of eosinophilic and non-eosinophilic inflammation
phenotypes in patients with mild to severe bronchial asthma, its
influence on main clinical and functional outcomes and efficacy
of inhaled steroid treatment
Maris Bukovskis1, Normunds Jurka2, and Immanuels Taivans3. 1Pauls Stradins
Clinical University Hospital, Pulmonology and Allergology, Riga, Latvia;
2University of Latvia, Institute of Experimental and Clinical Medicine, Riga,
Latvia; 3University of Latvia, Department of Pathology, Riga, Latvia.
Background: Bronchial asthma is probably not a single disease, but a
complex of separate syndromes. One of the methods to standardise asthma
phenotypes is identiﬁcation of inﬂammatory pattern. Inﬂammation subtypes
may inﬂuence treatment efﬁcacy with ICS.
Objective of our study was to determine the percentage of patients with
eosinophilic and non-eosinophilic asthma phenotype, sputum inﬂammatory
cell spectrum in each patient group, its inﬂuence on main asthma control
parameters and ICS treatment efﬁcacy.
Methods: Lung function, PD20 of Mch, induced sputum cell count, asthma
symptom score and $2-agonist use was investigated in non-smoking, steroid
naive and ICS treated patients with mild to severe persistent bronchial asthma.
The cut-off point between patient groups was deﬁned as sputum eosinophilia
93%. Steroid naive patients were allocated to the treatment with FP 250 6g
twice daily for 12 weeks and treatment efﬁcacy on previously mentioned
parameters was evaluated.
Results: 21 steroid naive and 77 patients previously treated with ICS were
included in our study. In steroid naive patient group 72% of patients were
classiﬁed as asthmatics with eosinophilic phenotype and 28% with non-
eosinophilic phenotype. In ICS treatment group 39% were classiﬁed as
eosinophilic and 61% as non-eosinophilic asthmatics. Patient demographic
data and ICS dose was similar. In patients with non-eosinophilic asthma we
found signiﬁcantly higher relative and absolute sputum neutrophil count,
asthma symptom score and $2-agonist use (p G 0.05). There was no signiﬁcant
difference between FEV1 83.1 T 18.1% vs. 87.6 T 25.6% and 90.1 T 20.7% vs.
96,3 T 12.5% in steroid naive and ICS treated patients respectively; p90.05)
and lgPD20 Mch (j 1.343 T 0.765 vs. j 1.894 T 0.733 mg and j 0.729 T
0.702 vs. j 1.462 T 1.023 mg in steroid naive and ICS treated patients
respectively; p90.05).
11 patients with eosinophilic and 10 with non-eosinophilic asthma
were treated with FP. We observed statistically signiﬁcant better improvement
of FEV1 and morning PEF in patients with initial airway eosinophilia
compared to non-eosinophilic asthma (p G 0.05). Change of lgPD20 of Mch,
asthma symptom score and $2-agonist use was similar in both patient groups.
Conclusion: Non-eosinophilic asthma phenotype is associated with increased
sputum neutrophilia, more severe symptoms, higher rescue medication use
and less effect of ICS treatment on lung function.
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Influence of anti-IgE antibody omalizumab on airway
remodeling and the expression of interleukins in asthma
Oleksii Korzh, Sergiy Krasnokutskiy, and Elizaveta Lavrova. Kharkov
Medical Academy of Postgraduate Education, Internal Diseases and Clinical
Pharmacology, Kharkov, Ukraine.
Background: To study the relation between interleukin-4 (IL-4), IL-5, IL-13,
transforming growth factor-beta (2) (TGF-beta (2)) and airway remodeling and
to investigate the effects of omalizumab on airway inﬂammation and airway
remodeling of asthma.
Methods: Thirty ﬁve female BALB/c mice were randomly divided into a
remodeling group and a treatment group (omalizumab group), with 10 BALB/
c mice in each group. The mice were sensitized by ovalbumin (OVA), and only
the omalizumab group was treated with omalizumab. The number of total cells
and eosinophils in bronchoalveolar lavage ﬂuid (BALF) were counted. Light
and electronic microscope were used to detect the pathologic histology and
morphologic change. In situ hybridization and reverse transcription-poly-
merase chain reaction (RT-PCR) were used to measure IL-4, L-5, IL-13, and
TGF-beta (2) mRNAs in the lung.
Results: The numbers of total cells and eosinophils in BALF of the
remodeling group were (5.7 T 1.3) x 10(5)/ml and 2.43 T 0.18, while those
of the treatment group were (4.1 T 1.4) x 10(5)/ml and 1.67 T 0.23,
respectively, the difference being signiﬁcant (P G 0.05). Histological and
electronic microscopic examination showed extensive airway inﬂammation,
notably accumulation of signiﬁcant numbers of eosinophils and lymphocytes
in the remodeling group. Other features including prominent proliferation of
airway epithelial cells protruded like ﬁngers, increased thickness of smooth
muscle, hyperplasia of connective tissue, goblet cell hyperplasia and a marked
increase in airway mucus secretion with mucus plugging and extensive
collagen deposition around the airways were also noted in the remodeling
group. In the treatment group, the inﬂammation was signiﬁcantly decreased,
with decreased production of mucus, decreased collagen and granule of mucus
around airway, less proliferation of airway epithelium, smooth muscle
hypertrophy and airway spasm. In situ hybridization showed that the
expression of IL-13 mRNA and TGF-beta (2) mRNA in the lung oQf the
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remodeling group were 22 T 9 and 18 T 3 respectively, while those of the
treatment group were 16 T 5 and 9 T 4.
Conclusions: Omalizumab could effectively inhibit airway remodeling and
decrease in the expression of IL-13 mRNA and TGF-beta (2) mRNA as well as
IL-4 mRNA and IL-5 mRNA in the lung in asthma.
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IgE and IgG4 autoreactivity in bronchial asthma
Anna Konischeva, and Valentina Gervasieva. Mechnickov Research Institute
for Vaccines and Sera, RAMS, Moscow, Russian Federation.
Currently, it pays much attention to the phenomenon of autoreactivity
in the immunopathogenesis of allergic diseases. The chronic allergic
inﬂammation in the bronchial tree leads to the tissue injury, which results in
the modiﬁcation of its structure and releasing intracellular autoantigens. It was
discovered IgG - autoantibodies to DNA and bronchial endothelium cells
antigens in patients with bronchial asthma (BA).
Goal: to determine the content of IgE and IgG4-autoantibodies (Ab) to some
tissue antigens in patients with atopic BA different degrees of severity.
Materials and Methods: We identiﬁed IgE-autoAb and IgG4-autoAb with
ELISA to the following tissue antigens: epithelial keratin, III and VI collagen
types, myelin basic protein (MBP), elastin and myosin (Sigma, USA) using
speciﬁc IgE and IgG4 reference sets BDr. Fooke[ (Germany). It was studied
serum samples of 64 adult asthmatic patients and 25 healthy individuals the
same age.
Results: The level of IgE-autoAb determined from control subjects was taken
us for the average homeostatic norms and it was 1.5 T 0.07 IU/ml. Compared
to them, in patients with easy and middle BA was noted reliable elevation of
IgE-autoAb to keratin (13.7 T 4.3 IU/ml), collagen III and VI types (4.4 T 2.1
IU/ml, 6.8 T 3.2 IU/ml), elastin (4.9 T 2.4 IU/ml) and myosin (18.21 T 11.5
IU/ml). In patients with severe asthma were raised autoAb only to elastin (2.2
T 0.7 IU/ml), collagen type III (1.7 T 0.2 IU/ml) and myosin (7.5 T 3.1 IU/
ml). At the same time, increased total IgE correlated with IgE- autoAb to
elastin and myosin (r = 0.68 and r = 0.45, respectively). IgG4 auto-Ab were
also determined in the 35 serum samples of severe and middle asthmatic
subjects and in the serum of 25 healthy people. Its normal average value was
2380 T 89.5 ng/ml. The level of IgG4-autoAB to all tissue antigens in
asthmatic patients was a 1.5 times higher than in healthy controls. We also
revealed signiﬁcant negative correlation between IgG4 and IgE-autoAB to
elastin (r = j0,7), III collagen type (r = j0,56), MBP (r = j0,9). So the data
indicate that IgE and IgG4-autoreactivity contributes to the development of
chronic inﬂammation in patients with atopic BA and needs to be further
investigated.
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Changes of internal diameter of large airway during and after
exacerbation of bronchial asthma
Sang-Hoon Kim, Byoung Hoon Lee, and Jae Hyoung Lee. Eulji Hospital,
Internal medicine, Seoul, Republic of Korea.
Background: Exacerbation of bronchial asthma was characterized by
increased airway responsiveness induced by lower airway inﬂammation and
resultant airway obstruction. Small airways are known to be the main area of
obstruction which causes limitation of airﬂow, but inﬂammatory change
during exacerbation occurs in entire airway including large airway. We
evaluated the changes of internal diameter of large airway during and after
exacerbation.
Methods: High resolution computed tomography (HRCT) and pulmonary
function test were done as soon as possible after admission in patients with
exacerbation of asthma and follow up studies were done after improvement of
symptoms and discharge. With HRCT scanned images during exacerbation,
internal diameters of large airway were measured consecutively from right
main to right subsegmental bronchus and measurement was repeated after
discharge at the same level and angle of scanned bronchus.
Results: Ten patients (male 5, mean age 43 [range 19Y64]) completed studies.
Pulmonary function was markedly improved after treatment of exacerbation;
mean FVC from 2.93 T 0.82 L to 3.72 T 0.64 L (p = 0.001) and mean FEV1
from 1.55 T 0.55 L to 2.61 T 0.56 L (p = 0.001). Mean internal diameter on
HRCT during exacerbation was 3.38 T 0.81 mm and after treatment 3.41 T
0.80 mm (p = 0.80). There was one patient with signiﬁcant increase of internal
diameter and it decreased in 2 patients. Improvement of FEV1 was not as-
sociated with changes of internal diameter on HRCT (r = 0.39, p = 0.26).
Conclusion: Before and after treatment of asthma exacerbation, there was
marked improvement of pulmonary function but changes of internal diameter
measured by HRCT were not consistent.
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Effect of soluble TNF-" receptor on airway inflammation in mice
model of bronchial asthma
Sook Young Lee, Ji Young Kang, Seung Jun Kim, Young Kyoon Kim, Sung
Hak Park, and Jin Gook Lee. The Catholic University of Korea, Int Med,
Seoul, Republic of Korea.
TNF-" is an important pro-inﬂammatory cytokine that is also a well
known inducer of the inﬂammatory response and a regulator of immunity. A
strong argument exists for TNF-" being a critical cytokine in the
pathogenesis of chronic inﬂammatory disorders of the airways. Once
released in the airways, TNF-" acts by inducing a general inﬂammatory
response mainly through enhanced release of pro-inﬂammatory/chemotactic
mediators and upregulation of adhesion molecules such as E-selectin,
VCAM-1, and ICAM-1, thus facilitating the migration of neutrophils and
eosinophils. To date there is very limited information on the use of TNF-"
blocking agents in asthma. The present study investigated the effect of
soluble TNF-" receptor on the airway inﬂammation in mice model of
bronchial asthma. Mice were treated with intraperitoneal soluble TNF-"
receptor during the OVA challenge. Mice exposed to OVA developed
sustained eosinophilic airway inﬂammation and sustained AHR to methacho-
line compared with control mice. Intraperitoneal administration of soluble
TNF-" receptor inhibited the development of AHR and eosinophilic
inﬂammation. Moreover, soluble TNF-" receptor treatment reduced IL-4,
IL-5, IL-13 and IL-10 level in bronchoalveolar lavage ﬂuid. These results
suggest that soluble TNF-" receptor can modulate the airway inﬂammation
and AHR via inhibition of inﬂammatory cytokine production.
207
Detection of multi-locus genetic interaction in aspirin-intolerant
asthma with multifactor-dimensionality reduction analysis
Seung-Hyun Kim1, Hyun-Hwan Jeong2, Hyun-Young Lee1, Myeong-Ki
Kim2, Bo-Young Cho1, Jungseob Lee3, Kyubum Wee2, and Hae-Sim Park1.
1Ajou University School of Medicine, Department of Allergy and Rheumatol-
ogy, Suwon, Republic of Korea; 2Ajou University, School of Information &
Communication, Suwon, Republic of Korea; 3Ajou University, Department of
Mathematics, Suwon, Republic of Korea.
Background and Objective: Aspirin-intolerant asthma (AIA) is a common
phenotype of aspirin hypersensitivity and affects about 10~20% of asthmatic
patients. Recently, the single gene polymorphism associated with the AIA
susceptibility has been investigated, but identiﬁcation of multi-locus single
nucleotide polymorphism (SNP) set in association with the susceptibility has
not been investigated.
Subjects and Methods: In this study, we selected 23 SNPs in 13 candidate
genes for 94 asthmatics with aspirin hypersensitivity (AIA) and 152
asthmatics without aspirin hypersensitivity (aspirin-tolerant asthma, ATA)
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and genotyped each SNP by a primer extension method. Multi-locus genetic
interactions were examined with multifactor-dimensionality reduction (MDR)
to test all multi-locus SNP combinations for the efﬁcient prediction of AIA.
Results: Through a MDR analysis, we identiﬁed four-locus gene-gene
interaction models that predict AIA disease risk among asthmatic patients with
64.2 % balanced accuracy.
Conclusion: These results suggest that signiﬁcant epistatic effect of four-
locus genetic interaction may exist in the susceptibility for AIA in asthmatic
patients which may be a useful in vitro method to diagnose the AIA with
acceptable sensitivity.
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IL-5 production in response to Candida Albicans secretory
aspartic protease 2 is the marker of isolated late-phase bronchial
responses upon inhalation challenge for nonatopic asthma
Akio Mori1, Noriko Kitamura1, Takayuki Otomo1, Miyako Yamaguchi1,
Yuichiro Kajiyama1, Masami Taniguchi1, Yuji Maeda1, Mamoru Otomo1,
Haruhisa Mita1, Maki Hasegawa1, Kazuo Akiyama1, and Osamu Kaminuma2.
1National Hospital Organization, Sagamihara National Hospital, Clinical
Research Center, Sagamihara, Japan; 2Tokyo Metropolitan Institute of
Medical Science, Department of Allergy and Immunology, Tokyo, Japan.
To delineate the mechanisms of nonatopic asthma, peripheral blood
mononuclear cells (PBMC) obtained from atopic asthmatics, nonatopic
asthmatics, and healthy controls were incubated with various allergen
molecules.
IL-2, IL-4, IL-5, IL-13, and IFN-, productions were measured by
speciﬁc ELISAs. T cell proliferation was assessed by 3H-thymidine uptake.
IgE and IgG antibody were assayed by RAST and ELISA, respectively.
Intradermal and bronchial inhalation challenges of the antigens were
performed according to the standard procedures. Histamine releasing tests
(HRT) were performed using peripheral blood leucocytes.
Proliferative response to crude Candida albicans (CA) extract was not
statistically different among the three groups, indicating a common sensitization
against CA antigen. Signiﬁcant amount of lL-5 was produced by PBMC
obtained from several nonatopic asthmatics upon incubation with crude CA
extract and a puriﬁed antigen, secretory aspartic proteinase 2 (SAP2). IL-5
production was undetectable for the PBMC obtained from healthy control
subjects in response to SAP2. Upon intradermal and bronchial challenge of
SAP2, late but not immediate skin and bronchial responses were observed for the
IL-5-producing asthmatics, respectively. Neither IAR nor LAR was detectable
for the IL-5-nonproducing asthmatics, indicating the speciﬁcity of the responses.
LAR was not induced for the IL-5-nonproducing, IL-13-producing asthmatics.
IgE-dependent mechanism was ruled out by negative RAST, HRT, or immediate
skin reaction. Anti-SAP2 IgG antibody (precipitin) was not detectable in the
serum of either the asthmatics or the control subjects.
Nonatopic asthma may be caused by an IgE-independent, T cell-
dependent immune-recognition, and in vitro cytokine synthesis become a
reliable diagnostic test for BT cell allergens[.
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Correlation between serum immune markers and bronchial
hyperreactivity
Adrien Halasz1, Endre Cserhati2, Karoly Cseh3, Endre Cserhati, MD, D.SC.2,
and Karoly Cseh, MD. D.Sc3. 1Pediatric Institute Svabhegy, Allergy and
Pediatric pulmonology, Budapest, Iceland; 2I. Pediatric Clinic Semmelweis
University, Pulmonology, Budapest, Hungary; 3Karolyi Hospital, I. Internal
Medicine, Budapest, Hungary.
Background: Asthma is characterised by an underlying allergic inﬂammation
resulting bronchial hyperreactivity. The aim of the examination was to study
the correlation between serum biological markers (IL-13, RANTES, total IgE)
and bronchial hyperreactivity. Symptom-free adults with childhood bronchial
asthma and their symptom-free children were studied (n:76).
Methods: Bronchial hyperreactivity was proved with metacholine airway
provocation in 51 symptom-free patients (30 adults, 21 children), but it was
not in 25 patients (21adults, 4 children). Serum IL-13, RANTES and IgE
detection was perfomed by ELISA.
Results: Signiﬁcant higher IL-13 (XTSD:13,53 T 20,24 pg/ml vs. 5,64 T 4,24
pg/ml, pG0.01), RANTES (XTSD:1098 T 543,1 pg/ml vs. 901,8 T 322,8 pg/
ml, pG0.01) and IgE (X T SD:360,7 T 352,9 KU/l vs. 130,0 T 117,8 KU/l
pG0.0001) concentrations were proved in symptom-free patients with
bronchial hyperreactivity compared to non-hyperreactives. In symptom-free
patients with bronchial hyperreactivity signiﬁcant positive linear correlation
was proved between the serum levels of IL-13 and RANTES, IL-13 and IgE.
Conclusion: The serum IL-13 level correlated with the IgE concentration in
non-hyperreactive patients as well. In bronchial hyperreactivity IL-13 shows a
correlation with the chemokine RANTES and total IgE. A persisting
inﬂammation can be detected in bronchial hyperrectivity even in symptom-
free patients.
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The local and serum level of IL-6 and its soluble receptor
(srIL-6) at teenagers with bronchial asthma
Elena Markelova1, Anna Kostyushko1, Elena Prosekova1, Natalya Derbasova2,
and Tatjana Sereda2. 1Siberian Branch of Russian Academy of Medical Science,
?The Fareastern Scientific CentreX, Research Insti, Vladivostok, Russian
Federation; 2Hospital 1, Allergic Center, Vladivostok, Russian Federation.
The analysis of dynamics of system and local content SR-IL-6 at
teenagers with various clinical forms of allergic diseases has revealed higher
levels of systemic content SR-IL-6 in comparison with its local maintenance in
nasal lavage. Despite of different levels of IL-6 and SR-IL-6 the correlation of
these markers was found in studied biological liquids estimation the results of
the research. So, bronchial asthma (BA) SR-IL-6 level was 23,09 + 0,27 ng/ml
in serum of blood and 2,24 T 0,2 ng/ml locally.
However, IL-6 research revealed the opposite direction in the present
group of patients: higher levels in nasal lavage in comparison with serum
(1,97 + 0,4 pg/ml and 3,97 + 0,61 pg/ml accordingly). Combined SR-IL-6 level
in serum of blood BA and the atopic dermatitis (AD) patients tended to increase
in comparison with group of patients BA and made 27,24 + 0,32 ng/ml, and the
SR-IL-6 level in nasal a secret was below, than at BA (1,02 + 0,04 ng/ml).
IL-6 research at BA patients in combination with AD revealed
authentic (8G0,05) increase of serum level of present cytokine (3,31T0,22 pg/
ml) and decrease local one (0,97 T 0,06 pg/ml). Content SR-IL-6 practically
did not differ comparing BA and atopic rhinitis (AR) patients and BA patients
making 23,64 T 0,38 ng/ml in serum of blood and 2,03 T 0,14 ng/ml in nasal
secret. However, quantity of IL-6 in the present group was the highest both in
serum of blood, and in nasal secret (9,68 + 1,11 pg/ml and 4,73 + 0,56 pg/ml
accordingly) (8G0,05). Combining clinical forms of AR and AD levels IL-6
and SR-IL-6 cytokines were the least of the studied clinical variants of atopic
march, making 21,19 T 0,11 pg/ml in serum and 0,49 T 0,01 pg/ml locally for
IL-6 and 0,18 T 0,001 ng/ml and 0,17 T 0,02 ng/ml for SR-IL6 accordingly.
Thus, the greatest increase of IL-6 level in serum of blood and in nasal
secret occured while combination BA? and A?R with children and teenagers
having all forms of atopic march. The level of soluble receptor of IL-6 with
children also increased while combining BA? and A?R, whereas with
teenagers - while having clinical evidences of BA? and AD more essentially.
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Zinc iron ratio in allergic asthma and allergic rhinitis
Vojislav Djuric. Institute of Allergology and Immunology, Functional
Diagnostics Unit, Belgrade, Serbia and Montenegro.
Background: Zinc was shown to have protective effect on the respiratory
system exposed to oxidative stress, soit may play a role in allergic airway
diseases. Iron can have a role in oxidative stress in allergic respiratory
Abstracts World Allergy Organization Journal & November 2007
S66 * 2007 World Allergy Organization
Copyright @ 2007 World Allergy Organization. Unauthorized reproduction of this article is prohibited.
diseases. Iron, as well as copper, can transfer electrons and produce reactive
oxygen species which can damage epithelium in allergic diseases. Both trace
elements also have signiﬁcant inﬂuence on immune system.
Methods: Using atomic absorption spectrophotometry, we have measured
concentration of zinc and iron in serum and in supernatant of induced sputum
in 21 patients with allergic asthma, in 13 patients with allergic rhinitis and in
10 control subjects.
Results: Postivie corelation was found between serum zinc and iron
concentrations of patients with allergic asthma. There was no correlation
between zinc and iron concentration in sputum.
Conclusion: Zinc and iron trace elements with antagonistic action on
respiratory epithelium are positively correlated in serum of alergic asthmatics.
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Immunohistochemical co-localization of transient receptor
potential vanilloid-1 in the trachea using a guinea-pig
asthma model
Naoto Watanabe1, Syunji Horie2, Domenico Spina3, J. Gregory Michael4,
V. John Priestley4, P. Clive Page3, and Teruomi Miyazawa1. 1St. Marianna
School of Medicine, Division of Respiratory and infectious disease,
Kanagawa, Japan; 2Josai International University, Faculty of Pharmaceu-
tical Sciences, Chiba, Japan; 3Kings College London, Sackler Institute of
Pulmonary Pharmacology, London, United Kingdom; 4Queen Mary Uni-
versity of London, Neuroscience Centre, London, United Kingdom.
Aim:We investigated the distribution of transient receptor potential vanilloid-
1 (TRPV1) in the airway of guinea-pigs.
In this study, we compared the changes in TRPV1 in the trachea using
a guinea-pig asthma model.
Methods:We created an asthmamodel of 5 guinea-pigs by the administration of
ovalbumin (OA) and 5 controls (Sham) according to a double blind study. Each
trachea was removed from them and sectioned (306m) in a cryostat. The slide-
mounted sections were incubated in 10% normal donkey serum for 1 hr followed
by 0.3% H2O2 for 30 minutes. In addition, they were blocked by avidin/biotin
blocking kit. And the subsequently sections were incubated in polyclonal anti-
TRPV1 antibody (1:30,000) for 40 hr. Next, they were incubated with
biotinylated donkey anti-rabbit immunoglobulin G (1:400) for 90 minutes.
Then they were incubated in streptavidin biotin-peroxidase complex
for 1 hr followed by ﬂuorescein tyramide (1:75) for 7 min.
Finally, we observed the TRPV1 activity of each section by confocal
microscopy and then compared the results.
Results: The TRPV1 immunoreactive axons were localized to the ﬁne axons
within the epithelium and around the smooth muscle area. The TRPV1 axons
were found to be stronger and more frequent in the OA group than in the Sham
group.
Conclusion: These ﬁndings suggest that the TRPV1 immunoreactive axons of
the trachea increase in number under allergic inﬂammatory conditions.
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Water soluble chitosan attenuates mite allergen-induced
macrophage activation in allergic asthmatic patients
Wang Jiu-Yao1, and Chen Chih-Lung2. 1College of Medicine, National Cheng
Kung University, Tainan, Taiwan, Department of Pediatrics, Tainan, Taiwan;
2Biomedical Engineering Lab, The Industrial Technology Research Institute,
Hsing-Chu, Taiwan, Stem Cells and Cell Therapy Program, Hsinchu, Taiwan.
Chitin and chitosan have versatile anti-tumor, anti-fungal, and anti-
microbial biological properties. Oral intake and intranasal administration of
chitin attenuated allergen-induced airway inﬂammation in sensitized mice,
which may be due to its Th1 adjuvant properties. However, the detailed
mechanism of action is not clear. In this report, we demonstrated that water
soluble chitosan had speciﬁc immunomodulatory effects on dust mite allergen
Dermatophagoides farinae (Der f)-stimulated, monocyte-derived macrophages
(MDM) in the shifting of Th2 cytokine polarization, decreasing inﬂammatory
cytokine production of IL-6 and TNF-", down-regulation of CD44, CD14,
TLR14, and PAR2 receptor expressions, and inhibiting T-cell proliferation in
the presence of allergen-stimulated MDM. Under scanning electron micro-
scope (SEM) examination, chitosan reduced cellular change of pseudopodia
formation in Der f-stimulated MDM from allergic asthma patients. The effect
of chitosan on allergen-stimulated MDM may occur through inhibited PKCUa
phosphorylation and NF-kB pathway activation. In a murine model of asthma,
we found that intranasal application of chitosan attenuates Der f-induced lung
inﬂammation by reducing inﬁltration of inﬂammatory cells, epithlieal damage,
and goblet cell hyperplasia. The production of Arg1, iNOs and thymic stromal
lymphopoietin (TSLP) in the bronchial epithelium of allergen-challenged
sensitized mice was markedly decreased in chitosan-treated mice. Therefore,
we believe that these results of examination of the anti-allergic effect of
chitosan may provide a new therapeutic modality for allergic asthma.
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Basic FGF2 plays a key role in the allergic sensitization of
airways and the pathogenesis of asthma
Seong Gyu Jeon1, Young Koo Jee2, Sang-Heon Cho3, Kyung-Up Min3, You-
Young Kim3, and Yoon-Keun Kim1. 1Postech Biotech Center, Department of
Life Sciences, Pohang, Gyeongbuk, Republic of Korea; 2Dankook University
College of Medicine, Department of Internal Medicine, Cheonan, Republic of
Korea; 3Seoul National University College of Medicine, Department of
Internal Medicine, Seoul, Republic of Korea.
Background: Asthma is characterized as a chronic inﬂammatory disorder of
the airways associated with airway hyperresponsiveness (AHR), mucus
production, and airway remodeling such as smooth muscle hypertrophy and
subepithelial ﬁbrosis. Basic FGF (FGF2) is a member of the large FGF family
and plays roles in the proliferation of ﬁbroblast, and the migration and
proliferation of airway epithelial cells during wound healing. However, the
role of FGF2 in the allergic sensitization is totally unknown, although FGF2
levels are thought to be elevated in patients with asthma.
Objective: To evaluate the immunological roles of FGF2 on airway allergen
sensitization, and pathogenesis of asthma.
Methods: 6-week-old female BALB/C mice were sensitized intranasally
with LPS-depleted ovalbumin (OVA) in the presence or absence of 106g of
rFGF2 at days 0, 1, 2, 7, and then challenged intranasally with OVA at days
14, 15, 21 and 22. AHR was measured by whole both plethysmography
after 24 hours from last challenge. Mice were sacriﬁced at day 24, and then
BAL cellularity, lung histology, and several immunologic parameters were
assessed to evaluate the effects of rFGF2 co-treatment.
Results: AHR against methacholine challenge was signiﬁcantly increased in
mice sensitized with OVA plus rFGF2 compared with other groups. And
number of total cell, macrophage, eosinophils, and lymphocytes in BAL ﬂuids
were also makedly increased in rFGF treated mice, accompanied by severe
peribronchial and perivascular eosinophilic inﬂammations from histologic
ﬁndings. Mucus secretion and subepithelial ﬁbrosis were also increased in
these mice, respectively. IL-4, IL-13, and TGF-$1 levels in BAL ﬂuids were
markedly enhanced in mice sensitized with OVA plus rFGF2.
Conclusion: These ﬁnding suggested that FGF2 plays important roles in the
pathogenesis of allergic asthma, especially promoting allergic sensitization via
production of inﬂammatory cytokines, such as IL-4, IL-13, and TGF-$1.
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The role of VEGF and its receptors on airway allergic
sensitization and pathogenesis of asthma
You-Sun Kim, SungWook Hong, Tae Seop Shin, Yu-Mi Tae, and Yoon-Keun
Kim. Postech Biotech Center, Department of Life Sciences, Pohang,
Gyeongbuk, Republic of Korea.
Background: VEGF (vascular endothelial growth factor) is known to be a key
regulator of angiogenesis that is a known feature of chronic inﬂammatory
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diseases such as asthma and chronic bronchitis. It has been reported that the
levels of VEGF in tissues and biologic samples are increased in patients with
asthma. VEGF has been assumed to contribute to asthmatic tissue edema
through its effect on vascular permeability. The recent study using lung
speciﬁc VEGF over-expressing transgenic mice showed that VEGF induced
TH2 lung inﬂammation. However, it still remains whether the VEGF affects
during allergen sensitization or adaptive immune responses by allergen
speciﬁc T cells.
Objective: To assess the roles of VEGF and its receptor (Flt-1/KDR) in
allergic sensitization of airways.
Methods: C57BL/6 wild type mice were sensitized intranasally with LPS
depleted with ovalbumin (OVA) in the presence of 10 lsˇg of LPS on days
0, 1, 2 and 7 and then challenged intranasally with OVA on days 14, 15,
21 and 22. Before sensitization, the mice were intraperitoneally injected
with SU5416 as the inhibitor of VEGFR1 and VEGFR2 at the only
sensitized period. On the proper times (days 4, 23), we sacriﬁced mice and
analyzed phenotypes including BAL cellularity, lung histology and
evaluation of immunologic parameters such as the production of cytokines
in BAL ﬂuid.
Results: On day 4, the number of total cells, macrophage, lymphocytes and
neutrophils increased in BAL ﬂuid from the mice sensitized with OVA in the
presence of LPS compared to only OVA treated mice. Interestingly, SU5416
blocked the recruitment of inﬂammatory cells in sensitization period. At this
time, the production of TNF-" and IL-12 also decreased in BAL ﬂuid from
SU5416 treated mice. After OVA challenge (day 23) the number of total cells
was decreased in BAL from mice treated SU5416 at sensitized period. And
histological ﬁnding showed that inﬁltration of inﬂammatory cells was also
signiﬁcantly decreased in SU5416 treated mice.
Conclusion: VEGF induced during allergic sensitization and its signaling
pathway play a key role in allergen speciﬁc T cell priming.
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Cytokine responses during exacerbation compared with stable
phase in asthmatic children
YingwanMoonsup1,WasuKamchaisatian1, Suwat Benjaponpitak1, Kalayanee
Atamasirikul2, and Thidarat Rujirawat3. 1Faculty of Medicine, Ramathibodi
hospital, Mahidol university, Division of Pediatric Allergy/Immunology,
Bangkok, Thailand; 2Faculty of Medicine, Ramathibodi hospital, Mahidol
University, Department of Pathology, Bangkok, Thailand; 3Faculty of
Medicine, Ramathibodi hospital, Mahidol University, Research Center,
Bangkok, Thailand.
Background: Bronchial asthma is a chronic inﬂammatory disorder of the
airways. T lymphocytes are crucial for the initiation and maintenance of the
allergic inﬂammatory response, particularly T helper 2 (Th2) cells. Balancing
in Th1 and Th2 response is targeted in treatment. Recent studies show that
interleukin-10 (IL-10) have an important role in the regulation of Th2 and
allergic responses and decreased in asthmatic patients.
Objective: To examine cytokine responses, including interferon-gamma
(IFN- ,), IL-4, IL-10 in asthmatic children during acute exacerbation.
Methods: Fourteen asthmatic children were included in this study. Fresh
whole blood obtained from patients at two phases: exacerbation and stable
phase, were separated to peripheral blood mononuclear cells and were
stimulated with phytohemagglutinin (PHA) and mite allergen (Der p1) for 72
hours. ELISA assays were applied to measure cytokine concentration (IFN-,,
IL-4, IL-10) of supernatant.
Results: IL-10 level (PHA-stimulated) was signiﬁcantly decreased in acute
asthma exacerbation (464 T 628.25 pg/mL) compared with stable phase
(859.5 T 796 pg/mL) (p = 0.03). IL-4, IFN-, levels and cytokine ratios for
all stimulations were not signiﬁcantly different among episodes. For PBMC
with PHA-stimulated, IL-10 levels were slightly decreased in moderate
persistent asthma compared with mild persistent asthma (737 T 691.25 vs.
1,375 T 870.75, p = 0.055). There were no correlations between severity of
exacerbation, asthma score, size of skin prick test and cytokine levels.
Conclusion: The decrease of IL-10 production in asthmatic children during
acute exacerbation may have a role in asthma exacerbation. The decrease of
IL-10 production in more severe asthma (moderate persistent) supports the
idea of defective immune regulation of IL-10. Further studies in IL-10
producing cells and treatment to enhance IL-10 responses might be useful in
prevention and treatment of asthma.
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Alternative transcripts of cysteinyl leukotriene 1 receptor
(CysLTR1) in patients with bronchial asthma
Karolina Wodz1, Milena Sokolowska1, Malgorzata Cieslak2, Andrzej
Bednarek3, Marek L. Kowalski2, and Rafal Pawliczak1. 1Medical University
of Lodz, Immunopathology, Lodz, Poland; 2Medical University of Lodz,
Immunology, Rheumatology and Allergy, Lodz, Poland; 3Medical University
of Lodz, Molecular Carcinogenesis, Lodz, Poland.
Introduction: Cysteinyl leukotrienes are lipid mediators that have been
implicated in pathogenesis of several inﬂammatory processes, including
asthma. They cause bronchoconstriction, mucous hypersecretion, increased
microvascular permability, bronchial hyperresponsiveness, and eosinophil
inﬁltration. The biological action of cysLTs ismediated via CysLT1 andCysLT2
receptors. Human CysLTR1 gene consists of ﬁve exons variably spliced.
Transcript I, composed of 1, 4 and 5 exons is a major transcript present in
human leukocytes, smoothmuscles. Transcript II, composed of 1 and 5 exons is
less abundant but ﬁnd in blood leukocytes, smooth muscles, hart, brain. The
role of alternative transcripts in asthma pathogenesis is still not known.
Aim: The goal of our study was to investigate differences in expression of
CysLTR1 alternative transcripts I and II in patient with bronchial asthma and
healthy control group.
Methods: PBMCs were obtained from peripheral blood of 20 patients with
severe and non-severe asthma and 15 healthy volunteers. Total RNA was
obtained from mononuclear cell using TotalRNA and cDNAwas synthesized
using Reverse Transcriptase. We designed speciﬁc primers spanning exon-
exon junction in the transcript I (exons 1Y5) and transcript II (exon 1Y4) and
common primer in the CysLTR1 coding region according to published
CysLTR1transcripts sequences. Real-time PCR reactions were performed on
RotorGene using Evagreen dye.
Results: We found that CysLTR1 transcripts I and II are present in patients
with asthma and in control group. The CysLTR1 transcripts II/I ratio was
26,02 % in patient with severe asthma, 25,99 % with moderate asthma,
56,44 % with mild asthma and 44,20 % in control group. In addition, we
found signiﬁcant difference in CysLTR1 transcripts II/I ratio in severe asth-
matic subgroup in comparison to controls [p = 0,004], severe asthmatic in
comparison to mild [p = 0,018] and in CysLTR1transcripts II/I ratio in
moderate asthmatic in comparison to control group [p = 0,0004] and in mild
asthmatic in comparison to control group [p = 0,007].
Conclusion: Differences in CysLTR1 alternative transcripts expression might
possibly contribute to airway inﬂammation in patient with bronchial asthma.
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Prostaglandin production in different asthma patients
Valeriya Nemtsova, Inga Fedotova, and Volodimir Fedotov. Kharkov
Allergological Center, Allergology, Kharkov, Ukraine.
Background: Special regulatory role of prostaglandin E2 has been postulated
in aspirin-induced asthma. The aim if this study was to investigate the effects
of aspirin on systemic production of prostaglandin E2 and cysteinyl
leukotrienes in patients with asthma.
Methods: We determined urinary concentrations of two main prostaglandin
E2 metabolites: 13,14-dihydro-15keto-PGE2 using commercial enzyme
immunoassay and 9,15-dioxo-11alpha-hydroxy-2,3,4,5-tetranor-prostane-
1,20-dioic acid using gas chromatography/mass spectrometry; and leukotriene
E4 using immunoassay. Determinations were performed at baseline and
following oral aspirin and celecoxib challenges, in two well-defined asthma
phenotypes: aspirin-sensitive and aspirin-tolerant patients.
Results: Aspirin precipitated bronchial reactions in all aspirin-sensitive, but
in none of the aspirin-tolerant patients. Celecoxib 400 mg was well tolerated
by all patients except for one with aspirin-induced asthma. At baseline mean
prostaglandin E2 metabolites values did not differ between the groups.
Following different aspirin provocation doses, the two main prostaglandin
E2 metabolites were decreased in the aspirin-tolerant group, but their mean
level remained unchanged in the aspirin-sensitive group. The dose of aspirin
had no effect on the magnitude of the response on the prostaglandin E2
metabolites and its duration. In both groups urinary prostaglandin E2 me-
tabolites decreased following celecoxib challenge. No correlation was found
between prostaglandin E2 metabolites and leukotriene E4.
Conclusion: Aspirin-precipitated asthmatic attacks are not associated with
changes in the systemic prostaglandin E2 production. In contrast, prosta-
glandin E2 systemic production becomes depressed by aspirin in non-
sensitive patients. This different response might indicate COX-1 dependent
prostaglandin E2 control of inflammatory cells in AIA. Thus, PGE2 is
released during the clinical reactions to aspirin through an alternate COX-2
pathway. Clinical implications of this finding are in line with current ob-
servations of good tolerance of the selective COX-2 inhibitors in sensitive
patients.
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Mast-cell activation in aspirin-induced asthma
Inga Fedotova, Irina Feclina, and Irina Tikhonova. Kharkov Allergological
Centre, Allergology, Kharkov, Ukraine.
Background: There is increasing evidence of the importance of cysteinyl
leukotrienes (LT) as mediators of aspirin-induced bronchoconstriction in
aspirin-sensitive asthma but the cellular origin of the LT is not yet clear.
Methods: Urinary concentrations of leukotriene E4 (LTE4), 11-dehydro-
thromboxane B2, 9alpha,11beta-prostaglandin F2, and Ntau-methylhistamine
were measured during the 24 h following cumulative intravenous administra-
tion of increasing doses of lysine aspirin to asthmatic patients. In addition, the
urinary concentrations of these metabolites were measured on 10 consecutive
days in a patient who suffered an asthma attack after percutaneous
administration of nonsteroidal anti-inflammatory drugs.
Results: In aspirin-induced asthma patients (AIA, n = 18), the basal con-
centration of urinary LTE4, but not the other metabolites, was significantly
higher than that in aspirin-tolerant asthma patients (ATA, n = 16). After
intravenous aspirin provocation, the AIA group showed a 12.6-fold
(geometric mean) increase in excretion of LTE4 during the first 6 h, and
9alpha,11beta-prostaglandin F2 also increased in the AIA group during the
first 0Y6 h and the 6Y9 h collection period. Ntau-methylhistamine excretion
was also increased, but to a lesser degree. Administration of aspirin caused
significant suppression of 11-dehydrothromboxane B2 excretion in both the
AIA and ATA groups. When the percentage of maximum increase of each
metabolite from the baseline concentrations was compared between the AIA
group and the ATA group, a significantly higher increase in excretion of
LTE4, 9alpha,11beta-prostaglandin F2, and Ntau-methylhistamine was
observed in the AIA group than the ATA group. An increased excretion
of LTE4 and 9alpha, 11beta-prostaglandin F2 has been detected in a patient
who suffered an asthma attack after percutaneous administration of non-
steroidal anti-inflammatory drugs.
Conclusion: Considering that human lung mast cells are capable of producing
LTC4, prostaglandin D2, and histamine, the results of our study support the
concept that mast cells, at least, may participate in the development of aspirin-
induced asthma.
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Markers of inflammation in asthmatic patients
Zlatica Goseva, Angelko Gjorcev, Dejan Dokic, Tatjana Caparoska, and
Zoran Arsovski. Clinic of Pulmology and Allergy, Department of Allergy,
Skopje, Macedonia, Fyrom.
Background: Bronchial asthma is characterized by airway inflammation,
hiperresponsiveness to variety of stimuli and airway obstruction, which can be
reversible. Different cells are involved in the pathogenesis of asthma, like:
T-lymphocytes, mast cells, eosinophils, macrophages etc. A number of
different inflammatory cells infiltrate the airways. The trigger can cause the
release of inflammatory mediators from the cells, which could be the markers
of inflammation.
Methods: We have investigated the role and the importance of inflammatory
cells and mediators like eosinophils, ECP, IL-4 and IL-5. We studied 77
subjects divided in three groups as follows: 1. asthma patients; 2. patients with
obstructive bronchitis and 3. control group.
Results: The number of eosinophils was significantly increased in the group
of asthma patients versus second and third group. The eosinophils have
their very important role in allergic inflammation. We found that the
presence of ECP demonstrate an ongoing inflammation, with or without
clinical symptoms in asthma patients. There was significant difference
between the values of ECP of asthma patients versus second group with
bronchitis and healthy controls. The values of IL-4 were not significantly
increased between the groups. We found the explanation in the fact that
IL-4 is a marker for early allergic inflammation. Our results have shown that
IL-5 is involved in the pathophysiology of asthma. The values of IL-5 were
significantly increased versus second group and controls. We also found the
decrease of the values of inflammatory markers after the treatment with
corticosteroids.
Conclusion: We concluded that eosinophils, ECP and IL-5 could be useful
markers for selecting allergic patients and they could be used together with
other examinations. The markers of inflammation could have their important
role in the measurement of the allergic inflammation and they could be the
monitors of treatment effects.
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Mucosal immunotherapy with CpG oligodeoxynucleotides
increases local IL-10 concentration in a murine model of
chronic asthma
Tahereh Mousavi, Alireza Salek Moghadam, and Reza Falak. Iran university,
Immunology, Tehran, Islamic Republic of Iran.
We examined CpG motif effects on a previously developed murine
model of asthma in which chronic airway inflammation was induced by
repeated allergen [Chenopodium album (Ch.a)] inhalation. Using this model,
we examined the responses to mucosal administration of CpG DNA
(oligonucleotides) and specific antigen immunotherapy. CpG-based immu-
notherapy significantly reversed both acute and chronic markers of
inflammation compared with specific Ag immunotherapy. IL-10 levels were
also measured both in splenocyte and lung culture supernatants. The results
showed that antigen recall responses of lung culture from mucosal treated mice
demonstrated an antigen-specific enhanced release of IL-10, but the concentra-
tion of this regulatory cytokine had no significant changes in splenocyte
culture medium. These results suggest that mucosal immunotherapy with CpG
DNA may induce local production of cytokines without systemic effects on
Th responses. We suggest that mucosal co-administration of CPG /Ag may
provide the basis for a more efficient form of immunotherapy in allergic
asthma. Indeed local induction of cytokines by this procedure may diminish
potential toxicity of systemic antigen administration.
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Assessment of airway remodeling by HRCT in asthmatics:
correlation with age, smoking, disease duration and severity
Aliae Mohamed-Hussein1, W Hasan1, G Agmy1, S Abdel Aziz2, and E Abou
Elhamd2. 1Assiut University Hospitals, Assiut, Egypt, Chest, Assiut, Egypt;
2Assiut University Hospitals, Assiut, Egypt, Radiology, Assiut, Egypt.
Background: To date, airway remodeling is usually assessed using
histological examination of airways. However, now it is possible to assess
and quantify the extent of airway remodeling in vivo using high-resolution CT
(HRCT). The aim of this study was to prospectively evaluate airway wall
thickness as indicator of remodeling by using thin section HRCT in
asthmatics, and to correlate these findings with pulmonary function tests
(PFTs) results and other clinical indices in asthmatics.
Methods: 41 patients with asthma and 20 healthy controls participated in the
study. Remodeling as measured by whole airway wall thickness was assessed
with HRCT. Thickness-to diameter ratio (TDR) and the percentage wall area
(PWA) were determined. Spirometric tests were also performed.
Results: TDR and PWA were significantly higher in asthmatics than in
controls. Both TDR and PWA were strongly correlated with disease severity
and duration. Also, TDR and PWA were inversely correlated with the
percentage of predicted forced vital capacity (FVC %), forced expiratory
volume in 1st second (FEV1%) and FEV1/FVC and post- bronchodilator
reversibility in asthmatics.
Conclusion: These findings indicate that HRCT is useful non- invasive
method for assessment of airway wall thickness. Airway wall thickening
occurs more in patients with moderate and severe asthma and its degree
is related to the duration and severity of asthma and degree of airflow
obstruction.
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Clinical and immunologic findings of methylene diphenyl
diisocyanate -induced occupational asthma in a single car
upholstery
Gyu-Young Hur1, Dong-Hee Koh2, Gil-Soon Choi1, Han-Jung Park1, Sung-Jin
Choi1, Young-Min Ye1, Kyoo-Sang Kim2, and Hae-Sim Park1. 1Ajou University
School ofMedicine, AllergyandRheumatology, Suwon,Republic ofKorea; 2Korea
Occupational Safety and Health Research Institute, Incheon, Republic of Korea.
Background: Although methylene diphenyl diisocyanate (MDI) has been
widely used in many industries, there have been few studies of MDI- induced
occupational asthma.
Objectives: We investigated to present the clinical and immunologic find-
ings in methylene diphenyl diisocyanate-exposed workers in a single industry
of car upholstery.
Methods: Fifty-eight exposed workers in a single industry were enrolled.
Work related respiratory symptoms were screened using a respiratory ques-
tionnaire. Serum specific IgE and IgG antibodies to MDI-human serum al-
bumin conjugate were measured by ELISA. Atopy status was evaluated using
allergy skin prick test. For confirmation of MDI-induced occupational asthma,
methacholine bronchial challenge test and MDI-specific inhalation test with
changes of sputum eosinophil counts were performed in symptomatic workers.
Results: Thirteen (22.4%) subjects had complained of respiratory work-
related symptoms. The prevalence of MDI-occupational asthmawas noted in 5
(8.6%) workers and occupational eosinophilic bronchitis was noted in 2
(3.45%) workers. The prevalence of specific IgG (20.7%) was higher than that
of specific IgE (8.6%). The prevalence of MDI-occupational asthma/
eosinophilic bronchitis was strongly associated with the presences of work-
related respiratory symptoms and MDI-specific IgG antibodies (P G 0.01,
P G 0.05, respectively).
Conclusion: MDI may be a causative agent of occupational asthma among
MDI-exposed workers. The prevalence of MDI-occupational asthma was
8.6%, and MDI-eosinophilic bronchitis was confirmed in 2 workers. The
presence of work-related lower respiratory symptoms and serum specific IgG
to MDI-human serum albumin conjugate may be useful to predict MDI-
occupational asthma/eosinophilic bronchitis in MDI exposed workers.
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Risk factors for spider mite (Tetranychus urticae) allergy among
table grape farm workers in South Africa
Mohamed Jeebhay1, Roslynn Baatjies1, Y-Y Kim2, Y-K Kim3, Vicky Major4,
and Andreas Lopata5. 1University of Cape Town, Occupational and
Environmental Health Research Un, Cape Town, South Africa; 2Seoul
National University College of Medicine, Department of Internal Medicine,
Korea, Japan; 3University of Science and Technology, Department of Life
Science, Postech Biotech Center, Korea, Japan; 4Cape Peninsula University of
Technology, Department of Health Sciences, Cape Town, South Africa;
5Division of Immunology, Institute of Infectious Diseases and Molecular
Medicine, RMIT University, Allergy Research Group, Melbourne, Australia.
Background: Various studies among workers in vineyards and orchards have
reported an increased prevalence of respiratory symptoms including asthma.
The aim of this study was to identify risk factors associated with spider mite
allergy among table grape farm workers.
Methods: A cross-sectional study of 207 workers in table grape farms was
conducted. Skin prick tests (SPT) used extracts of 8 common aeroallergens
(ALK), grape mould (Botrytis cinerea) and Tetranychus urticae (TU). Specific
IgE to TU was quantified using ImmunoCAP (Phadia). Erythrocyte
cholinesterase (AChE) levels were determined using the Test-mate ChE
Cholinesterase Test System (Model 460).
Results: The average duration of employment of workers was 10 years and
12% were pesticide crop sprayers. Work-related wheeze (26%), ocular-nasal
(24%), urticaria/skin symptoms (14%) were more prevalent in the orchards.
The prevalence of sensitization (SPT) was the highest to TU (22%) followed
by house dust mite (16%), with 25% being atopic. The prevalence of allergy to
TU (skin reactivity and work-related symptoms) was 9.5%, with respiratory
(6%) more common than skin allergy (3%). Work-related ocular-nasal
(OR = 4.9) and skin (OR = 3.7) symptoms were more commonly reported by
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pesticide crop sprayers. Workers with TU-allergic rhino-conjunctivitis and
probable asthma were more likely to be atopic, spray pesticides and have low
(G30 U/g Hgb) AChE levels.
Conclusion: This study demonstrates that spider mite, T. urticae, is an
important outdoor allergen among table grape farm workers. The increased
risk of spider mite allergy appears to be related to high pesticide exposure
among crop sprayers.
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A novel murine model of toluene diisocyanate-induced asthma
Li-Zhi Sun1, Kirsi Vaali1, Tor Aasen2, Thien Van Do3, Nils Aardal4, Aung
Htun Lin1, and Erik Florvaag1. 1University of Bergen, Institute of Medicine,
Bergen, Norway; 2Haukeland University Hospital, Department of Occupa-
tional Medicine, Bergen, Norway; 3Haukeland University Hospital, Labora-
tory of Clinical Biochemistry, Bergen, Norway; 4Haukeland University
Hospital, Department of Pathology, Bergen, Norway.
Background: Toluene diisocyanate (TDI), a highly reactive industrial chem-
ical, is one of the leading causes of occupation-related asthma in indus-
trialized countries. The pathogenesis of TDI-induced asthma remains not
fully understood, in part due to lack of appropriate animal models. In our
study, we established a novel TDI asthma mouse model by epicutaneous
sensitization and intranasal challenge.
Methods: Thirty two 6Y8 week BALB/c mice were randomly divided into four
groups (n = 8): TDI, acetone olive oil (AOO), ovalbumin (OVA) and saline (sal).
On days 0, 7 and 14, the mice were epicutaneously sensitized with 1% TDI in
100 2l acetone: olive oil (3:2, AOO), 100 2l AOO, 100 2l 0.1% OVA in sal and
100 2l sal respectively, every allergen or solvent was placed on a patch of
sterile gauze (11 cm) which was taped to the skin of shaved mouse back
and kept for 3 days per sensitization. On days 21, 23 and 25, mice were
challenged intranasally with 25 2l identical allergen or solvent respectively
once a day. All mice were sacrificed on day 27. 24 hours before first
intranasal challenge and after last intranasal challenge, airway responsive-
ness to methacholine (Mch) was measured in an unrestrained whole body
plethysmogragh and was expressed as enhanced pause (Penh). Mice were
exposed to nebulized phosphate-buffered saline as the baseline and then
increasing dose of Mch, namely 5%, 10%, 20% and 40% followed by
measurement of Penh values for 5 minutes. TDI- and OVA-specific IgG1,
IgG2a and IgE in sera were measured by ELISA and expressed as optical
density (OD) mean value’s.
Results: 1. Histology: TDI-exposed mice exhibited neutrophil-dominant
pulmonary inflammation in the peri-bronchial and peri-vascular regions by
lung tissue haematoxylin and eosin (HE) staining, and increased mucus
secretion by PAS staining, while OVA-treated mice exhibited an eosinophil-
dominant inflammation and mucus production. 2. After challenge in TDI-
treated mice airway responsiveness was significantly augmented, but not in
OVA- and solvent-treated mice. 3. Significant increased production of sera
TDI-specific IgG1, IgG2a and IgE in TDI-treated mice was observed as well
as the increased OVA-specific IgG1, IgG2a and IgE in OVA mice.
Conclusion: Our study showed that allergic asthmatic responses to a chemical
sensitizer such as TDI may occur after dermal sensitization and airway
challenge via IgE-mediated mechanism.
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A case of occupational allergy in a platic industry
Remei Guspı´ Bori1, Cinta Castella` Valldeperez2, and Miquel Baltasar Drago1.
1Hospital of Tortosa Verge de la Cinta, Unit of Allergy, Tortosa, Spain;
2Hospital of Tortosa Verge de la Cinta, Internal Medicine, Tortosa, Spain.
We report a case of a patient male of 33 years old with recurrent
symptoms of rhinitis, conjunctivitis, and dermatitis related with his job.
He hasn_t had family nor personal antecedents of atopy. His symptoms
were recurrent pruriginous eczema located to body and legs, accompanied of
rhinitis and conjunctivitis, without symptoms of bronchial reactivity. These
symptoms appeared while he was in the place of work and improved at the
weekend and holidays. He was working for eighteen months in a pipe_s
factory as support agent. They used polyvinyl for made the pipes and was in
contact with resins, cobalt, styrene and glass fibre in this factory.
We preformed a skin prick test with a battery of common aeroallergens
and a standard patch test (True test\) with negative result. The basal
espirometry performed had a normal pattern and the bronchodilatation test was
negative. The blood analysis showed a normal biochemical levels and normal
haematological values, with antinuclears and antitissue antibodies negatives.
The specific IgE determination against anhydride phthalic was 25,7 KU/l and
against formaldehyde was G0.35kU/l.
Our diagnosis_ suspicion was sensitization to anhydride phthalic as the
cause of the symptoms that he presented.
The patient_s evolution after the job_s change was very favourable. He
has remained asymptomatic until nowadays and the specific IgE levels to
anhydride phthalic has gone lowering, being of 0.42 KU/l eighteen moths
later. The use of anhydride phthalic as hardener of epoxy resins forms polymers
that are useful to make materials as glass fibre. Sometimes there are too many
substances in the occupational environment then it can difficult the causal
diagnosis.
The acid anhydrides are substances with a low molecular weight
that can cause rhinitis, asthma and contact dermatitis associated to an IgE
mediated mechanism. The airborne exposition to anhydride phthalic can
happen more frequently in the plastic industry.
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Predictors of work-related symptoms, allergic sensitisation and
occupational asthma among supermarket bakery workers
in South Africa
Roslynn Baatjies1, Andreas Lopata2, Ingrid Sander3, Monika Raulf-
Heimsoth3, Eric Bateman4, Thomas Robins5, Tim Meijster6, Dick Heederik7,
and Mohamed Jeebhay1. 1University of Cape Town, Occupational &
Environmental Health Research Unit, Cape Town, South Africa; 2RMIT
University, Allergy Research Group, Melbourne, Australia; 3Ruhr-University
Bochum, Research Institute for Occupational Medicine (BGF, Bochum,
Germany; 4University of Cape Town, Lung Institute, Cape Town, South
Africa; 5University of Michigan, Department of Environmental Health
Sciences, Michigan, United States; 6TNO Quality of Life, Zeist, Department
of Food & Chemical Risk Analysis, Utrecht, Netherlands; 7Utrecht University,
Institute for Risk Assessment Sciences, Utrecht, Netherlands.
TDI-specific-IgG1 TDI-specific-IgG2a TDI-specific-IgE OVA-specific-IgG1 OVA-specific-IgG2a OVA-specific-IgE
TDI 3.01 T 0.09* 1.96 T 0.80* 0.93 T 0.34* 0.20 T 0.05 0.15 T 0.11 0.10 T 0.05
AOO 0.24 T 0.16 0.15 T 0.05 0.11 T 0.01 0.11 T 0.04 0.11 T 0.02 0.08 T 0.01
OVA 0.31 T 0.11 0.20 T 0.12 0.15 T 0.08 2.97 T 0.11* 0.48 T 0.36# 0.20 T 0.12#
sal 0.23 T 0.07 0.21 T 0.08 0.11 T 0.02 0.17 T 0.15 0.13 T 0.04 0.09 T 0.03
Compared to solvent control, P G 001; compared to solvent control, P G 0.05.
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Background: A recent study reported a high risk of developing work-related
asthma among supermarket bakers. This study aimed to determine the
predictors for work-related symptoms, allergic sensitisation, non-specific
bronchial hyper-responsiveness (NSBH) and baker’s asthma in small bakeries
of a supermarket chain store in South Africa.
Methods: A cross-sectional study of 517 (current and previously employed)
bakers was conducted in 31 Cape Town bakeries using a modified European
Community Respiratory Health Survey (ECRHS) questionnaire, skin prick
tests to common aeroallergens and cereal flours, as well as serum specific IgE to
wheat flour, rye flour and fungal alpha amylase by ImmunoCAP-system
(Phadia, Sweden). NSBH was assessed using the Medic Aid Pro Nebulizer
Dosimeter method. Exposure-response modeling was conducted to identify
significant determinants.
Results: The mean age of bakers was 32 years and 47% were current smokers.
The prevalence of atopy (positive SPT to Q1 common aeroallergen) was 42%.
Common work-related symptomswere ocular-nasal (31%) and chest tightness/
wheezing (17%). One third of bakers were sensitised to bakery allergens with
25% sensitised to cereal flours such as wheat and rye. There were 22% of the
workers who demonstrated evidence of bronchial responsiveness with 2/3 of
these having airway obstruction. Doubling the employment duration was
associated with an increased odds for specific IgE reactivity to wheat (OR:
1.28, CI: 1.01 Y C 1.62), rye (OR: 1.37, CI: 1.07 Y C 1.75), and allergic ocular-
nasal symptoms due to wheat (OR: 1.32, CI: 1.0 Y C 1.83). Workers in the
bakery sensitized to wheat flour were almost four times more likely (OR: 3.75,
CI: 1.79 Y C 7.84) to be bakers and six times more likely to be supervisors/
managers (OR: 6.03, CI: 2.37 Y C 15.38), the latter group having generally
lower dust exposures. Stratification of the jobs per employment duration
maintained the inverted U-shaped exposure response curve observed.
Conclusion: Job title and, to a lesser extent, employment duration are im-
portant predictors of sensitisation among supermarket bakery workers. The
non-linear exposure response relationship observed in this study needs
further exploration.
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Rhinitis, conjunctivitis and asthma due to deer antler
M. T. Palomeque1, Miguel Torrecillas1, N Martı´nez1, MR Gonza´lez1, DL
Martı´nez1, AE Martı´n1, and B Bartolome´2. 1Complejo Hospitalario
Universitario de Albacete, Allergology Section, Albacete, Spain; 2Bial-
Arı´stegui, R&D Department, Bilbao, Spain.
Background: Occupational allergy in cutlers is a very strange phenomena
even though they handle a lot of potencially allergenic substances.
Case Report: A 40-year-old man, cutler since he was 14, active smoker of 20
cigarettes/day. He was referred to our deparment because he presented during the
last 4 months daily dysnea, wheeze, cough and thoracic oppression accompanied
by rhinitis and conjunctivitis of diurnal predominance and clearly related to his
work place. He had been treated with formoterol 9 mcg/ budesonida 320 mcg
every 12 hours since 45 days before his visit. He got worse throughout the week
and specially on Fridays, when he swept the floor of the factory, forcing him this
fact to go to the emergency deparment in 3 occasions. He improved during the
weekend and referred to work with metals, wood of olive tree, oak (Bwith resin[)
and an artificial wood, although other workers next to him handled deer antler
(since 4 years before) and bull horn. In his previous work in a cutlery (16 years
before), he used towork with deer antler andwood; during the last three months of
working there he presented daily cough, dysnea and wheeze which were related to
wood dust. Once he changed the company to the present one, he remained
asymptomatic during 15 years until now.
Results: Skin prick test (SPT) with a standard battery of inhaled and epithelial
allergens and a battery of woods and mites: all of them were negative. SPTwith
an extract of deer antler gave positive results (44 mm) with 10 negative
controls (5 were atopic patients). SPT with bull horn: negative. Respiratory
functional tests after remaining 48 hours without treatment: Forced spirometry:
mild obstructive pattern (FVC: 82%, FEV1: 75%) with positive bronchodilator
test. Total IgE: 75 UI/ml. Specific IgE was measured by EAST method
(Enzyme AllergoSorbent Test) obtaining the following results: deer antler, 0.7
kU/l (class 1); fur and dander from cow, 1.6 kU/L (class 2); epithelium from
dog, cat and horse, all of them less than 0.35 kU/L (class 0). The serum specific
IgE levels to serum albumins from bovine, cat and chicken (alpha livetin) was
also measured, and all of them were below 0.35 kU/L (class 0).
The molecular mass of the IgE binding proteins was determined by
SDS-PAGE inmunoblotting: two bands of 63 and 52 kDawere detected in deer
antler extract.
Conclusion: We report the first case in the literature of allergic rhinitis,
conjunctivitis and asthma caused by deer antler.
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Acute allergic reaction and chronic pulmonary effects of
occupational inhalation exposure to talc dust
Masoud Neghab1, Ebrahim Rahimi2, Ali Emad3, and Abdolreza Rajaeifard2.
1School of Health, Shiraz University of Medical Sciences, Occupational
Health, Shiraz, Islamic Republic of Iran; 2School of Health, Shiraz University
of Medical Sciences, Epidemiology, Shiraz, Islamic Republic of Iran; 3School
of Medicine, Shiraz University of Medical Sciences, Internal Medicine,
Shiraz, Islamic Republic of Iran.
Objectives: The main purpose of this study was to assess and characterize the
pulmonary reactions associated with occupational exposure to talc dust.
Methods: Ninety-seven talc workers and 110 unexposed employees as the
reference groupwere randomly selected from a local rubber industry. Standardized
respiratory questionnaires were administered to the subjects, they underwent chest
X-ray and were examined by a specialist for any possible respiratory abnormality
to be diagnosed. Furthermore, Pulmonary Function Tests (PFTs) were measured
just before and after thework shift.Moreover, to assess the extent towhichworkers
had been exposed to talc dust, using standard methods, inhalable and respirable
dust concentrations were measured in different dusty worksites.
Results: The average (mean T SD) age (years), weight (kg), height (cm) and
duration of exposure to talc dust (years) for the exposed group were 35.8 T
6.75, 73.1 T 9.2, 172.3 T 5.9 and 11.79 T 5.3, respectively. The corresponding
values for the non-exposed group were 36.1 T 6.87, 73.36 T 8.1, 173.2 T 5.7
and 0 T 0, respectively. Atmospheric concentrations of inhalable and respirable
talc dust were estimated to be 41.8 T 23.52 and 19.8 T 8.04 mg/m3, (mean T
SD), respectively. Talc exposed subjects had a significantly higher prevalence
of respiratory symptoms. Similarly, PFTs revealed that exposure to this
lubricating agent was associated with significant decreases in the mean
percentage predicted of vital capacity (VC), forced vital capacity (FVC) and
forced expiratory volume in the first second (FEV1). Likewise, there was a
general tendency for VC, FVC and FEV1 to decrease as estimated cumulative
exposure (years worked) increased. Moreover, there was an acute reduction in
some parameters of pulmonary function such as VC, FVC and FEV1, over the
work shift. Chest radiographs of exposed workers showed that pneumoco-
niosis profusions were between p 0/0 and p 2/1 according to the ILO 1980
chest X-ray classification.
Conclusion: These results support the notion that occupational inhalation
exposure to talc is associated with chronic respiratory disorders and induces
bronchitis and interstitial lung disease. Additionally, they support the
hypothesis that inhalation exposure to talc dust induces acute aalergic
reversible adverse effect on PFTs.
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Change of lung function and airway hyperresponsiveness in
occupational asthma
Cheol-Woo Kim and Jae-Hwa Cho. Inha University College of Medicine,
Department of Internal Medicine, Incheon, Republic of Korea.
Background: Improvement of respiratory symptoms and airway hyperrespon-
siveness (AHR) of occupational asthma (OA) may be prolonged after cessation of
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exposure to causative agents. Significant improvement or disappearance of
symptoms or AHR at follow up period is frequently used for the parameter of OA
outcome measurement. However, few studies have longitudinally evaluated the
change of lung function and AHR by serial measurement. To evaluate the
significance of the lung function or AHR as outcome parameter, we serially
measured it and compared its change with the clinical condition of OA.
Methods: Pulmonary function test, methacholine bronchial provocation
testing, asthma symptom and medication scores were evaluated at regular
interval in 35 patients with OA confirmed by specific challenge tests.
Results: AHR continuously resolved during the follow-up period (mean:
7.5 years, range: 1Y16 years) in 5 (14.3%) of 35 patients. AHR transiently
disappeared, however, subsequently re-developed in an additional 5 patients.
The level of AHR improved (increase in methacholine PC20 by 3.2-fold or
more) in 9 (25.7%) patients, but fluctuated in remaining 16 (45.7%) pa-
tients. The level of FEV1 was fluctuated along with the severity of asthma
symptom, but not in proportion to the level of AHR. In 20 of 24 patients
with reduced lung function at initial examination, lung function did not
recover during the follow up period. Significant improvement of symptoms
and maintenance of nearly asymptomatic state were achieved in 5 patients.
Three of them had disappearance of AHR, but 2 patients showed fluctuated
levels of AHR. Lung function and severity of asthma at diagnosis, and the
interval between the development of OA symptoms and avoidance was
associated with functional impairment.
Conclusion: In spite of medical treatment and avoidance, many patients
with OA had persistent and fluctuated AHR and lung function impairment
even in the absence of respiratory symptom. Intermittent or single assess-
ment of lung function or AHR as outcome measure might lead to incorrect
clinical evaluation, and more comprehensive approach will be required.
RHINITIS AND RHINOSINUSITIS
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ARIA suggested drugs for allergic rhinitis and Quality of Life.
A GA2LEN review
Anna Porcu1, Ilaria Baiardini1, Fulvio Braido1, Francesco Tarantini1, Sergio
Bonini2, Pascal Demoly3, Torsten Zuberbier4, and Giorgio Walter Canonica1.
1University of Genoa, Department of Internal Medicine, Genoa, Italy;
2Second University of Naples, Chair Allergology and Clinical Immunology,
Naples, Italy; 3Hoˆpital Arnaud de Villeneuve, Exploration des allergies et
INSERM U454, Montpellier, France; 4Charite´-Universitta¨smedizin Berlin,
Department of Dermatology and Allergy, Berlin, Germany.
Background: Allergic diseases constitute a global health problem, as they
have an increasing economic and social impact and, especially, they can deeply
interfere with patients_ daily life, being a cause of physical and emotional
discomfort. This is why health related quality of life (HRQoL) has become
increasingly important in healthcare research.
Aim: To examine the scientific literature of the last three years dealing with the
impact of allergic rhinitis (AR) treatments suggested by ARIA guidelines on
patients_ HRQoL, and to identify the unexplored or not fully investigated areas
concerning this issue.
Methods: Studies were sought from MEDLINE (1 January 2004 to 31
December 2006) using as key words the ARIA suggested drugs [AND] allergic
rhinitis [AND] and quality of life. Only randomized, DBC trials published in peer-
reviewed journals, using validated questionnaires were selected.
Results: Our research has lead to a selection of 34DBPC trials, 4 in paediatric and
30 in adult population. HRQoL has been assessed in a total of 10957 patients. The
RQLQ questionnaire was used in 27 studies. The Rhinasthma was applied in one
study involving patients with both rhinitis and asthma. SF-36 was used together
with the specific questionnaire in 3 trials. Only a paper on sublingual immu-
notherapy (SLIT) evaluated health status by means of SF-36 and subjective
satisfaction by means of Satisfaction Profile (SAT-P).
The duration of the studies varied from 2 days to 3 years. 19 studies
were about SAR, 3 about PAR, 1 about seasonal and perennial rhinitis. 6
studies investigated rhinitis according to ARIA classification: 3 of them were
about persistent allergic rhinitis, and 3 considered persistent allergic rhinitis
and its comorbidity with asthma. 3 studies investigated rhinitis without
providing any classification of the disease. Out of 34 trials, only 8 evaluated
the possible presence of comorbid asthma.
Discussion: On the basis of our research, it is possible to identify some
unexplored areas in HRQoL of patients affected by allergic rhinitis: the new
ARIA classification (intermittent and persistent rhinitis) should be carried
out for all the treatments in order to fully appreciate the effect of drugs
used in AR on aldult and children patients_ HRQoL; the effect of
comorbidity on HRQoL should be extensively investigated; HRQoL study
should include some other aspects of patient_s perspective life (i.e.
satisfaction, adherence).
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Disturbances in nocturnal sleep, excessive daytime sleepiness
and sleep-specific quality of life impairment in patients
with allergic rhinitis
Danish Jamal and Ashok Shah. Vallabhbhai Patel Chest Institute,
Respiratory Medicine, Delhi, India.
Background: Nocturnal sleep disturbances, excessive daytime sleepiness and
impairment in quality of life (QOL) in allergic rhinitis are often overlooked
both by patients and physicians alike.
Methods: Consecutive skin allergy test positive patients with allergic rhinitis
and matched controls were subjected to computed tomography of paranasal
sinuses (CT-PNS) Patients were categorized as allergic rhinitis (group 1),
allergic rhinitis with sinusitis (group 2) and controls (group 3). They were
evaluated for nocturnal sleep, excessive daytime sleepiness and sleep specific
QOL disturbances using the Pittsburgh Sleep Quality Index (PSQI),
Epsworth Sleepiness Score (ESS) and Nocturnal Rhinoconjunctivitis Quality
of Life Questionnaires (NRQLQ) respectively. They were also categorized as
Bsneezer-runners[ or Bblockers[.
Results: Of the 207 patients (141 males, 66 females), 75(36%) were in group
1, while 132(64%), in group 2 and 23 in group 3. Patients in group 2 had
significantly higher mean scores for PSQI, ESS and NRQLQ questionnaires




with sinusitis (group 2)
N = 132 (64%)
allergic rhinitis
only (group 1)
N = 75 (36%) P value
PSQI 9.8 + 4.1 8.6 + 4.4 0.02
ESS 11.4 + 5.8 7.4 + 3.2 0.001
NRQLQ 47 + 8.9 41.7 + 10.3 0.06
Group 1 subjects had higher mean scores for PSQI, ESS and NRQLQ which





N = 75 (36%)
controls
(group 3)
n = 23 P value
PSQI 8.6 + 4.4 1.2 + 0.5 0.001
ESS 7.4 + 3.2 2.3 + 0.8 0.012
NRQLQ 46.7 + 10.3 4.7 + 0.5 0.016
158 subjects (84%) had persistent disease whose mean PSQI, ESS and
NRQLQ scores were significantly higher as compared to 33 patients (16%)
having intermittent allergic rhinitis.
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rhinitis n = 158 (84%)
intermittent allergic
rhinitis n = 33 (16%) P value
PSQI 9.7 + 4.4 4.0 + 4.5 0.016
ESS 13.3 + 7.0 7.0 + 7.1 0.028
NRQLQ 41.0 + 15.1 20.1 + 12.1 0.001
133/158 (84.2%) subjects with persistent allergic rhinitis and sinusitis had
significantly higher means for PSQI, ESS and NRQLQ scores respectively as










sinusitis n = 25/158
(15.8%) P value
PSQI 9.8 + 4.5 5.2 + 5.0 0.001
ESS 13.1 + 7.5 8.61 + 7.3 0.01
NRQLQ 41.6 + 15.8 24.5 + 20.7 0.016
Patients of allergic rhinitis with urticaria/eczema reported higher mean scores
on all three questionnaires as compared to thosewithout skin allergy (P = 0.01).
55/207 (26.6%) patients were classified as Bsneezer-runners[ and 152/207
(73.4%) patients were classified as Bblockers[. BBlockers[ had significantly
higher means of 9.5 + 4 (P = 0.001), 11 + 5.6 (P = 0.005) and 46.6 + 10.3
(P = 0.015), as compared to 7.4 + 3.4, 8.8 + 4.5 and 27.5 + 8.1 among
Bsneezer-runners[ for PSQI , ESS and NRQLQ scores respectively.
Conclusion: Nocturnal sleep disturbances and excessive daytime sleepiness
are significantly associated and result in significant impairment of sleep
specific QOL in allergic rhinitis. These are higher in patients with concomitant
sinusitis, persistent disease, Bblockers[ and allergic skin disorders.
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Seasonal allergic rhinitis symptoms correlate with the quality
of life in patients with ragweed allergy in the environmental
exposure chamber model
A. M. Salapatek, S. McCue, H. Sauve, P. Tanna, and P. Patel. Allied Research
International, Research and Development, Mississauga, Canada.
Seasonal allergic rhinitis (SAR) is a hypersensitive immune response
to allergens that causes nasal and ocular symptoms and leads to significant
decline in the sufferers’ Quality Of Life (QOL). In the Environmental
Exposure Chamber (EEC) model of allergen exposure, the relationship
between SAR scores and their QOL has not been investigated. To this end, a
specialized Rhinoconjunctivitis QOL (EEC-RQOL) Questionnaire has been
developed to evaluate the QOL problems experienced by patients while they
are in the chamber. The questionnaire contains 16 questions in 4 domains:
Non-nose/Eye symptoms (NNE), practical problems (PP), emotional problems
(EP), and global assessment (GA).
Aims: To examine whether correlations exist between QOL and instantaneous
scoring of SAR symptoms in study subjects at the EEC. Secondly, to
determine the effect of sequential EEC visits on QOL.
Methods: A group of 208 Ragweed-sensitive study subjects were exposed
to Ragweed pollen (3500 T grains/m3) in the EEC for 3h in which they
recorded instantaneous TSS every half-hour on 4 consecutive days. The
relationship between EEC-RQOL scores and TSS over the 4 visits was
examined using Pearson’s correlation and linear regression.
Results: During each of the four visits, all individual domains as well as
the total EEC-RQOL scores significantly correlated with the symptom
scores (see Table 1). As subjects participated in subsequent EEC visits, the
line of linear regression from 1st to 4th visit shows a clear rightward shift
and a gradual increase in slope.
Conclusion: The QOLmeasured in the EEC using EEC-RQOLQuestionnaire
significantly correlated with the SAR symptoms of subjects on all visit days.
The change in linear regression over the four visits indicates an increasing
SAR severity, and that is accompanied by a subsequent decline in QOL.
Moreover, subjects appear to experience a greater deterioration in QOL over
visits as its rate of decline is faster than the worsening of SAR symptoms. Our
findings suggest the negative effect on QOL associated with EEC confinement
and thus confirm the importance of developing an EEC-specific RQOL
questionnaire. Furthermore, we have demonstrated its cross-sectional
construct validity. Table 1: Correlation of QOL Scores to TSS in EEC from
Visits 2Y5.
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Quality-assessment of disease-specific quality of life
questionnaires for rhinitis and rhinosinusitis: a systematic review
Caroline van Oene1, Ellen V Reij1, Mirjam Sprangers2, and Wytske Fokkens1.
1Academic Medical Centre, ENT, Amsterdam, Netherlands; 2Academic
Medical Centre, Medical Psychology, Amsterdam, Netherlands.
Background: In recent years multiple HRQL questionnaires have been
developed specifically for rhinitis and rhinosinusitis. Several reviews
described HRQL questionnaires concerning rhinitis and/or (rhino) sinusitis.
However, little attention has been paid to the quality of the psychometric
properties of these questionnaires.
Objective: The aim of this systematic review is to give a quality-assessed
review of the existing disease-specific health related quality of life
questionnaires concerning rhinitis and rhinosinusitis for adults.
Methods:We reviewed the literature up to May 2007 in Pubmed, EMBASE
and Medline, to identify studies of interest. Additionally the database of
the AAAAI Quality of Life Resources and the Patient-reported Outcome
and QOL Instruments Database were searched. The quality is assessed by
defining the characteristics of a quality of life questionnaire with assessment
criteria.
Results: The results of the construction, description, feasibility, and the
psychometric performance of the instruments are provided. We finally
provide a clinician_s guide to choose a questionnaire based on the
measurement goals, the discriminant validity, responsiveness and the points
obtained in the quality assessment. Of the top scoring instruments regarding
the overall quality assessment, only 4 health related quality of life
TABLE 3
RQOL Questionnaire Domains Visit 2 Visit 3 Visit 4 Visit 5
PP 0.565, p G 0.001 0.361, p G 0.001 0.426, p G 0.001 0.457, p G 0.001
NNE 0.244, p G 0.001 0.279, p G 0.001 0.258, p G 0.001 0.282, p G 0.001
EP 0.272, p G 0.001 0.260, p G 0.001 0.252, p G 0.001 0.244, p G 0.001
GA 0.292, p G 0.001 0.262, p G 0.001 0.168, p G 0.02 0.216, p G 0.002
Total Score 0.368, p G 0.001 0.337, p G 0.001 0.329, p G 0.001 0.344, p G 0.001
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questionnaires for rhinitis and rhinosinusitis met our criteria for the
discriminant validity and responsiveness.
Conclusion: The current review with its quality assessment of the existing
disease-specific HRQL questionnaires concerning rhinitis and rhinosinusitis
for adults assists in making a deliberate choice for the most appropriate
questionnaire, in a specific context.
235
Eustachian tube dysfunction in children with allergic rhinitis
Felicia Manole. Faculty of Medicine Oradea, Otorhinolaryngology, Oradea,
Romania.
The cause of a disorder of ventilation and drainage of the middle ear
is mainly a disorder opening mechanism of the Eustachian tube.The purpose
of the study is to evaluate the persistent symptoms of serous otitis media
in children with adenoid hypertrophy and allergic rhinitis.
Materials and Methods: The group study is made up of 128 patients with
adenoid hyperplasia and serous otitis media, examined and treated in the
Pediatric Hospital of Oradea. From all of this, 72 patients were diagnosed with
allergic rhinitis.
The objective endocavitary E.N.T. examination was systematically
performed on all patients. Evaluation criteria: degree of hearing loss, serous
rhinorrhea, nasal obstruction and sneezing.
We perform adenoidectomy under general anesthesia in all the patients.
In the second phase, 3 and 6 month later, patients were re-evaluated clinically
and audiological.
Results: In the case of patients group just with adenoid hypertrophy, serous
otitis media was remitted in 89% of cases at 3 month re-evaluation. In the case
of patients with allergic rhinitis and adenoid hypertrophy, serous otitis media
was remitted just at 39% of cases, with fluctuant evolution. At 6 month re-
evaluation, after treatment with desloratadine, mucolitic agents, the serous
otitis media was remitted completely. On second evaluation, in the case of the
first group, the study showed the reduction of nasal obstruction in 78% of
patients as compare to the second group, where recovery was present in only
38% of patients, certified by hearing tests and clinical aspects of tympanic
membrane at otoscopy.
Conclusion: As a result of adenoidectomy, improvement in permeability of
the Eustachian tube, diminish the effusion into the middle ear, but they persist
in the case of patients with associated allergic rhinitis. Antihistaminic drugs,
desloratadine, have an important role to prevent recurrent attacks of serous
otitis media in children.
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Allergic rhinitis and asthma survey: clinical and
psychological perspectives
Fulvio Braido, Ilaria Baiardini, Silvia Brandi, Anna Porcu, and Giorgio
Walter Canonica. University of Genoa, Allergy and Respiratory Diseases,
Genova, Italy.
Background: The existence of a close link between asthma and rhinitis, which
brings consequences both in therapy and disease management, has been
demonstrated by many studies.
Objectives: The trial we performed had the following aims: to assess
physicians_ knowledge on rhinitis/asthma comorbidity, to evaluate patients_
management behaviour and their experience about symptoms and expecta-
tions, to investigate the clinical and psychological meaning of GPs_ and
patients_ knowledge.
Methods: 101 general practitioners and 504 asthmatic patients were involved
in the study. They were asked to fill in two different multiple-choice
questionnaires about the association between asthma and rhinitis and its impact.
Results: 34.7% of general practitioners are aware of the asthma-rhinitis link,
and 43.6% of them assume the comorbidity on the basis of their clinical
experience. 21.8% of physicians make the diagnosis autonomously. 27.8% of
asthmatic patients experience three or less rhinitic symptoms, 41% from 4 to 6
symptoms, and 31.2 more than 6 symptoms. The symptoms have a deep
impact on daily life, as they are cause of sleep problems (87.3%), lack of
concentration (78.9%), difficulties in spare time (71.8%) and sport (71.7%).
Rhinitis symptoms are responsible for the worsening of asthma, with an
increase of dyspnoea (86.3%), cough (73.9%) wheezing (59%). 93% of
patients state they are interested in a combination therapy approach.
Conclusion: Asthma and rhinitis are associated in the development of clinical
burden and influence on quality of life. The survey results assume different
perspectives if are evaluated from the clinical and psychological point of view.
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Clinical efficiacy of antileukotriene threapy in allergic rhinitis:
changes in subjective and objective parameters, and quality
of life measures
Cemal Cingi1 and Kivanc Gunhan2. 1Eskisehir Osmangazi University, ENT,
Eskisehir, Turkey; 2Celal Bayar University, ENT, Manisa, Turkey.
Background: Leukotrienes and histamine are thought to be quantitatively
the most prominent mediators in the final pathways of allergic rhinitis (AR).
Intranasal corticosteroids and oral antihistamines are the cornerstones of
therapy. Antileukotriene therapy combined with antihistamine showed a
synergistic effect in treating AR, however, there is little data on objective
parameters and quality of life measures.
Methods: This multi-centered, prospective, randomized and plabebo
controlled study randomized 275 patients with mild or moderate intermitant
AR into three groups as: fexofenadine (120 mg/day), fexofenadine plus
montelukast (10 mg/day) or fexofenadine plus placebo. The nasal endoscopic
examinations, objective upper airway measurements (anterior rhinomanome-
try), were evaluated before and at end of 21 days treatment period. Daily
symptom scored by a standard visual analoge scale (VAS) and by a daily
diary of quality of life measures.
Results: Nasal endoscopic examination showed an additional effect on tur-
binate congestion with combination therapy. Objective nasal airway assess-
ment revealed that total nasal resistance decreased from 0,42 Pa/cm3/s to
0,32 Pa/cm3/s with monotherapy, and from 0,43 Pa/cm3/s to 0,27 Pa/cm3/s
with combination therapy (p G 0,05) in average. Mean symtom scores of
nasal congestion, nasal itching and sneezing pointed out a significant decline
in the first three days, however nasal congestion scores were better with the
antileukotriene add-on therapy. The positive effect on quality of life mea-
sures mainly in sleep, daily life activities and performance were increased,
but combination therapy revealed significantly better results at the end of
21 days. It is significantly more effective than placebo. No side effects
were encountered.
Conclusion: These data provide a basis for optimism in the control of AR
with antileukotriene-antihistamine combination therapy. The control on nasal
congestion was more pronounced subjectively and objectively comparing to
antihistamine alone. The effect might be due to the additional anti-
inflammatory activity as provided by reduction of inflammatory infiltrate
and cytokine levels. More long-term studies are needed to evaluate the clini-
cal effectiveness of antileukotrienes, especially as add-on therapy. Available
data suggest it is reasonable and safe to add these agents to standard therapy
if nasal symptomatology remains unresolved.
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The role of montelukast on perennial allergic rhinitis and
associated sleep disturbance and daytime somnolence
Carah Santos1, Chris Hanks1, Jeff McCann1, and Timothy Craig2. 1Penn
State College of Medicine, Allergy, Hershey, United States; 2Penn State
University, Medicine- Allergy, Hershey, United States.
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Background: One of the main manifestations of perennial allergic rhinitis is
congestion. Nasal congestion can predispose to sleep apnea and microar-
ousals. This sleep disturbance can result in daytime somnolence and fatigue.
The use of montelukast may be effective at reducing congestion, but
objective and subjective studies are lacking that demonstrate if the reduction
of congestion will result in improved sleep and reduced somnolence. It was
the purpose of this research to determine if montelukast is effective at
improving sleep and daytime somnolence in patients with perennial allergic
rhinitis.
Methods: The study was a crossover, double-blinded, placebo-controlled
study using montelukast 10 mg tablet or matched placebo and was approved
by the IRB. Active phase of the study included a 2-week run-in followed by a
treatment period of 2 weeks. After a wash out of 2 weeks, subjects were
crossed over to the alternate arm of the study for 2 weeks. Subjective
instruments to assess sleep and daytime somnolence were utilized. SAS was
used for statistical assessment.
Results: Montelukast 10 mg as compared to placebo statistically improved
daytime sleepiness (p = 0.0089) and daytime fatigue (0.0087). With our small
cohort we were unable to significantly demonstrate decreased congestion;
however; congestion was reduced by 0.52 on a scale of 0Y3, while placebo
reduced congestion by 0.16.
Conclusion: Montelukast can reduce daytime somnolence and fatigue and
may be a suitable alternative to topical nasal corticosteroids in those unwilling
to use or are intolerant to nasal steroids and have daytime impairment from
perennial allergic rhinitis.
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Intranasal phototherapy is more effective than fexofenadine
hydrochloride in the treatment of seasonal allergic rhinitis
Edina Garaczi1, Zsolt Bella2, Ma´rta Boros-Gyevi1, Emese To´th1, Zsanett
Csoma1, Lajos Keme´ny1, and Andrea Koreck1. 1University of Szeged,
Dermatology and Allergology, Szeged, Hungary; 2University of Szeged,
Otolaryngology, Head and Neck Surgery, Szeged, Hungary.
We recently showed that intranasal phototherapy represents an efficient
therapeutic modality in the treatment of allergic rhinitis. The aim of this
study was to compare the efficacy of intranasal phototherapy with that of
a second generation antihistamine fexofenadine HCl in allergic rhinitis. A
randomized open study was conducted in patients with history of moderate
to severe ragweed-induced allergic rhinitis. Thirty-one patients were ran-
domly assigned to receive either intranasal irradiation (low doses of UV-B,
UV-A and visible light, referred to as mUV/VIS) 3 times a week for 2 weeks
(n = 18), or 180 mg fexofenadine HCl per day for 2 weeks (n = 13). Each
patient kept a diary of symptoms for nasal obstruction, nasal itching,
rhinorrhea, sneezing and palate itching during the treatment. Total nasal score
(TNS), a sum of scores for nasal symptoms was also calculated. In the mUV/
VIS group the individual scores significantly decreased compared with
baseline for all of the parameters, sneezing (p = 0.0001), rhinorrhea (p =
0.0004), nasal itching (p = 0.0005), nasal obstruction (p = 0.009) and palate
itching (p = 0.0001). In the fexofenadine HCl group none of the scores
improved significantly at the end of the treatment except sneezing (p = 0.03).
TNS was significantly decreased in the mUV/VIS group (p = 0.00003), but
no significant change was observed in the fexofenadine HCl group. In
conclusion, we found that intranasal phototherapy is a more efficient ther-
apeutic tool than fexofenadine HCl in reducing clinical symptoms for
allergic rhinitis.
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The burden of illness of allergic rhinitis in Canada
Paul Keith1, Martin Desrosiers2, SusanWaserman3, and Robert Schellenberg4.
1McMaster University, Medicine, Hamilton, Canada; 2McGill University,
Universite de Montreal, Medicine, Montreal, Canada; 3McMaster University,
Allergy and Clinical Immunology, Hamilton, Canada; 4University of British
Columbia, Medicine, Vancouver, Canada.
Background: The objective was to assess the burden of symptoms in
Canadian adults with allergic rhinitis (AR).
Methods: A cross-sectional, random-digit-dialing telephone survey of
30,987 Canadian households was conducted in July 2006 to identify adult
AR patients. After screening 3671 adults, structured interviews were done
with 1001 respondents (patients diagnosed by a physician as having AR or
taking medication for AR).
Results: About 45% of Canadian adults report suffering from nasal symp-
toms due to allergies unrelated to colds. Less than half (45%) have been
diagnosed by a physician. Half only have seasonal symptoms, with spring
and summer being the worst seasons. Of those with AR, 27% had asthma,
17% chronic or recurrent sinusitis and 5% nasal polyps. More than one-
quarter cannot tolerate their symptoms without treatment. Most (83%) have
sought medical attention for their symptoms at one time and one-quarter
have done so in the past year. The most bothersome symptoms include stuffy
nose, runny nose, repeated sneezing and watering eyes. In their worst
month, two-thirds of patients reported having a stuffed nose either daily or
several days per week. Almost one-quarter reported headaches and sleep
loss. One-fifth describe symptoms as poorly controlled or not controlled
during the worst month of the year. One-half use only OTC products, 12% use
only prescriptions while one-quarter use both.
Conclusion: Despite treatment, many Canadians experience allergic rhinitis
symptoms that could be better evaluated and controlled. Asthma, sinusitis
and nasal polyposis are common concomitant conditions.
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Radiofrequency tissue ablation treatment in persistent allergic
rhinitis: effects on quality of life and objective parameters
Kivanc Gunhan, Halis Unlu, Ali Vefa Yuceturk, and Murat Songu. Celal
Bayar University, Otorhinolaryngology and Head-Neck Surgery, Manisa,
Turkey.
Background: In patients who suffer from persistent allergic rhinitis (PAR), a
severe drug-resistant hypertrophy and increase in glandular structures of the
inferior turbinates may develop, which leads to constant nasal obstruction and
rhinorea. Radiofrequency tissue ablation of the turbinates can reduce nasal
obstruction and secretions.
Methods: This prospective, single-sited study randomized 50 patients with
mild or moderate PAR who had substantial bilateral hypertrophy of the
inferior turbinates to mometasone furoate monohydrate nasal spray
(MFMNS), (2 sprays per nostril [total dose 200 2g] once daily), or
radiofrequency inferior turbinate ablation (RIFA), (2 or 3 punctures on each
site, total dose of 1510 T 110 joule, plateau temperature of 75-C, energy of
10 watt) treatment groups. Both objective outcomes evaluated by total nasal
resistance at anterior rhinomanometry and subjective outcomes assessed
with the Quality of Life Questionnaire were analyzed before and at least 12
months after treatment.
Results: The median total nasal resistance in patients treated with MFMNS
decreased from 0,49 T 0,17 Pa/cm3/s to 0,39 Pa/cm3/s (p = 0,42), and 0,51 T
0,18 Pa/cm3/s to 0,29 Pa/cm3/s in patients with RIFA (p = 0,003) 1 year
postoperatively. Compared with preoperative scores, the postoperative scores
of these patients significantly improved in both 7 separate domain scores
and overall Quality of Life Questionnaire scores (p = 0,004). Nasal symp-
tomatology was markedly reduced 1 month after radiofrequency applica-
tion. No adverse reactions including bleeding, infection, adhesions or
worsening of allergic symptoms were encountered. The patients experienced
a lasting benefit from this procedure.
Conclusion: These results suggest that topical mometasone reduces the
volume of inferior turbinate at some point while improving the quality of
life in patients with PAR. Radiofrequency inferior turbinoplasty is also
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improving quality of life and is more effective for decreasing nasal
resistance in patients with PAR who have substantial nasal congestion. This
effect might be due to the switch between the inflammatory cells and the
fibrotic tissue. Histopathologic and longer term studies are required to
enlighten the potential of RIFA in the management of allergic rhinitis.
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The role of allergic rhinitis in suppurative chronic otitis media,
prelaminary reports
Mehdi Bakhshaee1, Mohsen Rajati2, Mohammad Feraydouni3, and Ehsan
Khadivi1.1Mashad University of Medical Sciences,Imam Reza Educational
Hospital, Otolaryngology-Head & Neck Surgery, Mashad, Islamic Republic
of Iran; 2Mashad University of Medical Sciences, Quaem Educational
Hospital, Otolaryngology-Head & Neck Surgery, Mashad, Islamic Republic
of Iran; 3Mashad University of Medical Sciences,Bouali Research Center,
Immunology, Mashad, Islamic Republic of Iran.
Background: Eustachian tube dysfunction has a significant effect on
pathogenesis of ear diseases especially chronic otitis media (COM). In the
other hand, allergic rhinitis as a prevalent disease is a well-known condition
which has some effects on eustachian tube function and its role in serous otitis
media has been studied from several aspects, but its effects on chronic
suppurative otitis mediawith&without cholesteatoma has not been studied yet.
Methods: In a prospective case control study, 40 patients with suppurative
chronic otitis media who were candidates for surgery and 38 healthy, sex and
age-matched persons were evaluated for allergy using the standard ques-
tionnaire, prick test and serum IgE.
Results: Fifteen of patients (37.5%) and six of controls (15.8%) have allergic
rhinitis. The results showed the higher incidence of allergy in the patients’
group (P G 0.05).
Conclusion: To the authors’ knowledge, this is the first documented survey
showing the correlation between allergy and chronic otitis media. More
extensive studies on the effect of allergy especially allergic rhinitis on
chronic otitis media even postsurgical prognosis strongly recommended.
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Nasal mucosa remodeling and re-activation of epithelial
mesenchymal trophic unit in human allergic rhinitis
Tong Wang. Tongren Hispital Beijing, China, ENT Department, Beijing,
China.
Objective: To investigate the histopathologic characteristic of a marked
chronic inflammatory reaction and remodeling, and that the role of re-
activation of epithelial mesenchymal trophic unit in this marked structure
change of the nasal mucosa in allergic rhinitis.
Methods: Our study will be divided into two parts. The first part is to
investigate whether remodeling of the airway mucosa are present in nasal
mucosa of allergic rhinitis. The second part is to investigate the possible
role of epithelial mesenchymal trophic unit in the pathogenesis of
inflammation and remodeling in allergic rhinitis. The tissue blocks were
embedded in paraffin, and stained with hematoxylin and eosin (HE), alcian
blue periodic acid-Schiff (AB-PAS), Masson’s Trichrome(MT), and
immunohistochemical staining. The infiltrating eosinophils in nasal
mucosa were examined, AB-PAS-positive cells in the surface epithelium
in nasal mucosa were counted. The percentage area of MT stained
extracellular matrix in mucosa and conchae and damage of epithelium
were determined by an image analyzer. immunohistochemical staining
revealed EGF, EGFR, TGF-", and !-SMA immunoreactivity in nasal
mucosa.
Results: Epithelial damage (shedding), basement membrane thickening,
submucosa fibrosis, mucosal goblet cell hyperplasia, submucous gland
hyperplasia, and strikingly eosinophil infiltration, lymphocyte infiltration
was more prominent in patients with AR compared to the non-AR group
(p G0.05). Compared with the control group, immunohistochemical staining
revealed EGF, EGFR immunoreactivity in the damaged epithelium were
decreased in allergic rhinitis. However, stronger TGF-" and !-SMA
immunoreactivity was observed in allergic rhinitis mucosa as compared
with normal nasal mucosa.
Conclusion: The histopathologic findings of asthma, epithelial damage,
goblet cells hyperplasia and extracellular matrix deposition, namely,
inflammation and features of airway remodeling, are also present in
allergic rhinitis. It maybe result from activation of the epithelial-
mesenchymal unit, leading to myofibroblast activation and propagation of
remodeling responses into the submucosa. The concept of epithelial-
mesenchymal unit maybe contribute to the further understanding the
pathogenesis of allergic rhinitis and may provide potential targets for novel
therapy of allergic rhinitis.
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Rhinophototherapy in grass pollen induced allergic rhinitis
Zsolt Bella1, Edit Kadocsa1, Laszlo Szekely2, and Jozsef Jori1. 1University of
Szeged, ENT, Szeged, Hungary; 2MediCenter Medical Institute, ENT, Szeged,
Hungary.
Objectives: Our previous randomised double blind clinical study proved that
intranasal phototherapy using a combination of UVB (5%), UVA (25%) and
visible light (70%) (mUV/VIS)(Rhinolight\) is an effective modality to treat
allergic rhinitis (AR). The aim of this study was to show our clinical
experiences on grass pollen sensitized allergic patients.
Methods: We have treated AR patients (N = 243) with intranasal mUV/VIS
between 2003Y2006. 79 patients had moderate/sever intermittant grass pollen
induced AR. The pollen counts were over 40/m3 continuously. Rhinopho-
totherapy was performed in monotherapy or combined with oral antihista-
mines (once a day) or/with nasal steroids (maximum 400 2g/die). Each
intranasal cavity was irradiated 2Y3 times a week, for 2 weeks with mUV/VIS.
The dose of irradiation was raised step by step from 1.6 to 2.7 J/cm2/nasel
cavity. Nasal symptoms of each patient were registered on the treatment days
with a scale of 0 to 3 and the total symptoms on a visual analog scale
(VAS: 0Y10).
Results: 3 patients dropped out (3,8%). Finally 75 patients got full therapy.
Monotherapy mUV/VIS: got worse: 6% of the patients, didn’t change 19%,
improved: 75% by VAS. mUV/VIS+drugs: got worse 5%, didn’t change 8%,
improved 87%. The nasal symptoms were significantly improved in each
group. Rhinophototherapy was tolerated well. Using vitamin A oil 3Y4 times a
day the development of painful xeromucosa could be avoided. Only 2 patients
(2,53%) needed to have extra (more than one) brake days between two
treatment occasions.
Conclusion: These results suggest that intranasal phototherapy alone or
with drug combined is an effective modality to treat grass pollen induced AR.
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Clinical characteristics of children with allergic rhinitis (AR)
vs those with nonallergic rhinitis (NAR) from a university
pediatric allergy clinic
Chanthana Suratannon, NualanongVisitsunthorn, and Piyarat Lerdbannapong.
Mahidol University/ Siriraj Hosital, Pediatrics, Bangkok, Thailand.
Background: Proper differentiation of chronic rhinitis into AR and NAR is
essential since avoidance of offending allergen in AR could rapidly lead to
alleviation of symptoms whereas NAR is usually a chronic and non-remitting
condition. Unfortunately, allergy skin test is not feasible in general practice in
several countries around the world. The aim of this study is to determine
specific characteristics among pediatric patients with AR and NAR.
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Methods: Three hundred and two children with symptoms of chronic rhinitis
presented to a Pediatric Allergy Clinic between January to December 2006
were categorized into 2 groups, i.e, allergic rhinitis (AR) and nonallergic
rhinitis (NAR) according to their skin prick test results. Nasal cytology was
performed to further subcategorize NAR into nonallergic rhinitis with
eosinophilia syndrome (NARES).
Results: There were 222 (73.5 %) patients with AR and 80 (26.4 %) with
NAR. Nineteen (23.7%) NAR patients had NARES. The median age of onset
in patients with AR and NAR were 4 and 3 years old, respectively. Symptoms
of rhinorrhea, postnasal drip and nasal congestion did not differentiate the two
groups apart. Interestingly, nasal itching, sneezing and eye symptoms were
more common among AR than in NAR group (p G 0.01) while snoring and
sinusitis were more common in NAR than in AR group (p G 0.01). Seasonality,
severity of symptoms and the proportion of asthma did not differ between both
groups. Prevalence of food allergy were more common in AR than NAR group
(p G 0.05).
Conclusion: AR was about threefold more prevalent than NAR among
children presented to our allergy clinic with chronic rhinitis. Nasal itching and
sneezing were more common in AR than NAR group (p G 0.01) while snoring
and sinusitis were more common in NAR than AR group (p G 0.01). Eye
symptoms and history of food allergy were more common in AR than NAR
group (p G 0.01, p G 0.05).
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Impact of levocetirizine on symptoms of allergic diseases. Result
of questionnaire survey in Hungary in 2005
Erzse´bet Juha´sz. Kora´nyi National Institute for Pulmonology, XIV.Pulm. Dep.,
Budapest, Hungary.
Allergic diseases are the increasing global health problem either in all
over the world or in Hungary. In 2006 the incidence of allergic rhinitis was
25429 new cases (252%oo ), and the prevalence 263 925 (2619 %oo), and
incidence of allergic asthma was 12 693 (126,0%oo) and prevalence 141 561
(1404,,9%oo).
The basic treatment of the allergic disease has been H-1 receptor
antagonists, and the levocetirizine is a new oral, non-sedating H-1 antihis-
tamine, that has been shown to be effective against allergic symptoms, and
offers good tolerability.
Objective: To collect data concerning the treatment of allergic disease in
general practice. to measure the effectiveness of levocetirizine in the allergic
disease. to report the side effects during the levocetirizine therapy.
Methods: A nationwide survey was organized in 2005 in Hungary with
using the same questionnaire, filled two times ( at the start and at he end of
treatment period) in.The patients participated in survey had allergic disease and
was treated by levocetirizine during 6 months.Data of 17800 questionnaires
were analysed. 57,8% of patients were female and 42,2 % male (p G 0,001).
57,2% of all patients has been aged 20Y49 y, 19 % was younger than 19 y.
Results: 14 637 patients ( 82%) had allergic rhinitis, 3335 (19%) had urticaria,
3660 (20%) had allergic asthma, 1048 (6,8%) had atopic dermatitis, and 365
(2%) had food allergy. 57,1% of patients had symptoms of allergic disease
longer than 4 years. Cutan test was performed in diagnosing of allergic disease
in 78,5 % of patients, and in 92% was positive.
The allergic disease influenced the way life of patients in 76,3%, but
88% of patients had clinically important symptoms (serious 40,4 %, or
intermedient 47,4%). At the end of the survey 6,7% of patient had clinically
significant symptoms, so in 93,3 % of patients_s symptoms improved. The
58,5% of allergic rhinitis and 51,0% persistent rhinitis patients become
symptomless, and the ratio of symptom free cases was 51,3% of allergic
asthma, 43,8% of atopic dermatitis, 51,9% of food allergy and 47,0% of
urticaria. 52,4% of patients were treated by combination therapy. Side effects
occured in 2,1% of patients during the treatment period.
Summary: According the results of 6 months treatment of allergic diseases by
levocetirizine it has been established that the levocetirizine was effective,
decreased the clinical symptoms of allergic diseases, was well tolerated
without important side effects.
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Frequency of adenoid hypertrophy and atopy in childhood
Elena Korovkina. Mechnikov’s research institute for vaccines and sera,
Allergological department, Moscow, Russian Federation.
Background: The adenoid is a part of Waldeyer’s ring, the basic function of
which is antibody formation, that react later against a great variety of antigens.
Pediatric adenoidal obstruction of the nasal airway is associated with
significant morbidity and is a frequent indication for surgery, but its
relationship to allergy has not been often studied.
Methods: To examine the influence of atopy on the adenoid hypertrophy we
studied 35 children 1Y11 years old. In the analysed group all children suffered
from difficulty in nose breathing, rhinorrhea, recurrent upper respiratory tract
infections, hearing disorders, sleep disturbance. For the diagnostic of adenoid
hypertrophy we had used the anamnesis, anterior rhinoscopy, endoscopy
rhinoscopy. All patients had been consulted by the allergist-immunologist. For
the diagnosis of allergic rhintis we had used interview, skin prick-test, presence
of sIgE (RAST) in the serum, nasal provocation test with dust and polen
allergens.
Results: All children had had adenoid hypertrophy 2 or 3Y4 degree, 3 of them
had got the relapse of adenoids after the surgery. In the analised group 21
children (60%) had had the positive skin prick-tests and/or positive reactions
to specific IgE, mostly to different kinds of pollen or house dust mites;
eosiniphils in nasal secrete; positive nasal provocation tests. In this group 9
patients (25%) had had the bronchial asthma, and 6 children (17%) Y atopic
dermatitis. All patients with adenoids and allergic rhinitis had got the
complex therapy Y topical nasal steroid and antihistaminic in the ages
doses. The children with brochial asthma and atopic dermatitis also
received a pharmacological treatment. In a during of 3 weeks we observed
the most significant decrease of clinical symptoms and endoscopic adenoid
size.
Conclusion: The study shows that allergy and sensitivity to different kinds of
allergens is an important risk factor for a greater degree of adenoid
hypertrophy in children. Chronic allergic inflammation of the upper airway
is the causes of lymphoid hypertrophy with prominence of adenoidal and
tonsillar tissue. So, all patients with the difficulty in nase breathing and
reccurent upper respiratory tract infections need in the consultation by
allergist-immunologist for exception of allegic diseases.
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The quality of life in patients with atopic asthma associated with
allergic rhinitis
Ion Gabriel Stoica. Spitalul de Pneumologie, Ambulatoriul TBC Sector 3,
Bucharest, Romania.
Objectives: The aim of the study was to assess the effect of allergic rhinitis on
quality of life in patient with atopic asthma.
Methods: We examined 45 atopic asthmatics patients with persistent allergic
rhinitis and 36 patients with atopic asthma without allergic rhinitis. Quality of
life was measured by the Asthma Quality of Life Questionnaires (AQLQ).
Clinical symptom score and use of rescue medications were recorded in diaries
for 4 weeks before the assessment of quality of life. Lung function was
measured on the same day as the study of quality of life.
Results: Clinical symptom score and use of shortYacting $ 2Yagonists were
similar in both groups and there was no difference in FEV1 (63.00 3.75 vs.
65.84 3.58, p 9 0.05). Asthma symptom scores (2.83 0.14) and activity
limitation (3.47 0.22) within AQLQ were significantly lower for patients with
asthma and allergic rhinitis compared with those asthma patients without
allergic rhinitis (4.01 0.21 and 4.23 0.25, p G 0.05).
Conclusion: Persistent allergic rhinitis may have a negative effect both on
asthma symptoms and on quality of life in patients with atopic asthma.
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Study of the prevalence of aeroallergens in the patients with
allergic rhinitis referred to semnan allergy clinic between
December 2005 to December 2006
Mohammad Nabavi1, Mohammad Khaleghi Hashemian1, Mandana Keshavarzi2,
and Anahita Keshavarzi3. 1Amiralmomenin Hospital, Semnan Medical
University, Pediatric Immunology & Allergy, Semnan, Islamic Republic of
Iran; 2Alavieh Zanjaniha clinic, Allergy, Tehran, allergy, Tehran, Islamic
Republic of Iran; 3Medical Service Insurance Organization, Budget, Tehran,
Islamic Republic of Iran.
Background: Allergic rhinitis is the most common cause of rhinitis affecting
approximately 20% of the population. While allergic rhinitis is not a life-
threatening condition, complications can occur and the condition can
significantly impair quality of life, which leads to a number of indirect
costs. In susceptible individuals, exposure to certain foreign proteins leads to
allergic sensitization, which is characterized by the production of specific IgE
directed against these proteins. This specific IgE can be tracked with Standard
Skin Prick Test.
Methods and Materials: During 6 months of study, 334 cases of allergic
disorders referred to our allergy clinic, among them 295 were allergic rhinitis.
Standard Skin Prick Test with ALUSTAL prick allergens, aero-allergens and
food allergens, were performed for all of them and compared with negative and
positive standard control. Wheals of 3-mm and flares of 10-mm larger than
negative control regarded as positive test. Results were analyzed with SPSS
11.5 and prevalence of allergens was calculated in different groups of patients
in regard to age, sex and type of allergic rhinitis (perennial or seasonal).
Results: 150 males with mean age of 25.6 years (SD: 14.31) and 145 females
with mean age of 28.32 (SD: 12.93) were studied among them 85 patients
(30%) had seasonal Allergic Rhinitis (SAR), 117 patients (41.3%) had
Perennial Allergic Rhinitis (PAR), 65 patients (23%) had PAR with seasonal
aggravation and 16 patients (5.7%) had only episodic symptoms. 116 patients
had less than 5 years, 117 patients had 5Y10 years and 102 patients had more
than 10 years history of rhinitis. Aeroallergen sensitization were detected in
256 (86.5%) of patients and botanical allergens` sensitization were shown to
be present in 225 (76%) of patients. Chenopodiacea including Chenopodium
alba and Rough pigweed, trees especially ash, platanus, willow and birch, 12
grasses including artemisia, rye-grass and timothy were among the most
prevalent botanical allergens.
Conclusion: Allergic rhinitis is the most prevalent allergies which cause signs
and symptoms in genetically susceptible patients confronting environmental
allergens. In our study, aeroallergens were studied. As in other studies,
aeroallergens especially botanical allergens were shown to be the most
common allergens both in Seasonal and perennial allergic rhinitis with 86.5%
sensitive to one or more aeroallergens and 76% sensitive to one or more
botanical allergens.
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Rhinitis: is it allergic or not?
Azita Hekmatdoost, Nader H. Rad, and Meran Ghoreishi. Tehran University
of Medical Sciences, Faculty of Health, tehran, Islamic Republic of Iran.
Introduction: there are no acceptable criteria for distinguishing between
allergic and non-allergic rhinitis. The aim of this study was to compare the
clinical and para-clinical features of allergic and non-allergic rhinitis.
Methods: in a retrospective study, we compared the clinical and para-clinical
features of 442 allergic and 103 non allergic rhinitis patients (18Y50 year-old).
The evaluations included respiratory signs and symptoms, lab tests, and
respiratory function tests.
Results: patients with allergic rhinitis had more signs and symptoms within
their season in terms of cough, sneezing, nasal congestion, rhinorrhea, itchy
eyes and nose, and respiratory function test (p G 0.001), whereas those with
non-allergic rhinitis had more persistent symptoms, and headaches (p G 0.01).
Food allergy, OR = 1.8, (1.4Y2.1), P G 0.01, serum Ig E, OR=2.1, (1.9Y2.19),
P G 0.001, and airway hyperresponsiveness, OR=1.7 (1.4Y1.9), P G 0.01 were
more common in patients with allergic rhinitis.
Conclusion: our results indicate that the signs and symptoms have
more fluctuation in allergic rhinitis, and more sever within their season.
More studies with respect to both adults and children with rhinitis is
recommended.
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Allergic and non-allergic rhinitis in adolescent and adults
Levan Bolokadze, Eugeniya Bolokadze, and Volodimir Fedotov. Kharkov
Allergological Centre, Allergology, Kharkov, Ukraine.
Background: The aim of this study was to describe differences between
allergic rhinitis (AR) and nonallergic rhinitis (NAR) in a large community-
based sample of adolescents and adults.
Methods: A total of 354 subjects, 10Y50 years of age, who in a screening
questionnaire had reported a history of airway symptoms suggestive of asthma
and/or allergy, or who were taking any medication for these conditions were
clinically examined. All participants were interviewed about respiratory
symptoms and furthermore skin test reactivity, lung function and airway
responsiveness were measured using standard techniques.
Results: A total of 64% of the subjects with rhinitis had AR, whereas 46%
had NAR. Subjects with NAR were more likely to be females, OR = 2.13
(1.24Y3.22), P = 0.004, to have persistent symptoms within the last 6 weeks,
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OR= 1.87 (1.23Y2.65), P = 0.002, and to have recurring headaches, OR = 1.94,
(1.34Y3.45), P = 0.021. On the other hand, subjects with NAR were less likely
to have airway hyperresponsiveness, OR = 0.34, (0.32Y0.46), P G 0.001, food
allergy, OR = 0.32, (0.18Y0.33), P = 0.007 and to have been treated with
antihistamines in the last 6 weeks, OR = 0.23, (0.22Y0.35), P G 0.002 compared
with subjects with AR. Subjects with AR were symptomatically worse within
their season in terms of sneezing (P G 0.002) and itchy eyes (P G 0.002),
compared to subjects with NAR, whereas nasal congestion and rhinorrheawere
equally frequent in the two groups (P = 0.32 and P = 0.44, respectively).
Conclusion: The proportion of subjects with NAR in an adolescent and adult
population with rhinitis is around one-fourth. Women have NAR twice as often
as men. In general, subjects with NAR have more persistent but equally severe
symptoms compared to subjects with AR. However, subjects with allergic
rhinitis have more sneezing and itchy eyes within their particular season of
allergy compared to subjects with nonallergic rhinitis.
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Relationship between histamine H1 receptor occupancy (RO)
and reduction of symptoms of seasonal allergic rhinitis (SAR) by
levocetirizine (L) in subjects exposed to pollen in an
environmental exposure unit (EEU)
Margherita Strolin Benedetti1, Marie-Etienne Pinelli2, Michel Gillard3, Rhys
Whomsley4, and Michael Canning5. 1UCB Pharma SA, Non Clinical
Development, Nanterre, France; 2UCB Pharma SA, Global Medical Affairs
Allergy and PCP, Nanterre, France; 3UCBPharma SA, In Vitro Pharmacology,
Braine l’Alleud, Belgium; 4UCB Pharma SA, Non Clinical Development,
Braine l’Alleud, Belgium; 5UCBPharma SA, Non Clinical Department, Braine
l’Alleud, Belgium.
Background: the estimation of in vivo RO, which takes into account the
affinity of an H1 antihistamine for the histamine H1 receptor and its free
plasma concentration, is a far better predictor of human pharmacodynamics
evaluated by the inhibition of histamine or allergen-induced wheal & flare than
considering in vitro affinity and plasmatic half-life only (Gillard et al. Inflamm
Res 2005, Frossard et al. Br J Clin Pharm 2007). The purpose of this study is to
assess whether this is valid also for other pharmacodynamic models such as
that scoring the symptoms of SAR in ragweed sensitive subjects exposed to
ragweed pollen in an EEU.
Methods: 119 subjects (mean age 34 yrs, mean bodyweight 81 kg) were
exposed to pollen in the EEU at 9 am of Day 1. At 11 am, they received a
single dose of 5mg L and remained in the EEU until 4 pm. On Day 2, subjects
were exposed again to pollen in the EEU from 8 am until noon. The primary
efficacy variable was the reduction from baseline in the Major Symptoms
Complex (MSC) score (calculated as the sum of the following 6 symptoms:
runny nose, itchy nose, sniffles, nose blows, sneezes and watery eyes).
Baseline value was the MSC score before drug administration (9Y11 am of
Day 1). The MSC score was evaluated at different times after L administration
(see table). Plasma concentrations at different times after administration of a
single dose of 10 mg L were obtained from a study in 24 healthy volunteers
(mean age 35 yrs, mean bodyweight 67 kg) (Baltes et al. Fund Clin Pharm
2001), normalized to the therapeutic dose of 5 mg (see table). The plasma
protein binding data of L come from Bree et al. (Fund Clin Pharm 2002). The
RO has been calculated as described by Gillard et al. (Inflamm Res 2005).
Results: The kinetics of change from baseline in MSC score fit much better
with those of RO than with those of free plasma concentrations (see table). It is
possible however that the free plasma concentrations of L do not represent
those at the receptor at very short times and that the RO values calculated are
over-estimated at these times. It is also possible that there is a lag time between
the RO and the relief of some of the symptoms.
Conclusion: the EEU model confirms previous results that the kinetics of RO
by L are a better predictor of the efficacy of the drug than are plasma
pharmacokinetics.
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Expression of matrix metalloproteinase 2, 9 and 13, TIMP 1, 2 in
the allergic nasal mucosa
Mori Sachiko, Ruby Pawankar, Chika Ozu, Ryuta Takizawa, Manabu Nonaka,
and Toshiaki Yagi. Nippon Medical School, Department of Otorhinolaryngol-
ogy, Tokyo, Japan.
Background: Matrix Metalloproteinases (MMPs) are extracellular matrix











occupancy (%) MSC score (mean)
Change from baseline*
in MSC score (mean)
0.25 124.3 24.2 89 V V
0.5 230.3 44.9 94 17.11 0.74
1.0 230.9 45.0 94 12.18 j4.18
1.5 205.0 39.9 93 9.86 j6.51
2.0 189.1 36.8 93 8.71 j7.66
2.5 V V V 7.53 j8.83
3.0 168.4 32.8 92 7.24 j9.12
3.5 V V V 7.14 j9.22
4.0 151.1 29.4 91 7.24 j9.13
4.5 V V V 6.96 j9.40
5.0 V V V 7.20 j9.16
6.0 110.4 21.5 88 V V
9.0 75.1 14.6 83 V V
12.0 54.5 10.6 78 V V
16.0 35.1 6.8 69 V V
21.5 V V V 8.18 j8.17
24.0 18.4 3.6 55 8.82 j7.52
* MSC at baseline = 16.36
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inhibitors of MMPs known as TIMP regulate MMP function. Allergic rhinitis
(AR) and asthma share many similarities in their inflammatory response but
epithelial shedding, basement membrane thickening and fibrosis are not seen
in AR. By contrast, nasal polyps share some features with asthma. As in
asthma, we demonstrated an increased expression of MMP-9 and low TIMP
in nasal polyps. We hypothesized that the differential expression of MMPs
may at least in part contribute to the differences between AR and asthma.
Methods: We performed nasal allergen challenge (NAC) in AR patients with
mite allergen disks and control disks and analyzed the number of MMP 2,9,13
and TIMP 1,2 in nasal biopsies at 30 min, 6 hrs and 12 hrs post challenge. By
ELISA, we examined the levels of MMP-2, 9 and 13, and TIMP1,2 in the nasal
mucosa of AR patients.
Results: At 30 min post NAC, MMP-2 and 13 were increased. At 6 hrs post
NAC, MMP-2 and at 12 hours post NAC, MMP-2 and 13 were significantly
increased. TIMP-1 was increased at 30 min. At 30 min and 12 hr post NAC,
the MMP 2 : TIMP1,2 and MMP-13 : TIMP1,2 ratio was high. The levels of
MMP-2 and 13 but not MMP-9 were high in the allergic nasal mucosa.
Conclusion: These results suggest that MMP-2 and 13 may play an important
role in the pathomechanisms of allergic rhinitis and that this differential
expression of MMPmay contribute at least in part contribute to the differences
between AR and asthma.
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CRTH2 plays an essential role in the pathophysiology of Cry j
1-induced pollinosis in mice
Mitsuhiro Okano1, Rie Nomiya1, Tazuko Fujiwara1, Kazunori Nishizaki1,
Kosuke Kino2, Hiroyuki Hirai3, and Masataka Nakamura4. 1Okayama
University Graduate School of Medicine, Dentistry and Pharmaceutical
Sciences, Otolaryngology - Head & Neck Surgery, Okayama, Japan; 2Meiji
Co., Iyaku Jigyobu, Odawara, Japan; 3Bio Medical Laboratories, Inc.,
Department of Advanced Medicine and Development, Saitama, Japan;
4Tokyo Medical and Dental University, Human Gene Sciences Center, Tokyo,
Japan.
Background: Prostaglandin (PG) D2 is the major prostanoid produced during
the acute phase of allergic reactions. Two PGD2 receptors have been isolated,
DP and CRTH2, but whether they participate in the pathophysiology of
allergic diseases remains unclear. We investigated the role of CRTH2 in the
initiation of allergic rhinitis in mice.
Methods: First, we developed a novel murine model of pollinosis, a type of
seasonal allergic rhinitis. Pathophysiological differences in the pollinosis were
compared between wild-type and CRTH2-gene deficient mice. An effect of
treatment with ramatroban, a CRTH2/T-prostanoid dual antagonist, was also
determined.
Results: Repeated intranasal sensitization with Cry j 1, the major allergen of
Cryptomeria japonica pollen, in the absence of adjuvants significantly
exacerbated nasal symptoms, Cry j 1-specific IgE and IgG1 production,
nasal eosinophilia, and Cry j 1-induced in vitro production of IL-4 and -5 by
submandibular lymph node cells. In addition, CRTH2 mRNA in nasal mucosa
was significantly elevated in Cry j 1-sensitized mice. Following repeated in-
tranasal sensitization with Cry j 1, CRTH2-gene deficient mice had sig-
nificantly weaker Cry j 1-specific IgE/IgG1 production, nasal eosinophilia, and
IL-4 production by submandibular lymph node cells than wild-type mice.
Similar results were found in mice treated with ramatroban.
Conclusion: These results suggest that the PGD2-CRTH2 interaction is
elevated following sensitization and plays a proinflammatory role in the
pathophysiology of allergic rhinitis especially pollinosis in mice.
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The clinical course of allergic rhinitis and asthma and changes
in skin prick test and spirometry in the aftermath of
hurricane Katrina
Prem Kumar, Annette Fiorillo, Sandhya Mani, and Douglas Barstow. LSU,
Allergy/Immunology, New Orleans, LA, United States.
Background: Allergic rhinitis and asthma are both prevalent diseases seen in
everyday practice. In the aftermath of hurricane Katrina several of our patients
reported exacerbations of allergic rhinitis, allergic conjunctivitis and either
exacerbations or development of asthma. As a result of Katrina many homes
were flooded, causing significant increased mold levels. We sought to
investigate if these changes in reported symptoms correlated with changes in
Skin Prick Test (SPT) reactivity and/or changes in spirometry.
Methods: At the start of the study, we looked at patients who reported
increased allergic symptoms and in whom we had previously performed SPT.
We then repeated SPTand compared the results to earlier findings. In addition,
patients who had a history of asthma or those complaining of respiratory
symptoms had spirometry done and their results were compared with those
done before Katrina.
Results: Four of five patients were reactive to many antigens to which they
were previously anergic. Reactivity to molds was increased, most commonly
Alternaria, Aspergilus fumigatus and Cladosporium. In addition changes in
spirometry were also noted. In one patient who initially had normal spirometry
with negative methalcholine challenge, developed abnormal spirometry. This
patient’s FEV1 was markedly decreased and improved by more than 15% after
bronchodilators.
Conclusion: There has been much concern about the effect Katrina may have
had on patient health. Many patients have demonstrated increased symptoms
relating to allergic rhinitis and asthma. These cases demonstrate that atopic
patients in New Orleans have been sensitized to new allergens. Patients that are
experiencing increased symptoms of rhinitis, conjunctivitis or asthma should
be re-evaluated with SPT, spirometry and a thorough history to environmental
exposure. With the large number of people affected by Katrina, further studies
should be performed as more patients return to the New Orleans area.
256
Mechanisms of mast cell migration into the allergic
nasal epithelium
Chika Ozu, Ruby Pawankar, Takizawa Ryuta, Nonaka Manabu, and Yagi
Toshiaki. Nippon Medical School, Departoment of Otorhinolaryngology,
Tokyo, Japan.
Objective: Mast cells are increased in the nasal epithelium of patients with
allergic rhinitis (AR). Yet, the precise mechanisms of this increase are unclear.
We previously reported that nasal mast cells express CCR3 and exhibit
increased chemotaxis to RANTES suggesting a role for RANTES in mast cell
migration. To further confirm this, in the present study we examined the levels
of RANTES, eotaxin and SCF in the epithelium and lamina propria of patients
with AR and the kinetics of RANTES+, tryptase+, and CCR3+ cells in the
epithelium and lamina propria after nasal allergen challenge.
Methods: By ELISA, we examined the levels of RANTES, eotaxin and SCF
in homogenized nasal scrapings and lamina propria of AR patients. In AR
patients, we performed nasal allergen challenge with house dust mite, took
biopsies at 30 min, 6 hrs, and 12 hrs and by immunohistochemistry, we
examined the number of Tryptase+ RANTES+, eotaxin+ and CCR3+ cells as
compared to control.
Results: The levels of RANTES, but not Eotaxin and SCF was greater in the
epithelium than in the lamina propria. At 30 minutes after nasal allergen
challenge, Tryptase+, RANTES+ and CCR3+ cells were increased in the
epithelium. At six hours post challenge, Tryptase+ and RANTES+ cells were
increased in the epithelium but at 12 hrs only an increase in Tryptase+ cells
was detected.
Conclusion: Migration of the mast cells in the allergic nasal epithelium
occurred as early as 30 min with a parallel increase in CCR3+ and RANTES+
cells. These results further confirm that RANTES is one of the critical factors
regulating mast cell migration into the allergic nasal epithelium.
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The effect of levocetirizine and dextrocetirizine on the transport
of tetraethylammonium in chinese hamster ovary cells
transfected with the human organic cation transporter OCT2
Rhys Whomsley1, Margherita Strolin Benedetti2, Theresa Wunz3, and
Stephen Wright3. 1UCB Pharma SA, Non Clinical Development, Braine-
l’Alleud, Belgium; 2UCB Pharma SA, Non Clinical Development, Nanterre,
France; 3University of Arizona, Department of Physiology, Tucson, United States.
Background: Recently a pharmacokinetic interaction between cetirizine and
pilsicainide was reported (Tsuruoka S, et al, CPET 2006 ; 79(4) :389Y96) and
explained as a consequence of competition between the two drugs for renal
excretion mediated by the transporter proteins organic cation transporter 2
(hOCT2) and P-glycoprotein. The effect of levocetirizine and dextrocetirizine,
the eutomer and the distomer of cetirizine, respectively, on the transport of
the hOCT2 substrate tetraethylammonium (TEA), was investigated in vitro in
chinese hamster ovary (CHO) cells stably transfected with hOCT2.
Methods: CHOhOCT2 cells were seeded in 12 well plates and grown to
confluence. Once confluent, transport experiments were conducted. Transport
buffer containing [3H]TEA, and levocetirizine, dextrocetirizine or positive con-
trol (cimetidine) were added to the wells. At intervals, the transport buffer was
removed, and each well rinsed three times with 1 mL of ice cold buffer to stop
transport. Cells were solubilized and aliquots removed for scintillation counting.
Results: Levocetirizine and dextrocetirizine inhibited TEA uptake in
CHOhOCT2 cells with IC50 values of 197 and 714 6M, respectively. In
comparison, the positive control cimetidine inhibited TEA uptake with an IC50
of 266M.
Discussion: Levocetirizine is a weak inhibitor of hOCT2. The IC50 value for
inhibition of tetraethylammonium transport by levocetirizine is more than 300
fold the Cmax (0.66 6M) at steady state following the therapeutic dose of 5 mg.
It is unlikely that levocetirizine can cause drug interactions by interference
with renal elimination through inhibition of renal OCT2. As dextrocetirizine is
a weaker inhibitor of hOCT2 than levocetirizine, the racemate cetirizine is also
unlikely to cause drug interactions through inhibition of hOCT2.
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Expression of glucocorticoid receptor-$ in
glucocorticoid-resistant allergic rhinitis
Akihiro Ishida, Nobuo Ohta, and Masaru Aoyagi. Yamagata Univ., School of
Medicine, Department of Otolaryngology, Yamagata, Japan.
Background: Glucocorticoid (GC) has been commonly used as an anti-
inflammatory reagent in the treatment of chronic allergic diseases including
allergic rhinitis. The effects of GC are mediated by glucocorticoid receptor-"
(GR-"). Upon binding GC, activated GR-" can not only enhance transcription
of anti-inflammatory genes but also interact with other protein regulating
inflammation, such as nuclear factor-0B (NF-0B). However, these clinical
benefits are sometimes limited because some patients demonstrate persistent
tissue inflammation despite treatment with high doses of GC. It is generally
considered that the interference of non-functional GR variants in immune cells
may result in GC-resistance. GR-$ is a well-known natural spliced variant
consisting of 742 amino acids including exon 2-8 and part of 9$ as coding
region, but cannot bind to GC. It has been reported that there was an increase
of GR-$ expression in patients with bronchial asthma and in ulcerative colitis
patients who did not respond to GC administration. We have tested
this hypothesis by investigating correlation between the expression of GR-",
GR-$, and NF-0B proteins in patients with allergic rhinitis and the
responsiveness to GC treatment.
Methods: The patient group consisted of 20 subjects with allergic rhinitis
showed persistent GC-resistance, resulting in a required surgical removal after
the GC treatments for over 6 months. As normal control, nasal tissues were
obtained from 10 subjects underwent maxillofacial surgery. They had not been
exposed to GC treatment. We have performed immunohistochemical analysis
to detect GR-", GR-$ and NF0-B proteins in nasal tissues.
Results and Conclusion: Compared to normal subjects, whereas the number
of GR-"-positive inflammatory cells was decreased, the number of GR-$-
positive cells was significantly increased in nasal tissues from patient group.
The number of NF-0B-positive cells was at a similar level both patients and
normal control. In conclusion, our data suggests that increased over expression
of the GR-$ relative to GR-" is associated with GC-resistance.
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Effect of azelastine on substance P release into nasal lavage from
non-allergic rhinitis patients
Radoslaw Gawlik1, Barbara Jawor1, and Lawrence DuBuske2. 1Silesian
University School of Medicine, Allergy and Immunology, Zabrze, Poland;
2IRINE, Allergy and Immunology, Gardner, United States.
Introduction: Non-allergic rhinitis is a condition which affects 30 to 50% of
patients with perennial nasal symptoms, occurring either alone or in
conjunction with allergic rhinitis. Neural mechanisms may have a role in
this condition. This study assesses the impact of intranasal azelastine on the
concentration of substance P (SP) in nasal lavage fluid.
Methods: 28 patients were defined as having non-allergic rhinitis by history,
examination in addition to the presence of negative skin prick tests using
common inhalant allergens and low total IgE using the Phadia CAP. 16/28
patients were treated with intranasal azelastine two sprays twice daily for 10
days. The control group consisted of 12 patients with non-allergic rhinitis who
used a saline nasal spray, 2 sprays twice a day. Nasal lavages were performed
before and after a 10 day treatment period with intranasal azelastine or control
saline nasal spray. The concentration of SP in nasal lavage fluid was
determined by an EIA (Assay Designs Inc., USA) method. All patients
recorded their nasal symptoms daily, including rhinorrhea, sneezing, pruritus,
and congestion, using a Visual Rating Scale (VRS).
Results: The baseline concentrations of SP in the nasal lavage fluid were
similar in the azelastine and the placebo group (86.8 T 18.2 pg/mL versus 82.3 T
21.4 pg/mL). Significantly lower concentrations of substance P were noted in
nasal lavage fluid after 10 days of azelastine treatment (73.2 T 16.9 pg/mL)when
compared with placebo treatment (83.1 T 17.8 pg/mL). The differences between
the azelastine and the placebo treated group VRS symptom scores (6.4 T 2.4
versus 8.6 T 3.2) were also statistically significant demonstrating that the
reduction in nasal lavage SP levels occurred in conjunction with improvement in
clinical symptoms.
Conclusion: Intranasal azelastine reduces substance P release into nasal
lavage fluid of non-allergic rhinitis patients associated with clinical
improvement during a 10 day treatment period. The efficacy of azelastine in
perennial non-allergic rhinitis may be related to reduction of release of SP and
other non-adrenergic non-cholinergic neural mediators into nasal secretions.
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A double blind placebo controlled study on the clinical efficacy
and in vivo pharmacodynamics of potassium humate in the
treatment of hayfever in patients with inhalant allergies
Johanna Meeding, Justin Gandy, Constance Medlen, and Jacques Snyman.
University of Pretoria, Pharmacology, Pretoria, South Africa.
Humic acids are macrocolloidal molecules resulting from the
decomposition of plants and are natural components of drinking water, peat,
soil and brown coal. The beneficial effects of humic substances have been
partly ascribed to the ability of humic acids to absorb or chelate toxic
compounds or metals and to absorb xenobiotics mutagens and mycotoxins.
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Several mechanistic studies were done on potassium humate, derived
from bituminous coal, during the last few years. It was established that this
product stimulates lymphocyte proliferation by an increased production of
the growth factor, IL2.
However, no in vivo studies have been done on the anti-inflammatory
effects of humate derived from coal in humans. It was proven that humic acid s
extracted from brown coal have no toxic or teratogenic effects.
Purpose: The aim of this study is to investigate potassium humate`s anti-
inflammatory properties in patients suffering from exacerbations of hayfever
during the grass pollen season in South Africa, using clinical symptoms and
signs as well as establishing changes in inflammatory markers using
established and new laboratory techniques.
A total symptom score over a 12 hour period and a quality of life
questionnaire were evaluated.
Potassium humate (1.8g in daily divided doses) was randomly assigned
to 20 atopic patients presenting with acute symptoms of hayfever. 20 Patients
received a placebo resembling the humate. Treatment period was one month,
preceded by a one week run-in period.
Symptoms were scored on a scale of one to four for nasal and non-
nasal symptoms.
A global clinical impression was scored by the doctor at end of study:
Measurement of surface area of skin prick test was done at baseline and again
at the end of the study. It was restricted to the inhalant that indicated the biggest
reaction.
Results: No differences in the presence and improvement of symptoms were
detected between the 2 groups. Results of the quality of life assessment were
also the same for the 2 groups.
Flare size comparison showed some promising results with a
significant difference (p G 0.05) observed when comparing the before and
after results of the treated versus placebo groups respectively.
Conclusion: Potassium humate shows promise in the treatment of hayfever or
allergic rhinitis. The study was also conducted on inflammatory markers and
showed positive results, the results presented elsewhere. The duration of the
study, one month, might have influenced the results.
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Evidence that nasal mucosal hyperreactivity in healthy women is
induced by high levels of estrogen
KarinToll1, PeterGraf 2,MagnusBackheden3, andParStjarne1. 1Karolinska Institutet,
Division of Otorhinolaryngology, Stockholm, Sweden; 2Karolinska
Institutet, Dept. of Women and Child Health, Stockholm, Sweden; 3Karolinska
Institutet, LIME, Stockholm, Sweden.
Background: Pregnancy rhinitis, a common condition, is thought to affect
18Y30 % of pregnant women. It is very annoying for many women, may
develop at any time during pregnancy and usually disappears shortly after
delivery. The cause is not known and it may be due to hormonal factors. Some
data have shown that there may be a relation between high estrogen levels and
nasal mucosal reactivity. The knowledge of the etiology of this condition is
important since no satisfactory treatment is available. The aim of this study
was to determine whether nasal mucosal reactivity and microcirculation
change with various levels of estrogen in the blood, but constant levels of other
hormones.
Methods: 15 women who were undergoing in vitro fertilization (IVF) were
included. The examination and measurements of the nasal mucosa were done
in the first part when the concentrations of estrogen in the blood are extremely
low and then, when the concentrations of estrogen is high. The nasal mucosa
was studied with a combination of rhinostereometry and laser-Doppler
flowmetry during challenge with histamine. The swelling of the nasal mucosa
was recorded with rhinostereometry. This optical, direct, non-invasive method
is designed to measure nasal mucosal swelling with a high degree of accuracy.
Laser-Doppler flowmetry, a non-invasive method for studying the micro-
circulation, is providing continuous and instantaneous measurements of nasal
mucosal blood flow. The combination of rhinostereometry and Laser-Doppler
flowmetry has the advantage of using two non-invasive methods which
permit direct and simultaneous measurements of congestion and the
microcirculation.
Results: With rhinostereometry we found an increase in nasal mucosal
swelling after histamine challengewhen the estrogen levels in blood were high.
With laser-Doppler flowmetry the increases of the microcirculatory parameters
velocity of moving blood cells and perfusion were lower when the estrogen
levels in blood were high.
Conclusion: High levels of estrogen in blood during IVF treatment of healthy
women may induce nasal hyperreactivity and changes in microcirculation.
This suggests that estrogen plays a role in pregnancy rhinitis.
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Effect of a Lactobacillus paracasei on grass pollen
allergic rhinitis
Sophie Nutten1, Jacqueline Wassenberg2, Re´gine Audran2, Julie Moulin1,
Ire`ne Corthe´sy-Theulaz1, Annick Mercenier1, and Fran0ois Spertini2. 1Nestle
Research Center, Nutrition and Health Department, Lausanne, Switzerland;
2CHUV, Service d’Immunologie et d’Allergie, Lausanne, Switzerland.
Background: Lactobacillus paracasei strain NCC2461 has been found to
exert anti-allergic effects in animal models.
Aim: the aim of the present study was to investigate the effect of NCC2461 in
patients with allergic rhinitis to grass pollen.
Methods: 31 subjects (18-35 years-old) were enrolled in a randomized
double-blind, placebo-controlled cross-over study. The study consisted of
a first 4 weeks period in which subjects consumed either fermented milk
containing NCC2461 or placebo (acidified milk drink), a washout period of
six to eight weeks and a final 4 weeks period cross-over of the first
treatment phase. The entire study was performed out of the pollen season.
Clinical symptoms were analysed after a nasal provocation test using
grass pollen allergens and immunological parameters (specific immunoglo-
bulins in serum, percentage of eosinophils in nasal washes and cytokines
secreted by restimulated PBMC) were compared between the two treatment
periods.
Results: A trend to a decrease of nasal itching favouring probiotic treatment
was noticed, and a significant improvement of the nasal blockage favouring
probiotic treatment was observed. However, no significant change of the nasal
reaction threshold was observed between the end of the first and second
treatment periods, whatever the sequence (active product before or after
placebo) of product consumption. Immunological parameters’ analyses are
under investigation. No side effects were reported for both groups during the
study period.
Conclusion: A decrease of nasal blockage was observed in allergic
patients nasally challenged with grass pollens, after NCC2461 consump-
tion. The ongoing analysis of immunological parameters should help
understanding the mechanisms leading to the mitigation of respiratory
allergy symptoms.
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Fluticasone furoate nasal spray demonstrates consistent efficacy
against both the nasal and ocular symptoms of seasonal
allergic rhinitis
Robert Naclerio1, Tom Toler2, and Anna Ellsworth2. 1University of Chicago,
Department of Surgery, Chicago, United States; 2GlaxoSmithKline, Research
and Development, Research Triangle Park, NC, United States.
Background: Fluticasone furoate (FF) is a novel enhanced-affinity gluco-
corticoid that has been developed for topical respiratory use. Data from four
randomised studies are presented to demonstrate the consistent nasal and
ocular efficacy of FF nasal spray (FFNS) in adolescent and adult patients with
seasonal allergic rhinitis (SAR).
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Methods: Patients aged Q12 years with confirmed SAR were enrolled in the
four studies (n = 1141, combined total) and received once-daily double-blind
treatment with FFNS 110 6g (n = 571, combined total) or vehicle placebo
spray (n = 570, combined total) for 2 weeks. Individual nasal and ocular
symptoms were scored by patients each on a 4-point categorical scale (0 =
none to 3 = severe) each morning and evening. Nasal and ocular efficacy was
evaluated by the mean change from baseline over the 2-week treatment period
in daily reflective Total Nasal Symptom Score (rTNSS; average of AM and
PM score totals for nasal congestion, nasal itching, rhinorrhoea, and sneezing)
and daily reflective Total Ocular Symptom Score (rTOSS; average of AM and
PM score totals for eye itching/burning, tearing/watering, and redness). The
AM pre-dose instantaneous Total Nasal Symptom Score (iTNSS) and Total
Ocular Symptom Score (iTOSS) were also assessed as a measure of 24-hour
symptom control.
Results: Significant and consistently greater improvements in rTNSS were
seen with FFNS than with placebo across all four studies (least square [LS]
mean difference: j2.012, j0.777, j1.757, j1.480; Pe0.003). In addition,
ocular efficacy was demonstrated consistently across studies, with signifi-
cantly greater improvements in rTOSS in FFNS recipients than in placebo
recipients (LS mean difference:j0.736,j0.546,j0.741,j0.600; P=0.008).
FFNS showed sustained efficacy against both nasal and ocular symptoms over
24 hours, based on the AM pre-dose iTNSS (LS mean difference vs placebo:
j1.885,j0.902,j1.898,j1.370; PG0.001) and iTOSS (LS mean difference
vs placebo: j0.734, j0.519, j0.764, j0.560; Pe0.009). FFNS was well
tolerated in all four studies.
Conclusion: FFNS once daily consistently demonstrates significant and
sustained efficacy against both the nasal and ocular symptoms of SAR in
adults and adolescents in prospective analyses performed over a programme of
four clinical studies.
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Favourable safety and tolerability with fluticasone furoate nasal
spray in children with allergic rhinitis
Jorge Maspero1, Eli Meltzer2, Ita Tripathy3, Wei Wu4, Junghee Lim4, and
Edward Philpot4. 1Fundacion Cidea, Allergy and Respiratory Research Unit,
Buenos Aires, Argentina; 2Allergy & Asthma Medical Group & Research
Center, , San Diego, United States; 3Phelps County Regional Hospital, Rolla,
MI, United States; 4GlaxoSmithKline, Research and Development, Research
Triangle Park, NC, United States.
Background: The safety profile of the novel enhanced-affinity glucocorticoid
fluticasone furoate (FF) administered using a unique, side-actuated device has
been investigated in children with perennial (PAR) and/or seasonal allergic
rhinitis (SAR).
Methods: Safety was evaluated in an integrated analysis of data from three
randomised, double-blind, parallel-group studies in 1224 paediatric patients
aged 2Y11 years with SAR or PAR. Patients received once-daily FF nasal spray
(FFNS) 55 6g (n = 369) or 110 6g (n = 426), or placebo (n = 429) for 2 weeks
(SAR study) or 6 or 12 weeks (PAR studies). Assessments included evaluation
of adverse events (AEs), clinical laboratory tests, nasal examinations,
ophthalmic examinations (12 week PAR study only) and electrocardiograms
(ECGs). In the 6-week study, the effects of once-daily FFNS 110 6g on
24-hour serum cortisol (SC) was assessed in a domicile setting in patients
with PAR.
Results: No safety or tolerability issues were identified in paediatric patients
with PAR or SAR. In the integrated analysis, the most common AEs with an
incidence of 93% and more common in FFNS than in placebo were headache,
nasopharyngitis, epistaxis, pyrexia and pharyngolaryngeal pain. The inci-
dences of drug-related AEs were similar across the FFNS 55 6g and 110 6g
treatment and placebo groups: epistaxis was reported in 4%, 2% and 3% of
patients, respectively, and headache in 2%, G1% and 1% of patients,
respectively. Data from the 6-week PAR study demonstrate that SC levels
following administration of FFNS 110 6g were similar to those following
placebo (least squared means, 0.94 vs 0.97; treatment ratio, 0.97; 95%
confidence interval, 0.88, 1.07) which suggests that FFNS 110 6g is not
associated with any effect on the HPA axis. In addition, plasma levels of FF
were non-quantifiable.
Conclusion: Once-daily FFNS 55 6g or 110 6g has a favourable safety and
tolerability profile in children aged 2Y11 years with PAR or SAR.
Furthermore, FFNS shows low systemic exposure and is not associated with
hypothalamic-pituitary-adrenal axis suppression in children aged 2Y11 years
with PAR.
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Long-term safety of fluticasone furoate nasal spray 1106g once
daily in adults and adolescents with perennial allergic rhinitis
Connie Katelaris1, Andres Rosenblut2, Melissa Faris3, Wei Wu4, Mark
Caldwell3, and Wytske Fokkens5. 1University of Western Sydney, Westmead
Hospital, Campbelltown, Australia; 2Hospital Dr Sotero del Rio, Puente Alto,
Santiago, Chile; 3GlaxoSmithKline, Research and Development, Greenford,
United Kingdom; 4GlaxoSmithKline, Research and Development, Research
Triangle Park, NC, United States; 5Academisch Medisch Centrum, Amster-
dam, Netherlands.
Background: Fluticasone furoate is a novel enhanced-affinity glucocorticoid,
with unique pharmacological properties suitable for topical use in rhinitis. This
study investigated the long-term safety and tolerability of fluticasone furoate
nasal spray (FFNS) over 12 months in adults and adolescents with perennial
allergic rhinitis (PAR).
Methods: Following a 7- to 14-day screening period, patients aged Q12 years
with PAR were randomised in a 3:1 ratio to double-blind treatment with once-
daily FFNS 1106g (n = 605) or vehicle placebo nasal spray (n = 201) for 12
months. Adverse event (AE) data were collected using diary cards and
interviews at each study visit; the investigator graded AE severity as mild,
moderate or severe, and assessed the relationship of each AE to the
administration of study treatment. Safety was assessed by 24-hour urinary
cortisol excretion, nasal and ophthalmic examinations, ECGs and clinical
laboratory testing. Plasma levels of FF were determined from blood samples.
Compliance was measured using diary cards, change in bottle weights, and
symptom scores.
Results: 592 patients (73%) completed the study. Demographic characteristics
were similar in treatment and placebo groups. FFNS was well tolerated: the
incidence of most AEs in the FFNS group was similar to that in the placebo
group, with the exception of epistaxis (defined as any observation of blood in
or from the nose, irrespective of quantity), which was more frequent in FFNS
than placebo recipients (20% vs 8%). There were no other clinically
meaningful differences between FFNS and placebo in terms of safety
assessments, including 24-hour urine cortisol excretion, mean ophthalmic
parameters, ECGs and clinical laboratory tests. Plasma levels of FF were not
quantifiable in the majority of patients following administration of FFNS.
Compliance with study treatment was high based on diary cards (85% of
patients had 990% compliance) and bottle weights. Over the treatment period,
improvements in reflective Total Nasal Symptom Score were greater with
FFNS (j3.37) than with placebo (j2.49).
Conclusion: Long-term (12-month) administration of FFNS 1106g once
daily in adult and adolescent patients with PAR revealed a safety profile typical
of intranasal corticosteroids as a class, with no evidence of clinically relevant
systemic corticosteroid exposure.
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The prevalence of allergic rhinitis in college students at Kenya
Medical Training College-Nairobi,Kenya
Charles Gathiru1, and Isaac Macharia2. 1Malindi District Hospital, Ear Nose
Throat Department, Mombasa, Kenya; 2University Of Nairobi, Department of
Surgery-Ear Nose Throat, Nairobi, Kenya.
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Background: Allergic rhinitis is one of the commonest atopic diseases world
wide yet its epidemiology in Kenya remains largely unknown. Currently, there
is only one questionnaire based study (International Study of Asthma and
Allergies-ISAAC) in children documented in Kenya.
Objectives: The primary objective was to determine the prevalence of allergic
rhinitis in Kenya Medical Training College students, aged 18Y50 years. The
other objectives were; to determine the severity, pattern of symptomatology
and the common aeroallergens involved in the study group.
Methods: The study was done in two steps. In stage 1, using a stratified
random sampling, 423 students were screened for symptoms of allergic rhinitis
based on International Consesus Report definition of rhinitis. In stage 2, the
positive responders (63 students) were subjected to a physical examination and
a skin prick test to confirm presence of allergic rhinitis.
Results: A point prevalence rate of 13% was found with no sex or age
predilection in the study group. The average age of onset was 15.2
years,seasonal peaks were in January, July and December. 81.8% of the
students with allergic rhinitis had their daily activity affected to a certain
degree. Sneezing (83.6%) was the commonest smptom and hypertrophied
inferior turbinates (70.9%) the commonest physical finding. Patients with
intermittent disease (73%) were the most, while 36% of the students with
allergic rhinitis had a family history of atopy. The commonest aeroallergen was
the house dust mite (76.4%) and the least was Aspergillus Niger (1.8%).
Conclusion: Allergic rhinitis affects a significant proportion of the college
students and has symptoms which have an impact on the lifestyles of these
patients. The common aeroallergens are found within our immediate
surroundings e.g, house dust mite, which can be controlled if patients are
educated and proper, cheap enviromental control measures are instituted.
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Inflammatory mediators level in nasal polyposis
Eduard Semyatichko, Valeriya Nemtsova, and Irina Tikhonova. Kharkov
Allergological Center, Allergology, Kharkov, Ukraine.
Background: Nasal polyposis (NP) often coexists with asthma and rhinitis.
Polyp histology typically shows chronic, eosinophilic inflammation including
eosinophils, lymphocytes, plasma cells and mast cells. We studied mediator
levels and leukocyte values in nasal fluids (NFs) and eosinophil cationic
protein (ECP), total IgE levels and eosinophils in the blood in both allergic and
non-allergic patients with NP and in patients with allergic rhinitis (AR).
Methods: Forty-six patients with NP and 37 patients with AR as a control
group: 15 patients with seasonal AR to grass pollen, 12 with AR sensitive to
Parietaria and 10 with AR sensitive to house dust mite (HDM) entered the
study. Twenty-one patients with NP were also allergic patients (11 were
sensitive to Parietaria and 10 - to HDM), whereas 25 were non-allergic
patients. Tryptase and histamine values were assayed in NFs, total IgE was
determined in serum. ECP values were assayed both in NF and serum.
Eosinophils were quantified both in the blood and NFs.
Results: Tryptase levels were significantly higher in the NFs from patients
with NP than in those from patients without NP (3.9 vs. 3.5 U/l, p G 0.001) and
correlated with symptom scores (r(s) = 0.36, p G 0.0001). The median levels of
histamine in NFs from patients with NP were significantly higher than those in
patients without NP (40.0 vs.19.4 ng/ml, p G 0.001), but did not correlate with
symptom scores. The median levels of ECP in NFs from patients with NP
were significantly higher than those in patients without NP (37.4 vs. 17.2
ng/ml, p G 0.001) and correlated with symptom scores (r(s) = 0.33, p G 0.001).
With regard to leukocyte counts in NFs, no significant differences were
between rhinitis patients with NP and those without NP. With regard to serum
ECP and serum total IgE, no significant differences were detected between the
two groups. Blood eosinophil levels in patients with NP were significantly
higher than those in patients without NP (5.7 vs. 5.5, p = 0.002).
Conclusion: Chronic eosinophil mucosal inflammatory disease in NP
involves a self-sustaining mechanism independent of allergen stimulation of
nasal mucosa. Increased release of inflammatory mediators contributes to the
development of NP, determining oedema and an increased recruitment of
inflammatory cells. Eosinophils, mast cells also play a key role in this process.
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Physicians’ compliance with international guidelines in the
treatment of allergic rhinitis
Ralph Mo¨sges, and Juliane Ko¨berlein. University of Cologne, IMSIE,
Cologne, Germany.
Background: Allergic rhinitis (AR) is an allergy associated with a high
burden of costs. This disease is also considered an important risk factor in the
development of asthma. Within a time slot of 10 years, 20Y40% of rhinitis
patients develop asthma. The ARIA guidelines, introduced in 2001, address
this problem and make treatment recommendations for allergic rhinitis based
on the concept Bone airway, one disease.[ Several studies have investigated the
implementation process of these guidelines and have stressed their suitability
for daily use.
Methods: The objective of the present analysis was to estimate the compliance
with and the acceptability of international guidelines among ENT specialists
and general practitioners when treating patients with allergic rhinitis. For this
purpose, we examined data from 122,000 patients using an IPD meta-analysis
from seven post-marketing surveys collected from 1998 to 2005.
Results: First, we investigated the data pool as a whole, and the results showed
that 38% of the patients who were treated by ENT specialists received therapy
according to these international guidelines. In contrast, only 16.3% of the
general practitioners heeded the guideline recommendations. Next, we
examined the time line in general, regardless of the physician`s specialty.
We observed that the rate of compliance and acceptability in 2002 was higher
than that in previous years. Moreover, in more than 50% of cases the patients
with rhinitis and concomitant asthma were treated by their ENT specialists
according to the ARIA guidelines.
Conclusion: The results are evidence of the well-structured and successful
implementation process of the ARIA guidelines. ENT specialists could apply
the recommendations in practice more easily as compared to other guidelines.
However, the investigation also shows that the ARIA document has not yet
found its way into the daily routine of general practitioners. This finding thus
supports the goals set by the BInternational Primary Care Respiratory Group[
for implementing special guidelines for general practitioners in the primary
care setting.
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Inhibition of the nasal reaction by second-generation
antihistamines in patients with Japanese cedar pollinosis in an
artificial pollen exposure chamber (OHIO chamber)
Kimihiro Okubo1, Minoru Gotoh1, and Kazuhiro Hashiguchi2. 1Nippon
Medical School, Department of Otolaryngology, Tokyo, Japan; 2Kitasato
Institute Hospital, Department of Otolaryngology, Tokyo, Japan.
Background: Pollinosis is seasonal allergic rhinitis due to pollen antigens,
and its prevalence is high enough to be called a national disease in Japan.
Among the many pollen antigens, Japanese cedar pollinosis is the most
common. A pollen exposure chamber (OHIO Chamber) was built in central
Tokyo, Japan, in order to study seasonal allergic rhinitis (SAR). Epinastine
hydrochloride (epinastine), the second-generation antihistamines, is largely
used in the indication of allergic rhinitis in Japan. The purpose of this study
was to investigate the protective efficacy of epinastine in patients with
Japanese cedar pollinosis in an artificial pollen exposure chamber (OHIO
Chamber).
Methods: The study was designed as a double-blind study. After preliminary
study, 20 volunteers were initially exposed to a low concentration (4500
grains/m3) of JC for at most 1 hour in this chamber, volunteers were
randomized into 2 groups (group A and group B) and allocated to receive
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either epinastine 20 mg tablets or a placebo tablets once a day for 2 weeks. At
the end of 1 week interventional period, volunteers were exposed to a low
concentration (4500 grains/m3) of JC for 2 hours. And then at the end of
another 1 week interventional period, volunteers were exposed to a high
concentration (6000 grains/m3) of JC for 2 hours again. Subjective nasal and
ocular symptoms were recorded at 0, 15, 30, 60, 90, and 120 minutes using
personal computer systems and the amount of nasal secretion was measured
during the allergen exposure periods.
Results: Total symptom scores (TSS) in epinastine group was significantly
lower than in placebo group during low concentration of JC exposed. However
during high concentration of JC exposed, significant differences in TSS were
not observed.
Conclusion: This is the first clinical study using Japanese cedar pollen under
well-controlled conditions in the OHIO chamber. This study showed that
20mg of epinastine once daily reduced the severity of allergic symptoms
compared with that once in a week or placebo in pollen season.
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Development of a next-generation delivery system for allergic
rhinitis: fluticasone furoate nasal spray
Jim Godfrey. GlaxoSmithKline, Research and Development, Ware, United
Kingdom.
Background: Patients with allergic rhinitis (AR) consider ease of use to be the
most important feature of prescription nasal sprays, with formulation-related
attributes (e.g. medication that runs down the throat/out the nose and bitter
taste) being key barriers to continued use. Thus, improved delivery systems
and formulations may help improve adherence to nasal spray treatment.
Methods: The fluticasone Furoate nasal spray (FFNS) device was designed for
optimal ergonomics. Following a review of published data, key dimensions and
operational ranges required for device operation were determined, and device
concepts were modelled and evaluated by user groups, whose feedback was
used to refine and finalise the design. The reliability of device was tested in
vitro, and its ease of usewas assessed in a Phase III clinical study in 302 patients
with AR. The delivery system was developed with minimal steps for use, to be
suitable for use by a wide patient population, for easier third-party
administration and to allow determination of medication remaining in the pack.
Results: In vitro tests confirmed that the FFNS device is robust, operates
reliably when a force of 25Y45N is applied to the side lever, and delivers a
consistent dose, even when left unused for 6 weeks. A low-dose volume
(50 6L) is delivered as a fine mist which consistently delivers 27.5 6g/spray
and minimises the amount of formulation available to run down the back of
the throat or drip from the nostrils. In a Phase III clinical study, 84% of
302 patients found the device easy to use, 95% found it easy to carry, and
97% found the drug product comfortable to use. In addition, a review by an
independent ergonomist concluded that the FFNS device is more comfortable
to hold and easier to operate than current Btop-down[ nasal spray devices and
is suitable for use in children as young as 2 years. The unique side-actuated
delivery mechanism also allows for easier third-party administration.
Conclusion: The novel FFNS device is easy to use, delivers a consistent dose,
and addresses patient-reported barriers to the use of existing nasal sprays.
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Subsequent development of asthma in allergic rhinitis:
a questionnaire based study
Yong Won Lee, Chan Ho Kim, Jin Sun Kim, Jin Ha Lee, You Jung Ha, Nu Ri
Cheon, Yoo Seob Shin, Jung-Won Park, and Chein-Soo Hong. Yonsei
University College of Medicine, Dept. of Internal Medicine, Institute of
Allergy, Seoul, Republic of Korea.
Background: Subsequent development of bronchial asthma (BA) in allergic
rhinitis (AR) patients is common. We investigated the clinical aspects of
subsequent development of BA in AR patients by a questionnaire based study.
Methods: Total 227 patients, visited us for ARwithout BA (2001~2004), were
enrolled in 2006. We reviewed their clinical data and followed them up with a
BA-detecting questionnaire, based on International Primary Care Respiratory
Group (IPCRG) guidelines 2005. These results were statistically analyzed.
Results: Among 227 (215 loss to f/u, 12 regular visitors), 91 responded to the
questionnaire (85 by phone, 6 via mail). 37 responders, who answered yes to
either doctor-diagnosed asthma or any of 4 pivotal IPCRG questions, were
suspected as the group with subsequent development of BA (BAS). BAS
showed higher female rate (73%) than non-suspected group (NBAS, 54%). In
BAS, males were younger and females had higher BMI than NBAS (p G 0.01,
respectively). Familial allergic diseases (36.8%) and nasal polyp/surgery were
more frequent in BAS. BAS had longer AR duration (10.7T10.1 yrs) than
NBAS (6.3 T 4.5 yrs). According to the increase of AR duration, BAS (%)
increased linearly (p = 0.012). Current AR symptoms were more prevalent in
BAS (89.2%, NBAS 64.8%). Atopic tendency, skin test results, serum total
IgE, and induced sputum eosinophil (%) were not different between both
groups. In pulmonary function test, BAS males showed lower initial FEV1 (L)
and FVC (L) (p G 0.05, respectively). In initial methacholine challenge test
(M-test), airway hyperreactivity (AHR: PC20 G 25 mg/mL) were more
common in BAS (93.7%, NBAS 33.3%).
Conclusion: 40.7% of AR patients (mean duration 8.0=57.5 years) were
suspected to develop subsequent BA. Such progression might be suggested by
female gender, younger age in male, higher BMI in female, longer AR
duration, and more frequent AHR positive results in initial M-test. AR patients
without lower respiratory symptom should be followed up regularly for early
diagnosis of subsequent BA.
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Possible roll of the nitric oxide as an immune marker for
the diagnosis of respiratory pathologies in Venezuelan
scholar children
Franca Puccio1, Domenico Cifarreli1, Lisete Machado1, Maria E Ghezzi1,
Elianska Lopez1, Luis Sarmiento2, and Nelson Vasquez1. 1Instituto de
Biomedicina, UCV, Inmunopatologia, Caracas, Venezuela; 2Catedra de
Inmunologia, UCV, Facultad de Medicina, Caracas, Venezuela.
Background: It has been proposed a clear association between exhaled nitric
oxide (NO) and asthma exacerbation. We evaluated the NO in nasal mucus and
sera, from 144 Venezuelan scholar children (6Y12 years old), from low to
middle socioeconomic background covering different areas from Caracas,
Venezuela, with allergic rhinitis and bronquial asthma.
Methods: All children were evaluated with a validated modified Graffar’s
socioeconomic questionnaire and an allergic rhinitis, asthma and atopic
dermatitis after ARIA, GINA and Hannifin criteria; skin prick testing (ALK-
ABELLO) for common food and inhalant allergens plus total IgE (ELISA),
complete blood count (COULTER) and serial feces examination for ova and
parasites were performed in all children. Pre and post bronchodilator FEV1
and PEF spirometric measurements values were obtained (MICROLOOP) (we
obtained the approval by the ethical committee of the Institute of Biomedicine,
ratified by the academic council of the medical Faculty of Central University of
Venezuela, After an informed consent was signed from parents or guardians).
In nasal mucus and sera from children NO were detected by a simple
colorimetric method based on Griess Methodology.
Results: According to clinical evaluation children’s were classified in four
group. Healthy children’s, children’s with rhinitis and without asthma,
children’s with asthma and without rhinitis, and children’s with asthma
plus rhinitis. Healthy children present lower NO value both in sera (X =
34,482M) and nasal mucus (X = 7,992M). Rhinitis children had the higher
NO levels both in sera than in nasal mucus, finding statistical differences in
nasal mucus levels (21.232M) compare to control group (7,992M). In
asthmatic children NO levels were lower than in rhinitis once, but higher
than healthy control group.
Conclusion: In nasal mucus, the study of immune parameter as nitric oxide by
a rapid and simple methodology, could clarify the local inflammatory process
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related to allergic rhinitis in order to bring better strategies for the diagnosis
and also for the evolution of the treatment.
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Inducement of eosinophils to apoptosis by injection of steroid
into nasal polyp
Kensuke Watanabe, Tomonori Eguti, and Sigenori Ohde. Dokkyo Medical
University Koshigaya Hospital, Department of Oto-Rhino-Laryngology,
Koshigaya, Japan.
Background: It is wellknown that the basic protein of eosinophils induce
respiratory epitherial disorders. The eosinophils which migrate to nasal
mucosa do not return again into the circulating blood stream. It has been
reported that eosinophils into nasal mucosa and mucus were degranulated by
cytolysis. It is preferable treatment of allergy that the eosinophils are promptly
excluded nasal mucosa without degranulation. It is aspired that the eosinophils
induced to apoptosis not but necrosis.
Methods: After the polyp was taken from the right nostril of the patient in
whose mucus many eosinophils were observed, corticosteroid was injected into
the polyp of left nostril. Two days after the steroid injecion, the polyp of the left
nostril was taken. The both side polyps were fixed with 2% glutaraldehyde for
1 hour and postfixed with 2% osmic acid for 40 minutes and embedded in
Epon 812. Ultrathin cross sections were prepared and observed under trans-
mission electron microscope. The total numbers of eosinophils and macro-
phages with and without phagocytosing eosinophils. In some ulrathin cross
section, the localizaionof ss-DNAwas examinedwhichwas amarkof apoptosis.
Results: The nucleus of eosinophils showed typical characteristics of
apoptpsis but apoptoic bodies were not observed after the steroid injection.
The ss-DNAwas admitted in the part of heterochromatin of the nucleus, which
proved apoptosis had been caused. It has been known that the cells are
phagocytosed by macrophages as soon as they were induced to apoptosis.
There was not a significant difference in the number of total eosinophils and
macrophages in the polyp before and after the steroid administration, but the
rate of eosinophil phagocytosis by macrophage significantly increased after
the steroid administration.
Conclusion: It was clalified that eosinophils were induced to apoptosis after
the steroid administration by the feature of nucleus with electron microscope
and proof of ss-DNA. Eosinophils which had induced to apoptosis were
promptly phagocytosed by macrophages.
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Acoustic Rhinometry in children with allergic rhinitis
Fernando de la Torre, Eva Perez Rodriguez, Elena Rodriguez Plata,
Guacimara Hernandez Santana, and Victor Matheu. Hospital Universitario
NS Candelaria, Tenerife, Spain, Allergy Service, Santa Cruz de Tenerife,
Spain.
Acoustic Rinometry (AR) is a sound-based techinique by which the
reflected wave provides information about volume & area of the nasal cavity.
By AR the explorer has the abilitiy to assess nasal patency in patients suffering
nasal obstruction.
Goal of Study: To study basal figures of endonasal measurements in subjects
with allergic rhinitis by dust mites during winter season in Canary Islands
(subtropical climate with high humidity (65Y80%) and mild temperatures
j20Y25-C-) and to compare with subjects without obstruction.
Methods: Patients with clinical history of Rhinitis were assessed. Skin Prick
Test (SPT) with mites and German cockroach were performed. Acoustic
Rinometry was performed with Rinometer RhinoScan with SER 2000 module
(Denmark). Three measurements were made for each nose. The mean area
distance curve was calculated for each side of the nose. Curves with artifacts
were discarded. Patients without blockage have a normal Minimal Cross-
Sectional Area (MCA) at C-notch with values around 0.7 cm2
Results: A clinical history of rhinitis and positive SPTwith mites was seen in
82% of patients. In most, the history was a mild/severe persistent rhinitis. In
17% of patients SPTwere negative. In most of patients 86% of patients MCA
was located in first notch (I-notch), which corresponds with Itsmus nasi and
the remainder MCA was located in second notch (C-notch), which
corresponds to the head of the inferior turbinate. In all the study, the average
distance calculated from nostril to the head of inferior turbinate was 22.0 mm.
Average of MCA was 0.54 cm2 in allergic patients and 0.57 cm2 in non-
allergic rhinitis patients with no significant differences between groups
ConclusionMeasurements by AR are similar between allergic and non-allergic
rhinitis patients. In most of patients MCAwas located in first notch (I-notch),
which corresponds with Itsmus nasi AR has major advantages of over other
methods for assessing nasal patency since it is a very simple method and
requires minimal cooperation.
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Clinical and therapeutic aspects of moderate/severe allergic
rhinitis in Transylvania
Ioana Adriana Bujor, Diana Dumitrascu, and Luise Horvath. University of
Medicine and Pharmacy BIuliu HaSieganu^, 3rd Medical Clinic, Allergology,
Cluj Napoca, Romania.
Background: Moderate/severe allergic rhinitis (MSAR) is an affection of
nasal mucosa induced by allergen exposure and produced by a specific IgE
mediated chronic inflammation. Symptoms are present in over 4 days in a
week, and over 4 weeks (ARIA guide), and the symptoms interfering with
activities and sleep. It is related that MSAR has a 10Y25% incidence from all
allergic rhinitis, it is more frequent in adolescent and young people (who,
usually don`t have the financial resources for the therapy: topical corticoster-
oids, immunotherapy). SMAR patients have a reduce quality of life, and by
absenteeism and costs this seems to be an important health problem.
Methods: The aim of this study is to evaluate 40 patients with SMAR that last
over a year, for 8 months (age between 9 and 57 years, medium age 33.85).
Our patients have completed questionnaires about their nasal symptoms and
the effect of the treatment (antihistamines, topical corticosteroids and im-
munotherapy. They were evaluated by skin prick tests to 10 inhaled allergens,
rhinoscopy for nasal mucosa and questionnaires for the symptoms score.
Results: The majority of MSAR have a polisensitization (80%: to dust mites
90.62%, to cat 37.5%, to pollen 37.5%, to cockroach 37.5%, to moulds 37.5%,
to dog 18.75%). Only 20% from our patients have monosensitization (to house
dust mites). The score of the symptoms was high- over 4 on a day in 4 days
from the last 7 days- we evaluated the nasal congestion, rhinoreea, nasal
itching and sneeze by 0 to 3. Antihystamines therapy has a lower efficiency- to
one patient (3.12%) - in polisensitization patients, and in those with severe
congestion has practically no effect, in 26 patients none feels better. The only
therapeutic method with higher efficiency was topical corticosteroids, witch
make an obvious amelioration, the score of the symptoms decreased between 0
and 2 on a day in 7 days. The financial aspect of the patients with MSAR
showed that only a few from them could provide the topical corticosteroid for
at least 3 months (12.5%-5 patients).
Conclusion: MSAR is hard to be treated and controlled without topical
corticosteroids.
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The effects of olopatadine hydrochloride on rhinitis induced by
intranasal instillation of toluene-2,4-diisocyanate in rats
Tadafumi Tamura, and Masato Komai. Kyowa Hakko Kogyo Co., Ltd.,
Pharmaceutical Research Center, Shizuoka, Japan.
Background: The main symptoms of allergic rhinitis are sneezing, rhinorrhea
and nasal obstruction. In patients with AR, the levels of neurotrophin nerve
growth factor (NGF) and neuropeptides substance P (SP) increased. Therefore,
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they are considered important modulators in the development of AR.
Olopatadine hydrochloride (olopatadine), is an anti-allergic agent with
histamine H1 receptor antagonistic action. We reported that olopatadine
inhibited the elevated levels of NGF and SP in the mouse model of chronic
inflammatory dermatitis.
Objective: To investigate whether olopatadine has an effect on the production
of NGFand SP, we used TDI-sensitized rats as an animal model of nasal allergy.
Methods: After the intranasal challenge of TDI, the numbers of sneezes were
counted in a blinded way. To determine NGF and SP production in the nasal
lavage fluids (NALF), rats were anesthetized and nasal lavages were done. Olo-
patadine was orally administered orally before the nasal instillation of TDI.
Results: In TDI-challenged rats, nasal allergy-like behavior (sneezing,
rhinorrhea and inflammation) was provoked after TDI challenge. The amounts
of NGF and SP in the NALF were increased. Olopatadine reduced nasal
allergy-like behavior. Moreover olopatadine inhibited the increases of NGF
and SP production.
Conclusion: Our findings suggest that the increase of NGF and SP production
is one of the mechanisms responsible for nasal allergy-like behavior in TDI-
challenged rats. These results suggest that the suppression of neurogenic
inflammatory reaction might partially be involved in the improvement of
allergy-like behavior by the treatment of olopatadine.
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Do topical steroids reduce subjective and objective measures of
nasal congestion in persistent allergic rhinitis?
Kivanc Gunhan, Halis Unlu, Ali Vefa Yuceturk, and Murat Songu. Celal Bayar
University, Otorhinolaryngology and Head-Neck Surgery, Manisa, Turkey.
Background: Nasal breathing is essential in maintaining the physiologic
functions of the upper and lower airways. The predominant symptom of
allergic rhinitis is nasal congestion, which also has a significant impact on
quality of life and work productivity. In patients who suffer from persistent
allergic rhinitis (PAR), a severe drug-resistant hypertrophy and increase in
glandular structures of the inferior turbinates may develop, which leads to
constant nasal obstruction. Objective methods are strongly recommended for
use in the evaluation of pharmacologic agents that are expected to improve
nasal airflow.
Methods: This prospective, single-sited study randomized 50 patients with
mild or moderate PARwho had substantial bilateral hypertrophy of the inferior
turbinates to desloratadine (5 mg/day) or additional mometasone furoate
monohydrate nasal spray (MFMNS), (2 sprays per nostril [total dose 200 6g]
once daily) treatment groups. Patients with previous treatments, concomitant
sinonasal disorders or systemic diseases were excluded. Both objective
outcomes evaluated by total nasal resistance at anterior rhinomanometry and
subjective outcomes assessed with endoscopic nasal examination and Quality
of Life Questionnaire were analyzed before and at least 12 months after
treatment.
Results: The median total nasal resistance in patients treated with MFMNS
decreased from 0,49T0,17 Pa/cm3/s to 0,39 Pa/cm3/s (p = 0,42), and at least 12
months later. Compared with pretreatment scores, the post treatment scores of
these patients significantly improved in both 7 separate domain scores and
overall Rhinoconjunctivitis Quality of Life Questionnaire scores (p = 0,004).
Nasal symptomatology was reduced 2 months after MFMNS application. No
adverse reactions including bleeding, infection, or hormonal disorders were
encountered. The patients experienced a lasting benefit from this treatment.
Conclusion: Nasal congestion affects most individuals with allergic rhinitis,
and has a notable impact on quality of life, emotional function, productivity,
and the ability to perform daily activities. These results suggest that topical
mometasone reduces the volume of inferior turbinate at some point while
significantly improving the quality of life in patients with PAR. Histopatho-
logic and longer term studies with larger groups will enlighten the potential
and mechanism of efficacy of topical steroid in management of inferior
turbinate hypertrophy in patients with PAR.
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Topical treatment for perennial allergic rhinitis in children
Felicia Manole. Faculty of Medicine Oradea, Otorhinolaryngology, Oradea,
Romania.
Background: Topical corticosteroid is now accepted as safe and most
effective in controlling all symptoms of both allergic and nonallergic rhinitis.
Mometasone furoate monohydrate nasal spray is a once daily topical
corticosteroid preparation.
Objective: To evaluate the efficacy and safety of mometasone furoate
monohydrate nasal spray in children 6 to 12 years of age with perennial
allergic rhinitis.
Methods: A double-blind, placebo-controlled, parallel group of 112 recruited
patients of whom 96 were evaluated. Treatment with once daily mometasone
furoate monohydrate nasal spray 100 mcg once daily or placebo for 6 weeks
followed by a 3-week follow-up period. Forty-eight patients of each group
were treated with mometasone furoate monohydrate nasal spray or placebo by
randomized assignment.
Results: There was no statistical significance of the sex, mean age, weight, and
height of the two groups. Patients treated with mometasone furoate
monohydrate nasal spray showed a significant decrease in total symptom
scores rated by physicians at 3 weeks and 6 weeks, respectively (P G .01,
P G .05). The rhinitis symptom scores in treatment group rated by patients
(nasal blockage, sneezing, watery rhinorrhea) were significantly decreased at
3 weeks (P G .05, P G .01). Nasal symptoms as assessed by doctors (turbinate
swelling, color of nasal mucosa, secretion, and postnasal drip) also decreased
at 3 and 6 weeks, but were not statistically significant, except for the secretion
at 3 weeks and postnasal drip at 6 weeks (P G .05). There was no evidence
of effects on adrenal function by morning plasma cortisol concentration
between the two groups.
Conclusion: Mometasone furoate monohydrate nasal spray was safe and
effective, well tolerated in children aged 6 to 12 years with perennial allergic
rhinitis with incidences of adverse events comparable to placebo.
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Effects of seasonal allergic rhinitis on fatigue levels and mood
Ziad Adwan. Saha, Allergy, Reo De Janero, Brazil.
Objective: Many allergy patients complain of fatigue, moodiness, and
dysphoria during their allergy seasons. This study evaluated the effect of
symptomatic allergic rhinitis on both fatigue level and mood.
Methods: Symptomatic ragweed allergic rhinitis patients on no medications
and healthy control subjects completed the Multi-Dimensional Fatigue
Inventory and the Positive Affect-Negative Affect mood rating scales in an
in-out-in ragweed season research design.
Results: During ragweed seasons, allergic patients reported higher levels of
general fatigue and mental fatigue, but not physical fatigue, as well as reduced
motivation. Patients described experiencing feelings of greater sadness and
reduced pleasurable engagement. Increased anxiety or emotional distress was
not reported.
Conclusion: These findings suggest that having allergic reactions to ragweed
pollen causes significant fatigue and mood changes in at least a subgroup of
patients. Psychoneuroimmunology and medical genetics research suggests
that allergic reactions engender biochemical changes that directly affect the
central nervous system.
Key Words: allergic, rhinitis, fatigue, depression, mood
Abbreviations: CNS = central nervous system; FSL = Flinders sensitive line;
IL = interleukin; MFI-20 = Multidimensional Fatigue Inventory; NA =
negative affect; PA = positive affect; TNF = tumor necrosis factor.
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Patient perception of levocetirizine in allergic rhinitis:
A multicenter study in Taiwan
Sheen-Yie Fang. National Cheng Kung University Hospital, Dept. of
Otolaryngology, Tainan, Taiwan.
Background: Levocetirizine (Levo) is a potent latest-generation, non-sedating
oral H1-antihistamine for which no data in Taiwanese population has yet been
published.
Objectives: Primary: patients` perception of Levo in the treatment of allergic
rhinitis (AR). Secondary: adverse events (AEs) and incidence of intermittent
(IAR) and persistent (PER) AR (as defined by ARIA) in Taiwan.
Methods: A multicenter observational study (6 medical centers) conducted
fromMay 2006 to March 2007 in Taiwan assessing the treatment perception of
236 AR patients on Levo. Runny nose, nasal and ocular pruritus, sneezing and
nasal obstruction were measured (0 = absent, 3 = severe). Total 5 Symptom
Score (T5SS, sum of the above symptoms (range 0Y15)) and asthma symptoms
(per GINA): mild (91x/week, G1x/day); moderate (daily); severe (continuous)
were determined. The observational period was 2Y4 weeks. The onset of action
was rated very rapid (G30min), rapid (930min, G1hr), and moderate (91hr). A
visual analogue scale (VAS) was used to evaluate global satisfaction of patients
and physicians (range: 0Y10).
Results: 236 patients were included and 217 completed the study. 19 patients
(8%) were lost to follow-up due to AEs, none serious. 56 patients (24%) had
concomitant asthma. PER was diagnosed in 191 (81%) and IAR in 45 (19%)
patients.
T5SS improved by 56%, from 10 (T3.3) at baseline to 4.4 (T2.3) at end
of treatment. Overall efficacy and tolerability were assessed as Bgood/
excellent[ by 60% and 66% of patients, respectively. At least 61% of all
patients and 75% of those with Bmoderate/severe^ symptoms reported
complete recovery or marked improvement of any individual symptom. 50%
of subjects reported the onset of action as very rapid or rapid. Levo was
reported as better than their previous therapy by 56% of patients. BGood/
















Complete or partial relief 75% 72% 71% 64% 61% 44%
Unchanged 21% 23% 28% 33% 32% 55%
Worse 4% 5% 1% 3% 7% 1%
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50% and 53% of patients, respectively. Global satisfaction with Levo treatment
was high for both physicians and patients (VAS = 6.9). Most frequently
reported AEs were somnolence (7.4%) and fatigue (3.7%).
Conclusion: Results confirm western studies that Levo is potent, effective and
well tolerated in Taiwanese patients with PER and IAR. The majority of
patients considered it as better than their previous treatments and the global
satisfaction with Levo was consistent in both physicians and patients.
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Medicamentous therapy of allergic rhinitis
Djakhangir Shamsiev. Tashkent Medical Academy, ENT, Tashkent, Uzbekistan.
Background: Todevelop algorithms of treatment of allergic rhinitis in different
clinical situations and complex scheme of treatment for allergic rhinitis.
Methods: We observed patients with diagnosis of seasonal and all-the-year-
round allergic rhinitis. All the patients were evaluated clinical efficacy of
medicamentous treatment.
Results: Seasonal or intermittent allergic rhinitis. The treatment of the mild
form of rhinitis with episodic symptoms the treatment should be begun with
per oral or topic administration of antihistamine (non-sedative) drugs. Other
variants of treatment are the topic decongestants (for no longer than 10 days)
and per oral decongestants (which are not recommended for children). If
eye symptoms are prevailed over the rhinitis symptoms or if they were
not stopped with administration per orally of antihistamine preparations
then the same preparations may be additionally used as eye drops. In cases
of moderate severe and severe forms with episodic symptoms the treatment
includes per oral antihistamine preparations with decongestants and topic
glucocorticoids.
The all-the-year-round or persistent allergic rhinitis. In cases of
light clinical course when the symptoms of disease do not required special
treatment and only the measures for elimination of allergen may be
performed. Variants of medicamentous therapy include per oral or topic
antihistamine preparations, per oral antihistamine preparations with
decongestants and topic glucocorticosteroids. Efficacy of therapy performed
must be evaluated in 2Y4 weeks.
In moderate severe and severe forms of rhinitis the preparations of the
first line are the topic glucocorticosteroids. In sharp disturbance of the nasal
breathing this treatment may be added with short course of systemic steroid
therapy. The effect of this therapy is evaluated in 2 weeks.
Conclusion: The causes of insufficient efficacy of topic glucocorticosteroids
may be: irregular dosing of preparation by physician or patients, insufficient
administration of preparation into the nasal cavity because of sharp edema of
mucous membrane, presence of concomitant pathology (deformation of nasal
septum, chronic rhinosinusitis and others), power effect of unremoving
allergen and irregularly established diagnosis.
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The impact of Flixonase on quality of life in paediatric patients
with seasonal allergic rhinitis
Maia Kherkheulidze, Nani Kavlashvili, Nino Adamia, and Eka Kandelaki.
State Medical University, Pediatrics, Tbilisi, Georgia.
The aim of our study was to investigate the efficacy of Flixonase in
children with seasonal allergic rhinitis and to evaluate the impact of treatment
on quality of life. 38 (4Y12 years old) outpatient children with seasonal allergic
rhinitis were enrolled into the clinical study. We evaluated history, clinical
symptom severity (nasal symptom severity Y such as sneezing, runny nose,
itching, stuffiness; non-nasal symptom severity Y such as eye, ear, throat
symptoms, chronic cough, and headache). Rhinoscopy (swelling and
hyperemia of mucous) and evaluating allergic markers (eosinophyles) in
nasal lavage detected diagnosis of rhinitis. We studied blood immunity data
(IgE). For the assessment of the quality of life we used the Juniper
Rinoconiuctivities quality of life (Pediatric and adolescent) scale. The baseline
results showed that eosinophilia in peripheral blood was observed in 35%,
patients, IgE hyper production in 72%. There was determined correlation link
between IgE hyper production and severity of diseases and eosinophil count in
nasal lavage. Flixonaze was administered 50 mcg once a day. The treatment
with Flixonase (time of treatment 14 days) showed significant improvement of
clinical symptoms and patients condition, reduction of nasal as well as non-
nasal severity symptoms. Medication assessment average score was 6, 6 + 0.3.
At the same time was observed decrease of eosinophil count in nasal lavage.
After the two weeks trial period, the overall RQLQ scores of the treated
patients improved by 68% + 7 from baseline.
So, we conclude that using of Flixonazein paediatric patients with
seasonal allergic rhinitis improved patient`s condition as well as their quality
of life.
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Allergic rhinitis: especially of nasal’s microflora in the children
Alsu Sharifullina and Rustem Fassakhov. Federal State Institution Kazan
Scientific Research Institute of Epidemiology and Microbiology of Rospo-
trebnadzor, Federal State Institution Kazan Scientific Researc, Kazan,
Russian Federation.
Background: Staphylococcus aureus is proved to play unduestionable role in
development of atopic dermatitis. In this connection investigation of bacteria
role in dermatitis pathogenesis is of considerable interest. The aim of the
present study was to investigate microbial microflora of the nasal cavity in
patients with persistent allergic rhinitis (PAR).
Methods: A total of 89 PAR sufferers aged 3 to 17 years have been
investigated, bacteriological study of nasal secretion being carried out.
Results: Staphylococcus haemolyticus in diagnosticaly insignificant titer was
isolated in every second person in the group of PAR patients (n = 38),
Staphylococcus aureus in diagnosticaly insignificant titer being isolated in
23% of patients. High level of dissemination (more than 103Y104 KOE/ml)
was noted in 10 out of 38 patients: Staphylococcus haemolyticus-15,8%
(n = 6); Staphylococcus aureus-10,5% (n = 4). In PAR patients along
with atopic bronchial asthma (n = 42) rising Staphylococcus haemolyticus
titers-24% (n = 10), Staphylococcus aureus-33% (n = 14) was observed. In
6 out of 14 patients isolated Staphylococcus a ureus strain was combined
with Klebsiella, Escherichia coli, Citrobacter spp. Isolation of permissible
for normal microflora values was equal to 19% for Staphylococcus
haemolyticus (n = 8); and 16,7% (n = 7) for Staphylococcus aureus.
Streptococcus haemolyticus was isolated in 3 patients. In the group of
PAR patients along with atopic dermatitis (n = 9), Staphylococcus aureus
(in 7 patients under study) was the main representative of the nasal cavity
microbiocenosis.
Conclusion: Prevalence of staphylococcal found out in the course of study in
nasal cavity of PAR patients may suqgest the ability of these microorganisms
to support allergic inflammation.
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Efficacy topical desensitization in chronic rhinosinusitis and
nasal polyposis with association nonsteroidal anti-inflammatory
drugs hypersensitivity
Sergey Zenokhov1, Vyacheslav Treskynov2, Irina Sidorenko3, and Tatiana
Zakharzhevskaya3. 1Outpatients Clinic # 185, Allergology, Moscow, Russian
Federation; 2Scientific Research Institute of Physical and Chemical Medicine,
Clinical Immunology, Moscow, Russian Federation; 3Moscow Medical
Academy, Clinical Allergology and Immunology, Moscow, Russian Federation.
Background: Subject suffering from aspirin and over nonsteroidal anti-
inflammatory drugs (NSAID’s) hypersensitivity frequently develop chronic
rhinosinusitis (CRS) with nasal polyposis (NP). Previous studies showed that
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aspirin-lysine topical desensitization may be effective to CRS and NP
treatment and prevent recurrent NP.
The Aim of the Study: To evaluate the efficacy of topical desensitization by
sodium diclofenac in patients (SD) with NSAID’s hypersensitivity and chronic
rhinosinusitis with nasal polyposis.
Methods: Ten subjects (5 male and 5 female, mean age 52.5 T 2.1 years) after
intranasal polypotomy with positive results of nasal challenge with SD
underwent topical SD desensitization and daily treatment with SD 20 mg
during 1 year. Additionally 5 patients were receiving intranasal corticosteroids
in stable dose.
Results: There were significant reductions of the total endoscope count (10.4 T
2.8 to 5.8 T 1.9, p G 0.05) and nasal symptom score (6.6 T 2.2 to 3.2 T 0.8, p G
0.05) in the subgroup with combination desensitization and topical
corticosteroid therapy. In both subgroups there were improvement of nasal
inspiratory peak flow (75,0 T 13,8 l/min to 86,5 T 9,2 l/min, p G 0.05) and
pulmonary function. Using of inhalation corticosteroids were decreased. There
were no recurrences of nasal polyposis in all patients after one year observation.
Conclusion: Topical sodium diclofenac desensitization is an effective
treatment in chronic rhinosinusitis and nasal polyposis with association
NSAID’s-hypersensitivity.
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Influences of allergic rhinitis to the outcome of functional,
endoscopic sinus surgery
Sylvi Meuret, Heidrun Mueller, Gero Strauss, and Andreas Dietz. University
Clinic Leipzig, ENT Department, Leipzig, Germany.
Background: The exact pathogenesis of nasal poyposis (NP) is still unknown.
Empiric data show that patients who suffer from NP and allergic rhinitis (AR),
do not benefit as much of functional, endoscopic sinus surgery (FESS) as
patients without AR.
Methods: In this study we want to present our expirience in FESS in patients
with AR. 120 patients were included and devided into three groups: 1. 45
patients with AR without NP and without FESS 2. 43 patients with AR and NP
and FESS a) 32 patients with SIT b) 11 patients without SIT 3. 32 patients with
NP without AR. In our protocol we included a score of symptoms, the
endoscopis findings and a CCT of the sinuses.
Results: In general, patients in group 3 have a better outcome of FESS than
patients in group 2. Group 2a benefits more of FESS than group 2b.
Conclusion: In this investigation, we can show that there is a tendency that
patients with NP and AR who are treated by SIT have a better outcome of
FESS than patients without AR.
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Expressions of mammaglobins A and B are not different between
nasal polyps with and without allergic rhinitis
Supinda Saengpanich1, Chuntima Phannaso2, Siraprapa Tongkobpetch3,
Songklot Aeumjaturapat1, Yong Poovorawan3, Kanya Suphapeetiporn3, and
Vorasuk Shotelersuk3. 1Chulalongkorn University, Department of Otolar-
yngology, Bangkok, Thailand; 2King Chulalongkorn Memorial Hospital,
Department of Otolaryngology, Bangkok, Thailand; 3Chulalongkorn Uni-
versity, Department of Pediatrics, Bangkok, Thailand.
Background: Nasal polyposis is a chronic disease of nose and sinuses. Its
actual causes remain unclear. Mammaglobins have been implicated in the
pathogenesis of nasal polyps. However, their association with the occurrence
of nasal polyps in the presence of allergic rhinitis has not been explored.
Objective: The aim of this study was to compare the expression levels of
mammaglobins A and B between the nasal polyps with allergic rhinitis and
without allergic rhinitis.
Methods: 31 patients with bilateral nasal polyposis underwent skin prick test
to specific aeroallergens. Nasal polyp tissues were obtained from all patients
and divided into 2 groups as nasal polyps with allergic rhinitis and nasal polyps
without allergic rhinitis depending on the skin prick tests` results. All polyp
tissues were analyzed for the levels of mammaglobin A and mammaglobin B
by using real-time quantitative polymerase chain reaction technique (RTQ-PCR).
Results: Of the 16 samples from patients having nasal polyps with allergic
rhinitis, only one expressed a detectable level ofmammaglobin A (1/16). There
was no detectable expression of mammaglobin A in tissues from the group of
nasal polyps without allergic rhinitis (0/15). Expression of mammaglobin B
was detected in all nasal polyp tissues from both groups. The mean expression
of mammaglobin B was not significantly different between nasal polyps with
allergic rhinitis (0.059; range 0.0002 to 0.343) and nasal polyps without
allergic rhinitis (0.133; range 0.003Y0.628).
Conclusion: Expressions of mammaglobins A and B are not different between
nasal polyps with and without allergic rhinitis. Our findings suggest that
mammaglobins` implication in the pathogenesis of nasal polyps is independent
of an underlying allergic rhinitis.
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Characteristics and associated conditions of acute sinusitis in
Thai children: a prospective evaluation of 140 patients
Maleewan Kitcharoensakkul and Orapan Poachanukoon. Faculty of Medicine
Thammasat University, Department of Pediatrics, Pathumthani, Thailand.
Backgroud: Sinusitis is a common disease in children. Even though new
research findings are continually being published on various aspects of this
disease, reports of its clinical characteristics and associated conditions are
still limited.
Objective: To describe the characteristics and associated conditions of acute
sinusitis in Thai children.
Materials and Methods: Our study consisted of 140 acute sinusitis patients
who presented to Thammasat University Hospital. Acute sinusitis is diagnosed
on the basis of clinical presentation including persistent, severe or worsening
nasal symptoms. An informed consent form was obtained from each patient
before the study. Radiography has been used to aid in the diagnosis of acute
sinusitis. Allergic skin prick test was also performed in this study.
Results: Age range of the 140 patients were between 1.1 to 15 years with a
mean (+/-SD) of 5.67 +/-2.85 years. History of allergic rhinitis, confirmed by
positive skin prick test or nasal cytology, was found in 64%. The parental
history of atopy was found in 50.4 %. Positive history of tobacco smoking was
found in 25.9 %. Familial members with diagnosis of a cold or sinus infection
during the same time was found in 43.2 %. 69.8% of the patients attended day
care or school more than five days per week. 38.1% of the patients had a history
of swimming or diving during the past 1 month. 51.8 % of the patients had a
past history of sinus disease . The four most common symptoms were nasal
blockage (88.5%), rhinorrhea (81.3%), nighttime cough (79.9%) and snoring
(73.4%). The three most common signs were swelling of turbinates (75.5%),
erythema of turbinates (74.8%) and tonsillar enlagement (48.2%). All
paranasal sinuses X-rays were abnormal with maxillary sinus being the most
commonly involved sinus (97.5%) followed by ethmoid sinus (58.8%). 58.8%
of the patients had involvement of more than one sinus. Adenoid hypertrophy
was positive in 36% of all patients. The skin prick tests were positive in 62.6 %
of all patients who the tests were performed.
Conclusion: Nasal blockage, rhinorrhea, nighttime cough and snoring are
very common in acute sinusitis. The present study demonstrates that allergic
rhinitis and recurrent sinusitis is common in our patients.
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Alteration of paranasal sinus mucosa in children
with allergic rhinitis
Felicia Manole. Faculty of Medicine Oradea, Otorhinolaryngology, Oradea,
Romania.
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The purpose of the study is to determine the alteration of paranasal
sinuses in pediatric patients diagnosed as having allergic rhinitis. We have
studied 80 patients aged between 8 and 16 diagnosed with allergic rhinitis in
the period 2005Y2006. The associated diseases have been established: asthma,
sinusitis, serous otitis media, hypertrophic chronic pharyngitis. Allergic rhinitis
has been found to be perennial in 34 cases and seasonal in 46 cases. Associated
sinusitis has been diagnosed in 42 patients, all of this have a high level of Ig E,
from whom 28 patients had seasonal rhinitis. Main clinical symptoms: nasal
discharge, nasal obstruction, sneeze, headache, eye itching, cough, postnasal
drip. Clinical and radiological examination (X-ray) of paranasal sinuses has
shown the alteration of maxillary, ethmoidal and frontal sinus mucosa. The
mucosa is swollen or with serous effusion. The results of the study demonstrate
that: maxillary and ethmoidal sinusitis is predominating affected in patients
with seasonal allergic rhinitis. Radiological examination has shown predomi-
nant lesions of the type of sinusal swollen mucosa. Postnasal drip and cough
associated with allergic rhinitis are indirect symptoms of the alteration of the
paranasal sinuses. Allergic rhinitis in children must not be considered an
isolated disorder, but must be considered in the context of a systemic allergic
disorder. Sinus disorder in children is often misdiagnosed. Nasal mucosal
edema at the level of the middle meatus favors associated sinus disorders.
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Presence of eosinophilic inflammation and airway remodelling
signs in sinus tissues of patients with asthma
and chronic rhinosinusitis
Dilek Saka1, Cem Saka2, Filiz Cimen1, Sema Canbakan1, \stemihan Ak]n2,
Funda Demirag3, and Nermin Capan1. 1Ataturk Chest Diseases and Chest
Surgery Education and Research Hospital, Respiratory Medicine, Ankara,
Turkey; 2Diskapi Yildirim Beyazit Education and Research Hospital,
Otorhinolaryngology-Head and Neck Surgery, Ankara, Turkey; 3Ataturk Chest
Diseases and Chest Surgery Education and Research Hospital, Pathology,
Ankara, Turkey.
Background: Chronic rhinosinusitis exists in a high amount of asthma
patients. It is still unknown whether a cause and effect relationship is present
between the two diseases or they are the manifestations of the same underlying
disease process affecting the whole respiratory tract.
Objective: The aim of this study was to find out if sinus tissues in chronic
rhinosinusitis have asthma related histological features such as eosinophilic
inflamation and airway remodelling.
Methods: The sinus tissues taken from 15 asthmatic patients with chronic
rhinosinusitis and who had ungergone functional endoscopic sinus surgery
were examined histologically. The patients did not have nasal polyposis. The
’Hematoxylin and eosin’ staining was used to detect epithelial damage.
Basement membrane thickening of the airway mucosa was evaluated with PAS
staining. These two signs were accepted as signs of airway remodelling.
Eosinophil semiquantitative scoring system (0Y4) was used to detect presence
and amount of the eosinophils.
Results: 15 patints with mean age of 37 T8.19 years were included in the study.
12 patients were female, 3 were male. 9 patients were found as atopic with skin
prick test. 9 (60%) patients had epithelial damage with severe damage in 7
(46.6%). 11 (73.3%) patients had basement membrane thickening. 10 ( 66.6%)
patients had eosinophils in the sinus tissue. 6 of these patientswere allergic. The
rate of allergy was the same in patients who had not eosinophils in sinus tissues.
Conclusion: In patients with asthma and chronic rhinosinusitis without nasal
polyposis, the histopathologic signs of asthma can also be seen in sinus tissues
of the patients taken with functional endoscopic sinus surgery. This can be a
clue of the same pathogenetic event of the whole respiratory tract.
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Alveolar concentration and bronchial output of exhaled nitric
oxide in chronic rhinosinusitis
Enrico Heffler, Iuliana Badiu, Giuseppe Guida, Luisa Bommarito, Pietro
Marsico, and Giovanni Rolla. University of Torino - ASO Ordine Mauriziano,
Allergy and Clinical Immunology, Torino, Italy.
Background: Rhinitis and chronic rhinosinusitis (CRS), particularly with
nasal polyps, are strong risk factors for asthma. Exhaled nitric oxide (FENO), a
reliable non-invasive marker of airway inflammation, is known to be elevated
in patients with asthma and rhinitis. In this study we investigated inflammatory
and functional airway involvement in patients with CRS.
Methods: We recruited 47 patients with CRS, in all of them respiratory
questionnaire, spirometry and FENOmeasurement (at constant flow of 50, 100
and 200 ml/sec) were obtained. Alveolar concentration (FANO) and maximal
bronchial output (QbrMaxNO) of nitric oxide were calculated for each patient
using a nonlinear model described by Silkoff et al. All patients with asthma-
like symptoms were further investigated by methacholine inhalation challenge
and/or bronchodilating test.
Results: 19 (40.4%) of our patients met the functional and clinical criteria of
asthma, and 34 (72.3%) had nasal polyps. Among the 28 patients without
asthma, 11 (39.3%) complained asthma-like symptoms. FENO was higher in
patients with asthma (63.9, I.C. 95%: 47Y81 ppb) and asthma-like symptoms
with normal lung function (64.7, I.C. 95%: 39Y91 ppb), compared with those
without asthmatic symptoms (29.8, I.C. 95%: 21Y39 ppb), pG0.01. All the
three groups of patients had FENO higher than healthy controls (13.4, I.C.
95%: 6Y19 ppb, pG0.01). QbrMaxNO was more elevated in patients with
asthmatic symptoms, with and without lung function criteria for asthma (3.2 ,
I.C. 95%: 2.3Y4.1nL/s and 3.5, I.C. 95%: 1.5Y5.6 nL/s respectively) compared
with patients without asthma-like symptoms (1.9, I.C.95%: 1Y2.8 nL/s), p G
0.05. FANO was higher in patients with asthma-like symptoms but normal
lung function (4.5, I.C. 95%: 2.4Y6.6 ppb) compared with those with asthma
(2.4, I.C. 95%: 1.6Y3.4 ppb) and those without asthmatic symptoms (2.8, I.C.
95%: 1.1Y4.5 ppb), p=0.03.
Conclusion: Patients with CRS showed higher levels of FENO compared to
normal controls, suggesting a diffuse airway inflammation. FENO values were
particularly elevated, with increased maximal bronchial output of nitric oxide,
in patients with asthmatic symptoms, irrespectively of lung function
(asthmatics or not), while alveolar concentration of nitric oxide was
significantly higher only in patients with asthmatic symptoms, but normal
lung function, suggesting a more peripheral inflammation in these patients
than in patients with asthma.
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Microbiology of patients with a clinical diagnosis of sinusitis
Jacquelynne Corey1, Nedra Joyner2, Asli Sahin-Yilmaz3, Adam Holdt2, and
Patricia Fishman2. 1University of Chicago, Otolaryngology, Chicago, United
States; 2University of Chicago, Otolaryngology-Head & Neck surgery,
Chicago, United States; 3Takesim Egitim ve Arastirma Hastanesi, No: 148
KBB Klinigi, Istanbul, Turkey.
The diagnosis of Acute Bacterial Rhinosinusitis (ABRS) involves
clinical symptoms and signs, without the use of plain sinus radiographs. We
wished to determine the microbiology of sinusitis using these criteria
compared to endoscopic culture results, with and without plain sinus films.
Methods: 103 patients diagnosed with acute sinusitis by clinical criteria were
studied. Clinical criteria included biphasic illness, signs and symptoms of
sinusitis and purulent sino-nasal drainage. After entry, patients had an
endoscopic ostiomeatal culture and a Water_s view plain radiograph.
Results: The pathogens identified in descending order were: Staphylococcus
aureus (48.6%), Streptococcus pneumoniae (22.9%), Moraxella catarrhalis
(11.4%), Pseudomonas (11.4%), Enterococcus (8.6%), Haemophilus influen-
zae (5.7%), Proteus mirabilis (5.7%), and other Strep species (5.7%). We also
found 1 Methicillin Resistant Staphylococcus Aureus (MRSA) and 1
Aspergillus niger. The symptoms with the best combination of sensitivity,
specificity, Positive Predictive Value (PPV) and Negative Predictive Value
(NPV) were colored/purulent nasal drainage, congestion, and facial pain.
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Adding a positive x-ray produced a specificity of 68.7%, and NPVof 68.7%,
but reduced sensitivity and PPV to 36.4% each (respectively). Utilizing the
clinical criteria of colored nasal drainage, congestion and facial pain together
(without x-ray) provides the best combination of sensitivity, specificity, PPV,
and NPV.
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Mometasone furoate nasal spray in seasonal allergic rhinitis
Ziad Adwan. Saha, Allergy, Swaida, Syrian Arab Republic.
Background: Mometasone furoate nasal spray (MFNS) is effective for
preventing and treating nasal symptoms in seasonal allergic rhinitis (SAR). Its
effects on ocular symptoms have not been investigated. This retrospective
analysis examined the effects of MFNS on ocular symptoms in subjects with
SAR.
Methods: Ocular symptom data were pooled and analyzed from four
randomized, double-blind studies comparing MFNS 200 mcg once daily (n =
494) with placebo (n = 497). Subject-reported ocular itching, redness, and
tearing were recorded at baseline and twice daily throughout treatment on a
scale of 0 (none) to 3 (severe). Total ocular symptom score (TOSS) was
defined as the combined 2-week average symptom scores.
Results: MFNS produced a statistically greater reduction in TOSS from
baseline as compared to placebo (j1.33 vs.j0.94, p G 0.05). Likewise, mean
2-week reductions in individual symptoms were significantly improved with
MFNS (p G 0.05 for each symptom). In subjects with TOSS 4 at baseline,
MFNS recipients (n = 298) reported a significantly greater reduction in TOSS
as compared to placebo recipients (n = 304; j1.97 vs. j1.51, p G 0.05), with
statistically significant benefits also observed in individual ocular symptoms
(p G 0.05 for each symptom).
Conclusion: MFNS has a beneficial effect on ocular symptoms, in addition to
its established effects on nasal symptoms, in subjects with SAR.
DIAGNOSIS OF ALLERGY
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Identification of major allergens of royal jelly using
2-dimensional electrophoresis and mass spectrometry analysis
Shahnaz Murad1, Rosmilah Misnan1, Geeta Patel2, Dinah Rahman3, Meinir
Jones4, Noormalin Abdullah1, and Masita Arip1. 1Institute for Medical
Research, Allergy and Immunology Research Centre, Kuala Lumpur,
Malaysia; 2Imperial College, Department of Proteomics, London, United
Kingdom; 3Institute for Medical Research, Allergy and Immunology Research
Centre, London, United Kingdom; 4Imperial College, Department Occupa-
tional and Environmental Medicine, London, United Kingdom.
Background: Royal jelly is a health supplement widely consumed in the
community and has perceived benefits ranging including boosting the immune
system. However, royal jelly consumption has been linked with contact dermatitis,
acute asthma, anaphylaxis and death. Case reports of allergy to royal jelly have
been reported among atopics. Our previous study among local allergic patients
demonstrated that royal jelly sensitivity was found to be present in this country.
Several major allergens in the range of 39 to 71 kD have been detected. Thus, the
aim of this study is to identify the major allergens of royal jelly using 2-
dimensional electrophoresis and mass-spectrometry analysis.
Methods: Extract of royal jelly was fractionated by charge and molecular
weight using 2-dimensional electrophoresis (2-D). Immunoblotting of the 2-D
profiles were performed to identify the allergenic spots of the major allergens
using sera from royal jelly allergic patients. Spots were then excised from the
2-D gel, digested with trypsin and analyzed by MALDI-TOF MS and Q-TOF
MSMS. For protein identification, the masses obtained were used to search
databases to identify the proteins.
Results: 2-D gel fractionated the royal jelly proteins to more than 50 different
protein spots. Out of these, 31 spots demonstrated specific IgE to the sera
tested. Digested peptides of most allergenic spots as compared to the amino
acid sequence in databases identified the fragments of royal jelly homologus to
major royal jelly protein 1 (MRJ1) and major royal jelly protein 2 (MRJ2). Our
results confirmed that the major allergenic spots of royal jelly are MRJ1 and
MRJ2.
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Identification of IgE-binding proteins of Thunnus tonggol
(tongkol) by mass spectrometry analysis
Rosmilah Misnan1, Shahnaz Murad1, Meinir Jones2, Graham Taylor3, Dinah
Rahman3, Noormalin Abdullah1, Masita Arip1, and Jamaluddin Mohamed1.
1Institute for Medical Research, Allergy and Immunology Research Centre,
Kuala Lumpur, Malaysia; 2Imperial College, Department Occupational and
Environmental Medicine, London, United Kingdom; 3Imperial College,
Department of Proteomics, London, United Kingdom.
Background: Fish is one of the most frequent cause of food allergy.
Parvalbumins represent the main major allergens and responsible for IgE
cross-reactivity between various species of fish. Tongkol belongs to the genus
Thunnus that includes several species. Tuna, which is widely consumed
worldwide, also belongs to this genus. The aim of this study was to
characterize IgE-binding components of Thunnus tonggol (tongkol/ Northern
bluefin tuna).
Methods: Uncooked and cooked extracts of the fish were prepared from the
fish meat. Protein profile and IgE binding pattern was demonstrated by sodium
dodecyl polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting
using sera from subjects with fish allergy. The major allergens of the fish were
then identified by two-dimensional (2-D) electrophoresis, followed by mass
spectrometry analysis of the peptide digest.
Results: The SDS-PAGE of raw extract revealed 26 protein fractions over a
wide molecular weight range, while cooked extract demonstrated only nine
protein fractions. The 1-D immunoblotting detected 17 IgE-binding proteins,
ranging in molecular weight from 151 to ~12 kD. Two protein fractions with
molecular weight of ~51 and 42 kD have been identified as the major
allergens of this fish. Both proteins were sensitive to heat. The 2-D gel profile
of the raw extract demonstrated about 9100 distinct proteins spots and
immunoblotting detected at least 10 different major IgE reactive spots with
molecular masses as expected and isoelectric point (pI) values ranging from
4.1 to 6.1. Comparison of the major allergenic spot sequences of the ~51 and
42 kD proteins with known protein sequences in databases revealed extensive
similarity with fish enolase and triose phosphate isomerase, respectively. In
conclusion, this study demonstrated that enolase and triose phosphate
isomerase are the major allergenic component of this species of fish.
Interestingly, our study also detected a heat resistant protein at ~12 kD as
parvalbumin, which is similar as Sal s 1. However, this protein was only seen
as a minor allergen for this fish.
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The analysis of mite and cockroach allergen in vitro test for
allergic disease
Baoqing Sun, Lili Wei, Hongyu Wang, Chunqing Zhang, Jing Li, and
Nanshan Zhong. Guangzhou Institute of Respiratory Diseases, Allergy Dept,
Guangzhou, China.
Objective: To investigate the level of specific IgE (SIgE) of mite and
cockroach in allergy patients’ blood serum, and study their correlation.
Methods: By ELISA test to examine the mite and cockroach allergen’s sIgE
from the blood serum of 199 outpatients who were recruited during 2004 Oct
to 2005 Oct at Respiratory department and Allergy department.
Results: In the mite (dermatophagoides pteronyssinus(d1), dermatophagoides
farinae(d2), and Blomia Tropicalis(d201) allergic group, the children showed
higher proportion of positive result than the adult group. Some strong positive
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results were all recorded from children. In the cockroach allergic patients, the
positive results were all under the class IV level. For those patients who
allergic to both of mite and cockroach, the mite allergen SIgE in blood was
significantly higher then that of cockroach allergen (p G 0.01).
Conclusion: Mite and cockroach are both important allergens of allergic
diseases, from which mite played a dominant role. For those patients who are
allergic to both mite and cockroach, they are proved to be more sensitive to
mite allergen.
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Recombinant tropomyosin of american cockroach,
Periplaneta americana
Nitaya Indrawattana1, Nitat Sookrung2, Anchalee Tungtrongchitrc3, and
Wanpen Chaicumpa4. 1Department of Microbiology and Immunology,
Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand;
2Office for Research and Development, Faculty of Medicine Siriraj Hospital,
Mahidol University, Bangkok, Thailand; 3Department of Parasitology,
Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand;
4Biomedical Sciences Programme, Faculty of Allied Health Sciences,
Thammasat University, Pathum-thani, Thailand.
Background: American cockroach (CR), Periplaneta americana is an
important source of indoor allergens among Thais. Currently, screening and
monitoring allergic status of allergic patients are performed by skin prick
test using crude CR extract which varies in the allergenic composition from
batch-to-batch. Thus, recombinant CR allergens may be a better
standardized alternative. Thus, in this study, we produced recombinant
tropomyosin (Per a7) which is one of the P. americana major allergens. The
protein was tested for its ability to bind to IgE in sera of CR allergic Thai
patients.
Objectives: To produce recombinant tropomyosin of American cockroach,
and to determine the IgE binding ability of the recombinant allergen.
Materials and Methods: Sera of patients with CR allergy who gave
positive skin prick test to CR extract and sera of non-allergic counterparts
were collected. Total RNA was extracted from adult P. americana and first
strand cDNA was produced by RT-PCR. Gene encoding tropomyosin was
amplified using oligonucleotide primers and the cDNA as a template. The
amplified sequences were cloned into a cloning vector and a protein
expression vector. The latter was used to transfect an Escherichia coli
host. E. coli transformant was grown and production of tropomyosin
protein was induced by IPTG. The protein was extracted and purified from
the bacterial lysate.
Results: Gene encoding American cockroach tropomyosin (450 bp) was
amplified and cloned into a cloning vector, i.e. pGEM T and a protein
expression vector, i.e. pET 20 b+. Amplified sequence showed 100%
homology to the tropomyosin gene sequence in the database. Recombinant
tropomyosin was produced and purified from whole cell lysis of an E. coli
transformant grown under IPTG induced-condition. The protein (~16 kDa)
was found to bind IgE in sera of allergic Thai patients.
Conclusion and Clinical Relevant: Recombinant tropomyosin of
P. americana was successfully produced in pure form. The protein binds
IgE in sera of CR allergic Thai patients. Thus, the protein may be used as a
standard reagent for screening and monitoring of the allergic status of patients.
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Serum allergen profiles related to moth and house dust mite
in cockroach-allergic patients in-vitro assay and
correlation analysis
Baoqing Sun, Nili Wei, Jing Li, Mei Jiang, and Nanshan Zhong. Guangzhou
Institute of Respiratory Diseases, Dept of Medicine, Guangzhou, China.
Objective: To look at the serum profiles of specific immunoglobin E (SIgE)
related to moth and house dust mite allergens in cockroach-allergic patients
and provide evidences for further research on insect hypersensitivity.
Methods: Thirty-three patients who presented to our Respiratory or Allergy
Clinics between October 2004 and May 2007, and tested positive of Blattella
germanica allergen by both skin prick test and SIgE test, were further
evaluated for allergens related to Periplaneta americana, moth and house dust
mite using fluorescence enzyme-linked immunosorbent assay.
Results: In patients who showed concurrent hypersensitivity to all of studied
allergens, responses to the cockroaches and moth were weak-positive (below
Grade IV), with significantly lower SIgE levels than as found for house
dust mite (P G 0.001). Linear regression showed positive correlations in
allergenicity between the two species of cockroaches and moth (P G 0.001),
but not between house dust mite and moth or cockroaches.
Conclusion: High response to house dust mite was demonstrated in patients
with multiple allergies. Allergens from Blattella germanica, Periplaneta
americana and moth appeared to share some IgE binding site in common.
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Production and identification of major allergens of two species of
local crab: blue/ swimming crab (Portunus pelagicus) and red
crab (Charybdis japonica)
Rosmilah Misnan, Shahnaz Murad, Noormalin Abdullah, Siti Masitah
Jamaluddin, Yuslina Yusoff, and Amir Shahmi Md Ali. Institute for Medical
Research, Allergy and Immunology Research Centre, Kuala Lumpur,
Malaysia.
Background: Crab has been recognized as a source of potent allergens
especially in countries where seafood forms a large portion of the diet of the
community. Blue/ swimming crab (Portunus pelagicus) and red crab
(Charybdis japonica) from Family Portunidae are among the most commonly
consumed crab in Malaysia. The objective of this study is to characterize the
IgE-binding proteins and major allergens of these species of crab.
Methods: Cooked and uncooked extracts of both crab were prepared and
fractionated by sodium dodecyl polyacrylamide gel electrophoresis (SDS-
PAGE). IgE-binding proteins were then demonstrated by immunoblotting tests
using sera from 99 and 76 patients with positive skin prick test (SPT) to blue
and red crab extracts, respectively.
Results: Both species of crab had similar protein profiles. The uncooked
extracts of both crab produced 19 protein bands in the range of 15 to 138 kD.
Several protein bands between 17 to 25 kD and 50 to 71 kD which were
present in the uncooked extracts appeared to be denatured in the cooked
extracts. The immunoblotting of blue and red crab revealed 14 and 15 various
IgE-binding proteins, in the range of 24 to 138 kD, respectively. The most
common IgE-binding proteins were identified in the range of 34 to 46 kD.
A 34 kD protein was identified as a major allergen for both crab. A 36 kD
protein was also demonstrated as a major allergen in red crab and two proteins
at 38 and 46 kD were also seen as major allergens in blue crab. Interestingly,
these major allergens at 34, 36 and 38 kD were similar in size with
tropomyosin, the main major allergen and responsible in the majority of
allergic reactions to various seafood species including crab.
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Skin prick test reactivity to peanut and tree nuts in adult and
children with atopy
Noormalin Abdullah, Shahnaz Murad, and Rosmilah Misnan. Institute for
Medical Research, Allergy and Immunology Research Centre, Kuala Lumpur,
Malaysia.
Background: Nut allergy (peanut and tree nut) is a common cause of allergy
and can even cause severe anaphylactic reactions. Peanut allergy is more
common than tree nut allergy, but many subjects develop hypersensitivity to
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both peanuts and tree nuts. Peanuts are known as ground nuts, earth nuts and
monkey nuts while tree nuts refer to nuts such as Brazil nut, hazel nut, almond,
walnuts and cashew nuts. The peanut plant, Arachis hypogaea, belongs to the
botanical family Leguminose and do not related botanically to nuts such as
Brazil nut, hazel nut or almond. There are no reports of prevalence of peanut
and tree nuts allergy in Malaysia neither is there reports of fatal anaphylaxis
due to nut allergy.
Methods: A total of 621 children and adults with history of atopy (asthma,
allergic rhinitis, hives and food allergy) were skin tested to a panel of peanuts
and tree nuts (commercial and in-house extracts).
Results:We found that children have higher skin test positivity to peanuts and
tree nuts compared to adults. In children, skin prick test showed 8.5%
positivity to raw peanut and walnut, 6% to big peanut and 4.3% to almond, and
cashew nuts extracts whilst skin prick test positivity to both hazel nuts and
walnut were lower at 2.6% and 1.7% respectively. In adults, the most common
skin test reactivities are peanuts, 5% and 4% to cashew nuts.
Conclusion: It appears that skin test reactivity to nuts exist in subjects
with no clinical presentation of nut allergy. A large number of individuals
have skin test reactivity to multiple nuts and this is probably due to cross-
reactivity.
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Allergen-specific IgE-values to inhalant and food allergens in
China - comparison between two commercial immunoassays:
Dr. Fooke ALLERG-O-LIQ versus Pharmacia CAP-System
Baoqing Sun, Jing Li, and Nanshan Zhong. Guangzhou Institute of
Respiratory Diseases, Dept of Medicine, Guangzhou, China.
Purpose of the Study: Comparison of two in vitro assays for the detection of
allergen-specific IgE (sIgE) and Total IgE (TigE) (Dr. Fooke ALLERG-O-
LIQ, Neuss, Germany, www.fooke-labs.de; Pharmacia CAP-System, Upsala,
Sweden, www.pharmacia.com) re-analyzing sera with sIgE to common
inhalatans and food allergens and TIgE.
Materials and Methods: Allergens: Inhalants: housedust mite D. pter. d1,
D.farinae d2, Blomia tropicalis d5, Cat (Epithelia) e1, Dog (Epithelia) e5,
German Cockroach i6, Aspergillus fumigatus m3; food allergens (FA): hen’s
egg f1, cow’s milk f2, Crab f23, shrimp f24.
Patients Sera: Sera from allergic patients (bronchus asthma, allergic rhinitis
and chronic cough) were collected from Oct. 2004 to May. 2007 at Guangzhou
Institute of Respiratory disease out patient department. Clinical data were not
evaluated.
Performance: sIgE was measured in single runs according to the
recommendations of the manufacturers. Assay features and methodological
differences are listed in table 1.
Calculation: Associations between quantitative sIgE-levels of different assays
were calculated using non-parametric Spearman-Ranktest and depicted with
log scales. Sensitivity, Specificity and Agreement per allergen was calculated,
using following formula: 1) Sensitivity (%) = (# of LIQ+ results)/(# of CAP+
result per allergen) 2) Specificity (%) = (# of LIQ- results)/(# of CAP- result
per allergen).
Results: 1. Data see the appendix. 2. Quantitative values of both systems are
associated to different degrees, depending on the specific inhalant allergen. 3.
Dr. Fooke Allerg-O-LIQ has a good sensitivity, specificity and Agreement to
the Pharmacia CAP-System.
Comments: Values of sIgE to inhalants detected by different in vitro methods
show better correlation than sIgE to FA. Allergens with one dominant major
allergen (i.e. e1) seem to be less difficult than complex allergen mixtures (i.e.
d1). Identical units (kU/l) are no guarantee for equivalent sIgE results. The data
presented do not allow estimates of the true sIgE concentrations or judgement
on superiority of one of the tests over the other.
Conclusion: Comparative studies are necessary and helpful to define the
concordance of sIgE-values detected by different immunoassays. Lack of
concordance (complex allergen mixtures 9 simple allergens; FA 9 inhalants)
should prompt subsequent improvement of allergens used in test systems
detecting specific IgE.
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Cow’s milk and gluten allergy in correlation with behaviour in
autism children in Malaysia
Noormalin Abdullah, Shahnaz Murad, Rosmilah Misnan, and Masita Arip.
Institute for Medical Research, Allergy and Immunology Research Centre,
Kuala Lumpur, Malaysia.
Background: Autism is a neuropsychiatric condition that presents with
abnormal, bizarre behaviour patterns and accompanied by learning difficulties.
Peptides known as casamorphin (from milk proteins) and gliadinomorphin
(from gluten protein) are absorbed from the gut into the blood stream leading
to the theory of Bleaky gut syndrome[.
Methods: Eighty-four autism children, divided into 2 groups: younger age
(less than 5 years) and an older age group (5 to 19 years) were skin prick tested
(SPT) to a panel of food allergens. Blood test for specific Immunoglobulin E
(IgE) to cow’s milk, wheat, soya and oat, specific Immunoglobulin G (IgG) and
Immunoglobulin A (IgA) to alpha-lactalbumin, beta-lactoglobulin, casein and
gliadin were carried out. Questionnaires on behavioural pattern of children
were filled by parents.
Results: The majority of autism children were Chinese (76.2%) and male
(88%). In the younger group, we found that SPT to soya 8.3%, wheat
3.5%, and cow’s milk 2.3%. Specific IgE to cow’s milk 9.52%, wheat
2.3%, and soya 1.2%. 8.3% had detectable levels to IgG alpha-lactalbumin,
5.9% to IgG beta-lactoglobulin, 1.2% to IgA beta-lactoglobulin and 4.76% to
IgG casein. No IgA alpha-lactalbumin, IgG casein, IgG gliadin, IgA casein and
IgA gliadin were detected in this group of children. In the older children, 23%
has positive SPT towheat, 17.8% to soya, and 9.5% to cow’s milk. Specific IgE
to cow’s milk and wheat was 9.52% whereas to soya 8.3%. 11.9% had
detectable IgG alpha-lactalbumin, 7.1% to IgG beta-lactoglobulin, 3.5% to IgG
gliadin while 2.3% had detectable levels of IgG casein, IgA alpha-lactalbumin,
beta-lactoglobulin, gliadin and 1.2% to IgA casein. As to behavioural pattern,
the study showed that 70.6% of younger group and 64.2% of older group
presented with unawareness of the world, 88.4% in younger group has poor eye
contact compared to 61.2% in older group. There is not much difference in
TABLE 2.
Dr. Fooke Allerg-O-LIQ Pharmacia CAP-System
Test principle fluid phase reversed enzyme-immuno-assay (R-EAST) solid phase fluorescence-enzyme-immuno-assay (FEIA)
Allergens fluid phase allergens solid phase allergens
Test procedure 1. IgE binds to anti-IgE. 2. Allergen binds to sIgE 1. sIgE binds to allergen. 2. Anti-IgE binds to sIgE
Markers biotinylated allergens "-galactosidase coupled anti-IgE
Detection Photometry fluorophotometry
Units kU/l kU/l
Classes 0 Y 6 0 Y 6
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general learning ability and antisocial behaviour observed in both groups. In
conclusion this study showed children 5 years and above had a higher SPT
positivity to wheat and cow’s milk. Casein was found to be low in both age
groups and no gliadin was detected in the younger group. Behavioural pattern
seemed to be improving as they became older and has no correlation with cow’s
milk and gluten allergy.
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Indigenous allergens in Saudi Arabia: Efficacy of diagnostic kits
S. M. Hasnain1, A. R. Al-Frayh2, J. L. Subiza3, and S. T. Al-Sedairy1. 1King
Faisal Specialist Hospital and Research Centre, Biological and Medical
Research, Riyadh, Saudi Arabia; 2College of Medicine King Saud University,
Pediatric Department, Riyadh, Saudi Arabia; 3Inmunotek Madrid, Allergy
and Immunology Department, Madrid, Spain.
Background: In order to diagnose allergic patients with more relevant
allergenic species which they are directly exposed to, indigenous species were
collected and prepared commercially along with other allergens under a
collaborative project with M/s Inmunotek, Madrid, Spain. These allergens
were tested in allergic patients in the region to evaluate the efficacy and
reactivity.
Methods: A total of 30 allergenic extracts with 50% indigenous species were
included in the Diagnostic Panel. These allergenic species were selected after
comprehensive aerobiological studies in many parts of the country and their
growth and availability in the region. Glycerinated extracts were prepared by
Inmunotek under a brand name of Allergotek. Standard prick tests with
histamine and saline controls were conducted on 541 allergic individuals in the
Middle East and Africa. The method is considered to be convenient and
economical providing nature of sensitizing allergen(s) and an opportunity for a
possible successful immunotherapy.
Results: A total positive reactions for all allergens (Mild,Moderate and Severe)
were recorded; Jeddah 1123 (n = 194) Riyadh 731 (n = 108), Dammam478 (n =
103, Khamesh 244 (n = 40), Hofuf 163 (n = 40) UAE 53 (n = 6) and Sudan 397
(n = 50). An overall reactivity pattern of 41% (1273 positives) was recorded
with outdoor allergens and 59% (1916 positives) with indoor allergens.
Maximum combined reactivity with pollen allergens for all sites were recorded
with Cynodon dactylon (11.8%), Chenopodium murale (10.8%), Phoenix
dactylifera (10%) Salsola imbricata (9.2%) Prosopis juliflora (8.9%) and
Lolium perenne (8%). The maximum indoor allergens reactivity was recorded
with D. farinae (15.7%), D. pteronyssinus (15.7%), Felis domesticus (12.5%)
Periplaneta americana (10.4%), Blatella germanica (9.7%) and Blatta orietalis
(8.4%).
Conclusion: The results of this efficacy trial of indigenous allergens revealed
that majority of these allergens were effective with moderate to severe
reactions. Asthmatic and allergic individuals were found to be comparatively
more sensitive to indoor allergenic species than the outdoor allergens. While
the cultural habits and climate appear to have played a role, socioeconomic
conditions did not influence the overall sensitization pattern. It is further
suggested that, if possible, regional species and/ or allergenic material should
be included in the diagnostic test panel.
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Prevalence and sensitization to weeds pollen in Saudi Arabia
Syed Mohammed Hasnain1, Abdulrahman Al-Frayh2, and Mohammed
Osman Gad-El-Rab3. 1King Faisal Hospital and Research Centre, Allergy
and Aerobiology Unit, Riyadh, Saudi Arabia; 2King Khalid University
Hospital, Pediatric Department, Riyadh, Saudi Arabia; 3King Khalid
University Hospital, Immunology Department, Riyadh, Saudi Arabia.
Background: In an aerobiological study, airborne pollen grains from weeds
emerged to be the most dominant and prevalent pollen type in Saudi Arabia.
Therefore, we conducted Skin Prick Test (SPT) on 500 allergenic individuals
to examine IgE mediated sensitization level to a number of weeds allergens.
Methods: SPT on 500 individuals having asthma and other allergic
manifestations attending allergy clinics in six different regions was conducted
using commercial extracts. The selection of allergens was made after an
extensive nation wide aerobiological survey using Burkard Volumetric Spore
Traps. The major pollen components of the Kingdom_s environment were
identified as Amaranthus viridis., Atriplex polycarpa, Chenopodium album,
Cyperus rotundus, Rumex crispus and Plantago spp.
Results: The SPT data revealed a comparatively higher degree of sensitization
to weeds pollen. In the south, mountainous region (Abha), 21.8%, while in an
agricultural setting (Gassim) 75.5% patients reacted to weeds pollen. In an
another location in the Eastern region (Hofuf) 16.7% of the patients while close
to Red Sea region (Gizan) 9% of the patients reacted positively tovariousweeds
pollen, which included Atriplex polycarpa, Chenopodium album, Salsola
tennifolia and Rumex crispus. Individual pollen releaved Chenopodium album
with maximum reactivity (81.8%) in agriculture setting (Gassim) followed by
Salsola tennifolia (75.5%), (25% Al-Hofuf), Rumex crispus 27.3% (Gassim)
and 18.1% (Gizan). Apart fromCynodon dactylon, a grass pollen and Prosopis
juliflora, a tree pollen, highest skin reactivities were recorded by members of
the chenopodiace weeds in all regions.
Conclusion: The study indicates that sensitization and exacerbation of
symptoms in patients during pollination season may be caused by desert weeds
growing in the Kingdom, and may possibly be a major contributor of
respiratory allergy in Saudi Arabia.
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Specific IgG antibodies (total and subclasses) to saffron: a study
of their correlation with specific IgE and immediate
skin reactions
Homan Kaghazian1, Abdolreza Varasteh2, Fatemeh Vahedi3, Mojtaba
Sankian2, Shima Tavallaie2, and Mahmoud Mahmoudi2. 1Pasteur Istitute of
Iran, Immunology, Tehran, Islamic Republic of Iran; 2MUMS, Immunology,
Mashad, Islamic Republic of Iran; 3Razi Institute of Iran, Immunology,
Mashad, Islamic Republic of Iran.
Saffron (crocus sativus) cultivation is one of the most agricultural
products in Iran. Saffron contains an aeroallergen that causes reactive
respiratory allergic reactions in exposed subjects. To investigate the role of
specific IgE and IgG in this type of allergic reaction, saffron specific IgE and
IgG subclasses were determined in the sera of 38 exposed subjects (test group)
and 20 normal subjects (control group) by ELISA. Immediate skin reactions
were assessed in exposed subjects. The mean optical densities of saffron-
specific total IgG and IgE antibodies were significantly higher in the test
group than the control groups. Specific IgG4 antibodies were lower in the
test group. Other IgG subclasses did not have any significant difference in
the two groups. The immediate skin reactions were positive in 80% of the test
group. The specific IgE antibody levels correlate with the specific total IgG
antibody levels and the positive skin reactions (R = 0.67 and R = 0.42,
respectively). A reverse correlation was found between the specific IgE
antibody levels and the specific IgG4 antibody levels (R = 0.03).
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Can specific IgE testing in primary care be cost saving?
Carl Johan Petersson1, Giulio Vignati2, Staffan Ahlstedt3, Ulla Ytterstro¨m-
Ahlstedt†1, and Magnus Borres1. 1Phadia, Medical Department, Uppsala,
Sweden; 2Ospedale G. Fornaroli, Centro Malattie Endocrine e M, Magenta,
Italy; 3Karolinska Institute, Dep of Environmental Medicine and Center of
Allerg, Stockholm, Sweden.
Background: Allergy reduces quality of life and places a considerable burden
on society. Specific immunoglobulin E (sIgE) testing can improve manage-
ment and potentially reduce costs. The purpose of the study is to assess the
cost-effectiveness of allergy testing for patients with respiratory and/or skin
problems in primary care in Italy.
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Methods: A cost-minimization analysis was carried out in which the costs of
the two treatment alternatives were compared and assessed using a decision
model that includes costs for pharmaceuticals, physician visits in primary care,
and the costs of allergy testing. In the no-test-strategy part, patients were
classified as allergic, non-allergic or uncertain, on the basis of clinical
judgment without the test. In the test-strategy part, classification of patients
was also based on sIgE results.
Results: Agreement between physicians_ classification and test results was
substantially elevated in the test-strategy part (0.88) vs the no-test-strategy part
(0.52). Costs per patient over 2 years decreased from 784 in the no-test strategy
to 535 in the test strategy, owingmostly to reducedmedication costs. Sensitivity
to the prevalence of allergy and price of medications was demonstrated.
Conclusion: Allergy testing in primary care is cost-saving compared
with not testing. Decrease in false-positive or uncertain diagnoses is the
main component of cost reduction and enables more appropriate patient
management.
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Study of a clinical cohort of patients tested for allergy in a
diagnositic immunolocgy clinic
Heidemarie Saxarra, Glenn Reeves, and Karla Lemmert. John hunter
Hospital Haps, Immunology Haps, Newcastle, Australia.
A large number of patients (500) were studied and their allergy resuts
collated. The specific allergen tests to dust mite, grass mix, food mix, animal
epithelial mix, weed mix, latex and peanut were tabulated. This group of
patients was then analysed for trends in any of the following parameters:
(clinical notes and medical records were used ) age, sex, medication, general
health, symptoms of allergy and severity of the symptoms.
The study was limited in that all of the parameters were not available
for the cohort studied.
No significant trends noted. However useful guidelines established for
future reviews of a large patient cohort in the diagnositic laboratory.
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How can the royal college of pathologists of australasia
immunology qap help your laboratory?
Robert Heddle1, Sue Jovanovich2, and Peter Roberts-Thomson2. 1Flinders
Medical Centre, Department of Respiratory Medicine, Adelaide, Australia;
2Flinders Medical Centre, RCPA Immunology QAP, Adelaide, Australia.
Why does in vitro allergy testing survive? despite generally being less
sensitive, slower and more expensive than skin testing?
1. Applicable when:
& skin disorders (e.g. eczema, dermatographism)
& medications (e.g. H1 anti-histamines, tricyclic antidepressants)
& risk of anaphylaxis (e.g. initial testing for drug allergy; extreme nut allergy)
would prevent or inhibit skin testing
2. Does not require clinician to carry an expensive range of allergens
3. Lends itself to quality control, standardisation and regional collaboration
Why quality control in vitro allergy testing?
1. Some errors are clinically crucial; e.g. false negative result in nut allergy
2. Credibility of laboratory reagents, equipment and performance depends on
satisfactory performance in QC
3. Understanding discrepancies can enhance products and performance
4. Meaningful dialogue depends on comparability of results
The RCPA immunology quality assurance program (QAP) is an
internationally accredited (ILAC G13:2000) provider of External Quality
Assurance (EQA) in Clinical Immunology. The Program has been based
at Flinders Medical Centre in Adelaide since 1988. It offers 18 different
programs, 5 of which are based on Allergy:
& Total IgE
& Tryptase
& Specific IgE to a range of common inhalant and food allergens, allergen
mixes and Bee Venom
Participating Laboratories: Enrolled laboratories are drawn from Australia,
New Zealand, Malaysia, United Arab Emirates, Hong Kong, South Africa,
Singapore, France and Bahrain
Specimens: Serum specimens are obtained from patients with well
characterised allergic disorders and clinical histories are provided
Reports: Reports are returned within 2 weeks of the closing date and provide a
direct graphic comparison of individual laboratory results with all results
received and with participants using the same methodologies.
Assessment is by assignment of FAcceptable Scores_ which are based on
clinical criteria and set by a panel of clinicians, using skin prick test results if
available. Quantitative results are not assessed, but are displayed graphically
for comparative information purposes.
Education - Case Studies: Three informative clinical case studies provided
by clinicians are included free of charge each year to participants. Clinical
notes and results of preliminary investigations are provided. A discussion with
references is provided by expert clinicians.
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Appropriateness of reducing the number of pollen allergens
to three
Karuna Keat1, Karen Byth2, and Connie Katelaris1. 1Westmead Hospital,
Immunology Department, Westmead, Australia; 2Westmead Hospital, West-
mead Millenium Institute, Westmead, Australia.
Background: Skin prick testing (SPT) is an essential tool in the diagnosis
of allergic disorders. The optimal number and type of allergens used in
different settings remains undefined. We aim to describe SPT in our
clinical practice and propose the appropriateness of reducing the number
of pollen allergens to three. The aim is to improve cost-effectiveness and
reducing time spent on allergen testing, particularly in the community
setting.
Methods: Consecutive patients who attended the private rooms of 2
immunologists and the allergy/immunology clinic in a tertiary referral
hospital who required skin prick testing were evaluated from June 2006 to
November 2006. Statistical analysis was undertaken with the use of Pearson`s
Chi-square and Fisher`s Exact test to assess for significance. Multivariate
analysis was also performed.
Results: There were a total of 273 skin prick test sets performed. There was no
significant difference between the rates of SPT positivity with common pollen
allergens between the two clinics. A positive SPT to Perennial Ryegass
(Lolium perenne), Timothy (Phleum patense) or Bermuda grass (Cynodon
dactylon) had a sensitivity of 100% to Bent or Orchard grass (Dactylis
glomerate), with sensitivities of 97%, 96.3% and 94.8% to English Plantain
(Plantago lanceolata), Bahia grass (Paspalum notatum)and Dock/Sorrel
(Rumex sp) respectively. Use of Perennial Ryegrass, Timothy or Bermuda
grass also detected tree pollen sensitivity with sensitivities in Birch mix
(Betula sp) of 92.6%, Acacia (96.4%), Casuarina (89.1%), Platanus sp
(92.3%) and Privet(Ligustrum sp) (88.6%).
Conclusion: The use of 3 common grass pollen allergens in SPTs (Lolium
perenne, Phleum pratense and Cynodon dactylon) detected 90% of atopic
individuals with sensitivity to many pollen types. This information may be
useful in defining the most appropriate allergens to determine pollen
hypersensitivity in community settings.
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Clinical evaluation of a new allergy lateral flow assay for
professional and home use
Michael Mahler1, Lorenz Christine2, Ralf Lucassen1, Margrit Fooke3, and
Jo¨rg Kleine-Tebbe2. 1Dr. Fooke Laboratorien, Development, Neuss, Ger-
many; 2Allergy and Asthma Center Westend, Allergy unit, Berlin, Germany;
3Dr. Fooke Laboratorien, General manager, Neuss, Germany.
Background: Specific immunoglobulin E (sIgE) is a hallmark in the diagnosis
of type I allergic reactions and atopic diseases. A new allergy screening test
(Allergy Lateral Flow Assay; ALFATM) for qualitative detection of sIgE in
human whole blood, serum or plasma is based on a test device, allowing
linkage to a variety of allergens. Objective of our study was the evaluation of
ALFATM for professional and home use.
Methods: Untrained volunteers (n = 96) performed ALFATM Seasonal
Screen (S) [Birch (t3), Bermuda Grass (g2), Rye Grass (g5), Timothy Grass
(g6), June Grass (g8), Cultivated Rye (g12), Mugwort (w6) and Alternaria
alternata (m6)] and ALFATM Perennial Screen (P) [D. pteronyssinus (d1),
D. farinae (d2), cat (e1), dog (e2), Aspergillus fumigatus (m3) and
Aspergillus niger (m33)] with capillary blood. Each serum was tested for
specific IgE to all single allergens contained in both ALFATM tests by
ALLERG-O-LIQ. Furthermore, skin prick tests (SPT, Allergopharma) were
performed. Volunteers were defined allergic if patient`s history was
concordant with SPT and sIgE in-vitro results. ALFATM results and
patient’s diagnoses were analyzed by kappa agreement, Chi-square test,
positive (PPV) and negative predictive value (NPV) and diagnostic
efficiency (DE).
Results: ALFATM results were obtained from 91 (S) and 83 volunteers (P). 33/
91 (36.3%) volunteers, were defined as allergic for seasonal and 16/83 (19.3%)
for perennial allergens. Of those, 25/33 and 6/16 showed positive test results in
ALFATM S and P. Agreement between the ALFATM results and doctor’s
diagnosis was 94.5% (kappa = 0.75, pG0.0001, 22 = 49.3) for S and 91.6%
(kappa = 0.46; pG0.0001, 22 = 17.3) for P. Overall agreement was 93.1%
(kappa = 0.67; p G0.0001, 22 = 79.1). Sensitivity, specificity, PPV, NPVand DE
were 75.8%, 96.6%, 92.6%, 87.5% and 89.0% (S), 37.5%, 98.5%, 85.74%,
86.8% and 86.7% (P) and 63.3%, 97.6%, 91.2%, 87.1% and 87.9%
(combined).
Conclusion: Results, particularly for seasonal allergens, are in good
agreement with doctor’s diagnosis. Therefore, ALFATM offers the opportunity
for primary care physicians and patients to perform a screening test for early
type-I allergy diagnosis.
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Sensitization to five common aero-allergens in children suffering
from atopic eczema as examined by atopy patch tests, skin
prick-tests and specific IgE
Martin Liska, Petr Panzner, Vladimir Hrasko, and Vaclava Gutova. Faculty
Hospital Pilsen, Institute of Immunology and Allergology, Pilsen, Czech
Republic.
Background: Although the role of allergy in atopic eczema (AE) is still
controversial, some patients with atopic eczema suffer from exacerbation
of skin lesions after contact with or inhalation of aeroallergens. From the
histological examinations of the skin after contact with aeroallergenes is
known that the delayed-type hypersensitivity reactions mediated by
allergen-specific T cells can take a part in pathogenesis of atopic eczema.
Atopy patch tests (APT) represent a useful tool for detection of such
hypersensitivity.
Methods: We examined hypersensitivity to common aero-allergens (birch
pollen, grass pollen, cat dander, house-dust mites) using APT, skin prick-tests
(SPT) and specific IgE in 27 children suffering from atopic eczema. Results of
all methods were then compared.
Results: Delayed-type hypersensitivity was found out (using APT) in 16
patients (59%), immediate type of hypersensitivity was found out (using
SPT ) in 13 patients (48%), using specific IgE in 15 patients (55%). Only
immediate type of hypersensitivity was proved in 5 patients (18%), only
delayed-type hypersensitivity in 6 patients (22%). Both types of
hypersensitivity occurred concomitantly in 11 patients (41%). In 32 cases
the typeof hypersensitivity differed in the same allergen.Asignificant (pG 0.0005)
positive correlation was found between SPT and specific IgE. Correlation of
clinical symptoms of AE and positivity of tests was in 7 patients (26%) in
IgE mediated hypersensitivity and in 10 patients (37%) in delayed-type
hypersensitivity.
Conclusion: Various aero-allergens can influence substantially the course of
atopic eczema not only via specific IgE, but as well by specific T cell-mediated
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reactions. Therefore testing for hypersensitivity to aero-allergens both using
SPT and/or specific IgE, and atopy patch tests could be useful.
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Complex diagnosis of IgE mediated allergy by in vivo
and in vitro methods
Bogdan Petrunov1, Georgi Nikolov1, Antoaneta Michova1, Tzveti Ivanova1,
Julia Radenkova-Saeva2, and Hristo Taskov1. 1National Center of Infectious
and Parasitic Diseases, Allergology and Immunology, Sofia, Bulgaria;
2Emergency Hospital BPirogov[, Toxicology Department, Sofia, Bulgaria.
Background: The aim of the study is to assess the diagnostic potential of two
in vitro methods for IgE diagnosis and to compare them with the skin-prick test
(SPT) as a gold standard.
Methods: 131 patients with positive case history and SPT to grass pollen,
house dust mite, moulds, bee and wasp venom suffering of bronchial asthma or
allergic rhinitis /hay fever and 10 clinically health controls were studied. The in
vitro quantity of serum allergen-specific IgE (UniCap, Pharmacia) and the
percentage of allergen-specific basophil’s degranulation (FasImmune, BD)
were evaluated. The correlation and the percent of coincidence of the results
from the three methods were analysed (Statistica 5.5).
Results: Significant statistical correlation between the resuls from the three
methods in patients sensitized to grass pollen and house dust mite were
found. Strong positive correlation (Spearman, pG0.05) between the SPT
and the quantity of specific IgE- R=0.67 and R=0.61, between the in vivo
test and FasImmune - R=0.66 and R=0.62 and between the both in vitro
methods - R=0.67 and R=0.53 were determined. Data from patients, allergic
to insect’s venom, showed a high percent of coincidence between the three
methods - from 70% to 90%. Respectively a cincidence of 60% between the
SPT and the quantity of specific IgE in the group sensitized to moulds was
established.
Conclusion: The results from the invitro methods represent positive
correlation and coincidence with SPT, especially for the allergens of grass
pollen, house dust mite, bee and wasp venom. Their application ensures more
preceise diagnosis of patients and contributes to the complex assessment of
IgE mediated allergy.
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Development and optimization of quartz crystal microbalance
immunosensor for the detection of total IgE
Rawil Fakhrullin1, Rustem Fassakhov2, Victor Vinter1, Elena Sukmanskaya2,
and Olga Konovalova1. 1Kazan State University, Department of Biochemistry,
Kazan, Russian Federation; 2Kazan Reseach Institute of Epidemiology and
Microbiology, Department of Allergology and Immunology, Kazan, Russian
Federation.
Background: Allergic disease have a significant impact on clinical practice
due to their high prevalence. The total IgE quantification is one of the
important steps in the classic atopic disease diagnostics.The most widely used
methods for IgE detection are time-consuming and complex. Biosensors are
interesting tools offering certain operational advantages over standard
photometric methods, notably with respect to rapidity, ease-of-use, cost,
simplicity, portability, and ease of mass manufacture.
Methods: QCM work as sensors based on the relationship between frequency
change and mass loading on the surface of the crystal according to Sauerbrey
equation (Sauerbrey, J Phys, 1959). When antigens react with coated
antibodies on the surface, a frequency shift occurs and this change is
proportional to the mass loading.
Results: The monoclonal anti-IgE were successful immobilize in Nafion
polymeric matrix on silver electrodes of piezoelectric quartz resonator. The
optimal conditions for anti-IgE immobilization procedure and for piezoelectric
immunoassay have been determined. Only 10 microlitres of serum and
45 minutes reaction time is required to measure total IgE. It was found
that biosensor is capable to differentiate blood serums of patients with
low, intermediate and high level of IgE.
Conclusion: The quartz crystal microbalance immunosensor offers a number
of significant advantages over the currentlu available in vitro techniques for the
detection of total IgE. It is supposed that such biosensor can be used in
laboratory practice for IgE determination.
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Systemic reactions to percutaneous and intradermal skin tests
A Bagg, T Chacko, M Glaum, D Ledford, R Fox, and RF Lockey. University
of South Florida College of Medicine, Dept. of Medicine, Division of Allergy/
Immunology, Tampa, United States.
Background: The purpose of this study is to determine over 12 months, 2/1/
06Y1/31/07, the rate of SRs to both P and ID ST, the symptoms reported, and
the response to immediate treatment with epinephrine IM.
Methods: A retrospective review over a one year period was conducted to
evaluate SRs to P and ID ST to 20 to 50 allergens (trees, grasses, weeds,
animals, molds, foods, medications, and Hymenoptera) in 1,456 subjects. A
standard form was used to record symptoms, signs, and treatment. No
vasovagal reactions were included. Nurses as instructed by the attending
physicians administered epinephrine 1:1000 v/v, 0.2mL IM as soon as any
signs or symptoms of anaphylaxis occurred.
Results: 52 patients (3.5%) had SRs, 43 (83%) female and 9 (17%) male. The
average age of the patients with SRs was 40.6 years (range 13Y70, median 35.5
years). 17/52 (33%) had asthma. Symptoms reported: pruritic eyes, nose, and/
or pharynx (40%), worsening cough (27%), sensation of difficulty swallowing
(17%), worsening nasal congestion (15%), rhinorrhea (13%), chest tightness
and/or shortness of breath (13%), generalized pruritus (12%), sneezing (12%),
urticaria (4%), and wheeze (4%). No severe asthma, shock, hypotension,
unconsciousness, or late phase responses occurred. Treatment: 52 (100%)
patients received epinephrine (average dose, 0.2 cc, 1:1000 IM), 48 (92%) oral
prednisone, 9 (17%) oral prednisone to take 6 to 8 hours after reaction, 50
(96%) oral antihistamine (H1) , and 6 (12%) nebulized beta agonist.
Conclusion: SRs occurred in 3.5% of patients skin tested and readily
responded to early intervention with epinephrine. This early administration of
epinephrine by nurses appears to prevent more serious and late phase
reactions.
315
Clara cell protein in irritating and sensitizing effects of inhaled
benzalkonium chloride in rats
Tadeusz Halatek1, Radoslaw Swiercz1, Jan Stetkiewicz2, Aleksander
Krajnow2, Barbara Kur3, and Wojciech Wasowicz1. 1Nofer Institute of
Occupational Medicine, Department of Toxicology and Carcinogenesis,
Lodz, Poland; 2Nofer Institute of Occupational Medicine, Department of
Pathomorphology, Lodz, Poland; 3Nofer Institute of Occupational Medicine,
Department of Immunotoxicology, Lodz, Poland.
Background: Benzalkonium chloride (BAC) is a bacteriostatic agent used in
the pharmaceutical industry as a preservative and is known to cause
bronchoconstriction in asthmatic subjects. The aim of our study is
qualification of results of inhalation exposure to BAC in rats, with particular
reference to the effect on the remodelling of the respiratory system.
Conditioned allergic reactions that impair lung function, such as allergic
asthma, can be evaluated by specific lung biomarkers. It is known that the
irritant fumes affect nonciliated epithelial Clara cells, which release anti-
inflammatory and immunosuppressive Clara cell protein (CC16) into the
respiratory tract.
Materials and Methods: Female Wistar rats were exposed to BAC aerosol at
30 mg/m3 for 5 days (6h/day) and on day 16 were re-exposed to BAC for 6 h.
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After the exposure, bronchoalveolar lavage fluid (BALF) was collected. BALF
concentration of total protein, CC16, IgE, MMP-9, hyaluronic acid (HA),
IL-6, TNF-", MIP-2 and activity of lactate dehydrogenase (LDH) were
determined. CC16 as the marker of bronchiolar epithelium was assessed by
latex immunoassay. In the lung, histological examinations were done and the
activity of glutathione S-transferases (GST) was determined. Additionaly
total and differential cell number (lymphocytes, neutrophils and macrophages)
were measured.
Results: Benzalkonium exposure after challenge induced statistically
significant increases of BALF cytokines, LDH and IgE in BALF and serum.
CC16 level in BALF was significantly reduced. Significant negative corre-
lation of CC16 concentration in BALF with mediators (IL-6) of inflamma-
tory processes was seen. Huge increase of LDH correlated with the level of
total protein, MIP-2 and IgE in serum. Negative relationship was shown to
occur between CC16 and LDH. IgE in serum and BALF correlated with
MMP-9. In histopathology examination, focal agglomerations of alveolar
macrophages were noted as well as proliferation of peribronchial lymphatic
tissue.
Conclusion: CC16 play a protective role in allergic inflammation and take part
in remodelling effects of low molecular weight sensitizers. CC16 can be used
as a diagnostic marker for early detection of impaired respiratory function.
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Pulmonary irritation after inhalation exposure to benzalkonium
chloride in rats
Radoslaw Swiercz1, Tadeusz Halatek1, Wojciech Wasowicz1, Barbara Kur2,
Zofia Grzelinska1, and Wanda Majcherek1. 1Nofer Institute of Occupational
Medicine,Department of Toxicology andCarcinogenesis, Lodz, Poland; 2Nofer
Institute of Occupational Medicine, Department of Immunotoxicology, Lodz,
Poland.
Background: Benzalkonium chloride (BAC) is a quaternary ammonium
compound in which the alkyl groups have a chain length from C8 to C18. BAC
exerts toxic effects on microorganisms. This property has been utilized in the
cosmetic industry and medicine, where it is used as an effective germicide and
preservative agent. Various BAC-containing preparations used by people may
produce a number of adverse effects on the human body. Bearing in mind that
BAC is widely used in different branches of the national economy, its toxic
effect may constitute a major health problem.
Materials and Methods: Female Wistar rats IMP: WIST of body weight
165Y185 g were exposed to BAC aerosol at the target concentration of
30 mg/m3 in the dynamic inhalation chamber for 6 h and 3 days (6 h/
day). After the exposure and 18 h after termination of exposure to BAC
aerosol, bronchoalveolar lavage fluid (BALF) was collected from each
animal and BALF concentrations of total protein, Clara cell protein,
matrix metalloproteinase-9 (MMP-9) hyalurnic acid (HA), immunoglobu-
lin E (IgE) and cytokines (TNF-", IL-6 and MIP-20) and the activity
of lactate dehydrogenase (LDH) and GSH-S-transferase (GST) were
determined.
Results: All the rats survived inhalation exposure to 30 mg/m3 BAC. A
significant reduction of body weight was noted in the animals exposed
repeatedly by inhalation to BAC. Lung weight, total protein, HA level and
LDH activity in BALF were higher in rats after single and repeated exposure to
BAC, compared to control. Decreased concentrations of CC16 in BALF of rats
were observed after the single and repeated inhalation exposure. A
significantly higher level of IL-6 and IgE were noted in the BALF from the
animals exposed to the single and repeated dose. Concentrations of MMP-9,
TNF-", and MIP-2 in BALF of rats exposed to BAC were similar to those
found in the control animals.
Conclusion: BAC showed a strong inflammatory and irritating activity in the
lungs of the rats already after 6 hours of inhalation exposure. BAC stimulates
the dynamic patterns of IL-6 and IgE production and infiltration of protein
from blood circulation system to BALF. Continued exposure resulted in
changes involving cellular destruction, statistically increase of LDH activity
and a continuous reduction of CC16 concentration in BALF.
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Allergic bronchopulmonary aspergillosis in an asthma clinic
using essential minimal criteria
Soo-Keol Lee1, Doo-Kyung Yang1, Choon-Hee Son1, Ki-Nam Kim2, and
Ki-Nam Lee2. 1Dong-A University, Internal Medicine, Busan, Republic of
Korea; 2Dong-AUniversity, Diagnostic Radiology, Busan, Republic of Korea.
Objective: Allergic bronchopulmonary aspergillosis (ABPA) occurs in cases
of atopic asthma and may result in important lung disease. Early diagnosis is
essential as this disease is responsive to corticosteroids. However, there is still
no consensus about the diagnostic criteria, because patients in different stages
of ABPAmay not fulfill the criteria. In this study, we evaluate the prevalence of
ABPA or ABPA-like disease in an asthma clinic using essential minimal
diagnostic criteria.
Methods: A prospective evaluation of patients with bronchial asthma for
ABPA from July 2006 onward. ABPAwas diagnosed using essential minimal
criteria ?asthma, skin prick testing (SPT) positivity to Aspergillus fumigatus
(Af), elevated serum total IgE (CAP), elevated serum Af-specific IgE (CAP),
and central bronchiectasis on CT scans.
Results: Ninety consecutive patients with bronchial asthma were enrolled.
Forty-four of 90 patients were atopic (49.0%), 7 of 44 (18.0%) were positive to
SPT to Af. Five of 44 patients (11.0%) showed only elevated serum Af-specific
IgE without positive response to Af on SPT. A secure diagnosis of ABPA,
satisfying all essential minimal criteria, was evident in 4 of 12 patients
(33.3%).
Conclusion: There is high prevalence of ABPA in asthmatic patients
presenting our hospital. Further evaluations are required to differentiate
ABPA from asthma patients sensitizing to Af without ABPA. The role of
serum Af-specific IgE as a screening tool in diagnosis of ABPA should be
redefined.
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Clinical presentation in 12 patints with allergic
bronchopulmonary aspergillosis
Abdelmonem Sharara, Manaf Hijazi, Hythem El-Khushman, Jafer Momany,
and Mohammed Enjada. King Hussein Medical Center, Department of Chest
Disease, Amman, Jordan.
Purpose: Allergic bronchopulmonary aspergillosis (ABPA) is an immunolo-
gically mediated lung disease charecterise by a Complex hypersensitivity
reaction in patients with asthmawhich occurs when bronchi become colonized
TABLE 1.
No. of patients Average Average
Age (years) 25.3
Cough, wheezes and dyspnea 12
A history of asthma 12
Immediate skin test reactivity
to Aspergillus antigens
12
Serum total IgE concentration







High ESR mm in the first hour 12 64.4
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by Aspergillus. Repeated episodes of bronchial obstruction, inflammation, and
mucoid impaction can lead to bronchiectasis, fibrosis, and chronic lung
disease. Our aim of the study is to increase awareness of this disease.
Methods: We described a study of 12 cases with Allergic bronchopulmonary
aspergillosis Twelve patients (6 men and 6 women) were diagnosed in chest
department at King Hussien Hospital between 1993Y2003. The main criteria
for the diagnosis were A history of asthma, immediate skin test reactivity to
Aspergillus antigens, Serum total IgE concentration greater than 1000 ng/mL,
peripheral blood eosinophilia more than 500/mm3, Lung infiltrates and
proximal bronchiectasis.
Results: Demographic data for 12 patients with Allergic bronchopulmonary
aspergillosis.
Conclusion: ABPA is a rare disease, diagnosis is depending upon certain
criteria.
Clinical Implication: We have to think about the diagnosis of ABPA in any
patient with a history of asthma, lung infiltrates and peripheral blood
eosinophilia.
319
The significance of the diagnostic profile of the ophthalmic
allergies in excluding mimicking clinical conditions(MC)* which
may pose therapeutic difficulties
M Ishaq, I Khan Sameera, and Munir Imran Khan. Al-Junaid Hopsital,
Allergy/Pulmonology, Nowshera, Pakistan.
Introduction: Patients with (AC) with/without concomitant allergies in some
cases is a therapeutic dilemma.
Methods: In the series of patients, ages 10Y35 years usually with
intermittently red. eyes(shot redness), intractable itching of eyes, tearing
(stringy discharge) with/without seasonal association.
On laboratory investigations, is found raised tears & blood eosinophils
counts, total eosinophils counts. Total serum IgE measurement in most of the
cases had been higher than 200 to 300 kU/l. supported by, the. rise in titers of
allergen-specific IgE, by the radioallergosorbent test (RAST) method, Skin
prick test with a mixture of allergenic extracts had a conclusive evidence of an
allergy cause for the red eye.
On ophthalmoscope examination. Found pinkish papillae, with a
central vessel & characteristics, serous, watery conjunctival secretion.
Conjunctival scrapings, and tear cytology performed after topical
ocular allergen challenge to sensitized subjects have shown significant
increases in neutrophils and eosinophils, and their presence evidenced a
positive diagnostic criterion.
Results: Confirmation of a suspected allergic sensitization by skin prick test
for the diagnosis of immediate hypersensitivity is the most sensitive, fastest
and cheapest method to confirm an allergic sensitization. However, it carries a
small but a significant risk of systemic anaphylaxis.
Conclusion: Challenge tests are the only way to relate the specific allergen to
the triggering of ocular symptoms. but with a variable degree of systemic
anaphylaxis.
*Bacterial, chlamydial and viral conjunctivitis, superior limbic,
phlyctenular, conjunctivitis, keratoconjunctivitis, rosacea-associated conjunc-
tivitis, erythema multiforme, eoiscleritis/scleritis, and ocular cicatricial
pemphigoid.
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Electrodiagnostic study of phrenic nerve function in patients
with systemic lupus erythematosus
Nancy Mahmoud Abdelaty1, Mahmoud El Prince1, S.Maher Labib2, and
Mohammed Hefny3. 1Faculty of medicine, Suez Canal University, Chest
Department, Ismailia, Egypt; 2Faculty of medicine, Suez Canal University,
Medicine Department, Ismailia, Egypt; 3Faculty of medicine, Suez Canal
University, Physical Medicine Department, Ismailia, Egypt.
Objective: 21 patients with SLE were screened for the presence of Phrenic
nerve neuropathy and to determine whether neurophysiologic findings
correlate to clinical respiratory signs, spirometric abnormalities or serological
examination in patients with Systemic lupus erythematosus.
Methods: A total of 21 patients(18 female & 3 male)with systemic lupus
erythematosus (SLE) (age range, 16Y36 yr) were included and studied by
physical pulmonary examination, chest radiography, respiratory function tests,
as well as serological examination and bilateral transcutaneous phrenic nerve
conduction studies.
Results: 14(66.6%) patient complained of dyspnea ,only one patient showed
paradoxical abdominal movement .Pulmonary function tests showed propor-
tional reduction of the forced vital capacity (FVC) and forced expiratory
volume in 1 second (FEV1), suggesting a restrictive process which was severe
in 23% of patients. All patients were on corticosteroids, only 10 (47.6%)
patients were on immunosuppressive medication to include methotrexate or
cyclophosphamide. Phrenic nerve evaluation using transcutaneous stimulation
studies showed delayed latencies of RT, LT & both phrenic nerve in 17 (81%),
19(90%) and 17 (81%) patients respectively confirming a demyelinating
neuropathy. Also Phrenic nerve stimulation evoked a low-amplitude response
from the right, left and both in 17 (81%), 15 (71%) and 14 (66.6%) of patients
respectively confirming axonal neuropathy. There was no significant
correlation between electrical phrenic nerve stimulation and serum immune
markers, except there was decreased action potential amplitude in SLE group
with positive results for Anti DNA as14 (66.6%) of patients had Anti DNA +
ve, all showed reduced amplitude of rt phrenic nerve & 13(93%) of them
showed reduced amplitude of lt phrenic nerve. Fourteen (66.6%) patients
presented with dyspnea and all of them showed abnormal phrenic nerve
conduction studies. While 11 patients showed abnormal CXR with small but
clear lung fields, no evidence of major parenchymal lung or pleural disease
was found. There was no significant correlation between electrical phrenic
nerve stimulation and CXR abnormalities.
Conclusion: Diaphragmatic weakness in patients with SLE is both common
and is very likely to be caused by a phrenic neuropathy with evidence of
bilateral involvement.
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The search engine as a diagnostic tool in complex immunological
and allergic case reports: is google useful?
Carlo Lombardi, Martin Penagos, Moises Calderon, Elizabeth Griffiths, Briar
McLeod, and Stephen R. Durham. Imperial College of London and Royal
Brompton Hospital, Section of Allergy and Clinical Immunology, London,
United Kingdom.
Background: Web-based search-engines have become an important source of
knowledge and communication. Google is the most popular search-engine
(64% of all web-searches in March 2007) whilst Yahoo accounted for 21%.
Recently Google’s value to guide doctors to a correct diagnosis in case records
of the New England Journal of Medicine was reported.
Objective: To evaluate the utility of searching clinical information with
Google in order to obtain a correct diagnosis of complex immunological and
allergic (CIA) case reports.
Study Design: Comparative cross-sectional study.
Methods: Firty-five CIA case reports were randomly selected by an
independent investigator from peer-viewed medical journals. Clinical data
was presented separately to three observers blinded to final diagnosis.
Observer A is a Consultant in Internal medicine and Allergy with an expert
knowledge of these fields and basic computing skills. Observer B is a Registrar
in Internal medicine and Allergy. Observer C is a research nurse. Both
observers B and C had a more familiar knowledge of the regular use of
computer search engines. An internet-based search using Google was
conducted. In order to perform this, the observers individually studied each
text and independently selected five search terms, of their own choosing, from
each case record to enter into the standard Google search engine. The
observers then recorded for each case the single most prominent diagnosis that
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was evident from within the first three results pages of the conducted Google
search. Since Google does not necessarily include diagnoses within the search
results page itself, observers were permitted to select the diagnosis that best
fitted the case record from information after opening each direct results link
only. The independent investigator then compared the diagnoses obtained by
each observer with the definitive diagnoses as published in the Journals. The
main outcome measure of this study was the percentage of correctly obtained
diagnoses achieved by each observer.
Results: Observer A identified the definitive diagnosis in 30/45 cases (66%,
95%CI 52Y79). Observer B in 39/45 (86%, 95%CI 76Y95) and Observer C in
29/45 (64%, 95%CI 50Y77). Most diagnostic inaccuracies for both observers
were those related to primary immunodeficiency or pediatric cases.
Conclusion: This Google-based search was useful to achieve an appropriate




The anti-allergic properties of potassium humate
Johanna Meeding, Gandy Justin, Constance Medlen, and Jacques Snyman.
University of Pretoria, Pharmacology, Pretoria, South Africa.
Background: Although the anti-inflammatory properties of humate derived
from peat, sapropeles and mumie have been described, no clinical studies has
been done on the anti-inflammatory effects of humate derived from coal.
Leonardite humate compared favourably with prednisolone in suppressing
contact hypersensitivity in a rat model. According to a report by the European
Agency for the Evaluation of Medicinal Products on toxicity studies (Feb
1999), humic acids extracted from brown coal has no toxic effects on rats in a
chronic study at oral dosages as high as 1g/kg BW, whereas the LD50 in rats,
after oral administration of humic acids, has been reported to be greater than
11g/kg BW. This report has recently been confirmed by a separate study.
The objective of this study was to establish the safety and therapeutic
efficacy of oral potassium humate in reducing the signs and symptoms of hay
fever in atopic patients during the grass pollen season.
Methods: In this parallel double-blind placebo controlled phase II study
potassium humate was randomly assigned, at a dosage of 1.8g in divided
doses/day, to atopic patients (n = 40) presenting with acute symptoms of hay
fever. The blood and nasal samples were used to determine the safety and the
effects of potassium humate on basophil activation, cytokine levels and
eosinophil migration. A skin prick test was used to determine its anti-allergic
effects. An in vitro neutrophil adhesion test was used to determine the effects
of the product on the adhesion of human neutrophils to ICAM-1expressing
baby hamster kidney cells.
Results: A significant decrease in the skin prick test results (presented
elsewhere) and eosinophil counts was observed. No significant differences
were observed with regard to neutrophil adhesion nor were there any
differences observed with regard to the stimulation of basophils. However
decreases were observed in the expression of IL-4, IL-5, IL-8 and IL-1aˆ after
treatment, although not reaching statistical significance. The product had no
effect on neutrophil adhesion to ICAM-1.
Conclusion: This study confirmed, without doubt, that this product possesses
anti-inflammatory as well as anti-allergic properties possibly due to a
decreased recruitment of eosinopils to the site of inflammation.
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Anti-inflammatory effect of LipoPGE1 on therapeutic
intervention for intractable skin ulcer
Yorihisa Kotobuki, Hiroyuki Murota, and Ichiro Katayama. Course of
Integrated Medicine Graduate School of Medicine, Osaka University,
Dermatology, Osaka, Japan.
Background: Intractable skin ulcer is common in our daily practice. Although
patients’ QOL is severely impaired by this skin lesion, until now effective
treatment protocols have not been established. Wound healing process can be
separated into inflammatory phase, proliferating phase, and remodeling phase.
Recent reviews have described that prolonged inflammatory phase might
partly affect the pathogenic mechanisms of intractable skin ulcer. During the
inflammatory phase, various kinds of inflammatory cell infiltrates ware
observed in the affected area, and recruited macrophages secrete some
inflammatory cytokines including IL-6 and VEGF. Prostaglandin E1 (PGE1)-
treatment is believed to be one of the promising treatment for skin ulcers, and
LipoPGE1 also demonstrated improvement in a drug delivery system. To note,
it has been reported that infiltrated macrophages uptake LipoPGE1. Taken
these results together, we hypothesized that LipoPGE1 might have an anti-
inflammatory effect and thus contribute to the improvement of intractable skin
ulcer.
Methods: Patients with various kinds of intractable skin ulcers were
administered with intra-venous injection of 10 microgram/day LipoPGE1
(Palxus\) for twoweeks, and the size of the ulcer area and serum concentration
of CRP, IL-6, VEGF, and sICAM1 were measured before and after treatment.
Results: LipoPGE1 effectively reduced the size of the ulcer area and the serum
inflammatory markers after two weeks of LipoPGE1-treatment.
Conclusion: These results indicated that anti-inflammatory effect of
LipoPGE1 might contribute to the improvement of the intractable skin ulcers.
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Comparative efficacy of levocetirizine, desloratadine, clemastine,
kvifenadine and sekvifenadine on histamine prick test induced
weal reaction, blood perfusion evaluated by laser Doppler
flowmetry. Randomized, double-blind, placebo-controlled,
crossover design study
Maris Bukovskis1, Madara Tirzite2, Normunds Jurka3, Gunta Strazda4, and
Peteris Tretjakovs3. 1Pauls Stradins Clinical University Hospital, Department
of Pulmonology and Allergology, Riga, Latvia; 2University of Latvia, Faculty
of Medicine, Riga, Latvia; 3University of Latvia, Institute of Experimental
and Clinical Medicine, Riga, Latvia; 4University of Latvia, Department of
Pathology, Riga, Latvia.
Background: Evaluation of weal reaction and laser Doppler flowmetry are
valuable methods for evaluation of efficacy of different pharmacological
agents. The aim of our study was to compare the influence of different
H1-antihistamines on histamine induced weal reaction, increase of skin blood
perfusion and sedation.
Methods: Histamine prick test induced weal area in mm2, percentage of blood
perfusion change and area under curve during peak perfusion period
(AUCmax) was measured with Periflux System 4000 (Perimed AB, Sweden)
2 hours after intake of 5 mg levocetirizine, 5 mg desloratadine, 1 mg
clemastine, 50 mg kvifenadine, 50 mg sekvifenadine and placebo. Sedative
effect was measured in mm by visual analogue scale (VAS).
Results: Results were expressed as mean T 95%CI. Mean weal reaction area
was 6.9 (j3.9;+10.7); 17.5 (j12.6;+23.1); 20.2 (j14.9;+26.2); 18.1
(j13.1;+23.9); 17.8 (j12.8;+23.5) and 29.0 (j22.6;+36.1) mm2 respec-
tively. Statistically significant difference was observed between active
treatment and placebo (pG0.05), and levocetirizine and other H1-antihista-
mines (pG0.001). Increase of blood perfusion was 393.1% (j221.3;+613.8);
626.2% (j403.0;+898.3); 756.5% (j508.8;+1053.2); 741.0% (j496.2;
+1339.1); 1001.5% (j712.8;+1339.1) and 1033.2% (j739.6;+1375.8)
respectively. Significant decrease of augmentation of blood perfusion was
observed after pre-treatment with levocetirizine and desloratadine vs. placebo
(pG0.05) and levocetirizine vs. kvifenadine, sekvifenadine and clemastine
(pG0.05). AUCmax was 1298.7 (j781.2;+1947.0); 2197.3 (j1504.5;
+3020.9); 2454.3 (j1718.3;+3321.0); 2633.2 (j1868.6;+3528.6); 2551.7
(j1800.0;+3434.2) and 3166.2 (j2321.4;+4141.7) U*s. AUCmax was
significantly lower after pre-treatment with levocetirizine vs. placebo and
other antihistamines (pG0.05). Sedative effect was 24.5 (j17.9;+32.1); 21.1
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(j15.1;+28.1); 28.2 (j21.2;+36.2); 17.6 (j12.0;+24.1); 15.1 (j10.0;+21.0)
and 19.9 (j14.1;+26.7) mm of VAS. Significant difference of sedation we
observed between levocetirizine vs. sekvifenadine, clemastine vs. kvifenadine,
sekvifenadine and placebo (pG0.05).
Conclusion: Levocetirizine induced significant decrease of weal and flare
reaction and skin blood perfusion compared to placebo and other H1-
antihistamines. Influence of kvifenadine and sekvifenadine on weal reaction
area was similar to desloratadine and clemastine. Sedative effect of clemastine
was more pronounced than kvifenadine and sekvifenadine.
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Characterising the pharmacological properties of fluticasone
furoate, a novel enhanced-affinity glucocorticoid
Mark Salter1, Keith Biggadike2, Michael West2, Michael Haase2, David Gray3,
Stuart Farrow2, Petra Hogger4, and Anagnostis Valotis4. 1GlaxoSmithkline,
Global Project Management, Ware, United Kingdom; 2GlaxoSmithKline,
Respiratory and Inflammatory Drug Discovery, Stevenage, United Kingdom;
3GlaxoSmithKline, Discovery Research, Harlow, United Kingdom; 4Institute fu¨r
Pharmazie and Lebensmittelchemie, Bayerische Julius-Maximilians-Universita¨t,
Wu¨rzburg, Germany.
Background: Fluticasone furoate (FF) is a novel enhanced-affinity gluco-
corticoid developed for topical respiratory use. Its distinct pharmacological
properties have been investigated in several in vitro and in vivo studies.
Methods: Binding affinity of FF for the human lung glucocorticoid receptor
(GR) was determined by elucidation of association and dissociation rate
constants. Molecular interactions of FF with the GR were identified by X-ray
crystallography of the GR ligand-binding domain. Cellular onset of action was
determined by measuring nuclear translocation in human lung epithelial cells.
Measurement of human progesterone (PR), mineralocorticoid (MR), androgen
(AR), and oestrogen receptor (ER) activities was used to assess the steroid
hormone selectivity of FF. Cellular protection of FF to elastase or mechanical
wounding was determined in 16HBe human lung epithelial cells and anti-
inflammatory effects of FF in the lung were determined using the Brown
Norway Ovalbumin Rat model.
Results: FF has very fast association with, and slow dissociation from, the
GR, with a relative receptor affinity (RRA) of 2988T135 with reference to
dexamethasone (RRA: 100T5), higher than all other currently available
clinical glucocorticoids: mometasone furoate (MF) 2244T142, fluticasone
propionate (FP) 1775T130, beclomethasone-17-monopropionate 1345T125,
ciclesonide active principle 1212, and budesonide 855. FF has hydrogen bond
interactions with the GR through the 3-keto (with Gln570 and Arg611) and the
11$-hydroxy (with Asn564) groups; the 17 $-fluoromethylthioester group also
forms a favourable electrostatic interaction with Asn564. FF induces a rapid
translocation of GR into the nucleus (G20 minutes to maximum effect) and has
high selectivity for GR (30-, 790-, 9330,000- and 9330,000-fold) versus PR,
MR, AR and ER, respectively. FF confers substantial protection against
elastase-and mechanically induced damage, with more potent protection than
budesonide, FP and MF. FF completely prevents lung eosinophilia, an effect
greater than that with FP.
Conclusion: FF has enhanced affinity for the GR compared with other
available glucocorticoids, which translates into more potent protection against
cellular damage and lung inflammation. Coupled with its fast cellular onset of
action and high selectivity for the GR, these properties may contribute to a
favourable clinical efficacy and safety profile for FF.
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Downmodulatory effects of cetirizine and levocetirizine
on cytokine/chemokine production and CD54 expression
in keratinocytes
Miwa Kobayashi, Kenji Kabashima, and Yoshiki Tokura. University of
Occupational and Environmental Health Japan, Dermatology, Kitakyushu, Japan.
Cetirizine is an antihistamic drug of the second generation. Besides
its anti-histamic activity various actions have been reported in this anti-
histamic. In epidermal keratinocytes, cetirizine inhibits the expression of co-
stimulatory molecule ICAM-1 and the MHC class II molecule HLA-DR.
Moreover, it exerts anti-inflammation actions by suppressing the production
of cytokines and chemokines in various immunocompetent cells. Levocetir-
izine (L-cetirizine) is the optical isomer of cetirizine and widely used for the
treatment of allergic disorders in European countries. In this study, we
investigated whether there are differences between cetirizine and levocetir-
izine in the cytokine and chemokine production by normal human epidermal
keratinocytes (NHEK).While NHEK were stimulated with interferon-
,(IFN-,) and tumor necrosis factor-" (TNF-") cetirizine or levocetirizine
was added to the experimental cultures. Three day-culture supernatants were
measured for the concentrations of IL-1", IL-8, RANTES, Mig, I-TAC and
MDC. The IFN-,/TNF-"-augmented levels of IL-1", IL-8 and I-TACK were
significantly suppressed by the addition of either cetirizine or levocetirizine to
the culture in dose-dependent manners (10j9 Y 10j7 M). RANTES, Mig or
MDC was not suppressed by cetirizine. To examine the effects of these two
reagents on the expression of CD54 (ICAM-1) molecules, NHEK were
incubated with IFN-, with or without cetirizine or levocetirizine for 48 hrs.
Cetirizine and levocetirizine at 10j8 M downmodulated the expression of
CD54 molecules at similar levels to each other.This study demonstrates that
cetirizine and levocetirizine have comparable effects on the immunological
function of keratinocytes. It is noted that levocetirizine has slightly but
significantly stronger effects than cetirizine in the production of RANTES
and Mig.
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Efficacy and safety of levocetirizine 5mg as continuous or
on-demand treatment for persistent allergic rhinitis over 6months
Giorgio Walter Canonica, Enrico Compalati, Laura Guerra, Anthi Rogkakou,
Cinzia Gamalero, Pierangela Massacane, Federica Fumagalli, Christian
Zanella, and Ilaria Baiardini. University of Genoa, Allergy & Respiratory
Disease Department, Genoa, Italy.
Background: We aimed to document the efficacy and safety of levocetirizine
5mg as continuous (CT) or on-demand treatment (OnD) of persistent allergic
rhinitis (PER), as defined by ARIA.
Methods: This was a single-center, randomised, open-label study comparing
CT vs. OnD treatment of PER patients with levocetirizine 5mg, once daily,
over 6 months. Patients were allowed to have mild asthma treated with a short-
acting beta-agonist. Sneezing, rhinorrhea, nasal and ocular pruritus
(T4SS=sum of these 4 symptoms) and nasal congestion were measured
daily on a 0 (absent) to 3 (severe) scale. Rhinasthma questionnaire (RQ) was
used to assess subjects` quality of life (range 0Y100; 30 item questionnaire:
1=not bothered at all, 5=bothered very much). Quality of sleep was reported
on a VAS scale (0=worst; 10=best).
Results: 31 patients were enrolled per group; 18 in the OnD and 22 in the CT
group completed the study. No patients discontinued for drug-related serious
adverse events (AEs).
Improvement from baseline in T4SS was significantly higher in favour
of CT during months 5 (pG0.01) and 6 (pG0.03). The maximal T4SS
improvement was 80% for OnD and 87% for CT. The maximal improvement
in nasal congestion was 75% for OnD and 85% for CT. Quality of sleep
considerably improved at end of study: from baseline VAS=5.77 (OnD) and
VAS=5.63 (CT) to VAS=7.82 (OnD) and VAS=7.25 (CT). No serious (AEs)
were observed. 3.3% of subjects in the CT and 9.4% in the OnD groups
reported drug-related treatment-emergent AEs.
Conclusion: Our study confirms previous data that, when taking a potent
antihistamine, like levocetirizine, PER symptoms (including nasal congestion)
are effectively controlled over a 6-month treatment period. In addition, most of
the individual symptoms were controlled significantly better when treated
continuously. Regardless of the regimen, levocetirizine improved the patients`
quality of life and sleep, and was very well tolerated with fewer patients
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reporting AEs in the CT group. Our results support the long-term continuous
treatment of PER with a potent and well-tolerated antihistamine.
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Oxatomide-treated children with atopic dermatitis complicated
by food allergy and prevention of asthma development
Norifumi Ogawa, Toshiaki Saeki, Kawano Yutaka, and Takeshi Noma.
Kitasato University School of Medicine, Pediatric Department, Sagamihara,
Kanagawa, Japan.
Background: Recent epidemiology suggests the increasing prevalence of
allergic diseases in the industrialized countries including Japan, which
necessitates the analysis of the mechanisms of allergic diseases and
development of the effective treatment. Oxatomide (OXM), an antihistaminic
drug, has been shown to be clinically effective for the treatment of
hypersensitivity and childhood asthma. Its mode of action has been elucidated
to increase IFN-g activity as well as anti-histaminic reaction.
Objective and Methods: Peripheral blood mononuclear cells were obtained
from 41 patients with atopic dermatitis allergic to hen-egg ranging from
2 months to 2 years 10 months in age. The patients had recurrent eczema,
pruritus and positive skin reactions to egg white and/or cow`s milk. Patients
also had positive responses to the oral provocation test to raw hen egg and or
cow`s milk. Diagnostic criteria for atopic dermatitis was based on the criteria
of Hanifin and Rajk. To clarify the mode of action whereby OXM ameliorates
the conditions of the children with food allergy-complicated atopic dermatitis
and whether development of bronchial asthma is prevented, OXM-related
alterations of the clinical symptoms and examination, seen in patients during
the course of 8 months` to 6 years and 10 months` treatment was evaluated.
Results and Discussion: Scores for itching, sleep disturbance and skin lesions
(inflammation, lichenification, cracking) was improved from 10 to 2.7 (mean)
during the course of 8-16 weeks’ treatment with 2mg/kg of OXM in addition to
elimination diets, treatment of skin care (shower, Isodine[R], non-steroid
ointment), administration of hydroxyzine and/or oral sodium cromoglicate. In
further study, OXM efficiently suppressed incidence of asthma to approxi-
mately 9% of the patients (control:42.9%) and both of total IgE value and
peripheral eosinophils count was not elevated after OXM-treatment and
were lower than those in age-matched asthma patients un-treated with
OXM.
Conclusion: OXM, which is a significant candidate for one of the therapeutic
modalities against children with food allergy-induced atopic dermatitis, and
based on the clinical study, was also found to be effective prophylaxis for
development of childhood asthma.
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A comparison between intramuscular dexamethasone and
fluticasone propionate inhaler in treatment of croup
Jamal Faghihinia. Isfahan Univercity, Pediatric, Isfahan, Islamic Republic of
Iran.
Introduction: Croup is a common viral disease in children under 6 years old
with incidence rate of 2Y6%. The mainstay of treatment is airway manage-
ment. Treatment focuses on respiratory distress, using cold mist, epinephrine,
heliox and corticosteroids. In this study we tried compare the effectiveness of
Fluticasone spray with intramuscular Dexamethasone.
Materials and Methods: In this clinical trial, 107 children with croup
randomly assigned into two groups. The study group was treated by
Fluticasone Propionate and the control group was treated by intramuscular
Dexamethasone. Croup scoring was performed at the 6th and 12th hours from
initial administration according to Westley croup score.
Results: Improvement was observed in 83% of the study group and 66% of
the control group, 6 hours after initiation of treatment. In both groups 10% of
the patients didn`t respond to treatment (p = 0.03). 12 hours after treatment
the study group response was 85% and the control group response was 90%
(p = 0.4).
Conclusion: We found that Fluticasone Propionate and Dexamethasone have
similar efficacy in treatment of respiratory distress, considering the simple method
of using Fluticasone spray, it can be suggested as a good treatment for croup.
Key words: Croup, Fluticasone Propionate, Dexamethasone, Westley Croup
Score.
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Bioequivalency of single doses of desloratadine administered as
syrup and tablet formulations in healthy volunteers in China
Xue-Ning Li, Hong-Rong Xu, and Wei-Li Chen. ZhongShan Hospital, Fudan
University, Department of Clinical Pharmacology, Shanghai, China.
Background: Desloratadine (DL) is an oral, non-sedating, selective and


















Sneezing OnD j0.97 j1.22 j1.28 j1.14 j0.95 j0.77
CT j0.74 j0.86 j1.26 j1.31 j1.50 (0.004) j1.41 (0.008)
Rhinorrhea OnD j1.32 j1.47 j1.62 j1.51 j1.27 j1.05
CT j0.90 j1.07 j1.39 j1.54 j1.75 (0.023) j1.63 (0.019)
Nasal pruritus OnD j1.11 j1.38 j1.63 j1.46 j1.30 j1.14
CT j1.02 j1.10 j1.26 j1.47 j1.74 (0.022) j1.57 (0.081)
Ocular pruritus OnD j0.97 j1.11 j1.28 j1.32 j1.18 j1.06
CT j0.90 j1.01 j1.16 j1.37 j1.61 (0.016) j1.51 (0.055)
Nasal congestion OnD j1.08 j1.36 j1.54 j1.23 j1.19 j1.03
CT j1.11 j1.26 j1.41 j1.55 j1.66 (0.059) j1.39 (0.210)
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TABLE 1 Baseline Mean Month 1 Mean Month 2 Mean Month 3 Mean Month 4 Mean Month 5 Mean Month 6 Mean
RQ Upper
Airways
OnD 52.91 30.26 21.53 22.83 29.87 30.56 21.14
CT 53.11 33.62 29.68 21.71 19.67 22.47 23.86
RQ Lower
Airways
OnD 25.19 15.45 11.24 10.54 11.54 11.03 9.40
CT 29.78 19.19 18.50 12.87 11.92 13.81 14.53
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rhinitis and chronic idiopathic urticaria in pediatric and adult populations. The
clinical and pharmacological profiles of DL have been extensively investigated
and DL is available in a number of formulations, including tablets and syrup.
The bioequivalence of DL tablets and syrup has not been studied to date in a
Chinese population.
Methods: This randomized, open-label, single dose crossover trial studied the
pharmacokinetics of DL 5mg administered as a 5mg tablet or 10 ml of 0.5 mg/
ml syrup in 24 healthy adult male Chinese subjects. After providing written
informed consent and undergoing screening, subjects were admitted to a clinic
for baseline assessments. Subjects were randomized to receive one of the two
DL formulations in a fasting state. Blood tests for pharmacokinetics were
taken over 5 days (subjects remained in the clinic for the first 24 hours), and
after a 14 day washout period the subjects were crossed over to the other DL
formulation and underwent identical pharmacokinetic analyses. The main
pharmacokinetic variables for the two formulations were the log-transformed
AUC(I) and the Cmax for DL and 3-OH-DL. Biochemical and hematological
tests, ECG data and vital signs were also assessed during the study and adverse
event (AE) reports were collected.
Results: DL was safe and well tolerated when administered in the tablet or
syrup formulations; no AEs were reported. The Tmax, T1/2, Cmax, and
AUC(I) values for DL and 3-OH-DL were similar for both formulations. There
were no statistically significant differences between the tablet and syrup DL
formulations on the basis of log-transformed Cmax and AUC(I) values for DL
and 3-OH-DL (P90.05). The 90% CIs of AUC, and Cmax were
91.61Y103.97% and 86.04Y99.92% respectively for DL, and
94.22Y101.71% and 88.01Y101.35% respectively for 3-OH-DL. The relative
bioavailbility of the DL syrup was 99.4% for DL and 98.79% for 3-OH-DL,
which met the criteria for bioequivalence of the two formulations.
Conclusion: Both syrup and tablet formulations of DL 5mgwere safe and well
tolerated. When administered as a syrup formulation DL was bioequivalent to
the tablet form of DL in healthy Chinese subjects.
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The pharmacokinetic and safety profiles of desloratadine in
healthy korean volunteers
In-Jin Jang, Kyung-Sang Yu, Jung-Ryul Kim, Kyoung Soo Lim, Jaewoo Kim,
Bo-Hyung Kim, Min-Gul Kim, Tae-Eun Kim, and Young-ju Chung. Seoul
National University College of Medicine, Seoul National University Hospital,
Department of Pharmacology, Seoul, Republic of Korea.
Background: Desloratadine (DL) is a non-sedating, selective and potent H1-
receptor antagonist that is effective and well tolerated in the treatment of
subjects with allergic rhinitis and chronic idiopathic urticaria. The pharma-
cokinetics (PK) of DL have not been studied in a Korean population, to date.
Methods: This was a double-blind, dose escalation study of the PK and
tolerability of single doses of DL 5mg, 10mg and 20mg in 36 healthy male
Korean subjects. In each dose group 10 subjects received DL and 2 received
placebo. Safety was demonstrated at the 5mg DL dose before escalation to the
next dose group. Subjects were screened for eligibility during a 3 week pre-
baseline period. Subjects were confined on Day -1 and baseline blood/urine
tests and ECGs were performed. DL was administered fasting at 9 am on Day 1
and subjects remained confined until Day 3. Blood sampling was performed
for biochemistry, hematology and PK from DL administration until Day 8 and
the Tmax, terminal T1/2, Cmax and AUClast for desloratadine and it 3-OH-
DL metabolite were calculated. Vital signs, physical examinations and ECGs
were performed regularly and adverse event (AE) reports were collected.
Results: No clinically relevant changes in vital signs, biochemical,
hematological or ECG results occurred. Nine subjects reported 13 AEs during
the study. Only dizziness, gingival bleeding and a flu-like illness (all mild in
severity) were deemed potentially related to study drug. One subject developed
a hemopneumothorax on Day 6 after receiving DL 5mg. This was deemed as
being of unknown relationship to study drug. The mean terminal T1/2 for DL
was 23.7Y31.1 hr across the dose range, while the mean Tmax ranged from
1.75 to 2.0 hr. The Cmax ranged from 2.4 6g/L (DL 5mg) to 9.9 6g/L (DL
20mg); the AUClast ranged from 36.5 6g.hr/L (DL 5mg) to 170.3 6g.hr/L (DL
20mg). The mean AUClast and Cmax values for DL demonstrated moderate
intersubject variability (50.6% and 51.1%, respectively) at the 5mg DL dose.
The intersubject variability for AUClast and Cmax was less at the 20mg DL
dose (21.4% and 25.3%, respectively). The mean AUClast and Cmax for DL
and 3-OH-DL demonstrated linear PK.
Conclusion: Single dose DL was well tolerated in healthy Korean volunteers
across a dose range from 5mg to 20mg and is consistent with results in other
populations. With increasing doses of DL, AUClast and Cmax demonstrated
linear PK.
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Cardiac safety evaluation of loratadine in the treatment
of allergic rhinitis in elderly patients
Lei Cheng1, and Ying Liu2. 1Nanjing Medical University, The First Affiliated
Hospital, E.N.T. Department, Nanjing, China; 2Jiangsu Provincial Geriatrics
Hospital and Research Institute, E.N.T. Department, Nanjing, China.
Background: In elderly patients with allergic rhinitis, the second-generation
H1-antihistamines have not been adequately studies, although they are widely
used and assumed to be safe.
Objective: To evaluate cardiac safety of loratadine in the treatment of allergic
rhinitis in elderly patients.
Methods: A total of 40 patients with perennial allergic rhinitis were enrolled
in the study. There were 25 males and 15 females, aged 50 to 88 years (mean,
64.4-years-old). 17 cases (42.5%) had a history of cardiovascular diseases and/
or presented abnormal ECG parameters, but had no prolonged QT-interval.
The subjects received loratadine 10mg once-daily for 30 days. A series of
baseline ECG recordings was obtained before treatment. ECG effects of the
treatments were then compared with the baseline ECGs.
Results: There were no changes in sinus rhythm in all patients after 30 days
treatment by loratadine. No statistically significant difference was found
between the heart rates, P durations, PR and QRS intervals at baseline and end-
point ECGs (P 90.05), with no significant prolongation of the QT as well as
QTc corrected for heart rate using Bazett formula (P90.05).
Conclusion: The results suggest no cardiotoxicity of loratadine, at the usual
recommended dose, in long-term treatment of allergic rhinitis in the elderly.
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Propranolol cytotoxicity on human leukemic MOLT-4 cell line
Fatemeh Hajighasemi1, and Zahra Pourpak2. 1Faculty of Medicine, Shahed
University, Department of Immunology, Tehran, Islamic Republic of Iran;
2Tehran University of Medical Sciences, Immunology Asthma and Allergy
Research Institute, Tehran, Islamic Republic of Iran.
Background: Propranolol, a beta-adrenergic blocker has been used for
treatment of a large number of cardiovascular diseases. This drug is also an
inhibitor of phosphatidic acid (PA) phosphohydrolase and phosphatidic acid
biosynthesis. Phosphatidic acid is a growth factor for tumor cells. In addition,
the inhibitory effect of Propranolol on the development of a tobacco-induced
pulmonary adenocarcinoma and also its cytotoxicity on rat and human lung
macrophages and human lung tumor cell line has been reported. The
widespread and long-term use of propranolol in lots of heart diseases as well as
its cytotoxicity against some tumor cells, prompted us to investigate its
cytotoxic effect on a human T leukemic cell line (MOLT-4).
Methods: The MOLT-4 cells were cultured in complete RPMI medium and
then incubated with different concentrations of Propranolol ( 0.0004 Y0.4 mM)
for 10 and 20 hours. The cytotoxicity was then assessed by 3-[4,5-dimethyl
thiazolY2,5-diphenyltetrazoliumbromide (MTT) reduction and also trypan
blue dye exclusion methods.
Results: Propranolol induced a significant dose dependent cytotoxic effect on
human MOLT-4 cell line in less than 10 hours compared to untreated control
cells.
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Conclusion: The results showed that human T leukemic cell line was dose
dependently sensitive to Propranolol. Further studies investigating the in vivo




Human coronavirus infections in Hong Kong children:
epidemiology, disease spectrum and relationship with childhood
wheezing illnesses
ManYin To1, Ting Fan Leung1, Paul K. S. Chan2, Margaret Ip2, Edmund
Cheuk2, Wai Yip Lam2, Chung Yi Li1, Julian W. T. Tang2, and Pak Cheung
Ng1. 1The Chinese University of Hong Kong, Department of Paediatrics,
Hong Kong, Hong Kong; 2The Chinese University of Hong Kong,
Department of Microbiology, Hong Kong, Hong Kong.
Background: Human coronaviruses (HCoVs) are enveloped viruses with a
large plus-strand RNA genome. Five serologically distinct groups of HCoVs
have been described - HCoV-229E, HCoV-OC43, HCoV-NL63, HCoV-HKU1
and SARS-CoV. The clinical disease spectrum by HCoVs in our population is
not clearly defined. Preliminary studies suggested that HCoVs might be
related to childhood wheezing. This prospective study investigated the epi-
demiology and clinical features of HCoV infections in Hong Kong children.
Methods: Nasopharyngeal aspirate (NPA) samples were taken from children
who were hospitalised in our university teaching hospital between April 2005
andMarch 2006. The clinical features, diagnoses and laboratory investigations
in these subjects were prospectively collected, and laboratory staff blinded to
these details performed low-stringent reverse transcription-polymerase chain
reaction (RT-PCR) assays using 12 pairs of primers that detect constant regions
of HCoVs (i.e. pancoronavirus).
Results: 1139 subjects (57% males) were recruited, with mean (SD) age being
5.1 (3.6) years. The main discharge diagnoses were pneumonia (n=239), upper
respiratory infection (URI; n=227), asthma (n=191), seizure (n=107),
bronchiolitis (n=105), roseola infantum (n=98), croup (n=31), and others
(n=141). Twenty-eight (2.5%) of these NPA samples were positive for HCoVs.
The clinical diagnoses associated with these HCoV isolates included asthma
(n=7); seizure (n=6); URI (n=5); bronchiolitis, pneumonia, tonsillitis and
roseola infantum (n=2 for each); and croup and otitis media (n=1 for each).
HCoV infection was not related to age, highest respiratory rate and maximal
temperature (P90.3). HCoV infection was not associated with wheezing
illnesses as defined by Fasthma’, Fbronchitis’ or Fbronchiolitis’ (2.7% versus
2.4%; P=0.870) or with lower respiratory infections (the above three plus
Fpneumonia’; P= 0.341). HCoV cases were more likely to suffer from seizure
(5.6% versus 2.1%, P=0.040). Complete blood count and C-reactive protein
were not related to HCoV infections (P90.15).
Conclusion: HCoVs are uncommon yet important pathogens causing seizure
disorders in local hospitalised children. On the other hand, HCoV infections
are not associated with wheezing illnesses in Hong Kong children.
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Are there predominant strains of Staphylococcus aureus in
atopic dermatitis patients? : Genotypic characterization of
staphylococcus aureus isolated in adolescent and adult patients
with atopic dermatitis
Kyung Duck Park1, Jee Young Park1, Byung-Soo Kim1, Woen Ju Lee1, Seok-
Jong Lee1, Jung Min Kim2, Do Won Kim1, and Hong Dae Jung1. 1Kyungpook
National University School of Medicine, Department of Dermatology, Daegu,
Republic of Korea; 2Kyungpook National University School of Medicine,
Department of Microbiology, Daegu, Republic of Korea.
Background: The colonization of Staphylococcus aureus is one of the most
important aggravating factors of atopic dermatitis. Until now, the importance
of S. aureus in atopic dermatitis and a positive correlation between colo-
nization with S. aureus and clinical severity / skin barrier function has been
demonstrated. Qualitative analysis, especially a genotypic characterization of
S. aureus isolated from atopic patients, however, has rarely been reported.
Methods: This study aimed to find the genotypic characterization of S. aureus
from atopic dermatitis patients. We performed newly-developed typingmethods
- spa typing, multi-locus sequence typing (MLST) and toxin gene assay, by a
multiplex polymerase chain reaction, with 165 isolates of Staphylococcus.
Results and Conclusion: The results showed that there was no predominant
clone of S. aureuswith a high heterogenicity of spa typing and MLST. A toxin
gene assay showed very interesting results that all S. aureus strains had at least
two kinds of toxin genes; sea and tsst-1 being the most prevalent.
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Role of primary and secondary low-grade rhinovirus infection in
allergic airway inflammation in a murine model of allergic
asthma
Mykola Korzh. Kharkov National University, Fundamental Medicine,
Kharkov, Ukraine.
Background: Rhinovirus respiratory syncytial virus (RSV) infection is known
to develop and exacerbate asthma in young children. In adult, RSV causes
recurrent but asymptomatic infections. However, the impact of asymptomatic
RSV infection on adult asthma is yet to be determined. The aim of this studywas
to determine the effects of primary and secondary low-grade rhinovirus in-
fections on allergic airway inflammation in a murine model of allergic asthma.
Methods: A low-grade rhinovirus (2 x 10(3) plaque-forming units/mouse)
was inoculated, and this caused neither pulmonary inflammation nor
symptoms but induced significant IFN-gamma production in thoracic lymph
nodes. To investigate interaction between low-grade virus and Dermatopha-
goides farinae (Df), airway hyperresponsiveness, lung inflammation and
cytokine production from thoracic lymph nodes were compared after primary
and secondary low-grade rhinovirus infections in four groups of mice; control,
Df allergen-sensitized, rhinovirus-infected and Df-sensitized rhinovirus-
infected mice. A direct comparison between low- and high-grade rhinovirus
infections was also performed in primary infection. To investigate the role of
IL-5 during secondary rhinovirus infection, anti-IL-5 monoclonal antibody
(anti-IL-5 mAb) was injected in mice and similar parameters were compared in
four groups of mice.
Results: Primary high-grade rhinovirus infection increased allergen-induced
airway inflammation, while primary low-grade rhinovirus infection attenuated
allergen-induced airway inflammation concomitant with significant IFN-gamma
production in lung-draining lymph nodes. In marked contrast, secondary low-
grade rhinovirus infection increased both IFN-gamma and IL-5 production,
resulting in exacerbation of allergen-induced airway inflammation. Anti-IL-5
mAb treatment in secondary low-grade rhinovirus infection and Df allergen-
sensitized mice attenuated virus and allergen-induced airway inflammation.
Conclusion: Low-grade rhinovirus infection per se does not cause pulmonary
inflammation, whereas it induces a significant immunological response in the
allergen-sensitized host. These results indicate that subclinical and recurrent
rhinovirus infection may play an important role in exacerbation and
maintenance of asthma in adults, wherein IL-5 is critically involved.
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Serum zinc levels in young children with recurrent wheeze
Hai Lee Chung, and Sang Mi Kwon. School of Medicine, Catholic University
of Taegu, Pediatrics, Taegu, Republic of Korea.
Background: Zinc is one of the dietary antioxidants. Previous studies have
shown that zinc is crucial for normal development and function of cells
mediating non-specific immunity. Recently, zinc supplementation was
reported to reduce acute lower respiratory infections and prevent severe
pneumonia in children. Our purpose was to examine zinc levels in the serum of
the young children who had recurrent early wheeze and evaluate the clinical
and laboratory findings in relation to zinc status.
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Methods: Seventy-three patients (aged from 8 months to 6 yrs) admitted with
acute respiratory infection with wheezing were enrolled. All children had
experiencedmore than 3 episodes ofwheezing before admission. Zinc levelswere
measured in serum samples collected on admission using inductively coupled
plasma-optical emission spectrometry (ICP-OES) and the value of G 64 mg/dl
was defined as zinc deficiency. Clinical and laboratory findings in the children
with zinc deficiency were examined and compared with in the children who had
normal values. Zinc levels in sixteen age-matched controls were also studied.
Results: Median value of zinc levels in the patients was significantly lower
than in controls (PG0.001). 36 patients were found to have zinc deficiency
(49.3%), which was significantly higher than in controls (12.5%). Zinc
deficiency was observed in 56% of the patients = 2 yrs of age and 40.6% of
92 yrs of age. There was no significant difference in total WBC count,
lymphocyte count and atopic status in relation to zinc status in the patients.
CD4/CD8 ratio was significantly lower in the patients with zinc deficiency
(PG0.05), however, other immune profiles were within normal limit.
Conclusion: This study showed that medianvalue of zinc levelwas significantly
lower and zinc deficiency was more frequently found in the patients with
recurrent early wheeze compared with in age-matched controls. Our results
suggest that zinc deficiency may be associated with frequent respiratory viral
infections, a likely trigger for recurrent early wheeze in the young children.
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Persistent cough in patient with infection for mycobacterium
avium intracellulare infection
Aurora Losada Pena, Ma Luz Dı´ez Go´mez, Aythamy Henrı´quez Santana,
and Emma Gonzalez Seco. Hospital Ramon y Cajal, Allergy department,
Madrid, Spain.
Aim: Mycobacterium avium intracellulare (MAV) is the atypical Mycobacter-
ium most commonly associated with human disease. The pulmonary disease is
the most frequently clinical presentation and appears with higher prevalence in
immunosuppressed patients.
Materials and Methods: We present the case of a 46 years old woman, nurse
as profession , with cough and dysnea for a period of nine years. Nowheezing,
fever nor constitutional syndrome were referred. Skin prick tests with common
aero-allergens and latex, spirometry and bronchodilatation test were
performed. Total IgE, complement study, proteins electrophoresis, immuno-
globulins determination, cellular immunity study, HIV, X-ray study and
thoracic CT-scan, mantoux, zielh and sputum culture were done.
Results: Positive skin prick test for pollens and dog and cat epithelia were
obtained. The patient had normal spirometry values and a negative
bronchodilatation test. All the laboratory tests were in normal levels.
Determination of total IgE was 483 KU/l. The chest X-ray showed cavities
in both lungs with interstitial infiltrates. The CT-scan confirmed these findings.
Mantoux, Zielh with 50 BAAR/field and MAV culture were positive.
Mycobacterium tuberculosis was excluded by CRP. Cellular immunity,
complement, proteins electrophoresis and immunoglobulins determination
were in normal range. HIV test was negative.
Conclusion:We present the case of a patient with rhinoconjuntivitis due to
pollens hypersensitivity and persistent cough with pulmonary infection for
Mycobacteium Avium associated. The Mycobacterium Avium was not
described as human pathogen until 1950, when many series described
pulmonary infections for MAV. This mycobacterium mainly attacks im-
munosuppressed patients. This infection is less frequent in patients with
normal immunity. Our patient did not have immunosuppression nor risk
factors. At the present time she is being treated with antibiotics (ethambutol
and claritromicin) and she is in good general condition with no need of
hospitalisations.
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Molecular diagnosis of Chronic Granulomatous Disease in Iran
Shahram Teimourian1, Mohsen Badalzadeh1, Zahra Rezvani1, Elham
Zomorodian1, Zahra Pourpak1, Setareh Mamishi2, Davood Mansouri3,
Soheila Khalilzadeh3, Ghamar Taj Khotaei4, Masood Movahedi1, Caroline
Kannengiesser5, Nima Parvaneh2, Ali Reza Kordi1, and Mostafa Moin1.
1Immunology, Asthma and Allergy Research Institute, Medical Sciences of
Tehran University. Tehran, Iran, Immunology, Tehran, Islamic Republic of
Iran; 2Children`s Hospital Medical Center, Medical Sciences of Tehran
University. Tehran, Iran, Pediatrics, Tehran, Islamic Republic of Iran; 3Masih
Danneshvary Hospital, Shahid Beheshty University of Medical Sciences
Tehran, Iran, Infectious Diseases, Tehran, Islamic Republic of Iran; 4Hospital
Medical Center, Medical Sciences of Tehran University. Tehran, Iran,
Pediatrics, Tehran, Islamic Republic of Iran; 5Hopital Bichat Claude Bernard
Paris, Laboratoire de Biochimie, Paris, France.
Chronic Granulomatous Disease (CGD) is an inherited phagocytic
disorder caused by mutations in NADPH oxidase subunits. Patients with
CGD have life-threatening bacterial and fungal infections. Childrens Medical
Center at Tehran University is the referral center for immunodeficiency in
Iran. During two years of study forty five families with clinically diagnosed
CGD were referred to this center. Neutrophil functional assays performed for
affected children and their mothers; no activity or residual activity was
detected in affected neutrophils. PMN (Poly Morpho Nuclear) oxidative burst
revealed mosaic pattern in 12 mothers. Western blot analysis revealed gp91-
phenotype in all their sons. Mutation screening in CYBB gene using SSCP
analysis followed by sequencing, showed 9 different mutations including one
novel mutation. Western immunoblot subtyping of patients whose mother
showed no mosaic pattern by DHR123 revealed 24 patients with p47 null
expression, 7 and 2 patients with p22 and p67 defect, respectively. %GT
screening in Ncf1 gene for p47- patients, revealed 8 patients with this
mutation. Mutation analysis for the rest of Ncf1 gene for these patients is
understudy. CYBA mutation analysis revealed 6 different mutations
including three novel mutations in p22- patients. Overall, the number of
autosomal recessive patients with CGD in Iran is high and it seems
consanguineous marriages is one of its causative factors.
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First HIV/AIDS vaccine clinical trials in Russian Federation:
cohort formation
Georgy Gudima1, Irina Nikolaeva2, Svetlana Korobova2, Yulia Gornostaeva3,
Tatiana Klimenko4, Alexandr Chevalier2, Lydia Trubcheninova5, N.
Trefilieva5, Z. Gorbunova5, M. Ischenko5, Tatiana Petrova6, Dmitry
Trofimov6, Boris Pinegin7, Alexandr Chernousov8, Natalia Ilina9, Tatiana
Latysheva3, Edward Karamov10, and Igor Sidorovich11. 1Institute of
Immunology, Lab. of Physiology of Immunity and Allergy, Moscow, Russian
Federation; 2Institute of Immunology, Lab. of Biotechnology and AIDS,
Moscow, Russian Federation; 3Institute of Immunology, Dep. of Adults Im-
munopathology, Moscow, Russian Federation; 4Institute of social and foresic
psychiatry, Clinical Dep., Moscow, Russian Federation; 5Institute of Im-
munology, Lab. of Acquired Immunodeficites, Moscow, Russian Federation;
6Institute of Immunology, RPE DNA-Technology, Moscow, Russian Federa-
tion; 7Institute of Immunology, Dep. of Immunodiagnostics, Moscow, Russian
Federation; 8Institute of Immunology, Clinical Diagnostics Dep., Moscow,
Russian Federation; 9Institute of Immunology, Clinical Dep., Moscow,
Russian Federation; 10Institute of Virology, Lab. of Immunochemistry,
Moscow, Russian Federation; 11Institute of Immunology, Dep. of AIDS
Immunobiology, Moscow, Russian Federation.
Background: The first clinical trials of HIV/AIDS vaccine in Russia (phase
I) Y VICHREPOL, recombinant protein antigen (comprised C-terminal p17,
full length p24 and gp41 immunoreactive fragment) conjugated with
polyoxidonium adjuvant Y started in 2005 (HVRF-380-131004, IAVI List
of ongoing trials of preventive AIDS vaccines). Volunteers recruitment was
the first experience of cohort formation for clinical trials of HIV/AIDS
vaccines in Russia. Willingness, reasons to participate and reasons of refusal
were estimated also.
Methods: 15 volunteers (HIV non-infected healthy persons, 20Y50 y.o.) were
planned to enroll into phase I trials. Recruitment started by the wide
spreading of information on clinical trials of VICHREPOL through media,
medical centers and NGOs (predominantly in Moscow and Moscow region).
All appropriate papers and information were presented to volunteers.
Motivation, understanding of vaccine properties and trial procedure, risk
behavior, ability to perform the trial protocol were estimated. Volunteers
enrolled in trials after confidential medical investigation and informed
consent undersigning.
Results: 65 persons of 298 enquiries were screened as potential
volunteers. The main reasons for participation: help to HIV-infected
people (65%) including persons in nearest surround (wife, husband, friend,
child) (41%); contribution in development of HIV/AIDS vaccine (35%);
possibility of immune protection against HIV (18%), free insurance and/or
medical care (4%). 20% (13 of 65) of persons refused to participate in
trials. Reasons of refusal: doubts in vaccine safety and fear to receive
HIV-infection (61%), fear of side effects (30%), fear of vaccine-induced
HIV seropositivity (15%), impossibility to perform the trial protocol (7%),
low compensation (2%), unexplained (15%). 30 persons not refused to
participate in clinical trials, but decided to do it in future (clinical trials
phase II). Reasons: planned pregnancy or temporal impossibility to
perform the trial protocol. 17 volunteers (14 men, 1 woman, age 22Y31)
were enrolled in trials. 2 of them leaved trials after 1st vaccination
(unexplained reason), 9 successfully passed the trials protocol and 6 are at
final step of trials.
Conclusion: The first cohort for the clinical trials of preventive HIV/AIDS
vaccines was created in Russia and partially enrolled in clinical trials of
VICHREPOL vaccine. Cohort is stable (88%), expandable and may be
included into international multicenter trials.
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A novel mutation within exon 12 of the CYBB gene resulting in
severe form of x-link chronic granulomatous disease
Sureerat Pongpreuksa1, Orathai Jirapongsananuruk1, Deborah Noack2,
Siribangon Boonchoo1, Charin Thepthai3, Kulkanya Chokephaibulkit1,
Nualanong Visitsunthorn1, Pakit Vichyanond1, Voravich Luangwedchakarn4,
Surachai Likasitwattanakul5, and Surapon Piboonpocanun6. 1Department of
Pediatrics, Siriraj Hospital Mahidol University, Bangkok, Thailand; 2The
Scripps Research Institute, La Jolla, CA, United States; 3Department of Im-
munology, Siriraj Hospital Mahidol University, Bangkok, Thailand; 4Siriraj
Hospital Mahidol University, Department of Immunology, Bangkok, Thai-
land; 5Siriraj Hospital Mahidol University, Allergy and Immunology Div-
ision, Department of Ped, Bangkok, Thailand; 6Institute of Molecular Biology
and Genetics, Mahidol University, Nakhon Pathom, Thailand.
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Chronic granulomatous disease (CGD) is a primary phagocytic
disorder with defective superoxide formation and intracellular killing. The
most common form, X-linked CGD (X-CGD) resulted from the mutation of
CYBB gene on chromosome Xp21.1. We evaluated a Thai boy who had
multiple Salmonella septicemia, Aspergillus pneumonia and brain abscess.
His nitroblue tetrazolium (NBT) test was reportedly abnormal. The
dihydrorhodamine (DHR) flow cytometry assay was performed and the
fluorescence pattern upon stimulation was compatible with typical X-CGD.
CYBB analysis revealed a novel complex mutation atggacgY ttca in exon 12
(base pairs 1532Y1538). As a result, 3 amino acids Tyr 511, Gly 512 and Arg
513 were deleted and replaced by 2 amino acids, Phe and Gln. The DHR and
mutation analysis of his mother showed normal DHR pattern and no
mutations in exon 12 of CYBB gene. Over 300 CYBB mutations have been
registered in an internationally maintained X-CGD database. Most mutations
are distributed throughout the 13 exons or at exon/intron boundaries, and
almost 200 of these mutations are unique. We reported a novel mutation
within exon 12 of CYBB gene which was on the nicotinamide adenine
dinucleotide phosphate (NADPH)-binding domain in a CGD patient.
Functional defect was demonstrated by almost absence of fluorescence
upon stimulation of granulocytes on DHR histogram. This defect leads to a
severe form of X-CGD.
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Nutrition status in Iranian patients with primary antibody
deficiency
Azam Kouhkan1, Azam Kouhkan2, Zahra Pourpak1, Mostafa Moin1, Ahmad
Reza Dorosty3, Mehrnaz Mesdaghi1, and Anoshirvan Kazemnejad4.
1Immunology, Asthma and Allergy Research Institute, Tehran University
of Medical Science, Tehran, Iran, Immunology, Asthma and Allergy, Tehran,
Islamic Republic of Iran; 2Royan Institute, Tehran, Iran, Stem cell
Department, Tehran, Islamic Republic of Iran; 3Nutrition Department,
School of Public Health, Tehran University of Medical Science, Tehran,Iran,
Nutrition, Tehran, Islamic Republic of Iran; 4Department of Biostatics,
School of Medicine, Tarbiat Modaress, Tehran, Iran, Department of
Biostatics, Tehran, Islamic Republic of Iran.
Background: Nutrition is an important factor that influences immunity, and
nutritional deficiency can impair resistance to infections.Malnutrition is the
most common cause of immunodeficiency worldwide. Trace elements such
as zinc, selenium, iron, and copper can influence several components of
immunity. Primmary antibody deficiency disorders are a group of disorders
characterized by an unusual susceptibility to infections and malnutrition.
Impaired nutritional status has been reported in immunodeficient patients.
The aim of this study was to determine anthropometric indices and trace
elements status in these patients.
Methods: Thirty-eight children (28 males, 10 females, aged 2Y18 years) with
primary antibody deficiency referring to Children,s Medical Center of Tehran
University of Medical Science were enrolled in this research. Primary
immunodeficiency disorders consisting of CVID, XLA, IgA deficiency, IgG
subclass deficiency, and hyper IgM were assessed. Anthropometric indices,
comprised of height, weight that were measured and body mass index (BMI)
was calculated. Height-for-age (HAZ), weight-for-height (WHZ) and weight-
for-age (WAZ) were determined according to Z-score to study mild,
moderate and severe malnutrition. Serum copper, zinc, selenium and iron
levels were measured by an atomic absorption spectrometer.
Results: The most common disorders were CVID 52.5% and X-linked
agammaglobulinemia 27.5%. Based on BMI measuredment 21.1% of
patients had malnutrition. According to HAZ, 13.2%, 13.2%, and 36.8%
had severe, moderate and mild malnutrition, respectively. According to
WAZ, 10.5%, 18.4 %, and 28.6% had severe, moderate and mild
malnutrition, respectively. Regarding to WHZ, 14.3%, 28.6 %, had moderate
and mild malnutrition, respectively.Low selenium levels and high copper
levels were obsevd in 37.5% and 70.3%, respectively.
Conclusion: Anthropometric data showed that the frequency of malnutrition in
these patients was higher than the CDC standard. Low serum selenium levels
and high serum copper levels were observed, suggesting further research is
needed on these parameters. Most of the patients had serum zinc and iron levels
within the normal range. It is recommended that clinical immunologists and
nutritionists should make a collective effort to provide these patients with
standard or specialized diet so as to decrease the risk of infection.
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A registry of primary immunodeficiencies in a University
Hospital in Thailand: an 18 year-review
Patchanee Benjasupattananan1, Nualanong Visitsunthorn1, Pakit Vichyanond1,
Voravich Luangwedchakarn2, and Orathai Jirapongsananuruk1. 1Mahidol
University, Siriraj Hospital, pediatric, Bangkok, Thailand; 2Mahidol Uni-
versity, Siriraj Hospital, Immunology, Bangkok, Thailand.
Background: Primary immunodeficiencies are group of rare diseases which
are difficult to diagnose and manage. Most presenting symptoms were
infections from uncommon organisms leading to high morbidity and mortality.
Objective: To evaluate clinical characteristics of pediatric patients with
primary immunodeficiencies in Thailand.
Methods: Medical records of all patients diagnosed and treated for primary
immunodeficiency in the past 18 years, at Siriraj Hospital, Bangkok,
Thailand, were reviewed. Patients with secondary immunodeficiencies and
chromosomal abnormalities were excluded.
Results: A total of 85 pediatric patients (58 males and 27 females) were
registered. The earliest onset of symptom was in the newborn period. IgG
subclasss deficiency was the most common primary immunodeficiency
diseases (47%), followed by severe combined imuunodeficiencies (17.6%),
specific antibody deficiencies (14%), agammaglobulinemia (7.5%), common
variable immunodeficiencies (4.5%) and chronic granulomatous disease
(4.5%). The most common presenting symptoms of antibody deficiencies
were upper respiratory tract infections (49/56, 87.5%). In patients with T-cell
immunodeficiencies, most common presentations were PCP pneumonia
(9/15, 60%) with septicemia being the most of common presentations among
patients with phagocytic defect (2/4, 50%). There is an increasing trend of
early detection of primary immunodeficiency and decreasing diagnostic lag
month over the past 18 years. History of death in family is the important
information for rapid diagnosis.
Conclusion: Establishment of registry of primary immunodeficiencies may
provide the information for early detection and proper treatment to improve
the prognosis of these patients in Thailand.
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Paucity of adverse events associated with administration of ivig
Constance Katelaris1, and Marjorie Bennett2. 1University of Western Sydney,
Immunology ans Allergy, Sydney, Australia; 2Westmead Hospital, Immunol-
ogy and Allergy, Sydney, Australia.
Introduction: Intravenous immunoglobulin (IVIG) is a valuable treatment
for many immune-mediated disorders and it is vital management for those
with humoral immunodeficiencies. These individuals receive regular, long-
term therapy with IVIG. Adverse events associated with administration of
IVIG have been reported. In our specialist unit at Westmead, hospital,
Sydney, approximately 850 courses of IVIG are administered annually.
Aim: As we have a large experience of IVIG administration, we have
performed a retrospective analysis of adverse events (AE) experienced by
patients attending our unit.
Methods: Retrospective chart review of all IVIG infusions delivered in the
last four years was performed. Factors examined were patient demographics,
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diagnosis, previous administration of IVIG infusion and symptoms of AE.
IVIG products utilized were Intragam-P (CSL Bioplasma,Melbourne,Aus-
tralia.), Sandoglobulin (ZLB Bioplasma A G, Bern, Switzerland.), Octagam
(Octapharma AG, Lachen, Switzerland.). Patients receiving IVIG were not
routinely pre-medicated with either antihistamines or steroids.
Results: In our centre 3,320 infusions of IVIG were given in a 4 year period
to 112 patients (46 males - 66 females). 49 of the 112 patients had PID. 63 had
various autoimmune conditions or treatment induced hypogammaglobuline-
mia. 50 of the patients were long standing recipients of IVIG and 62 were
naBve to any IVIG products. During the 4 years there were 7 AEs observed. 3
of these patients were naBve to any IVIG products. 4 were long-term
recipients. 3 patients had PID and the remainder had autoimmune conditions.
Discussion: Our review showed that the incidence of AEs associated with
IVIG infusions is very low (0.4%) for 3,320 infusions, which are similar to
figures reported elsewhere. All AEs may have been preventable as three of
the patients were naBve to IVIG and may have benefited from pre-medication
and three of the reactions occurred when recommended maximum infusion
rates were exceeded. The other reaction occurred due to patient delay
between infusions. All patients whom experienced AEs have continued on
IVIG without any reoccurrence of AEs and only one of these is routinely pre-
medicated. Therefore, in conclusion, with due regard to infusion rates, timing
between infusions and use of pre-medication IVIG is a safe treatment for
humeral immunodeficiences and autoimmune disorders.
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Complement levels in hereditary angioedema
Lilian Varga1, Zsuzsanna Kelemen1, Ga´bor Sze´plaki1, E´va; Ne´meth1, Judit
Ga´cs1, George Fu¨st1, Bea´ta Visy2, and Henriette Farkas1. 1Semmelweis
University, 3rd Department of Internal Medicine, Budapest, Hungary; 2Heim
Pa´l Children Hospital, Department of Internal Medicine, Budapest, Hungary.
The diagnosis of hereditary angioedema (HAE) is based on
complement tests, however the relationship between the clinical symptoms
and the complement levels is poorly studied. In our study we compared
complement values in 90 patients with HAE and 212 patients with
angioedema of unknown origin. In addition the complement parameters
(CH50, C1q, C3, C4, antigenic and functional C1-INH) tested at the time of
diagnosis were correlated with age, sex, severity of the disease in 99 patients
with HAE type I and 7 patients with type II. Unlikely to the previous findings
we have found that out of the complement parameters tested the functional
C1-INH had the highest specificity, but the lowest sensitivity in the diagnosis
of HAE, while highest specificity was observed with the antigenic C1-INH
assay. We did not find correlation between complement levels and age at the
time of diagnosis. No association was found between the complement levels
and sex or HAE type. We found significant association of baseline functional
C1-INH (p=0.0144), and CH50 (p=0.054) levels with the severity of disease.
As a conclusion we demonstrated that both antigenic and functional C1-INH
is required for the correct diagnosis of HAE and testing of C4 highly validates
the results. Determination of funcional C1-INH and C4 may have clinical
significance. Regular evaluation of these parameters can be a useful tool in
the strategy of long term prophylaxis, however further studies are required to
confirm these associations.
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Attacks of hereditary angiooedema (HAE) treated with
icatibant in the open-label phase of the fast-2 study
Henriette Farkas, Lilian Varga, Gabor Szeplaki, Gyo¨rgy Temesszentandrasi,
Laszlo Jakab, Bela Fekete, George Fust, and Istvan Karadi. Semmelweis
University, 3rd Department OF Internal Medicine, Budapest, Hungary.
Background: HAE is characterized by recurrent edematous swellings of the
subcutaneous or submucosal tissues. Bradykinin plays an essential role in
the development of angioedema. This study was conducted to investigate the
effects of the selective bradykinin-B2-receptor-antagonist Icatibant in the
treatment of attacks in patients with HAE due to C1-inhibitor deficiency.
Methods: During an open-label extension phase of a randomized, double
blind, controlled phase III study (FAST-2) patients with cutaneous and/or
abdominal attacks of hereditary angioedema were treated with Icatibant.
Within 6 hours after the onset of a moderate/severe attack they received a
single injection of 30 mg Icatibant subcutaneously. Symptoms were assessed
by patient (VAS, symptom score) and by physician (symptom score global
assessment, clinical global impression).
Results: 6 angioedema attacks in 2 patients with HAE were treated with
Icatibant. The affected sites were twice the extremities and once the genitalia
in Patient #1. Patient #2 experienced two abdominal attacks, while another
attack affected the gastrointestinal tract and one extremity. Clinical
symptoms of all attacks improved quickly. Time to first improvement of
symptom was 10Y23 minutes. The duration of complete resolution of
symptoms was shorter in abdominal attacks compared to attacks involving
the subcutaneous tissues (180Y240 min versus 480Y720 min). Drug related
adverse events and relapses were not experienced. Local skin reactions at the
injection site were tolerable and resolved within 4 hours.
Conclusion: IcatibantYwhich differs from earlier drugs concerning both the
mode of action and the method of administration as wellYhas been found
effective and safe in the treatment of angioedema attacks in patients with
HAE. The possibility of subcutaneous administration of Icatibant may
improve the daily life of patients suffering from HAE. In the present cases
repeated use of Icatibant did not result in reduced efficacy. The potential of
Icatibant for the treatment of other bradykinin mediated angioedema has to be
tested in further studies.
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Leukocyte adhesion deficiency: (LAD-1) Report of two cases
Zahra Chavoshzadeh1, Mahmod Mohamadi2, and Parvin Fathi2. 1Mofid
Hospital, Pediatric Infectious Research Center (PIRC), Tehran, Islamic
Republic of Iran; 2Omid Hospital, Pediatric Department, Abhar, Islamic
Republic of Iran.
Leukocyte adhesion deficiency-1 (LAD-1) is a genetic immunodefi-
ciency disease characterized by life-threatening infection results from the
mutations in the leukocyte integrin, CD18 molecule with severe and
moderate phenotype. We report a case of severe LAD occurred in a 1
month old girl and a case of moderate LAD which was presented with
aggressive periodontitis.
Case 1: Clinical features include delayed separation of the umbilical cord,
omphalitis, severe bullose and /ulcerative skin eruption which mimic picture
of staphylocolal scaled skin syndrom in neonatal period and persistent leuko-
cytosis. The immunological workup showed pathological values of CD11b,
CD18 (2.3%, 0.3% respectively). The patient is waiting for BMT now.
Case 2: A 4/5 year old boy with aggressive periodontitis in the primary den-
tition which pathologic examination showed actinomycosis ginigivits and
normal separation of umbilical cord. He had CD11b __ 4/6% and CD18 __ 3/
7% in peripheral blood flow- cytometery compatible with moderate
phenotype of LAD1. He is receiving antibiotic prophylaxis. Conclusion:
Although LDA is a rare form of congenital immuno -deficiency, severe
LDA1 should be considered when delayed wound healing and recurrent
bacterial skin infections are present in a newborn and moderate LAD1 in
aggressive periodontitis with normal wound healing.
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Clinical and molecular characteristics of Thai families with
X-linked chronic granulomatous disease
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Department of Pediatrics, Division of Medical Genetics and Metabolism,
Bangkok, Thailand.
Rationale: X-linked chronic granulomatous disease (X-CGD) is an
immunodeficiency disorder characterized by defective intracellular killing
of microorganisms due to neutrophils’ inability to generate superoxide ions.
Although it is caused by mutations in the same CYBB gene, clinical and
molecular characteristics vary among different ethnic backgrounds.
Materials and Methods: Two unrelated Thai boys presented with severe
persistent pulmonary infections at the age of two months. Their abnormal
DHR assays supported the diagnosis of X-CGD. Mutation analysis was
performed by polymerase chain reaction (PCR) amplification and sequencing
of the entire coding regions of CYBB. Mutations identified were confirmed by
restriction enzyme analyses.
Results: PCR-sequencing of the entire coding regions of CYBB identified
nonsense mutations, 271C9T (R91X) in exon 4 and 456T9A (Y152X) in
exon 5, in probands of each family. Both of the probands’ mothers were found
to be carriers.
Conclusion: This observation supports that CYBB is the gene responsible for
X-CGD across different populations and nonsense mutations are associated
with severe phenotypes.
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Immune Reconstitution Inflammatory Syndrome, right sided
hemiparesis, in a Thai HIV infected girl with severe
immunosuppression
Torsak Bunupuradah1, Thanyawee Puthanakit1, Oratai Butterworth2,
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longkornUniversity, Bangkok, Thailand, Pediatrics, Bangkok, Thailand;
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The
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Bangkok, Thailand, Internal Medicine, Bangkok, Thailand; 5South East Asia
Research Collaboration with Hawaii (SEARCH), Bangkok, Thailand,
Pediatrics, Bangkok, Thailand.
Background: Inflammatory responses to prior infections due to improved
immune responses to latent pathogens with paradoxical clinical worsening
observed in HIV-infected patients initiating potent antiretroviral therapy. No
case report of cytomegalovirus (CMV) associated CNS IRIS in children.
Methods: We report a case with serious atypical adverse events after initiate
ARV.
Results: A 7 years old Thai girl, CDC C due to wasting syndrome,
presented with history of fever and oral candidiasis with CD4% 6%, CD4
count 17 cells/ml, viral load 163,000 copies/ml. After 2 weeks cotrimoxazole
for PCP prophylaxis, she started antiretroviral therapy (ARV), stavudine,
lamivudune and nevirapine, at Chulalongkorn hospital. One week later, she
developed right sided hemiparesis without any history of headache, vomiting
and loss of consciousness. The neurological exam revealed right sided weak-
ness with motor power grade IV at both upper and lower extremities, normal
reflexes and clonus. The differential diagnoses were cerebral toxoplasmosis,
brain abscess and tumor. The CT brain with contrast media revealed gen-
eralized brain atrophy without mass or ring enhancement. Lumbar puncture
was performed. The cerebrospinal fluid (CSF) was colorless and clear with
WBC 2 cell/mm3, no RBC, protein 35.9 mg/dl and CSF sugar/ plasma sugar
70/96 mg/dl respectively. CSF bacterial culture was no growth but CSF
cytomegalovirus (CMV) was positive through PCR method. MRI brain was
shown hypodensity lesion at the right cerebellum. Ophthalmologic examina-
tion was normal.After 2 weeks of ARV, her CD4%, CD4 count and viral load
were 17%, 202 cells/ml and 440 copies/ml respectively. The diagnosis was
Immune Reconstitution Inflammatory Syndrome (IRIS). However, we did not
prescribe any steroids because of the bacteremia. During this period, she con-
tinued to take ARV as usual. One month after her hospitalization, she was
reexamined to be fine with full motor power. After a total of 6 months of ARV,
shewas finewithCD4%13%,CD4count 356 cells/ml, viral load 50 copies/ml.
Conclusion: We reported the CMV IRIS, right hemiparesis, after a week of
initiating antiretroviral therapy in an HIV infected girl with severe
immunosuppression. The diagnosis of atypical CNS symptoms after initiate
ARV with rapidly increased CD4 and decreased viral load should consider
as IRIS.
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Usefulness of quantification of C-reactive protein (CRP) for
diagnosis of bacterial infection in the febrile neutropenic child
Martin Penagos1, Fortino Solorzano2, Miguel A Villasis2, Andrea Tapia2,
Hugo Rivera2, and Roberto Bernaldez2. 1Pediatrics Hospital, CMN,
Pediatrics Section, Mexico City, Mexico; 2Pediatrics Hospital, CMN BSiglo
XXI[, IMSS, Pediatrics Section, Mexico City, Mexico.
Background: Diagnosis of bacterial infection in a neutropenic child with
fever becomes difficult due to a poor inflammatory response. Currently, a
method reliable and fast to identify patients with bacterial infection is not
available. CRP has been evaluated in these patients with controversial results.
Objective: To determine the sensitivity, specificity, predictive values and
likelihood ratios of CRP for diagnosis of bacterial infection in neutropenic
children with fever.
Design: Cross-sectional study.
Methods: We included patients less than 16 years of age with fever and
severe neutropenia (G500 AN/mm3). Blood cultures and CRP were taken in
the initial evaluation. All of them, had empirical antimicrobial treatment;
their evolution was followed up until discharge. Blood cultures were
processed by the automated system BACT-alert; CRP by nephelometry.
Patients were classified in 4 groups: Group I: Clinical and bacteriological
infection, Group II: Infection clinically defined, Group III: Fever due other
causes than infection and Group IV: Patients with cancer, neutropenia
without fever. Diagnostic test analysis, receiver operating curves (ROC) and
likelihood ratios were performed.
Results: One hundred twenty seven episodes were included from 113
subjects. Leukemia was the most frequent disease (61%). Twenty nine, 47, 20
and 31 episodes were included in groups I, II, III and IV respectively. We
found microbiological isolation in 29 episodes, Staphylococcus aureus
and Escherichia coli were the most common isolated germs (27.6% and
17.2%). Median for CRP levels (IQR) was of 282 mg/L (174Y385) in group I;
205 mg/L (119Y267) in group II; 27,3 mg/L (12.3Y55) in group III and
5,1 mg/L (2.4Y13) in group IV (pG0.001). By COR curves a CRP level higher
than 60 mg/L showed a sensitivity (S) of 94%, specificity (E) 94%, positive
PV (PPV) 96% and negative PV (VPN) 92% when we compared groups I
and II vs. III; at this cut level, likelihood ratio for a positive result was 15,6
and 0,06 for negative result. Among those patients with diagnosis of solid
tumor, S, E, PPV and NPVwere of 96, 100, 100 and 95%.We found that none
patient with neutropenia, fever with negative blood cultures and without focal
infection, with a CRP level lower than 30mg/L had not bacterial infection. All
patients with CRP levels higher than 100 mg/L were infected.
Conclusion: CRP is a useful, fast and economic test to identify bacterial
infection in the neutropenic patient with cancer and fever.
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Hyperimmunoglobulinemia E (Job) syndrome
Viktoriia Klymenko1, Anatolij Kojemiaka1, and Elena Pasichnic2. 1Kharkiv
State Medical University, Propedeutic Pediatria Department N2, Kharkiv,
Ukraine; 2Regional Kharkiv Children Hospital N1, Pulmonary Department,
Kharkiv, Ukraine.
Background: The hyperimmunoglobulinemia E (Job) syndrome is a rare
immunodeficiency disorder. The only one patient is present in Kharkiv
Region.
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Methods: The patient was observed by traditional clinical and paraclinical
methods of investigation.
Results: Clinical signs: 1) Recurrent furunculosis and episodes of skin cold
staphylococcal abscesses. An onset of streptostaphylodermia is 2month age. It
was the first clinical manifestation of disease. A frequency of exacerbation is
2Y4 times per year. 2) Recurrent bronchitis since 5 month. 3) Recurrent
pneumonia complicated pleuritis and pneumatocele since 4 year old. The child
had 1Y3 pneumonias per year. The child was operated at the age 4 year -
lobectomy of upper right lung lobe; at the age 8 year - lobectomy of upper left
lung lobe; and at the age 9 year - toracotomy and sewing up of the broncho -
pleura fistula of left lung. 4) Recurrent abscesses in abdominal cavity since 8
year. The child was operated many times - at 8 year due to acute appendicitis
complicated peritonitis; at 10 year - a huge abscesses of big omentum; at
11 year - an abscess in a region of afteroperation scar; in 3 month - an abscess
in left underdiaphragm region and an abscess of upper pole of spleen.
5) Presence atopic dermatitis since 3 month. The eczematous skin eruption
does not have a seasonal variation and is present, to some degree, at all times.
6) Presence skeleton anomalies: scoliosis, generalized hyperextensibility of
joints, facial abnormalities, retention of 4 primary teeth with unresorbed roots,
absent 2 lower premolaries, 1 upper premolaries, 2 lower and 2 upper molaris.
Lab Findings: high eosinophilia (7 Y 24 %), lymphocytosis (till 42 %), than -
neutrophilia (till 86 %), shift to the left (band neutrophils 6 Y 11 %), eleveted
ESR (25 Y 43 mm/hour), high level IgE (60498 IU ml). Imaging Studies:
dental abnormalities - delay of primary teeth shedding owing to lack of root
resorption, absent of some permanent teeth (X-ray); thin-walled cysts in both
lungs (X-ray); cysts in the liver and in the lungs (Ultrasonic, Computer
tomography). The patient was treated by prolonged course of antibacterial
therapy, fluconazole for mucocutaneous candidiasis, onychomycosis and
topical steroids for eczematous dermatitis.
Conclusion: This clinical case gives us an experience in observation and treat-
ment of children suffering from a rare primary immunodeficiency disorder.
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The evaluation of clinical and paraclinical in twenty CVID
patients and detection Of IL-2 as a significant cellular function
in these by invitro way
MarziehHeidarzadehArani1, Abolhassan Farhoudi2, AsgharAghamohammadi2,
and Gholamreza Ghasemiyeh3. 1Shahid Behashti, Pediatric, Kashan, Islamic
Republic of Iran; 2Children Medical Center, Immunology & Allergy, Tehran,
Islamic Republic of Iran; 3Shahid Behashti, Farmacology, Kashan, Islamic
Republic of Iran.
Subjective: Common variable immunodeficiency is the primary immuno-
deficiency disease. CVID is a heterogeneous group of immunologic disorder
of un known etiology, characterized by impaired antibody responses,
associated with number and function cells defect including lymphopenia,a-
nergy,impaired lymphocyte proliferation and deficit cytokine secretion that
the most important of them is IL-2.most prevalent of the
Objective: The goal of this study was evaluation of the clinical and
paraclinical characterized 20 CVID patients,interlukine 2 production and
compaired these to healthy control group.
Methods and Materials: We done a randomized cross sectional study in 20
CVID patients from department of immunology and allergy in children
medical center and 10 healthy control. The evaluation of the patients was done
by questioner and peripheral blood mononuclear cells of the twp groups were
cultured with PHA and supernatant were collected for quantitation of IL-2 by
ELISA.
Results: Mean of age the patients was 15.9+/j11.23 and distribution of
gender was 9 female and 11 male. There were high frequency hospitalization
in 80% of cases (over the two time).The most frequent of infection was
respiratory tract infection. There were opportunistic infection in 5Y10% of
them, autoimmunity in 40% of cases,un response DTH in 65% of cases and
IL-2 production was zero in15 patients and the 5 patients had level of IL-2
lower than corresponding levels in the healthy control (P valueG0.005).
Conclusion: In our the study, all of the patients showed that T cells of them
exhibit deficient production of IL-2 and manifestations of this deficiency
were high frequency of autoimmunity,granolumatose disease, bronchectasia
and recurrent infection in spite of given monthly IVIg in patients.
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A 3 years old female with SCID T(j)B(j)Nk(+) treated with
halogenic bone marrow transplantation. Case report
Horacio Del Olmo Tellez, and Francisco Espinosa Rosales. National
Institute of Pediatrics in Mexico, Allergy and Immunology, Mexico City,
Mexico.
A 3 years old female is the second of two children born to non-
consanguineous mexican parents after an uncomplicated, term pregnancy.
Birth weight was 3900 g, length 53 cm.
She had breast feed until 2 months of age. She didn’t receive
immunizations. She has history of a 9 years old brother who suffered
totipotent cell transplantation because severe immunodeficiency. He cursed a
neurologic infection and died. At age 45 days she had abundant, liquids, and
blood stools. She received ceftriaxone treatment with partial improvement.
After that a stool cultive test was positive for campylobacter yeyuni so she
was treated with claritromicyn for 14 days. She also had oral and esophageal
candidiasis treated with miconazol. Because the brother with immunodefi-
ciency, when she arrived to our hospital the following studies were done: cd3
0.2%, cd 20/19 0%, cd4 0.1%, cd8 0.1% cd 53 83%, igm 4 mg/dl (20Y40) igg
415 mg/dl (310Y852), iga 6.6 mg/dl (3.5Y67). A severe combined
immunodeficiency diagnosis was made with t (j) b (j) nk (+) features.
We supposed deficiency in enzimes of receptor’s recombination. We
restituted totipotent cells with halogenic bone marrow transplantation. The
hla compatibility was:
patient: a68 (28) y a2, b39 (16) y b61 (40), dr4 y dr 11(5), dq8 (3), dq7
(3) patient’s father: a68 (28) y a2, b61 (40) homozigous, dr4 y dr 11(5), dq8
(3) y dq7 (3).
High resolution study for dr
patient: drb1 0407
patient’s father: drb1 0407.
We decided to admistered only partial hidrolized formula because the
posible risk to adquired infections by breast feeding. She was treated with
immunosupresor as acondicionated treatment with busulfan 4 mgkgday
4 days, day j8 to j6, cyclophosphamide 60 mgkgday day j5 to j4. In
september 19 2003, our patient received hallogenic bone marrow trasplanta-
tion with prior medication with h1 blockers and steroids. We adminitered
120 ml of aferesis products with a total count of 189,000  10 3. 98.5%
mononuclears.
The patient presented host againts disease with papules, petechias in
abdomen. She was treated with metotrexate, ciclosphorine and methilpredni-
solone. She had citomegalovirus blood culture test positive and was treated
succesfully with ganciclovir. Nowadays she has normal blood citology,
immunoglobulin levels, lymphocyte subpopulations and she has completed




Is staphylococcal alpha-toxin a critical pathogenetic factor of
atopic dermatitis in highly atopic individuals?
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2Berufsgenossenschaftliches Unfallkrankenhaus Boberg, Department of
Dermatology, Hamberg, Germany; 3University of Erlangen/ Nu¨rnberg,
Med. Informatics, Biometry and Epidemiology, Erlangen, Germany.
Background: Staphylococcus aureus (S. aureus) is a well known trigger
factor of atopic dermatitis (AD). Besides staphylococcal superantigens alpha-
toxin ("-t) which is produced by one third of skin-colonizing S. aureus strains
in AD may influence the cutaneous inflammation. "-t can be detected both in
the upper epidermis and in the dermis of AD patients. Sublytic concentrations
of "-t have been shown to induce T-cell proliferation and secretion of T-cell
cytokines.
Objective: To explore the association of sensitization to inhalant allergens
and "-t producing skin colonizing S. aureus in AD. Methods: We investigated
127 adult patients with AD according to their skin colonization after
treatment with antiinflammatory and antiseptic substances, medical history,
severity of AD and sensitization to different allergens.
Results: 48 out of 127 patients where colonized with S. aureus. S. aureus
colonized patients suffered from a more severe AD (SCORAD: S. aureus
positive patients: 46, S. aureus negative patients: 33) and showed a higher
sensitization level to different inhalant allergens. Surprisingly, they also
suffered more frequently from allergic asthma (S. aureus positive patients:
69%, S. aureus negative patients: 44%). 30 of the 48 S. aureus skin-
colonizing strains produced "-t. The severity of AD was similar in patients
being colonized with "-t negative S. aureus ("-t- pts) compared to patients
with "-t producers ("-t+ pts). "-t+ pts had a significally higher specific IgE to
birch pollen (median: "-t+ pts: 100kU/l, "-t- pts: 32kU/l) and a trend of higher
total IgE values (median: "-t+ pts: 6849kU/l, "-t- pts: 2215kU/l) and specific
IgE to timothy grass pollen (median: "-t+ pts: 80kU/l, "-t- pts: 12kU/l).
Conclusion: Following topical treatment the colonization rate was lower
(38%) than expected. But there was a high rate of patients who were skin
colonized with "-t producing S. aureus. Colonization with S. aureus was
associated with a higher severity of atopic dermatitis, higher sensitization,
and a higher frequency of allergic asthma. Cutaneous colonization with "-t
producing S. aureus was associated with a higher sensitization to saisonal
inhalant allergens in AD. If this is a consequence of direct chronic cutaneous
T-cell stimulation by sublytic doses of "-toxin penetrating constantly into the
skin needs further investigation.
356
Trichophyton allergy: review of 98 cases
A.G. Palma-Carlos, and M.L. Palma-Carlos. Clinical Allergy Immunology
Center, CAIC, Allergology, Lisbon, Portugal.
Background: The association of mycosis or onicomycosis by dermatophyte
fungi and allergic diseases including urticaria/angioedema, rhinitis and
asthma has been described for over 70 years but large series of confirmed
cases have not been published.
Methods: From 9087 patients seen in the last few years 98 (1,07%) 20 to 66,
61 males (62,2%), 37 females (37,8%) had a clinical history and previous or
actual visible skin or nails infection and positive tests to Tricophyton. Skin
tests have been done in all the patients by prick in a first step and by
intradermal with 1/1000 and 1/100 dilution in a second step. Specific IgE has
been looked by UNICAP for Tricophyton rubrum in 78 cases. Treatment with
antifungal itraconazol has been tried as a first option in all the patients. When
allergic symptoms subsisted specific immunotherapy by parenteric route has
been started with a slow release vaccine during a minimal period of 3 years.
Results: Fungal infection presentation was tinea pedis in 66 patients (67,3%),
onicomycosis in 36 (36,7%), tinea cruris in 27 (27,6%) and remaining
pruritus after clear infection in 3 (3,0%). Dual infections were present in 33
patients (34,4%). Total of clinical mycosis 129. Allergic disease: urticaria/
angioedema in 64 patients (65,3%), rhinitis in 14 (14,3%), asthma plus
rhinitis in 11 (11,2%), eczema in 8 (8,2%) and conjunctivitis in 1 (1,0%).
Fifteen patients (15,3%) all rhinitic had also positive skin tests to house dust
mites. Prick tests for Tricophyton were positive in 61 patients (62.2%).
Intradermal tests were always positive. Specific IgE was positive in 52
(66,6%) cases with a range of 0,50 to more than 100 Ku/l. Treatment with
antifungal cleared allergic disease only in 20 (20,4%). Specific immunother-
apy has been tried in 60 patients with very good results (complete clearing) in
23 (38,3%), good in 36 (43,3%) and moderate or nil in 11 (9,4%).
Conclusion: Tricophyton IgE mediated allergy play a role in the
pathogenesis of Urticaria/angioedena, asthma and rhinitis in most patients.
Fungal skin and nails infection must be searched, skin tests and specific IgE
used for diagnosis. Sensitivity and specificity of skin prick tests and specific
IgE are roughly comparable. Specific immunotherapy must be tried if anti
fungal therapy failed with good results in most cases.
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Profile of inflammatory cell in erythema nodosum leprosum
patients, treated with minocycline-prednisone combination
drugs and prednisone
Faridha S. Ilyas1, Muh Adam1, Sitti Musafirah1, Mahmud Ghaznawie2, and
Sri Vitayani Muchtar1. 1Medical Faculty Hasanuddin University Makassar
Indonesia, Dermato-Venereology, Makassar, Indonesia; 2Medical Faculty
Hasanuddin University Makassar Indonesia, Pathology Anatomy, Makassar,
Indonesia.
Background: A clinical trial study was conducted with B pre-post treatment^
design, to know effectiveness minocycline-prednison combination drugs and
prednisone only in the erythema nodosum leprosum (ENL) patients by profile
of cells inflammation.
Methods: Sixty ENL patients released from treatment (RFT) were included
in this study. They were devided into 2 groups, 30 patients were treated with
minocycline-prednison combination drugs (group A) and the other 30
patients were treated with prednisone-placebo (group B). To evaluate result
this study, we performed histopathology examination by skin biopsy,
haematology test by peripheral blood sample that obtained from cubital
venous puncture, and the changes of clinical feature.
Results: The results, that the ENL patients group A were shown more
improve histopathologically (pG0.05) haematology finding not showed
difference between 2 groups (p90.05). There was more improve change
clinical feature in the patients get combination therapy.
Conclusion: Combination therapy, prednisone-minocycline, better than just
prednisone only in ENL patients, so that it may be alternative drug to reduce
steroid dependency in the ENL patients.
Key Words: neutrophil, ENL, minocycline, prednison
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Level of bacterial IgG and IgM antibodies in multiple sclerosis
patients
Svetlana Shabalina1, Vera Demkina2, and Valentina Gervazieva2. 1Central
Research Institute of Epidemiology, Federal Service for Surveillance on
Consumers` Rig, Moscow, Russian Federation; 2Mechnikov Scientific
Research Institute for Vaccines and Serum, Russian Academy of Medical
Science, Moscow, Russian Federation.
: Multiple sclerosis is one of demyelinating diseases based pathophy-
siologically on changes in vasculo-myelin system. Immunological basis of
these diseases is failure of immunological tolerance for brain antigens with
development of autoimmune cellular reactions. Important role in this failure
and development of demyelinating process is attributed to bacteria possessing
antigenic determinants common with myelin basic protein (MBP) molecule.
Therefore we performed in multiple sclerosis patients study of IgG
and IgM antibodies against Clebsiella pneumonia, E. coli, St. aureus, H.
influenzae, and pertussis anatoxin.
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The study was performed with serum from 78 patients with different
types of multiple sclerosis. Titer of antibodies against Clebsiella pneumonia,
E. coli, St. aureus, H. influenzae, and pertussis anatoxin was detected by
enzyme immunoassay. Results were expressed as 1Y5 classes of reaction.
The study showed that in recurrent type of multiple sclerosis
exacerbation is accompanied by increase of IgM antibodies level (to 4Y5
class) for all abovementioned bacteria. Remission is marked by lowering of
IgM level compared to exacerbation one, to 2Y3 class, and by increase of IgG
level to 3Y4 class. In progressive type of multiple sclerosis level of IgG as
well as IgM antibodies increased progressively (to 3Y5 class). If course of
multiple sclerosis lasted more than 5 years, levels of IgG and IgM antibodies
were the highest (mostly 4Y5 class). Based on data obtained, we concluded,
that degree of manifestation of antibacterial immunity reflects the severity of
multiple sclerosis and can be considered as negative prognostic factor.
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Local cytokine status and clinical morphological parameters of
chronic viral c hepatitis
Lidia Skljar1, and Elena Markelova2. 1Vladivostok State Medical University,
Department Infection Diseases, Vladivostok, Russian Federation; 2Vladi-
vostok State Medical University, Department pathophisiology, Vladivostok,
Russian Federation.
The current research is aimed at investigating the levels of local
cytokines in liver histology examination samples of the CCH patients taking
into account clinical morphological parameters as well as biochemistry and
virology investigations. Cytokine investigation in homogenizers of liver
histology examination samples was performed in the period of CCH clinical
manifestation accompanied with cytolysis. As a tool of control the samples of
the hepatic tissue belonging to 5 donors who did not have any chronic
diseases and markers of being infected with viruses of parenteral hepatitis
were used to investigate cytokine levels in homogenizers of liver histology
examination samples. In the process of investigation of liver histology
examination sample homogenizers in CCH patients it was established that the
they have the authentic increase of IL-1!, IL-4, TNF-! proportion and
decrease of IL-2, IFN-+ proportion. The considerable fluctuation in
proportion levels of each of them from the minimal to the maximal indices
was noted and the total distribution differed from the normal one, which
hampered the adequate assessment of the investigated indices. The patients
were divided into two groups that differed from each other by the median of
the low (V0,25) and upper (V0,75) percentiles of the quantitative contents of
the local cytokin levels. The first group whose levels of practically all
investigated cytokines in liver histology examination samples were
authentically different from those of the second group. IL-4 proportion in
the second group nearly twice exceeded its index in the first group. The
increase of TNF-! level in liver histology examination samples of CCH
patients of the second group six times as high as that of the first group was
noted. The considerable decrease of the local proportion of IL-2 and IFN-a˜ in
the second group (0,6 T 0,02 pg/ml versus 16,0 T 0,6 pg/ml, p G 0,001 and
4,2 T 0,65 pg/ml versus 18,9 T 2,7 pg/ml, p G 0,0001 correspondingly) was
noted. No difference in IL-1a´ levels in investigated groups was noted
(p 9 0,05). In accordance with the local cytokine levels along the median of
the extreme percentiles (V0,25 and V0,75) two CVH patient groups were
singled out, the groups having the authentic difference in clinical,
biochemical and morphological parameters.
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Modern representation of immunopathogenesis of hemorrhagic
fever with renal syndrome
Victoria Ivanis, Darya Rukina, Elena Markelova, and Larisa Pereverten.
Vladivostok State Medical University, Department Infection Diseases,
Vladivostok, Russian Federation.
HFRS is one of the clinical forms of Hantavirus infection that is
widely spread on Eurasian continent. In Europe HFRS is predominantly
associated with Puumala, Dobrava - Belgrad Hantaviruses (HV), in Asia -
with Hantaan, Amur, Seoul. Another clinical form, which is common for the
American continent is Hantavirus Pulmonary Syndrome (HPS), associated
with Sin - Nombre, Andes serotypes. On the south of Far East region, where
three serotypes of HV are collected, the similarity of the main pathogenical
and clinical aspects of HFRS and HPS were revealed. It is established that
in the pathogenesis the important role plays either HV, as the initiator of the
process, or the reactions of cellular immunity. The more virulent HV (Sin -
Nombre, Andes, Hantaan, Amur) and lass virulent (Puumala, Seoul) are
known. The studying of immunopathogenesis in HFRS patients revealed the
dependence of characteristics of immune response from the serotype of HV.
On the onset of the disease the level of misbalance of serum cytokines (high
levels of IFN - !, IL -1!, IL12p70, IL12p40, IL-8, IL-10 and low levels of
IFN-+) and also the number of cytotoxic lymphocytes CD8 correlated with
the severity of clinical symptoms and the serotype of HV. In HFRS,
associated with Hantaan, Amur serotypes severe and complicated
manifestations with hemorrhagic syndrome, hyperhydration of kidneys,
respiratory tract, liver tissue and multiorganic insufficiency. Severe forms of
Seoul - infection were less common and the characteristics of immune and
cytokine status were not changed a lot. The studying of the levels of
cytokines and metabolites of nitric oxide in urine and exhaled air
condensates showed the absence of correlation of their production locally
and systemically. That fact reveals the independent synthesis of the immune
response mediators and allows supposing the respiratory tract, as the
kidneys to be the target - organ of HV. Viremia begins after the respiratory
infection of alveolar macrophages and then the central cells of pathogenesis
- endothelial cells of the lungs, kidneys and other organs. So, the results of
the study of cytokines in different biologic substrates (serum, urine, exhaled
air condensates) in the onset of the disease showed the prevalence of
immune reactions in the pathogenesis of HFRS without any dependence
with the Hantavirus serotype.
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The comparison of allergenicity between L3ESP and L4ESP
and the cytokine production profile in experimental infection
of rats with Anisakis simplex
Ju Hyeon Lee1, Haneul Nari Lee1, Sungae Cho2, Han-Gyum Kim3, Kyung-
Whan Joo4, Joon-Sang Lee4, Guan Gyu Song5, and Sung-Weon Cho4.
1Korea University Graduate School, Department of Microbiology and
Immunology, Seoul, Republic of Korea; 2Institute of Pasteur in Korea,
Tuberculosis Unit, Seoul, Republic of Korea; 3Korea University College of
Medicien, Department of Pathology, Seoul, Republic of Korea; 4Korea
University College of Medicine, Department of Parasitology, Seoul,
Republic of Korea; 5Korea University College of Medicien, Division of
Rheumatology, Internal Medicine, Seoul, Republic of Korea.
Background: Anisakis simplex is the marine parasite which belongs to
ascaroidea. This worm normally live within marine mammals, however
frequently induces allergy in the infection of mammals on land by third stage
larvae (L3) carried by marine fishes. When L3 infect mammals, these worms
develop into fourth stage larvae (L4). Each state larva produces different
excretory-secretory products (ESP) in main protein constituents. This
investigation compared ESP from L3 (L3ESP) with L4ESP in antigenicity
and allergenicity to develop on efficient method to diagnose the allergy by
L3, and analyzed cytokine profile in reinfection of L3, which is critical period
in allergy development.
Methods: The kinetics of specific antibody production of sera harvested from
rats infected by L3 was analyzed by indirect ELISA using either L3ESP
or L4ESP as antigen immobilized on ELISA plate. The cytokine kinetics of
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IL-4 and IFN-r was analyzed with rat sera harvested for 5weeks from
L3 reinfection.
Results: The kinetics of antibody production showed that specific antibody
level against L4ESP was higher in antigenicity than the level against L3ESP
in IgG1 IgG2b IgG2c and IgM, and very similar in IgG2a. However, the latter
had evidently higher allergenicity than the former in specific IgE level. In L3
reinfection sera, the level of IL-4 was relatively constantly maintained. In
contrast, that of IFN-Yj+ ; was decreased continuously.
Conclusion: These results indicated that L3ESP be better than L4ESP for
allergic state analysis and Th2 cytokine be comparatively dominant in
Anisakis simplex larva reinfection.
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Effects of jungle honey on immune functions
Miki Fukuda1, Kengo Kobayashi1, Yuriko Hirono1, Hisae Ishikawa1,
Emenike C Ejiogu2, Masaharu Sawai3, and Minoru Takeuchi1. 1Kyoto
Sangyo University, Biotechnology, Kyoto, Japan; 2Origins Japan Co. Ltd,
CEO, kyoto, Japan; 3TAKARA SHUZO Co. Ltd, Development, Kyoto, Japan.
Introduction: Jungle honey (JH) is collected from timber and blossom by
wild honey bees that live in the tropical forest of Nigeria. This is used on
traditional medicine for cold, skin inflammation and burn wound as well as
health care. However, the effect of Jungle honey on immunomodulatory
activity is not yet clearly. We have investigated the effect of Jungle honey on
immune system and anti-tumor activity in mice.
Methods: JH was provided by Nihon origins. JH was dissolved with
distilled water, and freezed dry, and then adjusted with PBS at each
concentration. JH was fractionized to Fraction (Fr.) 1, 2, 3, 4 and 5 by
HPLC size chromatography. Female C57BL/6 mice were injected with JH
at dose of 1mg/mouse/day, 7 times intra-peritoneal. After 7 times injections,
peritoneal cells (PC) were obtained by peritoneal lavage with PBS. Total
numbers of PC were counted with homocytometor. Cell differentials were
observed by microscope after Giemsa stain. Expressions of surface antigens
(CD3, CD11b, CD19, NK, and Gr-1) on PC were analyzed by FACS. H2O2
production of PC was assayed by FACS using DCFH-DA. Chemotactic
assay was analyzed by TAXIScanTM using neutrophils from peripheral
blood of human or guinea pig. IL-1$ mRNA expression of PC were
analyzed by RT-PCR. Anti-tumor activity was assayed by using Lewis Lung
Carcinoma/2.
Results: Total numbers of PC were increased in JH-injected mice compared
with control mice. In Dot Plot analysis by FACS, neutrophils were increased
in JH-injected mice. Percent of Gr-1 surface antigen positive cells and
intensity of Gr-1 antigen expression were also increased and H2O2 production
of PC was increased by JH. Chemotactic activity for Neutrophil from human
or guinea pig was expressed at concentration of 1, 5mg/ml or 1, 5, 10mg/ml of
JH. IL-1$ mRNA expression of PC was increased by JH or Fr.2. Molecular
weight of Fr.2 was approximately 261. Inhibitor of tumor growth was showed
by JH.
Conclusion: Chemotactic activity for neutrophils, increase of neutrophil
counts and H2O2 production of PC by JH may prevent bacterial and viral
infections.
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A case report of 11-month-old boy infant with Toxocara canis
eosinophilic meningitis
Nuntiya Pitaksit, Pantipa Chatchatee, and Jarungchit Ngamphaiboon. King
Chulalongkorn Memorial Hospital, Pediatrics, Bangkok, Thailand.
An 11-month-old boy infant was referred due to prolonged fever for 4
weeks, drowsiness and bulging at the anterior fontanelle. The clinical was no
response with high dose cefotaxime for 2 weeks that treated as bacterial
meningitis. Neurological examination revealed meningeal irritation and
bulging at the anterior fontanelle. Marked increase of absolute eosinophils
count (1,893/mm3) was presented. A lumbar puncture showed 270
leukocytes/microliters with 60% of eosinophils; protein 50 mg/dL; CSF
culture was no growth and negative PCR for TB. The immunoblotting assay
was positive for Toxocara canis in both serum and in CSF. The CT scan of
brain showed communicating hydrocephalus. The patient was close contact
with cats with poor sanitation. A diagnosis of eosinophilic meningitis due to
Toxocara canis was made and started treatment with albendazole 200mg oral
twice a day for 4 weeks, prednisolone 2 mg/kg/day and tape off within 8
weeks. The clinical was improved and discharged at 5 days after start both
medications. Follow up monthly for clinical symptom and monitored for
absolute eosinophil count. No abnormal neurological symptoms were
detected. The parents had got rid of the cats out of the household area.
Serum absolute eosinophil count and lumbar puncture results turn to normal
within 11 months after treatment. The serological follow up 8 weeks after
treatment for Toxocara canis was positive in both serum and in CSF by the
use of immunoblotting assay but decrease in intensity. He had normal growth
and development. Then long term follow up was done and aware for
reinfection in this patient. Reinvestigation for immunoblotting assay and
follow titer for Toxocara canis will be done.
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Activity of allium ascalonicum (shallot) and myrtus communis
extract as two novel antibacterial agents against acne vulgaris
Ahmad Farajzadeh Sheikh, Mohammad Ali Mashhdizade, and Mohammad
Radmanesh. School of Medicine, Jondishapor University of Medical
Sciences, Ahwaz, Iran, Microbiology, Ahwaz, Islamic Republic of Iran.
Background: Acne vulgaris is a common skin disease. Its etiology and
pathogenesis is not well known, and treatment is not satisfactory, therefore
study for novel drugs to replace to common drugs will be necessary.
Methods: From 136 patients who suffered from acne lesions, swabs were
obtained. Each swab was cultured on 2 blood agar plates and stored
aerobically and anaerobically condition. Sensitivity test from 2 herbal
extracts against bacterial isolations done by disk diffusion method, and were
compared with tetracycline disks.
Results: From 176 bacterial strains isolations, 113 (64.2%) Coagulase
Negative Staphylococci (CONS), 52 strains (29.5%) Propionibacteria spp., 7
strains(4%) Diphtheroids, 2 strains (1.13%) E. coli and 2 strains (1.13%)
Streptococci spp. were isolated. 53% of CONS and 10% of Propionibacter-
ium isolates were resistant to tetracycline, whereas only 8% of CONS
and14% of them was resistance to Shallot and Myrtus communis water
extract respectively. No Propionibacterium strains and only 4% of
Propionibacterium were resistant to shallot and Myrtus communis water
extract respectively. Also 11% of CONS Isolates were resistant to shallot
alcohol extract and 12% of them were resistant to the Myrtus communis
alcohol extract. Two percent of Propionibacterium strains were resistant to
shallot alcohol extract and 3% of them were resistant to the Mmyrtus
communis alcohol extract.
Conclusion: Our finding revealed that bacterial agents of acne vulgaris are
highly resistant to tetracycline and this antibiotic is not efficient for treatment
of the disease. It is suggest that these herbal extracts may have potential for
acne treatment.
365
Galactomannan antigen detection in the diagnosis of invasive
pulmonary aspergillus
Shokouh azam Sarrafzadeh1, Samineh Kamali1, and Davoud Mansouri2.
1Children Medical Center Hospital, Immunology Department, Tehran,
World Allergy Organization Journal & November 2007 Abstracts
* 2007 World Allergy Organization S115
Copyright @ 2007 World Allergy Organization. Unauthorized reproduction of this article is prohibited.
Islamic Republic of Iran; 2Division of Infectious Diseases and Clinical
Immunology, National Research Institute of Tuberculosis and Lu, Tehran,
Islamic Republic of Iran.
Objective: The invasive aspergillus occurs almost exclusively in immuno-
compromised host. Aspergillus fumigatus is now the leading cause of
infectious mortality in many hematology bone marrow and allograft
transplantation. Galactomannan is hetropolysaccharid present in the cell
wall of aspergillus species. A rapid and important method for invasive
aspergillus diagnostic could be the circulating galactomannan aspergillus
(GM) measurement in the serum and BAL (Bronchoalveolar lavage) samples
of the patients. The aim of this study was determined the value of
galactomannan detection in serum to diagnosis of invasive aspergillus.
Methods and Patients: Fifty three patients (with recurrent pulmonary
infection suspected to aspergillus) were included in our study group. None of
the selected patients had received any anti fungal therapy prior to the study.
Direct microscopy and fungal culture of BAL (Bronchoalveolar lavage) was
done and galactomannan estimation in serum and BAL were measured.
Results: 32 patients (960 %) were considered galactomannan test positive
from a total 53 cases (30 male and 23 female) and 28 of these patients were
isolated aspergillus in microscopy and culture.
Conclusion: The GM EIA assay had greater sensitivity than culture and
microcopy in detection of aspergillus spp in BAL fluid in experimentally
induced invasive pulmonary aspergillus. GM positivity also allowed the
anticipation of invasive aspergillus diagnosis (from 3 to30 day before
mycological culture).
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Revisiting the hygiene hypothesis: Cross-reactivity studies
between house dust mites and Ascaris lumbricoides
Gardette Valmonte1, and John Donnie Ramos2. 1University of Santo Tomas,
Philippines, Dept. of Biological Sciences, UST, Manila, Philippines;
2University of Santo Tomas, Dept. of Biological Sciences, College of
Science, Manila, Philippines.
Background: The causal relationship between allergy and ascariasis remains
a matter of controversy. Despite growing evidence for protective immunity
exerted by helminth infections against allergic diseases, the molecular and
immunological mechanisms involved needs to be elucidated. In this study,
cross-reactivity of allergens from house dust mites (HDM) Blomia tropicalis
(Blo t), Dermatophagoides pteronyssinus (Der p), and D. farinae (Der f) with
antigens from Ascaris lumbricoides (Asc l) was determined.
Methods: Enzyme-linked Immunosorbent Assay was performed to deter-
mine the allergenicity of HDM extracts and antigenicity of Asc l extracts to
allergic (n=100), ascariasis (n=60), and healthy control (n=100) patients.
Inhibition assays and Western blot analyses were done using positive sera
from allergic (n=15) and ascariasis (n=15). Specific IgE levels of allergic
(n=50) and ascariasis patients (n=50) to a recombinant paramyosin peptide
(Blo t 11-fD) was determined.
Results: The allergenicity of HDM extracts was significantly higher among
allergic patients (Blo t=81, Der p=72, and Der p=80% positive reactions)
than ascariasis patients (20, 20, and 28.3%, respectively) while the
antigenicity of Asc l extracts among allergic patients (70%) was
significantly lower than ascariasis patients (87%). Cross-inhibition assay
showed that Asc l antigens can inhibit up to 92% of the IgE reactivity of
allergic patients to HDM allergens while up to 54% of the IgE reactivity of
ascariasis patients to Asc l antigens was inhibited by HDM allergens.
Western blot analysis showed multiple sensitizations of allergic patients to
HDM allergens with molecular weights ranging from 14Y240 kDa and of
ascariasis patients to Asc l antigens ranging from 15Y250 kDa. Positive
reactions to rBlo t 11-fD was observed among allergic (80%) and ascariasis
(46%) patients.
Conclusion: Multiple cross-reactive antigens are present in HDM and Al
extracts and may play a role in the complex immunological relationship
between allergy and ascariasis. These antigens might share homology or
similarity in epitope recognition sites and must be identified in future studies.
The potential role of paramyosin as a specific cross-reactive allergen present
in HDMs and A. lumbricoides was described. These findings provide support
for the Hygiene Hypothesis and may serve as basis for novel forms of
treatment and diagnosis of allergic diseases and helminthic infections.
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Functional model of in vitro infection of murine macrophages
by F. tularensis LVS
Jakub Novosad, Martina Loudova, Monika Holicka, Manuela Kudlova, Jan
Krejsek, and Irena Krcmova. University hospital, Department of clinical
immunology and allergology, Hradec Kralove, Czech Republic.
Background: In this work, we focused on mutual interactions between
intracellular parasitic bacteria Francisella tularensis LVS and murine
macrophage-like cell line J774.2, particularly on immunobiological effect
of infection. We established a functional model of infection and stimulation
by murine interferon gamma (IFN,) and lipopolysaccharide (LPS). This
model allows us to define basic principles of pathogenesis of infection on
cellular level. We are able to define precausions of effective macrophage
activation leading to subsequent infection elimination.
Methods: We followed up the expression of specific macrophages surface
markers: CD 86, CD 54 (ICAM-1), CD 16/32 (FcgIII/IIR) and CD 25,
including specific isotypic controls. The phenotypic changes expressed as
mean fluorescence intensity (MFI) or percentage of positivity, respectively,
were evaluated by flow cytometry.Morphologic changes were documented by
immunofluorescence microscopy. Murine macrophage-like cells (J774.2)
were incubated in cultivation flasks (2x106 cells/10ml of medium Dulbecco’s
MEM with Glutamax-1 with 10% BSA). The cells were activated with 5,
10,50 ng of LPS per 1ml of medium or with 10, 100, 1 000, 10 000 I.U. of IFN,
per 1ml of medium respectively and infected by F. tularensis LVS with
multiplication of infection 1:100 in particular time schemes.
Results: Infection of F. tularensis does not result in any activation of host
cells, as seen from stable phenotype profile of infected cells in time. In
contrary, stimulation of J774.2 cells by IFN, or LPS results in predictable,
time and dose dependent phenotypic changes. The phenotype profile of IFN,
activated cells is characteristic. These cells display a harmonic increase in
CD86 and CD16/32 surface expression in time. In contrary, activation by LPS
results in isolated CD16/32 expression elevation without increase in CD86
expression. Moreover, prior F. tularensis infection of macrophages prevents
subsequent activation, especially by LPS.We demonstrate an essential role of
IFN, in infection control. Minimal concentration of IFN, resulting in active
infection elimination is 1000 IU/ml.
Conclusion: We assume, that F. tularensis infection is able to interfere with
intracellular signaling triggered especially by LPS, less significantly by IFN,.
This interference leads to immunosupression and seems to be the efficient
escape mechanism of F. tularensis.
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Effects of cigarette smoke exposure on immune functions in
alveolar macrophage
Kengo Kobayashi1, Yuriko Hirono1, Miki Fukuda1, Hisae Ishikawa1,
Hidetsugu Asada2, Osamu Mazda2, Sonoko Nagai3, Toru Takeuchi4, Kent
E. Pinkerton5, and Minoru Takeuchi1. 1Kyoto Sangyo University, Biotech-
nology, Kyoto, Japan; 2Kyoto Prefectural University, Microbiology, Kyoto,
Japan; 3Kyoto Central Clinic, Healthcare, Kyoto, Japan; 4Kagoshima
University, Environmental Medicine, Kyoto, Japan; 5University of California
Davis, Center for Health and the Environment, Davis, United States.
Purpose: Cigarette smoke is inhaled into lung. In the lung, AM are known to
play an important role in lung immune system. In previous studies, we
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reported the inhibition of antibody production by alveolar macrophages (AM)
from cigarette smoke (CS) exposed mice. However, the mechanism of
immune suppression by CS on AM functions is not clearly understood.
Therefore, we investigated effects of CS on phagocytosis and antibody
production, expression of surface antigens, IL-1$mRNA in AM associated
with immune functions.
Methods: Female C57BL/6 mice were exposed to 20 cigarettes /day during
10 days. After 10 days, AM were obtained by bronchoalveolar lavage
(BAL). Phagocytosis activity was analyzed by FACS using FITC labeled
seep red blood cell (SRBC). Expression of surface antigens (Class II, B7.1,
CD11b, CD16/32, CD14, TLR-2) on AM were analyzed by FACS. IL-
1$mRNA expression of AM was analyzed by RT-PCR. Antibody
production was analyzed by plaque forming cell (PFC) assay using SRBC
antigen.
Results: Phagocytosis of AM was significantly decreased in smoked mice
(SM) compared with non-smoked mice (NSM). Surface antigens positive
cells in AM were decreased in SM compared with NSM. IL-1$mRNA
expression of LPS non-stimulated AM was increased, while in case of LPS
stimulated AM was decreased in SM compared with NSM. Antibody
production was significantly decreased by AM at induction phase, but not
expression phase in SM compared with NSM.
Conclusion: These results suggest that the inhibition of antibody production
is caused by the inhibition of phagocytosis and expression of surface antigens
in AM. Such inhibition of AM functions may be increased the risk of bacterial
and virus infections.
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Analysis of signaling pathways involved in peptidoglycan-
induced RANTES production by murine Langerhans cells
Katsuhiko Matsui, and Akemi Nishikawa. Meiji Pharmaceutical University,
Department of Immunobiology, Tokyo, Japan.
Background: Atopic dermatitis (AD) is a chronic inflammatory skin disease
with immunopathologic features that vary depending on the duration of the
lesion. The lesional skin of AD patients shows an increased number of
eosinophils in the dermis and superficial Staphylococcus aureus colonization.
Our previous study showed that percutaneous application of peptidoglycan
(PEG) from S. aureus induced eosinophil infiltration in murine skin through
RANTES production by epidermal Langerhans cells (LCs). Although it is
well known that PEG is an agonist of Toll-like receptor (TLR)-2, it is unclear
whether other TLR agonists are able to induce RANTES production by LCs.
In this study, therefore, RANTES production by murine LCs in response to
different TLR stimuli, and the signaling pathways involved, were
investigated.
Methods: PEG was applied to barrier-disrupted abdominal skin of mice
every 5 days. Twenty days later, eosinophils in the abdominal skin were
detected. LCs were purified from epidermal cells by the panning method
using anti-IAd monoclonal antibody. RANTES production in the skin and by
the cultured LCs was investigated by RT-PCR, immunohistologic analysis
and ELISA. Analysis of the signaling pathways responsible for RANTES
production by LCs was performed by ELISA using N-acetyl-L-cysteine,
SP600125, PD98059 and SB203580, which are specific inhibitors of NF-e?B
activation, JNK, ERK and p38 MAPK, respectively, and was finally
confirmed by Western blot analysis.
Results: The results of RT-PCR and ELISA showed that PEG, poly(I:C),
LPS and CpG DNA, whose signals are transduced through TLR-2, TLR-3,
TLR-4 and TLR-9, respectively, strongly induced the production of
RANTES. Although treatment with an inhibitor of NF-e?B activation
inhibited PEG-, poly(I:C)-, LPS-and CpG DNA-induced RANTES produc-
tion, treatment with a JNK inhibitor did not inhibit CpG DNA-induced
RANTES production. Furthermore, treatment with a p38 MAPK inhibitor
affected only PEG-and LPS-induced RANTES production, and the inhibition
of RANTES production was correlated with that of p38 MAPK
phosphorylation.
Conclusion: These results suggest that the signaling pathways involved in
RANTES production by murine epidermal LCs in response to different TLR
stimuli are not necessarily the same, and that inhibition of p38 MAPKmay be
a more specific therapeutic strategy for eosinophilic inflammation in AD
patients with S. aureus colonization.
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Eczema herpeticatum recidivans
Andreas Wollenberg1, Maria Grichtmeier1, Margitta Worm2, Thomas
Werfel3, Ake Svensson4, Natalija Novak5, Dagmar Simon6, Peter Schmid-
Grendelmeier7, Ulf Darsow8, Matthias Augustin9, Jean-Francois Stalder10, and
Stefanie Kamann1. 1Ludwig Maximilian University, Dept. of Dermatology and
Allergy, Munich, Germany; 2Charite, Uni Berlin, Dept. of Dermatology, Berlin,
Germany; 3MH Hannover, Dept. of Dermatology, Hannover, Germany; 4Uni-
versity of Malmo¨, Dept. of Dermatology, malmo¨, Sweden;
5
University of Bonn,
Dept. of Dermatology, Bonn, Germany; 6University of Bern, Dept. of Der-
matology, Bern, Switzerland; 7University of Zurich, Dept. of Dermatology,
Zurich, Switzerland; 8Technical University Munich, Dept. of Dermatology and
Allergy, Munich, Germany; 9University of Hamburg, Dept. of Dermatology,
Hamburg, Germany; 10University of Nantes, Dept. of Dermatology, Nantes,
France.
Purpose: Eczema herpeticum (EH) is defined as disseminated Herpes simpelx
Virus (HSV) infection of an eczematous skin disease, which in clinical reality
is almost exclusively atopic dermatitis (AD). High serum IgE and early onset
of the underlying AD are established risk factors. Many patients have one
episode of EH only (EHP), whereas some patients suffer from securrent EH
(EHR). This multicenter study was performed to identify clinical risk factors
for EHR.
Methods: A total of 217 patients with a serum IgE of 3450 T 6821 kU/l and a
SCORAD of 44 T 18, diagnosed from 1996 to 2006 with EH, were included in
the analysis. Intrinsic AD was diagnosed in one patient only.
Results and Discussion: Herpes blisters were present within the eczematous
skin lesions only, indicating a need for clinically active AD lesions to develop
EH. The frequency of EHR (26%) was markedly higher than reported in pre-
vious decades, which demonstrates a change of the clinical disease spectrum.
The EHR patients showed a higher serum IgE, more eosinophils and an earlier
onset of the underlying AD as compared to EHP. In addition, they used steroid
ointment less frequently.
Conclusion: In conclusion, EHR patients exhibit the established risk factors
for EH (severe, uncontrolled AD) in a more pronounced manner and may be
described as being even Fmore atopic` than EHP patients.
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Shallomin, a novel antimicrobial agent against bacteria
and fungi
Mansour Amin1, and Balo P. Kapadnis2. 1*Dept. of Microbiology, School of
Medicine, Ahwaz Jondishapor University of Medical Sciences, Ahwaz, Iran,
Microbiology, Ahwaz, Islamic Republic of Iran; 2Pune university, Micro-
biology, Pune, India.
Background: Studies in past decade confirm that the growth of both gram
positive and gram negative bacteria, yeasts and mold can be inhibited by garlic,
onion, cinnamon, cloves, thyme, sage, and other spices. The Latin name for
shallot is Allium ascalonicum. Shallots belong to the lily family. The name
Allium is known to be derived from the Celtic word Allium (pungent), whereas
the name ascalonicum could either be derived from its original site of culti-
vation, Ascalon, an old Palestinian town, or from the French name Echalogne.
Methods: In this study the extract of shallot was extracted by organic solvents
and purified with help of column chromatography and TLC. The pure
compound was named shallomin. Antimicrobial activity of this compound was
tested against 23 strains including pathogen and non pathogen microbes using
modified E test and broth dilution technique.
Results: All fungi and bacteria tested were sensitive to shallomin. The MIC
values of shallomin for microorganisms tested ranged from 2Y10 6g/ml. fungi
were more sensitive than bacteria to this novel antimicrobial compound. MLC
values were slightly greater than MIC indicate cidal nature of antimicrobial at
low concentration.
Conclusion: Shallot is commonly used as a folklore medicine, and used to
cure earache, fever, antidote for snake venom and also as an aphrodisiac. In
this study antimicrobial properties of shallot were investigated for discovery of
a new antibiotic. Based on this shallomin can be an effective medicine for
treatment of dermatomycosis and other infectious diseases.
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Hydatid disease of the lung
Nemeth Agnes1, Banfi Andrea2, Peterffy Erzsebet2, Baktai Gyo¨rgy2, Kosa
Lajos2, Goschler Adam1, Kurti Sandor3, and Fekete Gyo¨rgy1. 1Semmelweis
University, Faculty of Medicine, 2nd Department of Pediatrics, Budapest,
Hungary; 2Pediatric Institute of "Svabhegy", Bronchological Department,
Budapest, Hungary; 3Hete´nyi Ge´za County Hospital, Pediatric Department,
Szolnok, Hungary.
: Human hydatid disease is caused by metacestode of Echinococcus
granulosis. Hydatid disease of the lung appears more frequently in childhood.
The infection may result in asymptomatic to severe disease which may be fatal.
The conventional treatment of hydatid disease is the surgical intervention.
Several reports proved that the patients who have widespread disease and no
surgical resection is possible, the medical treatment remains the only opor-
tunity. Percutaneous aspiration and treatment of hydatid cysts was believed to
be contraindicated due to anaphylaxis and spillage of scolices, however several
investigators have reported neither anaphylaxis nor dissemination. The authors
present a successful treatment in pulmonary hydatid disease with broncho-
scopic investigations combined with mabendazole/albendazole therapy. A nine
year old boy was admitted to a county hospital because of intense black vomit
without any severe disease in his previous medical history. He lost 8 kgs within
amonth and once he had bloody split earlier. Chest X-ray showed decreased left
side basal transparency. CT scan suggested a tumor and he was referred to the
2nd Department of Pediatrics of Semmelweis University. Laboratory data
indicated the possibility of lung infection and we started antibiotic therapy. The
patient improved after few days and bloody vomit was stopped. Repeated CT
scan did not prove any improvement and bronchoscopy was required. Cysts
were found in the samples removed in the course of bronchoscopy. Histological
and serological investigations confirmed the diagnosis of pulmonary hydatid
disease. Repeated bronchoscopy, lavage and 50 mg/ bwkg/day mabendazole
then 10 mg/bwkg/day albendazole therapy were continued. After 10 months of
combined therapy the patient is in good medical condition (he gained weight,
he regulary performs physical activities). Control bronchoscopy and CT scan
showed mild bronchiectasis on left side in the S6 segment. After one year from
the beginning of the hydatid disease the patient recovered nearly completely.
Conclusion: The authors demonstrated the safety and efficacy of combined
medical and bronchoscopic treatment in pulmonary hydatid disease.
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Prevalence and clinical characteristics of recurrent wheezing
infants in the south of Brazil
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Herberto Jose Chong Neto1, Nelson Rosario1, Dirceu Sole´2, and Javier
Mallol3. 1University of Parana, Pediatrics, Curitiba, Brazil; 2University of
Sao Paulo, Pediatrics, Sao Paulo, Brazil; 3University of Santiago, Pediatrics,
Santiago, Chile.
Background: There are a few data regarding recurrent wheezing in infants
around the world. The aim of study is to verify the prevalence of recurrent
wheezing in infants from south of Brazil.
Methods: This is a cross-sectional study. A standardized questionnaire was
applied to parents of infants with 12 to 15 months-old attending Health
Centers for regular immunization between August/2005 and December/2006.
This instrument was previously validated and had questions about clinical
characteristics, wheeze, respiratory infections and risk factors. Among 107
Immunization Centers 35 were randomly selected in order to maintain a
homogeneous selection of population sample.
Results: Three thousand and three parents answered the surveys. Fourty five
percent have had at least one wheezing episode in the first twelve months of
life, starting with 5.5 T 3.1 months of age, and 678 (22.6%) have had 3 or more
wheezing episodes. In this group, 84.6%, 18.5%, 24.3% and 5.4% have used
$2-agonists, inhaled steroids, oral steriods and antagonists of leukotriene
receptors, respectively. Night-time symptoms, breathless and emergency room
visits were as frequent as 58.9%, 46.2% and 57.6% in all of wheezing infants,
12.7% had hospitalization for asthma and in 10.9% asthma was diagnosed.
Night-time symptoms, emergency room visits, severe symptoms, asthma
hospitalization and diagnosis of asthmawere more frequently among wheezers
with equal or more than 3 episodes (p G 0.001).
Conclusion: The prevalence of recurrent wheezing in infants in the south of
Brazil is high, it start early and carriers on great morbidity. Infants possibly
represent a high number of persistent asthmatics.
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Pediatric asthma severity score BPASS^ and pulmonary score
BPS^ as clinical tools compared to others instrumental measures
in acute asthmatic children
Khaled Taman, Malak Shaheen, and Lammia Mokhtar. Ain Shams,
Pediatrics, Cairo, Egypt.
Background: International guidelines for treatment of acute asthma call for
measurement of peak expiratory flow rate (PEFR) or other objective tests of
pulmonary functions. Such measures, however, are frequently difficult to
obtain in young children and those unfamiliar with the technique of PEFR.
Therefore a variety of clinical scoring systems have been developed for
evaluating the severity of acute exacerbations of asthma in children.
Aim: To cmopare between both pediatric asthma severity score BPASS[ and
pulmonary score BPS[ as clinical tools to others instrumental measures as peak
flow meter, pulse oximetry and arterial blood gases for assessing the severity
of acute asthmatic attacks in children. Also, our aim to find if clinical
assessment tools are of value for rapid intervention in treatment of acute
asthma, compared to laboratory measurements.
Patients and Methods: These clinical study was done on 100 ashtmatic
children attending ERwith acute attacks of asthma. Their age ranged from5Y16
years during the period from January 2005 to January 2006. Clinical assessment
of severity was done by using both BPASS[ and BPS[. The results of assessment
were compared to BPEFR[, oxygen saturation and arterial blood gases.
Results: There was significant association between BPASS[ and BPEFR[
before treatment, 20 minutes and 24 hours after treatment.There was also
significant association between BPS[ and BPEFR[ before treatment, 20minutes
and 24 hours after treatment. There was significant association between
both BPASS[ and BPS[ scores and oxygen saturation, after 24 houres of
treatment.
Conclusion: BPASS^ and BPS^ are of clinical utility in assessing the severity
of asthmatic attacks especialy if the patiant is unable to use the peak flowmeter
or when pulse oximetry or the peak flow meter are not available.
Key words: Acute asthma, assessment, pediatric asthma severity score,
pulmonary score, peak flow meter, pulse oximetry, arterial blood gases
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Some clinical and immunologices characteristics at children
with the pathology of the biliary systems proceeding on the
background of allergic diseases
Shahla Rustamova, Sanubar Rustamova, and Aslan Qasanov. Azerbaijan State
Advanced Training Institute for Doctors, Department of Pediatrics, Baku,
Azerbaijan.
Background: To study features of immune infringements at children with a
pathology biliar systems proceeding on a background of allergic diseases.
Methods: Under supervision there were 36 children with bronchial asthma
(BA). To all children determined a level of general IgE, absolute quantity of
basofils in a peripheral blood.
Results: At all surveyed children deformations of a bilious bubble (S-
figurative, prezense of excesses in the field of a body, a bottom and cervix ) have
been revealed. Thus similar features of a structure of a bilious bubble frequently
were found out in parents of surveyed children. Clinical displays were
characterized by an abundance and polymorphism of complaints. The in-
cidental nausea and vomiting was observed at 21 % surveyed with BA.
Dispepsia frustration were observed at 7 %, locks at 28 %, meteorism at 10 %,
abdominal a painful syndrome at 18 % of surveyed children. At the majority of
patients complaints of vegetative character were marked. The increase of local
or general sweating was established in all the patients. Patients complaints of
undue fatigability, emotional lability, sleeplessness, headaches, dizzy. Disturb-
ance of thermoregulation manifested itself by chilling and fall in temperature
of distal parts of extremities. Significant meteotropism was discovered in
children with BA (46,4 %), that caused the aggravation of general condition in
change of weather. At children with the expressed clinical displays of a
pathology biliar systems the tendency to higher parameters of the general IgE
(514 T 303 IU/ml), than at children with asymptomatic current of illness (320 T
200 IU/ml) was marked. At 15 % of children IgE was within the limits of
norm. Correlation analyses between level of general IgE and quantity of
basofile showed the positive correlation r=+0.63. One of in children with the
level of general IgE in limit norms observed increasing quantity of basofiles
peripheral blood. May to suppose that in these children happen IgE-
independent degranulation fat cell, connected, possible, with breach of vege-
tative innervation.
Conclusion: Thus, the lead researches dictate necessity of more profound
inspection immunologices parameters at the given contingent of children.
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Prognostic importance of IgE for the evolution of recurrent
wheezing into the bronchial asthma in children
Svetlana Sciuca. State of Medical Univercity, Pediatry, Chisinau, Republic of
Moldova.
TABLE 1. Characteristics of the Control and Patients With CPCharacteristics
of wheezes
Q 3 episodes
n = 678 (%)
G 3 episodes
n = 682 (%)
Night-time symptoms (36,6) (22,3)
Emergency room visits (34,7) (22,9)
Severe symptoms (29,6) (16,7)
Hospitalization for asthma (8,6) (4,1)
Doctor asthma diagnosis (8,1) (2,8)
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: The recurrent wheezing associated with childhood can evaluate in the
bronchial asthma in 30Y70%.
Aim: The study was performed to determinate the potential forecast of IgE for
the development of the recurrent wheezing into the bronchial asthma.
Methods: 37 children ages 2Y4 years old with the recurrent wheezing were
included in the study. The study has been done as a part of the detailed medical
cheek up in the follow-up period 3Y5 years. We used the stepwise selection
Student (t) criterion of statistical analysis, coefficient of contingent (2), U-
Fisher (F) criterion for the selection of forecast parameters in the development
of asthma in childhood.
Results: The statistical discriminative BStepwise[ analysis identificated the
level of IgE a parameter with potential informative prognostic for selection the
children with risk of asthma. The prognosis of asthma_s risk in children with
hiperimmunoglobulinemia E (582,03 T 83,27 IU/ml) which have specificity
56,16%, sensitivity 62,96% and prognosis index 59,46%. The favorable evo-
lutionwith complete recovery of childrenwithwheezing is determinated by IgE
(pG0,01) more increased (391,75 T 54,47 IU/ml) and potential prognosis
77,78%. Knowledge of such bronchial asthma risk_s needs elaboration of a
program for effective measuring to prevent asthma in children with recurrent
wheezing.
Conclusion: The level of hiperimmunoglobulinemia E in child with recurrent
wheezing permits to prognosis the risk of the development of bronchial
asthma.
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Thalassotherapy (seaside-treatment) in allergic children
Jaroslava Simonickova, Gabriela Polakova, and Vit Petru. Na Homolce
Hospital, Ctr Allergol Clin Immunol, Prague, Czech Republic.
Background: It is generally held that a comprehensive therapy for allergic
children includes thalassotherapy, i.e. seaside treatment. We have attempted to
objectify the effect of this therapy in two groups of children: one with the
diagnosis of bronchial asthma, the other with atopic eczema.
Methods: The effect of a three weeks` seaside stay was evaluated in a group of
31 asthmatic children, compared to 23 asthmatic children in a control group.
The evaluation was based on the following criteria: change of activity score,
pulmonary functions, price of an anti-asthmatic pharmacotherapy, number of
school absences and parent questionnaires. In the second group, which in-
cluded 25 children with atopic eczema, the effect was evaluated on the basis of
the extent of skin affliction, intensity of the symptoms, SCORAD index and
parent questionnaires.
Results: In the group of asthmatic children, the score fell from 3.8 to 1.9 (with
no change in the control group). The difficulties became less frequent, dyspnea
on exertion was alleviated, drug consumption fell, school absences and the
price of anti-asthmatic therapy were reduced. Pulmonary functions remained
unchanged. In the group of eczematous children the extent of skin affliction fell
from an average of 8.68 % to 1.88 %. The score reflecting the intensity of
difficulties fell on average from 2.44 to 0.56 points with each child. The average
value of the SCORAD index in the whole group before treatment was 10.26,
after treatment 2.32. The changes of all evaluated parameters are of statistical
significance.
Conclusion: A three week therapeutic seaside treatment reduces the activity of
bronchial asthma and atopic eczema and markedly improves an allergic
patient`s quality of life.
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Ready-to-use HDM atopy patch test (APT) in the diagnosis of
sensitization to HDM in children
Christophe Dupont1, Pascale Soulaines1, Nathalie Donne2, Pierre Henri
Benhamou1, and Nicolas Kalach1. 1Hopital Saint Vincent de Paul, Pediatrics,
Paris, France; 2Dbv Technologies, Dbv Technologies, Boulogne Billancourt,
France.
Background: Sensitization to allergens derived from house dust mites (HDM)
is strongly associated with asthma, perennial rhinitis, and atopic dermatitis. Its
diagnosis is considered crucial in the allergic work up of these conditions. An
increasing number of reports demonstrate the accuracy of atopy patch test
(APT) in the diagnosis of HDM allergy.
Aim: The aim of this study was to assess the accuracy of a new ready-to-use
HDM atopy patch test (APT) (Diallertest\) in the diagnosis of sensitization to
HDM in children.
Methods: A prospective study was carried out in 47 children, age 57.4 T 42
(mean T SD, ranges 7-176mo), 18 girls. Patients exhibited isolated or combined
atopic dermatitis (AD) (n=28, 59.57%). Children were tested for specific
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HDM-IgE [against D. pteronyssinus (DPT) and D. farinae (DF)], and skin
testing based on HDM (DPT and DF) skin prick test (SPT) and ATP, using
HDM-Diallertest\)
Results: Among the 47 enrolled children, 15 cases (31.9 %) exhibited
sensitization with positive specific HMD-IgE titers against both DPT and DF
and 16 (34.04) and 17 (36.1 %) positive SPT against both DPT and DF
respectively. The HDM-Diallertest\ was positive in 16 (34.04 %). Among
these 16 positive HDM-Diallertest\), 9 exhibited an eczematous reaction and
showed an excellent concordance with DPT and DF-SPT and specific IgE
against DPT and DF, respectively 93.3%, 97.77%, 90.47% and 90.47%.
Conclusion: The 3 diagnostic techniques exhibited a comparable level of
accuracy for the diagnosis of HDM allergens sensitization. The excellent
concordance with other techniques of HDM-Diallertest\) with eczematous
reactions strongly supports its use as a reliable non invasive diagnostic tool of
HDM sensitization.
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Prevalence of asthma, allergic rinoconjunctivitis and atopic
dermatitis in the southwest of Mexico City, ISAAC model study
Alvaro Pedroza, Jose Huerta Lopez, Francisco Espinosa, Gabriela Trevino,
Francisco Rivas, Cintia Ramos, Nadia Ramirez, and Horacio del Olmo.
Instituto Nacional de Pediatria, Pediatric Allergy and Immunology, Mexico
City, Mexico.
Introduction: The allergic diseases are themost frequent chronic entities in the
childhood, through the time their prevalence has been increased in the last three
decades, that is why it was deasigned a task force called International Study of
Asthma and Allergy in Childhood (ISAAC) that promotes the epidemiological
researches in asthma and allergic diseases.
Objective: To approach the prevalence and severity of asthma, allergic
rhinoconjunctivitis and atopic dermatitis in children between 6 and 7 year and
13 and 14 year old in the southwest of Mexico City.
Methods and Materials: It is an observational, transversal, descriptive,
prospective study, it includes students of first and second grade of primary
school whit age of 6 and 7 year old and junior high school students from 13 to
14 year old. The study was authorized by the Public Education Institute, school
principal and parents. The statistical analysis was made by Epi info version 6
whit a significative value of p e 0.05.
Results: There were 58 schools enrolled, with 6184 students from wouthwest
of Mexico city, 32 primary schools with 3093, 1585 girls (51.24%) and 1508
boys (48.75); junior high schools included 3034 students and 26 schools with
1538 girls (50.69%) and 1496 boys (49.30%). In the scholastic population the
antecedent of only one wheezing episode was present in 20.43% (632) and the
proportion of patients with severe asthma was 6.7% (207), from this data only
4.3% (134) had asthma diagnosded, in the teenagers only 172 (5.66%) had
diagnostic. The severe rhinoconjunctivitis was present in 399 kids (25.99%)
and only 103 teenagers (11.26%). The major part of students, kids and
adolescents did not give correctly the information, about atopic dermatitis,
only 9 (0.29%) joined with pets (cats and dogs).
Discussion: Similar studies made around the world reveals that asthma and
allergic diseases are a public health problem, with implications in quality of
life, it may lead to temporal o permanent incapacity, if they are not diagnoses
and treated in early approach. The variation in the prevalence are expected
because various factors, the most important is the diversity of each zone about
risk factors, in fact the results can not be compared with a different population,
they can be used for the epidemiological knowledge of this zone.
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Bronchial asthma and child physical activity in Lithuania
Egle Vaitkaitiene. Kaunas Medical University Institute for Biomedical Re-
search, Social pediatrics, Kaunas, Lithuania.
: The background of the study. Prevalence of child asthma is 2-3 % in
Lithuania. Asthma is not only clinical, but social problem also. The aim of this
study was to evaluate physical activity and its limitation in asthmatic children.
The method used. The study group included children suffering from asthma
between the ages of 7 and 17. The severity of asthma was assessed by grading
the asthma as mild, moderate or severe. We used standardized and disease-
specific PAQL questionnaire (national version). Responses of 186 asthmatic
children were analyzed. The results obtaines. Only one third of our
respondents were involved in extra activity: sport, dancing and singing.
62.9 % of parents noticed that their children have no extra activity. 17,7% of
children with asthma were not attending sports at their school. We asked
childrens to name three activities, in which they had been bothered by asthma.
16,6 % of respondents indicated more than three daily activities, restricted by
asthma. Asthma for boys was the most disturbing while running (85.2%),
playing with pets (23.8%), playing ball (25%) and sleeping (26%). Girls
marked different activities, such as running (64%), housekeeping (46.9%) and
school sports (25%). Asthma bothered boys on the run and playing ball more
often than girls. Girls were bothered by asthma more often than boys when
doing chores and singing. Statistically significant differences were found
comparing all the three main activities for boys and girls: the first activity -
2= 44.9, df = 15, p G 0.001; the second activity - 2 = 42.8, df = 26,
p = 0.02; the third activity - 2 = 47.9, df = 23, p = 0.002. The conclusion
reached. Asthma is a limiting factor in the childrenFs level of physical activity.
It prevents children from doing various activities. Due to asthma, children were
not able to run, play ball, do their chores, play with their pets. Boys more often
complained thet asthma had limited their physical activity (running, playing
games), whereas girls indicated that the disease had limited both, their physical
activity (such as running) as well as passive activities (such as doing chores, in
addition to dancing and singing).
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Analysis of allergen-specific serum IgE in children with asthma
or cough variant asthma
Xin Song, and Jing Zhao. Capital Institute of Pediatrics, asthma center,
Beijing, China.
Objective: To investigate the positive rates of food allergen (Fx5), mixed
molds (mx1), phadiatop and house dust mites (d1) allergen-specific serum IgE
(sIgE) in children aging from 6 months to 16 years diagnosed of asthma or
cough variant asthma (CVA). Their age distribution characteristics were also
compared and analyzed.
Methods: Blood samples of 597 asthmatic children were applied to fx5, mx1,
Phadiatop and d1 tests using fluoroenzyme-immunometricassay, UniCAP100.
The positive rate of fx5,mx1,Phadiatop and d1 were compared. Age
distribution characteristics of children with positive SIgE were analyzed.
Results: 1, The positive rate of fx5, mx1, Phadiatop and d1 were 34.6%, 30.%,
35.2% and 23.5% respectively; 2, The highest positive rate of Phadiatop and d1
were highest in children of 8-16 age group (73.6% and 49.1%); The positive
rate of fx5,mx1 peaked in children of 2 years and 5 years separately(44.1% and
53.6%); 3, Among 181 children with mx1 positivity 90 cases manifested
phadiatop negativity. 4, 65% of children with clinically diagnosed asthma or
CVA presented positivity in test in fx5,mx1 or phadiatop at least.
Conclusion: Two-thirds asthma and CVA patients existing sIgE; Asthmatic
infants mainly manifested food allergen sensitization. The positive of Pha-
diatop increased with age. Positivity of mx1 increased with age in
children e 5 years , and it decreased in older children (Q 6 years). Mx1 was
one of the main allergens of asthmatic children.
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An observational study on the effectiveness of montelukast in
children with chronic rhinitis
Thidarat Pongsiripipat, Pantipa Chatchatee, and Jarungchit Ngamphaiboon.
Chulalongkorn University, Department of Pediatrics, Bangkok, Thailand.
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Background: Impacts of chronic rhinitis in children especially nasal con-
gestion included learning disorder, impaired school performance and quality of
life. Intranasal corticosteroid is the most effective medication for chronic
rhinitis treatment. Recently, leukotriene receptor antagonist has been added to
the modes of therapy approved by the US Food and Drug Administration of
allergic rhinitis.
Objective: To assess the effectiveness of add-on montelukast with intranasal
corticosteroid in children with chronic and persistent rhinitis.
Methods: We enrolled children attending the allergy clinic, Department of
Pediatrics, Faculty of Medicine, Chulalongkorn University, with poorly con-
trolled rhinitis during the period of April, 2005 to December, 2006. Diagnosis
of allergic rhinitis was made by positive prick skin test to at least one aero-
allergen. Intranasal corticosteroid was the first-line medication for treatment of
persistent symptoms. Montelukast was added in cases that no response to
intranasal corticosteroid, mostly due to nasal congestion. Efficacy was assessed
by symptom improvement (nasal congestion, rhinorrhea, itching, sneezing)
reported by patients and physical examination by allergist.
Results: There were 10 boys and 16 girls (average age 13). The mean duration
of symptom before diagnosis was 4.7 years. Twelve children were diagnosed to
be allergic rhinitis and 14 children were non-allergic rhinitis by prick skin
testing. The mean duration of intranasal steroid use was 4.4 year in children
with allergic rhinitis and 2.7 years in children with non-allergic rhinitis.
Symptom improvement, especially nasal congestion, was reported in 8 of 12
(66.6%) allergic rhinitis subjects and 11 of 14 (78.5%) non-allergic rhinitis
subjects after add-on 10 mg of montelukast daily. Montelukast was overall well
tolerated. Mean duration of montelukast therapy was 1.7 years in both groups.
Intranasal corticosteroid was able to stop in 8 of 14 (57%) children with non-
allergic rhinitis and unable to stop in all children with allergic rhinitis, but all
of the patients were satisfied with these treatment.
Conclusion: Montelukast have an advantage in additional treatment of either
allergic or non-allergic rhinitis children, but particularly more benefit on
children with non-allergic rhinitis.
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Sputum eosinophils in childhood asthma: Correlation with
PEFR in controlled asthmatics and with exacerbation
Maria Cristina Edquilag, and Agnes Andaya. University of Santo Tomas
Hospital, Department of Pediatrics, Section of Allergy, Manila, Philippines.
Background: Sputum eosinophilia is a non-invasive airway inflammatory
marker. Airway inflammation which is the characteristic functional abnorm-
ality peculiar of asthma, leads to variable airflow limitation. Significant
correlation between PEFR and absolute eosinophil counts have been observed
among patients with asthma. However, these studies are limited and others
show conflicting results.
Objective: To determine the correlation between sputum eosinophilia and
PEFR among patients with asthma.
Methodology: Following clinical assessment and peak flow determination,
sputum eosinophil count was determined among patients with stable asthma
(29) and acute exacerbation (36). Patients were classified as to intermittent and
persistent asthmatics. Age, sex, atopic status and asthma duration were
obtained. Sputum eosinophil count of = 3% was considered significant.
Results: Patientswith sputum eosinophilia had lower PEFR, compared to those
without sputum eosinophilia (p = 0.004). Patients with sputum eosinophilia
were more likely to have abnormal PEFR compared to thosewith normal PEFR
(OR = 6.64, 95% CI = 2.02-21.90). Patients with persistent asthma were
more likely to have sputum eosinophilia compared to those with intermittent
asthma (OR = 3.06, 95% CI = 1.02Y9.18). Similarly, patients in acute
exacerbation were more likely to have sputum eosinophilia compared to
those with stable asthma (OR = 3.42, 95% CI = 1.07Y11.04).
Conclusion: This study demonstrates that there is a direct correlation between
sputum eosinophilia and PEFR among patients with acute exacerbation.
However, no correlation could be made among patients with stable asthma
since all patients had normal PEFR.
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Serum levels of VEGF, TGF$2, IL-4, IL-2R and ECP in children
with acute astma bronchiolitis
Kadir Kocak1, Bilal Yildiz2, Yesim Kural2, and Omer Colak3. 1Eskisehir
Osmangazi University, Faculty of Medicine, Pediatric Allergy, Eskisehir,
Turkey; 2Eskisehir Osmangazi University, Faculty of Medicine, Pediatrics,
Eskisehir, Turkey; 3Eskisehir Osmangazi University, Faculty of Medicine,
Biochemistry, Eskisehir, Turkey.
Background: Asthma is leading cause of chronic illness with increased
vascularity, vascular permeability, airway and lung tissue remodeling. Al-
though, various growth factors and cytokines have been implicated in modu-
lating in these processes, the role of factors and cytokines are not known very
well in asthmatic children. Aim of this study is to determine the serum levels
of vascular endothelial growth factor (VEGF), transforming growth factor beta-
2 (TGF$2), interleukin-4 (IL-4), interleukin-2-receptor (IL-2R), and eosino-
philic cationic protein (ECP) in acute astmatic children (AAC) and compare
with acute bronchiolitis and healthy subjects and to assess the changes with
treatment.
Methods: These parameters were measured by ELISA techniques in AAC and
bronchiolitis patients before and after inhaled or systemic steroid (SS).
Results: Serum VEGF, TGF$2, IL-4 and IL-2R levels were increased in
patients with AAC and bronchiolitis than in controls before therapy. These
parameters were higher in AAC than bronchiolitis except IL-2R (Table-I).








VEGF (before treatment) 469,7 T 117,8 145,9 T 56,1 870,75 T 496,5 210,3 T 50,5 p1, 2, 3 G 0, 0001
IL2R (before treatment) 2663,3 T 829,6 904,6 T 178,2 2458,2 T 851,80254 909,6 T 196,9 p4, 5 G 0,0001, p6 9 0, 05
IL4 (before treatment) 15,0 T 3,7 5,3 T 3,2 28,6 T 8,9 4,3 T 3,0 p7, 8, 9 G 0, 0001
TGFB (before treatment) 8661,4 T 2384,5 3220,7 T 1556,7 18573,2 T 8862,7 3434,3 T 1638,5 p10, 11, 12 G 0, 0001
ECP (before treatment) 16,9 T 5,2 5, 2043 T 2, 6 55,6 T 23,0 4,6 T 2,2 p12, 13, 14 G 0, 0001
VEGF (after treatment) 257,5 T 100,7 145,9 T 56,1 366,1 T 268,2 210,3 T 50,5 p15 G 0, 05, p16,
17 G 0, 0001
IL2R (after treatment) 2020,6 T 790,9 904,6 T 178,2 1272,9 T 515,9 909,6 T 196,9 p19 G 0, 0001, p20 G 0, 05,
p21 G 0,0001
IL4 (after treatment) 2, 2T 1,8 5,3 T 3,2 6,8 T 4,8 4,3T3,0 p22 G 0, 0001, p23 G 0, 05,
p24 G 0,0001
ECP (after treatment) 7,8 T 4,0 5,2 T 2,6 23,1 T 14,9 4,6 T 2,2 p25 G 0, 05, p26 G 0, 0001,
p27 G 0, 0001
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Serum VEGF, IL-2R and ECP levels were higher in AAC than in controls after
treatment. After steroid therapy, VEGF, IL-4 and ECP levels were higher in
AAC than in bronchiolitis but IL-2R levels were higher in patients with
bronchiolitis. Only serum IL-4 levels in bronchiolitis were similar with
controls after treatment. By the severity of disease, only VEGF levels were
increased in modarate AAC and bronchiolitis higher than in mild patients
(p G 0,0001). Only VEGF levels were lower in AAC who were treated with
prophylactic drugs than in AAC without prophylactic treatment (p G 0,05).
According to modality of steroid treatment, only VEGF levels were lower in
AAC whowere treated with inhaled steroids compared with SS(p G 0,001). In
AAC; VEGF, IL-4, IL-2R and ECP levels were higher than in controls after
treatment with SS (p G 0,0001). But in AAC who were treated with inhaled
steroids, VEGF and IL-4 levels were similar with controls after treatment
(p 9 0,05).
Conclusion: VEGF, TGF$2, IL-4 and IL-2R may play role in pathogenesis of
asthma and bronchiolitis. These parameters aren’t useful for distinguishing
asthma and bronchiolitis. VEGF could be useful parameter for distinguishing
mild and moderate disease in asthma and bronchiolitis. According to our
findings, inhaled and SS could be combined for appropriate treatment in
moderate AAC. Also, anti-VEGF therapy may be useful in AAC.
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Effect of self-management education on asthma complication
and pulmonary function in Iranian children with asthma
Maryam Afrasiabi1, Efatalsadat Marvasti2, Najaf Zare2, Marzieh Orooj3, and
Sara Kashef4. 1Social Security Organization, abstract department, Shiraz,
Islamic Republic of Iran; 2Shiraz University of Medical Sciences, Abstract
Department, Shiraz, Islamic Republic of Iran; 3Motahari Clinic, abstract
department, Shiraz, Islamic Republic of Iran; 4Professor of Pediatrics, Division
of Immunology and Allergy, Allergy Research Center, Shiraz University of
Medical Sciences, abstract department, Shiraz, Islamic Republic of Iran.
Background: Despite global efforts to manage asthma, the adverse outcome of
this disease is increasing. Effective self-management and treatment compliance
is important in achieving good symptom control in asthma. The aim of this
study was to determine whether asthma nurse intervention during clinical
period could increase knowledge and improve self-management and whether
this would influence the frequency and severity of symptoms, and pulmonary
function test.
Setting: A university hospital pediatric outpatient clinic.
Methods: Randomized controlled trial of 60 children with intermittent and
mild to moderate persistent asthma were assessed to indicate whether the
educational self-management intervention would improve lung function and
the use of inhaler with spacer score, increase feeling of control over asthma, and
decrease the use of health care services. 60 children with asthma, who were
categorized based on disease severity, duration of disease, age were randomly
assigned to an experimental group (n=30) which received an educational
program or to a comparison group (n=30) which received common education.
The education program consisted of 4 group sessions which focused on
improving the patients and parents’ self-management skills. The follow-up
continued for 4 months. Results: At follow-up, most indicators of the use of
MDI and spacer score and asthma control test had improved significantly
(p G 0.005) among educated patients. Also cough decreased significantly in the
intervention group (p G 0.005). The pulmonary function test did not show
increase in FEV1/FVC after this period, it was not statistically significant as
compared to the control group.
Conclusion: The nursing educational intervention for children with asthma
and their parents effectively improved inhaler use skills and decreased cough
and ER visits in this group of patients. Regarding the insignificant changes in
FEV1/FVC, it should be considered that pulmonary function test is not already
seriously affected in the group of intermittent and mild to moderate persistent
asthma. Further studies including severe asthma patients and longer periods of
follow up are warranted.
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Toxocarosis in the background of chronic cough in childhood:
a longitudinal study in Hungary
Olga Bede1, Zsuzsanna Sze´na´si2, Ka´lma´n Gyurkovits3, and Do´ra Nagy1.
1Albert Szent-Gyo¨rgyi Medical and Pharmaceutical Center, Department of
Pediatrics, Szeged, Hungary; 2eJohan Be´la` National Center for Epidemiol-
ogy, Department of Parasitology, Budapest, Hungary; 3County Hospital for
Chest Diseases, Department of Pediatrics, Mosdo´s, Hungary.
Background: Chronic cough lasting 8 weeks or more often seems an
intractable problem in childhood. Toxocara infestation is associated with an
increased prevalence of airway symptoms and may be the possible etiologic
agent of chronic cough.
Methods: Spirometry, bronchial reversibility tests and nonspecific bronchus
provocation testswere carried out in patientswho could cooperate in these tests.
Measurements were made of the peripheral blood eosinophil count, the serum
total IgE level, the serum total magnesium (Mg) concentration. The serological
examination for Toxocara canis, based on the most widely used enzyme-linked
immunosorbent assay of IgG (Toxocara canis IgG ELISA, Novatec, Germany)
and more sensitive Western blotting (Toxocara Western Blot IgG, LDBIO,
France) methods, was performed. All patients with positive serology for
T. canis index of positivity 9 9 were treated with albendazole in a dose of
10 mg/kg/day, patients weighing 9 40 kg received 400 mg albendazole a day
for 7 days. All patients with bronchial asthma and CVA were treated with
inhaled corticosteroid (ICS). Further, short-term beta2-mimetics could be
administered in cases of dyspnoea Bas needed^.
Results: One-hundred and thirty-six of 425 children (32%) aged 2Y17 years
were seropositive for T. canis antigens. Ninety-three children were adequately
assessed, diagnosed and followed up during 1 year. Bronchial asthma was
diagnosed in 40%, cough variant asthma (CVA) in 27% and nonasthmatic
eosinophilic bronchitis (NAEB) in 33% of children with chronic cough. The
eosinophil cell count, the Toxocara canis IgG, the total IgE levels and the total
Mg concentrations in the serum are predictors of the improvement or the
decline of the patients` condition. We could significantly decrease the dose of
ICS in 23 of 37 (62%) children with bronchial asthma. Anthelminthics and
avoidance were sufficient for children with NAEB; none needed ICS. ICS
therapy could be stopped 2-3 months later in 17 (68%) of 25 patients with
CVA. We found that 8 of 25 patients with CVA (32%) presented asthmatic
symptoms at the end of the 1-year period.
Conclusion: In Hungary, T. canis may be the potential sensitizer for chronic
cough in seropositive children. Deworming therapy will then alleviate the
airway symptoms without exacerbation in patients with bronchial asthma, and
definitively treat children with NAEB and the majority of children with CVA.
388
Peak inspiratory flow rate via incheck-dial \ in children
with asthma
Wiparat Manuyakorn1, Chalerat Direkwattanachai1, Suwat Benjaponpitak1,
WasuKamchaisatian1,CherapatSasisakulporn2,andWallapaTeaesomboonkit1.
1Ramathibodi Hospital, Department of Pediatrics, Bangkok, Thailand;
2Ramathibodi Hospital, Research Center, Bangkok, Thailand.
Background: The detrimental effect of chlorofluorocarbon on the ozone layer
has resulted in the prohibiting of CFC-containing medication usage. Dry
powder inhaler (DPI) devices are alternative devices to deliver medication for
treatment of asthma. Drug delivery and lung deposition from DPI are
dependent on the peak inspiraory flow rate (PIFR).
Methods: Using PIFR meter (Incheck-dial) that mimics the internal resistance
of commonly use DPI devices one high-resistance(Turbuhaler) and two low-
resistance (Accuhaler and Easyhaler) determined the PIFR generated by
asthmatic children aged 5-18 years through each of them. Pulmonary function
was measured by using spirometry.
Results: 252 asthmatic children were studied, 169(67%) children were male.
The mean age was 10.58 + 2.97 years. The mean FEV1 (% of predicted) was
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80.30 + 10.91. The mean PIFR with the internal resistant of turbuhaler,
accuhaler and easyhaler was 85.11 + 14.84 L/min, 103.01+16.01 L/min, and
114.72+11.74 L/min, respectively. PIFR was statistically significant correla-
tions with age, body weight and height (p value G0.001). All children could
generated PIFRmore than 30 L/min in both accuhaler and easyhaler resistance.
8(3.17%) children were unable to generate PIFR more than 60 L/min in
turbuhaler resistance. There were no significant correlations of FEV1 (%of
predicted), FEV1/FVC% or FEF25-75 with PIFR.
Conclusion: Most children aged at least 5 year can generate enough PIFR for
using DPI devices especially in low-resistance devices.
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IgE level, CD26, CD30 expression and intracellular interferon-,
production by cord blood mononuclear cells as predictors of
atopic dermatitis forming in infants: a one-year prospective birth
cohort study
Sergey Tereshchenko1, Viktor Prokhorenkov2, Ivan Novitzkiy1, Igor
Olkhovsky1, Nataliya Shakina1, Igor Isakov1, and Lyudmila Vasilieva1. 1Medi-
cal Research Institute for Northern Problems, Russian Academy of Medical
Sciences, Krasnoyarsk, Russian Federation;
2
Krasnoyarsk State Medical
Academy, Russian Ministry of Education, Krasnoyarsk, Russian Federation.
: It is supposed that prenatal Th1/Th2 polarization of immune response
is possible, but the markers of such polarization, trustworthy associated with
atopy forming are not known.
Aim: To evaluate the connection between IgE level, CD26, CD30 expression
and intracellular interferon (IFN)-, production by cord blood mononuclear
cells (CBMC) and the risk of infant atopic dermatitis (AD) forming.
Methods: We defined per cent content of CD26+and CD30+in CBMC by
using flow cytometry as well as the concentration of total IgE in 117 full-term
newborns. Simultaneously, intracellular IFN-, expression as well as early
activation marker CD69 (separate for total mononuclear cells population and
CD4+lymphocytes) were examined (95 newborns). We estimated AD
presence in 41 enrolled newborns in the age of one year (medically diagnosed
AD was marked in 25 of them). Data are shown as median (25-75% quartiles)
of absolute cells count (10(-)6/l). Statistical analysis was performed using the
Mann-Whitney test. Relative Risk (RR) was present with 95% CI.
Results: Only for nonactivated CBMC, producing IFN-, (subtype CD69-/
IFN-,+), the association with AD forming has been found. The number of
CD69-/IFN-,+CBMC in AD infants was 3.3 (0-6.4), as opposed to infants
without AD -9.4 (5.3-16.5), p = 0.006. Relative risk for AD forming in
newborns with low CD69-/IFN-,+( G 5.0 - median for our cohort) was 3.4
(1.19-9.69). Significant differences in the number of CD69-/IFN-,+CBMC
was kept after adjusting to such factors as family atopic history, place of living
(city/village), birth order (first/second or later), the number of family members
living together, bedsharing smoking, pets owing and the newborn gender.We
revealed the negative concentration of total IgE in cord blood with the ratio
CD26+/CD30+CBMC (r = j0.37, p = 0.0005). We did not find any
association of CD26, CD30 expression, the CD26/CD30 ratio, as well as
the level of total IgE with AD forming in infants (medians were chosen as cut
off points). RRs were 1.5 (0.67-3.33), 0.67 (0.37-1.19), 0.78 (0.42-1.45) and
1.24 (0.59-2.61), respectively.
Conclusion: Thus, the decreasing of intracellular IFN-, production by
nonactivated CBMC, proving the prenatal displacement in Th1/Th2 balance, is
the strong predictor of infant AD forming. However, the decreasing of CD26/
CD30 ratio as well as the level of total IgE in cord blood are not the predictors
of atopic phenotype forming in infants.
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Sputum eosinophil level in children with mild, moderate to
severe exacerbation and stable asthma
Maria Cristina Edquilag, and Agnes Andaya. University of Santo Tomas
Hospital, Department of Pediatrics, Section of Allergy, Manila, Philippines.
Background: Sputum eosinophilia is a non-invasive marker in the evaluation
of airway inflammation as well as asthma control. Increased proportion of
sputum eosinophils have been observed among subjects with asthma,
especially among those with exacerbation. However, there are also studies
that show airway eosinophilia among patients with controlled asthma.
Objective: To determine sputum eosinophil level among asthmatic patients in
exacerbation and those with stable asthma and determine its association with
severity of disease.
Methodology: Following clinical assessment and peak flow determination,
sputum eosinophil level was determined among patients with stable asthma
(n = 29), mild (n = 18) and moderate to severe (n = 18) asthma exacerbation.
Age, sex, atopic status, asthma duration and medications were obtained.
Sputum eosinophil count of Q 3% was considered significant.
Results: The mean eosinophil count in children with stable asthma, mild
exacerbation and moderate to severe exacerbation were 4.65% T 12.53%,
1.94% T 4.30%, and 8.83% T 11.12% respectively. Sputum eosinophils were
significantly higher in children with moderate to severe exacerbation than in
mild exacerbation and stable asthma (p = 0.0086). The percentage of patients
with significant sputum eosinophilia was higher among those with moderate to
severe exacerbation (17%) than mild exacerbation (6%) and stable asthma
(8%). Statistically significant difference was seen among the three population
(p = 0.0234). Logistic regressions showed that wheezing (p = G 0.0001), peak
expiratory flow rate (p = 0.0010), sex (p = 0.0110) and asthma duration
(0.0232) were significantly associated with sputum eosinophilia (p = 0.432).
No statistically significant difference was seen with respect to long term
asthma severity classification (p = 0.432).
Conclusion: This study demonstrates that significant sputum eosinophilia is
seen among patients with moderate to severe asthma exacerbation compared to
those with mild exacerbation and stable asthma. Sputum eosinophilia was also
significantly associated with wheezing, lower peak expiratory flow rate, male
sex and longer asthma duration. Long-term asthma severity is not a defining
factor in the evaluation of sputum eosinophilia among asthmatics but the
severity of exacerbation.
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Allergy in children: managing patients at risk of anaphylaxis
Srinivas Bandi1, and Colin MacDougall2. 1Birmingham Heartlands Hospital,
Paediatrics, Birmingham, United Kingdom; 2University Hospital, Paedia-
trics, Coventry, United Kingdom.
Aim: To report the management of children with allergy in a district general
hospital, in particular to review prescribing practices of epinephrine auto
injectors (Epipen) and to compare the management of children seen in allergy
clinic with those seen in general paediatric clinic.
Methods: The clinical records of all children who were prescribed Epipen
or Epipen junior between November 2003 and October 2005 were retro-
spectively reviewed. 39 patients were included of which 23 were seen in
allergy clinic and 16 were seen in general paediatric clinics. There ages ranged
between 6 months to 17 years (median of 7 years).
Results: The common allergens were Nuts/seeds (79%) followed by egg
(23%), milk (18%) and fish (8%). 15 children had positive skin prick tests and
18 had positive RAST (total 33/39 had positive tests). Information on
treatment with Epipen was provided to 22/23(95%) children seen in allergy
clinic compared to 10/16 (62%) children seen in general clinics. Practical
instruction of Epipen administration was provided to 21/23(91%) compared to
Allergy Clinic General paediatric clinic
Allergen avoidance 82.6% 81.2%
Epipen information 95% 62%
Epipen Training 91% 75%
Information on
antihistamine use 91% 68%
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12/16(75%) children seen in general clinics. Information on treatment with
antihistamines was provided to 21/23(91%) children in allergy clinic
compared to 11/16(68%) in general clinics. Information on allergen avoidance
scored equally in allergy clinic (82.6%) and general clinics (81.2%).
Conclusion: This case series demonstrates that children managed in allergy
clinic are better informed about their allergies and management compared to
those managed in general paediatric clinics.
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Metabolic responses to treatment with salbutamol and
theophylline in asthmatic children
Mohammed Ragab. Alexandria University, Faculty of medicine, Alexandria,
Egypt.
: Drug therapy and its abuse have been incriminated as a main con-
tributive factor in asthma mortality. The effect of treating asthmatic with sal-
butamol inhalation (0.15 mg/kg body weight up to 5 mg/dose, group A),
theophylline (5mg/kg body weight, group C) or both drugs (group B) was
investigated in 30 asthmatic children. Ten healthy children of matching age and
sex were also included to serve as control. Serum glucose increased signif-
icantly in group A and B, but did not change significantly in group C as a
compared to pretreatment level. Serum inorganic phosphate decreased sig-
nificantly in group B and C, with no significant change in group A. serum
sodium level was significantly decreased an all asthmatic children before treat-
ment. Group B and c showed significant reduction in serum sodium level as
compared to pretreatment values. Serum sodium level did not change signi-
ficantly in group A. Serum potassium decreased significantly in the three
studied groups as compared to pretreatment values. These metabolic changes
could possibly help in explaining the observed increase in cases of fatal asthma,
when using a combination of inhaled beta-agonist and oral theophylline
preparation.
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Multymeasuring phenotyping and automated prevention system
of Bronchial asthma in children
Rusudan Karseladze1, Liana Jorjoliani2, Ekaterine Karseladze3, and Lali
Saginadze1. 1Tbilisi State University, Pediatric Department, Tbilisi, Georgia;
2Institute of Pediatrics, Allergy and Clinical Immunology, Tbilisi, Georgia;
3Tbilisi State University, Stomatology Department, Tbilisi, Georgia.
Background: Prevention in early age period significantly decreases morbidity
of allergic diseases and improve quality of life. Sometimes doctors are unable to
manage well this pathology, because of neglected early diagnostic. According
to the most actual and perspective direction of nowadays allergology it is
working out new scientific approach of resolution of bronchial asthma (BA)
problems in young population. Hereditary predisposition plays the most
important role in the developing of disease, but it is not everything recog-
nizable, it may be not demonstrated clinical symptoms in parents and other
close relatives of affected individual.
Aim: To elaborate the new automated assessment cost-effective system
which would allow early diagnostic and prevention BA by using
Bformalized cards^ by providing multymesure phenotyping in Georgian
children population. This system is based on the primary and secondary
prognosis of BA.
Methods: Choosing of markers: HLA-markers (Terrasaki micro lymphocy-
tetoxic tests) typing was performed with 2nd class (DR, DQ) and 1st class (A,
B, C) antigens locus`s; Erythrocyte markers: ABO, Rhesus and MNS systems,
Clinical-genealogic method (Falconer D., 1965): study of genealogical tree of
investigated families; Genetic- statistic analysis Y Informative Criteria of
different signs: ontogeny, phenotypic, environmental factors (by Kulback,
Goubler E.B, 1990). Method of multi-dimensional phenotyping: agglomera-
tive-hierarchical cluster analyse of chosen systems of signs. Analyse was
performed in the interactive order.
Results: Multi-dimensional phenotyping shoves phenotype classes: Classes of
basic predisposition, including up to 80% of individuals with manifested
asthma; Classes of relative predisposition, including less then 80% of indi-
viduals with manifested asthma; Phenotype classes including a few patients;
Phenotype classes not predisposed to BA, basically including healthy persons.
Conclusion: Elaborated computing table is enough simple and opportune for
comprehensive use. It is proposed, for primary prognostic of BA, to practical
doctors working in outpatient clinics and dispensaries, as well for military
doctors working with enlistment committee or in military units. This method
gives the possibility for prognosis predisposition to bronchial asthma in young
population.
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TBXA2R gene polymorphism and its pharmacogenetic effect to
leukotriene receptor antagonist in children with asthma
Ja-HyeongKim1, So-Yeon Lee2, Hyo-BinKim3, Hyun-Seung Jin4, Jin-HoYu4,
Byoung-Ju Kim4, Bong-Seong Kim5, Mi-Jin Kang6, Seong-Ok Jang6, and
Soo-Jong Hong4. 1Ulsan University Hospital, Department of Pediatrics,
Ulsan, Republic of Korea; 2Hallym University College of Medicine, Hangang,
Department of Pediatrics, Seoul, Republic of Korea; 3Inje University Sanggye
Paik Hospital, Department of Pediatrics, Seoul, Republic of Korea; 4Asan
Medical Center, University of Ulsan College, Department of Pediatrics, Seoul,
Republic of Korea; 5Gangneung Asan Hospital, Department of Pediatrics,
Gangneung, Republic of Korea; 6Asan Institute for Life Science, University of
Ulsan, Department of Pediatrics, Seoul, Republic of Korea.
Background: Thromboxane A2 receptor(TBXA2R) gene polymorphism has
been associated with atopy and asthma. However its role in children has not
been defined. We investigateed associations between asthma-related pheno-
types and TBXA2R polymorphism, and also to analyze whether TBXA2R
polymorphism has an effect on the efficacy of the leukotriene receptor anta-
gonist(LTRA), montelukast, in asthmatic children with exercise-induced
bronchoconstriction (EIB).
Methods: Asthmatic children(n = 695) and control children(n = 159) were
evaluated for asthma-related phenotypes including total IgE, pulmonary
function test, and BHR to methacholine or exercise. Genotypes were detected
by PCR-RFLP. In the montelukast study, exercise challenge was performed
before and after 8-week montelukast treatment.
Results: The TBXA2R polymorphism was not associated with asthma
susceptibility and clinical parameters of asthma. However, asthmatic children
with combinations of the TBXA2R + 795T 9 C and + 924T 9 C risk alleles
had significantly higher total IgE levels (P = .01), total eosinophil counts
(P G .01) and lower FEV1 (P = .02) and FEF 25Y75% (P = .02) than those
carrying the common alleles. When compared with individuals with the
common alleles, in patients with the TBXA2R + 924T 9 C TT homozygote
and TBXA2R+795T 9 C hetero-or homozygote (CT or CC) had a 3.67-fold
poor response to 8-week montelukast treatment regarding to maximum percent
fall in FEV1 after exercise (odd ratio, 3.67; 95% CI, 1.15-11.15).
Conclusion: A combined effect of TBXA2R + 795T 9 C and + 924T 9 C
risk alleles may be linked to IgE production, eosinophilic inflammation, and
severity of asthma. In addition, the combined genotype of TBXA2R may be a
predictive marker of clinical response to the LTRA in Korean asthmatic
children with EIB.
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A randomized prospective double blind controlled trial on effects
of long-term consumption of fermented milk containing
Lactobacillus casei in pre-school children with allergic asthma
and/or rhinitis
Filippo Salvini1, LorenzoMorelli2, Marco Sala3, Giovanni Radaelli3, Giuseppe
Banderali3, Carlo Agostoni3, and Marcello Giovannini3. 1University of Milan-
San Paolo Hospital, Department of Paediatrics, Milan, Italy; 2Microbiology
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Institute, Universita` Cattolica del Sacro Cuore, Piacenza, Italy; 3University of
Milan-San Paolo Hospital, Paediatric Department, Milan, Italy.
Background and Aim: Probiotics may have immunomodulatory functions,
exerting beneficial effects in allergic disease. We investigated whether
prolonged daily consumption of Lactobacillus casei DN-114 001 fermented
milk improve health status of children aged 3-6 years allergic to inhalants.
Methods: In a randomised prospective double blind controlled trial patients
were randomly assigned to receive for one year 100 ml per day of L. casei DN-
114 001 fermented milk (109 cells/ml), or no probiotics (controls). Clinical
evaluations occurred every 3 months. Faecal flora composition was assessed
every 6 months (30 treated, 15 controls). Outcome measures were time free
from and the number of episodes of asthma/rhinitis, number of fever or
diarrhoea episodes, IgE-G-A serological levels (12 months vs baseline).
Results: Participants (187; 92 treated) were similar regarding gestational age,
breastfeeding, family smokers, pets, siblings, day-care admission. No statistical
difference between intervention and control group occurred in asthmatic
children. In children with rhinitis, the annual number of rhinitis episodes was
lower in the intervention group,mean difference (95%CI), -1.6 ( -3.15 to -0.05);
the mean duration of an episode of diarrhoea was lower in the intervention
group, mean difference -0.81 (-1.52 to -0.10) days. Faecal analysis showed
Lactobacillus casei DN-114 001 in the gut flora of 9 78% of supplemented
children through the study period.
Conclusion: Long-term daily consumption of Lactobacillus Casei DN-114
001 fermented milk may positively influence on the clinical and immunolo-
gical status of allergic children.
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Prevalence of pediatric allergic diseases in the
first three years of life
Chizuko Sugizaki, and Motohiro Ebisawa. Sagamihara National Hospital,
Clinical Research Center, Department of Allergy, Sagamihara-City, Kana-
gawa, Japan.
Background: We have maintained birth cohort study in Sagamihara-City
since 2002 to clarify the prevalence of atopic dermatitis (AD), food allergy
(FA), bronchial asthma (BA), and Japanese cedar pollinosis (JCP) from
infancy to childhood.
Methods: Using the mass medical examination system at the age of 4 months
(mo) old, we first had obtained information of eczema, nutrition method, family
history of allergic diseases, and results of allergy examination by questionnaire.
We followed up the subjects, whose parents agreed to participate in this study, at
the age of 8 mo, 12 mo and 3 years (y) old using questionnaire by mail.
Furthermore the risk factors for the subjects to develop BA by the age of 3 y
were analyzed from the information obtained in the study.
Results: Informed consent was obtained from 5247 parents of 4 mo infants out
of 5932 parents from 1/1/02 to 12/31/02. We could follow up 4214 infants at
the age of 8 mo, 4068 infants at the age of 12 mo, and 2888 children at the age
of 3 y. The incidence of chronic eczema to suspect AD at 8 mo, 12 mo and 3 y
was 18.8%, 13.3% and 14.8%, respectively. The incidence of food elimination
due to FA reported by parents at 8 mo, 12 mo and 3 y was 17.0%, 12.8% and
5.4% respectively. Interestingly, the incidence of doctor-diagnosed FA at 8 mo,
12 mo and 3 y was 2.4%, 2.8% and 5.1% respectively. Confusion related to FA
and AD during infancy seems to exist between parents and doctors. The
prevalence of BA at 12 mo and 3 y was 2.9% and 8.7% respectively. The risk
factors for infants to develop BA by 3y were related to the possession of AD or
FA at 8 mo, 12 mo and 3 y, family history of allergic diseases and history of
indirect cigarette exposure. The incidence of JCP at 3 y was even 3.0%.
Conclusion: Since the population of children in Sagamihara-city represents
about 5% of that of Japan, we can now estimate the prevalence of allergic
diseases from infancy to childhood by the data obtained in this study. However,
it was very difficult to estimate the prevalence of FA especially during infancy
due to the under-evaluation by doctors and over-reaction by parents. It is
important for both doctors and parents to fix the confusion in our society. The
data can make us possible to clarify the prevalence of pediatric allergic
diseases and to reveal the transition of the diseases.
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Update of the guideline on allergy prevention
Torsten Scha¨fer, Cathleen Borowski-Muche, and ABAP, Consensus group.
Medical University Luebeck, Institute of Social Medicine, Luebeck, Germany.
Background: Prevention is crucial to counteract the rising trend of allergies.
In 2004, we published an evidence-based and consented guideline on primary
and secondary prevention of asthma, allergic rhinitis and atopic eczema. In
order to update this guideline, we repeated a systematic literature search in
2007 and present the results here.
Methods: A literature search was performed in Medline for the years 2003
through April 2007. The used mesh-term groups were as follows. Endpoints:
asthma, allergy, allergic, atopic, hay fever, dermatitis, eczema, rhinitis. Inter-
ventions: prevention, risk factor, epidemiology.
Study types: randomized controlled trial, clinical trial, control study,
systematic review, meta analysis, case control study, cohort study. Terms were
combined with Band[ within groups and Bor[ between groups. We included
studies on humans published in English or German language and excluded
therapeutic and drug trials. A first selection process was performed on the basis
of titles and abstracts.
Results: We obtained 1551 hits of which 139 potentially relevant studies were
identified. The later consists of 6 reviews, 9 RCTs, 91 cohort-and 33 case-
control-studies. After an initial review, the studies could be allocated to the
areas breast feeding, hypoallergenic formula, introduction of solid food, diet of
the mother and the child, smoking, mould and dampness and vaccination. The
recommendations of the guideline to these areas were supported by the actual
evidence. There is new evidence which allows a specification of the current
recommendations for the topics body mass index and exhaust. There is indi-
cation that the recommendations on house dustmite, pet keeping and unspecific
immune modulation need to be revised.
Conclusion: By this literature search it is possible to update the current
evidence-based recommendations on allergy prevention and to adapt the rec-
ommendations according to the current literature.
T Scha¨fer, C Borowski, TL Diepgen, M Hellermann, I Piechotowski, I
Reese, T Roos, S Schmidt, H Sitter, T Werfel, U Gieler und die Konsen-
susgruppe des Aktionsbu¨ndnisses Allergiepra¨vention. Evidenz-basierte und
konsentierte Leitlinie BAllergiepra¨vention[. Allergo J 2004;13:252-60.
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A specific mixture of short chain galacto-oligosaccharides and
long chain fructo-oligosaccharides induces an anti-allergic
immunoglobulin profile in infants at risk for allergy
Johan Garssen1, Sertac Arsnalognu2, Gunther Boehm3, Guido Moro2, Joyce
Faber1, Edward Knol4, Bert Ruiter4, Els Hoffen4, Linette Willemsen5, Laura
M’Rabet5, and Le´on M.J. Knippels1. 1Numico-research, Immunology,
Wageningen, Netherlands; 2Macedonio Melloni Maternity Hospital, Center
for infant nutrition, Milano, Italy; 3Numico research B.V., Research, Fried-
richsdorf, Germany; 4Academic hospital utrecht, Dermatology, Utrecht,
Netherlands; 5Utrecht Institute for Pharmaceutical Sciences, Pharmacology
and Pathofysiology, Utrecht, Netherlands.
Background: In a prospective study in infants with a family history of atopy a
specific prebiotic oligosaccharide mixture (90% short chain galactooligosac-
charides and 10% long chain fructo-oligosaccharides (GOS/FOS) (IMMU-
NOFORTIS) reduced the cumulative incidence of atopic dermatitis at six
months of age. In a subgroup of these infants it was possible to obtain a blood
sample at six months of age to analyse the potential effect of these dietary
oligosaccharides on the immunoglobulin profile.
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Methods: In this prospective double-blind randomized, placebo controlled,
study the infants received a hypoallergenic formula with either 8g/l GOS/FOS
or 8 g/l maltodextrine (placebo) for six months. At three months of age, child-
ren were vaccinated against diphteria, tetanus ad polio (DTP). At six months of
age total plasma levels of IgE, IgG1, IgG2, IgG3, and IgG4 as well as cow’s
milk protein (CMP) and DTP specific immunoglobulins were measured.
Results: Supplementation of GOS/FOS has lead to a significant reduction in
the plasma level of total IgE (p = 0.007), IgG1 (p = 0.0054), IgG2 (p = 0.029)
and IgG3 (p = 0.0343) immunoglobulins whereas no significant effect on
IgG4 was observed. The plasma levels of CMP specific IgG1 was significantly
decreased (p = 0.015) in the GOS/FOS group. The levels of CMP specific IgE
were very low and no effect of GOS/FOS supplementation could be observed.
CMP specific IgG4 was not detectable in the samples. No influence of GOS/
FOS supplementation was found on any vaccine specific antibody isotype
levels.
Conclusion: Evidently GOS/FOS supplementation induced an anti-allergic
immunoglobulin profile in infants at high risk for allergic diseases whereas
desired specific immune responses were not affected indicating the potential
role of oral GOS/FOS exposure for primary prevention of allergies.
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Bacterial DNA in infant faecal samples, as assessed by
Real-time PCR, in relation to allergy development in children up
to five years of age
Ylva M. Sjogren1, Maria C. Jenmalm2, Bengt Bjorkste´n3, and Eva
Sverremark-Ekstrom1. 1Stockholm University, Dep. of Immunology, The
Wenner-Gren Institute, Stockholm, Sweden; 2Linko¨ping University, The Dep.
of Clinical and Experimental Medicine, Linkoping, Sweden; 3Karolinska
Institutet, The Institute of Environmental Medicine, Stockholm, Sweden.
Background: An altered microbial exposure may underlie the increase of
allergic disease in affluent societies. Early colonisation with Bifidobacterium
(B.) and Lactobacilli (L.) have been postulated to prevent children from
developing allergy, while Clostridium (C.) difficile colonisation has been
associated with allergic disease. Previous studies have mainly been performed
with culture dependent techniques. However, lately the sequencing of bacterial
genomes has made it possible to study the gut flora with molecular techniques.
The Real-time PCR technique uses primers targeting conserved genes of
bacteria, leading to efficient qualitative and quantitative analysis of bacterial
DNA from faecal samples.
Methods: Presence and amounts of bacterial DNA in infant faecal samples,
collected at 1 week, 1 month and 2 months, were measured with Real-time
PCR and related to allergy development in Swedish children, followed
prospectively at 6, 12, 24 and 60 months of age. Children regarded as allergic
(n=14) had developed allergic symptoms and sensitisation to food and/or
inhalant allergens during their first five years of life while non-allergic children
(n=23) were non-sensitised without symptoms. Primers binding to C. difficile,
B. bifidum, B. longum/infantis, B. adolescentis, B. breve, Bacteroides fragilis,
Lactobacilli group I (L. rhamnosus, L. paracasei, L. casei) and Lactobacilli
group II (L. gasseri, L. johnsonii group) were used.
Results: The most abundant bacteria were B. longum/infantis while few
children were colonised with C. difficile. At one week of age none of the
allergic children was colonised with Lactobacilli group I compared to 56% of
the children who remained non-allergic (p=0.004). Also, at 1 month of age B.
adolescentis was more common in non-allergic than allergic children
(p=0.008). Furthermore, the persistent colonisation with these bacteria were
more common among non-allergic children, p=0.018 and p=0.060
respectively.
Conclusion: A more diverse gut flora might prevent allergy development and
the early colonisation might be of major importance.
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Efficacity of educational activity in the children with
bronchial asthma
Svetlana Sciuca, and Liliana Visnevschi-Rusnac. State Medical University,
Pediatry, Chisinau, Moldova, Republic of.
Aim: To evaluate the efficacity of educational activity from School of
Asthma in children with asthma and/or their family.
Methods and Materials: In the school of asthma children the specialists
have performed educational activities in 172 children with different forms of
asthma and their parents. Educational seminars consisted of 5 sessions which
approached the following subjects: triggers, asthma symptoms, prophylaxis
and asthma medicines. Each session also included individual interrogation of
the trained to estimate their knowledge of asthma before and after the
education session according to the theme of the working day. The quality of
knowledge of some children with asthma and/or their parents was also tested
after 3Y12 months and afterwards visits.
Results: It was found that the knowledge- of children and parents before the
training at the School of Asthma Children was incomplete and incorrect.
Children with severe asthma had wrong knowledge about triggers (47,73%),
about prophylaxis (52,76%) comparatively with those who suffer of mild
asthma (58,06% and 60,76% respectively) and moderate (51,81% and
55,94% respectively). Knowledge of children with mild asthma referring in
triggers has grown to 90,77%, of children with moderate asthma to 83,72%
and those with severe asthma to 80%. Also was established a growth in
knowledge about prophylaxis in all groups of children: mild asthma-83,82%,
moderate asthma - 85,72%, severe asthma - 79,26%. Knowledge of children
regarding clinic manifestations constituted: mild asthma - 5,5%, moderate
asthma - 74,79%, severe asthma - 78,28%. Knowledge level under the subject
"treatment" is the most incomplete in all groups of the questioned persons:
mild asthma - 37,93%, moderate asthma - 36,96%, severe asthma - 38,78%.
Towards the end of the course they were appreciated as follows: mild asthma
- 63,17%, moderate asthma - 72,67%, severe asthma - 73,0%. The average of
knowledge in all groups of children after 3Y12 month referring triggers was
79,72%, about prophylaxis 79,01%, regarding clinic manifestations - 69,75%
and referring treatment - 52,44%. For compare, the average of knowledge
before educational activity was: referring triggers - 52,43%, prophylactic
measures - 56,32%, clinic manifestations - 45,95% and treatment - 37,89%.
Conclusion: The knowledge of those questioned has little decreased during
3Y12 months, but it remained net superior to the level before the seminars.
401
The usage of paracetamole \ The subsequent development of
allergy and asthma -Study of matched patients- siblings
Constent Ngolle Bide1, Theresia L.M. Nnoko2, and Marie N. Noel3. 1Institute
of Applied Medical Sciences-Cameroon, Department of Research and
Development, Buea, Cameroon; 2University of Nsuka, Nigeria, Life Sciences,
Nsuka, Nigeria; 3University of Douala, Sciene, Douala, Cameroon.
Background:Many studies on this field have come to the suggestion that, the
intake of paracetamole during pregnancy and during the first Months of life is
risky as it increase the risk of childhood asthma. Our aim is to deterring the
asocial between paracetamole usage during pregnancy and the first ten moths
of life and childhood allergy, allergy asthma and asthma.
Methods and Precautions: A matched patients-sibling study comparing
patients with allergic asthma with their healthy siblings without any
symptoms of allergic diseases. Allergic in patients and their siblings was
determined by skin prick tests. We assumed that children having up to one
positive skin prick test were considered to be allergic. Intake of paracetamole
was assessed by standardized interviewer Yadministered, questionnaire.
22 pairs of allergy asthma patients` vs. non-allergic siblings were
compared to determine the risk factors for allergic and asthma. While 12 pairs
of allergic asthma patients vs. allergic siblings were compared to determine
the risk factors for asthma. However, 35 pair of allergic asthma patients vs.
non-asthmatic sibling ( with and without allergy) were compared to determine
the risk factors for asthma, also 15 allergic siblings were compared with 19
non-allergic siblings (with asthma ) to determine the risk factors of Allergy.
Results: Intake of paracetamole during pregnancy was associated with
allergic asthma (P = 0,04). Intake of paracetamole between birth and ten
months of age and between four to seven moths of age, was also found to be
associated with non-allergic asthma (p = 0.004 and p = 0.03) respectively.
Usage of paracetamole during pregnancy and during early months of life may
play a role in the development of allergic and non Yallergic in children.
Conclusion: Intake of paracetamole during pregnancy and during first month
of life is associated with an increase risk of childhood asthma.
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Cow’s milk allergy in premature infants: a ready-to-use cow’s
milk atopy patch test before starting an amino-acid formula
Christophe Dupont1, A. Lapillone1, Pascale Soulainesv, Pierre Henri
Benhamouv, and Nathalie Donne2. 1Hopital Saint Vincent de Paul,
Pediatrics, Paris, France; 2Dbv Technologies, Dbv Technologies, Boulogne
Bllancourt, France.
Background: Cow’s milk (CM) allergy (CMA) is an infantile disease,
usually appearing in the first months of life, with very few cases up to now
reported in the premature infants. The study was designed to detect CMA in
premature infants with digestive symptoms, based on a ready-to-use Atopy
Patch Test (APT), Diallertest\.
Methods: During the year 2006, 13 premature infants (31 wT2 weeks, 4
girls), aged 42T18d , receiving formula for prematures with CM and
presenting with digestive symptoms (rectal bleeding, 5, vomiting,1, diarrhea,
3, severe reflux, 2, others, 2) were tested for CMA by Diallertest\. Whatever
the results, all children received an amino-acid formula (Neocate\ and the
outcome of symptoms was evaluated one month later.
Results: Among the 13 premature infants tested, the digestive symptoms
disappeared under amino-acid formula in 10. Diallertest\ was positive in 7
cases. All infants with a positive Diallertest\ improved with the amino-acid
formula (no false positive) and 1 child with a negative Diallertest\ improved
with the diet (1 false negative).
Conclusion: CMA is a frequent and mostly underestimated cause of
digestive symptoms in premature infants, mostly fed with CM based formula.
APT seems an appropriate method to diagnose CMA in this age range and
Diallertest\ might thus be a useful tool in the neonatal ward.
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Which is more important regarding psychological
consequences: level of asthma control or overall disease severity
in paediatric asthma?
Alexandra Szabo´, Gyo¨rgyi Mezei, and Endre Cserha´ti. Semmelweis
University, First Department of Pediatrics, Budapest, Hungary.
Aim: The study’s objective was to examine the consequences of overall
asthma severity and current asthma control regarding psychological
symptoms in paediatric asthma.
Methods: 108 patients, age: 11.75T3.10 (meanTSD) years; (boys 11.6T2.8
years and girls 12.1T3.7 years) completed the Child Depression Inventory
(CDI), the State Trait Anxiety Inventory for Children (H.STAIC), the
Pediatric Asthma Quality of Life Questionnaire (PAQLQ), and a symptom
score. FEV1 was also measured.
Results: Mean FEV1% was 97.4T12.8. Twenty-three patients (21%) had
intermittent asthma, 40 patients (37%) had mild persistent, 43 patients (40%)
had moderate persistent, 2 patients (2%) had severe persistent asthma. The only
factor associated with depression is: FEV1% less than 100. Factors associated
with anxiety are: night symptoms, asthma control. Factors associated with
quality of life are: the age at the beginning of asthma, asthma duration, current
symptoms, night symptoms, day symptoms. Factors that have no association
with the above are: disease severity, other allergies, skin test positivity.
Conclusion: Not the overall disease severity, other allergic co-morbidities,
but more the current asthma status and level of control alter the psychological
status of the asthmatic child. They can distinguish between very small
changes in the level of control. Thus professional asthma care should focus on
achieving the best possible asthma control at all times.
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Changes of induced sputum cytology by leukotriene antagonists
Tetsuya Takamasu, Yukinori Enomoto, Naoka Ito, Chisato Inuo, and
Kazuyuki Kurihara. Kanagawa Children’s Medical Center, Department of
Allergy, Yokohama, Japan.
Inhaled corticosteroids $B!J (BICS $B!K (B and leukotriene receptor
antagonists $B!J (BLTRA $B!K (Bare major controllers for bronchial
asthma. In our previous observation, ICS decreased eosionophils, and
increased neutrophils in induced sputum. In this study, we examined changes
of induced sputum cytology after starting LTRA.
Methods: Subjects were 8 patients (mean age was 11T3 years, 6 boys and 2
girls) who were prescribed LTRA for asthma control. Before and 1 month
after starting LTRA (pranlukast for 6 cases, montelukast for 2 cases), we
obtained sputa by inhalation of 4.5% saline. Samples were treated for cell
counts and differential cells by Eosin stain.
Results: Cell numbers before and after starting LTRAwere 31T30104 cells/
ml, and 21T17104 cells/ml, respectively (n.s.). The percentage of
eosinophils were 13T11%, and 3T2% (pG0.05), and that of neutrophils
were 79T17%, and 76T27% (n.s.).
Conclusion: LTRA decreased sputum eosinophils as well as ICS, however
did not increase neutrophils.
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Abnormal lung function and bronchial hyperreactivity in early
infancy Y a predictor for severe respiratory syncytial
virus infection?
Porntiva Poorisrisak, Lotte Loland, and Hans Bisgaard. Gentofte Hospital,
Danish Pediatric Asthma Centre, Hellerup, Copenhagen, Denmark.
Background: Two-three percent of infants react with severe bronchiolitis to
infection with Respiratory Syncytial Virus (RSV). The cause for such
exaggerated response to a common infection is unknown, but it has been
suggested that it may be associated with pre-existing abnormal pulmonary
function.
Aim: To compare lung function and bronchial hyperresponsiveness in
newborns who later develop severe RSV bronchiolitis and infants who do not
develop such severe infection.
Methods: A prospective birth cohort study (Copenhagen Studies on Asthma
in Childhood) was conducted in 411 infants of asthmatic mothers. Lung
function was scheduled at 1 month of age by means of the raised volume rapid
thoraco-abdominal compression technique during sedation measuring forced
expiratory volume at 0.5 s (FEV0.5). Bronchial responsiveness was
determined by metacholine challenge using transcutaneous oxygen as end-
point (PD15-TcO2). We defined severe RSV bronchiolitis as a child admitted
to hospital or requiring medication with high-dose inhaled budesonide
(9800mcg) or oral prednisolone for RSV-verified bronchiolitis.
Results: In this prospective cohort study 23 children developed severe RSV
infection before age 2 (mean age, 8 months). All completed baseline lung
function measurements before subsequent RSV infection. Children with
severe RSV infection and controls never presenting severe RSV bronchiolitis
did not differ significantly at baseline lung function (FEV0.5) or metacholine
challenge (log PD15-TcO2); p-value90.1 for all comparisons.
Conclusion: Severe RSV infection in infancy was not associated with pre-
existing abnormal lung function and bronchial hyperreactivity.
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A double-blind randomized placebo controlled clinical trial on
the supplementation of probiotics in the first six months of life
in high risk Asian infants- Effect on eczema in the first year
of life
S.E. Soh1, M. Aw1, I. Gerez1, B.W. Lee1, Y.S. Chong2, M. Rauff2, H.B.
Wong3, N.N. Pai4, and L.P.C. Shek1. 1National University of Singapore,
Paediatrics, Singapore, Singapore; 2National University of Singapore,
Obstetrics and Gynaecology, Singapore, Singapore; 3Clinical Trials and
Epidemiology Research Unit, Biostatistics, Singapore, Singapore; 4Clinical
Trials and Epidemiology Research Unit, Clinical Project Coordination,
Singapore, Singapore.
Background: Several studies have explored the role of probiotics in the
treatment or prevention of atopic diseases. The findings were however
inconclusive.
Objective: To assess the effect of Bifidobacterium longum and Lactobacillus
rhamnosus GG supplementation in the first 6 months of life on the incidence
of eczema and allergen sensitization in the first year in high risk Asian infants.
Materials and Methods: Infants (n = 253) with a first degree relative with a
family history of allergic disease and sensitization to dust mites were
randomized in a double blind, placebo-controlled manner to receive a cow`s
milk based infant formula with or without probiotics (daily dose of 1x109
colony-forming units (CFUs) of Bifidobacterium longum and Lactobacillus
rhamnosus GG) for the first 6 months of life. Subjects were assessed at 1, 3, 6
and 12 months for atopic diseases and skin prick test was conducted at the 12
month visit.
Results: Out of 253 subjects, 235 were followed-up to 12 months (drop out
rate 7%). The subjects in the two treatment groups were comparable in terms
of demographic and birth characteristics, except for gender and birth order.
Incidence of eczema in the probiotic (n = 33/122; 27%) group was found to be
similar to placebo (n = 33/113; 28%) (OR, 1.07; 95% CI, 0.60 to 1.89). There
was no difference in the rate of sensitization to common allergens (probiotic =
25% vs placebo = 21%, OR, 0.78; 95% CI, 0.42 to 1.45). Sensitization to dust
mite allergens (Dermatophagoides pteronyssinus, Blomia tropicalis) was the
most common (Probiotic = 20% vs Control = 18%), followed by eggs
(Probiotic = 6% vs control = 5%). None of the subjects were sensitized to
cow`s milk or soy. Potential confounding factors including birth order,
household size, smoking exposure, presence of pets and breastfeeding did
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not affect these outcome measures. Adjustment for imbalance of gender
and birth order between treatment groups did not affect the findings
significantly.
Conclusion: This study did not show a protective effect of probiotic
supplementation for the first 6 months of life on eczema or allergen
sensitization in high risk Asian infants at 1 year of age. The prevalence of
eczema in our cohort is also lower than in reported studies.
407
Detection of fecal Bifidobacterium infantis in the first year of
life in infants at risk of atopy supplemented with Lactobacillus
rhamnosus GG and Bifidobacterium longum from birth till 6
months old
G.C. Yap1, K.W. Mah1, C. Lay2, L.P.C. Shek1, M. Aw1, K.Y. Chua1, G.W.
Tannock3, and B.W. Lee1. 1National University of Singapore, Department of
Paediatrics, Faculty of Medicine, Singapore, Singapore; 2A*STAR, Institute
of Microelectronics, Singapore, Singapore; 3University of Otago, Department
of Microbiology and Immunology, Dunedin, New Zealand.
Background: Studies have suggested that oral administration of probiotic
bacteria in early life may positively modulate the immune system of infants at
risk of atopy towards a non-allergic state.
Aim: This study aims to monitor the intestinal transit of a probiotic
supplementation (Lactobacillus rhamnosus GG and Bifidobacterium longum
BB536) in the first 6 months of life in at risk infants (first degree relative with
allergic disease) participating in an ongoing randomized double-blind
placebo controlled trial. Effect of this supplementation on Bifidobacterium
infantis prevalence was also investigated. This particular bifidobacterial
species has been implicated as a potential signature of infants at low
prevalence of atopy.
Methods: Newborns at risk of allergies received either probiotic preparation
(n = 55) or placebo (n = 48) daily for the first 6 months of life. Analysis of
fecal bacteria and clinical examinations were conducted serially at birth, 1, 3,
and 12 months. Bacterial DNA extracted from fecal samples was evaluated
with nucleic acid amplification approach using specific PCR primers
targeting Lactobacillus rhamnosus GG and Bifidobacterium infantis.
Results: All extracted DNA samples were amplified with universal primers
targeting a conserved region of 16S rRNA to ensure extraction of intact DNA.
Lactobacillus rhamnosus GG was more commonly detected in the probiotic
group compared to the placebo group [at 3 days (94.1% vs 6.8%), 1-month
(92.7% vs 14.9 %), 3-month (86.5% vs 21.3%, respectively) (pG0.0001)] but
not significantly at 1-year old (28.8% vs 14.9%, p90.05). Infants
supplemented with probiotics were also more likely to harbour Bifidobacter-
ium infantis at 3 months (n = 19/52; 36.5%) compared to placebo (n = 7/47;
14.9%) groups (p = 0.0267).
Conclusion: Our data suggests that probiotic supplementation from birth
may modulate the intestinal bifidobacterial species composition. Its effect on
allergy outcomes remains to be examined.
408
Allergen sensitization in paediatric patients requiring
hospitalisation for their severe asthma in Martinique from 2002
to 2005
Sylvie Lafosse-Marin1, and Enrique Ferna´ndez-Caldas2. 1Cabinet d’Aller-
gologie, Allergologie, Fort de France, Martinique; 2Dr. Beckmann Pharma
GmbH, Research and Development, Seefeld, Germany.
Background: Asthma is an important health care problem in tropical regions
worldwide. Hospitalisations for asthma were followed from 2002 to 2005 in
Fort de France, Martinique.
Objective: The main objectives of this study was to establish allergen
sensitization in a large proportion of children who required hospitalisation for
a severe exacerbation of their asthma. Material and Methods: Patients
hospitalised at the Victor Fouche Hospital were monitored from 2002 to
2005. Patients were contacted by phone after leaving the hospital. After-
wards, they were skin tested with 16 common aeroallergens, including 4 mite
species, 3 cockroaches, cat and dog, grasses and 4 foods. A detailed
questionnaire concerning environmental and social risk factors was answered
by the parents.
Results: A total of 632 hospitalisations were counted in this period of time. A
total of 492 children (294 boys and 198 girls; mean age 5.93 years) were
hospitalised. The mean number of hospitalisations per child was 1.3 (1 to 8
times). The mean days of admission per patient was 2.81 (1 to 27). The
number of hospitalisations in 2002 were 156, in 2003, 191; in 2004, 148 and
in 2005 137. A total of 269 patients (54.67%) (159 boys and 110 girls) agreed
to undergo skin testing. From this group, 11 had been skin tested prior to the
entry in the study and 3 had started, and abandoned, immunotherapy. One
hundred ninety six (72.86%) children had at least 1 positive skin test; 158
(58.74%) were sensitised to at least 3 allergens. 183 (68.03%) were positive
to at least 1 mite species; 99 (36.8%) to at least 1 cockroach species; 63
(23.42%) to at least one food, among these, 61 were sensitised to shrimps; 18
(6.69%) were sensitised to cat and 14 (5.2%) to dog and just 5 (1.86%) to
grass pollen.
Conclusion: We have identified a high rate of sensitization to aeroallergens
in a large cohort of young paediatric patients with severe asthma that required
hospitalisation in Martinique. Mites, cockroaches and shrimps accounted for
the largest number of sensitisations. These results are similar to those
obtained in a control group of allergic children being evaluated for allergic
respiratory diseases during the same period of time.
409
Specific IgE levels to ascaris spp. in a cohort of paediatric
patients hospitalised for severe asthma in Martinique from 2002
to 2005
Sylvie Lafosse-Marin. Cabinet d’Allergologie, Allergologie, Fort de France,
Martinique.
Background: In tropical regions, there is a large proportion of the population
which has been in contact with intestinal parasites, including the roundworm
Ascaris spp. There are conflicting reports on the protective effect or harmful
influence of sensitization to Ascaris spp. in patients with allergic respiratory
diseases, such as allergic asthma. Objectives: to investigate specific IgE
levels in children hospitalised with severe asthma in the tropical island of
Martinique.
Materials and Methods: From 2002 to 2005 we investigated specific IgE
levels in the serum of children hospitalised for severe asthma in Fort de
France, Martinique. As controls we used a group of 484 children (mean age
7.42) evaluated for allergic respiratory diseases at an outpatient clinic.
Specific IgE to Ascaris spp. was measured by the CAP system (Phadia).
Results: A total of 117 children (68 boys and 49 girls; mean age 6.45) were
investigated. Mean number of hospitalisations and of days stayed in the
hospital were 1.35 and 3.02 days, respectively. A total of 60 children
(51.28%) had a positive determination (mean value 6.69 kU/L). The mean
number of hospitalisation in the positive group was 1.28 and the mean days
stayed at the hospital, 3.05 days. 47 children stayed 3 or more days in the
hospital; in this group there 22 Ascaris spp. negative and 25 Ascaris spp.
positive children (NS). In the negative group, the mean number of
hospitalisation was 1.42 times and the mean days stayed at the hospital,
2.98 days. In the control group, 215 (44.42%) had a positive specific IgE
determination to Ascaris spp.
Conclusion: In contrast to what has been proposed for other tropical
countries, sensitization to Ascaris spp. seems not to influence the severity of
asthma in Martinique. Similar rates of sensitization to Ascaris spp. are
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detected in allergic children who do not require hospitalisation for their
allergic asthma.
410
Demographic of monitoring and treatment of childhood asthma
in Surakarta, Central Java, Indonesia
Johannes Ridwan T. Sugiarto1, and Prof. Hugo Van Bever, PhD2. 1Dr. Oen
Hospital, Pediatrics, Surakarta, Indonesia; 2National University Hospital,
Pediatrics, Singapore, Singapore.
Background: In Surakarta, one of the districts in Central Java, Indonesia,
with a population of around one million, many areas house industrial
companies, leading to high pollution, that can trigger childhood asthma. As
the most common chronic illness in children, childhood asthma causes school
absences and limitations of children`s activities, making asthma especially
serious for them.
Methods: Standardized questionnaires were distributed randomly to 200
doctors in Surakarta, who are general physicians, general pediatricians and
pediatric pulmonologist.
Results: Of the 200 questionnaires, 78 were returned: 74 from general
physicians and 3 from pediatricians. Most of the doctors never use score cards
to monitor childhood asthma, never used spirometry and never used peak
flow meters. For the treatment of acute asthma methylprednisolone was first
choice in 83%, while 17 % used dexamethasone. For maintenance treatment
of childhood asthma no physician used montelukast because this drug is not
available in Surakarta. However, as a first choice maintenance treatment,
most physicians used a long-acting beta-agonist (LABA) in combination with
an inhaled corticosteroid in infants, preschoolers and older children.
Conclusion: Striking results were the low usage of score cards, lung function
testing in monitoring childhood asthma, and the high usage of a LABA in
combination with inhaled corticosteroids as first choice maintenance
treatment, suggesting that guidelines on asthma monitoring and treatment
are not strictly followed in Surakarta.
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Frequency of infections, atopic eczema and asthma outcome
in infancy
John Warner1, Augustin Huret2, and Marie-Etienne Pinelli3. 1Imperial
College, Paediatrics, London, United Kingdom; 2Business EffiScience,
Science strategy, Paris, France; 3UCB Pharma, Global Medical Affairs-
Allergy, Brussels, Belgium.
Studies of association between frequent early infection and allergic
disease outcomes have produced diametrically opposed results. Some have
associated reduced frequency and others increased frequency of infection
with more allergic disease. We have employed a unique algorithm (Business
EffiScience) to the analysis of a large database from early prevention of
atopic asthma in children (EPAAC) trial. 510 infants between 1Y2 years of
age with atopic eczema (SCORAD9 10) entered the study and 434 completed
18 months follow up. As there was no difference between active and placebo
intervention all subjects were merged for the purposes of this analysis which
were to establish which factors at recruitment either singly or in combination
had the greatest impact on the subsequent development of asthma defined as
greater than or equal to three episodes of wheezing and/or paroxysmal cough
disturbing sleep for at least three consecutive nights. To analyze the impact of
early infection on asthma we analysed the effect of the number of infections
per year of infants from birth to asthma onset or end of the study when asthma
was not observed. A bell shaped curve was identified with 27% infants less
often developing asthma if they had 1.5 or less infections per year, 25% more
often to have asthma with 1.5 to 4 infections per year and 11% less often to
have asthma with more than 4 infections per year. The only other interaction
was with proximity to a factory as a surrogate for pollution exposure which
only increased the risk of asthma if there was a frequency of infections
between two and five per year. Thus the combination of atopic eczema with
raised IgE and proximity to a factory was associated with a 77% uplift in
frequency of developing asthma if the frequency of infections was between
1.5 and 4 per year. The bell shaped curve of frequency of infection in relation
to asthma risk may well explain the discrepant results in various studies. Very
low frequency of infection occurs in infants with an effective TH1 response
and therefore reduced probability of developing allergic disease while those
with a very high frequency of infection have a greater probability of inducing
TH1 responsiveness while normal rates of infection in an atopically
predisposed individual will not modify the outcome.
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Challenges of Fpeanut challenge`
Srinivas Bandi, and Scott Hackett. Birmingham Heartlands Hospital,
Paediatrics, Birmingham, United Kingdom.
Background: The diagnosis of peanut allergy has important consequences
for patients and their families. An accurate diagnosis of peanut allergy is
essential as it is usually life long and can potentially be fatal. The
cornerstones of diagnosis are a detailed history, skin prick tests (SPT), IgE
estimation with or without an oral peanut challenge.
Objective: 1. To demonstrate the importance of peanut challenges in
diagnosing children with peanut allergy 2.To see whether we can predict
children who are likely to outgrow peanut allergy 3.To assess the safety of
peanut challenges.
Methods: A retrospective study of peanut challenges performed at a tertiary
care paediatric hospital allergy clinic between January 1997 and December
2006.
Results: Of the 79 peanut challenges performed, (data available for 77), 14
(18%) were positive. All children had a history suggestive of peanut allergy
and 72 had a skin prick test (SPT) or IgE RAST performed prior to the
challenge (SPT-63, IgE-6, SPT and IgE-3) The results (72) of SPTTIgE
RAST: &23 were negative (SPT-20, IgE-2, SPT+IgE-1) &49 were either
positive for RAST or SPT or both (IgE-4, SPT-43, both-2)
.
SPT (mm) n=66 Positive challenge n=14 Negative challenge n=52
Q10 mm 3 2
6 Y 9 mm 7 7
e5 mm 3 21
negative 1 22
Only 1 child who had a negative SPT developed a positive challenge
(4%), whereas 36/49(73%) children with positive SPT or RAST had a
negative challenge. Further analysis of these children who had a negative
challenge shows that majority had a SPT of e 5 mm (21/36), where as 7 had
SPT of 6Y9mm, 2 had SPT of Q 10mm. 3 had positive IgE RAST and 2 had
both SPT and IgE RAST positive. SPTs e 5 mm was strongly associated with
a negative peanut challenge; Fishers Exact test p = 0.02 Adverse clinical
effects of positive peanut challenges included urticaria, lip swelling, vomiting
and in one anaphylaxis; 6 required medical treatment (5- antihistamines,
1- adrenaline).
Conclusion: The majority of children with a diagnosis of peanut allergy,
based on history and skin prick / antibody tests had a negative challenge.
Peanut challenges are not warranted in patients with a definite history of
peanut anaphylaxis with positive SPT. We recommend that where the history
is suggestive but SPT is negative or borderline positive, i.e. e 5 mm, a peanut
challenge is necessary to confirm the diagnosis. We plan to SPT and RAST
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test all patients before they have peanut challenge to see if this improves
sensitivity and specificity of our challenges.
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Effect of lysed Enterococcus faecalis FK-23 (LFK) on intestinal
microflora in antibiotic treated mice
Takashi Shimada1, Tadao Enomoto2, and Lei Cheng3. 1Nichinichi
Pharmaceutical Co., Ltd., Central Research Laboratories, Iga-city Mie,
Japan; 2Japanese Red Cross Society Wakayama Medical Center, Depart-
ment of Otolaryngology, Wakayama, Japan; 3Nanjing Medical University,
International Centre for Allergu Research, Nanjing, China.
Background: Antibiotic use in infancy may be associated with an increased
risk of developing allergic diseases. Lysed Enterococcus faecalis FK-23
(LFK) could suppress the allergic responses; however, the mechanism
responsible for this phenomenon remains unclear.
Objective: To evaluate the effect of LFK on intestinal microflora in
antibiotic treated weaning mice.
Methods: Three-week-old BALB/c mice were sensitized with cedar pollen
allergen to establish an experimental model. Orally administered erythro-
mycin, one kind of macrolide antibiotic, was used for the experiments. The
intestinal microbiota, and the allergen-induced accumulation of eosinophils
and IgE level in sera were determined in the control, antibiotic, LFK and
antibiotic-LFK groups (n = 7, respectively).
Results: The total aerobes, total anaerobes and Enterococcus of intestinal
microflora were not significantly different among all groups. Lactobacillus was
distinctly eliminated in the mice exposed to erythromycin on day 7 and totally
recovered in erythromycin-treated mice with LFK intervention on day 28, but
could not recovered in the erythromycin-treatedmicewithout LFK intervention.
Conclusion: LFK improved the intestinal ecosystem disturbed by antibiotic
use, and may prevent subsequent development of allergy.
AUTOIMMUNITY
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Anti-neutrophil cytoplasmic antibodies in patients with
pulmonary tuberculosis
Roya Sherkat1, Kamyar Mostafavizadeh1, Laleh Ziedabadie2, and Parisa
Shoaie2. 1Alzahra University Hospital, Infectiouse Disease, Isfahan, Islamic
Republic of Iran; 2Sedigheh Tahereh University Hospital, Infectiouse
Disease Reasearch center, Isfahan, Islamic Republic of Iran.
Background: Mycobacterial tuberculosis is a major cause of mortality and
morbidity worldwide.Infection with this bacteria is known to induce the
development of autoantibodies and a few of these antibodies are also known
to be diagnostic markers for some other diseases. ANCA`S are one of
autoantibodies used in clinical setting for diagnosing systemic vasculitic
syndrome . More than 20 studies investigating ANCA positivity in diseases
other than small vessel vasculitis . This study was undertaken to determine
the prevalence of ANCA in pulmonary tuberculosis (TB) which could lead to
false diagnosis of wegner`s granulomatosis or vice versa.
Materials and Methods: In a caseYcontrol study 32 consecutive smear
positive pulmonary TB patients and 32 normal individuals were studied . All
cases and controls screened for ANCA by indirect immunoflurecent (IIF) and
also myeloperoxidase antibodies (anti-MPO) and proteinase 3 antibodies
(anti-PR3) were tested by ELISA.
Results: Perinuclear pattern (P-ANCA) was detected in 25% of cases and
6.25% of controls and cytoplasmic pattern(C-ANCA) in 3.1% of both cases
and controls by IIF assay. ANCA specificities by ELISA in cases revealed
that 75% had anti-myleperoxidase and 12.5% had anti-Proteinase 3. In
controls 3.12% had anti-MPO and no person had anti Y PR3 . The positive
ANCA significantly correlated with tuberculosis (p valueG0.018) and also
positive anti-MPO significantly correlated with TB (p valueG0.01).
Conclusion: Autoantibodies especially ANCA`S may present in both
disease, Wegner Granulomatosis and Tuberculosis .The presence of
autoantibodies in TB patient could have a multifactorial etiology. The
presence of human T lymphocytes reactive to heat stress proteins may be an
important target of immune response against certain intracellular auto-
antigens such as anti-MPO from PMN added to the mechanism of molecular
mimicry would explain the association of ANCA and TB.
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The cells in psoriatic skin
Jela Petriskova1, Mojmir Vrlik2, and Kantarova Daniela3. 1Martinske
Centrum Imunologie, Laboratory, Martin, Slovakia; 2Martinske Centrum
Imunologie, MCI, Martin, Slovakia; 3Martinska Fakultna Nemocnica, I.
Interna Klinika, Martin, Slovakia.
Rationale: The psoriasis is an autoimmune disease with significant role of
the immune system.
Methods: We investigated the group of 16 patients with active form of
chronic psoriasis vulgaris before and after treatment with cyclosporine A. The
results was compared with the control group of the patients without any skin
disease. In the samples of the skin tissue we detected the cells with surface
markers CD14, CD45, CD3, CD19, CD46+56, CD4, CD8, HLA-DR, CD25
(we have used the monoclonal antibodies Immunotech, Becton-Dickinson).
Results: The lymphocytes represent 7,3% in the samples of the skin in
patients in the active state of psoriasis, 2,1% in control group (pG0,0001) and
3,1% in patients after treatment (pG0,001).Cytotoxic T-cells (CD3+CD8+)
represent 37,8% in the samples of the skin tissue in psoriatic patients, 32,4%
in control group and 28,4% after treatment, The cytotoxic T-cells expressed
HLA-DR in 25,6% in psoriatic patients before treatment, in 10,7% after
treatment and in 11,4% in the control group. We found 44,3% of the
lymphocytes with CD3+CD4-CD8-phenotype in the skin of patients before
treatment, 29,6% (pG0,05) after treatment and 10,3% in the control group.
The expression of the surface marker CD25 was lower in the active stage in
comparison with control group ( 9,6% vs 13,1%), its expression increased
after treatment at 38,4%.
Conclusion: The activated cytotoxic T-cells and T-cells with a˜a¨-TCR-
receptors (CD3+CD4-CD8-) play the important role in pathogenesis of
psoriasis. The results of our study confirmed possible regulation role of the T-
cells with CD4+CD25+phenotype.
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Anti-endotoxin immune responses in systemic lupus
erythematosus and rheumatoid arthritis
Kseniya Byeloglazova1, Vladimir Beloglazov1, Anna Alexeeva1, Ilona
DuBuske2, and Lawrence DuBuske2. 1Crimea State Medical University,
Allergy and Immunology, Simferopol, Ukraine; 2Immunology Research
Institute of New England, Gardner, Massachusetts, United States.
Introduction: Rheumatoid arthritis (RA) and systemic lupus erythematosus
(SLE) are autoimmune diseases with respectively T cell mediated and B cell
mediated mechanisms. Endotoxin (ET) from gram negative flora can rapidly
induce or reactivate experimental arthritis, probably by stimulation of
secretion of Th1 inflammatory cytokines. ET is a potent polyclonal B-
lymphocyte activator. This study investigates anti-endotoxin humoral
immunity in patients with RA and SLE.
Methods: 27 patients were studied including: Group I-18 patients with RA;
and, Group II-9 patients with SLE. The age range was 30Y50 years. Disease
duration was from 6 months to 10 years. Disease status based on clinical,
including joint involvement, and laboratory data were less than or equal to
class II degree of activity. Peripheral blood was obtained and serum analyzed.
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Quantification of IgA, IgM, and IgG anti-ET antibodies was done by ELISA.
ET from Esherichia coli K30 (09:K; O:H12) was employed as the antigen.
The control group included 32 healthy donors.
Results: Patients with RA had levels of IgA anti-ET and IgM anti-ET which
were 2.3 fold less (pG0.001) than the average in healthy controls. The levels
of IgG anti-ET antibodies were not different from the healthy control group.
Patients with SLE had levels of IgG anti-ET antibodies which were 2.2 fold
greater (pG0.01) than normal controls. These same SLE patients had levels of
IgA anti-ET and IgM anti-ET which were respectively 2.3 (pG0.001) and 2.1
(pG0.01) fold less than in the healthy control group. Reduced IgA anti-ET
levels occurred in 56.7% (pG0.001) and reduced IgM anti-ET levels occurred
in 53.6% (pG0.01) of SLE patients. Reduced IgA anti-ET levels occurred in
56.7% (pG0.001) and reduced IgM anti-ET levels occurred in 56% (pG0.001)
of RA patients.
Conclusion: Anti-ET IgG levels in RA patients demonstrate a normal level
of response while in SLE patients greater than normal responses to ET occur
Dysfunctional anti-ET immune responses occurred with respect to reduced
IgM and IgA anti-ET antibodies in both SLE and RA patients. There may be a
role for gut flora and immune responses to ET as factors modulating immune
responses in RA and SLE patients.
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Activity of systemic lupus erythematosus in Mexican children.
Correlation between medical clinical evaluation and evaluation
based on the use of five indicators of activity
Rosa Maria Cortes Grimaldo, Francisco Espinosa Rosales, Marcia del
Carmen Perez Ruiz, Martin J. Penagos Paniagua, and Daniel Garcia Imperial.
Instituto Nacional de Pediatria, Allergy and Immunology, Mexico, Mexico.
A computer program has been developed to evaluate five of the most
important SLE AI: SLEDAI, SLAM, BILAG, LAI, ECLAM. These
indicators have a close correlation with each other in the case of adult
patients and also, when they are compared with the expert opinion. On the
contrary there is sparse information of the usefulness of these indicators in
children with SLE.
Objective: To determine whether is there a correlation between 5 different
SLE AI in children and to assess the correlation between the clinical
evaluation of activity by physicians of the Department of Immunology and
that provided by the use of the five AI of SLE.
Materials and Methods: A transverse analytical study was undertaken in
patients under 18 years of age diagnosed with SLE at the National Institute
of Pediatrics in Mexico City. A questionnaire was used containing every
variable included in the five indices of SLE activity. Statistical analysis.
The median and interquartil limits were used as descriptive ststistics
because the variables did not show a normal distribution with the
Kolmogorov-Smirnov test;. To ascertain the degree of association among
quantitative variables, correlation test of Spearman was used. Sensibility,
specificity and predictive values were estimated at different cut-off levels
selecting the best one using Receptor Operator Curves (ROC). Results. We
included 30 patients with SLE; 28 females (94%) and two males. Median
age was 15 years (liq 13-17). The median time of evolution from the time
of diagnosis was 41 months (liq 16-5). According to the expert 14 patients
had active SLE (47%); according to the SLEDAI 13 patients had active
SLE (43%) (p = 0.79).
Conclusion: The indices with the greater correlation with the SLEDAI were
the opinion of the expert and the SIS; those that best correlated with the
appraisal of the clinician were the SLEDAI and the SIS. Sensibility and
specificity for each one of them were 92% and 89% for the expert; 85% and
88% for the SIS and 85% and 89% for the SLEDAI respectively.
418
The value of the *corticosteroids(CSP) in countering the residua
of the protracted tuberculous infection/inflammation(TI)
I. Khan Sameera, Munir Imran Khan, Ali Iftikhar, and M. Ishaq. Al-Junaid
Hopsital, Allergy/Pulmonology, Nowshera, Pakistan.
Purpose: (CS) BThe double edge sword^ in function the favorable therapeutic
advantage against disadvantage should be weighed when the indications arise.
Methods: (TI) being a lingering process is associated with an enhanced degree
of exudation,caseation fibrogenesis etc.there may be binding ,obstruction.con-
strictoion,compression of the surrounding inflamed surfaces,also the constitu-
tional symptoms as a consequence of the release of the inflammatory
products.Exudative changes in the cerebrospinal fluid pathways were associated
with features of space occupying lesions. (TI) as pleural, pericardial and
peritoneal; effusions were associated with fibrous bands formation, also
exudative changes in and around the inflammed joint spaces may lead to
interferencewith the function of these structures. In all these cases corticosteroids
with in the therapeutic dose had been associated with a remarkable degree of
improvement without any fibrous residua and prodromal manifestations were
relieved favourably. In relatively seriously ill patients also patients with in the
terminal stages of illness (at the verge of death) from advanced tuberculosis and
inanition,corticosteroids may be indicated purely on humanitarian grounds as
these(CS) detoxicate the patients and allow the chemotherapeutic agent to take
their principal effects. Dosage regimen for adults 40mg/day in divided dose for
the first day then 20mg/day in divided dose for 3Y6weeks to be tapered by 5mg at
3Y5 days intervals.For children 2mg/kg/day for those less 2 years, 1.5mg/kg/day
for those more than 2years but less than 10 years age.
Results: Patients with a reasonably certain degree of diagnosis of (TI), (CS)
in concomitant anti-tuberculosis drugs had a remarkable therapeutic response
evidenced as fall of temperature ,improvement in appetite and vigor.
Conclusion:With un-certain diagnosis of (TI), (CS) may mask the untowards
effect of chemotherapeutic agents,creating a false sense of improvement and
may precipitate steroid dependence.
Clinical Implication: The safety of (CS) is only out of question,if these had
been indicated for the shortest possible time and then tailed off in a step
ladder pattern.*Prednisolon sulphate.
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The prophylactic value of the low dose intravenous
immunoglobulin(IVIG) in reducing the incidence of the
infection in chronic lymphatic leukemia(CLL) and
secondary hypogammaglobulinaemia
M. Ishaq, I. Khan Sameera, and Munir Imran Khan. Al-Junaid Hopsital,
Allergy/Pulmonology, Nowshera, Pakistan.
Objective: In the study concerened low dose of IVIG was as effective as high
dose in reducing the risk of infection in patients with Chronic Lymphatic
Leukemia(CLL) and secondary Hypogammaglobulinaemia without the
inclusion of the control group, behind the idea to assess the IVIG superiority
over the empirical therapy.
Materials and Methods: 5 Patients with CLL with the background of
hypogammaglobulinaemia(IgGG600mg/dl ) with a history of 2 infection
episodes in almost 6 months were included, all had been randomly allocated
to receive regularly an infusion of 300mg/kg IVIG every 4 weeks for 6
months then for financial reasons 4 could not afford the expense while 1 was
continued with the ongoing IVIG schedule.
Results: In response to IVIG there were immediate and accumulative
increase in the serum IgG levels and an associated decrease in total and
serious infections. In the 12 months study only 4 incidence of infection (1
with severe and 3mild) with 1 neutropenia observed. Four patients having
completed 6months IVIG had an overall 50% reduction in the incidence of
infection, while 1 patient with 12 months IVIG had 65%reduction in the
incidence of the infection.
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Conclusion: Infection as the main cause of morbidity and mortality
consequent upon the hypogammaglobulinaemia with the background of
cell mediated immunity was associate with protracted cytotoxic drugs
therapy. In the trials concerened, the protective values of IVIG had been time
related than dose related (longer the period of IVIG therapy les was the
incidence of infection). Bearing in mind the cost, IVIG is only advisable in
pateints with life threatening infection and then too with lower dose to reduce
the expense incur upon the treatment. khan et al aljh nsr nwfp pk.
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A six year old girl with recurrent varicella infections associated
with a mutation in CD16 (FCGR3A, FcyRIIIA)
Suthida Kankirawatana, Yuling Dai, and T. Prescott Atkinson. University of
Alabama at Birmingham, Division of Allergy and Immunology, Department
of, Birmingham, United States.
Background: Natural killer (NK) cells are a subset of lymphocytes that play
a pivotal role in innate immunity. NK cells recognize antibody-coated target
cells using CD16 (FcyRIIIA), and kill the target cells by the process called
antibody-dependent cell-mediated cytotoxicity. Quantitative and qualitative
defects in NK cell function result in susceptibility to intracellular microbes.
Methods: Lymphocyte subpopulations in peripheral blood were determined
using flow cytometry. NK cell surface expression of CD56 and CD16 and the
intracellular expression levels of perforin and granzyme B were analyzed by
flow cytometry. Patient cDNA for CD16 was sequenced to screen for
mutations within the coding region.
Results: The patient is a 6 year-old girl who suffered from recurrent upper
and lower respiratory tract infections. She had experienced two episodes of
varicella despite receiving the vaccine, and, despite this, varicella antibody
was negative. She also has numerous warts on her fingers. Immunologic
studies revealed low serum immunoglobulins (IgG 413, IgA 38, and IgM 37
mg/dL at 42 years), but she had exuberant antibody production in response to
pneumococcal vaccine. Peripheral blood lymphocyte phenotyping revealed
slightly low T cell numbers for age with preservation of the CD4/CD8 ratio, B
cells were normal in percentage and number. CD56+ NK cells were 6 % of
the lymphocyte gate, but the expression of CD16+ was less than 1 % using
Leu11c/B73.1. However, analysis of NK cells using a different antibody to
CD16, NKP46/9E2, revealed normal CD16 surface expression. Sequencing
of peripheral blood cDNA demonstrated a homozygous TA transversion at
base pair 489 in the CD16 mRNA sequence producing a Leu to His
substitution at residue 102 in the peptide sequence, a mutation previously
described in a patient with recurrent orolabial HSV exacerbations and
respiratory infections (Jawahar et al 1996, Clin. Exp. Immunol. 103:408).
Conclusion: Patients with recurrent respiratory infections and panhypogam-
maglobulin-emia with exuberant polysaccharide antibody responses may




Rurikasari Dwi Cahyani1, Andi Amal Alamsyah1, Safruddin Amin1, Muh
Dali Amiruddin1, and Mahmud Ghaznawie2. 1Medical Faculty Hasanuddin
University / Dr. Wahidin Sudirohusodo General Hospital, Dermato-
Venereology, Makassar, Indonesia; 2Medical Faculty Hasanuddin Uni-
versity, Pathology Anatomy, Makassar, Indonesia.
Background: Cicatricial pemphigoid (CP) is a rare autoimmune subepithe-
lial blistering disorder, characterized by predominant involvement of the
mucous membrane and occasionally the skin, chronic course, and tendency
towards scarring of the affected areas. Most common sites of involvement are
oral mucosa and conjunctivae. In our hospital, this is the second case of CP,
and the first case with skin involvement for the last five years.
Case: A 72 years old male had undergone dysphagia and blistering disorder
in the skin for six month. Clinical manifestation were erythematous and
erosions in oral mucous, tongue, and crust in lips. Skin lesions were tense
hemorrhagic blisters with negative Nikolsky sign, erosions and crust in chest,
axilae, abdomen and left lower arm. Few slight atrophic scars were also
found. Pharyngoscopy showed erythematous and brittle of the pharynx, soft
palate and tongue. The histopathology examination showed subepidermal
bullae, epidermal atrophy, sparse perivascular and periappendageal inflam-
matory infiltrates consisted of mostly lymphocytes with few polymorpho-
nuclear leukocytes and eosinophils and fibrosis in the dermis. The patient
favorably responded to oral steroid, prednisone 45 mg daily in combination
with dapsone 100 mg daily, and improved after seven weeks.
Discussion: CP is a rare autoimmune subephitelial blistering disorder,
characterized by predominant involvement of the mucous membrane.
According to the literature, skin involvement in CP occurs in about one-
fourth of cases. Diagnosis in this case was suggested by the presence of
scarring lesions in pharyngeal mucous membrane with dysphagia, slight
atrophic scar in the skin and confirm by histopathology. Prednisone and
dapsone are used due to severe disease and to prevent potential severe
complication.
Conclusion: CP with skin involvement is uncommon. Diagnosis is based on
clinical manifestations and, confirmed by histopathology. Therapy with
prednisone and dapsone shows good result in CP.
Keywords: cicatricial pemphigoid, skin involvement, oral steroid, dapsone
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Prevalence of IgA deficiency in individuals with autoimmune
thyroid diseases and DM TI in Iceland
A´rin E. O¨rno´lfsson1, Gu8mundur H. Jo¨rgensen2, Ari J. Jo´hannesson1, Sveinn
Gudmundsson1, Lennart Hammarstro¨m3, and Bjo´rn R. Lu´dvı´ksson1. 1Uni-
versity of Iceland, Department of Medicine, Reykjavı´k, Iceland;
2
Landspitali-
University Hospital, Department of Immunology, Reykjavı´k, Iceland;
3Karolinska Institutet, Center for Biotechnology, Stockholm, Sweden.
Introduction: IgA deficiency (IgAD) is the most common immunoglobulin
deficiency and one of the most frequent primary immunodeficiencies. The
prevalence of IgAD in Icelandic blood donors has recently been estimated to
be 1:570. Correlations between having IgAD and various autoimmune
diseases, including autoimmune thyroid disease (AITD), have been
rapported.
Materials and Methods: IgA was measured in serum from 319 patients with
thyrotoxicosis and 199 patients with DMTI. In comparison IgA levels from 609
blood donors was evaluated. IgA was measured with Beckman Array 360
System Nephelometry. IgA levels were also studied in relation to titers of TSH
Receptor Antibodies (TRAb) and Thyroid Peroxidase Antibodies (anti TPO).
TRAb was measured with ELISA and anti TPO was measured using FEIA.
Results: None of the 319 thyrotoxicosis patients had IgAD (IgA in serum G
0,05 g/L). Women with thyrotoxicosis had significantly lower levels of serum
IgA compared to men with thyrotoxicosis ([IgA] male = 2,67 T 1,16 g/L vs.
[IgA] female = 2,11 T 1,04 g/L; PG0,001). However, similar gender
difference was also found in the blood donors. IgA levels increased
significantly with age in patients with thyrotoxicosis (PG0,01) and a similar
correlation was found in the blood donor group. A negative correlation was
found between levels of IgA in serum and TRAb (correlation
coefficient=j0.322, P = 0,0455) and also between levels of IgA and
antiTPO (correlation coefficient=j0,376, P = 0,0204). One individual with
DM TI had hypogammaglobulinemia, but none had selective IgAD in that
cohort. Interestingly, men with DM TI had lower serum IgA than women.
Conclusion: These results are a strong indication that the prevalence of IgAD is
not increased amont patients with thyrotoxicosis or DM TI in Iceland. The
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negative correlation between IgA levels and thyroid autoantibodies suggests a
possible role of IgA in the pathogenesis of autoimmune thyroid diseases. IgA
might have a protective role in the formation of autoantibodies against thyroid
structures or a mutual autoimmune mechanism might cause brake-down of IgA
and the formation of thyroid autoantibodies.
POSTER GROUP 2YTUESDAY
ALLERGIC & IMMUNOLOGIC MECHANISMS
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Airway inflammations induced by allergen with LPS are
partially dependent on IL-12, but completely dependent on
STAT4 signalling
Jun Pyo Choi, Jay Hyun Jo, Sun Ok Kang, Jee In Lim, Jung Mi Baek, and
Yoon-Keun Kim. Postech Bioteck Center, Department of Life Sciences,
Pohang, Gyeongbuk, Republic of Korea.
Background: Asthma is a chronic inflammatory disorder of the airways
associated with reversible airway obstruction and airway hyperresponsive-
ness. It has been thought that Th2 response play a critical role in the
pathogenesis of asthma. However, recently, there have been reported that Th1
response also play a important role in pathogenesis of asthma. In Th1 immune
response, IL-12 and STAT4 are key molecules. IL-12 play a important role in
Th1 development, and promotion of Th1 responses and the production of
interferon-gamma. And STAT4 are believed that it also play a important role
in Th1 immune rsponse. But it still remains unclear whether these molecules
play key roles in asthma development in vivo.
Methods: To evaluate the roles of IL-12 and STAT-4 in murine model of
asthma, 6-week-old IL-12 receptor $2 (j/j), STAT4 (j/j) null mutant, and
their littermate wild type control mice were used, respectively. The mice were
sensitized four times with 756g of OVA at days 0, 1, 2, and 7 in the presence or
absence of 106g of LPS, and then challenged 4 times intranasally with 506g of
OVA at days 14, 15, 21, and 22. STAT4 (j/j) and wild type control mice were
sensitized and the challenged in the same manner. After challenging, we tested
the airway hyper-responsiveness (AHR) against methacholine challenge. The
mice were sacrificed 48 hours after last allergen challeng, and various
immunological parameters were evaluated such as BAL fluids cellularity.
Results: Total cell number of BAL fluids was increased in the mice sensitized
with LPS and OVA compared with mice sensitized with OVA only. BAL
fluids flammatory cells were similar between IL-12 receptor l$2 knock-out
mice and wild type mice, but significantly decreased in STAT4 null mutant
mice. Interestingly, IP-10 level in BAL fluids was partially decreased in IL-12
(j/j) mice, but markedly decreased in STAT4 (j/j) mice.
Conclusion: In Th1 experimental asthma, airway inflammatory responses are
partially dependent on IL-12, but dependent on STAT4 signaling pathway.
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The role of the sensitized alveolar macrophage in
T cell proliferation
Bo Ram Bang, Eunyoung Chun, Heung-Woo Park, Yoon-Seok Chang, Sun-
Sin Kim, Sang-Heon Cho, Kyung-Up Min, and You-Young Kim. Seoul
National University, College of Medicine, Institute of Allergy and Clinical
Immunology, Seoul, Republic of Korea.
Background: It is well known that alveolar macrophage (AM), which
composes more than 90% of the bronchial alveolar cells, is the first barrier
protecting lung from the harmful antigens. However, few different studies
suggest that sensitized alveolar macrophage could exacerbate the asthma
phenotype such as airwayhyperresponsiveness (AHR). The exact roles of
alveolar macrophages in asthma have been unknown. Thus we undertook to
determine whether sensitized alveolar macrophage could induce T cell
proliferation in asthma animal model.
Methods: BALB/Cmice were intraperitoneally sensitized by ovalbumin with
alum on day1 and 7, followed by challenge with 1% ovalbumin on day 21, 22,
and 23. The lung cells were isolated and analysed by FACS analysis. T cells
isolated from the bronchial lymph node and bronchial alveolar lavage (BAL)
cells were cocultured with or without ovalbumin in vitro in order to determine
ability of sensitized alveolar macrophages to induce T cell proliferation.
Results: After challenge, the percent of CD11chigh/CD11blow lung cells
(alveolar macrophage) were not changed, but the MHC II expression of
CD11chigh/CD11blow lung cells increased compared to PBS group. The
proliferation of T cells increased 3 times in IP group than other groups
without stimulation of ovalbumin. Furthermore, the BAL cells of IP group
with stimulation of ovalbumin induced 8 times increase of T cell proliferation
compared to that of other groups.
Conclusion: It is suggested that the sensitized alveolar macrophages in BAL
could facilitate the proliferation of T cells in asthma animal model.
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Toll-like receptor 2, 4, and 6 expression and function in
peripheral blood mononuclear cells from asthma patients
Eun-Jin Shim, Eunyoung Chun, Heung-Woo Park, Sun-Sin Kim, Yoon-Seok
Chang, Sang-Heon Cho, You-Young Kim, and Kyung-Up Min. Seoul
National University, College of Medicine, Institute of Allergy and Clinical
Immunology, Seoul, Republic of Korea.
Background: Asthma is a chronic inflammatory lung disease that is caused
by impairment of adaptive immune system like many immunologic diseases.
However, the pathogenesis of this unwanted response has not well
determined. Toll-like receptors have been shown to play a pivotal role in
both innate and adaptive immune responses. Recently, many research groups
have hypothesized that these TLRs are likely to play important roles in
asthma pathogenesis, but, most studies are focused on the effect of TLR
polymorphism. Therefore, we investigated whether the expressions of several
TLRs are different in asthma patients compared to normal subjects and if so,
whether the functionality of these receptors could be related to this change.
Methods: The expressions of TLR2, 4, and TLR6 on peripheral blood
mononuclear cells (PBMCs) from asthma patients and normal subjects were
analyzed by flow cytometry. To study the functional responses of these
receptors, PBMCs were stimulated with PGN and Pam3Cys as TLR2 ligands,
LPS as a TLR4 ligand or FSL-1 as a TLR2/6 ligand for 24 hours and the
amounts of TNF-" and IL-1$ were determined by ELISA.
Results: The expression of TLR2 was up-regulated on PBMCs from asthma
patient as compared to normal subject. Upon stimulation with PGN or
Pam3Cys, TNF-" and IL-1$ production significantly increased in asthma
patients. In contrast, the response to LPS (TLR4 ligand) stimulation on
PBMCs was higher in normal subject than asthma patients, although the
expression of TLR4 was not significantly different between asthma patients
and normal subject. In case of TLR6, surface expression was significantly
reduced in asthma patients. However, no difference was observed in the
amounts of TNF-" and IL-1$secreted from PBMCs treated with FSL-1.
Conclusion: Our data suggest that the difference of the phonotypical
expression and the functional responsiveness of TLRs might be related with
pathogenesis of asthma.
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Influences of anti-IgE antibody omalizumab on
allergen-induced airway inflammation and bronchial
hyperresponsiveness in murine models of asthma
Oleksii Korzh, and Olena Pavlova. Kharkov Medical Academy of Postgraduate
Education, Internal Diseases and Clinical Pharmacology, Kharkov, Ukraine.
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Background: The aim of this study was to examine the effects of treatment
with omalizumab, an anti-immunoglobulin E antibody, on allergic-airway
responses in mice after inhalation of the naturally occurring aeroallergen
Aspergillus fumigatus (Af) and to examine the effects of omalizumab on
specific immune responses to a defined protein antigen with the use of an
ovalbumin (OVA) model of asthma.
Methods: Mice were subjected either to repeated, intranasal application of
Af extract or to intraperitoneal immunization with OVA, followed by
inhalation challenge. Omalizumab or a control fluid was given daily
throughout the sensitization process. Immunoglobulin E (IgE) levels,
bronchoalveolar lavage-fluid cytokines and cytology, lung histology, and
physiologic responses to methacholine were assessed in the allergen-treated
mice. Anti-OVA IgE responses and OVA-driven T-cell cytokine production
were examined.
Results: Treatment with omalizumab did inhibit bronchial inflammation and
bronchial hyperresponsiveness in both Af- and OVA-treated mice. This
inhibition required that omalizumab be administered concurrently with
allergen sensitization, indicating that the attenuation of bronchial hyperre-
sponsiveness and inflammation was not caused by anticholinergic receptor
effects. OVA-responsive T cells from omalizumab-treated mice exhibited
depressed production of IL-4, IL-5, and IL-13 and normal amounts of
interferon-gamma. The amounts of IL-5 and IL-13 were also diminished in
the bronchoalveolar lavage fluid.
Conclusion: Omalizumab, given at the time of exposure to the allergen,
inhibits the induction of allergic pulmonary inflammation, and bronchial
hyperresponsiveness. These results suggest that omalizumab or similar agents
given during times of antigen exposure might alter disease progression in
patients with respiratory allergy.
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The non-proteolytic major house dust mite allergen Der p 2
induce proasthmatic responses in bronchial epithelial cells
partly through NF-0B and MAPK pathways
Camilla Osterlund1, Hans Gronlund2, Sofia Sundstrom2, Guro Gafvelin2,
and Anders Bucht1. 1FOI CBRN Defence and Security, Resp. Medicine and
Allergy, University Hospital, Umea˚, Sweden; 2Karolinska Institute, Dep. of
Medicine, Clinical Immunology and Allergy, Stockholm, Sweden.
Background: House dust mites (HDM) belong to the most common sources
of airborne allergens worldwide and sensitization to them is strongly
associated with development of allergic airway diseases. Many proteolytic
HDM allergens can activate respiratory epithelial cells to produce pro-
inflammatory mediators. In contrast there is limited knowledge regarding
potential similar effects of non-proteolytic allergens, although they include
many major allergens. One of them is Der p 2 of Dermatophagoides
pteronyssinus. To investigate whether Der p 2 activate respiratory epithelial
cells to produce mediators involved in pathogenesis of allergic asthma and to
elucidate the mechanism of such activation, we exposed the human bronchial
epithelial cell line BEAS-2B to this allergen.
Methods: Bronchial BEAS-2B cells were exposed to recombinant Der p 2
(1-80 6g/ml). After 2-24 hours the mRNA levels and the secreted amount of
soluble mediators as well as the expression of cell adhesion receptors
involved in recruitment, survival and binding of inflammatory cells, for
instance GM-CSF, IL-6, IL-8, MCP-1, MIP-3" and ICAM-1, were analyzed.
After exposure the adhesion of leukocyte cells U937 to the epithelial cells
was also studied. In order to study if the activation was dependent on
signalling through NF-0B and the MAP kinases ERK1/2, p38 or JNK specific
inhibitors were used.
Results: Der p 2 induced dose-dependent up-regulation in gene expression
and protein secretion of granulocyte-macrophage colony-stimulating factor
GM-CSF, IL-6, IL-8, MCP-1 and MIP-3". Expression of ICAM-1 was also
up-regulated, which was associated with a subsequent increased adhesion of
leukocytes to the epithelial cells. These responses were partly dependent on
NF-0B and MAPK activation, since the specific inhibitors reduced the
activation.
Conclusion: Taken together these results imply that Der p 2 may potentiate
asthmatic responses in airways by direct activation of lung epithelial cells in a
protease-independent manner.
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House dust mite (Dermatophagoides pteronyssinus) increases
expression of pro-inflammatory cytokines in the human
eosinophil cell line, EoL-cells
Ji-Sook Lee1, In Sik Kim2, Joo-Hwan Kim2, Dong Hee Kim3, Ki-Beom
Suhr4, Hye-Jin Choi1, Ji-Sun Ryu1, Dong-Hwan Seo1, and Chi-Young Yun1.
1Daejeon University, Department of Biology, Daejeon, Republic of Korea;
2School of Medicine, Eulji University, Department of Biomedical Laboratory
Science, Daejeon, Republic of Korea; 3College of Oriental Medicine,
Daejeon University, Department of Pathology, Daejeon, Republic of Korea;
4CnU Skin Clinic, Atopy, Daejeon, Republic of Korea.
Human eosinophils play important roles in the pathogenesis of
allergic diseases, specifically asthma. Interleukin 6, IL-8 (CXCL8), and
Monocyte chemotactic protein 1 (MCP-1/CCL2) play a pivotal role in
mediating the infiltration and activation of immune cells into pathogenic
lesions, including the lung and skin. The aim of this study was to examine
whether the house dust mite Dermatophagoides pteronissinus extract (DpE)
affects the mRNA and protein expression of IL-6, IL-8 and MCP-1 in the
human eosinophil cell line, EoL-1 by performing RT-PCR and ELISA. DpE
increased the mRNA and protein expression of IL-6, IL-8 andMCP-1 in EoL-
1 cells. The increased expression of MCP-1 and IL-8 was inhibited by PP2, an
inhibitor of Src, rottlerin, an inhibitor of protein kinase C & (PKC&), and
PD98059, an upstream inhibitor of extracellular-signal-regulated kinase
(ERK). It indicates that DpE increases MCP-1 and IL-8 expression through
Src, PKC & and ERK. We also found that IL-6 expression due to DpE was
related to Src, PKC &, and p38 mitogen-activated protein kinase (MAPK). In
early signal pathway, the expressions of IL-6, IL-8 and MCP-1 are regulated
by Src family tyrosine kinase and PKC & pathway activated by DpE. This
finding may contribute to the elucidation of the pathogenic mechanism
triggered by DpE.
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Perturbations of NK cell regulatory functions in respiratory
allergic diseases
Francesca Scordamaglia1, Antonio Scordamaglia1, Maria Cristina Mingari2,
Lorenzo Moretta2, Giorgio Walter Canonica1, and Massimo Vitale3.
1University of Genoa, Allergy and Respiratory Diseases, Genoa, Italy;
2University of Genoa, Sperimental Medicine (IST), Genoa, Italy; 3National
Institute on Cancer Research, Sperimental Oncology (IST), genoa, Italy.
Background: Allergic diseases are characterized by abnormal responses to
allergens favored by an inappropriate regulation of the Th1-Th2 polarization.
NK cells give rise to a complex NK/DC cross-talk that would help Th1
response. By analyzing Peripheral Blood NK cells from 12 patients suffering
from either allergic rhinitis or rhinitis and intermittent asthma, we evaluated
whether, these cells were impaired in their ability to interact with DC.
Methods: Different circulating NK cell subsets were analyzed by flow
cytofluorimetry. Mixed NK/DC cultures were performed to assess the
reciprocal functional interactions. NK cells were analyzed for their ability to
induce DC maturation and cytokine production, and to kill immature DC. In
addition, DC were assessed for their ability to induce cytokine production by
NK cells.
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Results: We first analyzed the CD56+CD16+/jcells: a subset of circulating
NK cells that is able to respond to DC by proliferating and producing IFN-,.
Our analysis revealed that this NK cell subpopulation was sharply reduced in
most patients. This was reflected by reduced NK cell-mediated IFN-,
production in response to DC. Also the capability of promoting DC
maturation and/or to kill immature DC, a function sustained by CD56+
CD16+NK cells, was reduced in most patients.
Conclusion: We suggest that allergic diseases are accompanied by a partial
impairment of the NK cell capability of promoting and maintaining
appropriate Th1 responses.
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Humoral and cellular immune responses to blomia tropicalis and
its concanavalin a-binding fractions in atopic patients
Ernesto Taketomi1, Ronaldo Alves1, Deise Silva1, Jorge Fernandes1, Karine
Almeida1, Leandro Ynoue1, Cristiane Bernardes1, Priscila Moreira1, Moˆnica
Sopelete1, Margareth Gennari-Cardoso2, and Sun-sang Sung3. 1Federal
University of Uberlaˆndia, Laboratory of Allergy and Clinical Immunology,
Uberlaˆndia, Brazil; 2State University of Santa Cruz, Immunology, Ilhe´us,
Brazil; 3University of Virginia, Rheumatology and Immunology, Charlottes-
ville, United States.
Background: Blomia tropicalis (Bt), Dermatophagoides pteronyssinus (Dp)
and D. farinae (Df) are the prevalent house dust mites (HDMs). Concanavalin
A-binding components derived from B. tropicalis (Bt-ConA extract) have
shown to be highly immunogenic in allergic diseases. This study aimed to
evaluate the humoral and cellular immune responses to B. tropicalis in
sensitized patients.
Methods: A total of 137 patients with allergic rhinitis with/without asthma
and 109 non-atopic subjects were selected and analyzed for skin reactivity
(SPT), total serum IgE and specific IgE levels to both Bt-total and Bt-ConA
extracts, proliferative response and cytokine (IFN-+ and IL-5) production by
peripheral blood mononuclear cells stimulated with both extracts.
Results: SPT showed that 70% of patients were sensitized to Bt (Bt+) and no
patient was monosensitized to Bt. Similar levels of specific IgE to Bt-total and
Bt-ConA extracts were found in Bt+patients, while higher levels of total serum
IgE were found in atopic than non-atopic subjects. Significant PBMC
proliferation was observed in response to Bt-total extract in Bt-sensitized, but
not in Bt-non-sensitized patients and non-atopic subjects, while Bt-ConA
extract was able to induce increased proliferative responses in all patient
groups. Significant IFN-+ production was observed only after Bt-ConA
stimulation in Bt+patients, while Bt-total extract showed no changes. IL-5
production was consistently seen in Bt+patients after allergen-specific
stimulation or even with no stimulus.
Conclusion: We can conclude that Bt-ConA extract may contain relevant
antigens that are involved in both humoral and cellular immune responses,
with potential use in diagnostic procedures.
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Inhibitory action of epinastine hydrochloride on eosinophil
survival in vitro
Ken-ichi Kanai1, So Watanabe1, Atsuko Furuta1, Kazuhito Asano2, and
Harumi Suzaki1. 1Showa University, Otorhinolaryngology, Tokyo, Japan;
2Showa University, School of NRS, Division of Physiology, Tokyo, Japan.
Background and Purpose: Eosinophils are well accepted to be the most
important cells in the development and maintenance of the clinical conditions
of allergic diseases such as allergic rhinitis and asthma. It is also accepted that
nasal mucosal epithelial cells secrete several types of cytokines and
chemokines, which affect eosinophil accumulation into the site of the disease
and cell survival. However, the influence of second-generation antihistamines,
which are used for the treatment and prevention of allergic diseases are not
well understood. The present study, therefore, was undertaken to evaluate the
influence of epinastine hydrochloride (EP), the most famous second-
generation of antihistamine in Japan, on cytokine secretion and eosinophil
survival.
Materials and Methods: Epithelial cells from nasal polyps were stimulated
with 25 ng/ml TNF-! with or without EP for 24 h. Cytokine levels in culture
supernatants were examined by ELISA. Human peripheral blood eosinophils
were cultured with epithelial cell conditioned medium (CM) and EP.
Eosinophil survival was assessed by Trypan blue dye exclusion test. Results
are expressed as the mean SE of cytokine concentrations (pg/ml) and
eosinophil survival index (%).
Results: Addition of EP into cell cultures dose-dependently inhibited the
ability of cells to produce granulocyte-macrophage colony stimulating factor
(GM-CSF), vascular endothelial growth factor (VEGF) and IL-8, which are
increased by TNF-! stimulation. EP also could inhibit eosinophil survival
induced by CM and the minimum concentration of EP that caused significant
suppression of the survival was 20.0 ng/ml.
Conclusion: The inhibitory effect of EP on inflammatory cytokine production
from epithelial cells and on eosinophil survival contributed to its therapeutic
effect on allergic airway diseases, including allergic rhinitis.
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Inhibitory action of epinastine hydrochrolide on the production
of anti-angiogenesis factors from mouse peritoneal mast cells
in vitro
Atsuko Furuta1, Ken-ichi Kanai1, Kazuhito Asano2, and Harumi Suzaki1.
1Showa University, Otorhinolaryngology, Tokyo, Japan; 2Showa University,
Division of Physiology, School of NRS, Tokyo, Japan.
Background: H1 receptor antagonists, so called antihistamine, are accepted to
have anti-angiogenesis properties in addition to being H1 antagonists.
Epinastine hydrochloride (EP) is the most famous H1 receptor antagonists
in Japan and used for treatment of allergic upper airway inflammatory diseases
such as pollinosis with remarkably success. However, the influence of EP on
pro-angiogenesis factor production is not well understood. In the present
study, therefore, we investigate the influence of EP on the production of
angiogenesis factors, vascular endothelial growth factor (VEGF), keratino-
cyte-derived chemokine (KC) from murine mast cells in vitro.
Materials and Methods: Murine mast cells were stimulated with ovalbumin
in the presence of various doses of EP for 24 h. The levels of vascular
endothelial growth factor (VEGF), keratinocyte-derived chemokine (KC) and
tumor necrosis factor (TNF)-! levels in culture supernatants were examined by
ELISA. mRNA expressions of these factors were also examined by
semiquantitative RT-PCR in 4 h-cultured mast cells.
Results: EP could suppress the production of VEGF, KC and TNF-! induced
by an IgE dependent-mechanisms in dose-dependent manner. The minimum
concentration of the agent that caused significant suppression was 45ng/ml. EP
also suppressed mRNA expression examined when the agent was added to cell
cultures at a dose of 45 ng/ml.
Conclusion: These findings strongly suggest that anti-angiogenesis activity of
EP may confer the attenuating effect of the agent on allergic diseases,
including allergic pollinosis.
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Reduced levels of total serum IgE and FcRI expression in
releaser and non-releaser basophils
Pawan Kumar1, Bharat Singh2, Rup Lal3, G.W. Rembhotkar4, and Anand
Bahadur Singh1. 1Institute of Genomics and Integrative Biology, Aerobiology
and Allergy, Delhi, India; 2University College of Medical Sciences, Blood
Bank, Delhi, India; 3University of Delhi, Deparment of Zoology, Delhi, India;
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4Institute of Genomics and Integrative Biology, Central Instrumentation
Facility, Delhi, India.
FcRI mediated signal pathway in basophils and mast cells leads to
release of histamine and other mediators in-vitro and in-vivo systems.
Interestingly, basophils from 18-20% of the population do not release
histamine and other mediators on activation of the IgE signal transduction
pathway and this has been attributed to the absence of tyrosine kinases
Lyn and Syk. The present work deals with the histamine releasibility in
Indian subjects to assess relationship between releasers and non releaser
basophils with expression of FcRI and total serum IgE levels.Basophils
from peripheral blood of healthy adults was purified by density gradient
centrifugation and negative immuno- selection technique. Histamine
release assay was performed flourometrically. Assessment of IgE receptor
expression was carried out by flowcytometry and total serum IgE was
estimated by ELISA method.Histamine release after ConA challenged
varied from 0Y100% in Indian subjects. Eighteen percent subjects showed
less than 5% histamine release and were considered non-releasers while
those with more than 20 % were considered as releasers. Flowcytometric
analysis revealed a significantly reduced expression of FcRI in non
releaser basophils (p G 0.05 ). Interestingly, total serum IgE levels were
also significantly (p G 0.05) reduced in non-releasers suggesting a
common regulator of the phenotype. An in depth evaluation could lead to
identification of a potential target for the development of therapeutics for
allergic patients.
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An Investigation into the interaction of IgE with truncated
recombinant CD23 (Fca˚RII) fragments
Naser Nazari. Kermanshah University of Medical Sciences, Department of
parasitology, Medical School,, Kermanshah, Islamic Republic of Iran.
CD23, low-affinity receptor for IgE, has been widely implicated in the
synthesis of IgE as well as in IgE-mediated immune and inflammatory
functions. There are two forms of CD23 in humans-CD23a and CD23b, their
cell expression and functional activities are different. Structurally, CD23
presents a single membrane-spanning domain followed by an extracellular
domain that consists of three regions: the a´-helical coiled coil stalk region,
which mediates the formation of trimers, followed by the lectin head, which
binds IgE, and at the C terminus, a short tail containing an inverse RGD (Arg-
Gly-Asp) sequence.
Aims of the project is to express defined truncated fragments of CD23
and to assess the physical and biological properties of these truncated
fragments with regard to: IgE independent mast cell /basophile secretayogue
activity. After obtaining all the necessary information concerning the different
generation of CD23 fragments as well as the vector PET-14 and pIRES-EGFP,
the appropriate primers were designed. The primers are essential for PCR
amplification of the desired sequences and for subsequent cloning into the
PET-14 and pIRES vectors.
CD23 a and b YRGD sequence and also the whole things of CD23 a
and b have been cloned into pIRES vector for transfection and subsequent
evaluation of IgE in functional assays. Overlap PCR was used to produce the
different truncated fragments of CD23 molecule, consisting of CD23 a and b
minus the RGD sequence ( adhesion part).
In the meantime, the plasmid vectors PET-14 and pIRES were
introduced to XL1-E.coli cells in order to be obtained using the Mini and Midi
preps protocol (gene transfection). Their DNA and protein was purified and
obtained the characterisation by electrophoresis.
CD23 a and b- RGD sequence and their whole things was transfected
into the J558L (mouse myeloma cells) in order to study of expression of EGFP
and biological activity by FACS (Fluorescence activated cell sorting) and
FACS analysis for investigating the interaction of the IgE with different
expression of CD23. Binding of IgE-Fc fragments to cell surface and
expressed human CD23 were assessed using flow cytometry to detect the
binding of IgE to cell surface receptors, using a biotinylated anti-IgE, followed
by a streptavidin phycoerythrin conjugate.
The results show that there is no expression of CD23 a- RGD sequence
on J558L cells and these cells can express CD23 b-RGD sequence but it is not
stable.
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Allergenic and hypoallergenic isoforms of the major birch pollen
allergen Bet v 1 are differentially uptaken by DCs of allergic and
healthy individuals
Ursula Smole1, Nina Balacz1, Esther C. de Jong2, Martien L. Kapsenberg2,
Otto Scheiner3, Karin Hoffmann-Sommergruber3, Heimo Breiteneder3, and
Stefan Wagner3. 1Center for Physiology and Pathophysiology, Medical
University of Vienna, Department of Pathophysiology, Vienna, Austria;
2Academic Medical Center, University of Amsterdam, Department of Cell
Biology and Histology, Amsterdam, Netherlands; 3Medical University of
Vienna, Center of Physiology and Pathophysiology, Department of Patho-
physiology, Vienna, Austria.
Background: The major birch pollen allergen Bet v 1 is present in structurally
slightly different isoforms that vary in their allergenic properties. Whereas Bet
v 1a represents a potent allergen, the naturally occurring isoforms Bet v 1d and
the engineered Bet v 1mut display strongly reduced allergenic activity.
Although the biology of T cells in allergy is well understood, little is known
about the mechanisms that control the initial T cell polarization by DCs in
response to allergens.
Objective: The present study investigated the different properties of Bet v 1
isoforms to be uptaken by human monocyte-derived DCs (MoDCs) of birch
pollen allergic and healthy individuals.
Methods: Eight birch pollen allergic and 7 healthy donors were included in
this study. MoDCs generated from peripheral blood and taken at day 7 of
differentiation were incubated with various concentrations of fluorescein
isothiocyanate (FITC)-labeled recombinant Bet v 1a, Bet v 1d, and Bet v 1mut
for 10 to 120 minutes at 37-C and studied by means of flow cytometry.
Mechanisms of antigen internalization were investigated by the same
experimental setup in the presence of inhibitors of pinocytosis, endocytosis,
and receptor internalization.
Results: FITC-labeled proteins were taken up by MoDCs in a dose-and time
dependent manner. The percentage of FITC positive cells increased from 1 to 5
2g/ml of labeled proteins whereas the cells internalized most proteins between
10 and 30 minutes. At the lowest concentration of 1 2g/ml, the uptake of Bet v
1a was lower compared to the uptakes of Bet v 1d and Bet v 1mut in DCs of
both study groups. This fact did not change for healthy individuals when
higher concentrations of proteins were used whereas in allergic individuals Bet
v 1a uptake at higher concentrations was similar to that of the two other
isoforms. Inhibition of the uptake was generally lower using DCs from allergic
compared to those of healthy individuals.
Conclusion: All different agents showed inhibitions indicating that the uptake
of Bet v 1 isoforms is not only mediated via one pathway but an interplay of
mechanisms like receptor-mediated internalization, endocytic processing and
macropinocytosis. Our observations implicate that different mechanisms are
involved in Bet v 1a uptake in allergic individuals possibly leading to the
induction of signals for Th2 polarization. This study was supported by the SFB
F1802 of the Austria Science Fund and the Austrian Academy of Sciences.
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HLA-DRB1 polymorphism in atopic dermatitis with egg white
allergy in korean children
Hwa Young Park1, Myoung Hee Park2, Kang Mo Ahn3, and Sang I.L. Lee3.
1Eulji University/Eulji General Hospital, Pediatrics, Seoul, Republic of
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Korea; 2Seoul National University/Seoul National University Hospital,
Clinical Pathology, Seoul, Republic of Korea; 3Sungkyunkwan University/
Samsung seoul Hospiral, Pediatrics, Seoul, Republic of Korea.
Purpose: It is known that polymorphism of the human leukocyte antigen
(HLA) class II can restrict specific IgE responses. We investigated whether
particular HLA-DRB1 polymorphisms contribute to the development of AD
and EW sensitization in Korean children with AD.
Methods: A total of 185 patients with AD and 109 normal controls (NC)
with no personal and family history of allergy were included. HLA-DRB1
typing was done using PCR-SSO (sequence specific oligonucleotide) and
PCR-SSCP (single strand conformation polymorphism) methods. Pheno-
type frequencies of the HLA-DRB1 alleles of AD patients were compared
with those of NC. AD patients with allergy to EW was defined as group
A (96 patients) whose EW specific IgE was over 2 kU/L in less than 2
year old age and over 7 kU/L in greater than 2 year old age. Group B
(89 patients) was defined that EW specific IgE was negative among AD
patients. Phenotype frequencies of the HLA-DRB1 alleles in group A and
group B were compared with those of NC. HLA-DRB1 alleles were
classified into functional groups (A, De, Dr, E, Q, R, a) and frequencies
of HLA-DRB1 functional groups in group A and group B were compared
with those of NC.
Results: HLA-DRB1*1101 was present at significantly higher frequency
in AD patients compared with NC (12.4% vs 1.8%, P=0.002, OR=7.796,
CI 1.775Y32.883) and was regarded as a factor associated with AD
susceptibility. The result was significant after Bonferroni correction
(Pc=0.048). The frequency of HLA-DRB1*0803 (10.8% vs 19.3%,
P=0.043) was decreased in AD compared with NC, showing a weak
protective effect against the development of AD. HLA-DRB1*0802 was
decreased in group A compared with group B (2.1% vs 10.1%, P=0.021)
and was regarded as a weak protective factor against the development of
egg allergy in AD. HLA-DRB1*1501 was increased in group A compared
with group B (22.9% vs 11.2%, P=0.036) and was regarded as a weak
susceptibility factor associated with the development of egg allergy in AD.
HLA-DRB1 functional group "a", in which DRB1*1501 is included, was
also weakly associated with the development of egg allergy in AD.
However, none of theses results remained significant after Bonferroni
correction.
Conclusion: There was a significant association between HLA-DRB1*1101
and AD. Weak association between HLA-DRB1*1501 with susceptibility to
and HLA-DRB1*0802 with protection against the development of EWallergy
in AD were observed.
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Participation of indicators of sensitized T lymphocytes in
diagnosis IgE independent and IgE dependent cow’s milk allergy
in children
Maria Golebiowska-Wawrzyniak1, Katarzyna Markiewicz1, Agata Kozar1,
Marta Pojawa1, Jolanta Waclawek1, Krystyna Jastrzebska-Janas1, Iwona
Czerwinska-Kartowicz1, Krzysztof Rytwinski1, Piotr Derentowicz1, and
Zbigniew Wawrzyniak2. 1Institute of Mother and Child, Department of
Clinical Immunology, Warszawa, Poland; 2Medical University of Warsaw,
Faculty of Health Science, Warszawa, Poland.
Background: Food allergy is an abnormal response of immunological
system, especially of mucosa immunological system on antigens supplied
per os. There are very complicated and still unexplained to the end
immunological mechanisms, which lead to hypersensitivity reaction. Most
often food hypersensitivity is identified as the effect of atopy, which is
connected with humoral response (specific IgE antibody). On the contrary
cell immunological response are less investigated, however they can be
very important, especially as a significant factor to initiate pathological
allergic processes.
Aim: The study concern the usefulness of flow cytometry to estimate specific
sensitization of subpopulation of lymphocytes to food allergens in the allergy
diagnosis.
Methods: The investigations were performed on 60 children since 6 month to
5 years old: 20 children with CMA IgE dependent, 20 with CMA IgE
independent and 20 healthy children. IgE total, sIgE, IgG, IgA, IgM, basic
immunological panel, CD 23, CD25, CD26, CD30, CD69, PCNA were
measured.
Results: We noticed decrease of expression of CD4+CD30+between I and II
examine (p=0,029), between I and III (p=0,009); decrease of expression of
CD8+CD26+between I and III test (p=0,038); decrease of expression of
CD19+CD23+between I and II examine (p=0,012) in I type of hypersensi-
tivity. We observed decrease of expression of CD4+CD25+between I and III
examine (p=0,026) and decrease of expression of CD4+CD26+between I and
III examine (p=0,036) in IV type of hypersensitivity. Expression of CD69 was
decreased after diet in allergy IgE dependent. Values of expression of PCNA
are similar in I and IV type of hypersensitivity in children with CMA. Decrease
of expression of PCNA in II examine was observed in both cases. Allergen
reintroduced caused increase of expression of PCNA in both types of allergy
(p=0,048 and p=0,041).
Conclusion: Our recent research confirm changes of the expression of T
lymphocytes activation markers. It is connected with in vivo stimulation to
allergen or with allergen elimination. The study of expression of activation
markers using flow cytometry in food allergy in children can be helpful in
observation of the dynamic progress process, but it cannot be used as a single
diagnosis test.
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Probiotic components can induce the Th1 polarization through
keratinocytes
Yoon Sung Kang, Yoon Young Kim, Hyung Ok Kim, and Young Min Park.
Kangnam St. Mary’s Hospital, College of Medicine, The Catholic University
of Korea, Dermatology, Seoul, Republic of Korea.
Background: Probiotics are defined as live non-pathogenic microorganisms
that beneficially affect the host. It has been suggested that administration of
probiotics may have therapeutic and/or preventive benefits by improving the
Th1 responses in atopic dermatitis (AD).
Aim: We investigated the possibilities that skin can be used as a target for the
prevention of AD and Lactobacillus rhamnosus, one of the most commonly
used in the therapeutic intestinal probiotics, can induce the Th1 responses
through keratinocytes.
Methods: Keratinocytes were treated by L. rhamnosus for 2 hours and then
cultured with new media for 24 hours. The supernatant (KCM) of L.
rhamnosus-treated keratinocytes were collected and used for the maturation
of immature dendritic cells from 5 normal and 5 AD individuals. CD14+
cells and naive T cells were isolated from peripheral blood of normal and
AD individuals using isolation kits. CD14+cells were differentiated to
immature dendritic cells (iDCs) with GM-CSF (200 ng/ml) and IL-4 (20 ng/
ml) for 6Y7 day. The iDCs were activated by KCM or LPS lipopolysacchar-
ide (LPS) (positive control) for 48 hours and cocultured with naive T cells
for 7 days.
Results: We could confirm the maturation of iDCs by KCM and LPS through
morphological changes and the expression of mature DC specific markers
(CD80, CD83, and CD86) in normal and AD individuals. ELISA analysis
showed that the mature DCs activated by KCM could induce the Th1 reponses.
So, the IFN-+ was significantly increased in the co-cultured supernatants of
mature DC and naive T cells, but IL-4 level was almost based. Furthemore, we
found that IL-8 and HBD-3 were highly increased in keratinocytes after L.
rhamnosus treatment.
Conclusion: Probiotics, L. rhamnosus, can improve the Th1 responses
through keratinocytes. The effects of probiotics will be mediated by IL-8 and/
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or HBD-2 secreted by keratinocytes. However, there is no difference for the
effects of probiotics between normal and AD individuals.
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Interaction of aeroallergens with the respiratory interphase:
degradation, processing and transmission via the
epithelial barrier
Arnd Petersen1, Kristina Ro¨schmann2, Torsten Goldmann3, Florian
Schiemann4, Artur Jochen Ulmer2, and Wolf-Meinhard Becker1. 1Research
Center Borstel, Molecular and Clinical Allergology, Borstel, Germany;
2Research Center Borstel, Cellular Immunology, Borstel, Germany; 3Research
Center Borstel, Clinical and Experimental Pathology, Borstel, Germany;
4
Research Center Borstel, Biological Chemistry, Borstel, Germany.
Background: Antigen presenting cells are considered as the most important
immune cells giving rise to allergy or tolerance development. But APCs are
already embedded in a cytokine milieu, which in part predicts the immune
response. Epithelial cells form a barrier to the environment and they are
activated upon contact with molecules e.g. allergens. Therefore, they might
play a pivotal role in the sensitization process. We studied the fate of the major
grass pollen allergen Phl p 1 and its molecular modifications after contact with
the respiratory interface.
Methods: The influence of mucosal secretions (nasal secretion, bronchial
lavage fluid) was investigated by immunoblotting and zymography and the
uptake and transmission of the allergens by epithelial cells (cell lines and nasal
and lung biopsies) were studied by FACS analysis, determination of cytokine
release and immunohistology.
Results: Nasal secretions of individuals suffering from bronchial inflamma-
tions or allergy to aeroallergens showed proteolytic activity. Experiments using
supernatants from mast cells or neutrophils, similar to acute inflammation,
resulted in a partial cleavage of the allergens. To investigate the allergen uptake
two epithelial cell lines were used mimicing different sections of the lung,
A549 (derived from alveolar pneumocytes) and Calu-3 (from the upper
respiratory epithelium). Both cell lines were activated by Phl p 1 as
demonstrated by the release of IL-8 and IL-6. Calu-3 cells in contrast to
A549 cells expressed MHCII, a prerequisite for antigen processing and
presentation. A549 cells, on the other hand, take up allergens by
macropinocytosis and probably perform transcytosis. First results of human
lung slices incubated with Phl p 1 showed only a faint allergen uptake, while
macrophages in the alveolar space showed a considerable uptake. Whether
macrophages after allergen uptake enter the interstitium again and/or whether
the epithelial cells transfer allergens or fragments to professional APCs in the
interstitium is still under investigation.
Conclusion: The secretions of the respiratory tract cause a more or less
incomplete fragmentation of allergens which may facilitate the allergen uptake
by epithelial cells. Our results reveal differences in the uptake and transmission
of allergens in the upper and lower airways. While the epithelial cells of the
upper part probably degrade and process the allergens, cells of the lower part
seem to transmit the unprocessed allergens.
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The level of IL-6 and its soluble receptor at children with
atopic march
Elena Markelova1, Anna Kostyushko1, Natalya Derbasova2, and
Elena Prosekova1. 1Siberian Branch of Russian Academy of Medical Science,
?The Fareastern scientific centreX, Research Insti, Vladivostok, Russian
Federation; 2Hospital, Allergic Center, Vladivostok, Russian Federation.
The estimation of influence of various programs of therapy on
system and local level IL-6 and SR-IL-6 was made at development atopic
march of teenager patients. The research allowed to reveal, that therapy with
the help of topical steroids practically did not influence SR-IL-6 level in
serum of blood (22,72T0,25ng/ml), but led to decrease in IL-6 level at
patients with BA (0,17T0,001 pg/ml) and combination BA` and A`R
(3,59T0,37 pg/ml). At combination of BA` and A`R the simultaneous
decrease of IL-6 and SR-IL-6 was established while using topical steroids.
On the contrary, having clinical BA` and AD evidence steroid therapy led to
one-stage increase cytokine (6,45T0,41pg/ml), and level of receptor to it
(31,76T0,15ng/ml). Thus, research of nasal lavage can be offered as
nonivasive method for the control of efficiency of therapy of patients having
combination BA` and A`R while using topical steroids. Therapy with topical
steroids of patients with BA` and with combination BA` with A`R and A`R
with AD provided decrease of IL-6 level and did not lead to change of SR-
IL-6 level in serum of blood. Therapy with topical steroids did not lead to
decrease in content of IL-6 both in serum and in nasal secret only in group
of patients with combination BA` and AD.
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Systems biology of type-I birch pollen allergy in human patients
Sakari Joenvaara1, Pirkko Mattila1, Jutta Renkonen2, Antti Makitie3,
Sanna Salmi4, Timo Paavonen5, Raija Sormunen6, and Risto Renkonen7.
1Medicel Oy, Research, Helsinki, Finland; 2University of Helsinki, Haartman
Institute, Helsinki, Finland; 3University of Helsinki, Helsinki University
Central Hospital, Helsinki, Finland; 4University of Tampere, Tampere
University Central Hospital, Tampere, Finland; 5University of Tampere,
Department of Pathology, Tampere, Finland; 6University of Oulu, Department
of Pathology, Oulu, Finland; 7University of Helsinki, Bacteriology and
Immunology, Helsinki, Finland.
Previous work in type-I pollen allergies has focused on lymphocytes
and immune responses. Here we begin to analyse with a systems biology
top-down view the differences in nasal epithelium obtained from healthy
and allergic subjects. Light and immunoelectron microscopic analysis
showed that birch pollen Bet v 1 allergen bound to epithelial cell surfaces
within minutes even during non-symptomatic winter seasons only in
allergic, but not healthy individuals. Bet v 1 also travelled through
epithelium together with lipid rafts/caveolae and reached mast cells only in
allergic, but not healthy individuals within minutes. A putative viral entry
protein E3 ubiquitin-protein ligase and three enzymes involved in lipid
rafts/caveolae metabolism were among the few Bet v 1 binding proteins
found in allergic subjects with affinity chromatography and LC-MS2. Nasal
epithelial cell transcriptomics during non-symptomatic winter season
identified a list of putative receptors by which Bet v 1 might be
recognized. It also suggested that defence mechanisms (such as expression
of histatins) could be impaired in allergic patients. Comparing nasal
epithelial transcriptomics taken in winter and during symptomatic summer
seasons provided hints to the cellular perturbations enabling the Bet v1
traffic through nasal epithelial cells and tissues. Thus application of
discovery and hypothesis driven methodologies on human nasal epithelial
tissue could provide new hypothesis worth further analysis of the
underlying molecular mechanisms.
The most significant aspect of this and other top-down explorative
studies using whole genome or other large-scale analysis is that they can
provide truly new hypothesis. Before this work few would have argued that the
nasal epithelium is so markedly different in healthy compared to allergic
subjects already during non-symptomatic winter session. Now based on these
validated results the mechanisms of Bet v 1 pollen allergen binding to and
traffic through the epithelium can be further explored and analysed.
Furthermore it must be noted that no single data domain, whether is
would haven microscopy, proteomics, transcriptomics etc. would have alone
pointed out the above-described phenomenon. Thus systems level under-
standing of complex pathophysiological phenomena will need all possible wet
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lab techniques combined with computer sciences as the biology will be
transformed into computer-readable format.
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Maternal tolerance achieved before pregnancy is transferred
to the offspring and prevents asthma development in the
next generation
Tobias Polte1, Christian Hennig2, and Gesine Hansen2. 1Martin Luther
University Halle-Wittenberg, Department of Pediatrics, Halle, Germany;
2Hanover Medical School, Department of Pediatrics, Hanover, Germany.
In this study we hypothesized that immunologic tolerance acquired
before conception can be transferred from the dam to the pup. In a murine
model, we induced tolerance before conception by oral application of antigen.
We than immunized the offspring of tolerized dams with the same antigen.
While the offspring of naBve dams developed an asthma-like phenotype with
airway hyperreactivity, inflammation, Th2-cytokine production after immuni-
zation, the offspring of tolerized dams was protected, even when immunized as
late as 8 months after birth. Critically involved in tolerance transfer is allergen-
specific IgG that was increased during pregnancy in the tolerized mouse, fetus
and newborn. FcRnj/jmice, that cannot transport IgG via the placenta,
transferred tolerance to the offspring only when the missing diaplacental IgG
transfer was compensated by IgG transfer via breast milk from tolerant dams
but not when the offspring was crossfostered by naBve mice. Inhibition of IFN-
+, produced by memory B cells in the offspring, abrogated the protective effect
of maternal tolerance demonstrating its crucial memory role in materno-fetal
tolerance transfer. Our data show that maternal immunologic memory has
significant and persistent impact on the immune response of the offspring
indicating that e.g. allergy prevention strategies might be effective for more
than one generation.
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Meditation as a suggestion for allergies and autoimmune diseases
Parisa Karimi1, and Alireza Salekmoghaddam2. 1Immunology, Asthma and
Allergy Research Institute, Medicine, Tehran, Islamic Republic of Iran; 2Iran
University of Medical Sciences, Medicine, Tehran, Islamic Republic of Iran.
Objective: The aim of the present study was to analyze the effects of a
Meditation program on Complete Blood Cell count(CBC), IgG and C3 as a
marker of specific and nonspecific humoral immunity.
Methods: 78 subjects, aged 18Y56 years, of whom 62 were male and 20
female undergoing a period of one month Meditation, were excluded. They
were all experiencing meditation for the first time. Before starting the
meditation training, all of these volunteers have been visited by a physician and
only healthy subjects(78 subjects), not taking any type of drug and with regular
life habits were chosen to be at this clinical trial. Blood samples were taken
from all subjects, the day before the study commenced, and again one month
later, at the end of the study. The blood parameters investigated included the
number of Leukocytes(total Leukocytes, Monocytes, Neutrophils, Eosino-
phils, Basophils, Lymphocytes),Red cell count(RBC), Hemoglobin(Hb),
Hematocrit(Hct), Mean cell volume (MCV), Mean cell hemoglobin (MCH),
Mean cell hemoglobin concentration(MCHC), Red cell distribution width
(RDW),Platelet count, as well as the concentrations of immunoglobulins(IgG)
and complement(C3). 4 of these volunteers has been excluded from research
plan because of their sickness during the period.
Results: Statistically significant differences were found between first and
second blood samples of volunteers showing lower numbers of total
Leukocytes(P=0.02) and Eosinophils(P=0.01),number and percentage of
Monocytes(P=0.01),as well as complement C3 concentration(P=0.004).
Conclusion: These findings demonstrate that one month of practicing
Meditation, can decrease some immunological parameters. According to
these results Meditation can be suggested for Hypersensitivities(Allergies and
Autoimmune Diseases) although further studies seem to be needed.
Key words: Meditation, Complete Blood Cell count(CBC), IgG, C3.
ASTHMA TREATMENT
444
A randomized, double-blind, placebo controlled trial on the
effect of zinc supplementation on bronchial asthma as
measured by sputum eosinophil count and asthma control
test (ACT) in children
Felix Bernard Cepeda, and Agnes Andaya. University of Santo Tomas,
Section of Allergy, Asthma Immunology, Manila, Philippines.
Backround: Zinc being a major dietary anti-oxidant has a protective role in
the airway epithelium. It may therefore have important implications for asthma
where the physical barrier is vulnerable and compromised.
Objective: We investigated the effects of zinc supplementation on bronchial
asthma as measured by sputum eosinophil levels and asthma control test
(ACT) in children.
Methodology: There were sixty-six asthmatic subjects age range 7 to 18 years
old were randomized to receive zinc 20mg/day(n=29) or placebo (n=37).
Sputum eosinophil count were checked before supplementation and 12 weeks
later. Likewise asthma control test (ACT) scores were obtained before
supplementations and at 4 weeks, 8 weeks and 12 weeks thereafter.
Results: After 12 weeks of supplementation, the sputum eosinophil count
decreased in both groups but the zinc group has the more significant change in
eosinophils as compared to placebo at p=0.029 and p=0.059 respectively.
However, ACT score from week 1 to week 12 showed no difference between
the zinc and placebo group. (p=0.069).
Conclusion: A dietary zinc supplementation significantly reduced sputum
eosinophil count as compared to placebo. However, the decline in sputum
eosinophil count was not associated with improvement in asthma control. Zinc
should be considered in decreasing airway inflammation but not asthma
control.
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Documentation of the relative efficacy and safety profile of the
salbutamol delivery by slow infusion(SI) VS inhalation(IN) to
patients with acute severe bronchial asthma
I. Khan Sameera, M. Ishaq, and Munir Imran Khan. Al-Junaid Hopsital,
Allergy/Pulmonology, Nowshera, Pakistan.
Purpose: Patients with acute severe bronchial asthma are in a moribund
position. The art of devising an effective delivery system which may be
followed by an optimal relief in the degree of bronchospam is the goal of
resolving the imminent urgency of an acute severe bronchial Asthma.
Methods: Patient’s both sex age16Y50 years, with history of acute severe
bronchial asthma have been included in the study. They had been Group A,
medicated with Prednisolon 15Y20 mg immediately followed by 10 mg
6hourly for 2 days along with Salbutamol 4mcg/kg body weight in slow
infusion. Group B, having being medicated with Prednisolon as in Group A,
along with inhalational delivery of Salbutamol in dilution of 1.5ml+2.5ml and
1.25ml+2ml (for adult and childhood bronchial asthma respectively).
Therapeutic response as observed had been as under.
Results: Group B, had been followed with optimal bronchodilation in about
5Y10 minute while with group A, it was 15Y20 minutes.
Conclusion: Group B had therapeutic advantages vs A (e.g.) optimal
bronchodilation in a relatively shorter period, no hazard of parental
administration and a simple technique of delivery that can be managed even
by any one.
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Clinical Implication: Both techniques of delivery of Salbutamol are effective
with in the limits of availability of services of healthy care providers and
appropriate selection of cases.
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Role of body weight reduction by diet control and physical
exercise in controlling asthmatics (children and adults)
with obesity
Ehsan Sabry1, Eman Yasseine2, Manal Eldeib3, Ahmed Eltaweil4, and
Neveine Elhelaly5. 1Kasr ALAini Hospitals,Faculty of Medicine, Cairo
University, Chest Diseases, Giza, Egypt; 2Kasr ALAini Hospitals, Cairo
University, Fitness and Rehabilitaion, Cairo, Egypt; 3Kasr ALAini Hospitals,
Cairo University, Internal Medicine, Cairo, Egypt; 4Kasr ALAini Hospitals,
Cairo University, Chemicl Pathology, Cairo, Egypt; 5Kasr ALAini Hospitals,
Cairo University, Pediatrics, Cairo, Egypt.
The prevalence of asthma has increased worldwide since the 1960s.
The incidence of asthma is high among children; however, a relative high
annual incidence is also estimated in adults. Studies for risk factors have
mainly analyzed cross-sectional design data based on prevalent cases of
asthma. Such studies may determine either cause, consequence or both.
Incidence studies have mostly focused on occupational asthma or smoking
habits. Since the late 1990s, obesity has been reported to be associated with
asthma, and an increase in the prevalence of obesity has been reported along
with a parallel increase in asthma prevalence. However, a convincing
relationship between asthma and obesity has not been established. Accord-
ingly, this study was carried out aiming at demonstrating the effect of weight
reduction on clinical, functional and serological parameters in obese
asthmatics. In this study, obese asthmatic patients showed marked improve-
ment clinically, functionally, with marked decrease in number of exacerbations
and medications used.
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Feasibility and applicability of secondary prevention of asthma
in allergy practice
Mahesh Padukudru Anand1, Amrutha Holla Devidas2, A.K. Prabhakar2,
Biligere S. Jayaraj1, C.P. Chathura2, Rao B. Chaitra2, and Pudupakkam K.
Vedanthan3. 1JSS Medical College, Department of Pulmonary Medicine,
Mysore, India; 2Allergy Asthma and Chest Center, Department of Allergy,
Mysore, India; 3University of Colorado Health Sciences, Department of
Allergy, Colorado, United States.
Background: The possibility for secondary prevention of asthma was
highlighted by the prevention of asthma study, which demonstrated that
immunotherapy in patients with allergic rhinitis, could prevent asthma in some
patients. The feasibility of secondary prevention of asthma and the proportion
of patients likely to be benefited need to be demonstrated as immunotherapy
requires time to exert its beneficial effects.
Methodology: All the patients who underwent a detailed evaluation including
allergy testing during the period 2003 to 2006 were included in the study. A
structured questionnaire was applied to collect data on demography, a detailed
clinical history, the duration of asthma and allergic rhinitis and the proportion
of patients whose rhinitis preceded asthma and the time interval between the
development of rhinitis and asthma.
Results: A total of 934 cases were included in the study. 701 (75%) patients
had allergic rhinitis for varying intervals before they developed asthma.
143(15.5%) patients continued to have rhinitis for more than 5 years
without developing asthma. 57(6%) patients had only asthma without
rhinitis. 33(3.5%) patients developed asthma before they developed rhinitis.
327 (46.6%) developed asthma within 1 year of developing rhinitis. Of
these, 164 developed asthma within 6 months and 169 between 6Y12
months. 374 patients developed asthma more than a year after the onset of
rhinitis and the frequency gradually decreased with increase in duration of
rhinitis.
Conclusion: Majority of patients had rhinitis before they developed
asthma. Nearly 50% of these patients with preceding rhinitis developed
asthma within one year, who may not be amenable for secondary
prevention with immunotherapy due to the delays in referral to the allergist
and the time required for obtaining the necessary benefit from
immunotherapy. Patients who develop asthma alone or develop rhinitis
after the onset of asthma are not candidates for secondary prevention. Of
the total cases studied, less than 40% can undergo interventions targeted
towards secondary prevention of asthma. Intense education of the Family
physicians and ENT specialists is needed to ensure prompt referral to the
allergist to help these patients.
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Asthma control assessd by the asthma control test and markers
of airway inflammation
JoseM. Olaguibel, Maria J. Alvarez, Blanca Garcia Figueroa,Maria PuyUribe,
and Maria Luisa Tallens. Alergologia, CS conde Oliveto. HVC, Pamplona,
Spain.
Aim: to assess the relationship between ACT and different markers of airway
inflammation in asthmatic subjects
Methods: In a crossover design, we studied 106 patient suffering from mild or
moderate asthma (median age 31years IQR 16Y45) ). Fifty five percent were
only treated with short beta agonist on demand. On the same visit patients
fullfiled the ACT questionnaire, exhaled nitric oxide (eNO) (NiOx Mini) was
measured and bronchial challenge with hypertonic saline and sputum
induction were performed.
Results: On the whole sample ACT was modestly correlated with eNO (r=
j0,40, pG 0,001), eosinophils in induced sputum (r=j0,30, pG 0,05) and the
slope of hypertonic saline bronchial challenge (r= 0,43, pG 0,001). Patients
with very good control (ACT 24 0r 25) had significantly lower levels of eNO
(41 vs 72 ppb, pG0,001) and eosinophils (10 vs 6%, pG 0,05). Correlations of
all these variables improved, when only the 55 patients treated with beta
agonist on demand were included: eNO (r=j0,55, pG 0,0001), eosinophils in
induced sputum, (r=j0,50, p= 0,002), and slope of hypertonic saline
bronchial challenge (r= 0,52, pG 0,0001. ACTwas not correlated to FEV1 of
FEV1/FVC.
Conclusion: asthma control assessed by the Asthma Control Test was
correlated to direct and indirect markers of airway inflammation. ACT and
pulmonary function variables were not correlated.
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Salbutamol metered-dose inhalation is as effective as
nebulisation in managing acute asthma exacerbations in
hospitalized children in accordance with an asthma pathway
Anne Goh1, Oh Moh Chay1, Jenny Tang1, Ling Ho1, Oon Hoe Teoh1, and
Kee Chong Ng2. 1KK Women’s and Children’s Hospital, Department of
Paediatric Medicine, Singapore, Singapore; 2KK Women’s and Children’s
Hospital, Children’s Emergency, Singapore, Singapore.
Background: Acute asthma exacerbations have traditionally been managed
with nebulised bronchodilators in the emergency rooms as well as for
inpatients. In 2003, Singapore was hit by SARS and the fear that the use of
nebulisation could cause the spread of the virus prompted the development of
an asthma pathway using MDI.
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Aim: To compare the length of stay in children admitted for asthma
exacerbations before and after the introduction of an asthma pathway for
managing acute exacerbations with salbutamol metered-dose inhalers(MDI)
instead of nebulisation.
Methods: Children presenting to the Children_s Emergency and admitted to
the wards for asthma exacerbations were managed according to an asthma
pathway.
Results: There was no increase in admissions from the emergency department
or to high dependency or to the intensive care after implementation of the
asthma pathway with the use of Salbutamol MDI instead of nebulisation. The
average length of stay decreased from a high of 2.78 days pre-implementation
of pathway to a low of 2.19 days post-implementation. The average cost per
patient decreased from $1,136.85 in 2001 to between $974.00 Y$1,011.05 post
pathway implementation.
Conclusion: The asthma pathway has shown that the use of salbutamolMDI is
as effective as nebulisers in the management of acute asthma exacerbations
and has led to a decrease in the average length of hospitalisation as well as
decreased cost per patient.
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A troublesome diagnosis of Churg Strauss Syndrome
Pierangela Massacane, Anthi Rogkakou, Laura Guerra, Enrico Compalati,
Antonio Scordamaglia, and Giorgio Walter Canonica. University of Genoa,
Allergy and Respiratory Diseases, Genoa, Italy.
Case Report: A 41- year-old asiatic man was admitted to the emergency room
of our hospital with fever, wheezing, dyspnea, arthralgias.
His past history was remarkable for allergis rhinitis and recurrent
episodes of asthma since his arrival in Italy at the age of 34.
The patient was treated with a course of systemic corticosteroids
(80mg daily prednisolone), theophylline, inhaled budesonide/ formoterol 160/
4.5 mcg (twice a day), montelukast 10 mg . His chest radiograph and full blood
count including eosinophil count were normal. His spirometric test showed
FEV1 1.57 ( 42%), FVC 2.52 (57%), PEF 240 l/min.
One month later he was seen in the outpatients department and noted to
be generally unwell, very wheezy and 2 days before the visit he has noticed the
comparison of hemoptysis.
His chest radiograph and full blood count, including eosinophil count,
were normal. Antinuclear antibody and antineuthrophil cytoplasmic antibody
(ANCA) were both negative. Sputum culture and urine microscopy were
unremarkable. Aspergillus precipitins and radioallergosorbent test (RAST)
against Aspergillus were negative. Cultures for mycobacteria were negative.
The electrocardiogram and echocardiogram were both normal.
Computed tomography of the paranasal sinuses dimostrated a near-
total opacity with the material of the soft parts of the normal sinus and right
sphenoidal sinus, as well as of ethmoidal cell, the right maxillary sinus and
nasal cavities. Thorax computed tomografy revealed generalized enlargement
of the mediastinic lymph nodes.
Treatment with montelukast was stopped and high dose oral
prednisolone was commenced.
The patient elected to discontinue his inhaled treatment .Three months
later his symptoms of asthma returned. Chest- X-ray showed patchy bilateral
infiltrates in the lungs. He had marked hypereosinophilia (15%), elevated
serum IgE levels (465 IU/ml), and antineuthrophil cytoplasmic antibody
(ANCA) were positive. His spirometric test showed FEV1 1.60 (45 %), FVC
2.35 (55%), PEF 240 l/min. He required a further short course of oral
coricosteroids.
His symptoms remained troublesome and his treatment was changed to
cyclosporine 3 mg/ kg and his condition showed marked clinical as well as
radiological improvement.
Discussion: We must carefully diagnose and treat patients with middle-age
onset of severe asthma, because the symptom may be a lung manifestation of
CSS, in which various organs are involved as a result of systemic necrotizing
vasculitis.
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Educational courses improve asthma management
and treatment
Angelko Gjorcev, Zlatica Goseva, Marija Zdraveska, Deska Dimitrievska, and
Dejan Todevski. Clinic of Pulmology and Allergy, Asthma Department,
Skopje, Macedonia, Fyrom.
Background: Education of the patients is one of the first goals of asthma
management in all the international treatment protocols. We made this study in
order to estimate the need and the effect of an educational program prepared by
the Macedonian Asthma Center.
Methods: We studied 300 asthmatics. We prepared a pilot educational course,
covering the most important and ’’hot’’ subjects concerning asthma, following
the guidelines from the Global strategy for asthma management and
prevention. (May 1996), and a questionnaire with 10 questions treating the
problems concerning the treatment problems in asthma management. The
questions were grouped in 2 parts : I - general knowledge of asthma
medications and the necessity of adequate and continuous anti-inflammatory
treatment; and II - accent on the emergency interventions and actions during
acute exacerbations. The questionnaire was completed by all of the patients,
before and after attending the educational course.
Results: Before visiting the course, only 46.3% answered correctly the
questionnaire (39.9% correct answers on part I and 52.8% on part II). These
results imply that more than 50%of the tested asthmatic population do not
realize the need for preventive medication or would in fact take the wrong
medication during worsening of their disease. After visiting the educational
course the results are as follows: 54.8% overall correct answers (nonsignifi-
cant-NS). The results from part I showed that only 52.4% (NS) of the patients
gave correct answers and 73.6% (significant) answered the II part correctly.
Conclusion: We conclude that patients more willingly accept advice on
emergency self management of acute asthma exacerbations, but it is the most
difficult to overcome the ’’fear of preventive treatment’’ and to change the
dogmatic opinion on the therapeutic issues of asthma management. The study
shows the necessity of organizing further and continuous asthma educational
programs on all levels of the health care.
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Clinical evaluation of severe asthma attack requiring tracheal
intubation and respirator management
Kiyoshi Sekiya1, Masami Taniguchi1, Keishi Sugino2, Hidenori Tanimoto1,
Yuuma Fukutomi1, Emiko Ono1, Chiyako Oshikata1, Takako Hojyo2, Kazuo
Akiyama1, and Sakae Honma2. 1National Hospital Organization, Sagami-
hara National Hospital, Clinical Research Center for Allergy, Kanagawa,
Japan; 2Toho University Medical Center, Department of Respiratory
Medicine, Tokyo, Japan.
Background: Recently, the number of patients requiring hospitalization
because of an asthma attack has decreased; however, there are still patients
who require hospitalization for tracheal intubation and respirator management
for a severe asthma attack. Therefore, we evaluated the background features of
20 asthmatic patients who required tracheal intubation and respirator
management in our hospital.
Methods: We evaluated 20 asthmatic patients who visited our hospital from
January 2001 to December 2005 and required tracheal intubation and
respirator management. All the patients had severely exacerbated asthma, as
determined on the basis of the guideline of the Global Initiative for Asthma
(GINA) 2006, and they required tracheal intubation and respirator manage-
ment. We evaluated their history of smoking, the days from asthma attack
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onset to their visit to our hospital, the level of asthma control as determined
from the GINA 2006 guideline, treatments taken before the patients visited our
hospital, their frequency of visiting a hospital, the reason for tracheal
intubation and respirator management based on the Asthma Prevention and
Management Japanese Guideline 2006, and their prognosis.
Results: The patients who required tracheal intubation and respirator
management were the following: 1. smokers, 2. patients not taking or
irregularly taking treatment, 3. patients who used inhaled short-acting "2
agonist only at the time of an asthma attack, and 4. patients not using inhaled
glucocorticosteroids. The reasons for tracheal intubation and respirator
management were as follows: PaO2 of less than 50mmHg despite maximum
oxygen administration in 30% of the patients; sudden increase in PaCO2
leading to unconsciousness in 20%; both PaO2 of less than 50mmHg despite
maximum oxygen administration and sudden increase in PaCO2 leading to
unconsciousness in 25%; and severe ventilatory or cardiorespiratory
disturbance in 25%.
Conclusion: We observed that a thorough education of patients and treatment
mainly using inhaled glucocorticosteroids are important for preventing a severe
asthma attack that requires tracheal intubation and respirator management.
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Assessment of quality of life in caregivers of asthmatic children
Shima Sayanjali, and Fariborz Zandieh. Tehran University of Medical
Sciences, Asthma, Allergy and Immunology, Tehran, Islamic Republic of Iran.
Background: Interest in the impact of illness on day to day function is leading
investigators to include both disease specific and generic health related quality
of life (HR QOL) questionnaires in a broad range of clinical studies and to gain
a full picture of the impact of asthma on the lives of caregivers of asthmatic
children, it is necessary to make direct measurement of health related quality
of life.
Methods: In response to this need, we used Juniper_s Pediatric Asthma
Caregiver_s Quality of Life Questionnaire (PACQLQ) that has been developed
based on guidelines for construction of over a dozen validated disease specific
quality of life instruments.The PACQLQ that contains 13 items in two domains
of emotional and activities disturbances. The study design consisted of an 18
month single cohort study. Patients participating in the study were 113
children, 7Y17 years of age, with a wide range of asthma severity and their
caregivers. For each caregiver a PACQLQ was completed. One week before
visit patients recorded morning peak flow rates, medication use and symptoms
in a diary. After complete physical examination, for determining of asthma
severity, spirometry was performed.
Results: The questionnaires after statically analysis showed good levels of
both longitudinal and cross sectional correlations with the conventional
asthma indices and with general quality of life.
Conclusion:We found a good relevancy between severity of asthma and QOL
scores and more disturbances of QOL in caregivers of male asthmatic patients
than caregivers of female asthmatic patients. Bronchial asthma as a chronic
and devastating disease can affect not only life style of the patients but also
their caregivers. Increment of our knowledge about these disturbances can help
the physicians for better understanding of burdens of their patients.
454
Unified treatment in school children with allergic rhinitis
and asthma
Jelena Moskovljevic. Emergency Center, Immunology, Nis, Serbia and
Montenegro.
Aim: To verify the efficacy of beclomethasone dipropionate (BDP),
administered through nasal inhalation, in the simultaneous treatment of
asthma and allergic rhinitis (AR).
Methods: 30 patients with asthma and AR, aged 7Y17 years were randomly
allocated. During eight weeks, 20 of them received BDP-CFC (at least 500
mcg/day) inhaled exclusively by the nose (mouth closed) using a large-volume
(650 ml) spacer attached to a facemask. Control group (10 subjects) received
conventional treatment, i.e., BDP by dual administration (aqueous intranasal
and oral inhalation through the mouthpiece of the same spacer device). Every
twoweeks a clinical score for AR and peak expiratory flow (PEF) was assessed
by independent observers. Spirometry was performed at admission and at the
end of the follow up. A minimum decrease in 66% in clinical scoring was
considered as therapeutic success.
Results: Therapeutic success rate was of 50.0% for the experimental group
and of 70.0% for the control group (p=0.11). PEF and FEV1weren_t
statistically different in the two groups neither at admission nor by the end of
the treatment (p 9 0.10).
Conclusion: Results suggest that this alternative treatment could be
recommended for the simultaneous treatment of AR and asthma, specially
in developing world. Other advantages are higher compliance, lower costs and
fewer side effects.
455
Influence of topical intranasal steroids on improvement of
ventilating capability of lungs in patients with bronchial asthma
Tair Nurpeissov, Rimma Akpeissova, and Bibigul Ilyasova. Institute of
Internal Diseases, Republican Allergological Center, Almaty, Kazakhstan.
Background: Treatment of a bronchial asthma (BA) is often conducted without
an allowance of a concomitant allergic rhinitis (AR), which can be a reason of
unsuccessful results in an achievement of a maximized therapeutic effect.
Research about an interaction between BA andAR is conducted in the republican
allergic center of scientific research institute of cardiology and internal diseases
under Ministry of Public Health of the Republic of Kazakhstan.
Aim: To determine the degree of influence of allergic inflammation of the
upper respiratory tracts on ventilating capability of lungs in patients with
bronchial asthma.
Materials and Methods: The thirty patients with severe BA and concomitant
the AR were prescribed to intranasal mometazon spray in a dose of 100
microgram two times a day for a one month. This treatment followed after two
weeks course of standard hospital therapy that includes steroids (intravenous,
inhalation), b2-a`gonists, etc. The age of the patients was ranged from 25 to 50
years old. Therapy effectiveness was controlled both by clinical and by
laboratorial methods: spirography and daily pickflowmetry, determination of
the resistance of a bronchial tree, rhinomanometry and identification of ECP.
Results: All patients at the end of the first month of treatment mentioned the
stable improvement of nasal breathing and sleep recovery. Also, a valid reduction
of the resistance of nasal apertureswas discovered (pG0.005). Themajority of the
patients (93.3%) have the improvement of clinical picture of the BA, which
confined in less amount of asthma attacks and also improvement of the functional
and laboratorial measures: PEF growth, decrease of its variability (pG0.05),
reduction in the resistance of the bronhial tree (pG0.05) and normalization of ECP.
Conclusion: Conducted research proved a valid increase in the effectiveness
of supporting therapy of the BAwith the combination of active treatment of the
AR, which becomes apparent besides clinical improvement in an additional
growth of measures of ventilating capability of lungs, level of the resistance of
the bronchial tree and nasal apertures and normalization of ECP content.
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An all Wales audit of secondary care of acute asthma during
February 2006
Brian Davies1, Pearl Symonds1, Ravish Mankragod1, and Keith Morris2.
1Llandough Hospital, Wales Asthma, Allergy & Immunology Research Unit,
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Cardiff, United Kingdom; 2University of Wales Institute Cardiff, Statistics,
Cardiff, United Kingdom.
We audited the secondary care offered to acute asthmatic patients
admitted to all 17 hospitals in Wales, UK during February 2006. The audit
analysed referral source, care delivered by the ambulance service,
emergency units, medical admission units and inpatient units in all cases
of asthma aged 18 years or greater. All data was extracted by qualified
medical personnel. The results show that 248 patients were admitted during
that month (36 patients were excluded as not having asthma). 44 were
acute severe/severe, 91 moderate, 75 mild and in 38 severity was not
documented. Ambulance transfer was used in 99 cases, 63 patients calling
the ambulance directly. Overall, ambulance staff measured vital signs well
but peak flow (PFR) was measured only 8 cases. Most patients received
nebulised bronchodilators/high flow oxygen in the transfer process but
steroids were used rarely and observations were repeated in only 27 cases.
Emergency units were the primary site of acute care. PFR was measured in
only 67% of cases compared to 90% having oxygen saturations measured.
Only 162 of 248 cases had a record of steroid administration and only
67% were reassessed. Of those admitted (99) only 51% were under
specialist care and only 32% were treated in a specialist respiratory ward.
Overall discharge planning both from emergency and inpatient units was
disappointing with only 13% of inpatients having written management
plans and only 4.5% of patients discharged directly from emergency units
offered further review.
Secondary care of acute asthma in Wales does not confirm to national
guidelines for acceptable levels of care.
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A survey in physicians in China on monitoring and treatment of
childhood asthma
Chunmei Zhu, and Yuzhi Chen. The Capital Institute of Pediatrics, Asthma
Clinic and Education Center, Beijing, China.
Objective: To investigate the approach (monitoring and treatment) of
pediatricians and general physicians to childhood asthma in China.
Methods: A standardized questionnaire survey, which was construced by
APAPARI on monitoring and treating childhood asthma was send to
physicians in 25 provinces and cities of China.
Results: 1863 questionnaires were received, of which 912 were completed
(48.95%) 57% of the doctors were general pediatricians, 20% were pediatric
pulmonologists or pediatric allergists, 9% were adult pulmonologists or
allergists who also treatment children, and 14% were others (non-specified).
Working places were: 71% in a tertiary hospital, 23% in a secondary hospital,
and 4% work in a first grade hospital.Most of the doctors (66%) used peak
flow meter or spirometry to monitor childhood asthma, while 31% of them
used diary cards. For treating acute asthma exacerbations, the first choice
treatment was nebulized salbutamol/terbutaline every 20 mins (29%), the
second choice was salbutamol inhalation with a spacer (22%) and the third
choice was systemic corticosteroids (12%). Pediatric pulmonologists and
pulmonologists tended to use ICS for acute asthma. The most frequently used
systemic corticosteroids for acute asthma treatment were dexamethasone
(86%), methylprednisolone (83%) and hydrocortisone (81%). The criteria
applied by doctors to start a maintenance therapy in asthmatic children were
the frequency of symptoms (36%), severity of symptoms (32%) and whether
or not there was a severe disturbance in lung function testing (27%). For the
selection of drugs, doctors tended to choose ICS. Generally, the first choice
of drugs used in maintenance treatment of asthma in young children (0Y3y)
were ICS (85%), the second was montelukast, and the third was ICS+ oral
LABA(slow release sulbutamol) (67%), while in preschool and school
children (4Y16y) the first choice was a LABA + ICS (84Y87%), the second
was ICS (81Y83%) and the third montelukast (73%). For moderate to severe
asthma , the first choice was ICS + LABA.
Conclusion: The awareness and recognition of childhood asthma, the use of
peak flow meter, the implementation of GINA guidelines and the use of ICS
has improved among the doctors of the cities in China. Nevertheless,
dissemination of the GINA program among non-specialists and doctors in
countries and communities must be continued and re-enforced.
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Impact of patient education on knowledge, attitude, practice and
self-efficacy in patients with asthma in India
Mahesh Padukudru Anand1, Sabin Thomas2, and Parthasarathi Gurumurthy2.
1JSS Medical College, Department of Pulmonary Medicine, Mysore, India;
2JSS College of Pharmacy, Department of Clinical Pharmacy, Mysore, India.
Background: Patient related factors like poor knowledge, individual beliefs
and attitudes of patients influence control of asthma leading to nonadherence.
This study was conducted to develop a validated KAPSE questionnaire for the
Indian population and to assess the knowledge, attitude, practices and self-
efficacy (KAPSE) of patients in Mysore regarding asthma and the impact of
patient education on KAPSE in these patients.
Methodology: A total of 225 adult patients participated in the KAPSE study
and were part of the study that compared the efficacy and quality of life in
patients receiving beclomethasone, budesonide or fluticasone. A questionnaire
with 22 items was selected from Knowledge, Attitude and Self- Efficacy
(KASE), a validated instrument for asthma and suitably modified to suit the
cultural and educational level of the population. Two medical experts
performed content validation and only those items with content validation
index of above 0.75 were retained. Cognitive debriefing in 5 patients
confirmed the suitability and acceptability of the questionnaire. Patient
counseling individually and in groups and information leaflets about the
pathology of asthma, drugs and delivery systems were conducted at every visit
on 7 occasions, until 6 months. KAPSE was assessed at baseline before
education and at the end of the study.
Results: Patient education significantly improved most of the questions
assessing Knowledge, Attitude, Practice and Self-efficacy compared to the
baseline (pG0.05). Subgroup analysis revealed that KAPSE at baseline were
not influenced by Age, Gender and Duration of disease (p90.05), but was
related to educational levels and area of residence (pG0.05). Following patient
education KAPSE of all the patients improved significantly (p G0.05) and there
was no difference between patients of different areas of residence.
Conclusion: This study demonstrated that regular patient education
significantly improves different aspects of Knowledge, Attitude Practice and
Self-efficacy of patients regardless of their age, gender, education or place of
residence, which could positively influence patient medication adherence.
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Asthma - a curable disease
Sivanandhan Kasimalliah. Sri Ragavendra Clinic, Paediatrics, Pollachi,
India.
Background: In normal individuals, the Serum Histamine Binding Capacity
(SHBC) is 20 to 30%whereas it is only 0 to 5% in allergic patients. The SHBC
can be raised with Histaglobulin (HG) if it is given after preparing the patient
properly and drugs like mast cell stabilisers, bronchodilators, antihistamines
and anti-inflammatory drugs are given along with HG therapy. In allergic
patients serum IgE level is high which comes down after HG therapy and
medicines. Patient becomes symptom free and cured.
Methods: It was an observational study for 14 years. 161 patients were
registered at different periods from out-patients consisting of all age-group,
both sexes and from urban and rural areas. Immunoglobulin E (IgE) levels
were estimated and other routine tests were done before starting treatment.
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Patients were prepared before HG therapy; HG was given in two phases: Phase
I Y 6 primary doses, Phase II Y3 booster doses. Along with HG therapy, drugs
like mast-cell stabilisers, and H1 receptor-specific Histamine antagonists
(Loratadine, Rupatadine, Cromolyn etc.) bronchodilators (Theophylline),
antihistamines (Cetirizine, Levocetirizine) and anti-inflammatory drugs
(Monteleukast) were given. 2 to 3 months after 3rd booster dose IgE levels
were estimated for 61 patients. Patients were examined periodically to assess
clinical improvement.
Results: Out of 161 patients, 152 patients (94.6%) are free from asthma and
allergic rhinitis symptoms. Among 152, 96 patients are free for more than 4
years. 9 patients did not respond satisfactorily. Out of 61 patients, 55
patients (90.2%, pG0.0001) showed reduction in IgE level and are clinically
free from asthma. 6 patients showed raised IgE level and correspondingly
no clinical improvement. It is also found out that allergic manifestations are
lowest up to 2 years of age; between 2Y5 yrs, it increased and more males
are affected; the occurrence rate came down in the age group of 6Y15 yrs in
both sexes. Above 15yrs, again occurrence rate raised and more females
were affected.
Conclusion: Thus in our study comprising of 161 patients having the
complaints of allergic asthma with or without allergic rhinitis, the HG therapy
given after preparing the patient and continuing the above-mentioned drugs,
during HG therapy was found to be effective in curing the allergic asthma. HG
is effective in raising the SHBC thereby improving the immunity of the patient
and also in reducing the serum IgE level.
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Flavonoids and related compounds as anti-allergic substances
Toshio Tanaka1, Toru Hirano1, Mari Kawai1, Shinji Higa2, Junsuke Arimitsu1,
Yusuke Kuwahara1, Tomoharu Ohkawara1, Kaori Nakanishi1, Keisuke
Hagihara1, Yoshihito Shima1, Atsushi Ogata1, and Ichiro Kawase1. 1Osaka
University Medical School, Respiratory Med. Allergy and Rheumatic
Diseases, Suita City, Osaka, Japan; 2Tondabayashi Hospital, Internal
Medicine, Tondabayashi City, Osaka, Japan.
: The prevalence of allergic diseases has increased all over the world
during the last two decades. Dietary change is considered to be one of
environmental factors that cause this increase and worsen allergic
symptoms. If this is the case, an appropriate intake of foods or beverages
with anti-allergic activities is expected to prevent the onset of allergic
diseases and ameliorate allergic symptoms. Flavonoids, ubiquitously
present in vegetables, fruits or teas possess anti-allergic activities.
Flavonoids inhibit histamine release, synthesis of IL-4 and IL-13 and
CD40 ligand expression by basophils. Analyses of structure-activity
relationships of 45 flavones, flavonols and their related compounds
showed that luteolin, ayanin, apigenin and fisetin were the strongest
inhibitors of IL-4 production with an IC50 value of 2-5 mM and
determined a fundamental structure for the inhibitory activity. The
inhibitory activity of flavonoids on IL-4 and CD40 ligand expression
was possibly mediated through their inhibitory action on activation of
nuclear factor of activated T cells and AP-1. Administration of flavonoids
into atopic dermatitis-prone mice showed a preventative and ameliorative
effect. Recent epidemiological studies reported that a low incidence of
asthma was significantly observed in a population with a high intake of
flavonoids. Thus, this evidence will be helpful for the development of low
molecular compounds for allergic diseases and it is expected that a dietary
menu including an appropriate intake of flavonoids may provide a form of
complementary and alternative medicine and a preventative strategy for
allergic diseases. Clinical studies to verify these points are now in
progress and we will present the result in the congress.
461
Sublingual progesterone dilutions as bronchodilator in
asthmatic females
Russell Roby1, Patricia Richardson2, Richard Richardson2, Shilpa Shah3, and
Benoit Tano4. 1Roby Institute, Director, Austin, United States; 2University of
Texas, Integrative Biology, Austin, United States; 3University of Texas,
Integrative Biology, Austin, United States, & Breach Candy Hospital Trust,
Mumbai, India; 4University of Texas Health Center, Allergy & Immunology,
Tyler, United States.
Background: Asthma is associated with hormones. Increases in asthma
symptoms have been associated with menstrual variances. Pre-menstrual
asthma has been noted in the literature and studies from as early as 1921 have
suggested an allergic reaction to hormones. Bronchial asthma in female
patients could be due to allergy to self-hormones particularly progesterone.
Interestingly, progesterone is also a potent respiratory stimulant. The present
study was aimed to evaluate efficacy of sublingual progesterone dilutions as
bronchodilator.
Methods: This study was approved by the ethics committee of Austin, Texas.
Sixteen females who had a previous diagnosis of severe asthma and who were
nebulization dependent were selected for the study. After obtaining written
informed consent from each patient spirometric studies were performed on
these subjects Using sublingual progesterone as a bronchodilator. We analyzed
changes over time of the forced expiratory volume in one second (FEV1), the
forced vital capacity (FVC), and the peak expiratory flow (PEF). For each
patient we measured lung function three times: (1) before treatment, (2) after
sublingual normal saline treatment (3) after sublingual progesterone treatment.
Results: After treatment with sublingual progesterone, twelve of the sixteen
patients (75%) experienced a significant bronchodilator effect (greater than
12% increase) in either FEV1 or FVC. Eight (50%) experienced significant
increase in both FEV1 and FVC. Eight (50%), had an increase of 27% or
greater in PEF.
Conclusion: Progesterone dilutions are candidate drugs for the treatment
of bronchial asthma. The possibility that dilutions of progesterone can
act as a progesterone antagonist and that bronchial smooth muscle may
be sensitive to such dilutions of progesterone due to activation of the
L-arginine-nitric oxide (NO) pathway is interesting because of the close
relationships between the immune and neuroendocrine systems. The study
might have important implications for the development of a novel safe
non-invasive treatment strategy against bronchial asthma due to hormone
allergy.
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A randomized, double-blind, placebo controlled trial on the
effect of zinc supplementation on bronchial asthma as measured
by sputum eosinophil levels and asthma control test (ACT) in
children ages 12Y18 y/o
Kristine Marie Gutierrez. World Citi Medical Center, Pediatrics, Quezon City,
Philippines.
: Zinc may have its role in bronchial asthma by regulating airway
inflammation and subsequently preventing asthma exacerbation.
Objective: To determine the effects of zinc supplementation on bronchial
asthma as measured by sputum eosinophil levels and asthma control test
(ACT) in children ages 12Y18 y/o.
Methods: After consent was obtained, 30 children at a local community ages
12Y18 years old diagnosed with intermittent, mild-moderate persistent asthma
were randomly allocated to receive zinc supplementation 20 mg/day or
placebo for thirty days. A change in the sputum eosinophil level and ACT
score was obtained before and after intervention.
Results: Fifteen subjects were included in the zinc group and 15 subjects in
the placebo group. There were no differences in the demographic profile
between the two groups in terms of age, severity of asthma, atopy, use of
maintenance medications and infections during the study period. Intragroup
statistics showed a statistical significance in the zinc group for sputum
eosinophil (p=0.045) and ACT score (p=0.004) while the placebo group
showed no statistical significance for sputum eosinophil (p=0.954) but was
statistically significant for ACT score (p=0.045). The mean difference in
sputum eosinophils between zinc and placebo showed no significant difference
between the two groups. (p=0.270). The mean change in the ACT score of zinc
and placebo group showed a significant difference between the 2 groups
(p=0.067).
Conclusion: Supplementation with zinc sulfate improves bronchial asthma in
terms of ACT score but not in sputum eosinophil count in children ages 12Y18
years old.
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The application of the small doses of the human recombinant
alpha-2 interferon oromucosal for the patients with seasonal
atopy (bronchial asthma and allergic rhinoconjunctivitis)
Veronica Osipova1, Seda S. Grigorian2, and Alexandr G. Chuchalin3.
1Institute Research of Pulmonology, Allergological Department, Moscow,
Russian Federation; 2Institute of Gamalei, Department, Moscow, Russian
Federation; 3Institute Research of Pulmonology, Department, Moscow,
Russian Federation.
Purpose: Of the research is to determine an influence of the small dose of the
human recombinant alpha-2 interferon (HRa´2-IFN) on the symptoms of
allergy, on the level of ECP of the patients with seasonal atopic allergy.
Materials and Methods: 20 patients with seasonal atopic allergy (bronchial
asthma and allergic rhinoconjunctivitis, sensitizing to the allergens of the
pollen of trees). All of these patients had been taking for 30 days oromucosal
HRa´2-IFN in the dose of 2000 ME everyday till the begining of the season of
the blossoming of trees. The group of control - 11 patients.
All of the patients filled out an individual form where fundamental
clinical symptoms of pollinosis.
The immuneYenzyme method in commercial test system Immuno CAP
100, Pharmacy, Sweden was used to determine ECP.
Results: The analisis of the journals of the patients showed that in comparison
with three previous years the intensity of the stuffiness in nose, rhinorrea
owing to the preventive therapy HRa´2-IFN were authentically lower in
comparison with the group of control and were 0.85 T 0.75 and 1.00 T 0.97; in
the group of control j1.64 T 1.03 and 1.75 T 0.79. The necessity in B2-
agonists was authentically two times lower in the analyzing group of patients
than in the group of control so that it was in the analyzing group 3.25 T 4.12
days while in the control group it was 7.82 T 7.78 days.
The level of ECP before the medical treatment was higher in the
analyzing group 252.89 T 141.15 mkg/l (the norm is till 11.5 mkg/l), than in
the control group 61.36 T 55.47 mkg/l. After the medical treatment the level of
ECP authentically became lower in the analyzing group 100.57 T 124.68mkg/l,
however after the season of the blossoming of trees the unauthentic increase of
it was registrated till 161.16 T 143.32 mkg/l. The level of ECP in the control
group unauthentically increased after the medical treatment till 84.81 T 111.60
mkg/l, however the level of ECP in this group authentically increased after the
season of the blossoming of trees till 151.02 T 183.98 mkg/l.
Conclusion: we can assert that the prevention usage of small doses of HRa´2-
IFN guarantees positive clinical effect on the pollinosis (bronchial asthma and
allergic rhinoconjunctivitis), provides for the lowering of the levels of ECP and
therefore the decrease of inflammation process in the windpipe. So it can be
recommended as the modern medicine for the prevention theraphy for the
patients with the seasonal atopy.
464
Polyprenol as a possible supplement for treatment of steroid
resistance in patients asthma
Galina Kuznecova, Inese Joksta, and Klara Jegina. Preventive Medicine
Research Laboratory, Allergy Unit, Riga, Latvia.
Background: Plant Polyprenol (PP) is approved as a substitute of Dolichyl
Phosphate (DP) which decreases P-glycoprotein, enhances IL-10 synthesis
and alpha GP isoforms expression in vitro. In a proof of our previous study, the
effect of oral administration of PP was investigated in steroid resistant asthma
(SRA) patients.
Methods: The samples obtained from 58 patients with asthma: 27 patients with
SRA, 31 patients with steroid sensitive astma SSA and 20 donors. The patient’s
forced expiratory volume in one second (FEV1) and forced vital capacity (FVC)
was measured with a microspirometer, following recommended procedures for
standardization of pulmonary function measurements. Patients with forced
expiratory volume in 1 s (FEV1) G 70% predicted were studied. SSA patients
were with FEV1 increased 9 30% after a 1-wk course of oral prednisone 20 mg
twice daily and SRA if they failed to increase 9 15%. Dolichol (Dol) in blood
and urine were assayed by HPLCmethod. Dolichyl phosphate, alpha- and beta-
GR isoforms expression were measured in CD4+ T-cells.
Results: Blood Dol concentration in persons SSA was 255.6 + 25.9 ng/mL
and urinary Dol concentration was 18.9 + 4.5 mg/mmol. Blood Dol in patients
with SRA was increased up to six times making up 689.2 + 47.9 ng/mL.
Urinary Dol concentration was increased up to 590.9%, making up to 48.8 +
9.7 mg/mmol. The normal levels of Dol in donors are 8,0 + 2,9 mg/mmol
in urine and 110,4 + 12,6 ng/mL in blood. The synthesis of DolP was
8.8Y10.5-fold decreased in T-lymphocytes in patients with SRA. 10 days
course of PP 5 mg supplementation in SRA patients returned DolP con-
centration in blood, urine and T- cells to the normal level. 8 of the 10 SRA
patients demonstrated a significantly increase FEV up to 30% after 2-wk
course of oral prednisone 20 mg twice daily and 5 mg of PP.
Conclusion: Dolichyl Posphate Cycle (DPC) disorder is a rate limiting
mechanism of steroid resistance in asthma and associated with a marked defect
of glucocorticoid receptors (GR) N- glycosylation in CD4+ T-cells. Presented
findings provide evidence that PP supplementation in patients with SRA
enhanced the expression of alpha GP isoforms, restore the possibility to induce
IL-10 synthesis and made CD4+ T-cells more responsive to steroids. Plant
Polyprenol and prednisone increase FEV and FVC in SRA patients. These
preliminary results may have important implications for the design of
alternative treatment approaches for steroid resistant asthma.
465
Uncontrolled severe asthmatic patients clearly improve under
anti-IgE (Omalizumab) treatment. 14 cases reported
Beatriz Huertas1, Miguel Hinojosa1, Jesus Gonzalez-Cervera1, Belen De la
Hoz1, M Luz Diez-Gomez1, Moises Sanchez-Cano1, and Adalberto Pacheco2.
1Ramo´n y Cajal Hospital, Allergology, Madrid, Spain; 2Ramon y Cajal
Hospital, Pneumology, Madrid, Spain.
Background: Anti-IgE Monoclonal antibodies (Omalizumab) had been
recently introduced in the treatment of bronchial asthma. Last October 2005,
the EMEA authorized this drug in the European Union for allergic severe
asthmatic patients as an add-on therapy. Experience with a 14 patient-
treatment is reported.
Methods: 14 patients, 11 females and 3 males, were studied, age average 57
years, all of them suffering from severe allergic asthma (step V present GINA
guideline) from the last 5Y37 yr, average 19 yr. A positive skin prick test and/or
specific IgE antibodies to a variety of common aeroallergens was observed in
all patients. IgE sera levels were between a range of 40Y1000 IU/ml (overage
316 IU/ml). FEV1 were under 80% predicted in all patients, overage (63%
predicted). All patients were under treatment with high doses of inhaled
corticosteroids, long acting inhaled beta-agonists and leukotriene modifiers
and eleven of them also were on treatment with oral corticosteroids,
prednisone, in a range from 5Y20 mg. Omalizumab 150 to 600 mg per
month were subcutaneously administrated to each patient once or twice
monthly depending of IgE levels and body weight. Every month after onset of
treatment the following parameters were evaluated: Asthma quality of life
questionnaire (AQLQ, E. Juniper) Asthma control questionnaire (ACQ, E
Juniper), FEV1, physician overall assessment and possibility of side effects.
Patients were following up for two to ten months.
Results: A marked improvement of AQLQ and ACQ could be observed in 11
out of 14 patients. Physician overall assessment also improved in the same
patients. This improvement was moderate in the remaining 3 patients.
Response to treatment was appreciated into the first two months in all patients.
FEV1 also improved in all patients in a range of 8 to 35% predicted. One
patient developed marked edema in both legs after 12 wk and another acute
otalgia and erythema nodosum in legs after 20 wk of treatment. Both patients
withdrew omalizumab treatment. Oral corticosteroids were withdrawn in two
patients and lowed in other four.
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Conclusion: Omalizumab treatment has proved to be effective in patients with
uncontrolled severe allergic asthma. A total control was shown in more than
half of patients and an enough control was got in the remaining patients. No
exacerbations were observed in any patient all over the omalizumab treatment.
Adverse reactions possibly but not sure related to omalizumab were shown in
two patients.
466
Efficacy of budesonide/formoterol in the treatment of children
with moderate-severe asthma
Lina Chen1, Yuzhi Chen2, Chunmei Zhu2, and Shuo Li2. 1West China Women
and Children’s Hospital, Sichuan University, Pediatrics, Chengdu, China;
2Capital Institute of Pediatrics, Asthma Clinic and Education Center, Beijing,
China.
Background: Our previous survey indicated that Chinese pediatricians tended
to choose iv corticosteroids when treating moderate-severe childhood
asthma,while GINA recommends the combination of inhaled corticosteroids
(ICS) and long-acting "2 agonists (LABA) for the treatment of persistent
asthma. In order to evaluate one combination product budesonide/formoterol
in the treatment of moderate-severe childhood asthma, we investigated its
efficacy and safety.
Methods: In a 12-week study, 34 children with moderate-severe asthma (28
males, 6 females,mean age 9.7T2.5years; receiving no systemic corticosteroids
4 weeks prior to study and having no LABA or SABA 1 week before study)
were given nebulized budesonide suspension and salbutamol plus ipratropium
bromide to relieve acute exacerbations at the clinic, then were given
budesonide/formoterol (160ug/4.5ug) one inhalation in the morning and two
in the evening for 2 weeks and one inhalation twice daily afterwards till the end
of 12 weeks. Oral prednisone for 1Y3 days and slow release salbutamol for 3
days were prescribed to severe asthmatic children. Lung function, symptom
improvements and adverse effects were mornitored after inhalation therapy.
Results: Lung function variables such as FEV1, FEV1%, FVC, FVC%, PEF,
PEF%,MMEF and MMEF% were statistically improved 2 weeks and 1 month
post treatment (PG0.01).The mean time for relief were 3Y4 days after
inhalation therapy. 91.2% of the children gained complete asthma control in 2
weeks and all children gained complete control at 4 weeks, 8 weeks and 12
weeks post treatment. No child had emergency treatment and short-acting "2
agonist inhalation during the period. Such side effects as hoarseness and
pharyngeal discomfort were observed.
Conclusion: Budesonide/formoterol is an effective and safe treatment option
for children with moderate-severe asthma, such treatment regimen may reduce




Therapy of chronic airway diseases with nucleic acids
Stefanie Thiele, and Andreas Pahl. University of Erlangen, Department of
Pharmacology, Erlangen, Germany.
Background: RNA interference (RNAi) holds considerable promise as a
therapeutic approach to silence genes involved in inflammatory pathways. It
has been reported that intranasal administration of small interfering RNA
(siRNA) is able to down-regulate protein expression. Aim of the project is the
development of a nucleic acid based therapy for asthma and other chronic
airway diseases.
Methods: Different knock-down strategies were evaluated in vitro. Various
cell lines were transfected with siRNA or short hairpin RNA (shRNA) using
different transfection reagents. Furthermore, the optimal route of application in
vivo was investigated. The intranasal administration and the intratracheal
administration of RNAi agents were investigated. For these studies
constitutively GFP-expressing transgenic mice were used, which allowed the
monitoring of cell specific knock-down effects. Finally genes relevant for
chronic airway diseases will be knocked down in vivo.
Results: In comparison to other transfection reagents, a cationic lipid showed
highest transfection efficiency along with lowest toxicity in vitro as well as in
vivo. Using this reagent in vivo an uptake of shRNA in 30% of lung cells could
be detected. In comparison down-regulation of GFP in cultured lung cells from
transgenic GFP-mice was analysed. siRNA directed against GFP silenced GFP
expression by about 40%.
Conclusion: The cationic lipid transfection reagent is suitable for RNAi in
vitro and in vivo. Lung cells are amenable for RNAi agents as shown by
intranasal application of a shRNA vector.
469
Effect of immunotherapy with ISS-ODN and allergen in animal
model of mugwort allergy
Junwoo Kim, and Bin Zhou. University of Tennessee, Department of
Medicine, Memphis, United States.
Background: Despite a number of effective pharmacological options for the
prevention and treatment of the pathophysiologic responses that occur in sen-
sitized patients on allergen exposure, the termination of allergic hypersensi-
tivities remains an elusive therapeutic goal. By specific immunotherapy (SIT)
with allergen extracts, allergy can be cured, however it has a limited scope of efficacy.
Immunostimulatory sequence oligodeoxynucleotide (ISS-ODN) was known to
provide potent allergen-independent immune redirection from Th2 into Th1.
Objective:We investigated that with the animal model of mugwort allergy, the
allergic inflammation is controlled by ISS-ODN and what is the mechanism of
the immune redirection. Also we investigated that ISS-ODN with allergen as a
model of potentiated SIT could have better anti-allergy effects on allergic
inflammation induced by specific allergen over ISS-OND alone.
Methods: Experiments were performed in four groups of mice which
designed to develop mugwort allergy with sensitization and aerosol challenge
with mugwort extract. Group 1 received 100 mg of ISS-ODN with 110 mg of
mugwort allergen as a therapeutic group, Group 2, ISS-ODN with bovine
serum albumin, Group 3, C-ODN (control ODN) with mugwort allergen,
Group 4, ISS-ODN alone. Cytokine profiles of IL-4, IL-5, IL-10, IL-13, and
IFN-+, degree of inflammation in lung histology, and differential counts of
bronchoalveolar lavage cells were measured.
Results: Significant decreases of allergic inflammation in lung were observed
in ISS-ODN with allergn group and ISS-ODN alone group comparing to
negative control groups. IFN-+ was significantly increased in ISS-ODN with
allergen group and ISS-ODN alone group comparing to control group.
Conclusion: Allergic inflammation is controlled by ISS-ODN with allergen,
which could be a new treatment of human allergic diseases.
470
Estrogen exerts protective effects in a murine model of asthma
Manav Segal, Abdo Berro, Shuping Jia, and Thomas B Casale. Creighton
University Medical Center, Allergy/Immunology, Omaha, United States.
Background: Sex hormones have been suggested to play a role in the
pathophysiology of airway diseases. Recent studies indicated an important role
for estrogen in the development and severity of asthma. However, the exact
effect of estrogen on lung physiology and asthma status remains poorly defined.
Objective: We investigated the effect of estradiol (E2) on airway
hyperresponsiveness (AHR) in vivo and airway contraction in vitro.
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Methods: A mouse model of asthma was established by sensitizing and
challenging female BALB/c mice with ovalbumin (OVA). In addition, some
mice were given intranasal (IN) IL-13, which induces an asthma-like disease,
including airway inflammation and airway hyperresponsiveness. For in vivo
studies, the effect of IN E2 treatments on methacholine (MCh)-induced
bronchoconstriction was analyzed by using a Buxco system, and airway
responsiveness was recorded as PenH values. An increase in bronchoconstric-
tion is reflected by an increase in PenH values. PenH was expressed as the
mean T SEM. For in vitro studies, lungs of OVA-sensitized female BALB/c
mice were sectioned and mounted in a perfusion chamber, and observed under
a microscope. Images of selected airways were captured pre- and post-
treatment with acetylcholine (ACh) or E2.
Results: In vivo, the MCh-induced PenH of OVA-sensitized mice before
treatment with E2 was 8.30T0.58.When this group of mice was treated IN with
1 nM E2 4-hr prior to MCh challenge, their PenH was lower (5.54T0.84).
OVA-sensitized mice pre-treated with IN PBS, on the other hand, did not
display any change in PenH. In preliminary studies, E2 also suppressed airway
responsiveness in IL-13-treated mice (PenH of 5.35T2.39 versus 7.34T1.95 for
E2 and control mice, respectively). In vitro, ACh-induced airway contraction
(lumen area measured 99.7 2m2 after 1 2M ACh compared to 116.8 2m2 at
baseline) was reversed when treated with 1 2M E2 (109.1 2m2). Pre-treatment
of the airways with 12M E2 pre-treatment blocked the ACh-induced
contraction (lumen area measured 125.1 2m2 after 12M ACh compared to
126.8 2m2 at baseline and 125.8 2m2 after E2).
Conclusion: These data suggest that estradiol can inhibit and prevent AHR
associated with antigen and IL-13 in a murine model of asthma. Thus, estrogen
analogues might play a therapeutic role in the management of asthma.
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Engineering combination vaccines for allergic and
infectious asthma
Johanna Tinhofer1, Margarete Focke-Tejkl1, Birgit Linhart1, Kerstin
Westritschnig1, Sandra Scheiblhofer2, Angelika Stoecklinger2, Josef
Thalhamer2, Theresia Popow-Kraupp3, and Rudolf Valenta1. 1Medical
University Vienna, Department of Pathophysiology, Vienna, Austria; 2Uni-
versity of Salzburg, Department of Molecular Biology, Salzburg, Austria;
3
Medical University Vienna, Department of Virology, Vienna, Austria.
: Allergens and rhinovirus infections are among the most common
elicitors of asthma, a severe disabling disease affecting more than 300 million
people worldwide. We report the construction of a recombinant combination
vaccine for allergen- and rhinovirus-induced asthma. Using a peptide from one
of the most frequent respiratory allergens, the major timothy grass pollen
allergen Phl p 1, and the human rhinovirus-derived coat proteinVP1 required for
infection of respiratory cells a recombinant fusion protein was produced.
Immunization with this fusion protein induced in mice and rabbits protective
IgG antibodies which recognized the allergen and neutralized the infection of
cells expressing the receptor for human rhinoviruses. The vaccine exhibited
neither IgE nor T cell-mediated allergenic activities. The described principle
may be used for the combined vaccination against allergic and infectious asthma.
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Adherence to treatment by patients with asthma or COPD:
Comparison between inhaled drugs and transdermal patch
Gen Tamura1, and Ken Ohta2. 1Airway Institute in Sendai, Respiratory
Medicine, Sendai, Japan; 2Teikyo University School of Medicine, Respiratory
& Allergology, Tokyo, Japan.
: An Internet-based questionnaire study was conducted of patients with
asthma and chronic obstructive pulmonary disease (COPD) and parents of
children with asthma to evaluate adherence to regimens of treatment and
convenience of use of inhaled and transdermal preparations. Valid responses
were obtained from 1,470 patients. Among asthmatic patients, the percentage of
those who selected Btaking as prescribed[ was 52.7% for inhalant users and
83.2% for transdermal users. Among patients with COPD, the corresponding
values were 54.7% and 86.6%. There was a significant difference (pG0.01) in
percentage between inhaled and transdermal preparations for both airway
diseases. The most common reason for poor adherence was Bfrequency of
administration[, and a high proportion of patients, 83.2%, preferred once-daily
administration. In addition, patients who had used both preparations preferred
transdermal to inhalant drugs, to a significant extent. In conclusion, health care
professionals should further educate their patients about the importance of
treatment with inhalants, since poor adherence to treatment with inhaled agents
significantly hinders achievement of optimal efficacy. In addition, transdermal
tulobuterol patch, which is administered once daily as a long-acting beta2-
agonist, appears to be useful for long-term control of both asthma and COPD.
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Aerosol characteristics of admixture of budesonide inhalation
solution with beta2-agonist, procaterol
Toshiko Itazawa1, Yuichi Adachi1, Hiroyuki Mochizuki2, Naoki Shimojo3,
Toshishige Inoue4, Toshiyuki Nishimuta5, Akihiro Morikawa2, and Sankei
Nishima6. 1University of Toyama, Pediatrics, Toyama, Japan; 2Gunma
University Graduate School of Medicine, Pediatrics, Maebashi, Japan;
3Chiba University, Pediatrics, Chiba, Japan; 4Sumitomo Hospital, Pediatrics,
Osaka, Japan; 5Shimoshizu National Hospital, Pediatrics, Shimoshizu,
Japan; 6Fukuoka National Hospital, Pediatrics, Fukuoka, Japan.
Background: Nebulizer solutions of asthma medications are often mixed
together in order to simplify inhalation regimens, although not recommended.
We therefore evaluated the effect of admixture on aerosol characteristics.
Methods: An 8-stage cascade impactor was used to measure the particle size
distribution of admixture of Pulmicort\ Respules\ (budesonide, 0.5mg/2mL)
with Meptin\ Inhalation Solution Unit (procaterol hydrochloride, 302g/
0.3mL) from a jet nebulizer, PARI LC Plus\. Concentrations of each drug
were assayed by HPLC. Physico-chemical compatibility was also assessed up
to 48 hours after mixing.
Results: Impaction analysis revealed no differences in aerodynamic size and
output of each drug between admixture and single-drug solutions. The mass
median aerodynamic diameter (MMAD) of budesonide from the admixture
with procaterol was 2.92 T 0.03 2m, and 2.99 T 0.14 from single-drug solution.
The respirable mass of budesonide from the admixture was comparable with
that from single solution (146.8 T 2.9, 147.6 T 8.2 2g, respectively). There was
no significant change in pH or visual identification of a precipitate in the
admixture. Recovery rates of each drug kept more than 96% of the initial
values during the observation period.
Conclusion: Our study demonstrated compatibility of co-administration of
budesonide with procaterol in the aspect of aerodynamic characteristics and
physico-chemical stability. In vivo data will be needed for the clinical
implications of our findings.
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Efficacy of sublingual immunotherapy in asthma control
Sylvia Novakova1, and Rositsa Dimitrova2. 1The IVth Outpatient Clinic,
Allergology, Plovdiv, Bulgaria; 2Regional Hospital of Pulmonary Diseases,
Allergology, Veliko Tarnovo, Bulgaria.
Background: It has been of great interest to evaluate the clinical efficacy of
sublingual immunotherapy (SLIT) in achieving asthma control. This interest is
justified as the most recent GINA guidelines put an emphasis on control of
asthma as a baseline for asthma management. Furthermore, this is the first
study on SLIT in Bulgaria since this rout of administration of immunotherapy
has been available for two years in the country.
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The aim of the study was to investigate the potential effect of one year
SLITwith dust-mites on asthma control.
Methods: 50 patients with asthma and allergy to dust mites (Dermatophagoides
pternyssinus and/or Dermatophagoides farinae or both) were included in the
study. 21males and 29 females, aged from 12 to 35 years (mean 23,5). SLIT has
been prescribed in 25 of them (12 men) for one year along with other antiasthma
therapy. A control group of 25 patients (10 men) had been maintained on medical
therapy alone. Asthma Control Test /ACT/ was performed to asses the level of
control for the last four weeks. On the basis of number score, asthma control was
estimated as: out of control, partially controlled and completely controlled.
Assessments of FVC and FEO1 were performed too.
Results: From the group of patients, subjected to SLIT + medical treatment,
12 (48%) were completely controlled, 9 (36%) Y partially controlled and 4
(16%) out of control for the last four weeks of the study. From those on
medical treatment alone, 5 (20%) were completely controlled, 10 (40%)
partially controlled and 10 (40%) were out of control for the past four weeks.
FVC and FEO1 did not differ in both groups. Patients on SLIT were better
controlled (pG0.05) after the first year of treatment.
Conclusion: The results of the study suggest that SLIT affords additional
benefit to medical treatment in patients with asthma and allergy to dust mites.




Evolution of quality of life in patients treated with therapeutic
vaccine containing depigmented and polymerized allergen
extracts of dermatophagoides pteronyssinus and D. farinae in
allergic asthmatic patients: results of a double-blind placebo
controlled study
Jose Carlos Garcia Robaina1, Inmaculada Sanchez Machin1, Paloma Poza
Guedes1, Fernando de la Torre Morin1, and Miguel Casanovas2. 1Hospital
Universitario Ntra Sra de Candelaria, Allergy, Santa Cruz de Tenerife, Spain;
2Laboratorios LETI, R & D, Madrid, Spain.
Background: Depigmented and polymerised allergen vaccines have shown to
be efficacious using objective and subjective outcomes. It is now recognized
that treatments under evaluation should enable patients to feel better in their
day-to-day life activities. The objective was to evaluate the impact in the
quality of life of a group of 64 asthmatic patients sensitised to house dust
mites.
Materials and Methods: The study was double-blind and placebo-controlled.
Sixty-four patients were randomly allocated to either receive active treatment
(n=32) or placebo (n=32). The active treatment was a therapeutic vaccine
containing a mixture of depigmented and glutaraldehyde polymerized mixture
of allergen extracts of D. pteronyssinus and D. farinae. The Asthma Quality of
Life Questionnaire developed by Marks was used. It was conducted at baseline
and after each administration of allergen vaccine (19 times). This is a 20-item
self administered questionnaire, developed to measure quality of life in adult
subjects with asthma by measuring a total scale score together with subscale
scores for breathlessness, mood disturbance, social disruption and concerns
for health. The result was expressed as the mean of all 19 measurements,
Mann-Whitney’s test was used to evaluate the statistical differences between
both groups, and Hodges-Lehmann for the effect size of these differences.
Results: The AQLQ overall score was the sum of all individual scores. The
values of the mean for these scores were 7.44 (95% CI: 5.78Y9.11) for the
active group and 11.44 (95% CI: 9.67Y13.22) for the placebo. The differences
between both groups were significant (p=0.043, Mann-Whitney’s test) and
relevant (Hodges-Lehmann test: j4.36, 95% CL: j8.69,j0.10). The active
group showed an improvement of 34.98% over placebo.
Conclusion: The results of this clinical trial show that the immunotherapy-
treated patients, in contrast with untreated, experience a significant improve-
ment in the overall quality of life related to asthma. The statistical significance
as well as the improvement on the active group compared with the placebo
occurred also in the domains of breathlessness, social disruption and concerns
for health, with the exception for mood disturbance.
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The leukotriene receptor antagonist pranlukast improves quality
of life in poorly controlled asthmatic patients
Hiroko Arioka. International Medical Center of Japan, Pulmonology, Tokyo,
Japan.
Background: Asthma is a chronic inflammatory disease, and inhaled
corticosteroids have been shown to be very effective in controlling symptoms.
However, it is important to minimize the dosage of corticosteroids used
because of local and systemic adverse effects. The importance of leukotrienes
in the pathogenesis of asthma is established and many studies have shown that
leukotriene receptor antagonists can improve asthma control in patients with
poorly controlled asthma despite the use of inhaled corticosteroids.
Objective: The aim of this study was to assess the effects of 8 weeks’
pranlukast treatment on quality of life and pulmonary function in patients with
inadequately controlled asthma.
Methods: This study was conducted at 312 hospitals and clinics in Japan from
October 2004 to March 2005. We recruited 1546 outpatients (mean age
51.4T18.5 years) with mild-to-severe asthma (as defined by the Japanese
Society of Allergology) who were not well controlled with daily antiasthmatic
treatment. During the 8-week treatment period, patients received pranlukast
(225mg, twice a day) in addition to their previous treatment. Patients were
required to complete symptom diaries and record peak expiratory flow (PEF)
on a daily basis. Quality of life (QOL) was assessed using the Asthma Health
Questionnaire (AHQ).
Results: A total of 839 asthmatic patients were enrolled. Significant
improvements were observed in the AHQ total score and all subscale scores.
When the patients were classified according to baseline disease severity (mild,
moderate and severe), the improvement from baseline remained significant for
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all AHQ subscale scores other than the economics subscale in all patient
groups.
Patients also demonstrated significant improvements from baseline in
PEF (+34.9 L/min; p G 0.001), forced vital capacity (+0.17L) and forced
expiratory volume in 1 second (+0.14L; both p G 0.005).
Conclusion: The leukotriene receptor antagonist pranlukast improves QOL
and pulmonary function in asthmatic patients inadequately controlled with
antiasthmatic therapy.
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Effectiveness of short-term oral corticosteroid for preventing
relapse following the emergency treatment of acute asthma
Tomoyuki Serizawa, Shoji Yoshida, and Itsuo Iwamoto. Asahi General
Hospital, Research Center for Allergy and Clinical Immunolog, Asahi City,
Japan.
Background: Acute asthma is responsible for many emergency department
(ED) visits. It has been shown that high-dose intravenous methylpredni-
solone in addition to standard emergency treatment for acute asthma
induces the early termination of the asthmatic attacks and reduces the
number of hospitalizations. In addition, it has been reported that about 15
to 30% of the asthmatic patients treated in the ED will relapse to require
additional interventions within 2 weeks of ED discharge. However, little is
known about the efficacy of oral corticosteroid in reducing the relapse in
the asthmatic patients discharged from the ED after treatment of acute
asthma. The purpose of this study was to determine the effectiveness of
oral corticosteroid in reducing relapse following the emergency treatment
of acute asthma.
Methods: Patients with acute asthma were treated with nebulized salbutamol
and intravenous 125 mg methylprednisolone and 200 mg theophylline and
were then discharged from the ED. Upon discharge, some patients were given
oral 20 to 30 mg/day prednisolone for 5 days.
Results: The asthmatic patients who received oral prednisolone had a
significant decrease in the need for repeated emergency care (5.4%, 4 out of 74
patients, pG0.0001) within 2 weeks as compared with those who did not
(33.3%, 73 out of 219 patients). The mean dose of prednisolone was 24.4 mg/
day and the mean duration was for 4.4 days.
Conclusion: It is concluded that a 5-day course of medium-dose oral
prednisolone (0.5 mg/kg/day) in outpatients prevents the relapse following the
emergency treatment of acute asthma.
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Management of childhood asthma in east-java indonesia
Sulistiowati Santosa1, Handoko Tanuwidjaja2, and Hugo van Bever3. 1Adi
Husada Hospital, Paediatrics, Surabaya, Indonesia; 2Dr. Ramelan Navy
Hospital, Pulmonary and Allergy, Surabaya, Indonesia; 3National University
Hospital, Paediatrics, Singapore, Singapore.
Background: Treatment guidelines for childhood asthma is available, but it is
important to know whether this guideline is being used in East Java.
Methods: Using a standardized questionnaire on monitoring and treatment of
childhood asthma, distributed to doctors treating childhood asthma in East
Java.
Results: Only 70 (20%) out of 350 doctors participated in this
questionnaire study. General practitioners were 75.7%, 5.7% paediatricians
and 2.9% pulmonologists. 88.6% worked in policlinic or private hospitals,
and only 5.7% worked in university hospitals. Symptom score, peak flow
meter or spirometry never or seldom used to monitor childhood asthma
(94%). Nebulised salbutamol/terbutaline was the first drug of choice
(63.8%) for treating acute asthma attack, followed by iv or im
corticosteroids (23.7%), and iv aminophylline (30.6%). The three main
criteria for admitting acute attacks were based on personal clinical
judgement (80.0%), no improvement after 2 or 3 doses of salbutamol
inhaler (44.4%) and other factors such as home distance and travel time
(37.0%). IV aminophylline was seldom used (60.0%). Systemic (57.1%)
and inhaled corticosteroids (50.7%) were seldom used in outpatient
setting. Corticosteroids were used in all admitted patients. The
corticosteroid of choice were dexamethasone (50.0%), methylpredniso-
lone(45.7%), and were used same the dose for 5 days. Oxygen therapy,
based on pulse oximetry reading were used only for severe asthma
(45.6%). Antibiotics were used only in case of pneumonia, otitis media or
sinusitis (40.0%). Drug of choice in the maintenance treatment of asthma
in all ages were the same: LABA was the first choice, followed by LABA
+ inhaled corticosteroid and inhaled corticosteroids. Maintenance treatment
was seldom used in all ages. The main criterium to start a maintenance
treatment was the severity of the symptoms (47.1%). Specific immu-
notherapy never been used (72.1%).
Conclusion: Although treatment guidelines for asthma in children is available,
in daily practice we still find many modifications, including the usage of a
LABA as first choice maintenance treatment. More efforts in socialization of
the guidelines and providing tools for monitoring and treatment of asthma in
children are needed.
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The use of yoga as an adjuvant therapy in the management of
bronchial asthma: based on a randomized controlled trail
Ramaprabhu Vempati, and Deepak KK. All India Institute of Medical
Sciences, Physiology, New Delhi, India.
Background: Complementary and alternative medicine (CAM) therapies
such as herbal therapy, acupuncture, yoga, chiropractic, relaxation techniques,
nutrition and dietary supplements, continue to gain popularity as modalities
for the management of asthma. However there is a dearth of qualitative
research with strong methodology to understand plausible mechanism of
action of these therapies on asthma. The present randomized controlled trial
(RCT) examines the use of yoga as an adjuvant therapy in the management of
bronchial asthma.
Methods: The study was conducted on 57 adult patients having mild or
moderate bronchial asthma who were allocated randomly to either the yoga
group (n = 29) or the wait-listed control group (n = 28). The control group
received conventional treatment whereas the yoga group received, in addition
to conventional treatment, also an intervention based on certain yogic
practices. The outcome measures were assessed in both groups at 0 wk
(baseline), 2 wk, 4 wk and 8 wk.
Results: In the yoga group, there was a steady and progressive improvement in
pulmonary function. There was also a trend towards a reduction in exercise-
induced fall in timed vital capacity (FEV1) in the exercise-sensitive (exercise
induced asthma) subgroup of subjects in the yoga group. However, there was
no corresponding reduction in the excretion of urinary prostaglandin D2
metabolite (11"-PGF2!) in response to the exercise challenge, which is an
indicator of mast cell activation. There was also no significant chan there was a
significant reduction in serum soluble interleukin-2 receptor (sIL-2R) levels
after 2 wk in yoga group alone. NNT for quality of life indicators worked out to
be 2.41 in QOL symptoms, 1.66 in QOL activity limitation, 1.91 in QOL
emotional function, 1.70 in QOL environmental stimuli and 1.82 in total
quality of life.
Conclusion: The results indicate that of yoga in addition to conventional
treatment as an adjuvant therapy in asthmatic patients results in improvement
in pulmonary function and quality of life; reduction of T-cell activation and
response to exercise stimuli. These findings provide yet another substantial
evidence towards the use of yoga as an adjuvant therapy in the management of
bronchial asthma.
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The effect of inhaled steroids and long-acting beta2 -agonists on
oxidative stress in stable asthmatics
Eduard Semyatichko, Valeriya Nemtsova, and Olga Shevchenko. Kharkov
Medical University, Allergology, Kharkov, Ukraine.
Background: The effect of inhaled steroids on oxidative stress in asthmatics is
unclear. In this study the levels of lipid peroxides in the serum of asthmatic
patients, whose symptoms were controlled with inhaled corticosteroids and
long-acting beta(2)-agonists, were measured.
Methods: Twenty-four asthmatic patients and 15 matched, healthy controls
were recruited. Oxidative stress levels were quantified by measuring
thiobarbituric acid reactive substances.
Results: After 3 months of treatment, the mean lipid peroxide concentrations
were significantly higher in asthmatic patients than in the healthy controls (4.3
+/j 0.15 micromol/mL vs. 3.4 +/j 0.03 micromol/mL, respectively).
Conclusion: The parameters of oxidative stress was higher in patients with
asthma than in healthy controls, even when the asthma is well controlled after 3
months of treatment.
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Effect of thalidomide in murine model of asthma
Hyouk-Soo Kwon1, Min-Suk Yang1, So-Hee Lee1, Chang-Han Park1, Heung-
Woo Park1, Yoon-Seok Chang1, Sun-Sin Kim1, Sang-Heon Cho1, Kyung-Up
Min1, Bo-Ram Bang2, Eun-Jin Shim2, Eun-Young Chun2, Soo-Yeon Lee2,
Hyun-Seung Lee2, and You-Young Kim1. 1Seoul National University College
of Medicine, Department of Internal Medicine, Seoul, Republic of Korea;
2Seoul National University Medical Research Center, Institute of Allergy and
Clinical Immunology, Seoul, Republic of Korea.
Background: Tumor necrosis factor-alpha (TNF-alpha) has been identified
as a proinflammatory cytokine that might be important in airway
hyperresponsiveness (AHR). Thalidomide exhibits diverse actions of
anti-inflammation and immunomodulation including attenuation of TNF-
alpha production.
Objective: To evaluate the role of thalidomide in murine model of asthma.
Methods: Six-week-old female C57BL/6 mice were sensitized with LPS
0.1 mg/ml and ovalbumin (OVA) via intranasal route and were exposed to
OVA via intranasal route for 3 days. Thalidomide 50mg/kg was given via
gavage twice a day from a day before the challenge. Airway
responsiveness, inflammatory cells, cytokines in bronchoalveolar lavage
fluids (BALF), serum OVA-specific IgE, IgG1, IgG2a, and histological
examination were carried out.
Results: Airway hyperresponsiveness decreased significantly in mice treated
with thalidomide. There were no differences in IL-4, IL-5, IL-12, IFN-gamma,
and eotaxin levels in BALF.
Conclusion: Thalidomide decreases AHR in murine model of asthma.
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Therapeutic comparison between low-dose sustained-release
theophylline dry syrup and capsule in children with mild
persistent asthma
Lee Keun Young1, Jin-Tack Kim1, Hyun Seung Lee1, and Lee Joon Sung2.
1Uijongbu St. Mary’s Hospital, Pediatrics, Uijongbu City, Republic of Korea;
2KangNam St. Mary’s Hospital, Pediatrics, Seoul, Republic of Korea.
: Theophylline has been recently reported to have concurrent anti-
inflammatory effects at low therapeutic plasma concentration which is below
the dose at which significant clinically useful bronchodilatation is evident.
Sustained-release formulation as capsule and dry syrup forms was developed
to reduce its adverse effects and improve its clinical effects. We compared
between therapeutic effects of theophylline dry syrup and capsules in children
with mild asthma.
Methods: Ninety children with mild asthmawere randomized to receive either
theophylline dry syrup (n = 44) or theophylline capsules (n = 46), 4 mg per
kilogram of body weight twice a day for 12 weeks. Baseline and serial
measurements of daytime and nighttime asthma symptom score were
performed. Compliance score, drug swallowing score, and drug usability
score were measured every 4 weeks. Each scoring rated on a scale of 0Y4.
Serum theophylline concentration were mesured at 4 and 12 weeks. To
examine anti-inflammatory effect of theophylline on asthma, Serum
eosinophilic cationic protein as a marker of airway inflammation caused by
eosinophil was measured 12 weeks pre- and post-administration.
Results: Daytime and nighttime asthma symptom score of two groups
after 4 weeks significantly improved than baseline score. Daytime and
nighttime asthma symptom score in dry syrup group were statistically
lower at all time points except for nighttime symptom score at 4
weeks. Compliance score, drug swallowing score, and drug usability score
in dry syrup group were significantly higher at end time point. Only
in dry syrup group, serum ECP at end time point was statistically lower
than baseline.
Conclusion: Low-dose sustained-release theophylline may be safe and
effective in bronchial asthma and this effect may be mediated by its anti-
inflammatory action mechanisms. Especially, when used in children with
asthma, dry syrup formulation is recommended because of its higher
compliance than that of capsule formulation.
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Steroid-dependent bronchial asthma: how to reduce the dose of
oral glucocorticosteroids and improve asthma control?
Rustem Fassakhov, and Irina Reshetnikova. Kazan Scientific Research
Institute of Epidemiology and Microbiology attached to Rospotrebnadzor,
Allergology and Immunology Department, Kazan, Russian Federation.
Background: Patients with chronic severe asthma are often dependent on the
long term prescription of oral glucocorticosteroids. The use of steroids is
associated with serious side effects. Physicians treating such patients continue
to search for alternative therapies that reduce the need for chronic dosing oral
steroids.
Aim: To assess efficacy and safety of 24- months treatment with Salmeterol/
Fluticasone propionate (100/ 1000 mcg daily) and Fluticasone pro-
pionate (1000 mcg daily) in 105 steroid-dependent bronchial asthma
patients aged 18 to 60 years, who had received oral glucocorticosteroids
(predisolone equivalent) less than 10 mg daily (75,2%) and more than 10
mg daily (23,8%) for at least 6 months but not more than 10 years.
Methods: This was comparative, randomized, multicentre, open study in
parallel groups (15 visits at 2 weeks intervals). Oral glucocorticosteroids dose
reduction phase started at 3-rd visit.
Results: Inspite of continual treatment with oral glucocorticosteroids patients
did not reach asthma control. After 6-months treatment maintenance dose of
prednisolone was 6 times lower in comparison with baseline. Moreover, oral
glucocorticosteroids were abolished in each second patient receving
Salmeterol/ fluticasone propionate and each third patient receiving
Fluticasone propionate. At the same time asthma control and quality of life
significantly increased. Administration high doses of fluticasone propionate
and decreasing dose of oral glucocorticosteroids lead to reliable increase the
morning level of serum cortisol by the sixth month of treatment in both
groups of patients.
Conclusion: The treatment with Fluticasone propionate and Salmeterol/
fluticasone propionate allows reduce the dose of oral glucocorticosteroids,
moreover in the most causes patients can abolish oral glucocorticosteroids
maintaining good asthma control.
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Cycloferon treatment of atopic bronchial asthma exacerbations
with respiratory infections
Tatiana Ospelnikova. The Gamaleya Institute of Epiremiology&Microbiology
RAMS, The Gamaleya Institute of Epiremiology&Microbiolog, Moscow,
Russian Federation.
: Respiratory infections (viral and bacterial) may be trigger of atopic
bronchial asthma (ABA) exacerbations. Was revealed II-III degree Interferon
(IFN)-a and IFN-g production deficiency of leukocytes by all 19 patients with
moderate and mild ABA in unstable remission phase and also acute mixed
(viral and bacterial) respiratory infections. The purpose of this study was to use
low molecular IFN inducer cycloferon for to improve IFN system indices and
to reduce ABA exacerbations rate. It is known, that low molecular IFN inducer
cycloferon have both antiviral and immunomodulating activities, can be
successfully used in acute respiratory viral diseases. Cycloferon have affinity
to alveolar macrophage receptors and induce of IFN in lungs. After the
administration of cycloferon IFN-a and IFN-g producing capacity of
leukocytes was 2-fold higher in comparison before treatment (pG0,05). 82%
of patients (n=9) in group with cycloferon and basic therapy had positive
clinical effect versus 50% of patients (n=4) with only basic therapy. Effective
schemes of therapy viral/bacterial infections with use antiviral drugs, IFN
inducers and IFN preparations, having both immunomodulatory properties
and antiviral/antibacterial effects, have to be worked out for improvement of
treatment efficacy of patients with BA exacerbations.
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The effect of inhaled beclomethason dipropionate (BDP) versus
budesonide (B) in asthmatic patients-comparative, randomized,
double blind clinical study
Zoran Arsovski1, Dejan Dokic1, Miroslav Gavrilovski1, Biserka Kaeva1,
Zlatica Goseva1, Tatjana Caparoska1, Gjurgica Dzonova2, and Aleksandar
Kafedziski2. 1Clinic of Pulmonology and Allergy, Scientific Department,
Skopje, Macedonia, Fyrom; 2Lek Skopje, Development, Skopje, Macedonia,
Fyrom.
Aim: The aim of the study was to compare the two different topical
corticosteroids in the treatment of asthmatic patients.
Material and Methods: 100 naive asthmatic patients with the baseline values
of FEV1 from 60-80% were divided in two groups. The first group received
BDP and second received B aerosol in total of 800 2g/day, for 4 weeks. Short
acting "2 agonist (salbutamol) was used as needed. Clinical symptoms, FEV1,
FVC, PERF and the usage of "2 agonist were recorded. Local adverse effects
were also documented.
Results: Indices of dynamics show an increase of the values of FEV1 and
FVC during the four weeks_ therapy with B and BDP, were in average of
22% and 15,6%, respectively. In patients who took B, FEV1 was increased
in average 25%, and in patients who took BDP 19%; the difference in
proportions was not statistically significant, it was accidental in our sample
(pG0,5). In patients who took B, FVC was increased in average 16,3%, and
in patients, who took BDP 15%, the difference in proportions was not
statistically significant, it was accidental in our sample (pG0,88). With B,
minimal increase of FEV1 was 9,3%, and maximal was up to 51% of the
baseline value. Minimal increase of FVC was 3,7%, and maximal increase
of the value was 36% after therapy with B. With BDP minimal increase of
FEV1 was 5,8% and maximal was up to 40% of the baseline value.
Minimal increase of FVC was of 5%, and maximal increase of the value
was 31% after therapy with BDP. The difference between morning and
evening values of PEFR under the influence of B became reduced in 86%
and under the influence of BDP in 92%, the difference in proportions was
not statistically significant (pG0,08). 25 patients complied on sore throat 19
on hoarseness and in 6 Candida albicans was isolated.
Conclusion: The therapy with topical corticosteroids improved the clinical
symptoms and values of FVC, FEV1 and PERF in both study groups, but that
difference between them was not statistically significant.
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Fluticasone propionate/salmeterol combination compared to
Fluticasone propionate alone in asthma (our experience)
Gorica Breskovska, Biserka Kaeva, Gencijana Stevcevska, and Jagoda
Stojkovic. Pulmology and Allergology Clinic Medical Faculty, Pulmology
and Allergology, Skopje, Macedonia, Fyrom.
Background: The rates of morbidity and mortality associated with asthma are
increasing.Asthma is chronic inflammatory disease characterized by recurrent
attacks of dyspnea associated with wheezing. Inhaled corticosteroids are the
effective controller medications currently available.ICS may not provide
optimal control of asthma when taken alone and additional therapy is
necessary.
Objective: The objective of the research work is to identify the efficiency of
Fluticasone/salmeterol (discus inhaler) a 250 2g tvice dauly compared to
Fluticasone a 2502g twice dauly in patients with asthma. We have analyzed a
group of 35 asthmatics (aged 21Y32) being sensitive to allergen dermatopha-
goides pt and grass pollen. We split them up into two groups:group I consisted
of patients who have undergone FP/Sal. (no=19); group II were the patients
who have been treated by Fluticasone alone (no=21). All of them have been
given a skin sensitivity test to Dermatophagoides pt. from 2+ to 3+,symptom
score (0Y30,FEV1,morning and evening expiratory flow.
Results: The results of the nvestigation showed statistically significant
improvement of thr score symptoms with the first group:the reduction of the
number of asthmatic approaches,the increase of FEV1 from (78,1T3,2) to
(95,3T2,1) and a cough prevention (pG0,01).Following a 12 weeks
tratmwnt,93% of the patients from the first group and 73% of the patients
from the second group have not shown any side effects during the treatment
period.We have notice significantly greater improvements in morning and
evening peak expiratory flow of the patients from the first group.Patients
from the second group needed additional therapy of short acting
beta2agonist.
Conclusion: Patients on FP/Sal. had significantly greater improvement in
asthma control than patients on Fluticasone allone.
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Study of inhalation therapy with special reference to inhalation
technique and patient’s perception
Suresh Koolwal. Sawai Mansingh Medical College, Jaipur, Respiratory
Diseases, Jaipur, India.
: Drug delivery by aerosol rout is often regarded as a twentieth century
innovation,but in fact records of inhalation therapy can be found in the
writtings of ancient cultures, notably those in China, India, Greece, Rome and
the Middle East. The modern era of inhalation dates back from 70 years ago.
One of the major problem in the management of Bronchial Asthma and COPD
lies not in the airways but on the prescription. Technique of inhalation is
crucial for the management of such diseases. With this background the present
study was designed to find out, How the patients are using their inhalation
devices? How does patient education affect their inhalation technique? What
are their views and apprehensions regarding inhalation therapy and problems
they face with this mode of therapy. The study was undertaken in 284 patients,
196 using Dry Powder Inhalation and 88 using MDI. The results were
evaluated and we found that about half of the patients were not using their
devices correctly. Among incorrect users majority were those with MDI.
Among correct users majority of patients were educated the technique by their
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physicians or paramedics. One fourth of patients were wrong while preparing
for inhalation, more than 80% incorrect users were not breathing out before
inhalation, half of the patients were inhaling drug with inadequate efforts and
more than 85% were not holding breath after inhalation. Cough, sudden spasm
and dysphoniawere the pr5oblems faced by 20%, and fear of addiction was the
most common apprehension of using inhalation. Details of the study will be
presented.
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A psychosocial perspective: Asthma in the third world, a portrait
of a society malady
Arnaldo Capriles Hulett. Hospital San Juan de Dios, Unidad de Alergologia,
Caracas, Venezuela.
: Asthma in Latin America is a pressing and growing health problem
affecting the young and mostly impoverished urban populations across the
continent. Venezuela, an oil rich country with 80 % or more of the population
living under variable conditions of poverty, has an acute asthma morbidity that
ranks ahead of diarrheas and seconds the Bviral syndrome[ and thus
representing more than one million visits per year at the ambulatory health
services of the Ministry of Health (caring for the majority of the population), a
tendency constantly on the rise for roughly 27 million inhabitants.
Efforts for over 25 years by an existing National Asthma Program and
the dissemination of GINA and similar guidelines have all been unable to
reverse this trend; the prevailing asthma approach centers around a perverse
paradigm of vicious cycles consisting of repeated acute asthma care; this
boldly denotes a morbidly persistent lack of awareness in the minds of
physicians (Health System), patients and lay public at large.
A unique trait, valid alike for the upper rich as well as Venezuelas’ poor
and marginal classes, is acknowledged from many years of psychotherapeutic
practice: it is a tendency of sorts to live in a Bstate of emergency[, a lacking in
future provisions of any kind and an attitude of strong accent on the immediacy
of life along with no risk prevention. Poverty, understood as a Bprecarious
condition of daily life[, lies beneath these set of highly complex issues. Our
asthma abounds in these attributes and have been in part considered a
psychosomatic expression of this malady i.e.: Bif....when a next asthma attack
or crisis comes, we’ll then see about it[. The above represents an
overwhelming historical challenge that heavily pounds on individual minds
and society, undermining a much needed reflection and making the surge of a
proper response no easy task.
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Allergy & asthma training program in India
Pudupakkam Vedanthan1, and DJ Christopher2. 1Univ of Colorado Health
Sciences Center, Dept of Medicine, Lakewood, Colorado, United States;
2Christian Medical College, Pulmonology, Vellore, India.
Background: India with a population of a billion and estimated number
of allergy & asthma patients running into the millions, had no formal
training program in Allergy & Asthma. In spite of significant advances in
pharmacological infrastructure, there has been a total lack of formal
physician educational programs in this growing important field of
medicine.
Methods: International Asthma Services (IAS) a charitable organization
started by P.K.Vedanthan MD in the late 80s in Colorado,USA dedicated to
patient and physician education in allergy and asthma in several parts of the
globe, has partnered with Christian Medical College & hospital (CMC) at
Vellore,India to initiate a formal training program in the field of allergy &
asthma for the first time in India.
Diploma in allergy & asthma (DAA) is a year long distance learning
course, with Personal Contact sessions(PCS) every quarter, with final oral and
written exams at the end of the course. The course is limited to 20 post
graduate doctors specialized either in medicine,Pediatrics, respiratory
medicine will be selected. International and national faculty teach in this
course.
Results: The first batch of 18 physicians hailing from different parts of India
will be awarded the Diploma this July 2007. The 2nd batch of 20 physicians
will be starting the course in the later part of July 2007.
Conclusion: This unique partnership between IAS & CMC will hopefully
meet the present challenges of unmet physician manpower needs in the field
of allergy & asthma in the Indian subcontinent over the coming years.
Allergy-Asthma network of India is also is in the process of formation to
facilitate free flow of educational,research, charitable activities throughout
the country.
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The implementation process of asthma guidelines in primary
health care
Eeva Ahonen and Risto Makinen. Espoo Health Care Centre, Finland, Lep-
pa¨vaara, Espoo, Finland.
Background and Aim: To improve the clinical practices is known to be a
challenging process. Here we describe the implementation of asthma
guidelines and the development of the house rule and patient self management
protocol. The setting is Leppa¨vaara health care centre with six GP-nurse teams
each providing primary care for 10 000 inhabitants.
National Asthma Programme 1994Y2004 delegated the responsibility
in preventing and treating asthma to the primary health care. The evidence
based guidelines published 2000, updated 2006, gives the general outline in
asthma treatment.
Materials and Methods: Participatory observation and document analysis
using qualitative methods
Results: Two GPs and two nurses were nominated to asthma co-ordinators to
act as internal consultants. They organizedmanyworkshops during 2000Y2007
to introduce the guidelines and to develop asthma management. The gov-
ernmental Centre for Pharmacotherapy Development joined the implementa-
tion activities by providing training of trainers, and material and tutorial
support. Therefore, the workshops after the year 2003 were problem-based and
multi-professional, and used EBM, feed-back of prescription practises, and
case reports as learning methods.
The Leppa¨vaara health centre team produced a written agreement of
inter-professional collaboration and asthma management process, the Lep-
pa¨vaara house rule of asthma care, in aworkshop in 2004. They arranged a new
workshop in 2005 to assess the changes in asthma care. A multi-professional
group developed a written self management protocol for the patients in 2006.
The team renewed the house rule in a workshop in 2007 according to updated
national asthma guidelines.
Discussion: The evidence based asthma guideline was a valuable Bgolden
reference[. To implement it the interactive multi-professional workshops were
used to develop the house rule. This method seemed to support the pro-
fessionals to commit to true team work and to jointly agreed practices.
The implementation has been a necessary process, which has to be
continued by supporting, giving feedback and evaluating.
We will evaluate the professionals’ attitudes towards the usefulness of
the house rule, the rate of admissions to the secondary care, and changes in
prescription patterns.
Producing guidelines is not enough: The improvement of clinical
practices demand the interesting and useful implementation process to
every day work.
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Clinical implications of immunological and inflammatory
markers in exercise induced bronchospasm
Surekha Joshi1, Deoman Tripathi2, Swati Bhave3, Sharada Kankonkar4, and
Hirenlal Dhar1. 1Medical Research Centre, Bombay Hospital, Research,
Mumbai, India; 2Medical Research Centre, Bombay Hospital, Allergy,
Mumbai, India; 3Medical Research Centre, Bombay Hospital, Paediatrics,
Mumbai, India; 4Medical Research Centre, Bombay Hospital, Tissue Typing,
Mumbai, India.
: Exercise-induced bronchospasm (EIB) is widely prevalent in asthmatic
individuals particularly in children varying from 40% to 90% in various
reports. There are, however, few studies addressing the effects of asthma
severity on airway responsiveness to exercise from India.
Aim: In examining the mechanisms of exercise-induced bronchospasm (EIB),
it is important to determine which factors mainly affect the severity of EIB. We
report such factors in patients with asthma by stepwise multiple-regression
analysis.
Methods: Sixty five asthmatic children (age range 10Y14 years), 200 adults
between 20 to 44 years old were selected randomly as representative of persons
living in the city of Mumbai. All subjects filled out a questionnaire on
respiratory symptoms. Bronchodilator therapy was withheld three days before
the study. The exposure to house dust mite allergens was estimated from dust
samples obtained in the subjects’ homes. Eosinophil count was done from
peripheral blood. Serum Il-4 was estimated in adult asthmatics by ELISA
method. Atopic status was labeled on the basis of Total serum IgE and
Modified Skin Prick Test and subjected to exercise challenge. assessments of
atopy. An exercise challenge test was done (8 min) bout of cycle-ergometer
exercise): decrease in PEFR of 15% was considered positive for EIB.
Results: Atopic adults showed significantly higher sensitization to house dust
mite compared to children (p G 0.05). Significant rise in incidence of EIB was
observed in adults (62.6%) against 40% in children ( p G 0.05) showing direct
relationship of house dust mite sensitization in both the groups ( adults
correlation coefficients: r = 0.955 p G 0.001, children r = 03135 p T 0.05).
Relative risk of developing EIB associated with HDM sensitivity was higher in
adults (2.85 at 95% CI ). Regression analysis showed direct relationship
between the severity of EIB and serum IL-4 levels (r2 = 0.03 p G0.0001).
Raised eosinophils were well correlated with serum IL-4 levels.
Conclusion: The findings suggest that though EIB is common in children,
adults were more significantly affected. Allergen specific IgE to house dust
mite, serum IL-4 and eosinophilia were the major associated contributing
factors in the development of EIB in asthmatic patients.
Clinical Implications: Patients with exercise induced bronchospasm may
benefit from novel tharapies specially designed to target the specfic mech-
anisms underlying airway inflammation.
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Asthma control and Quality of Life in asthmatic patients
Valeria Ghiglione, Sara Balestracci, Fulvio Braido, Sara Cauglia, Ilaria
Baiardini, and Giorgio Walter Canonica. University of Genoa, Department of
Internal Medicine, Genoa, Italy.
Background: As indicated in Asthma guidelines, treatments` goal should be
the total control of asthma and consequently a minimal impact of asthma on
patient`s life.
Aim: The aim of our study was to investigate the relationship between FEV1,
control of asthma and quality of life in real life.
Methods: In a 1 month period, asthmatic patients were enrolled consecutively
during their routine control visit. A spirometry was performed for every
patient. Patients were asked to complete 2 different questionnaires: the Asthma
Control Test (ACT), a brief instrument developed to assess asthma control of
patients in a clinical setting, and the Rhinasthma, a 30 items tool aimed at
evaluating the impact of respiratory allergy on quality of life. It provides 4
different scores: Upper Airways (UA), Lower Airways (LA), Respiratory
Allergy Impact (RAI) and Global Summary (GS).
Results: Seventy-four asthmatic outpatients (30 men and 44 women; mean
age 44.11 + 14.83) were enrolled. 53 had concomitant rhinitis. For 39 patients
(52.7%) the control of asthma was achieved; 35 (47.3%) didn`t obtain asthma
control. FEV1 value (mean 88.45 + 16.13) correlates with ACT and with
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Rhinasthma, LA and RAI. ACT significantly correlated with the four
Rhinasthma scores. Subdividing patients according to the score (optimal and
good control vs non control) and comparing the level of control measured by
means of ACTwe obtained a significant correlation between ACT and LA (p.
0.0001), RAI (p. 0.01) and GS (0.0001) and no correlation with Rhinasthma
UA score (p 0.053). The analysis of the patients’ population showed that a well
or total control was achieved in 53% of patients with asthma and 51% of
patients with both asthma and rhintis. The subanalysis of 53 patients with
concomitant rhinitis showed worse Rhinasthma scores for all the domains
compared with patients with asthma alone (p. G 0.05).
Discussion: Our results show that asthma control is related to an improvement
in quality of life; nevertheless, asthmatic patients often refer also symptoms
due to rhinitis that have an important impact on their Quality of Life. So, in
order to improve Quality of Life of asthmatic patients, the treatment of
patients with rhinitis and asthma includes both lower and upper airways
treatment.
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Relationship between quality of life related to chronic cough and
asthma level of control; a pilot study
Sara Balestracci, Fulvio Braido, Valeria Ghiglione, Silvia Brandi, Ilaria
Baiardini, and Giorgio Walter Canonica. University of Genoa, Department of
Internal Medicine, Genoa, Italy.
Background: The antiasthmatic treatments nowadays available can induce a
good or total disease control. Recent evidences have also shown that the level
of control is strongly related to health related quality of life (HRQL).
Aim: The aim of our real life observational study was to evaluate the
relationship between HRQL related to chronic cough and asthma level of
control defined according to Asthma Control Test score (ACT).
Methods: In a 1-month period, asthmatic patients were consecutively enrolled
during their scheduled visits. Patients were asked to complete 2 different
questionnaires: the ACT, a brief instrument developed to assess asthma control
of patients in a clinical setting, and the Chronic Cough Impact Questionnaire
(CCIQ), a 16 items validated questionnaire divided into 4 areas (sleep/
concentration, social relationship, mood and daily life impact).
Results: Seventy-four asthmatic outpatients (30 men and 44 women; mean
age 44.11 SD: +/<14.83) were enrolled. 53 had concomitant rhinitis. 39
patients (52.7%) had total or well controlled asthma (ACT score 9 20); 35
(47.3%) had non controlled asthma (ACT score G 20) .
ACT didn`t correlate significantly with any of the CCIQ domains:
sleep/concentration (p. 0.689), social relationship (p. 0.741), mood (p. 0.704),
and daily life impact (p. 0.458).
Taking into consideration that concomitant rhinitis could induce a post
nasal drip related cough, the subanalysis of patients with both asthma and
rhinitis didn`t show any correlation between CCIQ and ACT.
Discussion: Previous studies showed a significant correlation between asthma
level of control and HRQL. Despite these evidences, analysing the HRQL
related to a specific symptom (cough) occurring in asthma, the correlation is
lacking. Our pilot observations seem to demonstrate that ACT is an useful tool,
but a specific instrument should ameliorate patients` evaluation. Moreover, the
presence of other causes of cough should be investigated in well controlled
asthmatic patients with persistent cough.
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Clinical effect of clean air administered directly to the breathing
zone (Airsonett Airshower\) on perennial allergic asthma
Paivi Soderman1, Christophe Pedroletti2, Olof Zetterstrom3, Eva Millinger3,
Katalin Zara3, Katarina Damm4, and Barbro Dahle´n4. 1Children`s Hospital,
Karolinska University Hospital Huddinge, Stockholm, Sweden; 2Dept of
Department of Women and Child Health, Karolinska University Hospital
Solna, Stockholm, Sweden; 3Dept of Clinical Physiology, University Hospital
Linkoping, Linkoping, Sweden; 4Dept of Medicine, Karolinska University
Hospital Huddinge, Stockholm, Sweden.
Background: Studies previously made on air cleaning has shown little or no
effect on patients with perennial allergic asthma. We examined a novel
treatment (Airsonett Airshower\) using a laminar airflow directed to the
breathing zone of a patient during the night, on teenagers and young adults
with moderately severe allergic asthma. We hypothesised that this directed
treatment would have effect on the bronchial inflammation and consequently,
the quality of life.
Methods: 22 patients 12Y33 year of age (mean 18.8 yr) was randomized
double-blind to 10 weeks active treatment respective 10 weeks placebo
treatment. All patients received both active and placebo treatment (cross-over)
with a 2 week wash-out period in between treatments. Maintenance treatment
with inhaled corticosteroids was unaltered (400 6g budesonid/day or
equivalent) during the trial period. Health related quality of life, miniAQLQ,
was the primary effectiveness measure. Exhaled nitric oxide (FENO) and lung
function was also investigated.
Results: Active treatment resulted in an improved quality of life compared to
placebo (mean score 0.54, p G 0.05, n = 20). Also an effect on the bronchial
inflammation was detected with significantly lower FENO values during the
active treatment period (mean <6.95 ppb, p G 0.05, n = 22).
Conclusion: The result of clean air, administered directly to the breathing
zone during sleep, can have effect on the bronchial inflammation and
consequently, the quality of life on patients with perennial allergic asthma.
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Current status of Korean traditional medicine for Korean
allergic patients
Jung-Won Park1, Hun-Jong Dhong2, Hae-Shim Park3, Young-Joo Cho4,
Sang-Heon Cho5, Bok-Yang Pyun6, Kwang-Hoon Lee7, Hae-Ran Lee8,
Jean-HeeCho9, andChein-SooHong1. 1SeveranceHospital, Yonsei University,
Internal Medicine, Seoul, Republic of Korea; 2Samsung Seoul, Otorhinolar-
yngology, Seoul, Republic of Korea; 3Ajou University, Internal Medicine,
Swon, Republic of Korea; 4Ewha University, Internal Medicine, Seoul,
Republic of Korea; 5Seoul National University, Internal Medicine, Seoul,
Republic of Korea; 6SooncheonhyangUniversity, Pediatrics, Seoul, Republic of
Korea; 7Severance Hospital, Yonsei University, Dermatology, Seoul, Republic
of Korea; 8Hallym University, Pediatrics, Seoul, Republic of Korea; 9Catholic
University, Otorhinolaryngology, Seoul, Republic of Korea.
Background and Aim: Korean traditional medicine (KTM) is popular in
Korea. We evaluated the prevalence and compliance of these unproved
practices in Korean allergic patients.
Methods: 649 allergic patients were enrolled from 10 general hospitals. Their
mean age was 42.5T15.3 years old. Proportions of asthma, allergic rhinitis,
atopic dermatitis, and urticaria were 50.7%, 41.3%, 26%, and 11.3%, res-
pectively. The Questionnaire which consisted of 12 items regards the pres-
cription rates, reasons for referring to these remedies, and their opinions for the
efficacy of KTM.
Results: 259 (39.9%) patients had experienced KTM (herbal decoction
?34.2%, herbal pills ?6.0%, acupuncture ?12.3%, moxa cautery ?4.1%), and
33.2% of the patients with the history of KTM experienced 2 or more KTM
practices. Patients?income or final academic career did not affect the
prescription rates of KTM. 34.6% of the KTM experienced patients were
satisfied to the practices (herbal decoction ?35.6%, herbal pills ?22.2%,
acupuncture ?34.2%, and moxa cautery ?44.4%), and 40.6% of the KTM
experienced patients were inclined to further KTM practices. The patients with
respiratory allergic diseases were more satisfactory to KTM than those with
allergic skin diseases (p = 0.006). The most frequent reasons for choosing the
KTMwere safety (15.6%), worries about adverse reactions of the proved drugs
(20.2%), and boostering effects on immunity or physical predisposition by
KTM (36.3%). However, 18.9% of the patients with KTM had experienced the
adverse reactions to the practices; skin rashes ?13.5%, gastrointestinal dis-
comforts ?2.3%, and hepatitis ?0.7%. The prescribed patients expensed 915US
dollars/year on average.
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Conclusion: Many Korean allergic patients are compliant to KTM and ex-
perienced significant adverse reactions. Educations for the proved manage-
ments are necessary in Korea.
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Anxiety symptoms in allergic patients: identification and
risk factors
Ziad Adwan. Saha, Allergy, Rio de Janeiro, Brazil.
Objective: Multiple relationships between anxiety, allergic symptoms, and
treatment difficulties have been observed. The aim of the present study was to
estimate the prevalence of anxiety disorders in outpatients with various allergic
diseases, to identify diagnostic cues or possible risk factors, and to test the
usefulness of self-administered questionnaire screening at the allergy clinic.
Methods: Six hundred forty-six (646) consecutive patients with rhinocon-
junctivitis (59.3%), asthma (26.8%), or Bother[ allergy (13.9%), aged 16 to
65 years, completed self-administered questionnaires in six outpatient allergy
clinics; 60 of the respondents also participated in structured psychiatric in-
terviews. Anxiety was measured with the Spielberger State-Trait Anxiety.
Results: According to the interviews, STAI-T 9 52 predicted with 86% ac-
curacy a current psychiatric diagnosis, without differentiating between anxiety
and depression. Using this threshold, the rate of anxiety and/or depressive
disorders is estimated as 19% (95% CI: 15.9Y22.1) in our unselected allergic
outpatient sample; 46% of these patients never received any psychopharma-
cological treatment, indicating that anxiety related disorders are under-
diagnosed and undertreated. Risk indicators were female gender; asthma;
perennial symptoms; sleep problems; nonspecific allergy triggers like strong
emotions; stressful situations; and considerable limitation in everyday activities
attributed to the allergic symptoms.
Conclusion: Our findings confirm a high rate of anxiety and/or depressive
disorders in patients visiting the allergy clinic. Self-administered question-
naires such as STAI-T provide reliable help for the identification of these
frequent psychiatric problems.
Key Words: anxiety, allergy, rhinitis, asthma, Spielberger State-Trait Anxiety
Inventory, depression.
Abbreviations: DSM-IV = Diagnostic and Statistical Manual of Mental
Disorders fourth edition; STAI-T = trait anxiety and STAI-S: state anxiety
subscales of the Spielberger State-Trait Anxiety Inventory.
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Healthcare assessment methodology in developing country
S. D. Joshi1 and Kalpana Panday2. 1Nepal Medical College Teaching Hospital,
Medical Sciences, Kathmandu, Nepal; 2Community Health and Environmental
Society Nepal, Community Health, Kathmandu, Nepal.
Issues: Health care assessment system in Nepal is still take long time and high
cost. Collection of data about prioritization of community health problems by
the community is essential for planning and monitoring of programs and in-
terventions for improving community health status. Scientific Rapid Commu-
nity Health AssessmentMethodology needs to be validated in rural community
developing country like Nepal which is economic and less time consuming.
Objective: To validate the Rapid Community Health Assessment Methodol-
ogy (RCHA) for prioritization of community health problems in a rural
community.
Study Area: 14 Villages of rural areas. STUDY POPULATION: 34 Primary
School Teachers from 10 randomly selected Primary Schools in above
villages. (One Teacher each from Class I to V, in each School). VALIDATION:
Heads of households from 500 Households (50 per village, systematically
sampled). DATA Collection technique: Self-Administered Questionnaires for
Teachers, Interview Schedules for Heads of Households. DATA ANALYSIS:
with the help of EPI info program.
Results: There was significant correlation between the responses of the school
teachers and heads of households on community health problems viz., (a) the
prioritization of ten village problems(r = +0.77, p G 0.02), (b) prioritization of
utilization of services of various health functionaries for treatment of and
advice for children`s illnesses (r = + 0.75, p G 0.05), and (c) prioritization of
households using water from different sources(r = + 0.975, p G 0.02). The
method was also found to be more rapid (3.3 times) and less costly (6.3 times)
compared to the traditional household survey method.
Conclusion: Rapid Community Health Assessment Methodology (RCHA)
for prioritization of community health problems in a rural community is
validated. The information thus obtained can be utilized for purposes of health
policy and program planning, monitoring and evaluation. This is especially
relevant for micro planning of child health services in developing countries.
Repeated use of questionnaires for monitoring disease control programs must
be carefully considered. Further studies to confirm and reconfirm the results of
this study may be done before wider application of above methodology.
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Longitudinal assessments of habitual use of medicines in a nested
case-control study of italian adults
M. Simoni, S. Baldacci, M. Borbotti, A. Angino, F. Martini, B. Piegaia,
S. Maio, F. Di Pede, F. Pistelli, L. Carozzi, and G. Viegi. CNR Institute of
Clinical Physiology, Pulmonary Environmental Epidemiology Unit, Pisa, Italy.
Aim: To assess the temporal changes of medicines consumption in relation to
risk factors for respiratory symptoms/diseases in a subsample of a general
population of Italian adults.
Methods:Within the Po Delta and Pisa epidemiological surveys, subjects who
habitually used medicines at baseline were selected as cases. Controls were
non-drug consuming subjects randomly drawn and matched for gender and
age groups. 1663 subjects (89% of those invited) participated in a telephone
interview (follow-up = 11 years) with questions on current drug consumption,
respiratory health status, life habits, and comorbidity, beside socio-demo-
graphic characteristics. Main characteristics were: 37.2% males, mean age
63yrs, cases = 46.2%. We used logistic regression models accounting for
smoking habit, gender, age, comorbidities, respiratory symptoms, occupa-
tional/passive smoking/environmental exposure.
Results: There was a non significant increase between baseline and follow-up
for prevalence of asthma (5.8 vs 7.1%) or rhinitis (20.6 vs 23%). Prevalence
rate of habitual use of any medicine at follow-up was 70.1 vs 46.2% at baseline
(p G 0.001). Among the users (N=1166), we found higher prevalences of
broncho-pulmonary (7.5 vs 4.8%) (significantly) and antiallergic drugs (2.4 vs
1.3%) (non significantly) at follow-up. New regular use of any medicines at
follow-up was 60.4%, while persistence and cessation were 37.6 and 18.6%,
respectively. Only asthma resulted significantly related to the use of medicines
at baseline (OR 1.69, 95%CI 1.04Y2.73), while at follow-up the relation was
significant for both asthma (2.92, 1.51Y5.66) and rhinitis (1.55, 1.03Y2.33).).
The association of the use of specific medicines (brochopulmonary/
antiallergic/cardiovascular/diuretic vs other medicine/no use) was significant
with asthma at baseline (3.36, 1.97Y5.75) and at follow-up (3.94, 2.14Y7.30).
Non significant associations were found for positive skin prick tests with use of
specific medicines both at baseline (1.19, 0.74Y1.90) and follow-up (1.25,
0.78Y2.00), and for elevated values of IgE with use of any medicines (1.36,
0.94Y1.96, at baseline) and of specific drugs (1.16, 0.79Y1.70 at baseline;
1.14, 0.78Y1.66, at follow-up).
Conclusion: In this epidemiological study, ageing, asthma and rhinitis were
determinant factors of medicines consumption.
URTICARIA & ANGIOEDEMA
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Effects of treatment of Helico bacter Pylori (HP) infection in
idiopathic chronic urticaria
Javad Ghaffari1, Reza Farid2, Farahzad Jabbari Azad3, and Zeinab Nazari4.
1Buali Hospital , Mazandaran University of Medical Sciences, Pediatrics, Sari,
Islamic Republic of Iran; 2Ghaem Hospital, Mashhad University of Medical
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Sciences, Allergy and Immunology, Mashhad, Islamic Republic of Iran;
3Ghaem Hospital, Allergy and Immunology, Mashhad, Islamic Republic of
Iran; 4Buali hospital, Gyn & Obs / Pediatrics, Sari, Islamic Republic of Iran.
Background: Urticaria is one of the most important cause of skin itching. The
aim of this study was to examine effects of treatment of Helico bacter
Pylori(HP) infection on urticaria in regard to the possible role of HP infection
as a cause for idiopathic chronic urticaria(ICU).
Methods: 56 patients suffering from ICU (Male = 16 and Female = 40) with
negative response to skin prick test for common aeroallergens were chosen. For
diagnosis of HP serologic tests of antibodies against HP (IgG and IgA) through
ELISAmethod and Ureas Breath Test (UBT) were done. In the basis of the test
results, patients were put into three groups: case group (M = 8, F = 15) treated
with antiHP drugs(Amoxicillin, Metronidazole, Omeperazole and Bismuth for
twoweeks), positive control group (M = 3, F = 12) without treated and negative
control group (M = 5, F = 13) without HP infection. After one month UBTwas
done for control of the response to treatment.
Results: The results were analyzed through Chi-Square testing. In the case
group 17 patients(74%) were significantly cured (23% partially and 52%
compeletly) (P = 0.003). In the positive control group 6 patients (40%) partially
treated and in the negative control group 40% of patients were cured.
Conclusion: Anti-HP treatment is significantly effective in treatment of
ICU.
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Helico bacter Pylori (HP) infection and chronic urticaria
Javad Ghaffari1, Reza Farid2, Zeinab Nazari3, and Farahzad Jabbari Azad2.
1Buali Hospital, Mazandaran University of Medical Sciences, Allergy and
Immunology, Sari, Islamic Republic of Iran; 2Ghaem Hospital, Mashhad
University, Allergy and Immunology, Mashhad, Islamic Republic of Iran;
3Emam Hospital, Mazandaran University, Allergy and Immunology, Sari,
Islamic Republic of Iran.
Background: Urticaria is one of the most important cause of skin itching.the
aim of this study was to examine effects of treatment of Helico bacter
Pylori(HP) infection on urticaria in regard to the possible role of HP infection
as a cause for idiopathic chronic urticaria(ICU).
Methods: 56 patients suffering from ICU(Male = 16 and Female = 40) with
negative response to skin prick test for common aeroallergens were chosen. For
diagnosis of HP serologic tests of antibodies against HP (IgG and IgA) through
ELISAmethod and Ureas Breath Test (UBT) were done. In the basis of the test
results, patients were put into three groups: case group (M = 8, F = 15) treated
with antiHP drugs (Amoxicillin,Metronidazole,Omeperazole and Bismuth for
twoweeks), positive control group (M = 3, F = 12) without treated and negative
control group (M = 5, F = 13) without HP infection.after one month UBTwas
done for control of the response to treatment.
Results: The results were analyzed through Chi-Square testing. In the case
group 17 patients (74%) were significantly cured (23% partially and 52%
compeletly) (P = 0.003). In the positive control group 6 patients (40%) partially
treated and in the negative control group 40% of patients were cured.
Conclusion: Anti-HP treatment is significantly effective in treatment of
ICU.
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Chronic idiopathic urticaria and brucellosis
Roya Sherkat. Alzahra University Hospital, Infectiouse Disease, Isfahan,
Islamic Republic of Iran.
Introduction: Chronic urticaria/angio-oedema has traditionally been defined
as daily or almost daily symptoms lasting for more than 6 weeks. Chronic
urticaria affects 0.5Y1% of individuals (life-time prevalence) and significantly
reduces quality of life.
Optimal management of chronic and acute intermittent urticaria de-
pends on a thorough understanding of clinical presentation, etiologies, triggers
and aggravating factors.
An underlying extraneous cause for chronic urticaria cannot be
identified in most patients, but infections may play a causative role in a few
cases, and when present, chronic infections such as dental sepsis, sinusitis,
urinary tract infections and cutaneous fungal infections should be treated.
However exhaustive investigations searching for underlying infections are not
indicated. Infection with Helicobacter pylori (HP) has been proposed as a
possible cause, but the association is unlikely to be causal (particularly in
otherwise asymptomatic children where the background prevalence of HP
infection is high). Also complement activation can mediate or augment
histamine release frommast cells via the anaphylatoxin C5a. This inflammatory
pathway is triggered by antibody and antigen interacting to form immune
complex-associated urticaria, e.g. in hepatitis C and hepatitis B, EBV, other
viral and possibly parasitic infections. However common triggers for episodes
of chronic urticaria are intercurrent viral infections and possibly stress.
Human brucellosis is an infectious disease produced by Brucella
species: small, coccoid or rod-like, aerobic, Gram-negative bacteria. Every
organ and system of the human body can be affected in brucellosis a fact that
underscores the importance of including brucellosis in the differential
diagnosis in areas of endemic disease, even if clinical features are not entirely
compatible. The infection can also affect the skin.
We present a case of chronic urticaria who also had fever and chills at
presentation for a week. His urticaria-like papules and plaques and a red,
raised, itchy rashes especially in his face continue after his fever has stopped.
In a vast array of laboratory investigation brucella serology, using both eliza
and serum agglutination method, was positive. Only treatment of underlying
infection has leaded to resolution of symptoms.
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Bronchial hyperresponsiveness in patients with chronic urticaria
Zikica Jovicic, Mirjana Bogic, Sanvila Raskovic, Aleksandra Peric Popadic,
and Ljiljana Stefanovic. Institute of Allergology and Immunology, CCS,
Department of Allergology, Belgrade, Serbia and Montenegro.
Background: Involvement respiratory system in patients with chronic
urticaria is still a controversial subject. Large number of patients report
dyspnea. The aim of this study was to investigate the present of bronchial
hyper responsiveness in patients with chronic urticaria.
Methods: A total of 23 patients (17 women, 6 men, age range 19Y56 years)
who had urticaria for at least 6 weeks, without other known causes of urticaria,
were enrolled in the study. Diagnostic programme of urticaria include:
eosinophil count, skin prick test with inhalation and nutritive allergens, test for
NSAID intolerance, pulmonary function tests and methacholine provocation.
Patients are investigating during a phase of remission.
Results: Three patients had (13%) abnormal pulmonary function tests, ten
patients (43,4%) showed significant bronchial hyperresponsiveness on
methacholine provocation, three (13%) had elevated eosinophil count, four
(17,3%) had positive skin prick test with inhalation and/or nutritive allergens
and twelve (52,1%) had NSAID intolerance. Airway hyperresponsiveness was
not associated with eosinophil count, skin prick test with inhalation and
nutritive allergens, NSAID intolerance.
Conclusion: Significant number of patients with chronic urticaria show
bronchial hyperresponsiveness, and performing of this test is reasonable in
patients with chronic urticaria.
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An audit of referrals from public sector primary care physicians
to an allergy clinic in Singapore
Bernard Thong, Khai-Pang Leong, Chwee-Ying Tang, Yew-Kuang Cheng,
Faith Chia, Justina Tan, and Hiok-Hee Chng. Tan Tock Seng Hospital,
Singapore, Rheumatology, Allergy and Immunology, Singapore, Singapore.
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Background: An electronic registry for all new referrals (New Case Registry)
to our adult Allergy Clinic was set up in July 1998 to determine the sources of
referrals, referring diagnoses and final diagnoses. Sources of referrals include
primary care physicians in the public and private sectors, specialists, national
dermatology centre, military services and self referrals.
Aim: To describe the pattern of referrals from primary care physicians in the
public sector to an Allergy Clinic in Singapore.
Methods: All new referrals were prospectively captured in the New Case
Registry during the study period 1 July 1998 to 31 December 2006.
Results: There were 227 referrals from public sector primary care physicians
comprising 8.4% of all referrals. More than half (57.7%) were females and
mean age was 36 T 18 years. The majority (79.7%) were Chinese. The most
common referring diagnoses were drug allergy [DA] (35.7%), urticaria and
angioedema (23.3%) and food allergy [FA] (10.1%). In contrast, the final
diagnosis of the attending allergist was DA in 9.7%, NSAID intolerance in
22.5%, and FA in 7.5% respectively. Among cases with primary care physician
diagnosed DA, the allergist`s diagnosis was DA in 23.5%, NSAID intolerance
in 40.7% and not DA in 35.8%. Among cases with primary care physician
diagnosed FA, the allergist`s diagnosis was FA in only 31.6%. Chronic
idiopathic urticaria comprised 19.1% of all cases of urticaria/angioedema. The
following conditions were under-diagnosed by family physicians compared to
allergists: anaphylaxis (1.8% versus 4%), asthma (2.6% versus 6.6%), atopic
eczema (1.8% versus 6.6%), allergic rhinitis (7.5% versus 19.8%). Among all
referrals for suspected allergy, 5.7% were deemed not to have any allergic
disorder upon completion of evaluation.
Conclusion: DA, urticaria/angioedema and FA were the most common
reasons for referral. NSAID intolerance accounted for the majority of cases of
Fdrug allergy` referred by primary care physicians. Allergic rhinitis, asthma,
atopic eczema, and anaphylaxis were under-diagnosed, potentially leading to
patients being deprived of appropriate therapy for allergic airway disease and
life-saving epinephrine autoinjectors. Increasing the awareness and education
may be useful in improving the diagnosis and treatment of allergic diseases in
the community.
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Chronic urticaria: alternative treatment with beta-agonists
Summit Shah1, Lekha Nair2, and Jonathan Bayuk3. 1Tufts-New England Medi-
cal Center, Allergy Department, Boston, United States; 2Tufts-New England
Medical Center, Pharmacy, Boston, United States; 3Hampden County Phys-
icians, Allergy, Springfield, United States.
Background: To describe a 46 year old patient with chronic urticaria,
unresponsive to standard therapy, who responds to oral beta agonists and to
propose possible mechanisms of action.
Methods: We performed basic bloodwork and checked eosinophil levels,
ANA, ESR, CBC, CMP, anti-thyroid antibodies, TSH and complement levels.
Skin biopsy was performed as well.
Results: Patient with history of diabetes mellitus presents for treatment of
chronic urticaria x 15 years. Initially, patient responded to corticosteroids but
since then no medications have helped, including Allegra, Doxepin, and
Periactin. Test results revealed normal eosinophil levels, negative ANA, normal
ESR, CBC, CMP, Anti-thyroid antibodies, TSH and complement levels. As
patient was unresponsive to other medications and requiring frequent oral
corticosteroids, albuterol sulfate 4 mg tablets were given. Patient took
approximately 32 mg of albuterol orally each day for approximately 14 days
in addition to her anti-histamine. On return visit, patient`s symptoms had
resolved completely.
Conclusion: Beta agonists have a good side effect profile compared to oral
corticosteroids and may be of great benefit in reducing urticarial symptoms.
Possible mechanisms of action include inhibition of anti-IgE induced
histamine release thru desensitization of beta adrenoceptors. They may be a
promising pharmacotherapy in the treatment of chronic urticaria.
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A study on the impact of chronic idiopathic urticaria on the
quality of life in korean patients
Min Ju Kang, Hyung Ok Kim, and Young Min Park. Kangnam St. Mary’s
Hospital, College of Medicine, The Catholic University of Korea, Derma-
tology, Seoul, Republic of Korea.
Background: Chronic idiopathic urticaria (CIU) is a relatively common dis-
ease, and yet not much is known about the causative factors or the patho-
mechanism, which makes it difficult to cure. Due to its chronic nature, many
patients suffer from significant detrimental effects on their quality of life
(QOL). The purpose of this study is to assess the impact of CIU on the QOL
of Korean patients, and to determine whether a relationship exists between
QOL and the severity of disease.
Methods: One hundred twenty four patients with CIU, who first visited our
out-patient clinic from August 2005 to July 2007, were asked to complete a
questionnaire designed to assess the effects of CIU on the daily lives of patients.
QOL was divided into six different categories: mental status (MS), daily living
activities (DLA), leisure activities (LA), self-perception (SP), treatment-
induced restrictions (TIR), and social restrictions (SR). All of the QOL scores
were recalibrated to a 0Y100 scale, with 100 indicating the worst QOL, and 0
the most favorable. Pearson and Spearman correlation coefficients were used to
analyze the relationship between the six different QOL categories, as well as the
association between disease duration and QOL. One way ANOVAwas used to
analyze the relationship between disease severity and QOL. A p value less than
0.05 was considered significant.
Results: The average QOL scores obtained from the questionnaire were as
follows: MS (50.64), DLA (47.58), LA (39.85), SP (37.06), TIR (35.54), and
SR (33.23). The results showed that patients were most affected mentally, and
that social restrictions were the least significant. The six different categories
showed a positive correlation amongst themselves, which demonstrates that
CIU exerts an influence on not one, but many aspects of QOL. LA and TIR
were significantly affected in longer term CIU cases (p G 0.05), while SP, MS,
DLA, and SR did not show a significant relationship with disease duration.
Disease severity was found to have a significant effect on the SR, LA, and TIR
categories (p G 0.05).
Conclusion: Based on these results, it is suggested that CIU has a negative
impact on the QOL of Korean patients. Therefore, it is important to recognize
the effects CIU can have on QOL and consider them as candidates for
treatment as well.
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Neutrophil activation finding was noted in patients with ASA
induced urticaria
Sung-Jin Choi, Gyu-Young Hur, Seung-Youp Shin, and Seung-Hyun Kim.
Ajou University School of Medicine, Allergy & Rheumatology, Suwon, Re-
public of Korea.
Background and Objective: ASA ingestion could induce acute and chronic
urticaria, however their pathogenic mechanisms are not understood. We
compared the level of neutorphil activation and related cytokine between ASA
intolerant acute urticaria (AIAU) and ASA intolerant chronic urticaria (AICU).
Methods: The 88 patients with AICU, the 51 patients with AIAU and the 102
patients, normal control (NC) were enrolled. The clinical and laboratory
findings including serum myeloperoxidase (MPO) level, IL-8 and IL-18 levels
were compared among AIAU, AICU, and NC groups. The correlations
between MPO and, IL-8, IL-18 were observed.
Results: The level of serum MPO were significantly higher in AIAU than in
AICU and NC (p=0.032, p=0.014 respectively). The level of IL-18 was
significantly higher in AIAU than in NC (p=0.006), while no significant
difference was noted in IL-8 level. Within the AIAU patients, significant
correlationwere noted betweenMPOand IL-8 (r=0.36, p=0.01), notwith IL-18.
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Conclusion: Increased neutrophil activation finding in association with IL-8
was noted in AIAU patients, which may be involved in the pathogenic
mechanism of AIAU.
Key words: ASA intolerant acute urticaria, neutrophil activation, IL-8
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Most cases of urticaria are caused by gastrointestinal disorders
Semen Zheleznov1, Nickolay Didkovsky1, Galina Urzhumtseva2, Anna
Tanasova1, and Vladimir Androsov3. 1Research Institute of Physical and
Chemical Medicine, Laboratory of Clinical Immunology, Moscow, Russian
Federation; 2Moscow City Clinical Hospital N7, Endoscopy, Moscow,
Russian Federation; 3Moscow City Clinical Hospital N7, Allergology, Moscow,
Russian Federation.
: It is known that about 20% of people develop urticaria at least once in
their lives. Chronic idiopathic urticaria affects up to 3% of the population. The
incidence of acute urticaria is higher in people with atopy, and the incidence of
chronic urticaria is not increased in people with atopy. This study shows that
most cases of urticaria are related to such gastointestinal disorders as active
gastritis, esophagitis and peptic ulcer. One of the most interesting things is that
urticaria is likely to be only a single symptom of a severe and maybe life-
threatening gastrointestinal disorder.
Methods: 10 patients with acute (3) or chronic (7) urticaria passed
gastroscopy after 5Y14 days of the onset of urticaria. In addition to urticaria,
3 had angioedema, 1 suffered from severe pruritus with desquamation and 1
developed palmar eczema.
Results: All patients showed to have different gastrointestinal problems, which
correlated very well with the anamnesis data. 7 had gastric erosions, among
which 3 with esophagitis; 1 had esophagitis with atrophic gastritis, 1 eso-
phagitis alone, 1 patient with severe generalized urticaria had 2 big (1 cm each)
duodenal ulcers. The patient with concomitant pruritus had lots of severe
gastric, esophagal and duodenal erosions. Only 3 patients suffered from oca-
sional epigastric pain or heartburn, but none said that symptoms were severe.
Gastrointestinal cause was suspected because episodes of urticaria developed
or increased after irritating or acid food (spice, citruses, strawberries), drinks
(alcohol, soda) or drugs (NSAIDs, acetyl-cysteinum, ascorbinic acid) but
trigger factors were always different and dose-dependent. 9 patients that
underwent anti-reflux, antacid, antisecretory and some (2) antibiotic therapy
along with symptomatic antihistamine drugs recovered (8) or showed much
relief (1). 1 patient with severe pruritus didn’t pass prescribed treatment and
chose his usual intramuscular injection of diprospan instead. As always, he
reported a short 2-week relief of symptoms.
Conclusion: These data show that urticaria alone or with angioedema very
often occurs as a symptom of a gastrointestinal disorder. It is very important to
prescribe gastroscopy and adequate treatment not only to stop urticaria, but
moreover to prevent gastrointestinal bleeding or perforation, very genlty
operating with steroids, especially oral, in such patients.
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Etiology and prognosis of acute urticaria in a university
dermatology clinic in China: a follow-up study
Lin-feng Li and Yuan Cao. Peking University Third Hospital, Dermatology,
Beijing, China.
Background: Etiology and prognosis of acute urticaria has not been reported
in China.
Objective: To investigate the etiology and outcome of acute urticaria in a
university dermatology setting.
Methods: A prospective follow up study was performed. All patients with
acute urticaria seen by authors between March 2005 and July 2006 in
department of dermatology, Peking University Third Hospital were asked to
participate. Etiologic agents and triggers were evaluated by comprehensive and
detailed history and physical examination, supplemented with selected
laboratory testing and follow up. Prognosis was assessed at 9 months after
the first visiting. Cure was defined as complete free of symptoms for more than
6 months without relapse after cessation of the treatment.
Results: 75 patients participated. There were 22 male, 53 female, with age
ranged 1.5 to 83 years. Of those, 60% were between 18 to 40 years; 32% had a
history of acute urticaria during childhood; and 6.5% were atopic. Etiologic
agents or triggers could be identified in 54.7% of the patients including
medications (21.4%), infection (20%), food (8%), physical stimuli (2.7%),
insect bite (1.3%) and contactant (1.3%). In 71 patients finished the follow up,
58 cases (81.7%) cured. 13 patients, all etiology and triggers unidentified,
progressed to chronic urticaria, but 6 of them free of symptoms at the end of
evaluation. The overall cure rate in patients with disease duration less than one
week was 94%, which was much higher than that of patients with a longer
duration (41.2%, p G 0.05, chi-square test). Sex, age and severity of the disease
had no effect on the prognosis.
Conclusion: Etiology and triggers can be identified in more than half of acute
urticaria patients. Medicaments, infection and food are common triggers. The
outcome of acute urticaria is favorable. The longer disease duration (over a
week) is an important risk for poor prognosis.
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Angioedema in a department of medicine. IgE-mediated
mechanism the most suspected cause
Paul Gade Sørensen, Karin Juulsen, and Karl Marinus Christensen. SVS,
BrLrup, Department of Medicine, BrLrup, Denmark.
Background: In angioedema deep dermal and subcutaneous tissue is
affected.Even mucus membranes are involved and may be part of life-
threatening anaphylactic reactions. These patients are often seen in
departments of medicine.
Materials: 123 patients with angioedema remitted to the department of
medicine for evaluation and treatment during the period August 2002 Y May
2007. Mean age 45, range 17Y86 years. F/M ratio 2.3. 54%(64) had urticaria as
well. Method. Pathogenetic mechanisms and the cause were evaluated. IgE-
mediated allergy, aspirin-induced allergic-like reactions, direct drug induced
adverse reactions and c1-esterase inhibitor deficiency were considered.
Results: Among 152 patients remitted for evaluation of allergy to penicillins,
47(31%) had angioedema, but in only 39 (26%) penicillin was not excluded as
the cause (exclusion by controlled administration of penicillins and s-tryptase).
Aspirin (11), nonsteroidal antiinflammatory drugs (6), ACE inhibitors (10) and
other drugs (10) were seen as the cause mediated by leukotrienes, bradykinin
and direct mast cell degranulation. Food was suspected in 28. Insect sting the
cause in 16/40 (honeybee 1/9 and wasp 15/31) and occupational agents in 5/43:
latex (nurse), fish protein, flour, dyes, nikel. In only one the c1-esterase in-
hibitor was slight reduced. Angioedema was associated to allergic rhinocon-
junctivitis and asthma. Infections and physical stimuli were well known
inducers in rather few. Most patients with non-drug induced angioedema had
prophylactic anaphylactic medication with corticosteroid and antihistamines at
home. 48 had epinephrine (epipen, autoinjector).
Conclusion: Urticaria and angioedema are the most frequent manifestations
of severe allergic reactions (anaphylaxis). Many different causes may induce
angioedema. However, IgE-mediated mechanism is the most frequent sus-
pected cause of angioedema in a department of medicine.
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Successful treatment of chronic urticaria with low molecular
weight heparin
Valerio Pravettoni1, Maria Francesca Spina1, Marta Piantanida1, Alberto
Tedeschi1, andMassimo Cugno2. 1Foundation Ospedale Maggiore Policlinico,
Mangiagalli e Regina Elena, IRCCS, Clinical Allergy and Immunology Unit,
Milan, Italy; 2Foundation Ospedale Maggiore Policlinico, Mangiagalli e
Regina Elena, IRCCS, Dept of Internal Medicine, University of Milan, Milan,
Italy.
Abstracts World Allergy Organization Journal & November 2007
S162 * 2007 World Allergy Organization
Copyright @ 2007 World Allergy Organization. Unauthorized reproduction of this article is prohibited.
Background: Autologous serum skin test (ASST) has been used to detect
circulating vasoactive and histamine-releasing factors in patients with chronic
urticaria (CU). Recently, it has been observed that autologous plasma skin test
(APST) scores positive more frequently than ASST in CU patients, and its
positivity is associated with the activation of coagulation cascade.
Aim: We report a case of chronic urticaria successfully treated with anti-
coagulant therapy using lowmolecular weight heparin (LMWH) to seewhether
symptom control is associated with reduction of coagulation activation.
Methods: A 63-year-old woman, with a 3-year history of unremitting CU, was
evaluated in our outpatient allergy clinic. No other diseases were present in her
clinical history. CU improved only with prednisolone 0.5 mg/kg/day, plus anti-
H1 antihistamine, while therapy tapering led to symptom recurrence. Known
causes of CU were ruled out with laboratory and instrumental examinations.
ASST, APST, negative control with saline solution and positive control with
histamine were performed after a 5-day discontinuation of steroid and anti-H1
therapy, and repeated after 15 days of LMWH therapy. Prothrombin fragment
F1 + 2, marker of coagulation activation, and D-dimer, marker of fibrinolysis,
were measured by ELISA before starting LMWH therapy and 15 days later.
Results: At baseline, ASPT gave an unequivocal positive response (20 mm
mean wheal diameter), whereas ASSTwas negative; prothrombin fragment F1
+ 2 value was 833 pmol/l (normal range 69/229 pmol/l) and D-dimer value
was 27.15 nmol/l (normal range 0.50Y4.00 nmol/l) confirming an activation of
the coagulation cascade and fibrinolysis. LMWH therapy (enoxaparin 4000 UI
twice a day sc) was started. After few days CU improved and the patient
stopped anti-H1 and steroid therapy, without recurrence of CU. Fifteen days
later the patient was still asymptomatic, while receiving only LMWH therapy.
APST became negative and we observed a marked reduction of both
prothrombin fragment F1+2 (287 pmol/l) and D-dimer (2.84 nmol/l).
Conclusion: The activation of coagulation in this patient suffering from
CU can be counteracted by anticoagulant treatment, leading to symptom
control. Properly designed studies are needed to evaluate this new therapeutic
approach.
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Angioedema associated with the use of Angiotensin Converting
Enzyme: clinical features and insights into pathogenetic
mechanisms
Gianenrico Senna1, Patrizia Bonadonna1, Beatrice Caruso2, Maria Angela
Crivellaro3, Annarita Dama1, Michele Schiappoli1, Giovanni Passalacqua4, and
Gianenrico Senna1. 1Verona General Hospital, Allergy Service, Verona, Italy;
2Verona General Hospital, Lab. of Clinical Chemistry & Haematology, Verona,
Italy; 3Ospedale S. Orsola FBF - Brescia, Pneumoallergology Unit, Brescia,
Italy; 4University of Genoa - Dept. of Internal Medicine, Allergy & Respiratory
Diseases, Genoa, Italy.
Background: Angiotensin converting enzyme inhibitors (ACE-Is) are known
cause of angioedema. Its incidence is between 0.1% and and 2.2%, but its
clinical relevance is due to risk of life-threatening involvement of upper
respiratory tract. In the present study we reported the clinical features of
patients complaining of ACE-Is-angioedema referred to our Unit in a 5 year
period. In a subgroup of themwe studied the potential mast-cell involvement by
measuring serum tryptase.
Methods: Descriptive, observational on ACE-Is-induced angioedema during a
5-year period (January 2001Y December 2006). Serum tryptase level was
evaluated by ELISA assay during the angioedema attacks, and in baseline
conditions in three different groups: Group 1 = 12 patients complaining of
previous ACE-Is angioedema; Group 2 = 15 patients with previous non- ACE-Is
angioedema; Group 3 = 10 patients treated with ACE-Is without angioedema.
Results: We observed 32 patients (19 male; mean age 62.3 yrs, range 42 Y
88 yrs) with ascertained ACE-I-induced angioedema. Only one patient was
African, whereas the other werewhite. Patients reported an average of 3.8 attacks
of angioedema (range 1Y 9). Upper respiratory tract involvement was observed in
2 subjects. Eleven patients reported a concomitant use of NSAIDs or aspirin (five
at low dosage). One patient reported previous cough due to ACE-Is. Drugs
responsable were: lisinopril (7), fosinopril (7), enalapril (6), quinalapril (6),
rampril (4), captopril(2).
The period of time between the beginning of ACE-Is therapy and the
first angioedema attack ranged from 10 days to 4 years (mean 1.4 years). Most
of patients (72%) had an isolated angioedema (lips 53%, face 21%, tongue
9%). Only two patients were admitted to the medical intensive care unit and
one of them was intubated. Follow-up information were available only for 16
subjects and 12 of them had no relapse after stopping ACE-Is treatment.
During the attacks only one patient showed a slight increase of serum tryptase
(12 ng/mL), whereas no significant change was observed in baseline condition
in the three groups (Group A : 5.7 ng/mL; Group B : 4.9 ng/mL; Group C :
3.9 ng/mL of serum tryptase).
Conclusion: ACE-Is are a relevant cause of angioedema mainly in adult and
elderly population. Physicians should be aware of the potential risk of upper
airway involvement. Mast-cells seem not to be involved in the pathogenesis.
Keywords: Angiotensin converting enzyme inhibitors, angioedema, tryptase.
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Icatibant Yan upcoming subcutaneous treatment for acute
attacks in hereditary angioedema
Christian Bull, Susanne Haug, and Peter Schmid-Grendelmeier. University
Hospital Zurich, Allergy Unit, Dep. of Dermatology, Zurich, Switzerland.
Rationale: Hereditary angioedema (HAE) is characterised by skin swellings
in various parts of the body, laryngeal edema or abdominal pain. Besides the
deficiency or malfunction of plasma C1-inhibitor as cause of HAE, bradykinin
is considered to be a key mediator of symptoms in HAE attacks. A new
treatment for acute HAE attacks might be Icatibant, a synthetic and highly
selective bradykin-B2-receptor antagonist which can be administered sub-
cutaneously. We report on the effect of Icatibant in treating an acute attack in
one patient in our hospital.
Methods: In the open-label extension phase of a phase III, double blind,
randomized multicenter trial (FAST-2) which compared Icatibant versus
tranexamic acid, patients with abdominal or cutaneous attacks were treated
with Icatibant 30 mg sc. Symptom score by patient, documentation of time for
the onset of symptom relief measured by a visual analog scale and time to
complete resolution of symptoms were the main assessments.
Results: The patient treated in our hospital was a 22 year old, otherwise
healthy male with known HAE since the age of 6 month. He has been having
frequent attacks about twice per month which usually were treated with
tranexamic acid. The patient experienced in total 11 attacks (7 abdominal, 2
cutaneous and 2 laryngeal) with an average duration of 4 days during the last 6
months. The patient came to the clinic with a severe cutaneous edema of his
genitals. He received one single injection of 30 mg Icatibant sc. The onset of
symptom relief was reached rapidly after approximately 10 minutes. Complete
resolution of symptoms occurred within 5 hours, so the patient could leave the
hospital. Icatibant was well tolerated, only mild injection site reactions such as
pruritus were observed. No systemic adverse events were observed.
Conclusion: In the present case Icatibant provided fast and complete
resolution of severe cutaneous HAE symptoms and was well tolerated. The
treatment course of the HAE attack in our case complies with the results of the
double blind phase of the FAST-2 trial. The time to first improvement was 0.8
hours for Icatibant vs. 7.9 hours for tranexamic acid (p G 0.001).
The primary endpoint (median time to onset of symptom relief) was
met with 2.0 hours for Icatibant compared with 12.0 hours for tranexamic acid
(p G 0,001). The end of attack (almost complete symptom relief) was reached
after 10 hours during treatment with Icatibant compared to 51 hours for
tranexamic acid (p G 0.001).
514
Evaluation of the receptor occupancy by desloratadine and
levocetirizine in allergic subjects
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Margherita Benedetti1, Christian Otoul2, Michel Gillard3, Christine De Vos4,
Gabrielle Pauli5, and Nelly Frossard6. 1UCB Pharma SA, Non Clinical
Development, Nanterre, France; 2UCBPharma SA,Global Pharmacometrics -
Exploratory Statistics, Braine l’Alleud, Belgium; 3UCB Pharma SA, In vitro
Pharmacology, Braine l’Alleud, Belgium; 4UCB Pharma SA, Global Medical
Affairs, Brussels, Belgium; 5Hoˆpital Lyautey, Pneumology Dpt, Strasbourg,
France; 6University Louis Pasteur, Faculty of Pharmacy, Strasbourg, France.
Background: The inhibitory activity of the new generation H1antihistamines
levocetirizine (L) and desloratadine (D) on allergen-induced wheal & flare
reaction at different times after administration of therapeutic doses has been
evaluated in a previous study (Frossard et al. Br J Clin Pharm 2007). L
suppressed the cutaneous allergic reactions with a higher potency than D. The
receptor occupancy (RO) also evaluated for both drugs 24 h post-dose was
higher for L than for D. The purpose of the present study was to further analyze
the RO for both drugs at 12 h and 24 h after administration.
Methods: During a double-blind, randomized, single dose, cross-over,
placebo-controlled study in 18 allergic subjects (9 males, 9 females, all
Caucasians, age 18Y48 yrs, weight 54Y 93 kg), L and D plasma levels were
measured at 12 and 24 h post-dose. RO was calculated as RO % = ROmax
x Cfree¨ M (Cfree + Ki), where ROmax = maximal % of binding sites (set to
100%), Cfree = free concentration of drug at the histamine H1 receptor, and
Ki = equilibrium inhibition constant. Free concentration of the drug at the
histamine H1 receptor was considered as the free plasma concentration since
only the unbound drug is capable of entering and leaving the plasma and tissue
compartments (assuming the absence of active transport mechanisms, at least in
the target tissues containing histamine H1 receptors). As the Ki may vary with
pH (Gillard & Chatelain Eur J Pharmacol 2006) and acidosis appears to be a
hallmark of inflammatory processes [e.g. the exhaled breath condensate pH in
children (Profita et al. JACI 2006) and adults with allergic rhinitis is acidic
compared with healthy controls], RO was also calculated using the Ki values
obtained in acidic conditions. The statistical analysis was performed using the
Student-t-test for paired data.
Results:
Conclusion: In spite of the higher affinity (Ki) and longer t2 of D compared
with L, the higher free plasma concentrations of L at 12 and 24 h post-dose
produced higher percentages of RO probably accounting for the statistically
significant higher inhibition of allergen-induced wheal & flare induced by L.
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The impact of hereditary C1-inhibitor deficiency on the
development of atherosclerosis
Ga´bor Sze´plaki1, Ro´bert Szegedi2, Zolta´n Sze´plaki2, Zolta´n Proha´szka1,
Lilian Varga1, La´szlo´ Romics1, Istva´n Kara´di1, George Fu¨st1, and Henriette
Farkas1. 1Semmelweis University, 3rd Department of Internal Medicine,
Budapest, Hungary; 2Semmelweis University, Department of Neurology,
Ku´tvo¨lgyi Clinical Centre, Budapest, Hungary.
Background: Hereditary angioedema (HAE) is a rare disease characterized by
recurrent swellings of the subcutaneous or submucosal tissues caused by
the inherited deficiency of the C1-inhibitor (C1-INH) Ya main regulator of the
complement system. Atherosclerosis is an inflammatory disease and the
complement system plays a major role in the development of the plaques.
The aim of the present study was to investigate the possible impact of C1-INH
deficiency on atherosclerosis.
Methods: In a cross-sectional prospective study we included 57 adult patients
and 20 age and sex matched healthy individuals. The prevalence of cardio- and
cerebrovascular atherosclerotic diseases as well as distinct atherosclerotic risk
profiles were determined. In addition, the thickness of the intima-media (IMT)
of the common carotid artery was also determined. As severe HAE patients
receive long-term danazol prophylaxis Yan attenuated androgen-, patients were
divided into two subgroups according to prophylactic treatment.
Results: Low prevalence of atherosclerosis was found in HAE patients: only 2
subjects were affected (1-1 in the danazol treated and not treated group,
respectively) according to the medical history. Patients with long-term danazol
prophylaxis had an increased risk profile for atherosclerosis: significantly
higher body-mass index, LDL/HDL ratio, creatine kinase activity, creatinine,
GPT and hemoglobin levels were found compared to the other HAE patients
and healthy controls as well. However carotid IMT did not differ relevantly in
study subgroups.
Conclusion: Long-term danazol use results in a highly proatherogenic risk
profile in patients with HAE. However, it seems that it does not lead to early
atherosclerosis. The prevalence of cardio- or cerebrovascular diseases is low
in HAE patients irrespectively to their prophylactic treatment and carotid
IMT is comparable to healthy controls. We hypothesize, that the functional
deficiency of C1-INH might be a protective factor in these patients against
atherosclerosis Y which outlines the importance of the plasma enzyme
systems in the process which are regulated by C1-INH.
516
Patient perception of levocetirizine in urticaria: a multicenter
study in Taiwan
Yu-Yun Lee, and Ming-Shien Lu. National Cheng Kung University Hospital,
Dept. of Dermatology, Tainan, Taiwan.
Background: Levocetirizine (Levo) is a potent latest-generation, non-sedating
oral H1-antihistamine for which no data in Taiwanese population has yet been
published.
Objective: Primary: patients’ perception of Levo in the treatment of urticaria.
Secondary: adverse events (AEs), onset of action, and improvement in quality
of sleep and daily activities.
Methods: A multicenter observational study (6 medical centers) was
conducted from May 2006 to March 2007 in Taiwan assessing the treatment
perception of urticaria patients on Levo. Pruritus severity (0=absent, 3=severe)
and duration (mild G 1h; moderate 1Y6h; severe 9 6h), number (mild:1Y10;
moderate: 10Y20; severe: 9 20), size (mild = 1.5cm; moderate: 91.5cm G3cm;
severe: 9 3cm) and duration (mild G 1h; moderate 1Y6h; severe 96h) of wheals
and the frequency of symptoms (mild30min, G1hrs), and moderate (91hrs). A
visual analogue scale (VAS) was used to evaluate global satisfaction of patients
and physicians (range: 0Y10).
Results: 97 patients were included and 95 completed the study. 2 patients (2%)


















Ki (t 37-C, pH 7.4) 0.4 3
Ki (t 37-C, pH 5.8) 0.63 1.3
Free drug conc. (nM) (mean T SD)
C 12 h 0.394 T 0.118 11.3 T 2.61
C 24 h 0.215 T 0.075 3.90 T 1.59
Receptor occupancy (%) for Ki at pH 7.4 (mean T SD)
RO 12 h 48.6 T 7.6 78.3 T 4.4 29.8 (25.7Y33.8)*
RO 24 h 34.0 T 7.7 54.1 T 11.7 20.1 (14.3Y25.9)*
Receptor occupancy (%) for Ki at pH 5.8 (mean T SD)
RO 12 h 37.7 T 7.0 89.2 T 2.6 51.5 (48.0Y55.0)*
RO 24 h 24.9 T 6.4 72.2 T 10.2 47.4 (42.3Y52.4)*
When evaluated at pH 7.4, a statistically significant difference of 30 and 20 between
the percentages of RO by L and D was obtained at 12 and 24 h post-dose, respectively.
This difference reached 52 and 47 when RO computation was performed using the Ki
values obtained at pH 5.8 (see table).
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and 30 (31%) chronic urticaria. The use of concomitant antihistamines was
reduced from 58% (baseline) to 27% at end of treatment.
Conclusion: Results confirm western studies that levocetirizine potent,
effective and well tolerated also in Taiwanese patients with urticaria. Most of
the patients considered it as better than their previous treatments.
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Levocetirizine has a better overall efficacy than desloratadine in
chronic idiopathic Urticaria: A double-blind, randomized,
clinical trial
Annick Barbaud and on behalf of CUTE Study Group. Hoˆpital Fournier,
Service de Dermatologie, Nancy, France.
Background: Levocetirizine (Levo) and desloratadine (Deslo) are H1-
antihistamines of the latest generation. Levo has been shown to be significantly
more potent than Deslo in either histamine or allergen-induced wheal and flare
studies. So far, no head-to-head clinical studies in Chronic Idiopathic Urticaria
(CIU) have corroborated these findings.
Methods: A multicenter, double-blind, 2-parallel groups (438 adults on Levo,
448 on Deslo), randomised trial over 4 weeks (w) of treatment to compare the
clinical efficacy and safety of Levo 5mg vs. Deslo 5mg, both once daily.
Primary endpoint: pruritus severity score (0 = absent to 3 = severe) assessed
daily over the first week (w1) of treatment. Secondary endpoints: pruritus
severity over all 4 study weeks (w4); pruritus duration, number and size of
wheals over w1 and w4 (all on a 0Y3 scale); global satisfaction with treatment
(0 = very dissatisfied to 10 = very satisfied), and safety. CIU composite score,
representing the drug’s overall efficacy, was also assessed.
Results:
Conclusion: In this first head-to-head comparison of Levo and Deslo in CIU,
patients satisfaction with Levo was significantly higher, onset of action of
Levo was faster and the overall efficacy of Levo was significantly better than
Deslo in relieving CIU symptoms.
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Urticaria and angio-oedema due to the daily 80 mg dose of
acetylsalicylic acid
Hong D. Oei, Wilsa L. Kartanegara, and Richard L. Oei. Albert Schweitzer
Hospital, Allergology, Dordrecht, Netherlands.
Background: Low dose acetylsalicylic acid have been widely prescribed to
prevent or reduce the risk of strokes and heart attacks. There are many reports
concerning its known side effects, such as: acute urticaria. However, reports of
intermittent urticaria and angio-oedema due to the daily 80 mg intake of
acetylsalicylic acid are not common.
Methods:We have seen 4 patients (56y old man, 64y old man, 77y old woman
and a 79y old woman) who used a daily dose of 80 mg acetylsalicylic acid for
more than 6 weeks. They complained about multiple episodes of swelling of
the tongue, cheeks and urticaria. The frequency varied from once a week or
once in 2Y4 weeks, within a period of 6 to 12 months. Some patients consulted
a dermatologist and another physician without any results. Routine screening
investigations were negative.
Results: The symptoms disappeared in 3Y6 weeks after they stop taking
acetylsalicylic acid and taking clopidogrel instead.
Urticaria and angio-oedema will reappear within 3Y5 weeks, after the
patients continue taking the 80mg daily dose of acetylsalicylic acid, instead of
the replacement clopidogrel.















Complete or partial relief 80% 64% 73% 66% 60% 72%
Unchanged 19% 36% 26% 32% 37% 27%
Worse 1% 0% 1% 2% 3% 1%
Overall efficacy and tolerability were assessed as Bgood/excellent[ by 75% and 68% of patients, respectively. At least 60% of all patients and 75% of those with moderate/severe
symptoms reported complete recovery or marked improvement of any individual allergic symptom. 65% of subjects reported the onset of action as very rapid or rapid. Levo was reported
as better than their previous therapy by 72% of patients. Good to excellent improvement in quality of sleep and daily activities was reported by 61% and 74% of patients without
concomitant medications, respectively. Global satisfaction with Levo was high for both physicians and patients (VAS=7.4). Most frequently reported AEs were somnolence (7%) and
fatigue (3%).
TABLE 1CHARACTERISTICS OF THE CONTROL AND PATIENTSWITH CPHISTOPATHOLOGICAL DATA OF PATIENTS WITH CP
AFTER SURGERY
Baseline Mean (SD) Over week 1, Adj. Mean (SE) p value Over 4 weeks, Adj. Mean (SE) p value
CIU Composite score (SD) Levo 4.03 (1.07) 1.98 (0.08) 0.005 1.71 (0.07) 0.041
Deslo 4.07 (1.05) 2.23 (0.08) 1.88 (0.07)
Pruritus severity score (SD) Levo 2.20 (0.53) 1.02 (0.04) G0.001 0.86 (0.04) 0.004
Deslo 2.22 (0.53) 1.18 (0.04) 0.99 (0.04)
Pruritus duration (SD) Levo 2.11 (0.63) 1.08 (0.04) 0.002 0.93 (0.04) 0.009
Deslo 2.13 (0.64) 1.24 (0.04) 1.05 (0.04)
No. of wheals (SD) Levo 1.83 (0.66) 0.96 (0.04) 0.054 0.85 (0.04) 0.353
Deslo 1.85 (0.65) 1.05 (0.04) 0.89 (0.04)
Size of wheals (SD) Levo 1.94 (073) 1.01 (0.04) 0.025 0.89 (0.04) 0.085
Deslo 1.93 (0.71) 1.12 (0.04) 0.97 (0.04)
The improvements in the mean scores were: pruritus severity 54% and 61% (w1, w4) for Levo and 47% and 55% (w1, w4) for Deslo; pruritus duration 49% and 56% (w1, w4) for Levo
and 42% and 51% (w1, w4) for Deslo. The patient satisfaction with treatment was significantly higher in the Levo (7.62) compared to the Deslo (7.33) group (p=0.021) over w4. The time
to first symptom improvement reported by the 1st quartile of subjects was shorter with Levo (3h00) compared to Deslo (4h15). Drug-related adverse events (DRAEs): 13.7% for Levo and
11.2% for Deslo, without any serious DRAEs.
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Conclusion: We conclude that the intake of low dose acetylsalicylic acid may
have caused urticaria and angio-oedema in these patients. The reason behind
the attack of urticaria and angio-oedema that only happened in once a week
or once in the 2Y4 weeks is still unclear. The intermittent nature of urticaria
and angio-oedema attacks may also be the reason why many physicians are
not aware that the daily 80 mg dose of acetylsalicycic acid may cause of
this problem.
We suggest replacing the daily 80 mg use of acetylsalicylic acid with
clopidogrel, for those patients with urticaria and angio-oedema possibly caused
by acetylsalicylic acid.
Further studies are needed to investigate the mechanism of this
disorder.
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Distribution of HLA DRB1 specifities in patients with chronic
urticaria
Gruzdeva Maria1, Inna Danilycheva1, and Margarita Boldyreva2. 1Institute of
Immunology, Basic Allergology and Immunetherapy, Moscow, Russian Fed-
eration; 2NRC Institute of Imunology FMBA RF, Immunegenetics, Moscow,
Russian Federation.
Background: In 50Y80% of patients with chronic urticaria (CU) the origin of
disease is unknown. In most of CU cases autoimmune mechanisms are
involved. In CU patients auto antibodies such as aDNA, p-ANCA, ANF, RF
often detected along with the clinical manifestations of autoimmune pathology
(arthralgia, myalgia, photodermatitis, sub febrile body temperature). Predis-
position to autoimmune diseases is connected to certain variants of HLA
genes. Relative risk index Q2 demonstrates that individuals bearing this HLA
gene variant have higher risk of autoimmune pathology development than
other individuals. The goal of the study was to investigate association between
certain HLA specifities and CU development.
Methods: In our study patients were divided into 3 groups. First group -
patients with acute atopic urticaria (N = 30), second group - patients with CU
with clinical manifestations of autoimmune pathology (N = 31), third group -
normal individuals (N = 135). HLA-genotyping was performed with SSP-
variant of PCR.
Results: In the first group half of chronic CU cases revealed from childhood.
Weals persisted less than 6 hours in all cases, atopic background in 37% of
cases, 100% efficacy of AH drugs application. In the second group: urticaria
debut at the age of 24 to 51,urticaria persistence for 2Y4 years in average,
existence of autoimmune pathologymanifestation in reumo-tests. In the second
group statistically significant increase of autoantibodies was found in
comparison to the first group. According to HLA-genotyping data patients
with CU demonstrated statistically significant increase in the level of HLA
DRB1*04 in comparison to normal individuals.
Conclusion: We demonstrates that relative risk in patients with CU for
DRB1*04 specifity is 2,33. Data obtained points out possible autoimmune
mechanism of urticaria development.
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Desloratadine reduces symptoms and improves quality of life in
patients with chronic idiopathic urticaria: a multicenter,
practice-based study in China
Zheng Wang. Schering Plough (China) Ltd., Shanghai Schering Plough
Pharmaceutical Co., Ltd., Shanghai, China.
Background: Chronic idiopathic urticaria (CIU) is associated with a heavy
symptom burden, which translates into significant impairment in quality of life
(QOL). Non-sedating antihistamines are first-line therapy for CIU. Deslor-
atadine (DL), a non-sedating, selective H1 receptor antagonist has been shown
in multiple placebo-controlled studies in Europe and the United States to be
effective in reducing the severity of pruritus and wheals in CIU, while
improving QOL measures. The impact of DL on CIU has not been studied in a
Chinese population.
Methods: This open-label, multicenter study evaluated the efficacy and
safety of DL 5mg QD administered for 28 days in patients with CIU treated
during everyday practice in China. Patients aged Q18 yr and of either gender,
with a Q6week history of CIUwere eligible. Patients had to havewheals present
for Q3 days/week, and pruritus, wheals and overall CIU severity scores had to
be Q2 (0=none to 3= severe). At baseline and days 8, 15, and 29 patients rated
the severity of pruritus, wheal size/number, total CIU symptoms, interference
with sleep and daily activities and overall CIU condition using a 4-point scale.
QOL was assessed at the same time-points using the Dermatology Life Quality
Index (DLQI). At day 29 the global response to therapy was rated (1=complete
relief to 5= treatment failure); adverse events (AE) that occurred during the trial
were collected and rated for severity/relation to study drug.
Results: The study included 460 subjects (54.1% female), with a mean age of
37.2 years and a mean duration of diagnosed CIU of 25.7 months. Pruritus,
wheal size, wheal number, total CIU score, interference with sleep and daily
activities and overall condition of CIU were all significantly improved from
baseline at days 8, 15 and 29 (P G 0.0001 for all). DLQI also improved
significantly from baseline over the course of the study (P G 0.0001). The
percentage of patients with complete or marked relief of CIU rose from 64.8%
at day 8 to 80.3% at day 15 and 82.3% at day 29. DL was well tolerated and no
serious AEs were observed. The most frequent AEs rated as possibly/probably
related to treatment were drowsiness (3.7%), fatigue (1.7%), headache (1.5%),
thirst (1.5%) and dizziness (1.3%).
Conclusion: This practice-based study in Chinese subjects confirms that DL is
effective and well tolerated in the treatment of CIU and is associated with
improved QOL.
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Fresh frozen plasma for the treatment of acute
hereditary angioedema
Djahna Thomas1, Huamin Li2, Natalie Ball2, and Mark Scarupa2. 1Washington
Hospital Center, Internal Medicine, Washington, DC, United States; 2Institute
For Asthma & Allergy, Allergy and Immunology, Wheaton, United States.
Background: Chronic prophylactic therapies for hereditary angioedema
(HAE) have existed for some time but in the United States acute therapies are
lacking. Fresh frozen plasma (FFP) has been used to treat acute attacks but its
use is controversial because reports of FFP worsening HAE symptoms exist.
Methods: Twenty-three patients with HAE answered survey questions
regarding past experiences with FFP. The purpose of the survey was to
determine whether FFP administration during acute HAE attacks ever lead to a
worsening of symptoms. Additionally, patients were asked whether FFP was
perceived to be beneficial. Demographic data and data on the types of attacks
treated was also collected.
Results: Six of 23 patients received FFP for acute attacks and an additional
three patients received FFP for surgical or dental prophylaxis. Greater than 71
acute attacks were treated with FFP. One individual accounted for approxi-
mately 50 treatments. Attack locations included abdominal, peripheral, facial,
genital, and laryngeal. There were no episodes of acute worsening after
administration of FFP or spread to the larynx. Therewas perceived benefit from
FFP in all but five instances.
Conclusion: Until more specific therapies for the acute treatment of HAE are
widely available, FFP should be considered as a treatment option particularly
in non-laryngeal attacks.
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Hereditary angioedema prognosis in non treated
Algerian patients
Kamel Djenouhat1, Hassen Messaoudi2, and Mohamed Cherif Abbadi1.
1Institut Pasteur d’Alge´rie, Department of Immunology, Algiers, Algeria;
2CHU Mustapha Hospital, Internal Medecine Department, Algiers, Algeria.
Background: Hereditary angioedema (HAE) is an autosomal dominant dis-
ease that is characterized by quantitative or qualitative deficiency of a plasma
protein called C1 esterase inhibitor(C1INH). The disease is manifested by
episodic attacks of nonpitting, nonpruritic, localized oedema that progresses
rapidly without urticaria or erythema. Swelling of the intestine can cause in-
tense abdominal cramping associated with vomiting and diarrhoea. Laryngeal
oedema may prove fatal.
The main of the present retrospective study is to report the follow-up
care of HAE non treated symptomatic patients.
Patients and Methods: For each patient clinical score was established and
complement system investigation including antigenic quantification of C1
INH, C3, C4 and C1q by nephelometry (Dade Behring, Germany). And de-
termination of C1 inhibitor function by chromogenic assay (C1 Y INH,
IMMUNO AG, Vienna, Austria) were performed.
Results: The two most striking matters of HAE spontaneous course in our
patients comparing to literature data before androgenic therapy are, firstly a
very low mortality rate (about 5% versus 30%) and secondly, only few of them
(less than 10%) had developed moderate attack following dental care even
without preventive drug.
Conclusion: Our population seems to be more resistant to C1 inhibitor
deficiency than European and American patients. We suppose that treated
patients would become more sensitive to minor disorders than non treated ones,
andalso this difference couldbedue to environmental factor (s) such asmicrobes.
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Effect of cetirinax on the skin reactivity in patients with
chronic urticaria
Sonya Genova, Vania Tzvetkova, Hristina Dardanova, Desislava Yolcheva,
Ludmil Terziev, and Temenuga Yosifova. Medical University - Pleven, Clinic
of Allergy, Pleven, Bulgaria.
Background: Cetirinax\ (Actavis), a derivate of piperazine, belongs to the
family of the second-generation antihistamines. It is a fundamental phar-
macological active metabolic product of hydrazine Y a first-generation
antihistamine. Beside its antihistamine activity, Cetirinax\ posseses also
other varied qualities that augment its antiallergic properties. Suppression of
erythema and papula is traditional pharmacodinamical mechanism used to
determine activity of H1 receptor antagonists.
The purpose of that survey is to get in touch with suppressive effect of
Cetirinax\ on erythema and papula caused by histamine in patient with
chronic urticaria.
The aims that we put were to survey suprressive effect according to
time, clinical condition of patients, sex and age.
Methods: The study involved twenty patients with chronic urticaria, 18Y63
years of age. Histamine sensitivity of all patients was given by prick-test with
10 mg/ml histamine 20th minutes before treatment with 10mg Cetirinax\.
After that the same sensibility was determined on 30th minutes, 1st, 3rd, 6th,
9th, 12th and 24th hour.
Results: The suppressive effect of Cetirinax\ set in 30th minutes and is
highest marked in 3rd hour on the erythema and in 9th hour on the papula. The
difference were statistic important compared to basic size of papula and ery-
thema. Depression of erythema was equal like papula in various hours. Dep-
ressive effect was marked clearly in 24th hour.We determined that histamine
papula and erythemawere similar at patients independently ages, sex, and clinic
condition. The clinic effect correlates to the excellent suppressive functions.
Conclusion: Cetirinax\ is a medicine with excellent quality on the skin
reactivity.
EPIDEMIOLOGY - RISK FACTORS
524
Prevalence of bronchial asthma in children in Saudi Arabia
A.R. Al-Frayh1, and S.M. Hasnain2. 1College of Medicine King Saud Uni-
versity, Pediatric Department, Riyadh, Saudi Arabia; 2King Faisal Specialist
Hospital and Research Centre, Allergy and Aerobiology Unit, Riyadh, Saudi
Arabia.
Background: The impact of childhood asthma on the health care system is
considerable. As one of the most chronic diseases of children, asthma is
frequent caused for emergency room visits and hospitals admissions. Clinical
observations indicate that atopic diseases, particularly bronchial asthma and
allergic rhinitis are also common in Saudi Arabia. However, there were no
formal studies until recently on the prevalence and etiology of childhood
asthma in the country.
Methods: Prevalence of Bronchial Asthma in school children were studied in
different part of the country using a standardized protocol of 32 questionnaires.
The questionnaire was designed by a committee of international expert and first
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used in 1985Y1986, before ISAAC launched its first phase of limited age
prevalence studies. Our questionnaires, however is very similar to ISAAC
questionnaires but include children from 06 to 16 years of age. For compara-
tive purposes, we have continued using the same protocol for other parts of
the country. The questionnaires were translated in local language and distrib-
uted through the Ministry of Primary Education to different urban schools of
the Kingdom.
Results: Their studies were completed at different intervals within the past
several years. The combined data revealed varying prevalence of asthma with
highest 24% being in a coastal city bordering Yemen called Gizan (n = 362)
followed by Taif 23% (n = 594) and Hail 22% (n = 507) an agricultural city.
The prevalence rate of asthma for other places where Al-Gazim 16% (n = 384),
Abha 13% (n = 485), Dammam 12% (n = 889), Hofuf 14% (n = 923), Jeddah
12% (n = 531) and Riyadh 10% (n = 988). The prevalence for allergic rhinitis
was much higher than asthma.
Conclusion: Bronchial Asthma emerged to be one of the prevalent diseases in
Saudi Arabia and showed regional diversity. The socio-economic differences
between asthmatic and non asthmatic children were none striking. Environ-
mental and geographical influences were considered to be the reasons of the
variations in the rate of prevalence.
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Hygienic hypothesis and asthma in early adolescence
Ilija Kirovski1, Emilija Vlaski1, Katerina Stavric2, Mica Kimovska3, Lidija
Seckova1, Rozalinda Isjanovska4, and Collaborative Team of the Project 5.
1University Children‘s Hospital, Department of Pulmonology and Allergology,
Skopje, Macedonia, Fyrom; 2University Children‘s Hospital, Department of
Immunology, Skopje, Macedonia, Fyrom; 3University Children‘s Hospital,
Department of Intesive Care, Skopje, Macedonia, Fyrom; 4Institute of Epi-
demiology, Department of Epidemiology, Skopje, Macedonia, Fyrom; 5Public
Health Organization, Department of Pediatrics, Tetovo, Ohrid, Veles, Berovo,
Pehcevo, Delcevo, R., Macedonia, Fyrom.
Aim: A negative association between the number of siblings and older siblings
especially with allergic diseases symptoms through the impact of infections on
Th1/Th2 immune response is suggested. The study was aimed to examine the
influence of the presence of siblings and the presence of older siblings on
asthma in young adolescents.
Materials and Methods: The self-reported data by 5507 adolescents aged 12/
16 years from 8 cities in The Republic of Macedonia obtained through the
ISAAC phase 3 questionnaires on asthma and environmental risk factors in
2006 were analysed. The presence of siblings and older siblings separately
(adjusted for sex, passive smoke exposure at home, gas/wood cooking at
home, wood/coal/oil heating at home, duration of TV watching daily, cat
ownership) were correlated to wheeze ever, current wheeze, current speech-
limiting wheeze, exercise-induced wheeze and ever-diagnosed asthma. Odds
ratios (OR, 95% CI) in binary logistic regression were performed for statistical
analysis of data.
Results: A significant association of the presence of siblings in general and the
presence of older siblings especially with asthma and its symptoms was not
found (p 9 0.05 for all the parameters).
Conclusion: It seems that the presence of siblings and older siblings do not
influence asthma in young adolescents.
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Environmental tobacco smoke: a risk for bronchial
hyperreactivity and pediatric asthma
Mona Elganzoury1, Tharwat Deraz1, Karima Abd El2, and Mona Elganzoury2.
1Ain Shams University, Pediatrics, Cairo, Egypt; 2Ain Shams University,
Pediatric Pulmonology, Cairo, Egypt.
Background: Fifty passively smoking chiidren of whom at least one parent
was a chronic smoker were included in the present study their ages ranged
between 5Y15 years old.Exposure to cigrette smoke was recognized from
personal history and was confirmed by measurement of urinary cotinine(the
major metabolite of nicotine in urine).
Aim: To evaluate the effect of household environmental tabacco smoke on
bronchial reactivity and subsequent lung functions in passively smoking
children. We also aimed to correlate pulmonary functions in passive smokers
children with the number of smoked cigarettes of thier parents as well as the
duration of thier exposure to cigrarettes smoke. Urinary cotininwas studied as a
mirror image to the number of smoked cigarettes. Its levelwas also correlated to
bronchial hyperreactivity and lung functions in the studied children.
Methods: To asses bronical hyperreactivity,metacholine challenge test(MCH)
was done by using dosimeter, Pulmonary functions test were performed before
and after metacholine challenge test. Challange test was stopped when there is
a reduction in forced expiratory volume in 1st second by 20% from base line,or
when the maximum concentration of metacholine was reached (25mg/ml).
pulmonary function tests was performed by Med Graphics TM SPIROME-
TERY 1070 series 2,hard disc computer system. Urinary cotinin was measured
by high -performance liquied tomography.
Results: 68%(34 children) were found to have bronchial hyperreactivity,14
children out of the 34 did not perform challange test as they had basel
bronchial hyperreactivity. 20 chidren showed postive metacholine challange
test at various concentrations.
There was a significant relation between bronchial hyperreactivity
(BHR) AND THE NUMBER of smoked cigrattes.Also there was a significant
relaton between mean forced expiratory volumm one second(FEV1) reduction
as well as cumulative dose(CD) OFMCH and number of smoked cigarettes by
the parents.duration of tabacco smokewas found to be of great influence on the
chiidren pulmonary function tests.
Conclusion: Passively smoking children has subclinical bronchial hyperreac-
tivity with various degrees, and some of them may turn to be asthmatics.
Pulmonary functions of those children depends on multifactors in particular,
number of smoked cigarettes and duration of exposure to tobacco smoke.
Health education programs to explain the hazardous effect of passive smoking
are recommended.
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Association of skin allergy test with bronchial asthma patients
MD. A. Shakur Khan. Nidch, Mohakhali, Dhaka, National Asthma Center,
Dhaka, Bangladesh.
Purpose: Asthma is a major public health problem in Bangladesh. Allergy
plays an important role in asthma. Asthmatics tend to be more atopic and
thus more allergic skin test reactivity than non- asthmatics. Hence skin
prick test may serve as a useful adjunct in the diagnosis and management
of bronchial asthma. Results of Skin Prick Test are an important component
in the formulation of preventive plan for the management of bronchial
asthma.
Methods: This was a prospective case control study carried out in the Asthma
Centre, National Institute of Disease of the Chest and Hospital, Dhaka,
Bangladesh. 90 bronchial asthma patients were taken as case and 80 subjects
having no history of asthma or allergy were taken as control. The mean age of
cases was 25.06 T 1.28 with male female ratio 1.57: 1 and of control 23.09 T
1.31 with male female ratio 1.5:1
Results: Percutaneous skin test performed with 30 allergens. Frequency of
immediately reacting skin (positive) found in group A were, Mite (78.89%).
House dust (78.89%), Cockroach (33.33%), Mosquito (25.56), Fungi
(16.67%), Grain dust rice (32.22%), Paper dust (27.78%), Straw dust
(33.33%), Cow dander (30%), Cat dander (15.56%), Dog dander (12.22%),
Wool mixed (23.33%), Chicken feather (14.44%), Beans fresh (26.67%),
Coconut (13.33%), Ladies finger (14.44%), Chicken (12.22%), Egg white
(13.33%), Prawn (34.44%), Mutton (15.56%) etc. In Group B (Control),
positive skin test was detected in mite (7.50%), House dust (5%), Cockroach
(2.5%), Mosquito (3.75%), Ladies finger (2.5%), Tomato (1.25%), Chicken
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(2.5%), Egg white (1.25%) and Prawn (5%) In control non-allergic subjects’
1.25%Y7.5% shows positive skin test result. Cause of this positive reaction in
non-allergic control may be due to differences in selection of subjects,
standardization of extracts and recording of results.
Conclusion: Skin allergy test is the most sensitive method for detecting
specific IgE antibody. Positive skin test along with clinical relevance
determined the consideration of asthmatic patient for immunotherapy. High
prevalence of positive immediate hypersensitivity skin test reactions in the
asthmatics population is a strong argument that it should be included in the
initial evaluation of patients with asthma. Identification of allergen by positive
skin test may help in the preventive plan for the management of bronchial
asthma patients.
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The additional reasons of cardiovascular risk increase in
asthma exacerbation
Tatyana Brodskaya, Vera Nevzorova, and Boris Geltser. Vladivostok State
Medical University, Department of Therapy, Vladivostok, Russian Federation.
: Avascular disturbances has a great importance in asthma pathogenesis.
Research of mechanical properties of vessels, in particular of arterial stiffness
has special interest for the estimation of cardiovascular system function. It is
not clear whether increase arterial stiffness observes in patients with asthma.
Methods: We examined 54 patients with severe and moderate asthma by non-
invasive arteriography (arteriograph TensioClinic TL1 (TensioMed, Hun-
gary)). Control group included 25 age- and sex-matched healthy volunteers.
Results: The aortal stiffness in asthma exacerbation was significant more, than
in healthy persons. It was expressed in increase of aortic pulse wave velocity
(aPWV) and augmentation index (IA). APWV in patients with severe asthma a
two fold surpassed aPWV in healthy persons and was 10,5 T 1,3m/s. IA in
such patients a 6 fold surpassed control level and was 14,4 T 5,8%. Significant
raised (8 G 0,001) arterial stiffness can take part in increasing cardiovascular
risk during asthma exacerbation. Independently of increasing arterial stiffness
in asthma exacerbation, aPWVand IA essentially improved and came nearer to
control level in asthma remission. That suggests functional character of these
changes. Augmented arterial stiffness in asthma correlates to lung ventilation
dysfunction and hypoxia, disease duration and severity.
Conclusion: Described changes can explain cardiovascular events rising in
patients with exacerbation of asthma. Our data suggests transitory character of
arterial stiffness increasing in asthma exacerbation.
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Relations of arterial stiffening in asthma exacerbation
Tatyana Brodskaya, Vera Nevzorova, Boris Geltser, and Elena Motkina.
Vladivostok State Medical University, Department of Therapy, Vladivostok,
Russian Federation.
: Arterial stiffness is an independent factor of cardiovascular risk.
Exacerbation of asthma associates with increase arterial stiffness. The
mechanisms responsible of this association are not clear.
Methods: We examined 54 patients with exacerbation of severe and moderate
asthma and 25 age- and sex-matched healthy volunteers. Arterial stiffness was
estimated by noninvasive arteriography (arteriograph TensioClinic TL1
(TensioMed, Hungary)). Plasma IL-10 and TNF-a levels were determined by
the immune-enzyme analysis. Inflammation index calculated as ratio TNF-a/
IL-10. Systemic oxidative disbalance was estimated by ratio of oxidative and
antioxidative plasma activity, assessed by spectrophotometry. Hypoxemia was
assessed by digital pulsoximetry. NOn- plasma level was determined by
Greiss’s method.
Results: Central arterial stiffness was higher in patients with exacerbation of
asthma, than in healthy persons. It was expressed in increase aortic pulse wave
velocity (aPWV) and augmentation index (IA). As assessed by correlation
analysis both (aPWV and IA) was strongly correlated with hypoxemia
(r = Y0,921 and r = Y 0,876 (8 G 0,01)) and inflammation index (r = 0,902
and r = 0,868 (8 G 0,01)). Less strongly but clearly aPWV and IA correlated
with NOn- level (r = j0,543 and r = Y0,367 (8 G 0,01)) and systemic
oxidative disbalance (r = 0,611 and r = 0,459 (8 G 0,01)).
Conclusion: Our results suggests that hypoxemia, systemic inflammation,
hyponitrooxidemia and oxidative disbalance can be involved in raising arterial
stiffness in asthma exacerbation. This question requires future researches.
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Cockroach hypersensitivity in asthmatic patients
Mojgan Safari1, and Reza Amin2. 1Hamedan University of Medical Sciences,
Pediatric Ward, Hamedan, Islamic Republic of Iran; 2Shiraz University of
Medical Sciences, Pediatric Ward, Shiraz, Islamic Republic of Iran.
Background: Exposure to cockroach was reported to a cause of asthma in
many parts of the world.
Objective: To determine the prevalence of cockroach sensitivity in asthmatic
children less than 5 years of age in Iranian children with asthma.
Methods: Ninety two (33 female /59 male) patients were asked to complete a
questionnaire covering demographic characteristics, and were subjected to
skin prick testing for cockroach allergen. Blood samples were also withdrawn
for the assessment of total serum IgE and eosinophilia.
Results: Twenty seven percent (n = 25) of subjects had positive skin test
results for cockroach allergen. There were no significant correlations between
the prevalence of cockroach skin test positivity in male and female children,
rural and urban areas or infants under 2 years and olders. The age of youngest
subject with positive skin test for cockroach was 2 months. More over, the
parent`s levels of education and the types and ages of children`s residence had
no effects on the prevalence of cockroach skin test positivity. There was also
no significant correlation between total serum IgE and eosinophilia and the
prevalence of cockroach skin test positivity.
Conclusion: Cockroach is an important source of domestic infestations in the
city of Shiraz. Sensitization to cockroach allergens may develop early in life.
Skin test for cockroach allergen in children with infantile asthma may
provide useful information for institution of environmental controls.
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Relationship between sensitization and duration of asthma
associated with allergic rhinitis
Ion Gabriel Stoica. Spitalul de Pneumologie, Amabulatoriul TBC Sector 3,
Bucharest, Romania.
Objective: The aim of the study was to assess sensitization to common
inhalant allergens among adult patients with asthma associated with allergic
rhinitis (AR) and to find a relationship with the medication and the duration of
asthma/AR
Methods: A screening survey questionnaire including questions assessing
prevalence of symptoms of asthma over 12 months and questions relating
24 months prevalence of AR symptoms, were distributed to 763 of 16Y87 year
old (median age 46 yr) patients presented in the outpatients department during
of 1 years. The response rate was 83%. Asthmatic patients were diagnosed
according to the GINA definition of asthma. AR was diagnosed due to the
clinical symptoms (sneezing, itching, rhinorhoea, nasal congestion) and
sensitization to allergens.
Results: Hypersensitivity to inhalant allergens (house dust mite, animal dan-
der, pollen) was assessed by skin prick test (positive: 9 3 mm) in 32 responders
having a clinical history. 73% of patients with asthma and 64% with AR were
sensitized to house dust mites (D.pteronyssinus and D.farinae). Hypersensi-
tivity documented by positive skin prick test in patients with asthma and AR
was noted to pollen in 47% and 49%, to cat and dog dander in 27% and 11%,
respectively.
World Allergy Organization Journal & November 2007 Abstracts
* 2007 World Allergy Organization S169
Copyright @ 2007 World Allergy Organization. Unauthorized reproduction of this article is prohibited.
Conclusion: There was a significant correlation (r = 0.29, p G 0.05) between
frequency of sensitization to house dust mites and duration of asthma. The
house dust mite sensitivity is the most prevalent allergen sensitization in adult
patients with asthma and AR, establishing control of this allergen as critical for
optimizing their treatment.
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IL13 Haplotype and association with atopy
Svetlana Mazurina, Valery Kaznacheev, and Yuri Gervaziev. Mechnickov
Research Institute for Vaccines and Sera, RAMS, Moscow, Russian Federation.
Background: Bronchial asthma (BA) is a chronic disease associated with
elevated IgE levels. It was demonstrated that IL-13, as well as IL-4, plays a
crucial role in the regulation of IgE production. The aim of our study was to
reveal the association between C-1055T, Arg130Gln (G + 2044A) IL-13 gene
polymorphism and level of total IgE in BA patients.
Methods: The polymorphisms in IL-13 gene were analyzed by the PCR-RFLP
in 136 asthma patients and 64 healthy control subjects.
Results: Total IgE and IL-13 levels were measured by ELISA. The total serum
IgE level was found to be elevated in BA patients group: 290(47,5;495) *kU/L,
and within normal range in the control group: 25,5(19;100)kU/L. The levels of
total IgE in BA patients and healthy donors differ significantly, p G 0,001. The
frequency of alleles combination -j1055Tand + 2044A is 6.9% and reliably
is different from that in the control group (p = 0.008). Studying the influence
of the polymorphisms on the total IgE level we revealed that this level was
considerably elevated (up to 315(290;1077)kU/L) among the patients with -
1055T and +2044A alleles compared with a group who has allele +2044A and
j1055C, and the group who has allele +2044G and j1055C. Total IgE level
in this groups was 230(200;440)kU/L and 205(190;377)kU/L, respectively.
Patient with allelej1055T and +2044G were not identified. The link between
disease and studied traits (j1055T and +2044A) determined by the Wolf’s
coefficient of association , which was 0.9.
Conclusion: Thus in our study we revealed the association between C-1055T,
Arg130Gln IL13 gene polymorphism and total IgE levels and atopy.
*Data are presented as interquartile range: median (25% quartile; 75%
quartile).
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Asthma in the elderly in Korea: a comparison according to the
onset of asthma in the elderly
Deok-in Kim1, Hyouk-Soo Kwon2, Sang-Min Lee2, Sae-Hoon Kim2, Heung-
Woo Park2, Chang-Han Park2, Sun-Sin Kim2, Sang-Heon Cho2, Kyung-Up
Min2, and You-Young Kim2. 1Changwon Fatima Hospital, Department of
Internal Medicine, Changwon, Republic of Korea; 2Seoul National University
College of Medicine, Department of Internal Medicine, Seoul, Republic of
Korea.
Background: Despite its high prevalence, elderly asthma remains unrecog-
nized and misunderstood because its symptoms may not be typical as in young
patients. And because other cardiac or respiratory diseases may be frequently
associated. Only a few studies on the clinical characteristics of elderly asthma
have been reported till now.
Methods: To investigate whether the characteristics of elderly asthma were
different according to the onset of asthma, one hundred eighty asthmatic pa-
tients over the age of 65 were enrolled who attended the Asthma and Allergy
Clinic, Seoul National University Bundang Hospital.
Results: Of 180 patients, ninty nine patients have developed asthma over the
age of 65. This group with late-onset asthma (LOA) had a mean duration of
disease of 3.4 T 3.5 yr. The remaining groupwith early onset asthma (EOA) had
a mean duration of illness of 18.8 T 17.1 yr. These groups were indis-
tinguishable by the symptoms, themedication requirements and the serum level
of total IgE. These with EOA had a greater degree of airway obstruction in
FEV1 of predicted value (p G 0.028) and a greater likelihood of neutrophils in
induced sputum. Moreover, the novel indicator, namely, neutrophil/eosinophil
ratio of induced sputum was inversely related to several PFT indices, including
FEV1, FEV/FVC, FEF25-75%, and FEF25-75%/FVC. These findings suggest
not only eosionphil but also neutrophil could play an important role in the
airway inflammation and airflow limitation.
Conclusion: Our study sggested that cellular compositions of airway in-
flammation, and lung function depends on the onset and possibly duration of
disease in elderly asthmatics. These findings suggest that early onset and long-
standing asthma may lead to chronic persistent airway obstruction and thereby
mimic chronic obstructive lung disease.
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APAPARI: questionnaire based assessment of monitoring and
treatment of asthma by physicians in infants, preschool and
older children
Krishan Chugh. Sir Ganga Ram Hospital, Pediatrics, Delhi, India.
Background: The APAPARI questionnaire was designed to assess the treat-
ment patterns of childhood asthma in the Asia-Pacific region.
Methods: A total of 262 doctors treating asthmawere invited to respond to the
APAPARI questionnaire evaluating treatment patterns of childhood asthma.
Results: Of the 262 doctors, 80 completed the questionnaire while 2 did not
complete it as they did not treat children. 59 were pediatricians, 14 were
pediatric pulmonologists/ allergists, 2 were pulmonologists and 5 belonged to
other specialties. 37(45%) were in private practice or hospitals, 22(27%) were
in teaching hospitals while 23(28%) worked in other settings. Responses to the
use of symptom cards to monitor asthma were as follows:
TABLE 1 Characteristics of the Control and Patients With CPuse of symptom score card to monitor asthma number percentage (%)
never 28 42.0
seldom used 19 23.2
frequently used 21 25.6
always used 13 15.9
Responses for the criteria to monitor childhood asthma are tabulated
below:
For treating an acute attack, 62.8% used nebulised salbutamol/
terbutaline while 15.8% used inhaled salbutamol/terbutaline with spacer and
30.2% used oral corticosteroids. Criterion used for hospital admission in an
acute attack of asthma is given below:
Pulse oximetry as a basis for oxygen therapy was used by 31 (37.8%)
in all patients, 40 (48.8%) used oximetry only in severe asthma while 10
(12.1%) did not have pulse oximetry facilities. A favourable outcome was
reported by 31 (37.8%) doctors while 8 (9.75%) reported unfavorable results
in severe acute asthma with ventilatory support as compared to those treated at
a tertiary/university hospital. 36 (43.9%) did not have access to ventilatory/
ICU facilities to treat severe acute attacks. Maintenance therapy in asthmatic
infants was always used by 13 (15.8%), frequently used by 34 (41.4%), seldom
used by 25 (30.4%), while 8 (9.75%) never used it. Responses on the first
monitoring tool for childhood asthma number percentage (%)
only peak flow meter 33 40.2
peak flow meter and spirometry 24 29.3
neither of the two 24 29.3
critieria used for hospital admission number percentage (%)
used no criteria / asthma score 73 89.1
no improvement in sympton / signs 50 60.9
clinical judgement 48 58.5
peak flow meter reading 26 31.7
G 50% of best / predicted
desaturation (Sao2 G 90%) 48 58.9
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choice of maintenance therapy for asthma among infants, preschool and older
children were as follows:
58 of the 82 respondents (70.7%) knew but had never used any form of
immunotherapy, 11 (13.4%) occasionally used it while 9 out of 82 (10.9%)
had no knowledge regarding the availability of immunotherapy.
Conclusion: A significant segment of the doctors do not follow the current
management guidelines for childhood asthma.
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Expectancy of Bronchial Hyperreactivity (BHR) in children,
simply by the use of a short questionnaire
Anxhela Qirko Gurakuqi, and Sokol Agolli. UHC, Allergy Department,
Tirana, Albania.
Background: The provocation test for assesing BHR is time consuming and
sometimes impossible to be performed. Does our questionnaire offer an high
expectancy for BHR? Does this questionnaire has any practical value, to avoid
the provocation test in certain cases?
Methods: 200 children 9Y11 years old from Tirana performed bronchial
provocation test with 4.5% saline, according ISAAC protocol. These children
answered in the same day to our short and original questionnaire of 4 questions:
Have you ever had any shortness of breath or cough in these situations: 1-
During or after physical effort (gym hour, going up the stairs, etc) 2- In
exposure of tobacco smoke? 3- In exposure of car emanations, heating and
cooking gases? 4- By laughing loudly? Every positive answer was coded with
scores 1,2,3,or 4, with 0 score if no positive answer, and with 5 score if all
positive answers.
Results: Subjects with positive result of saline provocation (change of
FEV1 9 15% pre-post provocation) are divided according the scores 0,1, 2,
3, 4, or 5. The same is done for subjects with negative BHR. Not
surprisingly, 65% of subjects with negative result after saline provocation
had score 0, comparing to 10% of subjects with positive saline, also only
10% of subjects with negative saline resulted with score 5, when more than
50% of subjects positively reacting to saline provocation had score 5. When
the subjects with negative result to saline, regardless to result of score
questionnaire (nr = 183) are compared with the sub-category of subjects
which, beside the negative saline, had also score 5 (nr = 19), we found in the
last group a higher rate of personal and familiar history of asthma and
allergy. Sensibility, Specificity, Positive Predictive Value and Negative
Predictive Value of this questionnaire to forecast the BHR are calculated:
60%, 89%, 24% and 97% for the score 5 (presence of all symptoms) and for
score 0 (absence of all symptoms).
Conclusion: 1-This short questionnaire is able to forecast a negative BHR in
97% of cases, if all symptoms are missing (score 0). 2- Subjects with score 5,
regardless the provocation result, have an intriguing clinical profile, with
positive personal and familiar history for allergy, requiring more attention by
doctors and deeper investigations in the future. 3- By only asking 4 simple
questions, the time consuming bronchial provocation test could be avoided in
everyday medical practice most of the cases, if all the answers are negative.
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Use of asthma control test in clinical practice
Gabriella Galffy, Lilla Tamasi, Marta Orosz, and Gyorgy Losonczy.
Semmelweis University, Dept. of Pulmonology, Budapest, Hungary.
Introduction: The 2006 Global Initiative for Asthma (GINA) reports provide
a new asthma classification which is based not only on the severity but also on
the level of asthma control. Bronchial asthma is a word-wide problem, with an
estimated of 300 million affected individuals. There are more than 200,000
asthmatic patients in our country. Classification of asthma by severity is useful
when the doctor has made a decision about management and treatment of a
patient. The goal of asthma treatment is to achieve and maintain clinical
control. Asthma Control Test is one of a validated measurement to analyze the
controlled, partly controlled and uncontrolled levels of asthma.
Aim: The aim of the study was to investigate the level of asthma control in our
country.
Methods: In our outpatient clinic, we studied a group of 133 patients (female:
91, male: 42; mean age: 44y) with bronchial asthma. Asthma Control Test was
done by all patients and they also have an other eleven questions regarding
smoking habits, asthma medications, side effects, exacerbations, exercise
induced dyspnoe.
Results: Only 50% of our patients (n = 67 pts) had controlled and partly
controlled asthma level, an other 50% (n = 66 pts) had uncontrolled asthma
based on Asthma Control Test. The total control level has been achieved only
by 18% (n = 24 ) of our patients. There were unable to work and to have a job
the 16 % of the patients and 12% were not able to work even in their
household because of suffering asthma. Seventy eight % of patients have
reduced quality of life. However, 64% of our pts believed and felt they have
total asthma control and only 10% of pts subjective opinion were the
uncontrolled asthma.
Conclusion: In our study, we found that patient’s opinion about their own
condition of asthma did not correlate to an objective test. Asthma Control Test
show us the reality of the level of bronchial asthma. The test is very easy to use
even alone by the patient. The Asthma Control Test help to achieve and
maintain the clinically controlled asthma level.
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Obesity - a risk factor for asthma severity?
Nani Kavlashvili1, Maia Kherkheulidze1, Marina Lominadze2, Sofia
Broladze2, and Luiza Chilachava2. 1State Medical University, Departmet of
Pediatrics, Tbilisi, Georgia; 2M. Guramishvili Pediatric Clinic, Departmet of
Pediatrics, Tbilisi, Georgia.
: Recently obesity has reached epidemic proportions in many countries.
Evidence is now mounting that obesity is also a risk factor for asthma. The aim
of our study was to assess relation between obesity and asthma severity in
children. We conducted cross-sectional study in the out-patient department at
M. Guramishvili Pediatric Clinic in 2005Y2006yy. In the study were enrolled
63 children aged 12Y15 with a mean age of 13.75, 41 boys and 22 girls. We
used body mass index (BMI) to detect overweight and obesity. Weight
categories were defined by BMI number position on BMI-age growth chart -
risk of overweight - 85th to less than the 95th percentile, obesity - equal to or
greater than the 95th percentile. Asthma severity definition was based on
patients clinical and/or spirometeric parameters according to GINA guideline.
Children with a history of other lung disease were excluded. The prevalence of
obesity in our study population was 31.7%. Among girls 55% and among boys
only 19.5% were obese. Mean BMI of females with asthma were significantly
higher than males (p G 0.0001). The obese children had a difference in baseline
asthma classification (more likely to have persistent asthma). Despite similar
severity of illness at admission, they had a longer length of stay at hospital
(9.8 +/j 7.0 vs. 6.5 +/j 3.4 days, p G 0.01). We can conclude that there is
relationship between body weight and asthma severity and obesity may be a
potentially modifiable risk factor for asthma or asthma exacerbation.
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Overweight affects eotaxin levels in asthma patients
Algirda Krisiukeniene1, Agne Babusyte1, Sandra Ragaisiene1, Raimundas
Sakalauskas2, and Brigita Sitkauskiene2. 1Kaunas University of Medicine,
maintenance therapy infants: preschool: older children:
of choice n (%) n (%) n (%)
inhaled corticosteroids with 23 (28%) 30 (36.5%) 35 (42.6%)
long acting $2 agonists
inhaled long acting 8 (9.8%) 30 (36.5%) 12 (14.6%)
$2 agonists only
inhaled corticosteroids only 43 (52.4%) 40 (48.7%) 35 (42.6%)
did not use long acting
$2 agonists 52 (63.4%) 49 (59.8%) 52 (63.4%)
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Institute for Biomedical Research, Lab. of Pulmonology, Kaunas, Lithuania;
2Kaunas University of Medicine, Dpt. of Pulmonology and immunology,
Kaunas, Lithuania.
Background: Recent data from animal studies indicate that fat tissue is a
source of eotaxin, which may play an important role in asthma. However, the
link between obesity and airway inflammation in asthma is not well understood.
Objective: We aimed to investigate the impact of obesity on eotaxin levels in
patients with stable mild/moderate asthma.
Methods: 20 steroid-naive asthmatics (mean age: 57.2 T 2.2 yrs) and 9
control subjects without lung diseases (mean age: 59.4 T 9.7 yrs) were
investigated. According to the body mass index (BMI), subjects were divided
into the 2 groups: subjects with normal weight (BMI G 25kg/m2) and subjects
with overweight (BMI Q 25 kg/m2). Spirometry, bronchial provocation test
with methacholine (PD20), sputum induction and bronchoscopy were
performed. Eotaxin-1, -2, -3 concentrations in serum, sputum supernatant
and BAL fluid were measured using commercial ELISA kits.
Results: In asthma patients with overweight eotaxin-2 concentration in
induced sputum was significantly higher comparing to asthma patients with
normal weight (118.8 T 46.6 vs 20.1 T 9.3 pg/ml) and control subjects
(118.8 T 46.6 vs 16.7 T 7.2 pg/ml; p G 0.05). Whereas, eotaxin-1, eotaxin-3
did not significantly differ between studied groups, and there was no
correlations between eotaxin levels and number of eosinophils in induced
sputum and BAL fluid.
Conclusion: Elevated sputum eotaxin-2 concentration in asthmatics with
overweight let suggest, that increased body mass may upregulate inflammatory
markers in asthma patients.
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Assessment of quality of life in Iranian asthmatic children and
young adults and their caregivers
Fariborz Zandieh. Isfahan university of medical sciences, Asthma, Allergy
and Immuology, Isfahan, Islamic Republic of Iran.
Background: Interest in the impact of illness on day to day function is leading
investigators to include both disease specific and generic health related quality
of life (HR QOL) questionnaires in a broad range of clinical studies and to gain
a full picture of the impact of asthma on the lives of childrenwith this condition,
it is necessary to make direct measurement of health related quality of life.
Methods: In response to this need, we used the Juniper`s pediatric asthma
quality of life questionnaire (PAQLQ) and Juniper`s Pediatric Asthma
Caregiver`s Quality of Life Questionnaire (PACQLQ) that has been developed
based on guidelines for construction of over a dozen validated disease specific
quality of life instruments.
The PAQLQ consists of 23 items that in children with asthma have been
identified as troublesome in their daily lives and PACQLQ that contains
13 items in two domains of emotional and activities disturbances. The study
design consisted of an 18 month single cohort study. Patients participating in
the study were 113 children, 7Y17 years of age, with a wide range of asthma
severity and their caregivers. For each patient a PAQLQ and for each caregiver a
PACQLQ was completed. One week before visit patients recorded morning
peak flow rates, medication use and symptoms in a diary. After com-
plete physical examination, for determining of asthma severity, spirometry
was performed.
Results: The questionnaires after statically analysis showed good levels of both
longitudinal and cross sectional correlations with the conventional asthma
indices andwith general quality of life.We found that consistently QOL in boys
were more disturbed than females, a good relevancy between severity of asthma
and QOL scores and more disturbances of QOL in caregivers of male asthmatic
patients than caregivers of female asthmatic patients. We could not find any
significant relevancy between FEV1 percentage of predicted and overall scores
of QOL.
Conclusion: Smaller airways, and higher airway resistance and more activity
of males than females may explain why boys have more disturbed life style
than females.
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A Iranian asthmatic research
Shadan Pedram. Thehran University of Medical Science, Medical-Surgical-
Nursing, Thehran, Islamic Republic of Iran.
: Asthma and quality of life in iranian asthmatic patient asthma is a
chronic disease,that make many health problems in every where in the world.
The aspect of quality of life in iranian asthmatic patient are variable.
Objective: To determine factors influence to quality of life in patients with
asthma, who reffer to lung clinic of general hospital in tehran.
Methodology: This research is a descriptive study.the subjects consisted of
386 patients.samples selected by sample randomized.the method of collecting
data was by questionnaire.the data were collected in one stage and analyzed
with descriptive and inferential methods and spss soft ware.
Findings: The results showed that ,the quality of life inpatients from physical
aspect was inappropriateand, in social and economic aspects were rarely
appropriate. the most of patients from mental and sleep aspects were
inappropriate.
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Neither sex nor overweight are risk factors for having asthma
symptoms in adolescent population of Argentina
ATeijeiro1, RC Baena-Cagnani2, Maximiliano Gomez3, JS Croce4, R Saranz4,
MEZernotti5, VHCroce4, GWCanonica6, and CEBaena-Cagnani4. 1Paeditric
Hospital of Cordoba, Respiratory Departament, Cordoba, Argentina; 2Hos-
pital Paediatric, Respiratory Departament, Cordoba, Argentina;
3
San Ber-
nardo Hospital, Allergy and Inmunnolgy Departament, Salta, Argentina;
4Medical Faculty, Catholic University, Allergy and Clinical Inmunology
Department, Co´rdoba, Argentina; 5Allende Hospital, Otorrinologyst Depata-
ment, Co´rdoba, Argentina; 6University of Genoa, Dimi, Genova, Italy.
Background: A positive association between body mass index (BMI) and
asthma has been recently suggested; however, the sex-dependence of this
association remains controversial. The aim of the present study was to explore
the relationship between BMI and asthma, as well as its sex-dependence in
young adolescents.
Methods: Self-reported data obtained from the standardized International
Study of Asthma and Allergies in Childhood (ISAAC) Phase Three. Written
questionnaires of 5579 young adolescents aged 13Y14 years old from
randomly selected private and public schools in Salta and Cordoba (Argentina)
were used. The BMI for each individual was calculated; international cut-off
points for BMI for overweight and obesity by sex and age were used (Normal:
18 until 24.99 kg/m2, Overweight: 25 until 29.99 kg/m2 and Obesity 9 30 kg/
m2). Because of the very low prevalence of obesity (0.86 %), they were
included in the overweight group (4.6%). Each variable of the ecological
questionnaire considered as probable confounder was confronted in 2x2 tables
with having wheezed in the last 12 months(13,1%) and BMI, and those
variables found significantly associated were included in the final analysis. The
data were statistically analyzed by the chi-square test, P and odd ratios (OR,
95 % CI) in binary logistic regression.
Results: 51,4% of responders were male. Being a boy was associated with
overweight (OR 1,35. 95%CI 1,06-1,71; P 0,013), and exercising one or less/
week was associated with obesity (OR 2. 95%CI 1,07-3,70; P 0,025). After
adjusting for each one, both were significantly associated to an increased BMI
(P 0,02 and 0,01 respectively). Watching TVone or less hour/day was related
to have a lower BMI (OR 0,72. 95%CI 0,55-0,93; P 0.01). Exercising once or
less per week was the only factor associated to wheezing after adjusting for
BMI and sex (P 0.0001).
Conclusion: In our population, neither sex nor overweight were associated to
wheezing symptoms; however sex was significantly associated with over-
weight. Maybe the scarce obese population in our cities contributed to these
findings, however sedentary profile contributed to an increased BMI and to
wheezing symptoms also, as was expected.
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A three-year follow-up study of asthma, airway symptoms
and self-reported allergy among pilots and cabin crew at
commercial aircraft
Gunilla Wieslander1, Torsten Lindgren2, and Dan Norback2. 1Dep of Medical
Sciences, Occup and Env Med, Uppsala, Sweden; 2Department of Medical
Sciences, Occupational and Environmental Medicine, Uppsala, Sweden.
Background: Cabin air quality is important especially to employees with
sensitive airways. There are few studies on incidence of asthma and allergy in
pilots and cabin crew. The aim of the study was to study the relations between
occupational factors and personal factors (age, gender, atopy, smoking habits)
and incidence of asthma and allergy.
Methods: A standardized questionnaire (O¨rebro, MN040 NA) was answered
in 1997 by pilots (n = 577) and cabin attendants (n = 936). Three years later,
in 2000 the same questionnaire was sent to pilots (n = 436) and cabin
attendants (n = 698) on duty. The new onset of asthma and allergies (three year
incidence) were calculated by logistic regression related to personal factors
with logistic regression.
Results: The prevalences of airway symptoms and asthma were two to three
times lower in pilots than in cabin attendants. The three year incidence of
doctors diagnosed asthma was 1.2% among pilots, and 0.6% among cabin
attendants. The incidence of any airway symptom (wheeze, attacks of breath-
lessness) was 4.6% among pilots, and 12.5% among cabin attendants. The
incidence of chronic bronchitis (daily productive cough) was 1.1% among
pilots, and 3.5% among cabin attendants. Further, the incidence of pollen
allergy and furry pet allergy was 5.4%, and 1.6% respectively among pilots and
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5.7% and 2.4% respectively among cabin attendants. The incidence of food
allergy/ intolerance was 1.8% among pilots and 3.2% among cabin attendants.
The incidence of airway symptoms was lower in pilots (p G 0.05). The
incidence of doctors diagnosed asthma and food allergy was higher in atopics
(p G 0.01). Younger cabin crew and pursers had a higher incidence of pollen-/
furry pet allergy (p G 0.01). No relations was seen as to gender and own
tobacco smoking.
Conclusion: Age, atopy, and type of occupation was related to the incidence of
asthma and self-reported allergies. The incidence of doctors diagnosed asthma
among pilots (0.4%/year) was somewhat higher than expected. Airway
symptoms in genral were two to three times more common among cabin
attendants. The study started before the stop of smoking on intercontinal flights.
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Parietaria pollinosis (seasonal allergic rhinoconjuctivitis or/and
asthma) in Greece: an increasing problem during 20 years
(1987Y2006)
Christos Grigoreas, Dimitrios Vourdas, and Konstantinos Petalas. 251 Air
Force Hospital, Allergology Department, Athens, Greece.
Background: It is a well-known phenomenon that the prevalence of Seasonal
Allergic Rhinoconjunctivitis or / and Asthma (SAR/A) is increasing. But there
is little data about the changes in frequency of sensitization to pollens in new
patients with SAR/A during the time (years).
Objective: To determine the frequency of sensitization to three important
pollens (Grasses, Parietaria, Olive) in new patients with SAR/A, each year,
from 1987 to 2006(20 years) in Greece.
Methods: We have studied, each year (from 1987 to 2006), all new patients
with solely seasonal typical symptoms of rhinoconjuctivitis or/and asthma and
positive Skin Prick Tests (SPT`s) to Grasses, Parietaria and Olive (one or
more). SPT`s were considered as positive if the mean of diameters was at least
5-mm larger than the negative control. The proportion of men/women and the
mean age (years) in each year, from 1987 to 2006, were similar. For statistical
analysis we used the 2 for trend.
Results: Patients with SAR/A-positive SPT`s 2 for trend test Grasses
x2 = 28,83, p 9 0,05, Parietaria x2 = 63,78, p G 0,001, Olive x2 = 18,96,
p 9 0,05.
Conclusion: Our results indicate that Parietaria pollinosis is more and more
frequent, from 1987 to 2006, in Greece among patients with SAR/A. Parietaria
pollinosis appears to be an increasing problem during the last 20 years, in
Greece. This phenomenon may represent the influence of environmental
factors.
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Prevalence of asthma, rhinitis and eczema among Brazilian and
Japanese adolescents (AD) in the city of Sa˜o Paulo, Brazil
Ineˆs Camelo-Nunes1, Ricardo Yamada1, Luis Guilherme Pimentel1, Thales
Shibata1, Fla´vio Sano2, Dirceu Sole´1, and Charles Naspitz1. 1Federal
University of Sa˜o Paulo, Division of Allergy & Clinical Immunology, Sa˜o
Paulo, Brazil; 2Hospital Nipo-Brasileiro, Division of Pediatric Allergy, Sa˜o
Paulo, Brazil.
Objective: To evaluate the importance of the genetic background on the
prevalence of asthma (A), rhinoconjunctivitis (R) and atopic eczema (AE)
among AD born in Brazil and from different genetic backgrounds.
Methods: ISAAC´s written questionnaire was applied to two groups of 12Y15-
year-old AD of similar socioeconomic status living in the city of Sa˜o Paulo:
Brazilian (N = 381) and Japanese (third generation, born in Brazil, from
families without mixed marriages, N = 221). Affirmative response to BHave
had wheezing in the last year^ identified AD with A, to BNasal and ocular
symptoms in the last year^ those with R, and to BEczema in the last year
evidenced in flexural areas^ those with AE. Questions ^Speech problem in last
12 months during acute attack^, BNasal symptoms interfering with daily
activities^, and BKept awake at night by this itchy rash in the last 12 months^
characterized severity of A, R, and AE respectively.
Results: There were no differences according to gender in both groups except
for the prevalence of R that was higher among Brazilian females. The
prevalence of A (12.7% x 19.4%, p G 0.05) and the prevalence of R (10.4% x
24.4%, p G 0.05) were higher between Brazilian AD when compared to
Japanese AD, respectively. There were no difference in A severity (0% x 1.1%)
but R`s severity was significantly higher between Brazilian AD (10.4% x
24.4%, p G 0.05). The prevalence of AE was higher between Japanese AD
(7.7% x 3.1%, p G 0.05) but without differences in its severity (1.8% x 1.8%,
p 9 0.05). The prevalence of these diseases is not different from those
observed in Japan and in Sa˜o Paulo (ISAAC, phase 3).
Conclusion: The prevalence observed among the third generation of Japanese
AD without miscegenation born in Brazil, showed similar results to those
obtained in ISAAC phase 3 recently published in Japan. Considering that both
AD groups evaluated have been exposed to the same environment we might
speculate that the genetic background in this Japanese population is more
important than environmental influences on the development of asthma and
allergic diseases.
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Establishment of Cohort for Reality and Evolution of Adult
Asthma in Korea (COREA), a large multi-center long-term
cohort study of whole spectrum of asthma: Clinical
characteristics according to severity of asthma
Chan Sun Park, Tae-Bum Kim, Yun-Jeong Bae, You Sook Cho, and Hee-Bom
Moon. Clinical Research Center for Chronic Obstructive Airway Disease,
Asan Medical Center, University of Ulsan College of Medicine, Department
of Medicine, Seoul, Republic of Korea.
Background: Asthma is a chronic inflammatory disorder which has
widespread, variable airway obstruction and airway hyperresponsiveness
(AHR) leading to dyspnea, chest tightness, wheezing and cough. Because it
often presents heterogeneous features and various phenotypes according to its
severity, it is needed to find good predictable clinical factors concerning
severity. Also it cannot be discriminated from chronic obstructive pulmonary
Years Number Grasses(%) Parietaria(%) Olive(%)
1987 76 85.5 30.3 56.6
1988 141 68.8 34 60.3
1989 161 75.8 37.3 60.9
1990 148 63.5 39.9 52.7
1991 166 77.7 41.6 44
1992 205 69.3 50.7 57.1
1993 137 67.1 57.7 53.3
1994 173 64.7 58.4 54.9
1995 168 65.5 60.1 54.2
1996 217 68.2 56.2 40.1
1997 216 65.3 50.5 41.2
1998 189 70.4 51.8 40.7
1999 164 64 56.1 46.3
2000 182 60.4 59.3 52.2
2001 191 61.8 62.8 48.2
2002 238 61.3 60.5 50.8
2003 184 66.8 60.3 44.6
2004 147 63.3 64.4 42.9
2005 185 60.5 55.7 47
2006 178 55.6 55.1 43.3
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disease, many researchers used to recognize them as a spectrum of ’chronic
obstructive airway disorder’ (COAD). Accordingly, it is most important that
we can reveal prognostic factors influencing on natural course of asthma and
prohibit from progressing to severer and irreversibly uncontrolled asthma. It is
thought that this is possible only in case asthmatic patients should be observed
through long term follow up such as cohort study.
Objective: To define the important prognostic factors contributing to asthma
severity and suggest new clinical understanding and paradigm of COAD.
Methods: Researchers from 11 university hospital have established asthma
cohort named ’Cohort for Reality and Evolution of Adult Asthma in Korea’
(COREA) since year of 2005 in Korea, which will be continued up to 2013.We
have collected patients having chronic persistent respiratory symptoms such as
dyspnea, cough, sputumor wheezingmore than 3months and airflow limitation
by FEV1/FVC less than 0.7 or AHR confirmed by methacholine bronchial
provocation test (MBPT). As the first study of our cohort, we analyzed various
clinical factors influencing on the severity of asthma for registered 644 patients
at the time of first-visit. Severity was assessed by special allergists by the
definition of 2002 GINA guideline.
Results: Severity of asthma was associated with skin prick test positivity
(p G 0.006), history of hospital visit due to asthma exacerbation (p = 0.001),
symptom onset (p = 0.037) and duration of diagnosis (p = 0.041). Severity
alsowas significantly correlatedwith FVC, FEV1, and bronchodilator response
(all p G 0.001). However, smoking didn’t affect the severity of asthma, even in
case of passive smoking.
Conclusion: We suggest that history of hospital visit due to asthma
exacerbation may be an important clinical index reflecting severity of asthma.
Furthermore, it is expected that many valuable findings can be derived from
our cohort study
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Allergy in Latin America. A public health problem who’s time
has come
Franca Puccio1, Arnaldo Capriles2, Lisete Machado1, Maria E Ghezzi1, Luis
Sarmiento3, Elianska Lopez1, Maria C Di Prisco1, Domenico Cifarelli1, Frank
Blanco1, and Maria E Roque1. 1Instituto de Biomedicina, UCV, Inmunopa-
tologia, Caracas, Venezuela; 2Hospital San Juan de Dios, Alergia, Caracas,
Venezuela; 3Catedra de Inmunologia, UCV, Facultad de Medicina, Caracas,
Venezuela.
: In Venezuela, asthma causes more than one million crises per year, a
rather significant impact to the health system compared to USA reports. Our
demographics situation are similar to the rest of Latin America, with a young
and mostly urban population living under variable conditions of poverty;
application of massive vaccination programs and other public health measures
will ensue that non-communicable diseases occupy major roles in the near
future. For Venezuela ISAAC data shows an eighteen percent of wheezing in
the past year with an overall prevalence of thirty two percent is reported.
Methods: In order to explore such previous high prevalence, we carried out a
multidisciplinary and ongoing study (approved by the ethical committee of the
Institute of Biomedicine, ratified by the academic council of the medical
Faculty of Central University of Venezuela) in 1000 unselected school children,
6Y12 years old, from low to middle socioeconomic background covering
different areas from Caracas, Venezuela. After an informed consent was signed
from parents or guardians, all children from randomly selected schools were
evaluated with a validatedmodifiedGraffar‘s socioeconomic questionnaire and
an allergic rhinitis, asthma and atopic dermatitis validated questionnaire after
ARIA, GINA and Hannifin criteria; skin prick testing (ALK-ABELLO) for
common food and inhalant allergens plus total IgE (ELISA), complete blood
count (COULTER) and serial feces examination for ova and parasites were
performed in all children. Pre and post bronchodilator FEV1 and PEF
spirometric measurements values were obtained (MICROLOOP), and included
in data analysis.
Results: We found that 60% of the child evaluated had allergic rhinitis, 40%
had asthma, and 21.9% Atopic Dermatitis with or without other allergic
pathologies. We also found that 64.8% of the child evaluated had parasites and
41.1 had respiratory infectious disease associated.
Conclusion: Our data confirms the high prevalence of allergic diseases in
Venezuela employing questionnaires, a clinical exam and immune diagnostic
evaluationmethodology. Hence, our health system andmedical faculties should
be highly aware of these and similar findings for establish a proper education
programs, both at primary health care personnel and also in communities.
Developing nations are waiting for simpler but effective approaches in the
management of a public health problem who`s time has come.
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Validation of an instrument for epidemiologic studies of
recurrent wheezing in infants
Herberto Jose Chong Neto1, Nelson Rosario1, Ana Carolina Dela Bianca2,
Dirceu Sole´2, and Javier Mallol3. 1University of Parana, Pediatrics, Curitiba,
Brazil; 2University of Sao Paulo, Pediatrics, Sao Paulo, Brazil; 3University of
Santiago, Pediatrics, Santiago, Chile.
Background: Large international studies on asthma and allergies in childhood
have found notorious variation in prevalence and temporal trend among
countries. However, there is no international studies on the epidemiologic
characteristics of wheezing in the first year of life. The aim of this study is to
validate a questionnaire to assess the prevalence of recurrent wheezing infants.
Methods: This study was undertaken in pediatric emergency rooms (PER). A
randomized sample of parents visiting PER for lower respiratory illness,
answered a questionnaire on wheezing developed by the International Study of
Wheezing in Infants (EISL, from spanish Estudio Internacional de Sibilancias
en Lactantes). During visit, all infants were examined by one of the authors
(blind) who reported, or not, the presence of wheezing on chest auscultation.
Sensitivity, specificity, predictive positive value, predictive negative value and
concordance (0) level were calculated from parent and physician reports.
Results: Two hundred and nine infants aged 12 to 15 months participated in
the study. Fifty six parents reported current wheezing and 43 were confirmed
by physician; 153 parents did not report current wheezing and 146 had not
wheezes at physical examination (0 = 0,74, CI 95% 0,64 Y 0,85). This
questionnaire showed high sensitivity (86%), specificity (91,8%), positive
predictive value (76,8%) and predictive negative value (95,4%).
Conclusion: Regardless of previous experience with wheezing episodes,
parents can reliably inform when their infants are currently wheezing. A simple
and convenient questionnaire confirmed by physical examination produce an
accurate tool to asses the prevalence of asthma symptoms in infants.
World Allergy Organization Journal & November 2007 Abstracts
* 2007 World Allergy Organization S175
Copyright @ 2007 World Allergy Organization. Unauthorized reproduction of this article is prohibited.
551
Different seasonal (monthly) variation in asthma exacerbations
in patients with allergic and non allergic asthma
Christos Grigoreas, Dimitrios Vourdas, and Konstantinos Petalas. 251 Air
Force Hospital, Allergology Department, Athens, Greece.
Background: The recognition of clear seasonal (monthly) patterns of
Asthma Exacerbations (AE) in a particular area may allow preventive
strategies to be developed.
Objective: The aim of this study was to determine the seasonal (monthly)
variation in AE in patients with allergic and non-allergic asthma.
Methods: Data were obtained from our department in Athens, between
October 1986 and September 2006 (240 months). We evaluated all AE
occurring this period for patients with Allergic Asthma (AA) and Non-Allergic
Asthma (N-AA). The diagnosis and classification in AA and N-AAwere made
according to the results of skin prick testing (SPT) to common aeroallergens.
PatientswithAA defined as thosewith 9 1 positive SPTand patientswithN-AA
defined as those with negative SPT. A positive SPTwas defined as a wheal size
at least 3 mm greater than the negative control. AE were defined as a
deterioration in asthma resulting in an unscheduled visit (i.e patient-initiated)
leading to change in asthma treatment or the need for oral steroids for 93 days
and/or emergency room visit/hospitalization. Data are presented as monthly
averages of these years of combined data, as a percent above (+) or below (j)
the average monthly value (%) for the 240 months under study.
Results: Therewere 3.570AE (2.313 inmales, 1257 in females) in 2.345 patients
with AA (1.569males, 776 females). Also, there were 2.585 AE (1.335 in males,
1250 in females) in 1.518 patients with N-AA (736 males, 782 females).
Percent above or below an average monthly value (%).
Conclusion: These findings suggest that AE have a different clear seasonal
(monthly) variations between patients with AA and N-AA. Patients with AA
showed an increase in AE in April, May and June (spring and early summer).
Especially in May occurred a great increase (peak) in AE (+307,1). Patients
with N-AA had an increased AE from January until April (winter and spring)
and from September until November (autumn). These results may offer
significant opportunities for improved disease management.
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Seasonal (monthly) variation in asthma exacerbations in Greek














Christos Grigoreas, Dimitrios Vourdas, and Konstantinos Petalas. 251 Air
Force Hospital, Allergology Department, Athens, Greece.
Background: The recognition of clear seasonal (monthly) patterns of Asthma
Exacerbations (AE) in pediatric patients, in a particular area, may allow
preventive strategies to be developed.
Objective: The aim of this study was to determine the seasonal (monthly)
variation in AE in pediatric patients with weezing and/or asthma according
the age.
Methods: Data were obtained from our department in Athens, between
October 1986 and September 2006 (240 months). We evaluated all AE
occurring this period for pediatric patients 0Y4 years, 5Y9 years and 10Y14
years. AE were defined as a deterioration in wheezing/asthma resulting in an
unscheduled visit (i.e patient-initiated) leading to change in wheezing/asthma
treatment or the need for oral steroids for 9 3 days and/or emergency room
visit/hospitalization. Data are presented as monthly averages of these years of
combined data, as a percent above (+) or below (j) the average monthly value
(%) for the 240 months under study.
Results: There were 2.014 AE (1.285 in males, 729 in females) in 1.071
wheezer/asthmatic patients (658 males, 413 females). From 2.014 AE, 642
were identified in patients 0Y4 years, 854 in patients 5Y9 years and 518 in
patients 10Y14 years.
Percent above or below an average monthly value (%)
Conclusion: These findings suggest that AE have a different clear seasonal
(monthly) variation between the three age groups in pediatric patients.
Children under 5 years (0Y4 years) showed an increase in AE in March and
from September until December (autumn and early winter). Children 5Y9
years showed an increase in AE from February until May (late winter and
spring) and from September until November (autumn). The group of older
children (10Y14 years) had an increased AE in spring (March to May with a
peak in May +137,2%) and early summer (June) while in the rest of the
months only in September. This study suggests that difference in allergic
and environmental factors implicated in provoking AE in pediatric patients
and that clear seasonal (monthly) variations exist in AE which are specific
to age. These results may offer significant opportunities for improved
disease management.
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Seasonal (monthly) variation in asthma exacerbations in patients
allergic to pollens: the May epidemic of asthma in Greece
Months 0Y4 years 5Y9 years 10Y14 years
January j6.4 j15.5 j32.6
February j13.9 +4.2 j25.6
March +4.9 +2.8 +23.2
April j15.7 +22.5 +7
May j19.5 +35.2 +137.2
June j28.8 j16.9 +34.9
July j68.2 j33.8 j60.5
August j77.5 j74.6 j58.1
September +19.9 +15.5 +44.2
October +77.9 +39.4 j9.3
November +102.2 +33.8 j30.2
December +27.3 j9.9 j25.6
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Christos Grigoreas, Dimitrios Vourdas, and Konstantinos Petalas. 251 Air
Force Hospital, Allergology Department, Athens, Greece.
Background: The recognition of clear seasonal (monthly) patterns of Asthma
Exacerbations (AE), in a particular area, may allow preventive strategies to be
developed.
Objective: The aim of this study was to determine the seasonal (monthly)
variation in AE with allergy to pollens, in Greece.
Methods: Data were obtained from our department in Athens, between
October 1986 and September 2006 (240 months). We evaluated all AE
occurring this period for patients allergic only to pollens, according to the
results of skin prick testing. A positive SPTwas defined as a wheal size at least
3 mm greater than the negative control. AE were defined as a deterioration in
asthma resulting in an unscheduled visit (i.e patient-initiated) leading to
change in asthma treatment or the need for oral steroids for 93 days and/or
emergency room visit/hospitalization. Data are presented as monthly averages
of these years of combined data, as a percent above (+) or below (j) the
average monthly value (%) for the 240 months under study.
Results: There were 1.723 AE (1.099 in males, 624 in females) in 1.219
asthmatic patients (798 males, 421 females). From 1.723 AE, 218 were
identified in patients 0Y14 years, 615 in patients 15Y29 years, 600 in patients
30Y44 years and 290 in patients 945 years.
Conclusion: These findings suggest that AE in the Athens region have a
clear cut seasonal (monthly) variation in patients allergic to pollens. An
increase in AE occurred in three months (April, May, June) and a decrease in
the rest of the months. It is of great interest to note that especially in May
occurred a huge increase (peak) in AE (+476%) in patients allergic to
pollens (May epidemic). This study suggests that aeroallergens (pollens) can
exacerbate asthma, especially in May, in Greece and the results may offer
significant opportunities for improved disease management.
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Is there seasonal (monthly) variation in asthma exacerbations in
patients allergic to mites (D.Pteronyssinus, D.Farinae) in Greece?
Christos Grigoreas, Dimitrios Vourdas, and Konstantinos Petalas. 251 Air
Force Hospital, Allergology Department, Athens, Greece.
Background: The recognition of clear seasonal (monthly) patterns of Asthma
Exacerbations (AE), in a particular area, may allow preventive strategies to
be developed.
Objective: The aim of this study was to determine the seasonal (monthly)
variation in AE with allergy to mites (D. Pteronyssinus, D. Farinae), in Greece.
Methods: Data were obtained from our department in Athens, between
October 1986 and September 2006 (240 months). We evaluated all AE
occurring this period for patients allergic only to mites (D. Pteronyssinus, D.
Farinae), according to the results of skin prick testing. A positive SPT was
defined as a wheal size at least 3 mm greater than the negative control. AE
were defined as a deterioration in asthma resulting in an unscheduled visit (i.e
patient-initiated) leading to change in asthma treatment or the need for oral
steroids for 93 days and/or emergency room visit/hospitalization. Data are
presented as monthly averages of these years of combined data, as a percent
above (+) or below (j) the average monthly value (%) for the 240 months
under study.
Results: There were 590 AE (370 in males, 220 in females) in 342 asthmatic
patients (214 males, 128 females). From 590 AE, 193 were identified in
patients 0Y14 years, 231 in patients 15Y29 years, 116 in patients 30Y44 years
and 50 in patients 945 years.
Conclusion: These findings suggest that AE in the Athens region have a
seasonal (monthly) variation in patients allergic to mites (D. Pteronyssinus, D.
Farinae) in Greece. An increase in AE occurred in the spring months (March,
April, May) and the June (peak in the May +51%) and also in the autumn
months (September, October, November) with a peak in September (+49%). A
decrease in AE occurred in the rest of the months with a nadir in August
(j79,6%). Although AE may be triggered by a number of other factor (i.e
respiratory viral infections), this study suggests that asthmatic patients allergic
to mites represent a seasonal (monthly) variation in AE, in Greece. These
results may offer significant opportunities for improve disease management.
555
Epidemiology of bronchial asthma in Sverdlovsk region
Evgeniy Beltyukov1, A.Y. Petuchova2, M.L. Karakina3, and V.V. Naumova4.
1Urals State Medical Academy, Therapeutics Chair, Ekaterinburg, Russian
Federation; 2Central City Hospital 16, Pulmonology Department, Ekaterin-
burg, Russian Federation; 3Military Hospital, Allergology Department,
Ekaterinburg, Russian Federation; 4Sverdlovsk Regional Clinical Hospital
11, Therapeutics Department, Ekaterinburg, Russian Federation.
Background: The goal of the research was to study the prevalence of
bronchial asthma (BA) and bronchial asthma risk factors (RF) in Sverdlovsk
region.
Methods: The BA prevalence and RF were studied with the help of the
ECRHS questionnaire and the RF questionnaire, which were answered by the
rural and urban population in 2000 and 2006.
Results: It was found that the asthma prevalence rate in Ekaterinburg is 5,9%,
in villages - 3,6%. BA atopic form was 71% and 76% correspondingly. The
most spread asthma RF are: allergic rhinitis, a strain of asthma and allergy, bad
factors in production facilities, presence of cockroaches, birds and fish
aquariums in living apartments. In rural region the most spread asthma RF are:
allergic rhinitis, a strain of asthma and allergy, presence of fish aquariums in
living houses.
Months AE (number)
Percent above or below an
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Conclusion: In Sverdlovsk region BA is spread in the urban area wider than in
the rural region. The BA atopic form prevailes both in urban and rural areas. In
the city the important asthma RF are bad factors in production facilities and
presence of cockroaches and birds. Asthma RF common for urban and rural
areas are: allergic rhinitis, a strain of asthma and allergy, presence of fish
aquariums in living houses/ apartments.
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Outcome of childhood asthma in 205 asthmatic children
Mohammed Herrag, and Mustapha Iraqui. Ibn Sina University Hospital,
Pulmonology- Allergology, Rabat, Morocco.
The aim of this study was to investigate the outcome of childhood in
asthma. 205 asthmatic children aged 2 to 14 years seen between the years
1990Y91 were followed prospectively till 2005. The severity of asthma was
classified: mild, moderate or severe. The severity was evaluated every three
years by changes in respiratory symptoms and spirometry. Initially 32p.100
of children have mild asthma, 25p.100 moderate asthma and 43p.100 ware
considered as severe asthma. 67p.100 of children who had initially mild
asthma have the same severity ten years later, 21p.100 have moderate asthma
and 2p.100 have severe asthma. 70p.100 of children who had mild asthma
did have mild asthma ten years later. 60p.100 of children who had severe
asthma are considered severe ten years later. The final prognosis was
influenced by the initial severity of the asthma and presence of associated
atopic disease.
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Effects of nitric oxide synthase inhibitors on airway
hyperresponsiveness and inflammation in a murine
asthma model
Jin Young Lee1, Mi Jung Oh2, Jae Won Paeng3, Byung Jae Lee1, and Dong
Chull Choi1. 1Samsung Medical Center, Departments of Medicine, Seoul,
Republic of Korea; 2Bundang Jesaeng Hospital, Department of Medicine,
Seongnam, Republic of Korea; 3Samsung Biomedical Research Institute,
Division of Allergy, Seoul, Republic of Korea.
Introduction: Excessive airway production of nitric oxide (NO) has been
suggested to play a role in bronchial asthma. It is still not clear which iNOS
isoform is involved in eosinophilic airway inflammation.
Objective: A selective Inducible nitric oxide synthase (iNOS) inhibitor
1400W (N-3-(aminomethyl) benzyl) acetamidine) or a nonselective NOS
inhibitor L-NAME (N-nitro-L-arginine methyl ester) have been tested in a
murine acute asthma model.
Methods: Six week-old female BALB/c mice were sensitized and exposed to
aerosolized ovalbumin (OVA). BALB/c mice (each group, n = 4) were treated
with indicated dose of 1400W (2 mg/kg, 4 mg/kg, 8 mg/kg, intraperitoneal) or
L-NAME (10mg/kg, intraperitoneal) for five times before allergen challenge.
Methacholine bronchoprovocation test and bronchoalveolar lavage (BAL)
fluid analyses were performed.
Results: Airway inflammation was decreased only in 1400W- treated groups.
BAL fluid total cell counts (positive control 428 x 103/2l, 2 mg/kg 273x103/2l,
4 mg/kg 210x103 /2l, 8 mg/kg 154 x 103/2l, each p = 0.012, p G 0.001
p G 0.001) and eosinophil counts (positive control 318x103 /2l, 2 mg/kg 150 x
103/2l, 4 mg/kg 142x103/2l, 8 mg/kg 105x103/2l, each p = 0.016, p = 0.009,
p = 0.003) were decreased in 1400W- treated groups compared with positive
control group. But there were no significant differences in airway
hyperresponsiveness (Log PC200 p=0.719) regardless of treatment.
Conclusion: The results demonstrate that a selective iNOS inhibitor 1400W is
effective in improving the airways inflammations through reducing total
inflammatory cell counts in the OVA-sensitized BALB/c mice.
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Relationship with respiratory function tests and psychological
and somatic status in females with bronchial asthma
Levan Bolokadze, Inga Fedotova, and Volodimir Fedotov. Kharkov
Allergological Centre, Allergology, Kharkov, Ukraine.
Background: To assess the relationship among the sexual, psychological,
hormonal, and physical status of women with bronchial asthma (BA).
Methods: Twenty-nine women with BA and 18 healthy women as the control
group were enrolled in the study. The patients were asked to complete the
Female Sexual Function Index, General Health Questionnaire, and Medical
Outcomes Study Short Form 36-item Health Survey (SF-36). The mental and
physical component summary scores were calculated using the answers on the
SF-36. The same questionnaires were given to this group as well. Statistical
analysis was performed using the Mann-Whitney U test and Pearson
correlation tests.
Results: Statistically significant differences were observed for all question-
naire scores (P G0.01). The most common female sexual dysfunction was
diminished arousal (n = 21, 72.41%) in women with BA. In the correlation
analysis, the total Female Sexual Function Index score had a statistically
significant and positive correlation with the mental component summary score
(r = 0.517, P = 0.001) and a negative correlation with the General Health
Questionnaire score (r = j0.368, P = 0.01).
Conclusion: The results of our study have shown that bronchial asthma
can be a cause of female sexual dysfunction with mental and psychiatric
mechanisms.
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Oxide stress index and psychosomatic characteristics in children
with Bronchial Asthma
Ekaterine Karseladze1, Maia Davituri2, Rusudan Karseladze3, and Tinatin
Bigvava4. 1Tbilisi State University, Stomatology Department, Tbilisi,
Georgia; 2Tbilisi Children’s Hospital #1, Allergology Department, Tbilisi,
Georgia; 3Tbilisi State University, Pediatric Department, Tbilisi, Georgia;
4Institute of Pediatrics, Neonatology Department, Tbilisi, Georgia.
In the difficult pathogenesis of Bronchial Asthma is important nerve
inflammatory mechanism and unbalance of the various group of autonomic
nervous system. The process made by bronchial asthma cause lipid phase
cell membrane changes. The importance is the oxidation process
reinforcement and to development an antioxidant syndrome.
The study aimed to asses the last product of lipid peroxide oxidation
(LPO) - enzyms: Malon Dealdehyde (MDA), ceruloplasmin (CP) and
superoxidismutas (SOD) and the function of autonomic nervous system. The
situation and personal nervous status were fulfilling the diagnosis tests of C.
Spilberg, the emotional status were studied with Lusher`s color test. The
investigation of some index of oxidation stress and psychosomatic character-
istics in children with bronchial asthma. 90 patient (median age of patients was
7Y15 years) with bronchial asthma and practically, 100 healthy children were
investigated. The mathematical treatment of dates had made with program
package SPSS,v.12.
Results: In the blood serum of the patients the contemt of mda was 63% high
than in control group. (pG 0,05). Mda level in the patient with eytonic type of
vegetative regulation was lower than in vagotonyc patients (pG0.05).
Especially important was the coefficient dates. LPO product quantity in the
patients with 0,05). AtGvagotonyc tape is straight contact with emotional
stress (r=0,63; p the end of the study was carried out, that bronchial asthma is
conducted the high level of LPO products in blood serum. The LPO activate
has shown at almost everytime Y from 1 to 5 year and more. Results of the
investigation show us the LPO prosess activateing at the time of bronchial
asthma. It`s established the coordibation of the LPO level in the blood serum
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and the severity of disease of the patients with bronchial asthma, which
confirmed the antioxidant decrease in the patients. Low antioxide guard in the
patients with eytonic type of vegetatic regulation give us a chance to seperate
them as biochemical ?nontrustworthy X lipid peroxide oxidative system.
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Relation of BCG-Scar diameter and asthma in children
Soheila Alyasin1, and Reza Amin2. 1Nemazee Hospital, Pediatrics -Allergy
and Clinical Immunology, Shiraz, Islamic Republic of Iran; 2Nemazee
Hospital, Pediatric-Allergy & Clinical Immunology Research Lab, Shiraz,
Lao Peoples Democratic Republic.
There are conflicting ideas about the inverse relationship between
delayed type hypersensitivity reaction of BCG and atopic state. Stronger
response to PPD test as an indicator of more potent TH1 response is supposed
to influence TH2-modulated allergic reactions, but it is still doubtful whether
scar of BCG vaccine can also be supposed as an indicator of TH1-immune
response or not. In our previous study PPD test response was significantly
smaller in asthmatic patients, now in this study relationship between BCG scar
and asthma is investigated.
Methods: 100 patients younger than 5 years old, vaccinated at birth, with
variable severity of asthma were compared to the same number of age-
adjusted healthy control group in a case-control study. Mean of vertical and
longitudinal diameter was determined. At the same time, the severity of
asthma in the case group was evaluated (according to classification of
national institutes of health, national institutes of heart lung and blood), by
asking mothers about the frequencies of night and day symptoms or
intervals of attacks. The patients were divided to three groups: Mild,
Moderate and Severe groups (Mild intermittent and mild persistent groups
were classified as one group).
Results: In 97 case group the mean size of BCG scar was 4.93mm
+_1.89mm, again in 97 control group the mean size was 4.94mm +
_1.46mm (P = 0.949).
Conclusion: Against the result of our previous research which showed a
significant reverse relation between PPD-skin test response and asthma, but no
significant relation was found between BCG scar and asthma, this may
indicates that BCG-scar is not a good indicator of TH1 response and is
probably related to other mechanism such as wound healing.
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Asthma control test (ACT), FeNO and FEV1 correlation in
asthma control
Bilun Gemicioglu, Imran Ozdemir, and Bilge Ozgur Yuksel. Istanbul
University, Faculty of Medicine Cerrahpasa, Department of Pulmonary
Diseases, Istanbul, Turkey.
Backround: The ACT is a validated, 5-item questionnaire with a total
score ranging from 5 (poor control) to 25 (total control) (Nathan RA et al,
JACI 2004).
Aim: The correlations of ACT, FeNO and FEV1 were evaluated in not well
controlled asthma patients for a three month follow-up period.
Methods: ACT, FeNO and FEV1 are measured in 77 female and 20 male
persistent asthma patients followed in outpatient clinics of asthma. In 32 of
them with ACTG20 and/or FeNO 925ppb and/or FEV1G80% add-on therapy
were given and after 3 months, all parameters were remeasured. The corre-
lation of those parameters before and after add-on therapy were evaluated.
Results: Mean ACT scores, FeNO and FEV1 before (period 1) and after
(period 2) add-on therapy of 23 female and 9 male asthma patients with a
mean age of 40,1T13,3 are in the table. In 16 (50%) of the patients all three
parameters, in 6 (19%) FeNO and ACT, in 3 (9%) only FeNO, in other 3
(9%) ACT are under normal values. In the remaining 4 patients comorbid
diseases are found as the reason of uncontrolled asthma.
As a result; increases in all three parameters are significantly well
correlated.
Conclusion: We conclude that because these three parameters are well corre-
lated with each other, ACT by itself may be sufficient to observe the patients
alone although it would be best to measure all 3 parameters if they are available.
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Global approach to the psychological aspects of the child
with asthma
Anselmo Sanchez Palacios. Hospital Universitary Insular of Gran Canaria,
Allergology Unit, Las Palmas GC - Canary Islands, Spain.
Background: Although a significant incidence of various psychological
variables has been recognized for a long time in asthmatic children, its true role
is the subject of strong controversies. Stress, suggestion and external
conditioning can affect the respiratory tract. The chronic aspect of the disease,
its disruptive effects on the quality of life and the sensation of threat to their
life, can condition the appearance of different psychosocial alterations in the
patient, or in their immediate family environment. Experimental tests have
shown that the severity of the disease, multiple hospitalizations and the
absence of specific IgE mediated symptoms, upon exposure to allergens, could
contribute to increased emotional disorders in children.
Objective: To search for an efficient intervention procedure which includes
the improvement of these children in school and personal, familial and social
adaptation, and to help them modify their inadequate attributions and attitudes
towards their disease.
Materials and Methods: This was a random stratified prospective study
including a population of 168 pediatric patients with ages comprised between
9 and 11 years of age (100 boys and 68 girls); 74 had asthma, 56 rhinitis and 38
asthma and rhinitis. Patients were divided into active and control groups. The
following tests were used: multifactorial autoevaluation test for infantile
adaptation (TAMA), questionnaire for attributions and attitudes toward the
disease (ATAC), and a questionnaire for the evaluation of the physical aspects
of the disease (EVEO). The program applied to the case group consisted of an
emotional/instructive program (PIE_ASA).
Results: The psychotherapeutic approach to the treatment of these asthmatic
children using the program PIE_ASA achieved a global improvement of the
children, fulfilling the objectives of the program. The modification of the
negative attributions and attitudes towards their disease was accomplished. No
changes in other attitudes such as increase food intake and compliance with
medication were obtained. Better results were obtained in boys than in girls,
regarding social and school adaptation aspects. However, girls showed a
reduction in the number of emergency room visits.
Conclusion: We believe that the use of this type of evaluation en asthmatic
children is recommended, since it contributes to an overall improvement in the
asthmatic symptoms of children.
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Autoimmunte uveitis, 16 years experience (1988-2004) at
Instituto nacional de pediatria in Mexico city
Mario Rafael Duarte-Abdala
Introduction: Autoimmune ocular diseases can be divided in two categories:
ACT scores FeNO (ppb) FEV1
Period 1 18,9T5,3 32,1T17,8 80,3T17,6
Period 2 20,6T3,6 23,4T13,4 81,9T16,8
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external diseases that affect to the cornea and the conjunctiva and internal
disease that is denominated uveitis. The term Buveitis[ encompasses a wide
range of intraocular inflammatory disorders primarily or secondarily involving
iris, ciliary body or choroids. Later this term was used to describe any
intraocular inflammation that affects the uvea, retina, sclera and vitreous humor.
There are few reports of the disease in latin children.
Materials and Methods: The records of 59 patients with the diagnosis of
uveitis, younger than 18 years treated in the service of Immunology at the
Instituto Nacional de Pediatria in Mexico City from 1988 to 2004 were
reviewed retrospectively.
Results: Among 59 childrenwith uveitis 37 (62.7%)were boys and 22 (37.3%)
were girls. Mean age was 8,7 years (standard deviation, 3.8, range 2Y17). Most
frequent affected site was anterior uveitis in 19 (32.2%) patients, intermediate
uveitis in 18 (30.5%), panuveitis in 15 (25.4%) and posterior uveitis in 7
(11.9%) patients. The process was bilateral in 36 (61%), Unilateral right eye
affection was established in 13 (22%) patients, and unilateral left eye affection
in 10 (17%) patients. Familiar history was present in 4 (6.8%). Uveitis was
associated with systemic disease in 18 (30.5%), non-associated with systemic
disease in 4 patients (6.8%). Systemic diseases were juvenile chronic arthritis
in 9 (15.3%), spondylitis in 3 (5.1%), Vogt Kayanagi Harada disease, nodosa
poliarteritis, Wegener granulomatosis, sarcoidosis in 1(1.7%). Infectious
etiology agent was identified in 4(6.8%) patients. Clinical signs described
were diminution of the visual sharpness in 42 (71.2%), ocular pain in 11
(18.6%), fotofobia in 13 (22%), red eye in 28 (47.5%). We found antibodies
antinuclear positive in 17 patients, but with weak pattern. Immunosupresor
treatment used was cyclophosphamide in 50 patients, azatyoprin in 8 patients;
methotrexate was used in 11 children. Complications included synechias in 8,
cataracts and keratopathy in 6 patients. 11 patients left the treatment (18.6%).
Conculsion: The clinical and demographic characteristics of the presenta-
tion of this disease in latin children in a hospital of third referral hospital
are described.
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Respiratory allergic diseases: Italian monitoring study of GINA
and ARIA guidelines (ARGA)
S Maio, S Baldacci, M Borbotti, A Angino, F Martini, B Piegaia, P Silvi,
M Simoni, F Di Pede, and G Viegi. CNR Institute of Clinical Physiology,
Pulmonary Environmental Epidemiology Unit, Pisa, Italy.
Background: Asthma is a chronic inflammatory airway disease closely
associated with atopic diseases like allergic rhinitis. Both diseases are
increasing to epidemic proportion, with increasing medical costs, with a
reduced patients’ quality of life (QoL) and lower productivity.
The correct management of asthmatic and rhinitic patients would be
ensured by the use of international World Health Organization (WHO)
guidelines as GINA (Global Initiative for Asthma) and ARIA (Allergic
Rhinitis and its Impact on Asthma). Many studies prove that the guidelines
recommendations are not or only partially applied within the clinical practice.
Objective: To evaluate the applicability of the GINA and ARIA guidelines
and their impact on patients_ QoL in General Practice; to evaluate the short
and long term efficacy of a Continuing Medical Education (CME) intervention
for General Practitioners (GPs) in Italy.
Methods: Prospective observational study in different Italian areas (North,
Centre, South-Islands). 168 GPs (71 attended an educational intervention and
97 didn_t attend it) will enrol their patients with diagnosis of asthma/rhinitis
and with prescription of anti-asthmatic or anti-rhinitic drugs or asthmatic/
rhinitic-like symptoms in the previous 12 months.
The GPs and their patients will fill in a questionnaire about respiratory
allergic diseases and adverse drug events. The patient will fill in also the
Rhinasthma questionnaire about the QoL and the Asthma Control Test. A
follow-up will be done after 12 months.
Expected Results: 1. epidemiological data on asthma and rhinitis burden;
2. evaluation of applicability, utility and adherence to GINA and ARIA
guidelines by GPs and patients; 3. short term and long term efficacy of a CME
intervention; 4. evaluation of prescriptions appropriateness and treatment
cost/efficacy ratio.
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Respiratory and psychiatric comorbidity in an Italian primary
care population: *EPIDEA study
S Baldacci1, M Borbotti1, S Maio1, A Angino1, F Martino1, F Di Pede1,
M Balestrieri2, A Bellomo2, M Nardini2, and G Viegi1. 1CNR Institute of
Clinical Physiology, Pulmonary Environmental Epidemiology Unit, Pisa,
Italy; 2of Epidemiologic Research in Primary Care - EPIMED, -, Pisa, Italy.
Aim: To evaluate the relationship between psychiatric disorders and
respiratory diseases (chronic obstructive pulmonary diseases (COPD) and
asthma) in an Italian primary care population.
Methods: Cross-sectional survey carried out in 6 Italian geographical areas.
2083 subjects (68.1% of expected sample, mean age 44+13 yrs), randomly
selected by 143 (70.1%) general practitioners, participated in the study. Each
subject answered to a physician-administered interview, based on the
standardized National Research Council questionnaire, for the detection of
psychiatric disturbances, respiratory diseases and symptoms, relative risk
factors and pharmacological treatments, and filled out the General Health
Questionnaire (GHQ).
Results: Prevalence of current and lifetime psychiatric disturbances (affective
disorders and anxiety) were 27.5 and 46.0%, respectively. COPD and asthma
were significantly associated with the presence of anxiety alone and, above all,
with the co-presence of anxiety and depression.
By logistic regression models adjusted for independent effects of age,
area, smoking, education, working position, GHQ score, and sex, COPD
resulted associated with anxiety and depression in combination (OR: 2.8, CI:
1.8Y4.6) and with anxiety alone (OR: 2.6, CI: 1.7Y4.1). Asthma was also
associated with co-presence of anxiety and depression (OR: 2.2, CI: 1.3Y3.8)
and with anxiety alone (OR: 2.1, CI 1.2Y3.5).
Conclusion: EPIDEA study confirms the large diffusion of psychiatric
disorders in an Italian primary care population. The association between
respiratory diseases and affective and anxiety disorders suggests to take into




Exercise-induced anaphylaxis related to Cannabis sativa
smoke exposure
Jose´ Antonio Navarro1, Olga Villarreal2, Natividad Longo3, Alejandro Joral1,
Jose Francisco Garmendia1, Susana Lizarza1, and Ascension Aranzabal4.
1Hospital Donostia, Allergy Section, San Sebastian, Spain; 2Hospital de
Mendaro, Allergy Unit, Mendaro, Spain; 3Hospital de Santiago, Servicio de
Alergia e Inmunologia, Vitoria, Spain; 4Hospital de Zumarraga, Allergy Unit,
Zumarraga, Spain.
Background: Exercise-induced anaphylaxis is a life-threatening condition
that can be food-dependent (specific or non-specific) and drug-dependent;
sometimes the only trigger is exercise. We report here a case in which the
trigger of the episode was the previous smoking of marijuana (Cannabis
sativa) cigarettes.
The patient, a 23 years-old-man, had previosly been diagnosed of
cereal-dependent, exercise-induced anaphylaxis. In spite of strict avoidance
of these foods, he had recurrent episodes of anaphylaxis during exercise
(jogging). When he was reevaluated he recognized he used to smoke
marijuana cigarettes very often, sometimes before exercise. 2 years before
this evaluation he begun presenting sudden onset rhinoconjuctivitis each
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time he smoked a marijuana cigarette. He gave up marijuana smoking; since
then he hasna´t had any other anaphylactic reactions. He has been jogging,
eating cereals before exercising, without any problem for more than one year.
Methods: Skin tests (prick-prick test) with fresh Cannabis sativa leaves, skin
tests to a leave extract, IgE immunoblotting to aCannabis sativa leaves extract.
Results: Skin tests were positive, while they were negative in 10 controls On
the immunoblotting, the patient’s IgE recognized a 35 KD band.
Conclusion: We report here the first case of exercise-induced anaphylaxis in
which the trigger is the inhalation of Cannabis sativa smoke. The skin tests
and in vitro results, as well as the clinical picture and evolution after smoke
cessation are consistent with a BCannabis sativa smoke dependent, exercise-
induced anaphylaxis[, in a patient that also has a IgE mediated immediate
rhinoconjuctivitis due to marijuana smoking. The mechanisms of the
anaphylactic reaction are obscure; there are a few previous reports that
confirm that Cannabis sativa smoking can cause immediate hypersensitivity
symptoms, like bronchospasm, rhinoconjuctivitis or generalized itching in
sensitized individuals, but to our knowledge there are no previous reports of an
exercise-induced reaction that appears to be dependent on marijuana smoking.
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The usefulness of serum tryptase in the diagnosis of shrimp
anaphylaxis in children
Patcharaporn Wongkaewpothong, Punchama Pajarn, Chaweewan Sripramong,
Siriporn Boonchoo, Nualanong Visitsunthorn, Pakit Vichyanond, and Orathai
Jirapongsananuruk. Siriraj Hospital, Allergy and Immunology of Pediatrics
Department, Bangkok, Thailand.
Background: Anaphylaxis is a life-threatening allergic reaction, and foods are
one of the most common culprits. Serum tryptase is marker of mast cell
activation and could use to confirm anaphylaxis to shrimp.
Objective: To determine the utility of serum tryptase in the diagnosis of
shrimp-induced anaphylaxis.
Methods: Twenty-one patients with previous allergic reaction from shrimp
were recruited into a prospective study for shrimp challenge. Twelve patients
developed mild allergic reaction and nine patients developed anaphylaxis.
Serum tryptase were obtained before shrimp challenge and 1 hour after the
onset of symptoms.
Results: In both groups of patients, median tryptase levels were significantly
elevated after the onset of shrimp challenge as compared to baselines (baseline
tryptase - 1.08, peak tryptase - 2.33 2g/L in anaphylaxis group; baseline
tryptase -1.49, peak tryptase 1.56 2g/L in non-anaphylaxis group, p G 0.05).
The delta tryptase (peak minus baseline) values in the anaphylaxis group was
significantly higher than non-anaphylaxis group (1.33 VS 0.125 2g/L, p =
0.0004). The tryptase ratio (peak divided by baseline) values in the anaphylaxis
group was also significantly higher than non-anaphylaxis group (2.11 VS
1.055, p = 0.0001). Using the recommended cut-off range (peak tryptase G
12.0 2g/L) the sensitivity of such cut-off was 0.11 with specificity of 1.0.
Conclusion: We recommend using serial tryptase values, including tryptase
ratio and/or delta tryptase values, for the diagnosis of food-induced
anaphylaxis. The latter two values may be helpful than peak serum tryptase.
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Anaphylaxis to peach
Suleiman Eisa Al-Hammadi. UAE University, Pediatric, Al-Ain, United
Arab Emirates.
Food is considered the most common cause of anaphylaxis in children.
The common cause of food allergy and anaphylaxis are cow’s milk, hen’s egg
white, wheat, peanut, tree nuts, fish, shellfish and soya. Fresh fruits is also
common especially peach (prunus persica).
Case: 8 years old boy presented to emergency room with generalized itchy
erythematous skin rash all over the body after 30 min. of eating peach. There
was no history of having medication, new food or an insect bite. There were no
history of shortness of breath, wheezing, stridor, abdominal pain, vomitting,
swelling of tongue or mucus membrane or loss of consciousness. the was
significant hypotension noticed during obtaining the vital signs as low as 92/27
mmHg, lasted for about 24 hrs instead of 2 appropriate doses og adrenaline
injections, chlorpheneramine maleate IV and intravenous fluids.
Other history: No atopic dermatitis, allergic rhinitis, asthma. Breast-feded for
2 years and recieved goat milk as a child, mother had allergic rhinitis, father
and other 5 siblings are healthy.
This child continue to have oral allergy symptoms to accidental peach
ingestion in small amounts after the anaphylaxis incident, but never
anaphylaxis again to peach or other fruits or highly allergenic foods.
Conclusion: Rosaceae fruit allergy (typically peach) is a true fruit allergy. The
spectrum of symptoms range from oral allergy syndrome to rarely anaphylaxis
case, as in our patient. Anaphylaxis can be the initial presentation of fresh fruit
allergy even if it was consumed before. Avoidance and epinephrine auto-
injectors can be an appropriate management.
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Epidemiology of Anaphylaxis among children and adolescents
in Korea
Dae Hyun Lim1, Joo Hee Chang1, Jeong Hee Kim1, Byong Kwan Son1,
Young Yoo2, Yong Mean Park3, So Yeon Lee4, and Man Yong Han5. 1Inha
University Hospital, Pediatrics, Incheon, Republic of Korea; 2KoreaUniversity
Hospital, Pediatrics, Seoul, Republic of Korea; 3Konkun University Hospital,
Pediatrics, Seoul, Republic of Korea; 4Hangan Sacred Heart Hospital,
Pediatrics, Seoul, Republic of Korea; 5Bundang Cha Hospital, Pediatrics,
Sungnam, Republic of Korea.
Background: There was little information studied about the epidemiology of
anaphylaxis among children and adolescents in Korea until now. We identified
the epidemiology of anaphylaxis in Korea and established the on-line
registration of anaphylactic cases through the official internet site of Korean
Academy of Pediatric Allergy and Respiratory Disease (KAPARD).
Methods: We used the sample data from two sources. One from the National
Health Insurance Review Agency (NHIRA), and the other from the question-
naire by the pediatric allergy specialists in the university hospitals, all from the
KAPARD. The data from theNHIRAwas based on the diagnosis codes, specific
for anaphylaxis and other related diagnoses between 2001 and 2005.
Results: According to the data from NHIRA, the incidence of anaphylaxis was
0.8Y2.9 episodes per 100,000 person-years. There was no increase in incidence
between 2001Y2005.0The causes of anaphylaxis were identified as 45% for
unknown cause, 25% for insect, 15% for food, 10% for drug, 1% for serum.
According to the questionnaire from KAPARD, we identified 88 episodes of
anaphylaxis.Thecausesof anaphylaxiswere identifiedas40%for food,20%fordrug,
food and exercise for 5%, exercise for 1%, bathing for 4%, bee sting for 1%, unknown
for 17%. We could not identifty the incidence and the increase of anaphylaxis.
Conclusion: Further research and more reliable databases are necessary to
establish the epidemiology of anaphylaxis in Korea. We also encourage the
registration of anaphylaxis for pediatricians in the future.
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Wheat-dependent, exercise-induced anaphylaxis: A report of
5 cases among Thai children
Punchama Pacharn, Orathai Jirapongsananurak, Pakit Vichyanond, and
Nualanong Visitsunthorn. Siriraj Hospital, Pediatrics, Bangkok, Thailand.
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Background: Wheat is not an uncommon cause of food-dependent, exercise-
induced anaphylaxis. The aim of this study was to describe common clinical
characteristics, laboratory manifestations and natural history of the disease.
Methods: Children with history of wheat-dependent, exercise-induced
anaphylaxis were identified. Skin prick test and specific IgE for wheat were
done. A three-day challenge program including open challenge for wheat,
exercise and exercise challenge test after ameal containingwheatwas performed.
Results: Five children, aged 5-14 years (mean: 8 + 3.74 years) were evaluated.
Atopic history was found in 40% of patients. All patients had symptoms
involved skin and respiratory systems and two had hypotension. Sera specific
IgE for wheat were determined in 3 patients among which two were positive.
Three patients completed the three-day protocol. Anaphylaxis occurred in 2
out of 3 patients with the amount of wheat consumed prior to exercise being
more than 100 grams.
Conclusion: Wheat-dependent, exercise-induced anaphylaxis is more com-
mon in male. Skin and respiratory symptoms are major manifestations. A
three-day wheat challenge protocol is a definitive diagnostic tool. However the
amount of wheat required for challenging should be high.
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Anaphylaxis due to fish hypersensitivity in an exclusively
breastfed infant
Kazuki Sato1, Tomoko Numata1, Yoko Nezu1, Takayasu Arima2,
Yuzaboro Inoue2, Minako Tomiita2, Naoki Shimojo2, and Yoichi
Kohno2. 1National Shimoshizu Hospital, Department of Pediatrics, Chiba,
Japan; 2Chiba University Graduate School of Medicine, Department of
Pediatrics, Chiba, Japan.
Two cases of anaphylaxis in exclusively breastfeeding are reported.
Case1: 5-month-old boy with exclusive breastfeeding suffered from eczema
since 2-month-old and his mother restricted intake of egg and cow’s milk
since 4 month. He was hospitalized with tarry stools at 5 month of age.
Within an hour after breastfeeding after his mother had taken raw fish, he
developed whole-body rash three times. Skin prick test was positive to
horse mackerel, mackerel, salmon and codfish. After his mother res-
tricted fish ingestion no symptom was observed while breast feeding
was continued.
Case2: 9-month-old boy with exclusive breastfeeding presented severe
eczema at 1 month of age. Thereafter his mother and he avoided eggs, cow’s
milk, soy, and fishes. At 9 month, he was fed almost breast-fed and ate little
solid food. One day he developed rash and cough soon after mother fed him
breast milk. He was breast-fed again and 3 hours later presented vomiting
and rash over whole body and was hospitalized. Blood examination revealed
high titer of specific IgE to egg, cow’s milk, sardine and codfish in his
serum. Skin prick test was also positive to sardine and eggs. Only small
amount of allergens was detectable in breast milk. Although food their
mother took was not determined, anaphylaxis due to food allergens in breast
milk was most suspected. Systemic immediate type food allergy due to
small amounts of food allergens included in breast milk is rare and so far a
few case has been reported.
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Anaphylaxis in Chile: a 10-year review
Carolina Dı´az, Jessica Salinas, Antonieta Guzma´n, Paola Toche, and
Angelica Marinovic. University of Chile Clinical Hospital, Allergy and
Immunology Unit, Santiago, Chile.
Background: Anaphylaxis is a severe acute allergic reaction, quickly
progressive and potentially fatal, triggered mainly by food antigens and
drugs. No prevalence studies of this condition have been conducted in our
country, neither of the clinical presentation and/or etiology.
Objective: Determine the clinical characteristics of patients with anaphylactic
reactions seen at the Clinical Hospital of the University of Chile. Patients and
Methods: A retrospective review of medical records spanning 10 years (May
1997- May 2007) allowed us to obtain data of 127 patients who where derived
to the Allergy and Immunology Department of the Clinical Hospital of the
University of Chile with a diagnosis of anaphylaxis of unknown origin. Three
patients were excluded from this study, two with diagnosis of systemic
mastocytosis and the other with hereditary angioedema. We evaluated: sex,
age, number of episodes before consulting, interval between first and last
episode, history of atopy, time elapsed between exposure to the suspected
triggering factor and the appearance of symptoms, form of presentation,
severity of the reaction, treatment received and clinical/laboratory work up.
Results: 127 patients, 48 men and 79 women, were included. Age ranged from
11 months to 81 years, with a mean of 27.5 years; 61% were atopic. The
average delay before consulting was 4 years, and median number of previous
episodes was 2. Etiology was identified in 83% of cases; the main causes were
drugs (31%), followed by foods (27%) and Hymenoptera stings (16%). The
average time of onset of symptoms was 42 minutes post-exposure. Ninety six
percent of patients presented urticaria and/or angioedema and severe
manifestations (Grade III and IV) were seen in 70% of the individuals.
From the individuals who had indication of management with epinephrine,
only 42.1% received it in the Emergency room.
Conclusion: The clinical characteristics of the Chilean patients with
anaphylaxis are similar to those reported in other countries. It is relevant to
emphasize the great percentage of atopics patients in our series as well as the
delay in the consultation.
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Anaphylaxis in Singapore children
SMY Wong, WK Liew, WC Chiang, M Kidon, and A Goh. KK Women’s and
Children’s Hospital, Paediatric Allergy, Immunology and Rheumatology,
Singapore, Singapore.
Background: To study the epidemiology and review the treatment of
anaphylaxis in Asian Singapore children.
Methods: This is a 2-year retrospective study, which includes all patients with
anaphylaxis seen in the KK Children’s Hospital, Singapore. Cases were
identified by the relevant discharge codes from the Children’s Emergency (CE)
and hospital’s inpatient records, and cross-checked with referrals to the
Allergy clinic.
Results: 30 children with anaphylaxis were identified. 19 (63%) were male.
3 (10%)were less than 1 year old at the time of presentation, 8 (27%) were aged
1Y5, 11 (36%) were 6Y11, and 8 (27%) were 12Y16 years. Race distribution
corresponded to population demographics. 25 (83%) had features of atopy.
Food triggers were reported in 17 (57%), but food specific IgE sen-
sitization was demonstrated only in 11 children (37%). [Egg (4), peanut (4),
cow’smilk (1), clam (1), chinese pear (1)]. Therewere 11 (37%) cases secondary
to drugs: [NSAIDs (4), paracetamol (3), traditional Chinese medication (1),
asparaginase (1), desferrioxamine (1) and blood product (1)]. Two patients had
no identifiable triggers and were diagnosed as idiopathic anaphylaxis.
Most patients presented with dermatologic (87%) and respiratory
features (83%). 8 (27%) children had vomiting or abdominal pain, and 8 (27%)
had hypotension. There were no fatalities in this study.
Of the 23 (77%) patients that presented to the CE, 74% were admitted
for observation. 3 patients required admission to the intensive care unit
because of hypotension requiring fluid resuscitation at presentation.
12 (40%) childrenwere treatedwith epinephrine, but thiswas administered
mostly by the subcutaneous route. 18 (60%) were given antihistamines; 22 (73%)
steroids; 17 (57%) bronchodilator therapy; and 9 intravenous fluid boluses.
6 children were equipped with self-injectable epinephrine. Those who
did not receive self-injectable epinephrine included cases with drug triggers,
patients who defaulted, and parental refusal due to anxiety over self-injection
or cost concerns.
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Conclusion: Anaphylaxis is predominantly food triggered in Singapore
children, with a noticeable increase in peanut food allergy. There is also a
significant number of cases attributed to ibuprofen and paracetamol. Whilst
epinephrine is the cornerstone therapy for anaphylaxis only 40% of our cases
received this treatment. There is an urgent need to improve the awareness and
treatment of anaphylaxis in our population.
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The angiotensine converting enzyme activity in patients with an
anaphylactic reaction after Hymenoptera sting event
Renata Rubinsztajn1, Andrzej Dabrowski1, Aleksandra Safianowska1,
Jarosaw Go´ra2, Magdalena Paplin˜ska1, Renata Walkiewicz1, Hanna Grubek
Jaworska1, Zbigniew Gaciong2, and Ryszarda Chazan1. 1Medical University,
Dep of Pneumonology and Allergology, Warsaw, Poland; 2Medical University,
Dept of Internal Medicine, Hypertension & Angology, Warsaw, Poland.
The renin angiotensine system seems to play a significant role in the
response to anaphylactic reaction.
The aim of the study was to evaluate the serum activity of angiotensine
converting enzyme (ACE) in patients with anaphylaxis after Hymenoptera
sting event depending on the polymorphism of ACE gene and specific IgE.
Materials: The study group consisted of 31 patients, mean age 50T12 years.
There were 21 patients with specific IgE to wasp venom, 6 to bee venom and 4
to both venoms.
Methods: The ACE activity was measured according to the method described
by Liberman I/DACE polymorphism was determined based in PCR technique
employing insert specific- primers.
Specific IgE was measured with Allergopharma specific IgE ELISA
Kit, Germany.
Results: The ACE activity in studied group was 29,11T11,5 IU. Table 1
contains the ACE activity depending of the ACE gene polymorphism.
*p G 0,01 Table 2 contains the ACE activity depending of the specific
IgE to Hymenoptera.
**p 9 0.01
Conclusion: 1. The serum activity of ACE in the patients with anaphylactic
reaction to Hymenoptera is the same as in general population 2. There are
significant statistical differences between ACE activity in groups according to
the ACE gene polymorphism 3.The specific IgE does not influence on the
ACE activity
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I/D ACE gene polymorphism in patients with anaphylaxis after
Hymenoptera sting
Andrzej Dbrowski1, Renata Rubinsztajn1, Jaros3aw Go´ra2, Renata Walkiewicz1,
Zbigniew Gaciong2, and Ryszarda Chazan2. 1Medical University, Dept of
Pneumonology and Allergology, Warsaw, Poland; 2Medical University, Dep of
Internal Medicine Hypertension & Angiology, Warsaw, Poland.
The activity of the ACE may play an important role in the anaphylactiv
reaction. The ACE activity is genetically determinated. The DD genotype is
correlated with arterial hypertension and other vascular disorders. The ID
polymorphism in the Caucasian population is 0,53.
The aim of the study was to analyze the frequency of angiotensine
converting enzyme gene polymorphism in patients with documented history of
anaphylactic reaction to a Hymenoptera sting.
Materials: The study group consisted of 48 patients (38F, 16 M), mean age
48T14 years. There were 29 patients with specific IgE to wasp venom, 7 to
bee venom and 12 to both venoms. The control group was 23 healthy person
(9F, 14M), mean age 41T7 years.
Methods: I/D ACE polymorphism was determined based in PCR technique
employing inser-specific primers. Specific IgE was measured by Allergo-
pharma specific IgE ELISA, Germany.
Results: The ACE gene polymorphism in the control group were: DD n=5
(21.7%), ID n=15 ( 65.2%), II n=3 (13.1%) The ACE gene polymorphism in
the study group were: DD n=16 (33.3%), ID n=22 (45.85%), II n=10 (20.85%)
Conclusion: In the group of patients with documented anaphylactic reaction
to Hymenoptera sting there were no differences between the ACE gene
polymorphism and general population.
We did not observed differences of this polymorphism between the
wasp and bee group, but in the wasp/bee one the allel I was more frequent, and
therefore in larger groups of seems justified.
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Milk and wheat: the most common cause of anaphylaxis
in children
Zahra Pourpak, Rosita Akramian, Raheleh Shokouhi Shoormasti, Leyla
Ghojezadeh, Hasan Bemanian, and Mostafa Moin. Immunology, Asthma &
Allergy Research Institute, Immunology Department, Tehran, Islamic
Republic of Iran.
Background: Anaphylaxis is a medical emergency requiring immediate
recognition and treatment. We report common findings of the first case series
of anaphylaxis in Iran, which carried out in children who referred to the center
of Immunology, Asthma and Allergy.
Materials and Methods: Children referred to the clinic of allergy with a
previous diagnosis of anaphylaxis were considered in this study (2003 - 2006).
A specific questionnaire was completed for all of the patients and a detailed
clinical history and demographic data were recorded. For all of the patients,
Skin prick tests and specific IgE measurement were performed for suspected
allergens. Determination of causative allergen was based on patients’ history
and IgE mediated tests. Challenge test was not performed for any patient.
Results: 39 children ages ranged from 1m to 13 year old with a previous
diagnosis of anaphylaxis were referred to the clinic of allergy during 2
years. (48/1% male and 24/1% female respectively). Skin prick tests was
positive in 78/9% and specific IgE was positive in 88/2%. The most
probable causative agents in this population were foods (92/40%). Milk (55/
6%) and wheat (18/5%) were the most frequent causes of anaphylaxis in
this study.58% of children had more than 2 episodes of anaphylaxis in their
life; also 6 cases of multifactorial food anaphylaxis were identified for the
first time. The most common causative allergen for recurrence anaphylaxis
was milk in 20 patients Dermatologic signs and symptoms were the most
common (92/2%) vs. 76/%, 62/5%, 21/6%, 20/8% for respiratory,
gastrointestinal, neurological and cardiovascular signs and symptoms,
n ACE activity (IU)
DD 9 38,6T 9,1 *
ID 16 28,3T9,7 *
II 6 17,1T 6,1 *
n ACE activity (IU)
wasp 21 30,5T 11,4 **
bee 6 23,6T12,6**
wasp/bee 4 30,0T 10,8 **
ACE genotype n(%) wasp n=29 bee n=7 wasp/bee n=12
DD 9 (31.0) 0 7 (58.3)
ID 16 (55.2) 6 (85.7) 0
II 4 (13.8) 1 (14.3) 5 (41.7)
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respectively. Flushing was seen in 66/7%, prurities in 56/9%, urticaria in
54/9%, preorbital edema in 52/1% of patients, rash in 50%, erythema in
43/1% and angioedema in 41/2%.
Conclusion: These data confirm that foods specially milk and wheat are
the most common causes of anaphylaxis in children and dermatologic signs
and symptoms are the most common finding, thus parents and physicians
should be educated to recognize the most common causative allergens and
common presenting clinical manifestation of this disease to avoid the
progression of this life threatening syndrome and be able to manage
anaphylactic patients.
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Food anaphylaxis: a clinical study
Isabel Carrapatoso, Alexandra Santos, Emı´lia Faria, Celso Pereira, Carlos
Loureiro, and Celso Chieira. Coimbra University Hospital, Immunoallergol-
ogy Department, Coimbra, Portugal.
Background: Food allergy is one of the most common causes of anaphylaxis.
Objective: The aim of this study was to characterize a group of patients with
food anaphylaxis followed-up in a food allergy outpatient department during a
one-year period.
Methods: Twenty-two consecutive patients observed in our department
from June 2006 to May 2007 with a suggestive clinical history of food
anaphylaxis were selected. Foods involved in the severe systemic reactions
were identified and atopic co-morbidities, occurrence of anaphylaxis in
the study period and the medication used were investigated. A standardized
questionnaire and skin prick tests to airborne allergens (mites, moulds,
cockroach, cat and dog dander, pollens, feathers, latex) and food allergens
(egg, milk, seafood, mammals and birds meat, fruits, nuts, cereals, legumes,
spices and other vegetables) were performed. Serum specific IgE to
airborne and food allergens and/or prick-to-prick with natural food
extracts were done in selected cases (if there was evidence of clinical
reactivity).
Results: All the patients selected had a past history of an immediate severe
systemic reaction after ingestion of food. The mean age of the population
studied was 37T10 years. Fourteen patients were female. The mean age at
the first anaphylaxis episode was 24T11 years. Foods involved were fruits in
4 patients, crustaceans in 4 patients, cow’s milk in 4 patients, nuts in 3
patients, legumes in 2 patients, cereals in 2 patients, fish in 2 patients and
egg in 1 patient. All patients were sensitised to the culprit food.
Sensitisation to airborne allergens occurred in 19 patients (10 to mites, 7
to grasses, 5 each to weeds and trees, 3 to latex and 1 each to cockroach,
dog dander and feathers). Sensitisation to more than 1 food occurred in 16
patients. Eighteen patients had atopic co-morbidities related to airborne
allergens (12 patients had asthma). Recurrence of anaphylaxis occurred in 2
patients with cow’s milk allergy in the study period. Self-administered
adrenaline was used by 1 patient twice.
Conclusion: In the population studied a high proportion of atopic asthmatic
patients was found. Different plant and animal foods were implicated. Hidden
milk allergens can be extremely difficult to avoid and this fact could explain
the recurrence of anaphylaxis in 2 cow’s milk allergic patients, in spite of a
strictly restrictive diet.
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Two cases of anaphylaxis caused by octopus variabilis
Gil-Soon Choi, Han-Jung Park, Sung-Jin Choi, Gyu-Young Hur, Seung-Youp
Shin, Seung-Hyun Kim, Dong-Ho Nahm, and Hae-Sim Park. Ajou University
School of Medicine, Allergy and Rheumatology, Suwon, Republic of Korea.
Octopus variabilis, a kind of Mollusca, is a favorite food in oriental
countries. There have been no published report of anaphylaxis caused by
octopus and the mechanism of this food allergy has not been understood. We
experienced two cases of anaphylaxis developed afteringestion of raw octopus.
The first patient, a 52-year-old man without any previous allergic
diseases, experienced generalized urticaria, dizziness, and loss of conscious-
ness at one hour after ingestion of raw octopus. The skin prick test showed
weakly responses to octopus extract, D. pteronyssius, D. farinae, oyster,
shrimp (A/H ratio was all 2+). Serum specific IgE antibody to octopus extract
was undetectable by ELISA, whereas increased level serum specific IgG4
antibody to octopus extract was noted by ELISA.
The second patient, a 51-year-old woman with allergic rhinitis
and allergic conjunctivitis had suffered from recurrent abdominal pain, chest
discomfort and dizziness for 5 min after ingestion of steamed or raw octopus.
The skin prick test showed negative response to octopus extract, but positive
responses to D. pteronyssius and, D. farinae. Serum specific IgE, IgG1 and
IgG4 antibodies to octopus extract were not found by ELISA.
These finding suggest that octopus could induce anaphylaxis via
non-IgE mediated mast cell activation.
Key words: Anaphylaxis, Octopus variabilis
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Anaphylaxis: finding the causative agents in
a university hospital
Wicharn Bunsawansong1, Nualanong Visitsunthorn1, Torpong Thongngarm2,
Pakit Vichyanond1, and Orathai Jirapongsananuruk1. 1Faculty of Medicine
Siriraj Hospital, Mahidol University, Pediatrics, BKK, Thailand; 2Faculty of
Medicine Siriraj Hospital, Mahidol University, Medicine, BKK, Thailand.
Background: Anaphylaxis is an emergency condition. Attempts should be
made to find the causative agents for further prevention.
Methods: We prospectively studied 28 patients with anaphylaxis at Siriraj
Hospital, Thailand from January 1st, 2003 to July 31st, 2004. Direct patient
interviews and physical examinations were done. Skin prick tests and
challenges to the agents according to history, were carefully performed to
identify the causes of anaphylaxis.
Results: The causes of anaphylaxis were identified by positive skin test in
24/28 patients. In these 24 patients, oral challenge test and specific IgE
wereperformed and found positive in 3/3 and 4/4 patients, respectively. The
agents causing positive skin tests were ant (7 patients), seawater shrimp
(4patients), immunotherapy (3 patients), wheat (2 patients), wasp (2 patients),
seawater mollusk (2 patients), seawater crab (1 patients), wheat-dependent
exercise-induced anaphylaxis (WDEIA, 1 patient), cow’s milk (1 patient),
andciprofloxacin (1 patient). Four cases had negative skin test. In these
patients, the causative agents could not be identified in 3 cases and the
patientswere diagnosed with idiopathic anaphylaxis. One patient had skin test
negative to erythromycin but positive oral challenge to erythromycin. The
causes of positive oral challenges in 3 patients were seawater shrimp, seawater
mollusk and WDEIA (1 patient each). The causes of positive specific IgE
wereseawater shrimp, wheat, cow milk and ant (1 patient each). No patient
developed severe anaphylaxis during the tests.
Conclusion: Detailed history taking remains important to find the cause of
anaphylaxis. However, skin tests and/or challenges are helpful tools if they are
done carefully under a controlled condition.
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Anaphylaxis caused by light, a case report
Remei Guspı´ Bori1, Miquel Baltasar Drago1, Esther Serra Baldrich2, and
Maria Barnadas2. 1Hospital de Tortosa Verge de la Cinta, Allergy Unit,
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Tortosa, Spain; 2Hospital of Sta. Creu i S. Pau, Dermatology Department,
Barcelona, Spain.
We present the case of a woman, 36 years old, who smokes around 20
cigarettes a day, health worker, with a family history of atopy and a personal
history of tonsillectomy, left renal colic and habitual consumption of oral
contraceptives.
From the last five years she has been presenting episodes of urticaria
and occasionally angioedema, immediately after the solar exposure (at any
season of the year), located only in the exposed areas. The injuries remain for 2
to 3 hours and disappear without leaving any residual injury.
During three times she suffered head instability and afterwards loss of
consciousness, twice because of a heavy solar exposure (despite of having
applied sunscreen cream previously) and another time after reciveing an UVA’s
bronzed session.
Laboratory findings, including complete blood cell count, erithrocite
sedimentation rate, lactate dehydrogenase, renal and liver function, glucose,
immunoglobulins A, G, M, tryptase, complement C3, C4, rheumatoid factor,
total proteins and C-reactive protein did not reveal any pathological values.
Test for antinuclear, anti YENA, anti- mithocondrials, anti-muscular smooth,
anti- parietal cell antibodies were negative. The total IgE was 1000 UI/
mililiter. The 24 hours urine and faeces test analysis in order to detect
porphyrins were negative.
Skin prick test with a set of common air-allergens were positive for
house dust mites. Photobiological examination: urticarial lesions were caused
after unique exposure to UVB and to UVA irradiation, but not with the visible
light spectrum.
Although the minimal urticaria dose was not determined, the evolution
of this case show an extreme seriousness. She continues with clinic symptoms
in the area of exposure few minutes after minimal solar exposures in winter
(although she has not presented new episodes of anaphylaxis) in spite of the
continued treatment: topical broad spectrum sunscreen daily and all through
the year, different systemic H1 antihistamines (cetirizine 30 mg/day,
hidroxicina, ebastine, desloratadine), beta carotene supplementation, natural
desensitisation approach by regular sun exposure.
We suspect this is a case of solar urticaria that, clinically changed into
an anaphylaxis when receiving very high doses of radiation.
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Common insects causing anphylaxis in Thailand
Kanika Piromrat. Bhumibol Adulyadej Hospital, Pediatrics, Bangkok, Thailand.
Stinging insects comprised approximately 10 percent of the causes
of anaphylaxis in Thailand. We live in a tropical climate, so some of the
temperate inhabited insects do not exist in Thailand, such as yellow jackets
(Vespula spp.), white faced hornet (Dolichovespula maculata), and yellow
hornet (Dolichovespula arenaria). The poster presented pictures and brief
description of common insects that have a potential of causing anaphylaxis
in Thailand, such as tropical wasps, paper wasps, Giant bee, Indian bee,
Small bee, bumble bee, venomous ants, and kissing bugs. In conclusion,
the study described the species and characteristics of common stinging
insects that can cause anaphylaxis in Thailand.
INFLAMMATORY CELLS & MEDIATORS
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Do mast cell numbers differ in different inflammatory
periodontal diseases?
Surena Vahabi. University, Perio, Tehran, Islamic Republic of Iran.
Background: Mast cells play an important role in allergic reaction, host
defense, local homeostasis, inflammation and angiogenesis. The objective
of this study was to evaluate the relationship between mast cell numbers
and different types of periodontal diseases.
Methods: Gingival specimens were taken from 20 moderate to advanced
chronic periodontal and 19 moderate to advanced aggressive periodontal
sites as case groups and 18 healthy/gingivitis sites as control group in
routine periodontal surgeries (flap and crown lengthening) and were
examined after toluidine-blue staining for mast cells counting and
hematoxylin-eosin staining for assessing inflammation. Inflammatory and
mast cells in 5 micron sections were assessed by two observers 3 times,
utilizing light microscope at 100X and 400X magnification. ANOVA and T
tests with an alpha error level less than 5 percent were used to analyze
data.
Results: Mast cells numbers were higher in chronic versus aggressive
periodontitis and healthy/gingivitis (p=0.000). The aggressive period-
ontitis didn’t have more numbers of mast cells as compared to healthy/
gingivitis (p90.05). There were no relationship between mast cell
numbers and degree of inflammation in 3 groups.
Conclusion: The present study indicates more mast cell numbers presence
in the chronic periodontitis sites than other sites. The results of this study
suggest more studies to evaluate dynamic aspects of host defense in
conjunct with other aspects of immune system, simultaneously.
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Exogenous nitric oxide regulates cyclooxygenase-2 expression
and prostaglandin D2 generation in mast cells
Tae Chul Moon and A. Dean Befus. University of Alberta, Department of
Medicine, Edmonton, Canada.
Background: Mast cells (MC) are important effector cells in allergic and
inflammatory responses through secretion of various mediators following
activation. Nitric oxide (NO) is important signaling molecule that regulates
MC function. It can depress MC allergic responses such as leukotriene (LT),
cytokine and chemokine production, as well as MC degranulation. However,
the involvement of NO in prostaglandin (PG) D2 production, an important
lipid mediator produced in MC, is unclear. In PG synthesis, cyclooxygenase
(COX) is an important enzyme and two isozymes of COX, constitutively
expressed COX-1 and inducible COX-2, have been reported. It is well
established that mouse bone marrow-derived mast cells (BMMC) exhibit
biphasic PGD2 biosynthesis; COX-1-dependent immediate and COX-2-
dependent delayed PGD2 production, when BMMC are stimulated with
SCF, IL-10 and IL-1$.
Methods: The effects of NO on COX-2 expression and PGD2 generation in
BMMC were investigated using NO-donors, S-Nitrosoglutathione (SNOG)
and S-Nitroso-N-acetylpenicillamine (SNAP). PGD2 production by stimulated
BMMC was assayed using PGD2-MOX enzyme immunoassay kits. Western
blot and real-time RT-PCR were used to measure COX-2 protein and mRNA
expression.
Results: Exogenous NO augmented COX-2 protein expression and
increased COX-2-dependent PGD2 generation in response to SCF, IL-10
and IL-1$. The increased expression of COX-2 by NO-donors was reduced
by the p38 MAPK inhibitor, SB202190. Downstream of p38 MAPK,
NO-donors augmented not only COX-2 mRNA transcription but also its
stability. By contrast, NO-donors did not affect COX-1 protein expression.
However, in contrast to the augmentation of COX-2 expression and activity,
SNOG (100 to 500 6M), but not SNAP (up to 500 6M) inhibited COX-1-
dependent PGD2 generation.
Conclusion: Thus, exogenous NO regulates PGD2 production by MC
through regulation both of COX-1 and COX-2. Furthermore, these
findings help us to understand the role of NO in MC function and the
regulatory mechanisms of lipid mediator generation in MC in inflamma-
tory diseases.
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Cigarette smoke suppresses the production of cytokines but not
chemokines by IgE/Ag activation in mast cells
Esmaeil Mortaz, Gerts Folkerts, Ferdi Engels, Danielle Raats, Mehdi Vaezi
Rad, Frans Nijkamp, and Frank Redegeld. UIPS, Immunopharmacology,
Utrecht, Netherlands.
Background: Chronic obstructive pulmonary disease (COPD) is a major
incurable global health burden and will become the third largest cause of
death in the world by 2020. It is currently believed that an exaggerated
inflammatory response to inhaled irritants, in particular cigarette smoke
(CS), causes progressive airflow limitation. This inflammation, where
macrophages and neutrophils are prominent, leads to oxidative stress,
emphysema, small airways fibrosis and mucus hypersecretion. Mast cells are
important effector cells in anaphylactic reactions and are involved in a
variety of immunological and non-immunlogic processes. However, the role
of mast cells in pathogenesis of emphysema not yet documented. Recently,
we have demonstrated that CSM induces protease expression and
chemokine release by primary mast cells. In this study, we further
investigated the effects of CSM on the cytokine production of mast cells
respect to activation with IgE and antigen.
Materials and Methods: BMMC were cultured from BALB/cBy mice for 3
weeks. Cells were exposed against CSM and activated with IgE and antigen.
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Degranulation of cells was assessed by monitoring the release of the granular
enzyme beta-hexosaminidase. The amount of cytokines were determined in
supernatants and IkB-"\ degradation, P65 and CREP phosphorylation were
measured by Western blot.
Results: CSM attenuated degranulation and of cytokines releases of
mast cells by a concentration-dependent and non-cytotoxic manner. CSM
did not effect on cytokine releases induced by LPS. Moreover, CSM
induces phosphorylation of CREB and ATF-1 when activated with IgE and
antigen.
Conclusion: Thus, some of the inhibitory effects of CSM on degranulation
and cytokine releases may different than chemokine and leukoterine
releases.
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The suppressive effect of Houttuynia cordata extract on HMC-1
cell migration in response to stem cell factor
Eun Ju Yang1, Chi-Young Yun2, Dong-Hee Kim3, Ji-Sook Lee2, and In Sik
Kim1. 1Eulji University, Biomedical Laboratory Science, Daejeon, Republic
of Korea; 2Daejeon University, Biology, Daejeon, Republic of Korea;
3Daejeon University, Pathology, Daejeon, Republic of Korea.
Hottuynia cordata Thunb. (Saururaceae; HC) is known as a
therapeutic drug that has been used in traditional oriental medicine for
the treatment of allergic diseases. Mast cells function as regulatory cells in a
variety of inflammatory diseases, in particular, asthma and atopic dermatitis.
In this study, we examined the effect of HC extracts on the chemotactic
activity of the human mast cell line, HMC-1, induced by stem cell factor
(SCF). The survival rate of HMC-1 cells was not altered by treatments with
the HC extracts at a concentration of 10 2g/ml for 24 h. SCF showed the
typical bell-shape curve for the HMC-1 cell chemoattraction with the peak
of the curve at the SCF concentration of 100 ng/ml. HC-1, which was the
whole plant (Houttuynia cordata) extracted with 80% EtOH, and HC-3,
which was the residue successively partitioned with EtOAc, both had
inhibitory effects on HMC-1 cell movement. After the treatment with 10 6g/
ml HC-1 extract for 6 h and 24 h, the chemotactic index (CI) of HMC-1
cells decreased up to 73% and 63%, respectively. HC-3 extract significantly
inhibited the cell movement (72% T 6% and 44% T 2%). The HC-1 and
HC-3 extracts had no inhibitory effect on the mRNA and protein
expressions of c-kit, SCF receptor. SCF tranduces the chemotaxis signaling
via NF-kB translocation, and both extracts blocked the activation. Taken
together, our results indicate that HC-1 and HC-3 extracts inhibit the
chemotactic activity of HMC-1 cells in response to SCF by blocking the
NF-kB activation. These substances may be helpful for treating the
inflammatory diseases associated with mast cells.
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The effect of IL-3 and SCF mixture on cell proliferation and
rat mast cell protease-lT synthesis of rat bone marrow derived
mast cells
Haneul Nari Lee1, Ju Hyeon Lee1, Chul Hwan Kim2, Yoon Gyu Kang3,
Kyung-Whan Joo4, Joon-Sang Lee4, Guan Gyu Song5, and Sung-Weon Cho4.
1Korea University Graduate School, Department of Microbiology and
Immunology, Seoul, Republic of Korea; 2Korea University College of
Medicine, Department of Pathology, Seoul, Republic of Korea; 3Korea
University College of Medicine, Department of Rehabilitation Medicine,
Seoul, Republic of Korea; 4Korea University College of Medicien,
Department of Parasitology, Seoul, Republic of Korea; 5Korea University
College of Medicine, Division of Rheumatology Internal Medicine, Seoul,
Republic of Korea.
Background: Mast cells are the important immune cells to produce cytokines
chemokines and histamine, and closely related to allergic reactions processing.
The investigation of mast cell activation enhances the understanding of
allergies and requires easy supply of large number of mast cells of culture.
Bone marrow derived mast cell (BMMC) are the mast cells to provide
sufficient number of cells and are affected by the kinds of cytokine
combination and dose both in proliferation and in differentiation. This
investigation was about the effect of culture condition on rat BMMC
cultivation in serum supplement and cytokines.
Methods: Rat bone marrow cells were cultured with the media conditioned
differently by the addition of individual, or mixed cytokines of IL-3 IL-4 IL-6
and SCF. Rat BMMC proliferation was measured using CCk-8 assay. Rat
BMMC differentiation was analyzed by the level of RMCP-lT. Serum
supplement effect on rat BMMC culture was investigated by comparison of the
media including horse sera with the media carrying rat sera.
Results: In the culture with horse serum supplement, rat BMMC proliferation
in the presence of IL-3 (10 ng/ml) mixed with SCF (10 ng/ml) was the highest
among the applied cytokine mixture. Rat BMMC with the mixture of
cytokine concentration showed relatively high level of RMCP-lT. In the
culture with rat serum supplement, the cytokines condition of IL-3 10ng/ml
with SCF 10ng/ml did not induce RMCP-lT production. However the
adjustment of cytokine concentration with the mixture of IL-3 10ngml and
SCF 1.25ng/ml enhanced RMCP-lT synthesis, comparable to the level
produced by IL-3 10ng/ml and SCF 10ng/ml in the media supplemented with
horse serum.
Conclusion: These results indicated that rat BMMC preparation requires IL-3
and SCF, and that rat BMMC differentiation be affected by the ratio between
IL-3 and SCF and by the kind of serum.
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Mast cells involvement in stress-induced epithelial barrier
dysfunction in the rat jejunum
Mar Guilarte, Victoria Cardona, Maria Vicario, Carmen Alonso, Cristina
Martinez, and Javier Santos. Hospital Universitari Vall d’Hebron, Allergy.
Digestive Diseases Research Unit, Barcelona, Spain.
Background: Stress may facilitate intestinal inflammation by promoting
epithelial barrier dysfunction allowing luminal antigens to enter the mucosa
that may be crucial for the development of food allergy.
Methods: Male WKY rats were submitted to crowding stress (CS) (8 rats/
cage) or sham-crowding (2 rats/cage) for 15 days. In addition, ketotifen, a
known mast cell stabilizer or saline was injected i.p. at day 14th (1 mg/kg, 2
doses, 12 h interval). At the end of the stress or sham protocols, jejunal
segments were mounted in Ussing chambers to measure macromolecular
permeability to horseradish peroxidase (HRP). Rat mast cell protease II
(RMCPII), an indicator of mast cell activation, was measured in jejunal
perfusates and in jejunal homogenates at the end of stress or sham exposure.
Plasma corticosterone and CRH (corticotropin releasing hormone) receptor 1
(R1) and 2 (R2) expression in jejunal tissue was measured by an ELISA assay
by RT-PCR respectively.
Results: Plasma corticosterone was tree fold increased after the stress protocol
in the CS group (CS: 138T27 ng/mL vs. control: 52T16; p=0.0001; n=8/
group). CRH-R1 but not CRH-R2 expression was increased in the CS when
compared to control. Crowding stress (CS) induced an increase in HRP
permeability (CS: 18,2T5 pmol/cm2/h vs. control: 6,2T2.8; p=0.0004;), that
was diminished when ketotifen was administered (12,1T5,2 pmol/cm2/h;
p=0,015 vs CS; n=8/group ). Furthermore, jejunal RMCPII was higher in
perfusates from stressed rats (CS: 23.6 T 5.1 6g/L vs. control: 14.8 T 9.9;
p=0.021; n=8/group) and in tissue homogenates (CS: 456T123 ng/mg of tissue
vs. control 274T84; p=0.002: n=8/group) suggesting ongoing mast cell
activation. Ketotifen reduced the increased RMCPII in both jejunal perfusates
(16,5T7,2 6g/L; p=0,019 vs. CS; n=8/group) and in tissue homogenates
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(198T72 ng/mg of tissue; p=0,002 vs. CS; n=8/group). Ketotifen did not
induce any change in the parameters evaluated in the control groups.
Conclusion: Stress evoked an epithelial barrier defect that may facilitate the
uptake of luminal macromolecules and is mediated by mast cells. This
synergistic effect may play an important role in food allergy.
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Importance of matrix metalloproteinase -9 (MMP-9) and its
inhibitor (TIMP-1) in development of postoperative
complications of patients with degenerative-dystrophic
diseases (DDD) of hip joints
Roman Vinchel R and Elena Markelova E. Vladivostok State Medical
University, pathophisiology, Vladivostok, Russian Federation.
Purpose of our work was to estimate of prediction possibility of
development of complications in postoperative period by means of monitoring
of MMP-9/TIMP-1 level in patients’ blood serum before and after hips
replacement.
Materials and Methods: We tested blood of 27 patients before and after hips
replacement operation, undergoing, 11 patients (40.74%) from them had
postoperative infectious complications being developed, and 16 patients
(59.26%) had smooth postoperative course without infectious complications.
Blood of 30 healthy donors was as control. It was drawn fourfold blood
sampling, as the following: the first blood sampling was made before
operation, the second - during first 24 hours after operation; the third - during
fifth 24 hours after operation and the fourth - during fourteenth day after
operation. Estimation of MMP-9/TIMP-1 was made by immunoenzyme
method using of the test-system of BR & D System Inc.[, USA.
Results: It was detected the following: before operation patients from
group with smooth postoperative course had level of MMP-9/TIMP-1
equal 10.90T0.83 ng/ml that was essentially higher than patients of control
group had, being 0.22T0.07 ng/ml (pG0.05) typical for healthy people.
There was increase of MMP-9/ TIMP-1 (12.59T1.02 ng/ml, pG0.001) on
the first days after operation with subsequent continued increase up to
12.75T1.25 ng/ml, pG0.001 on the 5th day. Essentially decrease of MMP-
9/ TIMP-1 up to level of 12.40T0.98 ng/ml was observed on the first day
after operation that for certain did no differ from values of first day after
operation. In the patient group with complicated postoperative course the
index MMP-9/ TIMP-1 before operation was 9.54T1.37 ng/ml, this index
was higher in the control group as well (0.22T0.07 ng/ml (pG0.01). On
the first day after operation it was observed rapid growth of MMP-9/
TIMP-1 (13.37T1.41 ng/ml, pG0.05) in above-mentioned patient group,
and on the 5th day the level still persisted high (14.82T1.74 ng/ml). On
the 14th day the level of MMP-9/ TIMP-1 decreased slightly and was
14.27T1.07 ng/ml (p90.05).
Conclusion: Divergence of MMP-9/ TIMP-1 ratio towards its significant
increase already before operation for patients with DDD testifies to essential
pathogenetic role of MMP-9 in pathogenesis of dystrophic diseases of
hips.
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The role of hyalgan at inhibition of IL-1beta-stimulated
production of matrix metalloproteinase
Natalya Yatsyshyn, Roman Yatsyshyn, and Yevgen Neyko. Medical
University, Internal Diseases, Ivano-Frankivsk, Ukraine.
Background: Hyalgan is now widely used in the treatment of osteoarthritis
(OA) by intra-articular administration into the affected joints. Although a
clinical benefit of Hyalgan has been demonstrated with respect to pain
relief in patients with OA, the level at which the drug acts remains
unclear.
Objective: This study was aimed to investigate the mechanism of inhibitory
action of Hyalgan on interleukin-1beta (IL-1beta)-stimulated production of
matrix metalloproteinases (MMPs) in human articular cartilage.
Methods: IL-1beta was added to human articular cartilage with or without
changes of osteoarthritis (OA) in explant culture to stimulate MMP production.
Articular cartilage was incubated or preincubated with Hyalgan to assess the
effect of Hyalgan on IL-1beta-induced MMPs. Secreted levels of MMPs-1, -3,
and -13 in conditioned media were detected by immunoblotting, while
intracellular MMP synthesis in chondrocytes was evaluated by immunofluor-
escence microscopic analysis. Penetration of Hyalgan into cartilage tissue and
its binding to CD44 were analyzed by fluorescence microscopy using
fluoresceninated Hyalgan. Blocking experiments with anti-CD44 antibody
were performed to investigate the mechanism of HA action.
Results: Treatment and pretreatment with Hyalgan resulted in significant
suppression of IL-1beta-stimulated production of MMPs in normal and OA
cartilage explant culture. Fluorescence histocytochemistry revealed that Hyalgan
penetrated cartilage tissue and localized in the pericellular matrix around
chondrocytes. Hyalgan -binding blocking experiments using anti-CD44 antibody
demonstrated that association of HAwith chondrocytes was mediated by CD44.
Preincubation with anti-CD44 antibody, which suppressed IL-1beta-stimulated
MMPs, reversed the inhibitory effect of Hyalgan on MMP production induced
by IL-1beta in normal and OA cartilage.
Conclusion: This study demonstrated that Hyalgan effectively inhibited IL-
1beta-stimulated production of MMP-1, MMP-3, and MMP-13, which
supports the clinical use of HA in the treatment of OA. Such Hyalgan action
on IL-1beta may involve direct interaction between Hyalgan and CD44 on
chondrocytes.
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Nasal lavage fluid eosinophil cationic protein gradient reflects
the eosinophilic inflammation in RSV infection
N. Okamoto, M. Takasugi, E. Yoshimura, N. Takahashi, I. Nosjima, J. Yoshimoto,
T. Araki, and M. Ikeda. Fukuyama Medical Center, Pediatrics, Fukuyama,
Japan.
Background and Purpose: It is well known that after respiratory syncytial
virus (RSV) bronchiolitis during infancy and early childhood, a number of
children develop a persistent wheezing. The study of eosinophil cationic
protein (ECP) suggests that, as with asthma, eosinophilic inflammation
mechanisms may also play a role in RSV infection.
The aim of our study was to prove the existence of eosinophilic
inflammation in infant with RSV infection, by measuring local/systematic
ECP.
Methods: ECP was measured in the nasal lavage fluid and serum of 41
infants with RSV infection and 29 other respiratory infections, all who
were admitted to our hospital between October, 2005 and March, 2007
(they ranged from 0 months to 24 months of age, except for four pair of
twins).
Results: Nasal lavage fluid ECP levels were significantly higher in infants with
RSV infection than in the infants with other respiratory infections.
(3.148T0.527 vs 2.723T0.461 microgram/L, pG0.05). But serum ECP levels
did not indicate such a tendency. Moreover, a subanalysis showed that
wheezing infants also had significantly higher levels of nasal lavage fluid ECP
levels than in the case of non-wheezing infants, (3.240T0.512 vs 2.833T0.491
microgram/L, pG0.05), but serum ECP levels did not indicate such a tendency.
With regard to both nasal fluid lavage and serum, no significant difference in
ECP levels were found whether there was a family history of atopy or not. This
suggests that RSV infection may induce local eosinophilic inflammation even
during infancy.
Conclusion: Eosinophils are more strongly activated in RSV infection than
in other respiratory infectious disease. Theoretically, this result supports the
hypothesis that RSV infection may cause reactive airway disease.
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Mechanisms of eosinophil infiltration in the middle ear of
patients with eosinophilic otitis media
Yukiko Yokoyama1, Ruby Pawankar2, Chika Ozu2, Tetsuo Ikezono2, Manabu
Nonaka2, and Toshiaki Yagi2. 1Nippon Medical School Chiba Hokusoh
Hospital, Otorhinolaryngology, Chiba, Japan; 2Nippon Medical School,
Otorhinolaryngology, Tokyo, Japan.
Background: Patients with intractable otitis media (OM) with co-existent
bronchial asthma have an extensive accumulation of eosinophils in the
effusion and mucosa of the middle ear; called eosinophilic otitis media
(EOM). Previously, we reported that mast cells can regulate eosinophilic
inflammation in nasal polyps. In order to elucidate the mechanisms of
eosinophil accumulation in the middle ear, we analyzed eosinopil chemoat-
tractants like RANTES, eotaxin and their ligand CCR3 as well as mast cell
mediator tryptase in middle ear biopsies and effusion (MEE) of patients with
OM with and without asthma.
Materials and Methods: By ELISA, we analyzed the levels of RANTES and
eotaxin in MEE and mucosa of patients with OM with and without asthma
(control). The number of tryptase+ cells (mast cells), MBP+ cells
(eosinophils), RANTES+, eotaxin+ and CCR3+ cells were analyzed by
immunohistochemistry in middle ear biopsies.
Results: Levels of RANTES and eotaxin were higher in patients with OM
with asthma as compared to controls. Whereas in the mucosa of controls,
MBP and eotaxin+ cells were not detected, they were markedly increased in
patients with asthma in concert with high numbers of tryptase+, RANTES+
and CCR3+ cells.
Conclusion: These data suggest that mast cells may regulate eosinophilia
accumulation in the middle ear of patients with EOM via RANTES and
Eotaxin.
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Eosinophil functions induced by adhesion molecules and
leukotriene D4
Yotaro Takaku1, Mariko Mori1, Takehito Kobayashi1, Tomoyuki Soma2,
Koichi Hagiwara1, Minoru Kanazawa1, and Makoto Nagata1. 1Saitama
Medical University, Department of Respiratory Medicine, Saitama, Japan;
2Saitama Medical Center, Division of Respiratory Medicine, Saitama, Japan.
Background: Eosinophils preferentially accumulate at sites of airway
inflammation of asthma. For circulating eosinophils to participate in the
asthmatic airways, it is necessary to interact with adhesion molecules
expressed on endothelial cells and then expose to inflammatory mediators such
as cysteinyl leukotrienes(cysLTs). There is evidence that cysLTs including
leukotriene (LT)D4 regulate the functional status of eosinophils.
Objective: To investigate whether interaction with adhesion molecules
modifie eosinophil functions induced by cysLTs.
Methods: rh-VCAM-1, rh-ICAM-1, or rh-P-selectin was dissolved in 0.05 M
NaHCO3 coating buffer, added to 96-well EIA plates and incubated at 4 -C
overnight. Residual fluid was decanted and HBSS/0.1% gelatin was added to
reduce non-specific activation of eosinophils. Eosinophils were isolated from
blood of healthy donors, incubated in the EIA plates, and then exposed to LTD4.
The generation of superoxide anion (O2
j) and release of eosinophil-derived
neutrotoxin (EDN) were evaluated by cytochrome C reduction assay and ELISA,
respectively.
Results: In this experimental condition, neither VCAM-1 nor LTD4 (100nM)
directly induced eosinophil O2
j generation, however, VCAM-1 and LTD4 act
synergistically to induce eosinophil O2
j generation. The O2
j generation
induced by combination of VCAM-1 and LTD4 was blocked by anti-"4
integrin mAb and anti-$2 integrin mAb. ICAM-1 by iteslf induced eosinophil
O2
j generation and this was enhanced by LTD4. The enhanced O2
j
generation was blocked by anti-$2 integrin, but not anti-"4 integrin mAb.
P-selectin did not induce O2
j generation in the presence or absence of LTD4.
Finally, a combination of LTD4 and VCAM-1, but not ICAM-1 or P-selectin,
induced the release of EDN.
Conclusion: The combination of VCAM-Ior ICAM-I and cysLT effectively
induce effector functions of eosinophils. Eosinophil adhesion to and migrate
across endothelial cells via these speficic adhesion proteins and subsequent
exposure to cysLT may be involved in the manifestations of eosinophil
activation in the airways of asthma.
594
IL-21 and IL-21 receptor expression in eosinophils
Anker Hansen1, Lars K. Poulsen1, and Kresten Skak2. 1Rigshospitalet,
AllergyClinic, Copenhagen K, Denmark; 2Novo Nordisk, Department of
Pharmacology, Ma˚lLv, Denmark.
Introduction: Eosinophils are recruited to late phase inflammation and elicit
host defense against parasitic infections. However, in allergy eosinophils
contribute negatively by eliciting tissue damage. Our aim was to evaluate the
expressionof interleukin-21 (IL-21) and IL-21 receptor (IL-21R) in eosinophils.
Methods: Eosinophils where purified from blood samples taken from
allergic and healthy individuals using CD16 and CD3 microbeads to
deplete neutrophils and remaining T-cells from the granulocyte population.
RNA was purified using ABI prism 6100 robot and real-time PCR was
performed using applied biosystems Taqman Gene Expression Assays.
ELISA assays were performed for IL-21 receptor. Eosinophilic apoptosis
was measured in a flow cytometric assay using AnnexinV and propidium
iodide for 200,000 cells at 24, 48 and 72 hour time points.
Results: The yield of eosinophils from healthy and allergic persons was
64x103 and 137x103 eosinophils per ml full blood respectively. Using real-
time PCR no IL-21 mRNA could be detected; however IL-21 receptor
mRNA was detected with a mean Ct-value of 31.16 from 6 donors. No
difference was seen between allergic and healthy individuals. The naBve B-
cell line Ramos was used as a positive control and yielded a Ct-value of
È20, which is roughly a 1000-fold higher expression of IL-21R mRNA in
Ramos compared to eosinophils. The IL-21R mRNA expression in
eosinophils was comparable to the eosinophilic cell line HL-60 clone 15.
A sandwich ELISA for detection of IL-21R in eosinophil cell
lysate was established using a polyclonal rabbit anti-IL-21R antibody and a
mouse monoclonal anti-IL-21R. The ELISA had a detection limit of 1 ng/
ml or roughly 1000 receptors per cell and no IL-21R expression was
detected in either eosinophils or Ramos cell line. The effect on eosinophil
apoptosis in presence of IL-21 or the other Type I cytokines (IL-19, IL-20,
IL-22, IL-24, IL-26, IL-28 and IL-29) was examined, however, no apparent
effect of either increased survival or increased apoptosis could be seen.
Conclusion: Eosinophils express IL-21R mRNA. Real-time PCR showed a
mean Ct-value 31.16 from 6 donors. IL-21R protein expression was examined
using both flowcytometry and ELISA, but no IL-21R could be detected.
Functional apoptosis assay showed that IL-21 or the other Type I cytokines had
no effect on eosinophils, so it is unlikely that IL-21 stimulation of eosinphils is
of major significance.
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Anti-interleukin-5 (mepolizumab) therapy for a
hypereosinophilic syndrome
Gianenrico Senna1, Patrizia Bonadonna2, Mariangela Crivellaro2, Annarita
Dama2, Michele Schiappoli2, Giorgio Walter Canonica3, and Giovanni
Passalacqua3. 1General Hospital, Allergy Service, Verona, Italy; 2Verona
General Hospital, Allergy Service, Verona, Italy; 3Genoa University, Dept of
Internal Medicine - DIMI, Genoa, Italy.
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Background: IL-5 is critically involved in proliferation, activation, migration
and survival of eosinophils. As such, IL-5 may play a pathogenic role in
hypereosinophilic syndromes (IHES), which are a heterogeneous group of
disorders, characterized by sustained peripheral blood and/or tissue eosinphi-
lia. We assessed the safety and efficacy of a humanized monoclonal anti-IL5
antibody in a patient with IHES with respiratory involvement.
Methods and Results: The patient is a 25 year-old woman, with a 3 year
history of IHES. Biopsies confirmed on various occasions the involvement of
lungs and paranasal sinuses. The onset of the disease was an eosinophilic
pneumonia (56% eosinpohils in bronchial lavage) with asthma and respiratory
failure. The persistent eosinophilia and respiratory symptoms were success-
fully treated with doses of prednisone (25Y75 mg/daily), variable according to
eosinophilia. Attempts to shift to inhaled steroids plus montelukast, invariantly
lead to relapse. However, withdrawal of steroid treatment was forced by severe
systemic side effects and bleeding gastric ulcera. An attempt with initimab was
not effective.
A treatment with mepolizumab (5 mg/kg intravenously) monthly was
then started. Mepolizumab was well tolerated and rapidly reduced both
eosinophilia and symptoms. Eosinophils decreased from 998/mmc to 210 after
the first infusion and remained below 250/mmc at the subsequent controls.
After 8 weeks the oral steroid could be discontinued.
Conclusion:Mepolizumab is safe, and effective in lowering eosinophil count ,
has a glucorticoid sparing effect in patients with IHES.
Keywords: hypereosinophilic syndrome, pneumonia, mepolizumab.
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Influence of cetirizine and levocetirizine on
granulocyte-macrophage colony-stimulating factor and
interleukin-8 secretion by A549 human airway epithelial cells
stimulated with interleukin-1beta
Lin-Shien Fu. Taichung Veterans General Hospital, Section of Immunology &
Nephrology, Dep. of Pediat, Taichung, Taiwan.
Background: Recent studies suggest that several antihistamines can modulate
various inflammatory reactions besides their H1-receptor antagonism. We
investigated the effect of cetirizine (Ceti) and levocetirizine (Levo) on
granulocyte-macrophage colony- stimulating factor (GM-CSF) and
interleukin-8 (IL-8) secretion of A549 human airway epithelial cells.
Methods: A549 cells were pre-incubated with Ceti (0.1, 1, 2.5, 5, 10 6M) or
Levo (0.1, 1, 2.5, 5, 10 6M) individually for 16 hours and were then stimulated
with IL-1$ for 8 hours. The levels of GM-CSF and IL-8 in cultured
supernatants were measured by enzyme-linked immunosorbant assay
(ELISA).
Results: Our data showed that Ceti 5 and 10 6M and Levo 2.5, 5, and 10 6M
significantly suppress GM-CSF secretion by 29.29%, 38.45%, 39.94%,
38.09% and 42.85%, respectively. While Levo 5 and 10 6M significantly
suppressed IL-8 secretion (22.43% and 34.58%, respectively), this was
possible only with Ceti 106M (24.96%).
Conclusion: These results suggest that both cetirizine and levocetirizine at
higher concentrations reduce the release of GM-CSF and IL-8 from A549
human airway epithelial cells stimulated with IL-1$. These observations
indicate that these antihistamines may exert anti-inflammatory effects
beyond their antagonistic histamine H1-receptor activity. Our results suggest
that Levo could be more potent than Ceti in terms of anti-inflammatory
activity.
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A new interesting property of hydroxyzine, a drug used in the
treatment of chronic idiopathic urticaria and anxiety disorders
Jeffrey O’Sullivan1, Keith F. Tipton1, Rhys Whomsley2, and Margherita
Strolin Benedetti3. 1Trinity College, Biochemistry Dpt, Dublin, Ireland; 2UCB
Pharma SA, Non Clinical Development, Braine l’Alleud, Belgium; 3UCB
Pharma SA, Non Clinical Development, Nanterre, France.
Background: The histamine-H1 receptor antagonist, hydroxyzine (H) has a
wide variety of therapeutic applications, including the treatment of allergic
skin disorders and the control of nausea and vomiting caused by conditions
such as motion sickness. It is also used as a tranquilliser for the
symptomatic management of conditions such as generalised anxiety
disorder and the tension associated with psychoneuroses and in the
treatment of alcohol withdrawal symptoms. It is used too in the
management of pruritis associated with allergic conditions such as chronic
urticaria and histamine-mediated pruritus. Its Ki towards the human
histamine H1 receptor is 2 nM. The enzyme semicarbazide-sensitive
amine oxidase (SSAO; EC 1.4.3.6) exists as a soluble form in plasma
and a membrane-bound form associated with the exterior surface of the
plasma membrane in many tissues. The membrane-bound form can function
as a vascular adhesion in mediating the early stages of inflammatory
responses (Salter-Cid et al. JPET 2005). Monoamine oxidase (MAO) B
is involved in the oxidative deamination of an histamine metabolite,
N-telemethylhistamine.
Methods: H inhibitory properties towards the bovine plasma and membrane-
bound form of SSAO and towards rat liver MAO A and B have been
investigated as described by O`Sullivan et al. (J Neural Transm 2006).
Results: H is a relatively potent competitive inhibitor of bovine plasma SSAO
(IC50 = 20T0.5 6M; Ki = 1.8T0.4 6M). H was a somewhat less potent
competitive inhibitor of MAO B (Ki = 19T0.4 6M) and a very weak inhibitor
of the bovine membrane-bound form of SSAO (IC50È 900 6M) and MAOA
(IC50 È 650 6M).
Conclusion: The inhibitory values towards the bovine plasma SSAO are
higher than the reported plasma levels of the drug when administered at the
therapeutic doses of 25Y100 mg/day (Lader & Scotto Psychopharmacol
1998) [e.g. mean Cmax = 34 ng/ml (91 nM) and 73 ng/ml (195 nM) after a
single dose of 25 mg and of 39 mg, respectively (Simons et al. JACI 1984,
1995)]. However, as H plasma concentrations are higher after repeated




Level of GM-CSF secretion compared to IL-1$ (100%) Level of IL-8 secretion compared to IL-1$ (100%)
Cetirizine (%) Levocetirizine (%) p value vs. IL-1$ Cetirizine (%) Levocetirizine (%) p value vs. IL-1$
0.1 101.64T5.12 96.50T2.90 103.83T4.80 101.16T9.27
1 79.33T9.28 77.15T8.59 97.79T7.63 95.96T9.64
2.5 77.55T8.44 60.06T19.36 pG0.01 for Levo 98.73T2.60 88.97T5.69
5 70.71T11.80 61.91T15.00 pG0.05 for Levo & Ceti 89.70T1.06 77.57T6.09 pG0.01 for Levo
10 61.55T5.82 57.15T5.70 pG0.01 for Levo & Ceti 75.04T5.28 65.42T8.59 pG0.01 for Levo & Ceti
Mean T standard error of mean
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known, it would be interesting to examine the inhibitory properties of the
drug also towards the human plasma and membrane-bound form of SSAO,
in order to estimate the possible significance of such inhibition in terms of
the therapeutic actions of H.
598
Quantitative and qualitative analysis of circulating Vgamma9/
Vdelta2 T cells in newborns versus adults
Eduardo Campos, Naoki Shimojo, Masahiko Aoyagi, Takayasu Arima,
Yuzaburo Inoue, Minako Tomiita, and Yoichi Kohno. Chiba University,
Department of Pediatrics, Chiba, Japan.
Background: Human Vgamma9/Vdelta2 (V,9/V&2) T lymphocytes are
known to participate in the defense against microbial pathogens and have anti-
tumor activity. The cellular immune system of newborns is generally
considered to be immature and hypo-responsive in comparison to that of
adults. In this study we made a quantitative and qualitative comparison of the
V,9/V&2 T lymphocytes, their activation status and production of cytokines in
cord blood mononuclear cells (CBMC) versus those in adult peripheral blood
mononuclear cells (PBMC).
Methods: We employed flow cytometric analysis to compare numbers and
phenotypic characteristics of V,9/V&2 T lymphocytes between CBMC and
adult PBMC.
Results: Numbers of V,9/V&2 T cells are lower in CBMC than those in adult
PBMC while TCR expression levels were similar in both groups. Stimulation
of CBMC V,9/V&2 T cells with isopentenyl pyrophosphate (IPP) did not
induce IF-,, in contrast with adult PBMC positive production of this Th1
cytokine. The addition of IL-2 to IPP did not enhance IFN-, in CBMC V,9/
V&2 T cells. PMA/ionomycin stimulation did not lead to INF-, production in
CBMC V,9/V&2 T cells, inversely again, adult PBMC activation produced
this cytokine.
Conclusion: In addition to the immaturity of the adaptive immunity in
newborns, such as "$ T cells; CBMC V,9/V&2 T cells are hypo-responsive in
comparison with adult PBMC V,9/V&2 T cells and this may be associated
with the predisposition to infection with virus, bacteria and fungus, as well as
the development of allergic inflammation in newborns.
599
The matrix metalloproteinase 9 and its first type’s inhibitor type
(hMMP-9/TIMP-1) in bronchalveolar lavage fluid of pulmonary
tuberculosis patients
Andrey Safronov, Svetlana Sotnichenko, and Elena Markelova. Vladivostok
State Medical University, Pathophysiology, Vladivostok, Russian Federation.
Significant components of the territorial matrix are the matrix
metalloproteinase that is a group of proteolytic enzymes, which are
especially active in conditions of an inflammatory response. Matrix
metalloproteinase 9 (MMP 9) is produced by normal alveolar macro-
phages, granulocytes, and neutrophiles. Expression of MMP 9 is increased
in tissues affected by the process of remodeling and angiogenesis. Negative
influence of this process is restricted by tissular inhibitor of metallopro-
teinase (TIMP-1). Main function of TIMP-1 consists in regulation of
distraction of collagen and basic membrane components. We have
researched a quotient of MMP 9 and its first type’s inhibitor contained
in the bronchalveolar lavage fluid of 23 teenagers suffered from pulmonary
tuberculosis. Received results have been processed through statistical
analysis; an arithmetic mean (M) and a mean error (m) have been also
determined. Fidelity of results has been reckoned through Mann - Whitney
nonparametric test. Evaluation was made in accordance with the clinical
and laboratory findings and bacteriological test of sputum. The researches
have shown that quantity of hMMP-9/TIMP-1 in the bronchalveolar lavage
fluid of pulmonary tuberculosis patients comes to 2803, 85 T 270, 72 pg/ml.
It was also elicited a tendency for increase of hMMP-9/TIMP-1 in Koch`s
bacillus cases (+) (3127, 23 T 555, 20 pg/ml vs. 2735, 77 T 315, 58 pg/ml;
p90,05). Differences in hMMP-9/TIMP-1 of patients with local pulmonary
tuberculosis and infiltrative phthisis cases haven`t been revealed. The received
findings are not sufficient for making unambiguous conclusions concerning
pathogenetic value of the researched mediators and denote necessity for further
searches of diagnostic characters for inflammation in cases of teenagers`
pulmonary tuberculosis.
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The cytokines production at the experimental pneumonia
Anna Kostyushko and Elena Markelova. Siberian Branch of Russian
Academy of Medical Science, ¡The Fareastern Scientific Centred,
Vladivostok, Russian Federation.
Activation of cytokines system at different variants of the immune
inflammation occurs without dependence from the etiologic factor. At the
same time there is the data, testifying that microorganisms can develop the
products being similar cytokines, and thus influence on the cytokines cascade
at the immune answer. The purpose of the present investigation was to reveal
influence of the etiologic factor on parameters of the local and systematic
structure of the opposite cytokines (IFN, and IL-10) at the experimental
pneumonia caused by S. aureus and E. coli. Infection of mice of N˜AˆA` line was
spent intranasally in the doze of 1x103 mt/ml for S. aureus (I experimental
group) and 1x105 mt/ml for E. coli (II experimental group). Production of
cytokines by blood cells and mice lungs was investigated for the 10th day after
infection in reaction of IFA.
Results and Conclusion: At infection of mice S. aureus level of IFN,
considerably (8 G0,05) decreased (up to 0,84+0,1 pg/ml in blood and up to
36,38+2,38 pg/ml in supernatant of lungs). IL-10 level at mice of tentative
group also tended to decrease and made 14,15+1,3 pg/ml in blood and
70,8+2,88 pg/ml in supernatant of pulmonary tissue. At infection of mice
E. coli content of IFN, in blood changed little (3,97+0,28 pg/ml), and
decreased in supernatant of lungs, but not so prominently, as at mice of
tentative group (70,84+2,17 pg/ml). IL-10 level in blood of mice of the
second experimental group was authentic (8 G0,05) below than in group of
the control and made 10,8+0,87 pg/ml. And IL-10 level in supernatant of
pulmonary tissue at infection of mice by E. n˜oli increased practically in
2 times in comparison with the group of the control (186,08+5,13 pg/ml,
8 G0,05). Thus, carried out investigation revealed features of local and
systemic production of cytokines depending on etiology of the experimental
pneumonia. IFN, level under influence S. a`ureus prominently decreased.
Development of inflammatory process in the lungs, caused by E. coli,
rendered significant influence on local production of IL-10 increasing its
level more than in 2 times, moreover IL-10 authentically decreased in
peripheral blood.
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Rate of antiphlogistic cytokines in blood serum and lacrimal
liquid of the patients with ophtalmoherpes
Elena Markelova1, Natalya Derbasova2, and Anna Kostyushko1. 1Siberian
Branch of Russian Academy of Medical Science, ?The Fareastern Scientific
CentreX, Research Insti, Vladivostok, Russian Federation; 2Hospital 1,
Allergic Center, Vladivostok, Russian Federation.
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Ophtalmoherpes is a grand medical and social problem. Herpetic
infection of eyes is relapsed in 50% of cases and results to reducing acuity of
vision, disablement and deteriorates life activity. Enlargement of conception
regarding inflammatory mechanism let us opportunity to optimize respective
therapy.
Objective: To work out cytokines content (TNF-a´, GM-CSF, IL-12p70, IL-
12p40 and IL-2) in blood serum and lacrimal liquor of the patients.
Methods and Materials: Serum and lacrimal liquid of 60 ophtalmoherpes
patients were tested conformably (women 38, man 22). Control group
embraced 30 practically healthy volunteers without disease of organum visus.
Cytokines were quantified with IFA method using specific reagents BR and D
Diagnostics Inc.[ (USA).
Consequences and Discussion: We found polysemantic modification of
local and systemic cytokine profile of patients as against reference group. In
blood serum were determined acceleration of IFNa´ 30-50 times more
(n˜G0,001), IL-2 level 2-10 times more (pG 0,5), IL-12p40 content decreased
1,5-3 times (pG0,05), whereas GM-CSF and IL12p70 were near to standard.
The abovementioned indices in lacrimal liquor appeared in the following
way. Authentically increasing of IL12p70 level (10,08+1,29 pg/ml against
4,98+1,1 pg/ml, pG0,01) and GM-CSF (7,57+1,73 pg/ml against 2,15+0,64
pg/ml, pG0,01). TNFa´ and IL-12 modifications had a tendency to
heightening (pG0,2), whereas IL-12p40quantity reduced (pG0,05) in the
same way as in blood serum. Obtained results allow us to draw a
conclusion, that at ophtalmoherpes disease neutrophiles and macrophages
mainly are more active locally and produce GSM-CSF and IL-12p70.
System response is characterized by hyper production of TNF! and IL-2.
Compensative anti-inflammatory reaction distressed as locally as
systematically.
602
Streptokinaza indused pulmonary infilltrates with
hipereosinophilia-case report
Biserka Kaeva, Oliver Jovkovski, and Sasa Kaeva. Medical Faculty,
Pulmology and Allergology Clinic, Skopje, Macedonia, Fyrom.
The various drugs and enviromental agents capable of producing
acute pulmonary infiltrates with eosinophilia. We present a man on 48 with
acute infarct of myocardi who was treated with streptokinaza besides the
usual cardiological treatment. From the anamneza we faund aut that the
patient did not have problems with his heart, neither any kind of alergic or
some other kinds of ilneses. By the first impresion the patient was
conscious, skared,dispnoic, afebril,with strong pain on his chest. By
auskultation he had anormalvezicular breathig and heart rate of 110/min.
The other phisical finds were in order. Imidiately after the posed diagnoza, a
usual cardiological therapy was given and in the same time a streptokinaza
(1500 000IE) was included. The patient beard this treatment very well. On
the third day of the therapy his health condition deteriorated. He got
frequent chaemoptisis, increased temperature(38C), decreased blod presure,
and rich find of rales on clinical examinaton. Laboratory examination
showed:ESR 42mm/1st hour, strong blod reduction, eosinophilia 49%,
leukocytosis. On the x-chest ray both upper lobes were caracteristicaly
involved and were described as the Bphotographic negative[ the radio-
graphic shadows seen in pulmonary oedema. Chest CT showed bilateral
pulmonary infiltrates mainly in upper and middle lobes. Bacterial
examination and cultures of sputum were all negative. The search for
parasistic infestation was negative as well as for BK infection. The lung
volumens and diffusion capacities werw decreased and hipooxemia was
most prominent. We started the therapy with 40mg prednisone daily with
successive decrising in the folowing 6 weeks and also antibiotic and oxigen
therapy. Some improvement was seen in less than a week but the
radiograpfic shadows had completely resolved for 6 weeks. The number of
eosinophils olso came back to normal.
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Serum IgE and Eosinophils(Eo) as an indicators for severity in
pulmonary thromboembolismus
Biserka Kaeva, Gorica Breskovska, Zoran Arsovski, and Kamelija Busljetic.
Medical Faculty, Pulmology and Allergology Clinic, Skopje, Macedonia,
Fyrom.
Background: Pulmonary thromboembolismus can be presented through
pulmonary infiltration, which manifestation depends on extensiveness of the
pulmonary embolisation and the presence of pleural effusion (PE). In a period
of 3 years 29 pts with pulmonary thromboembolism were studied with regard
to serum concentrations of IgE, D-dimer and Eosinophils in the pleural fluid
during acute phase (on hospital admission) and after treatment (recovery
phase).
The aim of the study was to estimate the correlation between these
parameters during acute and recovery phases.
Methods: The number of eosinophils in the pleural fluid was determined
from smear of pleaural fluid colored by May-Grunwald Giemsa. Serum IgE
was measured with Radioimmunoassay diffusion (RID).
Results: The serum IgE concentration increased during the acute phase to
422+/- 307 IU/ml and decreased afterwards in all pts. The increase in serum
IgE concentration lagged a few days behind that of the serum D-dimer
concentration, indicating later IgE production then thrombus formation and
lysis. Most of the pts developed a small chaemoragic PE, while 7 of them had
more then 30% of eosinophils and highest levels of IgE measured in acute
phase.
Conclusion: These results indicated a relationship between serum IgE
concentration and patophisiology of pulmonary thromboembolismus. Serum
IgE and Eo count may be a good mark of severity for pulmonary
thromboembolismus indicating on pathogenesis and prognosis.
604
Modulation of peripheral and cord-blood derived gamma/delta
T cells immune response after stimulation with newly designed
compounds: possible new therapeutic approach
Mancino Giorgio1, Auricchio Giovanni1, Battistini Luca2, Galli Elena1,
Colizzi Vittorio3, Brunetti Ercole1, and Placido Roberta2. 1San Pietro
Hospital - Fatebenefratelli, AFaR Research Centre, Roma, Italy; 2Santa Lucia
Foundation - IRCCS, Neuroimmunology Unit, Roma, Italy; 3University of
Rome - Tor Vergata, Dept. Biology, Roma, Italy.
Immune system, in response to infective or allergic agents, makes
use of different cellular populations, such as alfa/beta and gamma/delta
(g/d) T cells. The latter are present in both peripheral (PB) and cord (CB)
blood, being the second in a immature stage, and respond to a variety of
non-peptidic antigens, through a HLA-independent system, by secreting
pro-inflammatory and immunomodulant cytokines, expressing membrane
receptors and costimulatory molecules, and producing cytotoxic effectors
such as perforin and granzyme. Recent studies have suggested that also the
less common g/d T cells may play a role as effectors and immunor-
egulatory cells in the development and perpetuation of allergic inflamma-
tion and also in bronchial asthma, rhinitis and eczema We aimed at
analysing the capability of g/d T cells derived from PB or CB to respond
to non-proteic antigens, in view of a putative therapeutic use in newborn or
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infant pathologies. We firstly found that CB-derived g/d cells strongly
respond to stimulation with aminobiphosphonate (ABs) compounds, such
as pamidronate and zoledronate, in terms of expansion, whereas
stimulation with pyrophosphates (PPs) only lead to no or little expansion.
The population expanded with ABs is also perfectly functional, since cells
are able to produce large amounts of cytokines (TNFalfa e IFNgamma) if
secondarily stimulated with he same antigens. Interestingly, also PPs can
induce ABs-expanded cells to cytokine production after a secondary
stimulation, suggesting the existence of different responsive pathways
concerning expansion and cytokine production in CB-derived g/d cells.
Once established that CB g/d T cells are functional and can be efficiently
stimulated, we focused our study to the stimulation or down-regulation of
g/d T cells with newly designed and synthesised compounds (NCs). We
therefore characterised a small-compounds library, and selected few
molecules for their capability to stimulate or down-modulate g/d T cells
from PB. We than used these molecules also for CB g/d stimulation. We
found that, following stimulation with NCs, CB-derived g/d T cells
strongly respond in terms of both cellular expansion and cytokine
production, and this result was confirmed though the use of CB-derived
gamma/delta clones. Studies are in progress to evaluate the toxicity of
these compounds, and consequently their employment in vivo as g/d T
cells immunomodulators in new therapeutic approach on infectious or
allergic diseases.
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A novel low molecular weight thiol compound, N-acetylcysteine
amide, attenuates allergic airway inflammation
and hyperresponsiveness
Yong Chul Lee1, Kyung Sun Lee1, So Ri Kim1, Hee Sun Park2, Seoung Ju
Park1, Kyung Hoon Min1, Ka Young Lee1, Yeong Hun Choe1, and Daphne
Atlas3. 1Chonbuk National University Medical School, Department of
Internal Medicine and Airway Remode, Jeonju, Republic of Korea;
2Chungnam National University Medical School, Department of Internal
Medicine, Daejeon, Republic of Korea; 3Silverman Institute of Life Sciences,
The Hebrew University of Jerusalem, Department of Biological Chemistry,
Jerusalem, Israel.
Background: Reactive oxygen species (ROS) play an important role in the
pathogenesis of airway inflammation and hyperresponsiveness. Recent
studies have demonstrated that antioxidants are able to reduce airway
inflammation and hyperreactivity in animal models of allergic airway disease.
A newly developed antioxidant, small molecular weight thiol compound, N-
acetylcysteine amide (AD4) has been shown to increase cellular levels of
glutathione (GSH) and to attenuate oxidative stress related disorders.
However, the effects of AD4 on allergic airway disease such as asthma are
unknown.
Objective: This study aimed to determine the effects of AD4 on bronchial
inflammation and airway hyperresponsiveness.
Methods:We have used a mouse model for allergic airway disease. The
effects of AD4 on bronchial inflammation and airway hyperresponsive-
ness studies by measurement of intracellular ROS, GSH, glutathione
disulfide, vascular permeability, proteins, tissue inflammation, and airway
resistance.
Results: The increased levels of Th2 cytokines, nuclear factor-.B (NF-.B)
and hypoxia-inducible factor-1! (HIF-1!), and vascular endothelial growth
factor, the increased ROS generation, the increased vascular permeability, and
the increased mucus production after ovalbumin inhalation were significantly
reduced by the administration of AD4.
Conclusion: These results suggest that AD4 attenuates airway inflammation
and hyperresponsiveness by regulating activation of NF-.B and HIF-1! as
well as reducing ROS generation in allergic airway disease of mice.
Clinical implication: These findings provide an important molecular
mechanism for the use of a novel antioxidant, AD4 to prevent and/or treat
asthma and other airway inflammatory diseases.
606
Th1-dominant shift of T cell cytokine production, and
subsequent reduction of serum immunoglobulin E response by
administration in vivo of beta-carotene in a mouse model
Mykola Korzh. Kharkov National University, Fundamental Medicine,
Kharkov, Ukraine.
Background: Th1 and Th2 cells, resulting from antigenic stimulation in
the presence of IL-12 and IL-4, respectively, are implicated in the
pathology of various diseases including allergic and autoimmune diseases.
In this study we have asked whether administration of beta-carotene brings
about a Th1/Th2 shift in vivo of the mice, and subsequent reduction of
circulating IgE.
Methods: Feed containing beta-carotene was administered orally to BALB/c
mice immunized intraperitoneally with ovalbumin (OVA) for approximately 1
month. The titers of OVA-specific IgE, OVA-specific IgG1 and OVA-specific
IgG2a in the mouse sera were determined. Cytokine productions by the spleen
cells and serum Ig concentrations were studied by ELISA. We also examined
the effect of fed beta-carotene on active systemic anaphylaxis.
Results: Feeding beta-carotene to mice immunized with OVA inhibited the
immediate reduction of the body temperature induced by antigen stimulation.
Furthermore, the increase in serum histamine in the mice fed beta-carotene
under active systemic anaphylaxis was lower than in controls. We then
examined the pattern of cytokine production by spleen cells from mice
followed by restimulation with OVA in vitro. The spleen cells showed
enhanced Th1-specific cytokine production; spleen cells from the beta-
carotene administered mice produced more IFN-gamma as compared with
those from control mice in an antigen-specific manner. IL-2 and IL-4
secretions of the spleen cells were comparable between the two mouse
groups. Beta-carotene administration did not reduce serum IgG concentra-
tion. It markedly reduced total IgE level and an IgG1/IgG2a ratio, reflection
of Th1/Th2 balance, in sera. Furthermore, beta-carotene administration
reduced ovalbumin (OVA)-specific IgE levels in sera of the OVA sensitized
mice.
Conclusion: Thus, beta-carotene enhances IFN-gamma secretion and thus
modulates Th1/Th2 cytokine balance, leading to reduction of serum IgE.
607
Effect of statins on PBMC and NK cells and on fibroblasts from
human nasal polyps and turbinates
Chiara Folli1, Desideria Descalzi1, Francesca Scordamaglia1, Anna Maria
Riccio1, Cinzia Gamalero1, and Marco Barbieri2. 1University of Genoa,
Department of Internal Medicine, Genoa, Italy; 2University of Genoa, ENT
Department, Genoa, Italy.
Background: Statins are serum cholesterol-lowering agents used for the
prevention of atherosclerotic vascular disease but there is, a growing evidence
they might have immunomodulatory activities.
Methods: To evaluate the effect of these drugs in allergic diseases we treated
PBMC from healthy and allergic patients in vitro with ParJ1,2 (5 2g/ml),
Fluvastatin (0,1 2M), Atorvastatin (1 2M) and Simvastatin (1 2M) alone and
in combination.
NK derived from healthy subjects were activated with IL-2 (300 U/ml)
alone or with the addition of statins.
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We also evaluated their effect on fibroblast cultures derived from
human nasal polyps and turbinates stimulated as follows: not treated and
treated with FGF (5ng/ml) alone or in combination with statins.
Results: After different days in culture, cells were analyzed by flow-citometry
for the evaluation of the following cell surface receptors: CCR3, CCR4,
CXCR3 and CCR5 for PBMC; NKp30, NKp44 and NKp46 for NK cells and
CD106 and CD54 for fibroblasts.
Our results show that statins have no modulatory effect on cell surface
protein expression from both PBMC and NK.
CD54 was not modulated by the treatments in nasal polyp fibroblasts,
whereas in turbinate fibroblasts its expression was upregulated by FGF and
downregulated after the addition of Fluvastatin or Atorvastatin.
Interestingly, also CD106 expression was not modified in nasal polyp
fibroblasts stimulated or not with FGF and statins. Fibroblasts from turbinates
showed an increased expression of CD106 after stimulation with FGFand only
the addition of Atorvastatin was able to downregulate it.
Conclusion: In conclusion, the different behaviour of statins on the diverse
kind of cells in vitro is prompting news in the studies about their use for the
treatment of inflammatory diseases.
ENVIRONMENTAL FACTORS
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Latex allergy in operating room; not frequent but severe
Gulbin Karakoc, Mehmet K]l]c, Ayfer Inal, Seval Kendirli, Derya Altintas,
and Mustafa Yilmaz. Cukurova University, Faculty of Medicine, Pediatric
Allergy-Immunology, Adana, Turkey.
Objective: Latex allergy is becoming a major health concern among
healthcare workers, of whom approximately 2.8 to 18% are reportedly
sensitized. The aim of this study to determine the prevalence of latex allergy
and potential crossreacting foods in operating room stuffs.
Methods: One hundred and four operating room stuffs (aged 24 years to 58
years) including doctors, nurses and technicians completed a latex allergy
questionnaire. They were questioned about symptoms of latex reactivity and
about other allergies particularly to foods that may crossreact with latex.
Informed consent was obtained and skin prick tests were performed with
natural rubber latex.and with five potentially crossreacting foods (banana,
kiwi, melon, tomato and potato). Specific IgE antibodies against latex and
these foods were evaluated (Pharmacia CAP RAST system).
Results: Five personnel (4.8%) described allergic symptoms they attributed to
latex exposure. All latex allergic stuffs had skin symptoms, 2 had severe
anaphylactic reaction and 2 had severe asthma. All these 5 personnel had
positive reactions to both latex and crossreactive foods. Specific IgE against to
latex was found to be positive in this group. There was no significant
difference between the latex SPT-positive and -negative health care workers
according to age, sex and total exposure time to latex.
Conclusion: In this study we found the prevalence of allergy 4.8% among the
operating room personnel. Although latex allergy was not more frequent in our
population its presence may lead to severe allergic reactions such as
anaphylaxis and severe asthma.
609
Dog ownership and contact with dogs during childhood and later
development of allergy; results of combined German birth
cohort studies
Chih-Mei Chen1, Verena Morgenstern1, Wolfgang Bischof2, Olf Herbarth3,
Michael Borte4, Heidrun Behrendt5, Ursula Kra¨mer6, Andrea von Berg7, Carl
Peter Bauer8, Sibylle Koletzko9, H.-Erich Wichmann10, and Joachim
Heinrich10. 1GSF Y National Research Centre for Environment and Health,
Institute of Epidemiology, Neuherberg, Germany; 2Friedrich-Schiller-
University of Jena, Department of Indoor Climatology (ark), Jena,
Germany; 3UFZ-Centre for Environmental Research Leipzig, Department of
Human Exposure Research and Epidemio, Leipzig, Germany; 4Sta¨dt.
Klinikum BSt.Georg[ Leipzig, Klinik fu¨r Kinder -und Jugendmedizin, Leipzig,
Germany; 5GSF, Germany, Environmental Dermatology and Allergology,
Neuherberg, Germany; 6IUF-Institut fu¨r Umweltmedizinische Forschung,
Institut fu¨r umweltmedizinische Forschung, Du¨sseldorf, Germany; 7Marien-
Hospital Wesel, Marien-Hospital Wesel, Wesel, Germany; 8Munich Technical
University, Kinderklinik und Poliklinik, Munich, Germany; 9Munich
University Hospital, Kinderklinik und Kinderpoliklinik im Dr. von Haune,
Munich, Germany; 10GSF, Germany, Institute of Epidemiology, Neuherberg,
Germany.
Background: The effect of dogownershipduring childhoodon the development
of allergy has been investigated in few studies with conflicting results.
Objective: We investigate the association between childhood dog ownership,
regular contact to dogs, and indoor endotoxin exposure during infancy and the
development of allergic sensitization and atopic disease up to age 6 in 2
German cohort studies.
Methods: Data from two ongoing birth cohorts GINI (n=1962) and LISA
(n=1193) were analysed. In both studies, information on children_s contact
with dogs and their allergic symptoms and doctor diagnosed allergic disease
were collected at each follow-up using questionnaire. Specific IgE antibodies
to common aeroallergens were measured at age 6. House dust samples were
collected when the children were 3 months old and the amount of endotoxin in
house dust was determined.
Results: Dog ownership in early childhood was associated with a significant
lower rate of mixed pollen and inhalant sensitization but had no effect on dog
sensitization and the prevalence of allergic symptoms and diseases up to age 6.
Regular contact with dog during childhood without ownership was not
associated with any of the health outcomes. No associations were found
between house dust endotoxin exposure during infancy and sensitization to
dog, mixed pollen, and inhalant allergens.
Conclusion: Dog ownership in early childhood protects against the
development of inhalant sensitization and this effect cannot be attributed to
the simultaneous exposure to endotoxin.
610
School-a source for exposure to furry-pet allergens
Lena Elfman, Yahong Mi, Dan Norba¨ck, and Greta Smedje. Occupational
and Environmental Medicine, Department of Medical Sciences, Uppsala,
Sweden.
Background: The school environment is an important source of exposure to
furry-pet allergens for most children in Sweden. This will have an impact on
their health and possibly on development of allergy. The aim of this study was
to compare two methods of allergen sampling, and to investigate the
association between percentage of animal owners and allergen levels.
Methods: Totally 120 classes in 35 primary and secondary schools in
Uppsala, Sweden, were randomly selected. A questionnaire, including
questions on pet ownership, was answered by 2 355 pupils aged 7Y13 years.
Samples of settled dust were collected from floors and furniture throughout the
classroom with a vacuum cleaner with a special sampling filter (ALK Abello).
Airborne particulates were collected passively in Petri-dishes placed in the
class-rooms over a week. Allergen levels for cat, dog and horse were
determined using ELISA. Correlations between allergen levels in settled dust
and air, and number of cat- and dog owners as well as those who ride in each
class were analysed by Spearman_s rank correlation, with a two-tailed
significance level of 5%.
Results: The geometric mean (GM) allergen level in settled dust was 1530
ng/g for Fel d 1, 1420 ng/g for Can f 1, and 1340 U/g for Equ cx. In Petri dish
samples, the GM allergen level was 1.8 ng/sample for cat, 1.3 ng/sample for
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dog and 4.7 U/sample for horse. The percentage (GM) of cat-owners was 27%,
dog-owners 14% and horse contact 8%. Cat allergen level in dust correlated
with cat in air (0.33, p=0.000) and percentage of cat-owners (0.30, p=0.001).
Dog allergen level in dust correlated with dog allergen in air (0.27, p=0.003),
and percentage of dog-owners (0.40, p=0.000). The same was valid for horse
allergen level in dust, which correlated with horse allergen in air (0.37,
p=0.000) and percentage of those who ride (0.44, p=0.000).
Conclusion: In all cases, we found a correlation between percentage of
animal-owners or riders and allergen levels in dust and air samples. A
correlation between dust and air allergen levels has seldom been shown before.
We believe that sampling over the whole floor, benches and chairs gives a more
representative value. However, dust levels are proxy variables, and air levels
may be a better measure of allergen exposure.
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Socioeconomic status and environmental factors affecting
cockroach sensitization in atopic children
Nipasiri Voraphani, Suparat Pohnu, Pantipa Chatchatee, and Jarungchit
Ngamphaiboon. Faculty of Medicine, Chulalongkorn University, Pediatrics,
Bangkok, Thailand.
Background: Cockroach is the second most common aeroallergen in all over
the world. However, there were few studies about the correlation of
socioeconomic status or environmental factors and cockroach sensitization
in Southeast Asia. The purpose of our study was to determine the
socioeconomic and environmental factors affecting cockroach sensitization
in atopic children.
Methods: One hundred and twenty children aged 3Y15 years attending the
allergy clinic, Department of Pediatrics, Faculty of Medicine, Chulalongkorn
University, with symptoms of asthma, allergic rhinitis or atopic dermatitis, and
with skin test reactivity to at least 1 allergen were enrolled. Questionnaires and
skin prick testing results were analysed.
Results: There were 80 boys and 40 girls (average age 9). Eighty one percent
of patients had allergic rhinitis, 23% had asthma, and 9% had atopic dermatis.
Cockroach sensitization was found in 76% of patients, of which 22%, 12%,
42% were sensitized to German cockroach, American cockroach, and both,
respectively. There was no statistical correlation between socioeconomic status
or environmental factors, including household income, home’s character,
home environment, amount of cockroaches seen in home, and cockroach
sensitization.
Conclusion: There was high incidence of cockroach sensitization in atopic
children. However, socioeconomic status, amount of cockroaches seen in
home, and other environmental factors were not correlated with degree of
sensitization.
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Asthma severity is influenced by indoor dust mites but not
endotoxin or nitrogen dioxide exposure in Hong Kong children
Ting Fan Leung1, Yun Sze Wong1, Edmund Yung1, Iris H. S. Chan2, Chung Yi
Li1, Christopher W. K. Lam2, and Gary W. K. Wong3. 1The Chinese University
of Hong Kong, Department of Paediatrics, Hong Kong, Hong Kong; 2The
Chinese University of Hong Kong, Department of Chemical Pathology, Hong
Kong, Hong Kong; 3The Chinese University of Hong Kong, Department of
Paediatrics, Shatin, N.T., Hong Kong, Hong Kong.
Background: Endotoxin exposure has dual effects on protecting against
wheezing disorders in early life but worsening control in Caucasian asthma-
tics. Exposure to house dust mites (HDM) and nitrogen dioxide (NO2) were
also known risk factors for severe asthma in this population. However, such
data is unclear in Asians. This study investigates indoor exposure to endo-
toxin, HDM and NO2 in Hong Kong asthmatic children, and its relation to their
disease severity.
Methods: Asthmatics aged 6 to 18 years old were eligible, and spirometry and
exhaled nitric oxide (eNO) were measured in the clinic. Home visits were done
within 10 days. Dust was collected from patients’ mattress, and carers com-
pleted ISAAC written questionnaire. House dust Der p 1 and endotoxin levels
were measured by enzyme-linked immunosorbent and chromogenic limulus
amoebocyte lysate assays, respectively. Average NO2 levels in kitchens were
measured over 48-hour periods by Ogawa sampler badge.
Results: 115 asthmatic patients, aged 12.4 T 3.2 years, were recruited. Their
median FEV1 and eNO were 92% predicted and 50.5 ppb. Fifty-eight percent
of these patients wheezed in past 12 months, and 44% of asthmatics received
inhaled steroid. During home visits, 39.2 (24.6/65.9) mg mattress dust was
collected. The median (IQR) mattress Der p 1 and endotoxin levels were
0.61 (0.24/2.46) 2g/g and 12.4 (6.4/19.5) EU/mg, respectively. A trend was
observed for the correlation between mattress Der p 1 and endotoxin load
(> = <0.176, P = 0.060), but neither factor was associated with indoor NO2
(P 9 0.15). Der p 1 levels = 2 2g/g was found in 29% of families. Kitchen
NO2 levels were 27.1 T 10.4 ppb, and which exceeded 21 ppb in 78% of
families. Indoor Der p 1 levels were significantly associated with night
awakening (P = 0.049) and eNO (P = 0.010), whereas mattress endotoxin
load was higher in patients with low peak expiratory flow rate (P = 0.031).
No association was found between indoor NO2 and any clinical or
spirometric parameter.
Conclusion: Our results suggest that asthma severity in Chinese children is
affected by current exposure to HDM allergen in mattress but not indoor
endotoxin or NO2 exposure.
613
Effect of indoor mold concentrations on daily symptom severity
of children with asthma and/or rhinitis monosensitized to molds
Ayfer \nal1, Derya Ufuk Altintas1, Gu¨lbin Bingo¨l Karako01, Hatice
Korkmaz Gu¨venmez2, Rukiye GeliSken2, Yeliz Aka2, Mustafa Yilmaz1,
Mehmet Kilic1, and Seval Gu¨neSer Kendirli1. 1Cukurova University, Faculty
of Medicine, Pediatric Allergy and Immunology, Adana, Turkey; 2Cukurova
University, Department of Biology, Adana, Turkey.
Little is known about the contribution of indoor molds to the symp-
toms of asthma and/or rhinitis in children monosensitized to molds. We aimed
to investigate the effect of indoor mold spore concentrations on daily
symptoms of asthma and/or rhinitis in children monosensitized to molds.
Nine-teen children with asthma and/or rhinitis sensitized only to molds
recorded their daily symptoms and PEF values to the diaries, from February
2005 to January 2006. In this study period, indoor mold concentrations were
measured monthly from the living/bedrooms.
The median indoor mold concentration was 37.5 CFU/m3. Most
commonly recovered indoor molds were Cladosporium (26.4 %), Penicillium
(24.7%) and Aspergillus (7%). There was not found significant correlation
between indoor mold concentrations and daily rhinitis score (r = <0.021, P =
.932), daily asthma score (r = 0.155, P = .554), daily morning PEF (r = <0.056,
P= .475) and evening PEF (r = <0.057, P= .471).
The effect of indoor molds is not evident on the symptoms of our
patients with asthma and/or rhinitis monosensitized to molds.
614
Influence of air quality in schools upon the children with chronic
bronchopulmonary diseases
Rodica Selevestru, Svetlana Sciuca, Grigore Friptuleac, and Cazacu Angela.
State of Medical Univercity, Pediatry, Chisinau, Moldova, Republic of.
Aim: To emphasize the influence of air quality in study rooms of schools in
children with chronic bronchopulmonary diseases.
Methods: The study planned to interview 1384 of pupils of I-IV class from
different schools, for selection of children with chronic respiratory diseases.
The lot of study included 54 of children with chronic bronchopulmonary
diseases. The clinic examination of these children emphasized 18 cases with
bronchial asthma, 9 cases with obstructive chronic bronchitis and in 27 cases
simple chronic bronchitis. The hygienic condition of occupation conditions in
study rooms of pupils was carried out by means of Air Quality Monitor (AQ-
5000, USA), that determines the values of microclimate factors (temperature,
air humidity, CO2 concentration).
Results: Hygienic evaluation of occupation conditions in study rooms
detected a subnormal thermal regime 15,54 T 0,1-C, at the beginning of first
lesson 16,8 T 0,2-C and at the end of last lesson (optimal t +20 +25-C). The
values of air humidity in study rooms were increasing from 51,11 T 1,8% at the
beginning of first lesson to 56,71 T 2,3% at the end of last lesson (optimal
humidity 30/60%). More significant are the modifications of CO2 in the air,
that varies during the day 0,07 T 0, 009% at the beginning of first lesson and 0,
21 T 0,02% (p G 0,001) at the end of last lesson (optimal concentration of
CO2 G 0,1%. The respiratory functional condition of children with chronic and
recurrent respiratory diseases certifies the presence of obstructive disturbances
(PEF j 72,3 T 1,7%; FVC/FEV1 j82,6 T 2,3%; FEF25j75 j91,7 T 2,1%
and minimal restrictive changes FVC Y 76,5 T 2,1% ; FEV1 j82,6 T 1,9%.
Conclusion: The reduced temperatures, increased humidity and excessive
concentrations of CO2 in child microambience lead to installation and
perpetuation of respiratory symptoms in children with bronchial asthma and
chronic bronchitis.
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Smoking and asthma-like symptoms in schoolchildren
Maya Tafradjiiska1, Antoaneta Manolova2, Galia Tzolova3, and Dimitar
Kostadinov4. 1University Hospital of Lung Diseases, Medical University,
Sofia, Diagnostic and Consultative Dept., Sofia, Bulgaria; 2National Center
of Public Health Protection, Child and Adolescent Health, Sofia, Bulgaria;
3National Center of Public Health Protection, Health Promotion and Disease
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Prevention, Sofia, Bulgaria; 4University Hospital of Lung Diseases, Medical
University, Sofia, Bronchology Dept., Sofia, Bulgaria.
Background: The prevalence of bronchial asthma has increased world-
wide over the last twenty years. This tendency is particularly valid for the
adolescent population.
The aim of the presented study is to evaluate the prevalence of ado-
lescent smoking patterns, parental smoke, exposure to environmental tobacco
smoke and the asthma-like symptoms in their relation with active and passive
smoking among teenage school-children.
Methods: It is done a cross-sectional questionnaire study (a modified ver-
sion of Compendium of European Respiratory Standard Questionnaires-
CERSQ) with 304 students, aged 15Y16 from three secondary schools in
Sofia-Bulgaria inquired.
Results: Active smokers are 85 students (28,7%), 45% of them smoke reg-
ularly. The average age for starting smoking is 13,2 years and average number
of smoked cigarettes per day is 7,4. Regular exposure to tobacco smoke is
reported by 201 students (66,3%) and the exposition is between less than
5 years and 15 years. Respiratory symptoms (during the last 12 months):
wheezing and whistling in the chest are reported by 22,3% of the students; with
in addition shortness of breath in 38.2% of them. Night cough is reported by
39,1% and asthma attack by 2,6% of the examined students. Antiasthma drugs
have been taken by 1.6%. The statistical analysis of the questionnaires showed a
significant association between Bwheezing and whistling in the chest[ and
Bactive smoking[ (p G 0,01); between Bnight cough[ and Bactive smoking[
(p G 0,01); Bnight cough[ and Bactive smoking[ (p G 0,05); Bnight cough[ and
Bpassive smoking[ (p G 0,01).
Conclusion: The founded associations support the idea that smoking (both
active and passive) plays a role in the initiation, development or maintenance
of asthma-like symptoms. The intervention strategies for smoking control
should include both public policies elements and preventive measures imple-
mented by health professionals, in particular the general practitioners and
school health staff.
616
School environment and children health impact in
developing country
Rajan Bhandari1 and Shambhu D. Joshi2. 1Community Health and Environ-
mental Society Nepal, Community Health, Kathmandu, Nepal; 2Nepal Medical
College Teaching Hospital, Medical Sciences, Kathmandu, Nepal.
Background: Developing country like Nepal has poor health status in school
students.
Objective: To know and evaluate the indoor environmental condition of
government and private-schools and the health impacts on students.
Methods: A cross sectional studied of representative samples of 35 schools of
selected region of Nepal including government and private schools. Onsite
observation and health check up & interview with students and teachers were
done. Specific scores was given in each criteria. The data were analysed and
edited in EPI info program.
Results: The results shows that 89% of government school and 45% of private-
schools have poor environmental condition and 69% of government schools
students are suffering from environmental-health problem while only 22% of
private school student are suffering from some kind of diseases especially
allergic. Government-school doesn_t have the standard classroom, adequate
sports facility, safe drinking water, light and ventilation in comparison with
private schools.
Conclusion:We conclude that the main causes are poor socio-economic status,
illiteracy of parents, negligence, hard housework for children, diseases,
malnutrition, incomplete immunisation and lack of health education. The poor
environment condition includes crowded students in a classroom, poor ven-
tilation, shortage of clean drinking water, untidy clothes of students, poor
nutrition and lack of greenery in the school area, school near by road, air
pollution and lack of environmental awareness among teachers and parents.
The government schools have limited budget, resources with compared to
private schools andmost of the lower and lower middle class family children are
studying in government schools which covers nation 82% of total students.
Recommendation: The government should allocate the special budget to the
government schools and it should be utilised from the available resources such
as good ventilation, limited student in a class, awareness among teachers and
parents. Last but not the least, this type of programs are helpful to prevent from
environmental health hazards also.
617
Air-conditioning bedroom and allergic sensitization in atopic
patients
Tachakwan Intapuntee, Panithi Boondumnern, Pantipa Chatchatee, and
Jarungchit Ngamphaiboon. King Chulalongkorn Memorial Hospital, Pedia-
trics, Bangkok, Thailand.
Background: One of the recommendation of environmental control for al-
lergic prevention was air-conditioning bedroom. The purpose of our study
was to determine the relationship between air-conditioning bedroom and al-
lergic sensitization.
Methods: Patients with asthma and/or allergic rhinoconjunctivitis attended
pediatric allergy clinic, King Chulalongkorn Memorial Hospital age
3/25 years old and had positive prick skin test for aeroallergen at least 1
antigen were studied by questionnaire.
Results: A total of 180 patients were included, 116 (64.4%) males, 64
(35.6 %) females, 96 (53.3%) lived in households with air-conditioning bed-
room. American cockroach sensitization was significantly more prevalent in
patients lived households without air-conditioning bedroom (58 %) compared
with the other who lived in air-conditioning bedroom (44 %) (p = 0.048, Odds
ratio 1.726). In contrast, Alternaria sensitization was significantly less
prevalent in households without air-conditioning bedroom (3.4 %) compared
with air-conditioning bedroom (15.6 %) (p = 0.006, Odds ratio 0.2). Poly-
sensitization (skin prick test positive at least 3 antigen) was no significantly
related among households without and with air-conditioning bedroom
(p 9 0.05). Cockroach is the second most common aeroallergen sensitization
from mite but there was no correlation between amount of cockroach seen in
the house and skin test results. There was no correlation between cat and dog
exposure or cigarette smoking and allergic sensitization.
Conclusion: Patients living in households without air-conditioning were at
increased risk of cockroach sensitization but decreased risk of in mold
sensitization.
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Efficiency of neem tree extract (Milbiol) in decreasing the level of
house dust mite allergens
Tiia Voor, Ylle Kuld, Tiina Rebane, and Kaja Julge. Tartu University
Hospital, Children´s Clinic, Tartu, Estonia.
Background: Sensitization against house dust mite (HDM) allergens is
common in Estonia and the level of D. pteronyssinus (Der p1) and D. farinae
(Der f1) is high in the houses. Diminishing contact with HDM reduces allergy
symptoms and therefore it is important to decrease the level of HDM allergens.
Milbiol (Hexal AG, Holzkirchen, Germany ) is an oil extract produced from
neem tree (margosa) seeds. Milbiol is harmless for humans and animals,
although it hinders growth and reproduction of mites.
Aim: To estimate the efficiency of Milbiol in decreasing the level of HDM
allergens.
Methods: Study period was Dec 2003 - Dec 2004. Study group comprised 44
beds from 19 homes. Twenty-five beds were vacuum cleaned and treated with
Milbiol (intervention group) and 19 beds were only vacuum cleaned (control
group). Frequency of cleaning was identical and it was performed at the same
time for beds of both groups. The dust samples were collected on the 1st, 3rd
and 12th month and treatment with Milbiol was performed on the 1st and 2nd
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month according to the manufactory instructions. The levels of Der p1 and Der
f1 in the dust samples were measured by ELISA method. Data about the living
conditions were also collected.
Results: In all beds the level of Der f1 (8614 T 2654 ng/g) was higher than the
level of Der p1 (520 T 260 ng/g, p G 0.001). HDM allergens were more
common in old brick houses, on lower floors, in rooms with carpets and in
beds older than 5 years. Before and after treatment with Milbiol the mean level
of Der f1 was 4180 T 1502 ng/g and 2784 T 868 ng/g, respectively; p 9 0.05,
however, after one year the level increased up to 6032 T 2092 ng/g. The level of
Der p1 increased after treatment with Milbiol from 556 T 353 ng/g up to 784 T
408 ng/g; p = 0.005; although after 12 months the level was lower than
before treatment (282 T 163 ng/g). The mean level of HDM allergen decreased
also in the control group beds due to vacuum cleaning - Der p1 from 471 T
394 to 177 T 121 ng/g and Der f1 from 14447 T 5628 to 8733 T 3700 ng/g,
p G 0.05; respectively.
Conclusion: Milbiol alone was not effective for decreasing HDM allergens in
beds during one-year period after treatment; however, more frequent treatment
with Milbiol could give better results. Lower level of HDM allergens was
gained also by regular vacuum cleaning.
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The analysis of Alpha1-Antitrypsin serum level among people
exposed to industrial dust
Larisa Fedarushchanka1, Tatiana Baranovskaya1, and Valentina Pischik2.
1Belarusian Medical Academy of Post-Graduate Education, Allergology and
Occupational Health, Minsk, Belarus; 210’th Clinical Hospital, Clinical
Laboratory, Minsk, Belarus.
Background: In healthy persons, alpha1 antiprotease serves as a protective
screen that prevents alveolar wall destruction. Long-term industrial pollutants
exposure may lead to imbalance in the oxidant-antioxidant or proteases-
antiproteases systems in the pulmonary tissue witch is followed by unimpeded
neutrophil elastase digestion of elastin and collagen in the alveolar walls and
progressive emphysema.
Methods:Wewere interested in comparing the level Alpha1-antitrypsin (AAT)
between patients with occupational pulmonary pathology, healthy men,
working under industrial pollutants exposure more than 15 years and healthy
donors. The subjects in the study were 84 men between the ages of 45 and 60.
Themain group of study included patientswith chronic occupational bronchitis
(n = 25), electric welder pneumoconiosis (n = 10), silicoses (n = 29); the first (1)
control group included 10 patients without occupational lung disorders and the
second (2) control group -10 healthy donors. We measured
the level of AAT by immunoturbidimetric assay for quantitative in vitro
determination of AAT in human serum on automated clinical analyzes. We
used reagents produced by BRoche-Diagnostics[. Normal level 0,9/2,0 g/l.
Results: We found that the level of AAT was under normal among patients
with electric welder pneumoconiosis (0,78 T 0,23). It was significantly
lower (p G 0,05) than the level in both control groups (group 1/1,23 T 0,16;
group 2 Y 1,26 T 0,16). We did not find significant differences of serum
concentration of AAT between silicoses (1,09T0,37), chronic occupational
bronchitis (1,15 T 0,27) and control groups. It was even normal. It was a
tendency of AAT concentration increasing due to the term of pollutants
exposure.
Conclusion: Long-term industrial pollutants exposure may lead to chronic
airway inflammation and caused the imbalance in proteases-antiproteases
systems. There was an activation of alpha-1-antitrypsin secretion as the most
important proteinase inhibitor among men working under industrial pollutants
exposure. The level of alpha-1-antitrypsin was normal among patients with
chronic bronchitis, silicoses and healthy workers. We found that AAT level
could be decreased among patients with electric welder pneumoconiosis. We
supposed that it could be the result of oxidative inhibition of the welding
aerosol components on AAT secretion.
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Environmental dust granulometry and microbial load in the
presence of tobacco smoke
Gianni Macrina1, Michele Baroffio1, Barbara Bruno2, Carla Tazzer2, Paolo
Crimi2, and Giorgio Walter Canonica1. 1University of Genoa, Department of
Internal Medicine, Genoa, Italy; 2University of Genoa, Department of Health
Sciences, Genoa, Italy.
Background: Several studies describe damage from passive smoking in
humans and animal models. However, how different chemical and physical
components relate to mechanisms of damage is not completely understood.
Cigarette smoke is composed by a gas phase and a particulate phase, in which a
lot of toxicologically relevant compounds are present. We focused our
investigations on the particulate phase of environmental cigarette smoke, as the
amount and dimensions of suspended particles have been only partially studied
so far. It is noteworthy that the size of particles is very important in the
inhalation process and in their subsequent deposition into the respiratory tract.
Methods: Differences in granulometry of suspended dust and bacterial load
were studied in a 120-cubic meter no-smoking room during and after one
cigarette smoke in ten different experiments. To evaluate granulometry in
suspended dust we used a 6 channel particle counter, which analyzes particles
according to their granulometry. We evaluated suspended bacterial load by
using a multipierced sampler on a fixed replaceable plate set to aspirate air.
Evaluation of sedimented bacterial load was performed by using the Air
Microbial Index technique which expresses the total number of microrganisms
settled by gravity onto a Petri plate.
Results: An increase of medium and small, but not large suspended particles
number was observed. Bacterial and mycotic load decreased during and up to
60 min after cigarette smoking. Gram-positive cocci never decreased while
chromogen-bacteria and mycetes decreases at 30 min. Furthermore, we
observed an increase of sedimented bacteria and mycetes at 60 min, a decrease
at 120 min and a stabilization at 180 min.
Conclusion: We hypothesize that tobacco burning accelerates sedimentation
of larger agglomerates of mean-size smoke particles and bacteria which may
be resuspended by movements of people in the room and consequently be
inhaled. They could have a stronger affinity with airways surfaces,
modifying the normal mechanisms of non-specific and immunologic
defenses against microbes, above all in children. This could partially explain
the increasing of respiratory infections in children exposed to second-hand
smoke.
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Proteomic analysis of birch and ragweed pollen artificially
exposed to NO2
Roberta Aina1, Elisa Berra1, Giada Marino1, Elide A. Pastorello2, and Sandra
Citterio1. 1University of Milano Bicocca, Dept. of Environmental Science,
Milan, Italy; 2Niguarda Ca` Granda Hospital, Unit of Allergology and Clinical
Immunology, Milan, Italy.
Background: Air pollutants seems to play a fundamental role in promoting
allergies and in worsening the health conditions of allergic people. New in-
teresting findings suggest that traffic-related pollutants do not only irritate the
airways, but can also make allergens more aggressive, especially pollen
allergens. In particular, air pollutants can induce and/or increase the expression
of some allergenic proteins. They can also induce post-translational modi-
fications (PTMs). These changes can make proteins more reactive towards the
IgE. Our objective has been to investigate the effect of nitrogen dioxide (NO2)
on pollen from birch (Betula pendula Roth) and ragweed (Ambrosia
artemisifolia L.), two very common and important sources of allergens
in Europe.
Methods: Pollen samples were artificially exposed to different concentrations
of NO2. Sera of birch and/or ragweed allergic patients were also collected.
Pollen proteins were extracted from control (C) and treated (T) samples,
separated by 2D electrophoresis, blotted onto nitrocellulose membranes
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and incubated: (a) with patient’s sera to identify pollen allergens; (b) with an
anti-nitrotyrosine antibody to estimate the entity of protein nitration; (c) with a
staining solution specific for glycosylated proteins. Finally, a treatment with
lambda protein phosphatase (e¨PPase) were performed to identify changes in
phosphorylation pattern.
Results: NO2 treatments did not induce new allergen expression, neither in
birch, nor in ragweed pollen. Regarding PTMs, the treatments induced mod-
ifications in both birch and ragweed phosphorylation patterns. On the contrary,
no changes in glycosylation profiles were detected in the analysed plants.
Finally, few nitrated proteins were induced in birch treated samples.
Conclusion: Exposure of pollen to NO2 induced PTMs in allergens. However,
future experiments are needed to confirm these first results.
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Mangifera indica a new pollen allergen
Vipul Shah. Allergy Clinic, Allergy, Surat, India.
Introduction: A new pollen allergen was suspected in patients who while
receiving allergen immunotherapy showed recurrence of symptoms during the
period Jan-March.
Methods: Fifteen patients having various allergic disorders were subjected to
skin allergy testing, were found to be sensitive to various allergens and they
were on immunotherapy. While on IT they developed recurrent symptoms
during Jan-March. To confirm presence of the new allergen, safranin stained
glycerin coated slides were exposed in the patients_ surroundings with
Bpersonal volumetric air sampler[. With this Bsampler[ pollen collection on the
slide is much better then simple exposure. Mangifera pollen was recorded in
abundance. Antigen of mangifera pollen was tested on all patients and strongly
positive reaction was recorded. These patients were subjected to allergen im-
munotherapy course with mangifera pollen allergen.
Results: Patients who showed positive results with mango pollen allergen and
then underwent immunotherapy course with this pollen antigens showed
significant improvement in their symptoms during the next pollen season of
mangifera indica.
Conclusion: 1) Mangifera Indica pollen could play an important role in naso-
bronchial allergy.
2) BAir sampler[ makes the detection of causative allergen
possible & easier when sometimes simple slide exposure may fail.
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Expression of transcription factor genes for T-cell differentiation
in the spleen of C3H/HeN and BALB/c mice by the inhalation of
low-level toluene
Atsushi Fukushima1, Tin-TinWin-Shwe1, Shoji Yamamoto1, NaokiKunugita2,
Yasuhiro Yoshida3, Keiichi Arashidani2, and Hidekazu Fujimaki1. 1National
Institute for Environmental Studies, Research Center for Environmental Risk,
Tsukuba, Japan; 2University of Occupational and Environmental Health,
Japan, Health Sciences, Fukuoka, Japan; 3University of Occupational and
Environmental Health, Japan, Medicine, Fukuoka, Japan.
Background: Since outdoor and indoor air pollutants are environmental risk
factors that have been shown to contribute to the development of respiratory
infections and allergy, it is speculated that there is a positive relationship
between allergic inflammation and inhalation of volatile organic compounds.
Effect of low-level toluene inhalation on Th1/Th2 balance in allergic response
remains unknown.
Methods: To study the effect of exposure to low-level toluene on transcription
factors for T-cell differentiation, male C3H/HeN and BALB/c mice were
exposed to filtered air (control), 5, 50 and 500ppm toluene by whole body
inhalation for 6 hours per day, 5 days per week, for 3 and 6 weeks. The allergic
model group of mice was injected intraperitoneally with 10 2g ovalbumin
(OVA) plus 2 mg alum, and each of these mice was then challenged with
nebulized OVA as a booster once every 2 weeks (weeks 2, and 4) during the
exposure period. Then, by using a quantitative real-time PCR method, we
investigated the expression of GATA3, T-bet and FoxP3 genes in spleen.
Results: Exposure to 500ppm toluene for 3 weeks significantly increased the
expression of GATA3 and FoxP3 mRNAs in spleen of C3H mice. In C3H
mice exposed toluene for 6 weeks, the expression of GATA3, T-bet and
FoxP3 mRNAs was increased at 50ppm toluene as compared to that of fil-
tered air control. However, we did not observe any such pattern for the expres-
sion of T-bet and FoxP3 mRNAs in spleen of BALB/c mice. The expression of
GATA3mRNAwas significantly suppressed by exposure to 500ppm toluene in
BALB/c mice.
Conclusion: This is the first study to show in vivo modulation of the ex-
pression of transcription factor genes in the different strains of mice by ex-
posure to low-level toluene, in concert with antigenic stimulation.
624
Clinical characteristics of asthmatics susceptible to acute
exacerbation by environmental triggers in Cohort for Reality
and Evolution of Adult Asthma in Korea (COREA)
Sang-Heon Kim1, Soon-Seog Kwon2, Tae-Bum Kim3, Dong-Ho Nahm4,
Jung-Won Park5, Heung-Woo Park6, Yong-Chul Lee7, An-Soo Jang8,
Yoon-Seok Chang6, Sang-Heon Cho6, Young-Joo Cho9, ByoungWhui Choi10,
Hee-Bom Moon3, and Ho Joo Yoon1. 1Hanyang University College of
Medicine, Department of Internal Medicine, Seoul, Republic of Korea; 2The
Catholic University of Korea College of Medicine, Department of Internal
Medicine, Seoul, Republic of Korea; 3University of Ulsan College of
Medicine, Department of Internal Medicine, Seoul, Republic of Korea;
4Ajou University School of Medicine, Department of Allergy and
Rheumatology, Suwon, Republic of Korea; 5Yonsei University College of
Medicine, Department of Internal Medicine, Seoul, Republic of Korea;
6Seoul National University College of Medicine, Department of Internal
Medicine, Seoul, Republic of Korea; 7Chonbuk National University College
of Medicine, Department of Internal Medicine, Jeonju, Republic of Korea;
8Soonchunhyang University College of Medicine, Department of Internal
Medicine, Bucheon, Republic of Korea; 9Ewha Womans University
College of Medicine, Department of Internal Medicine, Seoul, Republic of
Korea; 10Chung-Ang University College of Medicine, Department of Internal
Medicine, Seoul, Republic of Korea.
Background: Patients with asthma is prone to experience recurrent
exacerbation of symptoms especially when they are exposed to environmental
triggers. But it is not well defined what kind of clinical characteristics is
associated with this predisposition.
Methods: The Cohort for Reality and Evolution of Adult Asthma in Korea
(COREA) study is a prospective, observational multi-center study and will be
conducted for nine years (2005/2013) in Korea. Cross sectional data of
baseline clinical characteristics were compared between asthmatics susceptible
to asthma exacerbation by environmental triggers and asthmatics tolerable to
those triggers based on self reported questionnaire at the time of enrollment.
Results: Common cold (22.9%) was most frequent trigger followed by
polluted or dusty air (16.6%), second hand smoke (11.5%), emotional stress
(9.5%), animal (3.8%), and drug (1.0%) in descending order. The environ-
mental triggers-sensitive asthmatics (TSA) showed female dominance (60.2%
vs. 50.5%, P = 0.027) and higher prevalence of rhinosinusitis (63.2% vs.
53.6%, P = 0.041) than environmental triggers-tolerable asthmatics (TTA),
while there was no significant difference in obesity, duration of symptom,
atopic status, and lung function. More patients among TSA reported
aggravation of asthmatic symptoms after moving to current house (16.1% vs.
3.9%, P = 0.001) and TSA had been living in the current house for significantly
less time than TTA (P = 0.002).
Conclusion: Female sex, having rhinosinusitis, moving into a new house was
significantly associated with the susceptibility to asthma exacerbation by
environmental triggers.
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A survey of the children often exposed to Passive Smoking (PS)
had relatively higher risk of developing obstructive pulmonary &
allergic diathesis
M. Ishaq, I. Khan Sameera, and Munir Imran Khan. Al-Junaid Hopsital,
Allergy/Pulmonology, Nowshera, Pakistan.
Introduction: Is to pursue the deleterious effects of (PS) on the health of the
exposed children.
Methods: In a retrospective study undertaken from1995/2004, including
600 nonsmoking asthmatic children ages 9/15years (mean age 12 years)
with history of house hold smoking as passive smokers (PS). They were
likely found to have 60/76% increased tendency of allergic & obstructive
pulmonary manifestations (eczema, allergic rhinitis, ocular allergies, middle
ear suffusion & shortness of breath) than those residing in a nonsmoking
household. Boys were more sensitive to (PS) than girls, and likewise
manifestations increased with age and duration of exposure. Children of
smoking parents had an increased prevalence of respiratory symptoms
(cough, sputum, wheezing) & lower pulmonary function tests (PFTs) values
than children of non smoking parents, the association of changes in (PFTs)
may persist into adulthood. The significance of the maternal smoking was
marked as adding to the population of childhood asthma. The later on
follow up has evidenced that passive smoking in early childhood increased
the risk of lower respiratory tract infection by 1.5 to 2.2 folds. In the same
study/follow up children with congenital pulmonary malformations & family
history of allergies were likely to be more sensitive to & exacerbated by
(PS) than non smokers.
On further follow up into adult life (PS) were. showing relatively
increased prevalence of recurrent infection & less productivity of life.
Results: Underestimation of the significance of (PS) in a house was followed
by the grave health related hazards, some of which were irreversible.
Conclusion: The impact of Smoking in a community has variable degree
of adverse reactions with paramount morbidity index on terminal ages. Mar-
ginlization of smoking to restricted places is followed by a positive socio
economic impact.
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The significance of the graded improvement in pulmonary
function & physical wellbeing amongst college students with
smoking cessation
M. Ishaq, I. Khan Sameera, and Munir Imran Khan. Al-Junaid Hopsital,
Allergy/Pulmonology, Nowshera, Pakistan.
Purpose: Significant change in respiratory function/physical well being were
documented with stepwise cessation of smoking that had socio-economical &
prospective impact upon the college students.
Methods: In the study College students ages 17/21 years both sex having had
1/4 years history of smoking, had manifestation like hacking cough,
breathlessness & wheezing more so at night. Some had raised temperature &
weight loss altered taste etc. Smoking cessation followed under supervision
from weeks to months with advise & encouragement. The outcomes had been
as under.
Results: Assessment of the pulmonary function Physical wellbeing,
Conclusion: Immediately after quitting, ex-smokers had been advised
breathing exercises with steep line increase in tempo. Improvement in
pulmonary function/physical well being had been inversely proportional to the
period & history of smoking.
Clinical Implication: Cessation advises followed under supervision with
incentives for smoker students in the form of credits in study, awards &
certificates for quitters of the week, months etc. khan et al aljh nsr nwfp pk.
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Ocular, nasal and skin signs of aircrews in relation to before and
after the ban on smoking on flights - a follow up study
Torsten Lindgren, Dan Norba¨ck, and Gunilla Wieslander. Uppsala University
Hospital, Dep of Occupational and Environmental Medicine, Uppsala,
Sweden.
Background: The main aim of this 3-years follow-up was to gain further
insight into ocular nasal and skin symptoms, and to determine whether the
incidence was related to personal, psychosocial, and occupational factors.
Methods: To evaluate the differences of ocular nasal and skin symptoms, a
self-administered questionnaire was mailed, in 1997 (n = 1857). Three years
later, in 2000 (n = 1446), the questionnaire was sent again to airline crew on
duty. The participation rate was 81% 1997 (n = 1513) and 79% 2000
(n = 1145). A cohort of 1134 subjects is used in this study. At the time of the
questionnaire study 1997, smoking was allowed on intercontinental flights.
Results: Atopy showed a significant reduction, and hay fever showed a sig-
nificant increase. During both 1997 and 2000 ocular nasal and skin symptoms
were more common in the cabin crew than in the pilots. The incidence of
ocular nasal and skin symptoms was more common in cabin crew compared to
pilots. The new-onset nasal and skin symptoms were more common in cabin
crew compared to pilots. Younger age, work satisfaction, and stress due to
excess of work were significantly more related to new-onset ocular nasal and
skin symptoms. Cabin crew had significantly more new-onset of nasal symp-
toms compared to the pilots. Airline crew with hay fewer reported significantly
more complaints on new-onset ocular and nasal symptoms. Airline crew with
doctor’s diagnosed asthma reported significantly more complaints on new-
onset nasal symptoms.
Conclusion: Age, hay fever, asthma, psychosocial working environment and
type of occupation are related to new-onset of symptoms.
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Atopic diseases, allergic sensitisation and exposure to
traffic-related air pollution in children
Verena Morgenstern1, Anne Zutavern1, Josef Cyrys1, Inken Brockow2,
Sibylle Koletzko3, Ursula Kramer4, Heidrun Behrendt5, Olf Herbarth6,
TABLE 1CHARACTERISTICS OF THE CONTROL AND PATIENTS WITH CP
Assessment of pulmonary function
Physical wellbeing,
6 weeks after quitting
Pulmonary function(FEV1)
on an averageG65%
Gradual resumption of taste Sleep pattern, Slight improvement
variable degree of craving for smoking
Physical well being definite
improvement observed,
slight irritability
12 Weeks after quitting
On Average (FEV1)
gradually resumed to 63*Y65%
Improvement more than before Refreshing Much improvement than previous
18 weeks of smoking cessation
On an average (FEV!) most had 65% Significant improvement No Hangover/Lang over Significant restoration of vigor
*Rapid restoration in Pulmonary function observed amongst students with relatively shorter history of smoking.
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Andrea von Berg7, Carl Peter Bauer2, H.-Erich Wichmann1, and Joachim
Heinrich1. 1GSF National Research centre for Environment and Health,
Institute of Epidemiolgy, Neuherberg, Germany; 2TU Mu¨nchen, Kinderklinik
und Poliklinik, Munich, Germany; 3Kinderklinik und Kinderpoliklinik, Dr. v.
Haunerschen Kinderspital, Munich, Germany; 4IUF-Institut fu¨r umweltmedi-
zinische Forschung, Working Area Epidemiology, Dusseldorf, Germany;
5Technical University Munich, Environmental Dermatoloy & Allergy, ZAUM,
Munich, Germany; 6UFZ Leipzig-Halle, Human Exposure Research and Epid,
Leipzig, Germany; 7Marien-Hospital Wesel, Marien-Hospital Wesel, Wesel,
Germany.
Background: In vitro studies, animal experiments and human exposure
studies have shown increased risks for atopic outcomes. However, results
derived from observational studies are inconsistent. To assess the relationship
between individual based exposure to traffic-related air pollutants and allergic
outcomes in a prospective birth cohort study during the first six years of life.
Methods: We followed-up 2860 children at the age of 4 years and 3061 at the
age of 6 years to investigate atopic diseases and allergic sensitisation. Long-
term exposure to particulate matter (PM2.5), PM2.5 absorbance and nitrogen
dioxide (NO2) was assessed at residential addresses using geographic
information systems based regression models and air pollution measurements.
The distance to the nearest main road was used as a surrogate for traffic-related
air pollutants.
Results: Strong positive associations were found between distances to nearest
main roads and asthmatic bronchitis, hay fever, eczema, and sensitisation. A
distance-dependent relationship could be identified with the highest Odds
Ratios for children living less than 50 m from busy streets. For PM2.5
absorbance statistically significant effects were found for asthmatic bronchitis,
hay fever and for allergic sensitisation to inhalant allergens due to pollen
sensitisation. NO2 exposure was associated with eczema, while no association
was found for allergic sensitisation.
Conclusion: There is a strong evidence for an increased risk of atopic diseases
and allergic sensitisation when children are exposed to particulate matter.
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Air cleaners or polyurethane bedcovers for asthmatic children
with cat or dog allergy
Rolfsjord Leif Bjarte1, Leiv Sandvik2, and Ragnhild Halvorsen3. 1Sykehuset
Innlandet HF, Paediatric Department, Elverum, Norway; 2Ullevaal Uni-
versity Hospital, Competence Center for Clinical Research, Oslo, Norway;
3National Hospital, Paediatric Clinic Voksentoppen, Oslo, Norway.
Background: We wanted to see if asthma severity could be reduced by air
cleaners in bedrooms and living rooms, and/or polyurethane covered cotton
bedcovers on pillows, eiderdowns and mattresses, in children with hospital
diagnosed asthma and allergy to dogs or cats.
Methods: Firstly, 60 children accepted invitation. Randomised: 49. Com-
pleted: 46. Bedcovers vs. placebo and certified H12/13 class HEPA room air
cleaners vs. placebo, in a double blind placebo 4 group design. Inclusion
criteria: Asthma, age 7 through 17, allergy to dog or cat. Exclusion criteria:
Positive skin prick test (SPT) to house dust mite (HDM); smoking. Only 11 of
the first 46 children had a cat or a dog in their homes throughout the trial. Tests:
Clinical examination, cold air hyperventilation, symptom score, life quality,
indoor environment questions, skin prick tests, specific IgE, serum ECP, dust
sampling from mattresses, furniture and air filters. Duration: air cleaners
12 months, bedcovers last 6 months of same period. Secondly, to see if the first
results on hyperreactivity and ECP were casual, 31 more patients accepted
invitation. 22 patients were included, 21 completed. Randomisation either to
active or placebo air cleaners, no bedcovers. Duration: 5 months. Inclusion
criteria: Asthma, age 8 through 17, allergy to dogs. Exclusion criteria: Positive
SPT to HDM, smoking, and this time, dogs or cats at home. Tests as in first part,
but no life quality scoring or dust sampling. Last visit in a colder season than the
first for all 67 completing children.
Results: No differences between bedcovers and placebo. Difference between
mean ECP (5 missing data) from the last and first visits in the air cleaner
placebo groups vs. the active air cleaner groups (0.53 vs. <8.04, p = 0.01, SD =
9.74 vs.12.59). Difference between mean % FEV1 fall at the last and first visits
in the placebo air cleaner groups vs. the active air cleaner groups (5.46 vs.
<1.09, p = 0.02, SD 11.14 vs. 11.37). No differences by Elizabeth Juniper’s
Life Quality Scores (PAQLQ and PACQLQ) or symptom scores.
Conclusion: No effects found from polyurethane bedcovers for 6 months in
homes of children with asthma and allergy to cats or dogs, without house dust
mite allergy. No effects on life quality by air cleaners for 12 months, but
significant effects on cold air bronchial hyperreactivity and ECP. Few homes
had cats or dogs.
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Methodology for field survey on the impact of indoor
environment on allergy and asthma
Kiril Naydenov1, Detelin Markov2, Elena Lyudskanova3, Arsen Melikov1,
Carl-Gustaf Bornehag1, Jan Sundell1, and Ted Popov3. 1Technical University
of Denmark, Int. Centre for Indoor Environment and Energy, Kgs. Lyngby,
Denmark; 2Technical University of Sofia, CERDECEN, Sofia, Bulgaria;
3Alexander’s University Hospital, Clinical Centre of Allergology, Sofia,
Bulgaria.
Background: A comparative multidisciplinary and inter-regional study on
allergy/asthma and indoor exposures could give important information leading
to an increased understanding of the aetiology of this morbidity. However, the
existing national studies followed different methodologies, which hampered
the use of the obtained data for potential comparison. Such drawback can be
overcome by following identical protocol with regard to questionnaires, in-
spections and measurements.
Objective: The present paper proposes a methodology for performing cross-
sectional and case-control studies on the impact of indoor home environment
on allergy and asthma among children based on the recently performed
ALLHOME (Bulgaria) and BDampness in Buildings and Health[ (DBH,
Sweden) studies.
Methods: The proposed approach includes a strategy for performing an epi-
demiological study, selection of target population, identification of the sample
size. All key steps in performing the cross-sectional and case-control studies are
listed. Suggestions for improving the quality of the obtained data are given.
Results: The DBH and ALLHOME studies identified cultural behaviour as an
important factor when performing epidemiological studies. Information ga-
thered from the descriptive cross-sectional study could provide clues leading to
the formulation of epidemiologic hypotheses, which could be tested in the
analytic nested case-control study. A target group of pre-school children was
proposed, since children at that age spend most of their time at home. A cross-
sectional questionnaire, developed for the DBH study and containing 87
questions on demographic data, health symptoms, housing characteristics and
lifestyle factors was proposed. The use of parental questionnaires for
information on housing characteristics could be an effective tool in conducting
studies on housing and health. The proposed nested case-control study includes
dwelling inspections of a non-destructive type (building checklist, sensory and
visual evaluation of dampness, dust sampling for HDM, moulds, pollens,
phthalates), engineering measurements (air temperature, humidity, CO2 level)
and medical examinations (general examination and skin prick test). Special
attention should be paid on storage of collected data, statistical analyzes and
dissemination of the research results.
Conclusion: The paper can be used as a guideline for performing studies on
indoor environment and allergy/asthma.
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Multiplex technologies - expanding horizons for assessment of
allergic sensitization and exposure
Eva-Maria King1, Chris Earle1, Amy Tsay1, Lisa Vailes1, Rebecca Godbout2,
Kerry G. Oliver2, and Martin D. Chapman1. 1Indoor Biotechnologies, R&D,
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Charlottesville, United States; 2Radix Biosolutions, R&D, Georgetown,
United States.
Background: Current methods used for the assessment of allergic sensitiza-
tion and allergen exposure require separate testing for each allergen-specific
antibody or allergen. We have applied fluorescent suspension array technology
to allow the simultaneous detection of total and allergen-specific IgE in serum
or multiple allergens in environmental samples in a single quantitative test.
Methods: Fluorescent multiplex arrays were developed to allow the
simultaneous detection of indoor allergens in environmental samples or total
and allergen-specific IgE in serum. A 9-plex suspension array measuring Der p
1, Der f 1, Der p 2, Der f 2, Fel d 1, Can f 1, Mus m 1, Rat n 1 and Bla g 2 was
developed using monoclonal antibodies covalently coupled to fluorescent
microspheres. A 10-plex array for the detection of total IgE and IgE specific to
Der p 1, Der p 2, Fel d 1, Can f 1, Bet v 1, Phl p 5, Bla g 1, Bla g 2 and Asp f 1
was created using monoclonal antibodies and purified allergens covalently
coupled to fluorescent microspheres. The multiplex arrays were validated by
comparing results between the multiplex methods and established enzyme
immunoassays.
Results: There were highly significant correlations between results obtained
by the multiplex methods and established enzyme immunoassays with
p G 0.001 (n = 970). In addition, the sensitivity, limit of detection,
reproducibility, intra assay coefficient of variance (CV), and inter assay CV
of the fluorescent multiplex array was shown to be equal to or better than the
ELISA methods.
Conclusion: Our results suggest that fluorescent multiplex technology will
facilitate epidemiological studies of exposure and allergic sensitization such as
birth cohort studies, population surveys and studies of gene-environment
interaction. The arrays can, in principle, be expanded to include other allergens
and allergen-specific antibodies.
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Reduction in indoor aeroallergen by using an xtreme 3000
air purifier
Nabarun Ghosh1, Jeff Bennert2, and Mandy Whiteside1. 1West Texas A&M
University, Life, Earth and Environmental Sciences, Canyon TEXAS 79016,
United States; 2Air Oasis, 3401 Airway Blvd., Amarillo, TX 79118, United
States.
The quality of the environment within buildings is a topic of major
importance for public health. Presently Indoor Air Quality (IAQ) is a major
concern at various work places. Here is an important quote on air quality from
a journal: BWith all the publicity, more and more people are realizing that
pollutants in the indoor air could make them sick. The worst thing that has
happened to the indoor air quality marketplace in the last year or so is also
mold. This is because much of the media coverage is designed to
sensationalize the topic and frighten the public - so much so, that the word
Fmold’ always seems to be preceded by the adjective Ftoxic._ Thus,
homeowners and building managers are scared to death of any minor
infestation that might possibly be toxic mold, and they often ignore other
health issues, such as combustion byproducts, Volatile Organic Compounds,
second-hand tobacco smoke and poor ventilation.[ This study was aimed at
examining the efficiency the air purifier 3000 Xtreme in reducing the indoor
spore and pollen counts of allergenic taxa present in different office facilities
and residential buildings. Sets of the Petri plates and coated slides were placed
with distances of 1foot, 2 feet, 4 feet, 6 feet and 12 feet away from the air
purifier. Assay was done with the Petri plates prepared from Brain Heart
Infusion agar (VWR) and Gelvatol coated slides with air purifier off for the
control and on for the treated. The control Petri plates and slides were placed in
the room without using the air purification system. The treated sets were
assayed after 24 hour, 48 hour and 72 hour treatment. The slides were
examined, analyzed, and photographed using a BX-40 Olympus microscope
attached to a DP-70 Digital Camera. Petri plates were examined with an SZ-40
stereo-scope to observe and count the colonies. The control set of plates showed
vigorous growth of the microbial colonies after incubation in an incubator at
37-C for 24 hours. Petri-plates closer to air purifier (2 ft. and 4 ft.) produced
least number of colonies after 24 h., 48h. and 72 hours of treatment of the
indoor air with the air purifier. There was very minor trace of inoculums from
the Petri-plates from 2 ft. 4ft. and 8 ft. after 24 hours. After a 2-month
continuous exposure of the room air with the Xtreme 3000 at BHigh[ setting
we found complete eradication of aeroallergens.
EPIDEMIOLOGY
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Prevalence of allergic disease in eastern Mexico city. A study
with ISAAC model
Rosa C. Covarrubias1, Gerardo P. Lopez1, and Patricia A. Chico2. 1National
Institute of Pediatrician, Allergy, Mexico, DF, Mexico; 2National Institute of
Pediatrician, Investigation Department, Mexico, DF, Mexico.
Background: Wide variations in the prevalence of asthma, rhinitis and
eczema have been reported between differents countries. The ISAAC
(International Study of Asthma and Allergies in Childhood) was thought in
order to maximize the value of epidemiological research into asthma, allergic
rhinitis and atopic eczema in childhood, stablishing a standarized methodology
and facilitating collaboration and comparison between severe countries.
Methods: A standard questionnaires was distributed through schools and self-
completed by 13/14 years old children and by the parents of 6/7 years old children.
Results: 1675 children aged 6/7 years ansewered the questionnaire and 3082
in the group aged 13/14 years. In the group of children age 6/7 years, the
prevalence of wheezing in the last year was 8.4% and 5.6% in the 13/14 years
group. The prevalence of rhinitis in the last year was 55.5% in the 6/7 years
group and 31.4% in the 13/14 years group. The prevalence of eczema in the
last year was 9.5% in the 6/7 years group and 6.2% in the 13/14 years group.
Conclusion: Prevalence of allergic disease was similar to reported in other
sdudies, except for rhinitis with hight prevalence rates with respect to other
studies performed worlwide.
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Alarming results of the comparison of the ISAAC Study in 6/7
and 13/14 years old children in Islamabad, Pakistan
Osman M. Yusuf1, Shahida O. Yusuf1, Mohsin S. Khan2, Naseeruddin
Mahmood3, Myda Khalid4, and Shaheena W. Ali1. 1The Allergy & Asthma
Institute, Pakistan, Allergy & Asthma, Islamabad, Pakistan; 2The Allergy &
Asthma Institute, Pakistan, Epidemiology, Islamabad, Pakistan; 3Aga Khan
Univeristy Hospital, Paediatrics, Karachi, Pakistan; 4The Allergy & Asthma
Institute, Pakistan, Pediatrics, Islamabad, Pakistan.
Background: Allergic diseases and asthma are registering an alarming
increase all over Pakistan, especially in children. Pakistan has a population of
over 160 million, in which almost 40% are children below the age of 15 years.
The ISAAC Study conducted in schools in 1997 and in 2001/2 is the only reliable
documented study looking at the prevalence of these illnesses in this country. A
comparison of the two study groups has been evaluated to assess the rising danger
of respiratory allergy and asthma, in Islamabad, the capital of Pakistan.
Methods: The standard Questionnaire based ISAAC protocol was used for
this study. Schools were randomly selected for the study, and all children
falling within the study age group were included in the study. Children of age
13/14 years answered the questionnaires themselves, while they were
answered by parents of the 6/7 year age group.
Results: Total Number of Children Studied.
Conclusion: The ISAAC study conducted in Islamabad has revealed that the
prevalence of nasal problems and wheezing is more than double in the 13/14
year age group, as compared to the younger 6/7 year children. The very large
number of 13/14 year olds reporting nasal problems is also very alarming, as
there is a 3 fold more danger of these children developing asthma later in life.
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The study also highlights the need for better diagnosis of asthma in both age
groups, as only 1 in every 4 wheezing children have been diagnosed to be
asthmatic. The results indicate the need for increased awareness amongst the
general public and the physicians regarding allergic diseases and asthma.
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Analysis of allergic rhinitis patients according to ARIA guideline
in Korea
Jeong-Whun Kim, Chul Hee Lee, and Jeong-Hun Jang. Seoul National
University College of Medicine, Otorhinolaryngology, Seongnam, Republic of
Korea.
Background: ARIA guidelines are in the way of general criterion in clas-
sifying allergic rhinitis.
Objective: The objective of study is research on Korean patients who are
underwent allergic rhinitis according to their symptoms, severity, frequency
and distribution patterns.
Materials and Methods: Statistical analysis was done in 610 patients who
had been diagnosed as allergic rhinitis at Seoul National University Bundang
Hospital and 540 patients at local clinics. All patients were categorized into 4
groups, mild intermittent, mild persistent, moderate to severe intermittent and
moderate to severe persistent groups according to their questionnaire research
and allergy laboratory results.
Results: The incidence of moderate to severe persistent group was 34.7 % and
moderate to severe intermittent group was 17.1%. In the allergy laboratory
results, there was a significant difference between groups in eosinophi count
(P = 0.004). In questionnaire research, there were significant differences
at each group concerning olfaction (P G 0.001), self-awareness of rhinitis
(P = .013), previous history of rhinitis (P G 0.001), self-awareness of asthma
(P = 0.001) and conjunctivitis (P G 0.001). There were significant differences
in frequency of symptoms for allergic rhinitis and severity between groups
(P G 0.001) and moderate to severe persistent group showed highest score.
Conclusion: According to ARIA guidelines in categorizing patients, moderate
to severe persistent group stands out as the biggest part. Consequently
differentiated therapeutic approach between groups will be useful.
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Associations between ocular and nasal symptoms, atopy,
personality traits and stress
Roma Runeson1 and Dan Norba¨ck2. 1Akademiska sjukhuset, Occupational
and Environmental Medicine, Uppsala, Sweden; 2Akademiska Sjukhuset,
Occupational and Environmental Medicine, Uppsala, Sweden.
: The aim was to study associations between ocular and nasal symptoms,
atopy, personality characteristics measured by Antonovsky_s Sense of
Coherence (SOC), Karolinska Scales of Personality (KSP), and stress
measured through projective drawing. Totally 194 subjects initially working
in 19 buildings with suspected indoor air problems were studied. Information
on a history of atopy, hay fever, ocular and nasal symptoms was gathered by a
postal questionnaire, including KSP, SOC and projective drawings of Ba
person in the rain[. Results on SOC: There were no associations between SOC
and history of atopy or hay fever, however those with low SOC had more
ocular (p = 0.005) and nasal symptoms (p = 0.04). On KSP: Those with atopy
had higher social desirability (p = 0.022), lower irritability (p = 0.016), and
lower guilt (p = 0.047). Those with hay fever had lower guilt (p = 0.045). Those
with eye symptoms had lower social desirability (p = 0.018), and higher
indirect aggression (p = 0.025).
Those with nasal symptoms had higher: somatic anxiety (p = 0.002),
muscular tension (p = 0.007), and psychic anxiety (p = 0.019). On projective
drawings: Those with atopy draw clouds (p = 0.023) and long rain strokes
(0.039) more often and short rain strokes (p = 0.005) less often. Those with hay
fever drew water puddles (p = 0.009) more often. Drawing of long rain strokes
was associated with ocular symptoms (p = 0.005). Drawings of strong wind
and rain was associated with nasal symptoms (p = 0.045).
Conclusion:History of atopy is associated with personality traits measured by
KSP and projective drawings. Ocular and nasal symptoms during non-pollen
season are associated with SOC, as well as KSP and projective drawings.
Different scales were associated with atopy and symptoms. Long rain strokes
were consistently associated with both atopy and ocular symptoms.
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Sensitization profile analysis in children with either asthma or
eczema alone using a panel of mite allergens from
Dermatophagoides pteronyssinus and Blomia tropicalis
Run Mei Angeline Chong1, Nge Cheong2, Su Min Audrey Teo3, Fong Cheng
Yi2, Pei-Chi Lynette Shek2, Yoke Chin Giam4, Kaw Yan Chua2, and van
Bever Hugo2. 1Nanyang Technological University, School of Biological
Sciences, Singapore, Singapore; 2National University of Singapore, Paedia-
trics, Singapore, Singapore; 3A*STAR,, Genome Institute of Singapore,
Singapore, Singapore; 4National Skin Centre, Dermatology, Singapore,
Singapore.
Background and Aim: The prevalence of multi-allergen sensitization to 2
mite species in patients with asthma from Singapore and Malaysia has been
reported earlier. It is important to discern whether a specific disease symptom
of allergy is correlated with different mite species. The present study is a
comparison of the sensitization profiles in children suffering from either
asthma or eczema alone using a panel of mite allergens from Dermatopha-
goides pteronyssinus (Der p) and Blomia tropicalis(Blo t).
TABLE 1CHARACTERISTICS OF THE CONTROL AND
PATIENTS WITH CP
Age Group Males Females Total Children
6 / 7 years 1741 (58%) 1276 (42%) 3017
13 / 14 years 1954 (60.3%) 1285 (39.7%) 3239
Number of Children Reporting Wheeze Ever in their life
TABLE 1CHARACTERISTICS OF THE CONTROL AND
PATIENTS WITH CP
Age Group Males Females Total Children
6 / 7 years 163 (68%) 77 (32%) 240 (8%)
13 / 14 years 355 (67%) 175 (33%) 530 (16.5%)
Number of Children Reporting Nasal Problems Ever in their life
TABLE 1CHARACTERISTICS OF THE CONTROL AND
PATIENTS WITH CP
Age Group Males Females Total Children
6 / 7 years 475 (60%) 318 (40%) 793 (26.3%)
13 / 14 years 1294 (64%) 727 (36%) 2021 (62.5%)
Number of Children Diagnosed as suffering from Asthma
TABLE 1CHARACTERISTICS OF THE CONTROL AND
PATIENTS WITH CP
Age Group Males Females Total Children
6 / 7 years 61 (67.8%) 29 (32.2%) 90 (3%)
13 / 14 years 125 (63.5%) 72 (36.5%) 197 (6.1%)
Asthma Diagnosed in those reporting Wheeze Ever















6 / 7 years 240 47 (68%) 22 (32%) 69 (28.8%)
13 / 14 years 530 84 (63%) 50 (37%) 134 (25.3%)
World Allergy Organization Journal & November 2007 Abstracts
* 2007 World Allergy Organization S203
Copyright @ 2007 World Allergy Organization. Unauthorized reproduction of this article is prohibited.
Methods: A total of 60 children (age between 4 to 16 years old), 30 with
asthma and 30 with eczema respectively were recruited in Singapore for the
present study. The IgE levels specific to a panel of house dust mite-allergens
from two mite species were measured using ELISA. The panel of allergens
used is Der p extract, Der p 1, Der p 2 and Der p 5 from Der p mites and Blo t
extract, Blo t 4, Blo t 5, Blo t 11 and Blo t 12 from Blo t mites.
Results: Children with asthma and rhimitis exhibited the highest sensitization
to Blo t 5 (77%) with relatively lower sensitization frequency to Der p 1 ( 50%)
and Der p 2 ( 67%) while children with eczema showed high sensitization to
Blo t 5 (73%), Der p 1 (50%) and Der p 2 (70%). Generally, more eczema
patients were sensitized to this panel of Der p allergens with much higher
measured IgE titres as compared to the asthma group.
Conclusion: These two patient groups tend to show differential sensitization
profiles to Der p and Blo t allergens. Patients with asthma and rhinitis show
high sensitization to Blo t mite allergens, especially Blo t 5 whereas eczema
patients showed high sensitization to Blo t 5, Der p 1 and Der p 2. This
suggests the possible correlation between the manifestation of different disease
symptoms of allergy and the mite species.
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Sensitization and clinical relevance of ragweed pollen in patients
with intermittent rhinoconjunctivitis
Angelika Sager1 and Hartwig Lauter2. 1Leti Pharma GmbH, Medical
Department, Witten, Germany; 2Fachkrankenhaus Kloster Grafschaft, Aller-
gology, Schmallenberg, Germany.
Background: In the past years ragweed (Ambrosia elatior) became of interest
in Germany since an increasing distribution of this type-1 allergy causing plant
was observed in Europe. We investigated the sensitization against ragweed in
patients with intermittent rhinoconjunctivitis and its clinical relevance.
Patients and Methods: 516 patients from North Rhine-Westphalia (Hoch-
sauerland) were tested intracutaneously and specific IgE against ragweed were
examined. If the i.c. test turned out positive, a placebo-controlled nasal
provocation test was performed. To exclude cross-reactivity with mugwort this
allergen was also tested intracutaneously.
Results: 189/516 patients had a positive i.c. test reaction on ragweed. All of
them underwent nasal provocation test and 66 revealed a positive result. In 21/
66 patients specific IgEs against ragweed could be detected. 40/66 developed
also a positive i.c. test reaction against mugwort.
Conclusion: 37% of our patients with intermittent rhinoconjunctivitis had a
sensitization against ragweed which was clinically relevant in 35%. 60% of
ragweed sensitized patients were also sensitized against mugwort. It remains
doubtful whether the clinical relevance of the ragweed sensitization can be
explained by cross-reactivity to mugwort taking into account that ragweed has
not been detected in the Hochsauerland region.
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Prevalence and evaluation of allergic conjunctivitis in population
of buenos aires, Argentina
Graciela Beatriz Ozon, Daniela Betina Agu¨ero, Laura Gabriela Fernandez
Fastuca, and Rosario Marı´a Donato. CAMI Allergy Center, Abstract
Department, Martinez, Buenos Aires, Argentina.
Introduction: Allergic conjunctivitis is defined as a bilateral conjunctival
inflammation, chronic and recurrent that appear in different times of the year,
caused by the direct exposure of the ocular mucosa to allergens present in the
environment. Patients who suffer this patology present other associate allergic
entities that alter their quality of life.
Objective: Evaluation of patients with ocular allergy pathology by
ophtalmologic examination, allergic sensitivity by skin prick test (SPT) with
Allergo-Pharma allergens, and serum IgE levels and in tears.
Methods: Population: 64 patients (39 women-25 men) aged between 2 and 75
years with suspected of allergic ocular pathology. Evaluation of allergic
sensitivity using allergens such as gramineae, trees, cats, dogs, alternaria,
cladosporium, dermatophagoides (d), pteronyssinus (pte) and farinae (fa) using
SPT. Measurement of serum IgE levels by RIA and IgE in tears by Elisa
method in both eyes. Correlation with other allergic diseases and/or purpose
of consultation.
Results: The total number of patients with ocular allergy pathology: 41%
belongs 9 40 year old, 39% between the 16/39 years old and 20% under
15 years old; 61% females and 39% males. As for the allergy sensitivity (+ )
for d.pte and d.fa (86%), alternaria and or cladosporium (60%), gramineae
(37%), trees (33%), cat (33%) and dog (12%). 45% of patients presented
elevated IgE in tear with normal serum IgE and 34% presented both
high. The purpose of consultation and/or associated pathology was perennial
allergic rhinitis (85%), bronchial asthma (23%), eczemas (14%) and pure
allergic conjunctivitis (5%).
Conclusion: We observed through our work that the majority of patients
consulted our centre for other allergic entities which aroused the suspicion of
this ocular affection by means of a complete interrogation and ophthalmology
examination and then confirming with the laboratory and/or SPT. We therefore
consider that it is a sub diagnosed entities as it is not the most common
consulting, but must be suspected by the Allergist in other allergy pathologies
and by the trained ophthalmologist by managing it with discipline to improve
the patients quality of life and to avoid after effects.
640
The incidence of allergic diseases in different age groups in
Western-Hungary 2002-2006
Laszlo Soti1, Zsuzsanna Petz1, Gabor Kovacs2, Laszlo Endre3, Lawrence
DuBuske4, and Lajos Antal Rethy5. 1Railway Outpatient Clinic, Allergology-
Asthma Department, Szombathely, Hungary; 2Sze´chenyi University, Faculty
of Low, Gyor, Hungary; 3National Health Institute, Department of Medical
Prevention, Budapest, Hungary; 4Immunological Research Institute of New
England, Head, Harvard, United States; 5Sva´bhegy National Institute of
Pediatrics, Allergology, Budapest, Hungary.
Rationale: In spite of detailed multi-country cross-sectional surveys focused
on allergies (1) there are little comparable data on the distribution pattern of
allergy-incidences in different age-groups. Our present aim was-like in a
former investigation- to determine it again in the Allergy Outpatient Clinic of
Western-Hungary receiving patients from a region located between Western
and Eastern Europe with a population of 300.000.
Patients and Methods: Including criteria: Patients with newly diagnosed
allergy. Besides clinical investigations allergy diagnosis was always confirmed
by skin Prick test and/or specific IgE tests as well. Age groups: Newborns -
96 years of age. Period of investigation: 2002-2006. Total number of patients:
15450
Results: Average total incidence during the investigated period was 160,9.
The highest peak was found in the age group of 3-6 years (361,8), the second
one was in the age group of 6-14 years (296,9). Adolescents (14-18 y.o) and
young adults had nearly the same incidences (average: 289). Further average
incidences: 0-3 y.o: 134,7, 30-60 y.o: 197,8; 60-80 y.o: 60,7, over 80 y.o: 7,3.
Conclusion: Peak incidences of allergic diseases were found, like in our
former investigation in the age group of 3-6 y.o children. Incidence patterns
may not necessarily follow the prevalence distributions of the atopic march.
Comparative studies are necessary to determine/analyse regional distribution
patterns worldwide.
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The prevalence of allergic diseases in rural and urban regions of
Poland - preliminary report
Boleslaw Samolinski, Agnieszka Lipiec, Filip Raciborski, Urszula Samolinska-
Zawisza, Aneta Tomaszewska, Edyta Krzych-Falta, Nina Jakubik, Justyna
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Marszalkowska, Jaroslaw Komorowski, Tomasz Gotlib, Adam Sybilski, Jacek
Borowicz, Piotr Samel-Kowalik, Lilianna Trzpil, and Justyna Gutowska.
Medical University of Warsaw, Dept. of the Prevention of Environmental
Hazards, Warsaw, Poland.
Aim: The aim of the study was to investigate the prevalence of allergic
diseases in two selected, rural and urban, regions of Poland.
Methods: The project consisted of two stages: survey using a questionnaire
and diagnostic tests in outpatient clinics. The questionnaire study (adapted
ISAAC and ECRHS II) was carried out in a randomly selected groups of
children, adolescents and adults (age groups: 6-7, 13-14 and 20-44 ). One third
of the subjects underwent medical examination directed towards allergy
recognition. The study was carried out in two regions: in Warsaw - the capital
city of Poland and the largest urban agglomeration, with high density of
population and dense traffic and in the rural region of southeastern Poland - two
districts in the province of Lublin (the districts of Zamosc and Krasnystaw),
both characterized by a very low level of environmental pollution, low density
of population and natural farming methods.
Results: In 2006 (June - October) 3833 questionnaires were completed. In the
rural area the number of answered questionnaires reached the level of 2237
(1105 children and 1132 adults) while in the urban area - 1596 (398 children
in age group 13-14, 378 children in the age group 6-7 and 811 adults).
Bronchial asthma was declared by 2,6% of all respondents from rural area and
by twice as many (6%) from urban area. 14,5% of respondents in
Zamojszczyzna and 24,8% in Warsaw declared themselves to suffer from
allergic rhinitis. The question concerning skin allergy was answered positively
by 23% of respondents from rural region and by twice as many of Warsaw
inhabitants.
Table presents questionnaire-based results in relation to age and place
of residence.
Conclusion: Preliminary questionnaire-based results may indicate higher
prevalence of allergic diseases in Warsaw residents in comparison with
residents of rural area of the southeastern Poland. Initial analysis of data from
medical examination does not confirm this finding, therefore further analysis is
essential.
TABLE 1CHARACTERISTICS OF THE CONTROL AND PATIENTS WITH CP
Age group 20-44 20-44 13-14 13-14 6-7 6-7
Place of residence Rural (n=1132) Urban (n=811) Rural (n=592) Urban (n=398) Rural (n=513) Urban (n=387)
Bronchial asthma 1,9% 5,1% 3,4% 9,1% 3,5% 4,7%
Allergic rhinitis 11,7% 22,7% 18,2% 26,4% 16,4% 27,5%
629 subjects living in rural area and 474 residents of Warsaw underwent verifying medical examination. Bronchial asthma was diagnosed in 5,1% of examined subjects from rural
region and in 3,2% fromWarsaw. 14,8% of examined rural area inhabitants and 16,5% of Warsaw inhabitants appeared to suffer from intermittent allergic rhinitis, while persistent allergic
rhinitis was diagnosed in 12,7% and 6,7%, respectively.
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Allergy for cat and sources of the allergens in the urban versus
rural areas of Poland
Liliana Trzpil, and Boleslaw Samolinski. Medical University of Warsaw,
Prevention of the Environmental Hazards, Warsaw, Poland.
Background: The aim is the comparison of a frequency of positive skin prick
test for cat allergen, and the frequency of animal presence at home in various
areas of Poland (rural versus urban). The presented data are a part of the
earliest outcome of large epidemiological study in the field of allergies which
is now run in Poland.
Methods: Randomized probe of various polish populations differing in the
age range (20Y44 13Y14, 6-7 years old) were included in to the study.
Analyzed urban population was gathered in Warsaw (capital of Poland). The
second selected region was Zamojszczyzna, being the typical rural area with
low industrial density. 3833 respondents completed questionnaires ECRHS II
and ISAAC (1596 at urban and 2237 at rural region). 1103 of them were
subjected to medical examination directed towards allergy recognition, and
had made a skin prick test (474 at the urban and 629 at rural region).
Results: 65,5% of persons from urban area revealed the positive skin results
(for at least one allergen), while of the rural one the prevalence was
significantly lower and equal to 34,5% (p = 0.0001). An frequency of positive
cat prick test is significantly higher for urban region when compared to the
rural region (18,4% vs. 10.8), and the intensity of the reaction measured as the
average diameter of the observed skin prick test bubble is also significantly
higher (4,01 vs. 3,63 mm).
It was found that a significant difference between urban and rural areas
was observed for the cat frequency of presence at home 15% vs. 30%. This
data can be also compared with the general frequency of the cat presence in the
home and surrounding. For rural areas cat is present in about 59.8% of homes
and surroundings, while in urban areas cat is present in 15.4% of homes
and surroundings.
About 50% of people with positive skin tests for cat have cat at home.
In urban area these values are significantly lower and equal to 19.5%.
Conclusion: For cat allergies one can observe that frequency of positive skin
prick test is higher on the urban region than on the rural region, contrastively to
the lower presence of the animal allergy sources. Additionally the frequency of
cat presence in homes of sensitive persons is much higher in rural areas than in
urban ones. This observation can lead to the conclusion of protective,
immunotherapeutic role of the high environmental allergen concentration in
rural region.
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Clinical characteristics of new-onset respiratory
allergy in immigrants
Carlo Lombardi1, Gianenrico Senna2, andGiovanni Passalacqua3. 1Ospedale S.
Orsola FBF - Brescia, Unita` di Pneumoallergologia, Brescia, Italy; 2Verona
General Hospital, Allergy Service, Verona, Italy; 3University of Genoa -
Dept. of Internal Medicine, Allergy & Respiratory Diseases, GENOA, Italy.
Background: Allergy is influenced in clinical characteristics by genetic and
environmental factors. We assessed the clinical characteristics of new-onset
respiratory allergy in immigrants in Brescia, Italy.
Methods: We collected the data of all the immigrants referred to our allergy
service within the last two years, focusing those patients without family or
clinical history of allergic diseases.
Results: Two hundred and 39 patients were evaluated (108 male, mean age 35
years). Their countries of origin were uniformy distributed among the 4
macroareas (Pacific southwest, Africa, South America, East Europe). None of
them had previous symptoms of allergy and their family history was negative.
The mean time of onset of symptoms after immigration to Italy was 5.21 years,
and the first clinical presentation was rhinitis+asthma in 68%, whereas the
remaining had rhinitis only. The percentage of monosensitized subjects was
25% and 20% had also sensitization to cockroaches. Only 16% and 6% had a
concomitant positivity for foods or drugs respectively.
Conclusion: In immigrants to Italy the new-onset respiratory allergy displays
a) long latence, b) preferential onset with rhinitis and asthma associated, c)
poor occurrence of sensitization to non inhalant allergens, d) high prevalence
of cockroach sensitization.
Keywords: immigrants, respiratory allergy.
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Reported pertussis infection and risk of atopy in 8Y12 year old
vaccinated and non-vaccinated children
Roos Bernsen1, Nico Nagelkerke1, Carel Thijs2, and Johannes van der
Wouden3. 1United Arab Emirates University, Community Medicine, Al Ain,
United Arab Emirates; 2Maastricht University, Epidemiology, Maastricht,
Netherlands; 3Erasmus MC- University Medical Center Rotterdam, General
Practice, Rotterdam, Netherlands.
Background: Pertussis infection has been suspected to be a potential causal
factor in the development of atopic disease because of the effect of pertussis
immunization on specific IgE antibodies. Although several studies found a
positive association between pertussis infection and atopic disorders, this
relationship has not yet been studied in a population stratified by vaccination
status. Objective of the present study was to assess the association between
pertussis infection and atopic disorders in pertussis-unvaccinated children and
in pertussis-vaccinated children.
Methods: Using data from a previously conducted study on the relationship
between the diphtheria-tetanus-pertussis-(inactivated) poliomyelitis vaccina-
tion in the first year of life and atopic disorders, the study population of 1872
8Y12 year old was divided into children pertussis-unvaccinated and children
pertussis-vaccinated in the first year of life. Within each group the association
between pertussis infection and atopic disorders (both as reported by the
parents) was assessed.
Results: In the unvaccinated group there were no significant associations
between pertussis infection and atopic disorders. In the vaccinated group all
associations between pertussis infection and atopic disorders were positive, the
associations with asthma (odds ratio (OR) = 2.24, 95% confidence interval
(CI95%): 1.36Y3.70), hay fever (OR = 2.35, CI95%: 1.46Y3.77), and food
allergy (OR = 2.68, CI95%: 1.48Y4.85) being significant.
Conclusion: There was a positive association between pertussis infection and
atopic disorders in the pertussis vaccinated group only. From the present study
it can not be concluded whether this association is causal or due to reverse
causation.
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Prevalence of allergies and asthma in Pakistan
M.Y. Noori1, S.M. Hasnain2, and M.A. Waqar1. 1Dr. Panjwani Center for
Molecular Medicine and Drug Research, Molecular Medicine Department,
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Karachi, Pakistan; 2King Faisal Specialist Hospital and Research Centre,
Allergy and Aerobiology Unit, Riyadh, Saudi Arabia.
Background: Allergic diseases are fairly common in all parts of the world and
involve all ethnic groups with bronchial asthma, allergic rhinitis, conjunctivitis
and eczema being the commonest manifestations. Despite our efforts, their
incidence is on an escalating path. There appear to be no authentic data on the
prevalence of allergic diseases in children in Pakistan, therefore the need was
felt to carry out the prevalence studies in the country.
Methods: To estimate the prevalence of allergic diseases in our country, this
first ever study was carried out in the largest coastal city of Karachi which
houses people from all ethnic groups and all socio-economic classes. As there
were no statistics available for any age group in this regard, a Saudi Arabian
Protocol using questionnaires for school children were used instead of ISAAC
Protocol. Questionnaires were distributed to 1200 school children, age 6-15
years, in three different areas for proper proportional representation of high,
middle, and low socioeconomic levels. A total of 700 (58.3%) questionnaires
returned by the parents were found valid and thus included in the survey. The
data was analyzed by using SPSS software.
Results: The result shows that the prevalence of allergic diseases is quite high
in Pakistan. The frequency of wheezing was found to be 15.2%, while the
diagnosed cases of asthma were 9.5%. The frequency of allergic rhinitis was
found to be 34.3%. The frequency of those having allergic rhinitis as well as
wheezing episodes was 8%. There was no statistically significant difference
between asthmatics and non-asthmatics by sex (P-value:0.402). Socio-
economic status was found to affect significantly (p value 0.001) as the
prevalence of diagnosed asthma cases was 6.17% in high socioeconomic class,
13.11% in the middle-class and 2.4% in the low socioeconomic class. Family
history of atopy was also found to be significantly higher in asthmatics.
Conclusion: Allergic diseases are quite common in Pakistan but they remain
under-diagnosed. The prevalence data of allergic rhinitis shows an alarming
situation. These diseases were found to affect middle-class the most, while the
lower and lower-middle class remains the least affected. In addition to
diagnosis and management, prevention and education may help the country to
fight back against the disease. Our study is in progress to increase the sample
size and compare with the data from other cities being collected under the
same protocol.
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Allergic sensitization among Surabaya suburb school children
and undergraduate students
Gatot Soegiarto1, Mai Shihah Abdullah2, Luki Agustina Damayanti1, Arief
Suseno1, Nasuruddin Abdullah3, and Chaerul Effendi1. 1Airlangga University
School of Medicine, Internal Medicine Department, Surabaya, Indonesia;
2Universiti Pendidikan Sultan Idris, Biology Department, Tanjong Malim,
Malaysia; 3International Islamic University, Internal Medicine Department,
Kuala Lumpur, Malaysia.
Objective: To identify major allergic sensitization among school children and
undergraduate students in Surabaya, a cross-sectional epidemiologic study was
done. Participants were recruited by multistage simple random sampling to
represent students of Surabaya_s suburb areas.
Methods: Only 499 out of 550 invited students were agreeing to be involved
in this study in voluntary basis. They were 128 students of primary schools,
221 of secondary schools, and 150 of a university. Complete personal and
family history of allergy, allergic symptoms or diseases, environmental or
home exposure of various common allergens were obtained, physical
examination and skin prick tests were done using a set of 36 different inhalant
and ingested allergen extracts. Total serum IgE and specific IgE RAST for
selected allergens were also measured.
Results: Therewas a trend of increasing skin prick test (SPT) positivity among
study subjects, being 21.90% among primary school children, to 29.05%
among secondary school children, and to 45.30% among undergraduate
students. Cockroach (42.85%) and mould (42.85%) were the most common
allergens in primary school children, followed by house dust mites (28.57%),
grass pollen (17.86%), and crab (14.29%). The order of most common allergens
for secondary school children were: house dust mites (63.16%), cockroach
(37.85%), mould (28.04%), grass pollen (23.38%), and crab (22.77%). The
order for undergraduate students were: house dust mites (58.82%), cockroach
(47.05%), crab (41.17%), mould (36.76%), and grass pollen (20.59%). There
were some multiple SPT positivity among them, toward 2 or 3 allergens in
general. Urticaria and rhinitis were the commonest clinical manifestation of
allergy. History of atopy in the family was positive for only 36.7% of
respondents.
Conclusion: The prevalence of allergic sensitization among school children
and undergraduate students in Surabaya suburb areas were increased, being
above the previous estimates for Indonesia in 2003. House dust mites
and cockroach were the most common allergen; while urticaria and rhinitis
were the commonest allergic manifestation.
Keywords: allergy, sensitization, schoolchildren, skin prick test, epidemio-
logic study
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Anaphylaxis rates in New Zealand (NZ)
Marianne Empson, and Julie Smith. Auckland City Hospital, Clinical
Immunology, Auckland, New Zealand.
Background: A high prevalence of atopic disease and asthma has been
documented in NZ based primarily on studies in children. No prevalence data
is available for anaphylaxis although anecdotally the incidence appears to be
high. This study obtains baseline data for anaphylaxis rates in a well-defined
adult population in Auckland, NZ.
Methods: A retrospective audit of adults admitted to Auckland City Hospital
(ACH) was performed. Patient charts for the audit were identified using a
broad range of diagnostic codes that may have been used in cases of
anaphylaxis. Four major diagnostic categories were included in the chart
retrieval: allergy/allergic reaction, anaphylactic shock or reaction, angioe-
dema/urticaria, and insect sting. Two time periods were selected for the audit,
1st July 2000 to 30th June 2001 (A), and 1st July 2005 to 30th June 2006 (B).
Files were reviewed and data extracted almost exclusively by one
author. A cohort of patients that satisfied the Olmstead County definition of
anaphylaxis was identified for each time period. Where the diagnosis of
anaphylaxis was uncertain the case was excluded.
Interval A included community-onset anaphylaxis only while B
included all cases of anaphylaxis.
Detailed data on the population served by ACH is available for both
time intervals. This was used to determine anaphylaxis rates in adults (older
than 14 years). National population data will be used to determine age-
standardised rates for New Zealand.
Results: 367 and 664 admissions were reviewed for intervals A and B
respectively. 129 episodes of community-onset anaphylaxis were identified in
121 individuals in A and 113 episodes in 111 individuals in B. The number of
individualsper100,000adults sufferingat leastoneepisodeofanaphylaxis in the
community per yearwas 41 (95%CI 34 Y 48) inA and 34 (95%CI 28 Y 40) inB.
An additional 37 episodes of anaphylaxis occurring in hospital were
identified in B. The total rate of anaphylaxis in all settings in B is therefore 46
(95% CI 39-53) per 100,000 adults per year.
Conclusion: The rate of anaphylaxis in NZ adults is one of the highest in
reported literature. However this is still an underestimate as it does not include
cases managed solely in the community or those misclassified as asthma. In
addition in this retrospective study some cases of anaphylaxis may have been
excluded due to uncertainty. Despite this it provides us with an important
assessment of the potential size of the problem for further studies.
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Knowledge and concerns of treatment and care among Thai
allergy patients in Rayong Province, Thailand
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Wirach Maek-a-nantawat1, Sarawan Maythaarttaphong2, Rawiwan Suphan2,
Hathairat Chueathai2, Urairat Phantong2, Doungngoen Khaminthakul2,
Kanokon Boontanom2, Suranya Sarapat2, Sukanya Tomkum2, and Udomsak
Silachamroon3. 1Mahidol University, Allergy Clinic, Clinical Tropical
Medicine, Bangkok, Thailand; 2Faculty of Tropical Medicine, Mahidol
University, Vaccine Trial Center, Bangkok, Thailand; 3Mahidol University,
Allergic Clinic, Clinical Tropical Medicine, Bangkok, Thailand.
Patient education and health promotion are important to prevent and
decrease morbidity and mortality in allergic diseases. Despite improvement
of health care system, improper knowledge, attitude and incorrect beliefs on
allergy have been worried. To evaluate the knowledge and concerns of
treatment and care of allergy would give the information for health care
personnel and physicians to develop a good campaign on prevention and
care among allergy patients in the future. Self-assessment by questionnaire
on knowledge and opinions about allergy and allergist was performed among
125 patients in Rayong Province, which is one of leading centers for tourist
and machinery industry. 44.8% know that allergy is an important global
health problem and 52.8% also think that it is not severe and life threatening.
39.2% agree to be treated only to relieve symptoms not for continuing
treatment and 59.2% need continuing therapy. So 56.8% used the over-the-
counter medicine from pharmacy and 4.8% had never used any drug to
relieve their allergic symptoms. 80% prefer oral drugs to inhaled drugs but
85% of them will follow the physician advice of using inhaled drug. 53.6%
still believe that allergy is permanently cured and about one-forth to third of
the patients think that allergic symptoms can be alleviated by nutrient (24%)
supplements and air cleaners (34.4%). Though 69.6% know the existence of
allergy specialist but few (9.6%) have visited the special clinic and only 7
patients (5.6%) were tested and known their own specific allergens by
allergen skin test. However, 89.6% indicated that allergen avoidance is a key
role of treatment and 84% know that house dust mite is the most common
allergen in Thai population. Only one-fifth (21.6%) satisfy an updated
information of allergy and all of them give their concerns on insufficiency of
the information provided to their community.
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Allergy and migraine - a significant comorbidity
M.V. Francis. Eye and Migraine Centre, Ophthalmology, Cherthala, India.
Background: Molecular mechanisms of peripheral sensitisation of nocicep-
tors could be identical for painful and pruritic (allergic) diseases. Therefore
therapeutic approaches for pain treatment may also be beneficial for allergy.
Montelukast, cyproheptadine and ketorolac tromethamine are found to be
effective in migraine and allergy. This study is to document the association
between migraine and allergic disorders.
Methods: Study spanning 5 years. 10240 migraine patients were questioned
about various allergic manifestations.
Results: 7995 (78%) were suffering from various allergic manifestations
either at the time of consultation or sometime in the past. Nasal allergy was the
commonest 6395 (80%), ocular allergy in 4797 (60%), bronchial allergyin
3198 (40%), and skin allergy in 640 (8%). 1439 were suffering from all 3
allergies(naso oculo bronchial).
Conclusion: Allergic disorders increased the risk for migraine and migraine
increased the risk for allergy. This bidirectional association immensely helps the
clinician to explain the causative molecular mechanisms and the genetic origin
of these two conditions in the most simple way to their patients.
RISK FACTORS FOR ALLERGY
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Dust mite one of the risk factor of allergic asthmatics
in developing country
Shambhu D. Joshi1, and Rajan Bhandari2. 1Nepal Medical College, Medical
Sciences, Ktm, Nepal; 2Community Health and Environmental Society Nepal,
Community Health, ktm, Nepal.
House dust are considered to be a source of potent allergen
responsible for different allergic manifestations. A total of 54 species of
mites belonging to 33 genera, 18 families under 3 orders have been recorded
from house dust samples collected from asthmatic patients residing in and
arround rural areas. All the allergenic mites viz. Dermatophagoides
pteronyssinus, D. farinae, Austroglycyphagus sp., Blomia tropicalis., Acarus
siro, Glycyphagus domesticus, G.destructor, Tyrophagus putriscentiae except
Euroglyphus sp. have been recorded. Among them Dermatophagoides alone
contituted more than 60% of the total mites isolated. Patients bed contained
significantly higher mite population than the control subjects bed dust
(pG0.02) and among two different habitats examined i.e. bed and
corresponding bed room floor dust, the former contained higher ( p G
0.01) mite density than the later. Analysis of skin prick test against dust
related allergens revealed that 82.4% of the patients showed marked
preference towards Dermatophagoides mite allergens. Estimation of total
serum IgE level indicates that patients sera contained significantly higher
level than the control sera (p G 0.001). RAST result further confirms the
higher degree of sensitivity towards house dust mites (84.76%). The clinical
history of the patients, the physical appearance of allergenic mites in higher
concentration in the patients bed, positive skin test results with mite extract
and identification of mite specific IgE antibodies in patients’ sera by RAST
technique established the role of dust mites on the aetiopathogenesis of
bronchial asthma in developing country.
651
Allergic reactivity to mites and Ascaris lumbricoides in a group
of Venezuelan amerindian children
Franca Puccio1, IsabelHagel2, DomenicoCifarelli3, Elianska Lopez3, andMaria
C Di Prisco3. 1Instituto de Biomedicina, Inmunopatologia, Caracas, Venezuela;
2Instituto de Biomedicina, UCV, Inmunoquimica, Caracas, Venezuela; 3Instituto
de Biomedicina, UCV, Inmunopatologia, Caracas, Venezuela.
Background: There was a strongly controversy between the protective or
inductor effects of parasites infections and the risk of development allergic
diseases in several countries. Moreover, It had been proposed that shared
antigens between helminthes parasites and environmental allergens could
modulated allergic immune responses. However, evidences for this process has
not been consistently establish.
Methods: The aim of this study was to evaluate the allergic reactivity and
helminthes parasites coexistence in a group of unselected 61 scholar Children,
reflecting a population with a profound socioeconomic depression, a high rate
of common childhood infectious diseases such as diarrheas (8344 x 100.00
inhabitants), acute respiratory infections (1528 x 100.00 inhabitants) and high
prevalence of helminthic infections (53%). Additionally by ELISA, we
detected the levels of th1 (INF+), and th2 (IL-4) cytokines as well as the levels
of total and specific IgE against Dermatophagoides pteronissynus, Blomia
tropicalis and Ascaris Lumbricoides. We performed an inhibition specific IgE
test between mites and Ascaris lunbricoides in order to establish the cross
reactivity between these allergens. We also performed clinical evaluation,
hematological studies and skin prick test with common food, mites and
parasites allergens.
Results: Sixty seven percent of children (group 1) showed respiratory
symptoms or skin manifestations. Fifty % had high leukocyte count and had
high INF+ levels (4190-5320 UI/ml) than control group. Skin prick tests were
positive in 43% of children to at least one of the common allergens evaluated:
77% were positive to Ascaris lumbricoides, 27% to Blo t and 27 % to D.pt.
Fifty % had high total IgE levels, (3812 - 910000UI). Eighty one percent
showed levels of specific IgE higher than 17.5 UI/ml to Ascaris and 67% to
D.pt. Before the inhibition test the median levels of specific IgE to Ascaris
diminished from 14.17UI/ml to 3,43UI/ml % and to D.pt from 12,94 to
3,37 UI/ml.
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Conclusion: These results indicates that high allergic reactivity, (evidenced by
clinical, skin prick test and specific IgE), and high levels of Th1 cytokines were
both been present in sera of children evaluated. We also found that there were
an inhibition in the level of specific IgE in the sera of these children,
suggesting a cross reactivity between mite and Ascaris allergens.
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The approach to improvement diagnosis of lambliasis in patients
with atopic bronchial asthma
Dmitry Dolbin, Yuriy Tyurin, and Sergey Kulikov. Kazan Scientific Research
Institute of Epidemiology and Microbiology, Rospotrebnadzor, Kazan,
Russian Federation.
Backround: Since 1859 when has described first time G. lamblia as the
activator of disease of a gastroenteric path, the huge material of
epidemiology and pathogenesis of lambliasis and as effective enough
ways of therapy of the given disease have been developing and collecting.
But also at the moment, concerning this disease, there are the numerous
questions expecting the decision. Most important of this group of problems,
intensively discussed problem of diagnostics and prevalence G. lamblia
among people is.
Methods: We use commercial ELISE-test and the immunochromatography
methods revealing specific antibodies in whey of blood and antigen_s in
excrements. They possess more sensitivity (66,3 Y 98,9 %) and high specificity
(92,6 %) unlike routine microscopic methods in diagnosis of lambliasis. In
connection with before be the aforesaid, till now the most widely applied test in
laboratory diagnostics of lambliasis, such as a microscopy of sedimentary
components of excrements or researching contents at duodenal sounding for
the purpose of revealing cysts of G. lamblia. In the literature as the method
enrichment formalin-radio is recommended. Unfortunately, the specified tests
of laboratory diagnosis of lambliasis possess low sensitivity, subject to
influence of some subjective and objective factors among which, such
as changeable allocation cysts of G. lamblia, difficulty for microscopic
identification.
Results: We used the combined method of research of excrements This
method allowed to improve essentially delectability cysts G. lamblia in
comparison with a routine method microscopy of fecal. We will especially
notice, that at comparative research of tests in which activators lambliasis
have been revealed and using three components a method and microscopy
research of fecal in the first case the big degree invasion came to light. It has
paramount value at definition of necessity of carrying out of therapy
lambliasis.
Conclusion: As using combined method using three components for flotation
of research of excrements, we managed to increase essentially delectability
G. lamblia and as to reduce quantity of repeated researches necessary for
the exact diagnosis of lambliasis. Accuracy of definition of degree invasion
an organism this elementary has besides, increased, that has allowed to
correct therapy.
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Titanium used for fabrication of obturators after
maxillectomy -an alternative therapeutic option in cases of
incompatibility of polymer based denture materials
Rita Depprich1, Eva Kusch1, Alexandra Meissner2, and Guido Meissner2.
1Heinrich-Heine-University Duesseldorf, Department of Cranio- and Max-
illofacial Surgery, Duesseldorf, Germany; 2Private Clinic, Cranio- and
Maxillofacial Surgery, Wuppertal, Germany.
Background:Microbiological colonization and subsequent biofilm formation
on denture materials play an important role in the development of denture
stomatitis often triggering allergic incompatibilty of denture materials as the
penetrability of the mucosa is changed. Despite the high standards in
reconstructive surgery and even with the use of free vascularized flaps post-
maxillectomy rehabilitation with obturator prosthesis is still the mainstay
reconstructive procedure in several cases. With current use polymer based
silcone- or methacrylate-obturators bear the risk of an increasing settlement
and penetration of bacteria and thus the risk of local or even systemic
infections. Titanium-obturators [TO] for oral rehabilitation offer favorable
characteristics concerning growth of microbial biofilms. The aim of our
study was to compare the prevalence of microbial contamination on
titanium- and polymer based -obturators [PO] used for post-maxillectomy
rehabilitation.
Materials and Methods: We investigated the obturators of 36 patients (17
TO, 19 PO), all had undergone maxillectomy due to malignancy in the period
1999-2204. Microbiological samples of the obturator surfaces, the adjacent
mucous surfaces and of the interior of the PO (when new fabrication was
planned) were collected with a sterile swab. Microbiological analysis was
performed by conventional methods, including microscopy and culture
on different agars. For statistical data analysis Fisher_s exact test [FT]
(P-value P e .05) and odds ratio [OR] (95% confidence interval) were used.
Results: PO showed a significantly higher quantitative contamination and a
shift to non physiological bacteria compared to TO (p = 4.944e-06 [FT], 6.84
[OR]). There is a high statistical risk (factor 1.4) for penetration of bacteria to
the interior of PO when the pathological bacteria are seeded on the surface of
PO (p = 0.01966).
Conclusion: The use of titanium-obturators for the oral rehabilitaton of
post-maxillectomy patients significantly reduces the risk of contamination
with pathological oral bacteria and therefore prevents patients from
local oral or systemic infections. Especially in cases of incompatibility of
polymer based denture materials titanium-obturators offer an alternative
therapeutic option.
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Atopy history in family associated with persistent allergic
symptoms in Thai population
Wirach Maek-a-nantawat1, Sarawan Maythaarttaphong2, Rawiwan Suphan2,
Hathairat Chueathai2, Urairat Phantong2, Doungngoen Khaminthakul2,
Kanokon Boontanom2, Suranya Sarapat2, Sukanya Tomkum2, and Udomsak
Silachamroon1. 1Mahidol University, Allergy Clinic, Clinical Tropical
Medicine, Bangkok, Thailand; 2Faculty of Tropical medicine, Mahidol
University, Vaccine Trial Center, Bangkok, Thailand.
Allergy has been estimated about 10Y20% of Thai population. Most
studies conducted in Bangkok and other regional centers showed a increase
trend of allergy prevalence in a recent decade. This study is aimed to determine
the prevalence of allergic diseases in an urban area, Rayong province, which
has high growth of industry and oil/gas refineries. 524 Rayong residents, with
mean age (T SD) of 26.26 (T 3.77) years old and male 59.4%, were asked about
their history of allergy regarding rhinitis, asthma, conjunctivitis, dermatitis
including urticaria, food allergy and drug allergy. Prevalence of overall allergy
is 15.6 %. Persistent rhinitis, asthma and dermatitis are 12.3 %, 3% and 2.3%,
respectively. About urticaria, 9.5% reported history of acute (78%) and chronic
type (22%). 4.4% revealed history of food allergy of which the most common
culprit was sea-food allergy (73.9%). 2.7% showed history of insect sting
allergy in which 46.2% of them had large local reaction and 3 of 13 had
anaphylactic reaction. Drug allergy is 2.3% with history of allergy to beta-
lactams (25%), NSAIDS (25%) and paracetamol (16.7%). Family history
of atopy is significantly associated with history of rhinitis (P G 0.0001), asthma
(P G 0.0001), urticaria (P = 0.001), conjunctivitis (P = 0.029) and food allergy
(p G 0.0001). There is no association between history of allergy and sex, age or
occupation. There is also a close association among chronic rhinitis, asthma
and food allergy (P G 0.0001). In conclusion, allergy is not uncommon even in
an urban area like an eastern part of Thailand. History of atopy in family is
useful to be a predisposing factor of allergic diseases.
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Effect of prenatal and postnatal exposure to low-level toluene
and peptidoglycan on systemic Th1/Th2 immunity in infant mice
Shoji Yamamoto1, Atsushi Fukushima1, Tin Tin Win Shwe1, Rieko Hojo1,
Yasuhiro Hojo2, Naoki Kunugita3, Keiichi Arashidani3, and Hidekazu
Fujimaki1. 1National Institute for Environmental Studies, Research Center
for Environmental Risk, Tsukuba, Japan; 2University of Occupational and
Environmental Health, Japan, Medicine, Fukuoka, Japan; 3University of
Occupational and Environmental Health, Japan, Health Science, Fukuoka,
Japan.
Background: Toluene, a widely used aromatic organic solvent, has been
well characterized as a environmental toxic chemical. Volatile organic
compounds including toluene are the possible substances causing chemical
sensitivity in human. Our laboratory has previously showed that the
exposure of low-level toluene causes immunological and neurological
modulation in adult mice. Recently, it has been suggest that TLR2/4 ligand
such as peptidoglycan (PGN) or LPS modulates Th2-driven allergic immune
responses in animal studies. The aim of the present study was to investigate
the effect of low-level toluene exposure and PGN stimulation on systemic
Th1/Th2 immunity in infant mice.
Methods: We exposed pregnant BALB/c mice to filtered air (0 ppm), 5
ppm, and 50 ppm toluene for 6 h/day on 5 days/week for 1 week (from day
14 of gestation until delivery) in the whole body exposure chamber. The
offspring were further exposed to toluene of same schedule for 3 weeks
(from the day of birth up to day 21). Some of the pregnant mice were
repeatedly exposed to aerosolized PGN 2002g/10 ml (3 times per week)
during the toluene exposure period. Offspring from the toluene and PGN
exposed pregnant mice were further repeatedly administered PGN 1002g (5
times per 2 weeks) intraperitoneally from day 7 up to day 21 during the
toluene exposure period. One day following the last toluene exposure, we
collected blood, spleen, and lung from each mouse. Then, total IgE, IgG1,
and IgG2a antibodies in plasma and the production of cytokines (IL-12,
IFN-+, IL-4, IL-5) in spleen and lung were assayed by ELISA method. Also,
the expression of cytokine and transcription factor T-bet mRNAs in spleen
was analyzed by real-time RT-PCR method.
Results: Exposure of mice to low-level (5 or 50 ppm) toluene resulted in
(1) increased IgG1 and decreased IgG2a antibodies in the plasma; (2)
decreased T-bet mRNA significantly in spleen; and (3) decreased IFN-+ and
IL-12 mRNA in spleen but not statistically significant. Next, exposure of
mice to low-level toluene by combination with PGN stimulation compared
to toluene alone resulted in decreased IgG1 and IgG2a antibodies in the
plasma and IL-12 mRNA in spleen.
Conclusion: These findings suggest that low-level toluene exposure from fetal
stage to neonatal stage may enhance the systemic Th2 function in infant mice.
However, the exposure to combination of low-level toluene with PGN
stimulation shifted Th1/Th2 immunity to suppressive direction.
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Risk factors for recurrent wheezing in infancy
Herberto Jose Chong Neto and Nelson Rosario. University of Parana,
Pediatrics, Curitiba, Brazil.
Background: Although recurrent wheezing is frequent, there are few data
regarding risk factors associated with this condition. The aim of study is to
verify the risk factors for recurrent wheezing in infants, in the south of Brazil.
Methods: Cross-sectional study using a standardized and validated ques-
tionnaire with 45 questions about recurrent wheezing and familiar, enviro-
mental, socio-economic and respiratory infections risk factors in the first
twelve months of life, from International Study of Wheezing in Infants (EISL,
from spanish: Estudio Internacional de Sibilancias en Lactantes). Parents of
infants that attended the Health Centers between August/2005 and December/
2006 for regular immunization were interviewed. Among 107 Immnunization
Centers 35 were randomly selected in order to maintain a homogeneous
selection of population sample. Factors associated to recurrent wheezing in a
univariate analysis were studied using multivariate regression of Poisson.
Prevalence ratio and confidence intervals of 95% were calculated due to a high
prevalence of wheezing infants and statistic was considered significant when
p G 0.05.
Results: Three thousand and three infants, aged 12-15 months-old were
studied. The prevalence of recurrent wheezing was 45.4%. There are
associations between recurrent wheezing and male gender, mother, father
and siblings asthma history, mother´s instruction (secondary and advanced),
others pets in domicile during pregnancy (birds), 6 colds episodes or more,
personal history of dermatitis and molds in home. Updated immunization was
a protection factor for recurrent wheezing.
Conclusion: Prognostic risk factors for recurrent wheezing in the first year of
life were male, familiar history of asthma, high mother´s instructions, other pets
during pregnancy and molds in home, a high number of colds episodes, and
personal history of dermatitis. Interventions acting on these factors may
decrease the occurence of recurrent wheezing in infants in Curitiba, Brazil.
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Monitoring of cytokines in breast milk from allergic and non
allergic mothers: prospective birth cohort study
Galli Elena1, Palmesi Francesca2, Nisini Rita2, Agostino Rocco2, Carpino
Valentina1, Gabriele Ida1, Mora Nadia G.M.1, Brunetti Ercole1, and Mancino
Giorgio1. 1San Pietro Hospital - Fatebenefratelli, AFaR Research Centre,
Roma, Italy; 2San Giovanni Calibita Hospital - Fatebenefratelli, Neonatology
Unit, Roma, Italy.
Background: It is well documented that human milk contains several
immunomodulatory components which are important during the newborn_s
immune system development. In this context, breastfeeding could provide the
best possible nutrition. Its role in the development of allergies remains
although controversial, due to possible individual differences and variations in
the composition of the breast milk. Furthermore, other stimuli could interact
with immune system during perinatal-neonatal period, interfering with breast
feeding and hence with the immune system development. For these reasons,
we are interested to investigate the different components (environmental, diet,
familiarity etc.) that could be involved in the allergic diseases apperarence.
Aim: The aim of this prospective birth cohort study is to investigate the
concentration of cytokines involved in allergic reactions, IgA antibody
production, soluble (s) CD14 and fatty acids in cord blood, colostrum and
mature milk, from allergic and non allergic mothers. Moreover, the aim is to
investigate whether breastfeeding practice, correlated with immunological
profile, is determinant for the increased risk of atopic disease development in
children. 32 mothers (17 allergics, 15controls) and their full term newborns
were included in the study, until now. We measured cytokines in colostrum
samples (2 days after birth), and in transitional breast milk samples (5 days
FACTORS PR 95% CI p-value
Male 1.14 1.05Y1.24 0.002
Mother_s asthma history 1.18 1.04Y1.33 0.007
Father_s asthma history 1.20 1.05Y1.39 0.008
Sibling_s asthma history 1.23 1.08Y1.42 0.002
Mother_s instruction (Secondary) 1.39 1.24Y1.55 G0.0001
Mother_s instruction (Advanced) 1.20 1.07Y1.35 0.001
Other pets in domicile during
pregnancy (birds)
1.28 1.07Y1.54 0.007
Q6 colds episodes 1.32 1.21Y1.44 G0.0001
Personal history of dermatitis 1.09 1.003Y1.19 0.04
Molds in home 1.14 1.04Y1.24 0.003
Updated immunization 0.79 0.63Y0.98 0.03
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after birth). Children underwent paediatrician evaluation till now at 6 months
of life.Levels of cytokines (IL-4, IL-5, IL-6, IL-10, IL-13, TGFBeta1,
TGFBeta2,TNF alfa and beta) were determinated by commercial ELISA kits.
Results: Different cytokines levels in colostrum and milk samples, were
evidenced between allergic and non allergic mothers. In particular, our
preliminary data showed that colostrum from allergic mothers has a significant
increased level of IL-4, IL-13, IL-5, TGF beta 1 e 2 compared to samples from
non allergic mother, while no differences in cytokines level were revealed in
the milk samples from the same two groups. Follow-up is in progress, first
round of clinical evaluation 6 months after birth, does not reveal yet any
allergic symptoms in all the children.
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Kawasaki disease and allergic disease - a sibling control study
Chee Wen Terence Lim1, Woei Kang Liew2, Bee Choo Tai3, Hamidah
Othman1, Teng Hong Tan2, Keng Yean Wong2, Swee Chye Quek4, and HP
Van Bever4. 1National University Hospital, Paediatrics, Singapore, Singa-
pore; 2KK Women’s and Children’s Hospital, Paediatric Medicine, Singapore,
Singapore; 3National University of Singapore, Community, Occupational and
Family Medicine, Singapore, Singapore; 4National University of Singapore,
Paediatrics, Singapore, Singapore.
Background: It has been shown that Kawasaki disease (KD) may increase the
risk of developing allergic diseases. We investigated the relationship between
KD and allergic diseases using a sibling control study design in order to
minimize the impact of familial effect confounders.
Methods: Children with a history of KD along with their healthy siblings were
recruited from the two major paediatric hospitals in Singapore. All subjects
undertook the standardized modified ISAAC questionnaire for allergic
diseases and underwent a detailed physical assessment as well as skin prick
testing (SPT) with a standardized panel of allergens.
Results: Eighty-one KD-sibling pairs were studied. There was no statistical
difference in gender and age distribution between the KD and the healthy
sibling controls. KD patients had an overall increased risk of allergic diseases
(Odds Ratio [OR] 3.29, CI 1.36Y9.07, p = 0.005) particularly allergic rhinitis
(OR 3.13, CI 1.37Y8.02, p = 0.005). KD patients also had a higher risk of
eczema (OR 1.38, CI 0.50Y3.94, p = 0.648), asthma (OR 1.80, CI 0.54Y6.84,
p = 0.424) and allergic conjunctivitis (OR 1.33, CI 0.41Y4.66, p = 0.791),
although the differences were not statistically significant. The risk of
sensitization against common allergens was also higher, although not
statistically significant, in KD patients (OR 1.33, CI 0.62Y2.82, p 0.500),
with risk of positive SPT highest against cockroach allergen (OR 3.33, CI
0.86Y18.85, p = 0.092) followed by Blomia Tropicalis (OR 1.41, CI
0.73Y2.80, p 0.349). There was no significant difference in wheal size against
histamine and allergens between KD patients and their sibling controls.
Conclusion: Our study suggests that KD may be an independent risk factor in
the development of allergic diseases, particularly allergic rhinitis.
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Serum total IgE levels and type of sensitization may predict
asthma onset in patients with allergic rhinitis
George Konstantinou1, Dimitrios Vourdas2, Konstantinos Petalas2, and
Christos Grigoreas2. 12nd Pediatric Clinic, Kapodistrian University of
Athens, Allergology and Clinical Immunology Department, Athens, Greece;
2251 Air Force General Hospital, Allergology and Clinical Immunology
Department, Athens, Greece.
Background: Recent epidemiological surveys suggest that allergic rhinitis
(AR) and asthma are intimately linked while AR is considered as a risk factor
for asthma development.
Objective: To investigate retrospectively the predicting value of total serum
IgE (tsIgE) and type of sensitizations in the onset of asthma to individuals with
allergic rhinitis (AR).
Patients and Methods: Serum total IgE analysis and Skin Prick Test (SPTs)
to 9 different, representative for Mediterranean populations, aeroallergens
(grasses, parietaria, olive, d. farinae, d. pteronyssinus, alternaria, cladosporiom
and cat) were performed to 1439 adults (20 to 60 years old). The adult-sample
was considered representative since it consisted of all staff of the Greek Air
Forces who were examined (after written consent was obtain from all) during
their obligatory annual medical check up. A mean wheal diameter of 3mm or
more, in the absence of any reaction in the negative control SPT, was
considered as a positive reaction. Multiple logistic regression was performed
to reveal any statistical significant association between type of respiratory
allergy (AR and/or asthma) and all known parameters (gender, age, type of
sensitization, tsIgE levels). Thereafter the diagnostic properties of tsIgE and
type of sensitization in discriminating between rhinitis and asthma were
analyzed using the Receiver Operator Characteristic (ROC).
Results: Patients with allergic rhinitis sensitized at least to indoor
aeroallergens have an increase risk of asthma onset 8.46 times [Confidence
intervals (CI) 3.28Y21.8, p G 0.0001], while this risk increases 1.36 times more
for every increment of 100kU/lt of the tsIgE (p G 0.0001). These two factors
provide an excellent discrimination between those with AR and AR and
asthma (ROC Area Under the Curve: 0.8319, CI:0.7813Y0.8825).
Conclusion: Type of sensitization and serum tsIgE seem to be promising
significant predictors of asthma development in patients with AR, although
they should be evaluated prospectively in future longitudinal studies.
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Allergic migraine
M.V. Francis. Eye and Migraine Centre, Ophthalmology, Cherthala, India.
Background: Molecules involved in allergy and migraine may be identi-
cal.This study is to document oculonasal allergies triggering migraine attacks.
Methods: 4 year study, 28 patients aged 15 to 50 years. Migraine diagnosed
according to ICHD 2 diagnostic criteria.
Results: 22 patients reported severe allergic rhinitis and 6 with severe ocular
itching precipitating headpain attacks resembling migraine 24 of them were
also getting migraine attacks when exposed to common migraine triggers in
this region. These common triggers are exposure to sunlight, travelling by bus,
sleep disturbances and missing meals at the right time. Travelling by bus
triggered allergic symptoms in 21 of these patients most probably due to
exposure to dust and smoke.
Conclusion: Molecules involved in allergic inflammatory processes definitely
trigger migraine episodes by exciting peripheral nociceptors.
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Familial allergy in Surabaya’s suburb schoolchildren
Gatot Soegiarto1, Mai Shihah Abdullah2, Luki Agustina Damayanti1, Arief
Suseno1, Nasuruddin Abdullah3, and Chaerul Effendi1. 1Airlangga University
School of Medicine, Internal Medicine Department, Surabaya, Indonesia;
2Universiti Pendidikan Sultan Idris, Biology Department, Tanjong Malim,
Malaysia; 3International Islamic University, Internal Medicine Department,
Kuala Lumpur, Malaysia.
Objective: To evaluate the influence of parental allergy to their offspring, data
of 358 schoolchildren were analyzed. They were parts of an epidemiologyc
study of allergy in schoolchildren and undergraduate students done in
Surabaya’s suburb areas.
Materials and Methods: A questionnaire was filled by the children with the
help of the researcher. Another questionnaire was filled by both of their
parents. Complete personal and family history of allergy, allergic symptoms or
diseases, environtmental or home expossures of various common allergens
were obtained. Skin prick test (SPT) were done to the entire children and their
accompanying parent(s), using a set of 36 different inhalant and ingested
allergen extracts.
Results: Of 358 schoolchildren, only 163 were accompanied by both of their
parents, so that the data could be analyzed. There were 60 children with SPT
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(+), among them 22 mothers only (36.67%), 14 fathers only (23.33%), and 9
both parents (15%) had positive SPT, while 15 (25%) were both negative.
Among 103 children with SPT (Y), there were 23 mothers only (22.33%), 17
fathers only (16.50%), and 14 both parents (13.59%) had positive SPT, while
49 (47.57%) were both negative. Atopic status of the mother had stronger
influence on their children’s SPT results (Pearson chi-square = 4.058, p =
0.044), while atopic status of the father did not (Pearson chi-square = 1.057,
p = 0.304).
Conclusion: Compared to the father, atopic status of the mother had
signifycantly stronger influence on the schoolchildren SPT results.
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Degree and clinical relevance of sensitization to common
aeroallergens in adult respiratory allergic population
of Calcutta City
Pampa Chakraborty1, Indrani Roy2, and Swati Gupta-Bhattacharya3. 1Sree
Chaitanya College-Habra, Department of Botany, Calcutta, India; 2Institute
of Child Health, Allergy Department, Calcutta, India; 3Bose Institute,
Department of Botany, Calcutta, India.
Background: The aim of the study was to assess the types of allergic
sensitization, risk factors and clinical impact of being sensitized in the adult
respiratory allergic population of Calcutta City, India.
Methods: In the period of 2003Y05, 1353 adult respiratory allergic subjects
from Calcutta were tested (skin prick tests) for common aeroallergens
including 29 pollen types, 19 mould spore types, house dust mites and animal
dander. All subjects were interviewed on symptoms and diseases including
respiratory irritants and childhood environments.
Results: The maximum sensitivity was recorded for D. farinae (94%), grass
pollen (76.55%) and Fusarium spore (53.92%) among the three groups of
allergens tested. The prevalence of at least one positive prick tests was 37.12%.
A large difference by age was found: 58.9%were sensitized in the age group of
20Y29 years, 42.8% in the age group of 40Y49 years and 28% in the age group
of 50Y60 years (p G 0.001). Sensitization to multiple allergens was common in
the age group of 20Y29 years with 42.1% of the sensitized responding to at
least four allergens, while this portion was only 12.8% of the sensitized among
those aged 50Y59 years. The prevalence of physician-diagnosed asthma,
allergic rhinitis (AR), conjunctivitis and wheeze increased significantly with
increasing number of positive skin responses. Having a family history of AR
or conjunctivitis was a significant risk factor for allergic sensitization and for
sensitization to any of the pollen grains. Further, urban living in childhood
added an increased risk for pollen sensitization.
Conclusion: The prevalence of allergic sensitization was high in the urban
adult population of Calcutta. More than half of those aged 20Y29 years were
sensitized and 42.1% was sensitized to at least four allergens. Sensitization to
multiple aeroallergens was associated with a high prevalence of asthma, AR or
conjunctivitis and wheeze.
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Association of HLAG gene polymorphism and house dust mite
respiratory allergy in an Algerian patient group
Reda Djidjik1, Mohamed Ghaffor1, Merzak Gharnaout2, Hicham Djidjik2,
Abdennour Benyounes3, Krishnamoorthy Rajagopal4, Mohamed Cherif
Abbadi5, Dominique Charron6, and Ryad Tamouza6. 1CHU BENI-MESSOUS,
Clinical BiologyDepartment, ImmunologyUnit, Algiers, Algeria; 2CHUBENI-
MESSOUS, Pneumology Department, Algiers, Algeria; 3Ben-Aknoun, Aller-
gology Center, Algiers, Algeria; 4Robert Debre´ Hospital, INSERM U763,
PARIS, France; 5Pasteur Institute of Algeria, ImmunologyDepartment, Algiers,
Algeria; 6Saint-Louis Hospital, Immunology and Histocompatibility Depart-
ment, AP-H, Paris, France.
HLAG, a nonclassical MHC class Ib molecule, plays a significant role
in immuno-tolerogenic processes. HLA-G expression through alternative
splicing generates membrane-bound and soluble isoforms secreted by
activated (by IL-10) peripheral blood CD14+ monocytes. Genetic diversity
of HLA-G consists of sequence variations in promoter, exonic and
3_untranslated (3_UTR) regions, some of which have been shown to affect
HLA-G mRNA stability. Polymorphisms in the HLAG promoter region had
previously been associated with asthma. Of interest is also the fact that the
gene encoding the effector IL-10 also exhibits genetic polymorphism in
populations. Given the plausible effect one over the other, in this study, we
investigated the potential role of a 14-bp insertion/deletion polymorphism in
the HLAG-3_UTR region in conjunction with IL10 gene promoter poly-
morphisms (-1082 A/G, -819 C/T and -592 C/A) on respiratory allergy
development. The association study involved 125 patients suffering from
asthma and/or rhinitis, all monosensitized against Derp 1 and 74 matched-
controls, all originating from Algeria. PCR-based techniques were used to
assess the HLAG and IL-10 genotypes. While the IL-10 promoter allele or
genotype frequency did not differ between patient and controls, the 3_UTR
+14-bp insertion allele was significantly more frequent in the patient group
than in the control group (Pc = 0.01) with the homozygous state of the
3_UTR -14-bp deletion allele being more prevalent in the healthy controls
(Pc = 0.04). Our findings suggest that HLA G gene may participate in the
pathogenesis of respiratory allergic diseases in our population. A possible
mechanism that could be envisaged is that the diminished immunosuppres-
sive activity, mediated by HLA-G, may contribute to initiation/persistence of
chronic airway inflammation in asthma.
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Sensitization to ascaris spp. influences total and specific IgE
levels to dermatophagoides pteronyssinus and blomia tropicalis
Sylvie Lafosse-Marin. Cabinet d’Allergologie, Allergologie, Fort de France,
Martinique.
Background: Although sensitization to Ascaris may not play a role in the
severity of asthma, it may be implicated in total and specific IgE levels to
common aeroallergens.
Objective: To determine sensitization to the mite speciesD. pteronyssinus and
B. tropicalis in patients who have a positive, or negative specific IgE
determination to Ascaris spp.
Methods: We analysed 852 consecutive patients (417 males and 435 females;
mean age 18.5 years; ranging from 9 months to 82 years. 518 children (302
boys and 216 girls) with allergic asthma and/or rhinoconjunctivitis with or
without eczemawere included. Patients were separated into 2 groups. Group A
consisted of Ascaris spp. positive patients and Group B of patients with a
negative specific IgE determination (Phadia) to Ascaris spp.
Results: A total of 370 individuals had a positive specific IgE determination to
Ascaris spp. (90.35 kU/L), and 482 had a negative result. Specific IgE to D.
pteronyssinus was positive in 598 patients and to B. tropicalis in 608. Mean
total IgE level was 840.35 kU/L. In group A, mean total IgE level was 1490.31
versus 341.42 in group B (p G 0.001). In group A, 345 patients were positive to
D. pteronyssinus with a mean specific IgE level of 45.0 kU/L. In group B, 253
patients were positive, with a mean specific IgE level of 26.41 kU/L (p G
0.001). In group A, 354 patients were positive to B. tropicalis and the mean
specific IgE level was 42.28 kU/L. In group B, 254 patients were positive (Chi
square p G 0.001), with a mean specific IgE level of 12.76 (p G0.001).
Conclusion: Sensitisation to Ascaris spp. seems to play an important role in
rising total, as well as specific IgE levels to D. pteronyssinus and B. tropicalis.
Statistically, more patients were sensitized to mites in the Ascaris spp. positive
than in the Ascaris spp. negative group. The clinical significance of these
findings remains to be established.
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In vitro sensitization to Ascaris spp. in a population of allergic
individuals in the caribbean island of Martinique
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Enrique Ferna´ndez-Caldas. Dr. Beckmann Pharma GmbH, Research &
Development, Seefeld, Germany.
Background: Sensitization to allergens of the nematodeAscaris spp. is common
in the tropics, where a large proportion of the population has been in contact with
this, and other intestinal parasites. It has been suggested that sensitization to
Ascaris spp. allergens may influence the allergic response to other allergens.
Objective: To study specific IgE levels to Ascaris spp. in a large population of
individuals consulting for allergic respiratory complaints in an Allergy Clinic
in Fort de France, Martinique.
Materials and Methods: This study has a prospective, cross-sectional design
and was conducted from January 2003 to March 2007. A total of 1,060
consecutive patients (507 males and 553 females; mean age 20.41 years; 6
months to 88 years), evaluated for allergic respiratory complaints were entered
in the study. Specific IgE to Ascaris spp. was measured by the CAP method
(Phadia). Results were stratified by age and sex.
Results: A total of 431 individuals; 239 men (47.14%) and 192 women
(34.72%) were positive to Ascaris spp. When analysing differences by age, a
total of 599 children with G15 years of age were included (349 boys and 250
females). In this population, 271 children (45.24%) were positive, including
169 boys (48.42%) and 102 girls (40.8%). In the group of patients with 915
years of age (461 individuals; 303 females and 158 males), 160 (34.92%) were
positive, including 70 men (44.3%) and 90 females (29.7%). Overall, there
was a steady decline in the percentage of positive results in males and females
until the age of 44. After this age, however, there was a sharp increase in the
prevalence of positive results in males.
Conclusion: This study demonstrates a high prevalence of sensitization to
Ascaris spp. in the Caribbean island of Martinique and confirms that
approximately 40% of patients seeking diagnosis, and or treatment, for allergic
respiratory diseases are sensitised to Ascaris spp. allergens. In younger
children, especially in boys, this prevalence is closer to 50%. Although
antiparasitic treatment may be required in these patients, we have not
confirmed if specific IgE to Ascaris spp. represents current infestation or the
effect of previous antiparasitic treatments, since the majority of children are
systematically treated against intestinal parasites in Martinique.
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Methylation status in the promoter region of IL-12 gene might be
correlated with allergy
Yasuko Kobayashi1, Hirokazu Arakawa1, Akihiro Morikawa1, and Takumi
Takizawa2. 1Gunma University Graduate School of Medicine, Pediatrics and
Deveropmental Medicine, Maebashi, Gunma, Japan; 2National Institutes of
Health, National Cancer Institute, Bethesda, Meryland, United States.
Background: Helper T cells can be classified into Th1 and Th2 subtypes,
which have been shown to contribute to cellular immunity and humoral
immunity, respectively. It is currently thought that impairment of the balance
between Th1 and Th2 cells may cause immune diseases, including allergic
diseases. Th1 and Th2 cells are polarized from naive T cells following their
contact with mature dendritic cells (DCs), which are antigen-presenting cells
resident at the frontline of immunity. Only mature DCs can activate naive T
cells. When the contacted DCs secrete interleukin (IL)-12, the naive T cells
become Th1 cells. In contrast, when the contacted DCs secrete IL-4, the naive
T cells become Th2 cells. Therefore, the type of cytokine secreted by the DCs
is very important. DCs generated from cord blood were previously shown to
secrete lower amounts of IL-12 than DCs from adult peripheral blood. The
authors suggested that this finding was correlated with the immune status of
infants, who have weak cellular immunity and develop allergic diseases easily.
Objective:We hypothesized that reduced secretion of IL-12 by DCs from both
allergic patients and cord blood would be due to methylation of the IL-12 gene
promoter region, and that the allergic status may be attributed to delayed
demethylation of this region. To clarify this hypothesis, we examined the
methylation status of the IL-12 gene promoter region in monocytes (DC
precursors) prepared from peripheral blood from healthy adults (HA) and
allergic adults (AA) and from cord blood from normal infants (NI).
Methods: Monocytes were purified from each of the three groups using a
MACS system and an anti-CD14 antibody. Genomic DNAwas extracted from
the monocytes. The methylation status of the IL-12p35 gene promoter region
was investigated using a bisulphate-sequencing analysis method. In addition,
real-time RT-PCR amplifications were carried out to determine the IL-12p35
mRNA levels in cultured and lipopolysaccharide-stimulated monocytes from
peripheral blood from HA and AA.
Results: Among the three groups, there were significant differences in the
methylation ratios at 7 CpGs in IL-12p35 gene promoter region. Contrary to
our expectations, the methylation ratios were significantly lower in AA and NI
than in HA. The IL-12p35 mRNA levels in HA and AA did not differ
significantly.
Conclusion: These results suggest that hypomethylation of the promoter
region may be involved in the development of allergic diseases.
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The membrane-spanning 4-domains, subfamily A, member 2
(MS4A2) +6960A/G genetic polymorphism and the risk of
allergic disorders
Roldan de Guia1 and John Donnie Ramos2. 1University of Santo Tomas,
Department of Biochemistry, Faculty of Pharmacy, Manila, Philippines;
2University of Santo Tomas, Research Center for the Natural Sciences,
Manila, Philippines.
Background: The atopic triad of asthma, allergic rhinitis, and atopic
dermatitis are multifactorial diseases with a considerable genetic component.
Several genes, through association and linkage analyses, have been found to
serve as susceptibility factor of atopy. A polymorphism in the membrane-
spanning 4-domains, subfamily A, member 2 (MS4A2 or FCER1B) has been
shown to be associated with increased IgE levels. The role ofMS4A2 +6960A/
G (E237G) polymorphism in modulating atopic disorders in the Filipino
population was evaluated in this study.
Methods: One-hundred two pairs of allergic individuals and controls were
phenotyped for total serum IgE level using enzyme-linked immunosorbent
assay (ELISA). Atopic status was defined by serum IgE concentration 9100
IU/mL. DNA was extracted and genotyped for the MS4A2 +6960A/G
polymorphism by amplification refractory mutation system-polymerase chain
reaction (ARMS-PCR). Allele Awas identified after PCR by a 280 bp band on
4% agarose gel and G allele by a 238 bp band.
Results: The study population was in Hardy-Weinberg Equilibrium (2 =
0.007521, df = 1, p G 0.05). There was no significant difference in the total
serum IgE levels between subjects with AA, AG, and GG genotypes (p90.05).
Likewise, allele frequencies of +6960A/G polymorphism did not differ
statistically between cases and controls (2 = 2.624, df = 1, p 90.05).
Frequency of the G allele was 0.103 in cases and 0.157 in controls (OR =
0.617, 95% CI = 0.342 Y 1.111).
Conclusion: The lack of association between MS4A2 +6960A/G polymorph-
ism and total serum IgE levels among allergic individuals in the Filipino study
population indicates that the single-nucleotide polymorphism may not directly
be involved in the development of allergic disorders.
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Alpha-1-antitrypsin genotype and allergy
A.G. Palma-Carlos and M.L. Palma-Carlos. Clinical Allergy Immunology
Center, CAIC, Allergology, Lisbon, Portugal.
Background: Alpha-1-antitrypsin deficiency (alpha-1-AT) is usually corre-
lated to COPD or to hepatic disease. However alpha-1-AT deficiency can be a
risk factor for allergy, co-existing or interacting with asthma or other allergic
diseases.
Methods: 2 patients with confirmed alpha-1-AT deficiency and allergic
diseases and complete identification of genotype have been studied. Genetic
studies have been done in the Genetics section of J. Chaves Clinical Pathology
Clinic.
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Results: Case 1: C.J.J. 62 male heavy smoker during 30 years, complaints of
cough, sputum from 7 years, more than 3 months each year. No diagnosis.
Previously treated with fluticasone salmeterol + tiotropium objective
examination respiratory sounds diminished. PFR 300 (normal 550T100).
CT. Centro lobular emphysema mainly in superior lobes. Hyperinsuflation.
Electrophoresis decrease of alpha-1 fraction (0,6% of 6,9) alpha-1 antitrypsin
64,5. Genetic study genotype Pi SZ mutations GLU 342 lys and GLU 264 val.
Case 2: C.M.C. 40, female, non-smoker, story of rhinitis and urticaria without
lower respiratory symptoms. Objective examination normal. On electrophor-
esis alpha-1 fraction was 0,6% of 7.45. Alpha-1 antitrypsin assay 25-
Genotype Pi ZZ mutation GLU 342 lys. Thyroid auto antibodies increased TG
72,3 TPO, 1.673.
Conclusion: Alpha-1-AT Z alleles are more frequent in northern Europe and
in Iberian Peninsula. The S variant gives alpha-1 antitrypsin levels of 60% and
Z variant 10% of normal (M allele). Therefore a MS heterozygote must have
levels of alpha-1-AT around 40% (30% from S allele and 10% from Z allele)
and a homozygotic ZZ had levels of 10%. In our cases the patient with the
slightest form of alpha-1-AT deficiency has respiratory symptoms and an
emphysematous pattern in CT. The theoretical more severe form ZZ
homozygotic presented only rhinitis and urticaria without any lower
respiratory complaints. That discrepancy could be explained by the non-
smoking habits of the homozygotic patient in contrast with a long history of
smoking habits of the patient SZ. In patients even without lower respiratory
complaints but presenting less than 1% of alpha-1 fraction in electrophoresis
assay of alpha-1-antitrypsin must be done and in cases of low values a genetic
study completed.
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Changes of "-casomorphins content in human
milk during lactation
Katarzyna Sidor1, Maciej Kaczmarski1, Malgorzata Iwan2, Elsbieta Kostyra2,
Henryk Kostyra3, Beata Jarmolowska2, and Krzysztof Bielikowicz2. 1Medical
University of Bialystok, IIIrd Department of Pediatrics, Bialystok, Poland;
2University of Warmia and Mazury, Chair of Biochemistry, Olsztyn, Poland;
3Polish Academy of Sciences, Institute of Animal Reproduction and Food
Research, Olsztyn, Poland.
Background: Milk is the best, complete food important for development
and nourishment of neonate. Except nutrients milk contains biologically
active opioid peptides derived from "-casein named "-casomorphins which
can exert effects in neonatal gastrointestinal tract as wall as in all
organism. It has been suggested that opioid peptides may play the role
in regulation of infants’ gastrointestinal functions and development and be
involved in the process of immune maturation. The content of
"-casomorphins in human milk during maturation phases has not been
studied so far. Therefore, the aim of this study was to determine the
content of "-casomorphin-5 ("C5) and -7 ("C7) in human milk in different
phases of lactation.
Methods: There have been chosen thirty healthy newborns and healthy
mothers who plan to breast feed. The milk samples were collected every two
months starting from delivery. The peptides were extracted according to
Halwarker and Elliot method, purified by SPE with the use of C18 columns
and identified using HPLC.
Results: A significantly highest "-casomorphin concentration was found in
colostrums "C5 = 5,03 T 1.02 2g/ml; "C7 = 3.10 T 0.892g/ml ) than in mature
milk. The concentration of "-casomorphin in milk collected in the second
month of lactation "C5 = 0,98 T 0,352g/ml; "C7 = 0.39 T 0.072g/ml) was
similar to the level obtained from the fourth month of lactation ("C5 = 0,58 T
0,21 2g/ml; "C7 = 0.33 T 0,132g/ml). The level of "-casomorphin-5 in
individual phase of lactation was not significantly different than the level of
"-casomorphin-7.
Conclusion: "-Casomorphins content in human milk is changing with the
period of lactation. The level of opioid peptides may depend on the function
of these peptides in neonate?s organism and change with the maturation
process.
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The concenttation of "-casomorphines 5 and 7 in women with
history of allergy and food hypersensitivity in their babies
Maciej Kaczmarski1, Katarzyna Sidor1, Elzbieta Kostyra2, Beata
Jarmolowska2, Krzysztof Bielikowicz2, Malgorzata Iwan2, and Henryk
Kostyra3. 1Medical University of Bialystok, IIIrd Department of Pediatrics,
Bialystok, Poland; 2University of Warmia and Mazury, Chair of Biochemistry,
Olsztyn, Poland; 3Polish Academy of Sciences, Institute of Animal
Reproduction and Food Research, Olsztyn, Poland.
Background: Breast milk provides the optimal nutritional supply which is
critical for the postnatal adaptation of newborns. Although human milk is
considered a hypoallergenic food, the proportions of breast-fed children
demonstrating symptoms of atopic dermatitis is increasing. The allergy
preventing effect of breast - feeding remains controversial and there are no
consistent data regarding the degree to which breastfeeding prevents, reduces,
delays or increases the development of allergic disease. A number of studies
reports suggested the differences between allergic and non-allergic mothers in
relation to milk concentration of immunological agents involved in allergic
reactions. "-casomorphine seems to be a milk ingredient associated with
pseudo-allergic reactions.
Methods: Samples of human milk were collected from 12 volunteer breast-
feeding women with a history of allergy and clinical manifestation of allergy to
bovine milk proteins and from 30 healthy women. Milk samples were collected
in two phases of lactation - first sample - colostrums, the second - one month
after delivery. In the allergic group 9 of 12 women had asthma, 4 were
diagnosed with allergy to bovine milk proteins; one women had both diseases.
All infants mothers of allergic group have presented skin allergic symptoms
i.e. atopic dermatitis. The peptides were extracted according to Halwarker and
Elliot method, purified by SPE with the use of C18 columns and identified
using HPLC.
Results: "-casomorphins concentration in colostrums in the allergic group
was roughly similar ("C5 = 1,58 T 0,402g/ml; "C7 = 1,67 T 0.422g/ml) and
there was no statistically significant difference in "-casomorphins content
between phases of lactation for both investigated peptides (mature milk: "C5 =
1,63 T 0,642g/ml; "C7 = 1,26 T 0.642g/ml). Results in the control group were
more diversified - the content of "-casomorphins ? 5 and -7 in colostrums
("C5 = 5,03 T 1,022g/ml; "C7 = 3,10 T 0.892g/ml) was significantly higher
than in mature milk ("C5 = 0,98 T 0,352g/ml; "C7 = 0,39 T 0,072g/ml):
p G0,001 and p G0,05 respectively).
Conclusion: The content of both investigated "-casomorhins: 5 and 7 in
healthy breast-feeding women is decreasing during lactation but remains
roughly constant in the group of mothers with allergy symptoms.
INSECT HYPERSENSITIVITY
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The use of a (!1-3)-Fuc-core-modified N-glycans-containing
glycoepitope from a seed glycoprotein for a novel approach to the
diagnosis and therapy of vespids and honey bee-allergic patients
Domenico Palumberi1, Roberto Guerranti2, Roberto Pagani2, and Floriana
Rosati1. 1University of Siena, Dept. Evolutionary Biology, Siena, Italy;
2University of Siena, Dept. Int. Med. Metab. endocr. science and
Biochemistry, Siena, Italy.
Background: Mucuna pruriens seeds are an oral prophylactic for snake
bite in humans. We demonstrated that GpMuc, a 29 kDa glycoprotein
found in these seeds, is the immunogen of the antibody that cross-reacts
with snake venom proteins. The immunogenic properties are postulated to
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reside in its core ("1-2)-linked xylose- and core !(1Y3)-linked fucose-
modified N-glycan chains. To verify this hypothesis we investigated
fragmented gpMuc for immunoreactivity. Since the same core modified N-
glycans in honeybee and vespid venoms have often been considered
immunogens responsible for venom allergies, we also investigated cross
reactivity between gpMuc and Hymenoptera venom proteins.
Methods: 1 mg of gp-Muc was trypsin digested. The digested sample was
fractionated by reverse-phase HPLC and an aliquot of each fraction was
analyzed for immunoreactivity to anti-gpMuc IgG by ELISA and dot blot tests,
and the positive glycopeptide analyzed by Maldi TOF MS.
Serum samples from patients with IgE positive to Hymenopera venoms
were investigated by immunoblot and/or ELISA for IgE and IgG against the
venom proteins, gpMuc and the corresponding glycopeptide. Anti-gpMuc IgG
were analyzed for reactivity against the proteins of venoms.
Results: The anti-gpMuc epitope was found to be a 1760 Da glycopeptide
characterized by N-glycans containing fucose. Anti gp-Muc IgG only cross
reacted with a protein having an apparent MW of 29 kDa when the venom
proteins of Vespula polistes, Vespa cabro, Vespula germanica were analyzed
and with a protein of 20 kDa in the protein fraction of Apis mellifera venom.
Twelve of eighteen patients with IgE positive to one or more Hymenoptera
venoms showed IgE and IgG positive to the 29 kDa venom protein of vespids
and/or to the 20 kDa protein of Apis venom and to the gpMuc and
corresponding glycopeptide.
Conclusion: Anti-gpMuc glycoepitope is included in a 1760 Da peptide and
the glycoepitope is shared by a similar venom protein in vespids and by a
different one in Apis. Second finding: IgE and also IgG cross reaction between
vespid and Apis venoms is restricted to one protein. The third finding was the
existence of IgE and IgG cross reaction between the cross reacting protein of
Hymenoptera venoms and gpMuc, specifically with the peptide containing the
glycoepitope. This raises the possibility of using the gpMuc glycopeptide in
place of whole venoms for the diagnosis and immunotherapy of Hymenoptera
allergies, at considerable saving and with reduced risk.
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Insect sting allergies of emergency department visits in Al-ain
Hospital, United Arab Emirates
Shirina Alsowaidi1, Abdulrahman Mohamed2, Awad Alessa1, and Abdishakur
Abdulle1. 1Faculty of Medicine, UAE University, Department of Internal
Medicine, Al Ain, United Arab Emirates; 2Al Ain Hospital, Internal Medicine,
Al Ain, United Arab Emirates.
Background: Insect sting is a common public health hazard in the United
Arab Emirates. However, nothing is known about the demographic, clinical
manifestation and management of insect sting allergic patients.
Objective: To assess the clinical manifestation of insect sting allergies and its
management in Al-Ain hospital.
Methods: In this retrospective observational study, we analyzed emergency
department (ED) records of insect stung patients in Al-Ain hospital. A total of
783 patients (Mean age T SD; 29.2 T 12.6 yrs) were seen at the emergency unit
of Al-Ain Hospital.
Results: Of the total sample, 425 (54.3%) were female. Only 39 (5%) patients
of the total were UAE nationals and 744 (95%) were heterogeneous expatriate
workers. The site of the sting of 130 (16.6 %) patients was on the leg, 70 (8.9
%) on the arm, 21 (2.7%) on the head, 21 patients (2.7 %) on the trunk, and 12
patients (1.5 %) on the neck. However, a significant majority of the patients
528 (67.4 %) there was no available data with regard to the site of sting. In this
study 41% of the subjects had local reactions, 40.4% had urticaria, 4.3% had
angioedema, 47.5% had dyspnoea or wheezing, while only 3 patients were
presented with unconsciousness. According to Muller classification, 17.8%
were of class I severity, 4.2% class II, 36.8% class III and 2.6 % class IV. At ED
68.2% of the patients received antihistamine, 90.5% systemic antihistamine,
53.3 % systemic corticosteroids and only 1% received epinephrine treatment.
Conclusion: Insect sting is common particularly among the expatriate
community, often under documented, and of sever presentation. Since most
of the insect sting was on the legs and arms, culturally covered clothing among
the UAE nationals may have had significant protection impact. Increasing
awareness, appropriate diagnosis, and adequate management of insect sting
allergies is required.
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Jack jumper ant sting anaphylaxis in South Australia
Robert Heddle1, Pamela Hudson2, and Simon Brown3. 1Flinders Medical
Centre and Flinders University of South Australia, Respiratory Medicine,
Adelaide, Australia; 2Flinders Medical Centre, Respiratory Medicine,
Adelaide, Australia; 3University of Western Australia, Emergency Medicine
Research Unit, Fremantle, Australia.
Background: In south eastern Australia the Jack Jumper Ant (JJA) is a
dominant cause of sting anaphylaxis. We have described the epidemiology of
JJA sting anaphylaxis on the island of Tasmania in a prospective study;
approximately 12% of allergic subjects were stung each year, 70% of these
experiencing further systemic reactions. Age over 35 years was a risk factor
for severe reactions.
Aim: To examine the natural history of JJA sting allergy in South Australia
(SA), 1000 km NW of Tasmania.
Methods: Subjects with a history of systemic reactions to ant stings were
recruited through the Australian Ant Venom Allergy Study (AAVAS).
Demographic details, blood samples for allergy testing, ant specimens and
details of sting reactions were obtained. Subjects were followed prospectively
for further sting reactions.
Results: In 116 subjects with a history of systemic reaction to JJA sting there
have been 15 further JJA sting events in 12 subjects during a mean follow-up
period of 10.8 months; theses stings led to a total of 12 systemic reactions in
9 subjects. Only 4 of the 12 who were stung were less than 35 years of age, all
reporting a lessened (2) or local only (2) reaction. Four of 8 older subjects
experienced reactions similar to their worst previous sting event.
Conclusion: Despite wide geographic separation the frequency of re-sting
(10% of subjects per annum) the proportion of systemic reactions (~75% of
subjects, 80% of sting events) and the tendency of those aged 935 to have
further serious reactions bears a striking similarity to the Tasmanian data.
Older subjects allergic to venom of this aggressive ant have a high risk of
further systemic reaction to future stings.
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Reactions to hymenoptera sting in adult patients: experience in a
clinical allergy/immunology service in Monterrey Mexico
Maricela Hernandez1, Sandra Gonzalez2, Gabriela Galindo2, Alejandro Diaz1,
and P Rodriguez2. 1University Hospital, Allergy and Clinical Immunology,
Monterrey, Mexico; 2Univerisity Hospital, Allergy, Monterrey, Mexico.
Introduction: The most commonly implicated insects in stings to humans are
the honeybee, yellow jacket wasp and paper wasp. Stinging ants include the red
and black fire ants. In Mexico, there are no data on the degree to which the
general population is affected.
Methods: A retrospective study, in which a questionnaire was given to all the
patientswho came to our clinic for the first time for different allergic symptoms,
from January 2001 to December 2001 the questionnaire, asks about personal
history of hymenoptera sting. We found 72 patients with positive history.
Results: The distribution by sex was male (26) 36.1%, female (46) 63.9%. The
distribution by insect_s sting was; Ant (58) 80.6%, honeybee (22) 30.6%,
yellow jacket wasp (13) 18.15%, paper Wasp (2) 2.8%, none identified
(1) 1.4%. The average age was 15 a 59 years SD (32.97 + 1.25) (63) 87.5% did
not havework risk, number of sting trough life (51) 70.8% 1 a 3 stings episodes,
(21) 15.1% 2 a 5, (19) 26.4% had an interval of 1Y6 months between sting
episodes, (16) 22.2 % had a 3Y5 years interval between stings. (36) 50 % had
itch or local pain, (6) 8.3%, had intense itching, (2) 2.8 % urticaria or
angioedema (2) 2.8 % cardiovascular symptoms, (2) 2.8 % referred to have late
reactions, (6) 8.3% had large local reactions. 69 (95.8%) did not seek for
medical attention, 4 (5.6 %) New the severity of the problem, 3 (4.2 %) New
what to do, (27) 37.7 % had allergic rhinitis and or allergic conjunctivitis,
(16) 22.2% had urticaria and or angioedema, (15) (18.9%) had contact derma-
titis, (7) 9.7% had asthma, (4) 5.6% have had at least one adverse reaction to
drugs, (3) 4.2% had atopic dermatitis, (1) 1.4% had food allergy, (1) 1.4%
present with anaphylaxis, (25) 34.7% had a family history of allergy.
Conclusion: About one third of those experiencing allergic sting reactions are
atopic. Most insect stings are associated with local reactions, including pain,
swelling and redness, which are self-limiting. However, systemic reactions can
lead to potentially life-threatening manifestations in 0.4% to 0.8% of children
and 3% of adults. Large local reactors have a 5%Y10% risk of subsequently
developing a systemic reaction if re-stung.
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Development of a murine model of cockroach allergy
Nitat Sookrung1, Nitaya Indrawattana2, Anchalee Tungtrongchit3, Pongsri
Thongtawe4, Thaweesak Songserm5, and Wanpen Chaicumpa4. 1Office for
Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol
University, Bangkok, Thailand; 2Department of Microbiology and Immunol-
ogy, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand;
3Department of Parasitology, Faculty of Medicine Siriraj Hospital, Mahidol
University, Bangkok, Thailand; 4Faculty of Allied Health Sciences,
Thammasat University, Pathumthani, Thailand; 5Faculty of Veterinary Medi-
cine, Kasetsert University, Bangkok, Thailand.
Background: An animal model resembling the human clinical manifestations
of allergy is needed for various aspects of allergy research, e.g. for inves-
tigating mechanisms and pathway of immunopathology, measuring allergeni-
city of a protein, testing drug and vaccine therapeutic efficacy.
Objective: To develop a murine model of cockroach allergy.
Materials and Methods: Individual BALB/cmicewere intraperitoneally (i.p.)
injected with three doses, i.e. on days 0, 7, and 14, of alum adjuvanted-crude
extract of American cockroach (CR), Periplaneta americana, which is the
predominant CR species in Thailand. The animals were subsequently aero-
solically challenged on days 21 and 22 with 10 ml crude CR extract (1.0% w/v
in PBS), using a home-made air-pressure nembulizer for mice. The mice were
bled and sacrificed on day 23. Their serum samples, broncho-alveolar lavage
fluids (BALF) and lungs were collected. Control mice received only alum i.p.
and aerosolic PBS via the nembulizer.
Results: All CR extract treated mice showed features of allergy. Their BALF
contained inflammatory cells that out-numbered those of the non-allergic
counterparts as determined by differential cell counts after cyto-spinning and
hematoxylin-eosin staining. Most of the cells were eosinophils. Eosinophil
infiltration was also pronounced in the lung tissues of the CR extract treated
mice and was negligible in the tissue of the controls. Levels of serum IgE
specific to the American CR extract rose significantly above those of the
control levels.
Conclusion: A murine cockroach allergy model with features resembling
the human allergic manifestations was successfully developed. The model
can be used for study of various attributes of CR allergy, e.g. allergenicity
of a protein of interest, immunopathology, and drug and vaccine
therapeutic efficacy.
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Crude Forcipomyia taiwana (biting midge) extracts stimulate
PBMC proliferation, IFN-!, IL-6 and IL-10 secretion from
midge-allergic subjects
Yi-Hsing Chen1, Mei-Fang Lee2, Hsin-Ru Wu1, and Guang-Yuh Hwang3.
1Taichung Veterans General Hospital, Division of Allergy, Immunology and
Rheumatology, Taichung, Taiwan; 2Taichung Veterans General Hospital,
Department of Medical Education and Research, Taichung, Taiwan;
3Tunghai University, Department of Life Science, Taichung, Taiwan.
Background: Forcipomyia taiwana (F. taiwana) is a tiny (1Y1.5 mm) blood-
sucking midge that is widely distributed in urban and suburban Taiwan as well
as in southern China. F. taiwana attacks in groups to exposed parts of the
human body during the day, causing intense pruritis and swelling in sensitive
individuals. There are two types of reactions after midge bite: 1) immediate
reaction: large local swelling develops within one hour of bites 2) delayed
reactions: intense itching papules and vesicles occur 6Y24 hours after bites.
The delayed lesions may turn centrally necrotic and last for weeks or even
months. We have previously reported that about 59.1% of the exposed subjects
develop hypersensitivity reactions to F. taiwana bites. Among which, about
14% developed immediate reaction only, 43% developed an immediate
reaction followed by delayed reactions and 43% developed solely delayed
reaction. Our previous study suggested that the immediate large local
reaction is IgE-mediated and the 24-, 35/36- and 64-kDa proteins are
major IgE-binding allergens. However, from our previous studies, we also
found that delay reactions to F. taiwana bites may not react through the
IgE pathway. Delay itching skin papules or vesicles usually last for weeks
or even months that causing an even greater impact on patient’s quality of
life than the rapidly resolved immediate reaction.Except some limited
studies focused on the immunologic mechanisms to mosquito bites, there
has been no report in the literature regarding the immunologic mechanisms
to biting midges.
Materials and Methods: Peripheral mononuclear cells (PBMC) from midge-
allergic patients with delayed reactions were cultured with media only, Con A
or F. taiwana crude extract at different time points. Cell proliferation was
measured by MTT assay. Change of cytokines in culture supernatants was
measured using fluorescent bead immunoassay.
Results: In the present study, we demonstrate that peripheral mononuclear
cells (PBMC) from delayed typed midge-allergic subjects proliferate and
secret more interferon-! (IFN-!), interleukin-6 (IL-6) and interleukin-10 (IL-
10) in response to crude F. taiwana extract. IL-4 and IL-5 were not detected in
the culture supernatants.
Conclusion: The delayed reactions of F. taiwana bites may be mediated by a
more Th1 type cells. The role of IL-10 in midge-bite allergy requires more
investigation.
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Local allergic reaction on bone wax in a patient with bee
venom allergy
Carlotta Wirz1, Heidrun Mueller1, Regina Treudler2, Gero StrauQ1, Sylvia
Meuret1, and Andreas Dietz1. 1University of Leipzig, ENT Department,
Leipzig, Germany; 2University of Leipzig, Clinc for Dermatology, Venerology
and Allergology, Leipzig, Germany.
Introduction: A 67 year-old farmer was transferred to our clinic after an
outpatient operation on his right middle ear (stapes reconstruction) that showed
an intraoperative strong bleeding. During the exploration of the ear in our
operation room a damaged raised bulb of the jugula vein could be detected. The
lesion was closed by conventional bone wax, fibrin glue and perichondrium.
Follow Up: Ten days after the removal of the endaural tamponade the patient
complained of chronical otorrhoea of the operated ear that showed resistance
to any treatment. The examination showed a distinct inflammation of the
external and middle right ear with a clear secretion. During the operative
revision of the situs an extensively grown granulation tissue around last bits of
the applied bone wax was seen. After its removal the defect was closed by
cartilage of the tragus.
Diagnostic Investigation: After the second operation the patient mentioned a
previously known bee venom allergy he had not mentioned in the first
examination. Recurrent anaphylactoid reactions had happened on bee stings.
We decided to get into contact with the producer of the bone wax. We
experienced that the used common bone wax consists of 80% of bee wax and
20% of isopropylpalmitate.
The allergy diagnostic on the patient confirmed the bee venom allergy
(prick test, RAST), furthermore the epicutaneous testing on the applied bone
wax batch showed a positive result.
The epicutaneous testing of the single components of the bone wax
(bee wax, isopropylpalmitate) was negative.
Conclusion: For the producer could not guarantee a 100% pureness of the
product, we conclude that the applied charge of bone wax containing bee wax
was probably contaminated with bee venom.
Bee wax represents a great part of the base of common ointment and
creams. The patient never mentioned reactions on those substances. Therefore,
the probabiltiy of an allergy against uncontaminated bee wax (allergic reaction
type I on propolis) is very low.
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In future, a detailed allergy anamnesis should be performed before
using bone wax in ear or any other ent surgery. Alternatively, hypoallergenic
substances should be used in patients with known bee wax allergy undergoing
ent surgery.
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Carpenter bee anaphylaxis: description of two cases and
identification of the responsable allergens
Valerio Pravettoni1, Marina Mauro2, Francesca Bertolotti1, Danilo
Lombardi3, and Igino Spadolini3. 1Foundation OspedaleMaggiore Policlinico,
Mangiagalli e Regina Elena, IRCCS, Milan - Italy, Clinical Allergy and
Immunology Unit, Milan, Italy; 2S. Anna Hospital, Como, Italy, Allergy Unit,
Como, Italy; 3Anallergo Laboratories, Florence, Anallergo Laboratories,
Florence, Florence, Italy.
Background: Carpenter Bee (Xylocopa violacea) is a solitary, fast flight,
ubiquitous bee usually non aggressive and rarely stinging. Up to now, in
medical literature Carpenter bee anaphylaxis has never been reported. Purpose:
to describe, for the first time, Xylocopa violacea venom anaphylaxis in two
patients and to determinate the relevant allergens of Xylocopa violacea venom.
Materials and Methods: Patients: we report the case history of two patients
(L.M. Y 26 y.o; B.S.M. Y 39 y.o.) with anaphylactic systemic reaction after
Xylocopa violacea sting. All the two patients were also stung by yellow jacket
before and after anaphylaxis, well tolerating the stings. At the clinical visit we
performed serum venom specific IgE antibodies and venom skin prick test and
intradermal tests with yellow jacket, paper wasp, european hornet, honeybee
and Polistes dominulus venoms. Five patients with negative allergenic history
were used as negative controls. Xylocopa violacea extract: Xylocopa violacea
extract was supplied by Anallergo (Florence, Italy).
SDS-PAGE and Immunoblotting: SDS-PAGE was performed with
Xylocopa violacea and honeybee venom extract. The gel was blotted on a
nitrocellulose membrane, cutted into strips and matched with the sera of the
two patients. After incubation with anti-IgE antibodies, the allergenic bands
were detected by a chemiluminescens revealing system.
Results: In the two allergic patients skin tests and serum IgE detection were
positive only for yellow jacket extract. In vitro analysis did not show any IgE
binding in the honeybee immunoblotting, while IgE reactivity was shown with
the band at 25,2 kDa, 18,8 kDa and 6,5 kDa in the Xylocopa violacea extract.
No response was found in control sera. The allergenic bands at higher
molecular weight were specific of Xylocopa violacea venom, while the band at
6,5 kDa corresponds to mellitin.
Conclusion: This is the first report of two cases of anaphylaxis caused by
Xylocopa violacea, a member of the Apidae family. Two allergenic bands (25,2
kDa, 18,8 kDa) are specific allergens of this venom extract, not shared with
honeybee venom extract.
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Tryptase, mastocytosis and Hymenoptera venom allergy
Petr Kucera1, Milada Cvackova1, Martina Heroldova1, Helena Vavrova2, and
Jan Ort2. 13rd Medical Faculty, Charles University and FNKV, Dept Allergy
Immunology, Prague, Czech Republic; 2FNKV, Dept Allergy Immunology,
Prague, Czech Republic.
Background: Elevation of basal serum tryptase as a one of signs of systemic
mastocytosis (SM) can be a risk factor for the reaction severity in patients
allergic to Hymenoptera venom (HV). The exact pattern of the relationship
between elevated basal tryptase and anaphylaxis is not completely understood.
We focused on the relationship between serum basal tryptase and patient_s
clinical data, severity of systemic allergic reactions (SAR) and safety of venom
immunotherapy.
Patients and Methods: We analyzed data from 69 consecutive patients with
SAR due to HVallergy. 27 men and 45 women were included; mean age 48.26
years, most of them with sensitization to relevant venom allergen (prick tests
or specific IgE positive). The IgE and tryptase level was measured by Phadia
ImmunoCAP FEIA assay.
Results: We found significant differences between mean tryptase values in
groups of different severity of SAR: Grade I (mean 4.77 ug/l), Grade II (5.56),
Grade III (5.48) and Grade IV (12.67, p=0.035). 10 patients (14.5 %) had
elevated basal tryptase (mean value 28.52 versus 5.28 ug/l, p G 0.0001).
Patients with elevated tryptase were significantly older than those with normal
value (61.3 and 46.2 years, p=0.0049). Two patients were diagnosed by
systemic mastocytosis, one by non-Hodgkin lymphoma, in two patients SM
was not confirmed. Venom immunotherapy was well tolerated.
Conclusion: The elevated basal serum tryptase level (not systemic masto-
cytosis only) can be a risk factor for more severe SAR caused by Hymenoptera
venom allergy, particularly at the higher age.
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Hymenoptera venom allergy: clinical importance of
tryptase values
Valerio Pravettoni, Maria Francesca Spina, Marta Piantanida, and Laura
Primavesi. Foundation Ospedale Maggiore Policlinico, Mangiagalli e Regina
Elena, IRCCS, Milan-Italy, Clinical Allergy and Immunology Unit, Milan,
Italy.
Background: Increased serum tryptase (ST) levels and Mastocytosis are
described in patients with severe anaphylactic reactions after hymenoptera
sting (from 7,3% to 10.5% depending on the study).
Aim of this study was to determine basal value of ST and its possible
clinical relevance in hymenoptera venom allergy.
Methods: One hundred six patients with a history of venom anaphylaxis (79
yellow-jacket, 10 paper-wasp, 5 european hornet, 12 honey-bee)were included.
The grade of allergic reactions was considered according to Mu¨eller clas-
sification. ST levels were measured by UniCAP, Pharmacia-Uppsala, (normal
range G11.4 2g/L) at baseline and in 25 patients after 1 year immunotherapy.
Venom serum specific IgE levels (sIgE) were measured at baseline by CAP
System, Pharmacia- Uppsala.
Results: Mean basal ST level were 3.86 (IQR 2.61Y5.39). Only 4 patients
(3.77) have elevated ST levels.
There were no significant difference in ST levels between HB and other
Vespid patients (3.47 vs 3.91). Mean basal venom-specific IgE (sIgE) was
higher in HB than in all the other venom allergic patients (19.4 vs 4.14).
In Vespid patients, but not in HB ones, higher ST levels were stat-
istically correlated with a higher Mu¨eller grade of reaction (p = 0.049), while
in HB patients there is an inverse correlation between basal ST and sIgE
(p = 0.053). No difference in ST levels was observed after 1 yr immunother-
apy in respect to baseline values.
Conclusion: In our population cutaneous or systemic mastocytosis appear not
to be so recurrent. The only patients with high ST levels were allergic to Vespid
venoms. HB patients, despite a higher specific venom IgE levels, did not
present statistically more severe reactions than Vespid patients. To note that HB
patients lower ST levels correlate with higher sIgE levels. These data suggest
that in HB patients severe anaphylactic reactions are due to the high sIgE level
and not to a larger number of mast cells which a higher ST levelwould indicate.
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Hymenoptera venom allergy: type of occupation as a risk factor
Patrizia Bonadonna1, Gianenrico Senna1, Michele Schiappoli1, Annarita
Dama1, and Giovanni Passalacqua2. 1Verona General Hospital, Allergy Ser-
vice, Verona, Italy; 2University of Genoa - Dept. of Internal Medicine, Allergy
& Respiratory Diseases, Genoa, Italy.
Background: Much is known about the risk factors involved in hymenoptera
venom allergy (HVA) including the work occupation. On the other hand, little
Abstracts World Allergy Organization Journal & November 2007
S218 * 2007 World Allergy Organization
Copyright @ 2007 World Allergy Organization. Unauthorized reproduction of this article is prohibited.
is known about the quantitative weight of the different work activities. Aim
of study was to evaluate the distribution of work habits among subjects
with HVA.
Methods: Subjects referred to our unit for suspected HVA underwent the
standard diagnostic workup. According to the modality of exposure to hy-
menoptera stings, they were classified: i) at high risk (subjects working usually
outdoors or in places were hymenoptera live): farmers, gardeners, firemen,
truck drivers, masons, beekeepers, dustmen; ii) occasionally at high risk
(working sometimes outdoors): plumbers, electricians, railswaymen, at low risk
(working indoors) students, housewives, clerks, professionals. The distribution
of occupations in the general population was provided by the Central Office for
the Work Insurance of Regione Veneto.
Results: Three hundred and 46 subjects (238male, mean age 44 T 15 yrs) seen
at our unit between 2000 and 2007 were diagnosed as having HVA. All had a
clinical history of systemic reactions to stings (20% bees, 17% polistes, 63%
wasps), of various grades of severity (56% grade III-IV). Concerning exposure,
23,4% of patients were at high occupational risk (43 farmers, 15 masons,
14 truck-drivers, 4 gardeners, 3 beekeepers, 2 dustman), 8,38 % had
occasionally high risk (3 warehousemen, 3 soldiers, 9 factory workers,
1 plumber, 5 electicians, 2 railwaymen 1 agronomist, 5 engineers) and 68,2 %
were at low risk. In the general population, wokers not at risk were 91.3%, at
occasional risk 0.9%, and at high risk 7,8%. Among the patients at high risk or
occasionally high risk (110 patients), 71% were stung only during their work
activity. Beekeepers, considered typically at high risk, in our databasewere less
represented than, for instance, masons and truckdrivers. Conclusions. The risk
of having HVA is higher than expected in some categories. Also taking into
account the limit of such a survey, where the data of the general population may
be imprecise, it is clear that some occupations are much more frequent in
patients with HVA. Thus, for some categories (farmers, truckdrivers) allergy to
hymenoptera venom could be considered an occupational disease.
Keywords: Hymenoptera venom allergy, work occupation, risk.
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Results of a modified ultrarush immunotherapy in hymenoptera
venom allergy
Julia Klecker, Heidrun Mueller, and Andreas Dietz. University of Leipzig,
ENT Department, Leipzig, Germany.
Background: Patients allergic to hymenoptera venom may develop local or
generalized sting reaction or they may show systemic reactions of differing
severity. If venom immunotherapy (VIT) is indicated, increase doses are usually
given during hospitalisation, because severe adverse reactions may occure.
There is a wide range of rush- and ultrarush protocols known. We have tested a
3-day ultrarush-VIT protocol according to its tolerance.
Methods: 20 patients were treated with VIT, 4 of them received bee-VIT, 16
vasp-VIT. We administered 15 injections over 3 days. Incidence and intensity
of adverse reactions were evaluated. Besides the coherence between
cardiovascular diseases (especially hypertension), severity of systemical
reaction to the insect sting challenge, specific IgE-level and skin prick test
and the intensity of adverse reactions during VITwere determined.
Results: In total 3 of 20 patients showed adverse systemic reactions, all of them
got a vasp-VIT. 2 of these patients had a third grade anaphylactic reaction
(according to Ring and Messmer) due to a hymenopteron sting in case history,
1 patient reported about a first grade anaphylactic reaction. Local reactions to
the injections ranged from mild (G5cm) to moderately severe (up to 10cm).
There was no obvious correlation between intensity of local reaction during
VIT and degree of anaphylaxis in case history. 2 of the mentioned 3 patients
showed positive reactions in skin prick test at 12g-dose, 1 patient just reacted at
1002g-dose. The specific IgE-level also showed no correlation to local or
systemic reactions.
Conclusion: The 3-day ultrarush protocol was well tolerated by our patients.
We noticed 3 systemic reactions. This is in accordance with the data of studies
in literature. Due to the small number of current participants we can find no
connection between the incidende of systemic reactions during VIT and the
other facts examined. The only noticeable fact was that 2 of 3 patients with
systemic reaction during treatment reported about third-degree anaphylactic
reaction by first sting challenge. Local reactions to the injections showed
moderate intensity, there were no skin effects more than 10cm.
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Leishmanial antigen detecting by dot immunoblot assay in
phlebotomus papatasi, in Iran
Hassan Nekouie. Pasteur Institute of Iran, Parasitology, Tehran, Islamic
Republic of Iran.
Introduction: Leishmaniosis is a polymorphic disease of the skin and viscera
caused by an intracellular Protozoan. Zoonotic Cutaneous Leishmaniosis
(ZCL) is a major health problem in rural areas of Iran.
Methods: A simple and highly reproducible dot-immunoblot assay was
developed to detect leishmanial antigen in Phlebotomus papatasi that were
naturally infected with Leishmania major. The test was sensitive to as little as
10 ng of antigenic protein and also appeared to be specific, in that it gave a
positive result with some P. papatasi (the primary vector of L. major in Iran) and
L. major but not with P. sergenti or other pathogens. When used to investigate a
large number of sandflies collected from areas of the Iran where cutaneous
leishmaniasis is endemic
Discussion: The assay appeared sufficiently sensitive and specific to detect the
naturally infected insects. The simplicity, reproducibility, high sensitivity and
high specificity of the assay should make it useful for field studies.
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Cockroach sensitization in patients with allergic airways disease
in reunion island
Bashir Omarjee1, Bernard Tanguy1, and Ahmad Zaidou2. 1Centre Hospitalier
Departemental, Insect Allergy, Saint Denis, Reunion; 2Centre Hospitalier
Departemental, Service de Maladies Respiratoires, Saint Denis, Reunion.
Background: The objective of this study was to evaluate the prevalence of
skin Prick sensitivity and RAST (UniCap-Pharmacia)to Blattela germanica,
Blatta orientalis,Periplaneta americanain patients with rhinitis and / or asthma
living in Reunion Island (Indian Ocean).
Methods: Patients were 51 male, 53 female, aged 5 to 65 years (mean age of
29.6 years) were evaluated in one private clinic and in one public hospital:
18.2% had asthma, 32.5% rhinitis and 49.3% rhinitis and asthma. They were
considered sensitized if the prick test induced a papulawith at least one half the
area of papula induced by histamine, or , if specific IgEwas superior to 0,70KU
A/L. Skin tests were conducted with extracts of B. germanica, B. orientalis, P.
americana and a battery of common aeroallergens (Allerbio, ALK Abello,
France).
Results: A positive skin test was recorded in 98 patients (94.5%), 87% of
which were positive to mites, 15% to pollens, 9% to moulds, 4.8% to epithelia
and 51.9% to at least one of the cockroach species tested; 24.9% of these
patients was sensitized to all 3 cockroaches and 27%were sensitized to just one
species.The prevalence of sensitization to the respective species was: 41.8% to
B. germanica, 33.9% to B. orientalis, 39.8% to P. americana. Mean values of
specific IgE for positive RAST were respectively: 34,9 T 36,4;25,1 T 31,0;
24,6 T 32,6. In addition, a significant correlation between results of skin test to
cockroach and mite was observed (p.0004).
Conclusion: The authors concluded that sensitization to cockroach is frequent
in Reunion Island. Our results suggest the recommendation that cockroach
extracts should be routinely used for evaluation of patients with asthma and
rhinitis,or both in tropical countries.
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Effective treatment of mosquito bites with rupatadine;
an experimental study
Timo Reunala1, Ari Karppinen1, and Henrikki Brummer-Korvenkontio2.
1Tampere University Hospital, Department of Dermatology, Tampere, Finland;
2National Public Health Institute, HIV Laboratory, Helsinki, Finland.
Background: People frequently experience whealing and delayed papules
from mosquito bites. Whealing is mediated by antisaliva IgE antibodies and
histamine.
Rupatadine is a new antihistamine and PAF antagonist effective in
allergic rhinitis and urticaria but the effect on mosquito-bite allergy is
not known.
Methods: A double-blind, placebo-controlled, cross-over study was performed
with rupatadine 10 mg and matched placebo in 30 mosquito-bite-sensitive
adults. The mean age was 37 years and the subjects had suffered from harmful
mosquito bites for amean of 15 years. Either rupatadine or placebowas taken at
8 am for 4 days, followed by a 5 day wash out period and then alternative
treatment was given for 4 days. On day 3, in the both drug periods the subjects
received two Aedes aegyptimosquito-bites on the forearm. The size of 15 min
bite lesions and intensity of pruritus (VAS) were measured.
Results: 27 subjects could be analysed for the efficacy. Rupatadine decreased
the size of 15 min wheals by 43% compared to placebo. This effect was
significant (P = 0.0065) whereas the effect on accompanying pruritus did not
reach statistical significance although there was a favourable trend
(P = 0.0621).
Conclusion: The present placebo-controlled study in mosquito-bite-sensitive
adults shows that prophylactically given rupatadine 10 mg is an effective
treatment for the mosquito-bite whealing.
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Staphylococcus species as potential virulence factors
in atopic dermatitis
Franziska Layer, BeniamGhebremedhin,Wolfgang Ko¨nig, and Brigitte Ko¨nig.
Otto-von-Guericke-University, Institute of Medical Microbiology, Magdeburg,
Germany.
Background: Atopic dermatitis represents a chronic inflammatory skin
disease which results from complex interactions between genetic and envir-
onmental mechanisms. Referring to this the colonization and infection with
staphylococci is a serious issue in skin disorders especially atopic dermatitis
(AD). Human skin epithelium provides a mechanical barrier to invading
bacteria and also participates in innate immune defence by producing cationic
antimicrobial peptides, e.g. "-defensins (hBD) and the cathelicidin LL-37. The
aim of our study was to determine the potential virulence of staphylococci from
AD patients in bacterial skin infections and to examine the innate immune
response to infection through expression of antimicrobial peptides.
Methods: Identification of the staphylococci was performed by using T-RFLP
analysis of the gap gene. Pathogenicity profiles of Staphylococcus spp. isolated
from AD patients were determined by screening genes for staphylococcal
enterotoxins (sea-see, seg-sej), toxic shock syndrome toxin 1 (tst) and Panton-
Valentine leukocidin (luk-PV) by PCR. Amodel of bacterial skin infection was
used to test the pathophysiology of these isolates in a human keratinocyte cell
line (HaCaT), including the induction of hBD-1, hBD-2, hBD-3, LL-37, IL-6
and IL-8 (real time PCR, ELISA) and cellular invasion (fluorescence staining,
confocal laser scanning microscopy).
Results: Toxin genes with various pathogenicity profiles were studied for S.
aureus. No superantigenic exotoxins by coagulase-negative staphylococci
were detected. Exposure of keratinocytes to Staphylococcus spp. triggers the
production of cytokines IL-6 and IL-8 and of "-defensins (hBD-1 mRNA (2-to
8-fold), hBD-2 mRNA (2-to 270-fold), hBD-3 mRNA (2-to 6-fold)) and the
cathelicidin LL-37 (2-to 6-fold), whereas the levels of this activity were
different for all clinical isolates. Adherence and invasion to keratinocytes was
shown for clinical isolates of S. schleiferi and S. aureus, but not for S. hominis,
S. epidermidis and S. capitis.
Conclusion: Staphylococci from AD patients showed various pathogenicity
profiles, invaded keratinocytes, the production of cytokines and antimicrobial
peptides. Thus, they are potential pathogens in skin infections, especially
atopic dermatitis.
688
Immunological study in patients of Pemphigus Vulgaris
Vinit Mehrotra1, G. Awasthi2, and S. Singh2. 1Himalayan Institute of Medical
Sciences, Biochemistry, Dehradun, India; 2Dolphin Institute of Biomedical
Sciences, Biochemistry, Dehradun, India.
Background: Pemphigus Vulgaris (PV) is an autoimmune, intraepithelial,
blistering disease affecting the skin and mucous membranes. It is mediated by
circulating autoantibodies (IgG) directed against keratinocytes cell surfaces
and potentially life-threatening. PV antibody binds to the keratinocyte cell
surface molecules Desmoglein-1 and Desmoglein-3 (Dsg-1 and Dsg-3). In
India the incidence of PV is 86% with the mean age 30Y40 years while in
Western countries is 40% only with the mean age 50Y60 years.
Methods: So it is very important to identify the implicated antigens in PV
patients and diagnosis the pattern of expression of Dsg1 and Dsg3 in patients
suffering from bullous diseases. The levels of cytokines-TH1 and TH2was also
studied for the involvement of T and B cells as inflammatory.
Results: It has been seen that the mucocutaneous type of PV is more
prevalent in Indian patients as two types of band pattern are observed
during immunoblotting with patient sera against 160kD and 130kD antigens
extracted from normal human patients. It was also found that cytokine
profiling of the patient sera that the level of TH2 like cytokines for example
IL-4 and IL-10 were significantly high during the active stages of PV
whereas, no relative difference was seen for TH1 like cytokine for example
IFN-g. Cytokine profiling for confirmed PV cases from sera showed direct
evidences for the involvement of auto reactive T cells responses to Dsg-3,
which may be critical for pathogenesis of PV. Among its other biological
activities IL-10 also induces B-lymphocytes to proliferate and differentiate
to produce antibodies, which may play a important role in production of
auto antibodies for PV.
Conclusion: This study indicates that PV is an antibody-mediated disease
with increase in TH2 cytokines and auto reactive T cells from PV patients
produced TH2 cytokine preferentially in active stages of PV disease. This
study will help to elucidate the cellular immune abnormalities leading to
production of IgG autoantibodies in PV patients.
689
Successful treatment in pulmonary alveolar proteinosis with the
combination of intravenous immunoglobulin and pulse
methylprednisolone: a case report
Nongnapa Jirarattanasopa1, Tantikul Chutsumarn2, Orathai Jirapongsananuruk2,
Nualanong Visitsunthorn2, and Pakit Vichyanond2. 1Siriraj Hospital, Allergy
and Immunology of Pediatrics Department, Bangkok, Thailand; 2Siriraj
Hospital, Pediatrics Department, Bangkok, Thailand.
Background: Pulmonary alveolar proteinosis (PAP) is a rare disease in child-
ren, characterized by intra-alveolar accumulation of lipoproteinaceous material
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that positively stained with periodic acid-Schiff (PAS). The susceptibility to
pulmonary infection is a salient feature of the disease which could be partly
explained by defective alveolar macrophage function.
Methods: We report a case of PAP and chronic interstitial pneumonitis in
a girl who presented with chronic respiratory distress since the age of 5
months. Her clinical condition progressively worsened with chest radiograph
showing diffuse hazy opacities of both lungs. High resolution computerized
tomography (HRCT) of the chest demonstrated crazy-paving pattern. Definite
diagnosis of PAP was made by open lung biopsy showing marked interstitial
lung inflammation with alveolar proteinosis pattern.
Results: Bronchoalveolar lavage were attempted twice without any clinical
improvement. The respiratory clinical collapse with continued recurrent
pneumonia was observed. After pathological diagnosis, a short tried of
G-CSF was attempted again to no avail. Low dose methylprednisolone and
hydroxychloroquine was then initiated without satisfactory improvement. It
was decided to start intravenous immunoglobulin (IVIG) (500 mg/kg, every
4 weeks) with pulse methylprednisolone (30 mg/kg, every 4 weeks) to
which she gradually responded. She no longer required oxygen supplement
after 21 months of treatment. Currently she is asymptomatic at age 4 years
and continues to receive IVIG and pulse methylprednisolone every 4 weeks.
Conclusion: Aside from therapeutic lung lavage and GM-CSF therapy, IVIG
and pulse methylprednisolone may have potential role in successful treatment
of PAP.
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Cytokine profile of children allergic diseases
Elena Prosekova1,2, Vladislava Derkach2, Shestovskaya Tatyana1, Svetlana
Netesova1, Yuliya Ivanova1, and Olesya Shchegoleva1. 1Far Eastern Branch
of Clinical Immunology Research Institute of Siberia Branch of Russian
Academy of Medical Sciences, Clinical Immunology, Vladivostok, Russian
Federation; 2Far Eastern Branch of Clinical Immunology Research Institute
of Siberia Branch of Russian Academy of Medical Sciences, Immunology,
Vladivostok, Russian Federation.
: Inflammation process is participated by a cascade of cytokines, which
predetermines development, direction and power of immune response and
regulates cellular interaction. The character of changes in cytokine profile may
be a distinguishing sign of a pathologic process.
The research objective was to investigate specific features of cytokine
spectrum of nasal secretion, saliva and blood serum in the process of children
allergic diseases development (allergic rhinitis, atopic dermatitis, bronchial
asthma). IL-4, IL-13, IL-8, IFN+, TNF! cytokine content, I IFN+/IL-4 cytokine
regulatory index and total IgE level were monitored within a year at different
stages of the disease. Cytokine level in biological liquids was determined by
immuno-enzymatic method, sandwich variant, with R and D Diagnostics Inc.
(USA) reagents. Researchers examined 22 children in the age from 1 to 16 with
allergic diseases, control group wasmade of 30 health children of the same age.
Control group examination results: serum cytokines IL-4 =
8,5 T 1,1 pg/ml, TNF! = 12,1 T 2,2 pg/ml, IL-13 = 8,01 T 1,6 pg/ml,
IFN+ = 50,6 T 4,2 pg/ml, I IFN+/IL-4 = 5,2 T 1,1; saliva cytokines IL-
4 = 0,3 T 0,1 pg/ml, TNF! = 1,47 T 0,4 pg/ml, IL-13 = 2,25 T 0,4 pg/ml,
IFN+ = 65,2 T 3,4 pg/ml, I IFN+/IL-4 = 80,5 T 5,4 respectively; nasal secretion
cytokines IL-4 = 1,88 T 0,64 pg/ml, TNF! = 6,87 T 1,08 pg/ml, IL-13 =
6,19 T 1,14 pg/ml, IFN+ = 156,8 T 4,8 pg/ml, I IFN+/IL-4 = 75,4 T 4,8.
High IL-4 and IL-13 levels at decreasing INF+were recorded mostly in
nasal secretion of children with allergic diseases in isolated allergic rhinitis
(AR) cases (I IFN+/IL-4=0,34 T 0,06). High IL-4 content 87,62 T 2,59 pg/ml
in nasal secretion were observed in exacerbation period and in rhinitis and
bronchial asthma (BA) combined cases, at the same time children with BA but
without AR showed 15,04 T 2,21 pg/ml and I IFN+/IL-4 = 4,6 T 1,2. In the
period of AR clinic remission IFN+ content in nasal secretion was
1,1 T 0,96 pg/ml, in exacerbation period Y 9,36 T 2,21 pg/ml. Cytokine
levels observed in saliva in children dermatitis cases were as follows: IL-
4 = 89,3 T 0,64 pg/ml, IL-13 = 124,41 T 5,9 pg/ml, IFN+ = 11,9 T 1,7 pg/ml,
blood serum IL-4 = 55,2 T 4,2 pg/ml, IL-13 = 39,4 T 4,9 pg/ml,
IFN+ = 21,2 T 2,0 pg/ml.
Investigation of local cytokine secretion and determination of their
ration help to specify the localization and rate of allergic inflammation
providing data for forecast and treatment effectiveness evaluation.
691
Severe eczema associated with IgG2/G3 subclass and IgM
deficiencies successfully treated with intravenous
immunoglobulin
Somboon Chansakulporn, Nualanong Visitsunthorn, Pakit Vichyanond, and
Orathai Jirapongsananuruk. Siriraj Hospital, Pediatrics, Bangkok, Thailand.
Background: Patients with severe eczema and recurrent infections should be
investigated for immunodeficiency. We report our experience in treating a pa-
tient with severe eczema, recurrent bacterial infections, chronic otitis media,
IgG2/IgG3 subclass and IgM deficiency with monthly intravenous immuno-
globulin (IVIG) infusion.
Methods: An 8 year-old boy was a case of long standing severe eczema with
multiple food and drug allergies since 2 years of age. He had had chronic otitis
media for the past 2 years. His treatment included elimination of suspected
foods and drugs, topical corticosteroid, oral antihistamine and topical calci-
neurin inhibitor without satisfactory improvement. He was admitted several
times due to bacterial skin infections with which he developed
Acenitobacter septicemia on one occasion. His CBC did not show
thrombocytopenia (platelet 300,000 /mm3) nor small platelets. Immunoglo-
bulins were: IgG 1,480 mg/dl, IgG1 1,030 mg/dl, IgG2 115 mg/dl, IgG3
10.7 mg/dl, IgG4 18.3 mg/dl, IgA 142 mg/dl, IgM 18.3 mg/dl, and IgE
8,080 mg/dl. Specific IgE for egg white and cow’s milk were positive.
Immunophenotype revealed: CD3 692 cells/mm3, CD4 284 cells/mm3,
CD8 351 cells/mm3, CD19 378 cells/mm3 and NK cell 193 cells/mm3.
Lymphocyte proliferative response to PHA was below normal. The antibody
response to pneumococcal vaccine increased 8.1 folds after receiving
conjugated pneumococcal vaccine.
Results: IVIG infusions at 400 mg/kg were given every four weeks. The
patient’s skin lesions were gradually improved after the 4th dose of IVIG
infusion.
Conclusion: The patient who presented with severe eczema and recurrent
infections should be evaluated for immunodeficiency. The mechanism of
beneficial effect of IVIG therapy in this patient was unknown but could be due
to prevention of infection and its anti-inflammatory effects.
692
Long-term effects of treatment on the cytokine production in
scleroderma patients
RomanYatsyshyn, Yevgen Neyko, and Natalya Yatsyshyn.Medical University,
Internal Diseases, Ivano-Frankivsk, Ukraine.
Background: Scleroderma, a debilitating acquired connective tissue disease,
is characterized by fibrosis, particularly of the skin and lungs. The cytokine
disbalance is one of the main manifestation of scleroderma. The treatment of
this pathology is very difficult problem for therapy.
Objective: To compare the long-term effects of infusion of alprostadil with
those of oral pentoxyphyllin on the production of cytokines in patients with
systemic sclerosis (SSc), and evaluate their relationship with effects of the two
treatments on clinical parameters.
Methods: The production of cytokines by alloactivated circulating
mononucleated cells was assessed before and after one year of treatment
in a subset of 50 patients enrolled in a one-year study. Twenty five patients
were treated with a 10-day (100 mkg) infusion of alprostadil - synthetic
analog of prostaglandin E2. Another 25 patients were treated with an oral
slow-release formulation of pentoxyphyllin, 600 mg twice daily. Quantita-
tive determinations of interleukin-1 beta (IL-1beta), interleukin-6 (IL-6),
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tumor necrosis factor-alpha (TNF-alpha) in the serum of patients were
performed with a ELISA.
Results: The production of IL-1beta was significantly lower in the alprostadil
group than in the pentoxyphyllin group. Both the cutaneous fibrosis and the
capillaroscopic patterns were better in patients treated with alprostadil. There
was significant positive covariance between IL-1beta and TNF-alpha changes
and the changes in both the skin score and the capillaroscopic score.
Conclusion: There are several mechanisms by which alprostadil could exert its
clinical efficacy. Vasodilatation and inhibition of platelet aggregation are
certainly important, but they are transient. We suggest that the long-lasting
modulation of the cytokine network observed in the present study could be
another potential mechanism responsible for the persistent efficacy of al-
prostadil despite its administration.
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Endothelial dysfunction and inflammatory markers at the
chronic heart failure with hypertension
Natalya Yatsyshyn, RomanYatsyshyn, and Yevgen Neyko.Medical University,
Internal Diseases, Ivano-Frankivsk, Ukraine.
: The chronic heart failure and arterial hypertension has a lot of bio-
chemical manifestation. The ideas of our research work were: 1) to compare
high sensitive C-reactive protein (hsCRP) and soluble receptors TNF alpha
(sTNF-Rs) with coronary heart disease (CHD) and the chronic heart failure
(CHF); in the control group (C group); 2) to compare ultrasound markers of
endothelium-dependent vasodilatation (EDV) and endothelium-independent
vasodilatation (EIV) in hypertensive (HT) patients in both groups.
Patients and Methods: 105 hypertensive pts (mean age 61.3 yrs.), with CHD+
CHF were investigated. In the NYHA classes I/ II/ III/ IV were 20/31/46/8 pts.
The C group was represented by 20 healthy volunteers. Ultrasound assessment
of flow mediated dilation (FMD) of brachial artery was used for the mea-
surement of EDVand the response to isosorbide dinitrate (ISDN) for the mea-
surement of EIV. sTNF-Rs and hsCRP were examined by the ELISA method.
Results: FMD was significant diminished in hypertensive pts. In 60th sec of
reactive brachial artery hyperemia the luminal size has not reached the basal
parameter (HT pts mean FMD: 92.0 T 9.9%, C group mean FMD:
109.5 T 7.8%, p G 0.001). EIV was significant reduced in HT pts comparing
with C group (HT pts mean EIV: 105.2 T 18.3%, C group mean EIV:
118.6 T 10.5%, p = 0.01). In HT group significant elevated levels of hsCRP
and sTNF-RI were found (HT pts mean hsCRP: 8.14 T 4.05 mg/l, C group
mean hsCRP: 3.81 T 3.02 mg/l, p G 0.01; HT group mean sTNF-RI:
1161.6 T 168.1 pg/ml, C group mean sTNF-RI: 638.5 T 37.5pg/ml,
p G 0.001). No significant difference in sTNF-RII levels between the groups
was found. Correlation between sTNF-RI and rest luminal size of brachial
artery was observed (r = 0.25, p = 0.05). No other correlation between EDVa
EIV and inflammatory markers was found.
Conclusion: Significant reduced endo thelium-dependent and endo thelium-
independent vasodilation of brachial artery in HT pts was found. Significant
elevated levels of hsCRP and sTNF-RI in these pts were measured, too. No
significant correlation between ultrasound markers of endothelial dysfunction
and inflammatory parameters was observed. Ultrasound assessment of endo-
thelial dysfunction and inflammatory markers may give us an information
concerning the severity and progression of disease.
694
Pharmacogenetic study for predicting cyclophosphamide side
effect in thai systemic lupus erythematosus
Pintip Ngamjanyaporn1, Ammarin Thakkinstian2, Oravan Verasertniyom3,
Monchand Vanichapuntu3, Kanokrat Nantiruj1, Kitti Totemchokchyakarn1,
and Suchela Janwityanujit1. 1Allergy Immunilogy and Rheumatology
Division, Ramathibodi Hospital, Mahidol University, Medicine Department,
Bangkok, Thailand; 2Ramathibodi Hospital, Mahidol University, Clinical
Epidemiology Unit, Bangkok, Thailand; 3Ramathibodi Hospital, Mahidol
University, Reseach Center, Bangkok, Thailand.
Background: Systemic lupus erythematosus (SLE) is the serious autoimmune
disease that primarily affect young women. Although cyclophosphamide
improves outcome of SLE, frequent ovarian toxicity is a major side effect of
this therapy. Cytochrome P450 (CYP), CYP2C19 polymorphism has been
shown to significantly influence the pharmacokinetics as well as the ovarian
toxicity of cyclophosphamide in Caucasian SLE patients.
Objective: To assess association between CYP2C19 polymorphism and
ovarian toxicity in Thai SLE patients who have been treated with
cyclophosphamide.
Patients and Methods: Female patients who were diagnosed as SLE ac-
cording to ACR criteria and treated with cyclophosphamidewere genotyped for
CYP2C19 polymorphism. Ovarian toxicity was defined as sustained amenor-
rhea for more than 12 months occurring before 50 years of age or lack of
menstruation for more than 4 months during treatment. Chi-square test was
used for assessing association. Logistic regression was applied.
Results: Seventy-one patients were enrolled for analysis. The mean age at
diagnosis and starting cyclophosphamide was 26.42 T 8.35 and 29.27 T 7.82
years. The mean cumulative cyclophosphamide dosage was 23.36 T 20.81
grams. Thirty-six (59.7%) patients developed ovarian toxicity. CYP2C19*2
allele frequencies were 27.8% and 21.4% in ovarian and non-ovarian toxicity
groups. Genotype frequencies in non-ovarian toxicity group were complied
with Hardy-Weinberg equilibrium (p = 0.304). ROC analysis was applied to
calibration cut-off of cyclophosphamide dosage and found that dosage of 23.75
grams yielded likelihood ratio for developing ovarian toxicity of 3.5. Logistic
regression analysis was applied to assess interaction effect between cyclopho-
sphamide dosage and CYP2C19 allele. We found that among CYP2C19*1
allele, patients received cyclophosphamide 23.75 grams or higher were 12.6
(95% CI = 3.3Y46.8) times more likely to have ovarian toxicity than patients
received cyclophosphamide G 23.75 grams. This risk was decreased to e 5.1
(95% CI = 1.1Y22.7) times if patients had CYP2C19*2 allele.
Conclusion: Cyclophosphamide dosage of 23.75 grams or higher carries a
high risk of inducing ovarian toxicity. However, the risk can be decreased if
patients have CYP2C19*2 allele.
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15-epi-lipoxin is a key mediator of Th1 adverse reaction induced
by aspirin and theophylline co-treatment
Hyung Geun Moon1, Sang-Heon Cho2, Kyung-Up Min2, You-Young Kim2,
and Yoon-Keun Kim1. 1Postech Biotech Center, Department of Life Sciences,
Pohang, Gyeongbuk, Republic of Korea; 2Seoul National University College
of Medicine, Department of Internal Medicine, Seoul, Republic of Korea.
Background: Aspirin-induced asthma (AIA) is a distinct clinical entity and
appears to be a specific subtype of asthma. There are lots of efforts to uncover
AIA pathogenesis, but adverse reaction by aspirin is still remains unclear.
Aspirin is a well known non-steroidal anti-inflammatory drug. The anti-
inflammatory action of aspirin generally has been attributed to direct inhibition
of cyclooxygenases (COX-1 and COX-2). AIA takes part in 10% of patients
with severe asthma. Theophylline has been demonstrated to have an anti-
inflammatory effects as an long-term medication for severe asthma and COPD.
It works as a PDE inhibitor and a nonspecific adenosine receptor antagonist.
Objective: To assess the therapeutic effects of aspirin, theophylline, and
combination of two drugs in murine model of asthma.
Methods: To generate a murine model of asthma induced by LPS with OVA,
6-week-old C57BL/6 mice were sensitized intranasally with 75 ug of OVA on
days 0, 1, 2, and 7 with or without LPS, and then challenged intranasally with
50 ug of OVA on days 14, 15, 21, and 22. Whenever mice were challenged,
aspirin (10mg/kg), theophylline (10mg/kg), and both were injected intra-
peritoneally. Asthmatic phenotypes such as lung inflammation using
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bronchoalveolar lavage (BAL) cellularity, cytokine production, and lung
histology were evaluated on day 24.
Results: Total cell number of BAL fluids in mice treated with each of Aspirin
and theophylline was significantly decreased compared with non-treated group
of mice. However, inflammatory cells in BAL fluids were increased in mice
treated with aspirin and theophylline combination. And similar results were
represented in histology. IP-10 protein, downstream of IFN-gamma, was
decreased in each aspirin and theophylline treated mice compare with each of
aspirin and theophylline non-treated group of mice. However, aspirin and
theophylline combination treated mice were represented increase of IP-10 level
in BALF. Moreover, only aspirin and theophylline combination treated mice
were revealed specially increased level of 15-epi-LXA, which generated from
lipid metabolite by aspirin.
Conclusion: In murine model of asthma enhanced by LPS and OVA, each of
aspirin and theophylline treatment is effective, but combinative treatment
resulted in adverse reaction.
696
Serum levels of immunoglobulin and complement factors in
beta-thalassemia major patients in Southern Iran
Reza Amin, Ahmad Amin, and Soheila Alyasin. Nemazee Hospital,
Pediatric-Allergy and Clinical Immunology Research Lab, Shiraz, Islamic
Republic of Iran.
Background: Beta-thalassemia major is one of the major health problems in
our country. Many studies have confirmed the fact that, these patients have an
increased susceptibility to bacterial infections.
Objective: In this study, we have assessed the humoral immune system in 68
thalassemic patients by measuring their serum concentration of Immunoglob-
ulin G (IgG), IgM, IgA, C3 and C4 in order to find out a responsible immune
defect.
Methods: Sixty eight beta-thalassemia major patients were enrolled randomly
from referrals to Dastgheib clinic of thalassemia. The same number of case
controls with matched age and sex were selected from healthy-people without
any history of recent or recurrent infections. Serum IgG, IgM, IgA, C3 and C4
levels were assessed using Single Radial Immunodiffusion (SRID).
Results: Serum levels of IgG, IgM and IgA were significantly higher
(P G 0.01) and those of C3 and C4 were significantly lower (P G 0.01) in
thalassemic patients than the controls. Considering the result of analytic tests, it
was revealed that, thalassemia patients show much more increase in serum
immunoglobulin levels as they get older. Splenectomized patients had higher
serum IgG and IgA levels than non-splenectomized patients but had no
difference in serum IgM, C3, and C4. Serum ferritin level had no correlation
with the changes of humoral immunity; however, patients with serum ferritin
level 9 2500 ng/ml had higher serum IgM level.
Conclusion: These results can be due to continuous exposure to antigens,
repeated infections, chronic liver disease and splenectomy but not iron
overload. The only probable cause of humoral immune deficiency found in
these patients is a defect in serum complement levels.
Keywords: Thalassemia Major, IgG, IgA, IgM, C3 and C4
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A rare cause of acute eosinophilic pneumonia
Boris Golzman1, Svetlana Turkot1, Jakob Kogan1, Alex Rozov2, Arie
Feldman3, Arela Rotlev1, and Shmuel Oren1. 1Barzilai Hospital, Internal
Medicine Department A, Ashkelon, Israel; 2Barzilai Hospital, Pulmonology
Unit, Ashkelon, Israel; 3Barzilai Hospital, Internal Medicine Department B,
Ashkelon, Israel.
Introduction: Acute eosinophilic pneumonia (AEP) is a rare disease de-
scribed as follows: an acute febrile illness with severe hypoxemia, diffuse
pulmonary infiltrates, an increase in bronchoalveolar lavage (BAL) eosino-
phils, no evidence of infection, asthma or atopic illness and complete res-
olution after treatment with corticosteroids. It is suggested that AEP is an acute
hypersensitivity reaction to an unidentified inhaled antigen. We report a case of
AEP that developed after Narghile water pipe smoking (WPS).
Case report: An 18-year-old womanwas admitted with a cough and high fever
for the last 4 days. She had no previous history of asthma or atopic disease.
Therewas no history of smoking, recent traveling or using medications. During
the week before her admission she smoked a narghile water pipe. The patient
was in moderate general condition, dyspneic, RR 20, Sat O2- 90% in room air,
T-38-C. The physical examination was unremarkable besides bilateral
inspiratory rales. Chest X-ray revealed bilateral ground glass opacities. Peri-
pheralWBC count was 14370 cell/mm3with 1465 eosinophils/mm3 (10%). IV
antibiotics, oxygen support and inhaled bronchodilators were administered.
Blood cultures were negative. The eosinophil count rose to 3700 eosinophils.
Total IgE level was 943 IU/ml (normal range 0Y100). A chest CT scan revealed
bilateral patchy ground glass opacities with no lymph node enlargement.
Fiberoptic bronchoscopy was performed and BALyielded 80% eosinophils. IV
corticosteroid therapy was givenwith remarkable improvement. The peripheral
blood eosinophil count returned to normal (1.7%) in two days. The patient was
discharged in good condition and 3 months later she was asymptomatic.
Discussion: Our case met the 6 diagnostic criteria of AEP: an acute illness of
short duration, high fever, severe hypoxemia, bilateral infiltrates on chest ra-
diographs, eosinophilia more than 25% on BAL, and no history of drug hyper-
sensitivity or evidence of infection. There are reports of AEP in new cigarette
smokers. Narghile tobacco smoke contains tar, nicotine, carbon monoxide and
heavy metals and it is higher than in cigarette smoke. Water-pipe smokers
may absorb higher concentrations of these substances due to the mode of
smoking (higher frequency of puffing, depth of inhalation).
A search in PUBMED revealed no case reports of AEP that evolved
after narghile water pipe smoking. In our case it was the only etiologic factor
that has emerged through detailed history.
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Serum concentrations of eosinophil cationic protein and
eosinophils of patients with Kimura’s disease
Nobuo Ohta, Shigeru Fukase, Yusuke Suzuki, Shinnichi Sakurai, Masaru
Aoyagi, and Shinichi Okazaki. Yamagata Univ., School of Medicine, Dep-
artment of Otolaryngology, Yamagata, Japan.
To clarify the role of eosinophils in the pathogenesis of Kimura’s
disease and the values of measuring serum levels of eosionophil cationic
protein (ECP) for monitoring disease activity, a total 14 serum and 7 tissue
samples from patients with Kimura’s disease were studied. The concentrations
of ECP and cytokines (interleukin-4 (IL-4), granulocyte-macrophage colony-
stimulating factor (GM-CSF), and interleukin 5 (IL-5)) in sera from patients
with Kimura’s disease were measured by enzyme-linked immunosorbent assay
(ELISA). The density eosinophils and the degree of activation of eosinophils in
the tissue were also studied immunohistochemically. The concentration of
ECP in sera from patients with Kimura’s disease was significantly higher than
that in the control group (p G 0.05). At the time of the remission, a significant
decrease of ECP was observed. In interfollicular areas, most infiltrated
eosinophils were positive for EG2 antibody (64.0Y94.0%) and the mean per-
centage of EG2-positive eosinophils was 75.7%. The concentrations of IL-4,
GM-CSF, and IL-5 in sera from patients with Kimura’s disease were within
normal ranges or below the detectable level in all sera examined. Our findings
suggest that eosinophils play an important role in the pathogenesis of Kimura’s
disease and ECP may be used as an additional parameter of disease activity.
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The evaluation of osteocalcin and osteoprotegerin, osteogenic
markers of bone remodeling in rheumatoid arthritis
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Cioaca Gabriela Ramona, Drugarin Doina, and Paunescu Virgil. Victor Babes
University of Medicine and Pharmacy Timisoara, Department of Physiology
and Immunology, Timisoara, Romania.
: The purpose of this study is to evaluate some osteogenic markers
involved in bone remodeling, such as the estimation of osteocalcin (OC) and
osteoprotegerin (OPG/RANK) concentrations in the sinovial fluid as well as in
the serum of rheumatoid arthritis (RA) patients. These measurements were
performed in the initial stage of the disease, without using any anti-
inflammatory non-steroidal therapy for at least 1 month before our study
began. The concentration of OPG in the sinovial fluid represented
14.25 T 0.75 pmol/l while in the serum the concentration was 1.69 T
0.80 pmol/l, which was significantly increased (p G 0.001) compared to the
values determined in the serum of healthy controls (1.19 T 0.30 pmol/l). The
increase of OC concentration evolves in the same manner in both sites of our
measurements, the values being of 6.43 T 4.80ng/ml and 19.9 T 4.8ng/ml
respectively, compared to the values determined in healthy controls, in the
sinovial liquid (G 0.5ng/ml) and in the serum (3.1 T 0.1ng/ml).
Key words: rheumatoid arthritis, osteocalcin, osteoprotegerin, bone remodel-
ing, bone metabolism
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The effect of probiotics on immune markers of undernourished
preschool Filipino children
Grace Uy1, Felizardo Gatcheco2, and Luisito Ruiz3. 1Philippine Children’s
Medical Center, Gastroenterology andNutrition, Quezon City, Philippines; 2Jose
Reyes Memorial Medical Center, Department of Pediatrics, Manila, Philippines;
3Muntinlupa Medical Center, Department of Surgery, Muntinlupa, Philippines.
Background: Undernutrition in children is associated with increased
susceptibility to infections and depressed effect on cell-mediated and humoral
immunity. Probiotics can enhance immune responses which can lead to illness
prevention or decrease duration and severity.
Objective: The study aims (1) to determine baseline immune markers
(CD3,CD4, CD8, CD19, CD 20, CD56) of undernourished Filipino children
aged 3Y5 years old (2) to determinewhether probiotics can enhance immunity by
(a) changes in immunemarkers, (b) changes inweight and (c) decreased incidence
and duration of common infections (e.g., colds, pneumonia and diarrhea).
Methodology: Undernourished children were randomized into control and
experimental group. Probiotics (mixture of Lactobacillus bulgaricus, L casei
subsp rhamnosus, L fermentum, L plantarum, Bifidobacteria bifidus, B breve,
B infantis, B longum, and B lactis.) were given 2 times a day for eight weeks.
Weekly weight, incidence and duration of illnesses were recorded. Blood for
immune markers was drawn before and after the study.
Results: 29 children were enrolled, 14 in the control and 15 in experimental
group. The basal levels CD3, CD4, CD8, CD19, CD 20, CD56 were normal in
both groups. The control group showed an increase in CD4, CD8 levels
compared to the probiotics group but both groups’ levels stayed within normal
limits. The probiotics group gained significant weight by 1 kg (p G 0.003). The
incidence of illnesses (diarrhea and colds) was the same for both, but there was
significant shorter duration for the probiotics group. The median was 2 and
14 days for the probiotics and control group respectively (p G 0.001).
Conclusion: Probiotics lead to significant weight gain. They also lead to
shorter duration of infections.
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Life expectancy of patients with leukocyte adhesion deficiency
in Iran
Habibeh Mozaffari1, Zahra Pourpak2, Neda Entezari2, Chavoshzadeh
Zahra2, Mohammad Hassn Bemanian2, Mohammad Gharagozloo2, Masoud
Movahedi2, Asghar Aghamohammadi2, and Asghar Aghamohammadi2.
1Immunology, Asthma and Allergy Research Institute, Medical Sciences/
Tehran University, Tehran, Islamic Republic of Iran; 2Immunology, Asthma
and Allergy Research Institute, Immunology Department, Tehran, Islamic
Republic of Iran.
Background: Leukocyte Adhesion Deficiency (LAD) is a rare congenital
immunodeficiency with fewer than 200 affected individuals in the world which
is characterized by sever recurrent infections. The purpose of this study was to
describe the survival time of Iranian patientswith LADover a period of 16 years.
Methods: Twenty seven patients with definite diagnosis of LAD (based on
standard criteria and laboratory tests), attending Allergy, and Immunology
clinic in Children Medical Center Hospital-from 1991 to 2006 ranging in age
from 3 months to 24 Years old, were studied and followed. Severity of disease
was defined as a presentation of CD18 marker on the surface of leukocyte (less
than 1% of normal expression). Also a questionnaire was filled for recording
all necessary information.
Results: All patients (63% male, 37% female) was LAD type I. The
prevalence of consanguineous marriage was 81.5%. The mean age at the time
of disease onset was 0.78 T 2.03 months and the mean age of diagnosis was
1.33 T 0.55 months. Overall 33.3% of patients (9 patients) had severe form of
disease. The overall 5 year survival rate was 67% and mortality rate was
22.2%. The mean of survival time for alive patients was 73 T 27 months
(CI:21Y125). The main leading cause of death was bacterial infections.
Conclusion:Mortality rate in other studies mentioned about 4% which is very
lower than our study (20.2%). Diagnostic delay can result in high mortality and
more complications in untreated patients and failure to provide therapy can be
a cause of low survival rate. Therefore early diagnosis, good control and
appropriate treatment will improve the survival rate.
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Acute myocarditis after steroid withdrawal in an asthmatic
patient
Elena Ossi1, Claudio Bilato2, Annamaria De Pellegrin1, Andrea Rossanese1,
Marilisa Andretta3, and Mauro Cancian1. 1Clinica Medica 1, Medical and Surgical
Sciences Dept., Padova, Italy; 2Cardiac Unit, Cardiology Department, Padova,
Italy; 3ENT Clinic, Medical and Surgical Specialities Dept., Padova, Italy.
A 64-year-old Caucasian man presented with febrile dyspnoea one
month after having withdrawn steroidal therapy previously prescribed to treat
asthma of recent appearance associated to a marked increase of serum IgE
(2493U/L). The finding of increased troponin andmyoglobin levels on hospital
admission, seemed to point to a cardiac ischemia, although ECG showed only
sinusal tachycardia and despite of a leucocytosis with 60% eosinophils, Thus,
he was directly referred to the cardiac intensive care unit, where he underwent a
cardiac catheterization and a stent was inserted in the left anterior descending
coronary artery. Three days later, cardiac enzymes started to increase again
(troponin up to 64 2g/L) and the clinical pictureworsenedwith severe dyspnoea
and fatigue. For this reason, he had a further catheterization done, that showed
no problemwith the stent. In the meantime, paresthesias and neurological pain,
slightly present on admission, worsened to a severe stage. The temperature
was still high and cutaneous signs of vasculitis appeared. At this point a
cardiac magnetic resonance was performed which revealed a diffuse sub-
endocardic necrosis. Finally, thinking of a Churg-Strauss Syndrome (CSS),
a myocardial biopsy was obtained and ANCA were tested, both confirming
the working hypothesis. Moreover, EMG showed a severe mixed multi-
neuropathy. High-dose-methylprednisolone was started, with prompt clinical
improvement and normalization of cardiac enzymes in 10 days of therapy.
CSS is a vasculitis characterized by asthma, hypereosinophilia and involvement
of other organs. Being CSS more prevalent in the fifth decade, when a novel
asthma presents in an individual aged 60 or more, it is common to think of a
previously latent atopy, made overt by the concomitant intervention of
precipitating factors, or of a cardio-pulmonary disease. In the present case
report, the steroid withdrawal in a novel asthma of an aged patient caused the
burst of a severe carditis in an undiagnosed CSS.
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Does breast feeding protect against asthma and other atopic
diseases?
Mohammed Herrag, and Mustapha Iraqui. Ibn Sina University Hospital,
Pulmonology-Allergology, Rabat, Morocco.
Rationale: Breast feeding is associated with the lowest asthma and allergic
disorders rates and it significantly reduces the severity of respiratory illnesses
during the first year of life.
Methods: we had included questions related to breast feeding in the ISAAC
questionnaires (the international study of asthma and allergies in childhood)
to see the outcome of allergic diseases in both groups: breast feeding and non
breast feeding.
Results: Mean (S.D) age: 9 years, weight: 30 kg and height: 135.6 cm.
Children breastfed more than 8 months had significantly lower prevalence
rates of persistent cough in the past year, ever rhinitis, rhinitis in the past year,
and itchy-watery eyes in the past year than those who were not breastfed
(18% vs 25%; 22% vs 32%; 15% vs 23%; and 6.5% vs 14.2%, respectively).
Incidency was lower of asthma and wheeze in breastfed children than those
who were not breastfed (asthma: 2.5y vs 4.5 y; 2.2y vs 3.9y, respectively).
Significantly higher proportion of children who breastfed more than 8
months were resolved from asthma, wheeze and eczema than those who
breastfed less than 8 months (89% vs 76%; 90.7% vs 77.2%, and 97.4% vs
82.2%, respectively).
Conclusion: Our Study shows the impact of breast feeding for at
least 8 months in protecting and reducing the prevalence of allergic
disorders.
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Transient IgM monoclonal gammopathy in an asthmatic child
A.G. Palma-Carlos1, M. Jose´ Rego Sousa2, and M.L. Palma-Carlos1.
1Clinical Allergy Immunology Center, CAIC, Allergology, Lisbon, Portugal;
2Laboratory Medicine Center Germano Sousa, Allergology, Lisbon, Portugal.
Background: Monoclonal gammopathies are extremely rare in children
either primary or secondary. A case of a transient monoclonal gammopathy in
a child is reported and the possible causes dicussed.
Methods: Patient JPA male, 5 years, consulting by Asthma and rhinitis
perenneal worsening in fall and winter and a previous history of atopic
eczema at 2 years. Objective examination was normal and prick skin tests
only positive to house dust mites. Blood analysis were requested.
Meanwhile an acute respiratory illness treated symptomatically by G.P.
On analysis PBC count was normal, IgG 891 mg/dl IgA 105 mg/dl IgM
155 mg/dl. In electrophoresis a peak was detected which leads to an
immunofixation showing an IgMK monoclonal gammopathy. Total IgE
was a 160 Ul/ml. Specific IgE 1,5 KU/l for D.pteronyssinus and 2,23 KU/l
for D.farinae. A battery of antibodies to Virus, Mycoplasma and
Leishmania which is slightly endemic in south of Tagus river was
requested. One week after new immunofixation showed a marked decrease
of monoclonal peak and IgM decreased to 113mg/dl. No light chains in
urine. 2 weeks after antibodies to EBV, CMV, Chlamydia pneumoniae
Leishmania were negative. Antibodies to Mycoplasma pneumoniae
positive: IgG 2,54, IgM 3,3 (normalG0,9). 4 weeks after new immunofixa-
tion was done with absence of the monoclonal peak.
Conclusion: Secondary gammophaties can be included in the broader group
of monoclonal gammopathies of indetermined signification (MGUS). In
general and with the exception of Leishmania infection a clear monoclonal
peak is not detected after an acute infection. IgM is the immunoglobulin
implied in primary response to infections. In children the occurrence of
monoclonal gammopathies is very rare and mainly described for CMV and
EBV. Transient monoclonal gammopathy is characterized by a fast decrease
of the monoclonal peak after the infection. In our case a recent Mycoplasma
pneumoniae infection was shown by positive serology for IgG as well for
IgM. This young patient has a slight increased concentrations of total IgE and
the values of specific IgE for house dust mites were not very high. The fast
decrease and disappearance of the monoclonal IgM peak points out to a
transient monoclonal gammopathy in an atopic child triggered by a
Mycoplasma infection.
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Cystic adenomatoid transformation (CAT) of lung in a child
with hyper IgE syndrome
Mozhgan Moghtaderi1, Reza Amin1, and Soheila Alyasin2. 1Nemazee
Hospital, Pediatrics-Allergy and Immunology, Shiraz, Islamic Republic of
Iran; 2Nemazee Hospital, Immunology and Allergy, Shiraz, Islamic Republic
of Iran.
Hyper IgE syndrome with recurrent infections is a rare immunodeficiency
characterized by recurrent skin infection and pulmonary abcess and
extremely elevated levels of IgE in serum, associated facial and skeletal
features have been recognized. Their frequency and genetic basis is
poorly understood. The patient is a seven-year old girl presented with
two years history of productive cough, superinfected facial eczema from
infancy and two prior hospitalization for pneumonia and perianal abcess.
She had coarse face, crackles on both lungs, clubbing of fingers, laxicity
of elbow joints. Immunological work up revealed eosinophilia and
markedly raised IgE levels. In view of the clinical features and other
finding diagnosis of hyper IgE syndrome was suggested. Chest X-ray
revealed multiple large cystic lesions in left total lung which confirmed
by spiral CT-scan. Left thoracotomy and pneumanectomy was done and
removed severe adhesions. Histological report revealed cystic adenoma-
toid transformation. CAT is Characterized by the presence of variously
sized cysts lined by epithelium. Probably, this is the first report of CAT
in a child with hyper IgE syndrome due to repeated infections. Early
diagnosis and prophylactic antibiotic therapy is effective in management
of these patients.
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Pulmonary complications and some changes in immune
reactivity on the course of acute heroin intoxication
Julia Radenkova-Saeva1, and Bogdan Petrunov2. 1Emergency Hospital,
Department of Clinical Toxicology, Sofia, Bulgaria; 2NCIPD, Department of
Immunology and Allergology, Sofia, Bulgaria.
Objective: To examine the complications in pulmonary system and changes
in immune reactivity (some parameters of humoral and cell mediated
immunity) on the course of acute heroin intoxication.
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Materials and Methods: The study includes 16 patients, with acute
heroin and mixed with other psychoactive drugs intoxications at average
age, 21,5 T 5.04 years (12 men and 4 woman), hospitalized in the Clinic of
Toxicology, MHATEM BN.I.Pirogov^, Sofia. We have used clinical, clinico-
laboratory, immunological, chimicotoxicological, instrumental methods.
Results: Results from the study shows that in severity intoxications with
heroin and other psychoactive drugs we observed spectrum of complica-
tions in pulmonary system - pneumonia, aspiration of gastric contents,
pulmonary edema, and ARDS. Death is registered in 3 persons. It was
found some changes of the immune reactivity: statistically significant
lower mean levels of IgG, IgA, IgM and tendency to lower mean levels of
complement components - C3 and C4 in the studied patients in comparison
with the values in healthy people. The changes were more demonstrative in
the group with pulmonary complications compared to the group without
pulmonary complications. We observed that the CD4 lymphocytes are
significantly less in the studied patients and is determined lower level of
CD56 bearing lymphocytes - natural killer /NK/ cells, compared to healthy
controls.
Conclusion: The acute heroin and mixed with other psychoactive drugs
intoxications leads to complications in pulmonary system, and changes of
some parameters of cell mediated and humoral immunity.
Key words: intoxication, heroin, psychoactive drugs, immune reactivity,
noncardiogenic pulmonary edema, pneumonia, ARDS
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Atypical presentation of polyarteritis nodosa: a case report
Horacio Del Olmo Tellez, Yamazaki Nakazhimada, Marco Antonio, and
Francisco Espinosa Rosales. National Institute of Pediatrics in Mexico,
Allergy and Immunology, Mexico City, Mexico.
Polyarteritis nodosa is a systemic vasculitis that affects median sized
muscular arteries, characterized by multi organ involvement. Presenting GI
manifestations include: abdominal pain, nausea, vomiting, diarrhea, acute
abdomen and, rarely, GI bleeding in the form of hematemesis, melena and
occult bleeding. A 14 year old boy presented five years ago with
hemetochezia, 5 to 7 episodes per day. he presented severe anemia and he
was hospitalized to investigate mieloproliferative disease or systemic lupus
erythematosus He was treated with IVIG and methylprednisolone with
clinical and hematic biometry improvement. A colonoscopy showed
suggestive data of CUCI with diffuse inflammation, pseudopolyps, adhered
fibrin to mucosa, inflammatory lesions involving descendent colon and
sigmoides, estenotic parts of the colon and bleeding. Hystologic examination
described ulcer and inflammatory infiltrate with polimorphonuclears,
limphocytes, plasmatic cells in lamina propia and submucosa, mild fibrosis
and eosinophils. He received treatment with methylprednisolone, mesalazine,
omeprazole, and azathioprine and he was referred. Physical examination
revealed severe emation 45.4 kg, hepatomegaly, splenomegaly, bilateral
pulmonar hipoventilation with bilateral crackles. The diagnosis of severe
desnutrition, CUCI, and communitary pneumoniae were made, and treatment
with cefuroxime and claritromicine was started. He presented fever,
rectorragia with hemodinamic compromise that required transfusion of
packed red blood cells, and platelets, and involvement of liver, kidney, gut
and persistent fever, pancytopenia and elevated ferritin. He required
orotraqueal intubation because ventilatory compromise, in the neurology
area, he had hypotonic proximal extremities, hiporreflexia, and generalized
seizures, which were controlled with phenytoin. The laboratory findings
revealed negative, antinuclear antibody, perinuclear antineutrophilic cyto-
plasmic antibody, hepatitis B surface antigen, and anti hepatitis C virus were
negative. Central nervous computed tomography showed isquemic temporal
areas. Magnetic resonance and angiography revealed microaneurysm in both
renal arteries, and vasculitis in central nervous system, hepatic and intestinal
arteries. These symptoms and laboratory findings were compatible with
diagnostic criteria for childhood classic polyarteritis nodosa, treatment of




The evidence on the efficacy of Specific Immunotherapy in the
treatment of respiratory allergy: A randomized controlled trials
database
Martin Penagos, Moises Calderon, and Stephen R. Durham. Imperial College
of London & Royal Brompton Hospital, Section of Allergy and Clinical
Immunology, London, United Kingdom.
Background: According to Evidence Based Medicine, conclusions from
meta-analyses and RCT represent the most solid evidence source to assess the
efficacy of an intervention. Specific immunotherapy (SIT) is currently
considered as the only allergen-oriented biological response modifier, and it
is regarded as an essential part of the therapeutic approach for allergic
diseases.
Objective: To provide a descriptive review of all available randomized,
double-blind and placebo-controlled trials (RCT BD PC) published which
evaluated the efficacy of SIT in the treatment of respiratory allergy.
Study Design: Systematic review.
Methods: A comprehensive search of the EMBASE and MEDLINE
databases up to April 30th, 2007 was carried out. The search strategy
retrieved citations containing the subject heading specific immunotherapy
limited to RCT DB PC combined with asthma, allergic rhinitis or both.
Variables recorded were the study design, journal impact factor, patient’s and
immunotherapy characteristics, clinical and laboratory outcomes and online
full-text papers’ availability.
Results: Two hundred ninety-six articles were identified and reviewed; 179
(61%) were RCT DB placebo-controlled. Of them, 116 evaluated efficacy of
subcutaneous IT (SCIT) and 63 sublingual IT (SLIT). Twenty-six percent
of studies (n= 46) had a minimum duration of 24 months (21% vs. 30% for
SCIT and SLIT, respectively). Characteristics of studies are described in
SCIT SLIT
Rhinitis Asthma Both Rhinitis Asthma Both
DB Placebo RCT 37 (32%) 32 (28%) 47 (40%) 30 (48%) 6 (10%) 27 (42%)
Sample Size + 40 (33-53) 28 (20-55) 35 (27-60) 56 (30-83) 30 (21-99) 37 (24-79)
Grass/mites (n) # 13/6 5/15 10/10 15/4 1/3 8/6
Time endpoint +* 12 (5-24) 12 (12-24) 12 (10-15) 10 (6-24) 10 (5-24) 12 (5-18)
Journal Impact factor ** 5.3 5.2 4.1 3.5 2.6 3.1
Mechanisms (n) @ 26 28 37 20 5 21
Full text Online 60% 50% 60% 73% 100% 70%
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Table. (+ Median-Interquartilic rank; # Number of studies found; * Months;
** Mean; @ At least one immunological mechanism studied)
Conclusion: One hundred seventy-nine Ib evidence-level studies on efficacy
of SIT in the treatment of respiratory allergy were identified in two electronic
databases. Both selection and search bias must be ruled out.
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The effect of antihistamine pretreatment on side effects during
specific immunotherapy
Zoran Arsovski, Dejan Dokic, Miroslav Gavrilovski, Biserka Kaeva, Zlatica
Goseva, and Olivera Caparoska. Clinic of Pulmonology and Allergy,
Scientific Department, Skopje, Macedonia, Fyrom.
During one year of our study in a group of 47 patients we have
conducted the specific immunotherapy (SIT) with House Dust Mite
(HDM) Novo Helisen Depot extracts and pollen Allergovit extracts. 493
shots were applied and 32 local reactions occurred (6,49%). All of them
were 9 5 cm and all of them occurred before the maintenance dose was
reached. No systemic reaction or life-threatening reactions were observed.
In a group of HDM treated patients 5,21% of injections resulted in large
local reaction versus 7,45% in a group of patients with pollens. There
was no statistical difference between those two groups p=0,31.
Reductions in IT-schedule were performed due to severe local reactions.
Only 6 patients experienced more than ones a large local reaction. Four
of them were on pollen immunotherapy and two were on HDM
immunotherapy. All of these patients have had skin reactivity on skin
prick test (SPT) more than 3+. We have decided to use loratadine 10mg
as antihistaminic premedication in these patients. After the administration
of the pretreatment antihistaminic drug, patients did not experience any
severe local reaction.
We can conclude that in a very limited number of patients who
underwent SIT (especially in those with very extensive cutaneous reaction to
SPT) it could be useful to use antihistaminic premedication to reduce/secure
the number and severity of cutaneous reactions.
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Shorter dosing intervals of sublingual immunotherapy lead to
more efficacious treatment in a mouse model of rhinitis
Carola Rask, Jens Brimnes, Sandra Urioste, and Kaare Lund. ALK-Abello´,
Experimental Immunology, HLrsholm, Denmark.
Background: Sublingual immunotherapy (SLIT) with allergen extract has
been shown to be efficacious in treating allergic rhinitis and asthma.
Clinically, SLIT is performed with varying doses of allergen extracts and
with varying intervals of dosing, and although a dose-response relationship
has been established in SLIT, the importance of dosing intervals remains to
be documented. The objective of this study was to explore the importance of
the dosing intervals in SLIT. For this purpose we used a mouse model of
allergic rhinitis, induced by a clinically relevant allergen, timothy grass
pollen extract.
Methods: Mice were sensitized to Phleum pratense (Phl p) by
intraperitoneal injections of alum-adsorbed allergen extract. Sensitized
mice were SLIT-treated with different intervals and with different doses of
Phl p extract. In order to study the importance of dosing intervals, doses of
25 kSQ, 58 kSQ or 175 kSQ were given sublingually to mice 7, 3 or 1 day
per week, respectively, resulting in a weekly cumulative dose of 175 kSQ
for all groups. Two additional groups receiving the lower dose (25kSQ) of
Phl p one or three days per week were also included. Following nine
weeks of SLIT, all mice were challenged intra-nasally with Phl p.
Antibody levels, T cell responses and numbers of inflammatory cells in
bronco-alveolar lavage (BAL) were used as read-outs for the efficacy of
SLIT in the different treatment groups.
Results: Increases in the Phl p specific IgA antibody levels showed a strict
positive correlation with increased dosing frequency. The levels of Phl p
specific IgE were reduced to the same extent in all groups, but both the
systemic- (spleen) and local (draining lymph nodes) T cell responses
decreased with increased dosing intervals, indicating a positive effect of
higher dosing frequency on T-cell tolerance. In addition, the maximal
reduction in allergen-induced inflammation in the lungs (BAL) was seen in
the group receiving SLIT for 7 days per week.
Conclusion: The group receiving SLIT for 7 days per week was the only
group with demonstrated positive effects of all immunological parameters
measured. Our data demonstrate that although the effect of SLIT is dose-
dependent when using the same allergen extract, a once daily regimen is more
efficacious than regimens where SLIT, with the same weekly cumulative
allergen dose, is administered with longer intervals.
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Faster reach to maintainance pleteau by delayed rush
immunotherapy
Naren Pandey. Bellevue Clinic, Allergy & Asthma, Kolkata, India.
Introduction: Intermittent Rush immunotherapy was tried on some patients
to evolve some faster and affordable immunotherapy modality to make the
patient achieve the maintenance pleatu within a very short time span which
does not also involves hospital stay. Conventional method of immunotherapy
is administered with long durations, rush immunotherapy is super fast
methodology in attaining the maintenance/boosting module, which requires
hospitalization and other precautionary methods, and multiple allergen
vaccines to be administered within short span of time. But in this method
which was tried it was found that within a duration of around 15-20 days the
relief of the immunotherapy was reached. Place of study: 1) Belle Vue Clinic,
kolkata, 2) Hope Super Speciality Hospital, Purnea.
Materials and Methods: 62 patients out of which 46 with urticaria allergy
and 16 with allergic Rhinitis. Were subjected for Intermittent Rush
Immunotherapy schedules. The therapy consists of administration of four
vials of allergen extracts, 1st vial : 1:25,000 dil, 2nd vial 1:2,500 dil, 3rd
vial 1:250 dil, 4th vial 1:50 dil. The 1st & the 2nd concs were
administered in daily schedules in a graphically rising manner. The patients
had been given pre-medication before the study. Follow-up of the patients
included blood examination IgG & IgE level estimation, before & after 8
weeks after the procedure.
Results: Some of the patients showed local skin reactions which subsided on
duration of time no drugs were required and 7 patients developed systemic
reactions which were managed by Deriphylline & Decdan injections. There was
substantial decrease in IgE level & increased IgG level was marked, significant
& marked satisfactory relief was observed in the patients symptomatology, thus
the procedure may be graded as a very fast & affordable immunotherapy.
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A two year double blind placebo controlled study on
immunotherapy with single and mixed allergen preparation
Shailendra N. Gaur1, Deepsikha Srivastava2, Naveen Arora2, and Bhanu P.
Singh2. 1Vallabhbhai Patel Chest Institute, Department of Respiratory
Medicine, Delhi, India; 2Institute of Genomics and Integrative Biology,
Allergy and Immunology, Delhi, India.
Background: Studies on immunotherapy with single allergen extract have
been performed to determine the efficacy in asthma and rhinitis patients.
However, very few studies have been performed comparing single and mixed
allergen immunotherapy in a double blind manner. Here, we have carried out a
double blind placebo control trial to assess the efficacy of single and mixed
allergen immunotherapy based on various clinico-immunlogic parameters.
Methods: One-hundred allergic patients were screened by history, skin tests
and specific IgE levels. Sixty patients fulfilling the criteria of the study were
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divided randomly into two groups Y (a) active- single allergen, (b) active-
multiple allergen and (c) - placebo containing 20 patients each. Single
allergen immunotherapy was given with housefly extract. In mixed allergen
immunotherapy, insect, pollen and fungal allergen extract were used in
vaccines. In vivo parameters such as skin test and airway reactivity were
assessed at baseline and after 2 year`s of immunotherapy. In vitro parameters
such as allergen specific IgE, IgG1 and IgG4 were also assessed. Apart from
these, symptom/drug score cards were filled by the patient and analyzed every
3 month. Efficacy of the treatment was analyzed in terms of clinical (skin test,
symptom score, and airway reactivity) and immunological parameters (IgE,
IgG4, IgE/IgG4, and IgG1/IgG4).
Results: Patients getting active immunotherapy in both single as well as
multiple allergen group showed significant improvement (pG0.01) in disease
state in comparison to placebo patients. Skin tests and IgE values however
showed non-significant reduction compared to baseline. There was a significant
improvement (pG0.01) in airway hyperreactivity, symptom score and IgG4
levels after 2 year of immunotherapy in active group. Also good correlation was
observed between symptoms reduction and increased IgG4 levels. All the above
parameters were non-significant in placebo group. In the group treated with the
single extract, fewer patients suffered with asthmatic symptoms after 2 years of
IT and required less medication than in the group treated with the multiple
extract. However, these differences, as well as differences in other clinical and
immunological parameters were not statistically significant.
Conclusion: Both single and mixed allergen immunotherapy for 2 years
have shown improvement in clinical and immunologic parameters of asthma
and rhinitis patients.
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A role of immunotherapy in allergic conjunjuctivites
Vipul Shah. Allergy Clinic, Allergy, Surat, India.
Introduction: Allergic conjunctivitis is many times an ophthalmologist’s
nightmare. Antiallergic eye drops which often contain corticosteroids, may
temporarily bring relief of symptoms but may bring an early cataract, among
other side effects. Allergy testing and immunotherapy based on the test results
can cure a significant number of these patients and provide relief to others.
Methods: 24 patients of allergic conjunctivitis were subjected to modified
skin allergy testing. Out of these 10 patients also had associated allergic
rhinitis and asthma. Common allergens found in these patients were: Dust,
Dustmites, Pollen, Fungi & Food. Based on test results, vaccines were
prepared for individual patients and immunotherapy given. The patients who
did not significantly respond to conventional medicines and vaccine, we
reviewed the history to discover any missed out allergen. A specially
designed indigenous Bpersonal volumetric air sampler^with safranine stained
glycerin coated slides inside, was kept in patients home, office and
surrounding atmosphere.
Results: Out of 24, 18 patients (75%) started improving within 3 months of
starting immunotherapy. After 6 months their eye drops and other medicines were
stopped. Restricted food items started one by one after 6 monthes. They are
symptoms free for last 12 to 2 years. For 6 patients who did not respond to above
therapy, specially designed Bair sampler^ brought great surprises. The fungi and
pollens, which were not tested, previously were found. Also three new pollens were
discovered. Appropriate immunotherapy made 5 out of 6 patients symptoms free.
Conclusion: Allergy testing and immunotherapy can cure allergic con-
junctivitis. Personal volumetric air sampler is a very useful tool to find out
additional allergens in case of resistant cases.
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Quality of Life and Symptoms assessment in sublingual
immunotherapy for patients with house-dust mite related
perennial rhinitis: definition of a responder profile
Paul Potter1, Barbara Nurse1, Diana Hawarden1, Anne Combebias2, and
Riad Fadel2. 1University of Cape Town Lung Institute, Allergy Diagnostic &
Clinical Research Unit, Cape Town, South Africa; 2Stallergenes, Medical
Department, Antony, France.
Background: The efficacy and safety of sublingual immunotherapy (SLIT)
in well-established in seasonal allergic rhinitis. However fewer data were
available regarding perennial allergic rhinitis. The aim of this study was to
assess the relationship between the effect of SLIT on symptoms and Quality
of Life changes in patients with perennial rhinitis.
Methods: This exploratory phase IIIb, double-blind, placebo-controlled trial
was conducted during years 2003 to 2005 in the Cape-Town area (South
Africa). Sixty patients having house-dust mite-induced allergic rhinitis were
enrolled. Patients were randomized to receive, during 2 years, Dermatopha-
goides pteronyssinus SLIT solution (Stallergenes, Antony, France), with a
maintenance dose of 300 IR (n = 39), or placebo (n = 21). The primary
efficacy endpoint was the mean T5SS [Total Symptom Score for five
symptoms: sneezing, runny nose, nasal congestion; ocular redness/itching/
tearing; itchy nose/throat/ears. The limit percentage of improvement was fixed
at 60% for the Bresponders^. Rescue medication intake, individual symptom
scores and quality of life (QoL-RQLQ) were assessed as secondary endpoints.
Results: The intention-to-treat (ITT) population included 55 patients (mean
age: 32.93 yrs T 11.31). The mean T5SS change was lower for the 300 IR
[-6.57] group compared to placebo [-5.02], but the difference did not reach
significance. The mean percentage of days with rescue medication, as well as
each individual symptom score were lower for the 300 IR group compared to
placebo. The percentage of good responders is significantly higher in the
active group (p=0.0405). For the QoL, the percentage of good responders the
ocular score is higher in the active group (p=0.0512), reaching significance.
The association between good responders to QoL and good responders to
T5SS gives an odds ratio = 15 (pG0.0001) for all patients (OR = 8.75,
p=0.0061 in active group) showing a good correlation. The most frequent
adverse events were oral pruritus and throat irritation. No related SAE
occurred throughout the study.
Conclusion: This exploratory study gives promising results with a two-year
treatment using Dermatophagoides pteronyssinus SLIT solution at a main-
tenance dose of 300 IR three times a week. A population of Bresponders^ may
be defined as patients with an improvement of 60% or more of the
clinical symptoms. QoL is strongly correlated to clinical symptoms.
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Measuring quality of life in the treatment of allergic rhinitis
with specific immunotherapy - identifying the best suitable
instrument
Ulrik Vestenbaek. ALK-Abello´, International Marketing, Hoersholm, Denmark.
Background: Quality of Life (QoL) is becoming an increasingly important
clinical outcome parameter, also in treatment of allergic rhinitis (AR). In AR
QoL is often assessed with Rhinoconjunctivitis QoL Questionnaire (RQLQ) -
a disease specific instrument. For pharmacoeconomic evaluation a generic
QoL instrument must be used. RQLQ only detects symptoms in the upper
airways. Due to a strong epidemiologic relationship between AR and asthma
suggesting that both are manifestations of the same disease, an instrument
also detecting symptoms in the lower airways seems more appropriate. To
show the full impairment of QoL caused by AR and to perform
pharmacoeconomic evaluation it is important to identify the right generic
instrument to be used in clinical trials with specific immunotherapy (SIT).
Methods: QoL gain with the grass allergen tablet (Grazax, ALK-Abello´)
against AR was assessed in a randomised, parallel-group, double-blind,
placebo-controlled trial with 634 subjects using the generic EQ-5D
questionnaire. EQ-5D contains 5 dimensions: mobility, personal care, usual
activities, pain/discomfort and anxiety/depression, with 3 levels within
each dimension. For each of the 5 dimensions the average score was
calculated. It was then tested if the difference in scores between active and
placebo was significantly different (t-test).
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Results: The treatment with the grass allergen tablet significantly increased
QoL compared to placebo (pG0.001). The difference between groups was
mainly due to differences within the dimensions: Usual activities and Pain/
discomfort. Mobility did also produce a borderline significant difference
(Table 1).
Conclusion: Although there is a significant increase in QoL for subjects
receiving treatment with the grass allergen tablet, the increase was only
justified in 2 of the 5 dimensions. EQ-5D is a very crude instrument and might
not be optimally suited to detect QoL impairment in a disease like AR. This
implies an underestimation of the QoL result with the grass allergen tablet.
An instrument with a more detailed focus on usual activities could be more
relevant to use within SIT and AR in future studies. Examples of potentially
well suited instruments are SF-36 and EQ-15D.
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Long-term comparison of the efficacy of adding sublingual
immunotherapy or montelukast in birch-induced asthma
Maurizio Marogna1, Igino Spadolini2, Alessandro Massolo3, Giorgio Walter
Canonica4, and Giovanni Passalacqua4. 1Macchi Foundation Hospital,
Pneumology Unit, Cuasso al Monte, Varese, Italy; 2Anallergo SpA,
Anallergo, Florence, Italy; 3University of Florence, University of Florence,
Florence, Italy; 4Genoa University, Dept of Internal Medicine - DIMI,
Genoa, Italy.
Background: There are no studies comparing the effects of immunotherapy
and antileukotrienes. The main limit is the long duration required to
appreciate the clinical effects of immunotherapy. We compared the effect of
montelukast or SLIT, added to standard therapy in moderate persistent
asthma up to 4 years.
Methods: Open controlled randomized trial. Patients with moderate asthma
(and rhinitis) solely due to birch pollen were randomized to receive either
monteukast MK (20 mg/day) or birch-SLIT (Anallergo, Florence, Italy) in
the pollen seasons, in addition to formoterol 25 mcg+fluticasone 500 mcg
twice daily. All patients received also salbutamol and cetirizien as rescue
medications. Asthma and rhinitis symptoms were evaluated by diary card
February-may at baseline and after 2 and 4 years of study. In-season nasal
eosinophils and outseason bronchial hyperresponsiveness were evaluated
as well.
Results: Thirty-three adult patients were enrolled and 29 completed. The
groups were homogeneous at baseline. In the SLIT vs MK e group the total
asthma symptom score at baseline, 2 and 4 years were: 178 vs 180 (NS), 76 vs
183 (G0.001) and 42 vs 167 (G 0.001). At the same timepoints the bronchial
scores were 80 vs 92 (NS), 48 vs 87 (0.01) and 25 vs 81 (G0.01). In both group
there was a significant decrease in the use of bronchodilators but in the SLIT
group there was a significant decrease of nasal eosinophils and an increase
of outseason bronchial hyperresponsiveness as compared to baseline and to
MK group.
Conclusion: In patients with grass-pollen induced moderate asthma and
rhinitis the addition of SLIT provides a greater clinical benefit compared
to MK.
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SLIT response in children with HDM and cockroach
Nagendra Prasad Komaral, and Paranjoty Kanni. Bangalore Allergy Centre,
Allergy, Bangalore, India.
Background: Recent times the allergy disorders is increased and most of the
therapeutic approach is incomplete and yet not promising. In recent time the
SLIT emerged with patient friendly Immunotherapy. This became a good
boon among the children who were depend only on the symtpmatic drugs.
This SLIT became an eye opener to Physicians and to parents to control the
allergy symptoms. SLIT is introduce in Indian continent and made it possible
at affordable price and showed good response in preventing the allergies.
Methods: A total 112 children aged about 2 to 14 yrs from various parts of
India who were previously diagnosed with Allergic Rhinitis and Allergic
Asthma and reported receiving allergy and asthma medication took part in
this study. These children were tested with aeroallergens by SPT and selected
for SLIT who were sensitive to House dust mite (body and fecal matter)
sensitivity and among insects who were sensitive to Cockroach.
Results: Most of the patients’ parents reported with good response and the
pharmacotherapy drugs relatively reduced over a period of time and the
symptoms drastically came down with increase PEFR. The drop outs were
more fascinated to the alternative medicine and they continue to search for
the relief from one system to another with continued suffering. Some reported
frankly and some said they feel better.
Conclusion: The results of this study provide insight into how the SLIT
greatly influence the therapy and increase the quality of these children and the
normal growth pattern which is appreciated with most of the parents.
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Long-term comparison of the efficacy of the efficacy of
sublingual immunotherapy vs inhaled budesonide in grass-
induced asthma
Maurizio Marogna1, Igino Spadolini2, Alessandro Massolo3, G. Walter
Canonica4, and Giovanni Passalacqua4. 1Macchi Hospital Foundation-
Varese, Pneumology Unit - Cuasso al Monte, Varese, Italy; 2Anallergo SpA,
Anallergo SpA, Florence, Italy; 3University of Florence, University of
Florence, Florence, Italy; 4University of Genoa - Dept. of Internal Medicine,
Allergy & Respiratory Diseases, Genoa, Italy.
Background: There are few study comparing the effects of immunotherapy
and inhaled steroids. The main limit is the long duration required to fully
appreciate the clinical effects of immunotherapy. We compared the effect of
inhaled budesonide vs SLIT in mild persistent asthma up to 4 years.
Methods: Open controlled randomized trial. Patients with mild persistent
asthma and rhinitis solely due to grass pollen were randomized, after a run-in
season, to receive either budesonide 800 mcg/day in the pollen season or
grass-SLIT (Anallergo, Florence, Italy) continuously for 4 years. Rescue
medications were prescribed to all patients. Asthma and rhinitis symptoms
were evaluated by diary card may through july at baseline and after 2 and 4
years of study. In-season nasal eosinophils and outseason bronchial
hyperresponsiveness were evaluated as well.
Results: Fifty-one patients were enrolled and 46 completed. The groups
were homogeneous at baseline. In the SLIT vs budesonide group the total
nasal symptom score at baseline, 2 and 4 years were: 120 vs 92 (NS), 56
vs 99 (G0.01) and 36 vs 108 (G0.001). At the same timepoints the
bronchial scores were 180 vs 161 (NS), 85 vs 138 (NS) and 56 vs 122
(G0.01). In both group there was a significant decrease in the use of
bronchodilators and no change in FEV1. In the SLIT group there was a













1.0472 1.0121 1.0967 1.1332 1.0780
Placebo 1.0716 1.0185 1.1498 1.2169 1.0864
p-value
(t-test)
0.095 0.468 0.003 G0.0001 0.666
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4 years (pG0.01). The outseason bronchial hyperresponsiveness improved
significantly only in the SLIT group.
Conclusion: In patients with grass-pollen induced asthma and rhinitis SLIT
was not inferior to inhaled budesonide concerning bronchial symptoms. On
the other hand, SLIT provided additional benefit on rhinitis symptoms and
outseason bronchial hyperresponsiveness
Key words: SLIT, Budesonide, Asthma
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Safety and compliance of sublingual immunotherapy in spray
A.G. Palma-Carlos. Clinical Allergy Immunology Center, CAIC, Allergol-
ogy, Lisbon, Portugal.
Background: Immunotherapy by sublingual route (SLIT) is nowadays
largely employed. Currently by drops or tablets. Sublingual spray has been
used for other therapies. This route offers a great potential for immunotherapy
increasing the area of mucosal contact with allergen and the rate of
absorption. A first trial of SLIT-spray has been done in order to validate
safety and patients compliance.
Methods: 40 patients with respiratory allergy, allergic rhinitis, asthma or
both have been included in the trial. Informed consent has been obtained
from all patients. SLIT spray has been given in a standardized schedule
from 4 vials in progressive concentrations A 1/125, B 1/25, C 1/5, D 1/1.
For mites the vaccine was standardized at 5 mcg/ml for Derp 1+Derp2 and
Derf1+Derf2. Cummulative dose at the end of induction was for Derp 1
around 490 mcg (DIATER Laboratories, Spain). The composition of SLIT-
spray was choosen in each case by history, skin tests and specific IgE. The
procedure has been carefully explained at all the patients. Daily application
for VIALS A,B,C 1 to 4 puffs. D manutention 1 puff daily continued 2
months more. A booklet with instructions was given to the patients and a
visual scale from 0 to 5 points marked in a second appointment:
convenience, practicability, clarity of instructions and general evaluation.
Side effects were registered for each dosage of each vial. Symptomatic
therapy was allowed during SLIT-spray.
Results: 40 patients, 30 adults (16Y45) (18 M, 12 F) and 10 children (5 M 5 F)
(9Y15). Allergens used, Dpteronyssinus 28 cases, D.farinae 26, Lepidogly-
phus 11, Tyrophagus 2, Blomia 1,cat 1, dog 1, grass pollens mix 6, Parietaria
judaica 3, Olea 1, Plantago 3.
Adverse effects in 8 patients only one withdrawal. adverse events
were reported. Adverse events reported: urticaria 1, bad taste 1, tongue
swelling 2, nausea 1 (withdrawal), sneezing 1, fever 1, wheezing 2, rhinorrea
1,(20%). Adverse events disappear with prosecution of immunotherapy.
Evaluation by patients: convenience, practicability, comprehension of
instructions and general scores of 4,3Y4,2Y4,0 and 3,5 in a 0Y5 scale.
Conclusion: SLIT-spray is a new safe and convenient form of SLIT. High
dosage is quickly attained, side-effects relatively rare. The evaluation by
patients give good level of appreciation. Larger studies must be done in order
to confirm these results.
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Role of SLIT with D.farinae in allergic conjunctivitis
Gautam Bhagat1, K V Nagendraprasad2, Raj Bhagat3, and Purvi R Shah4.
1Pathik Nursing Home, Allergy, Ahmedabad, India; 2Bangalore Allergy
Centre, Allergy, Bangalore, India; 3NHL Mun. Medical College, Medicine,
Ahmedabad, India; 4M J Institute of Ophthalmology, Ophthalmology,
Ahmedabad, India.
Background: Perennial conjunctivitis due to House Dust Mite is the most
frequent form of allergic conjunctiviis in urban environments. However, its
diagnosos remains difficult for the ophthalmologists. In India, very little work
is done in this field. Keeping this in mind, we have tried to present a case
report with Sublingual Oral Immunotherapy.
Methods: A male patient, Mr. Pravin J. Patel, 34 yrs,residing at Ahmedabad
was suffering from Perennial Allergic Conjunctivitis for over 4 years.
Routine therapy including local antiinflammatory drops, antihistaminics, etc
didn’t give him long term relief. The antigenspecific conjunctival provocation
test, skin prick tests and ImmunoCAP RAST were carried out with
D.pteronyssinus and D.farinae mites. CPT was positive at low dilution
allergen of D. farinae and negative for D.pteronyssinus. Skin Prick Tests
showed two plus sensitivity to D.farinae. ImmunoCAP RAST revealed Class
VI (Very High) sensitivity to D.farinae. Skin prick tests showed one plus
positivity and ImmunoCAP RAST showed Class I response to D.pteronyssi-
nus. The extract to be given for SLIT containing D.farinae was tested for
Conjunctival Provocation Test and Skin Prick Test to confirm the positivity.
The SLIT was given as twice a day schedule,initially in diluted form and
later on with increasing concentration. The maintenance dose was then
continued. Clinical assessment, Skin Prick Tests and ImmunoCAP RAST
were carried out at 6 months and 12 months interval. The patient is still under
SLIT therapy.
Results: It was observed that the patient was symptomfree at the end of six
months and the redness and swelling had totally disappeared. Skin Prick Tests
revealed one plus sensitivity to D.farinae at 6 and 12 months interval.
ImmunoCAP RAST showed 46.6 kUa/l (grade IV) and 16.5 kUa/l(grade III)
at the end of 6 and 12 months respectively.
Conclusion: Sublingual ORAL Immunotherapy has shown excellent
clinical response with significant improvement in skin prick test and
ImmunoCAP RAST test results in case of Perennial Allergic Conjunctivitis
due to D.farinae.This is an isolated case and much more cases need to be
studied.
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Safety, tolerability and efficacy of sublingual allergoid
immunotherapy starting with a 4-day build-up scheme.
Rationale and study design of an ongoing multicentre
Portuguese study in allergic patients
Carlos Fonseca-Moreira, et al. LLL, Pharmaceutical/Medical, Lisboa,
Portugal.
Rationale: The good efficacy, safety and tolerability of the sublingual
monomeric allergoid (allergoid SLIT, Lais\, Lofarma S.p.A., Milan, Italy),
either in tablets or drops, has already been shown in many studies. Yet, so far,
only one study on allergoid SLIT starting with a 4-day build-up phase to
achieve in a shorter time the maximum suggested dose for the maintenance
therapy was performed in 39 allergic patients with promising results. The
objective of the present study, still ongoing, is thus to confirm, in a broader
population, if this approach is really useful and safe.
Study design: One hundred and thirty patients, gathered from the normal
daily clinical practice of 16 Portuguese doctors, with an history of
oculorhinitis and/or rhinitis with or without mild-moderate asthma, were
enrolled during the last 24 months. The build-up rush scheme involved
the administration of daily increasing doses of the allergoid SLIT: 500
AU the first day, 1000 AU the second, 1500 AU the third and 2000 AU
the fourth. The cumulative dose administered in 4 days was 5000 AU.
Also during the maintenance period the treatment dose was kept higher
than one normally used. Main endpoints of the study were both
tolerability and safety, as well as treatment efficacy. For the evaluation
of this one, patient’s subjective perception has been taken into
consideration as well as the variations in the use of additional drugs
for symptom control during SLIT.
Results: The final results will be presented at the end of the study in a
subsequent poster.
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Sublingual immunotherapy for paediatric allergic rhinitis
Woei Kang Liew1, Wen Chin Chiang1, Mona Kidon1, Anne Goh1, Jenny
Tang2, Oh Moh Chay2, Ai Hui Teo3, Hwee Hoon Lim3, Ai Hui Teo3,
and Bala Abhilash4. 1KK Hospital, Paediatric Allergy, Immunology and
Rheumatology, Singapore, Singapore; 2KK Hospital, Paediatric Respiratory
Medicine, Singapore, Singapore; 3KK Hospital, Paediatric Medicine,
Singapore, Singapore; 4KK Hospital, Paediatric ENT, Singapore, Singapore.
Background: No immunotherapy programme existed in KK Hospital prior to
2006. Work commenced in late 2005, to start sublingual immunotherpy
(SLIT) as a new clinical service.
Methods: Paediatric AR patients, with moderate persistent symptoms that
are not responding to conventional pharmacotherapy, were enrolled. Other
inclusion criteria include house dust mite sensitisation, children 5 years and
above, with committed and motivated parents/patients. Doctor visits are
scheduled at baseline, 1st, 2nd months and 3 monthly intervals thereafter. An
ENT review is performed to exclude any anatomical lesions. Allergy
symptom scores were completed for 2 weeks prior to each visit and the mean
score calculated. Mean rhinitis quality of life (QOL) questionaires were
collected at 6 monthly intervals using a computerised database at the Allergy
laboratory. Medication usage and adverse events were documented in a file
diary provided. House dust mites allergen extracts (Dermatophagoides
pteronyssinus and/or Blomia Tropicalis) from Stallergenes (Staloral\) were
used, and immunotherapy was initiated as per recommended protocol.\
Results: 12 patients, 58% boys, were recruited over one year. The mean age
was 12 years old (range 5.5Y19 years). All had moderate persistent allergic
rhinitis, 91.7% had concomitant allergic conjunctivitis, 33.3% had asthma,
and 33.3% had eczema. Most (91.7%) have sensitisation to 2 different species
of house dust mites, and were prescirbed separate HDM allergens for SLIT.
There is an improvement in the mean allergy symptom scores in most patients
during the first 6 months ranging between 28Y53%. There is also a reduced
mean QOL scores from 40.4 to 22.7, though not reaching statistical
significance. There were no serious adverse events or anaphylaxis during
SLIT treatment. The most common adverse reaction is sublingual itch 66.7%,
which is transient and easily treated. In addition, there were complaints of
mild abdominal discomfort and nausea in 2 patients; urticaria rash in
1 patient. One patient had deterioration of pulmonary function and
cough 6 months after SLIT, requiring addition of inhaled corticosteroids
for asthma.
Conclusion: SLIT is a safe and effective treatment for paediatric persistent
AR. Good patient-medical team rapport is essential to the success of
such programmes.
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Follow up study in patiens with pollinosis after sublingual
immunotherapy (SLIT) compared to subcutaneous shorttime-
immunotherapy (SCIT)
Bettina Hauswald1, Cornelia Wahl2, and Thomas Zahnert2. 1University
Hospital Dresden, ENT Department, Dresden, Germany; 2Universal
Hospital Dresden, ENT-Department, Dresden, Germany.
The purpose of this study was to evaluate clinical efficacy and safety
of sublingual immunotherapy (SLIT) in comparison to subcutaneous
immunotherapy (SCIT) in patients with allergic rhinitis.
Alltogether we evaluated immunotherapy in 150 patients via inquiry
scedule. 101 patients were treated with SLIT and 49 patients were treated with
SCIT.
Patients treated with SLIT experienced a greater reduction of
allergic symptoms (80%) than patients treated with SCIT (75%). In both
therapies a reduction of antiallergic medication and an increase of quality
of life was shown. The main adverse reactions in SLIT were burning and
swelling of the mouth base mucosa especially during dose intensification.
In SCIT a local swelling and induration at the injection sight was
shown which disappeared completely within 4 to 6 weeks after the last
injection.
Due to the high compliance of patients and the good results in both
strategies the decision for the right therapy for each patient should be made
in regard of the patients individual needs and ailments.
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Tolerance of high dose sublingual immunotherapy with pollen
extracts administered under rush and ultra-rush schedules
Borja Bartolome´1, Begon˜a Madariaga1, Marı´a Cruz Go´mez1, Alberto
Martı´nez1, A`ngel Ferrer2, Antonio Rodrı´guez3, and Jose´ Vigaray4. 1Bial
ArU´stegui, R&D Department, Bilbao, Spain; 2Hospital Vega Baja, Allergy
Department, Orihuela, Spain; 3Hospital Virgen del Camino, Allergy Depart-
ment, Pamplona, Spain; 4Clı´nica Alder, Allergy Clinic, Madrid, Spain.
Background: High dose sublingual immunotherapy (SLIT) has been
demonstrated as an effective alternative to subcutaneous immunotherapy
(SCIT). However high doses could lead to adverse reactions, thus the
tolerance of every type of extract should be ascertained. Parietaria and grass
pollens are two of the most prevalent aeroallergens in southern European
countries. In this work, we tried to asses the tolerance of P. judaica and grass
high dose SLIT under two induction phases.
Methods: Biologically standardized extracts of P. judaica and grass pollen
were used to prepare vaccines at a concentration which reached monthly
accumulated doses of 20 and 50 fold, respectively, regarding conventional
SCIT. Par j 1, Par j 2 and grass group 1, were controlled in the final
preparations. Thirty-two subjects received grass SLIT and twenty P. judaica
SLIT. Rush schedule consisted in the administration of one drop (50 6l each)
the first day, two the second and thus successively until reaching five drops
the fifth day. Ultra-rush consisted in the same volumes given all in the same
day within 30 min intervals. Adverse events were registered and graded
according to EAACI.
Results: There was no systemic reaction nor in the patients treated with grass
vaccine neither in the patients treated with Parietaria. Only four out of the 22
patients treated with grass vaccine administered by an ultrarush schedule,
showed local reactions in the induction phase (3.6% of doses). Over the
whole period (6 months), eleven patients experienced some kind of local
reaction (itching and/or swelling), that is 0.38% of the doses. There were
three withdrawals due to local reactions. In the 30 patients under the rush
schedule, 8 local reactions appeared in the build up, that is 5.3% of the doses.
In the whole period, local reactions rose to nine (0.25% of the doses). There
was only one withdrawal in the Parietaria group of the study due to repeated
local reactions.
Conclusion: High dose SLIT vaccines with pollen extracts showed an
acceptable safety profile administered by accelerated schedules.
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Short term efficacy of sub-lingual spray immunotherapy
A.G. Palma-Carlos. Clinical Allergy Immunology Center, CAIC, Allergol-
ogy, Lisbon, Portugal.
Background: In the last few years sublingual immunotherapy (SLIT) has
gained increasing popularity at least in Europe and all allergen producers
laboratories have launched sublingual drops. Sublingual sprays have a larger
mucosal contact than drops or tablets increasing also the rate of absorption.
Therefore this method of dispensing drugs and allergens can also be applied
to SLIT. The efficacy of this technique must be assayed.
Methods: 40 patients with respiratory allergy, allergic rhinitis, asthma or
allergic rhinitis asthma syndrome have been included in the trial. Informed
consent has been obtained from all patients. SLIT spray has been given in
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a standardized schedule from 4 vials in progressive concentrations A-1/
125, B 1/25, C 1/5, D 1/1. For mites the vaccine was a standardized at
5 mcg/ml for Derp 1+Derp2 and 5 mcg/ml, for Derf1+Derf2 and Derf1.
Cummulative dose at the end of induction was for Derp 1 around 490 mcg
(DIATER Laboratories, Spain). The composition of SLIT-spray was
chosen in each case by clinical history, skin tests and specific IgE. In
children less than 10 years half-concentration of SLIT-spray was
employed. The procedure has been carefully explained at all the patients.
Daily application for VIALS A,B,C from 1 to 4 puffs each day. Vial
manutention dosage 1 puff daily. This dosage being attained only after 13
days and continued 2 months more. A booklet with instructions was given
to the patients and a visual scale from 0 to 5 points registered in a second
appointment to evaluate facility, convenience, practicability, clarity of
instructions and general evaluation of treatment. Side effects were
registered for all the patients for each dosage. Symptomatic therapy was
allowed during trial with anti-histamines nasal steroids, and formoterol-
budesonide when necessary.
Results: Short-term efficacy of immunotherapy was good in all patients
either for house dust mites allergy or pollens. Evaluation by the patients
give on a visual scale an average of 3,5 on 5 points (70%). Medical
evaluation was of good (12) or very good (24) results in the patients even
in the patients treated during pollen season. Only 1 patient withdrawed
from the trial due to the tongue swelling and nauseous state. SLIT spray is
effective generally well tolerated and very convenient for the patients.
Larger series of SLIT-spray must be evaluated in order to confirm these
preliminary results.
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Sublingual immunotherapy with canova, a homeopathic
formulation
Dr Tripathi DM. Allergy Clinic, Allergy, Mumbai, India.
Rationale: Clinical efficacy of sublingual immunotherapy has been
established using allergenic extracts, but there are very few studies using
plant extracts. Canova a homeopathic formulation consisting of aqueous
extract of Aconitum nepellus, Arsenicum album, Bryonia alba and Thuja
occidentalis has been used as immunomodulator along with subcutaneous
immunotherapy in patients suffering from different allergic disorders.
Methods: In a multi centre study, 30 subjects were selected, who had
sensitivity to various allergens, confirmed by Skin Prick Testing, and were
undergoing allergen specific immunotherapy course. These subjects were
advised for sublingual immunotherapy with Canova along with subcutaneous
immunotherapy (SIT). An other group was administered only SIT to compare
the results.
Results: No relevant side effects were observed with the subjects who had
undergone with sublingual immunotherapy with Canova. However, there was
a significant reduction of clinical scores for nasal obstruction, sneezing, nasal
itching and cough in this group in comparison to those subjects who were on
SIT.
Conclusion: Canova a homeopathic formulation could be used as an adjuvant
with allergen immunotherapy for the treatment of allergic rhinitis, allergic
asthma etc. Administration of SIT together with an immunomodulator
(Canova) may facilitate safe and effective immunotherapy.
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Treatment of patients with seasonal allergic rhinitis using
modified allergen vaccines intranasal and sublingual
immunotherapy
Nikolay Markin1, Irene Rudenko2, Andrey Zabelev1, and Michael Rudenko3.
1Clinical Center, BEuroDon^, Rostov-on-Don, Russian Federation; 2629
Out-patients’, Clinic, Rostov-on-Don, Russian Federation; 3Clinical Center,
Rostov-on-Don, Russian Federation.
Background: Type I allergy represents an important health problem that is
currently affecting approximately 25% of the population in Western
countries. SIT, the only causative treatment of Type I allergy, is currently
performed with crude allergen extracts. (Niederberger V, Valenta R.
Exp.RevVaccines.2006Feb;5(1):103-10.)
With the aim evaluate the efficacy of SIT in patients with SAR we
selected 25 patients with ragweed sensitization. The patients were divided
into two groups. 10 patients of 1 group were treated with modified SIT by
Na-DNA salt and 15 patients of the 2 group - SIT with the same allergen
and placebo (dilutant).
Methods: Microscopy of nasal smears, ELISA, blood tests, skin prick test,
intradermal tests, immunologic examinations and tests: (CD3,CD4,CD8,
T1.
Parameter Result relative
group 1 value MTm
Result absolute
group 1 value MTm
Result relative
group 1 value MTm
Result absolute
group 1 value MTm
CD3 57.5T3.2 1.01T0.13&109 56.6T2.49 0.94T0,17&109
CD4 34.3T1.55 0.52T0.05&109 33.7T1.1 0.57T0.02&109
CD8 20.4T0.1* 0.35T0.01&109 18.6T0.2* 0.32T0.03&109
CD16 5.2T3.41* 0.14T0.12&109 4.47T1.15* 0.08T0.06&109
CD3, CD25 3.6T0.85 0.06T0.02&109 2.7T0.72 0.04T0.01&109
CD3, CD95 5.2T1.2 0.08T0.03&109 7.2T0.9 0.09T0.02&109
CD3, HLA-DR 3.7T1.1 0.06T0.07&109 6.2T1.7 0.10T0.03&109
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CD16,CD20,CD3;CD95,CD3; HLADR,NST,IgA,IgMIgG,IgE,Th1,Th2).
All groups were treated with combinations of sublingual and intranasal
mucosal SIT using allergens dilutions beginning from 1:1,000,000 then
1:000,000 then 1:10,000 in doses of 0.1-0.2-0.4-0.8ml daily then 1:1000
given at the same doses 2 times per week; followed by 1:000 and 1:10
in doses of 0.1-0.2-0.3-0.4-0.5-0.6-0.7-0.8-0.9ml one a week until a dose
of 0.1 of pure allergen was reached as the maintain dose given one a
month.
Results: We stopped treatment for the period of seasonal manifestations and
examined patients again. After comparing results in turned out that the
patients overcame the therapy better in the 1 group. The cases of nasal
congestion and ocular irritation during treatment were in the 1 group in 0.1%
and in 1.2% of patients in the 2 group. No cases of systemic reactions were
fixed. The average number of eosinophilic cells in nasal smears in the period
of seasonal manifestations was less in the patients of the 1 group (68% in the
1 group and 95% in the 2 one). Patients of the 1 group noted that severity of
symptoms and need in additional medication was less then during previous
years and patients in the second group did not noticed major changes. The
immune system tests showed changes towards Th1 response.
Conclusion: We can speculate that these positive changes in immune system
of the patients of the 1 group could be the response of lymphoid tissue to the
modified allergen stimulation during SIT and the anti-inflammatory effect
that lead to better overcoming of the treatment. This shows the benefit of
using of modified allergen SIT with Na-DNA salt.
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Metanalisis of the efficacy of sublingual immunotherapy in
asthma in pediatric patients, 3 to 18 years of age
Martin Penagos1, Giovanni Passalacqua1, Enrico Compalati1, Carlos Baena-
Cagnani2, Socorro Orozco3, Alvaro Pedroza3, and Giorgio Walter Canonica1.
1Allergy & Respiratory Diseases Clinic, Genoa University, Department of
Internal Medicine, Genoa, Italy; 2University of Cordoba, Pediatric Department,
Cordoba, Argentina; 3Allergy Service, National Pediatrics Institute, Mexico
City, Mexico.
Background: Recent studies have documented the efficacy and safety of
sublingual immunotherapy (SLIT) in patients with rhinitis, but the value
of this treatment in asthma is still debated. We evaluated the efficacy of
SLIT in the treatment of allergic asthma in children, by a meta-analysis
of randomized, double-blind and placebo-controlled (DBPC) clinical
trials.
Methods: Electronic databases were searched up to May 31st, 2006, for
randomized, DBPC trials assessing SLIT in pediatric asthma. Effects on
primary outcomes (symptom scores and concomitant use of rescue
medication) were calculated with standardized mean differences (SMD)
using a random-effect model. RevMan 4.2.8 program was used to perform the
metaanalysis and we followed the recommendations of the Cochrane
Collaboration and QUORUM statement.
Results: Seventy three articles were identified and reviewed. Nine studies, all
published after 1990, fulfilled the selection criteria. 441 patients had a final
assessment and were included in the analysis. Two hundred thirty two
patients received SLIT and 209 placebo. The results of the present analysis
demonstrated a relevant heterogeneity due to widely differing scoring
systems. Overall, there was a significant reduction in both symptoms (SMD Y
1.14, 95%CI Y 2.10 to Y 0.18; p = 0.02) and medication use (SMD Y 1.63,
95%CI Y 2.83 to Y 0.44; p = 0.007) following SLIT.
Conclusion: SLIT with standardized extracts reduces both symptom scores
and rescue medication use in children with allergic asthma compared to
placebo.
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Local nasal immunotherapy in allergic rhinitis
Suzan Hosny. Ainshamsuniversity, Immunotherapy, Cairo, Egypt.
Background: To assess the clinical efficacy & safety of local nasal
immunotherapy &comparing it with other routes of immunotherapy in
allergic rhinitis patients.
Methodology: 1000 patients from 6 egyptian governorates were included in
this study.
Results: Skin tests showed significant improvement after local nasal
immunotherapy as well as blood, nasal& sputum eosinophilia were all improved
also totel ige & nasal symptoms before & after local nasal immunotherapy.
Conclusion: Local nasal immunotherapy showed very good efficacy, safety
& a more convenient allergen delivery in pts. With allergic rhinitis also sim-
plified, self adminstrable, method with reduction of local nasal symptoms.
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Efficacy and safety of sublingual immunotherapy with high dose
blomia tropicalis extract in children with allergic respiratory
disease: comparison study with drugs
Bashir Omarjee, Bernard Tanguy, and Ahmad Zaidou. Centre Hospitalier
Departemental, Service de Maladies Respiratoires, Saint Denis, Reunion.
Background: Sublingual immunotherapy (SLIT) might become a viable
alternative to drug in the treatment of airway allergies. The aim of this study
was to evaluate,in a pediatric population monosensitized to Blomia Tropicalis
mites, the clinical efficacy and safety of high dose SLIT in comparison with
drug treatment (antihistamines plus $ 2 agonists).
Methods: 97 children:52 males and 45 females with a mean age of 9.4 years,
range 7 to 13 years, were included in the study. Of them 49 were treated with
T1.
Study N. patients Asthma symptoms
score SLIT(SD)
N. patients Asthma symptoms score
PLACEBO(SD)
Weight % SMD (95% CI)
Caffarelli 23 2.39 (0.50) 20 4.60 (0.73) 10.64 -3.51 (-4.50;-2.53)
Ippoliti 17 1.29 (0.77) 39 3.15 (0.66) 11.47 -2.57 (-3.14;-1.99)
Tari 30 6.00 (1.62) 28 9.44 (0.96) 11.25 -2.53 (-3.23;-1.03)
Niu 49 0.04 (0.01) 48 0.06 (0.02) 11.68 -1.26 (-1.70;-0.82)
Pajno 12 2.50 (0.14) 9 6.60 (4.88) 10.69 -1.24 (-2.20;-0.28)
Hirsch 11 0.17 (0.30) 10 0.42 (0.58) 10.89 -0.53 (-1.40;0.35)
Rolinck-Wernighaus 20 2.54 (5.00) 19 2.50 (5.06) 11.38 0.01 (-0.62;0.64)
Bachecilier 7 0.42 (0.45) 7 0.29 (0.26) 10.46 0.33 (-0.73;1.39)
Vourdas 33 0.11 (0.08) 29 0.05 (0.02) 11.55 0.99 (0.46;1.52)
Chi2=144.10,df=8
(pG0.00001);I2=94.4%;z=2.32(p=0.02)
232 209 100 -1.14 (-2.10;-0.18)
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SLIT while 48 with the above mentioned drugs. Allergen extracts Blomia
Tropicalis from STALLERGENES namely STALORAL T.M were used.
Patients with severe persistent asthma, poliallergies and vernal conjunctivitis
were excluded. After the 3 week-induction period, the patients were kept on a
daily extract dosage of 20 drops of 300 IR/ml for another 21 weeks. The
cumulative dose came to about 41654 IR. Clinical efficacy was assessed
using symptom and medication scores.
Results: A gradual reduction in daily rhinitis/asthma scores was observed in
SLIT group (P G 0.001). In only 3 patients,out of 49, it was necessary to
employ antihistamines and in 7 out of 49 salbutamol. Also the symptoms
score was statistically lower (P G 0.01). The clinical efficacy was higher in
patients with mild/moderate persistent asthma. No patient showed local or
systemic side effects of any relevance. Local adverse reactions were oral
pruritus, gingivitis and aphthas.
Conclusion: In this study on patients with single sensitization to Blomia
Tropicalis allergen suffering from allergic respiratory disease, the SLIT
improves the allergic symptoms to a greater extent than drug treatment. SLIT
even at ultrahigh doses was safe and well tolerated.
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Immunological characterization of recombinant lactobacillus
plantarum expressing Bt5 major allergen protein
LM Liew1, CH Huang1, SV Seow1, Ying Ding1, HM Wen1, IC Kuo2, and
KY Chua1. 1National University of Singapore, Department of Peadiatrics,
Singapore, Singapore; 2A*STAR, Singapore Institute for Clinical Sciences,
Singapore, Singapore.
Background: Sensitivity to Blomia tropicalis (Bt) accounts for more than
50% of the incidence of mite allergy in the tropical regions and Bt5 is a major
Bt allergen. In recent years, numerous studies have suggested that
recombinant probiotics could be effective in primary prevention and
management of allergic diseases. The long term objective of this study is
to develop recombinant lactobacilli expressing dust mite allergen for clinical
application.
Methods: Bt5 gene was inserted into an expression vector pSIP412
containing a strong inducible promoter PorfX. Lactobacillus plantarum was
electrotransformed with pSIP412 vector carrying Bt5 gene and designated as
Lp-Bt5. Murine bone marrow-derived dendritic cells (BM-DCs) were pulsed
with heat-killed Lp-Bt5 overnight. The cell surface molecule expression and
cytokine production of the pulsed-DCs were examined by flow cytometry and
ELISA. The antigen presenting function of the pulsed BM-DCs were
analysed by co-culturing with Bt5-specific Th2 cell lines. In vivo study of
Lp-Bt5 was performed in C57BL/6 mice fed with the live Lp-Bt5 for three
consecutive days per week over three weeks duration. Sera and splenic
culture supernatants were collected for antibodies and cytokines analysis by
ELISA.
Results: High level of recombinant Bt5 expression was achieved in Lp-Bt5
upon induction using 50ng/ml sakacin P inducing peptide. After 4 hours
induction, approximately 406g of Bt5 protein was expressed by 109 cfu live
Lp-Bt5. Lp-Bt5-pulsed BM-DCs showed upregulation of CD86 and MHCII
with production of IL-10, IL-12 and TNF-alpha. Lp-Bt5-pulsed DCs were
capable of inducing cell proliferation but suppressing Th2 cytokines
production by the Bt5-specific Th2 cells. In contrast the wildtype-Lp-pulsed
DCs, in the presence of exogenous Bt 5 protein, induced both cell
proliferation and Th2 cytokine production by the Bt5-specific Th2 cells. In
vivo studies showed that the splenocytes of the mice fed with live LAB-Bt5
produced IL-5, IL-6, IL-10, INF-gamma and TNF-alpha upon stimulation
with Bt5 protein. 25% of the fed mice produced detectable levels of Bt5-
specific IgG1.
Conclusion: Recombinant lactobacilli expressing Bt5 allergen is potentially
useful for the modulation of allergen-specific T cells. Further studies are
required to assess its application in the prevention and treatment of allergic
diseases.
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Role of allergen specific Immunotherapy in allergic bronchial
asthma due to Sorghum Vulgare pollens
Sanjay Pawar. Shriratna Intensive Care & Hospital, Chest Medicine, Karad
(Satara) Mah, India.
Introduction: Immunotherapy for specific allergy is extensively used as
definitive therapy for bronchial asthma and it is suppose to be only disease
modifying treatment. In our area, Sorghum Vulgare crop is extensively
cultivated and lot many patients are having allergic manifestation during
pollination.
Aim: To find out role of sorghum Vulgare pollens in causation of bronchial
asthma with reference to pulmonary function test and also Study effect of
allergen specific Immunotherapy in comparison with pharmacotherapy.
Methodology: Prospective, comparative, Cohort study was planned.
Sorghum Vulgare pollens are collected and analyzed. For SV pollens
SDS page electrophoresis and ELISA_ inhibition assay done and 14Y100 kDa
proteins are separated. The SVextract was highly immune reactive and require
approximately 7 ng of proteins for 50% inhibition of specific IgE binding in
asthma. Immunoblot identified 8 allergenic brands of which 5 proteins (MWs
94,70, 40, 35, and 14 kDa) recognized by more than 90% of serum samples of
SV pollen sensitive patients. Skin test were done with Modified skin prick test
technique. Histamine diphosphate is used as positive control while buffered
saline is used as negative control. Testing is performed on forearm.
Immunotherapy of above extracts was given by subcutaneous route. Effect
of Immunotherapy was studied for 659 patients.
Results: Short term (4mth) improvement in clinical symptoms and pulmonary
function test (FEV1,PEFT,FVC,FEF25Y 75) is observed. Eleven percent
patient (n=4) showed improvement with immunotherapy and 86% (n=13) with
Pharmacotherapy. But long term (3yrs) improvement observed in 47% (n=17)
with immunotherapy and 20% with pharmacotherapy.
Conclusion: MWs 94, 70, 40, 35, and 14 kDa proteins are recognized in
sorghum vulgare sensitive patients. Allergen specific immunotherapy is
helpful in long term management allergic bronchial asthma due to sorghum
Vulgare pollens.
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Antigenicity prediction in melittin: approach for fragment based
peptide drug development from Apis dorsata
Virendra Gomase1, and Ganesh Vankhede2. 1Department of Bioinformatics,
MGMs, College of Computer Science and Information Technology, Nanded,
431605 MS, India, Bioinformatics, Nanded, India; 2Department of Zoology,
Sant Gadge Baba Amravati University, Zoology, Amravati, India.
The bee venom is used for treating a wide variety of conditions
from acute tendonitis to chronic back pain to rheumatoid arthritis
(RA). In this assay we found peptide nonamers from melittin pro-
tein of Apis dorsata, which can be used to select for use in rational
vaccine design and to increase the understanding of roles of the im-
mune system in allergic reactions. For development of MHC peptide
binder_s prediction, an elegant machine learning technique support
vector machine (SVM) method has been used. Antigenic epitopes on
melittin protein of A. dorsata are important determinants of protec-
tion against Rheumatoid Arthritis. As our knowledge of the immune
responses to a protein antigen progressed, it became clear that the
whole protein is not necessary for raising the immune response, but
small peptide fragments 4-AILKVLSTGLPALIS-18 of protein called
the antigenic determinants or the epitopes are sufficient for eliciting
the desired immune response. We also found peptide nonamers,
which are from a set of aligned peptides known to bind to a given
major histocompatibility complex (MHC) molecule as the predictor
of MHC-peptide binding. MHCII molecules bind peptides in similar
yet different modes and alignments of MHCII-ligands were obtained
to be consistent with the binding mode of the peptides to their MHC
class, this means the increase in affinity of MHC binding peptides
may result in enhancement of immunogenicity of melittin protein.
Predictions of binding affinity antigen peptides to MHC class I & II
molecules are important in vaccine development from A. dorsata.
Key words: Melittin, SVM, MHC, Secondary structure, Hydro-
phobicity, Hydrophilicity.
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Study of MHC nonamers and TAP activity of tertiapin from Apis
mellifera
Ganesh Vankhede1, Virendra Gomase2, and Nandkishor Chikhale3. 1Depart-
ment of Zoology, Sant Gadge Baba Amravati University, Amravati, Zoology,
Amravati, India;
2
Department of Bioinformatics, MGMs, College of
Computer Science and Information Technology, Bioinformatics, Nanded,
India; 3Principal, Shri. Shivaji College of Agriculture Sciences, Biotechnol-
ogy, Amravati, India.
Tertiapin is a neurotoxin from the honeybee venom. It inter-
acts specifically with calmodulin in the presence of Ca2+. Antigenic
epitopes on tertiapin protein of Apis mellifera (honey bee) is
important determinants sites for protection against disorders. This
assay we found peptide nonamers from tertiapin protein, which can
be used to select for use in rational vaccine design and to increase the
understanding of roles of the immune system in infectious diseases.
For development of MHC peptide binder_s prediction, an elegant
machine learning technique support vector machine (SVM) method
has been used. SVM has been trained on the binary input of single
amino acid sequence. In this analysis, we predicted the binding affinity
of tertiapin protein having 21 amino acids. We found the MHCII-IAb
peptide regions 7-RIIIPHMCW, 13-MCWKKCGKK, 10-
IPHMCWKKC, 11-PHMCWKKCG, (optimal score is 0.318);
MHCII-IAd peptide regions 3-CNCNRIIIP, 4-NCNRIIIPH, 5-
CNRIIIPHM, 6-NRIIIPHMC, (optimal score is 0.202); MHCII-IAg7
peptide regions 7-RIIIPHMCW, 9-IIPHMCWKK, 4-NCNRIIIPH, 8-
IIIPHMCWK, (optimal score is 0.805); and MHCII- RT1.B peptide
regions 1-ALCNCNRII, 13-MCWKKCGKK, 9-IIPHMCWKK, 11-
PHMCWKKCG, (optimal score is j0.730) which represented
predicted binders from tertiapin from Apis mellifera protein. These
peptide nonamers are from a set of aligned peptides known to bind to
a given major histocompatibility complex (MHC) molecule as the
predictor of MHC-peptide binding. MHCII molecules bind peptides
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in similar yet different modes and alignments ofMHCII-ligandswere
obtained to be consistent with the binding mode of the peptides to
their MHC class, this means the increase in affinity of MHC binding
peptides may result in enhancement of immunogenicity of tertiapin
protein. Predictions of binding affinity antigen peptides to MHC
class I & II molecules are important in vaccine development from
Apis mellifera.
Key words: Tertiapin, MHC, SVM, immune response.
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Systemic adverse events during rush Hymenoptera venom
immunotherapy (VIT) in relation to pretreatment methods
Krzysztof Specjalski, Lucyna Gorska, Marta Chelminska, Krzysztof Kuziemski,
Marcin Skrzypski, Marek Niedoszytko, Iwona Damps-Konstanska, Amelia
Szymanowska, Alicja Sieminska, Beata Wajda, Adrianna Drozdowska,
Katarzyna Lewandowska, and Ewa Jassem. Medical University of Gdansk,
Department of Allergology, Gdansk, Poland.
Background: Impact of H-receptors blockers on the safety profile during rush
Hymenoptera VIT is still relevant issue.
Objective: Evaluation of the frequency of systemic adverse events during rush
Hymenoptera VIT in patients pretreated either with solely H1-receptors
blockers or with combination of H1 and H2 - receptor blockers.
Methods: The initial phase was conducted according to 5-day rush protocol
with the use of standardized venom allergens of wasp or honeybee. All patients
were pretreated with either H1-receptor blocker (30mg cetirizine) or
combination of H1 and H2 - receptor blockers (30mg cetirizine + 300mg
ranitidine).
Results: The study group comprised 145 patients including 112 patients
receiving wasp venom and 33 - bee venom. 100 patients were pretreated with
H1-receptor blockers, 45 - with the combination of H1 and H2 - receptor
blockers During rush Hymenoptera VIT systemic adverse events occured in
22 patients (15,1%), more frequently in the group receiving bee than wasp
venom (24,2% vs. 12,5%), however the difference was not significant. Higher
percentage of systemic adverse events was observed in the subjects pretreated
with both H1 - and H2-receptor antagonists (24%) than in those pretreat-
ed with H1-blocker only (11%), pG0,05.
Conclusion: Considerable number of systemic adverse events, especially in
the group receiving H2 blockers requires particular attention during rush
Hymenoptera VIT.
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Hymenoptera venom specific immunotherapy in patients with
systemic mastocytosis
Patrizia Bonadonna1, Roberta Zanotti2, Luca Castellani3, Beatrice Caruso4,
Annarita Dama1, Gianenrico Senna1, and Giovanni Passalacqua5. 1Verona
General Hospital, Allergy Service, Verona, Italy; 2University of Verona, Dept.
of Clinical & Experimental Medicine, Verona, Italy; 3Rovereto Hospital, Dept.
of Dermatology, Rovereto, Italy; 4Verona General Hospital, Lab. of Clinical
Chemistry & Haematology, Verona, Italy; 5University of Genoa - Dept. of
Internal Medicine, Allergy & Respiratory Diseases, Genoa, Italy.
Background: The indication to specific vaccination in patients with
hymenoptera allergy and concomitant mastocytosis is still a matter of debate,
since severe adverse reactions have been described.
Methods: We treated with immunotherapy 16 patients with systemic
mastocytosis. All had positive bone marrow biopsy and elevated serum
tryptase and 3 of them had also positive skin biopsy for urticaria pigmentosa.
All the patients (12 male, mean age 51.8 years) have had severe adverse
reactions following hymenoptera stinging (Grade IVaccording to Mueller). Of
them, one was allergic to bee, 7 to polistes dominulus and 8 to jellow-jacket.
Theywere vaccinatedwith a slow-induction protocol (7-week induction phase).
Results: Only one patient had systemic urticaria in the updosing phase, that
was easily controlled slowing the escalation and giving antihistamine
premedication. No adverse event was recorded in the maintenance phases
with 100 mcg venom. Nine patients were re-stung while on maintenance.
Five had only a mild local reaction, two were stung by a different insect
without reaction and two had a grade III reaction. In these subjects the
maintenance was escalated to 200 mcg and after further re-sting they had no
more reaction.
Conclusion: Despite the relative rarity of systemic mastocytosis, hymenoptera
venom hypersensitivity can provoke life threatening reactions in those patients.
Based on our experience, specific immunotherapy with a slow induction is safe
and can lead to an relevant, although not complete, clinical improvement
Key words: Systemic mastocytosis, hymenoptera allergy, specific
immunotherapy
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A modified latex hevein (Hev b 6.02) retains lymphocyte
proliferation response
Christine Hafner1, Stefan Wagner2, Joanna Jasinska3, Dorothee Allwardt2,
Ursula Wiedermann3, and Heimo Breiteneder2. 1Medical University of
Vienna, Department of Dermatology, Vienna, Austria; 2Medical University of
Vienna, Department of Pathophysiology, Vienna, Austria; 3Medical Uni-
versity of Vienna, Department of Spec. Prophylaxis and Tropical Med.,
Vienna, Austria.
Rationale: We designed a hypoallergenic Hev b 6.02 peptide by changing all
cysteine residues to serine residues with the goal to produce a standardized
specific immunotherapy reagent.
Methods: Sera of 24 latex allergic patients with confirmed IgE reactivity to
MBP-rHev b 6.02 were tested for their IgE binding capacity to the modified
hevein peptide by ELISA. BALB/c mice were vaccinated either with this
modified Hev b 6.02 peptide alone or coupled to tetanus toxoid. The antibody
responses of these mice to natural Hev b 6.02 were analyzed by immunoblot
and to MBP-rHev b 6.02 by ELISA. Cytokine production was tested in spleen
cell cultures of immunized BALB/c mice.
Results: The Hev b 6.02 peptide showed markedly decreased IgE binding
(9/24) of latex allergic patients’ sera. Immunization with each of the
modified Hev b 6.02 peptide formulations induced Abs that cross-reacted
with the natural and the recombinant Hev b 6.02. Uncoupled Hev b 6.02
peptide induced lymphocyte proliferation and Th1 (IL-2, INF-+) cytokine
production in spleen cell cultures indicating that this peptide was able to
induce a Th1 biased T-cell response. Tetanus toxoid coupled modified Hev
b 6.02 peptide revealed high titers of IgG, mainly of the IgG2a subclass, to
MBP-rHev b 6.02.
Conclusion: The ablated allergenicity but retained lymphozyte proliferation
capacity of the Hev b 6.02 peptide showed that such a reagent can induce a
Th1-biased immune response that is also directed against the major latex
allergen Hev b 6.02.
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Clinical efficacy and CXCR3 - CCR3 modulation by parietaria
immunotherapy
Laura Guerra, Anna Maria Riccio, Ilaria Baiardini, Cinzia Gamalero, Chiara
Folli, Desideria Descalzi, Antonio Scordamaglia, Anthi Rogkakou, Enrico
Compalati, Pierangela Massacane, Giovanni Passalacqua, and Giorgio Walter
Canonica.University ofGenoa,Allergy andRespiratoryDiseases,Genoa, Italy.
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Background: It is well known that allergen immunotherapy modifies the
peripheral immunoglobulin profile down-regulating the Th2 cytokines.
Notably CCR5 and CXCR3 are found on Th1 cells, CCR3 and CXCR4 on
Th2 cells. Aim of the present study was to identify an immunological marker
that correlates with the clinical effects among CXCR3, CCR3, CXCR4, CCR5
expression on PBMC.
Materials and Methods: 18 patients were enrolled according to the following
criteria: moderate/severe rhinoconjunctivitis, moderate asthma since at least 2
years, sensitization to Parietaria only, age between 18 and 55 years, no
previous immunotherapy. After a one-week run-in period where an optimal
asthma therapy was prescribed, patients were received either SLIT to parietaria
(SLIT-ONE Alk-abello`) or drug treatment for rhinitis. Control visits were
carried out at 1, 2, 6, 10 and 16 weeks (follow-up visit). Quality of life was
evaluated with a validated questionnaire (Rhinasthma).
The immunological parameters assessed were: PBMC proliferation
with specific allergen Par-j1, detection of CD4, CD8, CD3 and chemokines
receptors CCR3, CXCR3, CXCR4, CCR5 before and after stimulation with
Par-j1
Results: The symptom scores decreased in the control group since the first
week of study whereas in the SLIT group a significant improvement versus
baseline was seen after 6 weeks of treatment. Starting from 6 weeks there was
no more difference in total symptom scores between the two groups. Quality of
life significantly improved in the SLIT group if compared with controls from
week 6. After 6 weeks SLIT group significantly decreased in drug doses for
asthma treatment whereas no statistical difference in therapy dosage was seen
in the control group until week 6 the SLIT group had a significant higher use of
rescue medication if compared with control group after week 6 the uptake of
rescue medications had an inverse trend with statistically significant higher
intake in the control group. In the same period there was a decrease in CCR3
and an increase of CXCR3 in treated group these variations became significant
at the end of the study from the baseline. No difference in CD4, CD8, CD3,
CXCR4, CCR5 expression.
Conclusions: This study demonstrates efficacy SLIT when compared to
conventional therapy for persistent asthma and rhinitis, correlations between
clinical scores and both CXCR3 and CCR3 seen after 6 weeks of
immunotherapy in treated patients demonstrate an immunological shift
towards Th1 lymphocyte pattern.
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Prediction of antigenic MHC binders of neurotoxin M14 protein
from Buthus eupeus
Virendra Gomase1, Nandkishor Chikhale2, and Ganesh Vankhede3. 1Depart-
ment of Bioinformatics, MGMs, College of Computer Science and
Information Technology, Nanded, 431605 MS, India, Bioinformatics,
Nanded, India;
2
Department of Biotechnology, Sant Gadge Baba Amravati
University, Biotechnology, Amravati, India; 3Department of Zoology, Sant
Gadge Baba Amravati University, Zoology, Amravati, India.
The new paradigm in vaccine design is emerging, following
essential discoveries in immunology and development of new major
histocompatibility complex (MHC) Class-I binding peptides predic-
tion tools. In this we analyzed MHC binders of neurotoxin M14 pro-
tein from Buthus eupeus [Lesser Asian scorpion] are important
determinant of protection against cardiovascular disorder. Buthus
venom was tested in vivo in anaesthetized rats and in vitro on isolated
cardiac and skeletal muscle preparations. In vivo, the venom caused
marked rhythmical fluctuations in blood pressure preceding cardiovas-
cular collapse and death. Scorpion toxins constitute a family of homol-
ogous proteins that exert potent pharmacological effects on potassium
or sodium ion channels. In this analysis, we predicted the binding af-
finity of B. eupeus protein neurotoxin M14 having 66 amino acids. We
found the fragments peptide regions 8-DDRNCVYTCALNPYCDS-
24 of protein called the antigenic determinant or the epitope is
sufficient for eliciting the desired immune response. The predicted
binding affinity is normalized by the 1% fractil. The MHC peptide
binding is predicted using neural networks trained on C terminals of
known epitopes. In analysis predicted MHC/peptide binding is a log-
transformed value related to the IC50 values in nM units. Predicted
MHC binding regions acts like red flags for antigen specific and
generate immune response against the neurotoxin M14 antigen. So a
small fragment of antigen can induce immune response against whole
antigen. This theme is implemented in designing subunit and synthetic
peptide vaccines. The sequence analysis method is allows potential
drug targets to identify active sites against venom action. The method
integrates prediction of peptide MHC class I binding; proteosomal C
terminal cleavage and TAP transport efficiency.
Key words: Neurotoxin-M14, MHC, TAP, hydrophobicity, hydrophilicity
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Birch pollen allergic patients undergoing allergen specific
immunotherapy also respond to minor allergen Bet v 2
Morten Svenson1, Uffe Bodtger1, Lars K Poulsen1, Mercedes Ferreras2, and
Jorgen N Larsen2. 1National University Hospital, Institute for Inflammation
Research, Copenhagen, Denmark; 2ALK-Abello, Research, Horsholm,
Denmark.
Background: Levels of allergen specific IgE are relatively unaffected by
allergen specific immunotherapy (SIT), whereas levels of allergen specific IgG
is markedly increased. The effect on antibodies to minor as compared to major
allergens is not clear. In this study antibodies towards Bet v 1 and Bet v 2 of
Betula verrucosa were investigated in sera of SIT treated patients.
Methods: Specific IgE was bound to monoclonal anti-IgE coupled to
paramagnetic beads and measured by the binding of 125I labelled purified
natural Bet v 2 and recombinant Bet v 1.2801, respectively. IgE depleted
serum was tested for specific IgG and following incubation with the labelled
allergen, free and bound allergen were separated by protein G affinity
chromatography. Sera were tested in immunoblotting with or without
absorption using 1 mg birch pollen extract per serum sample.
Results: All sera (n=50) were positive for IgG and IgE against Bet v 1 before
and after SIT. The relative binding activities of IgG compared to IgE were up to
30 times higher after SIT. In contrast, 22% of non-treated patients were
positive for IgE anti-Bet v 2 and 48% for IgG anti-Bet v 2. At 1.5 years of SIT,
the prevalence of IgG- and IgE-anti-Bet v 2 was unchanged, however, after 5
years of treatment, the prevalence of IgG anti-Bet v 2 was 91% but the
prevalence of IgE anti-Bet v 2 was unchanged when analysed by quantitative
immunoassay. Contrary to this observation, 3 sera became IgE anti Bet v 2
positive after 5 years of treatment when measured by immunoblotting.
Conclusion: The dominant binding activity against Bet v 1 and Bet v 2 in sera
from birch pollen allergic patients both before and after SIT resides in the IgG
fraction. Prolonged SIT treatment induced IgG against minor allergen Bet v 2
in most individuals. New IgE reactivities to Bet v 2 were observed after SIT in
3 patients by immunoblotting, however, this result was not confirmed by
quantitative solid phase immunoassay and may possibly indicate differences in
assay sensitivity with respect to denaturation insensitive epitopes.
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Development and characterization of allergen-specific
monoclonal antibodies and their inhibitory effects on allergic
patients_ IgE binding to the major birch pollen allergen Bet v 1
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Anna Gieras1, Petra Cejka2, Margarete Focke-Tejkl1, Birgit Linhart1, Otto
Majdic2, and Rudolf Valenta1. 1Medical University of Vienna, Department of
Pathophysiology, Vienna, Austria; 2Medical University of Vienna, Depart-
ment of Hygiene and Medical Microbiology, Vienna, Austria.
The induction of allergen-specific antibodies which inhibit the
IgE recognition of allergens is a major mechanism underlying
allergen-specific immunotherapy. In order to develop therapeutic
antibodies for the treatment of allergy to birch and related allergen
sources, we immunized mice with surface-exposed peptides derived
from the major birch pollen allergen Bet v 1 and established 14
hybridomas secreting peptide-specific mouse monoclonal IgG1
antibodies. When tested for interference with allergic patients_ IgE
by ELISA competition experiments, Bet v 1-specific monoclonal
antibodies inhibited polyclonal serum IgE reactivity of allergic
patients (n=44) to Bet v 1 and Bet v 1-homologous allergens between
60Y70%. After humanization, the described Bet v 1-specific
monoclonal antibodies may be used for passive vaccination or local
therapy of birch pollen allergy.
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Differences in specific cutaneous sensitivity between allergic
patients treated with dermatophagoides pteronyssinus
depigmented and glutaraldehyde polymerised extracts, non-
chemically modifed, and treated only with pharmacotherapy
Magdalena Lluch, Alfonso Malet, Pau Amat, Estrella Llamas, Mariela Dall ’
Aglio, Marcia Dias, and Casanovas Miquel. Al.Lergo Centre, Clinica,
Barcelona, Spain.
Background: The evolution of skin sensitivity is one of the objective tolols to
evaluate the efficacy of specific immunotherapy.
Objective: To compare the evolution of the cutaneous sensitivity of allergic
patients with rhinoconjunctivitis with or without asthma due to hypersensi-
tivity against D. pteronyssinus, treated with vaccines containing standardized
extracts of this mite (alum adsorbed depigmented and polymeryzed -modified-
or non-modified extracts -retard-) or only with pharmacological treatment.
Materials and Methods: It was conducted an open and controlled clinical
trial with 3 groups of patients. These patients received at random the modified
(n=21), the retard (n=21) or only pharmacological treatment (n=7). After an
initial wash-out period, and before receiving inmunotherapy, there were skin
prick testeds in duplicate, on the volar surface of the forearm using the same
batch of native D. pteronyssinus extract at 0.002, 0.02, 0.2 and 2 mg/ml. The
vial of maximum concentration had a potency of 100 HEP/ml and contained
40.70 mg of Der p 1/ml and 17.22 of Der p 2. These tests were repeated
after 6 and 12 months of treatment (end of study). The results were expressed
as the 10 HEP value (quantity of allergen extract that produces a wheal of
the same size as the wheal produced by histamine HCl 10mg/ml).
Results: The patients treated with the modified preparation needed to obtain
the 10 HEP value 0.233 mg at baseline, 0.508 mg after 6 months of treatment,
and 1.1 mg at the end of the study (P=0.008). In the group of patients treated
with the retard preparation the values were 0.328, 0.436, 0.880 mg,
respectively (p=0.037). The control group experienced an increase on the
cutaneous sensitivity (0.220, 0.188 y 0.115 mg, respectively), however the
difference was not significant (P=0.513).
Conclusion: This open and controlled clinical study demonstrates that the
patients sensitized against D. pteronyssinus and treated with specific
inmunotherapy experienced a highly significant reduction on cutaneous
sensitivity, being the group treated with the vaccine containing the modified
extract the first in presenting improvement (after 6 months of treatment),
whereas the patients treated with the retard experienced improvement after 12
months. The patients not treated with inmunotherapy did not show reduction
on the specific cutaneous sensitivity.
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Safety evaluation of a fast build-up schedule of immunotherapy
using therapeutic vaccines containing depigmented and
glutaraldehyde polymerised allergen extracts
Alfonso Malet1, Magdalena Lluch1, Pablo Amat1, Estrella Llamas1, Isabel
Garcia1, and Miquel Casanovas2. 1AlILergo Centre, Clinica, Barcelona,
Spain; 2Laboratorios Leti, L, Madrid, Spain.
Background: Various administration schedules of immunotherapy have been
reported to be beneficial for the treatment of inhalant allergy: conventional,
cluster and rush. The use of therapeutic vaccines containing modified allergen
extracts (depigmented and glutaraldehyde polymerised), in which the
allergenicity is decreased, and the immunogenicity maintained, allows to
reach the maintenance dose using conventional schedules with few
administrations in a very short period of time. The objective was to evaluate
the safety of a very short build-up phase using these hypoallergenic vaccines
containing standardised modified allergen extracts.
Materials and Methods: One hundred and nine patients (56 female and 53
male, mean age 29.7 years) with rhinoconjunctivitis and/or asthma, sensitised
to mites and/or pollens were included in an observational cohort study. All of
them received an individualised therapeutic vaccine containing depigmented
and glutaraldehyde polymerised allergen extract. The patients reached the
maximum dose after 2 injections of the vial of maximum concentration (0.2 as
the first dose the first day and 0.5 ml as the maintenance dose after 1 week,
followed by 0.5 ml after 1 month). The tolerance was assessed by recording all
side reactions related to immunotherapy, which were classified according to
the criteria of the EAACI.
Results: The total number of injections was 327. All patients reached the
maximum recommended dose the first week. No premedication with drugs
was used before the administration of the immunotherapy. Eight reactions
(2.44 % of the total injections) were recorded, 7 local and 1 systemic. The 7
local reactions consisted of 3 immediate (diameter 9 5 cm) and 4 delayed
(diameter 9 10 cm). One systemic reaction of grade 2 was reported. This
reaction consisted in a slight urticaria that resolved with treatment with
antihistamines (ebastine).
Conclusion: The therapeutic vaccines containing chemically modified
extracts can be safely administered using a fast schedule in an immunotherapy
unit, reaching the maximum dose the first week with 2 injections and without
the need of premedication and/or hospitalisation.
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The influence of different application forms of allergen
immunotherapy on the level of allergen specific IgG antibodies in
patients with grass pollen allergy
Ctirad Andrys, Irena Krcmova, Marcela Drahosova, and Yvona Hanzalkova.
University Hospital, Institute of Clinical Immunology and Allergology,
Hradec Kralove, Czech Republic.
Background: Allergen immunotherapy (AIT) is the only therapeutic approach
in the treatment of IgE mediated allergies which is targeting immunopatho-
genetic process. Allergen could be administered in several application forms
preferentially subcutaneously or sublingually. It is difficult task to follow the
efficacy of this immunomodulation. The aim of study is comparison of
influence of two different routes of application of immunotherapy on the
serum level of allergen - specific IgG and IgG4 antibodies.
Methods: Together 62 patients (31 male, 31 female) with grass pollen allergy
were enrolled. Allergen immunotherapy by subcutaneous injection (Phostal,
Stallergenes) was administered to 21 patients. Allergen immunotherapy in the
form of sublingual capsules (Staloral, Stallergenes) was administered to 18
patients. 23 patients were treated symptomatically during pollen season. The
blood samples were collected before the start of therapy (January, 2003), and
after 12, 24 and 36 months of treatment. The serum level of specific IgG and
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IgG4 antibodies against immunodominant allergen (timothy grass) was
evaluated by diagnostic kit (Dr.Fooke, Germany).
Results: No significant differences were found between groups of patients
before start of allergen immunotherapy in any parameter tested. There is
statistically significant increase in allergen specific IgG in both groups of
patients after one year therapy (both pG0.0001) and after 3 years of therapy
(both pG0.0001). Statistically significant increase was found in allergen
specific IgG4 in both groups of patients after 3 years of therapy (subcutaneous
group p=0.0007, sublingual group p=0.042). There is statistically significantly
higher level of allergen specific IgG and IgG4 (both pG0.0001) after 3 years of
therapy in patients treated by subcutaneous form of allergen immunotherapy in
comparison with patients treated by sublingual form of immunotherapy. The
level of allergen specific IgG and IgG4 in control group remains without any
significant change.
Conclusion: The subcutaneous application of allergen immunotherapy results
in strong increase of allergen specific IgG and IgG4 antibodies in comparison
with sublingual administration of immunotherapy.
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Two different application forms of grass pollen immunotherapy -
the changes in the levels of cytokines IL-4 and IFN+ after 36
months of immunotherapy
Irena Krcmova, Ctirad Andrys, Marcela Drahosova, and Jakub Novosad.
University Hospital, Institute of Clinical Immunology and Allergology,
Hradec Kralove, Czech Republic.
Background: Allergen immunotherapy (AIT) is the only therapeutic approach
in the treatment of IgE mediated allergies which is able to target
immunopathogenetic process. Allergen can be administered in several
application forms preferentially by subcutaneous or sublingual route.
Subcutaneous and sublingual forms are differentially interacting with immune
system. Data concerning the comparison of these two forms of application
favour studies with clinical efficacy over laboratory studies.
Aim: Of this study is the comparison of the influence of two different types of
AIT on the serum levels of cytokines IL-4 and IFN+.
Methods: Together 62 patients with grass pollen allergy were enrolled.
Subcutaneous AIT (Phostal) was administered to 21 patients. Sublingual AIT
(Staloral, 100 IR/ml)) was administered to 18 patients, 23 patients were treated
symptomatically. Blood samples were collected before the start of study
(January, 2003), after 12, 24 and 36 months. The serum level of cytokines IL-4
and IFN+ was evaluated by diagnostic kit (Quantikine, RDS).
Results: No significant differences were found between the groups before the
study. There was significant increase of IFN+ only in the group of
subcutaneous AIT after 12 months of therapy (p= 0.016) and after 36 months
(p= 0.0294). The IL-4 demonstrated significant decrease in the group of
subcutaneous AIT after 12 months of therapy (p= 0.022) and in both groups of
AIT after 36 months (pG 0.0001), but comparing to control group only
subcutaneous AIT group reached significance.
Conclusion: The subcutaneous and sublingual applications of AIT after 36
months resulted in the significant decrease of IL-4 in both groups, but decrease
of IL-4 in the subcutaneous group was manifested earlier - after 12 months.
Expecting increase of IFN +was significant only in group of subcutaneous AIT.
Immunomodulation by subcutaneous AIT seems stronger than sublingual AIT,
especially in the first year of the study. For continual sublingual AITare needed
higher concentrations of allergens then 100 IR/ml as maintenance dosage.
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Double blind placebo controlled trial of sublingual monomeric
allergoid in grass pollen allergy
A.G. Palma-Carlos, M. Branco-Ferreira, A.L. Pregal, A.S. Santos, and M.L.
Palma-Carlos. Clinical Allergy Immunology Center, CAIC, Allergology,
Lisbon, Portugal.
Background: Double blind placebo controlled trials of allergy vaccines are
considered the better method to confirm his efficacy. An assay of a sublingual
monomeric allergoid in tablets was done in patients allergic to grass pollens
during 2 years. This monomeric allergoid was obtained by carbamylation of
amino groups (lysine) of allergenic proteins.
Methods: 33 rhinitic patients allergic to grass pollens as confirmed by clinical
history, skin prick tests and specific IgE were included in the trial. Patients
were randomized between placebo and active vaccine both given as sublingual
tablets administered by the sublingual swallow method (LAIS, Lofarma,
Milano, Italy). A traditional posological scheme was used starting with a very
low dose increased progressively in the course of 14 weeks before grass pollen
season. Enrolment of the patients was preseasonal followed by a seasonal visit
in May and a end of the year visit in October. Patients were followed during 2
consecutive years. Nasal provocation tests with the allergens included in the
vaccine was done before treatment and after 1 and 2 years of treatment and
symptom scores registered after each challenge. The use of nasal steroids as
rescue was authorized for rhinorrea, sneezing and conjunctivitis. Symptom
scores for eventual side effects and pharmaceutical scores were registered for
each patient. Informed consent was obtained from all the patients.
Results: Results were evaluated after 1 and 2 years of treatment. Between
vaccines and placebo the score for rhinorrea (pG0,03) sneezing (pG0,03) and
conjunctivitis (pG0,02) was significantly decreased for the second wear of
treatment. Between the first and second years of treatment the scores for
placebo were not changed but for active vaccine, rhinorrea (pG0,03), sneezing
(pG0,03) and conjunctivitis (pG0,02) were significantly decreased. Sympto-
matic score after nasal challenge was decreased (pG0.03) after 2 years
treatment. Nasal steroid consumption were significantly decreased in the active
group during May and June both years of treatment (pG0,02). Only two light
local adverse events were reported in the active group and none with placebo.
Conclusion: Preseasonal treatment with a sublingual monomeric grass pollen
allergoid in tablets improved rhinorrea, sneezing and conjunctivitis and
reduced the steroid consumption. Tolerability was optimal.
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Phleum pratense alone is sufficient for allergen specific
immunotherapy against allergy to Pooideae grass pollens
Charlotte Hejl1, H Ipsen1, J N Larsen2, and N Johansen3. 1ALK-Abello´,
Vaccine Research, HLrsholm, Denmark; 2ALK-Abello´, Scientific Affairs,
HLrsholm, Denmark; 3ALK-Abello´, Serology Research, HLrsholm, Denmark.
Background: The grass family Poales contains more than 10.000 species which
can be divided into subfamilies based on their taxonomy. One of the larger
subfamilies is the Pooideae subfamily also denominated as the temperature
pasture grasses. In spite of the large number of grass species, grass pollen allergic
patients’ IgE show a high degree of cross-reactivity between Pooideae grass
species. Currently, immunotherapy for grass pollen allergy is often performed
with mixtures of grass species. However, high clinical efficacy of grass pollen
immunotherapy (SIT) using Phleum pratense (Phl p) alone has been
demonstrated in several studies. The aim of the study was to investigate the
antibody cross-reactivity towards Phl p and grass pollen extract mixes.
Methods: The amount sIgE reacting with Phl p pollen extract and four
different grass pollen extract mixes was determined in sera from grass pollen
allergic patients. The capacity of Phl p to inhibit the reaction of grass pollen
allergic patients’ IgE towards the four grass pollen extract mixes was
performed using excess inhibitory concentration of non-labeled Phl p extract.
The four mixes each comprised between 5 and 10 Pooideae grass pollen
extract species. Phl p SIT induced IgG4 was measured to Phl p pollen extract,
extracts of nine individual Pooideae grass species and the four grass pollen
extract mixes. All allergen specific antibody assays was performed using an
ADVIA Centaur solid phase immunoassay.
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Results: The correlation between the reaction of IgE towards Phl p and the
four grass pollen extract mixes, irrespective of the number included in the
mixes, is statistical significant (0.96Y0.98, Spearman). Phl p has the capacity to
inhibit the reaction of the patients specific IgE to the four grass pollen extract
mixes indicating a high degree of cross-reactivity of the patients IgE. SITwith
Phleum pratense induces IgG4 which exhibit a statistical significant
correlation (0.92Y0.99, Spearman) in their reaction with the individual nine
Pooideae grass pollen extracts and the four grass pollen extract mixes. Thus,
IgG4 induced by SIT with Phl p cross-react extensively with both single and
mixed grass pollen extracts.
Conclusion: Immunochemical and clinical data together support the
conclusion that Phl p alone is as effective for allergen specific immunotherapy
against allergy to Pooideae grass pollens as any mix or single specie fro the
Pooideae family.
750
Safety of subcutaneous immunotherapy for allergic respiratory
diseases: a prospective study
Gianenrico Senna1, Patrizia Bonadonna1, Maria Angela Crivellaro2, Annarita
Dama1, Carlo Lombardi2, Massimo Schiappoli1, G. Walter Canonica3, and
Giovanni Passalacqua3. 1Verona General Hospital, Allergy Service, Verona,
Italy; 2Ospedale S. Orsola FBF - Brescia, Pneumoallergology, Brescia, Italy;
3University of Genoa - Dept. of Internal Medicine, Allergy and Respiratory
Diseases, GENOA, Italy.
Background: The clinical efficacy of subcutaneous immunotherapy (SIT) in
the treatment of allergic respiratory diseases is well documented, but its main
drawback of is the risk of systemic reactions (SRs). This 3-years prospective
study evaluated the safety of SIT with standardized extracts in real life in
patients with allergic rhinitis and/or asthma.
Methods: Between January 2003 and June 2006 a total of 248 patients (140
male, mean age 31.4 years, range 7Y65) referred to our Allergy Unit were
prescribed SIT for their respiratory diseases. 176 of the patients had seasonal/
perennial rhinitis and 72 asthma with or without rhinitis. Allergen extracts
were all standardized by biological methods (ALK-Abello` and Stallergenes).
204 patients were treated according to a traditional (12 weeks) schedule,
whereas 44 underwent a cluster protocol (7 weeks). Patients were treated for
grass (35%), birch (13%), parietaria (31%), mite (21%). Systemic reactions
(SRs) were categorized into immediate SRs (occurring within 30 minutes) and
late (930 minutes). They were graded in four levels of severity according to
EEACI Immunotherapy Position Paper (0= No symptoms; 1= Non specific
symptoms probably non IgE-mediated; 2= rhinitis/asthma responding
adequately to treatment; 3= non life-threatening SRs, e.g. urticaria,
angioedema or severe asthma; 4= Anaphylactic shock).
Results: A total of 9,650 injections were administered in the 248 patients. SRs
registered are shown in table 1 and divided according to the two phases of the
schedule (build-up and maintenance). Results. There were 18 SRs (7.3%
patients and 0.20% injections). 13 occurred in the build-up phase and 5 in thye
maintenance. SRs were more frequent in females (66%). Grass pollens were
most frequently responsible of SRs (65%) than other allergens (parietaria
18%, tree 5%, mite 10%) SRs were Grade 1= 8 cases; Grade 2 = 7 cases;
Grade 3 = 1 case, Grade 4 = 2 cases (Epinephrine administered). Both severe
reactions occurred within 30 minutes after injection. Late reactions were less
common (7 SRs).
Conclusion: If properly used, SIT has a low and acceptable rate of side effects.
In our population female gender and build-up phase were the two main risk
factors. Keywords. Specific immunotherapy, injection, systemic reaction.
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Adjuvant effects of heat-killed wildtype Lactobacillus casei on
allergen immunotherapy in an allergy mouse model
Lay Hong Lim1, Chiung Hui Huang1, Hai Yan Li1, Yuan Kun Lee2, Bee Wah
Lee1, and Kaw Yan Chua1. 1National University of Singapore, Paediatrics,
Singapore, Singapore; 2National University of Singapore, Microbiology,
Singapore, Singapore.
Background and Aim: Probiotics, like lactobacilli have been used as a
management strategy for allergy diseases. Its effects on specific immunother-
apy have been previously studied in humans. The aim was to evaluate the
possible adjuvant effects of probiotics on allergen-specific immunotherapy in
an allergy mouse model.
Methods: C57BL/6 mice were pre-sensitized by epicutaneous patching with
recombinant Der p 2, and subsequently orally fed with either heat-killed
wildtype L. casei (Lc) NaHCO3 buffer for five weeks (n=6 per group). All
mice then received two subcutaneous (s.c.) immunizations of Der p 2 to mimic
allergen immunotherapy, followed by aerosol challenge with Der p 2 a week
later.
Results: The Lc fed Der p 2 sensitized mice showed significantly lower Der p
2 specific-IgE and IgG1 after s.c. immunizations and airway challenge
compared to the NaHCO3 buffer control group. Spleen T-cells and mesenteric
lymph node (MLN) cells of Lc fed mice showed suppression of Th-2 (IL-5, IL-
13, IL-10, IL-4) and pro-inflammatory (TNF-! cytokines), with an increase in
TGF-" production in MLN cells. In addition, these Lc-fed mice but not the
controls showed attenuated lung inflammation as demonstrated by the
significantly reduced lung histopathology and total cell count in BALF.
These results suggest that combined administration of the heat-killed L casei
and allergen could effectively down-regulate the pre-existing Th-2 allergic
responses.
Conclusion: Probiotics such as L casei have the intrinsic adjuvancity and
immunomodulatory properties that could potentially be exploited to improve
the efficacy of allergen-specific immunotherapy for allergic respiratory
diseases.
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Vaccinations with recombinant ProDer p 1 produced in E.coli
prevent the development of house dust mite allergy
David Walgraffe1, Christel Matte´otti1, Ce´line Marchand1, Lida Garcia1,
Michel Vandenbranden2, and Alain Jacquet1. 1Universite´ Libre de Bruxelles/
IBMM, Laboratory of Experimental Allergy, Gosselies, Belgium; 2Universite
Libre de Bruxelles, SFMB, Bruxelles, Belgium.
Our recent data indicated that recombinant ProDer p 1, an
enzymatically inactive Der p 1 precursor form, produced in E.coli
displayed very low IgE binding capacity but retained its T-cell
reactivity. To confirm this hypoallergenic character, the present study
investigated the prophylactic potential of ProDer p 1 produced in
E.coli in a Der p 1 sensitization murine model.
Gel fitration chromatography as well as FTIR spectroscopy
demonstrated that ProDer p 1 is produced in E.coli as aggregates
containing an higher "-sheet content than ProDer p 1 produced in
wild-type P.pastoris or in wild-type CHO cells. These conformational
changes could likely explain the drastic reduction of its in vitro IgE
binding activity towards human allergic sera. Compared with ProDer
p 1 produced in CHO, vaccination of naBve mice with ProDer p 1 coli
adjuvanted with alum induced a mixed Th1-Th2 immune response
characterized by the weak production of specific IgG2a, IgG1
antibodies and the absence of the specific IgE titers. Unpredictably,
the drastic reduction of specific IgE titers was maintained after mice
sensitizations with natural Der p 1/alum and subsequent challenges
with aerosolized house dust mite extracts. Moreover, the Th1-Th2
bias was confirmed as vaccination with ProDer p 1 coli induced the
secretion of IFN+ and IL-5 whereas the control allergic group secreted
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only IL-5. ProDer p 1 coli prevented the development of airway
eosinophilia following house dust mite extract challenges of
immunized mice. Furthermore, the increase in airways sensitivity to
inhaled methacholine was reduced by the prophylactic vaccination.
Taken together, our results indicated that ProDer p 1 coli could
represent an hypoallergen suitable for the prevention of house dust
mite allergy.
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Tolerance during dose-increase phase of specific immunotherapy
with standardized house-dust mite extract in asthmatic children
Li Xiang, Hong-yan Zhang, Ji-mei Zhao, Jian-xin He, and Kun-ling Shen.
Bejing Children_s Hospital Affiliated to Capital University of Medical
Science, Center of Asthma, Beijing, China.
Background: To determine the tolerance during dose-increase phase of
specific immunotherapy (SIT) with standardized house-dust mite extract in
asthmatic children.
Methods: Subcutaneous SIT with standardized house-dust mite extract was
administrated to 24 asthmatic children with allergy to house-dust mite
(Dermatophagoides pteronyssinus). We monitored the immediate and late
side-effects after each allergen injection during dose-increase phase of
immunotherapy treatment. Lung function test was done before and 30 min-
utes after each injection for every patient.
Results: All patients completed a total of 370 injections during dose-increase
period. 27 injections (7.30% of all injections) caused immediate side-effects
within less than 30 minutes after injection in 14 patiens (58.33% of all
patients), in which 26 side-effects (96.3% of all early reactions) were mild
local reactions (G5cm in diameter) and 1 episode of mild asthma occurred. 21
patiens(87.50% of all patients) reported 38 late side-effects(10.27% of all
injections) 30 minutes after injection, 9 late side effects occurred in 7 patiens
were mild systemic reactions which included asthma, allergic rhinitis, allergic
conjunctivitis and allergic dermatitis, all those systemic reactions responded
well to ordinary treatment. Others late side effects were 28 mild local reactions
and 1 moderate local reaction (5cm in diameter). The change rate of lung
function parameters after each injection showed a wide range of variance such
as FEV1(j18.9%15.8%), PEF(j35.6%33.3%), FEF25(j29.5%51.7%),
FEF50(j38.648.4%), FEF75(j49.1%249.2%), MMEF(j38.2%101.7%), but
there was no significant difference among all injections during dose-increase
period.
Conclusion: Subcutaneous SIT with standardized house-dust mite extract
showed a good tolerance in asthmatic children. A majority of local reactions
and all systemic reactions were mild and responded well to ordinary treatment
and adjustment of dose-increase schedule. No significant change of lung
function was observed during dose-increase phase of SIT.
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House dust mite (D.farine.pteronyssinus) immunotherapy in 45
patients of perenial and steroid-dependent bronchial asthma
Pooran Chand Kathuria, and Neelam Kathuria. National Allergy Centre/
India, Allergic Diseases, New Delhi, India.
45 patients of simple perenial bronchial asthma and steroid-
dependent bronchial asthma were studied before and after Immu-
notherapy with house dust mite (D.farine.pteronyssinus) alleregn
vaccine. The three years course of specific Immunotherapy (SIT) in
45 patients with perenial bronchial asthma and steroid- dependant
asthma showed significant reduction in amount of drug intake and
attacks during the treatment. The purpose of study was to investigate
the long term effect on the severity and of attacks in worst months as
well as the amount of drug intake (I.C.S and oral steroids) in perenial
and steroid-dependent asthma even after discontinuation of dust mite
immunotherapy. The inclusion criteria during the study was patients
suffering from perenial bronchial asthma sensitive to house dust mite
(3+/4+) by skin prick test, eosiniphilia, and specific IgE, while 10
patients were on standard control with symtomatic medications.
A total of 55 patients were followed up for three years during
Immunotherapy and three years after immuntherapy, SIT treated
group had significantly less intake of ICS and BD while patients
without Immunotherapy were found to have attacks in perenial
bronchial asthma, while in steroid dependant asthma severity of the
disease was found to decrease only during immunotherapy.
The result of the study revealed that specific Immunotherapy
for three years with standardised allergen extracts of house dust mite
results in decrease in severityand intensity of attack in both perenial;
and steroid-dependent bronchial asthma, while on discontinuation of
SIT, steroid-depenent astma patients reverted back.
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Effects of immunotherapy on symptoms, PEFR and spiromery in
patients with allergic asthma to house dust mite (HDM) on
inhaled steroid therapy
Gobinda Das. Shaheed Suhrawardy Hospital, Allergy and Clinical Immunol-
ogy, Dhaka, Bangladesh.
The present study was designed to investigate the effects of
immunotherapy (IT) with an extract of Dermatophagoides pteronys-
sinus (Alk-Abello, Spain and Credisol, India) during a 36 months
period in patients with allergic asthma to house dust mites. We
included 50 patients (mean age 18 years) treated with a combination
of IT and inhaled corticosteroids (ICS) in comparison to another 50
(mean age 20 years) treated with ICS alone. We evaluated symptom
scores, Salbutamol use, peak expiratory flow rates (PEFR) and
spirometry during 24 months of therapy with ICS and in the 12
months after ICS interruption. The two kinds of treatment were
efficient and comparable in relation to symptom score, salbutamol
use, morning PEFR, FVC and FEV1, but patients treated with IT and
ICS had a faster improvement of symptom score and PEFR
variability. The interruption of ICS after 24 months of therapy was
linked to an impairment of all end points which were more
pronounced in patients previously treated only with ICS. These
findings suggest that in selected asthmatic patients allergic to house
dust mites, the association of IT and ICS is more effective than
therapy with this ICS alone and to a lower rate of relapse after the
interruption of therapy with ICS.
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Antihistaminic therapy during house dust mite
immunotherapy (our experience)
Gorica Breskovska, Biserka Kaeva, Gencijana Stevcevska, Jagoda Stojkovic,
and Suzana Arbutina. Pulmology and Allergology Clinic Medical Faculty,
Pulmology and Allergology, Skopje, Macedonia, Fyrom.
The incidence of patients of allergic diseases has shown steady
increase recently. The mites, especially of the family dermatophagoides
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pteronyssinus are the main sources of the house dust allergens and
an important etiological factor in allergic respiratory diseases.
Specific allergen vaccination is an important tool to reduce allergic
symptoms and prevent more severe respiratory symptoms with
patients. The aim of the study is to evaluate the incidence of local
and systemic reactions during the HDM immunotherapy. We
investigated a group of 1200 patients allergic to dermatophagoides
pt. The age and sex analyses included patients aged 15-30 showing no
significant difference. We divided two groups depending on degree of
the skin reactivity:
First group: skin reactivity of 2+ and 3+(no-1100) and second
group: skin reactivity of 4+ (no=100). We have commenced with the
subcutaneous specific immunotherapy in accord with the standard
protocol. We analyzed the distribution if local and systemic reactions
during the immunotherapy in both groups. Out of 27000 injections
(97%) had not reaction.
810 injections caused local reaction (190 in the first group and
620 in the second group). We treated them with oral antihistaminic
and local with ice. We can conclude that specific immunotherapy with
house dust mites is safety. The majority of reactions were local and
occurred within less than 30 minutes after inections. Premedication
with antihistaminics is important especially in the beginning of the
immunotherapy.
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Specific immunotherapy for house-dust mite in a patient with
anisakis allergy: adverse reaction
Maria Teresa Ventura, Maddalena D’Erasmo, Roberto Armando Tummolo,
Augusto Arsieni, and Rosalba Buquicchio. University of Bari, Medical School,
Policlinico, Department of Internal Medicine, Immunology and In, Bari, Italy.
The nematode Anisakis simplex belongs to the Anisakidae
family. The third-stage larvae are commonly found in the entrails and in
the muscles of many fishes and if accidentally ingested can cause
clinical disorders and sensitization in humans. Previous studies have
shown cross reactivity betweenAnisakis simplex and different dustmite
species. We observed gastrointestinal symptoms during specific
immunotherapy for house dust mite in a patient with Anisakis
sensitization. In a patient suffering from allergic asthma with
sensitization to house dust mite developed gastrointestinal symptoms
during Sublingual Immunotherapy (SLIT). Sensitization was evaluated
by skin prick tests with common inhalant allergens, standard food
extracts, commercial extracts of Anisakis simplex and Radioallergo-
sorbent Test (RAST) to specific IgE antibodies. We obtained that Skin
Prick Tests (STP) with common inhalant allergens were positive to
graminacee (++j), cypress (++j) and house dust mite (+++j). SPT
with standard food extract and commercial extract of Anisakis simplex
demonstrated sensitization to Anisakis simplex. RAST showed specific
IgE antibodies against allergens of Anisakis simplex. Moreover, it is
important to underline that allergenic cross-reactivity between Anisakis
simplex and other nematodes, such as arthropods, is well known. In a
recent work, Johansson and his group underlined an association
between sensitization to Anisakis simplex and four different dust mite
species (Acarus siro, Lepidoglyphus destructor, Tyrophagus putrescen-
tiae and Dermatophagoides pteronyssinus). In their study, serum
samples collected from 69 subjects allergic to dust mites were analyzed
for IgE to Anisakis simplex by CAP FEIA and immunoblotting
inhibition. They found that 14/69 patients had detectable levels of IgE
antibodies to Anisakis simplex. In the CAP FEIA inhibition, all four
mite extracts inhibited, to various degrees, the IgE response to Anisakis
simplex on the solid phase. In the light of these findings, it is possible to
hypothesize that immunotherapy for dust-mite could pose an uninten-
tional challenge in patients with gastroallergic anisakiasis, due to cross-
reaction with anisakis simplex antigens. Even if further observations of
adverse reactions to sublingual immunotherapy with dust mite in
patients sensitized to Anisakis are needed, our data suggest that oral
treatment should be discouraged in these patients.
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Double-blind placebo-controlled study of treatment with a
depigmented and glutaraldehyde-polymerised extract of
dermatophagoides pteronyssinus and D. farinae: improvement in
skin sensitivity
Fernando de la Torre Morin1, Inmaculada Sanchez Machin1, Jose Carlos
Garcia Robaina1, Paloma Poza Guedez1, and Miguel Casanovas2. 1Hospital
Universitario Ntra Sra de Candelaria, Allergy, Santa Cruz de Tenerife, Spain;
2Laboratorios LETI, R&D, Madrid, Spain.
Background: There is a high prevalence of asthma in the Canary Islands,
Spain. Most asthmatic patients are sensitised to house dust mites. Exposure to
mite allergens is constant and levels regularly exceed 10 mcg of Der p 1 per
gram of dust. Immunotherapy using depigmented and glutaraldehyde modified
allergen vaccines produces clinical benefit, as evaluated by improvement in the
shock organ, symptom and medication scores, quality of life and skin sensitivity.
Objective: To evaluate the evolution of skin sensitivity in a group of asthmatic
patients sensitised to both mites in a double-blind and placebo-controlled
study of 1 year of duration.
Materials and Methods: Sixty-four patients were included, and 52 finished the
study (26 in the active group and 26 in placebo). The native extract of D.
pteronyssinus contained 20.35 mcg of Der p 1 and 12.30 mcg of Der p 2, and the
D. farinae extract contained 19mcg of Der f 1 per mg of freeze-dried extract. Due
to the polymerisation process, Der p 1, Der p 2 and Der f 1 were not detectable in
the modified extract. Patients were skin tested at baseline and at the end in
duplicate, on the volar surface of the forearm using the same batch of native D.
pteronyssinus extract at 0.002, 0.02, 0.2 and 2 mg/ml. The vial of maximum
concentration had a potency of 100 HEP/ml and contained 40.70 mg of Der p 1/
ml and 17.22 of Der p 2. Glycerinated saline solution and histamine HCl 10 mg/
ml were used as negative and positive controls, respectively. Skin reactions were
recorded after 15 minutes. The results were expressed as the 10 HEP value. The
Wilcoxon test was used to compare the results.
Results: Patients treated with the modified allergen extract received a total
accumulated dose of 593 mcg of freeze-dried modified material of D.
pteronyssinus and 453 mcg of D. farinae. The active group showed a
significant difference from baseline (P=0.029, Wilcoxon), whereas the placebo
group did not (P=0.900). The active group needed at the end of the study a
median of 21.9 mcg more of allergen extract to achieve the value of 10 HEP,
whereas in the placebo group the figure was j0.31.
Conclusion: This double-blind placebo-controlled trial demonstrates that the
treatment of mite allergic asthmatic patients with a mixture of depigmented
and glutaraldehyde-polymerised extracts of D pteronyssinus and D. farinae
induces a significant decrease in the skin sensitivity.
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Specific Immunotherapy with depigmented polymerized allergen
extracts of domestic mites in patients with persistent
rhinoconjunctivitis
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Angelika Sager1, and Hartwig Lauter2. 1LETI Pharma GmbH, Medical
Department, Witten, Germany; 2Fachkrankenhaus Kloster Grafschaft,
Allergology, Schmallenberg, Germany.
Background: There is limited knowledge about the clinical relevance of a
sensitization with domestic mites s.a. Euroglyphus maynei (Em), Lepidogly-
phus destructor (Ld), Acarus siro(As) and Tyrophagus putrescentiae (Tp). The
efficacy and safety of a SITwith these mites has not been described until now.
Patients and Methods:We investigated 107 patients suffering from persistent
rhinoconjunctivitis by i.c test, specific IgEs and placebo controlled nasal
challenge test with domestic mite allergens. If the patient had a positive i.c test
and/or specific IgEs and a positive nasal challenge test SITwas initiated with
the respective depigmented polymerized allergen extract. 20 patients have
been treated with the following allergen extracts either alone or in combination
for 6 months: 9x As, 6x Ld, 6x Tp, 4x Em. Patients symptoms and medication
consumption was recorded using a standardized questionnaires.
Results: 17/20 patients (85%) improved during the course of SIT. The
symptom and medication score was reduced in parallel. 1 patient did not
change during SIT and 2 patients were lost to follow-up and therefore
considered as treatment failure also. There were no systemic reactions and only
few and mild local reactions reported.
Conclusion: This is the first report of a successful SIT with Euroglyphus
maynei, Lepidoglyphus destructor, Acarus siro and Tyrophagus putrescentiae.
The treatment was efficacious and safe.
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Improvement in symptom and medication score after successful
treatment with a depigmented and glutaraldehyde-polymerised
extract of D. pteronyssinus and D. farinae: a double-blind
placebo-controlled study
Jose Carlos Garcia Robaina1, Inmaculada Sanchez Machin1, Fernando Torre
Morin1, Eva Perez Rodriguez1, and Miguel Casanovas2. 1Hospital Uni-
versitario Ntra Sra de Candelaria, Allergy, Santa Cruz de Tenerife, Spain;
2Laboratorios LETI, R&D, Madrid, Spain.
Background: There is a high prevalence of asthma in the Canary Islands,
Spain. Most asthmatic patients are sensitised to house dust mites. Exposure to
mite allergens is constant and levels regularly exceed 10 mcg of Der p 1 per
gram of dust. Immunotherapy using glutaraldehyde modified allergen vac-
cines demonstrated clinical benefit in several studies. The introduction of a
depigmentation step before polymerisation inactivates the enzymatic activity,
removes pigments and enhances the solubility of the polymer.
Objective: To evaluate the clinical efficacy of a depigmented and
polymerised vaccine containing 50% D. pteronyssinus and 50% D. farinae
in patients sensitised to these mites in a double-blind and placebo-controlled
trial.
Materials and Methods: Fifty-one patients were randomly allocated to either
receive active treatment (n=26), or placebo (n=25). The native extract of D.
pteronyssinus contained 20.35 mcg of Der p 1 and 12.30 mcg of Der p 2, and
D. farinae contained 19 mcg of Der f 1 per mg of freeze-dried extract. Due to
the polymerisation process, Der p 1, Der p 2 and Der f 1 were not detectable in
the modified extract. Patients recorded the symptom and medication
scores on a diary card. The area under the curve (AUC) and the number of
days free of symptoms and/or medication were calculated for each patient.
The values of AUC were compared groupwise using the Mann-Whitney test,
and the Hodges-Lehmann estimator was used to measure the effect size.
Fisher’s exact p value was used for the number of days free of symptoms or
medication.
Results: Patients treated with the modified extract received a total
accumulated dose of 593.3 mcg of freeze-dried modified material of D.
pteronyssinus and 452.7 mcg of D. farinae. The difference of AUC of
symptom and medication scores between both groups was significant
(pG0.05). The values of the Hodges-Lehmann were j1.6 (95%CL j18.9,
j4.4) and j8.6 (95%CL j14.9, j2.2) for symptom and medication scores,
respectively. Patients treated with the modified allergen had more days free of
symptoms and medication (Fisher’s exact p value G0.0001).
Conclusion: This double-blind placebo-controlled trial demonstrates that the
treatment of mite allergic, asthmatic patients with a mixture of depigmented
and polymerised extracts of D pteronyssinus and D. farinae produces a clinical
benefit in symptom and medication scores, with an important effect size (zero
value was not included in the 95% confidence limits).
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Clinico-immunologic study on immunotherapy with Periplaneta
americana extract: a double blind placebo controlled trial
Deepsikha Srivastava1, Shailendra N. Gaur2, Naveen Arora1, and Bhanu P.
Singh1. 1Institute of Genomics and Integrative Biology, Allergy and
Immunology, Delhi, India; 2Vallabhbhai Patel Chest Institute, Dept. Of
Respiratory Medicine, Delhi, India.
Background: Cockroaches produce several potent allergens associated with
sensitization and development of asthma. In highly susceptible or symptomatic
patients, allergen-specific immunotherapy may be beneficial, but the data are
limited. The present study is aimed to evaluate the role of immunotherapy in
cockroach allergic patients using standardized whole body extract.
Methods: Twenty patients belonging to allergic asthma, rhinitis or both were
recruited in active group and 20 in placebo group. The patients in active group
were administered with P. americana extract subcutaneously whereas the other
group received placebo injections for one year. To assess the benefits of
immunotherapy, the data was analyzed for symptom/drug score, airway
reactivity and immunoglobulins (IgE, IgG1 and IgG4) at the baseline and after
completion of one year of immunotherapy. Immunoblots of specific IgE and
IgG4 were made before and after therapy.
Results: Good improvement was observed in clinical status of patients with
respect to in vivo and in vitro parameters. Changes in symptom score, airway
reactivity and IgG4 values were highly significant in comparison to baseline
values and placebo group. Skin test and IgE values showed non-significant
reduction. Immunoblotting of specific IgG4 has shown development of more
bands of increasing density after 1 year of immunotherapy. While IgE blot
showed similar pattern of bands before and after immunotherapy.
Conclusion: Cockroach immunotherapy is well tolerated in patients of allergic
rhinitis and asthma. IgG4 immunoblotting has shown a correlation of clinical
efficacy with the immunologic response.
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At the question of the cytokines therapy of the nosocomial
pneumonia
Anna Kostyushko, and Elena Markelova. Siberian Branch of Russian
Academy of Medical Science, ?The Fareastern Scientific CentreX, Research
Insti, Vladivostok, Russian Federation.
Purpose: There were 74 patients with the hospital pneumonia of serious
current under our observation. Patients were distributed to the way of
introduction of the immunotroping drug. The first group (22 patients) received
recombination IL-2 on 500 000 I`A˚ dose intravenously. The second group (24
patients) received hypodermic introduction of the same dose of the drug, and
patients of the third group (28 person) received the combined introduction of
recombination IL-2: 250 000 I`A˚ dose of inhalation with the help the ultrasonic
inhaler simultaneously with hypodermic introduction of 250 000 Y 500 000 I`A
dose. The course of treatment consisted of 2Y3 procedures. The dynamic
research of the basic clinic-laboratory indexes were given to all our patients.
Results and Conclusion: It was fixed, that all three ways of recombination IL-
2 introduction provided positive dynamics of indexes of immunity on the
background of basic anti-inflammatory therapy of the pneumonia as the result
of our research. However, the condition of the local immunoreactivity of lungs
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was recovered only at combined inhalation and hypodermic introduction
(patients, contents of metabolites of oxide of nitrogen and !1-acidic
glycoprotein in the condensate of the exhaled moisture was normalized,
reaching similar indexes of healthy people). It is important to note, that
complete regress of radiological indexes was only at combined application of
recombination IL-2 inhalationly and subcutaneously. The analysis of
frequency rate of recombination IL-2 introduction showed, that it was not
enough single-pass introduction of the drug for the reduction of indexes of the
local immunity, and rates of their reduction in the course of the repeated
combined way of introduction were identical and depended on gravity of the
condition and the expressiveness of the inflammation in bronchopulmonary
system. The increase of frequency rate of recombination IL-2 introduction more
than 2Y3 times did not accelerate rates of clinical convalescence, reduction rate of
immune indexes and biochemical criteria of the degree of the expressiveness of
the inflammation in respiratory paths. Thus, we believe that it was efficient
combined recombination IL-2 application of the 250 000 I`A˚ inhalation dose and
500 000 I`A˚ dose subcutaneously 2 Y 3 times with the interval of 72 hours for
treatment of patients with the serious hospital pneumonia.
DIAGNOSIS
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Discrepancies between reported symptoms, lung function
measurements and PC20 in a Clinical Asthma Research Centre
Kheem Jones1, Cherylin Reinholtz2, and Christopher Corrigan2. 1King’s
College London School of Medicine, Asthma, Allergy and Respiratory Science,
London, United Kingdom; 2King’s College London School of Medicine, Asthma,
Allergy and Respiratory Science, London, United Kingdom.
Background: Diagnosis of asthma or non-asthma is critical for clinical
research. Using methacholine challenge testing (MCT), a well established
bronchial challenge test for assessing airway responsiveness, we have
identified groups of patients who have been incorrectly diagnosed as asthmatic
or non-asthmatic.
Methods: We screened 68 volunteers participating in clinical research in
asthma after they provided informed consent.
All volunteers were questioned about their general health, asthma
symptoms medication and family history of asthma. Atopic status was
determined with skin prick tests to a standard panel of aeroallergens. A
baseline spirometry was performed prior to MCT.
MCT was conducted following a recognised dosing protocol (Crapo,
R.O. et al Am J Respir Crit Care Med 2000 Vol 161 pp 309Y329) using a
Mefar MB3 breath activated dosimeter. Volunteers considered to be asthmatic
commenced at the lowest methacholine dose of 0.03125 mg/ml and continued
up the dosing protocol until a PC20 was reached. After each dose their FEV1
was obtained at 1 1/2 mins and at 2 1/2 mins post-inhalation with a subsequent
2 mins rest prior to the next dose.
Those considered to be non-asthmatic started their MCT challenge
from 0.5 mg/ml dose of the methacholine and continued up-dosing until the
highest dose.
The definition of asthma for the purpose of our studies was a PC20
below 8mg/ml at MCT. Non-asthma was defined as completion of the MCT at
16mg/ml without attaining a PC20.
Results: Of the 68 subjects screened for clinical research studies, 29 claimed
to have a physician diagnosis of asthma, but in 8 this was not confirmed by our
MCT criteria. Of these 8 subjects, 7 had normal spirometry (FEV1 980%
predicted) while 1 had FEV1 of G80% predicted.Conversely, 39 volunteers
reported non-asthma. Of these 2 had symptoms at methacholine challenge
testing and attained a PC20 G8mg/ml, thus fulfilling the definition of asthma
according to our criteria.
Conclusion: Diagnosis of asthma and non-asthma based on existing
symptoms, lung function testing and physician based diagnosis is surprisingly
unreliable.
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Asthma in pregnancy: diagnostic methods
Zahra Pourpak, Katayoon Bidad, Hasan Haidarnejad, Giti Shaiestehfar, and
Mostafa Moin. Immunology, Asthma and Allergy Research Institute,
Immunology Department, Tehran, Islamic Republic of Iran.
Introduction: Asthma is the most common respiratory disorder to complicate
pregnancy and represents a significant public health issue.
In many occasions, especially in the last trimester due to the pressure of
unborn child, these patients are unable to perform standardized spirometry.
The Impulse Oscillometry Technique (IOS) may be suitable in this application
since it allows the assessment of airway obstruction by requiring minimum
patient cooperation. Aim: Our aim was to identify the relationship between R5,
X5, and Resonant Frequency to the 1s forced expiratory volume (FEV1) and
forced vital capacity (FVC) in pregnant women.
Methods: In 42 asthmatic pregnant patients aged 18Y41 yr (mean 28.5 yr)
spirometry and impulse oscillometry (Erich Jaeger, Germany) was performed
according to standard guidelines and manufacturers instructions. Relation-
ships between spirometric indices and total Resistance (R5), central resistance
(R20), peripheral reactance (X5) and Resonance Frequency (FRes) were
obtained using correlation and regression analysis. Volumes are expressed in
litres and resistance in kpa.1.s.
Results: Mean T SD of FEV1 was 2.32T0.46, FVC was 2.93T0.64 , FEV1/
FVCwas 80.90T15.81 , R5 was 0.49T0.14 , X5 wasj0.11T0.14 and FRes was
19.71T5.00. There was significant (pG0.001) correltion between the R5 and
FRes, each with FEV1.R5: FEV1 = 3.14 Y 1.34 R5, R2= 0.21FRes: FEV1 =
3.90 Y 3.24 fres, R2=0.22.
Conclusion: These results suggest that Impulse Oscillometry is a valuable tool
to assess airway obstruction as it is simple and requires minimal subject
cooperation. This new field of oscillometry application may be particularly
useful in patients who are unable to perform spirometry. Further studies are
required to determine the sensitivity and specificity of this technique.
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The association between FeNO and acute exacerbation
of asthma in children
Sun-Hee Choi, and Yeong-Ho Rha. College of Medicine, Kyung Hee
University, Department of Pediatrics, Seoul, Republic of Korea.
Rationale: Asthma is a Th2 cell mediated chronic inflammatory airway
disease. Bronchoscopic biopsy is the best method to evaluate airway
inflammation but it is too invasive for children. Measurement of exhaled
nitric oxide (FeNO) is a relatively simple, noninvasive, and very reproducible
test for detection of endogenous inflammatory signals in childhood. Recently
measurement of FeNO level is emerging as a non-invasive tool for airway
inflammation. The aim of our study was to determine the relationship between
FeNO and acute asthmatic exacerbation, and to decide whether measurement
of FeNO could predict acute asthma exacerbation.
Methods: Thirty eight children with mild to moderate persistent asthma aged
from 3 to 15 years who presented to Kyunghee Medical Center were studied.
FeNO levels were measured by chemiluminescence during exhalation into the
NO analyzer. Patient’s data were based on out-patient records. We compared
FeNO levels between exacerbation group and non-exacerbation group.
Results: The mean FeNO level in the asthmatic children was 16.7T13.9 ppb.
In the range of abnormal FeNO level (Q10 ppb), there was significant
difference between asthma exacerbation group and non-exacerbation group
(p=0.004). There was also significant correlation between FeNO level and
acute asthma exacerbation (p=0.003).
Conclusion: Exhaled nitric oxide levels were related with acute asthmatic
exacerbation in childhood asthma. Thus measurement of FeNO can be a
promising clinical tool for predicting asthma exacerbation in mild to moderate
persistent asthmatic children.
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The analysis of the level of bronchial hyperresponsiveness in
astmatic children(2 - 18 years) by dosimetric, oscilometric and
tidal breathing methods to histamine and methacholine and
analysis of polymorphisms genes ADAM33 and STAT6
Radek Vrtel1, Radek Vodicka2, Martin Zapalka1, and Frantisek Kopriva1.
1Teaching Hospital of Palacky University Olomouc, Pediatrics, Olomouc,
Czech Republic; 2Teaching Hospital of Palacky University Olomouc, Medical
Genetics, Olomouc, Czech Republic.
Background of the study: The main pathogenic mechanism of bronchial
asthma is chronic eosinophil-based inflammation of the bronchial mucosa.
Airway hyperresponsiveness (AHR), is known to be a major risk factor for the
development of asthma and to be equivalent of asthma severity.
Methods:Main aim of this project, supported by IGAMZ CRNo. NR8383-3/
2005, is to test if the level of AHR is associated with certain alleles or
haplotypes of genes (ADAM 33 and STAT 6) involved in immune system
activity in course of allergic illness development and airway hyperrespon-
siveness. 80 children with bronchial asthma had histamine and methacholine
brochnoprovocation tests in a sequence with increasing levels using dosimetric
method and MedicAid and DeVilbiss nebulizers. Oscilometric assessment I
was followed by baseline spirometry, and with oscillometric assessment II
after a decrease in FEV19 20% versus baseline. Examinations of responsible
polymorphisms of ADAM 33 and STAT 6 genes were accomplished by
sequence analysis in 80 children with asthma bronchiale, their sibs and parents
and 50 control healthy children.
Results: Examinations of responsible polymorphisms of ADAM 33 and STAT
6 genes were accomplished by sequence analysis in 80 children with asthma
bronchiale, their sibs and parents and 50 control healthy children. In the
evaluation of the result it could be demonstrated that changes in resistance R5
and R20 between oscillometric assessments I and II more than 40% are
consistent with a decrease in FEV1 more than 20% in both dosimetric method.
The statistical evaluation of the association of genes polymorphisms with
asthma bronchiale occurrence and airway hyperresponsiveness level in
children will be presented by poster.
Conclusion: These results show that resistance R5 over R20, as measured
with IOS (impulse oscillometry), significantly correlates with the-gold
standard-FEV1. Description of influence of particular sequence changes
could contribute to additional insight to the airway hyperresponsiveness
genetical background.
767
Differential flow analysis of exhaled nitric oxide
in asthmatic patients
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Valeriya Nemtsova, Irina Tikhonova, and Inga Fedotova. Kharkov Allergo-
logical Center, Allergology, Kharkov, Ukraine.
Background: The majority of asthmatic patients achieve control of their
illness, but not all. It is therefore crucial to develop strategies that help the
clinician monitor the disease, improving the response to treatment.
Methods: We have quantified the inflammation in central and peripheral
airways by measuring exhaled nitric oxide (NO) at multiple exhalation flows in
42 asthmatic patients at different levels of severity (mild = 11; moderate
stable = 10; moderate during exacerbation = 9; severe = 12, 6 of whom were
receiving oral corticosteroids) and 15 healthy control subjects.
Results: Bronchial NO (bNO) in patients with mild asthma (2,283+/j346 pL/s)
[mean+/jSD] was higher than in patients with moderate stable asthma
(1,317+/j61 pL/s, pG 0.001), in patients with severe asthma receiving inhaled
corticosteroids (ICS) [1,023+/j72 pL/s, pG 0.001], and healthy control
subjects (697+/j31 pL/s, pG 0.001). There were no differences between
bNO in patients with mild asthma compared to patients with severe asthma
receiving ICS and oral corticosteroids (2,335+/j269 pL/s). Patients with
exacerbations showed a higher bNO (3,521+/j373.2 pL/s, pG 0.01) compared
to the other groups. Alveolar NO was higher in patients with severe asthma
receiving oral corticosteroids (3.1+/j0.2 parts per billion [ppb], pG 0.0001)
than in the other groups but was not significantly higher than in patients with
moderate asthma during exacerbation (2.7+/j0.4 ppb). No differences were
seen in NO diffusion levels between the different asthma groups. All the
measurements were highly reproducible and free of day-to-day and diurnal
variations.
Conclusion: Differential flow analysis of exhaled NO provides additional
information about the site of inflammation in asthma and may be useful in
assessing the response of peripheral inflammation to using therapy.
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Monitoring and treatment of childhood asthma in singapore: a
questionnaire study in physicians
Colin Tan, Belle Wong, Daniel Goh, and Hugo Van Bever. National
University Singapore, Department of Pediatrics, Singapore, Singapore.
Introduction: Asthma is the most common chronic disease in children and in
Singapore over 25% of children have ever been diagnosed with asthma by age
15. Most children are seen in the primary care setting, thus it is of value to
study the management practices of general practitioners and pediatricians in
comparison with gold standards. The aims of the study were to investigate: a)
methods of monitoring of childhood asthma, b) practices in managing acute
asthma exacerbations, and c) choice of therapy in maintenance treatment.
Methods: 2100 questionnaires of 35 questions were sent by post to general
practitioners and pediatricians throughout Singapore. 173 valid responses were
received and results were compared to 2006 Global Initiative for Asthma
(GINA) guidelines.
Results: Of respondents 76.3% were general practitioners. For monitoring
childhood asthma, most physicians (89.1%) did not use symptom score cards/
diaries, while 37.6% did not use peak-flow meters/spirometry. For acute
treatment, 83.8% used a short-acting aˆ-agonist, but only 41.0% used oral
corticosteroids in outpatients. In the maintenance treatment of asthma, across
all age-groups (infants, preschoolers, and older children) the most commonly
used first line drug was uniformly an inhaled corticosteroid. However,
combinations of long acting beta-agonists (LABA) and inhaled corticosteroids
were uniformly the second most popular maintenance treatment. Maintenance
treatment was frequently used by most doctors in treating preschoolers
(62.4%) and older children (64.7%). In contrast, most doctors seldom (45.1%)
or never (21.4%) applied maintenance treatment to infants. The vast majority
(158; 91.3%) of doctors never used immunotherapy in asthma management,
and 2.9% of respondents believed immunotherapy was not available locally.
Conclusion: Greater usage of diaries/score cards can be encouraged along
with objective peak flow/spirometry measurements. Management of acute
exacerbations is appropriate, but corticosteroids are under-prescribed by most
doctors. LABA continues to be prescribed for maintenance despite a lack of
established safety profile for infants, along with recommendations that they
only be used selectively in patients that are poorly controlled by inhaled
corticosteroids. Immunotherapy is not widely used and more awareness/
instruction should be generated among doctors.
ASTHMA<ASSOCIATED CONDITION
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Risk of HBV reactivation in asthma or COPD patients treated
with corticosteroids
Tae-Wan Kim, Jae-Woo Kwon, Hyouk-Soo Kwon, Chang-Han Park, Heung-
Woo Park, Yoon-Seok Chang, Sun-Sin Kim, Sang-Heon Cho, Kyung-Up Min,
and You-Young Kim. Seoul National University College of Medicine,
Department of Internal Medicine, Seoul, Republic of Korea.
Background: Viral reactivation in hepatitis B virus (HBV) carriers has been
reported to occur in association with immunosppresive agents in cancer or
transplantation patients. However, effects of inhaled corticosteroids (ICS) or
systemic corticosteroids (SC) in immunocompetent patients with chronic
respiratory diseases are not known.
Objective: To evaluate the course of HBV infection in stable HBV carriers
using ICS or SC for the treatment of asthma or chronic obstructive pulmonary
disease (COPD).
Methods: HBsAg seropositive patients using ICS were reviewed retro-
spectively from Jan 1997 to Mar 2007. We reviewed data of 183 patients who
met our inclusion and exclusion criteria including dose and duration of ICS
and SC treatment, HBVDNA titer, HBeAg/Ab and AST/ALT serum level, and
usage of antiviral drugs such as lamivudine.
Results: Among the 183 patients whowere using ICS, 66 patients were treated
with SC at least on one event. HBV reactivation occured in 5 out of 66 (7.6%)
subjects who have ever used SC and 2 out of 117 (1.7%) subjects under ICS
treatment alone. Among the 5 subjects with HBV reactivation who have ever
used SC, 4 (80%) subjects were treated with SC chronically due to difficult-to-
control asthma with more than 9000mg of total cumulative dose of
prednisolone. 2 subjects with HBV reaction who were using only ICS were
using moderate dose ICS.
Conclusion: Chronic use of SC and high total cumulative dose of SC are risk
factors of HBV reactivation in patients with asthma and COPD. ICS treatment
alone is not a risk factor of HBV reactivation. Prophylactic antiviral therapy
should be considered in patients who needs chronic or high dose SC treatment.
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Gastro-esophageal reflux in allergic asthmatic patients
Diana Dumitrascu, Dan Lucian Dumitrascu, Ioana Crisan, Adriana Bujor,
Corina Pastor, and Liliana David. Univ Med and Pharm Iuliu Hatieganu,
Allergy, Cluj Napoca, Romania.
Background: The prevalence of asthma is increasing in the last years. Also
gastro-esophageal reflux disease (GERD) is increasing in the last years. It is
known that gastro-esophageal reflux (GER) may be present and also may
aggravate asthma. There are no information regarding GERD and asthma in
Romania.
Aim: Our study was to evaluate the presence of GER in allergic asthma in
Transylvania.
Methods: We evaluate the patients with 56 allergic asthma for the presence of
GER. The pts had moderate persistent asthma treated with glucocorticoid
inhalers (and/or LABA). The pts had a 24-hours oesophageal pH-monitoring.
Reflux episodes identified reflux events as the percentage of time where the pH
was less than four. The pts had also an upper endoscopy. The pts were also ask
about there asthmatic symptoms during nights and regarding the heart burns.
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Results: The mean age was 36 years (18-54 years); 32 of the pts were women.
There were only 3 pts (5.7%) having heart burns. On 24-hours oesophageal
pH-monitoring we found 18 pts (32%) having acid reflux during day and night.
On endoscopy there were only 7 pts (12.5%) with esophagitis. There was no
relationship between spirometry results on one hand, and parameters of
gastroesophageal reflux on the other. The pts receive also for 4 weeks term a
proton pump inhibitor (PPI) (pantoprazol 80 mg/day). The measures of
symptoms (mean daily daytime and nighttime asthma symptom scores) did not
change significantly during the 4 weeks treatment with PPI . There was no
influence on rescue medication in the majority of the pts. Only 2 pts reported
an improvement of the asthma, with lower need for rescue medication. In our
Romanian patients we found no correlations between GER.
Conclusions: Our results indicate that acid in oesophagus or its short term
inhibition by proton pump inhibitors, has no influence on allergic asthma.
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The clinical implication of different pathophysiologic
manifestations between asthma and pure COPD
Yang Keun Rhee1, So Ri Kim1, Seoung Su Kim2, Yeong Hun Choe1, Ka
Young Lee1, Seoung Ju Park1, Heung Bum Lee1, and Yong Chul Lee1.
1Chonbuk National University Medical School, Department of Internal
Medicine, Jeonju, Republic of Korea; 2College of Medicine, The Catholic
University of Korea, Department of Internal Medicine, Daejeon, Republic of
Korea.
Background: Although physiologic and anatomic differences of chronic
obstructive pulmonary disease (COPD) and asthma are separated into distinct
categories of disease, in clinical practice a significant proportion of patients
have characteristics that are classically associated with both conditions.
Methods: To determine whether patients with fixed airflow obstruction have
distinct cellular and biochemical characteristics depending on their asthmatic
features, we characterized 30 consecutive outpatients presenting with fixed
airflow obstruction by bronchodilator response, peak expiratory flow
variability, serum total immunoglobulin E, allergen skin prick test, methacho-
line bronchial challenge test (MCT), and bronchoalveolar lavage (BAL). In
addition, to determine significance of MCT on differentiating asthma from
COPD, we exam MCTon 111 outpatients divided to asthma, pure COPD, and
control group.
Results: We found that subtypes of T lymphocytes did not show significant
difference in number and ratio on both groups, but neutrophils in BAL fluid
was significantly lower in group with asthmatic features. Additionally, their
cytokine analysis showed significantly higher level of IL-4 in asthmatic patient
compared with COPD patients, while lower level of IL-5 and INF-gamma in
asthma group compared with COPD group. In MCT results, area under the
receiver operating characteristic (ROC) curve of sensitivity and specificity has
shown that best cut-off value of PC20 is 15.4 mg/ml in classifying the asthma
and pure COPD.
Conclusion: We conclude that despite of similar fixed airflow obstruction,
subjects with asthmatic features have distinct cellular and biochemical
characteristics compared with pure COPD. In addition, we suggest that the
MCT using the new cut-off value could be a more useful diagnostic tool for
distinguishing asthma from pure COPD. Based on these findings, we expect
that this distinction of asthma from pure COPD using the different
pathophysiologic manifestations could provide more proper and specific
therapeutic management for the patients.
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Airway remodeling in patients with allergic
bronchopulmonary aspergillosis
Hidenori Tanimoto, Yasuo Takeuchi, Masami Taniguchi, Akemi Saito,
Kiyoshi Sekiya, Hiroshi Yasueda, and Kazuo Akiyama. National Hospital
Organization, Sagamihara National Hospital, Clinical Research Center for
Allergy and Rheumatol, Kanagawa, Japan.
Background: Allergic bronchopulmonary aspergillosis (ABPA) is a hyper-
sensitivity reaction to Aspergillus fumigatus (Asp.f) induced by IgE and IgG
antibodies which progress to central bronchiectasis (CBE) even at an early
stage. We hypothesized that the airway remodeling (=irreversible change of
bronchial wall) in patients with ABPA is accompanied by not only CBE but
also persistent bronchial narrowing at an early stage of ABPA.
Methods: We evaluated bronchial reversibility (BR) using salbutamol and
airway hyperresposiveness (AHR) using acetylcholine (Ach) in ABPA patients
with CBE (=classical ABPA) and without CBE (=seropositive ABPA), and
compared the BR and AHR of these patients with those of patients with
allergic fungal asthma without the IgG antibody to Asp.f. Nineteen classical
ABPA, 11 seropositive ABPA, and 21 allergic fungal asthmatics were
participated in this study.
Results: All the subjects were positive for the IgE antibody to Asp.f. All the
ABPA patients with or without CBE were positive for the IgG antibody to
Asp.f. In all classical ABPA patients, but not in seropositive ABPA patients,
typical CBE findings were detected in HRCT. There were no differences in
age, total IgE level (RIST), and %FEV1 among the three groups. However, not
only classical ABPA patients, but also seropositive ABPA patients showed
significantly attenuated BR after salbutamol inhalation (median increase in
FEV1: 170, 210, 340 ml, pG0.05). Moreover, about one-half of ABPA patients
showed normal or very mild AHR, on the other hand, none of the allergic
fungal asthmatics showed normal AHR.
Conclusion: These results suggest that ABPA patients, even at an early stage,
may show irreversible bronchial narrowing resistant to bronchodilators or
bronchostimulator inhalation.
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Follicular bronchiolitis: A rare mimicker of ‘‘severe asthma’’
Belle Peralejo, Peter Benincasa, and Leonard Bielory. University of Medicine
and Dentistry of New Jersey, Dept of Medicine, Division of Allergy/
Immunology, Newark, NJ, United States.
Background: Atypical presentations of asthma and abnormal imaging are
factors that prompt the pursuit of a lung tissue diagnosis. We present a case of
follicular bronchiolitis (FB) in a patient thought to have severe asthma.
Methods: A 35 year old male non-smoker developed productive cough,
dyspnea and wheezing for 2 years. He was treated with inhaled steroids, long
acting beta-agonists, montelukast, antibiotics and prednisone for late onset
asthma. Symptoms worsened with oral steroid taper.
Results: Pulmonary function tests revealed severe obstruction (FEV1 36%,
FEV1/FVC of 86%) with significant bronchodilator response (30%) and
mildly decreased diffusion capacity (68% predicted). Skin tests were positive
to dust mite, mold, cats and dogs. Immunological evaluation (Table 1) revealed
mild eosinophilia (557-1320 absolute eosinophils), normal T and B cells
(absolute lymphocyte count 1467, CD4 1040 cells/mcL, CD8 452 cells/mcL,
CD19 218 cells/mm3, CD4/CD8 2.06, CD56 143 cells/mm3), normal total
complement (76 U), normal immunoglobulin levels (IgE 50, IgA 206, IgM 9)
except for mild decrease in IgG1 and IgG3 (IgG 810, IgG1 387, IgG2 302,
IgG3 16.4, IgG4 49.1 mg/dL), negative cystic fibrosis screen, protective titers
to tetanus (0.41), and pneumococcal vaccine (protective titers of 8 out of 14
serotypes: 1,3,8,9,14,26,51,56). Further workup for infection (HIV, HTLV-1/2,
AFB, yeast, bacteria, CMV), sarcoid (ACE levels, calcium and gallium scan),
autoimmune disease (ANA, ANCA, MPO, Pr-3 Ab), Alpha-1 antitrypsin
deficiency and hypersensitivity pneumonitis was negative. CT scan of the
chest showed bilateral peribronchial thickening in central bronchi with few
small non-specific lymph nodes in the mediastinum. Right upper lobe wedge
resection showed acute and chronic bronchiolitis with lymphoid hyperplasia
consistent with FB. He improved with chronic steroids and azithromycin
(FEV1 72%, FEV1/FVC 92%).
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Conclusion: FB is a rare entity consisting of abundant lymphoid follicles
limited to the peribronchiolar area. It may be idiopathic or associated with
hypersensitivity phenomenon or collagen vascular disease. A few cases are
reported associated with immunodeficiency such as HIV or common variable
immunodeficiency (CVID). Initially, he was thought to have an immune
deficiency but repeat analysis revealed normal immunologic function. His
disease may, therefore, be idiopathic or related to a hypersensitivity reaction
not well understood. He is controlled with steroids and azithromycin.
TEST RESULT
FEV1 32 Y 51% (1.37 Y 2.18 L)
FVC 47 Y 62% (2.45 Y 3.21 L)
FEV1/FVC 60 Y 81%
Absolute eosinophil count 557 1320 cells/mcL (15Y550)
Absolute lymphocyte count 2113 cells/mcL (850Y3900)
CD3+/CD4+ absolute
helper count
1040 cells/mcL (490 Y 1740)
CD3+/CD8+ absolute
suppressor count
452 cells/mcL (180 Y 1170)
CD4+/CD8+ ratio 2.06 (0.865)
CD19 absolute count 218 cells/mm3 (106Y220)
CD56 absolute count 143 cells/mm3 (14Y402)
IgM 810 mg/dL (48Y271)
IgG 359 mg/dL (694Y1618)
IgG1 359 mg/dL (455.9Y892.6)
IgG2 393 mg/dL (199Y526.6)
IgG3 19.8 mg/dL (16.8Y99.8)
IgG4 38.9 mg/dL (13.5Y73.9)
IgA 206 mg/dL (81Y463)
IgE 50 mg/dL (G/=114)
Pneumococcal IgG serotype 1 pre -6.5, post-10.3 mcg/mL
Pneumococcal IgG serotype 3 pre -6.5, post-15.7 mcg/mL
Pneumococcal IgG serotype 4 pre -6.5, post-G0.2 mcg/mL
Pneumococcal IgG serotype 5 pre -5.6 post-0.5 mcg/mL
Pneumococcal IgG serotype 8 pre -4.7, post-8.9 mcg/mL
Pneumococcal IgG serotype 9 pre -912.5, post-7.4 mcg/mL
Pneumococcal IgG serotype 12 pre -3.3, post-0.3 mcg/mL
Pneumococcal IgG serotype 14 pre -1.6, post-918.8 mcg/mL
Pneumococcal IgG serotype 19 pre -1.7, post-G0.2 mcg/mL
Pneumococcal IgG serotype 23 pre -6.5, post-0.5 mcg/mL
Pneumococcal IgG serotype 26 pre -6.5, post-1.4 mcg/mL
Pneumococcal IgG serotype 51 pre -6.5, post-13.8 mcg/mL
Pneumococcal IgG serotype 56 pre -6.5, post-6.4 mcg/mL
Pneumococcal IgG serotype 68 pre -6.5, post-0.7 mcg/mL
Tetanus antitoxoid Ab 0.41 IU/mL (90.15)
Aspergillus precipitins







of blood and sputum
Negative for bacteria, yeast/fungus,
AFB, pneumocystic carinii, CMV
ANA Negative
c-ANCA, p-ANCA, anti-MPO, anti-Pr3 Negative
ACE 31 U/L (9<67)
Whole body gallium scan Negative
ESR 35 mm/hr (0<15)
CRP 0.2 mg/dL (G0.8)
Total complement 76U
Cystic fibrosis Negative for 23 mutations
Alpha-1 Antitrypsin No mutations
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The prevalence of respiratory viral infection in exacerbation of
asthma in hospitalized children
Euijung Roh1, Eunhee Chung1, Youngpyo Chang1, Woosung Park1, and
Jaekyung Kim2. 1Dankook University Hospital, Pediatric department,
Cheonan, Republic of Korea; 2Dankook University Hospital, Laboratory
medicine department, Cheonan, Republic of Korea.
Background: Respiratory viral infections are common exacerbating factor of
asthma in both younger and older children. Of these, Rhinovirus are
recognized as the most common respiratory virus associated with acute
asthma in school-aged children, whereas RSV in young children. The aim of
this study is to evaluate the seasonal trends and etiology of viral agents among
children hospitalized for exacerbated asthma.
Methods: Nasopharyngeal aspirates were obtained from hospitalized asthmatic
children at Dankook Univ. Hospital. from November 2005 through Febraury
2007. Polymerase chain reaction (PCR) assays were used for the detection of
respiratory viruses(influenza virus type A, B, parainfluenza virus type 1,2,3,
rhinovirus, resipiratoy syncytial virus type A, B, adenovirus, coronavirus 229E
and OC43, human metapneumovirus). The demographic and clinical
characteristics were reviewed retrospectively from the patients medical records.
Results: During study period, 1106 nasopharyngeal aspirates were examined
from hospitalized children with respiratory symptom, of these, viruses were
detected in 785(70.9%). From this population, 58 had hospitalization due to
acute asthma exacerbations. Of these, infectious agents were detected in
38(65.5%) of the patients. RSV was detected in 18(31%), IFV in 10(17.2%),
RV in 7(12.1%), CoV in 5(8.6%), AdV in 4(6.9%), PIV in 5(8.6%), HMPV in
2(3.4%). Coinfection was identified in 12(20.7%) of the samples. Exacerba-
tion of asthma symptoms was greatest in winter(38%). The highest number of
samples positive for respiratory syncytial virus was recorded in January(59%).
Conclusion: In conclusion, we confirmed that acute exacerbations of asthma
necessitating hospitalization was often associated with respiratory viral
infection, especially RSV in young children. Also, there were no significant
differences between young children and school-aged children in the prevalence
of respiratory virus.
We found that the causative virus in hospitalized children with asthma
exacerbations follow the epidemics of respiratory virus in hospitalized
children with respiratory infection.
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Chlamydia pneumoniae infection in asthmatic patients
Dejan Dokic1, Zlatica Goseva1, Elena Trajkovska-Dokic2, Beba Veljanovska3,
and Dimitar Krkinski1. 1Clinic of Pulmology and Allergy, Department of
Science, Skopje, Macedonia, Fyrom; 2Institute of Microbiology and
Parasitology, Department of Microbiology, Skopje, Macedonia, Fyrom;
3Pliva, d.o.o., Skopje, Macedonia, Fyrom.
Introduction: It has been suggested that chronic chlamydia pneumoniae
infection could be a cause for adult onset of asthma. There are data to suggest
that infectious organisms, particulary the atypical bacteria, Clamydia
pneumoniae, may be involved in asthma pathogenesis. It is not known
whether this organism was allowed to persist after an infection, or was present
prior to the development of asthma. The significance of atypical bacteria in the
exacerbation of asthma is stil unclear.
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Aim of the study: The purpose of this study was to determent weather anti-
chlamydial treatment with azitrhomycin will improve asthma symptoms and
lung function in asthmatic patients.
Materials and methods: 30 patients (mean age 35,5 years) with moderate to
moderately severe asthma were treated a median of 6 weeks with azithromycin
1000 mg once weekly. All patients had chlamydia pneumoniae infection
detected by specific IgA=1:40 and specific IgG= 1:256 against Chlamydia
pneumoniae. Post treatment lung function and symptom score (caugh,
wheezing, dyspnea) were compared with baseline values.
Results: After 6 weeks of treatment with azithromycin there was significant
reduction in symptom score (pG0,01) and significant improvement in lung
function FEV1 (pG0,01), Wilcoxon matched Pairs test.
Conclusion: Treatment with azithromycin significantly improved asthma
symptoms and lung function indicating that Chlamydia pneumoniae may play
an important role in enhancing the inflammatory processes in lower airways.
Awareness of inflammation as the main pathogenetic mechanism in asthma,
renewed the interest for the role of infaction in the ethiology.
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Influence of 8week therapy with Omeprazole on asthma
symptoms, pulmonary function and quality of life in asthmatics
with acid reflux symptoms
Kamelija Busljetic, Tatjana Caparoska, Biserka Kaeva, Sava Pejkovska, and
Kamelija Busljetic. University Hospital, Pulmo-allergology, Skopje, Mace-
donia, Fyrom.
Acid reflux symptoms has been found to occuere in 32 to 80% of
asthmatic patients. Although the association is evident, it has been difficult to
establish a casual relationship between them. Acid-suppressive treatment has
been inconsistent in improving asthma control.
The aim of the study was to determine whether a proton-pump
inhibitor improves asthma control in asthmatics patients with acid reflux
symptoms.
Twenty-two patients receiving usual asthma cove including an inhaled
corticosteroid. Patients had acid reflux symptoms and moderate to severe
persistent asthma. They received omeprazole, 20mg bid for 8 weeks. The
measurements were daily asthma symptoms by diary, daily morning and
evening peak expiratory flow, FEV1, FVC, asthma quality of life with
standardized activities(AQLOS) questionnaire score, rescue salbutamol use.
In this study we have shown that daily asthma symptoms, salbuterol
use, peak expiratory flow, FEV1, FVC at 8 week did not improve significantly
with omeprazole treatment. But there has been significant improvement in
nighttime asthma symptoms in patients with nocturnal asthma. The AQLOS
emotion function domain improved at 8 weeks(p=0,025) with omeprazole
therapy.
The conclusion is that daytime asthma outcome did not improve with
8-week omeprazole therapy,but there seams to be a subgroup of asthmatic
patients who benefit from excessive antireflux therapy.
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A 9 years old male with cervical lymphangioma and asthma: a
case report
Horacio Del Olmo Tellez, Socorro Orozco Martinez, and Jose Guadalupe
Huerta Lopez. National Institute of Pediatrics in Mexico, Allergy and
Immunology, Mexico City, Mexico.
Lymphangioleiomyomatosis (LAM) is rare idiopathic interstitial lung
disease predominantely affecting women. Although Van Stossel first described
pulmonary LAM in 1937 the natural history of LAM remains poorly
understood. The true incidence and prevalence of LAM are unknown.
Although current worldwide registries report LAM as a disease with no
geographic preference. Most of the delay in diagnosis results from
misdiagnosis and the lack of early specific clinical findings. Common
misdiagnosis include asthma, emphysema, and chronic bronchitis.
Tazelaar and coworkers describe nine cases of a distinct lymphatic
vascular lesions that they termed diffuse pulmonary lymphangiomatosis. Six
patients included wheezing or asthma (44%) and dyspnea (22%) presented for
3 months to 20 years.
We presented a 9 years old boy, who began sufferind at 8 months of life
with 38 grades fever, hiporexia, wheezing, dyspnea, cianosis. He received
Cefuroxime and Ceftriaxone treatment without diminished symptoms. He
enter to National Pediatrics Institute with sinusitis or laringothraqueitis
probably diagnosis, the patient continued with dyspnea and inspiratory
estridor, the cervical ultrasonography described hemangioma, biopsy reported
right lateral lymphangioma without malignancy, it was partially extracted. Tha
patient suffered thraqueostomy because compression in hypopharynx poster-
ior wall with 50 percent diminution, supraglotic inflammation and edema.
Moreover, our patient presented severe bronchoespasm with salbutamol and
dexamethasone nebulizers treatment.
Because asmatic mother background, at 1 year old, he received allergy
valoration, He developed nasal constipation, pruritus, and rhinorrea in the last
3 months. He received beta 2 agonist and budesonide, transfer factor, bacterial
vaccine. Diagnosis of severe moderate asthma, later he developed again,
volume increase in lymphangioma zone, he received OK 432. Laboratory
results: dermatophagoides farinae specific IgE 1.30 UI/ml, dermatophagoides
pterinissinus 2 UI/ml, total IgE 1922 Ui/ml, 7.6% eosinophilia, Prick test
positive: Chenopodium, Lolium, Quercus, Timothy, Fraxinus, ligustrum, and
DPT, he started sublingual immunotherapy.
This is an interesting case because lymphangioma is a rare disease,
mainly in children; the association with atopia, causes a difficult control
asthma. There are not references with lymphangioma and asthma in the
literature, our treatment is controverted and novel.
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A severe acute asthma exacerbation complicated by
pneumomediastinum and atelectasis of the lungs: a case report
Sanja Hromis1, Biljana Zvezdin1, Miroslava Trifkovic1, Senka Milutinov1,
Dusanka Obradovic2, and Violeta Kolarov3. 1Institute for Pulmonary
Diseases of Vojvodina, Asthma Department, Sremska Kamenica, Serbia
and Montenegro; 2Institute for Pulmonary Diseases of Vojvodina, ICU,
Sremska Kamenica, Serbia and Montenegro; 3Institute for Pulmonary
Diseases of Vojvodina, Oncology Department, Sremska Kamenica, Serbia
and Montenegro.
A severe exacerbation of asthma is a subacute or acute episode of
asthmatic symptoms aggravation accompanied by an increased airway
obstruction, respiratory insufficiency and a greater risk of complications.
Pneumomediastinum and subcutaneous emphysema are rare but well-known
complications of acute asthma. The generally accepted explanation for the
development of pneumomedistinumis that free air tracks from ruptured alveoli
along peribronchial vascular sheaths toward the hilum of the lung. From there,
it extends proximally within the mediastinum. Atelectasis of the lungs is due to
the formation of mucous plugs and usually responds well to the treatment of
the underlying disease. This is a csse report of a 47-year old female patient
L.D., who developed pneumomedistinum and atelectasis in the course of a
severe asthma exacerbation. The patient has a 27-year long history of asthma
and in 2004 she was vitally endangered and mechanically ventilated. In the
course of this exacerbation, she developed progressive dyspnea, cough and
fever. During acute coughing, an edema and crackles developed in the face,
neck and chest regions, accompanied by a sudden deterioration of dyspnea,
tachypnea and cyanosis. The arterial blood gas analysis at rest revealed a severe
manifested partial respiratory insufficiency, and the chest X-ray established
subacute emphysema. As no satisfactory regression of the disease was
achieved, the chest CT scanning was performed on the eighth day, revealing
atelectasis of the posterobasal left lung segment. Conclusion: pneumome-
diastinum and atelectasis are rare but possible complications which may
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accompany a severe asthma exacerbation. Dramatic in appearance, they
usually have a benign course and good response to conservative treatment.
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Bronchial asthma in surgical patients
Serge Chooklin, Roman Vatseba, and Ihor Bihalskyy. Medical University,
Departments of Immunology, Surgery, Lviv, Ukraine.
Background: The respiratory complications in patients undergoing the
abdominal surgery frequently develop and aggravate course on the presence in
these patients the bronchial asthma. Mechanisms of its pathogenesis and
possible ways of prophylactic remain the debatable. By that, the important role
plays cytokines, chemokines, adhesion molecules.
Methods: The blood levels of interleukins 4, 5, 8, 13, 16, 18, eotaxin,
myeloperoxidase, VCAM-1, IgE were measured in patients with bronchial
asthma, which underwent upper abdominal surgical intervention. Concentra-
tions of some cytokines were measured by bronchoalveolar lavage. Results of
investigation in patients without asthma who underwent surgery were regards
as control.
Results: The increasing of IL-5, 8, 16, 18, VCAM-1, IgE, eotaxin,
myeloperoxidase serum levels was noted in asthmatic patients. The level of
IL-13 decreased in these patients simultaneously. The high levels of IL-8 and
myeloperoxidase were noted in bronchoalveolar fluid. These changes was
more significant be respiratory complications (pneumonia, edema). Asthmatic
patients with bacterial infection had significantly higher serum MPO and IL-8
levels in compared with asthmatic patients without infection.
Conclusion: Inhibition synthesis of proinflammatory cytokines, chemokines
is an important link in the prevention of respiratory complications during
surgery in patients with asthma. The applying of IL-13 and interferon gamma
may be a perspective in this view.
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Etiology of chronic cough in a population of children reffered to
a pulmonologist
Mohammed Herrag, and Mustapha Iraqui. IBN Sina University Hospital,
Allergology-Pulmonology, Rabat, Morocco.
Chronic cough, has been estimated to affect 7 to 10p.100 of children.
When the diagnosis proves elusive, children with chronic cough are often
referred to a paediatric pulmonologist for consultation to determine the reason
for chronic cough. During the period from July 1994 to June 2005, 160
children were referred for chronic cough (longer than 3 week’s duration). The
mean age at presentation with chronic cough was 6 years. there were 83 girls
and 77 boys. The most cause of chronic cough in this series was asthma in
48p.100. Other causes are gastro oesophageal reflux in 28p.100, tuberculosis
in 8p.100, bronchiectasis in 8p.100, sinusitis in 5p.100 and psychogenic cough
in 2p.100. cough resolved after evaluation and treatment in all cases
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A family with irritant cough from March 2007
Mojgan Kiani Amin, and Fatemeh Bagherabadi. Qazvin Medical University,
Allergy and Immunology, Qazvin, Islamic Republic of Iran.
Background: Cough is a reflex response of the lower respiratory tract to
stimulation of irritant or cough receptors in the airways mucosa. The most
common cause in children is reactive airways(asthma). Specific lower
respiratory stimuli include excessive secretions, aspirated foreign material,
inhaled dust particles or noxious gases,and a inflammatory response to
infectios agents or allergic processes. Useful information that may aid in
distinguishing the cough origin may include a history or family history of
atopic conditions (asthma, eczema, urticaria, allergic rhinitis) a seasonal or
environmental variation in frequency or intensity of cough.
Case Report: We presented 3-members of a family with chronic cough (more
than 6-weeks duration) which started after an upper respiratory tract infection
and coninued in spite of antibiotic and bronchodilator therapy, In their past
history there was not any atopic condition, The young son had difficult
breathing especially in their house and got better outside, In allergy clinic we
couldn t find wheezy breathing in rest and also after activity in their son, and
PFC tests were in normal limits for parents, (the 4-year-old boy was
incooperative) In the next step (and second visit) when they admitted in
emergency ward we could find a problem in their house, they had been using a
wall heater and its airway has been closed by a bird nest. They were exposed to
noxious gases for a long time.
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Montoux test in BCG-vaccined children with asthma
Soheila Alyasin. Nemazee hospital, Pediatrics-Allergy and clinical immunol-
ogy, Shiraz, Islamic Republic of Iran.
Introduction: Recent studies have proposed a decline in tuberculosis
infection is a factor underlying the rising severity and prevalence of atopic
disorders in developed countries. There are also conflicting reports on the
effect of Bacillus Calmette-Guerin (BCG) vaccination on the subsequent
development of atopy and asthma. BCG as the most potent inducer of TH1 is
believed to suppress TH2 dependent atopic reaction.
Methods: Trying to prove this hypothesis, in a case-control simple sampled
100 patients younger than 5 years old who were known case of asthma with
variable severity received 5 units intradermal tuberculin test. The patients were
also BCG- vaccined at birth. As the control group 100 healthy children
previously vaccined at birth, whowere age-adjusted with case group, were also
test with tuberculin test (PPD). After 48 hours, induction area was measured in
two vertical and longitudinal diameters. At the same time, the severity of
asthma in the case group was determined (according to classification of
National Institutes of Health, National Institutes of Heart, lung and blood), by
asking mothers about the frequencies of night and day symptoms or intervals
of attacks. The patients were divided to three groups: Mild, Moderate and
severe groups (mild intermittent and mild persistent groups were classified as
one group).
Results: In our case group, mean size of PPD skin test response was
1.7mmT2.99mm but in the control group mean size was 4.42mmT3.69mm(
pG0.0001). Also in another test we divided our case group to two groups ; PPD
skin test less than 5mm and more than 5 mm; again with a significant P value.
Conclusion: As a conclusion, patients with definite asthma had a significant
weaker response to PPD test. This is indicator of weaker TH1 response in
allergic patients, can be proposed that stimulation of TH1-immune system by
BCG vaccination at birth can influence subsequent development of allergic
diseases dominantly mediated with TH2-Immune system. This may promise a
revolution in the future of asthma. Regarding the severity of asthma, no
significant evidence supported the relation between severity of asthma and
PPD skin test response, it may be explained by dominancy of moderate asthma
group.
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Relationship between coronary spasticity and airway
responsiveness in patients with coronary spastic angina
Inga Fedotova, Valeriya Nemtsova, and Irina Feclina. Kharkov Allergological
Centre, Allergology, Kharkov, Ukraine.
Background: Several reports have suggested a possible link between
bronchial asthma and coronary spasm, but the possibility of a relationship
in coronary spastic angina (CSA) has not been clarified.
Methods: Airway responsiveness to methacholine and coronary spasticity to
acetylcholine were examined in 39 patients with CSA and 28 patients with
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chest pain syndrome (CPS). Sixteen healthy subjects as the control group were
enrolled in the study and their airway responsiveness compared with that of the
CSA and CPS patients.
Results: The incidence of airway hyperresponsiveness was significantly
higher in the CSA group (71%) than in the CPS (21%) and control (16%)
groups (pG0.001). The geometric mean of the log minimum dose (Dmin),
defined as the cumulative dose at the point at which respiratory conductance
began to decrease, was significantly lower in the CSA group (0.73 log units)
than in the CP (1.18 log units) and control (1.41 log units) groups (pG0.01).
Conclusion: Results of this study demonstrate that acetylcholine-induced
coronary spasticity is significantly related to methacholine-induced airway
responsiveness in patients with coronary spastic angina. A generalized
hyperresponsiveness of the vascular and nonvascular smooth muscles,
including that through cholinergic mechanisms, may exist in patients with
coronary spastic angina.
784
GERD and anxiety in patients with severe COPD
Sherif Alsayed1, and Khalid Elnagar2. 1New Jeddah Clinic Hospital, Chest
Departement, Jeddah, Saudi Arabia; 2New Jeddah Clinic Hospital, Internal
Medicine, Jeddah, Saudi Arabia.
Objectives: To detect the impact of anxiety on shaping the prevalence of
gastro-intestinal reflux disease (GERD) in patients with sever chronic
obstructive pulmonary disease (COPD) based on FEV1 % less than 50%.
Methods: We examind the prevalence of symptomatic GERD ,using the
Vigneri score, cough and dyspnoea with the modified Medical Research
Council questionnaire in 29 male patients with COPD. Esophageal 24 h pH
monitoring was used to document the diagnosis of GERD in symptomatic
group. Beck Anxiety inventory was used to figuer out the impact of anxiety on
expressing GERD Symptoms.
Results: Reflux disease symptoms was recorded in eighteen patients of the
studied group (62%). GERD was diagnosed, based on esophogial 24 h PH
monitoring, in only 11 patients of those who expressing symptoms of GERD.
Mean of Anxiety score was higher among symptomatic group than non
symptomatic reflecting the attribution of differnt symptoms of anxiety to the
GERD syndrom.
Conclusion: Patients with severe chronic obstructive pulmonary disease have
a high prevalence of symptomatic gastro-oesophageal reflux. However True
GERD was documented in a fewer number of them. Psychological factors,
such as anxiety and somatisation may play a role, particularly in those patients
without esophageal inflammation.
785
An experimental study on effect of antioxidants on pulmonary
functions of smokers
Kazi S. Bennoor1, Noorzajan Begum2, Taskina Ali2, Chowdhury G.E.
Mostafa2, M. Rashidul Hassan3, Asif M. Mahmud3, and M. Ali Hossain3.
1National Institute of Diseases of Chest and Hospital, Respiratory Medicine,
Dhaka, Bangladesh; 2Bangabandhu Sheikh Mujib Medical University,
Physiology, Dhaka, Bangladesh; 3National Institute of Diseases of Chest
and Hospital, Respiratory Medicine, Dhaka, Bangladesh.
Backround: Cigarette smokes contain large number of free radicals, which
cause oxidative damage of airways and lower lung functions. A prospective
interventional study was carried out to observe the effects of supplementation
with antioxidant vitamins on lung functions of smokers.
Methods: 200 healthy male smokers were divided into 4 equal groups of
whom 3 groups were supplemented daily with either vitamin A 10,000IU or
vitamin C 500mg or vitamin E 200mg and 4th group with combination of all
three in same dose for 2 months. FVC, FEV1, FEV1/FVC and PEF were
measured at beginning, after 2 months of supplementation and at the end of
next 6 months without supplementation.
Results: After 2 months all groups showed significant improvement of all
measured parameters lung functions. The difference of improvement among
various supplementation groups was not significant. However, combined
vitamins yielded higher trend of improvement. All groups showed decline of
lung functions at the end of six months without supplementation indicating
insignificant retention effect.
Conclusion: Clinicians may prescribe anti-oxidant supplementations for
smokers to improve their lung functions. However, these supplementations
should be given for a long period as no significant retention effect was
detected.
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Symptom-limited stair climbing as a valuable predictor of
postoperative cardiopulmonary complications after
thoracic surgery
Magdy Ibrahim1, Nancy Mahmoud Abdelaty2, and Mahmoud Elprince2.
1Faculty of Medicine, Suez Canal University, Cardiothoracic Department,
Ismailia, Egypt; 2Faculty of Medicine, Suez Canal University, Chest
Department, Ismailia, Egypt.
Study objective: Thoracotomy is associated with high rate of postoperative
cardio-pulmonary complications (POCs). We hypothesized that symptom-
limited stair climbing predicts POCs after thoracic surgery.
Methods: A prospective evaluation of 40 patients undergoing thoracotomy.
The 28 men and 12 women completed symptom-limited stair climbing. A
separate investigator, blinded to the number of flights of stairs climbed,
assessed 30-day actual outcomes for POCs, including pneumonia, atelectasis,
mechanical ventilation for 9 48 h, reintubation, myocardial infarction,
congestive heart failure, arrhythmia, pulmonary embolus, and death within
30 days of surgery. The operations performed included 30 lobectomies, 1
wedge resection, 1 pneumonectomy, and 8 decortications.
Results: POCs occurred in 12 of 40 patients (30%). Of those unable to climb
one flight of stairs, 85.5% developed a POC. No patient able to climb the
maximum of five flights of stairs had a POC. The inability to climb two flights
of stairs was associated with a specificity of 92%, negative predictive value of
81% and positive predictive value of 75% for the development of a POC, while
the inability to climb the maximum of five flights of stairs was associated with
a sensitivity of 100% and negative predictive value of 100% for the
development of a POC. The number of days in the hospital postoperatively
decreased with a patient_s increased ability to climb stairs.
Conclusion: Symptom-limited stair climbing offers a simple, inexpensive,
valuable means to predict POCs after thoracic surgery.
787
Hepatopulmonary syndrome among patients of cirrhosis of liver
and portal hypertension
Nancy Mahmoud Abd-Elaty1, Gamela Nasr2, Azza El Eraky2, and Abd El
Hameed Serwah3. 1Faculty of medicine, Suez Canal University, Chest
Department, Ismailia, Egypt; 2Faculty of medicine, Suez Canal University,
Cardiology Department, Ismailia, Egypt; 3Faculty of medicine, Suez Canal
University, Medicine Department, Ismailia, Egypt.
Background: The hepatopulmonary syndrome(HPS) is characterized by a
clinical triad of liver disease, pulmonary gas exchange abnormalities leading
to arterial deoxygenation, and widespread pulmonary vascular dilatation
(IPVD).
Objectives: The study was undertaken to understand the frequency and
clinical and pulmonary functional characteristics of (HPS)among patients with
chronic liver disease.Methods:We studied 90 patients for the presence of HPS
using two-dimensional transthoracic air contrast echocardiography(CE)for
detection of pulmonary vasodilation, pulmonary function tests and Arterial
blood gas analysis.Those patients in whom(CE)showed intrapulmonary
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vascular dilatations were classified as the positive group while others were
labeled as the negative group.
Results: 90 patients were included in the study, of whom 24 (26.66%) had a
positive(CE); 12(13.33%) of them were found to have PaO2G70 mmHg and
were qualified for the diagnosis of ‘‘clinically significant’’ HPS;and other
12(13.33%) with PaO2970 mmHg were diagnosed as ‘‘subclinical HPS’’.
Using an increased alveolar-arterial difference for the partial pressure of
oxygen (AaDO2) as an indication of hypoxaemia,the prevalence of HPS
was considerably higher (915 mm Hg,(26.66 %); and920 mm Hg,(22.22%);
than using reduced partial pressure of arterial oxygen (PaO2) as a threshold
(G80 mm Hg, 20.0%; andG70 mm Hg, 13.33%). For AaDO2 as the cut off, the
positive predictive value for a diagnosis of HPS was low (35.29%, and 38.46%
respectively). In contrast, PaO2 as a cut off had considerably higher positive
predictive values (52.94%, and 75% respectively). Introducing PaO2G60mmHg
as the cut off, the positive predictive value increased to 100%. The Child-Pugh
score correlated significantly with the severity of HPS. Cyanosis, clubbing and
orthodeoxia were significantly commoner in the 12 patients of clinically
significant" HPS.
Conclusion: The study results showed presence of HPS and (IPVD)among
patients of chronic liver disease.
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Expression of c-met in malignant pleural mesothelioma: an
immunohistochemical study
Heba M. Wagih1, Amira Gamal2, Nancy Mahmoud Abdelaty3, and Ayman
Ekram2. 1Faculty of medicine, Suez Canal University, Pathology Department,
Ismailia, Egypt; 2Faculty of medicine, Suez Canal University, Puplic Health
Department, Ismailia, Egypt; 3Faculty of medicine, Suez Canal University,
Chest Department, Ismailia, Egypt.
Background: Most patients with malignant pleural mesothelioma present in
advanced stages of disease. Response rates and survival with currently
available therapies are poor. Therefore, it is critical to identify the molecular
markers of mesothelioma which would provide a way of understanding this
neoplasm and targeting these markers in therapy.
Objectives: To assess the immunoreactivity of c-Met in malignant pleural
mesothelioma and to analyze the potential link of the c-MET expression to
some clincopathological parameters such as tumor subtype, TNM stage and
patients’ survival. Methods: A total of 20 patients (7 females and 13 males)
with pathologically confirmedMPM; age range, (35 to 63 years) were included
in the study. The patient records for the clinical, radiological and laboratory
investigations and the results of closed pleura biopsies were analyzed. Pleura
biopsies were stained for c-Met using immunohistochemical technique applied
to paraffin sections.
Results: Of the studied tumors 18 (90%) were immunoreactive for c-Met.
There were no significant relations between c-Met and patient age (p=0.569) or
gender (0.755). Also there was no relation between c-Met expression and
clinical symptoms. All tumors that showed distant metastasis were c-Met
positive. While all c-Met negative tumors showed no metastasis. However, the
difference was statistically insignificant. There was also no relation between c-
Met and tumor subtype (p=0.40) or tumor stage (p=0.257). However, all T3
and T4 tumors were c-Met positive and the two c-Met negative tumors were of
T2. The 2 c-Met negative patients showed one-year survival. Whereas (7/18)
of patients with positive c-Met died. However, again the difference was
statistically insignificant (p=0.755).
Conclusion: c-Met receptor was expressed in a high proportion of MPM. It
may have a significant role in the development of MPM and could be a
beneficial target for therapy. Though there was no statistically significant
relation between c-Met expression and one-year survival or with different
prognostic factors in MPM, we observed more c-met expression in more
extensive cases and more deaths in c-Met positive cases. Additional larger-
scale studies of MPM are needed to confirm the prognostic role of c-Met
expression.
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Elevated c-reactive protein in patients with obstructive sleep
apnea hypopnea syndrome (OSAH)
Nancy Mahmoud Abdelaty1, Mahmoud Elprince1, Nanees A. Ismail2,
Waleed El-Sirougi3, and Mousa Elshamly4. 1Faculty of Medicine, Suez
Canal University, Chest Department, Ismailia, Egypt; 2Faculty of Medicine,
Ain Shams University, Puplic Health Department, Cairo, Egypt; 3Faculty of
Medicine, Cairo University, Chest Department, Cairo, Egypt; 4Faculty of
Medicine, Al Azhar University, Chest Department, Cairo, Egypt.
Background: Sleep disordered breathing (SDB) is a prevalent condition in
adults associated with increased cardiovascular morbidity. Circulating levels
of C-reactive protein (CRP), a pro-inflammatory protein, are associated with
increased risk for atherosclerosis.Therefore, CRP may be one of the links
between OSAH and cardiovascular disease (CVD).We hypothesized that
Patients with OSA have higher CRP values than do control subjects.
Methods and Results: We studied 28 patients (20 males and 8 females ) with
newly diagnosed (OSA), who were free of other diseases, had never been
treated for OSA, and were taking no medications. After polysomnography,
venous blood was collected at 5 AM and serum levels of CRP were
investigated. We compared CRP measurements in these patients to measure-
ments obtained in 20 control subjects (14 males and 6 females ) who were
matched for age and body mass index, and in whom occult OSAwas excluded.
Levels of CRP were significantly higher in patients with OSAS than in obese
control subjects (CRP PG0.000). We evaluated relationship between the Levels
of CRP and sleep study parameters such as Apnea Hypopnea Index (AHI),
Desaturation Index(DI), Average of Mean Saturation ,Average of Lowest
Saturation (LSAT) and Percentage of Sleep Time with Saturation less than 90
%. The results showed significant statistical positive correlations between CRP
values and AHI (pG 0.00), DI (pG 0.00) and percentage of sleep time with
saturation less than 90 % (pG 0.00) in the OSAS patients.
Conclusion: Levels of CRP are elevated in patients with OSAS. Therefore,
OSAS is associated with increased risks for cardiovascular morbidity and
mortality. The severity of OSA is proportional to the CRP level.
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Validity of multidimensional body mass index (B), airflow
obstruction (O), dyspnea (D) and exercise capacity (E), bode
index as predictor of hospitalization for COPD
Nancy Mahmoud Abdelaty1, Mahmoud Elprince1, Nanees A. Ismail2, and
Magdy Abd-Elsalam3. 1Faculty of Medicine, Suez Canal University, Chest
Department, Ismailia, Egypt; 2Faculty of Medicine, Ain Shams University,
Puplic Health Department, Cairo, Egypt; 3Faculty of Medicine, Ain Shams
University, Chest Department, Cairo, Egypt.
Background: We hypothesized that the BODE (body mass index, airflow
obstruction, dyspnea, and exercise capacity) index would better predict
hospitalization for COPD than FEV1 alone. Study objectives: the purpose of
this study was to test in a cohort of patients with COPD, how well a
multidimensional grading system that assessed the respiratory and systemic
expressions of COPD would better categorize and predict outcome in these
patients. Patients: A total of 150 patients with COPD(ages 45-83 yr; 89%
male) recruited from the outpatient clinic of Suez Canal University Hospital
were enrolled in 30 months, prospective study and followed up for a mean
period of 12 months from January 2004 YJune 2006.
Measurements: The BODE index was calculated for each patient using
variables obtained within 4 weeks of enrollment. The main outcome measure
was the number of hospital admissions for COPD during follow-up. The
following variables were assessed for each patient: age, sex, pack years of
smoking, FVC%, FEV1%, the best of two 6 minute walk tests done 30 minutes
apart, degree of dyspnea, body mass index (BMI). We evaluated the
relationship between FEV1%, the level of dyspnea, BMI, the best of two 6
minute walk tests done 30 minutes apart and BODE scores with the number of
hospital admissions.
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Results: After 30 months, 126 patients were available for the follow-up
examination (follow-up rate, 84 %). During the follow-up period, 85 (67%) of
patients required at least one hospital admission and 6(4.8%) died. In
multivariate analysis a significant effect of BODE score on the number of
hospital admissions was found (95% confidence interval [CI], 0.36 to 0.61; pG
0.000). In comparison, there was a significant but smaller effect of the pack
years of smoking, BMI and BMI score on the number of hospital admis-
sions {(95% confidence interval [CI], 0. 03 to 0.05; pG 0.000), (95% CI,-0.32
to-0.09; pG0.01) and (95% CI,-1.6 to-0.12; pG0.05) respectively}. FEV1%, the
level of dyspnea, and 6 minute walk test were significant predictors of
hospitalization in univariate analysis (pG0.000) but were excluded in
multivariate analysis.
Conclusion: The BODE staging system, which includes in addition to FEV1
other physiologic and clinical variables, is a better predictor of hospital
admissions than FEV1 in COPD.
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Acute and chronic eosinophilic pneumonia-our own experience
with diagnosis and treatment
Jan Plutinsky, Daniel Magula, Stefan Petricek, Dana Laukova, Stanislav
Majernik, and Ivan Marget. Specialized Hospital St.Zoerardus, 2nd
Pneumology, Nitra, Slovakia.
Eosinophilic pneumonia (EP) is a rare disease. Some EP may result
from other diseases, while in others the cause is unclear. EP is divided
into acute (AEP) and chronic (CEP) forms.
The aim of the study: The authors share their own experience with the
diagnosis, differential diagnosis and treatment of AEP and CEP.
Methods: Since 1995, AEP or CEP have been diagnosed in 21 patients (pts).
Clinical examination, radiograph, CT or HRCT scan, laboratory examinations
with peripheral blood count of eosinophils (Eo), microbiology, mycobacter-
iology, fiberbronchoscopy or histology were used. The pts were divided into
two groups: AEP and CEP. The ANOVA and Kruskal-Wallis tests were used
for statistical analysis.
Results: 13 female, median age 66 yrs (36Y87) and 8 male, median 67 yrs
(55Y85) had one of the two forms: AEP in 7 pts and CEP in 14 pts. The main
clinical symptoms were dyspnoe in 20 pts (95.2%), cough in 19 pts (90.5%),
fever in 17 pts (80.9%), pain in 5 pts (23.8%). AEP or CEP was the result of
concomitant disease in 3 pts with toxoplasmosis and in 1 pt. with sarcoidosis,
rhinitis and allergic bronchopulmonary aspergillosis. In 15 pts no concomitant
disease was identified. A statistical significance was found between the age of
pts with AEP (56T12.2) and CEP (67.8T12.9) (pG0.05). There were no
statistically significant differences between the absolute Eo count in male
(614.8T279.3) and female (709.3T811.3) and in the groups of AEP
(860.7T976.7) and CEP (579.6T429.3). 9 pts have been continually treated
with corticosteroids, 8 pts temporarily and 4 pts have not received any treatment.
The longest treated patient has been receiving corticosteroid for more than 9 yrs.
Conclusion: EP is a very interesting disease. The clinical symptoms are
similar to typical pneumonia, but treatment with antibiotics is unsuccessful.
The treatment with steroids is determined on an individual basis. Dividing
AEP and CEP is not so clear cut. We could consider using the results of
corticosteroids treatment as a way dividing AEP and CEP since the treatment
in AEP is only temporary and in CEP on-going.
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Bone mineral density changes in male patients with chronic
obstructive pulmonary disease: clinical and biochemical
variables in correlation with glucocorticoids use
Sherif Alsayed, and Essam Mousa. New Jeddah Clinic Hospital, Internal
Medicine, Jeddah, Saudi Arabia.
Recent studies have shown that osteoporosis and vertebral fractures are
quite common in postmenopausal women with chronic obstructive pulmonary
disease (COPD). Few data are available in correlation between bone mass
density (BMD) and men with COPD.This study was designed to investigate
the prevalence of osteoporosis in men with COPD. with special regards to the
role of glucocorticoids (GCs) use in these patients. We aimed to determine
factors that influencing bone metabolism and the clinical variables of this
group of patients. We also tried to answer the arising question: should COPD
patients be routinely evaluated for BMD?
Methods: The study included 56 male patients with documented COPD for at
least two years, their age ranged 24-66 years. Subjects were divided into 3
groups: group 1. consisted of 18 patients, who were oral GCs users, group 2.
consisted of 18 patients who were inhaled GCs users and group 3. consisted of
20 patients, never GCs users (this group was considered as the control group).
All subjects underwent measurement of BMD. pulmonary function tests
(PFTs) and a number of biochemical markers of bone metabolism. The
associations between BMD. PFTs. GCs use. biochemical markers and clinical
variables were analyzed.
Results: Of all 56 patients with COPD. the prevalence of osteopenia and
osteoporosis. as defined by WHO criteria was 26.8% and 21.4% at the lumber
spine. 30.4% and 23.2% at total hip. 35.7% and 28.5% at femoral neck and
32.1% and 28.8% for total body respectively. Patients included group 1 had the
lowest BMD at any site (pG0.0001). group 2 patients had over all bone mass
loss, that was indistinguishable from those who were received oral GCs. group
3 patients had less bone mass reduction than the other two groups. Of the
clinical and biochemical markers measured. N-telopeptide was significantly
correlated with bone mass (PG0.01), but there was no correlation with other
markers. The lowest mean of FEV1 (Forced Expiratory Volume in one second)
was observed in group 1 patients. BMI (Body Mass Index) was weakly
correlated with bone mass in the 3 studied groups.
Conclusion: Bone mass loss is a common problem in male patients with
COPD. while the use of oral GCs increase the frequency of osteoporosis,
inhaled GCs therapy offered no protection from bone loss. COPD patients who
had never treated with GCs had also a substantial risk for osteoporosis. We
advocate early screening and preventive intervention.
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Psychotherapy improve exercise tolerance in patients with Pink
Puffer syndrome
Alsayed Sherif, and Khaled Elnagar. New Jeddah Clinic Hospital, Internal
Medicine, Jeddah, Saudi Arabia.
Anxiety is common in the ‘‘pink puffer’’ syndrome associated with
chronic obstructive pulmonary disease (COPD). The degree of anxiety
correlates well with perceived dyspnoea. This study examines the effect of
psychotherapy on anxiety, exercise tolerance, and dyspnoea. 10 patients with
stable COPD (mean forced expiratory volume in one second (FEV1)=1.25 L)
had six 90 min sessions of cognitive and behavioural psychotherapy at weekly
intervals. Patients completed the Beck Anxiety Inventory (BAI), 1 day before
and 1 weeks after therapy. FEV1, forced vital capacity (FVC), blood gas
tensions and 6 min walking distance (6MWD) were measured. 10 control
patients attended weekly for lung function and 6MWD for 6 weeks, but had no
psychotherapy. There were no differences in mean baseline (BAI) score, lung
function, blood gas tensions or 6MWD between groups. After treatment, the
BAI score had decreased from 43.10 to 20.6 (pG0.001), in association, the
mean 6MWD had also improved in the psychotherapy group only, from 333 to
559 m (pG0.001), an increase of 75%. In conclusion, six sessions of cognitive
and behavioural psychotherapy produced a good improvement in exercise
tolerance in anxious patients with chronic obstructive pulmonary disease
(Pink puffer).
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Exhaled breath analysis with electronic nose in patients with
lung cancer, chronic obstructive pulmonary disease, asthma
and pneumonia
Immanuels Taivans1, Normunds Jurka2, Uldis Kopeika3, Maris Bukovskis4,
Vadims Ogorodniks5, and Janis Kleperis5. 1University of Latvia, Faculty of
Medicine, Riga, Latvia; 2University of Latvia, Institute of Experimental and
Clinical Medicine, Riga, Latvia; 3Pauls Stradins Clinical University Hospital,
Department of Thoracic Surgery, Riga, Latvia; 4Pauls Stradins Clinical
University Hospital, Department of Pulmonology and Allergology, Riga,
Latvia; 5University of Latvia, Institute of Solid State Physics, Riga, Latvia.
Background: Since developement of electronic nose (EN), it has been well
recognized that there is a great potential in applying this technology to the field
of medicine. Analysis of various biomarkers in exhaled breath allows com-
pletely safe, noninvasive, sensitive, and specific tool for the primary screening
for different lung diseases. The aim of this study was to test whether exhaled
breath analyzed with artificial nose could identify and discriminate between
asthma, COPD, lung cancer and pneumonia.
Methods: Exhaled air was collected in plastic bags and immediately analyzed
by electronic nose instrument (9185, Nordic Sensors AB) containing 14
different odour sensors. Multifactorial logistic regression analysis and support
vector machine was used to find relationships between the sensor response, on
derivative, on integral and the clinical diagnoses of patients.
Results: 62 individuals Y 25 asthma, 13 lung cancer, 13 pneumonia, 12 other
lung disease patients and 10 healthy volunteers were tested. Given table re-
presents p values of significant relationship between electronic nose sensors
and clinical diagnosis. Some sensors (1, 6, and 13) gave specific responses
to particular disease; some other sensors (3, 5, and 7) shared the response with
two diseases. The highest sensitivity and specificity was found for lung cancer
diagnosis compared to healthy control group It was 100% and 92,9%
respectively.
Conclusion: Artificial nose is able to discriminate among different lung
diseases. Further development of this approach is necessary to create new
screening and monitoring methods for different lung diseases.
AEROBIOLOGY
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Proteolytic activity of Per a 10 from Periplaneta americana
enhances allergenicity in a mice model
Thangam sudha V, Naveen Arora, and Bhanu P Singh. Institute of Genomics
and Integrative Biology, Allergy and Immunology, Delhi, India.
Background: Cockroach allergen sensitization has been implicated as a major
cause of allergy/asthma. Recently we have demonstrated a serine protease (Per
a 10) as an immunodominant allergen from Periplaneta americana (American
cockroach). So, we aimed to investigate the immune-inflammatory responses
to active serine protease in mice model of airway inflammation.
Methods: Balb/c mice were sensitized with proteolytically active allergen or
OVA through intraperitoneal and subcutaneous routes and challenged
intranasally with Per a 10 allergen (active / inactive), PBS or OVA. The cel-
lular infiltration (total cell count and EPO activity in BALF), Th1/Th2 cyto-
kines in BALF and spleen culture supernatant, serologic (specific IgE, IgG1)
and histopathologic events in the various animal groups were compared.
Results:Mice challenged with active serine protease allergen or OVA showed
tissue damage in the lungs, elevated serum IgE, IgG1, eosinophils and ex-
pression of inflammatory cytokines (IL-4, IL-5) in BALF and spleen culture
supernatant, indicating the induction of a Th2 response. Administration of
proteolytically inactive allergen (blocked irreversibly with AEBSF) induced
significantly lower levels of cellular infiltration in lungs, systemic IgE
production and Th2 cytokines. Quantitative evaluation of lung tissues showed
decrease in total inflammation score in mice challenged with inactive
protease.
Conclusion: Serine protease allergen from P. americana induces allergic
response in a mice model and its proteolytic activity enhances the airway in-
flammation. The inactivated allergen may have potential for therapeutic
applications.
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Cassia siamea pollen: an important aeroallergen of
tropical countries
Dola Boral1, Kashinath Bhattacharya2, Sunirmal Chanda3, and Swati Gupta-
Bhattacharya4. 1Krishnath College, Department of Botany, Berhampore,
India; 2Visva Bharati University, Department of Botany, Santiniketan, India;
3Center for Study of Man and Environment, Department of Environment,
Saltlake, India; 4Bose Institute, Department of Botany, Kolkata, India.
Background: It is well known that allergy in India and other countries appear
to be one of the commonest major health problems. Cassia siamea Lam. of the
family Fabaceae is an important avenue tree in tropics. Its pollen grain has been
known as one of the important pollinosis causing airborne bioparticles. The
present studywas demonstrated to identify its important allergenic components
and also to study the cross reactivity between the members of the family
Fabaceae.
Methods: The seasonal periodicities of airborne Cassia pollen were recorded
in a 2-year aerobiological survey using a seven-day Burkard volumetric
sampler (Burkard manufacturing Co., Rickmansworth, Herts, England). The
allergising potential of Cassia pollen antigen was investigated by in vivo skin
prick tests and in vitro IgE-enzyme linked immuno sorbant assay (ELISA).
The IgE specific immunoblotting confirm the IgE sensitive reaction between
the pollen allergen and patient`s sera. In the present study, the whole pollen
extract of C. siamea pollen was characterized by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE). The presence of glycopro-
tein in the crude allergenic extracts of Cassia siamea pollen was detected by
PAS (Periodic Acid Schif) technique.
Results: An intensely positive result (+++) was observed in response to SPT
with the antigenic extract of C. siamea pollen. Within 175 patients 30.85 %
shows positive allergic reactions. Immunochemical studies revealed the
presence of ten allergenic components in the molecular weight ranging
between 8Y83 KDA. Three major allergenic protein bands (22, 17, 9 KDA)
were isolated by IgE-specific immunoblotting with individual sensitive patients
sera. Crude pollen extract of C siamea showed four bands of molecular weight
89, 66, 55 and 19 KDA contain glycoprotein. In the present study, the result
AACXKNCX;’NKCLK
Sensor Nb. Lung cancer COPD Asthma Pneumonia
1 0.957027 0.350632 0.039670 0.072061
3 0.073306 0.082622 0.003552 0.005401
5 0.030928 0.822417 0.236019 0.021888
6 0.038484 0.070998 0.457104 0.241149
7 0.046645 0.136587 0.092022 0.017031
13 0.088195 0.740809 0.079040 0.023023
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of dot blotting analysis indicated the presence of cross-reacting allergens in
the relevant pollen extracts between the members of the Fabaceae family.
Conclusion: The aerobiological, clinical and immunological studies demon-
strated that C. siamea pollen is an important aeroallergen to cause respiratory
disorders in the area of their occurrence. Immunochemical studies with cassia
siamea pollen revealed three major allergenic components which will be
helpful for the clinicians for treatment of allergy.
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Human sensitization to different species of brassica (mustard)
pollen in India
Anand B Singh1, Shipra Shahi1, Shakuntla Lavasha2, Surendra Gaur3,
Vikram Jain4, Ashok Bhatnagar5, and Anand B Singh6. 1Institute of Genomics
and Integrative Biology, Allergy and Aerobiology Laboratory, Delhi, India;
2AllergyDiagnostic Centre, Sector 17, Chandigarh, India; 3V PChest Institute,
Respiratory Medicine, Delhi, India; 4S P Medical College, Pulmonary Medi-
cine, Bikaner, India; 5Delhi University, Dept of Botany, Delhi, India;
6Institute of Genomics and Integrative Biology, Allergy and Aerobiology,
Delhi, India.
Backed by the legacy of India`s 5000-year-old civilization, Rape-
seed- mustard is the second most important source of edible oil in India. On
the Indian subcontinent, B. campestris and B. juncea are extensively
cultivated but can share the same growing areas with B. nigra and B. napus
as well. A systematic evaluation of allergenic properties of the various
species of Brassica has been lacking. Therefore, the present work was
aimed at assessing the sensitization as well as heterogeneity in the
allergenicity of pollen of the four widely cultivated species of Brassica in
India. Allergen extracts from pollen of Brassica were prepared from four
different species of Brassica. Skin prick test was performed with the
aqueous extracts of mustard pollen and other common inhalant allergens in
159 atopic cases suffering from bronchial asthma and allergic rhinitis and
referred to allergy units for treatment. Among four species of Brassica
pollen, B. campestris is the highest sensitizer (2+ and above) showing skin
prick response in 13.20% cases, followed by B. juncea (11.94%) . B. nigra
and B. napus pollen showed positivity in 5. 0 % and 4.4% cases
respectively. Raised specific IgE in cases positive to pollen are 0.2795 +
0.08423 to B. campestris, 0.3025 + 0.1137 to B. juncea, 0.3380 + 0.1128 to
B. nigra and 0.3430 + 0.1648 to B. napus respectively based on O.D values.
Immunoblotting of B. campestris, showed 20, 25, 32, 37, 56, 76, 87 and 90
proteins as major allergens (more than 70% of cases). In B. juncea, however
individual heterogeneity was observed and proteins of mol wt 14, 20, 25,
32, 37, 56 and 90 kD were major (more than 70% of cases). IgE binding
proteins of B. nigra and B. napus were also identified. Thus, we conclude
that the pollen from four different species of Brassica grown in India lead to
sensitization in atopic patients.
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Aerobiological and immunochemical studies on Fungal aerosol
of North Calcutta, India
Himadri Shekhar Chakrabarti1, Shaonli Das2, and Swati Gupta-Bhattacharya1.
1Bose Institute, Department of Botany, Calcutta, India; 2Raiganj University
College, Department of Botany, Uttar Dinajpur, India.
There is an increasing concern about the exposure to fungal aerosol
in our environment that results in different allergy related respiratory
disorders of the sensitive subjects. Besides allergenicity and mycotoxicity,
microbial volatile organic compounds also get released from airborne fungi,
which may cause lethargy, headache, and irritation of the eyes, nose and
throat. The objectives of the present study are to prepare a fungal spore
calendar in the air of North Calcutta, India, including their diurnal and
circadian periodicity pattern throughout the year; to study the effect of the
meteorological parameters on their frequency; and to determine the role of
these spores to cause respiratory allergy.
Burkard 7-day volumetric sampler and Andersen 2-stage viable
sampler were used to monitor the airborne fungal spore and culturable mold
concentration over the studied area continuously for four years (Nov.`02-
Nov.`06). Diagnosis of their respiratory allergic disorders was based on
detailed medical history followed by their lung function test using Spirometer,
skin prick test and measurement of specific IgE level in patients-sera by
ELISA. Healthy asymptomatic patients were taken as control. Major allergens
of the selected allergenic molds have been identified by 12% SDS-PAGE and
Immunoblotting. A total of 45 fungal spore types and 24 culturable mold types
were identified and recorded throughout the total sampling period. Air
sampling showed 14 dominant (4.5Y27% contribution) spores, among which
concentrations of Cladosporium sp, Ascospores, Basidiospores and Aspergilli/
Penicilli group are notably high. Different Aspergillus species, Cladosporium
sp, Penicillium citrinum, Trichoderma harzianum and Alternaria alternatawere
among the prevalent culturable molds (9500 CFU/m3 air) as recorded.
Common occurrence of respiratory symptoms and airway obstruction and mild
type of lung function impairment was noted. Molds like, Aspergillus niger,
A. fumigatus, Trichoderma harzeanum, Rhizopus sp etc. showed high
reactivity to the patients. From Trichoderma harzianum two major allergens
(35.48 kDa and 15.49 kDa) have been detected by Immunoblotting. The
present survey and both qualitative and quantitative information, obtained
from the study could be useful for Aerobiologists and Clinicians to forecast
fungal spore load to the atmosphere and for therapeutic studies including
allergy diagnosis.
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Regional importance of Alnus pollen as an aeroallergen:
a comparative clinical and aeropalynological study of Worcester
(UK) and Poznan (Poland) regions
Matthew Smith1, Jean Emberlin1, Alicja Stach2, Magdalena Czarnecka-
Operacz3, Dorota Jenerowicz3, and Wojciech Silny3. 1University of Worcester,
United Kingdom, National Pollen and Aerobiology Research Unit,
Worcester, United Kingdom; 2Adam Mickiewicz University, Laboratory of
Aeropalynology, Poznan, Poland; 3Poznan University of Medical Sciences,
Dermatology, Poznan, Poland.
Genus Alnus is common and widespread in Central and Northern
Europe. Major Alnus allergens (Aln gI) are known to cross react with other
members of the Fagales order.
Aim: Assesment of contrasting regional importance of Alnus pollen in
1996Y2005 within Worcester and Poznan regions, which have differing
biogeographical and climatic regimes.
Methods: Daily average Alnus pollen counts were collected using Burkard
volumetric spore trap. Furthermore we analyzed skin prick test (SPT) results
(1996Y2005) and allergen-specific IgE (asIgE) measurement results
(2002Y2005) against the above aeroallergen in patients of Allergic Diseases
Diagnostic Center at the Department of Dermatology.
Results: The average number of Alnus pollen grains recorded annually in
Poznan was more than 2.5 times that of Worcester. Furthermore, daily average
Alnus pollen counts exceeded the thresholds of 100 grains/m3, 500 grains/m3
and 1000 grains/m3 more frequently in the area of Poznan in comparision to
Worcester. Approximately 11% of the population (n = 5032) tested for pollen
allergens (SPT) presented positive results for tree pollen allergens and 430 of
these were simultaneously positive for Alnus pollens. Annual number of
positive SPT results for Alnus pollen allergens was significantly related
(pG0.05) to seasonal variations in the magnitude of the Alnus pollen catch in
Poznan region. Patients with positive SPT results for Alnus pollen allergens
were diagnosed as: pollinosis Y 51%, atopic dermatitis Y 43%, asthma Y 4%,
chronic urticaria 1% and eczema Y 1%.
Conclusion: There is an undoubtful importance of Alnus pollen allergens,
being present in high amount over Poznan region, particularly considering the
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possibility of so called priming effect leading to patient sensitization in early
spring and resulting in marked exacerbation of clinical symptoms later on,
during birch (Fagales) pollen season.
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A novel group 2 mite allergen from dermatophagoides farinae
Akito Matsuoka1, Toshihide Isobe1, Tsunehiro Aki1, Seiji Kawamoto1,
Takaharu Hayashi2, Yoshiko Asaoku3, and Kazuhisa Ono1. 1Hiroshima
University, Graduate School of Advanced Sciences of Matter, Higashi-
Hiroshima, Japan; 2Takanobashi Central Hospital, Department of Otolar-
yngology, Hiroshima, Japan; 3Hiroshima General Hospital of West Japan
Railway Company, Department of Insurance, Hiroshima, Japan.
Background: Mite allergy is a disease induced by inhalation of mite bodies
and feces present in the house dust, leading to asthma, nasal inflammation, and
dermatitis. The identification of allergens is needed for the specific immu-
notherapy. Our allergenomic analysis of Dermatophagoides farinae body
extract by two-dimensional immunoblotting followed by mass spectrometry
has revealed a number of new allergens. The purpose of this study is to
characterize a 15-kD allergen, DFA22, with high frequency and intensity of
patients’ IgE binding.
Results: Based on the partial amino acid sequences obtained by mass
spectrometry, a full length gene encoding DFA22 was isolated by PCR.
Analysis of its deduced amino acid sequence and predicted molecular
conformation suggested that DFA22 is a new member of group 2 mite
allergens (ML protein). It was noted that DFA22 has a higher homology
with a sheep scab mite allergen, Pso o 2 (62% identity in amino acid
sequences), and a storage mite allergen, Lep d 2 (46%), than a house dust
mite allergen, Der f 2 (40%), indicating that there are at least two subgroups
in the group 2 mite allergens. In order to characterize the immunochemical
profile of the new allergen, a recombinant protein was produced using a
vector pCold-TF, which can express trigger factor (TF) fusion protein at
low-temperature, and Escherichia coli Rosetta-gami, which has an ability to
form precise disulfide-bond. The rDFA22 was purified by His-tag affinity
chromatography, removal of TF, and anion exchange chromatography. Mass
spectrometric analysis demonstrated that three disulfide-bonds characteristic
to the group 2 mite allergens are formed in the rDFA22. ELISA indicated
that its IgE binding frequency was 51% (n = 35; RAST scores to mite 9 3).
The binding of patients’ IgE to rDFA22 was partially inhibited by rDer f 2
(~32% inhibition) and Pso o 2 (~56%), implying that these allergens shear
common IgE epitope(s).
Conclusion: DFA22 is an important novel allergen that cannot be disregarded
to achieve successful specific immunotherapy against mite allergy. It is also
necessary to reconsider the molecular differentiation of the group 2 mite
allergens.
801
Experiences with the setting of a new polllen trap as a member of
the Hungarian airborne pollen network in southwest Hungary
Tamas Major, and Marianna Rakva´cs. Kaposi Mo´r Teaching Hospital,
Pulmonology, Mosdos, Hungary.
The Hungarian network of aeropalynology includes traps thruout the
country. In order to optimise this network, the Hungarian Institute of
Aerobiology has set up a new trap in the Hospital for Chest Diseases of the
Hungarian Calvinist Church In Hungary in Mosdo´s, Somogy county. The area
has high impotance in the view of the researchers, because it is located close to
the most poulated recreactional region, the Lake Balaton and this part of the
country is probably the most pollen Binfected[ territory in Hungary. The
equipment is a standard spore trap (Burkard), which is used all over the counry.
Our aeropalinlogy team includes: three assistants, two clinicians and a
technician. The team has already been reporting the pollen counts from the
begining of the polens season to the National Network on a weekly basis.
Objectives: To assess the situation of pollen counts and epidemiological data
on allergies in the region. Second objective was study the influence of
temperature, relative humidity, rainfall and wind direction on the occurrence
of pollen allergens in the atmosphere. Our results showed that, the occurrence
of pollen grains in the atmosphere markedly relates to meteorological factors.
We evaluated a correlation between the concentration of pollen grains in the
atmosphere of the region and temperature, relative humidity, rainfall and wind
direction during the vegetation period. For our analysis we selected one rep-
resentative of each phytoallergen group (trees, grasses, weeds). We have
chosen the Betula genus of trees, the whole Poaceae family of grasses and
ragweed (Ambrosia artemisiifolia) to represent weeds. The taxons mentioned
represent the most significant allergens in Hungary. Our data provides
predictive information on the forthcoming patient flow and the severity of their
allergic symptoms.
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Comparison of allergen spectrum in asthma and allergic rhinitis
children with 3~14 years of age
Li Xiang1, Ya-mei Zhang2, Yi-xin Ren1, Jie Zhang2, and Kun-ling Shen1.
1Bejing Children’s Hospital affiliated to Capital University of Medical
Science, Center of Asthma, Beijing, China; 2Bejing Children’s Hospital
affiliated to Capital University of Medical Science, Otolaryngology, Beijing,
China.
Background: To compare the allergen spectrum in asthma and allergic rhinitis
children with 3~14 years of age.
Methods: Inhalant allergen skin prick test (SPT) were done in 527 asthma
and 620 allergic rhinitis children respectively. The positive rates of different
allergen and allergen spectrum in asthma and allergic rhinitis were analyzed.
Results: There was no significant difference on the positive rates of SPT in
asthma and allergic rhinitis (77.8% vs78.9%, P 9 0.05). The main inhalant
allergens related to asthma and allergic rhinitis were Dermatophagoids
pteronyssinus, Dermatophagoids farinae ,alternaria, cat dander and
mugwort. The positive rates of Der.p, Der.f and molds mixture in asthma
were higher than those in allergic rhinitis (64.6% vs 49.5%, 59.8% vs
47.9%, 8.8% vs 3.9%, P G 0.05); The positive rates of summer-autumn
pollen and mugwort in allergic rhinitis were higher than those in asthma
(25.6% vs 19.3%, 26.0% vs 19.3%, P G 0.05). 40.2% asthmatics and
46.2% allergic rhinitis children were single allergen sensitization. The
multiple sensitization to mites, molds and pets were common in asthma
and allergic rhinitis.
Conclusion: Mites, molds, pets and summer-autumn pollen were the main
inhalant allergens related to asthma and allergic rhinitis children with 3~14
years of age. The allergen spectrums were similar in asthma and allergic
rhinitis. Mites and molds allergy were more popular in asthma while summer-
autumn pollen in allergic rhinitis.
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Epidermal skin prick test of airborne environmental
and food allergens
Fitriyani Sennang1, Fanny Iskandar2, Anis Irawan Anwar2, and Muh Dali
Amiruddin2. 1Medical Faculty Hasanuddin University/ Dr. Wahidin Sudir-
ohusodo General Hospital, Dermato Venereology, Makassar, Indonesia;
2Medical Faculty Hasanuddin University/ Dr., Dermato Venereology, Makas-
sar, Indonesia.
Background: Sensitization to food and airborne environmental allergens
data is still rare reported. This study evaluated the epidermal skinprick test
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of patients who applied to Dermato Venereology Department outpatient,
retrospectively.
Methods: Retrospective study has been done for patient who came to
Dermatology Venereology Department of Dr. Wahidin Sudirohusodo
Hospital, Jaury Akademis hospital and private practice for 1 year from
April, 2006 until April 2007. Epidermal skin prick test (ESPT) of 27 patient
consisted of 12 airborne environmental allergens and 21 food allergens.
Interpretation of this ESPT was divided into 3 groups: negative, positive-
negative, and positive group (positive 1, positive 2, positive 3).
Results: ESPT of 27 patients were evaluated. Of 27 patient 17 (62%) female
and 10 (58 %) male patient; 22 (81%) adult and 5 (19 %) pediatric patients.
Most positive result were airborne environmental allergens respectively: mixed
fungi 40,7 %, house dust 29,6 % and cockroach 25,9 %, while food allergens
were (peanut, cockle shells, crab, shrimp) 25,9 % (nut large fish) 22,2 % and
(soybean, milk fish, tuna fish) 18,5 %; whereas rice pollen and carrot allergen
showed negative results.
Conclusion: The result of this study showed common allergens that wa
found in patients related to tropic environmental and food habit of the
patient.
Key words: retrospective, airborne environmental allergen, food allergen
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Allergic sensitization to Cheyletus eruditus
Ruperto Gonzalez-Perez, Paloma Poza-Guedes, Victor Matheu-Delgado, Eva
Perez-Rodriguez, Inmaculada Sanchez Machin, and Jose Carlos Garcia-
Robaina. HUNS La Candelaria, Allergy Department, Santa Cruz de Tenerife,
Spain.
Background: Cheyletidae mites have been described as an etiological factor
for human dermatitis. In our subtropical area this family accounts as one of the
most frequently found, after Dermatophagoides spp and Blomia spp, in house
dust samples. The potential allergenicity of this mite family is still unknown.
Methods: We selected 15 non consecutive patients sensitized to Dermato-
phagoides spp and/or Blomia spp with perennial respiratory symptoms of
rhinoconjuctivitis and asthma without dermatological symptoms, and no pets
(dogs, cats and/or birds) at home. Ten subjects with non allergic rhinitis/
asthma were selected as control group. Skin prick test with Cheyletus eruditus
extract (1/50 w/v) were performed in the forearm followed by immediate
reading at 15 minutes. A skin prick test was regarded as positive with a wheal
of at least 3 mm.
Results: Thirteen out of 15 subjects showed a positive skin prick test. All
patients of the control group had negative readings of the cutaneous test with
the same extract.
Conclusion: We describe, to our knowledge, the first study to show IgE
mediated sensitization to Cheyletidae mite family in patients to respiratory
symptoms. More studies are needed to evaluate the actual prevalence
in the general population and the clinical relevancy of this allergic
sensitization.
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Allergenicity of pollen grains and pollen cytoplasmic granules
Oussama Abou Chakra1, Fran0oise Rogerieux1, Franck Robidel1, Emmanuelle
Maillot-Mare´chal1, Gabriel Peltre2, and Ghislaine Lacroix1. 1INERIS, DRC -
TOXI, Verneuil-en Halatte, France; 2ESPCI, Environnement et Chimie
Analytique, Paris, France.
Background: Since decades, epidemiological studies show an increased
frequency of respiratory allergies. These diseases coincide with the pollination
season but in most cases, no evident correlation with the pollen count is
observed. In parallel, several studies have shown that in contact with water
and atmospheric pollutants, pollen grains can release pollen cytoplasmic
granules PCG (0.5Y3 6m). Due to their small size, they may penetrate deeper
into the lungs and might induce higher allergic response. These granules are
suspected of playing a role in Bthunderstorm asthma[. The aim of our studywas
to compare the allergenic potential of PCG with those of the pollen, in the
Brown-Norway rat.
Methods: PCG are isolated from Phleum pratense pollen by osmotic
shock in pure water, following by filtration, centrifugation and two washes.
Rats were sensitized (D0) and challenged (D21) intratracheally with pollen
(0.5 mg per rat) or purified PCG (1.5x106 and 1.5x107 PCG per rat).
These two quantities correspond to the number of granules released by 0.5
mg of pollen, if 10% or 100% of pollen burst, respectively. Blood
samples, bronchial lymph node and bronchoalveolar lavage fluid (BALF)
were collected from the rats 4 days after the challenge. The number and
type of cells were determined in BALF. The IgE and IgG1 levels in sera
were assessed by ELISA. Pollen and PCG-induced proliferation of lymph
node cells was monitored by [3H]-thymidine incorporation in a lymph
node assay.
Results: The number of cells in the BALF was 2 times higher in the rats
exposed to pollen and to the strongest concentration of PCG (13.8x106and
14.1x106 respectively) compared to rats instilled with NaCl (6.7x106). Only
the rats sensitized to pollen show IgE and IgG1 levels higher than those of the
controls. The PCG do not induce an increase of the IgE and IgG1 levels.
Cultured lymph node cells of pollen or granules-sensitized rats significantly
proliferated in the presence of pollen or PCG. However, pollen appeared to be
more potent than PCG to induce the lymphocyte proliferation either in pollen
and granule-sensitized rats.
Conclusion: Phleum pratense pollen induced humoral and cellular allergic
responses in our rat model whereas PCG induced only a cellular response. This
difference may be due to an extensive wash of the granules and thus a loss of
soluble allergens. In perspective, we want to evaluate the allergenicity of non-
washed granules.
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Aerobiology and respiratory allergies in Santa Cruz de Tenerife
Paloma Poza-Guedes1, Ruperto Gonzalez-Perez1, Jordina Belmonte2, Rut
Puigdemunt2, Emilio Cuevas3, and Fernando Grau4. 1HNS La Candelaria,
Allergy Department, Santa Cruz Tenerife, Spain; 2Universitat Auto`noma de
Barcelona, Unitat Bota`nica, Barcelona, Spain; 3Instituto Nacional de
Meteorologı´a, Observatorio Atmosfe´rico de Izan˜a, Santa Cruz Tenerife,
Spain; 4Air Liquide Medicinal Espan˜a, Candelaria, Spain.
Background: In the Canary Islands the prevalence of respiratory allergy is
10Y12% of the general population. The climate is very mild (mean annual:
21.2- C) and poor rainfall (mean annual:214 mm), but a high ambiental
humidity (60Y80%). This climatic characteristics determine that the most
frequent cause of allergy in our area are house dust mites. Although
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prevalence and types of pollen causing allergic symptoms have not been
still well defined.
Methods: We selected consecutive patients with respiratory symptoms su-
gestives of allergic respiratory pathologies. They were studied by means of
standard prick tests with a battery of pollen extract, and seric specific IgE
analysis. A Hirst spore trap runs on a continuous-basis on the roof of
the BObservatorio Atmosfe´rico de Izan˜a[ headquarters, since October 2004.
The results corresponding to the period 2004Y2006, obtained following the
counting method of the Spanish Aerobiology Network (Red Espan˜ola de
Aerobiologı´a, REA), are presented.
Results: The most abundant pollen types have been (by decreasing order of
the annual indexes): Urticaceae, Asteraceae (99% Artemisia), Arecaceae,
Myrica, Poaceae, Ericaceae, Chenopodiaceae-Amaranthaceae, Olea, Cupres-
saceae, Polygonaceae, Pinus, Moraceae, Plantago Mercurialis, Myrtaceae, and
43 other pollen types (G1% of the pollen spectrum). Herbs predominate in the
pollen spectrum (60%) during the first half of the year. Trees (34%)
predominate during the summer time. Finally shrubs (5%) pollinate mostly in
spring. Most of the cited pollen types are able to cause allergy. Prevalence of
pollen allergy during the period 2004Y2006 was 16% of patients with res-
piratory allergy studied in our medical center. The most frecuent types of
pollen sensitization were: Artemisia vulgaris (64,5%), Poaceae family (Gra-
mineae) (45,2%), Parietaria judaica (24,6%), Chenopodium album (9,4%),
Salsola kali (6,2%) y Plantago lanceolata (4%). The prevalence of sensitized
patients to molds were less than 5%.
Conclusion: Pollen is a relevant cause of allergic respiratory diseases in our
area. More studies are needed to improve the accuracy of diagnosis of pollen
allergic patients.
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Distribution of allergens among allergic rhinitis patients living
shiraz (Iran) region
S. Hesamedin Nabavizadeh1, and Sohila Al-yasin2. 1Yasuj University of
Medicine, Pediatric Allergy and Immunology, Yasuj, Islamic Republic of Iran;
2Shiraz University of Medicine, Pediatric Allergy and Immunology, Shiraz,
Islamic Republic of Iran.
Objective: Allergic rhinitis is the single most common chronic allergic disease
worldwide. House dust mites, grass pollens and fungal spores play has been
identified to play a major role in the pathogenesis of allergic rhinitis. To
determine the distribution of allergens among allergic rhinitis patients living in
the shiraz region.
Methods: We investigated 56 allergic rhinitis patients (29 females, 27 males;
mean age 22.3+/j14.1 years) who had symptoms.
Results: The history and clinical examination revealed that 14 patients (25%)
had seasonal symptoms and 42 patients (75%) had perennial symptoms.
Common pattern of multiple allergens were tree mixture allergens (58.9%),
grass mixture (42.8%), mite (19.6%), candida (10.7%), tomato (5.3%), fruite
(3.5%), and feather mixture (3.5%) and cladosporium, oak, ash (3.5%),
alternaria, maple, hen egg, aspergillus (1.7%). Skin prick test were negative in
12 cases (21.4%). According to the prick test results, sensitivity to one allergen
was found in 5 patients (8.9%) and sensitivity to multiple allergens in 51
patients. Family history were positive in 29 patients.
Conclusion: The most common allergens were tree mixture and grass in the
shiraz region. It was concluded that the distribution of allergens was associated
with the climatic, environmental and socioeconomic features of the region.
Larger representative sample involving multi-centers in Shiraz should be
encouraged in the near future.
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A research on triticum aestivum allergy in east of turkey
Nejat Ozanguc. Gozde Hospital, Allergy and Immunology Center, Malatya,
Turkey.
: The patients who visited the Center of Allergy and Immunology in
Malatya/Turkey and diagnosed with seasonal allergic rhinitis (SAR),
bronchial asthma (BA) and SAR+BA. The result of the skin prick tests
applied to these patients with aeroallergens showed that 120 patients had
allergic reaction to only triticum aestivum (TA) and 37 patients tested
positive for ta with other aeroallergens in a total of positive 293 tests. There
were 134 male test participants and 159 female participants in this research.
48 male and 72 female tested positive for TA only. 18 male and 19 females
tested positive for TA and other aeroallergens. All these patients are
currently in our allergen immunotherapy program.These results were worth
giving attention to and I was informed by the Malatya Agriculture Bureau
that, Malatya and surrounding areas are the capital of growing wheat wh to
make bread, which is TA. On the other hand, Malatya is exporting the 20%
of the world’s apricot consumption. I am working on a detailed cross-
sensitisation research between TA and apricot tree pollen. Since, there is no
apricot tree pollen extract produced by any company, I gathered this pollen
in a powder form and made connection with companies to produce the
antigen to use in aeroallergen skin prick tests.
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Aerobiology of Islamabad
Katelaris CH1, Ajab Khan Mir2, Muhammad Syed Raza3, Shahid Abbas4,
Anand B Singh5, and M. Hassnain Syed6. 1University of Western Sydney,
Immunology & Allergy, Campbelltown, Australia; 2Quaid e Azam University,
Abstract Department, Islamabad, Pakistan; 3Rawalpindi Medical College,
Medicine, Rawalpindi, Pakistan; 4Allergy & Immunolgy, Allergy & Asthma
Centre, Islamabad, Pakistan; 5Institute of Genomics and Integrative Biology,
Allergy & Aerobiology, Delhi, India; 6King Faisel Specialist Hospital &
Research Centre, Allergy & Aerobiology Research, Riyadh, Saudi Arabia.
: Islamabad is one of the most beautiful capitals of the world with
mountains and greenery all arround. But it has also highest pollen counts in
asia with huge number of with Pollen allergy patients. In spring and fall
numerous patients visit emergency department of different hospitals. In 2004
WAO gave Burkards Sampler on loan basis to study the aerobiology of the
capital. There are two main flowering seasons in Islamabad i.e. spring season
starting from the end of February to the end of April and the second flowering
period during Mon-soon (fall) season starts in the middle of July to the end of
September Although there are about 350 species of plants in Islamabad but the
pollen trapped on the sampler were fewer.
With the Burkards Sampler we collected data for two years i.e 2005
and 2006. In 2005 total of 638017 pollen grains & 548647 mold spores per
cubic meter of air were trapped. While in 2006 total pollen grains were 510954
pollen grains & 528383 mold spores per cubic meter of air were collected. The
pattern of pollens and molds is nearly the sameIn spring season the highest
pollen counts were those of B. papyrifera i.e. 1149/cubic meter of air per hour
on 22nd March in 2005 while 1430/cubic meter of air on March 10th in 2006.
During fall season pollens of Cannabis sativa were prevalent. On 18th August
2005 highest pollen counts of Cannabis was 85 per cubic meter of air per hour,
while in 2006 highest pollen count of the same pollen was 25/cubic meter of
air per hour on 18th August.
TABLE 1CHARACTERISTICS OF THE CONTROL AND PATIENTS WITH CP
% SPT + to Dust % SPT + to POLLEN of % SPT + to POLLEN of % SPT + to POLLEN of % SPT + to POLLEN of % SPT + to POLLEN of
House Dust B. papyrifera Grass Cannabis sativa Morus alba Dandelion
50% 48% 29% 20% 7% 18%
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Mould spores found through out the year with periodic variation Pi-
thomyces spp, Alternaria spp, Cladosporium spp, Drechslera spp, Aspergillus
spp, Curvularia spp have allergenic importance while Stachybotrys spp
produce saratoxins causing toxic symptoms in humans. In our study 10%
patients coming to allergy centre had skin prick test positive to molds like
alternaria, cladosporium and Aspergillus spp.
Skin Prick Tests (SPT) were done on the patients coming to the Allergy
Centre with the extracts of these pollens and house dust. Following table
illustrate the results with other pollens. The SPT results of dust and B. papy-
rifera are nearly the same but the intensity of reaction and size of wheal with
extract of B. papyrifera is much greater. Total No. of Individuals = 702,
Persons with SPT Positive 412, Persons with SPT Negative 290.
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Evaluation of allergenicity to Brassica juncea in Indian
atopic population
shipra Shahi1, Asok Bhatnagar2, Shailendra Gaur3, Shakuntala Lavasa4, Raj
Kishor Katiyar5, and Anand Singh6. 1Institute of Genomics & Integrative
Biology, Aerobiology & Allergy, Delhi, India; 2Delhi University, Botany,
Delhi, India; 3V P Chest Institute, Respiratory Medicine, Delhi, India;
4Allergy Clinic, Allergy, Chandigarh, India; 5Indian Agricultural Research
Institute, Plant Biotechnology, Delhi, India.
: Rapeseed mustard is the second most important edible oil in India.
Allergy to Brassica seeds have been reported earlier from Austria, Finland etc,
but only scant information is available from Indian subcontinent.
We have investigated the allergenicity to B. juncea seed flour by in vivo
and in vitro methods in Indian atopic cases. Antigen from B. juncea was
extracted in 1:20 w/v by standard protocol. To assess sensitization, skin prick
test was carried out with antigen extract (1:10 w/v) of B. juncea on the above
cases. Total IgE and B. juncea specific IgE was estimated by Enzyme Linked
Immuno Sorbent Assay. To determine the allergenically important protein,
immunoblot was carried out.
A total of 159 atopic cases suffering from allergic rhinitis, bronchial
asthma or both were selected from general atopic population, referred to
clinical units for treatment. Of these, 37 (23.27%) were suffering with allergic
rhinitis, 44 (27.67%) with bronchial asthma and 77 (48.42%) with bronchial
asthma as well as allergic rhinitis. The mean age was 28.5 yr. (10Y50 yr.) and
sex distribution (female vs. male) was 80 vs. 79. The mean age of 50 healthy
volunteers included was 25.63 yr. Of these, 15 cases (9.43 %) showed 2+ &
above skin test response against seeds of B. juncea. The total IgE of 159 cases
ranged from 12 IU/ml to 2208 IU/ml. Raised allergen specific IgE was also
observed in the sera of skin test positive cases ranging from 0.221 to 0.848
Optical Density value. The antigen extract separated into 23 protein bands on
Sodium Dodecyl Sulphate- Poly Acrylamide Gel Electrophoresis, in the mol
wt range of 14Y97 kDa. The Immunoblot revealed 12 IgE binding protein
fractions in the sera of patients showing raised IgE Brassica specific
antibodies. Some heterogeneity in the IgE binding protein fractions amongst
individual patients is observed. Thus we conclude, that sensitization against
seeds of B. juncea does exists in Indian population.
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Identification of aeroallergens in Lebanon
Malek Alaouie1, Rouwayda Dana2, and Fares Zaitoun3. 1Allergy Asthma and
Immunology Center, Allergology Department, Hamra-Beirut, Lebanon;
2Essex Chemie AG, Medical Affairs Department, Beirut, Lebanon; 3Allergy
Asthma and Immunology Center, Research Department, Beirut, Lebanon.
Background: Aerosolized pollen are an important cause of respiratory allergy
worldwide. The availability of pollen counts in westernized countries is es-
sential for patient education and medical treatment. Aerobiological pollen data
is scarce in theMiddle East and had never been previously assessed in Lebanon.
In order to identify and quantify pollen prevalence in Lebanon, a national
aerobiology program was launched starting in the capital city of Beirut.
Methods: A Lanzoni pollen trap was placed on a roof top in Beirut 20 meters
above ground level. A seven-day cycle drum with a 168-hour film coated with
silicon adhesive was used to capture pollen grains. Slides were stained with
gelatin fuschin & examined with a light microscope using a 40x objective.
Pollen identification and counting was recorded on a weekly basis.
Results: A total of 9491 pollen grains/m3 were collected for the 12 month
period of 2006 (except for a brief interruption during the 2006 summer
military conflict). Twelve different types of pollen were identified which were
Alnus, Cupressaceae, Oleaceae, Pinaceae, Juglandaceae, Mercurialis, Cheno-
podiaceae, Artemesia, Parietaria, Plantago, Apiaceae, and Poaceae (table 1).
The 4 most common pollen found over the study period was Oleaceae (27% of
total) followed by Cupressaceae (24%), Pinaceae (18% of total), and
Mercurialis (17%) (table 2). The peak pollen level recorded was 327 pollen
grains/m3 on April 17th with an average daily count of 93 pollen grains/m3
throughout the month of April. The lowest total pollen count was in the month
of September with an average daily level of G2 pollen/m3/day.
Conclusion: This was the first aerobiologic pollen data ever recorded in the
country of Lebanon. Typical elevation of pollen counts in the spring was
TABLE 1CHARACTERISTICS OF THE CONTROL AND PATIENTS WITH CP




Alnus 51 24 10.2 20.4 5.4 1.8 0 41.4 3.6 34.2 192
Cupressaceae 26.4 369 1277.4 336 85.8 10.2 5.4 74.4 58.2 26.4 2269.2
Merculiaris Annua 76.8 129.6 143.52 365.4 0 0 0 838.8 19.2 76.8 1650.12
Pinaceae 0 7.8 416.52 701.4 347.4 42.6 2.4 206 0 0 1724.12
Oleaceae 0 0 86.28 1372.2 1029 87.6 6.6 0 0 0 2581.68
Parietaria 0 0 9 211.2 160.8 31.8 0 160.8 0 0 573.6
Juglandaceae 0 0 0 13.8 0 0 0 0 0 0 13.8
Plantago 0 0 0 27.6 0 0 0 0 0 0 27.6
Chenopodiaceae 0 0 0 0 0 0 13.2 3.6 0 0 16.8
Apiaceae 0 0 0 0 0 0 3.3 133.8 2.4 0 139.5
Poaceae 0 0 0 0 41.4 33.6 1.8 26.4 0 2.4 105.6
Artemesia 0.6 2.4 0 0 0 0 0 0 0 0 3
Indeterminate 27 30 53.52 42.6 30 7.8 3.6 0 0 0 194.52
Total 2006 monthly
count (pollen/m3)
181.8 562.8 1996.44 3090.6 1699.8 215.4 36.3 1485.2 83.4 139.8 9491.54
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observed however the levelwas surprisingly high for an urban area. The finding
of tree pollen (cupressaceae and Alnus) in winter months along with iden-
tification of a particular pollen (Mercurialis) not previously suspected were
important findings for this allergen information-poor country. Since pollen
collection took place in only one location (Central Beirut) and for only one year,
extrapolation to a nationwide impression can not be made. Nonetheless the
exciting pollen data generated in 2006, a first for Lebanon, will serve a pio-
neering role for the study of aerobiology and allergic disease in this country
and region.
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A ten year survey (1996Y2006) of the major pollen aeroallergens
in Sydney, Australia
Connie Katelaris, Therese Burke, and Pamela Burton. Campbelltown
Hospital, Clinical Immunology and Allergy, Sydney, Australia.
Background: Airborne pollen is amajor cause of allergic symptoms during the
spring months in Sydney, Australia. Establishing the predominant pollen
aeroallergens and the timing of highest pollen levels greatly assists medical
personnel in developing effective treatment plans for those individuals suf-
fering from allergic symptoms related to pollen sensitivity. This survey iden-
tifies which pollen aeroallergens are most prevalent during the springmonths in
Sydney and suggests possible reasons for the differences observed between
seasons in an attempt to determine effective predictors of severe pollen seasons.
Methods: Aeroallergen monitoring was performed during the spring months
1996Y2006 in Sydney, Australia. A Burkard 7 day volumetric spore trap was
used for pollen collection and slides were analysed using standard protocols. A
daily pollen count was expressed for each species in grains per cubic meter
(CuM). Data was collected from August to November of each year (spring in
the southern hemisphere).Daily rainfall data was obtained from the Bureau of
Meteorology and expressed as millimetres of rain on a daily basis for the entire
ten year period of the survey. Pollen data was then collated into 3 groups Y tree,
grass and weed pollen. Each group was analysed for seasonal trends and
correlated with rainfall data. For each year of the survey, the season duration
was identified, as well as peak day and peak count, average daily pollen count
and total season pollen count for each group.
Results: Tree pollens make up the majority of the total pollen count in Sydney,
followed by grasses and weeds. Major tree pollen species identified in Sydney
include Cypress,Pine, Plane and Casuarina. Tree pollens tend to reach peak
levels in mid to late September, and grass and weeds pollens in mid to late
October. The highest average daily pollen counts for all groups occurred in
years with the highest autumn/spring rainfall. Average daily pollen counts
ranged from 23Y147 grains/CuM (trees), 1Y25 grains/CuM (grasses) and
0Y15 grains/CuM (weeds).The period of pollen season duration also varied
considerably each year.
Conclusion: The results of this survey indicate the major pollen
aeroallergens present during the spring months in Sydney, Australia. The
survey also highlights considerable variability between pollen seasons and
the need for ongoing aerobiological pollen monitoring in the future because
of highly variable climatic conditions that clearly impact upon the pollen
counts.
814
Influence of meteorological variables on pollen counts in Sydney,
Australia: longitudinal data examining effects within and
between pollen seasons
Therese Burke, Pamela Burton, and Connie Katelaris. Campbelltown
Hospital, Clinical Immunology and Allergy, Sydney, Australia.
Background: Airborne pollen is a significant cause of allergic symptoms in
sensitised individuals. Various meteorological factors have an effect on pollen
levels, on a day to day basis throughout the pollen season, and on a seasonal
basis over time. By understanding the effects of these meteorological factors, it
may be possible to develop effective indicators which may assist in predicting
high pollen days within a season to assist in symptom management.
Method: Airborne pollen was collected between 1996Y2006 in Sydney,
Australia. A Burkard 7 day volumetric spore trap was used to collect data and
slides were made up and analysed using standard protocols. Pollen counts were
expressed as grains per cubic Meter (CuM) for various species and then
grouped into trees, grasses and weeds. Meteorological data was obtained and
included minimum temperature, maximum temperature, daily rainfall and
humidity. Spearman rank correlations were used to assess the effect of the
meteorological variables upon the day to day pollen counts and the seasonal
pollen counts as a whole. We then examined cross correlation plots between
first differenced 4 day moving averages in order to detect short term as-
sociations between fluctuations in meteorological variables and fluctuations in
pollen counts.
Results: Examining daily counts within a given pollen season, there was a
statistically significant positive correlation between daily maximum tempera-
ture and the daily pollen count for all pollen species (p G 0.05). Daily rainfall
and high humidity were negatively correlated with the daily pollen count
for all species (p G 0.05). Day to day changes in maximum temperature
were moderately positively correlated with a simultaneous change in the total
pollen count (r = 0.35), but weakly negatively correlated with a change in
the total pollen count 4 days later (r = j0.15). Examining season to season
associations, mean seasonal pollen counts were negatively correlated with
mean seasonal daily maximum temperature ( r = j0.782 total pollen and
r = j0.600 for grasses).
Conclusion: On a day to day basis, increases in daily maximum temperature
lead to an increase in pollen levels and daily rainfall leads to a simultaneous
decrease in the daily pollen level. Overall, cooler temperatures across a season
often lead to a higher total pollen count. Ongoing pollen monitoring is needed
to further examine the effects of meteorological factors on daily and seasonal
pollen counts.
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The characterization of native thaumatin-like allergen named
Cry j 3 from Japanese cedar (Cryptomeria japonica) pollen
Takashi Fujimura1, Norihiro Futamura2, Terumi Midoro-Horiuti3, Randall M
Goldblum3, Hiroshi Yasueda4, Kenji Shinohara2, and Masahiro Sakaguchi5.
1Chiba University, Graduate School of Medicine, Chiba, Japan; 2Forestry and
Forest Products Research Institute, Department of Molecular and Cell Biology,
Ibaraki, Japan; 3University of Texas Medical Branch, Child Health Research
Center, Galveston, United States; 4Sagamihara National Hospital, Clinical
TABLE 1CHARACTERISTICS OF THE CONTROL AND
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Research Center for Allergy and Rheumatol, Kanagawa, Japan; 5Azabu
University, School of Veterinary Medicine, Kanagawa, Japan.
Background: Japanese cedar (Cryptomeria japonica) pollinosis is one of the
most prevalent allergies in Japan. Four allergens named Cry j 1, Cry j 2, CJP-4,
and CJP6 have been identified as the causative allergens from Japanese cedar
pollen. Recently Cry j 3 has cloned as a homologue of Jun a 3. Jun a 3 is a
major allergen from mountain cedar (Juniperus ashei) pollen. However native
Cry j 3 has not been isolated and there were no reports on its allergenic activity.
Objective: The aims of this study were to isolate native Cry j 3 and assess its
IgE-binding capacity in patients with Japanese cedar pollinosis.
Methods: Cry j 3 was purified from Japanese cedar pollen by multi-
dimensional chromatography. We assessed the IgE-binding capacity by
immunoblot analysis and enzyme-linked immunosorbent assay (ELISA).
Moreover, we assayed the capacity of Cry j 3 to induce histamine release from
the patients’ leukocytes. We cloned cDNA corresponding to purified Cry j 3
from a cDNA library of Japanese cedar pollen.
Results: We purified native Cry j 3 from Japanese cedar pollen as a 27 kDa
protein. The IgE-binding frequency of Cry j 3 from the sera of patients allergic
to Japanese cedar pollen was estimated as 27% (27/100) by ELISA. Cry j 3
induced the release of histamine from leukocytes. We cloned the cDNA and
named it Cry j 3.8. Cry j 3.8 cDNA encoded 225 amino acids and had
significant homology with thaumatin-like proteins.
Discussion: Cry j 3 is an additional causative allergen in Japanese cedar
pollinosis and may play crucial rules in the cross-reactivity with oral allergy
syndrome.
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Structural characterization of norcoclaurine synthase suggests
the enzyme to be a true member of the Bet v 1 protein family
Hanna Berkner1, Kristian Schweimer1, Birgitta M. Wo¨hrl1, Peter J. Facchini2,
Stefan Vieths3, Paul Ro¨sch1, and Irena Matecko1. 1University of Bayreuth,
Department of Biopolymers, Bayreuth, Germany; 2University of Calgary,
Department of Biological Sciences, Calgary, Canada; 3Paul-Ehrlich-Institut,
Department of Allergology, Langen, Germany.
: The enzyme Norcoclaurine synthase (NCS) found in the common
meadow rue, Thalictrum flavum, and other plants shows sequence homology
to members of the class 10 of pathogenesis related (PR 10) proteins that
contains allergens such as the major birch pollen allergen Bet v 1, the major
cherry allergen Pru av 1, and the major apple allergen Mal d 1. The enzyme
catalyzes the condensation of dopamine and 4-hydroxyphenylacetaldehyde to
(S)-norcoclaurine, an important step during synthesis of benzylisoquinoline
alkaloids. This group of plant secondary metabolites includes pharmacologi-
cally active substances like the analgesic morphine.
Whereas the physiological function of PR10 class allergens is still
unknown, NCS activity was studied in detail. Investigation of the structural
properties of NCS by NMR spectroscopy can thus not only provide new in-
formation concerning the reaction mechanism of the enzyme, but is also
expected to help clarify the long standing and heavily debated question on the
physiological function as well as the reasons for the allergenic potential of
members of the Bet v 1 allergen family.
As the first important step towards the three-dimensional solution
structure, we optimized expression of recombinant NCS in E. coli and es-
tablished an efficient purification protocol yielding high amounts of pure
isotopically labeled protein. Spectroscopic analysis by circular dichroism and
NMR spectroscopy showed that the protein is properly folded with well defined
secondary and tertiary structure, probably similar to that of its allergen ho-
mologue Bet v 1. In consequence, comparison of NCS and Bet v 1 concerning
structural and allergenic properties might help to elucidate which structural
features are important for the allergenicity of Bet v 1 allergens. Enzyme kinetics
were investigated by monitoring substrate turnover using 1D-1H-NMR.
Additionally, NMR titration experiments with substrate analoga were carried
out to characterize substrate binding.
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Measurement of Alternaria spores and Alt a1 levels in the
atmosphere of Ciudad Real (Spain)
AnaAlonso-LLamazares1, JeronimoCarnes2, Francisco Feo-Brito1, PilarMur-
Gimeno3, Pedro Galindo-Bonilla1, and Enrique Fernandez-Caldas2. 1General
Hospital, Allergy Section, Ciudad Real, Spain; 2LETI Laboratorie, R&D,
Madrid, Spain; 3Puertollano Hospital, Allergy Section, Puertollano, Spain.
Background: Alternaria alternata is one of the mayor fungal antigen pro-
ducers. The mayor allergen Alt a1 is expressed by Alternaria and other taxo-
nomical species related.
Aim: Analyze the correlation between Alternaria spores levels and Alt a1 in
the atmosphere of Ciudad Real.
Method: Daily spore concentrations were sampled daily during 2003 an 2004
using a Burkard volumetric spore trap. The total number of spores was
expressed as n- spores/m3/day. An Air Sentinel and monoclonal binding were
used to measure the mayor allergen Alt a1 (pgr/ml). Meteorological data of the
years 2003 and 2004 were obtained.
Results: A wide variety of fungal spores were compiled. Cladosporium was
the most prevalent fungi (77%), followed by Alternaria (6,6%). The highest
airbone Alternaria spp. spore concentration were obtained during spring and
summer (may-june and august-september), with a decrease in july due to the
high temperature (less than 100 spores/m3/day, as the rest of the months).
Correlation may be established between the total spore counts and the
atmospherical conditions (temperature 20Y30- and accumulate rainfall but not
daily rainfall). Alt a1 levels are more homogeneous along the year. These are
no correlated with spore counts.
Conclusion: Fungal spore release is influenced by meteorological conditions.
No relation between Alt a1 levels and meteorological factors was observed.
818
Changes in the allergenic protein content of the Cupressus
arizonica pollen exposed to air pollution
Youcef Shahali1, Ahmad Majd2, Zahra Pourpak3, Maryam Haftlang3, and
Mostafa Moin3. 1Azad University, North Branch of Tehran, Department of
Biology, Tehran, Islamic Republic of Iran; 2Azad University, North Branch of
Tehran & Teacher Training University of Tehran, Department of Biology,
Tehran, Islamic Republic of Iran; 3Immunology, Asthma and Allergy Research
Institute/Tehran University of Medical Sciences, Children Medical Center,
Tehran, Islamic Republic of Iran.
: Cupressus spp. pollens are an increasing cause of allergies in various
regions. It is a common opinion that recent increases in this pollinosis are due
to extensive plantation of cypress trees, and the potential adjuvant effect of the
chemical pollution generated by the urbanism. In Tehran, the perfect adap-
tation of cypress trees to climatic conditions, have led to large-scale plantation
causing a significant augmentation of allergic diseases from the middle of
winter to the beginning of spring.
In this study, we tried to evaluate effects of air pollutants on pollen
protein content of the Cupressus arizonica planted in the highest polluted
areas of Tehran. Polluted areas of the city were selected according to data
provided by Air Quality Control company. In the first sampling, pollens were
collected just after microsporangia bursting, and the second sampling was
conducted 2 weeks later, in order to permit a natural pollen exposure to the
urban air pollution. After twoweeks exposure to urban air pollution, the colour
of purified pollens turned from a brillant yellow to a dark green. Bradford
protein assay showed an important diminution of the total protein content in
polluted pollens from 220 6g/ml to 150 6g/ml. Comparison of protein
components of polluted and non-polluted pollen extracts via SDS-PAGE and
densitometric analysis revealed appreciabe differences between their electro-
phoresis profiles. In non-polluted pollen extracts, a protein band with an
approximate molecular weight at about 45 kDa, called Cup a 1, (known as the
major allergen of C.arizonica pollens) represented 75% of all protein content
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and another protein at 35kDa constituted only 7% of the total protein content.
In pollutted pollens the concentration of the protein at about 45 kDa
considerably diminished to 14.6 % of the total protein content but the amount
of the protein fraction at 35kDa increased to 50.2%. Immunoblots, conducted
to evaluate sera IgE reactivity of cypress allergic subjects to the new major
protein of polluted pollen extracts, showed that the protein of 35 kDa was also
the major allergen of C.arizonica pollen extracts in allergic subjects living
in Tehran.
Important differences observed between protein profiles of non-
polluted and polluted pollen extracts, reflected the fact that environmental
pollution induce the augmentation of an allergenic protein which may have a
negative repercussion on the health of urban popullations.
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The allergen-specific IgE reactivity pattern of Chinese house
dust mite allergic patients
Chunqing Zhang1, Birgitte Gjesing2, Henrik Ipsen2, Helene Henmar2,
Michael Spangfort3, Jun Xu4, and Nanshan Zhong4. 1Guangzhou Institute
of Respiratory Diseases, Allergy Department, Guangzhou, China; 2ALK-
Abello, Vaccine Research, Horsholm, Denmark; 3ALK-Abello, Research,
Horsholm, Denmark; 4The 1st Affiliated Hospital of Guangzhou Medical
College, Guangzhou Institute of Respiratory Diseases, Guangzhou, China.
Background: Two species of house dust mites (HDM), Dermatophagoide
pteronyssinus (Der p) and Dermatophagoide farinae (Der f), have been rec-
ognized as major allergen sources in Chinese allergic patients according to
epidemiological surveys using in-vivo or in-vitro assays. The specific IgE
reactivity pattern of European and American HDM allergic populations are
well characterized. However, few studies have addressed the allergen-specific
IgE pattern of Chinese HDM patients.
Methods: Serum samples from 62 patients who had allergic asthma and/or
allergic rhinitis and who showed skin prick test and UniCAP positive to Der p
and Der f were obtained from South and Southwest of China. Sera were
analyzed by crossed radioimmunoelectrophoresis (CRIE) and immunoblotting
to visualize the allergen-specific IgE reactivity patterns.
Results: 23 allergens of Der p and 16 allergens of Der f were detected by
CRIE. The most frequent allergens were identified to belong to HDM group 1
and 2. All sera had specific IgE against both Der p 1 and Der f 1, while 92 % of
sera recognized Der p 2 and 95 % reacted against Der f 2. Antigen 16 of Der p
showed IgE binding by 69%. After immunoblotting, patients’ IgE mainly
showed binding to proteins of around 25 and 14 kDa which were identified as
HDM group 1 and 2 allergens, respectively. The reactions of the sera by
immunoblotting were 53 % for Der p 1, 63 % for Der p 2, 31 % for Der f 1 and
59 % for Der f 2.
Conclusion: The HDM specific IgE reactivity patterns of Chinese mite
allergic patients are similar to that of other patient populations. In addition to
the commonly recognized Der p 1, Der p 2, Der f 1 and Der f 2, a novel major
allergen, denoted antigen 16, was identified in the Der p extract. The analysis
indicates that the Der p and Der f extracts used in this study can be used
worldwide both for diagnosis and treatment.
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Immunoglobulin E and Immunoglobulin G epitope-mapping of
Blo t 5, the major allergen of Blomia tropicalis
Fong Cheng Yi, Hugo P Van Bever, Bee Wah Lee, and Kaw Yan Chua.
National University of Singapore, Paediatrics, Singapore, Singapore.
Background: Blomia tropicalis is one of the most predominant domestic mite
species in tropical and subtropical countries. Blo t 5 is a major allergen with
reported IgE sensitization rates of 43Y92% in Blomia tropicalis allergic
subjects.
Aims: The objective of this study was to determine the IgE, IgG1 and IgG4
epitopes of Blo t 5 in mite allergic children.
Methods: Five overlapping peptides, F1 (aa 1Y45), F2 (aa 41Y80), F3 (aa
70Y117), F4 (aa 1Y80), and F5 (aa 41Y117) were generated by PCR from Blo t
5 full-length cDNA. The IgE, IgG1, and IgG4 reactivities to these peptides and
full length Blo t 5 were determined by ELISA assay with 20 Blomia tropicalis
skin test positive children. The IgE ELISA unit was determined by a semi-
purified human IgE as standard curve, whereas IgG ELISA unit was det-
ermined by OD405nm X dilution factor.
Results: The IgE epitope mapping experiments revealed very low levels of
IgE binding to small peptides at N-terminal, F1 and F2 (p G 0.005) compared
to F3, and larger peptides, F4 and F5, indicating that Blo t 5 major IgE
epitopes were located at C-terminal and conformational dependent. In
contrast, higher levels of IgG1 to F1 and F3 were found compared to F2
(p G 0.005) indicating that the major IgG1 epitopes are located at both the
N- and C- terminal of Blo t 5. The peptides F1, F2, F3 and F4, bound lower
levels of IgG4 (p G 0.005) than F5 suggesting that the IgG1 and IgG4 epitopes
are unique and the major IgG4 epitopes seem to be located at C-terminal and
conformational dependent.
Conclusion: The data revealed both IgE and IgG4 epitopes are found mainly
in the C-terminal of Blot 5 and are highly conformational dependent, whereas
IgG1 epitopes are found throughout the whole Blot 5. The results suggest that
recombinant hypoallergenic Blo t 5 for immunotherapy can be achieved by
modifying the IgE epitopes while retaining the IgG epitopes.
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Aeroallergen sensitivity of Iranian patients with allergic rhinitis
Mohammad fereidouni1, Mehdi Bakhshaei2, and Abdolreza Varasteh1.
1Mashhad University of Medical Sciences, Immunology Research Center,
Mashhad, Islamic Republic of Iran; 2Mashhad University of Medical
Sciences, Otorhinolaryngology-Head and Neck Surgery, Mashhad, Islamic
Republic of Iran.
Background: Allergic rhinitis is a prevalent allergic disease throughout the
world. A recent study showed that allergic rhinitis is a common problem in
Mashad, Iran, However, Little is known about the relation between skin test
reactivity to aeroallergens and allergic rhinitis in Iran.
Objective: The aim of this study was to characterize the most frequent indoor
and outdoor (grass and tree) inhalant allergens involved in allergic rhinitis in
Mashad, Iran.
Methods: A total of 99 cases (females: 49, males: 50, aged between 3 to 68,
mean age 25 years), that were diagnosed with current active allergic rhinitis
based on the ISAAC rhinitis Core questionnaire and clinical presentation,
underwent a standardized skin prick test with 28 (7 indoor, 13 grasses and 8
trees) aeroallergens. Results: 75% of patients were reactive to at least one of the
aeroallergens and 69% of patients had positive reactions to more than 3
allergens but just 3% of patients were mono sensitized. Sensitization was more
prevalent for outdoor allergens than for indoor allergens in patients (74% vs.
31%).The individual pollen allergens with the highest positive rates were
pollens of Careless weed (Amaranthus palmeri) 67.4%, Russian thistle (Salsola
kali) 64%, Redroot (Amaranthus retroflexus) 61%, Burning bush (Kochia
scoparia) 58%, Lambsquarters (chenopodium album) 56%, Eastern cotton
wood (Populus deltoides) 54%, White ash (Fraxinus americana) 53%,
American sycamore (Platanus occidentalis) 43%. The most common Indoor
allergens were Dermatophagoides pteronyssinus %20, cockroach mix (Amer-
ican and German) 20%, house dust 20%, Dermatophagoid farinae 17%.
There was a significant but weak correlation between sum of all wheal
sizes and serum total IgE level (PG0.001) and also between the number of
positive skin test responses and the serum total IgE.The sum of mean wheal
sizes was larger in men than in women (371 vs. 219mm2) for outdoor allergens
but it was not statistically significant. Redroot, Russian thistle and Careless
weed had the greatest mean wheal size (60, 40 and 37 mm2, respectively).
Conclusion: The present study revealed that the prevalence of the Skin Prick
reactivity to outdoor allergens particularly grasses (weeds), is high among
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Iranian allergic rhinitis patients, although Indoor allergens do not seem to be
very common among patients.
822
Solution structure of Phl p 3, a major allergen from Timothy
grass pollen
IrenaMatecko1,KristianSchweimer1,ArndPetersen2,Wolf-MeinhardBecker2,
Roland Suck3, and Paul Ro¨sch1. 1University of Bayreuth, Department of
Biopolymers, Bayreuth, Germany; 2Molecular and Clinical Allergology,
Research Center Borstel, Borstel, Germany; 3Allergopharma Joachim Ganzer
KG, Allergopharma Joachim Ganzer KG, Reinbek, Germany.
: More than 20% of population in industrial countries suffer from
seasonal allergic rhinitis, commonly known as Bhay fever[. Pollen from
grasses, trees and weeds are some of the most frequent allergen sources.
Structural similarities found among the allergens from diverse allergen sources
represent the molecular and structural basis for immunologic cross reactivity
and thus explain why allergic patients can exhibit clinical symptoms and IgE
reactivity to various unrelated allergen sources. Binding of an allergen to the
corresponding IgE is an important step in the immunoreaction. Knowledge of
the structure and binding regions is therefore important to understand this
process in order to improve diagnosis of disease and to prepare better allergic-
specific immunotheraphy.
Timothy grass (PhleumPratense) pollen is an important allergen source
in Northern and Central Europe and its set of allergens is the best characterized
within different grasses. Phl p 3 was recently isolated from Timothy grass
pollen extract. From the amino acid sequence and homology comparison
belongs to the group 3 allergens. In this work we determined solution structure
of Phl p 3 by NMR. This solution structure and comparison with the structures
from other member of the group 3 (like Phl p 2 and Phl p 1) should help us to
find specific IgE-reactive eppitopes and to find better cure for the disease.
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Investigating pollen asthma deaths in islamabad, Pakistan
Osman M. Yusuf1, Shahida OYusuf1, QamaruzZaman Chaudhry2, Muhammad
Saleem3, Aslam M Gill4, and Muhammad Saleem5. 1The Allergy & Asthma
Institute, Pakistan, Allergy & Asthma, Islamabad, Pakistan; 2Pakistan
Meteorological Department, Director General, Islamabad, Pakistan; 3Paki-
stan Meteorological Department, Allergy, Islamabad, Pakistan;
4
Ministry of
Agriculture, Plant Biology, Islamabad, Pakistan; 5Pakistan Museum of
Natural History, Botany, Islamabad, Pakistan.
Introduction: Severe asthma and deaths have been reported in Islamabad
during the spring allergy season, which affects thousands of residents. We
investigated the deaths of 3 patients due to asthma, during the last ten days of
March. In order to find a possible cause of these symptoms, we investigated the
siblings of the deceased. Case 1: Male, 19 years, with a history of rhinitis
during spring season, developed sudden difficulty in breathing while walking
in the market, just after sunset. He was shifted to the nearest hospital. He died
just on reaching the hospital, approximately 15 minutes after the onset of the
attack. Case 2: A female medical doctor, 27 years, mother of 2 children aged 1
and 2 years, developed asthma suddenly about 1 hour after sunset. She was
rushed to the hospital but, like the previous case, expired before reaching the
hospital, approximately 20 minutes after onset of symptoms. Case 3: A 30 year
old female, mother of 2 children aged 2 and 4 years, expired at home just
before midnight, approximately 25 minutes after the onset of the first
symptoms of asthma. Commonalities in all cases: All the deceased patients
had a previous history of allergic rhinitis and occasional asthma during the
spring pollen season in Islamabad. None had ever suffered from severe asthma,
or been hospitalised. Very prominent is that the counts of Paper mulberry
pollens were in excess of 30,000 grains / cm3 that day, and humidity was
980%, due to a forthcoming thunderstorm and rain. None of the patients was
taking regular preventative treatment for allergy or asthma, at the time of the
episode. None had been investigated for allergy during their lifetime.
Methods: We contacted the siblings of the expired patients and found a
positive history of seasonal spring allergy in 2 brothers of case 1, 4 sisters and
one son of case 2, and one sister of case 3. One sibling each of cases 1 and 2
never reported any symptoms of asthma ever, while case 3 did not have any
other sibling.
Results: Skin prick allergy testing of all the symptomatic patients revealed
strong results (more than 10 mm wheal) to pollens of paper mulberry
(Broussenetia papyrifera) pollens.
Conclusion: It is probable that the deceased patients suffered from allergy to
pollens of paper mulberry, and expired due to the thunderstorm effect, during
the peak of paper mulberry pollen allergy.
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Incrimination of Blomia tropicalis as a potent allergen in Indian
house dust
Sanjay Podder, and Goutam Kumar Saha. University of Calcutta, Department
of Zoology, Kolkata, India.
Allergy to house dust mites particularly to the genus Dermatopha-
goides is a common feature in tropical climate like Kolkata, India leading to
various nasobronchial allergic manifestations. Analysis of house dust samples
collected from the houses of the asthmatic patients of Kolkata revealed a
variety of acarine fauna of which the mites belonging to the genus
Dermatophagoides predominated, comprising 60.4% of the total acarine
population followed by Blomia tropicalis (16.6%) and Austroglycyphagus
geniculatus (6.8%). Perusal of literature revealed that works on the role of
house dust mites in allergic etiology mainly concentrated with the genus
Dermatophagoides alone. No work incriminating the role of Blomia tropicalis
in house dust allergy has yet been reported from India, although it contributes
significantly towards the domestic acarine population. High prevalence of this
mite species in the patients` environment tempted us to search for an allergic
etiology towards this species of mite. Allergy skin test with house dust and
house dust mites revealed an encouraging result against Blomia tropicalis.
72% allergic asthmatics of Kolkata responded positively towards this species
of mites. The total serum IgE level in patients varies between 54 to 4040 KU/
ml (mean 369+487 KU/ml). Detection of allergen specific IgE antibodies
against this species of mites also confirms its role in house dust allergy. 30%
patients showed very high, 20% high and 40% showed moderate IgE level
against this mite antigen. The present study incriminates Blomia tropicalis as
an important source of allergen in house dust in Indian condition.
825
Aeroallergen sensitivity in patients with allergic rhinitis
and or asthma
Manimaran Marappan. DD Hospital and Research Centre, Pulmonology and
Allergy, Chennai, India.
Background: Allergic rhinitis and asthma are prevalent through out the world.
For the efficient diagnosis and its effective therapy it is very important to
know about the prevalance and pattern of sensitisation in a located
geographical area. Little is known about this in south coastal city of Chennai
in India, Southern Asia.
Aim: Aim of this study was to characterise the most frequent inhalant allergen
involved in Allergic rhinitis and Asthma.
Subjects and Methods: A total number of 104 cases [males 54 and females 50,
aged from 6 to 60] who were diagnosed to have Allergic rhinitis and or asthma
were subjected to undergo Standradised SKIN PRICK TEST with 22 common
Allergens.Reactionswas considered to be positive if themeanwheal diameterwas
atleast 3mmmore than that of the negative control. Each patient was evaluated for
sensitisation to allergen, number of positive reaction and mean wheal size.
Results: 78 % of the patients were reactive to atlest one of the allergen and 61 %
of the patients had positive reactions to more than 3 allergens. The most common
allergens were, D.PTERONYSSINIUS 65%, D.FARINAE 60% HOUSE DUST
52% MOSQUITO MIX 44%. Among Pollens PARTHINIUM 40% AND
CHENOPODIUM 28% and Among food allergens CITRUS MIX 45%.
Conclusion: The present study revealed that the prevalance of SKIN PRICK
REACTIVITY to allergens particularly to HOUSE DUST MITE is high
among with peoples in Chennai.
826
Sensitization to locally prepared allergenic extracts of house dust
mites in patients with respiratory allergy at the eastern of
kingdome of Saudi Arabia
Emad Koshak1, Hussein Almehdar2, Tarek Gheith3, and Magdy Abdelre-
heim4. 1King Abdulaziz University, Internal Medicine, Jeddah, Saudi Arabia;
2King Abdulaziz University, Biological Sciences, Jeddah, Saudi Arabia;
3Zagazig University, Microbiology and Immunology, Zagazig, Egypt; 4Ein
Shams University, Allergy unit, Cairo, Egypt.
Introduction: The prevalence of sensitization to allergens from house dust
mites (HDM) in patients with respiratory allergens appears to be directly
correlated with exposure.
Objective: To explore sensitization to locally prepared allergenic extracts of
HDM in patients with respiratory allergy at the Eastern of Kingdome of Saudi
Arabia (KSA).
Methods: House dust collected from different houses at KSA was put on
culture media plates containing a mixture of charcoal, gypsum and water,
which was then dried and wood excelsior with crushed maize for HDM
nutrition was added. These were incubated in chamber with an adjustable
relative humidity at 73% and temperature at 23 -C for one month with regular
observation. Three types of HDM were isolated and cultured: {(Dermatopha-
goid Pteronyssinus (DP), Dermatophgoid Farinae (DF) and Blomia Tropicalis
(BT)}. Allergenic extracts were prepared locally using the weight/volume
method concentration 1/10 for skin prick test (SPT). Sensitization was based
on a positive reactivity to standard SPT performed on patients with respiratory
allergy.
Results: 100 patients with the primary diagnoses of allergic rhinitis in 64
patients (64%) and bronchial asthma in 34 patients (34%) were studied. They
aged from 8 to 62 years old (mean=32 T13SD). SPTwas positive to: DP in 53
patients (53%) (44% polysensitization with other HDM and 9% mono-
sensitization), DF in 46 patients (46%) (42 % polysensitization with other
HDM and 4% monosensitization) and BT in 2 patients (2%) (2%
polysensitization with other HDM).
Conclusion: Prevalence of sensitization to locally prepared allergenic extracts
of HDM, especially DP followed by DF, was predominant in patients with
respiratory allergy seen in the Eastern of KSA. The sensitization to BT in few
patients is described for the fist time and needs further evaluation in
relationship to its significance in this geographical area. Properly manufac-
tured extracts to other local allergens may help to determine new regional
environmental factors for allergy.
827
Sensitisation to house dust and house dust mites in
nasobronchial allergic patients of Kolkata Metropolis, India
Sanjoy Podder, Goutam Saha, and Salil Gupta. University of Calcutta,
Zoology, Kolkata, India.
Background: Recent studies revealed the presence of huge quantity of
reported allergenic mites viz. Dermatophagoides pteronyssinus, D. farinae and
Blomia tropicalis in the indoor environment of Kolkata. Immediate
hypersensitivity to these dust mites along with house dust may play a role in
pathogenesis of nasobronchial allergic diseases. So, The present study
evaluated the sensitisation rates towards house dust and house dust mites
among patients suffering from various nasobronchial allergic manifestations
residing in Kolkata metropolis area, India.
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Methods: The Skin Prick Test was performed on a total of 1079 patients( 585
male and 494 female and 50 healthy controls) using extracts of four allergens
viz. Dermatophagoides pteronyssinus, D. farinae and Blomia tropicalis and
house dust allergens. Total serum IgE was measured by using EIA technique
and specific IgE to these allergens measured by following Pharmacia Immuno
CAP 100 System. The influence of age and gender, if any, on allergen
sensitivity was also investigated.
Results: The sensitisation rates among nasobronchial allergic patients to
house dust and house dust mite allergen tested were as follow: house dust
(96.22%), Dermatophagoides pteronyssinus (75.06%), Blomia tropicalis
(72%) and D. farinae(63.72%). The frequency of positive skin response was
found to be independent of age and gender. The total serum IgE level in
patients varies between 54Y4040 IU/ml ( mean 369 T 26.51). Specific IgE
antibody test proved that 83% patients showed sensitivity towards at least one
of the allergen tested.
Discussion: Nasobronchial allergic patients are highly sensitive to the house
dust and other three allergenic mites. Thus, these dust mites and house dust




Rabya Mian1, Iftikhar Hussain1, Allan Azarion2, and Sadia Khan3.
1Washington University School of Medicine, Allergy and Immunology, St
Louis, United States; 2Washington University School of Medicine, Internal
Medicine, St Louis, United States; 3Washington University School of
Medicine, Rheumatology, St Louis, United States.
: A 19 year old white male with past history of Crohn`s disease presented
to ED with one-week history of pain, rash and edema involving lower
extremities. Pain was localized to his lower extremities bilaterally extending
from mid shin to distal toes, particularly worse on the medial aspect of left
foot. He also noticed pruritis and palpable rash in the same area. His palpable
pruritic rash had improved to just a petechial rash by the time he presented. He
did bring pictures of the rash when it was at its worst. There were no symptoms
of exacerbation of Crohn`s disease. He was compliant with his medication.
The occurrence of rash was temporally related to injection of Adalimumab, his
last dose was 2 weeks prior to admission. Physical exam revealed edema
of both lower extremities with scattered nonblanching petechial rash. There
was also tenderness and decreased range of motion of ankle. There was no
sensory deficit.
Laboratory results including, CBC, CMP, PT, PTT, Rheumatoid factor,
Antihistone antibody, Anti-DS DNA antibody, C3 and C4 levels were within
normal range. ESR was 19, CRP was 9.080. ANA, ANCA, Serum
Cryoglobulin and Hepatitis screen were negative. Skin biopsy results revealed
mixed cellularity vasculitis, suggestive of resolving leukocytoclastic vasculitis.
After discharge, he received next dose of Adalimumab resulting in
redevelopment of the same rash only more severe in presentation.
Vasculitis appears to be a rare but potentially serious complication with
anti-TNF therapy that likely represents a type III hypersensitivity reaction. In
patients who develop this reaction, safe practice is to stop the TNF antagonist
and treat with a regimen of steroids and antihistamines with or without
immunosuppressive agents. This case represents a very rare hypersensitivity
reaction to humanized antibody like Adalimumab.
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Allergy to etanercept in a patient with rheumatoid arthritis
Miguel Zamorano Serrano1, M. Luz Diez Gomez1, and Bele´n De la Hoz
Caballer2. 1Hospital Ramo´n y Cajal, Allergy, Madrid, Spain; 2Madrid,
Allergy, Madrid, Spain.
Drugs that antagonize TNF-a´ have demonstrated their effect
controlling inflammatory activity and inhibiting the progression of structural
damage on patientswith chronic arthropathies. Otherwise the use of these drugs
can produce quite frequently some side effects, being skin reactions one of the
most frequent after infectious diseases. Awide amount of skin reactions have
being described with these drugs, such as systemic erythematous lupus,
necrotizing vasculitis, discoid lupus, multiform exudative erytema, Stevens-
Johnson syndrome, toxic epidermal necrolysis, eczema, urticaria, etc. We
introduce the case of a 57 year old patient with rheumatoid arthritis, which
developed a skin reaction with a high suspicion of being a hypersensitivity drug
reaction. After two years being treated with etanercept (25 mg, twice a week)
and leflunomide (20 mg a day), he developed 15 minutes after administrating
the drug a vesicular itchy rash on the injection sites with itchy isolated wheals
all over his body. We performed some skin tests including prick-test,
intradermoreaction and patch-test with etanercept, infliximab, adalimumab
and leflunomide. We used a blood sample of this patient to do a basophiles
activation test (BAT) with the same drugs. We performed subcutaneous
provocation with etanercept and adalimumab as well. In order to rule a possible
irritative reaction out, we performed prick-test and intradermoreaction with
etanercept, in five healthy controls.
Prick-test and intradermoreaction with etanercept were positive and
negative for the other drugs. BAT was positive with etanercept and negative
with leflunomide, infliximab and adalimumab. Due to these results, we carried
out subcutaneous provocation with etanercept and adalimumab, being positive
to etanercept and negative to adalimumab. The skin test in healthy controls was
in all of the cases negative.
We presented the first case of a patient with a type I hypersensitivity
reaction with etanercept, demonstrated with test in vivo and in vitro, and
confirmed with subcutaneous provocation. Despite the skin reactions with this
type of drugs are quite frequent, there is not enough evidence published trying
to clarify the immunologic mechanism implicated on it. This article opens a
new expectative on the study of the side effects and skin reactions of these
drugs, taking into account that they are very effective drugs in chronic
arthropathies and that their use will probably be widely spread.
830
Oral hydroxychloroquine desensitization in a 50 year old male
with cutaneous lupus
Cherry Ann Distor, Lara Aleta, and Madeleine Sumpaico. Philippine General
Hospital, Section of Allergy-Immunology, Manila, Philippines.
Background: Hydroxychloroquine is an antimalarial drug with immunomo-
dulatory and cytotoxic properties used in the treatment of lupus erythema-
tosus. Adverse cutaneous reactions in the form of rashes is its most common
side-effect occurring in about 3Y10%. Though, a mild reaction, it is the often
the reason for cessation of treatment. This is the first reported case of rapid oral
desensitization to hydroxychloroquine.
Methods: We present a rapid oral hydroxychloroquine desensitization
protocol in a patient who developed pruritus to hydroxychloroquine.
Results: This 50 year old patient diagnosed with cutaneous lupus presented
with a 1-year history of malar rash, arthralgia and diagnostic tests consistent
with cutaneous lupus. He was started on prednisone, calcium carbonate and
aspirin. After one year, he has was started on hydroxychloroquine for better
control at 200 mg per day. On the 2nd week of treatment, he developed pruritus
within two hours of intake. He was then referred for hydroxychloroquine
desensitization. We used a rapid desensitization protocol as opposed to a
published slow desensitization protocol by Mates, et al covering 36 days. Our
patient was started at 1/30th of the total dose doubling q 30 minutes reaching
the cumulative dose for the day of 200 mg. There was no pruritus and other
adverse reactions observed. The patient is still being maintained on
hydroxychloroquine at the present time.
Conclusion: This is the first reported rapid hydroxychloroquine desensitiza-
tion protocol. This demonstrates that rapid desensitization may be used when a
drug is essential in an allergic patient.
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Oral mitotane desensitization in an 18 year old female with
adrenocortical carcinoma
Cherry Ann Distor, Julia de Leon, and Madeleine Sumpaico. Philippine
General Hospital, Section of Allergy-Immunology, Manila, Philippines.
Background: Mitotane is a chemotherapeutic drug used in the treatment of
unresectable adrenocortical carcinomas. It is associated with various side-
effects that may affect intake. This is the first reported case of oral
desensitization to Mitotane.
Methods: We present an oral mitotane desensitization protocol in a patient
who developed pruritic maculopapular rash and angioedema to mitotane.
Results: This 18 year old patient diagnosed with adrenocortical carcinoma
presented with a 5-year history of amenorrhea, hirshutism, striae and obesity.
She underwent work-ups and excision biopsy on exploratory laparotomy
revealed adrenocortical carcinoma. Prednisone was started and her symptoms
subsequently resolved. On the 6th month post-surgery and medical treatment,
there was recurrence of the same symptoms. She was restarted on prednisone
and underwent another mass excision. Prednisone was discontinued. Mitotane
was initiated at 500 mg tablet three times a day. After 1 week, she developed
pruritic maculopapular rashes associated with angioedema and periauricular
swelling within two hours of intake. She was then referred for mitotane
desensitization. We used a protocol starting at an initial dose of 1/300th of the
total dose doubling q 15 minutes reaching the total cumulative dose after 3
days of 1500 mg. She tolerated the procedure well with no untoward side-
effects. Presently, she is still on mitotane.
Conclusion: This is the first reported successful mitotane desensitization
protocol. This demonstrates that desensitization may be an option when a good
alternative drug is not available in an allergic patient.
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A case of unusual insulin allergy and successful desensitisation
Ravishankar Sargur1, William Egner2, and R. Robinson3. 1Sheffield Teaching
hospitals NHS Foundation Trust, Clinical Immunology and Allergy Unit.,
Sheffield, United Kingdom; 2Sheffield Teaching hospitals NHS Foundation
Trust, Clinical Immunology and Allergy Unit., Sheffield, United Kingdom;
3Chesterfield Roayl Hospital, Medicine, Chesterfield, United Kingdom.
Background: Immunologic responses to insulin in the form of IgG and IgE
antibodies are common. Clinical problems related to these immunologic
reactions are uncommon. Gell and Coombs type I, II, III and IV reactions have
been reported. The antigenicity may be the result of any of several factors:
insulin as a heterologous protein, altered tertiary structure of insulin, presence
of non-insulin protein contaminants, or pharmaceutical formulation additives.
IgE mediated local reactions are the most common and almost always subside
spontaneously. With the use of human insulin these hypersensitivity reactions
have become rare.
Case report: We report a Type 2 diabetic who developed an interesting
combination of significant immediate cutaneous reactions and delayed Type III
and Type IV reaction to all the insulins including Human and recombinant
preparations. Skin tests performed with all forms of commercially available
insulin and insulin analogues were strongly positive, but skin tests were
negative for solvents, excipients and additives. High titre specific IgE and IgG
antibodies against insulin were demonstrated against bovine, porcine and
human insulin. Attempted desensitization with subcutaneous insulin- human
mixtard was initially unsuccessful. An intensive desensitisation regimen with
subcutaneous administration of Human actrapid followed by human mixtard
over 72 hours was done with the following Modified Insulin Desensitisation
Schedule
Results: On day 1, 0930 dose resulted in systemic urticaria after 45 minutes,
the next dose was reduced to 1/3rd of the previous dose which caused the
reaction and increments done by 1 units per injection. Hypoglycemia was
prevented by infusing 5 % dextrose throughout the desensitisation procedure.
After 96 hours patient was tolerating a Human mixtard dose 20 units and
10 units.
Conclusion: This is an unusal case of insulin allergy resluting from multiple
immunologic mechanisms which responded to a intensive desensitisation
regimen. Within 6 months of successful induction of tolerance there was
reduction in the IgG and IgE anti Y insulin titres.
833
Cutaneous hypersensitivity reactions to inhibitors of
cyclooxygenase-2
Souhad al Faqih. National Hospital, Allergy, Khartoum, Sudan.
Background: Most patients with cutaneous hypersensitivity to nonsteroidal
anti-inflammatory drugs (NSAIDs) exhibit clinical tolerance to specific
inhibitors (coxibs) of cyclooxyge-nase-2 (COX-2). However, a subset of such
patients will develop urticaria or angioedema when exposed to coxibs. The
mechanisms of urticaria and angioedema due to coxibs are presently unknown.
In this paper we discuss the prevalence of skin reactions due to coxibs and
possible mechanisms mediating such adverse manifestations.
Methods: A total of 206 patients (female 144, male 62, mean age 31.1T13.7
years) with urticaria and/or an-gioedema due to nonselective NSAIDs were
studied between September 1999 and September 2005. Drug pattern showed
167 crossreactors (81%) and 39 single-reactors (19%), with a cutaneous
clinical pattern in 122 (59.2%), mixed reactions (respiratory/cutaneous) in 82
(39.8%), and systemic reactions only in 2 (0.9%). Oral provocation tests were
carried out with preferential and specific COX-2 inhibitors. In addition, a
PubMed search of published studies on the tolerance to specific COX-2
inhibitors in NSAID-hypersensitive subjects was performed.
Conclusion: Positive oral challenges with nimesulide were observed in 31%
of studied patients, with meloxicam in 20.6%, with celecoxib in 18.4%, with
etoricoxib in 11.2%, with valdecoxib in 10.3%, and with rofecoxib in 9.4%.
While most NSAID-intolerant patients tolerated coxibs during oral challenges,
a small subgroup of patients developed urticaria. Although there are few
studies for valdecoxib and etoricoxib, these results are in agreement with the
majority of published studies dealing with tolerability to rofecoxib (reaction
rates 0Y34.7%) and celecoxib (reaction rates 0Y33.3%). Cutaneous reaction
rates correlated with in vitro inhibition of COX-1 by different COX-2
inhibitors. Two possible mechanisms are proposed to explain urticaria induced
by coxibs, an IgE-mediated allergic response, and inhibition of COX-1.
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The importance of drug challenge in the work-up of ADR to
chemotherapeutic agents
Wipa Utsawapreechawong, Orathai Jirapongsananuruk, Nualanong Visitsun-
thorn, and Pakit Vichyanond. Siriraj Hospital, Allergy and Immunology of
Pediatric Department, Bangkok, Thailand.
Day Time (hours) Insulin (Human) Dosage (Units)









Day 2 0800 Mixtard 16
2000 Mixtard 8
Day 3 0800 Mixtard 20
2000 Mixtard 10
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Background: Allergic reaction to chemotherapeutic agents among pediatric
patients suffering from malignancy is not common and poses an important
challenge since alternative agents are not commonly available. We report
pediatric cases with adverse drug reaction (ADR) to chemotherapeutic drug
reactions who required further management at Siriraj Hospital, Thailand.
Methods: The medical records of children with previous ADR to chemother-
apeutic agents from January 2004 through December 2006, were reviewed.
They underwent allergic investigations with skin prick tests (SPT), intradermal
tests (ID) and drug challenges.
Results: Eight patients (3 boys, median age 9.5 years) were documented to
have ADR to chemotherapeutic agents. Their presentations were urticaria (3/8
patients) and anaphylaxis (5/8 patients). Drugs causing reactions were
vincristine (3/8 patients), L-asparaginase (1/8 patients), Mesna (1/8 patients),
carboplatin (1/8 patients) and cyclophosphamide (1/8 patients). Among five
patients with anaphylaxis, two had alternative agents. Three other anaphylaxis
patients had no alternative drug and underwent successful graded challenges
(all with vincristine). Two of the urticaria patients also underwent successful
graded challenges (carboplatin Y 1 case and cyclophosphamide Y 1 case)
whereas one was switched to an alternative agent.
Conclusion: Although urticaria and anaphylaxis could develop among
patients required chemotherapeutic agents, a number of these patients could
tolerate a careful and successful graded challenge.
835
Provocation test in patients with history of aspirin
hypersensitivity
Krzysztof Specjalski, Marta Chelminska, Karol Kempinski, Krzysztof
Kuziemski, and Ewa Jassem. Medical University of Gdansk, Department of
Allergology, Gdansk, Poland.
Aim: The aim of the study was to evaluate the usefulness of aspirin
provocation test in patients with a history of aspirin hypersensitivity.
Methods: Patients with asthma and/or chronic urticaria/angioedema with a
history of aspirin hypersensitivity underwent provocation test with aspirin.
Single-blind oral provocation test was performed with increasing doses of
aspirin (placebo, 50mg, 100mg, 150mg, 300mg) administered orally. Anterior
rhinomanometry, spirometry and clinical monitoring were performed before
the test, during and after drug administration. Test was considered positive in
case of clinical symptoms of hypersensitivity, decline of FEV1 or positive
nasal response measured by anterior rhinomanometry.
Results: 62 patients (15 males, 47 females) aged from 19 to 71 (mean age: 48
years) including 26 patients with diagnosed asthma and/or nasal polyposis
(first group) and 36 patients with urticaria and/or Quinke oedema (second
group) were examined. All subjects had a history indicating hypersensitivity to
aspirin. Provocation test was positive in 28 patients (45,1%). There was not a
significant difference between the groups (first group - positive result in 12
patients (46%), in the second one- 14 patients (39%). The mean dose
provoking reaction was significantly lower in asthmatics (238,3 mg) than in
urticaria/angioedema group (392,8 mg); pG0,05.
Conclusion: Oral aspirin provocation test is a valuable tool in final diagnosis
in patients with a history of aspirin hypersensitivity. Doses provoking reaction
are lower in asthmatics than in urticaria/angioedema patients.
836
Skin tests in Nsaids hypersensitivity
A.G. Palma-Carlos, M. Medina, and M.L. Palma-Carlos. Clinical Allergy
Immunology Center, CAIC, Allergology, Lisbon, Portugal.
Background: The diagnosis of NSAIDS (non-steroidal anti-inflammatory
drugs) hypersensitivity relies on clinical history and skin or provocation tests.
In daily clinical practice double blind placebo controlled provocation tests are
not always possible and skin tests must be used first.
Methods: 245 patients with a history of rhinitis, bronchospasms, conjuncti-
vitis, urticaria and angioedema, anaphylaxis or anaphylactoid reactions related
to ingestion of NSAIDS, mainly to Aspirin (ASA) have been studied. Skin
prick tests and intradermal tests when pricks were negative or dubious have
been done in 215 cases. Lysine salycilate for ASA and solutions of more
commonly used NSAIDS and acetaminophen have been used after
discontinuing H1-antihistamines, psychotropic drugs and topical steroids.
Informed consent was obtained from all the patients. Aspirin was tested in 215
patients, diclofenac in 202, ibuprofen in 156, piroxicam-meloxicam in 112,
indometacin in 122, nimesulide in 186, celocoxibe in 105, etoricoxibe in 102,
metamizol in 37, acetominophen in 172, naproxene in 18, niflumic acid in 2,
with a total of 1430 skin tests (prick and ID when necessary).
Results: When identification of the drug was possible concordance with
positive skin tests was 98%. Positive NSAIDS skin tests: ASA 197 (91.6%),
Prick 65 (30.2%), Diclofenac 135 (91.6%), Prick 35 (17.3%), Metamizol 25
(67.6%), Prick 5 (3,5%), Celecoxibe 71 (67.6%), Prick 24 (22.9%), Piroxicam
57 (50.8%), Prick 21 (18.8%), Etoricoxibe 50 (49.0%), Prick 19 (18.6%),
Ibuprofen 68 (43.5%), Prick 40 (25.6%), Indometacin 52 (42.6%), Prick 31
(25.4%), Naproxen 18 (33,3%), Prick 3 (16,7%), Nimesulide 50 (26.9%),
Prick 24 (12.9%), Acetominophen 25 (14,5%), Prick 5 (2,9%), Niflumic acid
2-2 (both ID). Only local reactions have been observed without any severe
reaction.
Conclusion: Prick tests are more specific but less sensitive than ID which can
give false positive results. 3 NSAIDS groups can be considered: 1-Aspirin,
diclofenac and metamizol with a higher percentage of positivity. 2-For others
NSAID including the newer coxibes positivity around 50%. 3-Nimesulide and
acetaminophen with a lower of positivity. Skin tests can be used in NSAIDS
hypersensitivity to confirm clinical history but also to choose, case by case, a
drug less prone to give hypersensitivity reactions.
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IgE mediated anaphylactic reaction to omeprazole. Cross
reactivity among Proton-Pump Inhibitors
Efthalia Stefanaki1, Vasilios Vovolis1, Ioanna Letsa2, and Nikolaos
Koutsostathis1. 1Laikon General Hospital, Allergology and Clinical Im-
munology, Athens, Greece; 2Leicester Royal Infirmary Hospital, General
medicine, Leicester, United Kingdom.
Background: Omeprazole is a proton pump inhibitor (PPI) with an excellent
therapeutic index for Helicobacter pylori infection. Anaphylactic reactions to
omeprazole have rarely been reported.
Case report: A 38 year-old woman was referred to our department with
pruritus in the palms, facial angioedema, oedema of eyelids and nose, gen-
eralised urticaria, bronchospasm, nausea, dizziness and collapse 15 minutes
after the administration of an omeprazole capsule. No other drugs had been
administered during the previous 12 hours. She was effectively treated at the
emergency department. She had a past medical history of peptic ulcer for which
she had been taking Omeprazole for many years. She had no past medical
history of atopy.
Methods and Results: Skin prick tests with common inhalant, food allergens
and other Imidazole derivatives (ketoconazole, metronidazole) were negative.
The skin prick test with PPIs was positive to Omeprazole (cap 20mg/ml) and
negative to Lansoprazole (cap 30mg/ml) Pantoprazole (tab 40mg/ml)
Rabeprazole (tab 10mg/ml) Esomeprazole (tab 20 mg/ml). Intradermal tests
were positive for Omeprazole (vial 4mg/ml, 0.004mg, 0.04mg/ml) but they
have not been done for other PPIs. Five normal controls were tested and were
negative for skin tests to all substances. The serum was tested for IgE Ab
(ImmunoCap/Phadia) against omeprazole with experimental prototype
reagents and it was negative. The challenge test with omeprazole was not
carried out for ethical reasons. Also no adverse reaction occurred when the
patient took the capsule shell without the pharmaceutical substance. Sub-
sequently oral challenge in a single blind with placebo procedure was curried
out with lansoprazole and rabeprazole and no reaction was reported.
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Conclusion: Proton pump inhibitors are a rare cause of anaphylaxis but health
care professionals need to be aware of this possibility. Skin prick tests proved
to be an effective diagnostic tool for the IgE mediated hypersensitivity to PPI.
An anaphylactic reaction to one of the PPIs does not necessarily imply cross
reactivity with all PPIs. Oral challenge test with negative prick tests to PPIs
turned out to be safe and offered the patient the chance to be treated with a
different PPI with out any complication.
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Effective desensitization for allopurinol for oral way, in allergic
patient. Procedure of dilution
Gabriele Cortellini1, Barbara Gavioli2, Chiara Cherubini2, Christopher
Muscat1, Cristina Focherini1, Margherita Simoncelli1, Claudia Pari1,
Alessandra Bezzi1, Andrea Tarroni1, Sergio Pasotti1, and Angelo Corvetta1.
1Rimini Hospital, Internal Medicine and Rheumatology, Rimini, Italy;
2Rimini hospital, Pharmacy, Rimini, Italy.
The desensitization with allopurinol is an effective treatment in
selected patients, with cutaneous symptoms that do not respond to therapies
alternatives. Clinical case. Old patient, with gout arthropathy (uric acid:11
milligram/decilitre), allergic to allopurinol, with pruritus and maculopapular
rash. Associate pathologies: renal insufficiency (creatinine: 2,1 milligram/
decilitre); Myelodysplastic syndrome. The therapy with altenative drugs
(sulfinpyrazone, rasburicase) was not effective in reducing the level of uric
acid.
Method preparation: one tablet of 100 mg allopurinol was weighed and
crushed in a mortar ;1800 mg of rice starch (F.U.Italian) were added
progressively in the mortar, by standard geometric diluition technique to
obtain an homogeneous allopurinol dispersion in the mixed powder (total
weigth 2000 mg).To obtain unit doses containing 50 mcg, 100 mcg, 200 mcg,
500 mcg, 1mg, 5 mg, 10 mg, respectively were weighed 1 mg 2 mg 4 mg
10 mg 20 mg 100 mg 200 mg from the mixed powder. To obtain unit dose
containing allopurinol 25 mg, one tablet of 100 mg allopurinol was crushed in
a mortar and 1:4 of one tablet was weighed. The doses have been manifactured
in capsules. The successive treatment comes carried out following the outline
proposed from Fam AG. In consideration of associated pathologies, in
particular of the renal insufficiency, the dosage increment has been carried out
every 5 gg. Employed doses: 50, 100, 200, 500 mcg, 1 mg, 5, 10, 25, 50,
100 mg. Treatment is lasted in total 60 days and cutaneous adverse reactions
have not been taken place, neither pruritus symptoms. The first dosages have
been given in hospital, and the following in outpatients department, with the
necessary observation. We think that this procedure is easy and sure for
patients with this type of pathology.
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Stevens-Johnson Syndrome from hemodialysis-associated
hypersensitivity reaction in a 61-year old male
Leon Bautista, III, Cesar Joseph Gloria, and Madeleine Sumpaico. University
of the Philippines-Philippine General Hospital, Allergy-Immunology Depart-
ment, Manila, Philippines.
Background: Stevens-Johnson syndrome (SJS) is often described as diffuse,
severe, mucocutaneous eruption involving two or more mucosal surfaces and
majority of cases are attributed to drug exposures. Hemodialysis-associated
hypersensitivity reactions are well documented in literature and majority
would present as flushing, urticaria, periorbital and facial edema, bronchial
hypersecretion and hypotension. This is the first reported case of hemodia-
lysis-associated SJS.
Methods: To present a patient who developed SJS after hemodialysis.
Results: This is a 61-year old male diagnosed with chronic kidney disease, in
uremia. Less than 24 hours after the initiation hemodialysis, patient developed
generalized, pruritic, erythematous macular rahes. This was thought to be an
adverse reaction to present antibiotics thus, all antibiotics were discontinued.
After the second hemodialysis, rashes progressed with increase in erythema
and exfoliation. This was thought to be a an anaphylactoid reaction to ethylene
oxide present in dialyzers. Thus, pre-medication prior to subsequent hemo-
dialysis was done. But on subsequent hemodialysis these lesions became
localized flaccid bullae, later developing epidermal detachment involving
the eyes and oral mucosa. He received intravenous hydrocortisone up to
200 mg/kg/day (equivalent to 3mg/kg/day methylprednisolone). However,
patient`s condition worsened requiring endotracheal intubation. He subse-
quently died due to multi-organ failure. The strong history surrounding each
hemodialysis sessions with the progression of his lesions plus the high index of
suspicion pointed to ethylene oxide hypersensitivity as the cause of the SJS.
Conclusion: This is the first reported case of hemodialysis-associated SJS.
This case report demonstrates the importance of early detection, referral, and
management of hemodialysis-associated hypersensitivity reaction. Replacing
ethylene oxide with steam or gamma radiation may help solve this problem.
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The impact of polypharmacy intervention on adverse drug
reactions and cost of care in new orleans seniors
Prem Kumar, Kareem Elshatory, E. Elshatory, Carlos Vital, Sandhya Mani,
and Annette Fiorillo. Louisiana State University Health Sciences Center,
Allergy/Immunology, New Orleans, United States.
Background: In the United States (U.S.), more than 100,000 deaths annually
are attributed to serious adverse drug reactions (including but not limited to
drug allergy). The estimated total cost of these events in 1996 was 12.2 billion
(U.S.) dollars. Polypharmacy, particularly in seniors, contributes to the
increased likelihood of adverse drug reactions (ADRs). Polypharmacy is
defined as the use of five or more prescription medications on a long-term
basis. There are no reports of intervention studies from the state of Louisiana
(U.S.) where fifty percent of seniors are on polypharmacy in contrast to twenty
percent prevalence in the rest of the United States. The goal of this pilot
clinical observational study is to demonstrate whether cessation of
inappropriate medications would decrease adverse drug reactions and lower
the monthly cost of medications.
Methods: Nine patients, ages 66 to 83 years, that met the definition of poly-
pharmacy were evaluated. Patients with known Human Immunodeficiency
Virus (HIV/AIDS), transplant recipients, and malignancy were excluded
secondary to known requirement of multiple medications. The Medication
Appropriateness Index (MAI) was utilized to stop inappropriate medications.
ADRs, Mini Mental Status Exam (MMSE) scores and monthly cost of
medications were recorded before and after intervention.
Results: The mean number of medications used daily decreased from 13.5
medications to 7.3 medications before and after intervention respectively. The
ADRs decreased from 3.0 occurrences before intervention to 0.3 occurrences
after intervention (pG0.001), while MMSE mean scores improved from 25.5
prior to intervention to 28.1 post intervention (pG0.05). Monthly Cost of Care
(COC) values decreased from 352 U.S. dollars per month prior to intervention
to 128 U.S. dollars per month post-intervention (pG0.001).
Conclusion: Seniors on polypharmacy can be benefited by stopping inap-
propriate medications with intervention having a favorable outcome on mental
status, frequency of adverse drug reactions and the monthly cost of medica-
tions. Further prospective studies are in process on a larger number of patients.
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Desensitisation to antituberculosis drugs in cutaneous allergy:
about 6 cases
Houda Marouan1, Karima Marc2, Loubna Outalha1, Rachida Zahraoui1,
Mona Soualhi1, Jouda Benamor1, Jamal Eddine Bourkadi1, and Ghali Iraqi1.
1Hoˆpital Moulay Youssef, Rabat, Service de Pneumologie, Rabat, Morocco;
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2Service de Hoˆpital Moulay Youssef, Rabat, Service de Pneumologie, Rabat,
Morocco.
Tuberculosis continues to be a major cause of morbidity and mortality
worldwide. Currently available drugs are effective for treatment of the disease
or latent infection, but may cause serious allergic reactions, often difficult
to manage. Once the diagnosis allergic drug reactions have been established,
re-introduction of the drug, leading to tolerance can be considered, induction
of tolerance is usually possible in most patients.
We report the observations of 6 women, their age varies between 29
and 70 years, without immunodeficiency, treated for pulmonary tuberculosis
TPM+ (2 patients), pleural tuberculosis confirmed histologically (3 patients)
and a TPM-(1 patient) and having received an antituberculosis treatment
containing SRHZ for the two first and RHZ for the last four ones with adequate
posology. All our patients presented cutaneous reactions of gravity moderated
at severe, which have occurred between 3 and 45 days after the beginning of
the treatment. The treatment was stopped until disappearance of the lesions in
all the cases. The reintroduction was practised successfully at five of our
patients and the therapeutic protocol was changed in a patient considering the
gravity of the lesions.
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Cutaneous adverse drug reaction induced by a generic substitute
of zyloric with a residual sensitization to allopurinol
Marie-Lorraine Chandeclerc, Jean-Fran0ois Cuny, Jean-Luc Schmutz, and
Annick Barbaud. Hopital Fournier, Dermatologie, Nancy, France.
Cutaneous adverse drug reaction (CADR) due to a generic drugs seem
to be rare or have been rarely reported except with antiepileptic drugs. We
report on the first case of a CADR that occurred when a drug that had been well
tolerated for 15 years was replaced by a generic substitute. A 59 year old man,
who had taken Zyloric* pills for 15 years developed a maculopaplar rash
(MPR) 3 days after the replacement of Zyloric* pills by its generic substitute
called Allopurinol Ge*. Four days after stopping the intake of Allopurinol Ge*
the MPR spontaneously disappeared. Biological findings remained normal
without liver involvement. Two months after, the patient took Zyloric* again
and developed generalized eruption with a more severe involvement of the
flexure areas, the 3 days following the re-intake of the drug. This second CADR
was less severe than the previous one. Threemonths later, the intake of Zyloric*
was disrupted and the CADR vanished in 3 days. There was no other
modification in the usual treatment. Dermato-allergological investigationswere
performed three months after the disappearance of the CADR and after
stopping Zyloric*. Drug patch and pricks tests were done.
The results were negative for both tests. To our knowledge, we report
on the first case of CADR due to allopurinol, appearing after replacing well
tolerated Zyloric* by one of its generic substitutes. The generic substitute was
responsible for inducing a sensitization to allopurinol, which unfortunately led
a relapse of the CADR when Zyloric* was reintroduced, even though the
clinical eatures were less severe in the second CADR. There are no common
excipients between Zyloric* and its generic. In the few reported cases in
literature of CADR occurring after the replacement of a drug by its generic
substitute, the adverse effect does not relapse when the original drug is
readministrated. Thus, to our knowledge, here is the first case in which the
reintroduction of the original drug was associated with a relapse of the CADR.
From our observation, new mechanisms must be evoked for this type of
therapeutic accident, i.e. the role of excipients other than those listed on the
pharmacological notice or a non tolerated commercialized form of the drug
that induces a sensitization to the active compound.
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The value of skin tests in the investigation of suspected systemic
corticosteroids hypersensitivity
Nade`ge Michelet1, Philippe Trechot2, Jean-Luc Schmutz1, and Annick
Barbaud1. 1Fournier Hospital, Dermatology, Nancy, France; 2Central
Hospital, Pharmacology, Nancy, France.
Background: To establish the value of patch tests (PT), prick tests (pt),
intradermal tests (IDT) in suspected immediate or delayed hypersensitivity to
corticosteroids (CS) systemically administered.
Materials and Methods: 67 patients (52 women, 15 men, mean age 50,6 y.o)
referred for immediate (13,4%) or delayed (86,6%) cutaneous adverse reaction
(CAR) possibly due to a CS systemically administered, were enrolled. All had PT
with a special series of 12 CS diluted in petrolatum, read at 20 minutes, 48h, 96h
and one week. When negative, pt were carried out with tixocortol, budesonide,
betamethasone, betamethasone dipropionate, hydrocortisone 17 butyrate,
triamcinolone acetonide and the involved CS. If PT and pt were negative, IDT
were carried out at least with one CS of each group of the Goossens classification
(1): hydrocortisone (group A), triamcinolone acetonide (group B), betametha-
sone (group C), betamethasone dipropionate (group D1), with progressively
increasing dosages. If skin tests were negative, oral provocation tests with the
involved CS or another CS (same group or different group) were proposed. Oral
administrationswere performed under hospital surveillance, versus placebo, with
progressively increasing concentrations to the full dosage.
Results: 12 patients (18%) had positive results either on skin testing or oral
administration. PT were positive in 5 cases (7.5 %), none had positive pt, 3
patients had positive IDT, one had a positive repeated open application test. In
58 patients all tests were negative. Thirty-eight accepted one or more oral
administrations (OA) of CS (50 OAwere performed). Among them, 1/21 had a
positive OA to the involved CS, 1/9 had a positive OA to a CS belonging to the
same group; 2/20 had a positive OA with a CS belonging to another group.
Conclusion: Hypersensitivity to systemic CS is supposed to be rare but do
exist, as we confirmed a CS sensitization in 12 patients with an immediate or
delayed mechanism. We demonstrated that skin tests are useful in the
management of such patients. They have a mean value in investigating
suspected CS hypersensitivity, but they are well tolerated and seem to have a
good negative predictive value (92.1 % in our series). They allow to confirm a
sensitization (positive tests) and to lead the OA in the initially responsible
chemical group of CS or in another group with a low risk of reactivity.
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Anaphylaxis to Omeprazole
Stefan Cimbollek, Teresa Gonza´lez-Quevedo, Maria Robledo Avila, Angustias
Nieto, and Manuel Dı´az. Hospital U. Virgen del Rocı´o, Allergy Unit, Seville,
Spain.
Background: Proton pump inhibitors are widely used but only few cases of
anaphylaxis have been reported. In some cases cutaneous tests have proved
useful and in only one case cytometric cellular allergen test (FAST) was
performed and confirmed the existence of specific IgE.
Case report: We present a 26 year old patient whith previous history of
urticaria. In one episode he associated nausea and shortness of breath. He did
not correlate symptoms to food ingestions. He used ocassionally omeprazole
due to acid reflux.
Methods: Skin prick tests and intradermal tests were performed with
omeprazole and pantoprazole (1/100 and 1/1000 dilutions) with negative
results. Controlled oral challenge was programmed. The patient started with
generalized flushing and pruritus, eyelid edema, abdominal pain and shortness
of breath 45 minutes after last dose of omeprazole. Physical examination did
not reveal wheezing nor hypotension. The patient recovered in two hours
following intravenous infusion of 500 ml of saline, an iv push of one ampoule
of pheniramine and 80 mg of prednisolone. FAST, also called basophil
activation test, was performed with negative result.
Conclusion: We present a case of anaphylaxis to omeprazole which could not
be confirmed with cutaneous nor basophil activation tests as previously
reported.
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Drug allergy in pollinosis: is the pattern changing?
A.G. Palma-Carlos, M.H. Clode, and M.L. Palma-Carlos. Clinical Allergy
Immunology Center, CAIC, Allergology, Lisbon, Portugal.
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Background: We have presented at a previous EAACI meeting a study on the
association between pollen and drug allergies. In this study $-lactams were
more frequently associated with pollen allergy than non steroidal anti-
inflammatory drug (NSAIDS). The aim of the present study is to verify if the
association pattern has changed.
Methods: 952 patients allergic to pollens and 141 with hypersensitivity to
drugs have been studied in the last five years. 47 patients were simultaneously
allergic to pollens and drugs (4,9% of pollinosis) (33,3% of drug allergy).
Clinical history, skin prick tests for pollens and prick and ID when necessary
for drugs, specific IgE when possible done in all the 47 patients.
Results: 32 females (68,1%) and 15 males (31,9%), previously Females
(54,4%) Males (45,6%). 40 patients (85,1%) attended by pollinosis and 7
(14,9%) by drug allergy. In pollen allergy clinics was rhinitis in 45 and asthma
alone in 2. Drug allergy: urticaria-angioedema in 32 (68,8%), shock in 2,
bronchospasm in 2. Skin prick tests-grass pollens 32 (68%), Parietaria 19
(40,2%), olive tree 12 (25,5%). Drug allergy: $-lactams 19 (40,4%), NSAIDS
24 (51,1%) and other drugs (16,2%). There was no correlation between allergy
to one specific pollen and a group of drugs.
Conclusion: The association of pollinosis with drug allergy is not very
frequent. Reporting to the results previously obtained in these series there is a
greater number of grass pollens allergy instead of Parietaria and a greater
incidence of NSAIDS hypersensitivity instead of $-lactams. These results can
be explained by a decrease of antibiotics prescription to allergic patients and an
increase in the use of NSAIDS in the last few years.
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Adverse drug reactions: a five-year experience in a tertiary care
hospital (2002Y2006)
J.C. de Leon, M.W. Sumpaico, M.T. Recto, and M.R. Castor. Philippine
General Hospital, Pediatrics, Manila, Philippines.
Background: Drug hypersensitivity is a common clinical problem associated
with significant morbidity and mortality. According to Volchek (2004),
adverse drug reactions are a major health issue encountered frequently in both
the inpatient and the outpatient setting. Over the past few years, with the
increasing number of medications that have been manufactured, there has been
an increasing emphasis on pharmacotherapeutic vigilance in order to reduce
the incidence of such reactions.
Objective: The purpose of this investigation was to review records of patients
referred to for adverse drug reactions and determine the most commonly
implicated drugs, most common clinical manifestations as well as to look into
the source of the referral or the consult.
Methods: Chart review and frequency distribution Results: A total of 1,694
patients were referred to the Allergy Section from 2002Y2006 with a slowly
increasing trend each year. Forty percent of these patients were seen at the out-
patient clinic and 60% were in-patient referrals. Among those admitted, the
number of adult and pediatric cases were nearly the same (54% and 46%
respectively). In the out-patient clinics, adult referrals outnumbered pediatric
cases by more than two-thirds. The most common manifestations in the in-
patient setting were cutaneous reactions (maculopapular rashes, urticaria,
angioedema), followed almost equally by jaundice, difficulty breathing, fever
and chills. Rare generalized reactions such as Stevens-Johnson Syndrome
(SJS) and toxic epidermal necrolysis (TEN) were also reported, averaging 10
cases per year. The most commonly implicated drugs for both in-and out-
patient settings was still beta-lactam antibiotics, followed by anti-tuberculosis
medications, anticonvulsants, ASA/NSAIDs and others (L-asparaginase,
vitamin K and allopurinol). Over the five year period there was an increasing
trend of.
Conclusion: Results have shown that over the past five years, although the
implicated medications are the same, there has been an increasing trend in the
reporting of adverse drug reactions. This is most probably due to the fact that
there is a heightened awareness regarding the issue. An increasing number of
brand names and manufacturers may also lead to an increased number of
adverse reactions to medications.
Key words: adverse drug reaction
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A 10-year update from the Tan Tock Seng Hospital (TTSH)
prospective inpatient drug allergy reporting system
(1997 Y 2006)
Hiok-Hee Chng, Khai-Pang Leong, Yew-Kuang Cheng, Chwee-Ying Tang,
Faith Chia, Justina Tan, and Bernard Thong. Tan Tock Seng Hospital,
Rheumatology, Allergy and Immunology, Singapore, Singapore.
Background: We set-up the TTSH Prospective Inpatient Drug Allergy
Reporting System in 1997 in our 1200-bed hospital.
Aim: To describe the manifestations, risk factors and outcome of drug allergy
in hospitalized patients from the 10-year registry.
Methods: All newly developed cases, confirmed or suspected, of drug allergy
in inpatients were notified and subsequently verified by an allergist using the
network-based electronic system.
Results: From December 1, 1997 to December 31, 2006, 1094 cases were
reported from a total of 443,165 admissions. Just over half (51%) of the
patients were females. The majority (76.9%) were ethnic Chinese. The
patients` mean age was 57 T 20 (13Y96) years with 41% aged = 65 years
(elderly). Half of the patients developed drug allergy during the course of
hospitalization. In the 4 weeks preceding the allergy, 56.6% had received = 5
drugs. The most commonly implicated drugs were antibiotics (57.8%) and
anti-epileptic drugs (14.6%). The majority (72.9%) had delayed reactions.
Cutaneous eruptions were the most common presentation (95.6%), with
majority having maculopapular rash. Systemic manifestations occurred in
33.8%, of which hepatitis, haematological abnormalities, and drug fever were
equally common (16% each). Serious reactions occurred in 28.4% including
drug-induced hypersensitivity syndrome, (DIHS, 16.5%), Stevens Johnson
syndrome, (SJS, 7.5%), toxic epidermal necrolysis (TEN, 1.5%) and overlap
SJS-TEN (0.9%). Anaphylaxis occurred in 3.7%. Death occurred in 19 (1.7%)
patients. Systemic involvement (p=0.00), DIHS (p=0.008), anaphylaxis
(p=0.008) and SJS (p=0.001) were more common in non-elderly patients. In
multivariate analysis, non-elderly age was associated with DIHS (p=0.015)
and SJS (p=0.009). There were no statistically significant racial or gender
differences, or differences in outcomes between the elderly and non-elderly.
Conclusion: Drug allergy occurred in 2 per 1,000 hospitalizations, with
serious reactions in 28.4% and death in 1.7% of affected patients. Serious drug
allergies appeared to be more common in the non-elderly with no differences
in outcomes. It is possible that immune senescence may be a reason for the
milder drug allergy reactions in those aged = 65 years.
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Negative predictive value of drug skin tests in investigating
cutaneous adverse drug reactions
Julie Waton1, Philipe Trechot2, Carole Loss-ayav3, Jean-Luc Schmutz1, and
Annick Schmutz1. 1Fournier Hospital, Dermatology, Nancy, France; 2Central
Hospital, Pharmacology, Nancy, France; 3Marin Hospital, Epidemiology,
Nancy, France.
: Drug skin tests are useful in etiological analyses of cutaneous adverse
drug reactions (CADR), in order to determine if the drug can be re-
administered or to avoid a cross reaction with a substitute drug. The aim of this
study is to evaluate the negative predictive value (NPV) of drug skin tests.
Patients and Methods: After a retrospective analysis of the files of patients
referred for CADR between 1996 and 2006, we have enrolled those having
CADR with clinical features, onset`s delay after the drug intake and drug
imputability strictly determined, having had negative drug skin tests followed
by drug administrations. There were oral provocation tests (OPT) or sub-
stitution tests (ST) with a drug of the same class of those of the drug suspected
during the CADR.
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Results: From 1957 files analysed, 200 patients were included. After 403
patch tests, 403 prick tests and 304 IDTs, all negative, 260 OPTs and 143 STs
were performed, 307 different drugs were re-administered. The 42 positive
drug re-administrations were 27 OPTs and 15 STs (NPV=89.5%). The NPVof
our drug skin tests were 89.6% for OPTs and 89.5% for STs. The NPV of
betalactams were 95.8% % for OPTs and 86.6% for STs, for corticosteroids
100% for OPTs and 73,7% for STs.
Conclusion: Negative drug skin tests did not eliminate the responsibility of
a drug in CADRs even with a low imputability. Except for severe CADRs,
drug skin tests must be followed by a drug re-administration under hospital
surveillance.
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Drug adverse reactions and asthma
M.L. Palma-Carlos, and A.G. Palma-Carlos. Clinical Allergy Immunology
Center, CAIC, Allergology, Lisbon, Portugal.
Background: Studies of epidemiology and clinics of drug reactions in
patients attending Allergy Centers are scarce. The prevalence of drug allergy
and clinical manifestations in out-patients has been analysed.
Methods: The files of 9 067 patients have been reviewed. Clinical presentation
and suspected drugs registered. Skin tests with the group of drug incremated
have been done by prick and intradermal techniques in progressive con-
centrations when prick were negative informed consent was obtained from all
the patients. Specific IgE or leucotrienes release has been done in cases these
techniques are available.
Results: 448 (4,9%) out of 9 067 patients reported one or more drug adverse
reactions: (females 69,7%, males 30,3%). 90% of the patients reported
urticaria/angiodema and 10% rhinitis and/or asthma. NSAIDS were implied in
63,6% of the patients, $-lactams in 34,2%, local anesthetics in 4,7%.
Associations of reactions to NSAIDS and $-lactams were frequent (22,3%)
other drug less implied were sulfa drugs, quinolones, macrolides, ACE
inhibitors, angiotensin II blockers, statins, corticosteroids, vitamines, allopur-
inol, tetracyclin, gentamycin, furadantine, curarisers, tramadol, ranitidin,
thyocholchycosid, fibrates, fluconazol. Specific IgE and CAST (leucotrienes
release) were positive only in less than 50% of the cases.
Conclusion: NSAIDS and $-lactams are the more frequent cause of adverse
reactions in out-patients clinical history, skin tests step by step are the more
practical first diagnostic approach of drug allergy in out-patients. Drug
hypersensitivity can cause asthma, allergic rhinitis or both (Fermaid Widal
triad) in a non-negligible number of patients atopic or non-atopic.
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Current practice of antibiotics allergic skin testing in Korea
So-Hee Lee1, Sang-Min Lee1, Hyouk-Soo Kwon1, Chang-Han Park1, Heung-
Woo Park1, Yoon-Seok Chang2, Sun-Sin Kim1, Sang-Heon Cho1, Kyung-Up
Min1, and You-Young Kim1. 1Seoul National University Hospital, Depart-
ment of Internal Medicine, Seoul, Republic of Korea; 2Seoul National
University Bundang Hospital, Department of Internal Medicine, Seongnam,
Republic of Korea.
Background: Antibiotics skin testing (AST) is a useful procedure for
identifying patients with IgE mediated hypersensitivity to antibiotics. However
the procedure is not standardized and is performed in diverse and sometimes
inappropriate protocols among hospitals in Korea.
Objective: To examine protocols of AST in major hospitals of Korea and
compare it with that in the literature.
Methods: Routine protocols of AST performed in general wards of 12 general
hospitals were collected via allergists working in each hospital by using
questionnaire. In addition, we reviewed literatures searched from Pubmed/
Medline.
Results: All of the 12 allergists responded to the questionnaire. All hospitals
carried out ASTon volar forearm by intradermal method without any controls.
Two hospitals used saline as a negative control only if false positive result was
suspected. Penicillins and cephalosporins were tested in 10 hospitals and 11
hospitals. In detail, both were tested in 9 hospitals, only penicillins in one
hospital, and only cephalosporins in 2 hospitals, among which penicillin was
never prescribed in one. In addition, semisynthetic penicillins was tested in 8
hospitals, carbapenems in 9 hospitals, vancomycins in 4 hospitals, aminoglyco-
sides in 3 hospitals, and monobactams in one hospital. The testing con-
centration differed upto 10000 folds among the 12 hospitals. Standard of
interpretation also varied between hospitals. The generalized method of AST in
the literatureswas intradermal testing onvolar forearm. ASTwas recommended
as a routine practice for penicillins and cephalosporins but not for other
antibiotics in most of the literatures.
Conclusion: The protocols of AST varied greatly among 12 general hospitals
in Korea and differed from that commonly used in literatures. Thus
standardized guidelines for AST are required for the safe usage of antibiotics.
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Dual fixed drug eruption caused by Paracetamol
Marı´a del Mar Moro Moro, Concepcio´n Vila Albelda, Ma Victoria Mu´gica
Garcı´a, Ana Rosado Ingelmo, Miguel Angel Tejedor Alonso, and Daniel Paul
Lindo Gutarra. Fundacio´n Hospital Alcorco´n, Medicine (Allergy Unit),
Alcorco´n, Spain.
Introduction: Paracetamol associated Fixed Drug Eruption is uncommon and
occurs in less than 1.5 percent of all fixed drug eruptions.
Case report: A 19-year-old healthy male took amoxicilin for a respiratory
infection. After two days of treatment, some hours after the last dose, he
suffered pruritus, erythema, pain, and local inflammation of penis, with vessels
blisters and wounds of 1Y2 cm. He recovered after oral corticoids,
antihistamines and topic antibiotic, plus permanganate potassium washing.
Thewounds lasted 2Y3 weeks and left skin pigmentation. On another occasion,
he took paracetamol again for a sore throat. After 3Y4 days of treatment he
suffered similar wounds and needed the same treatment Following this, he has
tolerated other NSAIDs.
Methods and Results: With written consent we made the following study:
We performed a patch test with paracetamol 10% concentration that
was negative at 48 and 96 hours. Prick and ID tests with paracetamol were
both negative too. An oral controlled challenge test with paracetamol up to
500 mg was also negative. After this, we recommended that the patient be
taken 500 mg. of paracetamol every 8 hours three more days. After two
days of treatment the penis wounds appeared again and other wounds
between the 1st and 2nd finger of the left hand appeared too. This wound
was a 1-cm diameter, erithematous and descamative plaque. These wounds
recovered after oral corticoids and antihistamines that were administered
during 5Y6 days.
After the challenge the patient recalled that in the first reaction he had
taken paracetamol plus amoxicilin.
We performed cutaneous and oral challenge tests with amoxicilin with
negative results and the patient took amoxicilin for 5 more days with good
tolerance. Patch test with TRUE TESTi and challenge tests with other para-
amino drugs (sulfonamides and hydroclorotiazide) were all negative.
Conclusion: We present an infrequent adverse reaction due to paracetamol
confirmed by a challenge test. It is a skin reaction suggestive of dual fixed
exanthema in both penis and betwen 1st and 2nd finger of the left hand. We
have ruled out cross-reactivity with other para-amino drugs. Although
paracetamol allergy is infrequent, it is important to investigate and to study
all the drugs involved in an adverse reaction.
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Sensitization to cefuroxim
Bernard Arnoux1, Philippe Jean Bousquet2, Nazima Soohun3, Laure
Rouanet-Bousquet3, and Pascal Demoly3. 1INSERM, U454, Montpellier,
France; 2University of N^mes, Dept de l’Information Mdicale, N^mes,
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France; 3University Hospital of Montpellier, Exploration des Allergies,
Services de Maladies re, Montpellier, France.
Introduction: During drug hypersensitivity tests, cefuroxim, one of the most
common beta-lactam used in France, is often tested either as the suspected
drug or as an alternative. We report those tests and characterized patients with
a positive test.
Methods: Using our Drug Allergy and Hypersensitivity Database (DAHD),
we conducted an historico-prospective cohort study. All patients who
consulted between 1996 and 2007 for a suspected beta-lactam hypersensitivity
reaction and who underwent at least skin tests to cefuroxim were included.
Diagnosis (skin tests and challenges) followed the European Network on Drug
allergy (ENDA) recommendations.
Results: 650 patients [(188, 29.1% of male), 107 (16.5%) asthmatics and 355
(54.6%) atopics] were tested. 38 (5.8%) had a clinical history involving cefuroxim,
17 (44.7%) urticaria / angioedema, 10 (26.3%) exanthema and 6 (15.6%)
anaphylaxis / anaphylactic shock. Only 5 (13.2%) were positive (3 skin tests and 2
oral challenges). Among those tested as an alternative (612), 178 (29.2%) were
positive to at least one beta-lactam. 10 (1.6%) of them were also positive to
cefuroxim (3 skin tests and 7 challenges). The most common clinical presentations
were urticaria / angioedema (4, 40%) or anaphylaxis / anaphylactic shock (4, 40%).
Conclusion: 22.2% of patient with a drug allergy to beta-lactam, were positive
to cefuroxim. Among those positive to the later one, 20,8% had no history
involving this drug.
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An allergic evaluation of adverse drug reactions in the
hospital among Thai children as previously categorized according
to the World Health Organization-The Uppsala Monitoring
Centre System
Chutsumarn Tantikul1, Nualanong Visitsunthorn1, Pakit Vichyanond1,
Narumon Dhana2, and Kovit Jongjareornprasert3. 1Division of Allergy and
Immunology, Siriraj Hospital, Department of Pediatrics, Bangkok, Thailand;
2Drug Reaction Monitoring Center, Faculty of Medicine, Bangkok, Thailand;
32Adverse Drug Reaction Monitoring Centre, Siriraj Hospital, Department of
Medicine, Bangkok, Thailand.
Background: Confirmation of adverse drug reaction (ADR) is important for
proper further drug management in patients with such reactions. The gold
standard for diagnosis adverse drug reaction is drug challenge. Recently,
adverse drug reactions as categorized by World Health Organization-The
Uppsala Monitoring Centre (WHO-UMC) system has been suggested as a
practical tool for assessing and classifying adverse drug reactions (ADR).
However, confirmation of such classification by complete allergic evaluation
has been not previously studied. The objective in this study is to further
evaluate ADR among Thai children reported with adverse drug reactions with
the WHO-UMC system by complete allergic evaluation.
Methods: Cases of ADR documented by WHO-UMC criteria between
January 2005YJune 2006 at Siriraj hospital, Thailand were investigated by skin
prick tests (SPT), intradermal test (ID) and challenges to drugs. Serum tryptase
was measured in case of anaphylaxis.
Results: Twenty-seven patients with mean age of 6.9 year were documented to
have ADR by WHO-UMC criteria between January 2005YJune 2006. These
patientswere classified to have causality terms as certain in 4/27, probable in 6/27,
possible in 10/27 and unlikely in 7/27 cases. Antibiotics were the most common
drugs causing ADR in this group of patients (44.5%) which sulfonamides and
beta-lactam drugs being the common culprits (18.5% and 14.9%, respectively).
Skin tests and drug challenges were performed in 26 patients. Serum tryptase
weremeasured in 3 patients with drug-induced anaphylaxis. Drug challenges and
serum tryptase were positive in 8 and 1 patient, respectively. Overall, cases of
certain and unlikely drug allergy were identified in 9/27 and 18/27, respectively.
By performing drug challenges, the sensitivity and specificity were changed from
70% to 100% and 88.2% to 100% , respectively.
Conclusion: Skin tests, drug challenges and serum tryptase are helpful to
further confirmed adverse drug reactions among patients categorized by
WHO-UMC system.
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Adverse cutaneous reactions due to glycopeptides-induced
adverse cutaneous reactions: results of immunoallergical
investigations in 9 patients
Amandine Perrin1, Philippe Trechot2, Nadine Petitpain2, J. Fran0ois Cuny1,
J. Luc Schmutz1, and Annick Barbaud1. 1Hopital Fournier, Dermatology,
Nancy, France; 2CHU, Pharmacovigilance, Nancy, France.
Objective: With the emergence of hightly resistant staphylococcus,
vancomycin (V) and teicoplanine (T) usage has considerably increased but
they can induce cutaneous adverse reactions (CAR) for which the value of
immunoallergical investigations has not yet been determined.
Methods: Retrospective study (2006Y2006) including 9 patients (6 women,
3 men; mean age = 54.3) with CAR suspected to be due to glycopeptides,
V: 4 cases, T: 4 cases and successively V then T: 1 case. Red man syndromes
were not included. Imputability was estimated according to Moore’s criteria.
The CAR were 6 maculopapular rashes, 1 linear bullous dermatosis, 1 DRESS
and 1 urticaria. Six weeks later, according to ESCD’s guideline for drug skin
tests, immunoallergological investigations were carried out with successively
drug patch tests, prick tests and intradermal tests with all the drugs taken
during the CAR.
Results: Skin tests confirmed the responsibility of glycopeptides in 4/9 cases,
with cross-reactivity between V and T in 2/5 cases. Following negative
immuno-allergical investigations, 3 patients had well tolerated provocation
tests with glycopeptides.
Conclusion: In literature, T seems to be safer than V (ototoxicity, rashes,
nephrotoxicity) for a similar efficacy, inducing very few hypersensitivity
reactions such as red man syndrome (3 cases published). Allergic cross-
reactivity (V and T), already reported in literature, is not so rare (2 of our
patients) but unconstant (3 of our patients had indeed well tolerated
provocation tests with the other glycopeptide and we precise that all the skin
tests were negatives for V and T in these patients. In that way, this study has
important clinical implications, demonstrating that skin tests are useful in
CAR due to glycopeptides, in determining the responsible drug and if the tests
are negative, allowing the readministration of another glycopeptide with
hospital surveillance, as we demonstrated that cross-reactivity between
glycopeptides is not constant.
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A link between angioedema caused by inhibitors of angiotensin
converting enzyme and eotaxin and ECP
Malgorzata Basinska, Tomasz Basinski, Robert Pawlowicz, and Bernard
Panaszek.Wroclaw Medical University, Department of Internal Medicine and
Allergology, Wroclaw, Poland.
Background: Inhibitors of angiotensin-converting enzyme (iACE) and
Blockers of angiotensin II type 1 receptor (AT1 blockers) are commonly
used in hypertention and chronic heart failure treatment. These therapies are
believed to be safe. However, angioedema is a rare but a well recognized
potentially life-threatening adverse effect of iACE therapy. The aim of the
study was to estimate angioedema threat in patients treated with short and long
acting iACE in comparison to patients receiving AT1 blockers. Eosinophilic
cationic protein (ECP) and eotaxin serum concentrations were used as
indicators of the angioedema threat, since bradykinin is involved in the
activation of this chemokine and subsequently eosinophils.
Methods: Patients were divided into the following groups, according to the
treatment they have been receiving: AT1 blockers, short acting iACE, long
acting iACE and control. Patients with a history of angioedema of etiology
unrelated to the study were excluded. Eotaxin concentration in the serum was
determined by standard solid phase sandwich ELISA. ECP level in the serum
was assessed by the Pharmacia CAP system ECP fluoro enzyme immunoassay
(FEIA) method, according to the manufacturer`s instructions. Results are
shown as mean T SD. Student`s t test for unpaired samples was used for
statistical analysis.
Results: There were no statistically significant difference with regard to serum
ECP level between the AT1 blockers and control group. The same was true for
eotaxin. The levels of ECP in sera of patients taking short acting iACE
(12.9T3.30 6g/mL, pG0.001) and long acting iACE (10.8T4.9 6g/mL, pG0.05)
were significantly higher than in control group (5.22T2.5 6g/mL). The level of
eotaxin was higher in serum of patients taking short acting iACE (177.5T57.6
pg/mL, pG0.05) and higher in serum of patient taking long acting iACE
(156.1T44.8 pg/mL, pG0.05) compared to the control group (112.3T21.5 pg/
mL).
Conclusion: Serum concentration of eotaxin and ECP play potential role in
the pathogenesis of iACE induced angioedema and their concentration may be
a predicting factor of this adverse event. Thus, patients treated with AT1
blockers are at the significantly lower risk of angioedema in comparison to
patients taking iACE.
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Fixed drug eruption caused by traditional herbal
medicine (jamu)
Ratna Komala Dewi1, Mahmud Ghaznawie2, Fanny Iskandar1, Anis Irawan
Anwar1, and Muh Dali Amiruddin1. 1Medical Faculty Hasanuddin
University / Dr. Wahidin Sudirohusodo General Hospital, Dermato-
Venereology, Makassar, Indonesia; 2Medical Faculty Hasanuddin University,
Pathology, Makassar, Indonesia.
Background: Fixed drug eruption (FDE) are so named because they recur at
same site with each exposure to the medication. Jamu is the term commonly
used to describe traditional herbal medicine products from Indonesia. The
medicinal elements may be made from roots, bark, leaves, fruits, flowers, seeds
or other parts of a plant. Jamu pegal linu indicated for the treatment of
rheumatism, body ache and bone ache, muscle joint, giddiness, toothache and
backache usually consumed by hard workers. Commercial products are
available in the form of powders, pills, capsules, mixtures and creams. Some
illegal retailers adding phenylbutazone, allopurinol and paracetamol in to
jamu. FDE caused by jamu has never been reported yet.
Case: A 40-year-old man presented with multiple black macules on the upper
left eyebrow, left and right cheeks, lower lip and left and right hands. The
lesions initially appeared small and only a few, enlarge slowly, and became
obvious and of concern to the patient in the past 2 weeks. The lesions were
slightly itchy but there was no pain. He was otherwise healthy. He denied
taking any medication except traditional herbal medicine (jamu) for the past 1
year when feeling tired. Family history was negative. Laboratory examinations
were within normal limits. Skin biopsy from one of his lesions showed some
vaculolar degeneration of the basal cells, pigmentary incontinence, mild
superficial perivascular limpho-histiocytic infiltrates with a few eosinophils.
Discussion: The clinical presentation and histopathologic alterations are
consistent with the diagnosis of fixed drug eruption. The patient was treated
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with oral methyl prednisolone and topical hydrocortisone 2,5% for his face
and also topical desoximetasone 0,25% for his body. His condition improved
and the lesions disappeared in 6 weeks.
Conclusion: This was the first case of Fixed Drug Eruption caused by
traditional herbal medicine (jamu). Successfully treated with oral methyl
prednisolon and topical hydrocortisone for the face and topical desoximeta-
sone for the body.
Key Words: fixed drug eruption, jamu
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Anaphylactic reactions during general anaesthesia: diagnostic
approach and prevalence of anaesthetics involvement
Mauro Cancian1, Muzio Meroni2, Raffaele Bendo1, Elena Ossi1, and
Giuseppe Realdi1. 1Clinica Medica 1- University of Padova, Medical and
Surgical Department, Padova, Italy; 2ISTAR- University of Padova,
Pharmacology and Anesthesiology Department, Padova, Italy.
Background: Although anaphylactic reactions during general anaesthesia
show a very low incidence, the mortality reaches 5% or more, and additional
patients may experience significant brain damage. Neuromuscular blocking
drugs are usually reported as the most common cause of anaesthesia-elicited
anaphylaxis, but the possible involvement of induction agents, antimicrobials,
latex, plasma expanders and other drugs should be considered. Unfortunately,
the diagnostic approach is limited by the lack of validated commercial kits for
detection of specific antibodies, as well as by the occurrence of pseudoallergic
reactions, that are not mediated by circulating IgE.
Methods:We evaluated 20 consecutive cases (14 F, 6 M; age range 16Y68 yrs)
of well documented anaphylaxis during general anaesthesia, by laboratory
assays (WBC count; Eosinophil cationic protein; Serum Tryptase; Plasma C4
and C1-INH; IgA and total IgE levels; RAST for inhalant and food allergens,
latex and beta-lactams) and skin tests (Patch and/or Prick testing; intradermal
injection) for inhalant allergens, eggs, soybeans and exotic fruit, latex and
drugs administered before or during anaphylaxis onset. Drug skin tests were
performed with commercial formulations of beta-lactams, heparin, atropine,
benzodiazepins, vecuronium, norcuronium, mivacurium, rocuromium, fenta-
nyl, remifentanyl, propofol, droperidol and thiopental, at different dilutions.
Results: Two patients showed evidence of allergy to norcuronium and
mivacurium, respectively. Three subjects were allergic to amoxicillin and six to
latex. Heparin skin testing elicited a local weal-and-flare response in one
patient, whilst diffuse urticaria and itching were observed in one case. Finally,
apparent anaphylaxis followed by cardiac arrest during anaesthesia in an
asthmatic subject, seemed to be an adverse effect of a difficult intubation rather
than a true allergic or pseudoallergic reaction. Unfortunately, in the remaining
six patients we were not able to identify any triggering factors, also because no
diagnostic tests are available to assess NSAIDs hypersensitivity.
Conclusion: Latex allergy still represents, at least in our experience, the main
cause of anaphylaxis during general anaesthesia. Although the reliability of
skin testing with commercial drugs has not been well established till now, this
procedure can help to prevent the risk of further episodes in patients with a
documented anaphylactic reaction during anaesthesia.
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Four cases of steroid allergy with bronchial asthma
Yoko Murakami, Jyunko Ikei, Hiroshi Odajima, Rumiko Shibata, and Sankei
Nishima. Fukuoka National Hospital, Pediatrics, Fukuoka City, Japan.
Background: Corticosteroid preparations have anti-inflammatory and
immunosuppressive properties and are widely used in the treatment of asthma
and allergic disorders. However, steroids themselves can rarely induce
hypersensitivity reactions. The severity of the reaction can vary from a rash to
anaphylaxis or death. We report four cases regarded as the steroid allergy that
we experienced in our hospital recently.
Case Report: Case 1 was the 9 years old girl and hospitalized with moderate
asthma attack. Rash developed in several minutes when she was given
aminophilin continuous intravenous infusion and hydrocortisone succinate
(HC-S) 6mg/kg intravenous drip. An intradermal test by HC-S was positive
and we diagnosed the drug allergy. We changed it to predonine (PSL)
intravenous infusion, rash didn’t develop but persistence of wheeze and
decreased FEV1.0. The symptom and lung function were improved when all
steroid were canceled. Case 2 was 10 years old girl with many kinds food
allergy and hospitalized with moderate asthma attack. She was given
aminophilin continuous intravenous infusion, hydrocortisone succinate
(HC-S) 7mg/kg intravenous drip and PSL 1.0mg/kg$B!_#4(B/day intravenous
injection for 8 days. She showed persistence of wheeze and decreased$B!!(B-
FEV1.0. She was diagnosed steroid allergy and pertussis infection. By an
intradermal test, she showed positive for PSL, HC-S, methylprednisolone
succinate(MP-S), hydrocortisone sodium phosphate. Wheeze and FEV1.0
were improved by all steroid cancellation. Case 3 was a 23 years old female
patient hospitalized with moderate asthma attack. It was similar to case 2, she
had intractable wheeze and decreased FEV1.0 persisted. By an intradermal
test, she showed positive for PSL, HC-S and she was diagnosed steroid allergy.
Case 4 was a 10 years old boy with moderate asthma attack developed urticaria
and hypotension after receiving HC-S intravenous drip. In this patient the
intradermal tests HC-S and PSL showed positive and diagnosed steroid
allergy.
Conclusion: 3 in 4 cases did not show anaphylactic reaction. There were many
cases which showed persistence of wheeze and decreased FEV1.0 during
treatment of asthma. We thought that the steroid allergy that took the course to
protract of asthma attack could be present from these cases. It is important to
considerate striod allergy in treatment of acute exacerbation of intractable
asthma.
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Angioedema after administration of methylprednisolone to treat
drug allergy: a case report
Enrico Compalati, Laura Guerra, Anthi Rogkakou, Antonio Scordamaglia,
Giovanni Passalacqua, and Giorgio Walter Canonica. Allergy and Respiratory
Diseases Clinic, Genoa University, Department of Internal Medicine, Genoa,
Italy.
Background: Despite the large use of corticosteroids (CS), allergic reactions
to these drugs remain uncommon; Immediate allergic reactions to CS are
uncommon events usually provoked by excipients. Both immunologic and
nonimmunologic mechanisms are proposed. Delayed reactions are compa-
tible with a T-cell mediated response. Cross-reactivity has been observed
between different topical corticosteroids, but the classification of cross-
reactivity between them does not seem to be completely useful in adverse
reactions to systemic corticosteroids. Case report. We signal the case of a 39-
year-old woman with no atopy but contact sensitization to tixocortol-21-
pivalate 1%. The woman, before a recent administration of mepivacaine for
dental surgery, had proceeded with CS preventive administration (Prednisone
50mg 13hh, 7 hh and and clorfenamine 1h before the intervention). One
hour after the last dose of premedication, followed by anahestetic
administration, patient presented facial angioaedema. Further administration
of metilprednisolone to treat the adverse event had the effect of increasing
symptoms.
Management: Patient was studied for corticosteroids allergy. Patch test,
performed with Standard Series, confirmed mentioned sensitization. Skint
tests were carried out with metilprednisolone succinate, betametasone
fosfate, triamcinolone acetodine. Patient showed immediate local reaction
after intradermoreaction with metilprednisolone; no positivity for other CS
tested.
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Comments: Tixocortol-21-pivalate and prednisone belong to group A
corticosteroids, so a possible cross reaction may be suggestive. As CS are
poorly soluble in water or saline, they are coupled with esters. In this
circumstance patient reacted to both the previous administration of prednisone
and then to metilprednisolone; these two preparations are different only for the
presence of succinate ester in the second one, so an effect of this additive may
reasonably be excluded. Therefore all other excipients included in the tested
preparations were commonly existing in both tolerated and untolerated drugs.
Conclusion: Drug adverse reactions appearing altough preventive adminis-
tration of systemic CS should be reconsidered for possible allergic response to
CS. The classification of cross reactivity between CS, with patch testing and
intredermal testing, may provide useful support to confirm diagnosis and to
identify alternative tolerated molecules.
860
Erythema multiforme
Ketut Suteja Wibawa1, Siswanto Wahab1, Mahmud Ghaznawie2, and Muh
Dali Amiruddin1. 1Medical Faculty Hasanuddin University / Dr. Wahidin
Sudirohusodo General Hospital, Dermato-Venereology, Makassar, Indonesia;
2Medical Faculty Hasanuddin University, Pathology, Makassar, Indonesia.
Background: Erythema multiforme is a reaction pattern of blood vessels in
the dermis with secondary epidermal changes and manifests clinically as
characteristic erythematous iris-shaped papular, little or no mucous membrane
involvement; vesicles but no bullae or systemic symptoms. Eruption is usually
confined to extremities, face, classic target lesions.
Case: A 56 year-old girl with erythema multiforme minor developed typical
lesions involving most of the skin. The eruptions developed after she had taken
some medicines for antihypertension. Histopathology result showed focal
hyperkeratosis, acantosis, focal spongiosis in epidermis and inflammatory cell
infiltrate: lymphocytes and eosinophil in dermis without vacuolar
degeneration.
Discussion: Mild forms have appearance of little or no mucous membrane
involvement, vesicles but no bullae or systemic symptoms. In this case there
were erythematous patchs and vesicles in his skin. This eruption is usually
confined to extensor aspects of extremities, and classic target lesions. Clinical
manifestation characteristic by classic target lesions that characterized for
erythema multiforme but histopathology examination showed appearance like
drug eruption without vacuolar degeneration, that mean there is discrepancy of
clinical appearance and histopathology. Mild form of erythema multiforme
may developed to severe erythema but in this case the lesion improved after
treatment with steroid equivalent of dexamethasone 30mg orally a day in
divided doses.
Conclusion: There is discrepancy of clinical appearance and histopathology.
Erythema multiforme in this patient well responded to corticosteroid,
withdrawal of all possible offending drugs, and supportive therapy. Prompt
diagnosis and treatment give good result.
Keywords: erythema multiforme, mild forms, classic target lesions, vacuolar
degeneration.
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Severe reaction due to fluoroquinolones - Toxic epidermal
necrolysis case report
Ioana Adriana Bujor, and Diana Dumitrascu. 3rd Medical Clinic, University
of Medicine and Pharmacy BIuliu Hatieganu^, Allergy Department, Cluj
Napoca, Romania.
Background: Toxic epidermal necrolysis (TEN) is an uncommon fulminating
mucocutaneous disease associated with high prevalence of mortality.
Frequently TEN is associated to drug administration. TEN due to
fluoroquinolones are rare, 7 case reports in Medline with TEN due to
ciprofloxacin. Allergic reactions due to fluoroquinolones are very rare.
Anaphylactoid and/or anaphylactic reactions are estimated to occur in 0.46-
1.2 in 100,000 patients. Fluoroquinolones are new antibiotic drugs used
mostly in treatment of urinary and respiratory infections. Allergy to
fluoroquinolones may have many clinical manifestation: anaphylactic or
anaphylactoid reaction, acute urticaria with or without angioedema, fixed drug
eruption, serum sick-like illness, nummular eczema. The most frequent used
quinolones in Romania are ciprofloxacin and norfloxacin. 2812 patients were
evaluated in the department of Allergy, in Cluj Napoca between Jan 2005YDec
2006. Only 14 (0.49%) cases of allergic reaction due fluoroquinolones were
reported.
Case report: A 29-years-old smoking man was admitted in our hospital with
malaise, with an eritematous eruption in the whole skin with small areas of
denudation of epithelium, ulcers in nasal and oral mucosa. Those phenomena
were associated with a severe itching and burning sensation of the skin. The
patient began 10 days ago treatment with ciprofloxacin for an acute bronchitis,
that was the only drug he took in the last 6 months. After a complete
examination the patient presented also hepatocitolisis. After treatment with
corticosteroids, antibiotics intense care of the skin the patient recover
complete. Evolution in 2 months was Brestitutio at integrum^.
Conclusion: Toxic epidermal necrolysis (TEN) is a rare, but the increasing
rates of reports for this syndrome due to ciprofloxacin could reconsider first
choice option for this drug. More studies should be done in order to find the
prevalence of TEN to ciprofloxacin.
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Toxic epidermal necrolysis suspected due to nimesulide
R. Diana Putri1, Asnawi Madjid1, John M.F. Adam2, Abdul Wahab3, and Muh
Dali Amiruddin1. 1Medical Faculty Hasanuddin University/Dr. Wahidin
Sudirohusodo General Hospital, Dermato-Venereology, Makassar, Indonesia;
2Medical Faculty Hasanuddin University/Akademis Jaury General Hospital,
Internal Departement, Makassar, Indonesia; 3Medical Faculty Hasanuddin
University/Akademis Jaury General Hospital, Anaesthesiology Departement,
Makassar, Indonesia.
Background: Nimesulide is a new nonsteroidal anti-inflammatory drug with
antipyretic and analgesic properties. Pruritus and rash are the most common
cutaneous side effects associated with nimesulide. Toxic epidermal necrolysis
induced by drugs is a rare, potentially lethal syndrome characterized by the
sudden onset of widespread blistering of the skin. To the best of our knowledge
there have been no previous reports of toxic epidermal necrolysis induced by
the ingestion of nimesulide in the medical literature.
Case: A 68 years old woman, Buginesse. Previous history she ever had TEN
six years ago probable caused by paracetamol and metamphiron. The
diagnosis was established based on anamnesis and clinical manifestations. The
lesions consisted of generalized erythema, vesicles, bullae, Nikolsky sign was
positive, erosions, and epidermolisis more than 30%. Treatment was parenteral
infusion, dexamethasone intravenous 10 mg, cimetidine 1 ampule, cipro-
floxacin injection per drip and topically with silver sulfadiazine and framycetin
sulfate for erosion and denuded area.
Discussion: This case was diagnosis as toxic epidermal necrolysis based on
anamnesis and clinical manifestations. The most frequent cause is drugs, 80%
of cases have strong association with spesific medication. The probable cause
was nimesulide. Clinical manifestations toxic epidermal necrolysis are
extensive epidermal necrosis, and exfoliation of the skin. There is almost no
normal skin seen and in this form over 80% on the skin surface is involved.
Day 10th of hospitalization death ensued from sepsis and multiple organ
failure.
Conclusion: Toxic epidermal necrolysis is presumed to be a spesific immune
response, a recurrent exposure to the trigger should induce a more brisk and
intense (and in this case fatal) episode Multiple organ failure are the usual
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causes of death. Nimesulide should be added to the list of agents associated
with this serious adverse drug reaction.
Key words: toxic epidermal necrolysis, nimesulide
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Stevens Johnson Syndrome in Bandar Lampung, Indonesia
M. Syafei Hamzah. Dr. Abdul Moeloek Hospital, Dermatovenereology
Department, Bandar Lampung, Indonesia.
Background: Stevens Johnson Syndrome (SJS) is severe form of erythema
multiforme with related mucocutaneus disorder, often with severe constitu-
tional symptoms and associated high rate of mortaliy and morbidity.
Subject: To find out the incidence, etiology, treatment, lenght of stay and
complication.
Methods: A 3 years retrosprctive study (January 1, 2004 through December
31, 2006) of patients admitted to dermatology department of Dr. Abdul
Moeloek Hospital Lampung.
Results: Among 24 cases reviewed there were 11 (45,8%) male and 13
(54,2%) female. The youngest patient was a 10 years old girl and the oldest
one a 54 years old female. We assume that the caused were antibiotic
(penicillin derivate) 10 (41,6%), analgesic/antipyretic 8 (33,3%), antic-
onvulsant (carbamazepin) 3 (12,5%), and 3 (12,5%) patient unknown. There
was a variety in the length of stay of hospitalization from 1 until 27 days with
an average of 7,2 days.
Systemic corticosteroid was the of choice against fatality, 19 (79,2%)
recovered, 5 (20,8%) patient died, the cause of death were 3 (60%)
broncopneumonia, 1 (20 %) septicemia and 1 (20 %) gastrointestinal bleeding.
Conclusion: The incidence of Steven Johnson Syndrome in Dr. Abdul
Moeloek Hospital was found female is bigger than male, the highest group of
age was 24Y44 (54,1%) and the drugs most commonly involved were
antibiotics (41,6 %) followed by analgesic/antipyretic (33,3%), broncopne-
moni was the mostly cause of death (60%).
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Stevens Johnson syndrome suspected due to sulfasalazine
Eny Susilowati1, Faridha S. Ilyas1, Mahmud Ghaznawie2, Anni Adriani1, and
Irma Helina Amiruddin1. 1Medical Faculty Hasanuddin University / Dr
Wahidin Sudirohusodo General Hospital, Dermato-Venereology, Makassar,
Indonesia; 2Medical Faculty Hasanuddin University, Pathology Anatomy,
Makassar, Indonesia.
Background: Stevens Johnson Syndrome (SJS) is a diffuse, severe,
mucocutaneous eruption involving two or more mucosal surfaces with or
without visceral involvement most often induced by drugs and occasionally
elicited by infections. Sulfasalazine is a sulfa drug. The metabolite of
sulfasalazine may trigger an immune-response leading to cutaneous adverse
drug reactions.
Case: A 29 years old woman presented symptoms of skin, mucous membrane
and eye lesions. She had taken sulfasalazine for several days before the
eruptions. Physical examination revealed erythema, and blisters affected on
the face, neck, arms, upper trunk, erosions of the lips, and conjunctivitis.
Histopathology examination of skin lesion showed Toxic Epidermal
Necrolysis (TEN) appearance. The patient was treated with ringer lactate,
dexamethasone 5 mg per 6 hours, gentamycin 80 mg per 12 hours
intravenously, and topical steroids. After being hospitalized for 14 days, the
patient cured without complications.
Discussion: This case is diagnosed as SJS based on anamnesis and clinical
examinations, confirmed by histopathology finding subepidermal bullae with
necrosis of entire epidermis and inflammatory infiltrate, according to TEN
appearances. This case may be a degree of overlap as forms of SJS can evolve
into TEN. Sulfasalazine is a sulfa drug, used primarily as an anti-inflammatory
agent. SJS due to sulfasalazine is rare.
Conclusion: SJS due to sulfasalazine is rare. SJS is a life threatening
cutaneous adverse drug reaction and can evolve into TEN. Early appropriate
treatment may produce an excellent prognosis in SJS.
Key words: disparity SSJ-TEN, sulfonamide, corticosteroid
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Analysis of Stevens-Johnson syndrome and toxic epidermal
necrolysis in Japan
Zenro Ikezawa, Yumiko Yamane, Yuko Ikezawa, Yuki Shigehira, Chieko
Watanabe, and Michiko Aihara. Yokohama City University Graduate School
of Medicine, Enviromental Immuno-Dermatology, Yokohama, Japan.
Background: (B Stevens-Johnson syndrome (SJS) and toxic epidermal
necrolysis (TEN) are the representative severe cutaneous adverse drug
reactions with high mortality, in which the treatnent has not been established.
Methods: To present the current clinical characteristics and treatments of SJS
and TEN in Japan, we retrospectively analyzed the 43 cases of SJS (15 males
and 28 females, aged 44.8 in average) and 54 cases of TEN (27 males and 27
females, aged 45.5 in average) from reports of SJS and TEN published in
medical journals from 2000 to 2005.
Results: Thirty cases of SJS (69.8%) and all cases of TEN were caused by
drugs, such as nonsteroidal anti-inflammation drugs (NSAIDs), antibiotics,
and anticonvulsant drugs. As the organ involvement, hepatitis was most
common in both of SJS and TEN. Renal dysfunction and respiratory disorder
were also involved in some cases. Major complication was sepsis. As the
treatment, corticosteroid was administered systemically in most cases, and 26
cases (60.5%) of SJS and 32 cases (59.3%) of TEN were treated with
corticosteroids alone. Combination of plasmapheresis and/or immunoglobulin
therapy with corticosteroid therapy was performed in some cases. The
mortality rate of patient with SJS was 2.3%, and with TEN was 7.4%. The
mortality in TEN decreased remarkably as compared to 21.6% (58/269) in
the previous 17 years from1981 to 1997. The serious patients with TEN
were performed plasmapheresis and high-dose immunoglobulin therapy in
combination with steroid therapy and they were alive.
Discussion: These results suggest that the combination of the above-
mentioned 3 treatments might be useful in the serious patients. More
experiences is needed to confirm the effect.
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Adverse effects of DPT immunization in children up to 6 years of
age in Tabriz/Iran
Mahin Baradaran Rezaei1, and Sima Moghadassian2. 1Tabriz University of
Medical Sciences, Faculty of Nursing and Midwifery, Tabriz, Islamic Republic
of Iran; 2Tabriz University of Medical Sciences, Faculty of Nursing, Tabriz,
Islamic Republic of Iran.
Background: Vaccines, once hailed as "magic bullets" against disease,
sometimes fly astray. In fact, shots of common vaccine DPT (diphtheria-
pertussis-tetanus may in rare cases trigger serious health problems. In
reviewing existing data, the several studies found a link between the pertussis
component of the DPT vaccine and anaphylaxis, a life-threatening allergic
reaction. Vaccines have been highly effective at eliminating or significantly
decreasing the incidence of many once-common diseases. However, the public
is now focusing on the potential adverse effects of vaccines. The aim of this
study was to identify the adverse effects of DPT immunization in children up
to 6 years of age in Tabriz/Iran.
Methods: A descriptive cross-sectional survey was conducted in the city of
Tabriz in North-West Iran. Cases were defined as those notified with Adverse
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effects of DPT immunization over a 6 months period (between September 23,
2006- to March 20, 2007) in Tabriz health centers. All of the children aged 2
months up to 6 years who recived DPT vaccine in our selected health centers,
were carefuly checked up to 72 hours following immunization. A
questionnaire was used to elicit information related to Adverse effects of
DPT immunization in children. The data was anayzed by software of SPSS/
Win.
Results: The findings indicated that fever, limb swelling, unusual crying,
irritability, vomiting, erythema were 47.8%, 42%, 37%, 25%, 13%, 11.8%
respectively.
Conclusion: As immunizations are usually given to healthy people for
prevention of serious diseases, the risks for known adverse reactions to the
vaccine must be weighed against the potential benefits. Nurses and health
providers should be prepared to answer patients’ or parents’ parents questions
about common as well as alleged vaccine-related adverse events and must
utilize the Vaccine Information Statements for vaccines covered under the
National Vaccine Injury Compensation Program.
Also health care providers should continue to counsel parentss about
the benefits of the vaccine and recommend vaccination for clients.
Key Words: Adverse effects, DPT, Immunization, Children up to 6 years.
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The anticonvulsant hypersensitivity syndrome
Souhad al Faqih. Sedac, Allergy, Khartoum, Sudan.
Background: The anticonvulsant hypersensitivity syndrome is a potentially
fatal multisystemic reaction to anticonvulsant medications.
Objective: The purpose of this study was to investigate the clinical
characteristics of anticonvulsant hypersensitivity syndrome.
Results: A total 32 subjects, aged from 6 to 72 years, diagnosed as having
anticonvulsant hypersensitivity syndrome based on clinical and histopatholo-
gical findings, were included in the study. In 22 of the 32 cases, the
anticonvulsants had been administered prophylactically after craniotomy and
in 10 cases for epilepsy. When the cases were assessed for skin lesions,
maculopapular eruption was registered in 22, Stevens-Johnson syndrome in
five, and toxic epidermal necrolysis (TEN) in five. Treatment included
suspension of the offending drug and then, except for the cases with toxic
epidermal necrolysis, administration of corticosteroids. The 22 cases that
required anticonvulsant therapy were treated with valproic acid. In all cases,
we observed rapid clinical improvement corroborated by laboratory findings.
Conclusion: It is essential that due importance be given to the development of
an eruption in individuals to whom anticonvulsants are administered after
craniotomy because anticonvulsant hypersensitivity syndrome is likely to be
life-threatening.
868
Drug allergic reactions related to the vitally important
drugs - medical tactics
Gulnar Batpenova1, Tair Nurpeissov2, and Gauhar Kozhakeeva2. 1Kazakh
State Medical Academy, Dermatovenerology Department, Astana, Kazakh-
stan; 2Institute of Internal Diseases, Republican Allergological Center,
Almaty, Kazakhstan.
Background: Generally accepted practice of treatment of DA is a primary
cancellation of Bguilty^ drugs. At the same time in some cases, we face with
such events, when cancellation of the given drug can bring to unavoidable
consequences. Therefore, there is a dilemma between the danger of cancellation
syndrome and the development of heavy manifestations of the drug allergy.
Aim: To describe the running tactic of patient with a diabetes mellitus with the
concomitant polyvalent DA related to a number of drugs.
Methods and Results: A patient 62 years old is continuously receiving
human insulins. This patient has in anamnesis such episodes of allergic
reactions related to a number of drugs of different pharmaceutical groups. The
patient got a heavy allergic dermatitis to an Isosorbide in a dripping form. The
cancellation of this drug and the prescription of antihistamines didn’t improve
the situation. The patient examination with analyzer UniCap-100 brings to
light an existence of specific IgE c73 substances (Insulin Human). The
abolition of this drug was impossible due to the danger of decompensation of
the diabetes. Tests in vivo were impossible in consequence of the activity of
cutaneous process. That’s why the client passed the Damage Measure
of Neutrophils Test (DMNT) in the modified scheme. The hypersensibility
related to a number of drugs was displayed. From such types of insulin that
obtained negative results Insulin NPH and Insulin Rapid were administrated.
Parallel to this, the patient was prescribed to take a intravenous Prednisolone
(120 mg/day for 5 days), after that, the treatment was transferred to steroids per
os in the dose of 10 mg/day for one month with the gradual dose decrease and
the following cancellation. Glycemic profile had normalized and effects of
heavy allergic dermatitis had regressed completely.
Conclusion: In the case of the appearance of the DA on the vitally important
drugs, the cancellation of the given drug is contraindicated. It’s because, in the
case of further necessity of emergency infusion, the risk of anaphylactic shock
is increasing. The DMNT (sensitivity is about 95%, specificity- about 80%) in
the modified scheme is the effective method due to the impossibility of
conduction of more trustworthy tests in vitro and in vivo. Monitoring showed
the effectiveness and safety of the prednisolone course for the treatment of DA.
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Connubial systemic cutaneous adverse drug reaction
Corinne Vernassiere, J.F. Cuny, J.L. Schmutz, and Annick Barbaud. Fournier
Hospital, Dermatology Department, Nancy, France.
Observation: A 86 y.o. women has had for 24 hours, an itchy maculopapular
exanthema (MPR) on the trunk and the arms. The daily treatment had not been
modified, except concerning the switch from MOPRAL\ (omeprazole) to
INIPOMP\ (pantoprazole) 48 hours before. The biopsy samplewas compatible
with a drug allergy. There was an eosinophilia (1296/mm3). In her history, 11
years before, cutaneous tests were performed for calcium channel blockers and
penicillin sensitizations. Patch testswere positive for diltiazem. The chronology
of drug intake was done with his husband. Her treatment was prepared by his
husband because she had visual deficiency. A few days after the MPR`s onset a
member to the family reported that 48 hours before the MPR the patient had
taken by error the drugs of her husband put beside those of its wife: that were:
trimetazidine, diltiazem, atenolol, lysine acetylsalicylate, domperidone and
oxybutynine. The rash vanished within 3 weeks.
Discussion: This observation stresses the importance of the interrogation in
the assumption of a CADR in determining the chronology of drug intake. An
additional difficulty is to obtain this information from an old person (lack of
memory). The interrogation of the other family members, the GP and the
pharmacist can be crucial.
Masked drug exposure have been reported by kissing, but not by the
misadministration of drug intended for a spouse. The risk could become
significant because of the ageing of the population.
Conclusion: 1st case masked drug allergy due to diltiazem taken by mistake
(intended for a spouse).
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Drug hypersensitivity syndrome
Wahjuni Husain1, Andi Muhammad Adam1, Mahmud Ghaznawie2, and
Faridha S. Ilyas1. 1Medical Faculty Hasanuddin University / Dr. Wahidin
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Sudirohusodo General Hospital, Dermato-Venereology, Makassar, Indonesia;
2Medical Faculty Hasanuddin University, Pathology, Makassar, Indonesia.
Background: Drug hypersensitivity syndrome (DHS) is an idiosyncratic and
life-threatening adverse drug reaction that begins acutely in the first 2 months
after initiation of drug and is characterized by fever, skin rash, facial edema, or
an exfoliative dermatitis, lymphadenopathy, hematological abnormalities
(eosinophilia) and multi-organ involvement. In this case, there were no other
systemic organ involvement.
Case: A 26-years-old woman presented with fever, maculopapular rash, facial
edema and lymph nodes enlarged 2 weeks after taking cefadroxil and
mefenamic acid after fine needle aspiration biopsy (FNAB) for suspect thyroid
infection. After taking mebhydrolin napadysilate the rash become extended as
an exfoliative dermatitis, facial edema, and lymphadenopathy. Laboratory
examination including leucocytosis and eosinophilia. There were no other
biologic abnormalities including normal liver function test, chest radiograph
and cardiac echography. Histology examination showed hyperkeratosis, mild
spongiosis, vacuolar degeneration of basal cells with infiltration of
lymphocytes, neutrophil and eosinophil.
Discussion: The patient fulfilled the clinical criteria with her presentation of
fever, generalized maculopapular rash, facial edema, lymphadenopathy and
eosinophilia. The pathogenesis of DHS is not fully understood, including
genetic background, altered drug metabolism, and virus infection. The suspect
drug was mebhydrolin napadysilate. The treatment was dexamethason
intravenously started with 15 mg tid. Topical steroid and emollient were
given also. After 3 weeks, dexamethasone intravenously was substitute with
methyl prednisolone 24 mg orally a day and tapered. The rash progressively
improved.
Conclusion: Drug hypersensitivity syndrome is a severe skin reaction with
systemic manifestations. Internal organ involvement can be asymptomatic.
The suspect drug was mebhydrolin napadysilate. The treatment of
dexamethasone intravenously continued with methylprednisolone oral and
withdrawal of possible offending drug gave a good result.




Sima Moghaddasian, Mahin Baradaran Rezaei, and Nasrin Mehdipurzare.
Tabriz Faculty of Nursing and Midwifery, Medical Surgical Nursing, Tabriz,
Islamic Republic of Iran.
Background: Drug hypersensitivity reactions are common and can be life
threatening. Drug allergies are adverse reactions resulting from immunologic
responses to drugs or their metabolites. These reactions result in predictable
patterns of organ-specific or systemic hypersensitivity that usually recur on
subsequent exposure to the same drug. The objective of this study was to
evaluate the incidence of drug hypersensitivity in Sina Hospital in Tabriz
University of Medical Sciences March 2002 to March 2007.
Methods: This descriptive study was done retrospectively by reviewing the
existing records of 51 drug eruption diagnosed patients admitted in skin
diseases ward of Sina Hospital.
Results: 51 patients (17.65 % male and 82.35 % female) have entered our
study. Mean age was 36.19 years. Drug eruption was the most common cause
of admission (52.94 %) other clinical diagnoses of patients were Angioedema
(15.68%) and Stevens Johnson syndrome (21.56%). The most drugs were Co-
trimoxazole (89.80 %) and Carbamazepine (17.64%). The following
Symptoms are considered: rash, fever, generalized erythema and muculopap-
ular lesions.
Conclusion: Early recognition and appropriate treatment of these underlying
causes is recommended in order to prevent drug eruption. With special
examination and drug history we can diagnosis this hypersensitivity and with
this knowledge we can prevent the dangerous reactions.
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A 63-year-old man with multiple drug allergy and CNS tumor
Mojgan Kiani Amin1, and Zohreh Rahimi2. 1Qazvin Medical University,
Allergy and Immunology, Qazvin, Islamic Republic of Iran; 2Kermanshah
Medical University, Biochemistry, Kermanshah, Islamic Republic of Iran.
Background: Adverse reactions to pharmaceutical and diagnostic products
constitute a major hazard in the practice of medicine. Multiple risk factors have
been shown to modify the clinical expression of immunologic drug reactions.
These can be associated with the drug itself, with the disease state in which the
drug is used(chronic disease and infections), or the individual patient receiving
the drug. Similarly, some allergic drug reactions are much more likely to occur
if the drug is administered to patients with particular disease backgrounds, as
when aminopenicillins are given to patients with atypical or abnormal
lymphocytes or sulfonamides to patients with AIDS.
Case Report: We represent a 63-year-old man with prolonged history (more
than one year)of intermittent headache and use of NSAIDS. He had recurrent
history of anaphylaxis and urticaria after getting NSAIDS at first, and with the
other analgesics and also antihistamines there after. His laboratory evaluation,
includind cell blood count and differentials and complement assay was in
normal limits, He consulted with a neurologist, and brain CT-scan was done. It
showed CNS tumor. In literature review it was found a few chronic diseses
such as cyctic fibrosis or cryogobulinemia (or also immune deficiencies) can
cause drug allergy but there was no association between multiple drug allergy
and malignancies especially CNS tumors.
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Dapsene hypersensitivity syndrome in leprosy
Zakiyah Salim, Maya Milani, Sitti Musafirah, Dianawaty Amiruddin, Ratna
Komala Dewi, Muh Dali Amiruddin, Faridha S. Ilyas, and Sri Vitayani
Muchtar. Medical Faculty Hasanuddin University Makassar Indonesia,
Dermato-Venereology, Makassar, Indonesia.
Background: Dapsone Hypersensitivity Syndrome (DHS) is a rare well
recognized serious adverse effect characterized by fever, skin rashes,
generalized lymphadenopathy, hepatitis and hepato-splenomegaly. Hipersen-
sitivity reaction occur during first 6 weeks, but can occur after 6 months.
Objective: To find out the total cases for 2 years of dapson hypersensitivity
syndrome in the wahidin sudirohusodo general hospital, Makassar, Indonesia.
Methods: A retrospective study was carried out taken from medical record
and registration book. (January 2005- December 2006).
Results: Five patients with dapson hypersensitivity syndrome were reported.
All patients received dapsone as a part of MDT for leprosy. Fever, jaundice,
skin lesion were detected in 5 cases, but 1 case appearance like morbiliform.
Lymphadenopathy (2 cases), splenomegaly and acut psychosis (1 case).
Laboratory data on admission included : low hemoglobin, leucocytosis,
elevated level of serum liver enzymes, erythrocyte sedimentation, raised
bilirubin and hypoproteinemia. The interval between start of dapsone therapy
and appearance of symptoms varied from 2Y7 weeks. But one case the clinical
manifestation occur 8 months after consumption of Multi drug treat-
ment(MDT). All cases were treated with corticosteroids after withdrawing
dapsone, MDTwas continued by replacing dapsone with minocyclin.
Conclusion: There are significant clinical improvement in all cases, such as
complete resolution of skin lesions and other symptoms.
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Drug hypersensitivity in a patient diagnosed with Lemierre’s
Syndrome
Jenifer Otadoy, Omar Mejia, Cesar Joseph Gloria, and Madeleine Sumpaico.
Philippine General Hospital, Department of Medicine, Manila, Philippines.
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Background: Lemierre’s syndrome is an acute oropharyngeal infection with
suppuration of the lateral pharyngeal space, bacteremia and septic throm-
bophlebitis of the internal jugular vein, causing metastatic infection. It is a rare
disease with an estimated incidence of 1 case per million.
Methods: We report a patient diagnosed with Lemierre’s syndrome who
presented with a rash after 2 weeks of piperacillin-tazobactam, clindamycin
and phenytoin.
Results: This 27 year old male with no significant past medical illness
presented with a one week history of a dento-alveolar abscess of the right
molar, fever, trismus, dysphagia with erythema and swelling of the neck. Work
up showed a retropharyngeal extension of the dento-alveolar abscess,
pneumonia, pneumomediastinum and necrotizing mediastinitis. HIV enzyme
immunoassay was negative. The patient underwent cervical mediastinotomy
with subxiphoid drainage and was given piperacillin-tazobactam 4.5g IV q8
and clindamycin 300mg IV q6. During the course of his hospital stay, the
patient went into arrest, had post-gliottic seizures and was started on phenytoin
100mg cap q8.
On the 2nd week of piperacillin-tazobactam and clindamycin and on
the 8th day of phenytoin, the patient presented with erythematous, pruritic
maculopapular rashes initially on the upper extremities later on becoming
generalized. Antibiotics were shifted to meropenem and phenytoin was shifted
to levetiracetam. The patient received diphenhydramine, ranitidine and
prednisone, which resolved the rashes. He also completed 6 weeks of
meropenem and was discharged improved.
Conclusion: This is the first reported case of drug hypersensitivity in a patient
diagnosed with Lemierre`s syndrome. The importance of discontinuing the
offending drugs and shifting to structurally unrelated drugs is emphasized.
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Hydrochlothiazide-induced lichenoid eruption: Apropos
of 2 cases
Karim Aouam1, Hichem BelHadj Ali2, Amel Chaabane1, Montassar Amri2,
Naceur Boughattas1, and Jameleddine Zili2. 1Faculty of Medicine, Pharma-
cology Department, Monastir, Tunisia; 2Monastir’s Hospital, Dermatology
Department, Monastir, Tunisia.
Background: The aetiology of lichen planus is unknown. Stress, auto-
immunity and infection have been suggested as possible causes. Many drugs
can provoke eruptions that clinically and histologically are similar to lichen.
We describe in two patients a probable association between treatment with
irbesartan-hydrochlorothiazide and lichenoid eruption.
Case Reports:
Case 1: An 80-year-old woman presented to the dermatology clinic with a 4-
month history of acute onset of violaceus papules which started on her arms
and spread to her trunk, back and legs. She had been taking amiodarone for
auricular fibrillation for 15 months and irbesartan-hydrochlorothiazide for
hypertension for 8 months. On physical exam, the patient had accurate
violaceus and scaly plaques on the trunk, back and limbs. There were no
ocular, buccal or genital lesions and she had no systemic symptoms. Blood
count and biochemical profile were normal. Skin biopsy of involved skin
showed typical features of lichen planus. Treatment with desonide and
cetirizine provided no relief. Irbesrtan-hydrochlothiazide was substituted by
irbesartan and the skin eruption and prutitis had resolved within two weeks.
Case 2: A 56-year-old man presented with acute onset of a pruritic rash which
stated on his trunk and spread to his whole body. His past medical history
included hypertension and Sharp syndrome for which he was taking
irbesartan-hydrochlorothiazide and methotrexate. Methotrexate and irbesar-
tan-hydrochlorothiazide were started approximately 2 years and 8 months
before skin eruption respectively. On physical exam, the patient had accurate
violaceus and scaly plaques on the trunke, back and limbs. There were bilateral
shallow erosions of the buccal mucosa surrounded by a network of lacy white
striae. Blood count and biochemical profile were normal. Skin biopsy of
involved skin showed typical features of lichen planus. Treatment with
desonide and cetirizine provided no relief. Irbesrtan-hydrochlothiazide was
substituted by irbesartan and the skin eruption and prutitis had resolved within
two weeks.
Conclusion: These observations illustrate a rare association between lichen
and hydrochlorothiazide (On the basis of the Naranjo algorithm, it is probable
that the systemic reaction was due to hydrochlorthiazide therapy). Clinicians
should be aware of this potential adverse effect and recommend with-holding
the drug intake when temporal relation is evocative.
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Prevalence of allergic contact sensitization among hostel students
In Ajman University of United Arab Emirates (UAE)
Tarik Al Zubaidy1, Taki Almosawi2, and Zeena Sameer1. 1Ajman University,
Faculty of Pharmacy and Health Sciences, Ajman, United Arab Emirates;
2Al-Mafraq Hospital, United Arab Emirates.
Background: It is estimated that a round 20-30% of people all over the world
suffer from allergy. Contact with certain materials (allergens) is supposed to
cause allergic skin sensitization culminating in development of contact
dermatitis in some individuals. Some people are unaware of their sensitization
as it shows no or mild symptoms. The prevalence of specific allergens varies
by geographic area, population, age and sex.
Objective: The present study aimed at determining the relative frequency of
positive reactions to different sensitizers among hostel female students in
Ajman University-UAE.
Materials and Methods: Sampling approach was simple and descriptive. 46
female hostel students aged between 19Y26 years were tested using the
Universal standard patch test series (TRUE test) containing 23 common
allergen sensitizers and a negative control. Cross sectional questionnaire was
distributed for the same students and those with chronic diseases or pregnancy
were excluded.
Results: The results were analyzed by SPSS. In contrast to previous European
reports which suggest that nickel sensitization is the most common among
females, this study shows that thimerosal is the common sensitizer among
female hostel university students (32.6%), followed by nickel 15.2% and
colophony 8.69%.
Conclusion: Thimerosal is present in contact lens solutions and cosmetics and
most positive students who were unaware of their sensitization have used
contact lenses for cosmetic purposes. This study should raise the alarm in
using inert materials in contact lenses industry or at least warn females from
the consequence of sensitization.
FOOD ALLERGY
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Immunologic comparisons between sesame and perilla seeds
Jung Yeon Hong, Kyung Eun Lee, Kyung Won Kim, Hye Mi Jee, Myung
Hyun Sohn, and Kyu Earn Kim. Department of Pediatrics and Institute of
Allergy, Yonsei University College of Medicine, Brain Korea 21 Project for
Medical Science, Seoul, Republic of Korea.
Background: Sesame and perilla have been a Korean traditional crop and
mainly consumed as seasonings or seed oil. However, sesame food allergy is
an increasingly common problem in many countries. This study aimed at
comparing protein pattern of sesame with that of perilla and analyzing the
cross reactivity between sesame and perilla.
Methods: Seeds were placed in 1:1 ethyl ether and extracted with slow stirring
at 4-C for 2days in PBS (pH 7.4). To analyze protein patterns and specific IgE
to sesame or perilla, crude extracts were separated by SDS-PAGE and then
performed with Western blotting using sera diagnosed as allergic to sesame or
perilla. Sesame extract with various concentrations is pre-incubated with
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pooled sera before inhibition test, and then those sera were added to the ELISA
plate pre-coated with perilla extract.
Results: 1. Both sesame and perilla had the higher protein concentration and
contained protein bands of 6 Y 82.2 kDa. However, after cooked, the proteins
with high molecular weight disappeared and only 6 Y 14 kDa protein bands
existed weakly. 2. The IgE binding bands were also detected at 6 Y 14 kDa in
sesame and perilla by Western blot analysis. 3. In inhibition test, sesame
showed low inhibition rate (G45%) against perilla by inhibition ELISA test.
Conclusion: Sesame and perilla showed different protein pattern and low
cross reactivity each other. It suggests that perilla can be the replacement of
sesame in consumption. However, because they have the possibility of food
allergy, the further study about their major allergens is needed.
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Biochemical and allergenic properties of natural and genetically
modified soybeans
Pavel Samoylikov, Sergey Aleksandrovich, Valentina Gervazieva, and
Valentina Berzhets. Mechnikov Research Institute for Vaccines and Sera,
RAMS, Moscow, Russian Federation.
Soybeans are an important source of protein in human`s dietary intake
today. Some soybean proteins may be allergens and cause allergic reactions. In
this connection, the aim of the present study was to investigate the biochemical
and allergenic properties of extracts from natural and genetically modified
(GM) soybeans.
The protein extracts were obtained from whole natural and GM
soybeans, their capsules and cores and analyzed in SDS-PAGE, western
blotting and ELISA. The SDS-PAGE analysis has revealed similar results of
protein composition of allergenic extracts of core and whole natural and GM
soybeans. The main protein band of whole soybeans and soybean core have
low a molecular weight (m.w.) from 8,5 kDa to 20 kDa. The protein band with
m.w. of 20 kDa is largest and conform a protein group of Kunitz trypsin
inhibitor (Hor.v1, CMb, BDR). The protein fraction of capsule of soybeans
with m.w. 14 kDa conforming soybean profilin (Gly m 3) predominate natural
soy, whereas that with m.w. 34 kDa conforming vacuolar protein (Gly m Bd 30
k) predominate GM soy. We investigated 220 sera of patient`s blood different
age with atopic dermatitis and food allergy using ELISA. A frequency of
revealed IgE-Abs to soy was increasing from 20 % in infant patients to 57,8%
in adolescent patients. The increased levels of IgE-and IgG-Abs to capsule of
natural soybeans were determined most often. We revealed IgG-Abs to wide
protein spectrum of whole natural and GM soybeans using western blotting,
where the largest protein fraction had m.w. of 30 kDa. The soybean capsule is
known to contain proteins, which are homologous to the major allergens of
birch pollen (Bet v1); with this in view high frequency of revealed IgE-Abs to
the capsule of natural soybeans is fully explained in the context of cross-
reactive antigens. While analyzing the blood serum of the patients with
hypersensitivity to soy we revealed increased levels of IgE-Abs to birch pollen
(81 % of cases) with high level of IgE-Abs found in 25% of patients. Therefore
it was revealed that extracts of natural and GM soybeans contain proteins with
identified allergic properties, which may cause the development of allergic
diseases related to IgE-Abs and soy enteropathy related to IgG-Abs. Moreover,
due to a pronounced homology with allergens of birch pollen, foodstuff
containing soybeans may strengthen sensitization and intensify allergic
reactions in Pollinosis patients.
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Different proteomic approaches to the identification of wheat
flour allergens
Petr Sotkovsky1, Martin Hubalek2, Lenka Hernychova2, Petr Novak3, Marie
Havranova4, Martin Fuchs5, Jiri Stulik2, and Ludmila Tuckova1. 1Institute of
Microbiology v.v.i, Academy of Sciences of the Czech Republic, Department
of Immunology and Gnotobiology, Prague, Czech Republic; 2Purkyne
Military Medical Academy, Proteome Center, Hradec Kralove, Czech
Republic; 3Institute of Microbiology v.v.i, Academy of Sciences of the Czech
Republic, Biogenesis and Biotechnology of Natural Compounds, Prague,
Czech Republic; 4Synlab, Synlab, Prague, Czech Republic; 5Hospital
Bulovka, Department of Pediatrics, Prague, Czech Republic.
Background: Food antigens penetrating into the gastrointestinal tract do not
generally cause clinical symptoms, because most individuals acquire
tolerance. However, some food components are recognized as the cause of
adverse reactions in susceptible individuals. Wheat belongs among six major
foods, which are responsible for approximately 90% of food allergic reactions
in children. Although cereals are essential in the daily nutrition, only a few
proteins have been identified as cereal allergens on the molecular level.
Methods: To characterize wheat flour allergens, we prepared salt extract from
seven of the most frequently used wheat cultivars and compared them by SDS
PAGE. Proteins from the selected cultivar Sulamit were separated by 2-
dimensional gel electrophoresis (2-DE), analyzed by immunoblotting and IgE-
reactive proteins were identified by mass spectrometry (MALDI-TOF, QTOF
and LCQDECA nLC-MS/MS ion trap) and tested for the ability to activate
patient`s basophils (expression of CD63 and CD203c markers was measured
by flow cytometry). We developed ELISA to quantify patient`s IgE Abs
reactive with defined allergens. Wheat extract was also treated with pepsin.
Results: Patient sera can be divided into three groups: IgE Abs of the first one
recognizes wheat components G30kDa, the second 930kDa and the third one
reacts with components ranging from 6-170kDa. The pattern of wheat
components recognized by IgE Abs was significantly influenced by conditions
of protein separation and treatment with digestive enzymes. Using SDS PAGE,
2-DE, immunobloting and mass spectrometry we identified 19 potential wheat
allergens. Employing newly developed ELISA, levels of IgE Abs against
proteins from the Sulamit extract and one of the dominant wheat IgE binding
component, "-amylase inhibitors type 1 and 3, were quantified and shown to
be significantly elevated in sera of allergic patients compared to those of
healthy controls. Furthermore, the salt extract from the cultivar Sulamit as well
as "-amylase inhibitors were shown to by able induce significant activation of
basophils of allergic patients.
Conclusion: This study characterized the spectrum of wheat components
recognized by IgE Abs of allergic patients, analyzed the impact of proteins
separation and digestion on immunogenicity of wheat allergens, compared the
sensitivity and specificity of newly developed specific IgE ELISA assay and in
vitro basophils activation test using identified allergens.
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Heat-induced denaturation, aggregation and changes of
immunoreactivity of milk proteins
Milos Beran1, Petr Molik1, Marian Urban1, Dana Gabrovska1, Jana Rysova1,
and Radek Klubal2. 1Food Research Institute Prague, D. of Microbial
Products and Quality Features, Prague, Czech Republic; 2MUDr. Radek
Klubal, Narodni, Prague, Czech Republic.
Background:Milk for liquid consumption or for processing requires an initial
heat treatment to control the growth of microorganisms. However, heat
treatment of milk causes the heat denaturable whey proteins to aggregate with
.-casein (.-CN) via thiol-disulfide bond interchange reactions and other
changes. Influence of the soluble macroaggregates presence and other heat-
induced changes on immunogenicity of the commercial milks is still a
controversial issue. The aim of this study was to contribute to increase
knowledge in this area.
Methods: The kinetics of heat-induced precipitation of the main whey
proteins $-lactoglobulin ("-LG) and !-lactalbumin (!-LA) were examined in
water solutions of individual proteins, in fresh milk, whey, and model mixtures
of the both whey proteins with .-CN at 95-C during 30 min.
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At the same time, the kinetics of formation of heat-induced aggregates
of the main whey proteins with .-CN was investigated in fresh milk, whey, and
the model mixtures using GP-HPLC method.
Dot blot assays using sera of 19 allergic patiens containing specific
IgE antibodies against milk proteins were employed to assess the
immunochemical reactivity of the milk proteins containing samples before
or after heat treatment. Immunoreactivities of 6 commercial milk samples
(pasteurized, UHT and fermented) with different content of the soluble
macroaggregates were also assessed by commercial ELISA tests with
monoclonal antibodies against individual whey proteins and using the sera
of allergic patiens.
Results: The decrease of the main whey proteins $-LG and !-LA was
significantly higher in milk or whey than in solutions of the individual
proteins. The experiments with the model protein mixtures showed that
presence .-CN is necessary to form the aggregation complexes of the whey
proteins at 95-C. The kinetics of formation of the heat-induced aggregates in
milk and model protein mixtures was complex with two different maxima
during 30 min time interval.
Conclusion: Surprisingly, we have not observed significant changes of the
immunochemical reactivities of the milk proteins samples after the heat-
induced aggregation under the conditions of the dot blot assays. However, the
experiments will be continued to confirm the results.
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Characterization of the putative allergens in nine Chinese adults
with food allergy to limpet
Bernard Thong1, Fook-Thim Chew2, Tan-Ching Ong2, Kang-Ning Wong2,
Yew-Kuang Cheng1, Khai-Pang Leong1, Chwee-Ying Tang1, and Hiok-Hee
Chng1. 1Tan Tock Seng Hospital, Singapore, Rheumatology, Allergy and
Immunology, Singapore, Singapore; 2National University of Singapore,
Biological Sciences, Singapore, Singapore.
Background: Limpet, a gastropod mollusc, is the second most common cause
of IgE-mediated food allergy among adults attending our Clinical Immunol-
ogy/Allergy clinic. The aim of this study is to characterize the putative
allergen(s) and ascertain possible cross-reactivity with common inhalant and
food allergens in our patients with limpet allergy.
Methods: Consecutive adults presenting from 1 July 1994 to 31 April 2002
with immediate hypersensitivity following ingestion of limpet were studied.
Sera stored at j70-C were assayed for specific IgE to common inhalant and
food allergens. IgE western blotting and tandem mass spectrometric analysis
were performed to identify the allergens. ELISA inhibition assays were carried
out to compare the allergenicity of limpets with other gastropods, as well as to
recombinant tropomyosin and arginine kinase allergens from dust mites and
cockroaches.
Results: There were 9 patients (6 males) and all were ethnically Chinese. Their
mean age was 38 T 17 (19Y60) years. Eight patients had previously ingested
limpet, with allergic reactions occurring during a median of 2 occasions. Six
patients had history of asthma, allergic rhinitis and/or atopic eczema. Seven
patients (2 refused skin testing) tested positive on prick-prick test to canned
limpet, 3 were also positive to abalone, and 2 to pacific clam. On invitro
specific IgE assay, 77.8% were positive to shellfish mix, 77.8% to
Dermatophagoides pteronyssinus, 55.6% to Dermatophagoides farinae,
44.4% to Blomia tropicalis, and 33.3% to cockroach mix. Western blot and
protein mass spectrometric analysis showed that the putative limpet allergens
were a 37kD tropomyosin and a 40kD arginine kinase. ELISA inhibition
studies using recombinant dust mite and cockroach tropomyosin as well as
arginine kinase showed moderate cross reactivity between these allergens and
the allergens from limpet. There was no significant inhibition of binding by
abalone and clam.
Conclusion: The putative limpet allergens in our patients are a 37kD
tropomyosin and a 40kD arginine kinase, both of which are major allergens in
other gastropods (abalone and pacific clam), crustaceans, American cockroach
and house dust mite. Prior sensitisation to house dust mite and cockroach in
our patients could have played a role in limpet food allergy. Surprisingly there
was limited cross-reactivity with abalone and pacific clams, two closely related
gastropod molluscs.
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Cross reactivity among soy, penaut and lupine
Marianne Polga´r1, E´va Gelencse´r2, and Gyo¨ngyi Hajo´s2. 1Heim Pa´l-
Madara´sz Children Hospital, Gastroenterology, Budapest, Hungary; 2Central
Food Research Institute, Biotechnology, Budapest, Hungary.
Background: Soy protein is a common dietary protein, the intake is about 1Y2
g day in Europe among adults according a multicentre study. Soy based infant
formulae are often used in infancy and early childhood in cow`s milk allergy
and in healthy children instead of cows milk, too.
The prevalence of allergic reactions (gastrointestinal, skin, and
pulmonary) elicited by soy protein is around 6% in atopic children. Severe or
fatal reactions seem to be rare, but the rate higher in children with peanut
allergy. Lupine is a newly used legume in the human diet, which
theoretically can give also cross reaction with soy and peanut. Aim of the
study was to determine the cross reaction among soy protein, peanut and
lupine.
Methods: Immunoblot technique with SDS-PAGE protein separation and
ELISA method. Polyclonal antibody and IgE soy positive human sera were
used to detect reactions.
Results: Immunological cross reactivity was demonstrated between the
major allergens of studied legume proteins. The beta-conglycinin and their
oligomeric subunits in soybean have shown cross reactivity with the Ara h1
in peanut and the 7S vicillin allergens in lupine. Furthermore it was
observed an immunological cross reaction among the soybean glycinin
allergens and the Ara h3 in the peanut and the vicillin 11S allergens in
lupine, while the soybean profilin cross reacted with Ara h5 peanut allergen.
The 2S allergens of prolamin superfamily in soybean as trypsin inhibitors
and lectins shown cross reactive epitopes with Ara h2, Ara h6 and Ara h7
allergens in peanut. Soybean, peanut and lupine protein extracts did not
differ in their IgE reactivity with soy positive human sera.
Conclusion: Cross reactivity among the major allergens of soy, peanut and
lupine was proved with human soy positive sera in vitro. Results draw
attention to the possibility of anaphylaxis as a result of allergic cross
reaction in patients with peanut and soy allergy. On this basis, it has to
emphasise the need of precise labelling for food components to avoid the
anaphylaxis.
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Assessment of IgE reactivity and allergenic activity of cow’s milk
allergens by microarray and basophil degranulation experiments
Ulrike Schulmeister1, Heidrun Hochwallner1, Ines Swoboda2, Margarethe
Focke2, Mats Nystrand3, Annika Harlin3, Josef Thalhamer4, Sandra
Scheiblhofer4, Bodo Niggemann5, Santiago Quirce6, Christoph Ebner7,
Adriano Mari8, Gabrielle Pauli9, Rudolf Valenta2, and Susanne Spitzauer1.
1Medical University of Vienna, Inst. of Medical and Chemical Laboratory
Diagnostics, Vienna, Austria; 2Medical University of Vienna, Department of
Pathophysiology, Division of Immunopathology, CD Laboratory for Allergy
Research, Vienna, Austria; 3Phadia, AB, Uppsala, Sweden; 4University of
Salzburg, Department of Molecular Biology, CD Laboratory for Allergy
Diagnosis and Therapy, Salzburg, Austria; 5Charite´ Y Universita¨tsmedizin,
Dept. Pediatric Pneumology and Immunology, Berlin, Germany; 6Fundacio´n
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Jime´nez Dı´az, Allergy Department, Madrid, Spain; 7Allergy Clinic,
Reumannplatz, Vienna, Austria; 8IDI-IRCCS, Center for Clinical and
Experimental Allergology, Rome, Italy; 9Hoˆpitaux Universitaires, Service
de Pneumologie, StraQbourg, France.
Background: Milk allergy is the most common IgE-mediated food allergy in
early infancy. Cow`s milk contains about 25 proteins of which eight have been
identified as allergens but there are varying results regarding the frequency of
IgE recognition and the allergenic activity of the individual allergens. We
developed a microarray for milk proteins which allows to determine indiviual
patients’ IgE reactivity profiles as well as the biological activity of the disease-
causing allergens using small amounts of patients’ sera.
Methods: We dotted different milk components including whole milk
extracts, milk fractions as well as purified and recombinant milk allergens, and
recombinant and synthetic fragments of milk allergens onto microarray and
determined the IgE reactivity profiles of 78 milk allergic patients. In parallel,
allergenic activity of the milk components was determined using rat basophil
leukaemia (RBL) cells transfected with human Fca˚ receptor that had been
loaded with the very same sera.
Results: We found that 84.6% of milk allergic patients showed IgE
reactivity to whole cow’s milk extract. A high number of patients had IgE
antibodies to sheep’s and goat’s milk, 82.1 % and 67.9%, respectively. But
only 30.8% of the tested patients showed IgE reactivity to mare’s milk. The
most frequently recognized cow’s milk allergens in our study were alpha-
lactalbumin (62.8%), alpha-casein (48.7%), beta-lactoglobulin variant A and
B (48.7 and 50.0%, respectively), and beta-casein (43.6%). Lactoferrin and
BSA seemed to be of lesser importance since recognition frequencies were
below 5 %. The most potent cell activating component in the humanized
RBL assay was cow’s milk which induced a relevant degranulation in 47.4%
of the patients followed by goat’s and sheep’s milk (35.9 and 28.2%,
respectively). Among the single components the caseins showed the highest
biological activity (25 to 34.6% of the patients’ sera).
Conclusion: Using microarray technology in combination with data from
basophil release assays it is possible to test simultaneously the frequency of
IgE reactivity and the allergenic activity of a multitude of allergens using just a
few drops of patient’s serum. This test system will be important for diagnosis
and therapy of cow’s milk allergy.
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Epitope mapping on gliadins for patient sera reacting to
modified gluten
Sandra Denery-Papini1, Marie Bodinier1, Fabrice Battais2, Virginie Leduc2,
Chantal Brossard1, Martine Morisset3, Evelyne Paty4, Florence Pineau1,
Thomas Mothes5, and Denise-Anne Moneret-Vautrin3. 1INRA, Research Unit
BIA, Nantes, France; 2Allerbio Laboratory, R and D, Varenne en Argonne,
France; 3NancyHospital, Clinical Immunology and Allergology, Nancy, France;
4Necker Hospital, Allergology center, Paris, France; 5University Hospital
Leipzig, Clinical Chemistry and Molecular Diagnostic, Leipzig, Germany.
Background: Wheat gluten can be modified by enzymatic or chemical
treatment (wheat isolate) in order to improve its functional properties, increase
solubility and thus broaden its application in food industry. However, these
modifications were shown to induce IgE mediated allergies in individuals
usually tolerant to wheat. Leduc et al. (2003) published the first case of
anaphylaxis after ingestion of a reconstituted meat containing a wheat isolate.
Laurie`re et al. (2006) also showed that hydrolysed wheat proteins can induce
severe allergic reactions by contact or ingestion. The objective of our work was
to identify epitopes detected by IgE from patients with reactions to chemically
deamidated gluten (product in which some glutamine residues were modified
into glutamic acid).
Methods: Sera from twelve patients with anaphylaxis, urticaria or WDEIA
containing IgE antibodies to laboratory or industrial deamidated gluten in
ELISA or RAST were analysed by pepscan with overlapping synthetic
peptides. IgE-binding epitopes were searched among entire sequences of a˜ and
w2-gliadins with identification of critical animo acid and analysis of effect of
substitutions of glutamine into glutamic acid.
Results: Eight sera reacted with repetitive peptides of a˜ or w2-gliadin
containing a common octapeptide rich in proline and glutamine. Five critical
positions for IgE binding have been identified on this epitope. Substitution of
one of its glutamine into glutamic acid induced its recognition by two
additional sera and simultaneous substitution of two glutamine into glutamic
acid increased the intensity of responses obtained for the ten positive sera.
Conclusion: Patients with reactions to deamidated gluten possessed IgE
antibodies directed to linear sequences of the repetitive domains of a˜ and w2-
gliadins. IgE antibodies from most of the patient sera analysed in this study
bound to an immunodominant epitope of 8 residues. Deamidation of two
glutamines of this epitope increased significantly its recognition by patient
IgE. This epitope is similar to a B epitope evidenced for celiac patients. These
results show that some industrial treatments may increase the risk of allergy
development.
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Omega-5-gliadin allergen specific IgE antibodies are clinically
useful in the diagnosis of food allergy
Motohiro Ebisawa1, Lars So¨derstro¨m2, Komei Ito3, Rumiko Shibata4, Sakura
Sato1, Akira Tanaka2, Magnus Borres2, and Eishin Morita5. 1Sagamihara
National Hospital, Clinical Research Center for Allergy and Rheumatol,
Sagamihara, Japan; 2Phadia AB, Scientific and Medical Research, Uppsala,
Sweden; 3Aichi Children´s Health and Medical Center, Department of Allergy,
Obu, Japan; 4Fukuoka National Hospital, Department of Pediatrics,
Fukuoka, Japan; 5Shimane University School of Medicine, Department of
Dermatology, Shimane, Jordan.
Background: The relationship between food-specific IgE titers and the
outcome of food challenges is well established for egg and milk through
threshold values and probability curves. For wheat or components of wheat no
such relationships have been established.
Objective: To evaluate the clinical use of wheat and the wheat component
omega-5-gliadin specific IgE titres in relation to the outcome of food
challenge.
Methods: Two hundred and forty nine children with suspected wheat
intolerance, from 3 clinics in Japan, were included in the study. Age ranged
from 6 months to 15.4 years (mean=3.8 years, median=3.0 years). The
diagnosis of food allergy was judged through confirming symptom in food
challenge tests. In relation to their visit for food challenge, allergen specific
IgE antibody levels for wheat and omega-5-gliadin were measured
(ImmunoCAPi, Phadia AB, Sweden).
Results: One hundred and eighty five children were challenged. The most
frequent symptom for a failed challenge was related to the skin, then cough
and lower respiratory systems, 48%, 24% and 13%. Three children had an
anaphylactic reaction. Fifty four percent of the children had one symptom,
32% showed 2 symptoms, 13% showed 3 symptoms and 1 child had 4
symptoms. The specific IgE titres for both wheat and omega-5-gliadin were
higher for the children who failed the food challenge, Table 1.
In a simple logistic model both wheat and omega-5-gliadin showed a
significant relationship between the probability of challenge reaction to the
food and the specific IgE antibody concentrations, wheat, OR 1.41,
95%CI:1.17Y1.40 and omega-5-gliadin OR 1.97, 95%CI:1.51Y2.55. In a
multivariate model using both wheat and omega-5-gliadian, omega-5-gliadin
showed the strongest association with a failed challenge provocation, OR=
1.95 95%CI:1.41Y2.67.
Conclusion: Our results show that omega-5-gliadin specific IgE antibody
titres are related to the probability for a failed oral food challenge. Omega-5-
gliadin IgE in combination with wheat IgE antibodies are a good predictor of
wheat challenge outcome.
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Oral allergy syndrome due to plant-derived foods: a clinical
review of 63 patients over a period of 6 years
Naoko Inomata1, Akiko Morita1, and Zenro Ikezawa2. 1Yokohama City
University Hospital, Department of Dermatology, Yokohama, Japan;
2Yokohama City University School of Medicine, Department of Environ-
mental Immuno-Dermatology, Yokohama, Japan.
Background: $B!’(BThe clinical features of many patients with oral allergy
syndrome (OAS) due to plant-derived foods have rarely been reported in Asian
countries.
Objective: We aimed to determine the causative foods of OAS due to plant-
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Furthermore, we aimed to elucidate the association between causative foods
and sensitized pollens in patients with OAS due to plant-derived foods.
Methods: SPTs and specific IgE measurements (CAP-FEIA: CAP) were
performed in relation to foods and pollens in 118 patients with positive
histories of OAS due to plant-derived foods. Patients with positive histories
and with positive skin test responses were identified as having type I allergy to
the causative foods.
Results: The mean age of 63 patients with positive histories and positive skin
test responses was 29.2 years (range, 2-61years), and there were twice as many
females as male. The most frequent causative foods were found to be apple,
peach, kiwi, and melon in 13, 12, 12, and 11 patients, respectively. CAP
frequency was shown to be similar to that of SPT regarding apple, whereas it
was less than that of SPT regarding melon, peach, and kiwi. A significant
correlation between the frequencies of SPTandCAPwas found regarding apple
(R=0.39, pG0.05) but not peach, kiwi, and melon. Forty-one of 63 patients with
OAS (66.1%) had pollinosis and/or allergic rhinitis. In patientswith OAS due to
apple, the positive ratio of CAP response against alder pollen was higher than
that in patients with OAS due to melon. In patients with OAS due to melon, the
positive ratio of CAP responses against ragweed pollen, grass pollen, and
mugwort pollen was higher than that in patients with OAS due to apple.
Conclusion: In this study, positive ratios of SPT and CAP tended to differ
according to the causative food, showing a smaller potential for reaction than
might be suggested by patient history. Therefore, for the time being it would
be more accurate to use a skin test for the diagnosis of OAS due to plant-
derived foods.
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Pollen-Food Syndrome (PFS); characteristics, foods involved and
predictive factors in a UK cohort
Isabel Skypala1, Moises Calderon2, Anthony Leeds3, and Stephen Durham2.
1Royal Brompton and Harefield NHS Trust, Nutrition and Dietetics, London,
United Kingdom; 2Imperial College, Allergy and Clinical Immunology,
London, United Kingdom; 3Kings College, Nutrition and Dietetics, London,
United Kingdom.
PFS is a type of Oral Allergy Syndrome (OAS), a common cause of
food allergy in adults. To date, there have been no published studies on the
prevalence and characteristics of PFS in a UK cohort. This study, designed to
test a diagnostic questionnaire, also provided information on the foods
involved and and allergy history associated with PFS.
Subjects with reported springtime hay fever completed a PFS
diagnostic questionnaire (PFSDQ) and were allocated to either group 1 (has
PFS), group 2 (no PFS, ?food allergy) or group 3 (no PFS or food allergy).
They then completed a questionnaire (PFSPQ) on their rhinitis, concomitant
asthma, medication, symptom severity, reactions to foods, and severity of food
symptoms. Diagnosis of PFS was made using clinical history, prick by prick
tests (PPT) to fresh foods and oral food challenge.
119 subjects completed the study (mean age 36 years, 85 female); 88
subjects (Group 1 Y 58, Group 2 Y 30) reported reactions to 73 different foods.
A final diagnosis of PFS was made in 60 of the 199 subjects (50%). There were
no differences in age or gender between Groups 1Y3 or for final diagnosis.
Most variables in the PFSPQ did not differ between Groups 1Y3 or for final
diagnosis. These included family history of atopy, childhood allergy, age of
onset of rhinitis, symptom severity scores for rhinitis, the presence or absence
of asthma, number of years with a food allergy or onset of food symptoms
before, after or at the same time as the onset of their hay fever. Subjects most
commonly reported reactions to apple (39 subjects), hazelnuts (22), almonds
(21), milk (18), strawberry (16), walnuts (16), peach (14), cherry (14), Kiwi
(14) and wheat (13). Subjects in Group 1 reported symptoms to significantly
more foods than subjects in Group 2 (pG0.02). Apple, hazelnut, peach,
almond, kiwi and cherry were the commonest foods to have reported
symptoms confirmed by positive PPT. Milk and wheat had the lowest
concordance with PPT; only 21% of reported reactions to milk were confirmed
and 0% of reactions to wheat.
These data show that 50 % of a cohort of UK subjects with reported
springtime hay fever had PFS. The commonest foods to cause reactions were
similar to other published studies, although kiwi appeared to be a more
significant precipitant of PFS symptoms than previously reported. In this
study, age, gender, allergy history, asthma and time of onset of food symptoms
were not associated with a diagnosis of PFS.
888
Usefulness of skin prick test using bifurcated needle for the
diagnosis of food allergy among infantile atopic dermatitis
Mika Ogata1, Akinori Shukuya2, Chizuko Sugisaki3, Kaori Ikematsu4,
Takashi Komata5, Takanori Imai2, Morimitsu Tomikawa2, Hiroshi Tachimoto2,
and Motohiro Ebisawa3. 1National Hospital Organization Kumamoto Medical
Center, Pediatrics, Kumamoto-city, Japan; 2National Hospital Organization,
Sagamihara National Hospital, Pediatrics, Sagamihara-city, Japan; 3National
Hospital Organization, Sagamihara National Hospital, Clinical Research
Center for Allergy, Sagamihara-city, Japan; 4Tokyo Jikei University School of
Medicine, Pediatrics, Tokyo, Japan.
Objective: We investigated the usefulness of skin prick test (SPT) for the
diagnosis of egg white (EW) CAPRAST-negative egg allergy infants and
followed up the EW-CAPRAST in this study.
Subjects and Methods: Data of negative SPT using Bifurcated needle (BF)
were analyzed from the data of 202 infantile atopic dermatitis patients, who
had received SPT from January in 2001 to April in 2005. From the analysis of
SPT results, the average and standard deviation of negative value were
obtained to set the range of positive SPT result. Among 202 cases, 89
suspected-egg allergy infants with negative IgE CAPRAST against EW at the
time of first visit were recruited to this study to examine the usefulness of SPT.
Positive conversion of EW-CAPRAST was checked in 78 cases (65: egg
allergy+, 13: egg allergy-) who had been followed up in our outpatient clinic.
Results: Range of negative SPT control value (mean+ 2SD) using BF among
infants could be set as less than 2mm for wheal and 5mm for erythema. Among
89 suspected-egg allergy infants with negative EW-CAPRAST, 72 infants
(80.9%) were diagnosed as egg allergy by the combination of elimination and
provocation test, interestingly 39 infants (54.2%) showed positive SPT results
in 72 egg allergies. In the follow up study of 78 negative EW-CAPRAST cases,
47 EW-CAPRAST out of 65 egg-allergy cases turned positive later infantile
period (mean EW-CAPRAST: 9.6+/j16.7 Ua/ml at 9.9+/j5.6 months old).
EW-CAPRAST of 7 cases in 13 non-egg allergies also turned positive in the
follow up, however EW-CAPRAST titer was relatively lower compared to that
of egg allergies (1.1+/j1.5 Ua/ml at 13.3+/j2.6 months old).
Conclusion: We experienced fairly number of atopic infants with negative
EW-CAPRAST at the first outpatient visit, who were later diagnosed as egg
allergy. In about half of these cases, SPT was extremely useful for the
diagnosis. In the follow up of egg-allergy infants, three quarter of EW-
CAPRAST tuned positive around 10 months old. EW-CAPRAST of atopic
infants without egg allergy also turned transiently and slightly positive. In the
conclusions, SPT seemed to be more useful than EW-CAPRAST for the
diagnosis of egg allergy in early infantile period, however provocation test may
be required for the definitive diagnosis in suspected-egg allergy infants
without any proof of egg-sensitization.
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Optical near-field immunochip biosensor for rapid allergen
detection and clinical diagnosis
Irene Maier1, Michael R. A. Morgan2, and Fritz Pittner1. 1Max F. Perutz
Laboratories, University of Vienna, Department of Biochemistry, Vienna,
Austria; 2University of Leeds, Procter Department of Food Science, Leeds LS
2 9 JT, United Kingdom.
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Background: An optical immunochip biosensor has been developed as a
rapid method for allergen detection and in vitro immunosensing. The optical
near-field phenomenon underlying the setup design of the sensor is called
resonance-enhanced absorption (REA) utilizing gold nanoparticles as signal
transducers in a sensitive interferometry-setup. Combined with visual
readout that eliminates complex detection instrumentation, this assay system
excellently meets the requirements of a rapid method for allergen detection
and provides opportunities for the development of a miniaturised multi-
array-sensor with improved sensitivity for allergy testing in clinical
diagnosis.
Methods: REA is observed when light-absorbing metal clusters are positioned
at a nanodistance from a highly reflective mirror and illuminated with white
light of the visible and near-infrared spectrum from the particle side. As a
direct detection method based on distance-dependent light interference
between the mirror and the resonantly excited metal clusters, a REA based
capture assay has the power to link affinity binding with three-dimensional
structural information.
Results and Discussion: The immunochip biosensor showed concentration-
dependent colour development by capturing biomolecule-functionalised gold
nanoparticles on allergen or immunoglobulin coated chips. Semi-quantitative
immunochemical responses are directly visible to the Fnaked` eye of the
analyst with sensitivity comparable to common immunoassay procedures in
microtitration plate format (ELISA). Unspecific background signals were
minimized to the absolute target specificity of the antibodies and antisera used
in the bioassay. We have applied this method to the detection of the egg white
allergens ovalbumin and ovomucoid in complex food samples. To achieve
improved interpretation and cross-validation relating to the immunochemical
characterization of allergenic substances of processed food at the protein and
peptide level, complementary investigation (in terms of applicability,
reproducibility, and reliability of results) was carried out with alternative
immunological methods (performed in ELISA and immunoblot format). In
conclusion, the REA-based imunochip sensor is easy to fabricate, is
reproducible in its performance, has minimal technical requirements, and
will enable high-throughput screening of affinity binding interactions in
technological and medical application for determining allergenicity.
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AllergenOnline, a peer-reviewed protein sequence database for
assessing the potential allergenicity of genetically modified
organisms and novel food proteins
Richard Goodman1, Motohiro Ebisawa2, Hugh Sampson3, Ronald van Ree5,
Stefan Vieths5, John Wise1, and Steve Taylor1. 1University of Nebraska, Food
Science and Technology, Lincoln, NE, United States; 2National Sagamihara
Hospital, Pediatrics, Kanagawa, Japan; 3Mount Sinai School of Medicine,
Division of Pediatric Allergy and Immunology, New York, NY, United States;
4Academic Medical Center, Experimental Immunology, Amsterdam, Nether-
lands; 5Paul Ehrlich Institute, Allergy, Langen, Germany.
Background: New genetically modified (GM) organisms and novel processed
food proteins are being introduced into commerce. Countries require safety
assessments include a bioinformatics (sequence) comparison of the new protein
to determine whether the new protein is a known allergen or is so similar to an
allergen that currently allergic consumers would be at risk of reactions. If a
match is found, the product would have to be tested using sera from
appropriately allergic subjects. The quality of the database is a primary
determinant of the search efficacy. A peer review process was used to update
AllergenOnline and tools for an effective bioinformatics search are provided,
free to the public.
Methods: A list of 1758 Ballergens[ was compiled from NCBI using
keyword searches, plus entries in the Allergen Nomenclature list of the
International Union of Immunological Societies (IUIS) and AllergenOnline
version 6. Sequences were grouped based on taxonomy and sequence
identities. Peer reviewed articles were identified for each group. Criteria were
developed to evaluate the evidence based on in vivo and in vitro tests using
subjects with clinically defined, relevant allergic disease. Published data for
each group was compiled and evaluated by primary and secondary reviewers,
then the panel to remove groups with insufficient evidence of allergenicity
(no IgE binding or in vivo reactivity, with subjects having at least minimal
descriptions of allergies to the source of the protein). Free full-length and
sliding 80 amino acid alignment tools are provided to allow public searches
of the database. Key examples from the literature are used to illustrate the
appropriate use of the database.
Results: AllergenOnline version 7 contains 1251 sequences with published
data demonstrating at least evidence of specific IgE binding using sera from
subjects having some allergic symptoms when exposed to the source of the
protein. Many isoforms are listed for some proteins. Others are represented
by a single sequence. Bioinformatic comparisons with transgenic proteins
from approved products and the literature were evaluated. No approved
product exceeded Codex Guideline criteria, but some from the literature
(presumably not in commerce) did, indicating a likely need for serum IgE
testing.
Conclusion: The curated allergen database will markedly improve the




The EuroPrevall allergen library: a collection of high quality
purified natural and recombinant allergens for in vitro diagnosis
Karin Hoffmann-Sommergruber1, Ana Sancho2, Thomas Holzhauser3, Per
Skov4, Stefano Alessandri5, J.M. Wal6, Neil Rigby7, Justin Marsh8, Iris
Lauer3, Yan Ma1, Christina Oberhuber9, Vibeke Barkholt10, Ulrike
Griesmeier1, Merima Bublin1, Sonja Gaier1, Christian Radauer1, Stefan
Scheurer3, Gerald Reese3, Laurian Zuidmeer11, Jaap Akkerdaas11, Peter
Shewry12, Angela Neubauer9, Montserrat Fernandez-Rivas13, Barbara
Ballmer-Weber14, Stefan Vieths3, Ronald van Ree11, and Claire Mills2.
1Medical University of Vienna, Department of Pathophysiology, Vienna,
Austria; 2Institute of Food Research, Norwich, United Kingdom; 3Paul
Ehrlich Institute, Langen, Germany; 4The Reference Laboratory, Copenha-
gen, Denmark; 5University of Florence, Magnetic Resonance Center-
CERM, Florence, Italy; 6INRA, CEA de Saclay, Unite´ d’Immuno-Allergie
Alimentaire, Gif-sur-Yvette, France; 7Institute of Food Research, Norwich,
United Kingdom; 8Rothamstead Research, Harpenden, United Kingdom;
9Biomay, Vienna, Austria; 10Technical University of Denmark, BioCentrum-
DTU, Kgs. Lyngby, Denmark; 11Academic Medical Center Amsterdam,
Department of Experimental Immunology, Amsterdam, Netherlands;
12Rothamstead Research, Harpenden, United Kingdom; 13Fundacio´n Hospi-
tal Alcorco´n, Allergy Unit, Madrid, Spain; 14University Hospital Zurich,
Zurich, Switzerland.
Background: The quality of in vitro IgE tests used for food allergy
diagnosis mainly depends on the analytes used. Usually total extracts of the
suspected foods are used. However, in the recent past a rising number of
studies about component resolved diagnosis have attracted rising interest. In
many cases the use of purified single allergens either of natural origin or
applied as a recombinant product has shown a superior performance when
compared to total extracts. Within the EC funded IP Europrevall a library of
31 highly purified allergens from 10 foods listed in the new Labelling
directive of the European Commission was established for developing novel
diagnostics.
Methods: Highly purified allergens either natural or recombinant from 10
foods (apple, peach, hazelnut, peanut, celery, cow`s milk, goat`s milk, hen`s
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egg, fish and shrimp) were characterized regarding their structural integrity,
biological and allergenic activity. Protein mass was verified by mass
spectrometry and sequence integrity by MALDI-TOF and N-terminal
sequencing. Presence of isoforms in natural allergen preparations were
identified by 2D Gel electrophoresis and secondary structure was evaluated by
NMR maps of low molecular weight proteins. Allergenic activity was
characterized using a panel of sera from food allergic patients. Results:
Purification protocols for natural and recombinant allergens were established
and quality assessment of the purified batches performed. Depending on either
natural or recombinant origin different quality criteria were defined and met for
inclusion into the allergen library. Structural integrity of the purified proteins
was verified and IgE binding activity was assessed.
Conclusion: This panel of well characterized allergens will be used to prove
the concept of component resolved diagnosis and presents the necessary tools
for setting up novel diagnostics. Using a significant number of allergic
patients` sera across Europe it will contribute to identify relevant sensitization
patterns and to improve dietary recommendations for the food allergic patient
in the future.
893
Dominant epitopes and allergic cross-reactivity of the thaumatin-
like protein act d 2
Tea Pavkov1, Merima Bublin2, Fabio Dall’Antonia1, Heimo Breiteneder2, and
Walter Keller1. 1Karl Franzens University, Institute of chemistry, Structural
Biology, Graz, Austria; 2Medical University of Vienna, Department of
Pathophysiology, Vienna, Austria.
Background: Some important food allergens have been identified as
pathogenesis-related proteins (PRs). Thaumatin-like proteins (TLPs) belong
to the family 5 of PRs. Several structures of plant TLPs have been solved in our
group, including the TLPs from sweet cherry (Pru av 2), kiwifruit (Act d 2) and
apple (Mal d 2). Comparing different structures belonging to the same protein
family can lead to the identification of conformational epitopes.
Methods: ELISA inhibition analysis using the sera of kiwi allergic patients
was used for determination of immunological cross-reactivity between Act d 2
and other TLPs (thaumatin, zeamatin, Pru av 2 and Mal d 2). In order to
identify putative cross-reactive epitopes virtual epitope mapping was applied.
The similarities and differences in surface topology were compared.
Results: ELISA inhibition assays for Act d 2 showed a high cross-reactivity
with zeamatin, medium cross-reactivity with Pru av 2 and Mal d 2, and low
cross-reactivity with thaumatin. On the other hand, the sequence comparison
between Act d 2 and other TLPs yielded a different order of similarity:
zeamatin9 thaumatin9Pru av 29 Mal d 2. Combining the immunological data
and virtuale epitope mapping three putative epitope regions could be
determined on the surface of Act d 2.
Conclusion: High sequence homology/identity between two allergens is not
necessarily the indicator for high cross-reactivity. We used the comparison of
surface features of cross-reactive and non cross-reactive allergens to derive
conformational epitope regions.
894
Bet v 1 homologous proteins in kiwi fruit- relevant allergens?
Christina Oberhuber1, Sean Bulley2, Merima Bublin3, Barbara Ballmer-
Weber4, Stefan Vieths4, and Karin Hoffmann-Sommergruber3. 1Biomay,
Vienna, Austria; 2Hort Research, Auckland, New Zealand; 3Medical
University of Vienna, Department of Pathophysiology, Vienna, Austria;
4University Hospital Zurich, Department of Dermatology, Zurich, Switzer-
land; 5Paul Ehrlich Institute, Langen, Germany.
Background: In Central and Northern Europe birch pollen related food
allergy is mainly based upon cross reactive IgE to Bet v 1 and homologues
present in various plant derived foods. So far, actinidin, kiwellin and the
thaumatin-like protein have been identified from kiwi as relevant allergens.
However, till now nothing is known about Bet v 1 homologous proteins
present in kiwi. Preliminary efforts to purify natural Bet v1 homologues in
sufficient quantities from kiwi failed so far.
Methods: Two individual sequences (from green and gold kiwi fruit)
homologous to Bet v 1 were identified from an EST cDNA library, subcloned
into expression systems pETBlue-2 and pMW 175, respectively and expressed
in E. coli. The resulting recombinant proteins were purified and characterized
according to established methods. IgE binding activity of the purified
recombinant Bet v 1 homologous proteins from kiwi fruit was tested by IgE-
ELISA, IgE immunoblots, and inhibition assays.
Results: Alignment of recombinant kiwi Bet v 1 homologues and recombinant
Bet v 1a revealed an amino acid sequence identity of 50%. Well characterized
purified recombinant Bet v 1 homologues from green (Actinidia deliciosa) and
gold kiwi fruit (Actinidia chinensis) were recognized by birch pollen and kiwi
sensitized patients in IgE immunoblots and ELISA experiments. The presence
of a natural Bet v 1 homologous protein in green and gold kiwi fruit was
confirmed by IgE immunoblot inhibition experiments using natural kiwi fruit
extracts and immuno tissue prints. Cross-reactivity of the two recombinant
proteins with varying intensities to natural Bet v 1 related protein from green
kiwi and to rBet v 1a was demonstrated by ELISA and immunoblot inhibition
assay.
Conclusion: This is the first evidence of cross reactive Bet v 1 homologous
allergens present in gold and green kiwi fruits. The present data point out
that Bet v 1 homologues are relevant allergens in kiwi, especially for
patients sensitized to tree pollen and kiwi fruits and might have been
neglected so far due to low abundancy in the conventional extracts used for
diagnosis.
895
The evolutionary biology of allergens of the cupin and the Bet v 1
superfamilies
Heimo Breiteneder, Merima Bublin, Stefan Wagner, and Christian Radauer.
Medical University of Vienna, Department of Pathophysiology, Vienna,
Austria.
Background: The massive accumulation of sequence data of plant proteins
in recent years has made the classification of allergens into protein families
possible. By comparing sequences and structures, related proteins can be
grouped together into families, and related families can be grouped together
into superfamilies. This much broader picture now allows us to view allergenic
proteins in their evolutionary context.
Methods: Representative protein sequences were compiled by manually
searching the Pfam database of protein families. Multiple sequence alignments
and generation of neighbor-joining trees was performed using ClustalX.
Phylogenetic trees were drawn with TreeView.
Results: The cupin superfamily comprises numerous functionally highly
diverse protein families from all groups of organisms including archaea.
However, allergenicity within the cupins is confined to the vicilin and legumin
plant seed storage proteins. The Bet v 1 superfamily contains the PR-10 family,
the family of major latex proteins and ripening-related proteins, the
norcoclaurine synthases, and the cytokinin-binding proteins. The PR-10
proteins from certain taxa such as the Fagales and Rosaceae are the only
allergenic members of this superfamily. The divergence of the allergenic
members of the Bet v 1 superfamily from the related major latex proteins,
ripening related proteins and norcoclaurine synthases represents an ancient
evolutionary event. Apparently the ancestors of modern day allergens were
present long before any type of immune system had evolved.
Conclusion: This study of the distribution of allergenic and non-allergenic
members of protein families which was funded by the Austrian Science Fund
grant SFB F01802 will provide new insights into the evolution of allergenicity
and the factors that make proteins allergenic.
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Optimizing allergen components in litchi and peach extracts for
in vitro specific IgE assays
Anita Kober1, Hans O¨man2, Maria Lundberg2, and Maryam Poorafshar1.
1Phadia AB, R and D, Uppsala, Sweden; 2MIAB, R and D, Uppsala, Sweden.
Background: Allergy to fruits is often associated with pollinosis and is then
often related to milder symptoms such as oral allergy syndrom (OAS).
However, especially in warmer regions more severe symptoms are also
common. Fruits are here more prevalent foods and are also often eaten in more
sun-ripe forms. Allergy to fruits of the Rosaceae family is strongly associated
with Bet v 1 in northern regions but in warmer regions allergic reactions to
these fruits are more often related to lipid transfer proteins (LTPs) and
sometimes also profilins. The aim with this study was to explore new
extraction buffers and different parts of fruits trying to optimize extraction of
labile Bet v1 analogues as well as more stable profilins, LTPs and other
allergen components.
Methods: Peach was selected as a model for Rosaceae fruits where Bet v 1
homologues, profilin and LTPs are important allergen components. Litchi was
selected as a fruit where the exposure to the population in Europe is increasing
with changing feeding habits and where profilin is suggested to be an
important allergen. Extracts were produced using different buffers and
procedures and different parts of the fruits (pulp/peel) were used. Samples
from patients from different regions with different symptoms (from mild to
severe reactions) were analysed using ImmunoCAP coupled with improved
extracts as well as single components. IgE antibodies to components were also
assayed with a microarray using only 30 6l of sample.
Results: Optimal extraction performance was achieved by a cold extraction
procedure containing polyvinylpyrrolidone. Both pulp and peel were needed
for optimal performance. For selected samples, mainly reacting to Bet v1,
increased results as measured with ImmunoCAP was seen in 76% (62/81) for
Peach f95. In litchi profilin was the dominating allergen component in several
patient samples both measured by ImmunoCAP and using the microarray
assay. The results were confirmed by inhibition studies.
Conclusion: Improved extraction methods can enhance the content of both
Bet v 1 homologues and profilin in fruit extracts used for in vitro assays for
specific IgE. Microarrays are useful tools to analyse component profiles in
samples using very small volumes of sample. Profilin (Lit c1) is an important
allergen in litchi and may cause severe reactions. In peach LTP (Pru p3) and
the Bet v 1 homologue Pru p1 were the more important components in the
tested patient population.
897
Characterization of saffron pollen allergens
Sepehr Salehi, Majid Baseri Salehi, and Mehrdad Shariati. Islamic Azad
University, Kazeroun Branch, Biology, Kazeroun, Islamic Republic of Iran.
Grass pollen is one of the most important causes of IgE-mediated
allergic reactions. Hypersensitivity to saffron pollen is an occupational allergy
and is a serious problem especially among people dealing with saffron
(farmers). Saffron is a native plant of Iran and this study was performed on
saffron pollen in Khorasan province.
Saffron pollen allergenicity was proven using skin prick test. The aim
of this study was to characterize IgE-binding components of saffron pollen.
At first saffron pollen was extracted with phosphate-buffered saline
(PBS 125mM, pH 7.2Y7.4) at 4-C for 5 hours with gentle shaking. After
centrifugation and delipidation, the extract was concentrated by polyethyle-
neglycol (PEG20000) at 4-C. Concentrated saffron pollen extract was
fractionated by SDS-PAGE and transferred to nitrocellulose paper by western
blotting technique. After western blotting, using sensitive individual sera and
anti-human IgE-HRP immunoblot analysis was performed. Finally one
specific IgE-binding band was showed with molecular weight of 20-27 KD.
This study indicated that sensitive sera contain specific antibodies
directed against allergens present in saffron pollen extract. Also this
component can be bind specifically to IgG.
898
The role of Interleukin 4 and 5 (IL4, 5) in development of
chronic inflammations of stomach in patients with food allergy
Zbigniew Bartuzi, and Magdalena Bikowska. Collegium Medicum Bydgoszcz
Nicolaus Copernicus University, Department Allergy, Clinical Immunology
and Intern, Bydgoszcz, Poland.
The chronic gastritis can cause protracted iatrogenic effect of certain
medicaments, for example non-steroid anti-inflammatory drugs also. Still, to
little is known about the extent and role of hypersensitivity in patients with
atopic diathesis in the development of chronic gastritis. The aim of the study
was to determine serum concentrations of IL-4, IL-5 in patients with chronic
gastritis and food allergy, who had been infected with H. pylori. The study was
conducted on patients with atopic diathesis, suffering from dyspepsia and
abdominal pain, who were monitored in our Outpatient Clinic for Food
Allergy. The study group consisted of 71 patients, including 42 females aged
16=V54 years (mean age 35.5 years) and 29 males aged 18=V60 years (mean
age 36.2 years). The control group was formed of 40 patients with dyspepsia
and abdominal pain related to chronic gastritis and confirmed in endoscopy
and histopathological investigation. specimens. The patients underwent
endoscopy The samples were stained with eosin and hematoxylin (H and E)
and with modified Giemza stain. Selected serum cytokines: IL-4, IL-5, nwere
determined with ENDOGEN kits(Cambridge ). Serum levels of interleukin-4
in patients with food allergy ranged between 0.2 to 291 pg/ml, with mean value
of 27.85=O´34.89 pg/ml. In the group of non-atopic patients with chronic
gastritis, the range of determined values was 1.5 =V60.1 pg/ml =V mean
concentration was 13.26=O´7.0 pg/ml. In control patients with functional
dyspepsia, the concentration of IL-4 obtained ranged between 0 and 13.2 pg/
ml =V mean IL-4 concentration was4.31=O´2.8 pg/ml. IL-4 concentrations in
various groups are presented in table 1. The concentrations of interleukin-5 in
patients with food allergy ranged between 0 and 111.3 pg/ml (mean value
7.43=O´3.20 pg/ml). In control group of non-atopic subjects with chronic
gastritis, IL-5 levels were 0=V20.6 pg/ml (mean level 4.03=O´1.60 pg/ml). The
comparative analysis of IL-5 and IL5 levels between patients with food allergy
and control group with chronic gastritis showed statistically significant
differences (pG0.05). Conclusions: 1. Chronic exposure to the sensitising food
in patients with food allergy results in the significant elevation of IL-4 and IL-5
levels. 2. Patients with food allergy and chronic gastritis, who had been
infected with H. pylori manifest simultaneous increase in IL-4, IL-5, which
suggests the participation of allergic factors in the pathogenesis of
inflammation.
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Summary of blinded-food challenges against hen’s egg and cow’s
milk allergies in the past 11 years
Takatsugu Komata1, Takanori Imai1, Mika Ogata1, Sakura Sato2, Morimitsu
Tomikawa3, Hiroshi Tachimoto3, Akinori Shukuya3, and Motohiro Ebisawa2.
1Sagamihara National Hospital, Department of Pediatrics, Sagamihara-city,
Kanagawa, Japan; 2Sagamihara National Hospital, Clinical Research
Center, Department of Allergy, Sagamihara-city, Kanagawa, Japan; 3Saga-
mihara National Hospital, Pediatrics, Sagamihara-city, Kanagawa, Japan.
Objective: The aim of this study was to analyze the results of 175 single-
blinded food challenges (SBFC) against hen’s egg(HE) and cow’s milk(CM)
allergy patients.
Methods: We analyzed the data of the patients who had received the SBFC
in Sagamihara National Hospital from 1995 to 2005. The total numbers of
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examination was as follows; HE: 92 challenges (male: 65, female: 27, mean
age: 72.6 months), CM; 83 challenges (male: 62, female: 21, mean age:
71.0 months). SBFC was performed using dried powder (4g of whole egg
powder or 6g of CM powder) with 120g strawberry puree as vehicle and the
test was carried out along the AAAAI office procedure manual (JACI 82:
986, 1988).
Results: Most of the subjects received the SBFC prior to the entrance of
primary school whether or not they could take school lunch. The positive rate
of challenge test was as follows; HE: 70/92 (76%), CM: 37/83 (45%). The
most common symptom induced by HE challenge was GI reaction (83%),
followed by skin reaction (69%) and lower respiratory symptoms (17%). We
further confirmed challenges with heated hen’s whole egg against 62 subjects
in 70 diagnosed raw egg allergy patients. Interestingly a discrepancy of the
result between raw egg challenge and heated egg challenge was seen. Twenty
nine percentage (18/62) of raw egg allergy patients could take heated whole
egg. Egg white specific IgE level of patients who could not pass the
challenge (18.0UA/ml) was higher than that of those who passed (8.0UA/ml)
(pG0.05). For CM challenge, skin reactions were the most common (89%),
followed by lower respiratory symptom (65%) and GI reaction (19%). There
was no statistical difference of CM specific IgE level between failed
challenges (19.5UA/ml) and passed challenges (12.1UA/ml). Higher SPT
positive reaction to CM and higher complication rate of bronchial asthma
were recognized in failed cow’s milk challenge group.
Conclusion: SBFC for HE and CM was useful for the diagnosis at the time
of entrance to primary school. To improve the quality of life of raw egg
allergy patients, it is recommended for the patients to receive heated egg
challenge. It seems that HE challenge test tended to induce GI reactions more
than CM challenge and that persistent CM allergy may have something to do
with the complication of bronchial asthma in school age children.
900
Cow`s milk protein allergy presenting as necrotizing
enterocolitis: a case report
Sarayutdh Tonglor, Pantipa Chatchatee, and Jarungchit Ngamphaiboon. King
Memorial Chulalongkorn Hospital, Pediatric Allergy and Immunology,
Bangkok, Thailand.
Background: Gastrointestinal symptoms are common manifestation of cow`s
milk protein allergy. How ever necrotizing enterocolitis resulting from cow`s
milk protein allergy is rare.
Case report: A 3,300 gm. full term female infant had been fed with cow`s
milk formula since birth for ten days then switched to breast feeding alone.
At twelfth day of life, she gradually developed abdominal distension and
vomiting 2-3 times a day and was brought to see the pediatrician. Her
physical examination had no other abnormal finding exept abdominal
distension. So, she was advised to got some simethicone for abdominal
discomfort and continued breast feeding. She still had the same symptoms
that was vomiting and progressive abdominal distension. At twenty fourth
day of life, she had developed more frequent vomiting, mucous bloody
diarrhea, severe abdominal distension, hematochezia and pneumatosis
intestinalis was seen on her X-ray finding. Laboratory finding included
normal complete blood count, negative blood and stool culture. Necrotizing
enterocolitis was diagnosed and successfully tolerated with parenteral
antibiotics. She was placed on extensive hydrolysate formula which was
well tolerated. The prick skin testing, atopy patch testing and radio-
allergosorbent testing were all negative for cow`s milk protein. Three
months after, she grew very well with normal weight and height. She was
challenged with soy-based formula at four month of age and well tolerated.
At seventh month of age, she was challenged with cow`s milk protein and
developed vomiting, abdominal distension within four days. The diagnosis
of cow`s milk protein allergy was made based on positive symptoms after
challenge.
Conclusion: Cow`s milk protein allergy should be evaluated in patient
presents with necrotizing enterocolitis without obvious risk factors.
901
Calcium dependence of IgE reactivity of recombinant alpha-
lactalbumin, a major cow`s milk allergen
Heidrun Hochwallner1, Ulrike Schulmeister1, Ines Swoboda2, Josef
Thalhamer3, Sandra Scheiblhofer3, SantiagoQuirce4, AdrianoMari5, Gabrielle
Pauli6, Rudolf Valenta2, and Susanne Spitzauer1. 1Medical University of
Vienna, Inst. of Medical & Chemical Laboratory Diagnostics, Vienna, Austria;
2Medical University of Vienna, Department of Pathophysiology, Division of
Immunopathology, Christian Doppler Laboratory for Allergy Research,
Vienna, Austria; 3University of Salzburg, Department of Molecular Biology,
CD Laboratory for Allergy Diagnosis and Therapy, Salzburg, Austria;
4Fundacion Jimenez Diaz, Allergy Department, Madrid, Spain; 5IDI-IRCCS,
Center for Clinical and Experimental Allergology, Rome, Italy; 6Hopitaux
Universitaires, Service de Pneumologie, Strasbourg, France.
Background: Cow`s milk allergy is one of the most common causes of IgE-
mediated hypersensitivity reactions in the first years of life affecting about 2.5
to 6% of infants. Cow`s milk contains more than 25 proteins and several of
them are known to be allergenic. "-Lactalbumin ("-La) is a major cow`s milk
allergen of the whey fraction. It is a small (14.2 kDa), acidic (pI 4.8) protein of
123 amino residues with a single calcium binding site.
Methods: We expressed "-La as a recombinant, histidine-tagged protein
(r"-La) in Escherichia coli, and purified it to homogeneity using Ni-NTA
agarose. The molecular weight and the structure of r"-La were studied by
mass spectrometry and circular dichroism (CD), respectively. The IgE reac-
tivity of r"-La was analyzed with sera from cow`s milk allergic patients.
Biological activity was tested using a humanized rat basophil leukemia cell
line that expresses the "-chain of the human Fc(RI receptor. Calcium
dependence of IgE binding of r"-La was analyzed by IgE immunoblotting.
Results: Purified r"-La showed the expected molecular weight of 15.1 kDa in
mass spectrometry. The far UV-circular dichroism spectrum revealed that
r"-La represents a well structured, mainly "-helical protein. Thermal
denaturation experiments using CD showed that the protein retains most of
its native-like conformation even at 95-C and thus pointed to an extremely
high thermal stability. IgE immunoblots demonstrated that r"-La binds IgE
from cow`s milk sensitized patients and induces specific basophil degranula-
tion. Furthermore, calcium depletion assays led to a reduction of IgE binding
in sera from certain cow`s milk allergic patients.
Conclusion: We produced an IgE-reactive, correctly folded and biological
active r"-La. Calcium depletion experiments indicated the presence of
conformational as well as linear epitopes. This recombinant allergen may be
used for diagnosis of cow’s milk allergic patients.
902
Usefulness of Open Food Challenge (OFC) in the diagnosis of
food allergy
Kayo Kobayashi1, Yuji Kumagai1, Maho Sakamoto1, Shigeru Ito2, and
Tadaatsu Ito3. 1Tokatsu Hospital, Department of Pediatrics, Chiba, Japan;
2Tokatsu Hospital Affiliated Clinic, Department of Pediatrics, Chiba, Japan;
3Teikyo University School of Medicine, Department of Pediatrics, Chiba,
Japan.
Aim: According to the epidemiologic surveillance in a middle-sized city in
Japan, the estimated prevalence rates of food allergy are 5 to 10 % and 1 to
2% among infants and school children, respectively. However, these figures
seem exaggerated because the diagnoses are reported by parents and almost
based on RAST and/or skin tests. To find out real prevalence rate we
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compared the results of RAST and open food challenge tests (OFC) among
children who were under elimination therapy because of suspected allergy to
some foods.
Patients and Methods: The objects were 218 children, 139 male and 79
female, aged between 3mo and 12yr, suspected of food allergy. From January
2002 to May 2007, they were challenged with foods which seemed to have
provoked allergic symptoms previously or which doctors advised not to take
because of high scores of RAST tests and eliminated before the challenge. The
clinical symptoms after ingestion of foods were observed for 3 days,
documented and evaluated thereafter. Symptoms were classified into three
categories; none, mild and moderate.
Results: Foods challenged were egg white (61), egg yolk (58), cow milk (27),
noodle (13), buckwheat (9), chicken (6), peanuts (5), soybean (4), tofu (3),
mayonnaise (2) and others (30)(Figures in the parentheses are numbers of
challenges). Positive and negative family history of allergic diseases was 84%
and 16%, respectively. Symptoms after ingestion of foods were none in 78%,
mild in 14% and moderate in 8%. No life-threatening symptom was noted.
Specific IgE titers (RAST scores) against suspected foods were measured in
109 children. There was significant correlation between the symptoms and
RAST scores (P$B!a(B0.017). On the other hand, 73% of high score cases
(RAST score 5 and 6) were symptom free. These results show that there is
discrepancy between Symptoms and RAST score titers.
Conclusion: OFC is a simple and reliable method for clinical diagnosis of
food allergy in children.
903
The effect of soy-based formula on clinical symptoms and the
fatty acid compositions in Infants with atopic dermatitis
Jae-Won Oh1, Eun-Young Lee2, and Ha-Baik Lee1. 1Hanyang University
College of Medicine, Pediatrics, Seoul, Republic of Korea; 2Gyunghee
University, Nutrition, Seoul, Republic of Korea.
Atopic dermatitis and food allergy commonly occur in early child-
hood. Especially infants with cow’s milk allergy were reported to have the
reduced growth and special nutritional needs. Formulations of soy-based
infant formula have changed over the years to improve digestibility, the
stability and availability of minerals, and protein quality. soy-based formulas
are a rich source of essential fatty acids, linoleic acid and "-linolenic acid.
This study was intended to investigate whether soy based formula has an
effect on clinical symptom and the fatty acid composition in erythrocyte in
infants with atopic dermatitis. The infants were recruited from pediatric
allergic clinic in Hanyang University Guri hospital from September 2004 to
August 2005. One group was supplemented soy based formula (SBF, n=21)
and the other was supplemented hydrolyzed cow’s milk as controls (HCM,
n=20) for 12 weeks. The clinical severity was measured by using SCORAD
index. To evaluate nutrition status of the subjects, anthropometric indices
compared with Standard Value of Growth and Development for Korean
children. Blood samples were collected to analyze fatty acid composition and
immune parameters. Specific IgE measurement and Skin prick test was
performed. The mean age of the SBF group was 9.0 T 2.1 month, and the
HCM group was 8.8 T 1.9 month, and their SCORAD scores were mild or
moderate states that significantly improved after experimental period (before
SBF 40.9 T 2.4, after SBF 17.2 T 0.6, before HCM 45.7 T 24.6 after HCM
13.3 T 21.7). Although SBF grows consumed more "-linolenic acid (18:3, n-
3) intake, eicosapentaenoic acid and docosahexaenoic acid were decreased
after SBF. In the other hand, arachidonic acid (C20:4, n-6) was increased
after SBF feeding (before SBF 8.3 T 2.8, after SBF 8.8 T 0.6), however,
decreased after HCM (before HCM 8.6 T 1.0, after HCM 8.2 T 0.8). In
conclusion, SBF supported to improve symptoms with normal growth and
nutritional status in infants with atopic dermatitis but there were no evidences
to improve fatty acid compositions although giving a number of la´-linolenic
acid intakes. It might be suggested that %-6-desaturase was reported to
decrease in atopic dermatitis, SBF could not show to recover this enzyme
deficient condition in this study.
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Egg white-specific IgE levels as predictors of clinical reactivity in
the follow-up of egg allergy
E Montesinos, R Felix, JC Cerda, A Martorell, J Garde, and M Pont.
University General Hospital, Allergy Unit, Valencia, Spain.
Background: Our objectives were to describe the egg white proteins allergy
survival time in our population and analyze the correlation between egg white
IgE levels and oral contolled challenge test (OCCT) results.
Methods: We performed a retrospective study including 42 patients diag-
nosed to egg allergy in the first 2 years of life who were controlled at 3,4
and 5 years of age. In the annual controls skin-prick tests, determination of
egg white-specific IgE levels and OCCT were carried out until tolerance
developed. In different moments of the follow-up we determined cut-off
points of egg white-specific IgE levels that provided a probability Q 95 of
egg white tolerance, analyzed by Receiver-Operating Caharacteristic (ROC)
curve.
Results: The median survival time of egg allergy was 48.7 months. The
specific IgE levels cut-off points correlated with OCCT results differ in the
different periods of follow-up. The egg white-specific IgE levels which were
predictors of the clinical reactivity (positive predictive value (PPV) Q 95%) in
the different periods were: between 25 and 36 months 1.52 kU/L, between
37 and 48 months 1.35 kU/L and between 49 and 60 months 2.59 kU/L. For
these levels the negative predictive value (NPV) was 40%.
Conclusion: The monitorization of egg white-specific IgE levels in allergic
children to egg white allows us to predict the clinical reactivity along the egg
allergy follow-up. Egg white-specific IgE levels greater than those referred
would not be allow the OCCT in our population, while with lower levels we
would find tolerant patients.
905
The analysis of the severity of sensitization to extensively
hydrolyzed cow`s milk formula in infants with atopic eczema
dermatitis syndrome
Maciej Kaczmarski, Beata Cudowska, and Ma3gorzata Sawicka-ukowska.
Medical University of Bialystok, III Department of Paediatrics, Bia3ystok,
Poland.
Background: Children with atopic eczema dermatitis syndrome (AEDS) are
often sensitized to cow`s milk protein. The treatment is based on the
extensively hydrolyzed formula (EHF).
The aim of study was to analyse the severity of sensitization to EHF in
infants with atopic eczema.
Materials and Methods: 16 children aged 1- 36 months with symptoms of
atopic eczema and positive specific IgE to cow`s milk proteins were enrolled to
the study. The followed diagnostic tools were used to confirm cow`s milk
allergy: the concentration of total and sera specific IgE antibodies to milk
proteins as casein, aˆ-lactoglobulin and a´-laktoalbumin, oral food challenge
tests to hydrolyzed cow`s milk formula performed following standards.
Results: All of children were sensitized to casein, 9/16 of them to a´-
laktoalbumin and 7/16 to aˆ-laktoglobulin. The serum concentration of total
IgE (mean 623,1 T735,2 vs 88,21 T124,2; p=0,0001) and SCORAD index
(mean 60,01 T25,14 vs 52,01 T24,43; p=0,03) was significantly higher in the
group of children with allergy to EHF, but no correlation between total IgE and
SCORAD index has been stated. The IgE sera concentration to casein and
whey proteins was noticed most often in second and third class (0,7-17,5 IU/
ml). The number of plasma eosinophils (p=0,006) and white blood cells
(p=0,005) was significantly higher.
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Conclusion: Children with allergy to EHF demonstrated more severe
symptoms of AEDS than those without allergy to EHF. The atopic background
of clinical symptoms was more expressed in children with allergy to EHF.
Amino-acid based formula should be recommended in therapy of children
sensitized to EHF.
906
Hypersensitivity to cow`s milk protein in a premature infant
manifested with feeding intolerance and hypereosinophilia
Khanitha Siripool, Wasu Kamchaisatian, Suwat Benjaponpitak, Surat
Tungchaisin, and Chalerat Direkwattanachai. Faculty of Medicine Ramathi-
bodi Hospital, Mahidol University, Division of Pediatric Allergy/Immunology,
Bangkok, Thailand.
Background: Cow`s milk protein hypersensitivity is the most common food
hypersensitivity in infants. The current diagnostic approaches include a
thorough history taking, skin testing and measuring of serum specific IgE to
suspected food, elimination of suspected food and food challenge test.
Eosinophilia occurs frequently in premature infants and has been associated
with total parenteral nutrition and with cow`s milk protein allergy, a response
to foreign antigen presented to body through gastrointestinal tract, airway or
intravenous routes.
Methods: We reported a premature male infant, with gestational age of 33
weeks and birth-weight of 980 gram, who developed feeding intolerance to
premature infant formula since 3 days old. He was treated as necrotizing
enterocolitis and was stopped feeding for a few days which showed improving
of the symptoms. Then he was started feeding again on 7 days old and had
feeding intolerance with increasing of peripheral blood eosinophilia from 440 /
mcL to 9,640 /mcL at the age of 26 days.
Results: The allergy consultation was appreciated for evaluating the cause of
hypereosinophilia. After thoroughly excluding other causes of eosinophilia,
the patient was suspected to be allergic to cow`s milk protein. He was changed
the feeding to extensively casein-hydrolysated formula. The specific IgE to
cow`s milk was done and revealed a value of 7.77 kUA/L with total IgE of
114.3 IU/mL. His symptom of feeding intolerance was improved with a good
weight-gaining. The peripheral blood eosinophilia was gradually decreased to
2,220 /mcL within 5 days. One week later, the infant was reintroduced feeding
with cow`s milk protein formula for 3 days and developed vomiting,
abdominal distension and retention of gastric contents with a striking
peripheral blood eosinophilia to 16,592 /mcL. The feeding was changed
back to extensively casein-hydrolysated formula and the symptoms of feeding
intolerance were improved with decreasing of eosinophil count to 900 /mcL on
the age of 60 days and body weight of 2,000 gram.
Conclusion: Herein, we report a case of premature infant with feeding
intolerance and hypereosinophilia resulted from cow`s milk protein hyper-
sensitivity. Eosinophilia in premature infant may be one response to foreign
antigen mediated through gastrointestinal tract resulted in food
hypersensitivity.
907
A case of cow’s milk allergy, which was succesfully treated with
an amino acid-based formula but not with breast feeding
Yoshiyasu Ogata1, Masafumi Zaitsu1, Shuichi Yamamoto1, Eriko Muro1,
Natsuko Nishi1, Katsuya Tashiro1, and Rahmawati Minhajat2. 1Saga
university, Pediatrics, Saga, Japan; 2Saga university, Pathology, Saga, Japan.
Background: Hematochezia in infancy should be considered as one of the
symptoms of cow’s milk allergy (CMA). The most effective treatment of CMA
is complete avoidance of cow’s milk protein.
Objective: We have experienced a male infant with CMA, who tolerated an
amino acid-based formula but not breast feeding.
Case: The patient was a full-term baby boy initially raised with breast milk and
small amount of CM-based formula for about one month. From one month of
age, the patient was exclusively breast-fed. At 3 month of age, a supplement of
CM-based formula was started on a pediatrician’s recommendation, because of
slight poor weight gain. After ingesting a CM-based formula, he developed
visible rectal bleeding immediately. A presumed diagnosis of CM allergy was
made and mother was instructed to stop CM-based formula and to avoid
drinking CM. Because mucus blood mixed stool continued, he was admitted to
our hospital for diagnosis and treatment. Physical examination showed he was
no apparent abnormal findings. Stool culture was negative for routine
pathogens. The number of eosinophil in stool smear was elevated. Serum IgE
was 10 IU/ml and specific IgE for milk was positive. Lymphocyte proliferative
responses to CM-based formula and breast milk were positive, but to an amino
acid-based formula was negative. A skin prick test was positive for CM.
Rectocolonoscopy up to the sigmoid colon was performed, showing
macroscopic evidence of nodular lymphoid hyperplasia with small erosions
in rectum. Histological examination of biopsy specimen revealed colitis with
predominant eosinophil-infiltration in the lamina propria. Through these
findings we considered that this is a case of CMA and that breast milk
contained a small amount of CM. We asked mother to stop breast feeding and
CM-based formula and started to an amino acid-based formula. After
avoidance of breast feeding, resolution of hematochezia took place with in two
days. At the age of 14 months, the patient grows well on an amino acid-based
formula and food without CM protein.
Conclusion: It is difficult for mothers to avoid completely milk protein,
because a lot of food contain CM as ingredient, and therefore breast milk may
contain small amount of CM protein often. In this case, we successfully treated
the patient with an amino acid-based formula without breast feeding. And he
has no problem for his growth. An amino acid-based formula is a powerful tool
of treatment of CMA in infancy.
908
A prebiotic oligosaccharide mixture inhibits pathophysiological
changes in mice orally sensitized against casein or whey proteins
Bastiaan Schouten1, Betty van Esch1, Gerard Hofman1, Linette Willemsen1,
and Johan Garssen2. 1Utrecht Institute for Pharmaceutical Sciences,
Pharmacology and Pathophysiology, Utrecht, Netherlands; 2Numico-
Research BV, Immunology, Wageningen, Netherlands.
Background: Human breast milk is thought to protect the neonate from
development of allergies. In particular, oligosaccharides in human milk may be
beneficial. These prebiotics may have direct immunomodulatory capacities or
exert their effects by enhancing growth of lactobacilli and bifidobacteria. To
test the effects of prebiotic oligosaccharides on allergic sensitization, a diet
containing a 2% oligosaccharide mixture of fructo-, galacto- and acidic
oligosaccharides (GOS:FOS (9:1, 1,8%) and AOS (0,2%)) was tested in mice
orally sensitized against casein and whey proteins. The prebiotic mixture
mimicks the oligosaccharide composition in human milk.
Methods: For a period of 6 weeks, five week old female C3H-HeOuJ mice
were sensitized weekly by gavage (i.g.) with casein or whey (20 mg), using
cholera toxin (CT) as an adjuvant. Mice were fed with the control or prebiotic
(GFA) diet, starting two weeks prior to the first sensitization. At week 7 the
mice were challenged subcutaneously (ear) (10 6g) and orally (100 mg).
Serum levels of total IgE and allergen specific IgE, IgG1 and IgG2a were
measured. The acute allergic skin reaction was determined by measuring ear
swelling. Furthermore, isometric contraction of the colon was determined to
get insight into motility changes of the intestine.
Results: In the whey and casein sensitized animals the allergic skin reaction
was significantly reduced in the prebiotic group. This was most obvious in the
casein group (control vs GFA diet, 202 +/- 23 vs 73 +/- 11 6m; pG0.01). Casein
and/or whey specific IgG1 and IgE levels were unaltered, while in whey
sensitized animals IgG2a levels were enhanced by the diet (control vs GFA
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diet; 0.11+/- 0.003 vs 0.40 +/- 0.13 A450; pG0.05). The hypocontractility of
the colon of casein sensitized mice was restored to normal levels by the
prebiotic diet (control vs GFA diet, 1342 +/- 404 to 3515 +/- 1106 mg;
pG0.05).
Conclusion: A mixture of GOS/FOS/AOS oligosaccharides reduces systemic
and local allergic symptoms in mice orally sensitized to cow`s milk proteins,
when provided during the sensitization phase.
909
Balb/c mouse model of allergy to wheat gliadins: biochemical
and clinical manifestations
Marie Bodinier1, Michae¨l Leroy1, sandrine Ah-Leung2, Fany Blanc2, Olivier
Tranquet1, Sandra Denery-Papini1, Jean-Michel Wal2, and Karine Adel-
Patient2. 1INRA, BIA unit, allergy team, Nantes, France; 2INRA, Unit of
Immunology and Food Allergy, CEA Saclay, Gif-sur-Yvette, France.
Background: Animal models demonstrating IgE of the same specificity as
human IgE and clinical symptoms upon challenge close to those observed in
allergic patients are of great interest for the understanding of mechanisms
involved in the induction and regulation of allergy. Food allergy to wheat
(FAW) affects 0.1 to 0.4% of the global population. Major allergens have been
characterized in this pathology. Water/salt soluble albumin/globulin fraction
contains major allergens for children with the atopic eczema/dermatitis
syndrome (AEDS) and the insoluble w5-gliadins are involved in adults with
wheat-dependent exercise-induced anaphylaxis (WDEIA).
Aim: The aim of this study consisted of developing a mouse model of food
allergy to a gliadin extract, a wheat fraction containing major allergens by
testing different protocols.
Methods: Three strains of mice, Balb/c, C3H/HeJ and B10.A, were
immunized by 4 successive intra-peritoneal injections of gliadin extract. The
influence of the dose of gliadins (10 and 20 6g per mouse) was evaluated on
allergen specific IgE and IgG1 production, on the cytokines production by
activated T lymphocytes and on the elicitation of an allergic reaction. The
development of the allergic reaction was compared by testing the Th2 type
cytokine production and the eosinophil influx in the bronchoalveolar lavage
(BAL) fluids 24h after a single intra-nasal stimulation with a total gliadin
extract.
Results: Balb/c mice demonstrated higher gliadin specific IgE and IgG1
productions than the other mice, whatever the dose administered (i.e. 10 or 20
6g). This was confirmed by the Th2 type cytokine profile produced by
activated splenocytes. The significant eosinophil influx and the Th2 type
cytokine produced in the BALs also showed the elicitation of the allergic
reaction in Balb/c mice, whatever the sensitisation dose. Low to no elicitation
was evidenced in B10.A and C3H/HeJ mice at the 10 6g dose.
Conclusion: This study demonstrates for the first time the interest of Balb/c
strain as a mouse model of food allergy to wheat. Our project is to further
characterise the fine specificity of induced IgE and to compare the responses
obtained in humans and mice.
910
The number of IgE-binding cells in stomach mucosa in patients
with peptic ulcer disease and food allergy versus without food
allergy
Zbigniew Bartuzi. Collegium Medicum Bydgoszcz N. Copernicus University,
Department Allergy, Clinical Immunology and Intern, Bydgoszcz, Poland.
Immunoglobulin E is the main antibody responsible for immediate
type reactions. It can bind with FceRI receptors on mast cells and basophiles
including those in the alimentary tract.
Aim: The aim of this study was to compare a quantity of cells connected
with IgE antibody at stomach mucosa in patients with peptic ulcer disease
and food allergy, versus group of patients with peptic ulcer disease and
without food allergy The study group consisted of 33 patients with ulcer
disease and food allergy. The control group was formed of 21 non-atopic
patients with ulcer disease. We evaluate a quantity of cells connected with
IgE antibody in gastric mucosa by method of direct immunofluorescence.
Results: The number of IgE-binding cells in stomach in patients with peptic
ulcer disease and food allergy was average 15,55 instead in patients with
peptic ulcer disease 8,52. We found statistical significant difference of
quantity of cells connected with IgE between patients with peptic ulcer
disease and food allergy, versus patients with peptic ulcer diseases and
without food allergy (pG0,02).
Conclusion: This results confirm the important role allergic mechanisms in
pathogenesis of inflammatory changes in stomach mucosa observed in
patients with peptic ulcer disease and food allergy.
911
Relationship between ulcerative colitis, Irritable Bowel Syndrom
(IBS) and food allergy
Xueyan Wang, Xuefei Yang, Ruiqin Ma, Ming Zhang, and Huan He. Bejing
Shijitan Hospital, Allergy, Beijing, China.
Background: Allergic diseases are common diseases that involve many
clinical disciplines. Food allergy, the offending food and food additives are
concerned problems for doctors.
Objective: to explore the relationship between ulcerative colitis, irritable
bowel syndrome(IBS) and food allergy. [Method] During the periods of 2005
to 2007,30 patients with ulcerative colitis or IBS were tested food skin test,
serum food specific immunoglobulin G( sIgG), ANA. CIC, C3, C4, CH50,
ADNs.
Results: 13 patients have positive result to egg, 8 patients to wheat, 4 patients
to tomatoes, 3 patients to beans, 3 patients to fish, 2 patients to shrimp, 2
patients to peanut, 2 patients to corn, 2 patients to beef. Most of them
combined with more than two kinds of food. All of them were visited 3 months
and 6 months after examination. After avoiding positive food for 3 months,
15 patients with colitis have improvement, abdominal pain relieved, After
6 months, 22 patients recovered.
Conclusion: It is valuable to test food sIgG. According to the elevated sIgG,
these patients were asked to change food habits. 73.3% patients have
improvement. 26.3% patients have no effect. The study helps us to know the
close relationship between digestive disease and food allergy.
912
The study of the Chinese herbal medicine-Lonicera extract from
water solution on the ovalbumin- sensitized BALB/c mice
Fei Li, and Haiqi Li. Children’s Hospital, Department of Primary Child Care,
Chongqing, China.
Background: Few studies are available for treating food allergy by used
TCMs.
Objective: To investigate the effects of the Chinese herbal medicine Lonicera
on the ovalbumin-induced hypersensitivity BALB/c mice.
Methods: BALB/c mice sensitized with OVA were treated 4 hours after the
first challenge and then twice daily for 10 days with different Lonicera
concentrations extracted from water solution, i.e. 1g/ml as high dosage , 0.5g/
ml as middle, and 0.25g/ml as low.
Results: Part I: The conditions of hypersensitivity mice were markedly
improved by the high or middle Lonicera doses, such as reduced levels of
serum OVA-specific IgE , inhibited the abnormal monocular cell prolifera-
tions, alleviated the degranulation and aggregation of intestinal mast cells,
increased the percentage of intact mast cells and significantly reduction of
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histamine release, as well as downregulated the ratio of IL-4/IFN-, and
promoted the mRNA expression of IL-10 and TGF-$ in PLNMC. Part II: The
counts of Bifidobacterium and lactobacillus of the stool samples of the
sensitized mice were significantly increased by the high or middle Lonicera
doses, and meanwill the counts of Enterobacteriaceae and Staphylococcus
were markedly declined.
Conclusion: Our data first showed the immunological regulation effects to
food allergy from the high or middle Lonicera concentrations extracted from
water solution, such as anti-inflammation and immunoregulation of Th1/Th2
responses as well as activation of T regulatory cells. And the inbalance of
intestinal microflora in OVA-induced allergic mice were improved by the
Lonicera ext, which were helpful to improve the clinical manifestations of food
allergy.
913
Utility of fast in food allergy: a case report
Paola Minale1, Federica Fumagalli2, Annalisa Kunkle3, Matteo Caiti4,
Costantino Troise1, and Giorgio Walter Canonica2. 1San Martino Hospital,
Genoa, Allergy Unit, Genoa, Italy; 2University of Genoa, Allergy and
Respiratory Diseases DIMI, Genoa, Italy; 3San Martino Hospital, Genoa,
Diagnostica Citofluorimetrica, Genoa, Italy; 4University of Genoa, Dept of
Internal Medicine - DIMI, Genoa, Italy.
We describe the case report of a 29 years old man who experienced an
episode of urticaria and angioedema 30 minutes after having taken 100 mg of
nimesulide and having drunk a beer.
He was known to suffer from allergic rhinitis and food allergy (skin
prick test were positive to: Dermatophagoides Pteronissinus, Dermatopha-
goides farinae, Grass pollen, olive tree pollen, birch pollen, artemisia, hazel
tree pollen, peanuts, nuts). He had had urticaria and angioedema after the
ingestion of peanuts and nuts. As regards the last episode, both the drug
and the food were suspected to be the cause of the reaction, therefore we
performed skin prick test to beer and malt (previously tolerated), which
resulted positive; the FastImmune Basophil Activation Assay (Flow-Fast) for
beer confirmed the skin prick test positivity; Fast for nimesulide was
negative; to confirm this data the patient has been challenged to nimesulide
that was tolerated.
According to our clinical and laboratory findings, we concluded that
the diagnosis was urticaria due to beer allergy.
Fast reveals the presence of a very specific and sensitive cellular
activation marker that permits to diagnose IgE-mediate reactions and
pseudoallergies. In our case report has been helpful to confirm the positivity
to beer allergen skin prick test and exclude a drug reaction.
914
Therapeutic indications to amino acid-based formula in infants
with atopic eczema dermatitis syndrome
Beata Cudowska, Maciej Kaczmarski, and Ma3gorzata Sawicka-ukowska.
Medical University of Bialystok, III Department of Paediatrics, Bia3ystok,
Poland.
Background: Allergy to cow`s milk protein is one of the casual factor of
atopic eczema dermatitis syndrome (AEDS) in infants. Treatment is based on
diet, generally using an extensively hydrolyzed formula (EHF) or amino-acid
based formula (AABF).
The aim of study was to establish the therapeutic indications to amino
acid-based formula in infants with atopic eczema.
Materials and Methods: 30 children aged 1-36 months with AEDS were
qualified to the study. Allergy to cow`s milk proteins was established by the
measurement of total and specific IgE and verified by oral food challenge
following standards. According to the obtained results infantswere divided in two
groups: 16 children with allergy to EHF and 14 children without allergy to EHF.
Results: In all of children allergy to cow`s milk formula was confirmed. In the
group of children with allergy to EHF, hypersensitivity to casein hydrolysates
was confirmed in all of them, to whey hydrolysates in 9/16 of infants. Severe
atopic dermatitis was recognized more often in infants with sensitization to
EHF (SCORAD index: mean 60,01 T25,14 vs 52,01 T24,43 in the control
group; p=0,03). Total IgE was elevated significantly in the group of infants
with severe AEDS and allergy to EHF (mean 623,1 T735,2 vs 88,21 T124,2;
p=0,0001).
Conclusion: Amino acid-based formula should be recommended in children
with severe atopic dermatitis and allergy to extensively hydrolyzed cow`s milk
formula. Allergy to casein is the most common in infants with hypersensitivity
to EHF.
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915
Assessment of birch pollen immunotherapy effect on pollen-food
allergy syndrome to apple with in vitro passive sensitization
assay
Ramon Bencharitiwong, and Anna Nowak-Wegrzyn. Mount Sinai School of
Medicine, Allergy and Immunology, New York, United States.
Rationele: Polllen-apple allergy syndrome affects approximately 50% of birch
tree pollen-allergic adults. Allergy to apple results from cross-reactivity
between apple and birch pollen proteins. Subcutaneous immunotherapy with
birch pollen was reported to improve apple allergy in a subset of adult subjects.
Skin tests and serum allergen-specific IgE antibody levels correlate poorly
with clinical expression of apple allergy in birch-allergic individuals. Oral
food challenge to apple remains the most accurate diagnostic test, however,
standardized protocol is not easily available and the procedure is labour-
intense. We sought to determine whether RBL passive sensitization assay
might be used to evaluate effects of birch pollen immunotherapy in subjects
with pollen-food allergy syndrome to apple.
Methods: Birch-allergic individuals had apple allergy confirmed with double-
blind placebo-controlled oral food challenge and were randomized to birch
pollen immunotherapy arm or to control arm (no immunotherapy, continued
standard medical management). RBL-2H3 cells transfected with human Fc?
receptor were passively sensitized with sera from birch-allergic individuals
with oral allergy to apple at 1:40 dilution and following overnight incubation
were stimulated with serial dilutions (10-2-10-8) of in-house freshly prepared
raw Granny Smith apple extract. N-hexosaminidase content in the supernatant
was used as a marker of RBL degranulation and was expressed as a percentage
of total degranulation caused by Triton X.
Results: Eight subjects completed birch immunotherapy course. Median
baseline release was 2.6% (range; 1.2-19.5), not different from median post-
immunotherapy release 4.7% (range; 1.3-20.5), p=0.9. There was a trend for
decreased skin test responses to birch pollen extract (mean 13.1 mm pre-
versus 10.3 mm post-immunotherapy; p= 0.21) and fresh apple (mean 4.4 mm
pre-versus 3.3 mm post-immunotherapy; p=0.08). There was no significant
difference between pre-and post immunotherapy birch IgE and Bet v 1 -IgE
levels.
Conclusion: RBL cells passively sensitized with sera from birch- and apple-
allergic individuals undergo degranulation upon stimulation with fresh Granny
Smith apple extract. Mediator release to fresh apple extract is not different
before and after birch pollen subcutaneous immunotherapy. The performance
of the in vitro passive sensitization assay is affected by low concentration of
major apple allergens in the extract.
916
Development of the first multidisciplinary psycho-educational
intervention for parents and children with food allergy
Audrey DunnGalvin, and Jonathan Hourihane. University College Cork,
Paediatrics and Child Health, Cork, Ireland.
Aim: Development of an evidenced based intervention programme to help
children and parents to manage the biopsychosocial impact of food allergy on
their everyday lives.
Methods: 6 focus groups with parents of confirmed food allergic children and
10 focus groups with food allergic children aged 5-13 years. Qualitative
analysis using grounded theory was used to analyse transcripts.
Results: The transcripts gave rise to categories relating to risk perception,
illness cognitions, coping strategies, understanding of health and well-being,
meanings given to diet and food. Transcripts also revealed developmental,
parent/child, and sex differences vital to creating a targeted and food allergy
sensitive intervention. A psycho-education intervention was then developed
and is currently being validated with strong initial findings.
Conclusion: Middle childhood is a period when problems with anxiety, low
self-esteem, peer comparison, and malconstructive coping strategies emerge,
leading to higher risk in adolescence. Our data suggests that an intervention at
this critical point in the food allergy developmental perspective is vital to
ensuring successful biopsychosocial adjustment in day-to-day life.
917
A new questionnaire for food allergy
Federica Fumagalli1, Ilaria Baiardini1, Sara Pellegrini1, Micaela Bacic1, Paola
Minale2, Fulvio Braido1, Costantino Troise2, and Giorgio Walter Canonica1.
1University of Genoa, Allergy and Respiratory Diseases DIMI, Genoa, Italy;
2San Martino Hospital, Genoa, Allergy Unit, Genoa, Italy.
Despite clinical expertise suggest that food allergy has a substantial
burden on patients’ life, little data is now available on its impact and treatment
on quality of life.
The aim of our study is to evaluate patients? answers to the preliminary
version of a QoL questionnaire specifically addressed to food allergy. During
the development phase of the new tool, 32 items were administered to 27
patients (9 M, 18 F, mean age 40, SD˘ 7,2) suffering from food allergy. Patients
had to indicate, on a Likert scale with multiple options (1: not at all; 5: very
much), how much they were been troubled by each problem.
Results: A relevant percentage of patients reported a important burden in
many aspects of their life: Patients live in a state of alert: they are watchful to
new symptoms? appearance (21 out of 27) and to what they eat (18/27), they
are afraid to become sick when they eat something at risk (20/27) or a new
foods (15/27). Patients refer to feel uneasy when they go out for dinner (12/27)
and they are troubled because they have to read labels on every product (13/
27). Another relevant problem is the diet that, due to avoiding the food, could
be unbalanced (10/27). So food is a cause of concern for patients (14/27), and
they can’t enjoy food (10/27).
Conclusion: on the basis of our preliminary data, food allergy appears as a
problem that deeply interfere with patients life.
918
Sensitization to latex in patients with food allergy
Elena Gunter and Valeria Sveranovskaya. Mechnikov Research Institute for
Vaccines & Sera, RAMS, Moscow, Russian Federation.
The increased prevalence of latex allergy is associatedwith the increased
usage of the latex materials and with the cross reactivity to latex and food
allergens, due to the common determinants of the plants.
Goal: to reveal the cross sensitization to the latex allergen in the patients
with the food allergy using the test of allergic alteration of leucocytes
(TAAL).
Materials and Methods: 37 patients with the food allergy to fruit and 18
health care workers with glove-related skin symptoms (the itching, redness
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and dryness, sometimes an oedema, of the hand skin) were included in the
study. The diagnosis of latex allergy in the patients of the second group was
confirmed by the positive use test (in 10 from 10 ones), the negative results
of Contact Patch Test with rubber chemicals for type IV hypersensitivity
and by revealing of IgE antibodies to latex in 6 from 7 sera with ELISA
method. TAAL and skin testing with latex and fruit allergens (carrot, potato,
apple, tomato, kiwi, mango, melon, avocado, apricote, banana, perch -
BStallergenes[, France) were performed in all patients.
TAAL: 100 mkl of the each blood sample were incubated at 37oC during 30
min with 10 mkl of the standard solution of the ammoniated latex
(Stallergenes), then micropreparates were prepared, stained with acrydine
orange for luminescent microscopy and a percent of the alterated granulocytes
was counted. The result was considered to be positive if the number of the
alterated cells was more 10%. A sample of the same blood, incubated with
0.9% NaCl, was examined as a negative control.
Results: the positive results of TAAL and skin test with a battery of fruit
allergens were observed in the both groups of patients. In the latex allergy
patients the positive results of the TAAL and skin test with latex allergen were
observed in 77.8 and 83.3%, consequently. The positive results of the TAAL
with the same allergen were observed in 70.5% of patients with the food
allergy, and 76.4% of these patients had positive skin tests to the latex. The
high percentage of the sensitization to latex in the food allergy patients without
clinical symptoms to latex, established by two methods, may be the evidence
of the cross reactivity and the risk for development of latex allergy.
919
Latex recombinant hevein b IgE antibody in atopic children
sensitized to fruit, latex and pollen
Rumiko Shibata, Jyunko Ikei, Youko Murakami, and Sankei Nishima.
Fukuoka National Hospital, Pediatrics, Fukuoka, Japan.
Rationale: The associations of latex and fruit oral allergy syndrome (OAS)
with pollinosis have been reported in adult allergic patients. In childhood fruit
allergy, however, no significant data had been collected on clinical features and
frequency of cross-reacting IgE antibodies to latex. Latex antigen is clarified to
hevein b1 to 13, and primary allergen to be related to clinical manifestation has
been elucidated by IgE antibody determination for these recombinant hevein
(rHev) b proteins.
Objective: The aim of this study was to identify the specific IgE antibodies to
latex rHev b protein in fruit OAS children and latex allergy.
Methods: Twenty-six atopic children (aged 2-11 years, 5.6˘2.6 y.o.) with fruit
OAS sensitized to latex and 3 latex allergy children (3-8 y.o.) with having
operation history from early stage of age were enrolled in this study. Specific
IgE Antibodies to food, pollen, latex, rHev b 5, 6.01, 6.02, 8, 11 were
measured by CAP-FEIA (Phadia KK).
Results: The clinical manifestations of fruit OAS were due to banana (67%),
melon (63%) and kiwi (20%). With a fruit specific IgE antibody of 26 cases,
banana 80%, melon 78%, kiwi 54% were positive. All patients had IgE
antibodies to latex (0.6~31 UA/ml) and Japanese cedar pollen. In 6 fruit OAS
with clear latex elicitation history, latex IgE antibody levels were high and IgE
antibody to rHev b6.01 were positive in 3 cases and rHev b6.02 in 2 cases. In
14 of 20 cases without latex allergic provocative medical history, IgE antibody
to rHev b 8 (profiln) increased remarkably. Specific IgE to rHev b 5, 6.02 and
6.01 were clearly positive in 3 cases of latex allergy with operation history.
Conclusion: The results provide evidence that food allergy infants with fruit
OAS have the risk of early sensitization to latex and pollen. Measurement of
specific IgE to latex rHev b6.01 and 6.02 was useful as a prediction of latex
anaphylaxis in fruits OAS children with latex IgE antibody.
920
Turnip/oilseed rape and mustard allergy in Finnish and French
children with atopic dermatitis
Sanna Poikonen1, Fabienne Rance2, Tuija Puumalainen3, Gail Le Manach2,
Timo Palosuo3, Kristiina Turjanmaa1, and Timo Reunala1. 1Tampere
University Hospital, Department of Dermatology, Tampere, Finland; 2Hopital
des Enfants, Allergologie-Pneumologie, Toulouse, France;
3
National Public
Health Institute, Laboratory of Immunobiology, Helsinki, Finland.
Background: Finnish children with atopic dermatitis (AD) are frequently
sensitized to turnip/oilseed rape and French children to mustard. These plants
belong to the same Brassicaceae family and their seeds contain homologous
2S albumin allergens. We examined the relationship between the oilseed plant
and mustard allergy in the two patient populations.
Methods: 14 Finnish and 14 French AD children (mean ages 3.8 and 4.7
years) with positive skin prick test (SPT) to turnip rape were challenged with
seeds of turnip rape and mustard. IgE antibodies were measured by
ImmunoCAP and ELISA, and cross-reactivity examined by ELISA inhibition.
28 age- and sex-matched children with negative SPT to turnip/oilseed rape
served as controls.
Results: Labial or oral challenge to turnip rape was positive in all (100%)
Finnish and five (36%) French children. Mustard challenge was positive in five
Finnish and five French children. IgE antibodies to oilseed rape and mustard
were frequent (71% - 100%) in the Finnish and French children but uncommon
(4%) in the controls. IgE levels to 2S albumins were increased in most Finnish
and French children, and IgE inhibition experiments showed similar cross-
wise inhibition patterns.
Conclusion: The present results in children from Finland and France show
that turnip/oilseed rape, mustard or both are potential sensitizing allergens due
to highly cross-reactive 2S albumins. Vegetable oils made from the seeds of
oilseed/turnip rape are, in contrast to mustard, often added to foods but
whether these contain the 2 S albumin allergens are at present not known.
921
Nationwide survey of immediate type food allergy in Japan
Takanori Imai1, Chizuko Sugizaki2, and Motohiro Ebisawa2. 1Sagamihara
National Hospital, Department of Pediatrics, sagamihara-city,Kanagawa,
Japan; 2Sagamihara National Hospital,Clinical Research Center, Depart-
ment of Allergy, Sagamihara-city,Kanagawa, Japan.
Objective: The food labeling system for food allergens was introduced from
April 2002 in Japan. To confirm the effectiveness of the system, we regularly
conduct a nationwide food allergy survey every three years.
Methods: The survey was conducted in cooperation with 1190 volunteer
allergists in Japan form January to December in 2005. We sent questionnaire to
contributing doctors every three months based on the past survey system, and
contributing doctors were asked to report immediate type food allergy cases
seen by those doctors. In this survey, immediate type food allergy was defined
as the patients who had developed symptoms due to food allergic reaction
within 60 minutes after intake of offending food. The details of questionnaire
consisted of age, sex, cause of food allergy, symptoms, IgE CAPRAST, and
type of onset.
Results: A total of 2283 immediate type food allergy cases were reported by
the doctors. The most common offending foods were hen’s egg (39.5%), milk
products (18.1%), wheat (8.7%), salmon roe (4.5%), peanuts (4.2%), shrimp
(3.2%), buckwheat (3.2%), kiwi fruit (1.8%), soy bean (1.7%) and crab
(1.4%). The most common clinical symptom was observed on skin (91.2%)
followed by respiratory system (31.3%). Interestingly, the causes of food
allergy were completely different from infancy (egg, milk, and wheat) to
adulthood (crustacean, wheat and fruits). Anaphylactic shock was observed in
10.1% of the total reported cases. The cases of anaphylactic shock were due to
hen’s egg (26.1%), milk products (20.0%), wheat (18.7%), peanuts (6.1%),
buckwheat (3.5%) and shrimp (3.5%). Ten percentages of patients had been
hospitalized and 38.9% of the patients had developed food allergic symptoms
by accidental intake of offending foods.
Conclusion: We revealed the current condition of the immediate type food
allergy cases seen in Japan in 2005. Based on these data, countermeasures
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against food allergy are on going in collaboration with the Ministry of Health,
Labour, andWelfare in Japan in order to improve quality of life of patients with
food allergy.
922
Investigation of peanut processing and its effect on allergenecity
in Asian and North American populations
Elisabeth Berger, Birgitta Backhans, Ha˚kan Larsson, Maryam Poorafshar, and
Ingrid Holmquist. Phadia, R&D, Uppsala, Sweden.
Aim: Peanuts are cultivated over almost the whole world. Despite the
widespread consumption of peanut products, the prevalence of peanut allergy
is varying between different areas. Peanut is, prior to consumption, subjected
to different kind of processing in different parts of the world. In this study the
effect of different treatments, on a variety of peanut cultivated in North and
South America, trying to mimic different eating habits was investigated.
Finally the IgE-binding patterns to untreated and roasted peanuts were studied
in two different populations from US and Asia.
Methods: Peanut source materials, Jumbo Runner, from US and Argentina
were used. The peanuts were treated in three different ways; heated (90C, 20
min), boiled (20 min), or roasted (180C, 20 min) followed by grinding and
extraction. Untreated peanut was used as control. The proteins were separated
on both conventional SDS PAGE and 2D gel electrophoresis. Some spots from
the 2D electrophoresis gel were excised and analyzed by MALDI-TOF MS.
Immunoblotting analyzes were performed with sera from US and Asia from
individuals with peanut sensitization.
Results: Differences in protein patterns between the two source materials were
detected on SDS-PAGE electrophoresis. One prominent protein band of
approx 40 kD, in material from US was missing in the peanuts from Argentina.
As expected a decrease in protein amount dependent on treatment and
temperature was detected. Distinct spots in 2D electrophoresis at approx 60 kD
from untreated materials, were not visible after roasting. These spots were
identified as major peanut allergen Ara h 1 by MALDI-TOF MS. No obvious
differences in IgE-binding in Immunoblotting between the two populations
could be observed. For both populations there was a decrease in IgE-binding to
roasted compared to untreated peanuts, especially at approx 60 kD (Ara h 1)
and at 30-40 kD. Other differences in IgE-binding patterns were due to
individual differences.
Conclusion: Peanuts cultivated in different parts of the world may contain
different proteins and allergens. Different treatment and cooking habits can
influence the allergenicity. In this study no obvious differences in IgE-binding
patterns between the two populations were observed even though the
populations were chosen to reflect the different eating habits of peanuts. The
clinical relevance of the missing protein in peanut source materials from
Argentina need to be further investigated.
923
The outcome of food allergy among infants and children in Israel
Darit Aronov, Eli Somekh, and Ilan Dalal. E. Wolfson Medical Center,
Pediatrics Allergy Unit, Department of Pediatrics, Holon, Israel.
Background: Food allergy is common among infants and children. Milk, eggs
and soy allergy tends to resolve early in life while allergy to peanuts, tree nuts
and fish usually stay for life. The knowledge about the natural history of
sesame allergy is scarce. We did a survey among the children that were treated
in the allergy clinic in E. Wolfson medical center.
Methods: The survey was done based on the clinical records of children that
were diagnosed with food allergy. A phone survey and a detailed questioner
were filled. The emphasis was on the outcome of the child’s food allergy.
Results: We found 234 children that were suspected to have food allergy. 54
(23%) of them were found not to have food allergy. The 180 (77%) patients
with food allergy were found to be allergic to several foods: Milk-125, eggs-
71, sesame-30, soy-23, peanuts-14, tree nuts-9, fish-3, beef and chicken-2,
other foods-6. The children were followed up for an average period of 4.7
years. In 139 cases the allergy had resolved, in 93 it was still existing, and in 51
cases it was not clear whether the allergy had been resolved or not.
Among those with milk allergy, 86/125 (69%) were IgE-mediated
(group I) and 39/125 (31%) were non IgE-mediated (group II). In group I there
was clearly a more atopic background then in group II (P=0.0032). The allergy
had been resolved in 35/39 (90%) among group II patients, as compared to
only 32/86 (37%) in group I (PG0.0001).
Allergy to soy was found in 23 children, 21 of them were also allergic
to milk and only 2 were allergic just to soy. The number of children with soy
allergy among group II patients was higher than in group I. In 19/23 (83%) the
allergy resolved. 30 children had allergy to sesame. In third of them the allergy
presented as anaphylaxis. Most of the children with sesame allergy were found
to have atopic background. 5 of them have a first degree relative with sesame
allergy. In 9/30 (30%) the allergy had resolved in an average of 2.8 years.
Conclusion: The distribution of food allergens in Israel differs from other
countries. We found that the atopic status and the outcome of IgE-mediated
milk allergy.is significantly different compared to non IgE-mediated patients.
This survey may help to understand many aspects of food allergy among
children in Israel, and may help us provide appropriate guidance for the
children and their families.
924
Personal experiences of teenagers with food-hypersensitivity
Heather Mackenzie1, Darren Van Laar2, Graham Roberts3, and Taraneh
Dean4. 1University of Portsmouth, School of Health Sciences and Social
Work, Portsmouth, United Kingdom; 2University of Portsmouth, Department
of Psychology, Portsmouth, United Kingdom; 3Southampton University
Hospital Trust, Paediatric Allergy and Respiratory Medicine, Southampton,
United Kingdom; 4University of Portsmouth, School of Health Sciences and
Social Work, Portsmouth, United Kingdom.
Background: Teenagers are a high-risk group for food-hypersensitivity (FHS)
fatalities and engage in risk-taking in managing their condition. Existing
research has identified anxiety and impaired quality of life in children with
FHS and their parents. To date, however, research has not addressed what the
experience of living with FHS is like for teenagers. This study therefore aimed
to describe the lived experiences of teenagers with FHS.
Methods: Individual semi-structured in-depth interviews were conducted with
21 UK teenagers (aged 13-18 years) with a pre-existing diagnosis of FHS.
Participants were hypersensitive to a range of foods and experienced a variety
of reactions. Participants were excluded if they had a concomitant non-allergic
disease. Interviews explored the lives of the teenagers generally with particular
attention paid to the experience of living with FHS. Interviews were audio-
taped, transcribed verbatim and were then analysed using a phenomenological
approach.
Results: Four main themes were identified: FHS as a way of life, managing
FHS as an assessment of acceptable risk versus acceptable burden, living with
FHS as coping with necessary burden, and alleviation/exacerbation of the
burden of living with FHS. For participants the process of managing FHS was
not described as problematic but as a way of life. Managing FHS was described
as negotiable rather than prescriptive and was based on an assessment of
acceptable risk versus acceptable burden. Negotiating management did not
however completely relieve the burden felt and participants felt that a
necessary part of living with FHS was coping with necessary burden and a
variety of coping strategies were employed to this effect. Participants also
described ways in which the burden of living with FHS is alleviated or
exacerbated both by them personally and by others whose behaviour affects
their life with FHS.
Conclusion: The themes provide some explanations for why teenagers with
FHS engage in risky behaviours and describe how teenagers cope with
World Allergy Organization Journal & November 2007 Abstracts
* 2007 World Allergy Organization S295
Copyright @ 2007 World Allergy Organization. Unauthorized reproduction of this article is prohibited.
managing FHS and what factors make living with FHS easier or more difficult.
The themes indicate ways in which the lives of teenagers with FHS can be
improved and therefore provide new information about living with FHS from
the perspective of teenagers that will be of use to healthcare practitioners
working with teenagers with FHS.
925
Cow milk allergy fo associated to rhinitis atopic
Maria Alul. CIPEA: Centro de Inmunologia pediatrica, asmay alergia,
Alergia pediatrica, San Miguel de Tucuman, Argentina.
Background: The Allergy to the cow milk (CM)is one of the causes of
manifestations allergic but common in the childhood. It has an excellent one I
foretell since most of the cases they are solved from the 4 years of age. The
associated clinical disorders to the allergy to cow milk in these children
include atœpics conditions such as atœpics dermatitis, allergic rhinitis, asthma
and other manifestations corresponding to foods allergies.
Objective: To determine the association of allergy to cow milk and persistent
allergic rhinitis in smaller children of 4 years. Material and Method: 5 smaller
children of 4 years with diagnosis of allergic rhinitis and allergy to cow milk
through Clinical History evaluated themselves. They were made Prick Test
with cow milk standardized protein extracts (Casein, A-lactoglobulin and B-
lactoglobulin); Concentrated of Histamina 1mg/ml considering as positive
control the one presence papula of 5 mm, and saline solution as negative
control without presence of pa´pula. One quantified Ig and EspecU´fic to cow
milk in International Units mililiter by means of enzimoinmunoensayo. To the
clinical aims, the specific concentrations of IgE were evaluated according to
the following data: 5 UI/ml:nonsignificant ;0.51 - 1.0 Ul/ml:Low;1,1 - 5.0 Ul/
ml: Moderate ;5,1 - 25.0 Ul/ml:High;25,1 - 75.0 Ul/ml: Very elevated;9 75.0
Ul/ml:Highest.
Results: Of the 5 studied children, the totality I present/display direct atopicos
familiar antecedents; and manifestation of rhinitic symptoms from the
incorporation of the cow milk like dietario supplement (Three children from
birth and two as of the 2 months of life). Were levels of moderate specific IgE
in 3 of the 5 studied children (two with supplement of CM from birth and one
as of both months of life) presenting/displaying these prick positive for alpha
and beta lactoglobulin and negative test for casein; with serum of IgE a
superior to 100 UI/m. In other two patients of the five were levels of specific
IgE to nonsignificant CM with low serum values of IgE to 50 UI/ml and
negative prick test for cow milk proteins.
Conclusion: According to these results it is possible to be determined that the
cow milk is present in the allergic rinitis of smaller children to the four years of
age, and that his replacement could improve the clinical sintomatology of the
patients with medication saving for such.
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Prevalence of peanut and tree-nut allergy in Singapore teenagers -
estimates from a questionnaire survey, allergy testing and food
challenges
Irvin Francis Gerez1, Shu E Soh2, Jian Yi Soh2, Pao Zhing Ng2, Elizabeth
Morales1, Stefan Ma3, Bee Wah Lee2, and Pei Chi Lynette Shek2. 1National
University Hospital, Paediatrics, Singapore, Singapore; 2National University
of Singapore, Paediatrics, Singapore, Singapore; 3Ministry of Health,
Statistics, Singapore, Singapore.
Introduction: Peanut and tree nut allergy can potentially be life threatening.
Hence, awareness of its prevalence in the population would allow physicians to
better address the issues of diagnosis, management and education.
Objective: To estimate the true prevalence of peanut and tree-nut allergy in
Singaporean teenagers.
Methods: The prevalence of food allergy in 14 to 15 year old Singaporean
children was evaluated using a standardized questionnaire which was
distributed to students of randomly selected schools. Students who
responded positively to these food allergies were administered an extended
questionnaire to determine presence of convincing food allergy. A portion
of those with convincing allergy symptoms were recalled for skin prick
testing (SPT) as well as underwent a graded food challenge for those who
consented.
Results: From a cohort of 8072 students, 6765 (83.78%) responded. The
crude prevalence of self-reported allergy to peanuts was 0.90% and tree-
nuts 0.63%. However, using the criteria for convincing food allergy, the
prevalence fell to 0.33% for peanuts and 0.20% for tree-nuts. A proportion
of subjects with convincing allergy symptoms agreed to skin prick testing,
which showed low frequency of skin test positivity peanut 4.17% (1/24)
and tree-nuts 13.3% (2/15). Finally, all food challenges (5 for peanuts and
2 for tree-nuts) carried out on 7 subjects with either a convincing history
plus negative SPT or convincing history plus positive SPT, resulted in a
negative outcome.
Conclusion: Our results indicate that the prevalence of peanut and tree-nut
allergy in Singapore adolescents is low. Evaluation based on questionnaire
survey alone overestimated the prevalence of peanut and tree-nut allergy in our
population.
927
IgE-mediated food allergies in Swiss infants and children
Giovanni Ferrari, and Peter A Eng. Kantonspital Aarau AG, Children’s clinic,
Aarau, Switzerland.
Background: IgE-mediated food allergy is the most common type of
adverse reaction to food in infants and young children. It presents with a
wide spectrum of clinical reactions including life-threatening allergic
symptoms. The study has been performed to determine the most prevalent
food allergens inducing immediate clinical reactions in different age groups
of Swiss infants and children. Furthermore we investigated if there are
specific patterns of allergic reactions to individual food allergens.
Methods: Prospective analysis of patients referred from 2004-2006 for
assessment of immediate type allergic reaction to food. The study has
been carried out at the Food Allergy Clinic of the Children’s Hospitals
Aarau and Lucerne. Individuals presenting with atopic dermatitis and
evidence of delayed reaction to food were not included. Diagnosis of food
allergy was based on clinical history, skin Prick tests (with commercial
extracts), Prick-to-Prick testing using native food and determination of
specific IgE antibodies to food proteins by CAP-FEIA system. Food
challenges were performed in patients without history of life-threatening
anaphylaxis when the causative antigen could not be conclusively
determined.
Results: 278 food allergies were identified in 151 children (67% male,
33% female) with a median age of 1.9 years (range 3 months - 15 years).
Overall, the most prevalent food allergen is hen’s egg (23.7%), followed
by cow’s milk (20.1%), peanut (14.0%), hazelnut (10.4%), wheat (6.1%),
fish (4.3%), kiwi and soy (2.2% each). In infancy, the most common food
allergens are cow’s milk, hen’s egg and wheat. In the second and third
year of life, hen’s egg, cow’s milk and peanut are predominant whereas
above the age of 3 years, peanut, hen’s egg and fish are the most
prevalent. Urticaria is the most frequent reaction to food allergens.
However, beyond urticaria, there are different patterns of clinical reactions
to individual food. Cow’s milk and hen’s egg allergies are mainly presented
with gastrointestinal symptoms. Peanut and hazelnut with angioedema. Fish
with both angioedema and anaphylaxis and wheat with both angioedema
and asthma.
Conclusion: 8 allergens account for 83% of IgE-mediated food allergies in
Swiss infants and children. In each age group there is a specific order of most
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prevalent offending food proteins. Furthermore, there is a specific spectrum of
allergic symptoms to individual food allergens.
928
Immediate hypersensitivity to common food allergensYAn
investigation on respiratory allergic patients in Kolkata
(Calcutta), India
Mahasweta Das1, Jyotshna Mandal2, Indrani Roy3, Soma Chatterjee3, Nimai
Chandra Barui4, and Swati Gupta-Bhattacharya2. 1Surendra Nath College,
24/2 Mahatma Gandhi Road, Calcutta, India; 2Bose Institute, Botany,
Calcutta, India; 3Institute of Child Health, Allergy, Calcutta, India;
4Surendra Nath College, Botany, Calcutta, India.
Food allergy may be defined as an IgE-mediated immune response
to food proteins. Such studies have not been done systematically from
Calcutta, India. The present study was therefore undertaken to record the
sensitivity to commonly consumed food in patients of allergic rhinitis and
asthma. Affected individuals belonging to the age group of 5-60 years
were evaluated using a standard questionnaire and skin prick test results
(SPT). A survey of 800 patients (410 males & 390 females) reporting to
the Allergy Unit of the Institute of Child Health, Kolkata were selected for
the study, conducted from May, 2006 to April, 2007. Out of them 684
patients (85.5%) with a history of food allergy, most of them (49.41%) are
in 16-40 years, followed by 41-60 years (28.07%). 22.51% belonged to the
age group of 5-16 years. Most of the patients with food allergy suffered
with asthma (65.05 %), rhinitis and asthma (20.03 %) and skin allergies
(4.97%) such as itching, eczema and urticaria. The foodstuffs that were
found to elicit symptoms of hypersensitivity were egg, milk, wheat, pulses,
vegetables, fishes and fruits. The patients between 17-40 years (Male:
Female-1:1.19) were sensitive to prawn (61.5%), brinjal (43.42%), banana
(40.57%), lady’s finger (35.6%), papaya (33.34%), wheat (33.3%), egg
(31%), cauliflower (26.3%), spinach (23.8%), beef (20.6%) milk (18.42%),
lentil-Phaseolus mungo (11.76%), Lens culinaris (11.26%) and cabbage
(11.53%). The age group of 41-60 years (Male: Female- 1:1.04) had skin
reactivity to brinjal (55%), egg (41.6%), banana (40.54%) fish (38%),
Phaseolus mungo (33.33%), cabbage (28.5%), wheat (23.63%), beef
(22.2%) Lens culinaris (21.8%), milk (20.75%), spinach (20%) and tomato
(17.95%) Patients below the age of 16 years (Male: Female- 1:1.33) were
sensitized to brinjal (45.16%), prawn (44.4%), banana (40.67), spinach
(39.1%), egg (37.3%), papaya (28.95%), lady’s finger (28.8%), cauliflower
(25%), milk (25%), wheat (21.73%), Lens culinaris (18.75%), Phaseolus
mungo (18.1%), and cabbage (13.6%). Although the percentage of allergy
to beef is quite high, it is restricted only among the Muslim and Christian
communities of Kolkata. Thus, we see food hypersensitivity reflects
different genetic factors, variations in cultural and dietary habit of each
individual.
929
Sensitization to nut allergens in Zimbabweans
Sithando Ncube1, Elopy N Sibanda2, Sithando Ncube1, and Elopy N
Sibanda2. 1Twin palms, GammaCity laboratory, Harare, Zimbabwe;
2University of Zimbabwe College of Health Sciences, Immunology, Harare,
Zimbabwe.
Background: Peanuts, Arachis hypogea, are the prominent sources of
Immunoglobulin E (IgE) mediated allergic reactions to food items. They are
highly recognised for their nutritional value of proteins and oils. The major
allergens are Ara h 1 and Ara h 2 , which result in allergenic manifestations
such as eczema, urticaria, angiodema, asthma and sometimes fatal
anaphylactic reactions.
Objective: The aim of the pilot study was to establish whether Zimbabweans
had nut allergy in general and peanut allergy in particular as well as to identify
clinical entities associated with sensitization.
Methods: Patients for the study were selected upon review of sensitization to
peanut allergens. Sensitization was diagosed using the Skin Prick Test (SPT)
and the serological evidence of allergen specific IgE antibodies with the
Euroimmune assay. Most patients who came to the allergy clinic had eczema,
dermatitis and urticaria.
Results: 63 patients had nut allergies, peanut and hazelnut.16 patients reacted
to peanut only with 6 children of 2-8 years and 10 adults of 21-72 years of
age.22 patients reacted to hazelnut only, with 4 children of 1-7 years and 18
adults of 18-58 years. Cross-reactivity of peanut and hazelnut was noted in 25
patients with 10 children of 3-13 years and 15 adults of 17-68 years of age.
Conclusion: Allergen specific antibodies to peanut, hazelnut ,or both
peanuts and hazelnuts were demonstrated. We observed overlap in reactivity
of biologically different nuts one being a groundnut (peanut, Arachis
hypogea) and the other one being a tree nut (hazelnut ,Coryllus avellana) in
40% of the patients, hence our interest in further investigations to establish
whether it was cross-reactivity or that it was a mere co-sensitization between
the two nuts.
930
Peculiarities of a food sensitization of children with atopic
dermatitis in Ukraine
Viktoriia Klymenko. Kharkiv State Medical University, Propedeutic Pediatria
Department N2, Kharkiv, Ukraine.
Background: A food allergy affects the considerable quantity of children
because of their gastrointestinal tract immaturity and low immunologic
tolerance. According to the recent data of investigations from 1/3 to 1/2
children with an atopic dermatitis have a food sensitization. But the food
sensitization is different in different countries because of the national food
tradition and genetic factors. For example, there are not allergy reactions for
peanuts and shellfishes in Ukraine but they are characteristic for American
countries. From other hand, some food has changed its allergic properties. For
example, all over the world it is marked increasing allergy to soy.
Objective: To find out peculiarities of a food sensitization for early aged and
late school aged children with atopic dermatitis in Ukraine.
Methods: Sixty seven patients with atopic dermatitis were observed. The
patients were divided into two groups: the first one (28 patients) aged
from 3 month to 3 year and the second one (39 children) aged 12-18
year. The food sensitization was determined by the enzyme immunoassay
method for the measurements of the level of allergen specific human IgE-
antibodies in the blood for the first group and by a skin prick testing for
the second group.
Results: The food sensitization was revealed in 92,9% and 71,8% patients of
the first and the second group accordingly, including the high and very high
reactions for 92,9% and 21,4%, monoallergy for 7,1% and 5,1% children
accordingly. The high and very high levels of specific IgE were detected for
antigens of a corn (42,3 %), a chicken egg protein (39,3 %), a fish (30,8 %), a
rye (28,6 %), a chicken egg (26,9 %), oats (25 %), a cow’s milk (23,1 %), a
chicken egg yolk (21,4 %), rice (21,4 %), a tangerine (21,4 %), a lemon (21,4
%), and an orange (21,4 %) in children of the early age. The food tolerances for
a corn, a rye, a cow’s milk, oats, rice, a chicken egg protein, a tangerine are
formed to late childhood. Certain types of food are more likely than others to
be allergen for children of late school period: a chocolate (70 %), a tomato
(26,3 %), a pear (23,3 %), a carrot (20,6 %), a potato (20,5 %). Nobody
from 24 examined patients has sensitization to peanuts.
Conclusion: The established peculiarities of a food sensitization should be
taken into account at initial preventive maintenance of atopi, and also they
should be used for prescription of the empirical hypoallergic diet in Ukraine
and the East Europe.
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Sensitization to parvalbumin and collagen in 6 Japanese patients
with fish allergy
Michiko Hirokado1, Naoko Inomata1, Jyunko Yamaguti1, Katsura Yasujima1,
Mio Kirino1, Megumi Kondo2, Kuniyoshi Shimakura3, Kazuo Shiomi3, and
Zenro Ikezawa1. 1Yokohama City University School of Medicine, Depertment
of Enviromental Immuno-Dermatorogy, Yokohama, Japan; 2Kndo clinic,
dermatorogy, Yokohama, Japan; 3Tokyo University of Marine Science and
Technology, Depertment of Food Science and Technology, Shinagawa, Japan.
Background: Fish has been reported to be one of the most important
allergenic foods causing severe allergic reactions. Furthermore, parvalbumin,
a small calcium-binding protein, and collagen have been identified as
important cross-reactive allergens in fish.
Objective: To clarify the clinical and laboratory features of allergy to fish and
to detect the cross-reactive allergens by ELISA in Japanese patients.
Methods: Six patients with suspected hypersensitivity to fish were subjected
to skin prick tests and measurement of specific IgE antibody to fish.
Additionally, specific IgE against purified parvalbumin and collagen were
investigated by ELISA.
Results: The patients’(1 male, 5 females) age ranged from 8 months to 22
years. All of them also had other atopic diseases, such as atopic dermatitis,
bronchial asthma and pollinosis. The diagnosis based on symptoms after fish
ingestion and results of skin prick tests, was anaphylaxis and oral allergy
syndrome (OAS) accompanied with symptoms other than oropharyngeal
symptoms in 2 and 4 patients, respectively. The causative foods were saury,
yellowtail, and flatfish in 3 patients; and horse mackerel, mackerel, tuna,
salmon, Atka mackerel and flatfish in 2 patients. The SPT was positive for
more than three kinds of fish in all patients. The immuno CAP-RAST test
showed that 5 of 6 patients were positive for cod; 3 for flatfish; 4, for horse
mackerel; 5, for salmon; 4, mackerel. Furthermore, specific IgE against the
purified parvalbumin and collagen was detected in 4 patients each.
Discussion: The results indicated that our patients with fish allergy tended to
develop severe symptoms after ingestion of different kinds of fish due to
sensitization to cross-reactive allergens.
932
Induction of oral tolerance by breastfeeding
Hiroshi Narita1, Kumiko Kidu1, Tsutomu Honjoh2, Akihiro Kimura3, and
Junko Hirose4. 1Kyoto Women’s University, Food and Nutrition, Kyoto,
Japan; 2Morinaga Institute for Biological Science, Research and Develop-
ment, Yokohama, Japan; 3Itayado Clinic, Allergy, Kobe, Japan; 4The
University of Shiga Prefecture, Department of Life Style Studies, Hikone,
Japan.
Background: We found that significant amounts of food proteins were
secreted into human and rat breast milk as immune complexes with sIgAs. To
clarify a physiological consequence of this phenomenon, animal experiments
have been carried out in view of allergy prevention.
Results: SD rats were divided into two groups, one group (E-group) fed
only egg white proteins and the other (M-group) fed only cow’s milk
proteins as a dietary protein source. When infant rats fed their own mother’s
milk were immunized with egg white proteins by using Freund’s complete
adjuvant, serum concentration of anti-ovomuciod IgG was lower in E-
infants than in M-infants. When infant rats were immunized with cow’s milk
proteins in turn, serum concentration of anti-casein IgG was lower in M-
infants than in E-infants. Thus, the immune tolerance against food proteins
was acquired via breastfeeding from mothers fed the food containing the
relevant proteins. The acquired tolerance against ovomucoid diminished
spontaneously after weaning while the infants did not feed egg white
proteins. Similar immune tolerance via breastfeeding were also observed in
BALB/c mice.
Conclusion: We propose the hypothesis that breastfeeding, probably through
the immune complexes of food proteins and sIgAs, serves as the natural
drinkable vaccine against food allergy.
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Oral desensitisation in children with immunoglobulin e-mediated
hen’s egg allergy
Paolo Meglio1, Paolo Gianni Giampietro1, Simona Gianni1, Nadia GM
Mora1, Paola Palazzo2, Enrico Scala2, Adriano Mari2, and Elena Galli1.
1S.Pietro Hospital- Fatebenefratelli, Research Center, Roma, Italy; 2IDI-
IRCCS, Center Clinical Experimental Allergology, Roma, Italy.
Background: Basic treatment for food allergy has been to avoid the offending
item, to date. This approach is difficult in the case of common foods, and
where there is a risk of severe reaction, due to child’s and child’s family
concern of consuming the offending food, even inadvertently. In this study
preliminary data regarding 3 children allergic to hen’s egg (HE) orally
desensitised with increasing doses of this food, are shown.
Objective: To desensitise children with severe IgE-mediated HE allergy in a
period of 6 months by introducing increasing daily doses of HE in order to
enable the child to assume 25 ml of HE daily (corresponding to 3.2 protein
grams), or to induce tolerance of the highest possible HE dose.
Study Design: These are preliminary data of a larger study concerning
children at least 6 years old with severe IgE-mediated HE allergy. A positive
DBPCFC with HE confirmed the diagnosis. Oral desensitisation was done
with increasing doses starting from 0.06 mg of HE proteins. Specific IgE to HE
were evaluated through allergenic molecule-based approach with a proteomic
technology (VBC Genomics microArray).
Results: The 3 children achieved the daily intake of 25 ml of HE during a 7
month mean period. During this period a reduction of IgE values (kUA/L) for
Gal d 1 (Ovomucoid) was observed in all cases (in one case with negative
result after desensitization). No significative differences were seen comparing
the result for Gal d 2 (Ovalbumin), Gal d 3 (Conalbumin) and Gal d 4
(Lysozim)(see table).
Conclusion: We successfully desensitised 3/3 children with IgE-mediated HE
allergy in a mean period of 7 months. Moreover, we dramatically reduced the
risk of severe reactions after accidental or unnoticed introduction of low
quantities of HE. We observed a parallel reduction of specific HE IgE against
Gal d 1. We do not propose generalizing this method beyond trained staff.
934
Systemic anaphylaxis induced by lupin ingestion: two case
reports
Enrico Compalati, Laura Guerra, Anthi Rogkakou, Pierangela Massacane,
Antonio Scordamaglia, and Giorgio Walter Canonica. University of Genoa,
Allergy and Respiratory Diseases, Genoa, Italy.
Background: IgE-mediated food allergy is an important cause of anaphylaxis,
approximately 6% of young children and 3.7% of adults have a food allergy.
The most frequent finding in food allergic patients are: peanuts, tree nuts, milk,
egg, crustaceans and fish.
TABLE 1.
Child 1 Child 2 Child 3
Start End Start End Start End
Gal d1 (Ovomucoid) 0,34 0 5,81 2,51 2,89 1,45
Gal d2 (Ovalbumin) 0,3 0,31 0,92 0,9 0,77 0,45
Gal d3 (Conalbumin) 0 0 0 0 0 0
Gal d4 (Lysozim) 0 0 0,4 0,39 0 0
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Case Reports: We report the cases of two young women referred to our
department from emergency room for food induced anaphylaxis. The first
case occurred in a 42 year-old woman after few minutes from eating lupins,
with the development of cyanosis, inspiratory dyspnoea and sudden lack of
consciousness. She was immediately treated with epinephrine and systemic
steroids with remission of symptoms. The second case occurred to a 30
year-old woman showing anxiety, general itching, urticaria, vomit, facial
angioedema, hypotension and syncope after ten minutes from assumption of
gluten free cookies (patient was not celiac). The sudden administration of
systemic steroids and antihistamines induced patient’s recovery. Both
patients underwent prick test for inhalant allergens showing positivity
only in the second patient for dermatophagoides, birch, parietaria and grass
pollens. No positivity was observed for common food allergens mentioned
above. The two patients showed marked positivity to the prick-prick test
with lupin. A deep analysis of cookies-label showed the presence of lupin
flour. Previous reports described the sensitivity to lupin most of all in
patients with professional exposition to this legume flour. In our case
reports no specific risk factors to lupin allergy nor particular predisposition
to food allergens sensitisation were evident.
Discussion: Lupin products are gradually being introduced into more and
more foods including beverages, bread, biscuits and pasta as an additive to
wheat flour substitutive of soy flour often present in food for people affected by
celiac disease. In this contest allergy to lupin may be considered as an
emerging condition, related to the hidden presence of this allergen or
contamination, potentially dangerous for celiac patients.
935
A case of food protein-induced enteropathy with a polypoid
lesion
Kazuyo Kuzume1, Yuko Tezuka1, Munemitsu Koizumi1, Aya Chisaka2,
Hidehiro Murakami3, and Eiichi Ishii1. 1Ehime University School of
Medicine, Pediatrics, Toon, Ehime, Japan; 2Matsuyama Shimin Hospital,
Pediatrics, Matsuyama Ehime, Japan; 3Ehime University School of Medicine,
Medicine, Toon, Ehime, Japan.
Food protein-induced enteropathy (FPIE) is a cell-mediated
hypersensitivity disorder commonly seen in the first several months of
life, presenting with diarrhea and failure to thrive caused by ingestion of a
certain food. A case of FPIE with a polypoid lesion has not been reported
yet. We examined a case of FPIE by allergy-related blood and skin tests
and endoscopy.
A two month old Japanese female patient showed repeated blood
streaks in her stool. She was exclusively breast-fed and did not show any
other symptoms. Food protein-induced proctocolitis was considered and the
symptom was resolved temporarily by eliminating cow’s milk from her
mother’s diet. However, she developed diarrhea at 3 months of age and
began failing to thrive. At 4 months of age, gross bleeding in the stool was
observed 16 hours after her mother ate cake and breast-fed. The stimulation
index (SI) of the lymphocyte stimulation test (LST) for cow’s milk was
extremely high (783 %) and her mother stopped all dairy product intake.
The patient experienced gross bleeding in her stool 24 hours after eating
tofu at 6 months old. Her body weight did not increase for two months. The
SI of the LST for soy beans was also high at 407%. She showed positive
results in patch tests for cow’s milk, soy beans, wheat and pacific cod, but
did not show any positive results in skin prick tests. Also, antigen specific
serum IgE levels did not rise. Fecal examinations were repeated but
eosinophils and neutrophils were not found and microbiological results were
all negative.
For further investigation, we performed a colon endoscopy under
general anesthesia. Lymphoid nodules and mucosal edema were found in
the colon. A 7 mm polypoid lesion was found on the ileocecal valve and
juvenile polyposis was considered. However, the biopsy specimens showed
non-specific inflammation with massive lymphocyte infiltration and did
not indicate a solid tumor. Food protein-induced enteropathy was diagnosed.
She stopped breast-feeding and started to take highly hydrated cow’s milk
(MA-1, Morinaga Japan) and rice and vegetables as solid foods. She has not
shown gross bloody stool since, and her body weight has increased
dramatically. The endoscopic findings improved after 2 months of dietary
treatment.
In infants with intestinal bleeding and failure to thrive, the influence of
food allergies should be considered and the LST, patch test and an endoscopic
examination should be performed.
936
The investigation of cases which performed provocation test on
Food-dependent exercise induced anaphylaxis for the last 8 years
Junko Ikei, Yoko Murakami, Rumiko Shibata, and Sankei Nishima. Fukuoka
National Hospital, Pediatrics, Fukuoka City, Japan.
Background: Food-dependent exercise induced anaphylaxis (FDEIAn) is a
severe systemic syndrome induced by physical exercise after food ingestion. In
recent years there has been an increasing number of reports of FDEIAn, but the
actual situation is not known well.
Objective: To investigate the symptom of FDEIAn and grasp the actual
situation of provocation test we investigated about 19 cases that was doubted
FDEIAn, and were admitted for the purpose of detailed examination for the
last eight years.
Methods: Nineteen children (16 boys and 3 girls) 19 cases were enrolled in
this study. Age at onset was from 8 to 16 years old (average age 11 years old).
IgE was measured by CAP-FEIA (Pharmacia) and skin prick test was
examined in need. Provocation test by combination of food and exercise test
was performed for 18 patients and 4 of them with preadministration of aspirin.
Results: As for the symptom at the onset, facialangioedema or blepharedema
was present in 12 cases and urticaria in 10 cases, respiratory symptom in 13
cases ,hypotension in 5 cases, unconsciousness in 4 cases. Intramuscular
epinephrine injection was medicated for 4 cases. The causative food allergen
was as followed, wheat in 8 cases, crustacea in 7 cases, vegetables / cone / milk /
cheese for each 1 case, unknown in 4 cases. We could be able to estimate
food antigen by medical history in 17 cases. Related food specific IgE was
positive in 5 of them. Twelve cases were negative CAP-RAST ,and 8 of
them showed positive SPT. Two cases were not be able to estimate antigen
by medical history and negative CAP-RAST. And one of them showed
positive SPT. Four cases in 15 were positive by provocation tests with
combined foods and exercise. We performed administration of aspirin
before ingestion of food and exercise for 4 examples, symptom was
provocated in only one case.
Conclusion: Wheat or Crustacea was a major food allergen of FDEIAn, but
few case were caused by vegetables or fruit. Combination of CAP-RAST and
skin prick test was useful to specify the allergen. In our cases, a positive rate
was 50% by combination of food and exercise test or with preadministration of
aspirin. It is need to establish about laboratory methods on children with
FDEIAn such as food loading dose, exercise methods, and premedication of
aspirin in future.
937
IgE mediated anaphylaxis to sesame
Emmanuella Guenova1, Sonia Genova2, Bogomil Voykov3, and Silvia
Novakova2. 1Eberhard Karl University, Department of Dermatology,
Tuebingen, Germany; 2University Hospital, Department of Allergology,
Pleven, Bulgaria; 3Eberhard Karl University, Department of Ophtalmology,
Tuebingen, Germany.
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A 70-year-old Caucasian man presented with suspected food allergy.
In the past emergent medical help was needed, because of an acute systemic
anaphylactic reactions, timely associated with sesame ingestion. 15 minutes
after consumption of sesame-poppy-raisin sweets suffered the patient from
generalised urticaria, facial and laryngeal oedema, severe hypotension and
unconsciousness. Emergency treatment with intramuscular administration of
epinephrine and high doses corticosteroids and antihistamines intravenously
was needed. Previous allergic reactions were denied. The patient stated
occasional contact to sesame throughout his life span and non-contributory
further own and familial anamnesis. Skin prick tests to common inhalant
allergens, preservatives and food allergens were negative. Prick-to-prick
tests with poppy seed, raisins and wheat flour remained negative as well.
Surprisingly, skin prick-to-prick test with sesame seed and sesame oil
revealed a pronounced positive reaction. The specific IgE for sesame was
highly positive (8,37 kUA/l) whereas total serum IgE (93,5 kUA/l) and
basal serum tryptase level (3,1 2g/l) remained in the normal range. A
double blind, placebo-controlled food challenge with incremental doses of
sesame seeds was conducted. 15 minutes after distributing 100 mg backed
sesame seed, acute anaphylaxis occurred. The IgE mediated mast cell
activation was proven by increase of the serum tryptase level (17,52g/l) two
hours after the food challenge.
Prevalence of allergy to sesame (Sesamum indicum) with its
major allergens Ses i 1-7 becomes more significant due to its increasing
industrial importance. Sesame represents an insidious Bhidden allergen[,
found not only in alimentary products, but also in cosmetics and
medical products, especially sun-protection creams and solvents for intra-
muscular injections.
The incidence of food allergy is age-dependent, particularly affecting
children and young patients. In elderly, anaphylactic reactions tend to be less
severe and a primary manifestation is unusual.
Nevertheless we were able to diagnose the rare case of classic IgE
mediated anaphylaxis to sesame with primary manifestation in a 70-year-old
patient. This shows that the potential life-threatening severity of food
anaphylaxis, especially to foods with pronounced allergenic properties like
sesame, should not be underestimated, irrespective of the patient’s age.
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Assessment of quality of life in children with food allergy
Noriko Minamitani1, Takanori Imai2, Takatsugu Komata2, Mika Ogata3,
Chizuko Sugizaki1, Morimitsu Tomikawa2, Hiroshi Tachimoto2, and
Motohiro Ebisawa1. 1Sagamihara National Hospital, Clinical Research
Center, Department of Allergy, Sagamihara-city, Kanagawa, Japan; 2Saga-
mihara National Hospital, Department of Pediatrics, Sagamihara-city,
Kanagawa, Japan;
3
National Hospital Organization Kumamoto Medical
Center, Department of Pediatrics, Kumamoto, Japan.
Objective: The dietary life of children with food allergy (FA) is restricted
very much, and their quality of life (QOL) of diet would be affected.
Therefore we have to perform dietary management for such children, but we
have not yet known how they are restricted in their dietary life. We conducted
current study to clarify the problems of dietary life in children with FA in our
outpatient clinic.
Methods: By questionnaire we examined QOL of diet (burden of the
dietary life at home and outside, problems of nourishment, and parents’
psychological burden) against the parents of children with FA or without
FA (control group). In addition, only to parents of children with FA,
we interviewed to qualify the troubles they had in the dietary life just
after the diagnosis of FA and at the some time after starting elimi-
nation diet.
Results: A total of 544 patients was surveyed. In the QOL survey, 40.1% of
the children with FA had different menu from the family’s menu, whereas
only 21.7% of the control subjects did. In addition, 69.0% of parents of
children with FA had difficulty in making menu, and 96.8% of the parents
paid attention to food labeling, and 40.1% of those felt an economic burden
for purchasing foods for FA children. Furthermore, 54.1% of the children
with FA were not satisfied with eating-out, whereas only 35.4% of control
was not satisfied. Children with FA were satisfied with the quality of school
lunch by 71.9% but 95.4% for control. The most prominent problem just
after the diagnosis of FA was about Bmaking menu / cooking[ in all age
group. It was also a problem for the mothers to wean FA babies during
infancy. However, a tendency to diversify troubles by age was recognized
after starting elimination diet, such as problems concerning Bpurchase foods
and eating-out[, or Bschool lunch[.
Conclusion: The study revealed that children with FA were restricted in
terms of the dietary life, and that their QOL was deteriorated compared with
control group. Since we could obtain information of the dietetics of which
children with FA and their parents desired, it is important to pursue
appropriate dietary management for the children with FA.
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Imatinib decreases duodenal mast cell density and degranulation
in epicutaneously-sensitized food allergy model of mouse
Kirsi Vaali1, Aung Htun Lin1, Lizhi Sun1, Petri Kovanen2, Arnold Berstad1,
and Kari Eklund3. 1University of Bergen, Institute of Medicine, Section of
Gastroenterology, Bergen, Norway; 2Wihuri Research Institute, Helsinki,
Finland; 3Joint Authority for the Hospital District of Helsinki, Division of
Rheumatology, Helsinki, Finland.
Background: Balb/c mice, when sensitized epicutaneously with ovalbumin,
had increased serum ovalbumin-specific IgE as well as IgG1. After repeated
intragastric challenges (ig) with ovalbumin, mice developed acute diarrhea
within 60 min of the 6. ig dose, whereas there was no diarrhea nor increased
IgE or IgG1 in the control groups. Since the role of small intestinal mast cells
was undisputable in this model, we wanted to evaluate the effect of imatinib on
these cells. Imatinib (GlivecR) is a potent inhibitor of the most important
growth factor receptor of mast cells, the c-kit.
Methods: Imatinib (100 mg/mouse) was given orally to Balb/c female mice
(20-25 g) as a pre-treatment during each 4 sensitizations and every second day
from the day 39 at the same time with the 10 ig ovalbumin (50 mg/mouse)
challenges. Ovalbumin-specific IgE, IgG2A, and mucosal mast cell protease 1
(MMCP-1) were measured from the serum and histamine from the plasmawith
standard ELISA methods. Rectal temperatures were measured and diarrhea
evaluated before and after the 6.-10. ig challenge of ovalbumin. Chloroacetate
esterase (CAE) was used for general mast cell staining, for immunohisto-
chemical staining MMCP-1 antibody was used. For double staining
fluorescent method with MMCP-1 antibody and TUNEL methods were
used. The total amount of stained cells was calculated from the whole cross-
sectional specimens of duodenum.
Results: There were no significant differences in the levels of ovalbumin-
specific IgE or IgG1 between the imatinib-treated and the vehicle treated
ovalbumin-sensitized mice indicating that the treatment did not prevent the
sensitization of the mice. The serum MMCP-1 levels at the sacrification were
lower in the imatinib-treated mice than in the vehicle treated group (10100 T
10967 and 14173 T 11246 ng/ml, respectively). Imatinib decreased the number
of CAE+ cells (59 T 32 and 126 T 53 cells/mm2, p G 0.05) and MMCP-1+ cells
(13 T 15 and 65 T 47 cells/mm2), respectively. The combined MMCP-1 and
TUNEL staining indicated that the duodenal mast cells did not go into
apoptosis during the treatment.
Conclusion: Imatinib treatment indicates the important role of the intestinal
mast cell population, CAE+ and MMCP-1+ cells, of which MMCP-1+ cells
seems to represent the majority of intestinal mast cells in the mouse food
allergy model.
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Identification and immunochemical characterization of a
common allergenic pollen Cycas circinalis
Kashinath Bhattacharya. Visva Bharati University, Santiniketan, Botany,
Santiniketan, India.
Objective: Cycas circinalis is a common garden plant. The pollen grains of
Cycas circinalis are airborne and remain suspended in the air fromMay to June
with a peak concentration at the end of June. The allergenicity of the pollen
grains is very common among the local inhabitants, but has not been reported
so far.
Materials and Methods: The pollen extract showed high (25.6%) skin
reaction on 172 respiratory allergic patients. Sera from the subjects were tested
directly by ELISA for estimating the allergen specific IgE. The results were
expressed as P to N value (ratio of patient’s sera in respect to normal one). The
allergic fraction was separated in 12% SDS-PAGE.
Results: The results showed the presence of 14 components in the range
between 14-100 kDa. Sera of eight patients showing P to N value greater than
3.5 were used for immunoblotting to identify the specific IgE binding protein.
The proteins from the gel were transferred to PVDF membrane. Immunoblot-
ting was performed using eight patients sera, where anti human IgE-AP
conjugate was used as second antibody and NBT and BCIP as substrate.
Conclusion: The results showed two components of 20 kDa and 39kDa. Thus,
the Cycas circinalis pollen grain is an important aeroallergen in India. The 20
kDa and 39kDa components are the major allergens present in the pollen
extract.
941
The correlation between SNPs of GATA-3 and Chinese with
allergic rhinitis
XiangDong Wang, Luo Zhang, and Demin Han. Head and Neck Surgery of
Beijing Tongren Hospital affiliated to Capital Medical University, Beijing
Institute of Otorhinolaryngology; Departme, Beijing, China.
Objective: To discuss the correlation between SNPs of GATA-3 and Chinese
with allergic rhinitis.
Methods: 109 patients and 112 normal control people were enrolled in this
study. We detect SNPs of two sites of rs1269486 and rs2229360 with RFLP.
Results: We detected SNPs in both of the two sites. The genotypes of
rs1269486 are G/G, G/A and A/A, and the genotypes of rs2229360 are C/C, C/
Tand T/T. The distribution of G/G in patients was significantly higher than that
in control group (Pgƒ0.01). The haplotype frequency of GC in patient group
was significantly higher than that in control group (Pgƒ0.05), and the
haplotype frequency of AC in patient group was significantly lower than that in
control group (Pgƒ0.01).
Conclusion: This is the first study to evaluate the association between SNPs of
GATA-3 and allergic rhinitis, and we found that the SNPs of rs1269486 was
significantly different between Chinese with allergic rhinitis and normal
control people. The SNPs of GATA-3 may influence the phenotype of allergic
rhinitis in Chinese.
942
A novel approach to IgE epitope mapping Y virtual epitope
mapping
Fabio Dall’Antonia, and Walter Keller. University Graz, Inst. of Chemistry,
Graz, Austria.
Background: The determination of cross-reactive IgE epitopes on allergens is
a major challenge. Mapping of discontinuous (=structural) IgE epitopes by
experimental methods is extremely time consuming and possible for only few
allergens and epitopes. Most structural methods for epitope determination
(e.g., co-crystallization of Allergen-Fab complexes, NMR-based hydrogen
exchange or MS-based methods) work only with monoclonal antibodies and
therefore epitopes can only be determined one at the time and never represent
the polyclonal situation found in reality. The mapping of allergen specific
sequence motives onto the surface has been used or prediction of putative
epitopes. However, sequence homology (alone) may be a weak predictor for
cross-reactivity, as structural conservation is bound to be a major determinant
of cross-reactivity.
In order to improve the accuracy of the prediction of structural
epitopes, we have developed a new approach combining the 3D-structural
information and surface topology with the information on sequence
conservation.
Methods and Results: The computational methods for structure based
epitope mapping are integrated in a suite of programs which combine public
domain programs for sequence and structure alignment with topological
comparison algorithms and evaluation of chemical properties of the solvent
exposed surface. A program suite consisting of several Perl scripts, embedded
into a graphical user interface written in Tcl / Tk, provides automated surface
comparison. The following steps are executed by the program:
&Superposition of two or more user selected atomic models
&Calculation of solvent-accessible surfaces of the aligned structures
&Surface comparison (calculation of differences)
&Assign similarity scores to surface elements (including topology,
chemical similarity, H-bonding capacity, etc.)
&Averaging of similarity scores for each amino acid residue
&Graphical display of results
The program was tested with two families of cross-reactive allergens,
where the structures of three or more members have been determined.
Conclusion: We developed a novel method of IgE epitope mapping based on
the structural information of two ore more cross-reactive allergens. The
method uses sequence conservation as well as topological similarity for the
delineation of putative IgE epitopes. The graphical user interface allows for the
interactive visualization of the epitopes.
943
Exosomes in human blood plasma contain RNA Y a genetic
signal between cells at a distance?
V. Seyed Alikhani, H. Valadi, K. Ekstro¨m, A. Bossios, M. Sjo¨strand, and J.
Lo¨tvall. Go¨teborg University, Department of Internal Medicine, Respiratory
Medicine and Allergology, Go¨teborg, Sweden.
Background: Exosomes are vesicles of endocytic origin produced by many
cell types and released in the extracellular environment as 30?100 nm large
membrane vesicles. Exosomes are involved in different signalling events
including antigen presentation to T-cells and development of tolerance. It
has recently been shown that mast cell exosomes contain a substantial
amount of functional RNA (Valdi et al., Nat Cell Biol 2007). The aim of
this study was to investigate weather exosomes in human blood plasma
contain RNA and/or DNA.
Methods: Peripheral blood plasmawas derived from healthy blood donors and
exosomes were isolated by a series of ultracentrifugations and filtrations.
Purified exosomes were attached to anti-MCH class II coated dynabeads and
analysed using FACS. The tetraspanins CD 63, CD 9 and CD81, known to be
enriched in exosomes, were used as markers for exosome detection. We also
performed electron microscopy (EM) to detect exosomes in the sample. RNA
was precipitated using TrizolUˆ according to the manufacturer?s protocol. To
magnify the signal, the RNA was then converted to DNA using a random
primer, and separated by agarose gel. We also confirmed the presence of
mRNA in exosomes by using oligo d(t) primers for conversion of mRNA to
cDNA.
Results: The isolated vesicles from plasma were identified as exosomes by
both EM and flow cytometric analysis (FACS). The results from the EM
showed exosomal structures with a size of 30?100 nm in diameter. The FACS
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analysis showed the presence of MHC II, CD63, CD9 and CD81, all markers
of exosomes. The exosomes also proved to contain significant amounts of
RNA, but no DNA. Some of the exosomal RNA was identified as mRNA.
Conclusion: Our results show the presence of RNA-containing exosomes in
human plasma. Since exosomes have the ability to fuse with cells and deliver
their RNA to that cell, it is possible that the RNA in plasma exosomes
constitute a genetic signal between cells at a distance.
944
Identification of Cladosporium herbarum allergen by
immunoblotting technique
Mohammad Taghi Hedayati1, Saied Kaboli1, Zohreh Hajhaydari2, and
Tahereh Shokohi1. 1Mazandaran university of medical sciences, Department
of Medical mycology and Prasitology, Sari, Islamic Republic of Iran;
2Mazandaran university of medical sciences, Dept. of Dermatology, Sari,
Islamic Republic of Iran.
Background: Many studies on C. herbarum antigens has shown that it has
an important role to produce of specific IgE in atopic individuals and
exacerbate of clinical signs of these patients such as atopic dermatitis. The
purpose of this study was to identify C. herbarum allergen by immunoblot-
ting technique.
Methods: C. herbarum was cultured in Sabouraud?s dextrose agar. The grown
C. herbarum were harvested and ruptured by liquid nitrogen and glass beads.
Samples were centrifuged at 3000rpm in 15 minutes and then at 15500rpm
(4C) in 2 hours and then supernatant were collected as crude extract. The crude
extract was separated by Sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE). The separated proteins transferred to nitrocel-
lulose filter and then socked with atopic dermatitis patient’s sera. The
responsive bands to IgE were revealed by antihuman IgE antibodies
conjugated with enzyme in chromogenic substrate.
Results: In SDS-PAGE, the crude extract of C. herbarum showed 16 different
protein bands with molecular weight between 15.1-110 kDa. The bands with
15.1, 18.4, 25.1, 36.3, 45 and 54 kDa identified as strong bands. In
immunoblotting, the bands with molecular weights 15.1, 18.4, 42, 110 kDa
were reacted to sera IgE from patients with atopic dermatitis.
Conclusion: The results of this study showed that the strong bands in SDS-
PAGE had the most reaction with anti-C. herbarum IgE antibody in
immunoblotting technique. So we speculated the intensity of bands in SDS-
PAGE can affect on IgE response. In accordance to other studies we think the
C. herbarum antigen can trigger allergic reaction in atopic dermatitis patients.
Key words: Cladosporium herbarum, Atopic dermatitis, IgE, Immunoblotting.
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Increased expression of nerve growth factor in allergic rhinitis
Hee Joon Kang1, Heung-Man Lee1, Hyo-Hyun Park2, and Yong-Dae Kim3.
1Korea University College of Medicine, Department of ORL-HNS, Seoul,
Republic of Korea; 2Korea University College of Medicine, Division of BK21
Program for Biomedical Science, Seoul, Republic of Korea; 3Yeungnam
University College of Medicine, Otorhinolaryngology, Daegu, Republic of
Korea.
Background: Allergic airway diseases are characterized by inflammation and
hyperresponsiveness. There is evidence that, in the upper airways,
hyperresponsiveness can be attributed to increased neural activity. Nerve
growth factor (NGF) is a neurotrophin that has been shown to be an important
mediator of neural responsiveness in the airways of bronchial asthma patients.
Recent studies suggest that NGF may also be an important inflammatory
mediator. Therefore, NGF could be a link between allergic inflammation and
neural responsiveness However, expression of NGF has not been reported in
the nasal mucosa of allergic rhinitis patients. This study was performed to
investigate the expression of nerve growth factor (NGF) messenger RNA and
protein and to localize the NGF protein in the nasal mucosa of patients with
perennial allergic rhinitis and control subjects.
Methods: Inferior turbinate mucosa samples were obtained from 20 patients
with perennial allergic rhinitis and 20 matched non-allergic patients. NGF
messenger RNA was extracted from the inferior turbinate mucosae, and then
reverse transcription-polymerase chain reaction was performed. Western
blotting was used to analyze differences in expression levels of NGF protein
between patients with perennial allergic rhinitis and normal controls, and the
NGF protein was localized immunohistochemically.
Results: The expression levels of NGF messenger RNA and protein in the
nasal mucosa were significantly increased in patients with perennial allergic
rhinitis compared with those in controls. NGF protein was expressed in the
epithelium, infiltrating inflammatory cells, and submucosal glands.
Conclusion: This study provides evidence of NGF expression in the human
nasal mucosa and its increased expression in perennial allergic rhinitis. These
results suggest that NGF may contribute to the pathogenesis of perennial
allergic rhinitis.
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Upregulation of angiogenin in nasal polyps
Heung-Man Lee1, Hee Joon Kang1, Hyo-Hyun Park2, and Yong-Dae Kim3.
1Korea University College of Medicine, Department of ORL-HNS, Seoul,
Republic of Korea; 2Korea University College of Medicine, Division of BK21
Program for Biomedical Science, Seoul, Republic of Korea; 3Yeungnam
University College of Medicine, Department of Otorhinolaryngology, Daegu,
Republic of Korea.
Background: The exact etiologic mechanisms leading to the formation of
nasal polyps have remained largely obscure. However, the formation of new
blood vessels (angiogenesis) may play an important role in the development
of nasal polyp. Angiogenin, a heparin-binding 14 kDa plasma protein with
angiogenic activity, plays an important role in inducing angiogenesis. The
aim of the present study was to investigate the expression and distribution
of angiogenin in normal nasal mucosa and in nasal polyps and to evaluate
the implication of such expression as regards the development of nasal
polyps.
Methods: Normal inferior turbinate mucosa was obtained from 20 patients
undergoing surgery for augmentation rhinoplasty. Nasal polyps were obtained
from 20 patients undergoing endoscopic sinus surgery for chronic polypoid
sinusitis. Semi-quantitative reverse transcriptase-polymerase chain reaction
was performed for angiogenin mRNA. Sections were immunostained by using
specific antibodies for localization of angiogenin and quantitatively analyzed
using computer-based image analysis. Western blot analysis was done.
Results: Using immunohistochemistry, moderate to high levels of angiogenin
were mainly localized in the infiltrating inflammatory cells of nasal polyps,
and faint staining was found in normal turbinate mucosa. Semiquantitative
reverse-transcriptase polymerase chain reaction and Western blot analysis
showed that angiogenin expression was increased in nasal polyps compared
with that in normal turbinate mucosa.
Conclusion: The markedly increased expression of angiogenin in nasal polyp
compared with normal nasal mucosa suggests that angiogenin may play a
significant role in the formation of nasal polyp.
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Proteomic identification of known and novel allergens from
house dust mite Dermatophagoides pteronyssinus
Pattama Ekpo1, Sirichit Wongkamchai2, Sunthorn Puangyoy1, Nhujohn
Jansong1, Supachok Sinchaikul3, Shui-Tein Chen3, Chaweewan Bunnag4,
and Visith Thongboonkerd5. 1Faculty of Medicine Siriraj Hospital, Mahidol
University, Immunology, Bangkok, Thailand; 2Faculty of Medicine Siriraj
Hospital, Mahidol University, Parasitology, Bangkok, Thailand; 3Institute of
Biological Chemistry and Genomic Research Center, Academia Sinica,
Taipei, Taiwan; 4Faculty of Medicine Siriraj Hospital, Mahidol University,
Otorhinolaryngology, Bangkok, Thailand; 5Faculty of Medicine Siriraj
Hospital, Mahidol University, Office for Research and Development,
Bangkok, Thailand.
Background: Dermatophagoides pteronyssinus is the most predominant
house dust mite (HDM) species and the most important source of indoor
allergens in Thailand. Currently, there is no subunit vaccine available for
successful prevention of the allergy to HDM. Characterizations of all potential
HDM allergens that cause IgE production in the allergic patients are needed for
development of a proper vaccine. The present study was therefore conducted
to globally identify potential allergens from D. pteronyssinus using a
proteomics approach.
Methods: Proteins derived from D. pteronyssinus cells were resolved by two-
dimensional gel electrophoresis (2-DE), transferred onto a nitrocellulose
membrane, and subjected to immunoblot analysis using pooled HDM-
sensitive patients’ sera (n = 39) or pooled normal control sera (n = 5) as the
source of primary antibody. The membrane was then probed with mouse anti-
human IgE ("- chain specific) conjugated with horseradish peroxidase and
immunoreactive proteins were then visualized using a chemiluminescence
substrate. The corresponding spots in another parallel 2-DE gel stained with
Coomassie Brilliant Blue that matched to these immunoreactive spots were
excised and identified by quadrupole time-of-flight (Q-TOF) mass spectro-
metry (MS) and/or tandem MS (MS/MS).
Results: A total of 33 immunoreactive spots were observed using the pooled
patients’sera, whereas none was detected with the pooled control sera. Among
these, 23 were successfully identified by Q-TOF MS and/or MS/MS analyses,
including Der p 1, Der p 2, Der p 8, Der p 14 and other proteins that had not
previously been recognized as the HDM allergens.
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Conclusions: Combining the conventional immunological method to the
recent advanced proteomic technology allowed identification of a number of
known and novel allergens of D. pteronyssinus. Further characterizations of
these allergens may lead to successful development of an effective vaccine for
prevention of the allergy to HDM.
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Immunomodulation by Salvia mirzayanii: Effects on the cellular
and humoral immune response and the induction of apoptosis
in lymphocytes
Zahra Amirghofran1, Masoud Bahmani1, and Katayoun Javidnia2. 1Shiraz
Medical School, Immunology, Shiraz, Islamic Republic of Iran; 2Shiraz
Medical Science University, Chemistry and natural products research center,
Shiraz, Islamic Republic of Iran.
This study was performed to examine the possible immunomodulatory
effect of Salvia mirzayanii, a native herbal plant to Iran. Human peripheral
blood lymphocytes were used as target cells, and cell proliferation was
determined by [3H]-thymidine uptake. The results indicated a dose related
change of proliferation in phytohemagglutinin activated cells. The extract at
0.1 to 10 6g/ml was stimulatory and at 100 to 200 6g/ml was inhibitory
(pG0.01). Immunization of the extract-treated mice with the antigen using
delayed hypersensitivity (DTH) skin test and antibody measurement showed
an increase in the footpad thickness which the amount reached to the level of
the control when mice treated with more doses of the extract. The antibody
titer in immunized mice treated with 1 mg/kg of the extract was higher than the
non-treated mice, whereas treating mice with 100 mg/kg of the extract
decreased the titer to under the level of the control in both primary and
secondary response (pG0.007). In flow cytometer analysis the presence of
apoptotic cells in sub-G1 phase at higher concentrations of the extract in
mitogen-treated human lymphocytes was observed. DNA fragmentation
analysis confirmed the result of flow cytometry. In conclusion, these results
indicates that immunomodulatory agents are present in the extract of S.
mirzayanii and that the induction of apoptosis in lymphocytes might be the
mechanism responsible for the inhibitory effect of the extract observed at
higher concentrations.
949
IgE-binding epitope analysis of Bla g 5, German
cockroach allergen
Kyoung-jin Jeong, Kyoung Yong Jeong, and Tai-Soon Yong. Department of
Environmental Medical Biology and Institute of Tropical Medicine, Brain
Korea 21 Project for Medical Science, Yonsei University College of Medicine,
Seoul, Republic of Korea.
Background: Several allergens from cockroach have been identified. The
information on their B cell and T cell epitopes are limited, which are important
for diagnostic and immunotherapeutic approaches. This study was conducted
to analyze the linear IgE-binding epitopes of Bla g 5, a glutathione S-
transferase homologous allergen, using recombinant proteins.
Method: Full-length and five fragmented or truncated recombinant Bla g 5
were expressed (A, 1-100 amino acid residue; B, 91-201; Ba, 1-125; Bb,
1-150; Bc, 1-175). IgE reactivities of the recombinant proteins to the
cockroach-sensitized subjects were assessed by ELISA.
Results: Twelve (37.5%) of 32 sera tested showed positive IgE reactivity
to the full-length Bla g 5. Six serum samples were selected for the
epitope study. Any recombinant proteins containing 1-175 amino acid
residues were unable to bind human IgE while the full-length and B
fragment were recognized by 6 sera tested. These results suggests that the
C-terminal region between 176Y201 amino acid residues contains most of the
IgE-binding sites.
Conclusion: These findings will advance the understanding of the
allergenicity of cockroach allergen, thereby contributing to the development
of strategies for allergen specific immunotherapies.
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IgE binding capacity of peptide fragments of Bla g 2, German
cockroach allergen
Myung-hee Yi, Kyoung Yong Jeong, Haeseok Lee, and Tai-Soon Yong.
Department of Environmental Medical Biology and Institute of Tropical
Medicine, Brain Korea 21 Project for Medical Science, Yonsei University
College of Medicine, Seoul, Republic of Korea.
Background: Cockroaches cause various respiratory allergic diseases such as
asthma. Although Bla g 2 is one of the most important cockroach allergens,
researches on B cell and T cell epitopes of Bla g 2 have not been performed
yet. This study was conducted to identify IgE-binding epitope of Bla g 2 by
using recombinant proteins.
Method: The full-length and five peptide fragments (A, aa 1-75; B, aa 71-150;
C, aa 146-225; D, aa 221-300; E, aa 296-352) of Bla g 2 were generated by
PCR and over-expressed in E. coli. IgE binding reactivity was compared with
Pichia-expressed Bla g 2 (PrBla g 2) and E. coli-expressed Bla g 2 (rBla g 2)
by enzyme linked immunosorbent assay (ELISA). And the IgE binding
reactivities of the full-length rBla g 2 and peptide fragments were measured by
ELISA using 38 serum samples of from patients with cockroach allergies.
Results: Half of 38 sera showed IgE reactivities to PrBla 2 and rBla g 2. And
only two (5.3%) serum samples among them showed stronger reactivities to
PrBla g 2 than rBla g 2, indicating that they are reactive to conformational or
carbohydrate epitopes. All fragments showed IgE-binding reactivities (80% to
A fragment, 50% to B, 100% to C, 30% to D, 40% to E). Especially, amino acid
residues 1 to 75 and 146 to 225 are shown to be important for IgE-binding.
Conclusion: Various IgE-binding patterns to Bla g 2 in individual patients’
sera were observed. This information on IgE-binding epitope of Bla g 2 could
be helpful for precise diagnosis and treatment of cockroach allergy.
951
Production of interleukin-5 and interleukin-13 by stimulated
CD4+ T cells from children with wheezing
Jong Seo Yoon, Mi Hee Lee, Hyun Hee Kim, Jin Tack Kim, and Joon Sung
Lee. the Catholic University of Korea, Pediatrics, Seoul, Republic of Korea.
Background: Interleukin (IL)-5 and IL-13 have been recognized as
proinflammatory cytokines involved in allergic inflammation. However, the
role of these cytokines in children with wheezing is unclear. Thus, we
determined IL-5 and IL-13 production by CD4+ T cells in children with
wheezing in order to better understand the role of T lymphocytes in the
pathogenesis of wheezing disorders.
Methods: This study was conducted on hospitalized wheezing patients.
Wheezers may be atopic or nonatopic depending on the presence of
immunoglobulin E specific to several common allergens. The control
group comprised patients who were admitted for noninfectious and
noninflammatory diseases. CD4+ T cells were isolated from the peripheral
blood of the patients and incubated with phytohemagglutinin (PHA) for
72 hours. The levels of IL-5 and IL-13 in the cell culture supernatant
were measured.
Results: After stimulation with PHA, the CD4+ T cells of the atopic wheezers
produced increased amounts of IL-5 and IL-13 with statistical significance
(P G 0.017 and P G 0.002, respectively), while those of the nonatopic
wheezers and controls did not.
Conclusion: IL-5 and IL-13 production by the CD4+ T cells of wheezers
could play a role in the pathogenesis of wheezing disorders in children.
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Quantification of Fc(RI-bindable human IgE using chimeric
EGF receptor
Ryosuke Nakamura, Reiko Teshima, and Jun-ichi Sawada. Natl. Inst. Health
Sci., Div. Biochem. Immunochem., Tokyo, Japan.
Background: Quantification of human IgE (hIgE) in the patients’ sera is
important for the diagnosis of allergy. Most of conventional assay methods of
hIgE depend on the binding of anti-hIgE antibody and hIgE in the sera.
However, the hIgE concentration in the sera quantified by such methods is not
necessarily correlated to the activation of mast cells. One possible reason is
anti-hIgE autoantibody in the sera, which may interfere binding of hIgE to
high-affinity IgE receptor (Fc(RI). Therefore, it is important to develop a new
method which can detect hIgE actually contributed to the sensitization of mast
cells. In this study, we have tried to establish new quantification method of
surface-bound hIgE using chimeric receptor bearing the extracellular region of
Fc(RI " subunit and intracellular region of EGF receptor (EGFR).
Methods: The cDNAs encoding chimeric receptors with or without
intracellular EGFR region were made by fusing cDNAs of Fc(RI" and
EGFR based on PCR. The transmembrane domains of the chimeric receptors
were from those of both receptors. The cDNAs were inserted to a mammalian
expression vector, and the plasmids were transfected to HLR-Elk1 cells, which
are HeLa cell-derived cell line containing Elk1-transactivable luciferase gene.
The expression of the chimeric receptors were determined by confocal
microscopy and Western blotting. The phosphorylation of intracellular
signaling molecules induced by hIgE sensitization and crosslinking with
anti-hIgE was investigated by Western blotting. The crosslinking of the
chimeric receptors were measured by luciferase activity.
Results: Confocal microscopic analysis revealed that the chimeric receptors
with transmenbrane domain of EGFR were efficiently expressed on the plasma
membrane of HLR-Elk1 cells, however, those of Fc(RI" were less expressed
on the cell. Addition of hIgE to the chimeric receptor-expressing HLR-Elk1
cells caused significant phosphorylation of the chimeric receptor and MAPK,
and the phosphorylation was increased when anti-hIgE was applied. However,
crosslinking of hIgE with anti-hIgE did not augment luciferase expression
induced by hIgE addition.
Conclusion: The cells expressing Fc(RI-EGFR chimeric receptors could be a
useful diagnostic tool that detects binding of hIgE to the cell surface Fc(RI.
However, a new method to detect crosslinking of Fc(RI should be developed.
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AllFam Y the database of protein families of allergens
Christian Radauer1, Merima Bublin1, Stefan Wagner1, Adriano Mari2, and
Heimo Breiteneder1. 1Medical University of Vienna, Department of
Pathophysiology, Vienna, Austria; 2Allergy Data Laboratories, Instituto
Dermopatico dell´Immacolata, Latina, Italy.
Background: Along with the identification of a large number of allergenic
proteins from diverse sources, it has become clear that most allergens belong
to a limited set of protein families. Most currently available allergen databases
such as the official list of allergens (www.allergen.org) group allergens mainly
by source organisms and do not take into account evolutionary relationships
among allergens. Hence, we established AllFam, a database of protein families
of allergens.
Methods: Allergen data were downloaded from the Allergome (www.allergome.
org) database. Protein sequences from the Uniprot (www.expasy.uniprot.org)
database were compared to protein family definitions from the Pfam
(www.sanger.ac.uk/Software/Pfam). The AllFam database combines these
protein family data with exposure and source data from the Allergome. AllFam
contains a fact sheet for each allergen family with information on biochemical
properties and allergological significance.
Results: The Allergome database contained 831 allergen sequences not
including isoallergens. The sequences were classified into 182 protein
families. However, only 94 families contained more than one allergen. The
most abundant allergen families were the prolamin superfamily that comprised
several subfamilies, and the profilins, a ubiquitous group of cross-reactive
plant allergens. The family of EF hand containing calcium-binding proteins
included polcalcins from pollen and parvalbumins from fish and amphibians.
Allergenic tropomyosins were found as food allergens in crustaceans and
molluscs and as inhalative allergens in mites and cockroaches. A classification
of allergens by source revealed a similar number of protein families among
plant and animal allergens (72 and 79 families) and a considerably lower
number of fungal allergen families (50). Grouping of allergens by route of
exposure showed that the distribution of food allergens is biased towards a few
abundant protein families. The database contained 64 families of food
allergens with the seven most abundant families accounting for 55% of all
allergens. In contrast, there are 125 families of inhalative allergens with the
first seven families making up only 27% of all allergens.
Conclusion: The Allfam allows a quick overview of protein families of
allergens and their distributions among allergens from different sources and
with different routes of exposure.
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Aspergillus germ tubes induce higher cytokine responses in
human bronchial epithelial cells in comparison with spores
Kamiar Zomorodian1, Florian Gruber2, Michael Mildner2, Karin Jeager2,
Leopold Eckhart2, and Erwin Tschachler2. 1Shiraz University of Medical
Sciences, Medical Mycology & Parasitology, Shiraz, Islamic Republic of Iran;
2Medical University of Vienna, Department of Dermatology, Vienna, Austria.
Background: Aspergillus species are ubiquitous saprophytic fungi that cause
a variety of diseases, ranging from hypersensitivity reactions to flu-like
pneumonia and life-threatening invasive aspergillosis. As the lung is the
primary site of initial infection with airborne conidia, we investigated the
innate immune responses of bronchial epithelial cells against different forms
of Aspergillus.
Methods: Human bronchial epithelial cells were treated with equal numbers
of killed spores or germ tubes of either Aspergillus fumigatus or Aspergillus
flavus. Transcriptional activation of the cytokine genes in the presence of germ
tubes or spores was determined using real-time PCR analysis. Secreted
cytokines following treatment with the mentioned fungi were also measured
by enzyme linked immunosorbant assay.
Results: Analysis by real-time PCR showed that inflammatory cytokines such
as IL-8 and IL-6 as well as the proinflammatory protease, caspase-5 were
strongly upregulated by both treatments in a dose-dependent manner.
Consistently, germ tubes induced a stronger response than spores. TNF-"
and $-2-defensin were induced by high a concentration of germ tubes, but not
by spores. Furthermore, IL1 pretreatment highly induced the expression of
$-2-defensin, IL8 and IL12.
Conclusion: Taken together, our results show that germ tubes of Aspergillus
fumigatus and flavus are potent inducers of innate immune responses in human
airway cells. Considering the presence of Aspergillus spores in the air,
differentiation between transient spore contact and invasion, as represented by
germ tube formation, is important in order to determine proper immunological
response. Moreover, these results can also provide additional data in under-
standing pathophysiology of hypersensitivity reactions due to the aspergilli.
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Detection of fungal aeroallergens from wards of a teaching
hospital
Keyvan Pakshir1, Golsa Shekarkhar2, Setareh Mostagnie2, Azadeh Vaghefikia2,
and Behnam Sabayan2. 1Shiraz University of Medical Sciences, School of
Medicin, Parasitology & Mycology Dept, Shiraz, Islamic Republic of Iran;
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2Shiraz Medical School, Parasitology & Mycology Dept, Shiraz, Islamic
Republic of Iran.
Background: The importance of indoor bioaerosols has been emphasized in
the last decades. It is the fact that hospital environment is often contaminated
with fungal spores and control of the air quality in hospital wards has assumed
great importance. Exposure to the spore floating on the air in hospital wards
leading to appearance of several diseases that ranges from allergies to sever
fungal infections in hospitalized patients. The aim of this study was to identify
and evaluation of fungal air contamination rates in high risk wards of a
teaching hospital in Shiraz, southern Iran.
Materials and Methods: A settle plate assay was used for air sampling. Petri
dishes containing Sabouraud and Malt extract agar were opened and exposed
in high risk wards of a teaching hospital and incubated for five to ten days. The
colonies are then identified, enumerated, and reported as the number
depositing in one square meter of surface rooms.
Results: A total of 528 microbial colonies were detected which 223 (42.23%)
colonies yielded fungi. Fungal isolates belongs to 12 genera as follows:
Cladosporium, Aspergillus, Penicillium, Alternaria, Trichosporon, Aureoba-
sidium, Mucor, Rhizopus, Chrysosporium, Curvularia, Trichothecium,
Stachybotrys, Stemphylium, Acremonium, Bipolaris and Yeast. 4.25 percent
of rooms were as clean room and Cladosporium was the predominant fungal
isolates. The highest and lowest fungal spore concentration were 1015 and zero
colony forming unite in emergency and transplantation rooms, respectively.
Conclusion: Cladosporium, Aspergillus and many other fungi are the major
aeroallergens and causative agent of nosocomial infections. Detection of these
fungi from hospital area has a potential risk of infection to these diseases.
956
TH1, Treg and TH2 immunoregulation through TLR2 and
TLR4 by Lactobacillus plantarum IS-10506 probiotics in
reducing allergic reaction. Experimental study in mice subjects
Anang Endaryanto1, Subijanto Marto Sudarmo1, Suhartono Taat Putra2,
Ingrid S Surono3, S Suwarno4, and K Kusnoto5. 1School of Medicine,
University of Airlangga, Child Health Department, Surabaya, Indonesia;
2School of Medicine, University of Airlangga, Pathobiology Department,
Surabaya, Indonesia; 3University of Indonesia, Seameo-Tropmed RCCN,
Jakarta, Indonesia; 4School of Veterinary Medicine, University of Airlangga,
Veterinary Microbiology Department, Surabaya, Indonesia; 5School of
Veterinary Medicine, University of Airlangga, Veterinary Parasitology
Department, Surabaya, Indonesia.
The purpose of this study is to clarify the mechanisms and involvement
of Toll-like Receptor (TLR) 2 and 4 in reducing allergic reaction by
Lactobacillus plantarum IS-10506 (LIS) probiotics.
In the factorial design study, Balb/c mice subjects were randomized
into 6 experimental groups and were sensitized with OVA. Probiotics (LIS and
placebo) and TLR inhibitors (PD98059, LY294002 and placebo) are
independent variable. The expression of innate immune response (TLR2
and 4, NF.Bp65, NF.Bp105/p50); the activation of adaptive immune
response (IFN,, IL-2, IL-4, IL-5, TGF$ and IL-10, sera OVA-specific
IgG2a, IgA, IgE, ileum OVA-specific IgA and total IgE); and the allergic
reaction (histamine and symptoms score) are dependent variable.
The TLR2 and 4, NF.Bp65, NF.Bp105/p50, IFN,, IL-2, IL-4, IL-5,
TGF$ and IL-10-positive cells were measured on histological slices from the
small intestine of mice in all groups. Levels of sera OVA-specific IgA, IgE,
IgG2a and ileum OVA-specific IgA were determined with an indirect ELISA.
Measurement of total IgE antibodies in sera was done with Sandwich ELISA.
Histamine levels were determined with a competitive ELISA.
After final OVA sensitization, the LIS groups did not experience the
severe and fatal allergic reaction, however most of mice in control group did
experience. There were significant modulation of the innate and adaptive
immune response in the LIS group compared with the control group, except
IL-4 and total IgE. In control group, the low level of innate immune response
(TLR2 and 4, NF.Bp65, NF.Bp105/p60) was in conformity with TH2-
skewed (TH1 G Treg G TH2) and IgE-mediated mast cell degranulation which
produce histamine and clinical symptoms. LIS probiotics enhanced the innate
immune response (TLR2 and 4, NF.Bp65, NF.Bp105/p60), formed the TH1-
skewed (TH1 9 Treg 9 TH2), and reduced the mast cell degranulation
(decreasing the level of histamine and symptoms score). The involvement of
TLR2 and 4 in the effect of the LIS probiotics on decreasing of allergic
reaction was proved by the interaction effect between those probiotics and
inhibitor TLR in reducing allergic reaction.
In conclusion, LIS probiotics is involving TLR2 and 4 in reducing
allergic reaction through enhancement of the TH1 and Treg immune
responses and forming a new TH1-TH2 equilibrium without reducing the
level of TH2.
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Identification of interferon-inducible gene expression in
fibroblasts derived from allergic and nonallergic patients
M Yoshikawa1, K Wada1, T Yoshimura1, N Okada1, H Saito2, and H
Moriyama1. 1Jikei University School of Medicine, Department of Otorhino-
laryngology, Tokyo, Japan; 2National Research Institute for Child Health and
Development, Department of Allergy and Immunology, Tokyo, Japan.
Rationale: Recently, asthmatic tissue-derived cells are reported to retain their
characteristic features such as steroid insensitivity even when cultured for a
long time. In our previous study, we identified many differences in gene
expression patterns containing interferon-inducible CXC chemokine genes in
fibroblasts derived from allergic (AF) and nonallergic (NF) patients, although
the fibroblasts were cultured and stimulated under the same conditions.
Therefore, we determined differences in gene expression of IP-10/CXCL10
and I-TAC/CXCL11 between AF and NF.
Methods: Nasal fibroblasts were isolated from inferior turbinate mucosa from
allergic (AF) and nonallergic (NF) patients. Cells were stimulated with IL-4,
TNF-", IFN-,, IFN-$, poly I:C or their combination. After mRNA was
extracted, the expression of IP-10/CXCL10 and I-TAC/CXCL11 was
examined using real-time PCR.
Results: IP-10/CXCL10 and I-TAC/CXCL11 were more down-regulated
when stimulated with IL-4 and TNF-" in AF compared to NF, whereas their
expression levels were increased when treated with TNF-" alone in AF. In
addition, we found mRNA expression of these genes was significantly more
strongly up-regulated by TNF-" in AF than in NF.
Conclusion: We identified specific gene expression profiles containing
interferon-inducible CXC chemokine genes in AF and NF. The expression of
IP-10/CXCL10 and I-TAC/CXCL11 was up-regulated in AF compared to NF
even after cultured for several weeks in the same culture condition, suggesting
genetic or epigenetic modification may be involved in its mechanism.
Additional studies are needed to clarify the exact mechanism underlying this
finding.
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Novel two series of benzo[b]furan derivatives having potent and
selective LTB4 (BLT1and/or BLT2) antagonist
Yoshitaka Ohishi. Mukogawa Women’s University, Faculty of Pharmaceutical
Sciences, Hyogo, Japan.
Leukotriene B4 is a dihydroxy fatty acid produced mainly by
macrophages and neutrophils. LTB4 plays important physiological roles on
leukocytes trafficking to the site of infection and clearance of invaded
microorganisms. However, overproduction of LTB4 is reported to cause
inflammatory diseases including bronchial asthma and inflammatory bowel
diseases. Thus, much work has been done to prepare LTB4 antagonists for
clinical use as anti-inflammatory drugs. Unfortunately, no antagonist has yet
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been developed for clinical medicinal application. Recently, a novel cell
surface receptor (BLT2) for LTB4 has been isolated and its molecular cloning
has also been established. Current studies on LTB4 antagonists and its
receptors (BLT1, BLT2) suggest the possibility of the development of new
clinical drugs for treating arteriosclerosis, immunosuppression of allograft
rejection in organ transplantation, psoriasis, cancer, and rheumatoid arthritis.
Stable compounds with definite conformation should be favorable as
antagonists. Thus, we prepared two series of benzo[b]furan derivatives, 2-
alkylcarbamoyl-1-methylvinylbenzo[b]furans (1) and 2-(4-thiazolyl)-3-phe-
nylbenzo[b]furans (2), and evaluated their inhibitory activity for BLT1 and /or
BLT2. Some of them showed more potent and more BLT2 selective inhibitory
activity than positive standard compound ZK158252. Especially, 2-(2-N,N-
diethylcarbamoyl-1-methylvinyl)-7-(1-phenylethyl)benzo[b]furan ((E)-1c)
and 2-[2-[(dimethylamino)methyleneamino]-5-formylthiazol-4-yl]benzo[b]-
furans (2a) showed potent and BLT2 selective inhibitory activities. These
compounds will be assay for treatment ability concerning immflamatory and
asthma in vivo screening.
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Relation of IgE antibody to antigen 5 of echinococcus granulosus
Farideh Bagheri, Mohammad Reza Siavashi, and Alireza Khabiri. Pasteur
institute of Iran, Parasitology, TEHRAN, Islamic Republic of Iran.
Anaphylactic reactions, such as urticaria, edema, respiratory symp-
toms, and anaphylactic shock often complicate the course of Cystic
Echinococcosis (CE). To investigate the role of the IgE immunoreactive
Antigen 5 (Ag 5) in the sero-positive patients with CE, we determined N-
terminal of 57 kDa subunit of Ag5 responsible for IgE and C-terminal of this
active antigen related to induction of IgG specifically. Immunoblotting
analysis showed that specific IgE to 57-kDa subunit related to inter-chain
disulphide band of two 22 kDa and 38-kDa component of Ag5 and
conformational epitope on this subunits. In addition, IgE specifically
recognized N-terminal of 22 kDa subunit which remain bounds to the other
component, whereas IgG reacted with C-terminal of 38 kDa component of
Ag5. Recognation of the specific binding site on the 57 kDa subunit of Ag5
could leads to understanding the mechanism regulating IgE/IgG production in
some immune circumstances that IgE tends to some dominate, whereas in
other IgG predominates.
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Effect of the complex of beta-glucan and Zataria multiflora on
oxidative burst of neutrophils in BALB/c mice
Hojjatollah Shokri. University of Tehran, Microbiology and Immunology,
Tehran, Islamic Republic of Iran.
Background: Natural products, beta-glucan and herbal essences, have been
found to enhance immune functions. The aims of this study were to purify
beta-glucan from the cell wall of Saccharomyces cerevisiae and to investigate
its conjugate effect with Zataria multiflora essence on oxidative burst in
BALB/c mice.
Methods: After preparing the cell walls from the yeast, beta-glucan was
extracted from wall by alkaline-acid treatment (glucan-S1). This preparation
contained protein and mannan, which were removed by DEAE sephacel
chromatography (glucan-S2) and con-A sepharose chromatography (glucan-
S3), respectively. Glucan-S3, Zataria multiflora essence, and their conjugate
were injected into BALB/c mice intraperitoneally. Blood collected at days 4
and 7 after injection and oxidative burst was assayed by chemiluminescence
method. Results: The findings showed that intraperitoneally administration of
glucan-S3, Zataria multiflora essence and their conjugate significantly
increased oxidative burst of neutrophils both at days 4 and 7 when compared
to control group (PG0.05).
Conclusion: These results suggest that the complex of a`-glucan and Zataria
multiflora essence can be used as adjuvant agents to stimulate immune
functions in immunocompromised subjects.
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Effect of staphylococcal enterotoxin on inducible nitric oxide
synthase in the mice with allergic rhinitis
Si Whan Kim, Tae-Bin Won, Dae Woo Kim, Dong-Young Kim, Chae-Seo
Rhee, Sang-Wook Kim, and Yang-Gi Min. Seoul National University College
of Medicine, Departments of Otorhinolaryngology, Seoul, Republic of Korea.
Background: According to recent reports, inducible form (type II) of nitric
oxide synthase is expressed at higher levels in the nasal mucosa of allergic
rhinitis patients, and these patients show a higher carriage rate of
Staphylococcus aureus than normal adults.
Aim: Are to investigate the role of staphylococcal enterotoxin B in the
development of allergic rhinitis and to determine its relevance with inducible
nitric oxide synthase overexpression.
Methods: The nasal mucosa and serum were obtained from the sensitized and
negative control groups, and the frequencies of allergic symptoms, such as
sneezing, were compared. Eosinophil counts and inducible nitric oxide
synthase expression in the nasal mucosa were examined. The serum levels of
ovalbumin-specific IgE were measured by ELISA. Differences between the
sensitized and control groups were statistically analyzed using the Kruskal-
Wallis test and the Mann-Whitney U test.
Results: The frequencies of sneezing, serum levels of ovalbumin-specific IgE,
and degrees of inducible nitric oxide synthase expression were significantly
higher in the groups locally sensitized with a mixture of ovalbumin and
staphylococcal enterotoxin B or ovalbumin alone than in the negative control
group or in the group locally sensitized with staphylococcal enterotoxin B alone.
Conclusion: Inducible nitric oxide synthase may play a crucial role in the
development of allergic rhinitis whereas staphylococcal enterotoxin B may not
participate in this process.
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The anti-allergic effect of lactobacillus probiotics in
mite-allergen sensitized murine model
Kung-Chih Yeh1, Ren-Long Jan2, Shin-Hong Chen3, and JIu-Yao Wang4.
1College of Medicine, National Cheng Kung University, Department of
Microbiology and Immunology, Tainan, Taiwan; 2Chi-Mei Medical Center,
Liou-Yin Campus, Pediatrics, Tainan, Taiwan; 3Madou Shin-Lau Hospital,
Pediatrics, Tainan, Taiwan; 4College of Medicine, National Cheng KUng
University, Pediatrics, Tainan, Taiwan.
Background: Clinical trails have demonstrated that probiotics can improve
the allergic symptoms but the mechanisms responsible for these benefits are
still unclear. We sought to investigate the effects of probiotic organisms in a
mouse model of allergic airway inflammation.
Methods: First, Balb/c mice were treated with two probiotic organisms
Lactobacillus rhamnosus and Lactobacillus paracasei via gavaging needle for
two weeks daily before Dermatophoides pteronyssinus (Der p) allergen
sensitization and for another two weeks during sensitization and allergen
challenge. Second, to know the dose effect of Lactobacillus paracasei, we
further investigated the ability of three doses of Lactobacillus paracasei, 5 
107CFU/ml, 107CFU/ml and 3  106CFU/ml, in the prevention of allergic
airway inflammation.
Results: First, we found that treatment with Lactobacillus paracasei
significantly elevated Th1 cytokine, IL-12 in bronchoaveolar lavage fluid
(BAL) and decreasedDer p-specific IgG1 in serum but therewere no changes in
airway hypersensitivity, influx of inflammatory cells to the lung and serum IgE
level. Treatment with Lactobacillus rhamnosus did not have any significant
effects. In the second part, treatment with medium dose (107CFU/ml) of
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Lactobacillus paracasei significantly attenuated the influx of total leukocytes,
monocytes and lymphocytes to the airway and elevated IL-12 in BAL, Der
p-specific IgG2a in serum. Medium dose of Lactobacillus paracasei also
decreased airway hyperresponsiveness and increased IFN-, production in Der p
stimulated splenocytes. The high dose of Lactobacillus paracasei reduced the
influx of total leukocytes, monocytes in BAL and IL-4 production in Der p
stimulated splenocytes, increased Der p-specific IgG2a in serum and IFN-,
production in Der p stimulated splenocytes. The low dose of Lactobacillus
paracasei only elevated Der p-specific IgG2a in serum, IFN-, production in Der
p stimulated splenocytes and reduced the splenocyte proliferation activity.
Conclusion: Our results show that oral treatment with probiotics can attenuate
allergic airway inflammation by increasing Th1 immune response and these
effects are strain specific and dose dependent.
963
Aerobiological and Immunochemical studies in Domjur, Howrah
District, West Bengal, India
Indrani Choudhuri. Bose Institute, Kolkata, Botany, Kolkata, India.
Allergic diseases, like bronchial asthma, allergic rhinitis, conjunctivitis
due to exposure of various airborne biological particles are very common.
Pollen grains among them are known as a causative agent which cause
respiratory allergy in susceptible individuals. In this program, a rural area at
Howrah district, Domjur Block near Kolkata was selected for our aero-
biological and clinico-immunological studies. The area was selected as it is
rich in vegetation and a high density of population suffering from respiratory
allergy. Aerobiological Study was done using Burkard sampler. Preparation of
allergenic extracts was done using pure bulk of pollen grains using 0.1 M
phosphate buffered saline (PBS). Skin tests (SPT) with different pollen
extracts were performed following the method of Stytis (1982 ). Sensitive sera
were collected from the patients visiting the outpatients’ Department of the
Allergy Clinic of the Institute of Child Health, Calcutta. Normal sera were
obtained from healthy donors with no history or symptoms of atopy.
Electrophoresis and Western blotting was analyzed by SDS-PAGE according
to the method of Laemmli (1970). In order to prepare a pollen calendar, at
Domjur, rich in vegetation with wide agricultural farming aerobiological
survey was done. 47 air borne pollen types were recorded and identified from
the air of Domjur. The dominant types were, Areca catechu, Cocos nucifera,
Phoenix sylvesrtis, Riccinus communis, Lantana camara, Perthenium hyster-
ophorus, Trema orientalis, Moringa olifera, Carica pa paya, Catharanthus
roseus, Casuarina equisetifolia, Albizzia lebbeck, Cyperus rotundus etc.
Among the dominant pollen types, some were subjected to Skin Prick Test.
Areca catechu, Carica papaya, Catharanthus roseus, Cocos nucifera,
Amaranthus spinosus, Borassus flabellifer, Lantana Camara were found to
be highly positive. Carica papaya pollen was selected for the biochemical and
clinical investigations. SPT reaction was studied with the relevant pollen
extract on 320 respiratory allergic patients and 30% of them showed a positive
response. The native polyacrylamide gel electrophoresis of Carica pollen and
fruit showed the presence of a number of protein bands . In IgE specific dot
immunoblotting of Carica pollen showed remarkable cross reaction with
papain, an enzyme present in the latex, fruit and other plant parts.
964
Nasal mucosal infiltration of eosinophil after nasal provocation
Sung-Wan Kim, Joong Saeng Cho, Kun Hee Lee, and Seung Yeop Shin.
Kyunghee University Hospital, Dept. of ORL-HNS, Seoul, Republic of Korea.
The Background of the study: Eosinophils are found in the nasal lavage fluid
and nasal biopsies of patients with allergic rhinitis after nasal antigen
challenge. Numerous studies have been carried out to clarify the paticipation
of eosinophils in a late-phase allergic reaction or airway hyperresponsiveness.
However, there has been a few report describing in detail the role of eosnophils
during an early-phase allergic reaction. The aim of this study was to investigate
the degree of nasal eosinophil infiltration before and after nasal provocation
test and to evaluate the changes of degree of nasal eosinophil infiltration
according to the duration of allergic rhinitis.
Methods: One hundreds and forty-five allergic rhinitis patients who were
diagnosed by allergic work-up were included. The patients were divided into
three groups by duration of symptoms. Group 1 was the patients whose
duration of symptoms was less than 2 years (n = 40), group 2, 2 to 9 years (n =
58), and group 3, more than 10 years(n = 47). Symptom scores of the patients
were checked for nasal obstruction, watery rhinorrhea, sneezing, and itching
with visual analogue scale. Nasal mucosal scraping and smear was performed
with curette at before and 30 min after nasal allergen provocation. Degree of
eosinophil infiltration was evaluated in each slide by 6-point scale. And degree
of eosinophil infiltration was compared between before and after provocation.
The degree of eosinophil infiltration was evaluated and compared according to
the duration of symptoms.
Results: Prominent nasal symptoms of all 3 groupswas nasal obstruction and it
was increased by duration of symptoms. But other symptomswere more severe
in group 2 than in other group. Group 2 and 3 showed higher degree of
eosinophil infiltration compared with Group 1. And degree of eosinophil
infiltration was increased after provocation in group 2 and 3.
Conclusions: The eosinophil infiltration is increased even in early stage of
allergen provocation and increase of eosinphil infiltration in the nasal mucosa
after provocation is more significantly in chronic state. Eosinophil may be
involved in early reaction of allergy, especially in chronic state.
965
Association of cytochrome P450 (2C9, 2C19) gene polymorphism
with susceptibility to Ankylosing Spondylitis in a population
group from Algeria
Sofiane Samir SALAH1, Habiba AMROUN1, Rachida ALLAT2, Marc
BUSSON3, Antoine TOUBERT3, Rajagopal KRISHNAMOORTHY4,
Dominique CHARRON3, Mohamed Cherif ABBADI5, Hachemi DJOUDI2,
and Ryad TAMOUZA3. 1Institute Pasteur of Algeria, Immunology, Algiers,
Algeria; 2Douera Hospital, Rhumatlogy, Algiers, Algeria; 3Saint Louis
Hospital, Immunology and histocompatibility, Paris, France; 4Robert
Debre´ Hospital, Immunology, Paris, France; 5Pasteur Institute of Algeria,
Immunology, Algiers, Algeria.
Background: Cytochrome P450 (CYP) superfamily members CYP2D6,
CYP2C9 and CYP2C19 are polymorphically expressed enzymes that are
involved in the metabolic inactivation of several drugs, including, anti-
epileptics, NSAIDs, oral hypoglycemics, and anticoagulants.
Many of these drugs have a narrow therapeutic index, and several
studies indicates a prominent role of these enzymes polymorphisms in the
therapeutic efficacy and in the development of adverse effects among patients
treated with drugs that are CYP2D6, CYP2C9 or CYP2C9 substrates. Pre-
vious linkage and association studies has suggested the presence of a sus-
ceptibility gene for ankylosing spondylitis (AS) close to, or within, the
cytochrome P450 2D6 gene which could play an key role in pathophysiology
of AS. In our study, we examined whether common mutations of cytochrome
P450 (CYP) [CYP2C9*2,*3, CYP2C19*2, and CYP2D6*3,*4,*6,*7 and *8]
are involved in outcome of AS in Algerian patients and, find out and deter-
mine genotype frequency in Algerian population.
Methods: CYP genotype was determined in 160 AS patients [fulfilling the
modified Naw York criteria] and 204 healthy non-related subjects. DNA
isolated from blood samples was used for the analysis of CYP2D6, CYP2C9
and CYP2C19 allelic variants by allele-specific real-time PCR. Thus, with
respect to allelic variant frequencies, genotype distributions or predicted
phenotypes were deduced from genotype combinations.
Results: i) no significant difference was found in CYP2D6 allelic variants
between AS patients and control subjects; ii) the CYP2C9*3 allelic variant is
more frequent in AS patients than healthy subjects (pc=0,015,OR=2,98); iii)
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CYP2C19*2 allelic variant is more frequent in AS patients than healthy
subjects (pc=0,009, OR=2,06) ; iiii) and the frequency of the Bintermediate
metabolizers^ genotype and/or phenotype for substrates of CYP2C19 is 2-fold
more important in AS patients than controls (pc=0.0009).
Conclusion: It would exist a possible role of CYP2C9 and C19 polymorph-
isms in the risk for development of AS and probably on the metabolism of
some drugs used in treating AS patients.
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Exosomes from bronchoalveolar fluid of tolerized mice prevent
allergen-specific allergic reaction
Noela Prado1, Eva G Marazuela1, Elodie Segura2, He´ctor Ferna´ndez-Garcı´a3,
Mayte Villalba1, Clotilde The´ry2, Rosalı´a Rodrı´guez1, and Eva Batanero1.
1Universidad Complutense, Bioquı´mica y Biologı´a Molecular, Madrid,
Spain; 2Institut Curie, Pavillon Pasteur, Paris, France; 3Universidad Rey
Juan Carlos, A´rea de Histologı´a y Anatomı´a Patolo´gica, Madrid, Spain.
Background: Exosomes are nanovesicles originating frommultivesicular bodies
that are secreted by a variety of cell types. The dual capability of exosomes to
promote immunity or to induce tolerance has prompted their clinical use as
vehicles for vaccination against different human diseases. In the present study,
the effect of allergen-specific exosomes from tolerized mice on the development
of allergen-induced allergic response was determined using a mouse model.
Methods: Mice were tolerized by respiratory exposure to the olive pollen
allergen Ole e 1. Exosome-like vesicles were isolated from bronchoalveolar
lavage fluid of the animals by the well-established filtration and ultracen-
trifugation procedure, characterized by electron microscopy, western blot and
FACS analyses, and assessed in a prophylactic protocol. To this end BALB/c
mice were intranasally treated with tolerogenic exosomes or naBve exosomes as
a control, one week prior to sensitization/challenge to Ole e 1. Blood, lungs
and spleen were collected and analyzed for immune responses.
Results: Intranasal pretreatment with tolerogenic exosomes inhibited IgE
response along with a marked reduction of lymphoproliferative response and Th2
cytokine production. Moreover, the pathologic alterations of the lung associated
with airway inflammation, such as eosinofilia, were significantly suppressed.
Conclusion: These results demonstrate that exosomes can induce tolerance and
protection against allergic sensitization inmice. Thus, exosome-based vaccines could
represent an alternative to conventional therapy for allergic diseases in humans.
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Primary and secondary infection with Respiratory Syncytial
Virus (RSV) before allergen challenge enhanced airway
hyperresponsiveness in murine model
Lee Young-Mok1, Ryu Ji-Won1, Kim Yang-Ki1, Kim Ki-Up1, Soo-taek Uh1,
Choon-Sik Park1, Dakhama Azzeddine2, and Gelfand Erwin2. 1Soonchun-
hyang University School of Medicine, Internal Medicine, Seoul, Republic of
Korea;
2
National Jewish Medical and Research Center, Pediatrics, Denver,
United States.
Rationale: Respiratory viral infections have been implicated in both the
development and exacerbation of asthma. Although repeated RSV infection
and allergen sensitization can occur throughout life, the effects of respiratory
infection and subsequent allergen sensitization in the development of airway
hyperresponsiveness (AHR) are not well known.
Objective: To determine whether neonatal infection with RSV plays a critical
role in the development of AHR and pathophysiological response to
subsequent allergen sensitization in adult mice.
Methods: Mice were infected initially at 5-7 days of age with RSV and were
re-infected 5 weeks later. RSV-infected mice were exposed to ovalbumin
(OVA) at 1 or 3 weeks after infection via airway followed by assessment of
airway function by invasive method in changes of lung resistance to inhaled
methacholine (Mch), cytokine levels in bronchoalveolar lavage fluid (BALF),
and lung histopathology.
Results: RSV infection and subsequent allergen sensitization resulted in
development of AHR and inflammation, which is associated with increased
eosinophils influx into the lungs, increased IL-5, and mucus production.
Although enhanced AHR to Mch and inflammations are observed in both
RSV-infected mice at neonate and subsequently re-infected with RSV after
weanling, these response were more exaggerated in mice with early exposed to
ova than later after RSV infection.
Conclusion: Neonatal RSV infections predispose the adult to develop
enhanced airway responses and inflammation upon allergen exposure.
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Food allergy in Chinese preschool children: epidemiology and
disease spectrum
Ting Fan Leung1, Edmund Yung1, Yun Sze Wong1, Christopher Wai-kei
Lam2, and Gary Wing-kin Wong1. 1The Chinese University of Hong Kong,
Department of Paediatrics, Hong Kong, Hong Kong; 2The Chinese University
of Hong Kong, Department of Chemical Pathology, Hong Kong, Hong Kong.
Background: Food allergy is an early and potentially life-threatening
manifestation of Fatopy march’. There is limited published epidemiological
data of food allergy in Chinese children. To plan for possible intervention to
prevent the development of food allergy, it is important to identify its disease
spectrum and risk factors in our population. This study aims to determine the
prevalence and clinical features for self-reported food allergy in Hong Kong
preschool children.
Methods: Children aged 2-6 years living in Hong Kong were recruited
through randomly selected nurseries and kindergartens for this study to
ascertain the presence of self-reported symptoms of food allergy and other
atopic disorders. The parental questionnaire was developed from the Chinese
version of International Study of Asthma and Allergies in Childhood
questionnaire, with addition of validated items on details of food allergy.
Results: 3827 children from 21 local nurseries and kindergartens returned our
study questionnaires, of which 3677 (96.1%) children were evaluable for food
allergy. Two hundred and fifty-three (6.9%) children were born in mainland
China and subsequently migrated to Hong Kong. Four hundred and twenty-
two (11.5%) children were currently avoiding any food. The prevalence rates
of self-reported food allergy and self-reported, doctor-diagnosed food allergy
were 8.1% and 4.6%, respectively. The figures for ever wheeze, doctor-
diagnosed asthma and current flexural eczema were 14.0%, 5.0% and 31.9%.
The six leading causes of self-reported food allergy in our Chinese children
were shellfish (15.8%), egg (9.1%), peanut (8.1%), beef (6.4%), cow’s milk
(5.7%) and nuts (5.0%). When compared with children born and raised in
Hong Kong, children born in mainland China had significantly lower
prevalence of self-reported food allergy (4.0% versus 6.7%; P=0.016),
doctor-diagnosed asthma (1.7% versus 5.4%; P=0.006) and current
rhinoconjunctivitis (13.9% versus 25.4%; PG0.001) but not current flexural
eczema (P=0.257). The occurrence of food allergy was strongly associated with
current wheeze, rhinoconjunctivitis and flexural eczema (PG0.001 for all).
Conclusion: Food allergy is a significant atopic disorder in Hong Kong
preschool children, and coexisting airway and skin allergies are also
commonly seen in these children. Further studies to identify early life feeding
and environmental factors for food allergy are needed.
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A patient with tracheobronchial amyloidosis and complete
lung collapse
Sitara Khan1 and Michael Wood2. 1St Thomas’ Hospital, Respiratory
Medicine, London, United Kingdom; 2St Peter’s Hospital, Respiratory
Medicine, London, United Kingdom.
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Introduction: Tracheobronchial amyloidosis is a rare condition, characterised
by the deposition of amyloid plaques in the upper respiratory tract.
Background: A 65 year old lady with pre-existing tracheobronchial
amyloidosis presented to the emergency department with dyspnoea, cough
and coryzal symptoms. On the second hospital day, she developed stridor
and worsening hypoxia. Clinically there was no air entry in the right lung,
and chest radiography confirmed collapse. The patient was intubated and
ventilated and underwent emergency bronchoscopy. This demonstrated
mucus plugging and blood in the right main bronchus, which was aspirated
and washed out. The underlying mucosa was grossly oedematous and
friable. After bronchoscopy the patient required ventilatory support but air
entry in the right lung had increased significantly, and re-expansion was
confirmed by chest radiography. This was accompanied by a marked
improvement in oxygenation, and the patient was extubated 3 days later.
Discussion: Amyloidosis can be defined as a diverse group of disorders that
share a common aetiologyYthe extracellular deposition of protein in a
pathological fibrillar, insoluble form. Localised AL amyloidosis has a
predeliction for the respiratory, gastrointestinal and genitourinary tracts, and
is frequently nodular in character. Systemic AL amyloidosis is associated with
underlying monoclonal plasma cell dyscrasia, and features widespread organ
involvement. Gilmore et al outlined the main respiratory amyloid syndromes:
parenchymal (subclassified into nodular and diffuse alveolar septal) laryngeal
intrathoracic lymphadenopathy tracheobronchial. Tracheobronchial amyloi-
dosis refers to the deposition of amyloid plaques in the upper respiratory tract,
and is relatively rare. It occurs most frequently in a diffusely infiltrative form,
although a nodular form also exists. Reduction in airway calibre is the main
feature, with consequent atelectasis and recurrent pneumonia. Successful
treatment of endobronchial lesions using Nd-YAG laser irradiation has been
reported. External beam radiation is a relatively recent technique, and results in
improvement in spirometry, symptoms and bronchoscopic appearance. Other
treatment modalities include bronchoscopic resection, surgical resection,
carbon dioxide laser ablation and stenting.
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Detection of specific anti-Alternaria alternata IgE
in asthmatic patients
Hojjatollah Shokri and Ali Reza Khosravi. University of Tehran, Micro-
biology and Immunology, Tehran, Islamic Republic of Iran.
Background: Alternaria alternata (A. alternata) is well-known as source of
allergenic components in the cell wall and cytoplasm of conidia and hyphae
that cause allergic asthma.
Purpose: Purpose of this study was to purify the A. alternata antigens to evaluate
the skin allergic reactions and specific anti-A. alternata IgE in asthmatic patients.
Methods: Eighty-eight patients with asthma (46 male, 42 female) and 40 non-
atopic cases were enrolled with sequential trials. Alternaria alternata antigens
were prepared and then skin prick test (SPT) and dot-blotting assay were
performed for all patients.
Results: Positive SPT reactions were obtained on 70.5% of patients (PG0.05).
The males had more positive SPT reactions than female (PG0.05). Using dot-
blotting test, specific anti-A. alternata IgE antibody was detected in 46 (52.3%)
of patients and had strong positive responses to A. alternata antigens, but no
specific IgE antibody was detected in control group (PG0.05). However, 16
(18.2%) sera of patients showed weak positive IgE-dot blotting results, in
respect to sex and age, no significant differences were observed.
Conclusion: The results confirmed that different allergenic components ofA. alternata
may play an important role in producing signs of asthma in the sensitive patients.
971
Nonatopic asthma have more hazardous effects on the course of
chronic rhinosinusitis compared with atopic asthma
Hyo Yeol Kim, Hun-Jong Dhong, Seung Kyu Chung, and Jin-Young Min.
Samsung Medical Center, Otorhinolaryngology - Head and Neck Surgery,
Seoul, Republic of Korea.
Background: We wanted to investigate the clinical characteristics of CRS
patients with atopic and nonatopic asthma.
Methods: Twenty-one atopic and 25 nonatopic asthma with CRS and 30
nonasthmatic CRS patients were enrolled in this study. The severity of asthma
was evaluated and clinical parameters including the degree of nasal polyposis
and disease extension, pre- and postoperative subjective symptoms, and
surgical outcome evaluated with endoscopy.
Results: The severity of asthma was about the same between the two asthma
groups. While all groups showed improved rhinosinusitis symptoms,
significantly more severe disease extension and poorer endoscopic surgical
outcome was noticed in the nonatopic asthma group. No differences were
found in other parameters.
Conclusion: In this study, nonatopic asthma is supposed to make more
hazardous effects on CRS disease extension and surgical outcome in patients
with both asthma and CRS.
Clinical implications: CRS patients with nonatopic patients have more
possibilities of severe disease extension and poor surgical outcome, which
should be kept in mind when interviewing the CRS patients.
972
The changes of allergic sensitization with age in children with
allergic rhinitis
Hyo Yeol Kim, Hun-Jong Dhong, Jin-young Min, and Seung Kyu Chung.
Samsung Medical Center, Otorhinolaryngology - Head and Neck Surgery,
Seoul, Republic of Korea.
Objectives: Allergic disease in children has diverse characteristics &
sensitization with age because of allergen, pathophysiologic and immunologic
differences. There has been few reports regarding the changes of allergic
sensitization with age in children with of allergic rhinitis in Korea, sowe aimed
to find out these changes by CAP test.
Methods: A total of 464 children with allergic rhinitis were subjected to this
study. They were classified by age groups into less than 3, 4~6, 7~9, 10~12,
13~15 and 16~18 year-old. All children underwent the CAP test(Fluroenzyme
immunoassay) about two subtype of house dust mite, cat, dog, and grass, tree,
and weed mixture allergen. Also we analyzed the total IgE.
Results: Children with 10~12 ages had significantly higher specific IgE to
house dust mite (D. pteronyssinus=31.50 U/ml, D. farinae=53.64 U/ml) and
reactivity to multiple allergens than other age groups. There were positive
correlation between age and ratio of sensitization to weed and tree mixture
allergen but no correlations were not found in cat, dog, grass and mold
allergen. Also Total IgE was significant difference between sex (Male: 451.05
U/ml, Female: 252.46 U/ml) but no significant changes with age.
Conclusion: The sensitization in children with allergic rhinitis was changed
with age in some allergens by CAP test.
973
Etoricoxib role in hypersensitivity reactions to NSAIDs, a
tolerability evaluation
Oliviero Quercia, Francesca Emiliani, Francesco G Foschi, and Giuseppe F
Stefanini. Faenza Hospital, Internal Medicine, Faenza (RA), Italy.
Background: Adverse reactions to nonsteroidal anti-inflammatory drugs
(NSAIDs) are a frequent reported problem due to the fact that these molecules
are often used for pain and phlogosis control. Coxibs represent a new NSAIDs
class with a specific trigger action, involving the inhibition of the isoform 2 of
the cyclo-oxigenase (COX2) enzyme, without inhibiting the COX1 activity
and the endothelial and epithelial prostaglandin synthesis. These drugs,
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however, if taken for a very long time, can have cardiac side effects. Etoricoxib
is less cardio-toxic.
Methods: We have tested the drug on 65 patients with previous adverse
reactions to NSAIDs: 13 to salycilates, 18 to arylpropionics, 10 to arylacetic
acid, 12 to oxicam and derivates, 8 to pyrazolones and 4 to acetaminophen
(paracetamol-P). The reported symptomatology was urticaria and/or angioe-
dema in 69%, rhinitis reactions in 3% and one case of anaphylactic shock
(1,5%). Peroral challenges were performed at random controlled with placebo,
starting with a 10 mg dosage up to a total dosage of 90 mg. in the third day. The
challenge has been done in Day Hospital and the patients were cardio-
respiratory monitored for 4-6 hours.
Results: The tolerance test was fully carried out and well tolerated in 97% of
the patients. Only two systemic reactions and a slight tiredness along with
stomach-ache were reported during the first day.
Conclusion: Etoricoxib can be considered a safe molecule for those patients
with previous adverse reactions to NSAIDs.
974
Positive prevention by people living with HIV among injecting
drug users, mashhad positive club: A joint project with
UNAIDS Iran
Vahid Nowbahar1, Hamidreza Setayesh2, Ali Feizzadeh2, Mohammad
Tavakkoli2, Farhad Malekahmadi3, Hamid Nowbahar4, and Ehsan Matlabi1.
1Mashahd Positive Club, Research, Mashhad, Islamic Republic of Iran;
2UNAIDS, Iran Office, Tehran, Islamic Republic of Iran; 3Family Planning
Association, HIV and AIDS, Tehran, Islamic Republic of Iran; 4Mashahd
Positive Club, Reseaarch, Mashahd, Islamic Republic of Iran.
Background: Mashhad locates in North-East of Iran and so close to the
borders of Afghanistan and Turkmenistan, also considered as a migrated city
due to religious reasons. Injecting Drug Users are increasing due to its lower
cost and other interests especially in marginalized regions. Sharing the
contaminated syringes and injecting tools is the most important and common
way of HIV transmission in the country and city. Peer education with PLHIVs
among their peers and most at risk groups such as IDUs is a strategy of positive
prevention which also helps as psychosocial support for PLHIVs. Mashhad
Positive Club established to empower PLHIVs based on the national AIDS
program and positive prevention through UNAIDS, MOH CDC and Family
Planning Association support.
Method: After preparing PE Protocol and call for action, we trained 7 PLHAs
including 3 of them were IDU. They were going to the ruins, places for
group injection (blood sharing) and some in Drop In Centers in Daravey and
Nodeh, two marginalized regions of Mashhad. They have trained their peers,
IDUs and other positives, by face to face talking and distributing harm
reduction packages including syringes and condoms for safer sex came out
through FGD. The process monitoring was being done by writing a daily
and weekly report, going with another peer educator and officer direct visit.
The other training program is peer group sessions including movie display
titled BAIDS Borne^ then a discussion between trained educators and
beneficiaries.
Results and Conclusion: Based on one month evaluation (1-31 July 2007)
455 IDUs (431 Male and 24 Female),%88 of them were 20-30 years old, have
been trained by PLHAs and referring to DIC to exchange syringe program and
getting condoms or start MMT increased about 42 percent. An indirect finding
is health care workers in DIC have changed their attitude to PLHAs and see
them not as a problem also as key of problem solving which would be
decreasing social stigma.
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Gene polymorphisms of tumor necrosis factor !-308 and
interleukin 10-1082 among asthmatic Egyptian children
Ahmed Settin and Magdy Zedan. Mansoura Faculty of Medicine, Pediatrics,
Mansoura, Egypt.
Background: Tumor necrosis factor (TNF) !Y308 and interleukin (IL) 10-
1082 have potent in inflammatory response that may including bronchial
asthma.
Objective: Of this study was to check for association of polymorphisms
related to cytokine genes with susceptibility and severity of bronchial asthma
in Egyptian children.
Methods: Blood samples of 69 asthmatic children receiving treatment and
follow up at Allergy and Respiratory Medicine Unit, Mansoura University
Children Hospital, Egypt were subjected to DNA extraction and amplification
using PCR with sequence- specific primers for detection of single nucleotide
polymorphisms in the promoter regions of cytokine genes TNF-!-308(GYA),
IL-10-1082 (GYA).
Results: Compared to normal controls Egyptian asthmatic children showed
significant higher frequency of IL-10-1082 G/G homozygosity genotype
(PG0.0001, OR=7) with lower frequency of G/A heterozygosity genotype
among cases. This finding was also detected in cases with persistent asthma
and eczema. Whereas these cases showed significant lower frequency of TNF-
!-308 G/A heterozygosity (PG0.05, OR=0.44). Male cases and cases with
positive family history and persistent type of asthma showed higher frequency
of G/G homozygosity.
Conclusion: These specific Egyptian cytokine gene polymorphisms may
contribute to asthma susceptibility and severity of asthma among children.
Separate studies should be specified relating these cytokine genotypes to
response to various modalities in asthma therapy.
Key words: Gene Polymorphisms, TNF !-308 and IL 10-1082, Asthma,
Egypt, Children.
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A two-year aerobiological study and immunotherapy follow-up
with Phoenix sylvestris pollen to seasonal allergic patients from
West Bengal, India
Swati Gupta Bhattacharya1, and Pampa Chakraborty2. 1Bose Institute,
Kolkata, Botany, Kolkata, India; 2Sree Chaitanya College, Botany, Habra,
N-24 Parganas, Kolkata,West Bengal, India.
Phoenix sylvestris or date sugar palm commonly occur in India in
both wild and cultivated forms. The tree is economically important as it
yields fruit, sugar, alcoholic drinks etc. But this pollen was reported to be
allergenic also. So after aerobiological studies we tried to do immunother-
apy to the susceptible patients. A 2-year aerobiological suuvey in the
northern suburb of Greater Calcutta was carried out with the help of a
Burkard Volumetric Sampler. SPT was carried out with P. sylvestris pollen
extract on adult respiratory allergic patients. 35 subjects with typical
seasonal allergic rhinitis with/without bronchial asthma were selected.
Symptom-medication score (based on questionnaire and patient`s diary) was
correlated with pollen count as recorded in Burkard sampler. 18 subjects
were recruited in immunotherapy (IT) group receiving regular injections
containing standardized allergen extract and 17 were recruited to placebo-
controlled (PC) group. Changes in the level of specific IgE, IgG1 and IgG4
were recorded at three months intervals. Measurement of skin wheal
diameter, total IgE level and FEV1 were performed prior starting and after
one month of finishing therapy schedule. The pollen grains of P. sylvestris
were found to be airborne from January to March. Although the occurrence
of the pollen in the air was seasonal, during the peak month, i.e., in
February, it contributed 15.97% for the first year and 14.84% in the second
year of the total aeropollen load. 44.07% of the total patients showed
positive reaction in SPT. The IT group showed 33.5% and 57% decrease in
symptom-medication score during the first and second treatment season
respectively. This group showed a significant decrease of skin-reactivity to
PS pollen extract & specific IgE, significant increase in FEV1, specific IgG1
(1.95Y3.2 times) & IgG4 (21.24Y30.83 times) and no significant changes in
total IgE level. In case of PC group, no significant changes were recorded
for all the mentioned parameters excluding the development of new
sensitization in two cases against Saccharum officinarum (Poaceae) pollen
grain and Alternaria spore respectively. Phoenix sylvestris pollen are
airborne and they cause respiratory allergy to the susceptible patients.
Allergen immunotherapy with standardized PS pollen extract is effective in
seasonal respiratory allergic subjects susceptible to PS pollen with narrow
range of sensitization.
977
Fungal spore, a potential source of occupational health hazard
among the workers of potato cold stores in west Bengal, India
Nimai Chandra Barui. Surendranath College, Botany, Kolkata, West Bengal,
India.
Intense occupational exposure to a number of mould spores or their
fragments for brief or prolonged periods may be responsible for serious health
hazards. This had been the case with the workers of the Potato Cold Stores in
West Bengal. So the basic purpose of the present investigation was first to
assess the qualitative and quantitative estimation of the aeromycoflora of the
cold stores, to determine their allergenic potentialities to incite respiratory
diseases among the workers and also deterioration of the food grains. Burkard
personal Sampler and Andersen two stage sampler was used for this
investigation. Diagnosis of respiratory allergic disorders was based on
detailed medical history followed by skin-Prick test (SPT). A total of 20
fungal spore types were recorded during the survey period of two years
(July’2005 to June’2007) with the dominance of Aspergillus niger (21.73%),
Curvularia lunata (19.13%), Echinobotryum (15.96%), Alternaria alternata
(13.06%), Fusarium solani (5.78%), and Rhizopus nigricans (2.45%) etc.,from
the store houses. Clinical investigation of the susceptible workers with the
antigenic extracts of the six dominant spore types using Skin Prick Test
method clearly demonstrated their variable allergic potency. Among the 126
patients tested the highest positive reaction (2+ or more intensity) was noted in
Aspergillus niger (26.98%) followed by Rhizopus nigricans (21.42%),
Alternaria alternata (19.84%), Curvularia lunata (19.04%), Fusarium solani
(18.25%), etc. Allergenic symptoms were pronounced during monsoon and
summer season or whenever, there was prolonged disruption of power supply.
High frequency of positive response to SPT was due to an increased
prevalence of allergic fungal forms in the working environment, which can be
attributed to poor post-harvest storage and scientific management of the store
houses. The results obtained showed that the work environment was
considerably polluted with the spores of fungi of allergenic and immunotoxic
properties, which cause a high degree of health risk to people employed in
that area.
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Determination of total and specific IgE response in allergic
rhinitis patients of Kashmir Valley-India
Wani Nisar1, Munshi A.H.1, Shah Zaffar A2, Rasool Rohi2, and Akbar
Mudasir1. 1University of Kashmir, Department of Botany, Srinagar, India;
2S.K.Institute of Medical Science Srinagar, Immunology and Molecular
Medicine, Srinagar, India.
Allergy accounts for a substantial number of human diseases with
significant morbidity to patients. Kashmir valley has been witnessing an
increase in allergy related disorders usually due to aeroallergens present in the
environment mostly during spring and autumn seasons. The present study was
aimed at finding total and specific IgE responses in serum sample of 250
patients, reporting to various health centers across the valley with symptoms of
seasonal allergy. Samples were first screened for the total IgE levels by a
sandwich ELISA method. All the samples showed presence of high levels of
total IgE (650Y1200 iu/ml). Specific IgE levels were determined using grass
and tree mix antigens by a two step capture ELISA method. After recording
the concentration of total and specific IgE levels of 250 serum samples, 97
patients having severe symptoms of allergic rhinitis complaints were tested
clinically by intra-dermal antigen skin test method for different allergens like
pollen (18 types), insect (1 type), dust (5 types), fungi (5 types) and epithelia (2
types). 187 samples (74.80 %) out of 250 were reactive for the allergens used
in the present study. Specific IgE ranged from 1.1Y75.0 iu/ml representing
moderate to high specific IgE levels. 63 samples not reactive to the allergens
used above but had high total IgE levels were probably due to other allergens
which are further being evaluated. The skin test reactions were interpreted and
graded at 15 Y 20 minutes as per the criteria of Shivpuri (1974).
979
A study on association of pet ownership history and risk of
asthma among Iranian children
Laleh Sharifi1, Zahra Pourpak1, Saied Bokaie2, and Akram Karimi3. 1Medical
Sciences Tehran University, Immunology, Asthma and Allergy Research
Institute, Tehran, Islamic Republic of Iran; 2Tehran University, Faculty of
Veterinary Medicine, Tehran, Islamic Republic of Iran; 3Medical Sciences
Tehran University, Sought Hygiene Center, Avicenna Clinic, Tehran, Islamic
Republic of Iran.
Background: The identification, isolation, and elimination of allergen(s)
causing bronchial asthma are the most efficient aspect of treatment. The pet
industry has diversified recently, increasing the risk of pet owners’ exposure to
many unknown antigens.
Results: Of population studies have been contradictory and some epidemio-
logical studies showed the risk of pet keeping, some even suggesting that
keeping pets decreased the risk of sensitization and asthma.
Purpose: This study was to determine the association between pet ownership
and asthma.
Methods: A case-control study was conducted among 215 asthmatic
participants referred to Children Medical Center in Tehran in a 2 year period
and were asked to reply a questionnaire in concerning to kind of pet, its sex and
puberty, the place of keeping it, duration of keeping and the aim of pet
keeping. Cases were recruited and matched (age and sex) with 215 healthy
controls. Statistical analysis performed to calculate Odds Ratio (OR) of asthma
morbidity in individuals who had kept pets.
Results: Odds ratio of asthma morbidity in patients who had kept pets was
2.59, CI=1.60Y4.21 and P90.001. Financial aim was the most reason of pet
keeping (18.1%) and the most of pets were mature and were kept outdoor
(41.7%). Pet keeping duration was less than 6 months (87.6%). No difference
between genders was observed.
Conclusion: This study provides evidence that pet ownership is an important
risk factor for asthma.We suggest that individuals who are at the risk of asthma
(Atopic individuals) must avoid contacting with pets. However more research
in this field in Iran is necessary.
980
Health hazards in potato cold stores. Manas Ranjan Majumdar
Manas Ranjan Majumdar. HALDIA GOVERNMENT COLLEGE, BIOLOGY,
HALDIA, India.
Occupational exposure to a number of mould spores and fragments for
a brief or prolonged periods may be responsible for health hazards. Such has
been the csae with the workers of potato cold stores in West Bengal, India. The
investigation was carried out to assess the qualitative and quantitative
composition of air aeromycoflora of the store houses and then to determine
their allergenic potentialities to incite respiratory or other allergic disease
amonfg the workers. A total of 22 fungal types were recorded during the
investigation period for years (from August 2004 to July 2006)with the
dominance of Aspergillus niger (21.73%), Curvularia lunata, (19.13%)Echi-
nobotrynum (15.96%), Alternaris alternata (21.73%), Fusariun solani
(5.78%). and Rhizopus nigricans (2.45%). Cnincal investigation of the
susceptibel workers with the antigeniic extracts of the six dominat spore types
using Skin Prick test method clearly demonstrated their variable allergic
potency. Among the 100 patients tested a high positive reaction (2+ or more
intensity) was noted in Aspergillus niger (26.98%) followed by Rhizopus
nigricans (2.45%), Alternaria alternata (19.84), Curvularis lunatat, Fusarium
solani (18.25%), etc. Allergenic symptoms were pronunced during monosoon
ans summer season or wheneever there were prolonged disruption of power
supply. High frequency of positive response to SPT was due to an increased
prevalence of allergic fungal forms in the working environment which can be
attributed to poor post-harvest storage and scientific management of the store
houses.
981
Data inconsistencies in abstracts of research articles of three
allergy journals
Francis Wu1, Robert Siebers2, Chien-Ya Hung1, and Caroline Phung2.
1Changhua Christian Hospital, Emergency Medicine, Changhua, Taiwan;
2University of Otago, Wellington, Medicine, Wellington, New Zealand.
Background: Recent studies have shown data inconsistencies between the
abstract and full text of published papers.
Objective: The study was to determine data inconsistencies between the
abstract and full text of articles published in three leading allergy journals.
Methods: All articles published in Clinical and Experimental Allergy, Journal
of Allergy and Clinical Immunology and Allergy consecutively over six
months from January 2005 that contained data in the abstract were checked
against corresponding data in the body of the article.
Results: Of 96 articles in Clinical and Experimental Allergy, 33 contained
data in the abstract inconsistent with those reported in, or absent from the body
of the articles, giving an abstract data inconsistency rate of 35.4% (95% CI:
25.8Y45.0). Corresponding abstract data inconsistency rates for the Journal of
Allergy and Clinical Immunology and Allergy were 29.9% (95% CI:
20.3Y39.5; 87 articles) and 24.3% (95% CI: 16.3Y32.3; 111 articles)
respectively.
Conclusion: About one-quarter to one-third of research articles in three
leading allergy journals contained data in abstracts that were inconsistent with
corresponding data in the article, or were not in the article.
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Prevention of signs and symptoms of cold urticaria by ebastine
Markus Magerl, Jan Schmolke, Frank Siebenhaar, Torsten Zuberbier, Martin
Metz, and Marcus Maurer. Charite´ - Universita¨tsmedizin Berlin, Dermatol-
ogy, Berlin, Germany.
Cold urticaria is a frequent subtype of physical urticaria that is caused
by the release of proinflammatory mast cell mediators after cold exposure,
resulting in wheals and itching and sometimes in general systemic
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complications. Cold urticaria may be potentially life threatening, in any case it
has a profound impact on patient quality-of-life. Second-generation anti-
histamines are recommended as the first-line treatment, but to date only a few
have been scientifically tested for this condition. To assess the safety and
efficacy of ebastine in preventing ACU symptoms, we examined 22 adult
patients suffering from cold urticaria within the scope of a double-blind cross-
over trial administering a single dose of 20 mg ebastine or placebo before local
cold challenge. The safety of ebastine was sensitively assessed with a
psychometric battery testing cognitive performance and mood. After cold
challenge, wheal and erythema were assessed by the investigator and the
intensities of pruritus and burning were rated by the subject. We could show
that Ebastine had no negative impact on any of the parameters of cognitive
performance or mood. Most importantly, cold urticaria symptoms were
markedly reduced after challenge in the verum group, indicating that ebastine
can effectively protect patients from cold urticaria symptoms. These results
demonstrate the safety of ebastine and reveal its efficacy in treating patients
with cold urticaria.
983
Dermographic urticaria symptoms can be safely prevented by
ebastine
Markus Magerl, Jan Schmolke, Frank Siebenhaar, Torsten Zuberbier, Martin
Metz, and Marcus Maurer. Charite´ - Universita¨tsmedizin Berlin, Dermatol-
ogy, Berlin, Germany.
Physical urticaria includes a heterogeneous group of disorders
characterized by the development of urticarial lesions and/or angioedema
after exposure to certain physical stimuli. The most frequent physical urticaria
is the dermographic urticaria (DU), in which shearing forces on the skin result
in wheals and itching. Subsequent scratching aggravates the symptoms.
Second-generation antihistamines are recommended as the first-line treatment,
but to date only one has ever been tested for this condition. The aim of this
study was to assess the safety and efficacy of ebastine in preventing DU
symptoms. We administered 20 mg ebastine to seven adult DU patients in the
scope of a double-blind cross-over trial. The safety of ebastine was sensitively
assessed with a psychometric battery testing cognitive performance and mood.
After challenge by shearing forces, wheal and erythema were assessed by
the investigator and the intensities of pruritus and burning were rated by the
subject. We could show that Ebastine had no negative impact on any of the
parameters of cognitive performance or mood. Wheals, pruritus, and burning
were greatly reduced for the majority of subjects. These results underline the
safety of ebastine and reveal its efficacy in cold urticaria. and should be tested
on a larger scale.
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Sensitization to environmental allergens among the inhabitants
of Calcutta city and suburbs with special emphasis to inhalant
fungal allergy: an aerobiological and allergological study
Shaonli Das1, and Swati Gupta-Bhattacharya2. 1Raiganj College (Univesity
College), Botany, Raiganj, India; 2Bose Institute, Botany, Calcutta, India.
Background: Exposure to inhalant bio-particles including mold spore, pollen,
dander, dust mite may incite allergic reaction in pre-sensitized individuals.
Present study was designed to find out the prevalence of allergic diseases
among Calcutta population and to explore the role of mold spore as inhalant
allergen.
Methods: A Burkard sampler, installed in an agricultural field in suburban
Calcutta, operated from Nov 2002-Oct 2004 for catching the mold spores and
a mold calendar was constructed.
Subjects: (n = 1251, male-47.48%; female-52.52%, mean age =
37.97ı´A˜13.13 year) were selected from individuals attending the Allergy
unit of the Institute of Child Health, Calcutta. A questionnaire was used to
assess symptoms and personal factors (current smoking, pet keeping, family
history of asthma, and atopy). A 17 point scale (0 to 17) was constructed for
calculating symptom score. Skin prick test was performed with sterile
antigenic extract and the reaction was considered positive if the wheal diameter
was ıˆ? 3 mm. The values of lung function variables like FVC, FEV1, FEV1%
FVC and FEF 25Y75% were recorded by RMS Medspiror spirometer.
Relationship between symptom score and various personal, and environmental
factors was explored by linear regression at 0.05 probability level (p).
Results: A total of 37 mold spore types were identified and counted. The total
air-spora (cumulative concentration varies from 824.69Y3921.72 spore/m3)
attained a peak in December.About 67.80% of study population reported
symptoms of respiratory allergy (allergic rhinitis, bronchial asthma or both).
Subjects showed variable skin sensitization to different allergens: 46.03% to
molds, 93.65% to pollens, 65.08% to dust mite, 49.21% to cotton fibre and
3.17% to animal dander. About 40.28% subjects exhibited airflow limitation in
peripheral bronchi whereas 4.88% showed airflow limitation in both central
and peripheral bronchi. Symptom score was best predicted by family history of
atopy (adjusted beta 1.34 at 95%CI) at pG0.05 whereas sensitivity to
Azadirachta pollen was a significant risk factor for mold sensitization
(adjusted beta 0.27 at 95% CI) at pG 0.01. The predictors for FEV1%FVC
included female sex, age, sensitization to mold, and animal dander (pG0.05).
Conclusion: Prevalence of respiratory allergy was found in Calcutta
population. Family history of atopy, female sex, age, sensitization to mold,
and animal dander were risk factors for it.
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Eosinophil cationic protein in sputum of wheezing infants
Sirma Mileva1, Todor Popov2, Ivanka Galeva1, and Marta Baleva2. 1Medical
University, Alexandrovska Hospital, Pediatric Department, Sofia, Bulgaria;
2Medical University, Clinic of Allergy and Asthma, Sofia, Bulgaria.
Background: Considering the role of eosinophilic inflammation in asthma it
has been suggested that eosinophils or its granule proteins may be applicable
in the diagnosis of asthma.
Purpose: The study was to assess the level of eosinophilic inflammation of the
lower airways, eosinophils and eosinophil cationic protein (ECP) by sampling
induced sputum from the pharyngeal region of their oral cavities.
Methods: Fifty four infants with a mean age 9 months (2Y22 months), who
had been hospitalized in the Pediatric Department of the Alexandrovska
Hospital with acute wheezing episodes from October 2005 to March 2006
year, were included in the study. The wheezy children were divided into three
clinical groups according to the number of previous wheezy episodes:
group 1-first wheeze (n = 29), group 2-with recurrent wheeze (n = 15) and
group 3-those with persistent episodes of wheeze diagnosed clinically as
asthma (n = 10).
Results: Neither sputum eosinophils nor ECP turned out to be of
discriminative value for the three groups of children outlined on the basis of
clinical criteria. Still the median sputum ECP levels in the asthmatic group
tended to be higher (966 ı`g/L) than those in the recurrent wheezy group (575
ı`g/L) and in the first wheezy group (123 ı`g/L), with a considerable overlap
between the groups.
Conclusion: We documented very early presence of eosinophilic inflamma-
tion in infants with recurrent respiratory symptoms and suspected asthma.
986
Defining asthma phenotypes based on seasonal distribution of
exacerbation in children with bronchial asthma
Milena Yankova, and Slavi Filchev. Medical University, Alexandrovska
Hospital, Pediatric Department, Sofia, Bulgaria.
Background: Nowadays asthma is not considered as a homogenous disorder.
Several asthmatic phenotypes could be distinguished, especially in childhood.
No standardized method for determination of these phenotypes is available.
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Aim: To define asthma phenotypes in asthmatic children based on the seasonal
distribution and some clinical features of asthma exacerbations.
Methods: Object of research were 326 children with 1407 acute episodes
treated at the Clinic of Pediatrics in the period between 2004 and 2006. Based
on distribution of the exacerbation frequency throughout the year with two
well-marked peaks in December-January and in June-July three phenotypes
were defined: Bwinter^ phenotype (WP) /presumptive virus-induced obstruc-
tion/ in 145 children, Bsummer^ /atopic/ phenotype (SP) in 82 children, and
Bnon-seasonal^ /persistent/ phenotype (NP) in 99 children.
Results: Children with WP showed significantly lower average age (6.8 years
for WP versus 11.3 years for SP), dominating symptoms for respiratory
infection (88 % for WP versus 31 % for SP), and lower frequency of atopy (in
32 % for WP versus 78 % for SP). The asthma onset in SP group of children
was later (average age of 6.5 years) while in WP the onset was at average age
of 4.1 years. WP and NP showed slower improvement of the obstructive
syndrome and more manifested functional impairments after the treatment
(FVC 61 % of the expected for WP and FCV 67 % of the expected for NP).
Conclusion: Based on seasonal distribution of asthma exacerbations three
asthma phenotypes with different clinical features, course and treatment results
were defined.
987
Risk factors leading to hospital admission in Iranian asthmatic
children
Mostafa Moin1, Asghar Aghamohammadi2, Mohammad Hossein Gharavi3,
Ali Ardestani3, Armaghan Faghihimehr3, Ali Kouhi3, and Mehdi Mazloumi3.
1Children Medical Center, Immunology, Asthma & Allergy Research Institute,
14194, Islamic Republic of Iran; 2Children Medical Center, Department of
Clinical Immunology, Terhan, Islamic Republic of Iran; 3CHildren Medical
Center, Department of Clinical Immunology, Tehran, Islamic Republic of
Iran.
Background: Asthma is one of the most common chronic diseases in the
world, leading to an increased rate of hospitalization. We performed this study
to better understand the factors leading to admission among asthmatic children.
Methods: We performed a study among asthmatic children in a referral
hospital for asthma and allergy in Tehran. Sixtythree cases were selected from
asthmatic children admitted to the emergency room (ER) who still had an
indication for ward or intensive care unit admission after primary treatment.
Our control group was the asthmatic children discharged after primary
treatment and patients who were referred to the asthma and allergy clinic (63
patients). Data were obtained by structured questionnaires filled out during
clinical interviews.
Results: There was a significant difference in mean age (5 years for cases vs.
6years for controls; p = 0.049), personal and familial allergic history (69.8 and
57.1% for cases vs. 34.9 and 36.5% for controls; p G0.01 and p = 0.02,
respectively), history of recent respiratory infections (79.4% for cases vs.
49.2% for controls; p G 0.01), hospitalization history due to asthma (57.1% for
cases vs. 23.8% for controls; p G0.01) and regular use of inhaled corticosteroid
(66.7% for cases vs. 33.3% for controls; p G0.01).
Conclusion: Our findings confirm most previous observations, suggesting
that recent respiratory infections, hospitalization, personal or familial allergy,
disease severity and lower ages are important factors leading to hospitalization.
We also found that regular clinical follow-up, regular use of inhaled
corticosteroids, higher IgE levels and O 2 saturation may lower the probability
of hospitalization during asthmatic attacks.
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11Polymorphisms impairing histamine degradation moderate
behavioural responses to food additive challenge
John Warner1, Edmund Sonuga-Barke2, Donna McCann2, Kate Grimshaw3,
John Holloway3, and Jim Stevenson2. 1Imperial College, Department of
Paediatrics, London, United Kingdom; 2University of Southampton, School of
Psychology, Southampton, United Kingdom; 3University of Southampton,
School of Medicine, Southampton, United Kingdom.
Background: The relationship between artificial food colouring and
benzoate perservative (AFCP) intake and behaviour has hitherto been
contentious. We have previously shown in a population based DBPCFC
study, an adverse effect of AFCP on parentally-rated behaviour of 3 year olds
and have now confirmed the observations in 144 8Y9 year olds and 153 3
year olds using objective measures of observed behaviours in a school
setting. One potential mechanism is IgE independent histamine release from
circulating basophils.
Methods: From the second challenge study we have genotyped the children
using buccal cells and related findings to the magnitude of the behavioural
response to challenge.
Results: Polymorphisms of catecholamine genes, COMT Val108Met and
ADRA2A C1291G, previously associated with ADHD, had no impact on
responses but T939C and Thr105Ile polymorphisms of the histamine N-
methyltransferase gene (HNMT) significantly (p=0.02 and 0.04 respectively)
adversely affected responses to AFCP challenge.
Conclusion: HNMT polymorphisms impair histamine clearance and AFCP
cause histamine release. The presence of Histamine 3 receptors in the brain
provides a potential mechanism (and therapeutic target) to explain the effect
we observed. Many environmental factors increase histamine including
infections and many foods. This would explain the frequent claim that food
intolerance and infections adversely affect behaviour in some children. This
gene by environment interaction should be investigated in relation to AFCP
induced urticaria, asthma and other atopic conditions.
989
Serum specific IgE - is result enough?
Joana Caiado1, Susana Lopes da Silva1, and Jose´ Costa Trindade2.
1Hospital de Santa Maria, Servic¸o de Imunoalergologia, Lisboa, Portugal;
2Hospital de Santa Maria, Unidade de Imunoalergologia Pedia´trica, Lisboa,
Portugal.
Background: In vitro determination of serum specific IgE (sIgE) is an
essential diagnostic tool in allergy. Clinical analysis laboratories offer
different methods / technologies to determine sIgE, in some cases with
highly variable and poorly interchangeable results, concerning the different
allergens. Rotation between different methods may compromise allergic
patients follow-up, namely in those situations that may benefit from
sequential sIgE determinations, as food allergy and specific immunotherapy
efficacy evaluation.
Aim: To verify the availability of written information concerning the method
used in sIgE determination in lab result reports from clinical analysis
laboratories in Lisbon District.
Methods: During 2 months (April and May 2007), 3 Immunoallergologists
collected serum sIgE result reports from the patients they observed. Reports
from 50 different clinical analysis laboratories within Lisbon district were
obtained and analysed. Labs that did not mention the method that had been
used to sIgE determination were further inquired by phone, in order to get
that information.
Results: Among the 50 reports analysed, only 13/50 (26%) specified the
method that had been used, namely the immunoenzimatic (IE) method in 9 and
the chemiluminescent (QL) method in 4. Among the remaining 37 labs, when
later contacted by phone, we verified that 17/37 (46%) were using IE method,
14/37 (38%) QL and 6/37 (16%) were using both methods, according to the
different allergens. In 27/50 laboratories (54%), BRAST^was used as synonym
of sIgE.
Conclusion: We intend to alert to the generalized lack of written information
concerning the methods used in serum sIgE determinations in the lab reports
from Lisbon district laboratories. This lack of written information, the
persistence of the incorrect use of the term BRAST^ and the simultaneous use
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of both methods for different allergens reveal the unawareness of most
laboratories concerning this important issue, which is urgent to amend.
990
Chronic urticaria - why are patients dissatisfied with treatment?
Marcus Maurer1, Jean-Paul Ortonne2, and Torsten Zuberbier1. 1Universita¨ts-
medizin Berlin, Department of Dermatology and Allergy, Berlin, Germany;
2
Hoˆpital de L’Archet 2, Department of Dermatology, Nice, France.
Background: Chronic urticaria (CU) is a common skin disorder characterized
by recurrent spontaneous outbreaks of itchy wheals and/or angioedema.
Chronic urticaria has been shown to have substantial impact on patient quality
of life, but little else is known about patient perspectives on CU and its
treatment. In particular, it is not known whether patients actually follow
guideline treatment, and if not, why not.
Methods: To address these questions, a survey was conducted via an online
panel with 321 randomly selected, representative adults in Germany and
France who were diagnosed with CU. The survey included the Skindex-29
questionnaire on quality of life and questions about treatment and patients`
relation to their physician. Treatment was compared with recommendations
from the current GA2LEN/EAACI/EDF guidelines.
Results: The survey confirmed that CU has substantial impact on patient
quality of life. Notably, half the respondents were only Bsomewhat satisfied^
with their treatment of their CU and considered their physician only
Bsomewhat knowledgeable.^ Only 64% of the respondents were using
prescription medications as recommended by guidelines. Notably, 62% of
respondents reported that they avoid seeing their physician unless absolutely
necessary.
Conclusion: This survey implies that physicians either do not fully understand
the experience of many of their patients with CU or are not building
trustworthy supporting relations with them. Physicians need to talk with these
patients more about how the condition impacts their lives and feelings in order
to improve their compliance with treatment guidelines.
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Lidocaine/prilocaine-treated skin modulate allergic
inflammation induced by skin prick test
Rosaly Vieira dos Santos1, Hermenio Lima C2, Peter Martus3, and Marcus
Maurer1. 1Charite´ Universita¨tsmedizin Berlin, Allergy, Dermatology and
Venerology, Berlin, Germany; 2Federal University of Parana´, Clinical
Pathology, Curitiba, Brazil; 3Charite´ Universita¨tsmedizin Berlin, Department
of Biostatistics, Berlin, Germany.
Background: There are evidences that peripheral nerves contribute to the
pathophysiology of many dermatologic diseases. The effects of neurogenic
inflammation in allergen-induced skin prick test reaction are not clear and no
study has been measured the effect of inhibition of peripheral nerves on all
inflammatory skin signals induced by skin prick tests.
Objective: The purpose of this study was to investigate the anti-inflammatory
effects of lidocaine/prilocaine cream on histamine and allergen-induced skin
inflammation.
Methods: Skin prick tests using histamine and allergens were performed
in 48 subjects on lidocaine/prilocaine and vehicle-treated skin. Volume,
temperature, erythema size and pruritus on skin test area have been
determined and compared.
Results: The absence of functional cutaneous nerves has significant and
similar effects on all qualities assessed (rubor, calor, tumour, pruritus) in both
allergic and histamine-induced inflammation skin responses. Effects on
hyperthermia were found to be mild, i.e. similar to those on wheal formation.
Pruritus responses were unaltered or even enhanced in denervated skin.
Conclusion: Lidocaine/prilocaine-treated skin modulate allergic inflamma-
tion induced by skin prick tests.
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A differential effect of two probiotics in the prevention of eczema
and atopy
Kristin Wickens1, Peter Black2, Thorsten Stanley3, Edwin Mitchell4, Penny
Fitzharris5, and Julian Crane1. 1University of Otago, Wellington School of
Medicine and Health Sciences, Wellington, New Zealand; 2University of
Auckland, Faculty of Medical and Health Sciences, Auckland, New Zealand;
3Wellington Hospital, Paediatrics, Wellington, New Zealand; 4University of
Auckland, Department of Paediatrics, Auckland, New Zealand; 5Auckland
City Hospital, Immunology, Auckland, New Zealand.
Background: The role of probiotics in the prevention of allergic disease has
not been clearly established, despite early reports that Lactobacillus GG halves
the risk of atopic eczema at 2 years. This study aimed to determine whether
probiotic supplementation in early life can prevent the development of eczema
and atopy at 2 years.
Methods: Randomized double blind placebo controlled trial of infants at risk
of allergic disease and their mothers. From 35 weeks gestation, pregnant
women were randomized to take Lactobacillus rhamnosus, Bifidobacterium
lactis or placebo daily until 6 months if breastfeeding, and their infants from
birth to 2 years (n = 474). The infant`s period prevalence of eczema and point
prevalence of atopy, using skin prick tests to common food and environmental
allergens, was assessed at 2 years (n = 466).
Results: Compared to infants in the placebo group, those receiving
Lactobacillus rhamnosus had a significantly (p=0.01) reduced risk of eczema
(OR=0.47, 95% confidence intervals (CI) 0.26Y0.84), but this was not the case
for infants taking Bifidobacterium lactis (OR=0.88, 95% CI 0.53Y1.49). There
was no significant effect of Lactobacillus rhamnosus (OR=0.65, 95% CI
0.38Y1.11) or Bifidobacterium lactis (OR=0.76, 95% CI 0.45Y1.28) on atopy.
Conclusion: The protective effect we found for Lactobacillus rhamnosus
against eczema but not atopy is consistent with findings from some other
studies. The effect of probiotics on eczema may depend on the particular
probiotic selected for use.
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Sublingual Immunotherapy with Honeybee venom reduces large
local reactions: a randomized, double blind controlled study
Maurizio G Severino1, Giorgio Cortellini2, Patrizia Bonadonna3, Elisabetta
Francescato4, Ilaria Panzini5, Donatella Macchia1, Paolo Campi1, Igino
Spadolini1, Giovanni Passalacqua6, and Giorgio Walter Canonica6. 1Nuovo
Ospedale San Giovanni di Dio, Allergy Clinic, Florence, Italy; 2Rimini
Hospital, Internal Medicine and Rheumatology, Rimini, Italy; 3Verona
General Hospital, Allergy Unit, Verona, Italy; 4Entomon, Sas, Florence,
Italy; 5Rimini Hospital, Research and Innovation Unit, Rimini, Italy; 6Genoa
University, Dept of Internal Medicine - DIMI, Genoa, Italy.
Introduction: Hymenoptera venom immunotherapy (VIT) is highly effective,
since it confers a clinical protection against hymenoptera sting, including
honeybee (HB) in about 90% individuals (1). The effectiveness of VIT can be
easily demonstrated by the reduction of the intensity and size of large local
reactions (LLR)(3, 4). VIT is currently given only by subcutaneous injections.
Sublingual immunotherapy SLIT proved effective and safe in respiratory
allergy, therefore its use in hymenoptera allergy can be hypothesized. We
aimed at evaluating the clinical efficacy of SLITwith HB venom in beekeepers
or their family members, by assessing the effect on LLR to HB stings. LLR
was chosen as evaluation parameter for safety reasons, as this is a pilot study.
Methods: This was a randomised, double blind, placebo controlled study.
Patients with LLR due to HB sting and skin tests/CAP-RAST assay solely
positive to HB were enrolled. They were randomised to receive either HB
SLIT (15 patients) or undistinguishable placebo (15 patients) for six months.
The HB SLIT (Anallergo, Florence, Italy) involved a 6-week build-up,
followed by a maintenance phase where 400 mcg were given monthly. LLR on
HB sting were measured before SLIT and after no less than 3 months of
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maintenance. Treated patients and placebo were compared by Pearson test.
P values less than .05 were considered statistically significant.
Results: 30 adult patients were enrolled and 26 completed the study, with 1
dropout in the active and 3 dropouts in the placebo group. In SLIT patients the
peak diameter of LLR was reduced 9 50% in 8/14 (57%). No change in LLR
was seen in 11 of 12 placebo patients, and a systemic reaction (generalized
urticaria) occurred in a patient on re-sting. The difference was significant
(P = .004) between the 2 groups. No adverse event was reported and no
discontinuation of SLITwas required.
Conclusion: HB-SLIT significantly reduced the extent of LLR in HB allergic
subjects, and its safety profile was satisfactory. This pilot study envisages the
possible use of SLIT also in hymenoptera allergy, and trials in patients with
systemic reactions should be the next step to confirm our observations.
994
Mometasone furoate nasal spray effectively treats the ocular
symptoms of seasonal allergic rhinitis in patients with all degrees
of severity over 24 hours
L Bielory1, MR Danzig2, and D Gates2. 1UMDNJ-New Jersey Medical
School, Asthma and Allergy Research Center, Newark, New Jersey, United
States; 2Schering-Plough Research Institute, Kenilworth, New Jersey, United
States.
Background:Mometasone furoate nasal spray (MFNS) has been shown to be
effective in controlling the nasal symptoms of seasonal allergic rhinitis (SAR).
An analysis of subject-reported symptom data in MFNS trials was performed
to determine the impact of MFNS on ocular symptoms. This analysis
evaluated the effects of MFNS on SAR patients with varying degrees of
symptom severity and differences in symptom reduction in the morning (AM)
and evening (PM).
Methods: A retrospective analysis was conducted of data pooled from four
randomized, double-blind, placebo-controlled clinical studies (three 2-week;
one 4-week) with similar protocols that compared the effectiveness of MFNS
200 mcg QD and placebo in controlling ocular symptoms in subjects aged Q12
years with a Q2-year history of SAR. The analysis reviewed change from
baseline over a 15-day period in symptom scores for eye tearing, itching, and
redness on a 4-point scale (0=none; 3=severe), and calculated total ocular
symptom score (TOSS). The effect size of the Days 1Y15 average for subjects
with mild, moderate, or severe symptoms at baseline was compared, and TOSS
was evaluated approximately 12 hours postdose (PM) and on arising,
approximately 24 hours postdose (prior to dosing on next day, AM).
Results: Subjects in the MFNS (n = 491) and placebo (n = 492) groups had
similar baseline clinical and demographic characteristics. The mean baseline
TOSS was 4.35 (PM 4.39; AM 4.32) for the MFNS group and 4.5 (PM 4.60;
AM 4.43) for the placebo group. The decrease in TOSS with MFNS for the
Day 1Y15 interval was -19.8% vs -5.6% for placebo (PG0.001); the difference
reached statistical significance at Day 3. For the same time period, scores for
tearing decreased by -22.2%withMFNS vs -13.9%with placebo (PG0.001), for
eye itching by -17.3% with MFNS vs -12.3% with placebo (P=0.002), and for
redness by -15.7% with MFNS vs -8.3% with placebo (P=0.002). For the mild,
moderate, and severe symptom groups, the improvements in TOSS with MFNS
over placebo were 0.30, 0.42, and 0.50, respectively. Reductions in individual
symptom scores were significantly greater withMFNS thanwith placebo in both
the PM (Pe0.006) and AM (Pe0.001). Importantly, differences in TOSS
between MFNS and placebo in the PM (0.36) and AM (0.43) were similar.
Conclusion: MFNS reduced ocular symptoms of SAR over 24 hours
regardless of subjects’ baseline symptom severity.
995
Shrimp allergy: effect of vinegar soaking on allergenicity
Eden Perez-Macalalag1, Madeleine Sumpaico2, and Benigno Agbayani3. 1St.
Luke’s Medical Center, Department of Pediatrics, Quezon City, Philippines;
2UP-Philippine General Hospital, Department of Pediatrics, Manila,
Philippines; 3UP-Philippine General Hospital, Department of Internal
Medicine, Manila, Philippines.
Background: Previous studies demonstrated the muscle protein tropomyosin
as the major shrimp allergen. This allergen, Sa-II, was shown to be a 34-kDa
protein - rich in aspartic and glutamic acids. Heat-stability of this allergen has
been documented. However, no studies have shown yet the effect of vinegar on
this allergen. This study aimed to demonstrate if vinegar soaking prior to
cooking would have an effect on shrimp allergenicity, based on skin test results.
Methods: Eighteen shrimp-allergic and eighteen non-shrimp-allergic pedia-
tric patients were subjected to skin prick test using conventionally-prepared
shrimp extract. Mean wheal diameters obtained were compared to mean wheal
diameters obtained using 3 experimental shrimp extracts prepared with
preliminary vinegar soaking. For the adult group, twenty-six shrimp-allergic
and twenty-six non-shrimp-allergic parients were included.
Results: Mean wheal diameters obtained using shrimp extract prepared with
preliminary vinegar soaking were significantly smaller than mean wheal
diameters obtained using conventionally prepared extract. Wheal diameters
obtained for shrimp-allergic patients were significantly bigger than wheal
diameters obtained fo non-shrimp-allergic individuals. Results were similar for
pediatric and adult patients.
Conclusion: Results indicate that vinegar soaking prior to cooking can reduce
shrimp allergenicity. With resources, further validation of results using double-
blind placebo-controlled food challenges woul be ideal.
996
Mometasone furoate nasal spray improves symptoms of
perennial allergic rhinitis in children and adults in Peru
Percy Ruiz. Clinica Angloamericana, ENT Department, Lima, Peru.
Background: Perennial allergic rhinitis (PAR) is a highly prevalent disease
globally and is the most common chronic disease in children. Nasal obstruction
and other bothersome symptoms of PAR need to be treated year round.
Previous studies have shown the intranasal corticosteroid mometasone furoate
nasal spray (MFNS) to be well tolerated and clinically effective in relieving the
symptoms of PAR.A studywas conducted to assess effectiveness ofMFNS and
patient satisfaction with treatment in pediatric and adult subjects.
Methods: In this prospective, open-label, multicenter study, 33 Peruvian
subjects (age 8 to 69 years) with clinically diagnosed PAR recorded nasal
symptom data in a diary. Total nasal symptom score (TNSS) was evaluated at
15 and 30 days. Subjects also rated satisfaction with treatment, and the
investigators evaluated adverse events.
Results: Thirty-three subjects (61% female, 39% male) received MFNS 100
or 200 mcg QD (pediatric or adult dose). Their mean TNSS was reduced
from 10.7 (T 2.9 SD) at baseline to 4.1 (T 2.9 SD) at 15 days and 1.6 (T 2.2 SD)
at 30 days (PG0.001 for both reductions). At days 15 and 30, 25 subjects (76%)
and 31 subjects (94%), respectively, rated themselves as satisfied or very
satisfied with treatment. Mild adverse events (nasal irritation, sneezing,
epistaxis, and cough) occurred in 7 (21%); one subject stopped treatment due
to nasal irritation.
Conclusion: Mometasone furoate nasal spray 100 or 200 mcg QD safely and
effectively improved symptoms of PAR in children and adults.
997
Effect of postoperative mometasone furoate nasal spray on
wound healing following endoscopic sinus surgery
Mark Jorissen1, and Claus Bachert2. 1University of Leuven, ENT Department,
HNS, Leuven, Belgium; 2University Hospital Ghent, ENT Clinic, Ghent,
Belgium.
Background: Chronic sinusitis and nasal polyposis are diseases of the nasal
and sinus mucosa that affect approximately 15% and 4% of the population,
respectively. Functional endoscopic sinus surgery (FESS) is standard surgery
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for both diseases after failure of medical treatment. Approximately 20% of
surgery patients experience impaired wound healing following FESS, leading
to recurrences of sinusitis or complications requiring further surgery. A double-
blind multicenter study found that 6 months’ treatment with the intranasal
corticosteroid mometasone furoate nasal spray (MFNS) 200 mcg QD after
surgery for bilateral nasal polyps significantly prolonged the time to recurrence
compared with placebo. This study was undertaken to investigate whether use
of MFNS following FESS improves wound healing over 6 months.
Methods: In this double-blind, randomized, placebo-controlled study, subjects
with a diagnosis of chronic sinusitis or nasal polyps were randomized to
receive 6 months’ treatment with MFNS 200 mcg BID or placebo beginning
approximately 2 weeks after FESS. Endoscopic scores were assessed at 1 and 2
weeks, and at 1, 2, 4, and 6 months. The primary efficacy endpoint was the
investigator`s assessment of treatment outcome at 6 months. A combination
score was derived from scores for inflammation, edema, and polyps.
Postoperative symptom scores were recorded at 1, 2, 4, and 6 months.
Adverse events (AEs) were recorded throughout the study.
Results: Of the 99 randomized subjects, 91 (46 MFNS, 45 placebo) were
included in the intent-to-treat analysis. Subjects in the MFNS group received
oral steroids for the first 10 days postsurgery. For 24 subjects (11 MFNS, 13
placebo) who discontinued, results from the last study visit were used.
Preoperative symptom scores in the two groups were similar. At 6 months,
investigators` assessment of treatment outcome and reductions in total
endoscopic scores in all subjects were superior, but did not reach statistical
significance, with MFNS versus placebo. Combination endoscopic scores at 6
months showed significantly improved healing with MFNS versus placebo for
all subjects (median scores: 0.0 vs 3.0, P=0.02) and those with nasal polyps
(median scores: 2.0 vs 4.0, PG0.03). MFNS was well tolerated.
Conclusion: Treatment with MFNS following sinus surgery improved
healing, particularly in subjects with an initial diagnosis of nasal polyps,
and was well tolerated.
998
Mometasone furoate nasal spray reduces symptoms and
improves quality of life in chinese children with allergic rhinitis
Yamei Zhang. Beijing Children`s Hospital, Department of ORL-HNS,
Beijing, China.
Background: Approximately 40% of children and adolescents in China suffer
from symptoms of allergic rhinitis (AR). Effective treatment of AR in children
is important in minimizing or preventing behavioral problems and poor
academic performance and may help prevent the development of comorbid
disorders such as asthma, adenoidal hypertrophy, and otitis media with
effusion. This study was undertaken to evaluate the effects of mometasone
furoate nasal spray (MFNS) on clinical symptoms and quality of life (QoL) in
Chinese children with AR.
Methods: A total of 273 symptomatic children aged Q6 years and e12 years
with documented seasonal or perennial AR were treated in an open-label study
of MFNS 100 mcg QD for 4 weeks. Eligible subjects had a nasal stuffiness/
congestion score Q2 (on a scale of 0=no symptoms and 3=worst symptoms)
and a total nasal symptom score (TNSS) Q8 (total of the individual symptom
scores for rhinorrhea, congestion, nasal itching, and sneezing) at the start of
treatment. The primary efficacy variable was a change in the TNSS, and the
coprimary variable was a change in the individual symptom scores, while the
secondary efficacy variables included overall efficacy and Pediatric Rhino-
conjunctivitis QoL Questionnaire (PRQLQ) scores (assessing nasal and eye
symptoms, behavior, and daily life).
Results: MFNS significantly (PG0.05) reduced TNSS from baseline (mean
9.16) after 1, 2, and 4 weeks of treatment (mean scores 5.41, 3.47, and 2.10,
respectively). Significant improvements from baseline were observed at each
week for all individual nasal symptoms. The percentages of patients achieving
a 25% improvement (indicating at least moderate symptom reduction) from
baseline in TNSS at weeks 1, 2, and 4 were 74%, 95%, and 96%, respectively.
Moderate-to-complete symptom relief was reported by 71% of subjects at
week 1 and 99% at week 4. Significant reductions (improvements) from
baseline in total and individual PRQLQ scores were seen at weeks 2 and 4.
Mean behavior PRQLQ scores decreased by a statistically significant amount
from 13.99 at baseline to 5.70 at week 2 and 2.71 at week 4. Mean PRQLR
scores decreased from 8.30 at baseline to 3.12 at week 2 and 1.72 at week 4.
Less than 2% of subjects reported adverse events.
Conclusion:MFNS effectively relieved symptoms of AR, improved QoL, and
was well tolerated in Chinese children with AR.
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Mometasone furoate nasal spray improves quality of sleep and
reduces symptoms of allergic rhinitis in chinese patients
Demin Han. Beijing Tongren Hospital, Department of Otolaryngology Head
and Neck Surgery, Beijing, China.
Background: Between 20% and 40% of urban-dwelling adolescents and
adults in China report symptoms of allergic rhinitis (AR). Unlike other regions
where pollen allergy is common, in China dust mites and/or silk are the more
prevalent allergens. Consequently, many Chinese people with AR suffer from
symptoms throughout the year. One recent study found that once-daily
mometasone furoate nasal spray (MFNS) was an effective treatment for AR in
Chinese people in Hong Kong. An open-label study was undertaken to
evaluate further the effect of MFNS on clinical symptoms and quality of life in
Chinese patients with AR.
Methods: A total of 500 subjects aged Q12 years to e70 years with a physician
diagnosis and documented medical history of seasonal or perennial AR were
treated with MFNS 100 mcg QD for 28 days at 10 centers in China. At the
screening visit, eligible subjects had a total nasal symptom score (TNSS) Q8
(maximum of 12) and a nasal stuffiness/congestion score Q2 (maximum of 3).
The primary efficacy variables were change from baseline in TNSS and
individual symptom severity scores for congestion, rhinorrhea, sneezing, and
itching. Secondary efficacy variables were change from baseline in scores for
interference with sleep and daytime activities on the Nocturnal Rhinocon-
junctivitis QoL Questionnaire (NRQLQ) and the Mini-Rhinoconjunctivitis
QoL Questionnaire (Mini-RQLQ), respectively.
Results: MFNS significantly (PG0.05) reduced TNSS and individual nasal
symptom scores from baseline at each evaluation. Mean TNSS at baseline and
weeks 1, 2, and 4 were 9.24, 5.78, 3.99, and 2.98, respectively. Corresponding
mean scores for nasal congestion were 2.37, 1.57, 1.14, and 0.84; similar
improvement was seen with the other nasal symptoms. At week 4, 94.4% of
subjects reported moderate-to-compete relief of AR symptoms. Total and
individual NRQLQ scores and scores for sleep problems and for symptoms
during sleep and on awakening were significantly reduced after 1 week of
treatment. There were significant reductions from baseline in total Mini-RQLQ
scores and scores for activity problems and symptoms during activity after 1
week. MFNS was well tolerated.
Conclusion: MFNS 100 mcg QD effectively reduced symptoms of AR,
improved the quality of sleep and daytime activities, and was well tolerated in
Chinese patients with AR.
1000
Frequency of Dermatophagoides mite allergens in the homes of
allergic patients in Mashhad and Tabriz
Reza Farid Hosseini1, Mahnaz Sadeghi Shabestari2, Badrosadat Rahnema3,
Mohamad Hojati4, Navab Mosavi4, Mohamad Fereidoni5, and Mahnaz
Shabestari6. 1Immunology/Hmashhad Hospital, Immunology, Mashhad,
Islamic Republic of Iran; 2Division of Immunology and Allergy, Children’s
Hospital, Pediatrics, Tabriz University of Medical Scienses, Islamic Republic
of Iran; 3Imm, Immunology/Tabriz, Tabriz University of Medical Scienses,
Islamic Republic of Iran; 4Immnology/Tabriz, Madicl Scienses, Tabriz
University of Medical Scienses, Islamic Republic of Iran; 5Immunology/
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Mashhad Hospital, Immunology, Mashhad, Islamic Republic of Iran;
6Children’s Hospital, Pediatrics, Tabriz, Islamic Republic of Iran.
Introduction: Allergic diseases are common disorders with increasing rate
during the last 30 years. almost 30% of people have a kind of allergic disorders
during their life. Mites in house dust are the most important allergens in
allergic disorders. The optimal growth conditions for mites are temperature
and humidity and the most important sites are inside bedding, mattresses and
carpets. The aim of this study is the survey of frequency of Dermatophagoides
and their allergens in the homes of allergic patients.
Methods: This descriptive, cross-sectional study has been performed in Tabriz
and Mashhad cities, two major industrial centers in north western and north
eastern Iran, respectively, from 2005 to 2006. Twenty three allergic patients
with positive skin prick test to mites from each city were selected and all of the
methods for evaluation of mites and their allergens (specific antibodies of Derp
and Derf, density of mites and concentrations of mite allergens) were
measured. Because of high density of mites in carpets and bedding, sampling
was obtained from these two sites.
Results: The frequency of mite density in the homes of allergic patients was
32.6%, 95%CI, 31.25 to 33.95; specific antibody to mite allergens was 23.9%,
95%CI: 23.78 to 24; and concentration of HDM allergens which is performed
by ELISA, was not detectable.
Conclusion: Mites are common in worldwide, but the incidence of them is
various in different parts of world. The frequency of mites and their allergens
in two large provinces of Iran are lower than other studies, performed in other
parts of world. The most important factor in frequency and growth of them is
environmental humidity, and the other factors such as carpets and bedding
have less importance.
1001
The differences of clinical characteristics between childhood and
adult allergic rhinitis patients in Asians: according to ARIA
classification
Hyun Jong Lee1, Dong Wook Kim2, Jeong-Whun Kim1, and Chul Hee Lee2.
1Seoul National University Bundang Hospital, Otorhinolaryngology Head &
Neck Surgery, Seongnam-si, Gyeonggi-do, Republic of Korea; 2Seoul
National University Hospital, Otorhinolaryngology Head & Neck Surgery,
Seoul, Republic of Korea.
Background: The prevalence of allergic rhinitis varied across centres from
0.8% to 14.9% in the 6Y7-year-olds and from 1.4% to 39.7% in the 13Y14-
year-olds. The recent guidelines of Allergic Rhinitis and its Impact on Asthma
(ARIA) group, classified it as the frequency and severity may not be
appropriate for the children age group. The present study evaluates the
childhood and adult patients with the ARIA classification and analyzed the
clinical features of each age group.
Methods: 1,375 subjects with allergic rhinitis diagnosed by skin-prick test at
our hospital from December 2005 to July 2007 were included. These patients
were classifed according to age; babyhood(1Y4 years), preschoolers (5Y7
years), elementary schoolers (8Y13 years), adolescents (14Y19 years), young
adults (20Y35 years), adults (36Y55 years), middle age (55Y64 years), old age
(65 years).Clinical features including nasal obstruction, rhinorrhea, nasal
itching, sneezing, postnasal drip(PND), ocular symptoms and sleep dis-
turbance and the allergen was analyzed in each age group according to the
ARIA classification.
Results: A similar distribution of the ARIA classification groups were shown
among all ages; Mild & intermittent group 27.5%, moderate to severe &
intermittent group 17.8%, mild & persistent 18.5%, moderat to severe &
persistent 34.9%. There was a higher proportion of nasal obstruction(p=0.04)
and PND(p=0.042) in babyhood & preschoolers compared to adults, but
ocular symptoms(p=o.01) and sneezing(p=0.01) were shown more frequently
in adults. PND, sleep disturbance, nasal itching showed no distributional
difference between children and adults. For allergens, housedust mite(p=0.07)
showed a higher proportion in children whereas grass(p=0.01) and
weed(p=0.021) was more frequent in adults. Clinical features, IgE and
serum eosinophile count showed no significant relationship in each age ARIA
classification group.
Conclusion: Classification of the ARIA group into different ages helded to
identify the different clinical manifestations among children and adults. A new
treatment strategy taking children’s clinical features into account is deemed
necessary.
1002
Chronic idiopathic urticaria and autoimmune thyroid disease
Vincenzo Patella, Diomira Magliacane, and Giovanni Florio. U.O. of Allergy
and Clinical Immunology, Agropoli Comunity Hospital, Department of
Medicine of ASL SA/3, Salerno, Italy.
Chronic idiopathic urticaria (CIU) persists for longer than 6 weeks,
with a not determined cause. One of the interesting clinical associations is
between chronic urticaria with positive autologous serum skin test (ASST) and
thyroid disease. CIU and chronic tyroiditiis has not been completely
investigated.
Methods: We studied 94 patients (65 female and 39 male; mean age 44.7
years; range 15Y78 years) who had CIU and a history of thyroid dysfunction.
Thyroid function was investigated by means of thyroid-stimulating hormone
(TSH), fT3 and fT4 measurement and thyroid ultrasound. Thyroid antibodies
(anti-thyroid peroxidase and anti-thyroglobulin), total serum IgE levels and
ASSTwere performed in all patients.
Results: Antibodies to thyroglobulin and to peroxidase were positive in 26/94
patients (27.7%) with CIU and morphological or volumetric abnormalities of
the thyroid gland by ultrasonography. All the CIU patients with autoimmune
thyroiditis had a normal thyroid function, a negative ASST and a normal total
serum IgE levels (74.3 +/j 14.9 IU/ml; normal value G100 IU/ml). Antibodies
anti-thyroglobulin and anti-thyroid peroxidase were negative in 68/94 (72.3%)
CIU patients, of which 44/68 (64.7%) had high total serum IgE levels (395.2
+/j 180.6 IU/ml) and a negative ASST. Four of the thirty four CIU patients
(11.8%) with negative thyroid autoantibodies had a positive ASST and a
normal serum IgE levels, while 16/68 (23.5%) patients had a multinodular
goiter, ASST negative and normal value of total serum IgE levels.
Conclusion: We found a correlation between autoimmune thyroiditis and
normal total serum IgE levels in CIU patients with ASST negative. High total
serum IgE levels were found in CIU patients without thyroid disease. Thus, in
CIU patients the tests to detect thyroid autoantibodies are relevant in particular
in patients with normal value of total serum IgE levels. Further investigation of
mast cell activation by thyroid antigens is incoming.
1003
Perioperative allergic reactions: a case of intraoperative
anaphylactic shock
Aguiar Gonzalez, Gracia Maria, Arias Franco, Maria Jesus, Belen Carnero
Pinto, and Mejuto Castedo. Hospital Xeral Calde Lugo, Spain and, Rosa
Hospital Keral Calde Lugo, Spain.
The incidence published on perioperative allergic reactions is highly
variable, fluctuating between 1:3.500 and 1:20.000 anaesthesias, with a
mortality rate of 3 to 6%. During surgical procedures it is difficult to recognise
an allergic reaction.Under anaesthesia , bronchospasm and hypotension are
common and lacking in a set of symptoms typical of an allergic
reaction;especially when they occur separately;if the response to treatment is
effective, the symptoms are often not investigated and they are attributed to
another cause. Furthermore, 10Y14% of the reactions,primarily the most
severe, affect just one system;and that,too, leads to many cases not being
diagnosed. Therefore, epidemiological monitoring of these reactions is
required. This is a case of intraoperative anaphylactic shock: A 59-years old
female scheduled for an abdominal hysterectomy due to uterine sarcoma; her
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personal records showed no known drug allergies. General anaesthesia was
induced without incidents. After 15 minutes ,when beginning the surgical
incision and coinciding with the start of intravenous infusion of the following
drugs: cefazolin, ketorolac, ranitidine and ondasentron, a sudden severe
bronchospasm appeared, followed by cardiovascular collapse with severe
hemodynamic deterioration, which was treated immediately with i.v.
corticoids and ephedrine without an effective response. The surgical procedure
was interrupted and ,now with suspicions of a possible allergic reaction, all of
the drugs that were being administered were withdrawn, i.v. adrenaline was
administered up to a total of 1 mgr., forcing fluid resuscitation with crystalloids
and colloids.The shock was reversed in approximately 5 minutes. The surgical
procedure resumed 20 minutes after the symptoms, with clinical stability
subsequently maintained. The immediate study revealed a high serum tryptase
level 30 minutes and 6 hours following the reaction,the allergy study showed a
decidedly positive prick test for cephalosporins, and the intradermal reaction
was positive for cefazolin. The diagnosis was anaphylactic shock due to the
administration of cefazolin and hypersensitivity to cephalosporins.
1004
Swimming in asthma increases the risk or improved respiratory
functions in atopic patients
Mohammad Hassan Bemanian1, Shima Shirkhoda2, Mina Nakhjavani2,
Ahmad Shajari2, and Mehrdad Shakiba2. 1Shahid Sadoughi Hospital,
Department of Pediatrics, Division of Immunology, Yazd, Islamic Republic
of Iran; 2Shahid Sadoughi Hospital, Department of Pediatrics, Division of
Immunologyy, Yazd, Islamic Republic of Iran.
Background: This study designed to evaluate the role of swimming in
mechanics of lung in healthy individual and patients with asthma.
Methods: A total 76 girls who take part in course of regular swimming session
three day per week for eight weeks enrolled in this study. All of them
completed International Study of Asthma and Allergy in Childhood written
questionnaire and person who suspicious to asthma or other atopic diseases
referred to allergist for more evaluation. Peak expiratory flow rate was
recorded for participants at beginning, one hour after swimming and two
months later.
Results: According to International Study of Asthma and Allergy in
Childhood questionnaire 35.4% had asthma or other atopic diseases Increase
in Peak expiratory Flow rate more than 20% of personal best was seen in
21.9% after one hour swimming and in 27.6% after two months Increased in
Peak expiratory Flow rate was significant in healthy individual and asthmatic
patients and obese but not significant in patients with allergic rhinitis or
eczema.
Conclusion: Swimming in indoor chlorinated pool not only is less
asthmogenic but also can improve lung mechanics in normal and asthmatic
patients. Because breathing large volume of warm and moist air are good
for lung. The serious health problem with chlorinated pools is too much
chlorine uses to sanitize the water and don`t have adequate ventilation in
indoor pool.
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Are fast foods and additives main culprit of increasing atopy?
Mohammad Hassan Bemanian1, Shabnam Hashemzadegan2, and Mehrdad
Shakiba2. 1Shahid Sadoughi Hospital, Department of Pediatrics, Division of
Immunology a, Yazd, Islamic Republic of Iran; 2Shahid Sadoughi Hospital,
Department of Pediatrics, Division of Immunology, Yazd, Islamic Republic
of Iran.
Background: Frequency of atopic disease increased in last 3 decades and
hypothesis explained for this, among several factors that could be related to
increasing frequency of atopic disease. Using additives and fast food have the
more important role, so this study designed for checking this purpose.
Methods: 110 patients with atopic disease according to history and physical
exam and Para clinic study such as total IgE, skin prick test and spirometry,
compare with 110 normal healthy match group for using fast food, additives
and habitual diet.
Results: In case group 46.4% had allergic rhinitis and 34.5% had asthma. Pizza
was themost culprit in flare up allergic symptoms (9.1%), and themost symptoms
that exaggerated with fast foodswas cough (29.5%) and the next onewas flare up
of skin manifestation such as itching or Urticaria. The diet with out curry and
additive causes fewer symptoms in atopic patients and healthy individuals.
Conclusion: Fast foods and additives can increase and exaggerate symptoms
of atopic patient, they have important role in triggering allergic symptoms in
patients with atopic back ground.
1006
Biphasic anaphylaxis after multiple Hymenoptera stings in
patient with mastocytosis
Gabriele Cortellini.Rimini Hospital, InternalMedicineDepartment, Rimini, Italy.
Of note the mastocytosis is an important factor of risk for severe anaphy-
laxis, in particular from Hymenoptera stings. There is very few documentation
about anaphylaxis with bifasic course during stings. Equally multiple Hyme-
noptera stings do not seem to affect additional risk for anaphylactic reactions.
Case report: Male, 65 years old with anamnesis of urticaria pigmentosa. In
the past we observed urticaria angioedema after assumption of FANS and
assumption of amoxicillin/clavulanic acid. During the last years of observation
the patient present recurrent abdominal pain, headache and flashes. He came in
hospital after 5 vespides stings, with immediate symptoms of diffused
erythema, dyspnoea and loss of conscience, for a long time. He was discharged
after 6 hours of observation. After 12 hours from the multiple stings he showed
relapse of diffuse erythema and dyspnoea, that due to a new recovery.
We found Positive Skin tests for polistes Dominulus to 0.1 mcg;
Positive RAST to 1,23 KU. Tryptase 39,5 ng/ml. He now still presents
clinician symptoms of systemic mastocytosis with presence of 1 minor
criterion. The patient is now attending of bone marrow diagnostyic biopsy to
confirmation. The venom immunotherapy with Polistes dominulus venom has
been assigned to the dose of 200 mcg and well tolerated from the patient. It
would be possible that multiple hymenoptera stings and systemic mastocytosis
had caused a reaction with severe symptoms and biphasic course.
1007
Does prolonged breastfeeding prevent asthma and
allergic diseases?
Abdulbari Bener1 and Mohammad S. Ehlayel2. 1Hamad Medical Corpora-
tion, Department of Medical Statistics & Epideiology, Hamar, Qatar;
2Hamad Medical Corporation, Department of Pediatrics Sec of Allergy-
Immunology, Hamad, Qatar.
Background: Medical literature regarding the relationship between infant
feeding practices and the development of childhood asthma and allergic
diseases is conflicting with hardly any studies from developing countries.
Aim: The aim of this study is to assess the relationship between breast-feeding
(BF) and the development of childhood asthma, recurrent wheezing, and
allergic diseases after adjustment for maternal asthma.
Design: This is a cross sectional survey.
Setting: Immunization Centre and Pediatric Department at the 11 Primary
Health Care Centers and Hamad General Hospital, Hamad Medical
Corporation, State of Qatar.
Subjects: A multistage sampling design was used and a representative sample
of 1500 infants and pre-school children with age range of 0Y5 years and
mothers aged between 18 to 47 years were surveyed during the period from
October 2006 to September 2007 in Qatar. A total of 1278 mothers (85.2%)
made consent to participate in this study.
Methods: A confidential, anonymous questionnaire was completed by the
selected subjects assessing BF and allergic diseases. Questionnaires were
administered to women who were visiting Primary Health Centers for
immunization of their children. Questionnaire included asthma, recurrent
wheezing allergic rhinitis. Additional questions included breast feeding and
duration, passive tobacco exposure, number of siblings, family income, level
of maternal education, family history of allergies. Univariate and multivariate
statistical methods were performed for statistical analysis.
Results: Out of the 1500 child mothers, 1278 mothers agreed to participate in
this study with the response rate of 85.2%. More than half of infants
758(59.3%) initially were exclusively breastfed and followed by partial
breastfed (29.9%) and formula fed (10.8%). Length of breastfeeding was
associated with maternal age. Of these infants, prevalence of allergic diseases
in general and asthma (15.6%) allergic rhinitis (22.6%), and wheezing (12.7%)
were significantly less frequent in those with prolonged and exclusive BF. The
association between breastfeeding and asthma tended to be similar in children
with positive family history of asthma (pG0.001) and allergic rhinitis
(pG0.001) compared children without.
Conclusion: The current study indicated that exclusive BF has protective
effect against asthma and allergic diseases. Educated women were aware of the
importance of the BF. The study findings suggested possible avenue for
intervention to increase awareness and increase of BF. Stressing the practice of
BF could be one of effective measures directed against development childhood
asthma and allergic diseases in third world countries.
1008
The association of prolonged breastfeeding and allergic disease:
does breast-feeding reduce the risk for childhood eczema?
Mohammad S. Ehlayel1 and Abdulbari Bener2. 1Hamad Medical Corpora-
tion, Department of Pediatrics Allergy and Immunology, Hamad, Qatar;
2Hamad Medical Corporation, Department of Medical Statistics &
Epideiology, Hamad, Qatar.
Background: Prolonged breast-feeding (BF) was shown to reduce the risk of
diseases. In 2001 the World Health Organization (WHO) issued a revised
global recommendation that mother should breast feed exclusively for six
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months. This recommendation is likely to influence national policies on the
recommended age for the first introduction of solids, so it is important that
pediatricians are aware of the issues and the evidence (or lack of it) on which
the WHO recommendation is based. The fact that BF may protect against
allergic disease remains controversial, with hardly any reports from developing
countries.
Aim: The aim of this study to determine whether the protective effect of
longer breast-feeding on the risk of allergic diseases and eczema.
Design: This is a cross sectional survey.
Setting: Immunization Centre and Pediatric Department at the 11 Primary
Health Care Centers and Hamad General Hospital, Hamad Medical
Corporation, State of Qatar.
Subjects: A multistage sampling design was used and a representative sample
of 1500 infants and pre-school children with age range of 0Y5 years and
mothers aged between 18 to 47 years were surveyed during the period from
October 2006 to September 2007 in Qatar. 1278 mothers (85.2%) gave consent
to participate in this study.
Methods: A confidential, anonymous questionnaire was completed by the
selected subjects assessing BF and allergic diseases. Questionnaires were
administered to women who were visiting Primary Health Centers for immu-
nization of their child. Questionnaire included allergic rhinitis, wheezing,
eczema, and additional questions included breast feeding and duration,
tobacco smoke exposure, number of siblings, family income, level of maternal
education, and family history atopy. Univariate and multivariate statistical
methods were performed for statistical analysis.
Results: Out of the 1278 infants included in the study, more than half of infant
758(59.3) initially were exclusively breastfed. Length of BF was associated
with maternal age [29.1T5.6, meanTSD]. Of these children, prevalence of
allergic diseases in general and allergic rhinitis (22.6%), wheezing (12.7%)
and eczema (19.4%) were significantly less frequent in those with prolonged
and exclusive BF. The association between BF and eczema tended to be similar
in children positive family history of atopy (pG0.001) and eczema (pG0.001)
compared to those without.
Conclusion: This study confirms that prolonged duration of BF has protective
effect against development of allergic diseases and eczema in children. This
opens a possible avenue for intervention to increase awareness and enforce BF
practices as one possible way to reduce the risk of onset of childhood allergic
diseases and eczema.
1009
Coincidence of gastroesophagealreflux and laryngopharengeal
reflux in our asthmatics patients
Gu¨lfidan Aras1, Dilek Kanmaz1, Figen Kadakal1, O¨mer Develio8lu2, Ku¨rSat
Yelken2, and Sevim Purisa3. 1Yedikule Training and Research Hospital For
Chest Diseases, Chest Diseases, Istanbul, Turkey; 2Taksim Research and
Traing Hospital, Otolarygology, Istanbul, Turkey; 3Istanbul University, The
Medical Faculty of CerrahpaSa, Bioistatistics, Istanbul, Turkey.
Introduction and aim: We don_t know certainly, whether or not GER is a
cause of the asthma or a result of it. Esophagitis has been shown in 30%Y50%
of patients with typical symptoms of heartburn. Nonesophageal manifestations
of the regurtation of gastric contents promotes the use of the term
extraesophageal reflux. EER should be considered in patient. We aimed to
investigate the prevelance of GER and laryngopharengeal reflux (LFR)
symptoms in asthmatic patients and to determine the contribution of the
laboratory findings (endoscopic evaluation and pulmonary function test) to the
symptom based diagnosis.
Materials and Methods: We investigated 37 asthmatics patients having
primary reflux symptoms; heartburn and regurtation. At the same time we
asked other gastroesophageal and laryngopharengeal reflux symptoms. We
performed pulmonary function test and pulmonary carbon monoxide diffusion
test to all of the patients. All of asthmatic patients with GER were performed
esophagogastrodoudenoscopy by gastroenterologist and laryngoscopy by
ENR phycisian. All statistics were performed by using UNISTAT 5.1 statistics
pack program.
Results: Heartburn frequency was daily in 28.1%, a few days in a week in
18.8% and once a week in 26.6% of the patients. Regurtgitation was occuring
daily in 34.4% and once a week in 23.4% of the cases. 34.4% of the cases were
complaining of daily globus. FVC percentage was lower in severe cases when
compared to mild regurgitation (p=0.024). CO monoxide diffusion capacity
did not have a statistical difference according to severity of the symptoms. The
pulmonary diffusion capacity of obese cases were lower than the cases with
BMI G 29 (p=0.038). Reflux esophagitis in 24 of cases were also confirmed
with pathological diagnosis. Avarage refllux finding score (RFS) was
calculated as 5.2T4.15(min 0Ymax 15). Posterior comissure hypertrophy was
the most common finding 72%.
Conclusion: Laryngoscopic findings and RFS did not help in diagnosis. We
determined that reflux symptoms did not have any effect on reflux esophagitis.
Diffusion capacity changes result from high body mass index. Conducting
controlled studies with different diagnostic methods and a larger number of
case series which will contribute to the symptom based reflux diagnosis are
needed.
1010
Doxycycline reduces ECP, MMP9 and nasal polyp size, in a
double-blind, randomized, placebo controlled, multicenter trial
Philippe Gevaert1, Thibaut Van Zele1, Peter Hellings2, Susanne Mayr3,
Achim Beule4, Fenna Ebbens5, Paul Van Cauwenberge1, and Claus Bachert1.
1Ghent University Hospital, Department of Otorhinolaryngology, Ghent,
Belgium; 2University Hospital St. Rafael, Department of Otorhinolaryngol-
ogy, Leuven, Belgium; 3University Hospital Erlangen, Department of
Otorhinolaryngology, Erlangen, Germany; 4Adelaide University Hospital,
Department of Otorhinolaryngology, Adelaide, Australia; 5Academic Medical
Center, Department of Otorhinolaryngology, Amsterdam, Netherlands.
Background: Recent evidence suggests that a chronic microbial trigger might
play an important role in the pathogenesis of chronic rhinosinusitis with nasal
polyposis (NP). For treatment, doxycyline was selected based on its
antimicrobial effect and anti-inflammatory effect. The aim of the study is to
evaluate the effect of oral doxycycline on nasal polyp size, nasal peak
inspiratory flow (nPIF), signs and symptoms of nasal polyps.
Methods: In a randomized, double-blind, placebo controlled, parallel group,
multicenter study, 32 subjects with bilateral nasal polyps were randomized to
receive placebo or antibiotics at a dose of 200 mg doxycycline at day one,
followed by 100 mg doxycycline from day two till day 20. The effect was
assessed by endoscopic evaluation of polyp size, symptoms, peripheral
eosinophil counts, local IgE, MPO, MMP-9 and ECP levels.
Results: Doxycline treatment resulted in a significant decrease of the
endoscopic nasal polyp score after 4 to 12 weeks after the start of the doxycline
treatment compared to placebo. The concentrations of IgE, MPO, MMP-9 and
ECP decreased significantly in nasal secretions of doxycycline treated patients.
Conclusion: This is first study demonstrating the positive clinical effect of
doxycyline on nasal polyposis, paralleled by a sign impact on markers of local
inflammation and remodelling. Further, in a clinical setting the use of
doxycycline offers an additional advantage of providing both antimicrobial
and anti-inflammatory effects resulting in a decrease in nasal polyp size.
1011
Diagnosis of pollen sensitization using natural and recombinant
allergen in children with bronchial asthma
Dali Macharadze1, Tatyana Slavyanskaya1, Manana Chikhladze2, and Revaz
Sepiashvili1. 1Institute of Immunophysiology, Moscow, Russian Federation;
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2National Institute of Allergy, Asthma and Clinical Immunology, Tskhaltubo,
Georgia.
Birch is one of the main causes of pollinosis in children with bronchial
asthma in Europe and in Moscow. The aim of this study was to evaluate the
potential of natural and recombinant allergens from tree and grass pollen (Bet
v1, Bet v2, Phl p1, Phl p2, Phl p5, Phl p6, Phl p7) as diagnostic reagents in
comparison with standardized extract.
Methods: Prick-test with commercial pollen extracts were conducted in 31
children with bronchial asthma aged 8Y15 years. Recombinant forms of both
allergens were determined with ImmunoCAP.
Results: Of 15 children with prick-test of birch extracts (++), nine patients
displayed low levels of Bet v1, Bet v2; four children had moderate and two had
high allergen-specific IgE concentration. Four of six children with skin prick-
tests (++++) had low levels of allergen-specific IgE. Two of three children with
skin prick-tests (+++++) has low levels of allergen-specific IgE against birch
while 1 child had medium level. Only seven children were sensitized to
timothy-grass pollen. The concentration of allergen-specific IgE against
timothy-grass correlated with skin prick-tests results as three children with ++
tests and four children with +++ and ++++ tests revealed very high levels of
Phl p5 and Phl p7.
Conclusion: Prick-tests with natural extracts of birch pollen did not show
100% sensitivity with recombinant allergens while timothy-grass allergens
sensitivity was significantly higher.
1012
Correlation between fungus-specific IgE and skin test for fungus
allergens in patients with chronic cough or bronchial asthma
Eun Ju Jeon, Ju Han Song, Jae Cheol Choi, Jong Wook Shin, Jae Yeol Kim,
In Won Park, and Byoung Whui Choi. Chung-Ang University, Internal
Medicine, Seoul, Republic of Korea.
Skin tests can provide useful confirmatory evidence for a diagnosis of
specific allergy in patients with chronic cough and bronchial asthma. Skin
prick tests are relatively good correlation with specific IgE, but skin tests with
fungi are not. We aimed to investigate the correlation between fungus-specific
IgE and skin tests in patients with chronic cough and asthma.
Methods: We measured fungus-specific IgE(Penicillium notatum, Cladospor-
ium herbarum, Aspergillus fumigatus, Alternaria alternata, Fumigarium
moniliforme) testing with immuoCAP in 537 patients with chronic cough
and bronchial asthma., who were 1) all negative or 2) positive for one or more
of fungi or 3) positive for one mixed threshings in skin tests with common 55
allergens.
Results: 1. In 537 patients with chronic cough and asthma, 340 patients were
all negative, 34 patients were positive only for one or more fungi, 53 patients
were positive for one or more fungi with other one or more common allergens
and 62 patients were positive only for mixed threshings. 2. Total agreement
rate of 5 fungous allergens between skin test and fungus-specific IgE is 95.2%,
but 8 patients(2.4%) were positive for one or more fungus-specific IgEs among
340 patients with all negative skin tests. 9 patients(8.2%) were positive for one
or more fungus-specific IgEs among 110 patients with positive for mixed
threshings skin tests and negative fungus skin test. 3. The positive agreement
rate of Alternaria alternata-specific IgE was 41.7%(5/12), that of Fumigarium
moniliforme-specific IgE was 42.9%(3/7), that of Penicillium notatum-specific
IgE in positive skin tests was 70%(7/10), that of Cladosporium herbarum-
specific IgE was 100%(1/1), and that of Aspergillus fumigatus-specific IgE
was 100%(1/1). 4. The positive agreement rate of skin test for Alternaria
alternata in positive Alternaria alternata -specific IgEs was 41.7%(5/12), that
for Fumigarium moniliforme was 50%(3/6), that for Penicillium notatum in
positive Penicillium notatum-specific IgEs was 63.6%(7/11), that for
Cladosporium herbarum was 11%(1/9), and that for Aspergillus fumigatus
was 3.6%(1/28).
Conclusion: Fungus skin tests did not provide useful evidence for a diagnosis
of fungus-specific allergy in patients with chronic cough and bronchial asthma.
The clinical significance of serum fungus-specific IgEs will be evaluated.
Fungus-specific IgE may be considered to measure in mixed threshings-
positive patients with chronic cough and bronchial asthma.
1013
Tobacco smoking is a risk factor for asthma symptoms in
teenagers independent of weight and antioxidant diet
R. Maximiliano Gomez1, Alvaro Teijeiro2, Rodrigo Baena-Cagnani3, Martin
Najo3, Mario Zernotti4, and Carlos E Baena-Cagnani5. 1Hospital San
Bernardo, Allergy and Asthma Unit, Salta, Argentina; 2Hospital Pediatrico,
Respiratory Center, Cordoba, Argentina; 3Hospital Transito Caceres Allende,
Respiratory Department, Cordoba, Argentina; 4Sanatorio Allende, ORL
Department, Cordoba, Argentina; 5Universidad Catolica Cordoba, Faculty
of Medicine, Cordoba, Argentina.
Background: Multiple risk factors have been associated to the presence of
asthma symptoms, including overweight and environmental tobacco smoke
(ETS); however active smoking and the possible attenuation of its effects by
antioxidant diet have not been described in adolescents.
Methods: Cross sectional survey of 3000 13Y14 year old school attendants,
in north Argentina as part of the ISAAC study. Self reported questionnaires
were used to determine the prevalence of wheezing in last 12 months, and
the presence of parents smoking at home and active smoking. Food intake
habits allow grouping those having fruit and vegetables more than 3 times
per week, and body mass index (BMI) was calculated from weight and
height described. Contingency table was applied in order to determine the
odds ratio and 95% confidence interval (OR, 95% CI) for each variable; and
logistic regression analysis was used with all the variables related to
wheezing.
Results: 55% were female, and 12.5% reported wheezing in last 12 months;
12.9% of adolescents are active smokers and 49.9% have at least one parent
smoking. 67.8% of them eat fruit and vegetables regularly, and obese were
considered together with overweight since the prevalence of BMI above 25 is
only 5.1%. The odds of wheezing for active smokers were 1.85 (95% CI
1.40Y2.44), and for passive smoking 1.48 (95%CI 1.18Y1.84). Neither gender,
nor BMI or antioxidant diet were significantly associated to the presence of
wheezing; when applying logistic regression, none of them could modify the
effect of active (p = 0.001) and passive smoking (p = 0.006).
Conclusion: Smoking is a significant risk factor for asthma symptoms, not
affected by gender, BMI and antioxidant diet. Both active and passive smoking
confirm their detrimental effects on respiratory symptoms in adolescent
population.
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